Patient ID,Country,Region,Age,Gender,Cancer Type,Cancer Stage,Diagnosis Date,Treatment Start Date,Treatment End Date,Treatment Type,Hospital Type,Survival Status,Survival Duration (Months),Genetic Markers,Family History,Smoking Status,Alcohol Consumption,BMI,Socioeconomic Status,Urban vs. Rural,Healthcare System,Follow-up Visits,Recurrence,Clinical Trial Participation,Comorbidities,Quality of Life Score
PT00001,Finland,Southwest Finland,89.0,Male,Breast,III,2015-08-10,2015-09-20,2016-09-07,Targeted Therapy,Private,Alive,31.0,None,Yes,Current,Moderate,39.3,Medium,Urban,NHS,12.0,Yes,Yes,Diabetes,5.0
PT00002,Belgium,Flanders,49.0,Female,Prostate,IV,2010-01-27,2010-06-29,2011-02-09,,Public,Alive,101.0,KRAS,No,Never,Moderate,21.6,High,Rural,Private Insurance,10.0,,Yes,Diabetes,10.0
PT00003,Poland,Silesian,42.0,Male,Lung,III,2016-08-25,2016-10-23,2016-12-27,Targeted Therapy,Research Institute,Alive,69.0,EGFR,No,Never,None,23.7,Low,,Statutory Health Insurance,5.0,No,No,Obesity,1.0
PT00004,Ireland,Dublin,51.0,Female,Prostate,III,,,2011-02-28,Surgery,Private,Alive,82.0,KRAS,No,Current,Moderate,34.0,Medium,Rural,Private Insurance,4.0,Yes,No,Diabetes,5.0
PT00005,,Sicily,76.0,Female,Lung,II,2018-05-26,,2019-04-20,Surgery,Research Institute,Alive,69.0,BRCA1,No,Current,None,33.9,Medium,Urban,Statutory Health Insurance,5.0,No,No,Hypertension,6.0
PT00006,Sweden,Västra Götaland,28.0,Male,Pancreatic,IV,2019-03-06,2019-05-16,2020-03-23,Targeted Therapy,Private,Alive,79.0,KRAS,No,Former,None,23.2,Medium,Urban,Private Insurance,15.0,No,No,Obesity,6.0
PT00007,Finland,Southwest Finland,50.0,Female,Leukemia,I,2016-05-21,2016-09-14,2017-03-27,Immunotherapy,,Alive,6.0,None,Yes,Never,Moderate,29.4,Low,Urban,Private Insurance,6.0,Yes,No,Cardiovascular Disease,7.0
,Sweden,,28.0,Male,Colorectal,II,2012-01-07,2012-06-29,2012-08-24,Radiation,Private,Deceased,47.0,BRCA1,No,Current,None,18.6,Medium,Rural,Private Insurance,10.0,No,No,Diabetes,7.0
PT00009,Norway,Vestland,32.0,Female,Pancreatic,I,2020-07-14,2020-08-21,2020-12-23,Radiation,Research Institute,Alive,16.0,None,No,Former,None,30.7,Medium,Urban,NHS,6.0,,Yes,None,8.0
PT00010,Spain,Andalusia,77.0,Female,Ovarian,I,2013-07-22,2013-11-08,2014-11-04,Chemotherapy,Public,Alive,74.0,KRAS,No,,None,38.3,Medium,Rural,Statutory Health Insurance,7.0,No,No,Hypertension,7.0
PT00011,Spain,Andalusia,22.0,Female,Pancreatic,II,2012-12-27,2013-06-06,2013-12-27,Chemotherapy,Private,Alive,6.0,,No,,Heavy,21.9,Medium,Urban,NHS,18.0,No,No,None,2.0
PT00012,Norway,Trøndelag,54.0,Male,Colorectal,II,2010-08-21,2010-12-16,2011-03-31,Immunotherapy,Public,,70.0,None,No,Current,Moderate,18.3,,Rural,Private Insurance,,No,No,Diabetes,10.0
PT00013,Switzerland,Bern,,Male,Prostate,,2010-08-10,2010-09-01,2011-02-05,Radiation,,Deceased,88.0,,No,Never,,35.2,Low,Urban,NHS,5.0,Yes,No,Obesity,6.0
PT00014,Portugal,Lisbon,83.0,Female,,II,2011-03-29,2011-08-31,2012-06-01,Chemotherapy,Public,Alive,55.0,EGFR,Yes,Never,Moderate,38.8,High,Urban,Private Insurance,13.0,No,No,Cardiovascular Disease,6.0
PT00015,Norway,,71.0,,Lung,II,2022-01-17,2022-06-21,2023-04-24,Radiation,Public,Alive,74.0,KRAS,No,Former,None,24.1,Medium,Rural,Statutory Health Insurance,,No,No,None,8.0
PT00016,Germany,North Rhine-Westphalia,53.0,Male,Breast,I,2012-07-24,2012-08-14,2013-03-14,Radiation,Private,Deceased,81.0,KRAS,Yes,Never,None,37.5,Medium,Urban,Private Insurance,12.0,Yes,No,Hypertension,4.0
PT00017,Norway,Oslo,54.0,Female,Pancreatic,II,2013-09-05,2014-02-15,2015-02-10,Radiation,Public,Alive,97.0,None,Yes,Never,,28.0,Medium,Rural,Statutory Health Insurance,5.0,,No,None,5.0
,Germany,Berlin,,Female,Colorectal,III,2016-04-30,2016-06-16,2016-09-05,Chemotherapy,Public,Alive,65.0,KRAS,Yes,Current,None,35.4,Low,Urban,NHS,,No,No,None,4.0
PT00019,Norway,Trøndelag,25.0,Male,Pancreatic,II,2010-12-31,2011-02-19,2011-06-30,Chemotherapy,Private,Alive,42.0,None,Yes,Current,Moderate,24.6,Medium,Urban,NHS,16.0,No,,Hypertension,10.0
PT00020,Ireland,Munster,51.0,Male,Prostate,II,2017-08-21,2017-12-18,2018-09-29,Immunotherapy,Research Institute,Alive,28.0,None,No,Never,Heavy,38.4,Low,Urban,NHS,18.0,No,No,Hypertension,4.0
PT00021,Belgium,Wallonia,71.0,Male,Prostate,II,2013-06-04,2013-10-20,2014-02-03,,Public,Deceased,10.0,EGFR,No,Current,Moderate,19.6,Low,,Private Insurance,10.0,No,No,None,10.0
PT00022,Finland,Pirkanmaa,47.0,Male,Prostate,IV,2011-04-01,2011-07-21,2012-05-07,Chemotherapy,Public,Alive,,EGFR,No,Former,None,37.3,Medium,Urban,Private Insurance,5.0,No,No,Obesity,1.0
PT00023,Germany,Berlin,83.0,Male,Lung,III,,2014-11-27,2015-11-01,Targeted Therapy,Public,Alive,93.0,BRCA1,No,Former,Moderate,25.4,Medium,Urban,Private Insurance,2.0,No,Yes,Diabetes,9.0
PT00024,Sweden,Västra Götaland,38.0,Male,Ovarian,I,2020-08-28,2020-10-04,2020-11-04,Surgery,Public,Alive,86.0,,Yes,Never,Moderate,18.1,High,Urban,NHS,14.0,No,Yes,Hypertension,8.0
PT00025,Austria,Styria,34.0,Non-binary,Ovarian,IV,2022-02-10,2022-07-29,2023-03-18,Radiation,Private,Deceased,9.0,None,No,,Heavy,24.5,Medium,Rural,Statutory Health Insurance,18.0,No,No,Hypertension,3.0
PT00026,Spain,Madrid,25.0,Female,Pancreatic,III,2020-03-21,2020-05-11,2021-05-03,,Research Institute,Lost to Follow-up,,EGFR,Yes,Never,None,35.8,Low,Rural,Statutory Health Insurance,1.0,No,No,Diabetes,8.0
PT00027,Norway,Oslo,57.0,Male,Prostate,III,2012-03-29,2012-04-06,2012-10-10,Targeted Therapy,Public,Deceased,22.0,None,No,Former,Moderate,20.1,Medium,Rural,Statutory Health Insurance,19.0,No,No,Diabetes,10.0
PT00028,Ireland,Munster,45.0,Male,Leukemia,II,2021-03-16,2021-07-08,2021-12-12,Targeted Therapy,Public,Alive,35.0,BRCA1,No,Never,Moderate,32.6,Medium,Urban,Statutory Health Insurance,6.0,No,No,Obesity,9.0
PT00029,Denmark,Capital Region,70.0,Female,Breast,III,2015-05-20,2015-10-28,2016-04-06,Surgery,Private,Deceased,113.0,KRAS,Yes,Never,None,36.8,Low,Urban,Statutory Health Insurance,11.0,Yes,No,Hypertension,6.0
PT00030,Denmark,Central Denmark,72.0,Male,Ovarian,II,2019-04-15,2019-05-04,2019-07-14,Immunotherapy,Public,Alive,59.0,None,No,Current,Moderate,24.8,Medium,,Private Insurance,9.0,No,No,Cardiovascular Disease,8.0
PT00031,Portugal,Algarve,75.0,Female,Prostate,III,2012-01-06,2012-02-05,2012-08-22,Surgery,Public,Alive,94.0,EGFR,No,,None,27.6,Medium,Urban,NHS,7.0,No,Yes,Hypertension,2.0
PT00032,Belgium,Brussels,78.0,Female,Ovarian,IV,2019-11-16,2020-04-06,2021-03-08,Chemotherapy,Private,Alive,86.0,EGFR,No,Never,Moderate,18.3,Low,,Private Insurance,5.0,No,Yes,Obesity,7.0
PT00033,Netherlands,North Holland,89.0,Female,Lung,IV,2014-01-07,2014-02-12,2014-11-27,Radiation,Public,Alive,83.0,None,Yes,Never,None,22.8,Low,Urban,Statutory Health Insurance,5.0,No,No,Obesity,2.0
PT00034,Poland,Silesian,77.0,Male,Breast,II,2019-08-16,2019-12-29,2020-08-24,Immunotherapy,Public,Alive,28.0,None,No,Former,,22.4,Low,Urban,Private Insurance,10.0,No,No,Cardiovascular Disease,5.0
PT00035,Ireland,Munster,32.0,Female,Breast,IV,2020-05-03,2020-08-27,2020-11-01,Chemotherapy,Public,Alive,29.0,None,Yes,Never,Moderate,36.4,Medium,Rural,Private Insurance,8.0,No,No,Diabetes,2.0
PT00036,Germany,North Rhine-Westphalia,62.0,Female,Colorectal,,2022-10-06,2023-01-21,2023-03-13,Radiation,Research Institute,Deceased,22.0,KRAS,Yes,Never,None,37.6,High,Urban,NHS,2.0,No,No,None,5.0
PT00037,Finland,Uusimaa,70.0,Female,,I,2012-03-30,2012-05-03,2012-11-09,Radiation,Public,Alive,64.0,,No,Never,Heavy,29.8,Medium,Urban,NHS,12.0,No,No,Obesity,9.0
PT00038,Italy,Lombardy,38.0,Female,Prostate,II,2014-09-11,2015-03-08,2015-11-22,Chemotherapy,Public,Alive,57.0,BRCA1,Yes,Never,None,30.8,Medium,Urban,Statutory Health Insurance,,No,No,Diabetes,9.0
PT00039,Sweden,,40.0,Male,Pancreatic,III,2011-05-31,2011-07-02,2012-06-13,Immunotherapy,Public,Alive,51.0,BRCA1,,Never,,19.5,High,Urban,Statutory Health Insurance,18.0,No,No,Diabetes,5.0
PT00040,Italy,Veneto,43.0,Male,Lung,I,2013-11-29,2014-01-10,2014-03-15,Targeted Therapy,Public,Deceased,86.0,EGFR,Yes,Former,Moderate,30.2,Medium,Urban,Statutory Health Insurance,1.0,No,No,Hypertension,2.0
PT00041,Finland,Southwest Finland,45.0,Female,Leukemia,II,2019-10-31,2020-04-09,2021-02-17,Surgery,Public,Deceased,83.0,EGFR,Yes,,Moderate,23.6,High,Urban,Statutory Health Insurance,,No,No,Obesity,2.0
PT00042,Netherlands,Utrecht,64.0,Female,,I,2012-04-23,2012-08-20,2013-08-06,Immunotherapy,Private,Deceased,64.0,EGFR,Yes,Current,Moderate,,,Urban,NHS,4.0,No,No,Diabetes,8.0
PT00043,France,Île-de-France,47.0,Female,Leukemia,,2021-04-23,2021-05-07,2022-04-07,,Public,Alive,84.0,BRCA1,Yes,Former,Heavy,28.3,High,Rural,Private Insurance,17.0,No,No,Hypertension,6.0
PT00044,Denmark,Capital Region,48.0,Female,Colorectal,IV,2019-07-06,2019-12-09,2020-01-21,Targeted Therapy,,Alive,24.0,None,Yes,Former,None,30.8,High,Rural,Private Insurance,12.0,No,Yes,Cardiovascular Disease,5.0
PT00045,Poland,Lesser Poland,36.0,Male,Ovarian,III,2018-08-02,2018-11-24,2019-02-09,Targeted Therapy,Public,Alive,74.0,BRCA1,No,Never,Moderate,29.3,,Urban,NHS,18.0,No,No,Cardiovascular Disease,4.0
PT00046,Italy,Veneto,87.0,Male,Ovarian,II,2017-02-28,,2018-07-09,Surgery,Public,,22.0,EGFR,Yes,Current,Moderate,20.7,Low,Rural,Private Insurance,12.0,No,No,Cardiovascular Disease,7.0
,Denmark,Zealand,63.0,,Leukemia,IV,2021-11-03,2022-02-05,2022-11-03,Surgery,Public,Alive,102.0,None,Yes,Never,Heavy,28.7,High,Rural,Statutory Health Insurance,9.0,No,No,None,1.0
PT00048,Germany,Berlin,80.0,Male,Ovarian,III,2023-11-20,2023-12-21,2024-03-31,Surgery,Public,Deceased,108.0,BRCA1,Yes,Current,None,24.1,Low,Urban,Statutory Health Insurance,15.0,No,No,Cardiovascular Disease,3.0
PT00049,Sweden,Skåne,87.0,Female,Lung,III,,2021-04-24,2022-02-06,Targeted Therapy,Private,Alive,11.0,KRAS,Yes,Current,None,37.3,Medium,Rural,NHS,8.0,No,No,Diabetes,4.0
PT00050,Belgium,Brussels,44.0,Male,,III,2013-06-30,2013-11-09,2014-06-25,Chemotherapy,Public,Lost to Follow-up,,BRCA1,No,Never,Moderate,21.6,Low,Rural,NHS,12.0,No,No,Diabetes,3.0
PT00051,Italy,Lombardy,86.0,Female,Colorectal,IV,2014-02-20,2014-03-01,,Surgery,,Alive,30.0,None,No,Current,Moderate,32.4,Medium,Rural,Statutory Health Insurance,,Yes,No,Hypertension,4.0
PT00052,Ireland,Munster,21.0,Female,Prostate,III,2023-06-02,2023-09-10,2024-08-08,Targeted Therapy,Private,Alive,,None,No,Never,Moderate,35.6,Low,Urban,NHS,5.0,Yes,No,None,2.0
PT00053,Italy,Sicily,68.0,Male,Leukemia,II,2022-10-04,2022-12-13,2023-05-17,Immunotherapy,Public,Alive,22.0,None,No,Current,None,19.8,High,Rural,NHS,,No,No,Obesity,8.0
PT00054,Switzerland,Geneva,89.0,,Lung,II,,2018-03-06,2018-09-11,Targeted Therapy,Public,Alive,38.0,EGFR,Yes,,None,30.2,Medium,Urban,Statutory Health Insurance,18.0,,No,Obesity,3.0
PT00055,Poland,Lesser Poland,45.0,Female,Lung,,2012-06-13,2012-09-19,2013-07-10,Surgery,Public,Deceased,16.0,BRCA1,No,Never,None,23.2,Low,Urban,NHS,15.0,No,No,None,1.0
PT00056,Netherlands,South Holland,46.0,Non-binary,Prostate,II,2012-05-03,2012-07-07,2013-04-09,Surgery,Public,Deceased,38.0,KRAS,Yes,,Moderate,22.1,High,Urban,NHS,9.0,Yes,No,Obesity,4.0
PT00057,Switzerland,Bern,37.0,Female,Ovarian,III,2022-02-22,2022-07-17,2023-02-16,Surgery,Private,Alive,33.0,EGFR,No,Former,Moderate,23.2,Medium,Rural,Private Insurance,8.0,No,No,Obesity,6.0
PT00058,Portugal,Lisbon,73.0,Male,Lung,II,2016-08-07,2016-11-15,2017-10-12,Chemotherapy,Private,Lost to Follow-up,,BRCA1,Yes,Former,Moderate,,,Urban,NHS,4.0,No,No,Cardiovascular Disease,1.0
PT00059,France,Île-de-France,20.0,Male,Colorectal,II,2010-06-29,2010-12-11,,Radiation,Private,Deceased,111.0,,No,Never,None,36.4,Medium,Rural,Private Insurance,13.0,No,No,None,9.0
PT00060,Germany,Berlin,80.0,Male,Colorectal,II,2011-08-12,2011-10-01,,Chemotherapy,Public,Deceased,46.0,BRCA1,No,Never,Moderate,24.8,Low,Urban,Private Insurance,10.0,No,No,Hypertension,9.0
PT00061,France,Auvergne-Rhône-Alpes,22.0,Male,Pancreatic,III,,2016-01-28,2016-11-23,Immunotherapy,Public,Alive,64.0,KRAS,Yes,Never,Moderate,39.7,Low,Urban,Private Insurance,1.0,Yes,No,None,8.0
PT00062,Portugal,,87.0,Female,Breast,III,2018-10-31,2018-11-20,2019-04-17,Surgery,Private,Alive,10.0,KRAS,No,Never,,18.2,Medium,Rural,NHS,1.0,No,No,Obesity,6.0
PT00063,France,Île-de-France,,Female,Prostate,I,2016-07-27,2016-09-24,2017-06-03,Radiation,Research Institute,Alive,90.0,BRCA1,No,Never,Moderate,36.1,Low,Rural,NHS,6.0,No,No,Obesity,7.0
PT00064,Belgium,Flanders,56.0,Male,Ovarian,I,2018-04-25,2018-06-23,2018-12-13,Immunotherapy,Private,Alive,35.0,EGFR,Yes,Never,None,21.3,Low,Urban,Statutory Health Insurance,16.0,No,No,,9.0
PT00065,Netherlands,Utrecht,70.0,Male,Lung,I,2011-07-19,2011-10-17,2012-07-11,Targeted Therapy,Public,Alive,51.0,KRAS,No,Never,Moderate,35.0,Medium,Urban,Statutory Health Insurance,1.0,,No,Hypertension,5.0
PT00066,Denmark,Zealand,34.0,Male,Leukemia,I,2023-01-17,2023-06-05,2023-08-19,Radiation,Public,Deceased,95.0,EGFR,Yes,Never,Heavy,31.9,High,Rural,Private Insurance,8.0,No,No,None,9.0
PT00067,Ireland,Munster,27.0,Female,Pancreatic,I,,2021-04-30,2022-01-13,Chemotherapy,Private,Alive,61.0,KRAS,Yes,Never,Moderate,31.0,Low,Urban,Statutory Health Insurance,11.0,No,No,,4.0
PT00068,Switzerland,Zurich,57.0,Female,Colorectal,,2022-03-23,2022-05-27,2023-05-18,Surgery,Public,Alive,8.0,None,No,Former,Moderate,22.6,High,Urban,Statutory Health Insurance,17.0,No,No,Hypertension,10.0
PT00069,Spain,Catalonia,75.0,Female,Prostate,IV,2017-05-30,2017-08-15,2018-07-01,Radiation,Public,Deceased,118.0,,Yes,Current,Moderate,33.5,Low,Urban,Statutory Health Insurance,7.0,No,No,Hypertension,5.0
PT00070,Switzerland,Bern,66.0,Male,Ovarian,II,2023-02-11,2023-04-10,2023-07-14,Immunotherapy,Public,Alive,90.0,KRAS,No,Never,None,,Medium,Rural,Private Insurance,3.0,Yes,No,Cardiovascular Disease,
PT00071,,Lesser Poland,29.0,Female,Prostate,II,2020-11-10,2021-02-18,2022-01-26,Chemotherapy,Public,Deceased,,None,No,Current,Moderate,38.3,Medium,Urban,Statutory Health Insurance,17.0,No,No,Obesity,4.0
PT00072,Austria,Vienna,68.0,Male,Ovarian,III,,2022-07-14,2023-05-29,Immunotherapy,Public,Alive,12.0,KRAS,No,Former,Moderate,22.8,Medium,Urban,NHS,8.0,No,No,,4.0
PT00073,,Silesian,60.0,Male,Colorectal,IV,2020-10-01,2020-11-14,2021-07-28,Immunotherapy,Public,Deceased,31.0,EGFR,Yes,Never,None,37.1,High,Urban,Private Insurance,7.0,No,No,Obesity,1.0
PT00074,Italy,Sicily,49.0,Female,Breast,IV,2014-06-29,2014-11-18,2015-09-30,Surgery,Research Institute,Alive,49.0,BRCA1,No,Current,None,34.3,Medium,Urban,Private Insurance,1.0,No,No,,7.0
PT00075,Poland,Lesser Poland,,Female,Prostate,I,2014-07-09,2014-11-11,2014-12-22,Radiation,Public,Deceased,61.0,KRAS,No,Former,None,20.1,Medium,Rural,Private Insurance,15.0,No,No,,1.0
,Norway,,50.0,Male,Lung,I,2011-05-18,2011-07-09,2012-01-29,Immunotherapy,Research Institute,Alive,60.0,BRCA1,No,Current,Moderate,29.7,Low,Urban,Statutory Health Insurance,9.0,No,No,Hypertension,6.0
PT00077,Portugal,Lisbon,71.0,Male,Leukemia,I,2016-08-02,2017-01-11,2017-09-18,,Public,Alive,108.0,None,Yes,,None,33.4,Medium,Urban,NHS,16.0,No,No,Hypertension,6.0
PT00078,Sweden,Västra Götaland,42.0,Male,Leukemia,III,2010-03-03,2010-07-03,,Immunotherapy,Private,Alive,18.0,KRAS,No,Former,None,19.8,High,Rural,Private Insurance,19.0,Yes,No,Hypertension,7.0
PT00079,Netherlands,North Holland,67.0,Male,Colorectal,III,2019-06-12,2019-11-14,2020-04-20,Immunotherapy,Research Institute,Deceased,83.0,KRAS,No,Current,None,26.1,High,Urban,Private Insurance,17.0,Yes,No,Obesity,
PT00080,Ireland,Connacht,59.0,Female,Prostate,II,2022-06-14,2022-06-26,2023-06-25,Chemotherapy,Public,Alive,30.0,KRAS,No,Never,None,34.7,Medium,Urban,Statutory Health Insurance,16.0,No,No,Hypertension,4.0
PT00081,Netherlands,Utrecht,25.0,Female,Leukemia,IV,2018-12-31,,2019-11-13,Targeted Therapy,Private,Deceased,86.0,KRAS,No,Never,,27.7,Medium,Urban,NHS,,Yes,No,Diabetes,3.0
PT00082,Norway,Trøndelag,,Male,Prostate,II,2014-08-20,2014-11-18,2015-06-30,Immunotherapy,,Deceased,21.0,BRCA1,No,Never,None,22.6,Low,Urban,Private Insurance,8.0,,No,None,5.0
PT00083,Denmark,Zealand,60.0,Male,Colorectal,IV,2010-12-23,2011-06-09,2012-04-03,Chemotherapy,Public,Alive,97.0,BRCA1,Yes,Former,Moderate,21.4,Low,Urban,Private Insurance,9.0,No,Yes,Obesity,6.0
PT00084,Denmark,Capital Region,46.0,Male,Breast,I,,2011-12-01,2012-06-29,Surgery,Public,Lost to Follow-up,,None,Yes,Never,None,36.2,Medium,Urban,NHS,13.0,No,No,Cardiovascular Disease,7.0
PT00085,,,88.0,Female,Leukemia,I,2014-06-13,2014-11-09,2015-10-27,Radiation,Private,Alive,,,No,Former,None,,Low,Urban,Statutory Health Insurance,11.0,No,No,Cardiovascular Disease,5.0
PT00086,Portugal,Porto,76.0,Male,Lung,II,2013-02-03,,2014-06-13,Chemotherapy,Private,Deceased,46.0,KRAS,No,Former,,20.7,Low,Rural,NHS,7.0,No,No,Diabetes,5.0
PT00087,Belgium,Flanders,36.0,Female,Pancreatic,I,2016-09-07,2016-12-05,2017-04-13,Chemotherapy,Public,Deceased,87.0,BRCA1,Yes,Current,Moderate,36.4,Medium,Rural,Statutory Health Insurance,3.0,No,No,Obesity,8.0
PT00088,,Silesian,66.0,Male,Colorectal,III,2023-08-07,2023-08-19,2024-05-15,Radiation,Public,Alive,9.0,BRCA1,Yes,Never,Moderate,32.8,Low,Urban,Private Insurance,13.0,Yes,No,Obesity,4.0
PT00089,Ireland,Connacht,32.0,,Pancreatic,I,2015-07-24,2015-10-21,2016-03-14,Chemotherapy,Private,,,BRCA1,Yes,Former,None,23.2,Low,Urban,Private Insurance,4.0,No,No,Cardiovascular Disease,9.0
PT00090,Germany,Bavaria,30.0,Female,Breast,III,2018-09-08,2019-02-09,2019-08-21,Targeted Therapy,Public,Alive,45.0,BRCA1,Yes,Never,Moderate,21.7,Medium,Urban,Private Insurance,18.0,No,No,Diabetes,9.0
PT00091,Denmark,Capital Region,43.0,Female,Lung,I,2015-01-06,2015-02-11,,Surgery,Public,Deceased,56.0,EGFR,No,,,20.5,High,Rural,Private Insurance,3.0,Yes,No,Diabetes,1.0
PT00092,Italy,Lombardy,23.0,Female,Pancreatic,I,2020-10-28,2020-11-13,2020-12-23,Targeted Therapy,Public,Lost to Follow-up,,KRAS,Yes,Current,Moderate,19.1,Low,Urban,NHS,5.0,No,No,Cardiovascular Disease,
PT00093,Italy,Veneto,65.0,Female,Lung,III,,,2020-01-08,Immunotherapy,Public,Deceased,86.0,KRAS,Yes,Never,Moderate,22.6,Medium,Rural,Private Insurance,7.0,Yes,No,Obesity,5.0
PT00094,Norway,Trøndelag,37.0,Female,Leukemia,IV,2017-01-14,2017-05-07,2017-06-15,Surgery,Public,Alive,60.0,KRAS,Yes,Never,Heavy,34.9,High,Urban,Private Insurance,17.0,No,No,Obesity,4.0
PT00095,Germany,Bavaria,62.0,Male,Prostate,II,2010-04-03,2010-09-02,2010-11-21,Immunotherapy,Private,Alive,38.0,BRCA1,No,Current,Moderate,31.5,High,Urban,Statutory Health Insurance,,No,No,Hypertension,4.0
PT00096,Ireland,Munster,52.0,Male,Colorectal,IV,2023-06-01,2023-11-15,2024-09-27,Radiation,Private,Alive,44.0,KRAS,No,Never,Moderate,33.8,High,Urban,Private Insurance,2.0,,No,Hypertension,6.0
PT00097,Italy,Sicily,29.0,Male,,III,2016-01-10,2016-06-15,2017-06-07,Chemotherapy,,Alive,29.0,EGFR,Yes,Current,Moderate,39.4,Medium,Rural,Statutory Health Insurance,10.0,Yes,No,None,8.0
PT00098,Norway,Trøndelag,78.0,Female,Leukemia,II,2022-03-08,2022-08-14,2022-10-29,Chemotherapy,Private,Alive,88.0,EGFR,Yes,Former,Moderate,27.4,Low,Urban,Private Insurance,1.0,No,Yes,Obesity,6.0
PT00099,Spain,Andalusia,50.0,Female,Breast,III,2012-05-28,2012-07-30,2012-09-10,Surgery,Public,Deceased,68.0,BRCA1,No,Never,Moderate,38.4,Medium,Urban,NHS,10.0,No,No,Hypertension,6.0
PT00100,Netherlands,South Holland,47.0,Male,Ovarian,I,2022-11-17,2022-12-30,2023-12-17,Chemotherapy,Public,Deceased,111.0,BRCA1,No,Former,None,19.7,Medium,,Private Insurance,5.0,No,No,Cardiovascular Disease,2.0
PT00101,Italy,Sicily,79.0,Female,Lung,I,2015-03-12,2015-03-31,2016-03-03,Chemotherapy,Private,Alive,65.0,KRAS,,Former,None,35.3,High,,Statutory Health Insurance,2.0,No,No,Diabetes,3.0
PT00102,Switzerland,Geneva,22.0,Female,Breast,III,2012-09-09,,2013-12-29,Immunotherapy,Research Institute,Alive,115.0,,Yes,Former,Moderate,31.7,Medium,Urban,Private Insurance,15.0,No,Yes,None,2.0
PT00103,Switzerland,Geneva,74.0,Female,Colorectal,II,2018-02-12,2018-04-09,2018-09-06,Targeted Therapy,Public,Alive,103.0,None,No,Never,,32.1,,Rural,NHS,8.0,No,No,,10.0
PT00104,Austria,Styria,33.0,Female,Leukemia,I,2018-02-10,2018-03-25,2019-02-15,,Research Institute,Alive,99.0,BRCA1,,Never,Moderate,18.0,High,Urban,Statutory Health Insurance,18.0,No,No,,1.0
PT00105,France,Provence-Alpes-Côte d'Azur,77.0,Non-binary,Breast,I,2013-01-15,2013-03-04,2014-01-12,Immunotherapy,Research Institute,Alive,57.0,KRAS,Yes,Current,None,22.5,,Urban,NHS,13.0,No,No,None,1.0
PT00106,Portugal,Algarve,34.0,Male,Prostate,III,2011-01-18,,2011-11-28,Targeted Therapy,,Alive,54.0,None,No,Never,,39.0,Low,Rural,NHS,1.0,No,No,None,3.0
PT00107,Finland,Southwest Finland,21.0,Male,Pancreatic,,2020-06-07,,2020-09-25,Chemotherapy,Research Institute,Alive,100.0,,No,Former,Moderate,32.3,Medium,Rural,NHS,17.0,No,No,None,10.0
PT00108,Portugal,Porto,43.0,Female,Breast,II,2014-03-28,2014-07-16,2015-03-21,Surgery,Private,Alive,71.0,BRCA1,No,Current,None,38.1,Medium,Rural,Statutory Health Insurance,8.0,No,No,Cardiovascular Disease,3.0
PT00109,Belgium,Brussels,83.0,Male,Breast,IV,2017-12-28,2018-04-20,2019-03-01,Surgery,Public,Alive,46.0,BRCA1,Yes,Never,None,21.1,Low,,NHS,17.0,No,No,Hypertension,8.0
,Italy,Lombardy,43.0,Male,Leukemia,II,2016-09-24,2017-01-15,2017-06-16,Surgery,Public,Alive,20.0,KRAS,No,Never,Moderate,30.0,Low,Urban,Statutory Health Insurance,12.0,Yes,No,Diabetes,9.0
PT00111,Italy,Veneto,46.0,Female,Leukemia,III,2019-06-06,2019-10-13,2019-11-25,Radiation,Private,Deceased,62.0,BRCA1,No,Former,None,23.6,Low,Urban,Statutory Health Insurance,17.0,No,No,Cardiovascular Disease,4.0
PT00112,Italy,Sicily,56.0,Female,Lung,IV,2013-01-11,2013-01-30,2013-11-08,Surgery,Private,Deceased,115.0,None,Yes,Former,None,39.3,High,Urban,Private Insurance,6.0,No,No,Diabetes,8.0
,Spain,Madrid,58.0,Female,Pancreatic,III,2023-10-16,2023-10-17,2024-02-02,Chemotherapy,Public,Alive,54.0,BRCA1,Yes,Never,Moderate,34.9,Medium,Urban,Statutory Health Insurance,4.0,No,No,None,7.0
,Switzerland,Zurich,82.0,Male,Breast,,2011-03-07,2011-07-05,2012-03-28,Chemotherapy,Public,Alive,64.0,KRAS,Yes,Never,Moderate,39.2,,Urban,NHS,11.0,No,,None,6.0
PT00115,Austria,Styria,45.0,Female,Breast,III,2019-09-14,2019-12-11,2020-11-19,Surgery,Private,Alive,,BRCA1,Yes,Former,None,18.7,Medium,Urban,Statutory Health Insurance,13.0,Yes,No,Cardiovascular Disease,1.0
PT00116,Norway,Vestland,84.0,Male,Leukemia,II,2019-05-27,2019-10-27,2020-03-14,Surgery,Public,Alive,11.0,BRCA1,No,Former,Moderate,23.0,Medium,Urban,Private Insurance,14.0,Yes,Yes,Hypertension,10.0
PT00117,Norway,,23.0,Male,Ovarian,III,2016-09-25,2017-01-06,2017-04-09,Immunotherapy,Private,Deceased,102.0,None,Yes,,None,38.1,Medium,,NHS,19.0,No,No,Cardiovascular Disease,2.0
PT00118,Finland,Uusimaa,48.0,Female,Prostate,I,2015-09-14,2015-12-07,2016-02-18,Targeted Therapy,Research Institute,Deceased,69.0,BRCA1,No,Never,None,21.5,Medium,Rural,Private Insurance,2.0,No,No,None,5.0
PT00119,Switzerland,Geneva,20.0,Male,Ovarian,II,2020-03-16,2020-04-13,2021-02-06,Surgery,Private,Alive,,BRCA1,No,Never,None,32.8,Medium,,Statutory Health Insurance,5.0,,No,Cardiovascular Disease,9.0
PT00120,Ireland,,69.0,Male,Leukemia,I,2023-09-13,2023-12-29,2024-04-27,Immunotherapy,Public,Deceased,47.0,KRAS,Yes,Former,None,38.3,,Urban,NHS,8.0,No,Yes,Diabetes,4.0
PT00121,Portugal,Lisbon,30.0,Female,Prostate,I,2015-10-24,2015-12-08,2016-09-01,Chemotherapy,Research Institute,Alive,74.0,KRAS,No,Never,None,18.3,High,Urban,NHS,8.0,No,No,Diabetes,6.0
PT00122,Norway,Oslo,78.0,Male,Pancreatic,II,2017-10-29,2017-11-22,2018-10-17,Surgery,Private,Deceased,45.0,None,Yes,Never,Heavy,29.8,Medium,Urban,,3.0,No,No,Obesity,10.0
PT00123,Denmark,Central Denmark,,Female,Ovarian,IV,2010-10-11,2010-11-24,2011-11-05,Immunotherapy,,Alive,36.0,KRAS,No,Current,None,31.4,High,Urban,Statutory Health Insurance,7.0,No,No,Diabetes,4.0
PT00124,Switzerland,Geneva,,Female,Leukemia,I,,2012-05-06,2013-02-17,Immunotherapy,Public,Alive,19.0,EGFR,Yes,,,35.0,Medium,,Statutory Health Insurance,9.0,No,No,Obesity,2.0
PT00125,Germany,Bavaria,75.0,Non-binary,Pancreatic,I,2014-11-17,2015-04-17,2016-01-14,Targeted Therapy,Public,Alive,,BRCA1,No,Never,Moderate,35.1,Medium,Urban,Statutory Health Insurance,13.0,,No,Obesity,4.0
PT00126,Switzerland,Geneva,40.0,Male,Colorectal,II,2010-12-03,2011-02-19,2011-06-07,Chemotherapy,Public,Alive,102.0,BRCA1,No,Former,,30.1,High,Rural,Private Insurance,10.0,No,No,Obesity,1.0
PT00127,Finland,Uusimaa,32.0,Female,Breast,III,2019-11-12,,2021-01-06,Targeted Therapy,Public,Deceased,,EGFR,No,Current,Moderate,37.5,High,Rural,Private Insurance,,No,No,Obesity,8.0
,Poland,Lesser Poland,28.0,Male,Pancreatic,I,2011-08-09,2011-12-30,2012-09-22,Targeted Therapy,Public,,101.0,EGFR,No,Current,Moderate,23.8,High,Urban,Private Insurance,10.0,Yes,Yes,None,8.0
PT00129,Germany,,30.0,Female,Prostate,,2015-03-30,2015-09-06,2016-06-26,Targeted Therapy,Private,Deceased,17.0,EGFR,No,Current,None,27.1,Medium,Urban,Private Insurance,4.0,No,No,Obesity,
PT00130,Germany,Bavaria,89.0,Male,Colorectal,II,2011-07-21,2011-07-25,2012-02-28,Chemotherapy,Public,Alive,,BRCA1,Yes,Former,None,32.6,Low,Rural,Private Insurance,14.0,,Yes,Diabetes,2.0
PT00131,France,,20.0,Male,Prostate,III,2016-06-23,2016-10-27,2017-06-08,Surgery,Private,Alive,114.0,EGFR,Yes,Current,None,35.7,High,Rural,Private Insurance,14.0,Yes,Yes,Cardiovascular Disease,7.0
,Denmark,Zealand,89.0,Female,Lung,I,2023-08-11,2023-09-11,2024-03-24,Targeted Therapy,Research Institute,Alive,27.0,None,Yes,Former,Moderate,25.4,Medium,Urban,NHS,6.0,No,No,Diabetes,10.0
PT00133,Poland,Lesser Poland,75.0,Male,Lung,II,2014-07-10,2014-09-07,2015-04-22,Radiation,Private,Lost to Follow-up,,KRAS,Yes,Never,Heavy,25.6,Medium,Urban,NHS,11.0,,Yes,,5.0
PT00134,,Southwest Finland,50.0,Male,Breast,III,2013-08-13,,2013-11-19,,Private,,83.0,None,No,Former,None,28.2,Low,Urban,Private Insurance,12.0,No,No,Hypertension,6.0
,Denmark,Central Denmark,56.0,Male,Colorectal,I,2014-11-26,2015-02-03,2015-09-15,Immunotherapy,Research Institute,Deceased,40.0,EGFR,Yes,Never,None,24.3,High,Urban,NHS,1.0,No,No,Diabetes,2.0
PT00136,,Veneto,66.0,,Colorectal,I,2017-11-21,2017-12-05,,Immunotherapy,Private,Alive,93.0,KRAS,Yes,Never,Heavy,25.4,Medium,Rural,,10.0,No,No,Diabetes,2.0
PT00137,Poland,,66.0,Male,Lung,II,2012-08-12,2012-09-04,2013-03-10,Chemotherapy,Private,Alive,104.0,EGFR,Yes,Never,None,31.8,,Urban,NHS,5.0,No,,Cardiovascular Disease,7.0
PT00138,Poland,Silesian,88.0,Male,Breast,IV,2015-08-29,2015-12-15,2016-08-28,Immunotherapy,Public,Deceased,84.0,None,No,Former,None,22.8,Medium,Rural,Private Insurance,4.0,Yes,No,Diabetes,1.0
PT00139,Denmark,Zealand,77.0,Male,Pancreatic,I,2020-10-26,2021-02-17,2021-05-19,Chemotherapy,Public,Deceased,,KRAS,Yes,Current,Heavy,29.3,High,Rural,NHS,12.0,No,No,Hypertension,9.0
PT00140,Portugal,Algarve,55.0,Female,Lung,II,2017-11-01,2018-02-27,2018-08-10,Surgery,Public,Alive,45.0,BRCA1,No,Current,Moderate,39.2,Low,,Statutory Health Insurance,5.0,No,No,Diabetes,9.0
PT00141,Poland,Masovian,51.0,Female,Colorectal,,2016-02-16,2016-07-09,2017-01-14,Chemotherapy,Public,Alive,115.0,None,No,Former,,38.1,Low,Rural,Statutory Health Insurance,,No,No,Cardiovascular Disease,9.0
PT00142,Austria,Tyrol,83.0,,Prostate,IV,2010-03-04,2010-07-19,2010-12-02,Surgery,Public,Alive,26.0,BRCA1,Yes,Never,None,26.5,High,Urban,,3.0,No,No,Obesity,8.0
PT00143,Finland,Southwest Finland,61.0,Male,Ovarian,I,2012-10-10,2013-02-06,2014-01-31,Chemotherapy,Research Institute,Lost to Follow-up,,KRAS,Yes,Never,Moderate,,Medium,Urban,Statutory Health Insurance,17.0,Yes,No,Hypertension,9.0
PT00144,Austria,Tyrol,67.0,Male,Colorectal,II,2015-06-13,2015-09-19,2016-06-17,Targeted Therapy,Private,Alive,63.0,KRAS,Yes,Never,None,39.8,Low,Urban,Statutory Health Insurance,19.0,No,No,None,6.0
PT00145,France,Île-de-France,49.0,Male,Breast,III,2015-03-18,2015-08-24,2016-05-22,Radiation,Public,Alive,72.0,None,Yes,Former,None,22.8,Medium,Urban,Statutory Health Insurance,5.0,,,None,4.0
PT00146,Belgium,Wallonia,40.0,Male,,IV,2014-12-10,2015-01-24,2015-06-03,Surgery,Public,Alive,77.0,EGFR,,Never,None,36.0,Medium,Urban,Private Insurance,2.0,No,No,,6.0
PT00147,Finland,Uusimaa,79.0,Female,Leukemia,III,2019-02-08,2019-06-14,2020-02-23,,Research Institute,Alive,19.0,KRAS,No,Former,Moderate,39.0,Medium,,NHS,14.0,No,No,None,10.0
PT00148,Norway,Vestland,32.0,Female,Colorectal,II,2020-02-16,2020-06-30,2021-05-07,Immunotherapy,Public,Alive,119.0,BRCA1,Yes,,None,40.0,Low,Urban,Private Insurance,11.0,Yes,No,Hypertension,4.0
PT00149,Finland,Southwest Finland,20.0,Female,Leukemia,II,2012-10-22,2012-12-18,2013-02-28,Surgery,Private,Alive,,BRCA1,No,Never,Heavy,27.5,Low,,NHS,2.0,No,No,Cardiovascular Disease,
PT00150,,Connacht,84.0,Male,Lung,II,2012-05-27,2012-07-30,,Immunotherapy,Public,Alive,113.0,,No,Never,Moderate,27.3,Medium,Urban,Private Insurance,,,No,Hypertension,10.0
PT00151,Poland,Silesian,52.0,Female,Pancreatic,III,2019-03-12,2019-03-14,2019-05-05,Targeted Therapy,Public,Alive,112.0,EGFR,No,Never,Heavy,32.8,Medium,Urban,Statutory Health Insurance,16.0,No,No,Hypertension,3.0
PT00152,Ireland,Dublin,57.0,Female,,III,2010-05-12,2010-05-18,2010-08-19,Targeted Therapy,Public,Alive,15.0,EGFR,No,Former,Moderate,26.7,Low,Urban,NHS,7.0,,No,Cardiovascular Disease,5.0
,Belgium,Flanders,44.0,Female,Colorectal,III,2017-04-06,2017-07-23,2018-07-15,Surgery,Public,Alive,102.0,EGFR,No,Never,None,23.2,Medium,Rural,Statutory Health Insurance,1.0,No,Yes,Obesity,4.0
PT00154,Switzerland,Bern,45.0,Female,Pancreatic,II,2012-09-19,2012-11-19,2013-06-19,Surgery,,Alive,,KRAS,No,Never,Moderate,24.7,Medium,,Private Insurance,17.0,No,No,Cardiovascular Disease,1.0
PT00155,Poland,Masovian,78.0,Male,Ovarian,III,2012-12-06,2013-05-17,2013-11-06,Radiation,Public,Alive,61.0,KRAS,No,Never,Moderate,19.9,Medium,Urban,Private Insurance,17.0,,No,Cardiovascular Disease,3.0
PT00156,,Tyrol,52.0,Male,Pancreatic,IV,2014-10-26,2014-11-12,2015-04-10,Immunotherapy,Public,Lost to Follow-up,,,No,Former,Moderate,23.1,Medium,Rural,Private Insurance,15.0,No,,Hypertension,4.0
PT00157,Italy,Lombardy,60.0,Female,Colorectal,IV,2017-02-09,2017-03-07,2017-12-26,Radiation,Private,Alive,9.0,EGFR,No,Never,Moderate,22.1,Low,Rural,NHS,3.0,No,Yes,Obesity,1.0
PT00158,Norway,Oslo,49.0,Male,Colorectal,III,2018-06-27,2018-09-11,2019-06-27,Surgery,Public,Alive,60.0,None,Yes,Never,Moderate,28.2,Low,Urban,NHS,16.0,No,No,Cardiovascular Disease,9.0
PT00159,Belgium,Brussels,76.0,Male,Ovarian,III,2018-01-28,2018-06-25,2018-09-01,Radiation,Public,Lost to Follow-up,,KRAS,No,Never,None,39.5,High,Rural,Private Insurance,4.0,No,No,Cardiovascular Disease,9.0
PT00160,Germany,Berlin,68.0,Male,Breast,II,2012-06-20,2012-07-31,2013-06-25,Surgery,Private,Alive,14.0,EGFR,No,Never,Moderate,32.9,High,,NHS,,Yes,No,Obesity,9.0
,Portugal,Algarve,67.0,Male,Lung,I,2019-07-17,2019-11-04,2020-09-25,Chemotherapy,Private,Deceased,66.0,None,No,Never,None,22.2,,Urban,Private Insurance,4.0,No,No,Hypertension,8.0
PT00162,Ireland,Connacht,68.0,Female,Leukemia,I,2022-02-24,2022-06-03,2023-03-28,Immunotherapy,Research Institute,Alive,70.0,None,No,Never,None,38.0,Medium,Rural,Private Insurance,10.0,Yes,No,None,3.0
PT00163,France,Auvergne-Rhône-Alpes,66.0,Male,Prostate,II,2010-03-07,2010-06-14,2010-09-27,Targeted Therapy,Private,Alive,66.0,EGFR,Yes,,Moderate,21.5,Low,Rural,NHS,4.0,No,No,Cardiovascular Disease,8.0
PT00164,Belgium,Brussels,75.0,Male,,I,2022-11-16,2023-01-09,2023-11-14,Targeted Therapy,Private,Alive,61.0,KRAS,,Never,Moderate,29.6,Medium,Urban,Private Insurance,9.0,No,No,Hypertension,4.0
,Belgium,Brussels,84.0,Female,Colorectal,II,2020-04-22,2020-09-26,2020-12-12,Radiation,Public,Deceased,92.0,BRCA1,No,Never,Moderate,32.1,Medium,Urban,Statutory Health Insurance,15.0,No,Yes,Hypertension,3.0
,Ireland,Munster,31.0,Male,Prostate,III,2018-08-08,2018-09-25,2019-05-17,Targeted Therapy,Public,Deceased,82.0,KRAS,Yes,Former,None,26.0,Medium,Urban,NHS,17.0,No,No,Cardiovascular Disease,7.0
PT00167,Ireland,Munster,88.0,Non-binary,Prostate,II,2017-08-25,2017-11-28,2018-04-05,Chemotherapy,Public,Alive,98.0,EGFR,No,Never,Moderate,35.5,Medium,Urban,Private Insurance,13.0,Yes,No,Hypertension,8.0
PT00168,Sweden,Skåne,25.0,Male,Leukemia,I,2019-02-15,2019-05-16,2020-03-28,Chemotherapy,,Alive,58.0,EGFR,Yes,Never,None,21.0,Low,Urban,NHS,10.0,No,,Hypertension,6.0
PT00169,,Wallonia,84.0,Female,,I,2017-01-23,2017-06-22,2018-04-24,Radiation,Public,Alive,,BRCA1,No,,Moderate,29.6,,Urban,NHS,7.0,Yes,No,Hypertension,2.0
,Spain,Andalusia,44.0,Female,Leukemia,I,2013-11-20,2014-01-31,2014-08-07,Targeted Therapy,,Alive,61.0,None,No,Current,None,25.4,Medium,Urban,NHS,12.0,No,No,,5.0
PT00171,Belgium,Brussels,20.0,Female,Leukemia,I,2022-03-12,2022-06-24,2023-06-08,Targeted Therapy,Private,Alive,99.0,KRAS,No,Current,Heavy,18.2,High,Urban,Statutory Health Insurance,3.0,No,No,Hypertension,3.0
PT00172,Denmark,Capital Region,51.0,Male,Leukemia,IV,2013-11-16,2014-03-29,2014-10-07,Surgery,Public,Alive,44.0,EGFR,No,Never,None,28.3,Medium,Urban,Private Insurance,5.0,No,Yes,None,6.0
PT00173,Finland,Southwest Finland,22.0,Male,Ovarian,II,2011-01-11,2011-03-04,2011-08-24,Radiation,Public,Deceased,28.0,BRCA1,Yes,Former,Moderate,26.8,Medium,Urban,Statutory Health Insurance,11.0,No,No,None,10.0
PT00174,Austria,Styria,68.0,Female,Ovarian,I,2010-06-27,2010-06-28,2011-01-11,Surgery,Private,Lost to Follow-up,,KRAS,No,Never,Moderate,22.0,Low,Urban,,15.0,Yes,Yes,Diabetes,2.0
PT00175,Germany,Bavaria,38.0,Female,Lung,I,2010-08-23,2010-10-07,2011-02-03,Chemotherapy,Private,Alive,26.0,None,Yes,Current,Moderate,,Medium,Rural,Private Insurance,1.0,No,No,Obesity,2.0
PT00176,Denmark,Central Denmark,79.0,Male,Breast,III,2017-12-22,2018-04-19,2018-06-25,Radiation,Private,Deceased,108.0,KRAS,No,Never,None,21.7,Low,Urban,NHS,18.0,No,No,Hypertension,9.0
PT00177,,Masovian,,Male,Breast,III,2012-02-01,2012-03-12,2012-12-25,Surgery,Private,Deceased,82.0,KRAS,No,Former,None,27.7,High,Rural,Statutory Health Insurance,15.0,No,No,Diabetes,1.0
PT00178,Portugal,Porto,69.0,Female,Leukemia,I,2020-08-14,2020-08-25,2021-03-07,Chemotherapy,Public,Deceased,100.0,EGFR,No,Never,Moderate,27.3,Medium,Urban,Private Insurance,4.0,No,,None,
PT00179,Germany,North Rhine-Westphalia,21.0,Female,Breast,IV,2013-07-06,2013-11-09,2014-03-18,Targeted Therapy,Private,Alive,18.0,EGFR,Yes,Never,Moderate,31.5,High,Rural,Statutory Health Insurance,1.0,No,No,Cardiovascular Disease,4.0
PT00180,,Southwest Finland,75.0,Male,Leukemia,III,2013-06-17,2013-09-21,2014-07-05,Radiation,Private,Alive,64.0,BRCA1,,Former,None,24.1,Medium,Rural,NHS,15.0,No,No,Obesity,4.0
PT00181,France,Auvergne-Rhône-Alpes,36.0,Female,Leukemia,I,2019-10-15,2020-02-27,2020-12-11,Surgery,Private,Alive,31.0,None,No,Former,Moderate,22.4,Low,Urban,Statutory Health Insurance,7.0,No,No,Cardiovascular Disease,1.0
PT00182,Italy,Sicily,79.0,Female,Leukemia,II,2019-11-23,,2020-09-30,Immunotherapy,Public,Alive,118.0,BRCA1,No,Current,Moderate,33.7,High,Urban,NHS,4.0,No,No,Diabetes,7.0
PT00183,Denmark,Central Denmark,55.0,Female,Pancreatic,II,2022-03-05,2022-08-01,2023-02-21,Targeted Therapy,Private,Alive,93.0,None,No,Never,None,35.3,Medium,Urban,NHS,11.0,No,No,None,5.0
PT00184,,Veneto,80.0,Female,Lung,II,2022-09-11,2022-10-20,2023-03-04,Surgery,Research Institute,Alive,94.0,KRAS,Yes,Current,None,,High,Rural,NHS,14.0,No,No,Diabetes,9.0
PT00185,Finland,Uusimaa,36.0,Male,Colorectal,III,2019-04-07,2019-05-21,2019-10-08,Surgery,Public,Alive,52.0,BRCA1,Yes,Current,None,29.5,Medium,Urban,,4.0,No,No,Hypertension,1.0
PT00186,Austria,Styria,68.0,Non-binary,Breast,I,2018-03-29,2018-05-25,,Radiation,Private,Lost to Follow-up,,EGFR,No,Former,Heavy,28.6,Low,Urban,NHS,5.0,No,No,Hypertension,8.0
PT00187,Portugal,,79.0,Female,Breast,II,2014-06-11,2014-07-22,2014-09-27,Immunotherapy,Public,Alive,9.0,None,Yes,Former,None,27.6,Low,Urban,Private Insurance,1.0,No,No,Hypertension,8.0
PT00188,Ireland,,39.0,Female,Lung,II,2017-11-18,,2018-07-16,Targeted Therapy,Public,Alive,90.0,EGFR,No,Never,Moderate,18.5,Low,Rural,NHS,15.0,No,No,Cardiovascular Disease,5.0
PT00189,Norway,Trøndelag,69.0,Male,Lung,II,2010-01-30,2010-06-27,2010-08-03,,Public,Deceased,76.0,EGFR,Yes,Never,None,29.9,Medium,Urban,Statutory Health Insurance,2.0,,,,2.0
PT00190,Poland,Silesian,22.0,Female,Leukemia,IV,2010-11-05,2010-11-27,2011-01-18,Radiation,Private,Alive,75.0,EGFR,No,Current,None,32.0,Medium,Urban,Statutory Health Insurance,16.0,No,No,Hypertension,9.0
PT00191,Austria,Tyrol,62.0,Male,Leukemia,I,2014-02-18,2014-07-25,2015-01-04,Radiation,Public,Deceased,75.0,BRCA1,No,Never,None,36.1,High,Urban,Statutory Health Insurance,5.0,No,No,None,7.0
PT00192,Austria,Tyrol,76.0,Male,Pancreatic,I,2015-09-25,2015-11-10,2016-02-06,Radiation,Research Institute,Alive,48.0,EGFR,No,Never,Moderate,35.1,High,Rural,NHS,9.0,Yes,No,Diabetes,7.0
PT00193,Norway,Trøndelag,69.0,Female,,III,2019-05-24,2019-05-27,2019-08-22,Immunotherapy,Private,Alive,44.0,EGFR,No,Never,Heavy,22.7,Medium,Urban,Private Insurance,10.0,Yes,No,Obesity,1.0
PT00194,Portugal,Porto,87.0,Female,Colorectal,I,2010-05-17,2010-09-27,2011-07-09,Radiation,Public,Deceased,36.0,BRCA1,No,Never,None,38.5,Medium,Urban,Private Insurance,5.0,No,No,None,4.0
PT00195,Spain,Madrid,69.0,Female,Breast,I,2012-02-14,,2013-02-15,Immunotherapy,Public,Alive,78.0,EGFR,No,Never,None,19.8,Low,Urban,Private Insurance,1.0,Yes,No,Cardiovascular Disease,
PT00196,Finland,Southwest Finland,56.0,Male,Lung,II,2014-05-18,2014-07-24,2015-07-23,Immunotherapy,Public,Alive,7.0,KRAS,No,Former,None,30.1,High,Urban,Statutory Health Insurance,12.0,No,No,Cardiovascular Disease,5.0
PT00197,Germany,Berlin,,Female,Colorectal,I,2013-12-25,,2014-10-14,Chemotherapy,Private,Alive,90.0,BRCA1,Yes,Current,None,22.9,Medium,Urban,,1.0,No,No,Hypertension,2.0
PT00198,Germany,North Rhine-Westphalia,61.0,Male,Breast,II,2017-02-16,2017-07-26,2017-11-28,Radiation,Public,Alive,12.0,,Yes,Never,None,33.0,Medium,Urban,NHS,10.0,Yes,,,10.0
PT00199,Finland,Uusimaa,34.0,Female,,I,2016-10-16,2017-01-21,2017-07-16,Radiation,Public,Deceased,6.0,None,No,Current,Moderate,35.9,Medium,Urban,Private Insurance,16.0,No,No,Obesity,8.0
PT00200,Netherlands,South Holland,52.0,Male,,I,2012-04-26,2012-08-13,,Targeted Therapy,Public,Lost to Follow-up,,BRCA1,Yes,Former,Moderate,35.9,Medium,Rural,,15.0,No,No,Cardiovascular Disease,8.0
PT00201,Germany,Berlin,30.0,Female,Ovarian,II,2010-07-26,,2011-06-01,Radiation,Public,Alive,12.0,EGFR,Yes,Never,Moderate,23.9,High,Rural,Private Insurance,10.0,No,No,None,8.0
PT00202,Germany,Berlin,39.0,Female,Leukemia,I,2016-10-29,2016-11-27,2017-05-29,Immunotherapy,Private,Alive,14.0,None,Yes,Never,None,27.0,,Urban,NHS,13.0,No,No,Hypertension,9.0
PT00203,Belgium,Brussels,43.0,Male,Colorectal,IV,2018-07-28,2018-11-08,2019-10-11,Radiation,,Alive,94.0,KRAS,No,Never,Moderate,26.0,Low,Rural,Private Insurance,12.0,No,No,Obesity,1.0
PT00204,Norway,,,Male,,II,2013-05-14,2013-09-02,2014-08-30,Surgery,Public,Lost to Follow-up,,None,Yes,Never,Moderate,20.0,Low,Urban,NHS,14.0,No,No,Obesity,10.0
PT00205,Finland,Uusimaa,84.0,Female,Breast,III,2022-11-05,2023-02-22,2024-01-20,,Public,Alive,53.0,EGFR,No,Current,Moderate,35.6,Medium,Urban,Statutory Health Insurance,11.0,No,No,None,7.0
PT00206,Austria,Tyrol,36.0,Female,Pancreatic,III,2017-08-28,2017-09-08,2018-04-25,Surgery,Public,Alive,60.0,KRAS,Yes,Current,,25.6,Medium,Urban,NHS,16.0,No,No,Cardiovascular Disease,10.0
PT00207,Austria,Styria,80.0,Female,Breast,I,2018-11-04,2019-02-07,2019-03-22,Immunotherapy,Private,Deceased,82.0,KRAS,Yes,Current,Moderate,27.2,Medium,Urban,NHS,7.0,No,No,Cardiovascular Disease,
PT00208,Germany,Bavaria,34.0,Female,Leukemia,III,2013-02-01,2013-06-13,2013-12-13,Surgery,Private,Alive,,KRAS,Yes,Never,None,33.0,High,Urban,NHS,4.0,No,Yes,Diabetes,
PT00209,Sweden,Stockholm,70.0,,Pancreatic,III,2023-07-19,2023-10-20,2024-01-04,Immunotherapy,Private,Alive,65.0,BRCA1,No,Current,Moderate,31.8,High,Urban,Statutory Health Insurance,13.0,Yes,No,None,4.0
PT00210,Germany,Berlin,46.0,Male,Ovarian,I,2022-09-25,2022-11-18,2023-08-22,,Public,Alive,75.0,KRAS,Yes,Never,None,36.4,Medium,Rural,Statutory Health Insurance,19.0,,No,Hypertension,3.0
PT00211,Ireland,Munster,80.0,Male,Prostate,IV,2013-04-17,2013-08-16,2013-12-17,Chemotherapy,Public,Lost to Follow-up,,KRAS,No,Former,Moderate,27.7,Low,Rural,Private Insurance,2.0,No,No,Diabetes,6.0
PT00212,Denmark,Zealand,77.0,Male,Pancreatic,I,2016-08-02,2016-08-04,2017-04-22,Surgery,Private,Alive,115.0,KRAS,No,Never,Moderate,37.6,Medium,Rural,Private Insurance,10.0,No,No,Diabetes,9.0
PT00213,Austria,Tyrol,50.0,Female,,I,2013-07-11,2013-10-19,2014-03-03,Targeted Therapy,Public,Alive,83.0,BRCA1,,Former,None,39.7,High,,Private Insurance,7.0,No,No,Diabetes,3.0
PT00214,France,Auvergne-Rhône-Alpes,31.0,Male,Breast,III,,2023-06-30,2024-03-13,Chemotherapy,Public,Alive,63.0,None,No,Former,Moderate,25.8,Medium,Urban,NHS,9.0,No,No,Hypertension,10.0
PT00215,Austria,Tyrol,65.0,Female,,I,2011-07-03,2011-08-20,2012-06-02,Immunotherapy,Public,Alive,54.0,KRAS,,Former,None,21.6,High,Urban,Private Insurance,18.0,,No,Hypertension,8.0
PT00216,France,Île-de-France,50.0,Female,Colorectal,III,2020-10-20,2020-12-27,2021-07-02,Immunotherapy,Public,Alive,35.0,KRAS,No,Never,None,21.7,Low,Urban,Private Insurance,19.0,No,No,Hypertension,4.0
PT00217,Spain,Andalusia,51.0,Female,Ovarian,IV,2020-10-04,2020-11-17,2021-09-22,Chemotherapy,Private,Alive,27.0,EGFR,No,Current,Moderate,26.5,Medium,Urban,NHS,5.0,No,No,Hypertension,8.0
PT00218,Netherlands,South Holland,51.0,Female,Pancreatic,IV,2013-10-19,2014-02-24,2014-11-25,Targeted Therapy,Public,Alive,9.0,KRAS,No,Former,Moderate,27.1,Low,Rural,,1.0,No,No,Cardiovascular Disease,6.0
PT00219,Finland,Pirkanmaa,72.0,Male,Prostate,II,2013-06-27,2013-09-29,2014-01-18,Chemotherapy,Public,Alive,98.0,BRCA1,No,Current,Heavy,39.2,,Urban,NHS,17.0,No,No,None,8.0
PT00220,Norway,Trøndelag,80.0,Female,Colorectal,IV,2018-12-08,2019-03-01,,Surgery,Private,Lost to Follow-up,,None,No,Never,Moderate,36.8,High,Urban,NHS,16.0,No,No,Hypertension,9.0
PT00221,France,Provence-Alpes-Côte d'Azur,65.0,Male,,II,2012-03-17,2012-04-05,,Chemotherapy,Private,Deceased,71.0,EGFR,No,Never,Moderate,39.4,Low,Urban,Private Insurance,11.0,No,No,Diabetes,6.0
PT00222,Switzerland,Zurich,26.0,Male,Lung,I,2015-04-12,2015-10-01,2016-01-08,Radiation,Public,Lost to Follow-up,,BRCA1,No,Never,Moderate,30.7,Medium,Urban,Private Insurance,3.0,No,No,None,5.0
PT00223,France,Auvergne-Rhône-Alpes,23.0,Female,Prostate,II,2018-07-31,2019-01-06,2019-04-20,Surgery,Public,Deceased,35.0,EGFR,No,Never,Moderate,18.8,Low,Rural,NHS,15.0,No,No,None,3.0
PT00224,Norway,,71.0,Male,Breast,III,2020-11-25,2021-01-26,2021-07-09,Targeted Therapy,Public,Deceased,29.0,KRAS,No,Never,Moderate,25.4,Low,Rural,Statutory Health Insurance,11.0,,No,Diabetes,2.0
PT00225,Spain,Andalusia,50.0,,Pancreatic,II,2015-10-01,2016-02-21,2016-11-01,Surgery,Public,Alive,85.0,None,No,Former,Moderate,36.9,Medium,Urban,Statutory Health Insurance,1.0,No,No,Cardiovascular Disease,2.0
PT00226,Netherlands,North Holland,55.0,Female,Leukemia,II,2014-10-12,2015-03-18,2015-09-01,Immunotherapy,Public,Deceased,30.0,None,Yes,Former,None,29.8,Medium,Rural,NHS,3.0,No,No,,4.0
PT00227,Austria,Styria,73.0,Female,Leukemia,II,2022-01-26,2022-04-03,2022-11-19,Immunotherapy,Public,Alive,,KRAS,No,Never,None,31.6,High,,Statutory Health Insurance,13.0,No,No,Obesity,4.0
PT00228,Italy,Veneto,73.0,Male,Colorectal,II,2020-12-02,2021-02-26,2021-11-22,Immunotherapy,Public,Alive,81.0,KRAS,Yes,Former,None,31.6,High,Rural,Private Insurance,2.0,No,Yes,Diabetes,4.0
PT00229,France,Auvergne-Rhône-Alpes,36.0,Female,Pancreatic,IV,2022-04-11,2022-10-03,2022-11-26,Surgery,Private,Deceased,108.0,KRAS,No,Never,None,39.4,,Urban,NHS,14.0,No,No,Hypertension,2.0
PT00230,Netherlands,North Holland,,Male,Ovarian,II,2013-05-10,2013-08-02,2014-04-05,Immunotherapy,Public,,21.0,None,Yes,Never,,29.8,Low,Urban,Statutory Health Insurance,,No,No,Cardiovascular Disease,2.0
PT00231,Belgium,Flanders,41.0,Female,,I,2015-08-29,2016-01-01,2016-11-05,Targeted Therapy,Private,Alive,60.0,BRCA1,,Never,Moderate,33.4,Low,Urban,Private Insurance,2.0,No,Yes,Cardiovascular Disease,4.0
PT00232,Germany,North Rhine-Westphalia,62.0,Male,Colorectal,,2010-04-05,2010-04-12,2010-05-23,,Public,Deceased,32.0,KRAS,Yes,Never,Moderate,20.1,Low,Rural,NHS,15.0,No,No,Obesity,6.0
PT00233,Sweden,Skåne,46.0,Female,Prostate,II,2010-05-10,2010-09-16,2011-05-02,Surgery,Private,Alive,98.0,EGFR,Yes,Former,Moderate,27.8,Medium,Rural,Private Insurance,19.0,No,,Obesity,10.0
PT00234,Switzerland,Bern,56.0,,Leukemia,III,2018-12-13,2019-01-04,2019-06-16,Chemotherapy,Research Institute,Alive,98.0,KRAS,Yes,Former,Moderate,37.6,Medium,Rural,Private Insurance,17.0,No,No,None,9.0
PT00235,Sweden,Stockholm,65.0,Male,Prostate,I,2015-05-08,2015-07-04,2016-06-12,Chemotherapy,Research Institute,Alive,73.0,None,No,Never,Moderate,33.8,Low,Urban,Statutory Health Insurance,6.0,No,No,None,2.0
PT00236,Denmark,Zealand,54.0,Female,Leukemia,II,2016-04-26,2016-07-29,2016-11-18,Targeted Therapy,Public,Alive,65.0,BRCA1,Yes,Current,Moderate,28.4,Low,Urban,Private Insurance,18.0,No,No,Hypertension,2.0
PT00237,Germany,North Rhine-Westphalia,23.0,Male,Leukemia,I,2012-09-13,2013-01-16,2014-01-08,Surgery,Public,,107.0,BRCA1,No,Former,Moderate,34.2,Medium,Urban,Private Insurance,7.0,No,No,Hypertension,9.0
PT00238,Sweden,Stockholm,45.0,Female,Leukemia,I,,2018-09-19,,Targeted Therapy,Research Institute,Deceased,113.0,KRAS,No,Current,None,20.8,Low,Urban,Statutory Health Insurance,8.0,No,Yes,Cardiovascular Disease,3.0
PT00239,Sweden,Skåne,38.0,Male,Pancreatic,III,2019-10-13,2019-11-09,2020-10-20,Immunotherapy,Public,Alive,63.0,None,No,Former,Moderate,,Low,Urban,Statutory Health Insurance,9.0,No,No,Obesity,
PT00240,Austria,Tyrol,64.0,Male,Ovarian,II,2012-03-27,2012-05-04,2013-01-19,Immunotherapy,Research Institute,Alive,101.0,KRAS,No,Never,Moderate,35.7,Medium,Rural,Statutory Health Insurance,13.0,,,,6.0
PT00241,Italy,Lombardy,45.0,Female,Ovarian,IV,2017-02-13,2017-06-21,2017-10-28,Targeted Therapy,Private,Deceased,62.0,None,No,Former,,35.2,High,Rural,NHS,6.0,No,No,Diabetes,6.0
PT00242,Portugal,Porto,41.0,Male,Ovarian,II,2015-12-10,2016-02-24,2016-10-09,Immunotherapy,Research Institute,Deceased,53.0,KRAS,No,Never,None,30.1,Medium,Urban,NHS,8.0,No,No,Obesity,4.0
,Austria,Styria,77.0,Male,Breast,I,2014-11-15,2015-04-05,2015-11-13,Radiation,Private,Alive,114.0,BRCA1,No,Never,None,18.8,Low,Urban,Statutory Health Insurance,7.0,No,Yes,None,2.0
PT00244,Portugal,Lisbon,82.0,Female,Pancreatic,III,2012-01-27,2012-05-03,2012-11-18,Radiation,Research Institute,Alive,113.0,BRCA1,Yes,Never,None,35.8,Medium,Rural,Private Insurance,10.0,No,No,Cardiovascular Disease,4.0
PT00245,Finland,Southwest Finland,47.0,Male,Prostate,III,2013-03-13,2013-08-03,2014-01-21,Radiation,Public,Alive,46.0,EGFR,Yes,Never,None,19.1,,Urban,Private Insurance,8.0,No,Yes,Obesity,3.0
PT00246,Netherlands,Utrecht,84.0,Male,Ovarian,III,,2017-04-28,2018-01-30,Chemotherapy,Public,Alive,73.0,KRAS,No,Never,None,39.2,,Rural,NHS,15.0,No,No,None,10.0
PT00247,Portugal,Lisbon,63.0,Male,Pancreatic,III,2018-07-02,2018-10-08,2019-09-23,Chemotherapy,Public,Alive,39.0,BRCA1,No,Former,Moderate,32.1,Medium,Urban,NHS,12.0,No,No,None,4.0
PT00248,Germany,Bavaria,62.0,Male,Ovarian,I,2011-02-10,2011-03-30,2011-05-10,Surgery,,Alive,39.0,None,No,Former,Moderate,18.4,High,Rural,Private Insurance,16.0,No,No,Obesity,1.0
PT00249,Spain,Andalusia,56.0,Female,Colorectal,III,2015-01-27,2015-02-11,2015-10-09,Chemotherapy,Public,Alive,7.0,KRAS,Yes,Never,Moderate,20.3,Low,Urban,Statutory Health Insurance,6.0,No,Yes,Obesity,4.0
PT00250,Belgium,Brussels,85.0,Male,Lung,II,2016-08-08,2016-11-15,2017-09-10,Targeted Therapy,Private,Alive,97.0,None,No,Never,Moderate,31.9,Medium,Urban,Statutory Health Insurance,3.0,No,Yes,Obesity,5.0
PT00251,Denmark,Capital Region,36.0,Female,,II,2018-04-16,2018-05-26,2019-05-13,Surgery,Public,Alive,116.0,KRAS,No,Never,Moderate,40.0,Medium,Rural,Private Insurance,11.0,No,No,Hypertension,4.0
PT00252,Norway,Vestland,,Male,Pancreatic,IV,2021-03-11,2021-04-10,2021-09-01,Surgery,Private,Deceased,6.0,None,No,,Moderate,20.0,Medium,Rural,Statutory Health Insurance,4.0,No,No,None,8.0
PT00253,Austria,Vienna,57.0,Male,Prostate,II,2010-06-12,2010-10-02,2011-09-19,Targeted Therapy,Public,Alive,92.0,EGFR,No,Never,None,19.5,Medium,Urban,Statutory Health Insurance,15.0,No,No,Hypertension,1.0
PT00254,Belgium,Wallonia,,Male,Lung,III,2017-09-12,2017-10-05,2018-07-31,Radiation,Research Institute,Alive,107.0,EGFR,No,Former,None,32.9,Medium,Urban,Private Insurance,5.0,No,No,Obesity,9.0
PT00255,Portugal,Algarve,28.0,,Colorectal,II,2022-09-21,2022-09-30,2023-08-26,Chemotherapy,Public,Alive,42.0,BRCA1,Yes,Former,Heavy,31.7,Medium,,Statutory Health Insurance,16.0,,No,Diabetes,1.0
PT00256,Switzerland,,80.0,Non-binary,Lung,I,2010-05-11,2010-10-18,,Surgery,Public,Lost to Follow-up,,EGFR,Yes,Never,None,37.1,High,Urban,NHS,6.0,,,Cardiovascular Disease,7.0
PT00257,Italy,Lombardy,35.0,Female,Prostate,II,2018-09-03,2018-10-08,2019-04-12,Radiation,Private,Deceased,88.0,BRCA1,Yes,Never,Moderate,37.0,Low,Urban,Statutory Health Insurance,8.0,No,No,Cardiovascular Disease,2.0
PT00258,Netherlands,,21.0,Non-binary,Leukemia,II,2017-05-24,2017-07-12,2017-10-10,Immunotherapy,Private,Alive,64.0,KRAS,No,Never,Moderate,31.9,Low,Urban,Statutory Health Insurance,19.0,No,No,Cardiovascular Disease,1.0
PT00259,Denmark,Zealand,62.0,Male,Prostate,II,2018-05-14,2018-08-18,2019-07-02,Radiation,Public,Alive,96.0,BRCA1,No,Never,None,24.6,High,Rural,NHS,10.0,No,No,None,2.0
PT00260,Germany,Berlin,61.0,Male,Ovarian,II,2016-05-06,2016-10-26,2017-10-18,Radiation,Public,Alive,48.0,EGFR,No,Never,Moderate,33.2,Medium,Urban,Statutory Health Insurance,12.0,No,No,Hypertension,6.0
PT00261,Germany,Bavaria,76.0,Male,Breast,III,2018-01-30,2018-02-15,2018-08-31,Chemotherapy,Public,Alive,64.0,BRCA1,No,Current,None,22.1,Low,Urban,NHS,12.0,Yes,No,Hypertension,2.0
PT00262,,Madrid,86.0,Male,Lung,I,2023-05-15,2023-06-16,2023-08-07,Immunotherapy,Public,Deceased,81.0,KRAS,No,Never,None,20.3,High,Rural,Private Insurance,2.0,Yes,No,Obesity,6.0
PT00263,France,Provence-Alpes-Côte d'Azur,49.0,Male,Prostate,I,2016-08-09,2016-09-03,2016-11-30,Surgery,Private,Alive,70.0,KRAS,No,Never,Moderate,33.3,Medium,Urban,Private Insurance,4.0,No,No,Obesity,9.0
PT00264,Finland,Uusimaa,32.0,Male,Leukemia,III,2015-04-18,2015-07-21,2016-06-26,Targeted Therapy,Private,Deceased,18.0,KRAS,No,Never,Moderate,27.3,Low,Urban,,3.0,,Yes,Cardiovascular Disease,2.0
PT00265,Austria,Tyrol,38.0,Male,Leukemia,IV,,2019-09-13,2020-03-31,Surgery,Public,Alive,116.0,BRCA1,No,Former,Moderate,34.6,Medium,Rural,Statutory Health Insurance,10.0,No,No,Diabetes,1.0
PT00266,Italy,Veneto,26.0,Male,Prostate,II,2017-04-12,2017-05-19,2017-09-09,Chemotherapy,Public,,6.0,None,Yes,Never,Heavy,19.7,Low,Urban,Statutory Health Insurance,8.0,No,No,Cardiovascular Disease,7.0
PT00267,Portugal,Porto,28.0,Male,Colorectal,IV,2018-07-30,2019-01-09,2019-10-13,Surgery,Public,Deceased,50.0,KRAS,,Former,None,39.8,Medium,Urban,Private Insurance,16.0,No,No,Obesity,6.0
PT00268,Switzerland,Geneva,73.0,Male,,I,2018-02-27,2018-04-13,,Chemotherapy,Private,Alive,79.0,EGFR,No,Former,,29.3,Medium,Urban,Statutory Health Insurance,13.0,No,No,Obesity,3.0
PT00269,Sweden,Stockholm,80.0,Female,Leukemia,I,2013-09-08,2014-01-22,2014-07-04,Chemotherapy,Research Institute,Alive,19.0,None,Yes,Never,None,37.6,Medium,Urban,NHS,4.0,No,No,Hypertension,7.0
PT00270,Netherlands,North Holland,,Male,Prostate,III,2020-05-28,2020-11-19,2021-10-02,Surgery,Private,Deceased,45.0,,Yes,Current,Moderate,28.6,Low,Urban,NHS,,No,Yes,None,8.0
PT00271,Germany,North Rhine-Westphalia,69.0,Female,Breast,IV,2017-03-21,2017-04-26,2017-12-04,Targeted Therapy,Public,Lost to Follow-up,,BRCA1,No,Former,Moderate,23.4,Low,Rural,Statutory Health Insurance,2.0,No,No,Hypertension,5.0
PT00272,Sweden,Skåne,50.0,Female,Colorectal,I,2010-02-14,2010-06-12,2011-01-15,Targeted Therapy,Public,Alive,27.0,KRAS,Yes,Current,Moderate,25.1,High,Urban,Private Insurance,11.0,No,No,Diabetes,7.0
PT00273,Norway,Trøndelag,52.0,Male,Prostate,I,2010-12-13,2011-03-05,2011-09-02,Surgery,,Alive,51.0,EGFR,No,Never,Moderate,37.8,High,Urban,Private Insurance,14.0,No,No,Obesity,3.0
PT00274,Austria,Styria,30.0,Male,Leukemia,I,2023-03-03,2023-06-14,2023-12-17,Immunotherapy,Public,Alive,106.0,BRCA1,,,None,33.4,High,Urban,Statutory Health Insurance,5.0,No,No,Diabetes,8.0
PT00275,Norway,Trøndelag,52.0,Male,,I,2020-05-21,2020-10-06,2020-11-12,Radiation,Public,Alive,89.0,None,No,Never,None,22.2,Low,Rural,NHS,7.0,No,Yes,Obesity,6.0
PT00276,Spain,Andalusia,26.0,Female,Ovarian,III,2022-12-26,2022-12-27,2023-10-21,Targeted Therapy,Public,Deceased,52.0,BRCA1,No,Never,None,25.7,Low,Rural,Statutory Health Insurance,19.0,No,No,None,8.0
PT00277,Italy,,50.0,Male,Prostate,II,2016-08-13,2017-01-03,2017-04-05,Chemotherapy,Public,Deceased,64.0,BRCA1,No,Never,None,18.7,High,Urban,NHS,2.0,No,No,Diabetes,7.0
PT00278,Switzerland,Bern,67.0,Male,Lung,II,2022-03-12,2022-06-16,2022-08-09,Targeted Therapy,Research Institute,Lost to Follow-up,,KRAS,Yes,Current,,32.1,Low,Urban,Private Insurance,1.0,No,No,Obesity,2.0
PT00279,Finland,Pirkanmaa,66.0,Male,Prostate,,2016-12-17,2017-03-19,2017-09-21,Immunotherapy,Public,Deceased,97.0,None,No,Never,Moderate,26.2,Medium,Urban,NHS,2.0,No,No,Diabetes,5.0
PT00280,Portugal,Lisbon,72.0,Female,Breast,IV,2023-09-10,2023-12-06,,Surgery,Private,Alive,17.0,,No,Never,,19.2,High,Rural,NHS,8.0,Yes,No,None,3.0
PT00281,Sweden,Skåne,38.0,Male,Leukemia,I,2010-03-01,,2011-06-21,Immunotherapy,Public,Alive,62.0,EGFR,No,Never,None,36.1,High,Rural,Private Insurance,13.0,No,No,Cardiovascular Disease,10.0
PT00282,Switzerland,Geneva,25.0,Female,Pancreatic,III,2016-06-03,2016-09-26,2017-01-21,Radiation,,Alive,85.0,BRCA1,No,Current,Moderate,27.5,Medium,Urban,NHS,4.0,No,No,Diabetes,10.0
PT00283,Denmark,Capital Region,68.0,Female,Lung,IV,2021-11-05,2021-12-07,2022-05-10,Targeted Therapy,Private,Alive,70.0,None,No,,None,34.4,Medium,Rural,Private Insurance,6.0,No,No,Hypertension,6.0
PT00284,Switzerland,Geneva,69.0,Female,Pancreatic,I,2017-10-15,2018-03-12,2018-12-09,Chemotherapy,Private,Alive,23.0,,Yes,Former,Moderate,31.2,Medium,Rural,NHS,3.0,No,No,Obesity,
,Denmark,,31.0,Female,Prostate,III,2020-04-24,2020-06-19,,Chemotherapy,Public,Alive,73.0,EGFR,No,Never,Heavy,28.3,Medium,Urban,NHS,19.0,No,No,Diabetes,9.0
PT00286,Belgium,Flanders,42.0,Female,Ovarian,III,2011-03-24,2011-06-10,2011-10-01,Immunotherapy,Private,Alive,75.0,KRAS,Yes,Former,None,20.3,,Urban,Private Insurance,,Yes,No,Hypertension,
PT00287,Netherlands,Utrecht,73.0,Female,Colorectal,I,2016-08-12,2016-11-19,2017-07-02,Surgery,Research Institute,Alive,63.0,KRAS,Yes,Former,None,31.8,High,Urban,Private Insurance,10.0,No,No,Cardiovascular Disease,7.0
PT00288,Netherlands,Utrecht,88.0,Female,Breast,I,2021-03-02,2021-06-14,2022-04-17,Radiation,Research Institute,Alive,56.0,EGFR,No,Current,Moderate,30.2,Medium,Urban,Private Insurance,9.0,No,No,Obesity,8.0
PT00289,Germany,Berlin,78.0,Male,Breast,III,2022-09-24,2022-11-05,2023-04-18,Surgery,,Alive,67.0,,Yes,Never,Moderate,39.7,Medium,Rural,Statutory Health Insurance,9.0,,No,Cardiovascular Disease,9.0
PT00290,Switzerland,Geneva,55.0,Male,Ovarian,II,2018-04-24,2018-07-06,2019-06-18,Targeted Therapy,Public,Alive,67.0,EGFR,Yes,Current,None,30.8,Medium,Rural,NHS,16.0,No,Yes,None,3.0
PT00291,Netherlands,North Holland,22.0,Female,Breast,II,2016-05-13,2016-07-12,2016-12-06,Immunotherapy,Private,Alive,118.0,KRAS,Yes,Never,Moderate,29.9,High,Rural,NHS,14.0,No,Yes,Hypertension,8.0
PT00292,Portugal,Porto,77.0,Female,Ovarian,I,2023-06-28,2023-12-20,2024-10-10,Immunotherapy,Private,Alive,113.0,EGFR,No,Never,Moderate,38.7,Medium,Urban,Statutory Health Insurance,5.0,No,No,Hypertension,5.0
PT00293,Switzerland,Bern,74.0,Female,Lung,III,2021-02-09,2021-07-11,2022-05-23,Chemotherapy,Public,Alive,,EGFR,Yes,Former,None,28.5,Medium,Rural,Statutory Health Insurance,4.0,No,,Hypertension,4.0
PT00294,Austria,Styria,76.0,Female,Ovarian,I,2010-02-07,2010-03-20,2010-05-14,Targeted Therapy,Public,Alive,81.0,BRCA1,Yes,Never,Moderate,22.4,Medium,Urban,Statutory Health Insurance,13.0,No,No,Cardiovascular Disease,2.0
PT00295,France,Île-de-France,36.0,Female,Ovarian,II,2013-05-15,2013-05-19,2013-12-17,Chemotherapy,Private,Alive,32.0,EGFR,No,Current,None,26.6,Low,Urban,Private Insurance,11.0,No,Yes,Hypertension,2.0
PT00296,Austria,Styria,58.0,Male,Prostate,II,2010-10-16,2010-12-31,2011-09-25,Surgery,Public,Alive,61.0,None,No,,None,24.4,,Urban,Statutory Health Insurance,7.0,No,No,None,10.0
PT00297,,Lesser Poland,87.0,Female,Breast,III,2023-02-19,2023-08-17,2024-01-02,Immunotherapy,Public,Alive,34.0,KRAS,Yes,Never,Moderate,29.2,Medium,Rural,NHS,19.0,Yes,No,None,6.0
PT00298,Sweden,Västra Götaland,74.0,Male,Prostate,I,2016-07-09,2016-07-10,2016-11-06,Immunotherapy,Private,Alive,48.0,KRAS,Yes,Never,None,,Medium,Urban,Private Insurance,3.0,No,No,None,3.0
PT00299,Sweden,Skåne,64.0,Non-binary,Colorectal,I,2010-07-23,2010-08-06,2011-06-12,Radiation,Private,Alive,22.0,None,No,Never,Heavy,18.2,Low,Urban,,11.0,No,No,Obesity,5.0
PT00300,Italy,Sicily,20.0,Female,Ovarian,I,2012-11-09,2013-03-27,2013-08-23,Surgery,,Alive,42.0,None,Yes,Current,None,29.6,Low,Urban,Private Insurance,17.0,No,No,Diabetes,3.0
PT00301,Italy,Lombardy,40.0,Female,Prostate,I,2023-12-22,2024-03-28,2024-10-23,Targeted Therapy,Private,Alive,45.0,KRAS,No,Never,None,,High,Urban,NHS,3.0,No,No,Obesity,2.0
PT00302,Germany,North Rhine-Westphalia,40.0,Male,Pancreatic,I,2014-06-09,2014-11-20,2015-01-06,Radiation,Public,Alive,96.0,EGFR,Yes,Never,None,24.2,Low,Urban,Private Insurance,9.0,No,No,Diabetes,8.0
PT00303,Netherlands,South Holland,71.0,Male,Prostate,III,2018-02-07,2018-03-21,,,Public,Alive,62.0,None,No,Never,Moderate,29.9,Low,Rural,NHS,9.0,No,No,Diabetes,1.0
PT00304,Austria,Styria,62.0,Male,Prostate,III,2016-09-09,2017-01-09,2017-05-26,Targeted Therapy,Research Institute,Deceased,11.0,EGFR,No,Current,Moderate,37.7,Medium,Rural,Statutory Health Insurance,2.0,No,Yes,Diabetes,3.0
,Spain,Madrid,71.0,Female,Ovarian,III,2020-07-03,2020-08-20,2021-02-08,Chemotherapy,Public,Alive,105.0,,No,Never,Heavy,37.0,High,Urban,NHS,16.0,No,Yes,Obesity,6.0
PT00306,Norway,Oslo,86.0,Female,Leukemia,II,2018-07-21,2018-08-08,2019-05-28,Surgery,Public,Alive,64.0,None,Yes,Former,Moderate,22.4,Medium,Urban,NHS,10.0,No,No,Diabetes,6.0
PT00307,Norway,Oslo,63.0,Male,Pancreatic,I,2020-03-20,2020-06-17,2020-08-28,Chemotherapy,Public,,64.0,,No,,Moderate,29.5,Low,Rural,Statutory Health Insurance,,No,No,None,7.0
PT00308,,Wallonia,51.0,Female,Lung,IV,2018-12-02,2019-02-16,2019-10-20,Immunotherapy,Public,Alive,114.0,EGFR,No,Former,Moderate,34.1,Low,Urban,Private Insurance,9.0,No,No,Hypertension,7.0
PT00309,Finland,Pirkanmaa,29.0,Female,Ovarian,I,2020-04-14,2020-06-13,,Radiation,Public,Alive,76.0,EGFR,Yes,Former,Moderate,38.9,Medium,Urban,Statutory Health Insurance,11.0,No,No,None,4.0
PT00310,Finland,Pirkanmaa,83.0,,Prostate,III,2022-03-07,2022-08-10,2023-05-16,Chemotherapy,Research Institute,Alive,48.0,EGFR,No,Current,None,34.5,High,Rural,NHS,12.0,No,No,Diabetes,2.0
PT00311,Ireland,Connacht,88.0,Male,Breast,IV,2013-02-11,2013-02-20,2013-07-01,Immunotherapy,Public,Alive,89.0,BRCA1,No,Never,Moderate,32.5,,Urban,Private Insurance,10.0,No,No,Cardiovascular Disease,9.0
PT00312,Italy,Sicily,87.0,Female,Ovarian,III,2017-01-05,2017-06-06,2018-05-22,Chemotherapy,Public,Alive,,KRAS,,Never,,23.4,High,Urban,NHS,4.0,No,No,None,9.0
PT00313,Denmark,Central Denmark,47.0,Female,Leukemia,I,2011-06-30,2011-11-25,,Surgery,Private,Alive,,KRAS,Yes,Former,Moderate,29.2,High,Urban,NHS,13.0,No,No,None,2.0
PT00314,Denmark,Central Denmark,72.0,Female,Prostate,II,2021-12-26,,2023-01-16,Chemotherapy,Public,Alive,20.0,None,No,Never,None,26.7,Medium,Urban,Private Insurance,10.0,No,,None,1.0
PT00315,Switzerland,Zurich,70.0,Female,Leukemia,I,2011-11-04,2012-02-13,2012-08-14,Surgery,Private,,92.0,BRCA1,Yes,Former,Moderate,26.9,Medium,Rural,NHS,10.0,No,Yes,None,1.0
PT00316,Sweden,Västra Götaland,,Non-binary,Lung,III,2012-01-30,2012-07-16,2013-07-02,Surgery,Public,Deceased,15.0,None,Yes,,None,23.5,Medium,Urban,Statutory Health Insurance,3.0,No,No,Diabetes,8.0
PT00317,Belgium,Wallonia,23.0,Male,Ovarian,III,2013-09-06,2013-11-28,2014-09-23,Targeted Therapy,Research Institute,Alive,73.0,,No,Current,Moderate,25.3,High,Urban,NHS,16.0,No,Yes,Cardiovascular Disease,5.0
PT00318,Austria,Styria,36.0,Female,Leukemia,III,2011-06-04,2011-07-28,2012-01-02,,Public,Alive,38.0,None,Yes,Former,Heavy,34.4,Medium,Urban,Private Insurance,15.0,,No,Diabetes,10.0
PT00319,Belgium,Brussels,86.0,Male,Breast,I,2021-07-07,2021-10-01,2022-02-01,Chemotherapy,Private,Deceased,81.0,EGFR,No,Never,None,26.8,Medium,Urban,NHS,9.0,Yes,No,Hypertension,8.0
PT00320,Austria,Styria,66.0,Male,Prostate,III,2019-11-25,2020-02-15,2020-04-21,Immunotherapy,Private,,14.0,BRCA1,No,Never,None,19.4,Medium,Urban,NHS,10.0,No,No,Cardiovascular Disease,3.0
PT00321,France,Provence-Alpes-Côte d'Azur,75.0,Male,Breast,III,2023-10-28,2024-03-19,2025-01-16,Targeted Therapy,Public,Alive,32.0,,Yes,Never,None,19.1,Medium,Rural,Statutory Health Insurance,17.0,No,No,Cardiovascular Disease,8.0
,Sweden,Stockholm,42.0,Male,Ovarian,I,2023-01-28,2023-05-05,2023-11-08,Radiation,Private,Alive,67.0,BRCA1,Yes,Former,Moderate,22.5,High,Urban,NHS,16.0,,Yes,Diabetes,4.0
PT00323,France,Île-de-France,37.0,Non-binary,Ovarian,II,2014-05-21,2014-09-01,2015-03-04,Targeted Therapy,Private,Alive,16.0,KRAS,No,Former,Moderate,22.9,High,Urban,NHS,13.0,No,No,None,8.0
PT00324,Switzerland,Geneva,20.0,Female,Colorectal,III,2019-11-24,2020-05-21,2020-12-24,Chemotherapy,,Alive,101.0,None,No,Former,Moderate,38.7,Low,Rural,NHS,9.0,No,No,,4.0
PT00325,Netherlands,South Holland,54.0,Male,Leukemia,II,2023-11-03,2023-12-13,2024-05-03,Chemotherapy,Research Institute,,20.0,,Yes,Current,Heavy,30.8,Low,Urban,Statutory Health Insurance,16.0,Yes,No,Obesity,9.0
PT00326,Ireland,Munster,83.0,Female,Leukemia,I,2014-12-28,2015-06-17,2015-08-15,Chemotherapy,Public,Alive,76.0,None,No,Never,,35.6,Medium,Urban,Private Insurance,1.0,No,No,None,6.0
PT00327,Belgium,Brussels,77.0,Female,Leukemia,I,2015-07-18,2015-09-20,2016-06-20,,Public,Alive,95.0,BRCA1,No,Current,None,20.1,Low,Urban,Statutory Health Insurance,18.0,No,No,Obesity,6.0
PT00328,Belgium,Wallonia,78.0,Female,Pancreatic,III,2013-03-30,2013-08-12,2013-12-19,Targeted Therapy,Research Institute,Deceased,13.0,KRAS,No,Never,None,20.7,High,,NHS,12.0,No,Yes,Cardiovascular Disease,6.0
PT00329,Belgium,Flanders,20.0,Female,Ovarian,I,2020-05-01,2020-05-03,2020-06-22,Immunotherapy,Public,Alive,74.0,EGFR,,Current,Moderate,19.6,Medium,Urban,Statutory Health Insurance,6.0,No,No,Obesity,5.0
PT00330,France,Auvergne-Rhône-Alpes,22.0,Male,Ovarian,I,2011-01-15,2011-02-14,2011-04-02,Targeted Therapy,Private,Alive,71.0,BRCA1,,Never,Moderate,31.9,High,Urban,Statutory Health Insurance,14.0,No,No,Cardiovascular Disease,10.0
PT00331,Switzerland,Geneva,86.0,Female,Lung,III,2015-10-29,2015-12-20,2016-06-28,Radiation,Public,Alive,7.0,BRCA1,Yes,Current,Moderate,30.7,Medium,Urban,NHS,9.0,No,No,Cardiovascular Disease,3.0
PT00332,Portugal,Porto,56.0,Female,Pancreatic,III,2013-07-18,2013-10-27,2014-05-03,Surgery,Private,Alive,79.0,None,No,Never,Moderate,26.5,Medium,Rural,,4.0,No,No,Obesity,3.0
PT00333,Finland,Uusimaa,48.0,Female,Breast,III,2011-09-08,2011-12-20,2012-01-28,Surgery,Private,Alive,22.0,None,Yes,Never,None,19.7,Low,Urban,,12.0,No,No,Diabetes,8.0
PT00334,Norway,Trøndelag,52.0,Female,Ovarian,II,2011-03-12,2011-04-14,2012-01-18,,Private,Alive,82.0,EGFR,No,Current,None,27.6,High,Urban,Private Insurance,12.0,No,Yes,Hypertension,8.0
PT00335,Belgium,Flanders,80.0,Female,Colorectal,II,2023-09-27,2023-10-06,2023-11-08,Immunotherapy,Research Institute,Alive,14.0,KRAS,No,Never,Moderate,26.6,Medium,Urban,Statutory Health Insurance,2.0,No,No,Obesity,10.0
,Austria,Vienna,23.0,Female,Lung,,2018-08-16,2018-08-27,2018-10-10,,Public,Deceased,85.0,BRCA1,No,Former,None,20.2,Medium,Urban,Statutory Health Insurance,6.0,No,No,Hypertension,2.0
PT00337,Switzerland,,33.0,Female,Lung,IV,2014-03-28,2014-07-30,2014-10-20,Radiation,Public,Alive,76.0,EGFR,Yes,Never,Moderate,25.7,High,Urban,Statutory Health Insurance,9.0,No,No,Cardiovascular Disease,4.0
PT00338,Austria,Styria,52.0,Non-binary,Prostate,I,2023-05-23,2023-08-07,2024-03-10,Surgery,Public,Alive,,EGFR,No,Former,None,36.4,Low,Rural,Statutory Health Insurance,17.0,No,No,Hypertension,5.0
PT00339,Sweden,Västra Götaland,41.0,Male,,I,2013-02-08,2013-06-26,2013-09-18,Radiation,Research Institute,Alive,9.0,EGFR,No,Former,,37.7,Medium,Rural,NHS,,No,No,Cardiovascular Disease,6.0
PT00340,Austria,Tyrol,67.0,Male,Colorectal,I,2011-03-28,2011-05-21,2012-02-07,Radiation,Research Institute,Deceased,36.0,KRAS,No,Former,Moderate,23.5,High,Urban,NHS,7.0,No,No,Cardiovascular Disease,1.0
PT00341,Norway,Vestland,22.0,Male,Ovarian,III,2021-12-04,2022-02-17,2022-08-21,Chemotherapy,Research Institute,Alive,101.0,BRCA1,,Never,Moderate,,Low,Rural,Private Insurance,1.0,Yes,No,Cardiovascular Disease,4.0
,Austria,Styria,42.0,Female,Leukemia,II,2017-05-29,2017-09-03,2018-02-18,Immunotherapy,Research Institute,,105.0,BRCA1,,Never,Moderate,24.3,High,Urban,NHS,19.0,No,No,Cardiovascular Disease,10.0
PT00343,Germany,North Rhine-Westphalia,87.0,Female,Pancreatic,,2011-12-13,2012-05-09,2012-11-16,Radiation,Private,Alive,8.0,EGFR,Yes,Never,None,31.8,Medium,Urban,NHS,12.0,No,No,Hypertension,6.0
PT00344,Netherlands,Utrecht,40.0,Male,Leukemia,II,2020-02-07,2020-02-12,2020-11-17,Surgery,Research Institute,Alive,46.0,EGFR,Yes,,None,26.2,Medium,Urban,Private Insurance,11.0,No,Yes,Obesity,1.0
PT00345,Denmark,Capital Region,62.0,Non-binary,Ovarian,I,2015-06-02,2015-06-26,2015-11-27,Targeted Therapy,Public,Alive,12.0,EGFR,Yes,Former,None,32.7,Low,Urban,Statutory Health Insurance,,No,Yes,Obesity,5.0
PT00346,Portugal,Algarve,45.0,Female,Prostate,II,2020-11-04,2021-04-13,2021-09-05,Targeted Therapy,Public,Alive,71.0,KRAS,No,Former,Moderate,18.2,Medium,Urban,Statutory Health Insurance,11.0,No,No,Hypertension,4.0
PT00347,Austria,Vienna,60.0,Female,Pancreatic,IV,2020-05-25,2020-06-25,2021-02-28,Immunotherapy,Private,Deceased,80.0,BRCA1,No,Current,None,31.6,High,Urban,Private Insurance,8.0,No,No,Obesity,3.0
PT00348,Germany,North Rhine-Westphalia,57.0,Male,Leukemia,III,2017-05-23,2017-09-06,2018-07-13,Radiation,Private,Alive,55.0,EGFR,No,Never,Moderate,26.5,Medium,Urban,Private Insurance,3.0,Yes,No,Diabetes,3.0
PT00349,,Lisbon,30.0,Female,Breast,I,2010-06-16,2010-07-30,2011-04-25,Chemotherapy,,Alive,65.0,BRCA1,No,Current,None,31.8,Medium,,Statutory Health Insurance,14.0,No,Yes,Diabetes,2.0
PT00350,Norway,,48.0,Female,,I,2022-07-25,2022-12-19,2023-04-29,Radiation,Private,Alive,76.0,KRAS,Yes,Never,Moderate,38.1,Medium,Urban,Private Insurance,11.0,Yes,No,Diabetes,8.0
PT00351,Austria,Tyrol,79.0,Female,Ovarian,I,2015-10-21,2015-11-14,2016-01-22,Surgery,Public,Alive,52.0,KRAS,No,Former,Moderate,,Medium,Rural,NHS,4.0,No,No,Hypertension,2.0
PT00352,Norway,Oslo,86.0,Female,Pancreatic,III,2016-12-21,2017-04-18,2017-08-18,Radiation,Research Institute,Alive,62.0,None,No,Never,Moderate,30.1,High,Rural,Statutory Health Insurance,4.0,No,No,None,8.0
PT00353,Norway,Vestland,84.0,Female,Breast,II,2013-01-13,2013-01-25,2013-09-02,,Private,Deceased,89.0,EGFR,No,Never,None,21.9,Medium,Urban,NHS,10.0,,No,Diabetes,2.0
PT00354,Germany,Berlin,80.0,Male,Prostate,IV,2015-01-15,2015-07-12,2015-08-21,Targeted Therapy,Public,Deceased,27.0,BRCA1,,Never,Moderate,38.4,Medium,Urban,Private Insurance,14.0,No,No,Cardiovascular Disease,5.0
PT00355,Denmark,Central Denmark,38.0,Female,Prostate,,2018-01-17,2018-04-12,2018-11-15,Immunotherapy,Public,,27.0,None,No,Never,Moderate,28.6,Medium,Urban,Statutory Health Insurance,17.0,No,,None,7.0
PT00356,Portugal,Algarve,65.0,Male,Breast,II,2017-10-25,2018-02-17,2018-09-26,Surgery,Public,Deceased,94.0,EGFR,Yes,Current,Moderate,25.9,Medium,Urban,Statutory Health Insurance,6.0,,No,Hypertension,5.0
PT00357,Germany,Berlin,,Male,Pancreatic,III,2018-10-20,2018-11-14,2019-08-16,Immunotherapy,Public,Alive,23.0,BRCA1,Yes,Never,Moderate,21.1,Medium,Rural,NHS,4.0,,No,None,1.0
PT00358,Denmark,Zealand,41.0,Male,,III,2012-06-09,2012-12-05,2013-05-15,Radiation,Private,Deceased,79.0,BRCA1,Yes,Never,Moderate,38.1,Medium,Rural,Statutory Health Insurance,17.0,Yes,No,None,8.0
PT00359,Netherlands,South Holland,76.0,,Leukemia,I,2013-08-27,2013-12-22,2014-12-16,Chemotherapy,Research Institute,Alive,67.0,EGFR,No,Former,Moderate,39.2,Low,Rural,NHS,16.0,Yes,No,Hypertension,2.0
PT00360,Portugal,Lisbon,33.0,Male,Prostate,II,2019-06-03,2019-10-23,2020-09-26,Immunotherapy,Public,Deceased,119.0,KRAS,Yes,Never,None,39.2,Medium,Urban,Statutory Health Insurance,10.0,No,No,Hypertension,
PT00361,Austria,Styria,63.0,Female,Prostate,II,2014-09-16,2014-11-27,2015-02-20,Targeted Therapy,Public,Alive,106.0,BRCA1,No,Never,Heavy,28.2,Low,Urban,NHS,5.0,No,,Hypertension,
PT00362,Italy,Veneto,35.0,Female,Breast,II,2017-10-31,2017-11-29,2018-02-10,Surgery,Public,Deceased,17.0,None,No,Former,Moderate,36.7,Low,Urban,NHS,10.0,No,No,None,6.0
PT00363,Ireland,Dublin,31.0,Male,Prostate,I,2012-08-28,2012-09-22,2013-05-18,Radiation,Private,Lost to Follow-up,,BRCA1,No,Never,Moderate,33.5,Low,Urban,Private Insurance,,,Yes,None,4.0
PT00364,Finland,Southwest Finland,74.0,Female,Ovarian,I,2019-08-14,2019-11-09,2020-08-25,Surgery,Private,,34.0,None,No,Current,None,28.3,,Rural,NHS,6.0,No,No,None,2.0
PT00365,Belgium,Flanders,70.0,Male,,,2010-03-08,2010-06-16,2011-01-26,Surgery,Public,Alive,8.0,None,No,Former,Moderate,36.3,Low,Rural,NHS,19.0,No,No,None,7.0
PT00366,Portugal,Algarve,58.0,Male,Prostate,I,2020-07-12,2020-11-29,2021-03-18,Surgery,Public,Alive,58.0,None,,Never,None,28.3,Medium,Urban,NHS,17.0,No,,None,10.0
PT00367,Denmark,Zealand,52.0,Female,Breast,IV,2012-04-17,,2013-01-17,Targeted Therapy,Private,Alive,31.0,EGFR,,Current,Heavy,35.3,Low,Rural,Statutory Health Insurance,12.0,No,No,Cardiovascular Disease,
PT00368,Switzerland,Geneva,52.0,Female,Leukemia,III,2012-07-15,2012-12-02,2013-05-17,Chemotherapy,Public,Deceased,86.0,BRCA1,Yes,Current,Heavy,39.0,High,Urban,Private Insurance,18.0,No,Yes,Hypertension,8.0
,Denmark,Capital Region,48.0,Female,Colorectal,III,2019-11-15,2020-02-05,2020-03-09,Immunotherapy,Public,Alive,89.0,EGFR,Yes,Never,None,32.6,High,Urban,Statutory Health Insurance,6.0,No,No,Diabetes,8.0
PT00370,Norway,Trøndelag,88.0,Male,Breast,II,2010-12-07,2011-03-17,2011-08-10,Targeted Therapy,,Deceased,57.0,EGFR,No,Never,None,38.6,Low,Urban,NHS,1.0,No,No,Cardiovascular Disease,9.0
,Poland,Masovian,89.0,,Colorectal,III,2020-04-07,2020-09-30,2021-02-01,Chemotherapy,Research Institute,Alive,105.0,KRAS,Yes,Former,Moderate,29.7,High,Rural,Private Insurance,9.0,Yes,No,Obesity,8.0
PT00372,Italy,Lombardy,50.0,Female,Prostate,IV,2010-04-12,2010-10-07,2011-06-02,Radiation,Public,Alive,104.0,EGFR,No,Former,None,23.0,Medium,Urban,Statutory Health Insurance,4.0,No,No,Diabetes,6.0
PT00373,Switzerland,Bern,50.0,Non-binary,Leukemia,II,2019-04-09,2019-04-28,2019-06-12,Immunotherapy,Public,Alive,89.0,KRAS,,Former,Moderate,30.4,High,,Private Insurance,2.0,No,No,None,7.0
PT00374,Ireland,Connacht,65.0,Male,Prostate,III,2023-10-27,2024-02-16,2024-07-05,Chemotherapy,,Alive,108.0,BRCA1,Yes,Never,None,30.0,Medium,Urban,Statutory Health Insurance,2.0,No,No,Diabetes,
PT00375,Sweden,Skåne,71.0,Female,Leukemia,II,2013-02-07,2013-04-01,2014-03-22,Radiation,Public,,83.0,None,Yes,Never,Moderate,,Medium,Urban,Statutory Health Insurance,9.0,No,No,Diabetes,7.0
,Germany,Bavaria,29.0,Female,Lung,IV,2023-09-12,2023-10-17,2024-06-24,Immunotherapy,Private,,111.0,None,Yes,Former,None,33.1,Low,Urban,Private Insurance,2.0,No,No,None,5.0
PT00377,,Sicily,60.0,Non-binary,Prostate,IV,2016-07-17,2016-11-07,2017-09-03,Radiation,Public,Alive,46.0,EGFR,No,Former,None,21.4,Low,Urban,NHS,6.0,No,No,Diabetes,3.0
PT00378,Netherlands,North Holland,22.0,Male,,IV,2012-04-07,2012-09-09,2013-03-16,Targeted Therapy,Private,Deceased,18.0,EGFR,Yes,Current,Moderate,28.7,Low,Urban,Private Insurance,,No,No,Hypertension,4.0
PT00379,Poland,Lesser Poland,78.0,Female,Prostate,I,2017-06-19,,2017-12-26,Radiation,Public,Deceased,45.0,BRCA1,Yes,Former,Moderate,,Low,Urban,Statutory Health Insurance,19.0,No,No,Obesity,7.0
PT00380,Spain,Madrid,71.0,Male,Pancreatic,I,2015-12-22,2016-02-11,,Surgery,,Alive,97.0,BRCA1,No,Never,Moderate,39.6,Medium,Urban,NHS,7.0,No,Yes,Diabetes,6.0
PT00381,Norway,Vestland,53.0,Female,Breast,I,2023-12-10,2024-03-24,,Targeted Therapy,Public,,106.0,BRCA1,No,Never,None,22.4,Medium,Urban,Statutory Health Insurance,6.0,No,Yes,Hypertension,2.0
PT00382,Poland,,68.0,Male,Pancreatic,II,2011-01-20,2011-06-16,2012-05-06,Radiation,Private,Alive,56.0,BRCA1,No,Never,Moderate,38.9,Low,Rural,Private Insurance,4.0,No,No,Obesity,4.0
PT00383,Belgium,Brussels,47.0,Male,,II,2011-08-21,2011-10-03,2012-09-15,Targeted Therapy,Private,Alive,101.0,EGFR,No,Never,None,38.4,Low,Rural,Statutory Health Insurance,16.0,No,No,None,4.0
PT00384,Switzerland,Zurich,32.0,Female,Leukemia,I,2010-01-09,2010-02-13,2010-11-24,Immunotherapy,Research Institute,Alive,,KRAS,Yes,Never,Heavy,25.8,Medium,Urban,NHS,6.0,Yes,No,Hypertension,
PT00385,Germany,Berlin,88.0,Male,Leukemia,III,2021-08-02,2021-08-17,2022-07-31,Surgery,,Deceased,41.0,None,,Former,None,18.4,Medium,Urban,Private Insurance,15.0,No,,Cardiovascular Disease,4.0
PT00386,Austria,Tyrol,86.0,Male,Breast,I,2013-08-06,2013-12-28,2014-10-26,Surgery,Private,Lost to Follow-up,,KRAS,No,Current,Moderate,34.1,Medium,Urban,NHS,12.0,Yes,Yes,Obesity,9.0
PT00387,Norway,Vestland,80.0,Male,Leukemia,IV,2023-11-20,2024-02-27,2024-05-04,Radiation,Research Institute,Alive,19.0,KRAS,Yes,Former,Moderate,21.5,Low,Urban,Private Insurance,8.0,No,No,Hypertension,4.0
PT00388,Norway,,79.0,Male,Pancreatic,,2012-09-05,2012-11-13,,Immunotherapy,,Deceased,31.0,BRCA1,Yes,Never,None,32.0,Medium,Urban,Statutory Health Insurance,19.0,No,No,,
PT00389,Denmark,Capital Region,43.0,Female,Ovarian,II,2020-03-12,2020-06-05,2021-01-07,Targeted Therapy,Public,Alive,71.0,BRCA1,Yes,Current,Moderate,22.4,Low,Urban,Private Insurance,18.0,No,No,None,10.0
PT00390,Norway,Oslo,82.0,Female,Pancreatic,III,2015-09-22,2016-03-09,2016-05-02,Radiation,Private,Alive,,BRCA1,Yes,Current,None,18.5,Medium,Rural,Statutory Health Insurance,9.0,,No,Cardiovascular Disease,8.0
,Norway,Oslo,80.0,Female,Ovarian,III,2018-09-12,2018-10-12,2019-10-09,Chemotherapy,Public,Alive,78.0,None,Yes,,Moderate,18.8,Low,Urban,Statutory Health Insurance,16.0,No,No,Obesity,8.0
PT00392,Portugal,Algarve,42.0,Male,Prostate,,2015-01-22,2015-06-18,2015-12-06,Radiation,Public,Alive,55.0,KRAS,Yes,Former,Moderate,32.1,Medium,Urban,Statutory Health Insurance,13.0,No,No,,10.0
PT00393,France,Auvergne-Rhône-Alpes,49.0,Female,Colorectal,III,2018-06-30,2018-09-26,2019-02-26,Chemotherapy,Public,Alive,105.0,None,No,Never,None,36.2,Low,Rural,Private Insurance,4.0,No,Yes,Obesity,2.0
PT00394,Poland,Silesian,79.0,Female,Ovarian,II,2020-04-11,2020-05-27,2020-07-20,Surgery,Research Institute,Alive,76.0,BRCA1,No,Never,Moderate,37.1,Medium,Urban,,3.0,No,No,Cardiovascular Disease,
PT00395,Ireland,Dublin,37.0,Female,Lung,IV,2020-04-02,2020-06-01,2021-04-17,Radiation,Public,Alive,40.0,EGFR,No,Never,Moderate,31.6,Medium,Urban,Statutory Health Insurance,18.0,No,Yes,None,
PT00396,Finland,Uusimaa,75.0,Female,Leukemia,IV,2014-11-24,2015-02-11,2016-02-10,Radiation,Public,Alive,86.0,None,Yes,Current,Moderate,25.4,Medium,Urban,,3.0,No,No,Diabetes,3.0
PT00397,Austria,Styria,72.0,Female,Breast,II,2013-05-27,2013-06-20,2014-01-10,Surgery,Public,Alive,95.0,KRAS,No,Current,None,30.6,Medium,Urban,Private Insurance,19.0,No,No,Cardiovascular Disease,1.0
PT00398,Italy,Sicily,26.0,Female,Ovarian,IV,2015-07-01,2015-12-12,2016-08-29,Targeted Therapy,Private,Deceased,34.0,EGFR,No,Never,Moderate,32.7,Low,Urban,NHS,19.0,No,Yes,None,
PT00399,Ireland,Munster,88.0,Male,Breast,III,2010-04-23,2010-10-17,2011-04-09,Radiation,Public,Alive,43.0,BRCA1,No,,Moderate,31.6,Medium,Urban,Statutory Health Insurance,3.0,Yes,No,Diabetes,2.0
PT00400,Ireland,Munster,71.0,Male,Leukemia,IV,2020-04-24,2020-05-08,2020-06-29,Immunotherapy,Public,,38.0,BRCA1,Yes,Never,Moderate,,Medium,Urban,Private Insurance,,No,No,Cardiovascular Disease,6.0
PT00401,France,Provence-Alpes-Côte d'Azur,23.0,Female,Colorectal,IV,2019-02-14,2019-03-25,2019-12-03,,Research Institute,Alive,80.0,BRCA1,No,Former,Moderate,31.4,Medium,Rural,Statutory Health Insurance,5.0,Yes,No,None,8.0
PT00402,Finland,Southwest Finland,53.0,Female,Pancreatic,III,2019-09-13,2019-09-21,2020-02-19,Targeted Therapy,Public,Deceased,103.0,KRAS,Yes,Current,None,,Medium,Rural,NHS,17.0,No,No,,6.0
PT00403,France,Île-de-France,,Male,Leukemia,II,2013-09-25,2014-03-20,2014-11-27,Surgery,Private,Deceased,11.0,EGFR,No,Never,None,28.0,High,,NHS,5.0,No,No,Diabetes,6.0
PT00404,France,Auvergne-Rhône-Alpes,52.0,Male,Breast,I,2017-12-29,2018-03-19,2018-12-03,Surgery,Public,Deceased,23.0,EGFR,No,,Moderate,33.3,Low,Rural,NHS,1.0,Yes,No,Diabetes,7.0
PT00405,Ireland,,88.0,Female,Lung,IV,2020-12-09,2021-02-28,2021-04-15,Targeted Therapy,Public,Alive,36.0,KRAS,Yes,Former,None,32.4,Low,Rural,,19.0,No,No,None,3.0
PT00406,Austria,Tyrol,57.0,Female,Colorectal,III,2016-04-12,2016-05-23,2017-04-02,Targeted Therapy,Research Institute,Alive,84.0,KRAS,No,Never,None,,,Urban,NHS,12.0,No,No,Obesity,8.0
PT00407,Belgium,Wallonia,45.0,Male,Leukemia,I,2019-03-30,2019-05-04,2019-06-04,Targeted Therapy,Research Institute,Alive,99.0,EGFR,No,Current,None,18.0,High,Urban,Statutory Health Insurance,8.0,Yes,No,Hypertension,1.0
PT00408,Switzerland,Geneva,20.0,Male,Ovarian,II,2020-11-03,2020-12-27,2021-10-19,Immunotherapy,Private,Deceased,,KRAS,Yes,Former,Heavy,36.8,Medium,Urban,NHS,10.0,No,No,Obesity,2.0
PT00409,Portugal,Lisbon,23.0,Female,Lung,III,2019-05-26,2019-11-07,2019-12-22,Chemotherapy,Research Institute,Alive,82.0,KRAS,Yes,Current,None,33.4,Medium,Rural,NHS,13.0,No,No,Diabetes,8.0
PT00410,Netherlands,,,Female,Leukemia,II,2013-09-11,2013-09-29,2013-11-18,Surgery,Private,Deceased,,KRAS,Yes,Never,Moderate,37.6,Medium,Urban,NHS,11.0,No,No,Obesity,6.0
PT00411,,Masovian,,Male,Colorectal,I,2010-11-04,2010-11-25,2011-09-01,Radiation,Public,Alive,89.0,BRCA1,Yes,Never,None,23.9,Medium,Rural,Private Insurance,,,No,Diabetes,10.0
PT00412,Portugal,Algarve,52.0,,Breast,I,2013-09-08,2013-10-20,2014-08-22,Chemotherapy,Research Institute,Alive,45.0,BRCA1,No,Current,Moderate,39.7,Medium,Urban,Private Insurance,14.0,No,Yes,Cardiovascular Disease,3.0
PT00413,Belgium,,52.0,Female,Pancreatic,III,2012-05-16,2012-07-20,2012-08-24,Radiation,Public,Alive,52.0,BRCA1,No,Current,Moderate,27.5,Medium,Rural,Statutory Health Insurance,1.0,No,No,None,10.0
PT00414,Sweden,Stockholm,39.0,Female,Ovarian,II,2023-02-28,2023-07-14,2024-06-09,Radiation,Private,Alive,68.0,EGFR,No,Never,Heavy,38.2,Low,Urban,Statutory Health Insurance,18.0,Yes,No,Hypertension,7.0
PT00415,Netherlands,South Holland,35.0,Non-binary,Pancreatic,II,2014-02-21,2014-06-15,2015-03-08,Radiation,Public,Alive,87.0,KRAS,No,Current,Moderate,32.1,Medium,,NHS,3.0,No,No,None,6.0
PT00416,Sweden,Stockholm,40.0,Female,Colorectal,III,2016-04-02,2016-07-12,2016-09-02,Immunotherapy,Public,Alive,48.0,BRCA1,Yes,Current,None,24.1,High,Rural,Private Insurance,15.0,No,No,Cardiovascular Disease,9.0
PT00417,Belgium,Brussels,,Male,Prostate,III,2021-01-07,2021-06-23,,,Private,Deceased,7.0,None,Yes,Never,Heavy,25.4,Medium,Urban,Private Insurance,11.0,No,No,Diabetes,8.0
PT00418,Denmark,Zealand,81.0,Male,Pancreatic,I,2020-05-06,2020-07-06,2021-02-05,Chemotherapy,Research Institute,Alive,81.0,EGFR,No,Current,None,31.9,High,Urban,Private Insurance,5.0,No,No,Obesity,8.0
PT00419,Finland,Uusimaa,50.0,Male,Leukemia,I,2012-05-17,2012-05-27,2013-02-04,Targeted Therapy,Public,Alive,25.0,BRCA1,Yes,Never,None,33.0,Medium,Urban,Statutory Health Insurance,15.0,No,No,None,9.0
PT00420,,Zealand,61.0,Male,Lung,II,2013-10-14,2013-10-21,2013-12-28,Immunotherapy,Public,Alive,118.0,None,Yes,Never,Moderate,30.1,Medium,Rural,NHS,9.0,Yes,No,Diabetes,1.0
PT00421,Norway,Vestland,31.0,Male,Lung,III,2019-11-24,,2020-02-27,Surgery,Private,Alive,,None,Yes,Former,Moderate,38.9,Medium,Urban,,,No,No,Hypertension,10.0
PT00422,Italy,Veneto,84.0,Male,Ovarian,I,2015-09-04,2015-12-04,2016-01-04,Chemotherapy,Public,,,EGFR,,Current,Moderate,32.4,Medium,Urban,Private Insurance,5.0,No,Yes,Diabetes,3.0
PT00423,Spain,Madrid,22.0,Female,Pancreatic,II,2017-11-02,2017-12-14,2018-06-26,Surgery,Public,Deceased,78.0,KRAS,No,Former,Moderate,21.6,Medium,Urban,,14.0,No,No,Cardiovascular Disease,9.0
PT00424,Germany,Bavaria,28.0,Female,Colorectal,IV,2012-09-10,2012-12-07,2013-11-01,Radiation,Public,Alive,115.0,KRAS,No,Never,,19.2,Medium,Urban,Statutory Health Insurance,,Yes,No,Obesity,10.0
PT00425,Germany,Bavaria,,Female,Ovarian,IV,2012-10-21,2012-11-19,2013-04-24,Surgery,Public,Alive,40.0,KRAS,No,Never,Moderate,36.2,Medium,Rural,Statutory Health Insurance,4.0,No,No,None,1.0
PT00426,Switzerland,Zurich,35.0,Female,Colorectal,II,,2017-01-04,,,Private,Alive,60.0,BRCA1,No,Never,None,24.4,,Urban,Private Insurance,14.0,,No,Hypertension,10.0
PT00427,Austria,Tyrol,22.0,Male,Colorectal,I,2010-04-28,2010-06-05,2010-09-17,Surgery,Public,Alive,57.0,EGFR,No,Former,None,39.5,,Urban,Statutory Health Insurance,2.0,No,No,Hypertension,3.0
PT00428,Denmark,Capital Region,43.0,Male,Lung,I,2016-12-01,2016-12-03,2017-11-06,Radiation,Private,Alive,100.0,,Yes,Former,None,34.1,Low,Urban,NHS,,No,No,Cardiovascular Disease,2.0
,Portugal,Lisbon,32.0,Male,Breast,I,2015-12-01,2015-12-26,2016-04-09,Radiation,Public,Alive,50.0,EGFR,Yes,Former,None,24.5,High,Urban,NHS,10.0,,No,Obesity,
PT00430,Ireland,Connacht,21.0,Female,Lung,I,2013-05-03,2013-06-10,2014-04-10,Immunotherapy,Research Institute,,52.0,None,No,Never,Moderate,38.9,Medium,Urban,NHS,13.0,No,No,Obesity,1.0
PT00431,Germany,Bavaria,40.0,Male,Breast,II,2012-11-09,2013-01-07,2013-12-03,Chemotherapy,Public,Alive,98.0,EGFR,Yes,Current,Heavy,19.3,,Urban,Private Insurance,17.0,No,No,Hypertension,4.0
,Netherlands,North Holland,38.0,Female,Ovarian,II,2016-11-10,2017-02-24,2017-11-15,Targeted Therapy,Public,Deceased,56.0,None,Yes,Current,Moderate,29.0,Low,,NHS,12.0,No,No,Obesity,9.0
,Finland,Southwest Finland,66.0,,Ovarian,I,2020-06-11,2020-06-18,2020-09-10,Chemotherapy,Public,Alive,34.0,None,Yes,Never,None,21.6,High,Rural,Private Insurance,17.0,No,,Cardiovascular Disease,1.0
PT00434,France,Provence-Alpes-Côte d'Azur,41.0,Male,Ovarian,IV,2019-08-21,2020-02-14,2020-09-29,Targeted Therapy,Public,Alive,73.0,EGFR,No,,Moderate,38.3,High,Urban,NHS,10.0,No,No,Cardiovascular Disease,5.0
PT00435,Norway,Oslo,52.0,Male,Colorectal,III,2017-05-11,2017-08-27,2017-10-24,Immunotherapy,Public,Deceased,109.0,KRAS,Yes,Never,Moderate,18.7,High,Rural,Statutory Health Insurance,4.0,No,Yes,None,1.0
PT00436,Belgium,Flanders,51.0,Female,,II,2018-08-23,2018-10-03,2019-09-01,,Public,Alive,55.0,None,No,Former,Moderate,34.1,Medium,Urban,NHS,15.0,No,No,Hypertension,8.0
PT00437,Germany,North Rhine-Westphalia,83.0,Female,Lung,IV,2011-07-30,2012-01-25,2013-01-16,Immunotherapy,Public,Alive,19.0,KRAS,No,Never,Moderate,37.0,Medium,Urban,NHS,,No,No,None,2.0
PT00438,Spain,Madrid,58.0,Female,Colorectal,III,2019-02-28,2019-06-13,2019-09-13,Radiation,,Alive,33.0,None,No,Current,None,24.1,Medium,Rural,NHS,3.0,No,No,Cardiovascular Disease,5.0
PT00439,Denmark,,61.0,,Lung,IV,2017-10-18,2018-01-20,2018-07-17,Chemotherapy,Public,Alive,,KRAS,Yes,Current,Moderate,34.0,Medium,Rural,Statutory Health Insurance,12.0,Yes,No,Cardiovascular Disease,7.0
PT00440,Netherlands,North Holland,28.0,Female,Colorectal,I,2011-02-07,2011-03-03,2012-02-08,Targeted Therapy,Public,Alive,38.0,KRAS,,Former,None,19.9,,Urban,NHS,19.0,No,No,Diabetes,1.0
PT00441,Finland,Uusimaa,44.0,Male,Lung,I,2010-09-10,2010-10-16,2011-08-10,Chemotherapy,,Alive,109.0,KRAS,No,Never,Moderate,21.5,Medium,,NHS,7.0,,No,None,7.0
PT00442,Norway,Oslo,21.0,Non-binary,Leukemia,II,2014-06-18,2014-09-06,,Targeted Therapy,Private,Alive,77.0,None,No,Former,None,39.1,High,,NHS,10.0,No,No,Cardiovascular Disease,2.0
PT00443,Belgium,Flanders,38.0,Female,Lung,II,2017-06-02,2017-10-18,2018-05-31,Surgery,Public,Alive,56.0,KRAS,No,Never,Moderate,23.0,High,Rural,NHS,14.0,No,No,Hypertension,6.0
PT00444,Poland,Lesser Poland,39.0,Female,Leukemia,I,2023-01-17,2023-02-07,,Chemotherapy,Public,Alive,6.0,None,No,Never,None,24.4,Medium,Rural,NHS,3.0,Yes,No,None,9.0
PT00445,Belgium,Brussels,89.0,Male,Breast,III,2023-03-17,2023-04-13,2024-02-01,,Public,Alive,73.0,KRAS,Yes,Former,None,37.7,High,Urban,Private Insurance,1.0,No,No,Diabetes,9.0
PT00446,France,,36.0,Female,Lung,I,2019-02-14,2019-04-10,2019-07-22,Immunotherapy,Public,Alive,34.0,,No,Never,Moderate,24.4,Low,Rural,Statutory Health Insurance,16.0,Yes,No,Diabetes,7.0
PT00447,Belgium,Wallonia,87.0,Male,Breast,III,2021-01-26,2021-04-21,2021-08-03,Radiation,Research Institute,Deceased,40.0,BRCA1,Yes,Never,Moderate,29.4,Low,Rural,Statutory Health Insurance,,No,No,Cardiovascular Disease,4.0
PT00448,France,,22.0,Male,Prostate,II,2017-04-13,2017-08-24,2017-12-28,Radiation,Private,Alive,23.0,None,No,Former,Moderate,24.5,High,Urban,Statutory Health Insurance,15.0,No,No,Hypertension,9.0
PT00449,Spain,Madrid,70.0,Male,Pancreatic,III,2012-09-05,2012-12-31,2013-09-27,Chemotherapy,Private,Alive,107.0,None,No,Never,None,,High,Urban,Private Insurance,3.0,No,,Hypertension,1.0
PT00450,Netherlands,North Holland,45.0,Female,Pancreatic,II,2020-06-13,2020-08-11,2021-01-26,Surgery,Private,Alive,49.0,EGFR,,Former,Moderate,39.4,Low,Urban,NHS,9.0,No,No,Obesity,9.0
PT00451,Denmark,Zealand,75.0,,Leukemia,IV,2017-06-19,2017-11-30,2018-04-17,Surgery,Public,Alive,60.0,None,No,Never,None,20.6,High,Urban,NHS,11.0,Yes,No,Obesity,6.0
PT00452,Denmark,Zealand,,Male,Lung,II,2011-07-23,2011-10-05,2011-12-01,Targeted Therapy,Public,Alive,119.0,EGFR,No,Current,None,35.6,Medium,Urban,Statutory Health Insurance,5.0,Yes,,Diabetes,1.0
PT00453,Sweden,Västra Götaland,27.0,Female,Pancreatic,IV,2022-09-13,2022-10-17,2023-02-25,Chemotherapy,Research Institute,Alive,41.0,BRCA1,No,,None,30.6,High,Urban,Statutory Health Insurance,,No,No,Obesity,1.0
PT00454,Finland,Southwest Finland,56.0,Male,Breast,I,2022-08-20,2022-10-11,2023-03-08,Chemotherapy,Public,Deceased,109.0,KRAS,No,Current,None,29.9,Low,Rural,NHS,10.0,No,No,Diabetes,3.0
PT00455,Switzerland,Bern,46.0,Male,Pancreatic,III,2021-03-29,2021-08-10,2021-11-19,Surgery,Public,Deceased,24.0,KRAS,Yes,Never,Moderate,31.6,Medium,Urban,Private Insurance,8.0,No,,None,
PT00456,Austria,Styria,64.0,Male,Pancreatic,II,2021-08-23,2022-01-12,2022-03-09,Surgery,Public,Alive,54.0,BRCA1,Yes,Current,None,36.1,High,Urban,Statutory Health Insurance,6.0,No,No,None,2.0
PT00457,Belgium,Wallonia,23.0,Female,Colorectal,III,2017-08-04,2017-10-02,2018-03-30,Radiation,Public,Alive,26.0,EGFR,Yes,,Moderate,33.6,Medium,Urban,Private Insurance,13.0,No,No,,7.0
PT00458,Finland,Uusimaa,56.0,Female,Pancreatic,III,2021-08-07,2021-10-03,2022-04-20,Chemotherapy,Public,Alive,58.0,,No,Current,None,29.1,Medium,Rural,Statutory Health Insurance,9.0,No,No,Diabetes,5.0
PT00459,Norway,Vestland,52.0,Female,Breast,III,2021-02-06,2021-06-06,2021-12-12,Radiation,Public,Alive,85.0,None,No,Never,Moderate,18.6,Low,Rural,Private Insurance,15.0,No,No,None,1.0
PT00460,Spain,Catalonia,50.0,Female,Pancreatic,I,2017-05-10,2017-06-16,2017-12-04,Immunotherapy,Public,Alive,75.0,BRCA1,No,,None,26.8,High,Rural,Private Insurance,19.0,No,No,Diabetes,5.0
PT00461,France,Provence-Alpes-Côte d'Azur,74.0,Male,Lung,III,2020-12-12,2021-01-13,,Immunotherapy,Public,Alive,95.0,KRAS,No,Never,Moderate,37.8,Medium,Urban,Statutory Health Insurance,4.0,No,No,None,3.0
PT00462,Switzerland,Bern,31.0,Female,,I,2010-05-17,2010-06-06,2011-03-12,Surgery,Public,Alive,6.0,None,No,Former,None,30.7,Medium,Rural,NHS,8.0,Yes,No,Hypertension,3.0
PT00463,Switzerland,Zurich,30.0,Male,Prostate,I,2023-02-08,2023-06-14,2024-01-12,Targeted Therapy,Public,Alive,87.0,None,Yes,Current,Moderate,,Low,Urban,Statutory Health Insurance,5.0,Yes,Yes,Hypertension,10.0
PT00464,Austria,Vienna,51.0,Female,Pancreatic,I,2013-11-24,2014-02-13,2014-10-03,Surgery,Public,Deceased,112.0,,No,Former,None,19.5,High,Urban,Statutory Health Insurance,16.0,No,No,Cardiovascular Disease,4.0
PT00465,Spain,Catalonia,76.0,Female,Leukemia,II,2014-01-05,2014-04-24,2014-08-02,Chemotherapy,Public,Alive,6.0,,No,Former,Moderate,39.3,Low,,Statutory Health Insurance,18.0,No,No,Cardiovascular Disease,1.0
PT00466,Sweden,Stockholm,57.0,Female,,III,2019-02-21,2019-04-14,2019-11-12,Surgery,Research Institute,Lost to Follow-up,,BRCA1,No,Former,Moderate,23.1,Medium,Urban,,2.0,No,No,Obesity,2.0
PT00467,Austria,Tyrol,79.0,Female,Ovarian,I,2023-01-24,2023-04-22,2023-11-10,Radiation,Private,Lost to Follow-up,,EGFR,No,Current,Moderate,32.6,High,Urban,Statutory Health Insurance,6.0,No,Yes,Diabetes,6.0
PT00468,Germany,Bavaria,38.0,Female,Breast,I,2020-06-29,2020-09-22,2020-11-20,Surgery,Private,Alive,32.0,KRAS,No,Former,Moderate,31.0,Low,Urban,Private Insurance,3.0,No,No,None,5.0
PT00469,France,Provence-Alpes-Côte d'Azur,75.0,Male,Pancreatic,III,2014-03-17,2014-09-09,2015-08-26,Radiation,Private,Alive,24.0,KRAS,No,Never,Moderate,21.7,Medium,,NHS,7.0,No,No,Diabetes,10.0
PT00470,Ireland,Connacht,33.0,Female,Pancreatic,IV,2016-05-13,2016-07-31,2017-01-30,Immunotherapy,Research Institute,Alive,104.0,KRAS,No,Never,Moderate,22.6,High,Urban,NHS,3.0,No,No,,6.0
PT00471,France,Île-de-France,52.0,Male,Lung,III,2020-04-13,2020-08-30,2020-12-26,Radiation,Research Institute,Alive,95.0,BRCA1,,Former,None,38.7,High,Rural,Statutory Health Insurance,12.0,No,No,Cardiovascular Disease,6.0
PT00472,Netherlands,North Holland,29.0,Male,Ovarian,III,2013-10-11,2014-01-20,2014-09-27,Chemotherapy,Private,Alive,57.0,KRAS,No,Never,None,39.9,Low,Urban,Private Insurance,,No,No,Obesity,7.0
PT00473,Norway,Trøndelag,83.0,Female,Lung,II,2012-07-21,2012-12-26,,Surgery,Private,Alive,84.0,EGFR,Yes,Never,Moderate,26.1,High,Rural,Private Insurance,9.0,No,Yes,,8.0
PT00474,Netherlands,,83.0,Female,Leukemia,III,2020-07-12,2020-09-10,2021-08-26,Chemotherapy,Public,Alive,75.0,None,Yes,Former,Moderate,29.0,High,Urban,Private Insurance,16.0,No,Yes,Diabetes,3.0
PT00475,,Berlin,81.0,Male,Ovarian,IV,2012-12-03,2013-04-28,2013-06-21,,Public,Alive,68.0,EGFR,No,Never,None,29.4,Medium,Urban,Private Insurance,9.0,No,No,Hypertension,5.0
PT00476,Belgium,Brussels,87.0,Female,,II,2018-01-17,2018-05-17,2018-09-21,Radiation,Public,Alive,100.0,BRCA1,No,Never,None,20.8,Low,Urban,Private Insurance,6.0,No,No,Cardiovascular Disease,3.0
PT00477,Austria,Tyrol,62.0,Non-binary,,II,2010-07-30,2011-01-21,2011-04-02,Radiation,Private,Alive,103.0,BRCA1,Yes,Former,Moderate,39.4,Low,Urban,Private Insurance,15.0,Yes,Yes,Diabetes,6.0
PT00478,Denmark,Central Denmark,78.0,Female,Breast,IV,2016-07-18,2016-11-21,2017-10-16,Radiation,Public,Deceased,118.0,None,Yes,Current,Moderate,24.7,Medium,Urban,Statutory Health Insurance,7.0,No,No,Diabetes,5.0
PT00479,Sweden,Skåne,71.0,Female,Breast,IV,2017-09-07,2017-09-19,2017-12-26,Radiation,Private,Alive,115.0,None,Yes,Never,Moderate,27.7,Medium,Urban,NHS,4.0,No,Yes,None,8.0
PT00480,Norway,Trøndelag,38.0,Female,Leukemia,I,,2023-02-03,2023-11-23,Surgery,Public,Alive,86.0,None,Yes,Never,Moderate,37.4,Low,Urban,Statutory Health Insurance,11.0,Yes,No,Obesity,1.0
PT00481,Spain,Madrid,40.0,Male,Leukemia,II,2010-08-20,2010-11-30,2011-03-02,,Public,Alive,72.0,BRCA1,No,Never,Moderate,33.5,Low,Rural,Statutory Health Insurance,4.0,No,No,Diabetes,5.0
PT00482,Switzerland,Geneva,41.0,Female,Pancreatic,III,2012-03-14,2012-07-04,2013-02-24,Chemotherapy,Public,Alive,112.0,,No,,Moderate,24.5,Low,Rural,Statutory Health Insurance,14.0,Yes,No,Obesity,2.0
PT00483,Austria,Styria,28.0,Female,Colorectal,II,2013-04-08,2013-05-18,2013-11-11,Immunotherapy,Private,,89.0,EGFR,No,Never,,19.4,Low,Urban,NHS,7.0,No,No,Cardiovascular Disease,2.0
PT00484,Austria,Styria,28.0,Female,Breast,II,2019-07-08,2019-07-27,2020-07-19,Immunotherapy,,Deceased,7.0,BRCA1,Yes,Never,Moderate,21.0,Medium,Urban,Private Insurance,5.0,Yes,Yes,None,6.0
PT00485,,Dublin,46.0,Female,Breast,III,2010-08-22,2010-11-17,2011-08-28,Chemotherapy,Public,Alive,42.0,None,No,Current,None,26.6,Medium,Urban,Statutory Health Insurance,17.0,Yes,No,None,7.0
PT00486,Finland,Uusimaa,36.0,Male,Pancreatic,I,2017-01-11,2017-04-21,2018-01-26,Surgery,Private,Alive,58.0,BRCA1,No,Former,Moderate,27.8,Medium,Rural,Statutory Health Insurance,3.0,No,No,Obesity,5.0
PT00487,Spain,Madrid,63.0,Male,Colorectal,II,2015-11-18,2016-04-21,2017-02-05,Chemotherapy,Private,Alive,78.0,EGFR,No,Current,None,28.6,Medium,Urban,NHS,13.0,Yes,No,Hypertension,3.0
PT00488,Germany,North Rhine-Westphalia,64.0,Male,Ovarian,IV,2016-06-13,2016-09-01,2017-02-06,Radiation,Public,Deceased,92.0,BRCA1,No,Never,None,19.5,Medium,Urban,NHS,,No,No,Hypertension,4.0
PT00489,Germany,,27.0,Male,Colorectal,III,2017-10-21,2017-10-28,2017-12-07,Targeted Therapy,Public,Alive,102.0,KRAS,No,Never,None,18.9,High,Urban,Private Insurance,6.0,No,,Cardiovascular Disease,10.0
PT00490,Austria,Styria,37.0,Male,Colorectal,IV,2014-09-20,2014-12-06,2015-01-21,Chemotherapy,Private,Alive,116.0,EGFR,,Never,Moderate,31.7,Low,Urban,Statutory Health Insurance,19.0,No,No,Cardiovascular Disease,8.0
PT00491,Portugal,,52.0,Male,Lung,III,,,2022-09-09,Surgery,Private,,44.0,BRCA1,No,Former,None,21.6,Medium,Rural,NHS,11.0,Yes,,None,8.0
PT00492,Spain,Catalonia,20.0,Female,Colorectal,III,2013-02-20,2013-05-22,,Radiation,,Lost to Follow-up,,EGFR,Yes,Never,Moderate,32.4,Low,Urban,NHS,3.0,No,No,None,1.0
PT00493,Ireland,Dublin,25.0,Female,Prostate,III,2010-05-12,2010-10-18,2011-06-10,Chemotherapy,Public,Alive,36.0,KRAS,Yes,Never,Moderate,21.3,Medium,Urban,NHS,2.0,No,No,Cardiovascular Disease,6.0
PT00494,Ireland,Munster,60.0,Female,Leukemia,I,2015-10-11,2016-02-27,,Chemotherapy,Research Institute,Alive,24.0,,No,Current,None,30.1,Low,Urban,,1.0,Yes,No,Cardiovascular Disease,9.0
PT00495,Belgium,Flanders,74.0,Female,Colorectal,III,2012-04-11,2012-09-03,2012-12-08,Radiation,Research Institute,Deceased,47.0,KRAS,No,Never,Heavy,24.0,Medium,Urban,Private Insurance,1.0,No,,Hypertension,4.0
PT00496,Poland,Masovian,24.0,Male,Lung,II,2020-04-19,2020-06-24,2021-03-25,Surgery,Public,Deceased,56.0,BRCA1,No,Former,None,22.4,Low,Urban,Private Insurance,14.0,No,No,Obesity,4.0
PT00497,Spain,Madrid,78.0,Male,Ovarian,III,,2012-03-09,2012-12-30,Targeted Therapy,Public,Deceased,73.0,KRAS,No,Former,Moderate,22.9,Low,Urban,Statutory Health Insurance,6.0,No,No,Diabetes,
PT00498,Austria,Vienna,37.0,Female,Prostate,I,2011-02-07,,2012-02-08,,Public,Alive,116.0,KRAS,No,Never,Heavy,27.4,Medium,Rural,Statutory Health Insurance,,No,No,None,8.0
,Germany,Berlin,68.0,Female,Lung,I,2014-06-06,2014-09-28,2015-06-15,Radiation,,Alive,39.0,KRAS,No,Former,None,29.9,Medium,Urban,Statutory Health Insurance,18.0,No,No,Diabetes,10.0
PT00500,Switzerland,,84.0,Female,Lung,I,2021-04-02,2021-09-09,2022-05-24,Immunotherapy,Public,Alive,59.0,KRAS,No,Never,,36.1,Low,Urban,Statutory Health Insurance,15.0,No,No,Diabetes,8.0
PT00501,Norway,Vestland,73.0,Male,Pancreatic,III,2010-09-27,2011-02-26,2011-08-27,Surgery,Public,Alive,63.0,EGFR,No,Never,None,34.0,Low,Urban,,19.0,No,No,Hypertension,10.0
PT00502,Netherlands,South Holland,80.0,Male,,IV,2013-02-28,2013-03-13,2013-05-23,Immunotherapy,Public,Lost to Follow-up,,EGFR,No,Never,Moderate,22.7,Medium,Rural,Statutory Health Insurance,4.0,No,No,Cardiovascular Disease,7.0
PT00503,Denmark,Zealand,27.0,Female,Lung,IV,2016-06-06,2016-11-03,2017-09-19,Immunotherapy,Private,Alive,20.0,KRAS,Yes,Former,Moderate,27.6,High,Rural,NHS,9.0,No,No,Cardiovascular Disease,10.0
PT00504,Italy,Sicily,22.0,Female,,I,2017-07-14,2017-12-08,2018-03-26,Immunotherapy,Public,Alive,34.0,BRCA1,Yes,Current,,18.7,Medium,Urban,Statutory Health Insurance,17.0,No,No,Obesity,4.0
PT00505,Belgium,Flanders,44.0,Female,Leukemia,II,2015-06-07,2015-11-21,2016-02-17,,Public,Alive,112.0,None,No,Never,Moderate,30.5,Medium,Urban,NHS,17.0,No,No,Hypertension,4.0
PT00506,Denmark,Zealand,88.0,Female,Pancreatic,I,2022-05-20,2022-06-10,2022-11-03,Immunotherapy,Private,Lost to Follow-up,,None,Yes,Current,Heavy,33.5,High,Urban,Statutory Health Insurance,5.0,Yes,Yes,Hypertension,5.0
PT00507,Spain,Catalonia,74.0,Female,Pancreatic,II,2015-12-04,2016-04-26,2017-01-29,Radiation,Private,Alive,62.0,EGFR,No,Current,None,34.3,Medium,,Statutory Health Insurance,11.0,Yes,No,Hypertension,10.0
PT00508,Denmark,Zealand,59.0,Female,Breast,III,2016-04-02,2016-08-15,2016-10-31,Chemotherapy,,Alive,119.0,None,No,Never,Moderate,20.7,Medium,Urban,NHS,16.0,No,Yes,None,2.0
PT00509,Switzerland,Zurich,69.0,Female,Prostate,IV,2021-05-26,2021-08-18,2022-04-17,Radiation,Public,Alive,11.0,KRAS,Yes,Never,Moderate,29.0,Low,Urban,Statutory Health Insurance,14.0,No,Yes,Hypertension,4.0
,Portugal,Porto,52.0,Female,Breast,I,2017-08-22,2017-12-12,2018-09-26,Chemotherapy,Private,,51.0,KRAS,Yes,Never,,37.4,High,Urban,NHS,5.0,No,Yes,None,10.0
PT00511,Italy,Lombardy,37.0,Female,Pancreatic,I,2021-02-14,2021-06-20,2021-08-12,Targeted Therapy,Private,Alive,110.0,EGFR,Yes,Never,Moderate,22.1,High,Urban,Statutory Health Insurance,15.0,No,No,Obesity,10.0
PT00512,France,Île-de-France,76.0,Female,Prostate,I,2022-04-14,2022-07-01,2023-03-23,Immunotherapy,Research Institute,Deceased,,None,Yes,Never,Moderate,19.6,Medium,Urban,Private Insurance,6.0,No,No,Diabetes,8.0
PT00513,Ireland,Connacht,35.0,Female,,II,2015-11-22,2016-04-24,2016-12-06,Targeted Therapy,Public,Alive,,BRCA1,No,Former,Moderate,23.7,High,Urban,Private Insurance,15.0,No,No,None,9.0
PT00514,Spain,Andalusia,57.0,Male,Colorectal,III,2017-04-15,2017-07-10,2017-09-10,Targeted Therapy,Public,Deceased,94.0,KRAS,Yes,Former,Moderate,20.3,Medium,Urban,,10.0,No,No,Hypertension,8.0
PT00515,Belgium,Flanders,60.0,Female,Prostate,III,2012-02-12,2012-05-27,2013-05-17,Surgery,Research Institute,Deceased,6.0,BRCA1,Yes,Former,None,19.3,Low,,NHS,,No,No,Diabetes,7.0
PT00516,Switzerland,Bern,26.0,Female,Pancreatic,III,2015-05-21,2015-08-05,2016-02-25,Immunotherapy,Public,Alive,78.0,KRAS,No,Never,,22.9,Low,Urban,NHS,4.0,Yes,No,Diabetes,1.0
PT00517,Denmark,Capital Region,72.0,Male,Breast,II,2016-06-09,,2016-12-21,Targeted Therapy,Private,Deceased,27.0,KRAS,Yes,Never,None,26.1,Medium,Urban,NHS,15.0,No,No,Cardiovascular Disease,10.0
PT00518,Sweden,Västra Götaland,82.0,Female,Pancreatic,I,2016-08-23,2016-09-23,,Chemotherapy,Research Institute,,27.0,None,No,Never,None,34.4,Medium,Rural,Statutory Health Insurance,1.0,Yes,No,Cardiovascular Disease,8.0
PT00519,Switzerland,Bern,51.0,Male,Breast,I,2018-11-21,2019-03-05,2019-10-31,Chemotherapy,Private,Alive,58.0,BRCA1,Yes,Former,Heavy,19.6,Medium,Urban,Private Insurance,1.0,No,No,Hypertension,3.0
PT00520,Spain,Catalonia,57.0,Female,Prostate,I,2019-07-09,2019-09-15,2020-08-22,,Private,Alive,71.0,EGFR,No,Never,Moderate,39.4,Medium,Rural,Private Insurance,14.0,No,No,Obesity,9.0
PT00521,Finland,,41.0,Female,Breast,III,2021-06-15,2021-11-30,2022-07-30,Targeted Therapy,Public,Alive,75.0,BRCA1,,Never,Moderate,,Medium,Rural,Statutory Health Insurance,16.0,No,No,None,5.0
PT00522,,Veneto,35.0,Male,Prostate,III,2017-05-01,2017-05-28,2018-01-10,,Public,Alive,118.0,BRCA1,Yes,,Moderate,35.7,Medium,Urban,Statutory Health Insurance,11.0,Yes,No,Diabetes,7.0
PT00523,Norway,Trøndelag,71.0,Male,Lung,III,2022-12-04,2023-04-20,2024-03-10,Targeted Therapy,Private,,98.0,None,Yes,Former,None,18.1,Low,Urban,NHS,10.0,No,No,Diabetes,3.0
PT00524,Switzerland,Geneva,48.0,Female,Leukemia,I,2018-01-03,2018-04-06,2018-05-08,Surgery,Private,Deceased,70.0,KRAS,Yes,Former,Moderate,23.5,Medium,Rural,Statutory Health Insurance,19.0,No,No,Obesity,2.0
PT00525,Switzerland,Geneva,35.0,Female,Ovarian,III,2020-08-28,2020-09-13,2020-11-30,Immunotherapy,Public,Alive,60.0,EGFR,Yes,Current,Moderate,38.5,High,Rural,NHS,6.0,No,Yes,None,10.0
PT00526,Switzerland,Bern,36.0,Male,Prostate,I,2017-08-11,2017-11-30,2018-01-12,Targeted Therapy,Public,Deceased,,BRCA1,No,Former,None,27.5,Medium,Rural,,2.0,No,No,Diabetes,4.0
PT00527,Netherlands,Utrecht,83.0,Female,Ovarian,I,2023-12-13,,2024-11-25,Targeted Therapy,Public,Alive,116.0,EGFR,No,Former,None,25.5,Low,Rural,Private Insurance,6.0,No,No,None,5.0
PT00528,Finland,Southwest Finland,32.0,Female,Ovarian,,2016-09-28,2016-10-11,2017-05-22,Radiation,Private,,,EGFR,Yes,Never,None,32.5,Medium,Urban,NHS,10.0,No,No,Diabetes,
PT00529,Austria,Tyrol,75.0,Female,Lung,II,2011-03-31,2011-05-30,2012-04-04,Chemotherapy,,Alive,101.0,EGFR,No,Current,Moderate,34.9,Low,Urban,NHS,4.0,,No,Diabetes,7.0
,,Trøndelag,24.0,Male,Lung,III,2019-12-14,2020-03-02,2020-12-16,Immunotherapy,Public,Alive,,,No,Never,None,38.2,,Urban,NHS,,Yes,No,Obesity,7.0
PT00531,Norway,Vestland,31.0,Female,Lung,III,2018-11-21,2019-04-07,2020-01-08,Immunotherapy,Public,Alive,42.0,KRAS,Yes,Former,Moderate,38.1,Medium,Urban,NHS,11.0,No,No,Obesity,10.0
PT00532,Austria,Tyrol,60.0,Male,Ovarian,I,2023-10-10,2024-02-07,2024-05-09,Immunotherapy,Private,Alive,43.0,EGFR,Yes,Never,Moderate,33.4,Low,Urban,Statutory Health Insurance,,No,No,Diabetes,6.0
PT00533,Finland,Uusimaa,22.0,Female,Lung,I,2021-10-14,2022-02-16,2022-05-11,Targeted Therapy,Public,Deceased,73.0,KRAS,Yes,Former,None,,Low,Urban,,15.0,No,No,Cardiovascular Disease,2.0
PT00534,Spain,Madrid,52.0,Female,,I,2019-04-08,2019-07-25,2020-05-07,Radiation,Public,Alive,10.0,KRAS,No,Never,Moderate,24.8,Low,,NHS,7.0,Yes,No,Hypertension,10.0
PT00535,Poland,Masovian,69.0,Male,Ovarian,I,2016-08-15,2016-09-16,2016-11-07,Immunotherapy,Public,Deceased,119.0,BRCA1,Yes,Former,Heavy,24.6,Medium,Urban,Statutory Health Insurance,18.0,Yes,No,Obesity,4.0
PT00536,Norway,Vestland,75.0,Female,Ovarian,I,2017-10-21,2017-12-15,2018-05-01,Surgery,Private,Alive,28.0,BRCA1,Yes,Never,Moderate,25.1,Low,Urban,Private Insurance,10.0,,Yes,Diabetes,2.0
,Denmark,Capital Region,28.0,Male,,III,2015-11-04,2016-04-05,2016-10-27,Surgery,Public,Alive,65.0,BRCA1,Yes,Never,None,20.3,Medium,Urban,Private Insurance,9.0,No,No,Diabetes,8.0
,Switzerland,Geneva,69.0,Female,Lung,I,2022-12-26,2023-06-13,2023-07-27,Chemotherapy,Public,Alive,47.0,BRCA1,Yes,Former,Heavy,18.9,Medium,Urban,Statutory Health Insurance,16.0,No,No,Obesity,2.0
PT00539,Portugal,Porto,48.0,Female,Colorectal,III,2017-11-08,2017-12-04,2018-11-05,Radiation,Public,Deceased,86.0,KRAS,Yes,Never,None,23.1,Medium,Urban,Private Insurance,,No,Yes,Hypertension,7.0
PT00540,Belgium,Wallonia,58.0,Female,Lung,II,2019-02-20,2019-06-09,2019-12-07,Immunotherapy,Public,Lost to Follow-up,,None,Yes,Current,Moderate,30.8,High,Urban,,,No,Yes,Diabetes,8.0
PT00541,Netherlands,South Holland,64.0,Female,Breast,II,2014-09-18,,2015-12-24,Radiation,Private,Alive,103.0,None,No,Never,None,18.1,Medium,Rural,Private Insurance,5.0,No,No,None,2.0
PT00542,Sweden,Skåne,36.0,Female,Breast,II,2015-07-20,2015-11-25,2016-10-31,Surgery,Public,Alive,29.0,KRAS,Yes,Former,Moderate,37.5,Low,Urban,Statutory Health Insurance,19.0,No,No,Diabetes,7.0
PT00543,Denmark,Capital Region,75.0,,Leukemia,III,2013-04-01,2013-06-22,2013-08-28,Immunotherapy,Research Institute,Alive,47.0,,,Current,None,38.3,Low,Rural,Statutory Health Insurance,10.0,Yes,No,Diabetes,5.0
PT00544,Norway,Oslo,65.0,Female,Leukemia,II,2013-02-24,2013-04-01,2014-02-05,Targeted Therapy,Private,Alive,119.0,BRCA1,No,Never,None,31.5,,Rural,Private Insurance,14.0,No,No,None,5.0
PT00545,Poland,Masovian,86.0,Male,Ovarian,I,2017-11-14,2018-02-19,2018-06-14,Surgery,Private,Alive,118.0,KRAS,Yes,Never,Moderate,19.1,Low,Urban,Statutory Health Insurance,9.0,No,No,Cardiovascular Disease,4.0
PT00546,Sweden,Stockholm,88.0,Female,Lung,IV,2021-07-14,2021-10-06,2022-09-24,Chemotherapy,Public,Alive,,None,No,Current,None,39.6,Medium,Urban,NHS,10.0,No,No,Diabetes,5.0
PT00547,Switzerland,Bern,33.0,Female,Lung,I,2013-11-30,2014-04-10,2014-07-28,Immunotherapy,Public,Alive,103.0,BRCA1,No,Never,Heavy,31.6,Medium,Urban,NHS,,No,No,Obesity,8.0
PT00548,Spain,Madrid,86.0,Male,Pancreatic,IV,2011-10-11,2011-12-09,2012-11-22,Chemotherapy,Private,Alive,104.0,KRAS,Yes,Former,Moderate,29.7,,Urban,Private Insurance,19.0,No,No,Obesity,5.0
PT00549,Portugal,Porto,42.0,Male,Ovarian,I,,2011-06-02,2011-12-19,Radiation,Public,Deceased,11.0,KRAS,No,Current,None,28.5,Medium,Urban,Statutory Health Insurance,9.0,No,No,Hypertension,8.0
PT00550,Sweden,Stockholm,80.0,Male,Pancreatic,III,2017-09-24,2017-09-30,2018-01-08,Chemotherapy,Public,,107.0,BRCA1,No,Never,None,20.9,Medium,Rural,NHS,15.0,Yes,Yes,Hypertension,9.0
PT00551,Spain,Madrid,42.0,Male,Leukemia,II,2019-04-09,2019-09-15,2020-01-10,Chemotherapy,Public,Alive,72.0,BRCA1,No,Former,Moderate,35.5,Medium,Rural,Statutory Health Insurance,9.0,No,No,None,4.0
PT00552,Italy,Veneto,46.0,Male,Lung,II,2020-11-10,2021-04-19,2021-07-14,Targeted Therapy,Public,Deceased,115.0,,Yes,Former,None,28.9,High,Urban,NHS,11.0,Yes,No,Diabetes,10.0
PT00553,Italy,Lombardy,,Female,Pancreatic,I,2020-10-09,2020-11-20,2021-06-04,Chemotherapy,Public,Alive,21.0,,Yes,Never,Moderate,18.4,Low,Urban,Statutory Health Insurance,7.0,No,No,Diabetes,7.0
PT00554,Belgium,Brussels,29.0,Female,Colorectal,I,2020-10-09,2020-12-05,2021-05-02,Targeted Therapy,Public,Alive,34.0,KRAS,Yes,Former,None,21.4,Low,Rural,NHS,7.0,No,No,None,5.0
PT00555,Poland,Lesser Poland,35.0,Female,Prostate,III,2013-04-06,2013-06-18,2014-04-28,Chemotherapy,Public,Alive,79.0,BRCA1,No,Current,Moderate,24.3,High,Urban,Statutory Health Insurance,12.0,No,No,None,9.0
PT00556,Austria,Vienna,60.0,Male,,IV,,2019-08-31,2020-05-22,Targeted Therapy,,Alive,,KRAS,No,,None,38.1,Medium,Urban,Statutory Health Insurance,15.0,No,No,,10.0
PT00557,Sweden,Stockholm,74.0,Female,Leukemia,II,2021-05-27,2021-09-16,2022-08-31,Surgery,Private,Deceased,98.0,EGFR,No,Never,None,28.1,Low,Urban,,5.0,No,Yes,None,6.0
PT00558,Netherlands,North Holland,80.0,Female,Breast,II,2010-09-24,2010-12-21,2011-11-18,Targeted Therapy,Public,Alive,100.0,EGFR,No,Never,None,38.7,High,Urban,NHS,2.0,No,No,Hypertension,4.0
PT00559,France,Provence-Alpes-Côte d'Azur,,Female,Lung,I,2023-06-12,2023-08-07,2023-09-25,Surgery,Private,Alive,8.0,None,Yes,Current,None,24.0,High,Urban,Private Insurance,9.0,Yes,No,Diabetes,4.0
PT00560,Switzerland,Geneva,71.0,Female,Leukemia,III,2015-02-24,,2015-09-26,Surgery,Research Institute,Deceased,108.0,,Yes,Never,Moderate,39.7,Medium,Urban,Statutory Health Insurance,13.0,No,No,Diabetes,10.0
PT00561,Spain,Madrid,21.0,,Leukemia,I,2014-03-29,2014-07-30,2015-03-26,Immunotherapy,Private,Alive,115.0,BRCA1,,Never,Heavy,39.0,High,,,15.0,No,No,Cardiovascular Disease,3.0
PT00562,Denmark,,69.0,Non-binary,Pancreatic,I,,2011-06-24,2012-03-17,Surgery,Private,Alive,27.0,None,No,Former,Moderate,33.7,Medium,Urban,Private Insurance,18.0,,No,Diabetes,1.0
PT00563,Sweden,Västra Götaland,62.0,Female,Colorectal,III,2014-06-24,2014-12-05,2015-04-27,Immunotherapy,Public,Deceased,116.0,BRCA1,No,Never,Heavy,34.6,Medium,Urban,Statutory Health Insurance,14.0,No,No,Diabetes,5.0
PT00564,Switzerland,Bern,27.0,Male,Ovarian,II,2022-03-28,2022-04-23,2023-03-27,Targeted Therapy,Research Institute,Alive,70.0,EGFR,No,Never,None,18.5,Medium,Urban,NHS,5.0,No,No,Obesity,2.0
PT00565,Norway,Vestland,78.0,,Lung,,2011-11-16,2012-01-05,2012-07-10,Radiation,Public,Alive,36.0,KRAS,No,Never,None,23.1,High,Urban,NHS,18.0,No,No,Obesity,2.0
PT00566,Netherlands,North Holland,84.0,Male,Prostate,I,2022-08-07,2022-12-15,2023-12-01,Immunotherapy,Private,Alive,10.0,KRAS,Yes,Current,None,22.3,High,Urban,Private Insurance,2.0,No,Yes,,9.0
PT00567,Finland,Southwest Finland,31.0,Male,Colorectal,III,2016-04-03,2016-07-18,2016-12-21,Radiation,Public,Alive,96.0,BRCA1,Yes,Current,Moderate,39.1,Medium,Urban,Private Insurance,19.0,No,No,Hypertension,3.0
PT00568,Ireland,Connacht,23.0,Male,Prostate,I,2020-01-07,2020-04-24,2020-12-12,Targeted Therapy,Public,Alive,43.0,BRCA1,No,Never,Heavy,27.0,High,Rural,Statutory Health Insurance,2.0,Yes,No,Diabetes,10.0
PT00569,Portugal,Algarve,60.0,Female,Breast,IV,2016-06-30,2016-07-07,2017-03-17,Immunotherapy,Public,Lost to Follow-up,,None,No,Never,Moderate,31.2,High,Urban,Statutory Health Insurance,4.0,Yes,No,Cardiovascular Disease,6.0
,Finland,Southwest Finland,26.0,Female,Leukemia,II,2017-03-22,2017-08-24,2017-12-01,Targeted Therapy,Public,Alive,25.0,BRCA1,No,Never,,23.9,Medium,Urban,Private Insurance,17.0,No,No,None,7.0
PT00571,Poland,Lesser Poland,88.0,Female,Pancreatic,I,2023-04-12,2023-07-01,2023-11-27,Radiation,Private,Alive,70.0,EGFR,No,Never,Moderate,23.6,Medium,Urban,NHS,9.0,No,Yes,Obesity,2.0
PT00572,Austria,Vienna,88.0,Female,Colorectal,III,2015-05-06,2015-06-24,2015-12-23,Targeted Therapy,Research Institute,Alive,112.0,EGFR,No,Never,Moderate,27.2,Low,Rural,Private Insurance,4.0,No,No,Diabetes,1.0
PT00573,France,,49.0,Female,Prostate,II,2013-12-16,2014-01-31,2014-03-24,Radiation,Public,Alive,92.0,None,Yes,Never,None,25.0,Low,Urban,Statutory Health Insurance,19.0,No,Yes,None,8.0
PT00574,Switzerland,Geneva,25.0,Female,Lung,II,2023-03-21,2023-08-22,2024-02-07,Surgery,Private,Alive,69.0,EGFR,No,Never,Moderate,34.5,Medium,Urban,NHS,11.0,No,Yes,None,1.0
PT00575,Norway,Vestland,38.0,Non-binary,Breast,II,,2010-03-27,2010-08-15,Radiation,,Alive,73.0,None,Yes,Never,Moderate,31.7,Medium,Urban,NHS,15.0,No,No,Cardiovascular Disease,2.0
PT00576,Belgium,Flanders,85.0,Male,Ovarian,I,2022-01-18,2022-01-20,2022-07-06,Radiation,,Alive,35.0,BRCA1,Yes,Never,None,33.3,Medium,Urban,Statutory Health Insurance,13.0,No,No,Obesity,8.0
PT00577,Ireland,,29.0,Female,Breast,III,2019-05-18,,2020-03-01,Surgery,Research Institute,Alive,73.0,EGFR,Yes,Never,None,29.9,Medium,Urban,Private Insurance,18.0,No,Yes,Hypertension,5.0
PT00578,Spain,Andalusia,35.0,Female,Leukemia,II,2022-11-13,2023-01-16,2023-06-13,Immunotherapy,Public,Alive,12.0,None,Yes,Never,None,37.9,Medium,Urban,NHS,4.0,Yes,Yes,Diabetes,10.0
PT00579,Netherlands,Utrecht,,Male,Leukemia,III,2012-10-06,,2013-06-22,Chemotherapy,Research Institute,Alive,66.0,KRAS,No,Never,Moderate,19.4,High,Rural,Statutory Health Insurance,6.0,No,No,Diabetes,6.0
PT00580,Spain,Madrid,51.0,Female,Prostate,III,2022-06-07,2022-08-06,2023-03-11,Immunotherapy,Research Institute,Alive,97.0,EGFR,No,Former,Heavy,34.5,High,Urban,Private Insurance,18.0,No,No,Cardiovascular Disease,3.0
PT00581,Italy,Veneto,66.0,Female,Prostate,III,2012-12-17,2013-03-16,2013-07-04,Chemotherapy,Public,Alive,110.0,BRCA1,Yes,Never,None,23.3,,Urban,Statutory Health Insurance,16.0,No,No,None,4.0
PT00582,Spain,Catalonia,62.0,Female,Breast,III,2017-04-02,2017-08-17,2018-04-04,Surgery,Private,Alive,57.0,EGFR,No,Never,Moderate,31.7,Low,Urban,,16.0,No,No,,8.0
PT00583,Ireland,Munster,55.0,Male,Prostate,III,2023-04-15,,2024-04-20,Immunotherapy,Private,Alive,36.0,None,No,Former,Moderate,38.4,Low,Urban,Statutory Health Insurance,10.0,No,No,Obesity,8.0
PT00584,Netherlands,South Holland,,Female,Leukemia,II,2022-02-06,2022-07-21,2022-11-01,Targeted Therapy,Private,Alive,22.0,EGFR,No,Never,None,24.8,Medium,Urban,NHS,4.0,,No,Hypertension,10.0
PT00585,Finland,Pirkanmaa,29.0,Male,Breast,II,,2016-10-05,2017-08-08,Targeted Therapy,Public,Alive,83.0,KRAS,No,Never,None,,Medium,Urban,NHS,4.0,Yes,No,,6.0
PT00586,Italy,,50.0,Male,Breast,I,2020-04-14,2020-10-02,2021-03-06,Immunotherapy,Private,Alive,24.0,None,Yes,Never,Moderate,21.9,High,Urban,Statutory Health Insurance,12.0,No,No,Obesity,4.0
PT00587,,Masovian,48.0,Male,Ovarian,III,2016-09-18,2016-11-02,2017-05-06,Targeted Therapy,Private,Alive,12.0,None,No,Current,None,,Medium,Urban,NHS,11.0,No,Yes,Hypertension,1.0
PT00588,Portugal,Lisbon,24.0,,Lung,III,2020-12-08,2021-02-22,2021-09-22,Surgery,Public,Alive,116.0,None,Yes,Never,None,18.9,Medium,Urban,Statutory Health Insurance,9.0,No,No,Diabetes,3.0
PT00589,Portugal,Algarve,20.0,Female,Lung,I,2020-11-11,2021-04-16,2021-08-29,Targeted Therapy,Public,Deceased,28.0,EGFR,Yes,Current,Moderate,25.2,,,NHS,6.0,No,No,Cardiovascular Disease,2.0
PT00590,Italy,Veneto,22.0,Male,Prostate,IV,2020-03-30,2020-07-14,2021-07-12,Targeted Therapy,Private,Deceased,71.0,EGFR,No,Former,None,,Medium,Rural,Statutory Health Insurance,8.0,,No,Diabetes,3.0
PT00591,Denmark,Central Denmark,86.0,Female,Prostate,II,2020-09-18,2021-02-28,2021-08-23,Chemotherapy,Public,Alive,59.0,None,No,Current,Moderate,36.6,Medium,Urban,NHS,15.0,Yes,Yes,None,9.0
PT00592,Germany,Berlin,54.0,Male,Leukemia,,2020-05-24,2020-07-29,2020-08-28,Chemotherapy,Research Institute,Deceased,81.0,BRCA1,Yes,Former,None,,Low,Rural,Private Insurance,12.0,No,No,Cardiovascular Disease,2.0
PT00593,France,Provence-Alpes-Côte d'Azur,34.0,Male,Leukemia,I,2011-01-20,2011-06-23,2012-01-22,Radiation,Public,Deceased,117.0,KRAS,Yes,Never,Moderate,38.6,Low,Urban,NHS,8.0,No,No,Diabetes,4.0
PT00594,Belgium,,86.0,Female,Lung,II,2021-03-28,2021-08-23,2021-12-18,Surgery,Private,,,KRAS,No,Former,,21.4,Medium,Rural,Statutory Health Insurance,17.0,No,No,None,2.0
PT00595,Finland,Uusimaa,49.0,,Breast,III,2017-01-06,2017-05-15,2017-12-22,Targeted Therapy,Public,Alive,16.0,None,Yes,Former,None,37.1,Low,Urban,Private Insurance,4.0,No,Yes,Hypertension,3.0
PT00596,Finland,Pirkanmaa,62.0,Female,Colorectal,I,2016-01-27,2016-04-28,2016-08-22,Surgery,Research Institute,Deceased,34.0,EGFR,Yes,Former,None,37.5,Medium,Rural,Private Insurance,6.0,Yes,No,Hypertension,3.0
PT00597,Sweden,Stockholm,,Male,Pancreatic,II,2010-05-27,2010-06-26,2010-10-02,Surgery,Private,Alive,40.0,KRAS,Yes,Former,Moderate,34.2,,Rural,Private Insurance,11.0,No,No,Obesity,4.0
PT00598,Italy,Sicily,59.0,Male,Pancreatic,IV,2019-10-30,2019-11-09,2020-03-27,Chemotherapy,Public,Alive,66.0,BRCA1,No,Never,None,37.6,Medium,Urban,Private Insurance,4.0,Yes,No,Cardiovascular Disease,8.0
PT00599,Ireland,Connacht,84.0,Female,Ovarian,III,2015-04-11,2015-07-29,2016-02-15,Targeted Therapy,Private,Alive,33.0,KRAS,No,Never,Moderate,19.8,High,Rural,Statutory Health Insurance,3.0,No,No,None,8.0
PT00600,Germany,Bavaria,48.0,Female,Colorectal,II,2020-04-12,2020-09-09,2021-04-03,Radiation,Public,Deceased,63.0,None,No,Current,Moderate,38.4,Medium,Urban,NHS,,No,Yes,None,10.0
PT00601,Norway,Oslo,38.0,Male,Ovarian,II,2010-03-21,2010-04-19,2010-08-25,Immunotherapy,Public,Alive,101.0,None,No,Current,Moderate,28.2,Low,Urban,Private Insurance,19.0,No,No,Diabetes,8.0
PT00602,Netherlands,South Holland,22.0,Female,Prostate,I,,2023-08-09,2023-10-13,Radiation,Public,Alive,12.0,EGFR,Yes,Never,Moderate,24.5,Low,Rural,Private Insurance,12.0,Yes,No,Hypertension,4.0
PT00603,Italy,Lombardy,55.0,Female,Pancreatic,IV,2019-09-08,2020-01-22,2020-10-02,Chemotherapy,Public,Alive,22.0,EGFR,Yes,,None,18.1,High,Urban,Statutory Health Insurance,11.0,No,No,Obesity,9.0
PT00604,Denmark,Capital Region,,Female,,IV,2014-10-26,2015-03-14,2016-01-30,Radiation,Research Institute,Alive,71.0,EGFR,,Never,None,30.5,High,Urban,Private Insurance,7.0,No,No,,9.0
PT00605,Ireland,Connacht,34.0,Male,Pancreatic,III,2012-09-04,2013-02-05,2013-11-14,Chemotherapy,Public,Alive,27.0,BRCA1,Yes,Never,None,19.4,Low,Urban,Statutory Health Insurance,10.0,No,No,Hypertension,10.0
PT00606,France,Île-de-France,60.0,Female,Colorectal,I,2023-06-04,2023-10-29,2024-01-17,Chemotherapy,Public,,33.0,BRCA1,Yes,Former,None,18.3,Medium,,Private Insurance,1.0,,No,Cardiovascular Disease,5.0
PT00607,Switzerland,Bern,55.0,Female,Ovarian,I,2017-09-05,2018-01-30,2018-12-18,Surgery,Public,Deceased,62.0,KRAS,No,Former,None,27.2,,Rural,Private Insurance,14.0,No,No,Hypertension,5.0
PT00608,France,Auvergne-Rhône-Alpes,52.0,Male,Colorectal,I,2014-05-05,2014-10-10,2015-04-10,Targeted Therapy,Research Institute,Alive,,EGFR,No,Current,Moderate,19.3,Medium,Urban,Statutory Health Insurance,,No,No,Diabetes,3.0
PT00609,Austria,Vienna,24.0,Female,Lung,II,2022-01-08,2022-02-13,2022-11-06,Immunotherapy,Public,Alive,97.0,BRCA1,No,,Moderate,36.6,Medium,Rural,NHS,4.0,No,Yes,Diabetes,5.0
PT00610,Sweden,Stockholm,33.0,Female,Breast,I,2013-02-27,2013-08-16,2014-06-02,Chemotherapy,Public,Alive,89.0,None,No,Former,None,19.0,Low,Urban,Statutory Health Insurance,2.0,No,No,None,5.0
PT00611,Ireland,Munster,87.0,Female,Leukemia,III,2011-09-05,2011-09-14,2012-02-26,Chemotherapy,Private,Alive,66.0,,Yes,Current,None,30.4,Medium,Urban,Private Insurance,7.0,No,No,Obesity,1.0
PT00612,Finland,Southwest Finland,66.0,Female,Lung,II,2018-01-09,2018-05-24,2019-03-03,Surgery,Research Institute,Alive,80.0,KRAS,No,Former,None,29.6,Low,Urban,NHS,16.0,No,No,Obesity,10.0
PT00613,Denmark,Central Denmark,73.0,Female,Pancreatic,I,2014-12-16,2015-01-03,2015-12-07,Immunotherapy,,Deceased,50.0,EGFR,Yes,Never,Moderate,30.4,Medium,Urban,Private Insurance,13.0,No,No,None,1.0
PT00614,Spain,Catalonia,23.0,Female,Leukemia,III,2019-10-19,2020-03-04,2020-07-16,Chemotherapy,Private,Lost to Follow-up,,KRAS,No,Former,Moderate,20.9,Medium,Urban,NHS,15.0,No,No,Hypertension,7.0
PT00615,,Zealand,28.0,Female,Lung,I,2021-05-27,2021-10-08,2022-08-16,Targeted Therapy,Public,Alive,26.0,EGFR,Yes,Former,Moderate,37.4,Medium,Rural,Statutory Health Insurance,2.0,No,No,Obesity,
PT00616,Sweden,Stockholm,72.0,Female,Lung,III,2022-09-26,2022-11-10,2023-10-22,Targeted Therapy,Private,,87.0,None,Yes,Current,Moderate,32.4,High,Urban,Private Insurance,3.0,Yes,No,Hypertension,10.0
PT00617,Finland,Southwest Finland,79.0,Female,Colorectal,II,2018-02-04,2018-07-04,2019-06-19,Surgery,Private,Alive,61.0,None,No,Never,Moderate,35.2,Medium,Urban,Private Insurance,18.0,No,No,Diabetes,8.0
PT00618,,North Rhine-Westphalia,65.0,Male,Leukemia,II,2022-08-01,2022-10-19,2023-02-09,Chemotherapy,Private,Deceased,65.0,EGFR,No,Never,Moderate,36.6,Medium,Urban,Private Insurance,18.0,No,No,None,3.0
PT00619,Ireland,Connacht,73.0,Male,Lung,I,2018-10-12,2019-01-07,2019-08-23,Immunotherapy,Public,Alive,100.0,KRAS,No,Never,Moderate,37.7,Low,,Private Insurance,15.0,Yes,No,Hypertension,2.0
PT00620,Poland,,56.0,Female,Colorectal,,2012-04-09,2012-09-16,2012-11-29,Surgery,Public,Deceased,72.0,BRCA1,Yes,Current,Moderate,33.9,Low,,Statutory Health Insurance,,No,,Diabetes,10.0
PT00621,Belgium,Brussels,42.0,Male,Prostate,III,2022-08-03,2022-12-02,2023-07-08,Surgery,Public,Alive,41.0,,No,Current,Heavy,34.0,Medium,Urban,Statutory Health Insurance,14.0,No,Yes,Hypertension,7.0
PT00622,Sweden,,46.0,Female,Leukemia,II,2012-08-31,2013-01-22,2013-04-11,Radiation,Private,Alive,46.0,None,No,Never,None,21.3,Low,Urban,NHS,11.0,No,No,Cardiovascular Disease,10.0
PT00623,Belgium,Brussels,89.0,Female,Ovarian,I,2019-05-10,2019-09-17,2020-08-15,Surgery,Private,Deceased,111.0,EGFR,No,Former,Moderate,21.7,Medium,Rural,NHS,11.0,No,No,Diabetes,5.0
PT00624,Italy,Sicily,85.0,Female,Lung,III,,2012-02-10,2012-09-27,Radiation,Public,Alive,,BRCA1,No,Never,Moderate,34.6,High,Urban,Statutory Health Insurance,2.0,No,No,Obesity,7.0
PT00625,Portugal,Porto,80.0,Non-binary,Pancreatic,I,2012-06-19,2012-12-15,2013-07-07,Radiation,Public,Deceased,53.0,BRCA1,Yes,Former,Heavy,22.8,Medium,Urban,Private Insurance,14.0,No,No,Hypertension,10.0
PT00626,Finland,Southwest Finland,70.0,Female,Prostate,IV,2011-10-22,2011-11-05,2012-04-24,Chemotherapy,,Alive,12.0,KRAS,No,Never,None,30.2,,Rural,NHS,11.0,No,No,Cardiovascular Disease,7.0
PT00627,Germany,Bavaria,69.0,Male,Colorectal,IV,2012-01-31,2012-07-26,2013-05-26,Targeted Therapy,Public,Deceased,99.0,None,,Current,Heavy,24.0,Medium,Urban,Private Insurance,6.0,No,No,Hypertension,
PT00628,,North Rhine-Westphalia,38.0,Female,Lung,III,2010-11-28,2011-05-24,2011-12-29,Immunotherapy,Private,Alive,80.0,BRCA1,No,Never,Moderate,,Low,Rural,NHS,16.0,Yes,No,Cardiovascular Disease,9.0
PT00629,Poland,Masovian,20.0,Male,Pancreatic,IV,2012-08-16,2012-09-12,2013-02-22,Surgery,Public,Deceased,16.0,BRCA1,No,Former,None,27.9,Medium,Urban,Statutory Health Insurance,13.0,No,No,Hypertension,1.0
PT00630,Belgium,Brussels,59.0,Male,Colorectal,I,2019-07-24,2019-10-13,2020-02-20,Chemotherapy,Private,Alive,86.0,KRAS,No,Former,None,21.6,Medium,Rural,NHS,2.0,No,No,Diabetes,
PT00631,Denmark,Capital Region,51.0,Male,Colorectal,I,2014-10-25,2015-04-10,2016-02-02,Immunotherapy,Public,Alive,66.0,KRAS,No,Current,None,,Medium,Urban,Private Insurance,1.0,No,No,Diabetes,3.0
PT00632,Austria,Styria,41.0,Male,Ovarian,I,2022-01-26,2022-04-09,2023-03-06,Surgery,Private,,101.0,None,Yes,Former,Moderate,21.3,Medium,Urban,Private Insurance,11.0,No,No,Hypertension,4.0
PT00633,Finland,Pirkanmaa,85.0,Male,Pancreatic,,2015-01-30,2015-07-13,2015-09-13,Targeted Therapy,Private,Alive,9.0,KRAS,,Never,Moderate,35.1,Low,Urban,Private Insurance,,No,No,Diabetes,8.0
PT00634,France,Auvergne-Rhône-Alpes,59.0,Male,Colorectal,IV,2018-10-15,2018-10-25,2019-03-19,Targeted Therapy,Private,Alive,61.0,EGFR,No,Never,Moderate,28.3,Medium,Urban,Private Insurance,12.0,No,No,Obesity,6.0
PT00635,Ireland,Munster,57.0,Female,Leukemia,I,2010-12-21,2011-03-24,2011-07-28,Radiation,Public,Alive,11.0,EGFR,Yes,Former,Moderate,22.5,Medium,Rural,Private Insurance,17.0,No,No,Hypertension,4.0
PT00636,Ireland,Connacht,67.0,Female,Ovarian,IV,2016-03-22,2016-08-01,2016-10-10,Radiation,Private,Alive,67.0,None,Yes,Never,None,25.5,Low,Rural,Statutory Health Insurance,15.0,No,,Cardiovascular Disease,5.0
PT00637,Austria,Tyrol,,Male,,III,2022-11-23,,,Immunotherapy,Public,Alive,35.0,EGFR,No,Former,None,27.4,Medium,Urban,NHS,11.0,Yes,No,Cardiovascular Disease,3.0
PT00638,Ireland,Connacht,74.0,Male,Ovarian,II,2021-06-26,,2022-05-29,Surgery,Research Institute,Lost to Follow-up,,BRCA1,Yes,Former,None,24.1,Medium,Urban,Private Insurance,13.0,No,No,Diabetes,4.0
PT00639,Sweden,Västra Götaland,70.0,Female,Prostate,I,2023-05-23,2023-05-25,2023-07-22,Radiation,Public,Alive,64.0,,Yes,Never,Moderate,35.8,Medium,,Statutory Health Insurance,5.0,No,No,None,8.0
PT00640,Netherlands,North Holland,79.0,Female,Breast,I,2016-09-04,2017-02-07,2017-11-26,Chemotherapy,Private,Alive,48.0,KRAS,Yes,Current,None,25.8,Low,Rural,Statutory Health Insurance,6.0,No,Yes,Hypertension,9.0
PT00641,Sweden,Västra Götaland,27.0,Female,Ovarian,,2018-08-29,2018-11-26,2019-03-30,Radiation,Public,Alive,110.0,KRAS,Yes,Former,Moderate,28.8,Medium,Urban,Private Insurance,12.0,No,No,Hypertension,9.0
PT00642,Spain,Andalusia,87.0,Male,Ovarian,II,2020-08-16,2021-01-17,2021-08-16,Immunotherapy,Public,Alive,66.0,None,Yes,Current,Moderate,18.6,Low,Urban,Statutory Health Insurance,17.0,No,No,Diabetes,1.0
,Finland,Uusimaa,28.0,Female,Lung,II,,2010-11-21,2010-12-31,Chemotherapy,Public,Alive,115.0,EGFR,,Never,None,23.0,Medium,Urban,,11.0,No,No,,7.0
PT00644,Switzerland,Bern,21.0,Female,Ovarian,II,2020-11-09,2020-12-09,2021-02-18,Targeted Therapy,Public,Deceased,61.0,None,,Current,Moderate,19.8,High,Urban,Statutory Health Insurance,12.0,No,No,Obesity,10.0
PT00645,,Geneva,89.0,,Colorectal,III,2014-11-09,2014-11-18,2015-09-04,Chemotherapy,Public,Lost to Follow-up,,EGFR,No,Former,Moderate,38.0,Medium,Urban,Private Insurance,19.0,No,No,Hypertension,9.0
,Sweden,Stockholm,78.0,Male,Lung,II,2011-09-01,2012-01-08,2012-02-08,Immunotherapy,,Deceased,63.0,BRCA1,Yes,Former,Heavy,36.9,High,Rural,Statutory Health Insurance,2.0,No,No,Obesity,1.0
PT00647,Sweden,Skåne,38.0,Male,Prostate,,2017-05-04,2017-06-29,2017-09-09,Targeted Therapy,Public,Alive,64.0,EGFR,Yes,Former,Moderate,24.2,High,Rural,Private Insurance,1.0,No,No,Hypertension,2.0
PT00648,Netherlands,Utrecht,47.0,Male,Prostate,III,2013-02-14,2013-04-11,2013-05-14,Surgery,Public,Alive,82.0,KRAS,No,Former,Heavy,28.7,Low,Urban,,11.0,No,No,Obesity,9.0
PT00649,Portugal,Porto,33.0,Male,Colorectal,II,2021-05-24,2021-07-24,2021-11-25,Immunotherapy,Public,Alive,70.0,None,Yes,Current,Moderate,25.1,High,Rural,NHS,9.0,No,No,Diabetes,3.0
PT00650,Poland,Lesser Poland,43.0,Female,Leukemia,I,,,2016-04-30,Radiation,Public,,65.0,EGFR,No,Current,None,35.1,Medium,Urban,NHS,17.0,Yes,Yes,Cardiovascular Disease,2.0
PT00651,Poland,Silesian,63.0,Female,Pancreatic,III,2023-05-07,2023-09-25,2023-11-23,Immunotherapy,Private,Deceased,58.0,KRAS,No,Never,None,23.1,Low,Urban,NHS,2.0,Yes,No,Diabetes,4.0
PT00652,Austria,,75.0,Female,Colorectal,IV,2023-09-06,2024-01-26,2024-05-22,Immunotherapy,Private,Deceased,16.0,EGFR,No,Former,None,35.9,Medium,Urban,Statutory Health Insurance,12.0,Yes,No,None,3.0
PT00653,Germany,Bavaria,70.0,,Colorectal,IV,2023-06-25,,,Immunotherapy,Public,Alive,85.0,None,No,Never,None,22.0,,Urban,Statutory Health Insurance,1.0,Yes,No,Hypertension,4.0
PT00654,Germany,North Rhine-Westphalia,51.0,Female,Breast,I,2012-01-09,2012-06-02,,Targeted Therapy,Private,,114.0,KRAS,No,Never,None,24.4,High,Urban,Private Insurance,3.0,No,No,Cardiovascular Disease,
PT00655,Netherlands,North Holland,69.0,Male,Pancreatic,,2017-05-24,2017-10-16,2018-03-22,Immunotherapy,Private,Alive,54.0,None,Yes,Never,Moderate,37.5,Low,Rural,NHS,10.0,No,No,Hypertension,3.0
PT00656,Norway,Vestland,60.0,Non-binary,Ovarian,I,2020-03-12,2020-08-18,2021-03-06,Surgery,Public,Alive,47.0,KRAS,Yes,Never,None,24.3,Medium,Urban,NHS,15.0,No,Yes,Cardiovascular Disease,6.0
PT00657,Spain,Andalusia,85.0,Female,Leukemia,IV,2011-10-20,2012-04-11,2012-12-21,Immunotherapy,Private,Deceased,94.0,KRAS,Yes,Former,Moderate,38.0,Medium,,,5.0,Yes,No,Hypertension,1.0
PT00658,Spain,Madrid,44.0,Male,Lung,I,2017-06-19,2017-08-07,2018-06-06,Radiation,Private,Alive,115.0,BRCA1,No,Never,None,21.0,Medium,Urban,NHS,1.0,No,No,None,6.0
PT00659,Spain,Catalonia,80.0,Male,Pancreatic,I,,2013-04-14,2013-10-25,Chemotherapy,Public,Deceased,67.0,None,No,Current,Moderate,31.9,Medium,Urban,NHS,2.0,No,No,Obesity,8.0
PT00660,Austria,Tyrol,85.0,Female,Leukemia,IV,2018-10-18,2019-01-26,2019-08-01,Targeted Therapy,Public,Deceased,,None,No,Never,,24.1,Low,Urban,Statutory Health Insurance,14.0,No,No,Hypertension,5.0
PT00661,Netherlands,North Holland,61.0,Female,Colorectal,IV,2015-12-05,2016-03-07,2016-10-19,Radiation,Public,Alive,96.0,BRCA1,No,Current,Moderate,25.1,Low,Urban,Private Insurance,8.0,No,No,Hypertension,
PT00662,Italy,Sicily,84.0,Male,,III,2010-05-27,2010-06-14,2011-05-24,Surgery,Public,Deceased,117.0,BRCA1,No,Never,None,36.3,Medium,Urban,Private Insurance,,No,Yes,None,6.0
PT00663,Finland,Pirkanmaa,55.0,Female,Colorectal,I,,2021-02-18,2021-04-18,Immunotherapy,Private,Deceased,25.0,KRAS,No,Current,Heavy,30.6,Medium,,NHS,9.0,No,No,Cardiovascular Disease,5.0
PT00664,Spain,Madrid,28.0,Female,Colorectal,II,2022-09-06,2022-12-11,2023-07-24,Targeted Therapy,Private,Alive,99.0,None,,Current,Heavy,22.8,High,Rural,Private Insurance,9.0,Yes,No,,1.0
PT00665,Norway,Trøndelag,55.0,Female,Colorectal,III,,2019-03-15,2019-09-29,Targeted Therapy,Public,Deceased,22.0,EGFR,Yes,Never,Heavy,38.8,Medium,Urban,Private Insurance,17.0,No,No,None,8.0
PT00666,Belgium,Brussels,57.0,Male,Pancreatic,II,2022-05-12,2022-08-24,2023-07-26,Targeted Therapy,Public,Alive,94.0,None,No,Current,None,26.9,Medium,,NHS,15.0,Yes,No,Hypertension,5.0
PT00667,Italy,Sicily,52.0,Male,Ovarian,I,2017-03-03,2017-07-25,2017-10-29,Radiation,Public,Alive,49.0,None,No,Never,None,37.3,High,Urban,Statutory Health Insurance,18.0,Yes,No,Cardiovascular Disease,6.0
PT00668,Belgium,Brussels,61.0,Female,Pancreatic,I,2023-12-12,2024-04-27,2024-11-26,Chemotherapy,Public,Alive,21.0,BRCA1,Yes,Never,Moderate,38.1,Medium,Urban,NHS,15.0,No,No,Cardiovascular Disease,1.0
PT00669,Switzerland,Bern,80.0,Female,Ovarian,IV,2019-11-10,2020-01-17,2020-10-10,Chemotherapy,Public,Alive,63.0,None,Yes,Never,Moderate,27.2,Low,Rural,,7.0,No,No,Cardiovascular Disease,5.0
PT00670,Denmark,Zealand,65.0,Male,Pancreatic,II,2019-03-30,2019-09-19,2020-05-07,Surgery,Public,Deceased,26.0,EGFR,No,,Moderate,27.1,Medium,,Private Insurance,10.0,No,No,None,7.0
PT00671,Italy,Sicily,80.0,Male,Leukemia,,,2019-12-20,2020-05-06,Radiation,Public,Alive,58.0,BRCA1,Yes,Never,None,30.2,High,Rural,NHS,12.0,No,No,,3.0
PT00672,Belgium,Brussels,37.0,Male,Colorectal,II,2016-05-06,2016-09-02,2017-05-07,Radiation,Public,Alive,87.0,EGFR,No,Never,Moderate,32.0,Medium,Urban,NHS,16.0,No,No,Obesity,6.0
PT00673,Belgium,Brussels,,Male,Prostate,II,2012-07-10,2012-10-07,2013-01-20,Radiation,Public,Alive,15.0,,Yes,,Moderate,19.2,Medium,Rural,NHS,2.0,No,No,Hypertension,7.0
PT00674,Finland,Uusimaa,34.0,Female,Pancreatic,IV,2023-02-09,2023-06-09,2024-05-24,Immunotherapy,Private,Alive,115.0,None,No,Current,None,19.5,High,Urban,Private Insurance,,No,No,None,7.0
PT00675,Portugal,Porto,67.0,Non-binary,Prostate,II,2023-06-09,2023-07-01,2023-08-01,Radiation,Research Institute,Alive,11.0,EGFR,Yes,Former,None,23.5,,Rural,Statutory Health Insurance,7.0,No,No,Obesity,7.0
PT00676,Switzerland,Bern,32.0,Male,Breast,III,2019-09-10,2020-01-09,2020-02-18,Radiation,Private,Deceased,22.0,KRAS,No,Never,Heavy,,Medium,Rural,NHS,5.0,No,Yes,Obesity,6.0
PT00677,Denmark,Central Denmark,62.0,Male,Lung,I,2020-08-26,2021-02-19,2021-06-04,Targeted Therapy,Private,Deceased,17.0,BRCA1,Yes,Current,None,32.4,Low,Urban,Statutory Health Insurance,5.0,Yes,No,Obesity,9.0
PT00678,Netherlands,South Holland,79.0,Female,Pancreatic,I,2021-11-16,2022-04-14,2022-08-13,Targeted Therapy,Private,Alive,47.0,KRAS,No,Former,None,22.3,,Rural,NHS,5.0,Yes,Yes,None,7.0
PT00679,Italy,Veneto,76.0,Male,Prostate,III,2021-01-12,2021-03-27,2021-07-31,Targeted Therapy,Public,Deceased,65.0,KRAS,No,Former,Moderate,24.7,Low,Rural,Statutory Health Insurance,9.0,No,No,None,7.0
PT00680,Austria,Styria,36.0,Female,Breast,III,2018-02-26,2018-05-24,2018-12-09,Radiation,Public,Alive,38.0,EGFR,Yes,Never,Moderate,27.0,High,Urban,NHS,11.0,No,No,Obesity,8.0
PT00681,Sweden,Skåne,69.0,Female,Leukemia,III,2012-12-23,2012-12-27,2013-10-11,Radiation,Public,,41.0,None,No,Former,None,24.1,Medium,Rural,Private Insurance,5.0,No,No,Hypertension,2.0
PT00682,Poland,Masovian,51.0,Female,Lung,I,2018-09-02,2018-10-30,2019-09-21,Targeted Therapy,Public,Alive,99.0,EGFR,No,Former,Heavy,26.5,High,Rural,Statutory Health Insurance,7.0,No,No,None,6.0
PT00683,Belgium,Brussels,41.0,Male,Ovarian,I,2015-09-28,2016-01-24,2016-12-23,,Public,Alive,28.0,EGFR,Yes,Former,None,20.8,Low,Urban,Private Insurance,18.0,,Yes,None,6.0
PT00684,Belgium,Flanders,74.0,Male,Colorectal,IV,,2016-01-28,2016-05-19,Surgery,Public,Deceased,8.0,KRAS,Yes,Never,Moderate,18.3,High,Urban,Private Insurance,11.0,No,,Cardiovascular Disease,8.0
PT00685,Poland,Masovian,76.0,Female,Pancreatic,I,2012-07-05,2012-10-26,2013-02-14,Chemotherapy,Public,Alive,78.0,BRCA1,No,Former,Moderate,22.3,Medium,Rural,NHS,10.0,Yes,No,Cardiovascular Disease,9.0
PT00686,Switzerland,Geneva,32.0,,Pancreatic,III,2022-04-21,2022-10-05,,Immunotherapy,Private,Deceased,72.0,KRAS,No,Never,Moderate,24.0,High,Urban,NHS,,No,No,Obesity,1.0
PT00687,France,,66.0,Male,Colorectal,I,2023-04-29,2023-08-11,2024-04-19,Immunotherapy,Public,Deceased,67.0,BRCA1,No,Never,Moderate,35.4,Medium,Rural,Private Insurance,8.0,No,Yes,Diabetes,5.0
PT00688,Netherlands,Utrecht,81.0,Female,Ovarian,IV,2023-01-19,2023-05-28,2024-03-15,Chemotherapy,,Alive,51.0,KRAS,Yes,Current,None,34.5,High,Urban,Statutory Health Insurance,6.0,No,No,None,5.0
,France,Provence-Alpes-Côte d'Azur,73.0,Female,Leukemia,IV,2011-03-04,2011-06-10,2011-08-16,Targeted Therapy,Private,Alive,14.0,None,Yes,,Heavy,34.0,Low,Rural,Private Insurance,4.0,No,,None,6.0
PT00690,Denmark,Capital Region,48.0,Female,Lung,I,2018-06-16,2018-08-03,2019-01-12,Targeted Therapy,,Lost to Follow-up,,None,No,,Moderate,39.1,Medium,Rural,NHS,2.0,No,No,None,4.0
PT00691,Germany,Berlin,41.0,Male,Pancreatic,III,2021-06-08,2021-06-29,2021-09-27,Radiation,Public,Alive,88.0,KRAS,Yes,Former,None,27.0,Medium,Rural,Statutory Health Insurance,13.0,No,No,Hypertension,9.0
PT00692,Spain,Catalonia,84.0,Female,Prostate,I,2016-02-10,2016-07-18,2016-11-07,Immunotherapy,,Deceased,27.0,KRAS,Yes,Never,Moderate,20.3,Medium,Urban,Statutory Health Insurance,3.0,No,No,Obesity,4.0
PT00693,Belgium,Wallonia,48.0,Female,Ovarian,I,2011-12-10,2012-06-02,2013-01-22,Radiation,Private,Alive,83.0,KRAS,,Current,None,36.0,Medium,Urban,Statutory Health Insurance,10.0,Yes,,Obesity,5.0
PT00694,Ireland,Connacht,67.0,Male,Lung,II,2020-01-12,2020-02-04,2020-04-01,Radiation,Public,Deceased,55.0,BRCA1,Yes,Never,Moderate,30.8,Medium,Urban,NHS,1.0,,No,Hypertension,5.0
PT00695,France,Provence-Alpes-Côte d'Azur,,Female,Breast,II,2015-06-05,2015-09-04,2016-04-05,Immunotherapy,Private,,100.0,EGFR,No,Former,Moderate,40.0,Medium,Rural,Private Insurance,16.0,Yes,No,Obesity,8.0
PT00696,Austria,Styria,54.0,Male,Ovarian,II,2013-10-20,2013-10-27,2014-04-04,Targeted Therapy,Public,Alive,117.0,KRAS,No,Former,None,25.5,Low,Urban,NHS,11.0,No,,Hypertension,7.0
PT00697,Germany,Bavaria,65.0,Male,Pancreatic,II,2010-07-22,2010-11-27,2011-03-06,Surgery,Public,Alive,103.0,EGFR,Yes,Never,None,37.2,,Urban,Statutory Health Insurance,18.0,No,No,Hypertension,6.0
PT00698,Netherlands,Utrecht,54.0,Male,Leukemia,I,2019-01-16,2019-03-06,2019-10-28,Targeted Therapy,Public,Lost to Follow-up,,BRCA1,Yes,Never,Heavy,36.9,,Urban,NHS,12.0,No,No,,6.0
PT00699,Austria,Tyrol,64.0,Female,Ovarian,,2022-11-08,2023-02-15,2023-08-19,Targeted Therapy,Public,Alive,59.0,,Yes,Former,None,39.6,High,Urban,Private Insurance,8.0,No,No,,10.0
PT00700,Spain,Andalusia,32.0,Female,Prostate,II,2021-03-25,2021-04-25,2021-06-30,Radiation,Private,Alive,58.0,EGFR,No,Never,Moderate,39.7,High,Urban,Private Insurance,6.0,No,Yes,Hypertension,4.0
PT00701,Sweden,Västra Götaland,29.0,Male,Lung,II,2016-08-01,2016-12-04,2017-08-07,Radiation,Public,Alive,92.0,None,Yes,Never,None,39.8,Low,Rural,Private Insurance,4.0,No,Yes,None,7.0
PT00702,Denmark,Zealand,85.0,Male,Ovarian,,2019-08-22,2020-02-13,2020-06-17,Radiation,Public,Deceased,38.0,None,No,Never,Moderate,38.1,Medium,Urban,Statutory Health Insurance,10.0,Yes,No,Hypertension,
PT00703,,Capital Region,89.0,Male,Lung,III,2018-10-23,2019-01-24,2019-10-29,Immunotherapy,,Alive,46.0,None,Yes,,Moderate,23.7,Medium,Urban,Statutory Health Insurance,14.0,No,No,Cardiovascular Disease,3.0
PT00704,,Oslo,,Male,Prostate,IV,2015-10-04,2015-11-08,2016-06-07,Immunotherapy,Research Institute,Alive,97.0,KRAS,No,Current,Moderate,27.7,High,,Statutory Health Insurance,14.0,No,Yes,Cardiovascular Disease,8.0
PT00705,Denmark,Central Denmark,63.0,Male,Breast,II,2010-05-27,2010-06-30,2010-11-07,Chemotherapy,Public,Alive,26.0,KRAS,Yes,Never,None,39.4,High,Urban,Statutory Health Insurance,1.0,No,No,Hypertension,5.0
PT00706,Poland,Masovian,79.0,Male,Breast,I,2022-10-26,2022-11-10,2023-07-25,Radiation,Private,Alive,31.0,None,No,Current,Moderate,26.8,High,Urban,Statutory Health Insurance,5.0,No,No,Cardiovascular Disease,4.0
PT00707,Austria,Styria,66.0,Male,Ovarian,III,2012-09-06,2012-11-23,2012-12-25,Immunotherapy,Public,Alive,15.0,KRAS,No,Current,None,38.2,Low,Urban,NHS,6.0,No,No,Obesity,6.0
,Switzerland,Zurich,59.0,Female,Lung,III,2012-01-06,,2012-07-09,Chemotherapy,Private,Alive,69.0,EGFR,No,,None,34.6,High,Rural,Statutory Health Insurance,,No,No,Hypertension,7.0
PT00709,Portugal,,26.0,Female,Colorectal,II,2011-11-26,2012-02-05,2012-06-10,Radiation,Private,Alive,28.0,None,No,Current,Moderate,37.1,Medium,Urban,Private Insurance,8.0,No,,Diabetes,4.0
PT00710,Switzerland,Geneva,65.0,Female,Prostate,III,2012-05-03,2012-07-23,2012-11-14,,Public,Alive,72.0,EGFR,Yes,Never,Moderate,34.7,Medium,Rural,Private Insurance,4.0,No,No,,5.0
PT00711,Germany,Bavaria,42.0,Male,Pancreatic,II,2010-09-05,2011-02-22,2011-11-17,Surgery,Research Institute,Alive,15.0,KRAS,No,Never,None,26.4,Low,Rural,Statutory Health Insurance,,No,No,None,6.0
PT00712,Sweden,Västra Götaland,65.0,Male,Ovarian,I,2015-12-20,2016-05-14,2016-12-05,Immunotherapy,,Alive,114.0,EGFR,No,Never,None,24.0,High,Rural,NHS,17.0,No,No,Cardiovascular Disease,9.0
PT00713,France,Auvergne-Rhône-Alpes,32.0,Male,,III,2022-06-04,2022-07-12,2023-05-30,Chemotherapy,Research Institute,Deceased,109.0,None,No,Never,None,33.5,Low,Rural,Private Insurance,1.0,No,No,Hypertension,4.0
PT00714,Belgium,Brussels,40.0,Male,Pancreatic,I,2016-04-22,2016-06-25,2016-12-02,Radiation,Private,Deceased,6.0,BRCA1,No,Never,None,19.9,High,Rural,Statutory Health Insurance,10.0,,No,Hypertension,6.0
PT00715,Netherlands,South Holland,20.0,Male,Breast,II,2013-11-10,2013-12-09,,Immunotherapy,Private,Alive,33.0,KRAS,Yes,Current,Moderate,22.1,Low,Urban,NHS,6.0,No,No,Hypertension,5.0
PT00716,France,Provence-Alpes-Côte d'Azur,38.0,Female,Breast,II,2016-12-27,2017-04-24,2017-09-01,Chemotherapy,,Deceased,82.0,EGFR,No,Never,Moderate,18.7,High,Urban,Private Insurance,12.0,No,No,Obesity,8.0
PT00717,Austria,Vienna,79.0,Female,Leukemia,II,2020-04-29,2020-08-22,2021-04-25,Surgery,Public,Alive,44.0,BRCA1,No,Never,,24.2,Low,Urban,Statutory Health Insurance,19.0,No,No,Diabetes,
PT00718,France,Provence-Alpes-Côte d'Azur,52.0,Male,Ovarian,II,2016-09-29,2016-10-09,2017-05-14,Chemotherapy,Public,Alive,116.0,None,No,Never,None,24.9,Low,,Private Insurance,16.0,No,No,Diabetes,10.0
,Finland,Pirkanmaa,23.0,Male,Pancreatic,I,2020-03-26,2020-04-12,2021-01-12,,Public,Deceased,112.0,BRCA1,Yes,Former,None,,Low,Rural,Private Insurance,14.0,Yes,No,Hypertension,1.0
PT00720,Germany,North Rhine-Westphalia,22.0,Female,Colorectal,,,2013-02-19,2013-12-14,Targeted Therapy,Public,Alive,83.0,None,No,Never,Moderate,34.8,Low,Urban,NHS,9.0,No,No,Obesity,5.0
PT00721,Norway,Vestland,71.0,Male,Breast,III,2023-12-12,2024-04-05,2024-11-01,Targeted Therapy,Research Institute,,63.0,None,No,Never,Moderate,33.1,High,Urban,Private Insurance,5.0,Yes,,,8.0
PT00722,Finland,Uusimaa,47.0,Female,Colorectal,II,2021-02-06,2021-05-01,2022-04-01,Surgery,Public,Deceased,43.0,BRCA1,Yes,Never,None,35.5,Medium,Urban,Private Insurance,9.0,No,No,Hypertension,8.0
PT00723,Finland,Uusimaa,89.0,Non-binary,Lung,I,2018-08-01,2018-10-21,2019-04-22,Radiation,Public,Alive,70.0,BRCA1,Yes,Never,Moderate,32.0,High,Rural,Private Insurance,8.0,Yes,No,None,9.0
PT00724,Spain,Catalonia,89.0,Non-binary,Lung,I,2020-12-14,2021-06-06,2022-01-02,,Public,Alive,7.0,BRCA1,Yes,Current,None,23.8,Low,Urban,Private Insurance,11.0,Yes,No,Diabetes,2.0
PT00725,Spain,Catalonia,74.0,Male,Leukemia,III,2015-04-17,2015-06-27,2015-09-21,Immunotherapy,Private,Deceased,75.0,KRAS,Yes,Former,None,39.1,Low,Urban,NHS,4.0,No,No,None,9.0
PT00726,Sweden,Stockholm,76.0,Male,Colorectal,II,2013-11-21,2014-03-16,2014-05-30,Targeted Therapy,Private,Deceased,23.0,BRCA1,No,Current,None,21.0,High,Rural,NHS,9.0,No,No,None,2.0
PT00727,,South Holland,35.0,Male,Prostate,I,2023-05-29,2023-07-24,2023-11-16,Immunotherapy,Private,Alive,57.0,None,Yes,Never,Moderate,20.4,Medium,Urban,Private Insurance,16.0,No,No,None,3.0
PT00728,Sweden,Västra Götaland,43.0,Female,Leukemia,II,2010-05-03,2010-07-03,2011-03-24,Radiation,Private,Alive,59.0,EGFR,No,Never,Moderate,23.3,Low,Urban,Statutory Health Insurance,16.0,No,,Cardiovascular Disease,1.0
PT00729,Poland,Lesser Poland,88.0,Female,Breast,II,2016-05-06,2016-08-17,2016-12-06,Surgery,Public,Alive,23.0,None,No,Never,Moderate,36.8,Medium,,Statutory Health Insurance,10.0,No,No,Cardiovascular Disease,6.0
PT00730,Italy,Veneto,60.0,Female,Lung,III,2011-11-17,2011-12-31,2012-07-25,Targeted Therapy,Research Institute,Deceased,27.0,EGFR,No,Current,None,27.7,Low,Rural,Private Insurance,3.0,No,No,None,5.0
PT00731,Germany,Bavaria,66.0,Female,Ovarian,III,2014-07-20,2015-01-02,2015-12-23,Immunotherapy,Public,Alive,52.0,BRCA1,No,Never,None,26.7,High,Urban,Private Insurance,7.0,,Yes,Hypertension,5.0
PT00732,Ireland,Connacht,88.0,Female,Lung,IV,2015-04-05,2015-07-18,2015-11-17,Surgery,Public,Alive,81.0,BRCA1,Yes,Never,Moderate,24.2,Medium,Rural,Statutory Health Insurance,17.0,,No,None,5.0
PT00733,Poland,Masovian,50.0,Female,Prostate,I,2017-11-15,2018-05-12,2018-12-25,Radiation,Private,,80.0,KRAS,,Never,None,39.1,Low,Rural,NHS,8.0,Yes,Yes,Cardiovascular Disease,10.0
PT00734,France,Île-de-France,49.0,Female,Leukemia,III,2019-12-12,2020-02-24,2020-09-02,Chemotherapy,Public,,78.0,BRCA1,No,Former,Moderate,,Medium,Urban,Private Insurance,9.0,No,No,Obesity,6.0
PT00735,Germany,Bavaria,37.0,Female,Colorectal,I,,2022-03-22,2022-12-02,Chemotherapy,,Alive,116.0,EGFR,No,Never,None,21.6,,Rural,Private Insurance,15.0,No,Yes,Hypertension,7.0
PT00736,Portugal,Lisbon,63.0,Female,Ovarian,II,2023-07-28,2023-11-26,2024-07-05,Targeted Therapy,Public,Alive,33.0,KRAS,No,Former,Moderate,25.7,Medium,Urban,Private Insurance,1.0,No,No,Diabetes,4.0
PT00737,Austria,,46.0,Male,Lung,,2020-09-05,2020-12-04,2021-05-28,Surgery,Public,Deceased,47.0,EGFR,No,Never,Heavy,25.9,Medium,Urban,Statutory Health Insurance,18.0,No,No,Obesity,9.0
PT00738,Switzerland,Zurich,45.0,,Breast,I,2015-12-04,2016-01-26,2016-11-04,Immunotherapy,Public,Alive,44.0,BRCA1,Yes,,None,22.9,Low,Urban,Statutory Health Insurance,8.0,No,No,None,6.0
PT00739,Belgium,Brussels,79.0,Male,Prostate,II,2017-10-09,2018-04-03,2019-02-09,Surgery,Private,Deceased,24.0,None,No,Never,Moderate,20.8,High,Urban,Private Insurance,12.0,Yes,No,,5.0
PT00740,Austria,Vienna,37.0,Male,Prostate,III,2019-06-23,2019-06-24,2019-08-02,Targeted Therapy,Public,Deceased,25.0,None,Yes,Never,Moderate,36.4,High,Urban,Statutory Health Insurance,12.0,Yes,,Cardiovascular Disease,1.0
PT00741,Italy,Sicily,75.0,Female,Pancreatic,I,2015-04-04,2015-07-16,,Radiation,Public,Deceased,73.0,None,No,Never,None,29.5,Medium,Urban,NHS,12.0,No,No,Diabetes,2.0
,Finland,Southwest Finland,50.0,Female,Prostate,II,2015-09-29,2016-01-25,2017-01-03,Surgery,Private,Alive,,BRCA1,No,,Moderate,25.8,High,Urban,NHS,14.0,No,No,Hypertension,
PT00743,Denmark,Zealand,78.0,Female,Breast,IV,2013-03-17,2013-04-16,2013-08-14,Targeted Therapy,Private,,,EGFR,No,Current,None,19.3,Medium,Urban,Statutory Health Insurance,2.0,No,,Hypertension,9.0
PT00744,Switzerland,Zurich,21.0,Male,Prostate,II,2011-07-09,2011-07-18,,Targeted Therapy,Public,,96.0,KRAS,No,Never,Moderate,23.6,Low,Urban,NHS,19.0,No,Yes,Cardiovascular Disease,9.0
PT00745,Germany,North Rhine-Westphalia,58.0,Female,Colorectal,III,2018-10-13,2019-01-29,2019-03-14,Immunotherapy,Public,Deceased,,KRAS,Yes,Current,None,33.9,Medium,Urban,Private Insurance,19.0,Yes,,Obesity,3.0
PT00746,Spain,,80.0,Male,Pancreatic,III,2019-01-03,2019-02-05,2019-11-03,Radiation,Private,Alive,110.0,KRAS,No,Former,Moderate,37.7,Medium,,Private Insurance,6.0,No,No,Diabetes,7.0
PT00747,Germany,Bavaria,82.0,,Colorectal,I,2020-12-22,2021-01-17,2021-08-27,Surgery,Public,Alive,69.0,None,No,Former,None,,High,Urban,Private Insurance,3.0,Yes,,Obesity,5.0
PT00748,Ireland,,37.0,Male,Ovarian,I,2022-08-07,2022-09-18,2023-05-21,Targeted Therapy,Research Institute,Alive,69.0,KRAS,No,Former,Moderate,24.9,High,Urban,Private Insurance,7.0,No,No,Cardiovascular Disease,7.0
PT00749,France,Provence-Alpes-Côte d'Azur,36.0,Female,Leukemia,III,2014-12-22,2015-02-02,2015-11-20,Radiation,Public,Deceased,62.0,None,Yes,Former,Moderate,,Medium,Rural,Private Insurance,15.0,No,No,Hypertension,9.0
PT00750,Belgium,Wallonia,58.0,Female,Leukemia,,2015-02-21,2015-05-28,2016-02-02,Immunotherapy,Public,Deceased,55.0,KRAS,No,Never,None,21.2,Low,Rural,Statutory Health Insurance,2.0,No,No,None,1.0
PT00751,Belgium,Wallonia,73.0,Male,Ovarian,I,2010-07-08,2010-08-16,2011-01-26,Targeted Therapy,,Alive,97.0,None,No,Current,Moderate,24.3,Medium,Rural,Private Insurance,16.0,Yes,No,Cardiovascular Disease,2.0
,Netherlands,South Holland,54.0,Female,Ovarian,II,,2014-02-10,2014-12-30,Immunotherapy,Public,Alive,104.0,,No,Never,None,29.4,Low,Urban,Statutory Health Insurance,15.0,Yes,No,Hypertension,3.0
PT00753,Norway,Vestland,30.0,Female,Colorectal,II,2013-05-05,2013-06-21,2014-05-20,Radiation,Private,Alive,108.0,BRCA1,No,Never,None,35.1,Medium,Urban,NHS,8.0,No,No,Diabetes,9.0
PT00754,Poland,Silesian,80.0,Male,Breast,III,2017-02-10,2017-07-30,2017-09-12,Immunotherapy,Private,,6.0,KRAS,No,Current,None,38.0,Medium,,NHS,15.0,,No,Diabetes,2.0
PT00755,Finland,Uusimaa,63.0,Male,Pancreatic,II,2017-11-08,2017-12-26,2018-12-18,Surgery,Public,Alive,116.0,EGFR,No,Former,Heavy,38.7,,Urban,Private Insurance,13.0,No,No,Obesity,6.0
PT00756,Sweden,,87.0,Male,Leukemia,IV,2015-08-24,2016-02-01,2016-03-30,Immunotherapy,Research Institute,Alive,8.0,BRCA1,Yes,Never,,21.6,Low,Urban,NHS,17.0,No,Yes,Obesity,3.0
PT00757,Poland,Lesser Poland,44.0,Male,Prostate,IV,2023-11-11,2024-04-14,2025-01-26,Chemotherapy,,Alive,9.0,EGFR,No,Current,Moderate,27.7,High,Urban,Statutory Health Insurance,14.0,No,No,None,6.0
PT00758,Germany,,67.0,Female,Ovarian,III,2017-12-17,2018-06-06,2019-06-01,,Public,Alive,32.0,KRAS,No,Former,None,32.9,Medium,Urban,Private Insurance,11.0,No,No,Cardiovascular Disease,
PT00759,Spain,Andalusia,51.0,Non-binary,Colorectal,III,2014-09-12,2015-02-16,2015-10-04,Chemotherapy,Public,Alive,42.0,KRAS,No,Never,None,,Medium,Urban,Private Insurance,3.0,No,No,Cardiovascular Disease,4.0
PT00760,Finland,Southwest Finland,23.0,Male,Lung,II,2019-09-06,2020-01-31,2020-05-27,Chemotherapy,Public,Alive,28.0,BRCA1,No,Former,None,29.1,High,Urban,Statutory Health Insurance,18.0,No,No,Obesity,2.0
PT00761,Finland,Pirkanmaa,57.0,Male,Breast,I,2011-09-04,2012-01-10,2012-07-19,Surgery,Private,Lost to Follow-up,,KRAS,Yes,Current,Heavy,19.3,Medium,Rural,NHS,3.0,No,No,Hypertension,6.0
PT00762,Switzerland,Zurich,82.0,Female,Breast,II,2016-11-14,2017-02-21,2017-04-15,Targeted Therapy,Private,Alive,32.0,None,Yes,Never,None,35.6,Low,Rural,Statutory Health Insurance,18.0,No,No,Hypertension,8.0
PT00763,Finland,Pirkanmaa,66.0,Male,Colorectal,II,2018-01-04,2018-04-25,2019-01-20,Chemotherapy,Public,Alive,94.0,BRCA1,Yes,Never,Moderate,37.0,Low,Rural,Private Insurance,11.0,No,No,None,
PT00764,,Zurich,20.0,Male,Lung,II,2010-10-11,2010-11-08,2011-03-19,Chemotherapy,Private,Alive,87.0,BRCA1,Yes,,,37.6,,Urban,NHS,19.0,No,No,Hypertension,7.0
PT00765,Netherlands,Utrecht,22.0,Male,Breast,III,2017-04-24,2017-05-04,2018-03-10,Targeted Therapy,Research Institute,Alive,107.0,KRAS,Yes,Never,Moderate,37.3,High,Urban,Private Insurance,15.0,,No,Cardiovascular Disease,9.0
PT00766,Belgium,Wallonia,81.0,Female,Pancreatic,II,2021-03-18,2021-07-02,2021-11-25,Chemotherapy,Private,Alive,7.0,BRCA1,Yes,Never,Heavy,34.6,Medium,Urban,NHS,14.0,No,Yes,None,10.0
PT00767,Poland,Silesian,83.0,Female,Leukemia,III,2014-06-16,2014-11-07,2015-01-08,,Private,Deceased,15.0,None,Yes,Never,Moderate,27.1,,Urban,Statutory Health Insurance,11.0,No,No,Diabetes,2.0
,Denmark,Central Denmark,36.0,Female,Pancreatic,II,2014-05-31,2014-09-08,2015-06-18,Chemotherapy,Public,Alive,49.0,BRCA1,No,Current,None,22.0,Medium,Rural,Statutory Health Insurance,,No,No,None,2.0
PT00769,Switzerland,Zurich,81.0,Male,Lung,,2011-12-18,2011-12-19,2012-11-11,Targeted Therapy,Public,Alive,103.0,None,No,Never,Moderate,20.9,High,Urban,,17.0,No,No,Diabetes,8.0
PT00770,Finland,Pirkanmaa,54.0,Female,Pancreatic,II,2022-09-04,2022-12-31,2023-02-15,Targeted Therapy,Research Institute,Alive,95.0,EGFR,No,Former,None,33.6,Medium,Urban,NHS,6.0,No,No,Diabetes,6.0
PT00771,Austria,Styria,32.0,Female,Prostate,IV,2011-11-13,2012-02-03,2012-03-10,Radiation,Private,Alive,32.0,None,,Former,Moderate,35.1,Low,,NHS,18.0,No,No,,4.0
PT00772,Norway,Trøndelag,54.0,Female,Ovarian,III,2019-06-02,,2019-12-07,Immunotherapy,Private,Alive,101.0,None,Yes,Never,None,32.3,Medium,Urban,NHS,6.0,No,No,Hypertension,4.0
,Poland,Silesian,62.0,Male,Ovarian,I,2021-08-27,2022-01-06,2022-03-12,Targeted Therapy,Public,Alive,42.0,None,Yes,Former,Moderate,30.6,Medium,Rural,Private Insurance,2.0,No,No,Diabetes,3.0
PT00774,Belgium,Wallonia,21.0,Female,Leukemia,II,2021-09-09,2022-01-02,2022-10-29,Chemotherapy,Private,Lost to Follow-up,,None,Yes,Former,Heavy,31.0,Low,Rural,NHS,15.0,No,No,,6.0
PT00775,Portugal,Algarve,75.0,Female,Lung,IV,2014-03-03,2014-07-29,2014-11-05,Surgery,Private,Deceased,80.0,EGFR,No,Never,Moderate,19.4,Medium,Urban,Statutory Health Insurance,3.0,No,No,Diabetes,2.0
PT00776,,South Holland,70.0,Male,Colorectal,I,2013-09-21,,2014-06-25,Targeted Therapy,Public,Deceased,54.0,KRAS,No,Never,None,24.2,Medium,Rural,Private Insurance,19.0,,No,Hypertension,7.0
PT00777,France,Provence-Alpes-Côte d'Azur,73.0,Male,Breast,I,2015-09-05,2015-10-10,2016-06-23,Chemotherapy,Private,,,EGFR,Yes,Never,Moderate,21.7,High,Urban,Statutory Health Insurance,7.0,No,Yes,,6.0
PT00778,Belgium,Flanders,35.0,Female,Leukemia,I,2014-11-25,2015-03-21,2015-06-27,Targeted Therapy,Research Institute,Alive,82.0,KRAS,Yes,Never,None,28.0,High,Urban,Private Insurance,8.0,No,No,Hypertension,6.0
,France,Île-de-France,37.0,Female,Colorectal,II,2019-10-16,2019-11-30,2020-02-20,Radiation,Public,Deceased,13.0,KRAS,No,Never,None,19.7,High,Rural,NHS,19.0,No,No,Obesity,4.0
PT00780,Spain,Catalonia,26.0,Female,Lung,II,2019-03-25,2019-05-21,2020-02-11,Surgery,Public,Alive,93.0,BRCA1,Yes,Former,Moderate,25.3,High,Urban,Private Insurance,1.0,No,No,Hypertension,4.0
PT00781,Netherlands,South Holland,64.0,Female,Prostate,I,2016-10-20,2017-02-18,2017-10-02,,Private,Deceased,65.0,None,Yes,Former,Moderate,37.3,High,Urban,Private Insurance,19.0,No,No,Diabetes,10.0
PT00782,Spain,Catalonia,55.0,Female,Breast,III,2014-12-24,2015-05-25,2015-06-25,Chemotherapy,Public,Alive,98.0,BRCA1,Yes,Current,Moderate,,Medium,Rural,NHS,4.0,No,No,Obesity,6.0
PT00783,Netherlands,South Holland,60.0,Male,Breast,I,2015-08-21,2015-09-10,2016-01-24,Immunotherapy,Research Institute,Lost to Follow-up,,KRAS,No,Never,Heavy,30.4,Low,Urban,Private Insurance,14.0,No,No,Cardiovascular Disease,1.0
PT00784,Sweden,Skåne,61.0,Male,Leukemia,III,2017-04-20,2017-09-23,2018-03-17,Radiation,Public,Alive,70.0,EGFR,Yes,Current,Moderate,23.8,Low,,Statutory Health Insurance,17.0,No,,Cardiovascular Disease,10.0
PT00785,Norway,Trøndelag,26.0,Non-binary,Colorectal,II,2013-12-04,2014-05-19,2014-11-24,Immunotherapy,Private,Alive,82.0,None,Yes,Former,Moderate,26.2,Medium,Urban,,8.0,,No,Hypertension,10.0
PT00786,France,Provence-Alpes-Côte d'Azur,34.0,Male,Ovarian,II,2019-04-29,2019-09-28,2020-06-22,Surgery,Private,Alive,59.0,KRAS,No,Former,None,24.6,Medium,Urban,Private Insurance,18.0,No,No,None,3.0
PT00787,Switzerland,Zurich,79.0,,Lung,I,2019-04-08,2019-05-02,2019-10-04,Surgery,Private,Alive,30.0,None,No,Current,None,19.4,Medium,Urban,Private Insurance,17.0,No,No,,3.0
PT00788,France,Auvergne-Rhône-Alpes,59.0,Female,Lung,III,2018-05-31,2018-08-09,2019-02-11,Immunotherapy,Private,Deceased,106.0,None,No,Never,None,19.5,Medium,Rural,Private Insurance,18.0,No,Yes,None,2.0
PT00789,Germany,,,Female,,II,2011-06-07,2011-09-17,2012-08-16,Targeted Therapy,Public,Alive,12.0,None,No,Current,Heavy,28.3,Medium,Urban,,3.0,No,No,Diabetes,7.0
PT00790,Poland,Masovian,85.0,Male,Breast,II,2014-08-21,2014-12-26,2015-08-20,Immunotherapy,Public,Deceased,27.0,KRAS,No,Former,Moderate,36.6,Medium,,Statutory Health Insurance,14.0,No,No,Obesity,2.0
PT00791,Ireland,Dublin,74.0,Male,Colorectal,II,2021-06-15,2021-10-11,2022-05-31,,Private,,102.0,BRCA1,No,Never,,38.5,Medium,Urban,Private Insurance,5.0,No,No,None,3.0
PT00792,Ireland,Dublin,75.0,Male,Pancreatic,III,2016-04-08,2016-05-03,2017-04-13,Targeted Therapy,Private,Deceased,116.0,,No,Former,None,23.0,Medium,Rural,Statutory Health Insurance,5.0,No,No,Cardiovascular Disease,1.0
PT00793,Spain,Andalusia,63.0,Male,Ovarian,,2013-03-01,2013-05-21,2013-10-24,Targeted Therapy,Public,Deceased,20.0,None,No,Never,None,37.7,Medium,Urban,Statutory Health Insurance,9.0,No,No,Diabetes,4.0
PT00794,Norway,Vestland,76.0,Female,Lung,I,2011-08-21,2011-09-07,2012-07-16,Targeted Therapy,Private,Lost to Follow-up,,,Yes,Never,None,19.1,Low,,,19.0,No,,Hypertension,9.0
PT00795,Netherlands,North Holland,25.0,Male,,I,2014-07-04,2014-08-31,2015-03-03,Radiation,Public,Alive,8.0,EGFR,No,Former,None,36.5,High,Rural,NHS,2.0,No,No,Cardiovascular Disease,10.0
,Austria,Vienna,,Female,Breast,III,2015-11-29,,,Surgery,Public,Lost to Follow-up,,KRAS,No,Never,Heavy,30.1,Medium,Urban,Private Insurance,16.0,No,No,,10.0
PT00797,Spain,Andalusia,37.0,Female,Leukemia,II,2016-05-25,2016-05-27,2016-11-23,Surgery,Public,Alive,60.0,None,Yes,Never,Moderate,19.9,Medium,Urban,NHS,5.0,No,No,Obesity,10.0
PT00798,Netherlands,North Holland,87.0,Female,Pancreatic,III,2015-02-01,2015-04-25,2015-06-25,Targeted Therapy,Public,Alive,13.0,EGFR,No,Former,Moderate,19.7,High,Urban,Private Insurance,3.0,Yes,Yes,Obesity,7.0
PT00799,Italy,,26.0,Male,Breast,III,2014-09-11,2014-09-20,2014-11-03,Targeted Therapy,Public,Alive,108.0,BRCA1,No,Never,Moderate,21.1,Low,Urban,Statutory Health Insurance,7.0,No,No,None,2.0
PT00800,France,Île-de-France,27.0,Female,Prostate,IV,2020-03-27,2020-07-28,2021-01-01,Radiation,Private,Deceased,53.0,None,No,Never,None,19.1,Low,Urban,Statutory Health Insurance,11.0,No,,None,3.0
,Portugal,Lisbon,,Male,Prostate,II,2023-05-29,2023-09-10,2024-01-13,Radiation,Private,Alive,70.0,None,No,Never,Moderate,33.5,,Rural,,2.0,No,No,Hypertension,10.0
PT00802,France,Île-de-France,26.0,Male,Colorectal,II,2017-08-16,2017-11-07,2018-10-15,Chemotherapy,Public,Alive,81.0,EGFR,Yes,Never,None,31.6,Medium,Urban,Statutory Health Insurance,14.0,No,No,Diabetes,6.0
PT00803,Denmark,,60.0,Female,Ovarian,III,2018-09-12,2018-12-30,2019-11-27,Immunotherapy,Public,Alive,100.0,EGFR,No,Never,Heavy,36.5,Medium,Urban,Private Insurance,4.0,No,No,Obesity,2.0
PT00804,Germany,North Rhine-Westphalia,59.0,Female,Ovarian,I,2010-07-22,2010-11-19,2011-03-29,Surgery,Public,Alive,97.0,None,No,Never,None,28.7,Medium,Urban,Statutory Health Insurance,14.0,No,Yes,Obesity,2.0
PT00805,Austria,Tyrol,22.0,Female,Breast,,2017-12-08,2018-04-21,2018-09-15,Surgery,Public,,88.0,None,Yes,Never,None,30.8,High,Urban,NHS,6.0,No,No,None,4.0
,Germany,North Rhine-Westphalia,36.0,Male,Breast,I,2019-10-13,2019-10-24,2019-12-02,,Private,Alive,87.0,BRCA1,,Never,None,21.2,Medium,Urban,Statutory Health Insurance,14.0,,No,None,1.0
PT00807,Denmark,Central Denmark,85.0,Male,Lung,IV,2013-06-18,2013-11-14,2014-04-09,Immunotherapy,Research Institute,Alive,57.0,None,No,Never,Heavy,29.5,Low,Urban,Private Insurance,12.0,No,No,Obesity,2.0
PT00808,Belgium,Flanders,71.0,Non-binary,Leukemia,,2016-09-25,2017-01-09,2017-08-06,Radiation,Private,Alive,82.0,KRAS,Yes,Never,None,24.9,Medium,Urban,Statutory Health Insurance,13.0,No,No,Cardiovascular Disease,7.0
PT00809,Austria,Tyrol,41.0,Female,Pancreatic,I,2013-05-22,2013-09-27,2014-06-07,Chemotherapy,Public,Alive,104.0,,No,Current,None,27.9,Low,Rural,Statutory Health Insurance,4.0,No,No,Hypertension,3.0
PT00810,Sweden,Stockholm,23.0,Female,Breast,III,2014-04-04,2014-05-04,2015-01-12,Chemotherapy,Private,Lost to Follow-up,,None,No,Never,Moderate,36.4,Medium,Urban,Private Insurance,6.0,No,No,None,1.0
PT00811,Sweden,Västra Götaland,25.0,Female,Pancreatic,I,2020-03-31,2020-06-21,2021-03-25,Chemotherapy,Public,Deceased,43.0,None,No,Never,None,32.8,High,Rural,,6.0,,No,None,2.0
PT00812,France,Provence-Alpes-Côte d'Azur,57.0,Male,Colorectal,IV,2010-02-22,2010-06-17,,Radiation,Public,Alive,27.0,EGFR,No,Former,Moderate,19.3,Medium,Urban,Statutory Health Insurance,,No,No,Obesity,3.0
PT00813,Netherlands,Utrecht,45.0,Female,Lung,II,,2020-03-20,2021-03-03,Immunotherapy,Private,Alive,62.0,,No,Former,Moderate,39.1,Low,Rural,Private Insurance,13.0,Yes,No,Obesity,3.0
PT00814,Belgium,Brussels,,Male,Ovarian,III,2018-08-26,,2020-01-14,,Public,Deceased,110.0,,No,Never,None,23.7,Low,Urban,Statutory Health Insurance,10.0,No,No,Obesity,10.0
PT00815,Portugal,Algarve,36.0,Female,Pancreatic,II,2011-11-03,2012-01-03,2012-06-17,Surgery,Public,Alive,110.0,EGFR,No,Current,Moderate,28.1,High,Urban,NHS,8.0,No,No,Cardiovascular Disease,1.0
PT00816,Norway,Oslo,50.0,Female,Pancreatic,III,2021-03-28,2021-09-02,2022-05-19,Targeted Therapy,Public,Deceased,18.0,EGFR,Yes,Never,Moderate,28.3,High,Urban,Statutory Health Insurance,11.0,No,No,Hypertension,9.0
PT00817,Sweden,Västra Götaland,54.0,Female,Pancreatic,IV,2011-11-22,2012-05-14,2012-07-23,Immunotherapy,,Alive,41.0,None,No,Current,Moderate,32.3,Medium,Rural,,17.0,Yes,No,Diabetes,1.0
PT00818,France,Auvergne-Rhône-Alpes,35.0,Female,Pancreatic,III,2010-03-24,2010-04-11,2010-06-19,,Public,Deceased,59.0,None,No,Current,None,,,Urban,Private Insurance,13.0,No,No,Obesity,9.0
PT00819,Germany,Bavaria,,Male,Pancreatic,III,2021-10-30,2021-12-31,2022-10-28,,Private,Alive,110.0,KRAS,Yes,Former,Moderate,24.2,Low,Urban,Private Insurance,14.0,No,No,Cardiovascular Disease,4.0
PT00820,France,Provence-Alpes-Côte d'Azur,,Female,Ovarian,I,2019-10-09,2020-03-30,2021-01-05,Radiation,Public,Deceased,52.0,None,Yes,Never,Moderate,24.5,High,Rural,Statutory Health Insurance,19.0,No,No,Diabetes,3.0
PT00821,Portugal,Porto,46.0,Male,Lung,IV,2016-10-13,2016-12-13,2017-02-05,Chemotherapy,Public,Deceased,52.0,KRAS,Yes,Never,None,22.9,Low,Rural,Private Insurance,11.0,No,No,None,6.0
PT00822,Spain,Madrid,54.0,Male,Colorectal,III,2013-12-22,2014-02-19,2014-08-05,Chemotherapy,Research Institute,Alive,75.0,EGFR,No,Current,Moderate,34.7,Low,Rural,NHS,2.0,No,No,None,6.0
PT00823,Denmark,Zealand,64.0,Male,Pancreatic,,2015-07-14,2015-12-24,2016-01-31,,Research Institute,Alive,77.0,None,No,Never,None,32.0,Medium,Urban,Statutory Health Insurance,1.0,No,No,Diabetes,
PT00824,Switzerland,Zurich,54.0,Female,Pancreatic,III,2015-10-27,2016-02-14,2017-01-04,Targeted Therapy,Private,Alive,93.0,KRAS,No,Former,,22.6,Medium,Urban,NHS,1.0,Yes,No,Obesity,
PT00825,Poland,Lesser Poland,47.0,Male,Colorectal,I,2013-03-21,2013-08-18,2013-11-12,Surgery,Public,Deceased,106.0,KRAS,Yes,Never,Heavy,27.8,Low,Rural,Private Insurance,7.0,No,,Obesity,7.0
PT00826,Denmark,Zealand,28.0,Male,Breast,,2012-12-15,2013-04-08,2014-03-05,Radiation,Private,Deceased,85.0,None,No,Current,Moderate,26.9,Medium,Urban,Private Insurance,9.0,,No,Obesity,7.0
PT00827,Ireland,Connacht,34.0,Female,Breast,I,2016-08-01,2016-12-31,2017-05-28,Radiation,Private,Alive,88.0,EGFR,No,Current,Moderate,29.8,Medium,Rural,NHS,1.0,Yes,No,Hypertension,
PT00828,Denmark,Central Denmark,40.0,Female,,III,2013-07-06,2013-08-26,,Targeted Therapy,Public,Alive,43.0,None,Yes,Former,None,36.1,High,Urban,NHS,18.0,Yes,No,None,8.0
PT00829,Italy,Veneto,71.0,Male,Lung,II,2011-06-19,2011-08-23,2012-03-10,Surgery,Public,,,BRCA1,No,Former,Moderate,37.6,High,Urban,NHS,7.0,No,No,Diabetes,9.0
PT00830,Denmark,,54.0,Male,,,2020-07-15,2020-12-05,2021-07-26,Surgery,Private,Alive,53.0,EGFR,No,Never,None,22.8,Medium,Rural,NHS,10.0,No,Yes,Hypertension,9.0
PT00831,,Oslo,70.0,Female,Leukemia,IV,2022-10-11,2023-01-31,2023-04-27,Targeted Therapy,Private,Deceased,72.0,EGFR,No,Former,None,31.3,Medium,Rural,NHS,,Yes,,None,3.0
PT00832,Belgium,Wallonia,74.0,Female,Lung,IV,2022-10-18,2023-03-23,2023-09-13,Radiation,Research Institute,Alive,,None,Yes,Former,Moderate,35.7,High,Urban,NHS,5.0,Yes,No,Obesity,
PT00833,Ireland,,63.0,Male,Ovarian,IV,2016-09-19,2016-10-31,2016-12-24,Immunotherapy,Private,Alive,105.0,KRAS,No,Never,None,21.0,Low,Urban,NHS,5.0,No,No,None,2.0
PT00834,Netherlands,South Holland,84.0,Female,Colorectal,III,2015-12-03,2016-04-29,,Immunotherapy,Private,Deceased,27.0,None,No,Former,None,25.5,Low,Urban,NHS,14.0,No,Yes,,5.0
,Denmark,Zealand,44.0,Female,Pancreatic,III,2015-01-01,2015-02-13,,Surgery,Public,,67.0,BRCA1,No,Former,Moderate,21.5,Low,Rural,Private Insurance,18.0,No,No,Diabetes,2.0
PT00836,Switzerland,Bern,66.0,Female,Colorectal,III,2020-12-12,2021-06-01,2021-11-24,Surgery,Public,Alive,92.0,,No,Never,Moderate,26.3,High,Urban,NHS,4.0,No,No,Hypertension,7.0
PT00837,Germany,Bavaria,75.0,Female,Ovarian,I,2020-02-10,2020-02-12,2020-04-13,Radiation,Public,Deceased,,BRCA1,,Former,Moderate,18.9,Medium,Urban,NHS,3.0,Yes,No,Diabetes,7.0
,Italy,Sicily,57.0,Female,Leukemia,IV,2015-01-14,2015-06-14,2015-10-08,Surgery,Public,Alive,91.0,KRAS,,Current,Moderate,28.9,Medium,Urban,Statutory Health Insurance,4.0,No,No,Diabetes,3.0
PT00839,Switzerland,Geneva,30.0,Female,Prostate,IV,2021-02-11,2021-07-01,2022-01-06,Targeted Therapy,Private,Alive,68.0,None,Yes,Never,Moderate,39.9,Low,Urban,NHS,18.0,,No,Obesity,2.0
PT00840,Poland,Silesian,86.0,Male,Ovarian,III,2010-11-27,2011-05-20,,Immunotherapy,Public,,85.0,None,No,Never,Moderate,,Low,Urban,Statutory Health Insurance,17.0,No,No,Obesity,10.0
PT00841,Norway,Oslo,34.0,Female,Ovarian,IV,2017-08-04,2017-12-08,2018-01-28,Immunotherapy,Private,,47.0,,Yes,Never,Moderate,29.2,High,Urban,NHS,8.0,,Yes,Hypertension,3.0
PT00842,Poland,Lesser Poland,20.0,Female,Prostate,,2023-11-27,2024-05-06,2025-01-28,Surgery,Private,Alive,115.0,KRAS,No,Never,Moderate,30.9,Medium,Urban,Private Insurance,15.0,Yes,No,Diabetes,
PT00843,Denmark,Zealand,26.0,Male,Colorectal,II,2014-03-08,2014-04-21,2014-11-19,Targeted Therapy,Public,Alive,72.0,BRCA1,Yes,Current,None,34.9,Medium,Urban,Statutory Health Insurance,18.0,No,Yes,Cardiovascular Disease,
PT00844,Belgium,Brussels,20.0,Female,Prostate,IV,2021-06-15,2021-11-15,2022-04-29,Surgery,Public,Alive,7.0,BRCA1,No,Former,None,23.1,Medium,Urban,Statutory Health Insurance,3.0,No,Yes,Hypertension,2.0
PT00845,Norway,Vestland,68.0,Male,Ovarian,II,2011-07-28,2011-09-01,,Surgery,Public,Deceased,66.0,KRAS,No,Never,Moderate,30.1,Medium,Urban,NHS,18.0,No,No,Cardiovascular Disease,7.0
PT00846,Poland,Lesser Poland,48.0,Male,Ovarian,III,2020-02-13,2020-07-25,2020-08-28,Targeted Therapy,Public,Alive,108.0,None,No,Current,None,,,Urban,Private Insurance,13.0,No,No,None,7.0
PT00847,Norway,,45.0,Male,Prostate,II,2011-06-08,2011-08-12,2011-09-22,Targeted Therapy,Public,Alive,66.0,KRAS,Yes,Never,None,,High,Urban,NHS,14.0,No,No,None,7.0
PT00848,Germany,Berlin,64.0,Female,Ovarian,III,2013-03-17,2013-09-04,2013-10-30,Chemotherapy,Public,Alive,15.0,None,Yes,Current,Moderate,28.0,Medium,Rural,Private Insurance,12.0,Yes,No,Diabetes,2.0
PT00849,Ireland,,31.0,Female,Leukemia,III,2016-12-28,2017-06-05,2017-09-26,Immunotherapy,Private,Alive,41.0,EGFR,Yes,Never,Moderate,34.9,Medium,Urban,Private Insurance,15.0,,No,None,6.0
PT00850,Denmark,Zealand,51.0,Male,Ovarian,III,2021-06-11,2021-11-14,2022-01-18,Surgery,Public,Deceased,108.0,EGFR,No,Never,Moderate,26.4,Medium,Rural,Statutory Health Insurance,,No,No,Cardiovascular Disease,9.0
PT00851,Poland,Lesser Poland,39.0,Female,Ovarian,,2013-11-22,2014-04-10,2014-06-30,,Public,Alive,62.0,KRAS,Yes,Former,None,38.2,Medium,Urban,Private Insurance,9.0,No,No,None,
PT00852,Italy,Lombardy,70.0,Male,Pancreatic,II,2016-02-10,2016-03-13,2016-08-19,Surgery,Research Institute,Alive,109.0,BRCA1,No,,Moderate,37.8,Medium,Rural,Private Insurance,12.0,No,No,Cardiovascular Disease,7.0
PT00853,Germany,,55.0,Female,,III,2016-01-26,2016-04-01,2016-07-13,Surgery,,Deceased,21.0,KRAS,Yes,Former,Moderate,39.4,Medium,Urban,Private Insurance,16.0,No,No,Obesity,9.0
PT00854,Norway,Vestland,86.0,Female,Lung,,2015-11-26,2016-01-25,2016-10-28,Radiation,Public,Deceased,18.0,BRCA1,Yes,Former,Heavy,19.4,Medium,Urban,Private Insurance,19.0,No,Yes,Cardiovascular Disease,8.0
PT00855,Ireland,Dublin,,Female,Prostate,I,2012-05-01,2012-10-27,2012-12-07,Immunotherapy,Private,Alive,39.0,KRAS,Yes,Former,Moderate,31.4,Low,Urban,Statutory Health Insurance,13.0,No,No,Cardiovascular Disease,6.0
PT00856,Ireland,Connacht,46.0,Female,Breast,I,2013-03-25,2013-08-17,2013-11-09,Chemotherapy,Public,Alive,111.0,None,Yes,Current,None,22.5,Low,Urban,NHS,14.0,No,No,Diabetes,4.0
PT00857,,Utrecht,59.0,Male,Leukemia,I,2019-11-05,2020-02-28,2020-12-07,,Public,Alive,27.0,EGFR,No,Never,Moderate,19.8,High,Rural,Statutory Health Insurance,16.0,No,No,Diabetes,6.0
PT00858,Finland,,33.0,Female,Pancreatic,IV,2021-12-16,2022-02-22,2022-08-29,Chemotherapy,Private,Alive,24.0,None,Yes,Former,None,29.3,Low,Urban,Private Insurance,12.0,No,No,Diabetes,10.0
PT00859,Switzerland,Geneva,88.0,Non-binary,Pancreatic,III,2015-02-03,2015-07-19,2015-11-16,Surgery,Public,Alive,23.0,EGFR,No,Never,Heavy,38.5,High,Urban,Statutory Health Insurance,5.0,No,No,Obesity,1.0
PT00860,Poland,Silesian,25.0,Male,Prostate,IV,2023-09-11,2023-11-14,2024-05-21,Surgery,Research Institute,Alive,53.0,EGFR,No,Current,Heavy,24.5,Low,Urban,Private Insurance,12.0,No,No,Hypertension,9.0
PT00861,Denmark,,52.0,Female,Breast,II,2012-01-08,2012-05-18,2013-05-02,Radiation,Public,Deceased,15.0,KRAS,No,Current,None,26.8,Medium,Urban,Statutory Health Insurance,15.0,No,No,Hypertension,6.0
PT00862,Finland,,74.0,Non-binary,Breast,,2017-09-13,2017-11-06,,Radiation,Private,Alive,88.0,KRAS,No,Never,Moderate,33.0,Medium,Rural,NHS,18.0,No,No,Diabetes,7.0
,Belgium,Brussels,38.0,Male,Pancreatic,III,2017-08-24,2017-11-08,2018-03-08,Surgery,Private,Alive,32.0,None,No,Former,Moderate,37.3,Medium,Urban,Statutory Health Insurance,,No,No,Obesity,9.0
PT00864,Spain,Catalonia,48.0,Female,Leukemia,I,2017-09-19,2018-03-10,2019-02-17,Chemotherapy,Public,Alive,114.0,None,No,Never,None,20.2,High,Urban,Statutory Health Insurance,19.0,No,Yes,Cardiovascular Disease,6.0
PT00865,Finland,Southwest Finland,80.0,Female,Lung,II,2023-05-27,2023-10-01,2024-08-06,Chemotherapy,Private,,19.0,None,Yes,Former,Moderate,31.1,Low,Urban,NHS,10.0,No,No,Hypertension,5.0
PT00866,Netherlands,South Holland,89.0,Female,Pancreatic,II,2015-12-04,2016-05-10,2016-08-15,Immunotherapy,Research Institute,Deceased,17.0,BRCA1,Yes,,None,23.3,Medium,Rural,Private Insurance,15.0,No,No,Hypertension,10.0
PT00867,,Southwest Finland,43.0,Male,Ovarian,I,2023-11-05,2024-02-23,2024-09-11,Surgery,Private,Alive,114.0,KRAS,No,Current,Moderate,35.1,Low,Rural,NHS,1.0,No,No,Diabetes,5.0
PT00868,Norway,Oslo,42.0,Male,Pancreatic,II,2018-06-04,2018-08-31,2019-03-19,Targeted Therapy,Private,Alive,81.0,None,No,Former,None,23.8,Medium,Urban,NHS,,Yes,No,Diabetes,6.0
PT00869,Denmark,Zealand,29.0,Male,Ovarian,I,2021-05-24,2021-09-14,2022-03-05,Targeted Therapy,Public,Lost to Follow-up,,KRAS,No,Current,Moderate,,Low,Urban,NHS,7.0,No,Yes,Hypertension,3.0
PT00870,Ireland,Munster,73.0,,Colorectal,I,2011-06-11,2011-08-04,2012-04-14,Chemotherapy,Public,Deceased,91.0,EGFR,Yes,Former,Moderate,,High,Urban,NHS,7.0,No,No,Obesity,4.0
PT00871,Denmark,Capital Region,60.0,Female,Breast,II,2011-03-25,2011-05-12,2011-12-24,,Public,Alive,14.0,BRCA1,No,Never,None,39.5,Medium,Urban,Statutory Health Insurance,12.0,No,Yes,Diabetes,1.0
PT00872,Netherlands,,68.0,Female,Colorectal,III,2018-10-26,2018-11-30,2019-07-15,Radiation,Private,Alive,40.0,EGFR,No,Never,None,28.9,Low,Urban,Private Insurance,16.0,Yes,,Diabetes,1.0
PT00873,Poland,Masovian,36.0,Male,Colorectal,I,2021-05-24,2021-07-31,2022-02-18,Chemotherapy,Public,Alive,114.0,None,Yes,Former,Moderate,21.5,Low,Urban,Private Insurance,16.0,No,No,Cardiovascular Disease,3.0
PT00874,Sweden,Skåne,75.0,Male,Leukemia,II,2015-01-26,,2015-08-22,Immunotherapy,,Alive,19.0,KRAS,No,Current,None,35.4,Medium,Urban,Private Insurance,18.0,Yes,No,Obesity,4.0
PT00875,Denmark,Capital Region,64.0,Female,Pancreatic,I,2010-04-30,2010-07-11,2011-01-09,Surgery,Public,Alive,29.0,EGFR,,Former,Heavy,34.4,High,Urban,NHS,3.0,Yes,Yes,Hypertension,2.0
PT00876,France,Île-de-France,49.0,Female,Lung,II,2022-04-12,2022-07-09,2022-08-17,Targeted Therapy,Public,Alive,72.0,EGFR,No,Never,None,36.7,Medium,Urban,Statutory Health Insurance,1.0,No,No,Obesity,10.0
,Spain,Catalonia,63.0,Female,Ovarian,III,2021-12-31,2022-04-17,2022-11-22,Chemotherapy,Public,Alive,105.0,None,Yes,Former,Moderate,30.3,Low,Urban,NHS,3.0,No,No,Cardiovascular Disease,7.0
PT00878,Germany,,74.0,Female,Ovarian,IV,2017-10-18,2017-12-13,2018-01-23,Radiation,Public,Alive,117.0,BRCA1,No,Former,None,32.5,Low,Urban,NHS,5.0,No,No,Obesity,10.0
PT00879,Portugal,Porto,38.0,Female,Leukemia,III,2014-11-26,2015-02-03,2015-04-02,Surgery,Public,Alive,95.0,KRAS,No,Former,Moderate,39.2,Medium,Urban,,12.0,,No,Obesity,3.0
,Ireland,Connacht,48.0,Female,Breast,I,,2022-07-30,2022-10-10,Targeted Therapy,Public,Alive,115.0,BRCA1,Yes,Never,None,18.4,High,Urban,NHS,6.0,No,No,Diabetes,1.0
PT00881,Netherlands,Utrecht,21.0,Female,Lung,I,2018-04-06,2018-07-11,2018-11-05,Immunotherapy,Public,Deceased,51.0,EGFR,Yes,Former,Moderate,32.7,,Urban,Statutory Health Insurance,17.0,No,No,Hypertension,
PT00882,Switzerland,Bern,55.0,Male,Pancreatic,I,2010-12-17,2011-05-23,2011-10-10,Chemotherapy,Public,Alive,31.0,BRCA1,,Current,Moderate,28.1,Medium,Urban,Statutory Health Insurance,3.0,No,No,Hypertension,2.0
PT00883,Norway,Oslo,38.0,Female,Prostate,IV,2016-01-12,2016-05-17,2016-08-23,Surgery,Public,Alive,109.0,BRCA1,No,Never,Moderate,27.0,High,Urban,Private Insurance,12.0,Yes,No,Cardiovascular Disease,9.0
PT00884,Switzerland,Zurich,26.0,Female,,III,2019-02-15,2019-05-31,2019-10-26,Targeted Therapy,Public,Alive,51.0,KRAS,No,Never,Heavy,24.6,Medium,Urban,,11.0,No,No,Obesity,10.0
PT00885,Italy,,45.0,Male,Ovarian,I,2014-04-02,2014-05-31,2015-03-23,Immunotherapy,Private,Deceased,104.0,BRCA1,Yes,Former,None,34.0,Medium,Urban,Private Insurance,4.0,No,,Obesity,8.0
PT00886,Portugal,Lisbon,57.0,Male,Leukemia,I,2016-02-29,2016-03-25,2016-12-26,Radiation,Public,Deceased,76.0,EGFR,No,Never,Moderate,20.5,Low,Urban,Statutory Health Insurance,2.0,Yes,No,,6.0
PT00887,Ireland,Munster,22.0,Male,Leukemia,II,2023-11-09,2023-12-06,2024-11-18,Surgery,Public,Alive,34.0,None,No,Never,Moderate,23.0,Medium,Urban,NHS,8.0,No,No,Diabetes,1.0
PT00888,Sweden,Stockholm,85.0,Female,Colorectal,I,2018-11-12,2019-02-19,2019-04-11,,Public,Alive,10.0,BRCA1,Yes,Former,Moderate,25.1,Low,Urban,Private Insurance,10.0,No,No,Hypertension,
PT00889,Portugal,Algarve,62.0,Male,Pancreatic,III,2019-08-11,2019-09-02,2020-08-22,Targeted Therapy,Public,Alive,35.0,EGFR,Yes,Never,Moderate,22.5,Medium,Rural,Statutory Health Insurance,15.0,No,No,Obesity,10.0
PT00890,Portugal,Porto,81.0,Male,Prostate,II,2010-02-17,2010-04-05,2010-11-12,,Public,Alive,17.0,BRCA1,No,Never,Moderate,21.2,Low,,Statutory Health Insurance,7.0,No,No,Cardiovascular Disease,6.0
PT00891,Finland,Uusimaa,43.0,Female,Pancreatic,III,2016-03-26,2016-07-26,2016-11-22,Radiation,Private,Alive,94.0,BRCA1,No,Former,None,28.7,Low,Urban,Private Insurance,15.0,No,No,Diabetes,8.0
PT00892,France,Auvergne-Rhône-Alpes,58.0,Male,Lung,II,2020-05-24,,2020-12-28,Targeted Therapy,Public,Alive,66.0,BRCA1,Yes,Never,None,,Low,Urban,Private Insurance,16.0,No,Yes,Hypertension,10.0
PT00893,Denmark,Zealand,87.0,Female,Prostate,I,2023-12-04,2023-12-13,2024-11-05,Targeted Therapy,Public,,19.0,KRAS,Yes,Never,Moderate,24.8,Low,Rural,Statutory Health Insurance,16.0,No,No,Cardiovascular Disease,2.0
PT00894,Switzerland,Zurich,63.0,Female,Pancreatic,II,2021-01-07,2021-03-02,2021-08-03,Targeted Therapy,Public,Deceased,118.0,BRCA1,Yes,Never,Moderate,38.0,Medium,Rural,Private Insurance,16.0,No,No,None,7.0
PT00895,Ireland,Connacht,24.0,Female,Colorectal,III,2018-09-20,2019-01-12,2019-08-19,Surgery,Public,Deceased,36.0,EGFR,No,Never,Moderate,30.0,Low,Urban,NHS,18.0,No,No,Hypertension,5.0
,France,Auvergne-Rhône-Alpes,74.0,Male,Prostate,II,2015-03-08,2015-05-11,2016-04-27,Chemotherapy,Public,Alive,48.0,EGFR,No,Never,None,29.4,Low,Rural,Private Insurance,2.0,Yes,No,Diabetes,4.0
PT00897,,Uusimaa,49.0,Male,Prostate,II,2012-06-16,2012-10-12,2013-01-31,Radiation,Public,Lost to Follow-up,,KRAS,Yes,Former,None,35.8,Medium,Urban,Private Insurance,1.0,No,Yes,,7.0
PT00898,Austria,Styria,48.0,Male,Lung,III,2014-10-05,2015-01-22,2015-10-05,Immunotherapy,Public,Alive,117.0,BRCA1,Yes,Former,None,33.2,Medium,Urban,Statutory Health Insurance,1.0,No,No,Cardiovascular Disease,9.0
,Norway,Oslo,45.0,Female,Prostate,I,2012-08-26,2012-12-03,2013-06-30,Targeted Therapy,Public,Alive,116.0,EGFR,No,Never,None,26.0,Low,Urban,NHS,11.0,No,No,None,2.0
PT00900,Sweden,Västra Götaland,45.0,Female,Colorectal,II,2018-03-22,2018-09-05,2019-08-24,Chemotherapy,Public,Alive,81.0,BRCA1,No,Never,Heavy,21.0,Medium,Urban,NHS,12.0,No,No,Diabetes,4.0
PT00901,France,Auvergne-Rhône-Alpes,56.0,Male,Breast,II,2018-08-27,2018-11-18,2019-10-26,Immunotherapy,Private,Alive,67.0,KRAS,No,Current,None,34.6,Low,Urban,,18.0,No,No,Hypertension,10.0
,France,Auvergne-Rhône-Alpes,,Female,Breast,III,2022-12-25,2023-01-02,2023-07-02,Surgery,Research Institute,Alive,57.0,BRCA1,Yes,Former,None,20.4,Low,Urban,Private Insurance,12.0,No,No,Hypertension,9.0
PT00903,France,Île-de-France,49.0,Male,Leukemia,I,2021-03-30,2021-07-15,2022-01-14,Radiation,Public,Deceased,72.0,None,Yes,Never,Moderate,24.7,Medium,Urban,Statutory Health Insurance,19.0,No,No,Cardiovascular Disease,8.0
PT00904,Belgium,Wallonia,22.0,Non-binary,Breast,III,2018-06-26,2018-11-28,2019-10-28,Chemotherapy,Public,Alive,94.0,BRCA1,Yes,Never,Moderate,35.1,Low,Urban,Statutory Health Insurance,11.0,No,No,Diabetes,
PT00905,Spain,Andalusia,62.0,Female,Lung,I,2016-11-08,2017-02-28,2017-11-05,Chemotherapy,Public,Alive,50.0,EGFR,No,Never,Moderate,33.5,Medium,Urban,Statutory Health Insurance,5.0,No,No,Diabetes,2.0
PT00906,Belgium,Wallonia,26.0,Female,Leukemia,I,2014-01-10,2014-06-20,2015-05-09,Radiation,Public,Deceased,28.0,None,Yes,,Moderate,36.6,Low,Urban,Private Insurance,6.0,No,Yes,Cardiovascular Disease,7.0
,Austria,Vienna,68.0,Female,Breast,,,,2020-02-20,Radiation,Private,Deceased,99.0,KRAS,No,Current,,31.3,Medium,Urban,,19.0,No,No,Cardiovascular Disease,3.0
PT00908,Norway,Trøndelag,60.0,Female,Breast,III,2020-04-10,2020-07-25,2020-12-23,Targeted Therapy,Public,Alive,10.0,KRAS,No,Never,Heavy,31.8,Medium,Urban,Statutory Health Insurance,17.0,No,No,Diabetes,9.0
PT00909,,Veneto,73.0,Female,Leukemia,IV,2019-12-10,2020-05-02,2020-11-29,Radiation,Private,Deceased,63.0,,Yes,Never,None,28.9,Medium,Urban,Statutory Health Insurance,11.0,No,No,None,6.0
PT00910,Germany,North Rhine-Westphalia,88.0,Female,Lung,II,2023-11-09,,2024-03-24,Chemotherapy,Public,,102.0,None,Yes,Never,Moderate,24.7,Medium,Rural,NHS,1.0,Yes,No,Hypertension,7.0
PT00911,Austria,Vienna,46.0,Female,Leukemia,II,2017-03-23,2017-04-11,,Targeted Therapy,Public,Deceased,45.0,BRCA1,Yes,Never,Moderate,28.7,High,Rural,Statutory Health Insurance,18.0,,No,None,5.0
PT00912,,Lisbon,27.0,Female,Ovarian,III,2017-01-05,2017-02-26,2017-06-17,Radiation,Private,Deceased,17.0,KRAS,No,Current,Moderate,20.6,Medium,Urban,NHS,3.0,Yes,No,Cardiovascular Disease,9.0
PT00913,Finland,Uusimaa,51.0,Female,Ovarian,II,2022-04-22,2022-09-12,2022-11-04,,Public,Alive,118.0,EGFR,No,Never,None,39.9,Medium,Urban,Private Insurance,5.0,No,No,None,3.0
PT00914,Switzerland,Bern,83.0,Female,Lung,I,2019-11-13,2019-12-25,2020-07-09,,Public,Alive,99.0,EGFR,Yes,Never,Moderate,25.5,Medium,Urban,Private Insurance,2.0,No,Yes,None,7.0
PT00915,Norway,Trøndelag,29.0,Female,Lung,I,2011-01-22,2011-05-02,2011-09-11,Radiation,Research Institute,Alive,22.0,BRCA1,No,Never,Heavy,36.8,Medium,Urban,Statutory Health Insurance,14.0,No,No,Diabetes,2.0
PT00916,Austria,Vienna,32.0,Female,Pancreatic,I,2020-01-22,2020-04-27,2021-02-14,Chemotherapy,Private,Alive,20.0,KRAS,No,Former,Moderate,38.0,Medium,Urban,Private Insurance,13.0,Yes,No,Cardiovascular Disease,1.0
PT00917,France,Auvergne-Rhône-Alpes,82.0,Male,Colorectal,II,2010-05-18,2010-08-09,2011-04-26,Targeted Therapy,Private,Alive,48.0,KRAS,Yes,Never,None,18.6,High,Urban,NHS,2.0,No,No,None,9.0
PT00918,Germany,Berlin,54.0,,,IV,2020-04-09,2020-06-27,2021-01-24,Targeted Therapy,Public,Deceased,72.0,None,No,,None,31.1,Low,Urban,Statutory Health Insurance,5.0,Yes,No,Cardiovascular Disease,1.0
PT00919,Sweden,Skåne,80.0,Male,Pancreatic,III,2017-05-24,2017-11-06,2018-03-30,Targeted Therapy,Public,Alive,112.0,EGFR,No,Current,Moderate,36.8,Medium,Rural,Private Insurance,4.0,No,No,,
PT00920,Belgium,Brussels,73.0,Female,Breast,IV,2022-07-14,2022-11-19,2023-09-11,Surgery,Public,Alive,80.0,EGFR,Yes,Never,Moderate,27.6,Medium,Urban,Private Insurance,10.0,No,No,None,1.0
PT00921,Spain,Andalusia,27.0,Male,Pancreatic,IV,2010-10-27,2011-01-21,2011-10-04,Radiation,Private,Lost to Follow-up,,BRCA1,No,Never,Moderate,19.3,Medium,Urban,NHS,18.0,No,No,None,10.0
PT00922,France,Île-de-France,48.0,Non-binary,Prostate,II,2010-02-01,2010-03-22,2010-11-22,Surgery,Public,Alive,19.0,None,,Former,None,26.4,High,Urban,Statutory Health Insurance,9.0,No,No,None,5.0
PT00923,Poland,Silesian,60.0,Female,Ovarian,I,2016-11-09,2017-01-25,2017-12-18,Surgery,Public,Alive,64.0,None,Yes,Former,,24.1,Low,Rural,Statutory Health Insurance,12.0,No,No,,4.0
PT00924,France,,49.0,Female,Leukemia,II,2011-06-26,2011-09-18,2012-07-05,Immunotherapy,Private,Deceased,86.0,BRCA1,No,Former,Moderate,37.5,High,Urban,Statutory Health Insurance,8.0,No,Yes,Hypertension,9.0
PT00925,Belgium,Wallonia,40.0,Male,Pancreatic,IV,2019-06-19,2019-08-07,2019-09-08,,,,101.0,EGFR,No,Never,None,32.7,Medium,Urban,NHS,1.0,No,No,None,6.0
PT00926,Finland,Pirkanmaa,30.0,Female,Ovarian,II,2019-04-27,2019-07-15,2020-07-08,Surgery,Research Institute,Lost to Follow-up,,KRAS,No,Never,Heavy,23.7,Low,Urban,NHS,19.0,Yes,Yes,None,2.0
PT00927,Germany,Berlin,21.0,Female,Colorectal,II,2015-09-23,2016-02-20,2017-02-04,Chemotherapy,Public,Deceased,,KRAS,No,Never,None,35.7,Medium,Urban,NHS,1.0,Yes,No,Hypertension,2.0
PT00928,Poland,Silesian,69.0,Female,Breast,I,2011-07-01,2011-12-19,2012-02-22,Radiation,Public,Deceased,35.0,BRCA1,Yes,Current,None,29.2,,Urban,Private Insurance,6.0,No,No,Obesity,
PT00929,Spain,Andalusia,60.0,Male,Prostate,II,2012-09-10,2012-10-30,2013-05-31,Chemotherapy,Research Institute,Alive,74.0,None,No,Never,Moderate,37.3,Medium,Rural,NHS,14.0,No,No,Cardiovascular Disease,7.0
PT00930,Italy,Sicily,85.0,Female,Colorectal,II,2021-05-03,2021-07-26,2022-02-20,Targeted Therapy,Private,Alive,18.0,EGFR,Yes,Never,Moderate,35.6,Medium,Urban,Private Insurance,17.0,No,No,None,7.0
,Denmark,Zealand,22.0,Female,Lung,II,2011-01-15,2011-05-19,2011-10-20,Immunotherapy,Public,Alive,103.0,EGFR,Yes,Former,Moderate,32.6,Low,Urban,NHS,,No,No,Obesity,4.0
PT00932,Ireland,Connacht,70.0,Female,Breast,,2011-05-12,2011-05-31,2011-12-06,Chemotherapy,Public,Alive,26.0,EGFR,No,Never,None,20.5,Medium,Rural,NHS,17.0,No,No,None,10.0
PT00933,Ireland,Munster,87.0,Female,Ovarian,,2015-03-31,2015-06-30,2015-11-18,Chemotherapy,Public,Alive,95.0,None,Yes,Current,Heavy,31.3,High,Rural,Private Insurance,11.0,No,No,Obesity,1.0
PT00934,France,Provence-Alpes-Côte d'Azur,44.0,Female,Pancreatic,IV,2023-11-03,2024-01-14,2024-06-25,Surgery,Public,Deceased,43.0,KRAS,Yes,Never,Moderate,31.6,Low,Urban,Statutory Health Insurance,18.0,No,Yes,Hypertension,4.0
PT00935,France,Auvergne-Rhône-Alpes,49.0,Non-binary,Leukemia,,2015-12-26,2016-05-20,2017-05-19,Chemotherapy,Public,Alive,61.0,None,,Current,Moderate,35.9,Medium,Urban,Private Insurance,4.0,No,No,Diabetes,1.0
PT00936,Denmark,Zealand,30.0,Female,Colorectal,IV,2022-05-01,2022-05-11,,Immunotherapy,Public,Alive,75.0,None,No,,Heavy,22.0,Low,Rural,NHS,15.0,No,No,None,
PT00937,France,Île-de-France,36.0,Non-binary,Ovarian,II,2010-07-04,2010-08-23,2011-02-20,Chemotherapy,Public,Alive,73.0,KRAS,No,Never,,31.4,Low,Urban,Private Insurance,5.0,No,Yes,Obesity,5.0
PT00938,Sweden,Stockholm,45.0,Female,Prostate,III,2011-05-04,2011-06-22,,Chemotherapy,Public,Deceased,87.0,BRCA1,No,Never,None,36.2,Medium,Urban,Statutory Health Insurance,15.0,No,No,Obesity,1.0
PT00939,Sweden,Skåne,42.0,Male,Leukemia,I,2015-08-28,2016-02-13,2016-05-29,Targeted Therapy,Public,Alive,100.0,EGFR,Yes,Former,None,18.4,Medium,Rural,NHS,7.0,No,No,Hypertension,2.0
PT00940,Austria,Styria,,Male,Lung,III,2014-09-17,2014-12-25,2015-10-15,Immunotherapy,Public,Deceased,29.0,KRAS,Yes,Never,None,31.5,Medium,Urban,Private Insurance,16.0,No,No,Obesity,4.0
PT00941,Sweden,Skåne,71.0,Male,Leukemia,IV,2010-06-20,2010-11-10,2011-08-20,Chemotherapy,Private,Deceased,78.0,None,Yes,Never,Moderate,35.9,Medium,Urban,Private Insurance,19.0,Yes,No,Cardiovascular Disease,9.0
PT00942,Spain,Madrid,67.0,Male,Ovarian,I,2011-02-04,2011-06-04,2011-09-11,Targeted Therapy,,Alive,32.0,KRAS,No,Never,Moderate,27.9,Medium,Rural,Private Insurance,2.0,No,No,,1.0
PT00943,Germany,Bavaria,39.0,Male,Ovarian,I,2019-11-02,2019-11-25,2020-01-16,Radiation,Private,Deceased,13.0,BRCA1,Yes,Never,None,22.2,Low,Urban,Statutory Health Insurance,16.0,Yes,No,Diabetes,4.0
PT00944,Denmark,Zealand,21.0,Male,Prostate,II,2020-01-01,2020-03-17,2020-11-14,Chemotherapy,Private,Alive,95.0,,No,Never,Moderate,35.2,High,Urban,NHS,13.0,No,No,Hypertension,9.0
PT00945,Poland,Lesser Poland,50.0,Female,Lung,I,2010-08-27,2010-12-18,2011-10-16,Chemotherapy,,Alive,82.0,EGFR,Yes,Never,None,20.0,Medium,Urban,Private Insurance,16.0,No,No,Hypertension,2.0
PT00946,Finland,Pirkanmaa,46.0,Male,Prostate,I,2013-09-02,2013-09-29,2014-02-03,Targeted Therapy,Public,Deceased,69.0,BRCA1,No,Never,Moderate,29.7,Medium,Urban,Private Insurance,17.0,No,No,,
PT00947,Finland,Uusimaa,21.0,Male,Ovarian,III,2022-02-02,2022-02-08,2022-07-10,Targeted Therapy,Public,Alive,62.0,KRAS,No,Never,Moderate,18.1,Low,,Statutory Health Insurance,17.0,No,No,Obesity,9.0
PT00948,Spain,Andalusia,23.0,Female,Breast,I,2019-12-01,2019-12-25,,Targeted Therapy,Public,Alive,114.0,KRAS,No,Never,None,28.4,Medium,Rural,Statutory Health Insurance,9.0,No,No,Obesity,7.0
PT00949,Switzerland,Bern,,Female,Prostate,III,2017-01-13,2017-04-09,2017-06-15,Chemotherapy,Public,Alive,,BRCA1,Yes,Never,Moderate,37.7,Medium,Urban,NHS,19.0,No,No,Hypertension,2.0
PT00950,Poland,Masovian,,Non-binary,Leukemia,IV,2017-01-19,2017-06-05,2018-03-20,Surgery,Public,Deceased,10.0,None,Yes,Current,None,38.5,High,Urban,Statutory Health Insurance,19.0,No,No,Cardiovascular Disease,9.0
,Ireland,Dublin,85.0,Female,Ovarian,III,2013-09-10,2013-11-16,2014-06-28,Surgery,,,24.0,,No,Former,Moderate,21.6,,Urban,Statutory Health Insurance,3.0,No,No,Diabetes,8.0
PT00952,Germany,North Rhine-Westphalia,25.0,Male,Breast,I,2023-04-17,2023-06-26,2024-04-20,Targeted Therapy,Private,Deceased,,None,No,Never,Moderate,31.6,Medium,Rural,NHS,9.0,No,No,Diabetes,7.0
PT00953,Austria,Styria,50.0,Male,Breast,II,2015-09-21,2015-12-08,2016-09-28,Surgery,Public,Deceased,116.0,BRCA1,Yes,Never,Moderate,19.2,Low,Urban,NHS,10.0,No,No,Obesity,1.0
PT00954,France,Auvergne-Rhône-Alpes,29.0,Male,Colorectal,II,2010-08-22,2010-10-03,2011-01-06,Radiation,Private,Deceased,83.0,EGFR,No,Never,Moderate,33.0,Low,Rural,Statutory Health Insurance,,,No,None,8.0
PT00955,Spain,Catalonia,40.0,Male,Leukemia,II,2011-07-10,2011-09-08,2012-04-23,Surgery,Public,Alive,50.0,BRCA1,Yes,Former,,34.9,High,Urban,Statutory Health Insurance,16.0,No,No,Hypertension,1.0
PT00956,France,Provence-Alpes-Côte d'Azur,,Male,Leukemia,II,2016-10-20,2017-01-11,,Surgery,Private,Alive,42.0,BRCA1,No,Former,None,28.1,Medium,Urban,NHS,14.0,No,No,Cardiovascular Disease,8.0
PT00957,Norway,Vestland,22.0,Non-binary,Lung,IV,2015-05-09,2015-11-01,2016-07-28,Chemotherapy,Public,Alive,101.0,BRCA1,Yes,Current,Moderate,27.4,High,Rural,Statutory Health Insurance,12.0,No,No,Cardiovascular Disease,9.0
PT00958,Spain,Catalonia,51.0,Male,Prostate,III,2023-01-24,2023-04-21,2023-12-15,Surgery,Public,Alive,20.0,KRAS,No,Former,None,30.1,Medium,Urban,NHS,7.0,No,No,Diabetes,4.0
PT00959,Ireland,Munster,39.0,Male,Pancreatic,I,2020-03-22,2020-08-02,2021-01-04,Targeted Therapy,Public,Alive,63.0,KRAS,,Former,Heavy,24.5,High,Urban,Private Insurance,,No,No,,
PT00960,Germany,Berlin,48.0,Male,Prostate,,,2019-04-07,2020-01-27,Chemotherapy,Public,Alive,32.0,BRCA1,Yes,Never,,28.6,Low,Rural,NHS,18.0,No,No,Cardiovascular Disease,8.0
PT00961,Poland,Masovian,,Female,Leukemia,II,2023-09-13,2024-02-26,2025-01-25,Surgery,Public,Lost to Follow-up,,KRAS,No,Former,Moderate,37.2,Medium,Urban,NHS,3.0,Yes,No,Hypertension,5.0
PT00962,Portugal,Lisbon,,Male,Prostate,IV,2012-03-13,2012-08-07,2013-02-28,Radiation,Public,Alive,86.0,BRCA1,No,Never,Moderate,20.5,Medium,Rural,Statutory Health Insurance,11.0,No,No,None,5.0
PT00963,Germany,Berlin,53.0,Male,Leukemia,IV,2023-07-18,2023-09-27,2023-12-12,Chemotherapy,Public,Alive,103.0,BRCA1,No,Current,Moderate,30.1,High,Rural,NHS,19.0,,No,Obesity,10.0
PT00964,Sweden,Skåne,80.0,Male,Ovarian,II,2012-09-23,2012-10-17,2013-01-14,Chemotherapy,Private,Alive,96.0,,No,Former,None,25.0,Medium,Rural,Statutory Health Insurance,15.0,No,No,Diabetes,5.0
PT00965,Germany,Bavaria,,Male,Breast,II,2012-04-25,2012-08-08,2013-06-14,Chemotherapy,Public,Alive,96.0,KRAS,Yes,Never,Moderate,34.7,High,Urban,NHS,,Yes,No,,4.0
PT00966,Finland,Uusimaa,30.0,Male,Prostate,II,2013-08-12,2013-10-31,2014-04-13,Surgery,Private,Alive,13.0,EGFR,No,Never,Moderate,25.4,Low,Urban,,9.0,,No,Diabetes,9.0
PT00967,Italy,Veneto,82.0,,Ovarian,II,2021-04-10,2021-08-26,2022-08-23,Targeted Therapy,Public,Alive,53.0,EGFR,No,Former,None,35.5,Low,Rural,Private Insurance,17.0,Yes,No,Hypertension,7.0
PT00968,Netherlands,South Holland,40.0,Male,Prostate,I,,2015-02-03,2015-07-03,Immunotherapy,,Alive,31.0,KRAS,Yes,Never,None,26.7,High,Urban,Private Insurance,18.0,Yes,No,Cardiovascular Disease,
PT00969,Italy,,22.0,Female,Leukemia,III,2023-12-22,2024-05-13,2024-11-25,Immunotherapy,Public,Alive,107.0,EGFR,No,Never,None,31.6,Medium,Urban,Statutory Health Insurance,6.0,Yes,No,Hypertension,8.0
PT00970,Spain,,29.0,Female,Ovarian,II,2010-08-30,2010-11-02,2011-01-13,Immunotherapy,Public,Alive,83.0,None,Yes,Former,Moderate,33.4,Medium,Rural,Private Insurance,13.0,No,No,Cardiovascular Disease,7.0
PT00971,Poland,,46.0,Female,Leukemia,III,2017-11-30,2018-04-20,2018-07-04,Surgery,Private,Deceased,14.0,EGFR,No,Never,Moderate,25.1,Medium,Urban,,11.0,No,Yes,Cardiovascular Disease,3.0
PT00972,Norway,Trøndelag,31.0,Male,Lung,II,2017-03-10,2017-05-20,2018-01-21,Radiation,Public,Alive,81.0,EGFR,No,Never,None,27.2,High,Rural,Statutory Health Insurance,13.0,Yes,No,Obesity,2.0
PT00973,Finland,Pirkanmaa,26.0,Male,Prostate,III,2019-07-31,2020-01-15,2020-12-08,Chemotherapy,Public,Deceased,20.0,BRCA1,No,,Moderate,,Medium,Urban,,10.0,Yes,No,Cardiovascular Disease,
PT00974,Switzerland,Geneva,36.0,Male,Colorectal,III,2011-03-29,2011-08-12,2012-06-21,,Private,Alive,103.0,BRCA1,No,Former,,27.7,Medium,Urban,Private Insurance,16.0,No,No,Diabetes,
PT00975,Belgium,Wallonia,84.0,Female,Leukemia,II,2014-06-18,2014-10-01,2015-02-10,Targeted Therapy,Research Institute,Alive,114.0,EGFR,No,Current,None,28.3,Medium,Urban,NHS,16.0,No,No,Diabetes,10.0
PT00976,Austria,Vienna,83.0,Female,Colorectal,III,2016-03-10,2016-08-23,2016-12-16,Chemotherapy,Public,Alive,91.0,BRCA1,Yes,Never,Moderate,30.9,Low,Rural,,14.0,No,No,None,8.0
PT00977,France,Provence-Alpes-Côte d'Azur,45.0,,Breast,II,2019-01-26,2019-03-19,2019-10-28,,Private,Alive,17.0,KRAS,No,Never,Heavy,35.2,Medium,Urban,Private Insurance,6.0,No,No,Cardiovascular Disease,
,Ireland,Munster,34.0,Female,,I,2022-12-01,2022-12-03,2023-08-03,,Public,Alive,94.0,BRCA1,Yes,Current,,19.6,Medium,Rural,Private Insurance,10.0,No,No,Obesity,6.0
PT00979,Poland,Lesser Poland,52.0,Female,Colorectal,I,2011-07-13,2011-12-10,2012-08-21,Immunotherapy,Public,Alive,38.0,None,No,Former,,31.2,Medium,Urban,Private Insurance,,No,No,Diabetes,1.0
PT00980,Spain,Andalusia,81.0,Female,Pancreatic,I,2023-08-08,2023-12-05,,Targeted Therapy,Private,Alive,117.0,BRCA1,No,,Moderate,37.0,,Urban,Private Insurance,18.0,Yes,No,Obesity,1.0
PT00981,Italy,Veneto,66.0,Male,Breast,I,2017-06-08,2017-10-04,2018-04-06,Targeted Therapy,Private,Alive,111.0,BRCA1,Yes,Current,Heavy,,,Urban,Private Insurance,19.0,Yes,No,,8.0
PT00982,Switzerland,Zurich,54.0,Female,Colorectal,III,2012-12-04,2012-12-08,2013-01-09,Chemotherapy,Private,Alive,113.0,BRCA1,No,Never,Moderate,33.0,Low,Urban,Statutory Health Insurance,6.0,Yes,No,Obesity,7.0
PT00983,Spain,Madrid,84.0,,Lung,II,2017-07-17,2017-09-07,2018-08-14,Surgery,Public,Alive,109.0,BRCA1,No,Former,Moderate,23.7,Medium,Urban,Private Insurance,,No,No,Hypertension,6.0
PT00984,Switzerland,Geneva,44.0,Female,Lung,I,2013-06-14,2013-10-03,2014-09-17,Immunotherapy,Public,Deceased,9.0,,Yes,Never,None,,Medium,Urban,Private Insurance,9.0,No,No,Diabetes,9.0
PT00985,Switzerland,Geneva,76.0,Male,Breast,III,2017-08-02,2017-08-09,2018-06-11,Surgery,Private,Alive,10.0,EGFR,Yes,Never,None,21.8,Low,Urban,Statutory Health Insurance,10.0,No,No,Cardiovascular Disease,5.0
PT00986,Germany,Bavaria,51.0,Male,Ovarian,III,2022-08-08,,2022-10-01,Immunotherapy,Public,Alive,21.0,EGFR,Yes,Former,Moderate,33.9,Low,Urban,Statutory Health Insurance,11.0,No,No,None,2.0
PT00987,Portugal,Lisbon,82.0,Female,Colorectal,,2011-03-26,2011-06-17,2011-12-11,Radiation,Private,,58.0,,Yes,Never,Moderate,31.0,Medium,Urban,Private Insurance,11.0,No,No,Hypertension,10.0
PT00988,Norway,Oslo,31.0,Female,Colorectal,I,2019-12-19,2020-03-22,2021-02-22,Surgery,Public,Alive,115.0,None,,,Moderate,22.3,Low,Urban,,3.0,No,No,Cardiovascular Disease,9.0
PT00989,,Flanders,82.0,,Colorectal,I,2015-03-29,2015-07-21,2015-09-01,Radiation,Public,Alive,50.0,BRCA1,Yes,Current,Moderate,18.8,Low,Urban,Private Insurance,11.0,No,No,Obesity,6.0
PT00990,Italy,Sicily,20.0,Male,Pancreatic,II,2017-08-29,2017-10-23,2018-06-27,Immunotherapy,Public,Lost to Follow-up,,BRCA1,No,Former,None,36.2,High,Urban,Statutory Health Insurance,14.0,No,No,None,3.0
PT00991,Spain,Andalusia,70.0,Female,Breast,IV,2022-09-08,2023-01-03,2023-07-22,Targeted Therapy,Private,Deceased,73.0,KRAS,Yes,Current,Moderate,33.4,High,Rural,Private Insurance,19.0,No,No,Hypertension,9.0
PT00992,Portugal,Porto,89.0,Female,Pancreatic,I,2016-12-20,,2017-04-19,Radiation,Public,Deceased,24.0,BRCA1,No,Never,,27.9,Low,Rural,NHS,19.0,Yes,,Hypertension,5.0
PT00993,,Uusimaa,,Female,,II,2018-11-29,2018-12-27,2019-09-21,Immunotherapy,Public,Alive,,None,,,Moderate,22.5,Low,Rural,Statutory Health Insurance,3.0,Yes,No,Diabetes,6.0
PT00994,Poland,Lesser Poland,87.0,Non-binary,Leukemia,IV,2023-03-05,2023-03-19,2023-12-18,Immunotherapy,Public,Alive,,None,No,Never,None,39.2,Medium,Urban,Statutory Health Insurance,,,No,Obesity,5.0
PT00995,Belgium,Wallonia,24.0,,Colorectal,III,2022-04-23,2022-09-01,2023-01-10,Radiation,Public,Alive,8.0,KRAS,No,Never,Moderate,26.3,Low,Urban,NHS,5.0,Yes,No,Diabetes,3.0
PT00996,Switzerland,Geneva,58.0,Female,Leukemia,II,2019-06-24,,2019-09-07,Surgery,Private,Deceased,10.0,BRCA1,No,Never,Moderate,38.4,High,Urban,NHS,2.0,No,No,Hypertension,2.0
PT00997,Sweden,Västra Götaland,,Female,Lung,III,2013-12-30,2014-03-29,2015-01-23,Targeted Therapy,Private,Alive,20.0,BRCA1,No,Never,Moderate,22.9,Low,Urban,Private Insurance,6.0,No,No,Diabetes,8.0
PT00998,Finland,Uusimaa,87.0,Female,Leukemia,III,2012-07-09,2012-12-30,2013-08-19,Immunotherapy,Private,Alive,96.0,EGFR,No,Never,None,37.5,Medium,Rural,NHS,9.0,No,No,Cardiovascular Disease,3.0
PT00999,France,Provence-Alpes-Côte d'Azur,71.0,Male,Lung,II,2018-10-24,2019-02-12,,Surgery,Public,Alive,38.0,None,No,Never,None,30.0,Medium,Rural,Private Insurance,19.0,Yes,,Obesity,2.0
PT01000,Sweden,Stockholm,23.0,Female,Breast,IV,2011-04-02,2011-08-01,2012-01-30,Immunotherapy,Public,Alive,89.0,KRAS,Yes,Current,None,38.8,Medium,Urban,Statutory Health Insurance,7.0,No,No,Diabetes,6.0
PT01001,Poland,Lesser Poland,66.0,,Ovarian,II,2015-02-28,2015-07-09,2016-01-20,,Private,Deceased,46.0,BRCA1,No,Never,Moderate,20.7,Medium,Urban,Private Insurance,10.0,No,No,Hypertension,8.0
PT01002,Denmark,Zealand,40.0,Female,Ovarian,III,2011-10-07,2012-01-13,2012-03-25,Immunotherapy,Private,Alive,39.0,,Yes,Never,None,39.8,Low,Urban,NHS,11.0,No,No,None,9.0
PT01003,France,Île-de-France,75.0,Female,Pancreatic,IV,2016-05-18,2016-09-26,2016-12-04,Surgery,Research Institute,Alive,22.0,EGFR,Yes,,,22.5,Medium,Urban,Statutory Health Insurance,,Yes,No,None,7.0
PT01004,Denmark,,85.0,Female,Pancreatic,II,2022-05-07,2022-10-23,2023-04-21,,Public,Deceased,46.0,EGFR,No,Former,Moderate,20.1,High,Rural,Private Insurance,19.0,Yes,No,Cardiovascular Disease,4.0
,Ireland,Connacht,78.0,Female,Lung,III,2016-01-20,2016-06-25,2016-09-06,Targeted Therapy,Public,Deceased,63.0,BRCA1,No,Never,Heavy,30.4,Medium,Urban,,9.0,No,No,Diabetes,4.0
PT01006,Portugal,Algarve,26.0,Male,Lung,III,2023-07-10,2023-12-25,2024-04-13,Targeted Therapy,,Alive,12.0,KRAS,No,Former,Heavy,33.0,Medium,Urban,Private Insurance,9.0,No,No,Obesity,5.0
PT01007,Denmark,Capital Region,,Male,Colorectal,III,2021-08-27,2021-09-15,2022-06-28,Chemotherapy,Research Institute,Alive,49.0,,,Current,Moderate,26.3,Low,Urban,Statutory Health Insurance,6.0,No,No,Obesity,4.0
,Netherlands,Utrecht,35.0,Female,Prostate,III,2021-11-29,2022-04-26,2022-09-05,Immunotherapy,Research Institute,Alive,42.0,BRCA1,No,Never,Moderate,33.4,Medium,Urban,NHS,10.0,Yes,No,Hypertension,6.0
PT01009,Portugal,Lisbon,36.0,Female,,I,2012-12-29,2013-01-19,2013-03-30,Chemotherapy,Private,Alive,49.0,BRCA1,No,Former,None,38.8,Medium,Urban,Private Insurance,9.0,Yes,,None,10.0
PT01010,Italy,Sicily,53.0,Male,Leukemia,III,2016-09-25,2017-02-20,2018-02-02,Radiation,Public,Alive,109.0,KRAS,Yes,Never,None,35.5,Medium,Urban,Private Insurance,4.0,Yes,,Obesity,1.0
PT01011,Finland,Southwest Finland,52.0,Female,Breast,III,,2017-10-24,2018-05-29,Radiation,Public,Deceased,42.0,None,Yes,Never,Moderate,37.5,Low,Urban,Statutory Health Insurance,6.0,No,No,None,4.0
PT01012,Portugal,Lisbon,45.0,Male,Pancreatic,III,2015-08-05,2015-09-21,2016-05-15,Surgery,Private,,20.0,EGFR,Yes,Former,None,37.8,Low,Urban,Statutory Health Insurance,7.0,No,No,None,2.0
PT01013,Poland,Lesser Poland,85.0,Male,Leukemia,III,2010-02-05,2010-05-07,2010-09-21,Surgery,Public,Alive,,KRAS,Yes,Former,Heavy,24.6,Medium,Rural,Statutory Health Insurance,14.0,No,No,Obesity,2.0
PT01014,Austria,Tyrol,82.0,Female,Pancreatic,I,2011-04-15,2011-05-29,2012-05-21,Radiation,Research Institute,Alive,8.0,,Yes,Never,Moderate,33.6,Low,Urban,Statutory Health Insurance,4.0,No,No,Diabetes,2.0
PT01015,Finland,Pirkanmaa,60.0,Female,Breast,II,2010-11-05,2011-02-27,2012-02-25,Chemotherapy,Public,,71.0,EGFR,,Former,None,34.4,High,Rural,Statutory Health Insurance,2.0,Yes,No,None,9.0
PT01016,Austria,Styria,77.0,Male,Leukemia,,2018-12-13,2019-03-12,2019-10-21,Surgery,Public,Deceased,112.0,BRCA1,No,Never,None,20.7,,Rural,Statutory Health Insurance,17.0,No,No,Hypertension,8.0
PT01017,Norway,Vestland,,Female,Pancreatic,IV,2011-04-26,2011-04-28,2011-07-23,Chemotherapy,Public,,107.0,BRCA1,Yes,Never,None,28.7,High,Urban,NHS,11.0,No,No,None,7.0
,Poland,Silesian,34.0,Female,Lung,I,2012-02-28,2012-08-17,2013-01-14,Surgery,Public,Deceased,103.0,BRCA1,Yes,Never,None,32.4,Low,Urban,Private Insurance,10.0,No,No,Obesity,1.0
PT01019,Austria,Styria,61.0,Non-binary,Prostate,II,2010-10-18,2011-01-14,2011-12-07,Targeted Therapy,Private,Alive,65.0,KRAS,No,Former,Heavy,24.4,,Urban,NHS,6.0,No,No,None,5.0
,Denmark,Capital Region,76.0,,Lung,III,2011-03-06,2011-07-31,2011-11-22,Chemotherapy,Private,Alive,104.0,EGFR,Yes,Former,None,32.1,Low,Urban,Private Insurance,16.0,No,No,,1.0
,Netherlands,South Holland,36.0,Female,Ovarian,III,2011-08-21,2011-11-19,2012-02-22,Radiation,Public,Deceased,68.0,EGFR,Yes,Former,None,19.1,Medium,Urban,NHS,,No,No,Cardiovascular Disease,5.0
PT01022,Austria,Styria,79.0,,Pancreatic,III,2022-05-25,2022-11-15,2023-02-22,Radiation,Private,,117.0,None,No,Former,Moderate,31.0,Low,Urban,NHS,10.0,No,No,Diabetes,2.0
PT01023,Germany,Berlin,28.0,Male,Colorectal,I,2014-04-07,2014-09-23,2015-06-12,Surgery,Public,Deceased,89.0,,No,Never,None,,,Rural,NHS,1.0,No,No,None,10.0
PT01024,Poland,Lesser Poland,55.0,Female,Leukemia,III,2022-08-06,2022-10-12,2023-07-11,Chemotherapy,Public,,119.0,None,Yes,Former,Moderate,33.0,Medium,Urban,Statutory Health Insurance,16.0,No,Yes,Diabetes,4.0
PT01025,Portugal,Lisbon,55.0,Female,Prostate,,2011-11-04,2012-02-03,2012-11-25,Immunotherapy,Public,Alive,22.0,None,Yes,,None,32.4,High,Urban,Statutory Health Insurance,19.0,No,No,Diabetes,8.0
PT01026,,Lisbon,67.0,Male,Leukemia,,2017-10-25,2017-11-08,2017-12-11,Radiation,Private,Lost to Follow-up,,BRCA1,Yes,Current,None,31.7,Medium,Urban,Private Insurance,11.0,No,No,Cardiovascular Disease,2.0
PT01027,Finland,Southwest Finland,70.0,Non-binary,Colorectal,III,2014-04-28,2014-09-23,2015-01-09,Radiation,Research Institute,,100.0,EGFR,No,Never,None,23.7,High,Urban,Private Insurance,4.0,No,,Cardiovascular Disease,1.0
PT01028,France,Auvergne-Rhône-Alpes,89.0,Female,,,2013-12-03,2014-01-07,2014-09-11,Chemotherapy,Public,Alive,86.0,KRAS,,Never,None,32.7,High,Urban,NHS,13.0,No,No,None,
,France,Auvergne-Rhône-Alpes,87.0,Female,Colorectal,IV,2010-02-10,2010-07-13,2011-04-04,Chemotherapy,Public,Alive,79.0,KRAS,No,Current,,27.1,,Rural,Statutory Health Insurance,1.0,No,,Diabetes,8.0
,Germany,,41.0,Female,Pancreatic,III,2022-04-07,2022-08-13,2022-11-29,Surgery,Research Institute,Alive,92.0,BRCA1,Yes,Never,Moderate,29.8,Medium,Rural,Private Insurance,12.0,No,Yes,Obesity,3.0
PT01031,Italy,Lombardy,25.0,Male,Lung,II,2018-01-12,2018-05-24,,,Public,Alive,35.0,EGFR,,Former,Moderate,33.1,Medium,Urban,NHS,19.0,No,No,Hypertension,4.0
PT01032,Italy,Sicily,,Female,Pancreatic,IV,,2013-10-03,2014-07-01,Radiation,Public,Alive,42.0,EGFR,No,,Moderate,26.1,Low,Urban,,10.0,No,No,Diabetes,6.0
PT01033,Portugal,Algarve,22.0,Male,Lung,IV,2014-12-21,2014-12-23,2015-07-05,Chemotherapy,Private,,49.0,KRAS,No,Never,None,39.9,Medium,Rural,Private Insurance,10.0,No,,Diabetes,1.0
PT01034,Poland,Silesian,71.0,Female,Prostate,III,2021-09-18,2021-11-23,2022-09-24,Radiation,Public,Alive,71.0,None,Yes,Never,Moderate,19.4,Medium,Rural,NHS,4.0,No,No,Diabetes,7.0
PT01035,Belgium,Flanders,79.0,Male,Colorectal,II,2015-03-11,2015-06-08,,Immunotherapy,Public,Alive,46.0,EGFR,No,Never,Moderate,34.1,,Urban,Statutory Health Insurance,9.0,No,No,Diabetes,2.0
PT01036,Austria,Styria,82.0,Male,Ovarian,II,2012-11-29,2013-03-20,2013-10-13,Targeted Therapy,Public,Alive,65.0,KRAS,No,Never,None,23.3,Low,Urban,Statutory Health Insurance,4.0,No,No,None,3.0
PT01037,Belgium,Wallonia,84.0,Female,Lung,II,2019-01-10,2019-04-07,2019-10-12,Targeted Therapy,Private,Alive,75.0,BRCA1,Yes,Current,Moderate,39.6,Low,Urban,Statutory Health Insurance,9.0,No,No,Cardiovascular Disease,5.0
PT01038,Finland,Southwest Finland,71.0,Male,Breast,I,2010-05-18,2010-10-14,2011-09-08,Immunotherapy,Private,,108.0,BRCA1,Yes,Current,Moderate,29.7,Medium,Rural,Statutory Health Insurance,4.0,No,No,Cardiovascular Disease,8.0
PT01039,Denmark,Central Denmark,33.0,Male,Ovarian,II,2010-12-01,2011-02-28,2011-04-29,Chemotherapy,Public,Alive,18.0,None,No,Former,None,,,Rural,NHS,12.0,No,No,Obesity,6.0
PT01040,Switzerland,Bern,87.0,Female,Breast,II,2021-08-04,,2022-10-29,Targeted Therapy,Public,Deceased,110.0,,No,Former,Moderate,22.5,Low,Urban,Private Insurance,8.0,No,Yes,Cardiovascular Disease,5.0
PT01041,,Flanders,47.0,Female,Lung,I,2022-07-20,2022-09-10,2022-11-19,,Research Institute,Lost to Follow-up,,EGFR,No,Never,,37.4,High,Urban,Private Insurance,7.0,No,No,Obesity,10.0
PT01042,Finland,Pirkanmaa,,Female,Ovarian,IV,2022-10-16,2023-02-11,2023-03-16,Surgery,Public,Deceased,61.0,BRCA1,Yes,Never,Heavy,39.2,Medium,Rural,NHS,12.0,No,No,Hypertension,4.0
PT01043,Austria,Styria,76.0,Male,Ovarian,II,2017-04-30,2017-09-20,2018-07-16,Radiation,Public,Deceased,29.0,EGFR,Yes,Former,Moderate,29.9,Medium,Urban,Statutory Health Insurance,19.0,No,No,Cardiovascular Disease,5.0
,Finland,Uusimaa,85.0,Male,Prostate,II,2014-06-22,2014-12-13,2015-07-04,Surgery,Public,Alive,8.0,KRAS,Yes,Current,None,36.7,Low,,Private Insurance,13.0,No,No,Hypertension,5.0
PT01045,Denmark,Central Denmark,69.0,Male,Leukemia,II,2023-09-03,2023-12-27,2024-11-30,Targeted Therapy,Private,Alive,69.0,EGFR,Yes,Former,None,32.7,Medium,Rural,Private Insurance,19.0,No,No,Hypertension,1.0
PT01046,Austria,Styria,33.0,Female,Pancreatic,I,2014-03-14,2014-04-14,2014-08-13,Targeted Therapy,Private,,34.0,BRCA1,No,Never,None,23.4,High,Rural,Statutory Health Insurance,1.0,No,No,Diabetes,1.0
PT01047,France,Île-de-France,35.0,Female,Colorectal,IV,2013-01-13,,2013-07-12,Chemotherapy,Public,Deceased,21.0,None,,Never,Moderate,38.2,Low,,Statutory Health Insurance,14.0,No,No,Obesity,4.0
PT01048,Norway,Oslo,73.0,Male,Lung,II,2014-05-06,2014-06-09,2014-10-03,,Public,Deceased,93.0,BRCA1,,Never,,35.1,Medium,Urban,Private Insurance,5.0,No,No,None,3.0
PT01049,Germany,Berlin,62.0,Male,Prostate,III,2020-07-28,2020-09-02,2020-11-03,Chemotherapy,Private,Alive,9.0,EGFR,No,Former,None,37.6,Medium,Urban,Statutory Health Insurance,15.0,No,,Obesity,4.0
PT01050,Spain,Catalonia,61.0,Male,Ovarian,III,,2023-11-24,2024-05-08,Immunotherapy,Public,Alive,76.0,BRCA1,No,Former,Moderate,26.0,Medium,Urban,Private Insurance,19.0,No,Yes,Obesity,3.0
PT01051,France,Provence-Alpes-Côte d'Azur,41.0,Male,Pancreatic,II,2013-01-17,2013-05-01,2013-11-12,Targeted Therapy,Public,Deceased,59.0,EGFR,Yes,Former,Moderate,28.0,Low,Urban,,9.0,No,No,Obesity,8.0
PT01052,Spain,Catalonia,87.0,Male,Leukemia,II,2013-01-17,2013-03-02,2013-06-28,Immunotherapy,Private,Alive,118.0,,Yes,Never,,24.3,High,Urban,NHS,8.0,No,,None,3.0
PT01053,Austria,Styria,38.0,Female,Prostate,I,2016-03-16,2016-06-01,2016-09-20,Immunotherapy,Public,Alive,25.0,EGFR,Yes,,Moderate,25.4,Medium,Rural,NHS,3.0,No,Yes,Cardiovascular Disease,9.0
PT01054,Finland,Pirkanmaa,85.0,Male,Leukemia,I,2017-11-29,2017-12-17,2018-02-27,Radiation,Private,Alive,84.0,KRAS,No,Former,Moderate,23.7,Low,Urban,Private Insurance,4.0,No,No,None,10.0
PT01055,Poland,Masovian,58.0,Female,Breast,II,2010-12-16,2011-01-30,2011-07-13,Chemotherapy,Public,Deceased,78.0,BRCA1,No,,None,34.0,Medium,Rural,Statutory Health Insurance,12.0,No,Yes,None,10.0
PT01056,Austria,Vienna,38.0,Female,Pancreatic,III,2020-11-06,2021-02-22,2022-01-13,Immunotherapy,Public,Alive,62.0,BRCA1,Yes,Never,None,26.3,High,Rural,Statutory Health Insurance,16.0,Yes,No,None,4.0
PT01057,Switzerland,Bern,35.0,Male,Pancreatic,II,2015-04-08,2015-09-22,2016-02-17,Radiation,Public,Alive,108.0,BRCA1,Yes,Never,Moderate,34.1,High,Urban,,5.0,No,No,Hypertension,6.0
PT01058,,Connacht,73.0,Female,Leukemia,I,2022-04-28,2022-05-24,2023-05-06,Targeted Therapy,Private,Deceased,104.0,EGFR,Yes,Former,Moderate,32.8,High,Urban,Statutory Health Insurance,8.0,Yes,No,Hypertension,2.0
PT01059,Norway,Trøndelag,44.0,Female,Breast,,2010-02-12,2010-06-04,2011-01-02,,Private,Alive,72.0,KRAS,Yes,Never,Moderate,30.2,Low,Rural,Statutory Health Insurance,17.0,Yes,No,Diabetes,3.0
PT01060,Poland,Silesian,37.0,Male,Colorectal,III,,2019-12-26,2020-02-28,Immunotherapy,Private,Deceased,61.0,EGFR,No,Never,Heavy,32.8,Medium,Urban,Statutory Health Insurance,10.0,No,No,Obesity,7.0
PT01061,,Flanders,42.0,,Lung,II,2016-04-24,2016-07-08,2017-01-24,Targeted Therapy,Public,Deceased,94.0,BRCA1,Yes,Never,None,30.2,Medium,Rural,Private Insurance,3.0,Yes,Yes,Obesity,5.0
PT01062,Italy,Sicily,30.0,Male,Ovarian,I,2012-05-01,2012-08-05,2012-09-14,Chemotherapy,Private,Alive,69.0,,No,,,33.8,Medium,Rural,NHS,19.0,Yes,,Cardiovascular Disease,6.0
PT01063,France,Provence-Alpes-Côte d'Azur,,,Breast,III,2019-04-16,2019-05-10,2020-05-08,Targeted Therapy,Public,Deceased,72.0,None,No,Never,Moderate,25.2,,Rural,NHS,2.0,No,Yes,Cardiovascular Disease,7.0
PT01064,Belgium,Flanders,87.0,Female,Prostate,I,2023-12-28,2024-04-23,2024-08-09,Surgery,Private,Alive,20.0,BRCA1,No,,Moderate,35.2,High,Urban,NHS,18.0,No,No,None,9.0
PT01065,France,Île-de-France,44.0,Female,Leukemia,II,2013-07-10,2013-10-23,2014-04-03,Targeted Therapy,Public,Alive,80.0,EGFR,No,Former,Moderate,24.6,Medium,,Private Insurance,18.0,Yes,No,,1.0
PT01066,Spain,Madrid,82.0,Female,Pancreatic,II,,2017-04-14,2017-10-28,Immunotherapy,Public,Deceased,93.0,None,No,Current,None,39.5,Low,Urban,NHS,7.0,No,Yes,Diabetes,7.0
PT01067,Ireland,Connacht,49.0,Female,Prostate,IV,,2020-06-15,2021-03-07,Radiation,Public,Alive,75.0,EGFR,Yes,Former,Moderate,26.5,Medium,Urban,Private Insurance,11.0,No,No,Cardiovascular Disease,10.0
,Germany,Berlin,64.0,Female,Pancreatic,I,2022-08-31,2022-12-20,2023-11-16,Chemotherapy,Public,Alive,26.0,None,No,Former,None,18.3,Medium,Urban,Private Insurance,8.0,No,No,None,1.0
PT01069,Denmark,Central Denmark,80.0,,Breast,II,,2019-08-29,2019-10-18,Chemotherapy,Public,Alive,83.0,None,Yes,Never,None,28.2,Low,Urban,NHS,1.0,Yes,No,Hypertension,5.0
PT01070,Austria,Vienna,70.0,Male,Pancreatic,IV,2020-02-08,2020-05-01,2020-10-14,Radiation,Public,Alive,32.0,None,Yes,Former,Moderate,39.0,Low,Rural,Statutory Health Insurance,1.0,No,No,Hypertension,1.0
PT01071,Switzerland,Bern,28.0,Female,Ovarian,II,2015-10-18,2016-03-30,2017-03-21,,Public,Lost to Follow-up,,BRCA1,No,Never,Heavy,31.9,High,Rural,Statutory Health Insurance,16.0,No,No,Obesity,8.0
,Switzerland,Bern,21.0,Male,Pancreatic,III,2012-11-14,2013-04-30,2013-10-31,Immunotherapy,Public,Alive,82.0,,No,Never,,20.2,Medium,Urban,NHS,12.0,No,No,Diabetes,10.0
PT01073,,Zealand,24.0,Male,Ovarian,II,2017-02-28,,2018-01-17,Immunotherapy,Public,Deceased,92.0,BRCA1,Yes,Current,None,,High,Rural,NHS,11.0,No,No,Cardiovascular Disease,6.0
PT01074,Ireland,Dublin,81.0,Female,Pancreatic,I,2011-05-28,2011-06-20,2011-09-23,Radiation,Public,Alive,71.0,EGFR,No,Never,Moderate,27.9,High,Urban,NHS,13.0,Yes,No,Diabetes,2.0
PT01075,Denmark,Central Denmark,88.0,Male,Pancreatic,III,2010-07-02,2010-08-25,2011-05-13,Immunotherapy,Public,Alive,114.0,None,Yes,Never,Moderate,23.0,Medium,Urban,Statutory Health Insurance,11.0,No,No,Obesity,3.0
PT01076,France,Provence-Alpes-Côte d'Azur,71.0,Male,Ovarian,IV,2015-10-03,2016-03-15,2016-05-09,Surgery,Private,Alive,100.0,EGFR,Yes,Former,Moderate,31.3,Medium,Urban,Statutory Health Insurance,19.0,No,Yes,Cardiovascular Disease,5.0
,Sweden,Skåne,,Female,Ovarian,II,,2013-06-01,2014-01-16,Immunotherapy,Research Institute,Alive,82.0,BRCA1,No,Former,Moderate,38.5,Low,Urban,Private Insurance,12.0,No,No,Cardiovascular Disease,7.0
PT01078,Spain,Andalusia,78.0,Male,Prostate,III,2010-06-09,2010-10-17,2011-05-07,Chemotherapy,Public,Alive,21.0,BRCA1,No,Former,None,39.3,Low,Rural,Statutory Health Insurance,14.0,No,No,Cardiovascular Disease,8.0
PT01079,Spain,Catalonia,87.0,Male,Leukemia,III,2019-06-20,2019-09-04,2020-04-03,Radiation,Research Institute,Alive,6.0,None,No,Former,None,,Low,Urban,Private Insurance,11.0,No,No,None,6.0
PT01080,Portugal,Lisbon,28.0,,Lung,II,2012-01-08,2012-03-18,2012-05-26,Surgery,Public,Alive,71.0,BRCA1,Yes,Current,Moderate,24.5,High,,NHS,11.0,Yes,No,Diabetes,2.0
PT01081,Finland,Pirkanmaa,41.0,Female,Prostate,III,2016-04-30,2016-10-13,2017-08-10,Immunotherapy,Private,Deceased,101.0,BRCA1,Yes,Current,None,39.5,Medium,Urban,Statutory Health Insurance,16.0,No,No,Diabetes,9.0
PT01082,France,Auvergne-Rhône-Alpes,46.0,Female,Colorectal,I,,2017-06-26,2018-02-22,Surgery,Private,Deceased,71.0,None,Yes,Never,None,24.8,High,Rural,Private Insurance,8.0,No,No,Cardiovascular Disease,7.0
PT01083,Italy,Sicily,29.0,Female,Leukemia,II,2018-05-12,2018-07-01,2019-03-11,,Public,Alive,9.0,BRCA1,No,Never,Heavy,31.8,High,,Private Insurance,18.0,No,,Obesity,7.0
PT01084,Norway,Vestland,80.0,Female,Leukemia,,2019-04-04,2019-07-30,2020-02-04,Targeted Therapy,Private,Deceased,71.0,EGFR,Yes,Never,None,,High,,NHS,5.0,No,No,None,9.0
PT01085,,,70.0,Female,Ovarian,IV,,2018-10-08,2018-12-11,Surgery,Research Institute,Alive,9.0,EGFR,No,Former,Moderate,32.5,Medium,Urban,NHS,17.0,No,Yes,Cardiovascular Disease,8.0
PT01086,Ireland,Dublin,29.0,Female,Colorectal,II,2010-07-20,2010-07-21,2011-07-05,Targeted Therapy,Research Institute,Deceased,82.0,None,No,Never,Moderate,39.9,Medium,Urban,Statutory Health Insurance,2.0,Yes,Yes,Hypertension,9.0
PT01087,Spain,Madrid,25.0,Female,,III,2013-07-31,2013-08-21,2014-01-18,Targeted Therapy,Private,Deceased,50.0,KRAS,No,Never,Heavy,25.7,Medium,Urban,Statutory Health Insurance,8.0,Yes,No,Diabetes,8.0
PT01088,Denmark,Zealand,81.0,Female,Ovarian,I,2016-01-04,2016-03-01,2017-01-10,Targeted Therapy,Private,Lost to Follow-up,,None,Yes,Never,Heavy,20.6,Medium,Rural,,12.0,Yes,Yes,Diabetes,6.0
PT01089,Poland,Masovian,24.0,Male,Breast,I,2019-07-08,2019-12-02,2020-06-18,Radiation,Public,Alive,6.0,KRAS,No,Current,None,22.8,Medium,Rural,Statutory Health Insurance,1.0,Yes,No,None,
PT01090,Portugal,Lisbon,89.0,Male,Colorectal,,2023-02-28,2023-03-29,2023-12-14,Radiation,Public,Deceased,62.0,KRAS,,Current,Moderate,22.1,Medium,Urban,NHS,11.0,No,No,Cardiovascular Disease,4.0
PT01091,Netherlands,Utrecht,82.0,,Breast,III,2021-03-13,2021-09-07,2022-01-14,Targeted Therapy,Public,Deceased,72.0,BRCA1,Yes,Never,Moderate,37.9,Medium,Rural,Statutory Health Insurance,1.0,Yes,No,None,10.0
PT01092,Denmark,Capital Region,75.0,Female,Lung,II,2014-11-05,2014-12-09,2015-08-28,,Public,Alive,20.0,None,Yes,,None,28.2,Low,Urban,Statutory Health Insurance,1.0,Yes,No,None,5.0
,Austria,Styria,78.0,Male,Breast,,2018-11-30,2019-02-19,2019-03-22,Targeted Therapy,Public,Lost to Follow-up,,BRCA1,No,Current,Moderate,29.3,Low,Rural,NHS,7.0,No,No,Diabetes,8.0
PT01094,Portugal,Lisbon,82.0,Female,Ovarian,IV,2017-02-07,2017-04-02,2017-05-17,Targeted Therapy,Private,Alive,72.0,EGFR,Yes,Former,None,21.8,Low,Rural,NHS,6.0,No,No,Hypertension,10.0
PT01095,Ireland,Dublin,78.0,Female,Lung,I,2015-04-23,2015-05-25,2016-01-30,Targeted Therapy,Public,Lost to Follow-up,,EGFR,Yes,Never,None,22.7,Medium,Rural,NHS,15.0,No,No,Hypertension,10.0
PT01096,Spain,Madrid,70.0,Female,Lung,III,2013-05-17,2013-09-26,2014-07-15,Chemotherapy,Private,Deceased,102.0,EGFR,Yes,Never,Moderate,35.6,Low,Rural,Private Insurance,19.0,No,No,None,6.0
PT01097,Ireland,Munster,69.0,Male,Pancreatic,III,2023-08-08,2023-09-07,2024-04-06,Chemotherapy,Private,Alive,19.0,BRCA1,No,Never,Moderate,33.0,High,Urban,Statutory Health Insurance,18.0,No,No,Obesity,10.0
,Switzerland,Bern,23.0,Female,Pancreatic,III,,,2011-12-23,Targeted Therapy,Private,Alive,15.0,KRAS,Yes,Never,None,25.2,Low,Urban,Statutory Health Insurance,5.0,No,No,Hypertension,2.0
PT01099,France,Île-de-France,67.0,Male,Colorectal,IV,2010-03-23,2010-08-16,2011-05-19,Immunotherapy,Private,Alive,92.0,BRCA1,Yes,Current,Moderate,35.5,Medium,Urban,NHS,11.0,Yes,No,Cardiovascular Disease,3.0
PT01100,France,Provence-Alpes-Côte d'Azur,51.0,Female,Ovarian,III,2010-09-20,2010-11-28,,Surgery,Private,Deceased,48.0,KRAS,No,Never,None,19.2,High,Urban,Private Insurance,14.0,,No,Cardiovascular Disease,10.0
PT01101,Finland,Uusimaa,70.0,Female,Lung,II,2020-07-05,2020-08-03,2020-12-26,Radiation,Private,Deceased,,,No,,Heavy,19.6,High,Rural,Private Insurance,16.0,No,No,Cardiovascular Disease,8.0
PT01102,,Sicily,,Male,Ovarian,II,2018-02-18,2018-07-08,2018-10-14,Surgery,Public,Lost to Follow-up,,EGFR,,Former,None,19.9,High,Urban,Statutory Health Insurance,7.0,No,No,Obesity,2.0
PT01103,Portugal,Algarve,,Female,Breast,II,2010-10-13,2010-10-28,2011-04-16,Radiation,Private,Alive,6.0,EGFR,No,Never,Moderate,33.5,High,Urban,Statutory Health Insurance,8.0,No,No,None,3.0
PT01104,Belgium,Brussels,55.0,Male,Prostate,I,2010-01-23,2010-04-12,2010-07-02,,Public,Deceased,50.0,KRAS,No,,Moderate,31.1,Medium,Urban,Statutory Health Insurance,6.0,Yes,No,,2.0
PT01105,Austria,Vienna,89.0,Non-binary,Pancreatic,IV,,2020-03-09,2020-07-12,Chemotherapy,Private,Deceased,97.0,BRCA1,Yes,Never,None,37.0,Medium,Urban,Statutory Health Insurance,15.0,No,No,Obesity,3.0
PT01106,Italy,Veneto,62.0,Male,Leukemia,I,2020-12-04,2021-05-16,2021-08-08,Targeted Therapy,Public,Lost to Follow-up,,EGFR,No,Never,None,39.3,High,Rural,Private Insurance,7.0,No,No,,3.0
PT01107,,Flanders,35.0,Male,Leukemia,III,2019-09-16,2020-02-05,2020-12-15,Radiation,Research Institute,Alive,80.0,KRAS,No,Current,Moderate,25.5,Medium,Urban,Statutory Health Insurance,,Yes,No,None,8.0
PT01108,Poland,Lesser Poland,78.0,Male,Breast,III,2021-10-11,2022-01-22,2022-07-16,Targeted Therapy,Private,Alive,78.0,BRCA1,No,Current,None,31.8,Low,Urban,NHS,11.0,No,No,Diabetes,4.0
PT01109,Portugal,Lisbon,72.0,Male,,III,2013-12-26,2014-05-21,2015-03-29,Targeted Therapy,Public,Alive,48.0,KRAS,No,Current,Moderate,37.1,Low,Urban,Statutory Health Insurance,19.0,No,No,Diabetes,8.0
PT01110,Portugal,Porto,38.0,,Prostate,II,2010-04-05,2010-09-18,2010-12-06,Chemotherapy,Public,Alive,16.0,EGFR,No,Current,Moderate,23.1,Medium,Urban,Private Insurance,18.0,Yes,No,Hypertension,4.0
PT01111,Norway,Oslo,60.0,Female,Ovarian,III,2016-11-27,2017-02-21,2018-01-14,Radiation,Private,Deceased,46.0,BRCA1,No,Former,None,20.1,Low,Urban,NHS,9.0,No,Yes,None,4.0
PT01112,Spain,Andalusia,66.0,Female,Lung,II,2010-05-17,2010-10-30,2011-06-11,Immunotherapy,Public,Alive,70.0,EGFR,No,,Heavy,39.6,High,Rural,Statutory Health Insurance,15.0,No,No,None,2.0
PT01113,Norway,Vestland,73.0,Male,Pancreatic,III,2015-07-31,2015-09-24,2016-06-01,Chemotherapy,Public,Alive,45.0,BRCA1,No,Never,None,37.8,Medium,Urban,Statutory Health Insurance,19.0,No,No,Diabetes,3.0
PT01114,Germany,Bavaria,74.0,Male,Breast,II,2016-02-28,2016-07-16,2016-12-30,Targeted Therapy,Public,Alive,57.0,None,Yes,Never,None,31.4,Medium,Urban,Statutory Health Insurance,18.0,No,No,Diabetes,6.0
PT01115,Finland,Uusimaa,38.0,Female,Ovarian,IV,2023-10-18,2023-12-24,2024-01-31,Radiation,Private,Alive,72.0,None,No,Former,Moderate,18.2,,Urban,Statutory Health Insurance,3.0,No,No,Cardiovascular Disease,2.0
PT01116,Sweden,Västra Götaland,81.0,Male,Lung,I,2020-01-19,2020-03-12,2020-04-13,Chemotherapy,Public,Alive,92.0,EGFR,No,Current,Moderate,23.0,Medium,Urban,NHS,1.0,No,No,Diabetes,8.0
PT01117,Denmark,Zealand,78.0,Female,Pancreatic,II,,2021-11-20,2022-01-26,Chemotherapy,Public,Alive,119.0,None,No,Former,Moderate,33.3,Low,,Private Insurance,8.0,No,No,Obesity,10.0
PT01118,Switzerland,Bern,,Female,Colorectal,II,2013-09-07,2014-02-07,2014-05-17,Immunotherapy,Public,Alive,88.0,BRCA1,No,Current,,25.9,Medium,Urban,NHS,18.0,No,Yes,Obesity,4.0
PT01119,Norway,Vestland,87.0,Male,Prostate,,2022-09-19,2023-02-08,2023-05-17,Surgery,Public,Alive,50.0,KRAS,No,Current,None,30.5,High,Urban,Private Insurance,7.0,Yes,No,None,10.0
PT01120,Germany,Bavaria,47.0,,Leukemia,III,2017-05-08,2017-06-24,2017-12-28,Radiation,Research Institute,,14.0,None,No,Former,Heavy,19.2,Medium,Rural,,19.0,No,No,Diabetes,7.0
PT01121,Portugal,Lisbon,37.0,Female,Breast,I,2012-09-26,,2013-10-25,Radiation,Public,Alive,106.0,EGFR,No,Former,Moderate,30.1,Low,Urban,Private Insurance,12.0,No,No,None,3.0
PT01122,Poland,Silesian,45.0,Female,Leukemia,I,2018-11-12,2019-02-09,2019-03-12,Radiation,Public,Alive,75.0,None,No,Never,None,21.2,Low,Rural,Private Insurance,11.0,No,No,Obesity,
PT01123,Sweden,Västra Götaland,38.0,Male,Ovarian,,2012-10-21,2013-03-10,2013-07-18,Radiation,Private,Deceased,85.0,None,Yes,Never,None,20.3,Low,Urban,Statutory Health Insurance,7.0,No,No,Hypertension,6.0
PT01124,Italy,Veneto,74.0,Male,Lung,II,2022-01-04,2022-01-11,2022-06-25,Surgery,Private,Deceased,50.0,EGFR,No,Current,,28.8,Medium,Urban,Private Insurance,6.0,No,No,Cardiovascular Disease,
PT01125,Italy,Veneto,76.0,Male,Lung,II,2021-05-29,2021-11-22,2022-11-16,Chemotherapy,Research Institute,Alive,88.0,EGFR,Yes,Former,Moderate,29.3,Medium,Urban,Statutory Health Insurance,15.0,,No,Hypertension,7.0
PT01126,Spain,Catalonia,25.0,Male,Colorectal,II,2021-07-05,2021-11-24,2022-07-24,Chemotherapy,Public,Alive,24.0,EGFR,No,Current,None,37.8,Medium,Urban,NHS,19.0,No,No,Cardiovascular Disease,3.0
PT01127,Denmark,Zealand,,,Lung,III,2017-03-30,2017-09-03,2017-12-24,Surgery,Public,Alive,112.0,KRAS,No,Never,Moderate,,Low,Urban,Statutory Health Insurance,8.0,No,No,Hypertension,8.0
PT01128,Portugal,Porto,27.0,Female,Lung,II,2018-06-24,2018-12-16,2019-10-15,Chemotherapy,Research Institute,Alive,109.0,KRAS,No,Former,Moderate,20.4,Medium,Urban,NHS,19.0,No,No,Hypertension,7.0
PT01129,Switzerland,Geneva,70.0,Female,Ovarian,IV,2015-01-08,2015-05-30,2015-11-16,Surgery,Public,Alive,8.0,,No,Never,Moderate,24.9,High,Urban,Private Insurance,1.0,No,No,Hypertension,6.0
PT01130,Denmark,Capital Region,44.0,Female,Leukemia,I,2016-02-29,2016-08-26,2017-07-23,Surgery,Private,Deceased,,None,No,Never,Moderate,34.2,Low,Rural,NHS,19.0,No,,Hypertension,4.0
,,Zealand,66.0,Male,Leukemia,III,2019-12-14,2020-05-04,2020-10-20,Chemotherapy,Public,Alive,18.0,None,Yes,Never,Moderate,32.5,High,Urban,Private Insurance,11.0,No,No,Cardiovascular Disease,6.0
PT01132,Spain,Andalusia,74.0,Female,,,2014-02-07,,2015-03-26,Chemotherapy,Public,Alive,31.0,BRCA1,No,Never,Moderate,19.8,High,Rural,Statutory Health Insurance,11.0,No,No,Cardiovascular Disease,7.0
PT01133,Finland,Pirkanmaa,83.0,Male,Breast,I,2011-07-23,2011-12-06,2012-04-01,Surgery,Research Institute,Alive,25.0,KRAS,Yes,Current,None,19.3,Medium,Rural,Private Insurance,,No,No,Cardiovascular Disease,3.0
PT01134,Germany,Berlin,29.0,Female,Lung,II,2021-08-30,2021-11-15,2022-11-02,Immunotherapy,Public,Deceased,69.0,BRCA1,No,Never,None,27.1,Low,Urban,NHS,9.0,No,No,Obesity,
PT01135,Italy,Lombardy,75.0,Non-binary,Pancreatic,II,2023-10-05,2024-01-13,2024-11-18,Targeted Therapy,Public,Alive,28.0,None,No,Current,Moderate,28.9,Medium,Urban,Private Insurance,19.0,No,No,Obesity,5.0
PT01136,Netherlands,Utrecht,31.0,Female,Prostate,I,2013-07-16,2013-11-01,2014-07-29,Radiation,Public,,110.0,None,No,Former,Heavy,30.6,High,Rural,Private Insurance,9.0,No,No,Hypertension,8.0
PT01137,Denmark,Central Denmark,52.0,Non-binary,Breast,II,2021-09-15,2021-11-19,2022-04-09,Surgery,Public,Alive,116.0,None,No,Never,None,32.0,Medium,Urban,Private Insurance,15.0,Yes,No,Hypertension,6.0
PT01138,Switzerland,Zurich,36.0,Female,Lung,II,2017-03-30,2017-05-06,2018-04-01,Chemotherapy,Public,Alive,88.0,EGFR,No,Former,Moderate,28.6,,Urban,Private Insurance,6.0,No,Yes,None,7.0
PT01139,Denmark,Central Denmark,,Male,Pancreatic,I,,2011-05-03,2011-10-20,Surgery,,Deceased,36.0,BRCA1,No,Current,Moderate,33.8,Low,Urban,Statutory Health Insurance,11.0,No,No,Obesity,7.0
PT01140,Netherlands,South Holland,29.0,,Pancreatic,II,2019-12-01,,2020-10-25,Chemotherapy,Private,Alive,75.0,None,Yes,Former,None,20.6,Medium,Urban,Statutory Health Insurance,9.0,No,No,None,3.0
PT01141,Ireland,Dublin,50.0,Male,Leukemia,II,2011-06-16,2011-10-06,2012-05-26,Surgery,Public,Alive,104.0,BRCA1,Yes,Never,None,34.3,,Rural,Statutory Health Insurance,14.0,No,No,Cardiovascular Disease,8.0
PT01142,Ireland,Munster,79.0,Male,Pancreatic,I,2015-06-13,2015-07-15,2016-04-27,Chemotherapy,,Alive,56.0,BRCA1,No,Never,None,31.6,Medium,Urban,Statutory Health Insurance,4.0,Yes,No,Obesity,7.0
PT01143,Norway,Trøndelag,89.0,Female,Colorectal,I,2011-09-01,2011-11-25,2012-09-24,Immunotherapy,Private,Alive,11.0,KRAS,No,Never,Moderate,18.2,Medium,Urban,Private Insurance,3.0,No,No,,10.0
PT01144,Denmark,Capital Region,36.0,Male,Leukemia,III,2012-12-18,2013-05-25,2014-01-23,Targeted Therapy,Public,Lost to Follow-up,,None,No,,None,28.4,Medium,Rural,Private Insurance,12.0,No,,Obesity,4.0
PT01145,,Lombardy,69.0,Female,Leukemia,,2012-09-01,2013-01-27,2013-12-02,Chemotherapy,Public,Alive,22.0,None,Yes,Never,None,25.7,Low,Rural,Statutory Health Insurance,8.0,No,No,Cardiovascular Disease,5.0
PT01146,France,Auvergne-Rhône-Alpes,56.0,Male,Colorectal,IV,2012-09-01,2012-09-30,2013-05-06,Immunotherapy,Public,Alive,,BRCA1,Yes,Former,None,23.6,Medium,Urban,Private Insurance,11.0,No,No,Diabetes,5.0
PT01147,Norway,Trøndelag,81.0,Male,,I,2021-10-29,2022-03-30,2022-09-08,Targeted Therapy,Public,Alive,97.0,EGFR,Yes,Never,None,19.2,Medium,,NHS,10.0,No,No,Cardiovascular Disease,5.0
PT01148,Austria,Styria,48.0,Non-binary,Ovarian,I,2020-11-25,2021-04-03,2021-07-21,Chemotherapy,Public,Deceased,49.0,None,No,Former,Moderate,39.5,,Rural,Statutory Health Insurance,2.0,No,No,Hypertension,2.0
PT01149,Belgium,Flanders,51.0,Male,Leukemia,I,2021-09-24,2021-10-21,2022-02-28,Radiation,Research Institute,Alive,66.0,EGFR,No,Former,Moderate,24.2,Low,Urban,Statutory Health Insurance,5.0,No,No,Obesity,8.0
PT01150,Ireland,Dublin,30.0,Female,Breast,II,2021-05-17,2021-06-07,2021-09-08,Surgery,Public,Alive,100.0,BRCA1,No,Current,None,28.1,Low,Urban,NHS,19.0,,Yes,Hypertension,10.0
PT01151,Norway,Oslo,25.0,Female,Leukemia,III,2014-02-16,2014-07-11,,Surgery,Private,Deceased,113.0,EGFR,No,Former,None,20.1,Medium,Rural,NHS,4.0,No,Yes,Obesity,8.0
PT01152,Denmark,Zealand,54.0,Male,Colorectal,II,2023-06-22,2023-09-22,2024-02-21,Surgery,Private,Deceased,21.0,BRCA1,No,Never,,35.5,High,Urban,Statutory Health Insurance,,No,No,Obesity,6.0
PT01153,Belgium,Brussels,,Female,Lung,III,2022-04-29,2022-10-06,2023-02-21,Chemotherapy,Public,Alive,73.0,BRCA1,Yes,Former,None,,High,Urban,Statutory Health Insurance,14.0,Yes,No,Obesity,3.0
PT01154,Sweden,Västra Götaland,37.0,Male,Lung,III,,2012-02-25,,Radiation,Private,Alive,72.0,EGFR,No,Never,,31.0,Medium,Urban,Statutory Health Insurance,9.0,No,No,Diabetes,9.0
PT01155,Italy,Lombardy,56.0,Female,Lung,IV,2019-09-14,2020-01-06,2020-08-28,Radiation,Public,Lost to Follow-up,,None,No,Never,Moderate,24.1,Medium,Rural,Statutory Health Insurance,17.0,No,No,None,1.0
PT01156,Netherlands,South Holland,32.0,Female,Ovarian,I,2011-01-19,2011-04-27,2011-07-12,Radiation,Research Institute,Alive,12.0,KRAS,No,Current,,25.6,Medium,Urban,Private Insurance,15.0,No,No,None,3.0
PT01157,Sweden,Skåne,83.0,Male,Colorectal,I,2011-02-16,2011-03-10,2012-02-11,Targeted Therapy,Public,Alive,65.0,EGFR,Yes,Former,Moderate,29.5,Medium,Urban,Statutory Health Insurance,5.0,No,No,,2.0
PT01158,Portugal,Porto,20.0,Female,Colorectal,I,2019-03-31,2019-05-12,2019-09-17,Chemotherapy,Research Institute,Lost to Follow-up,,BRCA1,Yes,Never,None,28.3,Medium,,Statutory Health Insurance,16.0,No,Yes,Obesity,10.0
PT01159,Sweden,Skåne,82.0,Male,Breast,I,2017-08-07,2017-12-06,2018-11-29,Immunotherapy,Private,Alive,28.0,BRCA1,Yes,Current,Moderate,27.0,Medium,,Statutory Health Insurance,5.0,No,No,Diabetes,2.0
PT01160,Norway,Oslo,53.0,Female,Colorectal,IV,2016-04-02,2016-05-20,2017-02-07,Targeted Therapy,Public,Alive,73.0,None,Yes,Never,None,31.8,,Rural,NHS,6.0,No,No,None,1.0
PT01161,Belgium,Brussels,29.0,Female,Pancreatic,II,2011-10-25,2012-03-09,,Chemotherapy,Public,Deceased,25.0,None,No,Former,Moderate,30.1,Medium,Urban,NHS,16.0,No,No,Obesity,6.0
PT01162,Portugal,Lisbon,26.0,Female,Lung,II,2021-05-04,2021-09-11,2021-12-27,Radiation,Public,Alive,82.0,EGFR,No,Never,Heavy,25.3,High,Rural,Private Insurance,9.0,No,No,Diabetes,
PT01163,Italy,Lombardy,75.0,Female,Colorectal,II,2021-01-18,2021-05-31,2022-02-01,Chemotherapy,Public,Alive,77.0,EGFR,Yes,Never,Moderate,22.1,Medium,Urban,Private Insurance,18.0,Yes,No,Cardiovascular Disease,5.0
PT01164,Germany,Bavaria,56.0,Male,Prostate,I,2010-08-10,2010-09-07,2011-03-29,Radiation,Private,Alive,41.0,None,No,Never,Heavy,21.4,Low,Rural,Private Insurance,8.0,No,No,Diabetes,10.0
PT01165,Austria,Tyrol,48.0,Non-binary,Ovarian,I,2012-01-22,2012-06-02,2012-10-15,Immunotherapy,Public,,103.0,KRAS,,Former,None,18.8,Medium,Urban,Private Insurance,16.0,Yes,No,Hypertension,6.0
PT01166,Poland,Masovian,31.0,Male,Leukemia,II,2018-09-02,2018-10-25,2019-05-07,Radiation,Private,Alive,73.0,BRCA1,,Never,Moderate,27.8,Medium,Rural,NHS,18.0,,Yes,Diabetes,9.0
PT01167,Belgium,Wallonia,36.0,Female,Breast,III,2023-06-15,2023-09-23,2024-02-12,Targeted Therapy,Public,Deceased,31.0,EGFR,No,Never,None,21.8,High,Urban,Private Insurance,19.0,No,No,Obesity,9.0
PT01168,Norway,Vestland,67.0,Male,Lung,IV,2018-08-21,2018-12-28,2019-06-21,Chemotherapy,Public,Deceased,40.0,EGFR,No,Never,Moderate,37.4,Low,Urban,NHS,11.0,No,No,None,2.0
PT01169,Sweden,Stockholm,45.0,Non-binary,Pancreatic,II,2013-06-22,2013-09-09,2014-02-17,Surgery,Private,Alive,58.0,KRAS,Yes,Current,Moderate,27.3,Medium,Rural,NHS,16.0,Yes,Yes,Cardiovascular Disease,6.0
PT01170,Austria,Tyrol,31.0,Female,Pancreatic,II,2021-03-29,2021-08-10,2021-12-01,Radiation,Private,Alive,25.0,EGFR,Yes,,None,31.8,Medium,Rural,Statutory Health Insurance,7.0,No,No,None,9.0
PT01171,Belgium,Wallonia,,Female,Lung,I,2015-11-07,2016-02-03,2016-03-04,Radiation,Public,Deceased,15.0,None,Yes,Never,Moderate,24.9,Medium,Urban,Statutory Health Insurance,19.0,Yes,No,Diabetes,7.0
PT01172,,Flanders,,Male,,III,2016-07-01,2016-08-22,2017-05-31,Surgery,Public,Alive,75.0,KRAS,No,,None,23.7,High,Rural,Private Insurance,8.0,Yes,No,Hypertension,6.0
PT01173,Ireland,Connacht,80.0,Female,Prostate,I,2016-05-22,2016-08-07,2016-09-29,Targeted Therapy,Public,Deceased,99.0,EGFR,No,Current,Moderate,36.0,Medium,Urban,NHS,18.0,Yes,No,Hypertension,9.0
PT01174,Belgium,Flanders,77.0,Female,Breast,IV,2010-08-03,2010-08-27,2011-07-20,Immunotherapy,Public,Deceased,8.0,KRAS,Yes,Former,None,26.1,Low,Urban,Private Insurance,13.0,Yes,No,Hypertension,1.0
PT01175,Belgium,Wallonia,73.0,Female,Ovarian,II,2012-09-22,2012-12-24,2013-07-29,Immunotherapy,Private,Alive,89.0,BRCA1,Yes,Never,,20.1,Medium,Urban,Private Insurance,2.0,No,No,Diabetes,10.0
PT01176,Netherlands,North Holland,53.0,Male,Leukemia,I,2015-02-15,2015-07-17,2015-12-04,Targeted Therapy,Public,Alive,51.0,BRCA1,No,Current,None,25.1,Low,,NHS,18.0,No,No,Diabetes,8.0
PT01177,Portugal,Lisbon,26.0,Female,Breast,II,2018-10-16,2019-02-01,2019-03-26,Chemotherapy,Private,Alive,72.0,,No,Current,None,20.6,High,Urban,,11.0,No,No,Diabetes,6.0
PT01178,Sweden,Stockholm,54.0,Male,Breast,IV,2019-06-13,,2019-09-26,Immunotherapy,Public,Deceased,85.0,BRCA1,Yes,Never,None,28.2,Medium,Urban,NHS,16.0,No,No,Cardiovascular Disease,4.0
PT01179,Netherlands,Utrecht,34.0,Male,Ovarian,II,,2014-08-26,2014-12-02,Targeted Therapy,Public,Alive,9.0,BRCA1,,Former,Moderate,24.4,Medium,Urban,Statutory Health Insurance,4.0,No,,Obesity,9.0
PT01180,Germany,Bavaria,84.0,Male,Lung,I,2012-09-08,2012-09-23,2012-11-09,Radiation,Public,Deceased,111.0,EGFR,No,Current,Moderate,36.0,Medium,Urban,Private Insurance,3.0,Yes,No,None,5.0
,Poland,Lesser Poland,44.0,Male,Colorectal,I,2011-02-06,2011-03-29,2011-12-11,Surgery,Public,Deceased,,BRCA1,No,Current,,19.4,Medium,Rural,Statutory Health Insurance,1.0,Yes,No,Hypertension,6.0
PT01182,Germany,Berlin,78.0,Male,Leukemia,,2011-09-04,2012-01-09,2012-04-05,Chemotherapy,Private,Alive,44.0,KRAS,No,Current,None,39.7,,Urban,Statutory Health Insurance,10.0,No,No,,2.0
PT01183,Belgium,Brussels,25.0,Male,Breast,I,2023-06-26,2023-06-30,2024-01-08,,Private,Alive,22.0,KRAS,No,Current,None,35.5,Medium,Urban,Statutory Health Insurance,10.0,No,No,Hypertension,8.0
PT01184,Belgium,Wallonia,71.0,Male,Prostate,III,2012-06-24,2012-08-16,2013-01-24,Radiation,Public,Alive,117.0,BRCA1,Yes,Former,None,32.7,Medium,Urban,Statutory Health Insurance,11.0,Yes,No,Hypertension,
PT01185,Finland,Pirkanmaa,40.0,Female,Ovarian,IV,2022-03-11,2022-07-31,2023-04-05,Immunotherapy,Public,Deceased,34.0,,No,Current,None,19.2,High,Urban,NHS,7.0,No,No,Obesity,1.0
PT01186,,Île-de-France,51.0,Female,Lung,IV,2015-03-21,2015-08-29,2016-08-23,Chemotherapy,Private,,9.0,EGFR,Yes,Never,Moderate,39.6,Medium,Urban,Private Insurance,19.0,No,No,Obesity,1.0
PT01187,Germany,Bavaria,72.0,Male,Colorectal,,2021-12-09,2022-04-12,2023-02-19,Surgery,Public,Alive,79.0,EGFR,No,Never,Moderate,34.7,Low,Rural,Statutory Health Insurance,13.0,No,No,Obesity,6.0
PT01188,Italy,Sicily,78.0,Female,Colorectal,II,,2021-05-08,2021-10-23,Radiation,Private,Alive,112.0,KRAS,No,Never,Moderate,27.9,,Rural,,16.0,Yes,No,Hypertension,1.0
PT01189,Belgium,Flanders,88.0,Female,Lung,I,2013-01-11,2013-03-15,2013-04-16,Chemotherapy,Public,Alive,78.0,None,No,Former,Moderate,36.2,Medium,Urban,Statutory Health Insurance,1.0,,No,Diabetes,10.0
PT01190,Finland,Southwest Finland,81.0,Female,Breast,II,2010-08-16,2010-10-05,2011-07-20,Radiation,Public,Alive,80.0,BRCA1,Yes,Former,Moderate,25.4,High,Rural,NHS,8.0,No,Yes,Obesity,10.0
PT01191,Germany,North Rhine-Westphalia,23.0,Male,Ovarian,III,2015-06-12,2015-09-13,2016-07-19,Immunotherapy,Public,Alive,70.0,EGFR,Yes,,None,27.0,Medium,Urban,NHS,17.0,No,No,None,
PT01192,Austria,Tyrol,37.0,Male,Pancreatic,II,2015-12-19,2016-03-02,2017-02-26,Targeted Therapy,Private,Alive,100.0,EGFR,No,Never,Moderate,32.8,Low,Urban,Statutory Health Insurance,3.0,No,No,Cardiovascular Disease,7.0
PT01193,Spain,Catalonia,75.0,Non-binary,Lung,IV,2020-12-21,2021-06-03,2021-07-14,Radiation,Private,,22.0,BRCA1,No,Former,None,38.3,High,,Statutory Health Insurance,4.0,No,No,Obesity,
PT01194,Spain,Catalonia,43.0,Male,Pancreatic,III,2022-09-15,2022-12-10,2023-03-02,Immunotherapy,Public,Deceased,,None,,Never,Moderate,,High,Urban,Private Insurance,7.0,No,Yes,Cardiovascular Disease,5.0
PT01195,Sweden,Stockholm,85.0,Male,Colorectal,I,2010-09-01,2010-12-07,2011-09-16,Chemotherapy,Public,Alive,69.0,None,No,Never,Moderate,23.2,Medium,Urban,Private Insurance,12.0,No,No,Obesity,6.0
PT01196,,Zurich,32.0,Male,Colorectal,III,2013-06-03,2013-09-11,2014-01-14,Chemotherapy,Private,Deceased,105.0,None,Yes,Never,Moderate,32.1,Medium,Urban,,12.0,No,,None,4.0
PT01197,Austria,Styria,81.0,Male,Prostate,I,2011-03-20,2011-09-14,2012-06-01,Immunotherapy,Public,Deceased,52.0,BRCA1,Yes,Former,Moderate,37.5,,Rural,Statutory Health Insurance,6.0,Yes,No,Diabetes,9.0
PT01198,Norway,Vestland,73.0,,Prostate,II,2011-09-07,2012-02-23,2012-12-14,Chemotherapy,Private,Alive,,None,Yes,Current,Moderate,20.3,High,Urban,NHS,15.0,No,No,Diabetes,2.0
PT01199,Belgium,Brussels,34.0,Male,Colorectal,I,2020-05-08,2020-08-14,2021-01-02,Chemotherapy,Public,Alive,76.0,EGFR,Yes,Never,Heavy,22.1,Medium,Rural,Statutory Health Insurance,1.0,No,Yes,Hypertension,
PT01200,,Tyrol,88.0,Female,,IV,2012-04-04,2012-09-06,2012-11-21,Chemotherapy,Private,Alive,31.0,BRCA1,No,Former,Moderate,35.3,Medium,,Private Insurance,13.0,,No,Cardiovascular Disease,8.0
PT01201,Italy,Lombardy,22.0,Non-binary,Prostate,II,2019-09-03,2019-10-03,2020-05-01,Immunotherapy,Public,Deceased,29.0,KRAS,No,Never,Moderate,30.4,Medium,Rural,NHS,9.0,Yes,No,Hypertension,9.0
PT01202,Belgium,Flanders,56.0,Female,Prostate,III,2012-07-24,2012-12-31,2013-09-21,Immunotherapy,Public,Deceased,38.0,EGFR,Yes,Current,None,19.2,Low,Urban,Private Insurance,1.0,No,No,Diabetes,
PT01203,Italy,Sicily,56.0,Male,Colorectal,III,2014-10-11,2014-11-02,2015-08-12,Radiation,Public,Alive,95.0,BRCA1,No,Current,Moderate,29.8,Low,Urban,Statutory Health Insurance,18.0,No,Yes,Hypertension,2.0
PT01204,Germany,Bavaria,22.0,Male,Breast,III,2022-04-05,2022-06-13,2022-07-19,Surgery,Private,Alive,34.0,BRCA1,Yes,Never,Moderate,38.3,Medium,Rural,Private Insurance,7.0,No,No,None,1.0
PT01205,Germany,North Rhine-Westphalia,82.0,Female,Breast,III,2017-05-10,2017-10-06,2018-08-19,Targeted Therapy,Public,Alive,93.0,EGFR,No,Current,Moderate,22.0,Low,Urban,Statutory Health Insurance,17.0,No,No,Hypertension,10.0
PT01206,Norway,Trøndelag,54.0,Male,Ovarian,I,2011-06-06,,2012-06-04,Chemotherapy,Research Institute,Alive,51.0,BRCA1,Yes,Never,None,19.5,Low,Urban,Private Insurance,15.0,Yes,No,Obesity,4.0
PT01207,Norway,Vestland,71.0,Female,Leukemia,III,2023-07-09,2023-10-01,2024-08-31,Surgery,Public,Alive,81.0,BRCA1,No,Never,Moderate,38.8,High,Rural,Statutory Health Insurance,19.0,No,Yes,Obesity,3.0
PT01208,Italy,Sicily,47.0,Male,Prostate,II,,,2016-03-09,,Private,Alive,97.0,BRCA1,Yes,,Moderate,26.4,Medium,Urban,NHS,6.0,No,No,Obesity,5.0
PT01209,Finland,Uusimaa,37.0,Female,Breast,II,2021-01-15,2021-04-26,2021-06-19,Immunotherapy,Private,Alive,31.0,EGFR,Yes,Never,None,35.1,Medium,Urban,NHS,18.0,Yes,No,None,8.0
PT01210,Germany,North Rhine-Westphalia,55.0,Female,Leukemia,I,2016-01-15,2016-04-19,2016-05-24,Immunotherapy,Public,Alive,,KRAS,Yes,Current,Moderate,31.3,Medium,Rural,NHS,4.0,No,No,,8.0
PT01211,Austria,Styria,52.0,Female,Lung,I,2011-07-01,2011-12-19,2012-06-08,Surgery,Private,Alive,30.0,BRCA1,Yes,Never,Heavy,22.1,High,,Private Insurance,11.0,Yes,No,Diabetes,7.0
PT01212,Belgium,Brussels,83.0,,Prostate,IV,2016-12-28,2017-05-23,2017-12-29,Immunotherapy,Research Institute,Alive,20.0,EGFR,No,Current,Moderate,22.4,Low,Urban,NHS,10.0,Yes,No,Obesity,8.0
PT01213,Italy,Sicily,45.0,Male,Breast,I,2017-11-08,2017-12-07,2018-06-02,Radiation,Public,Deceased,112.0,EGFR,No,Current,Moderate,34.3,Medium,Rural,Private Insurance,1.0,Yes,No,Cardiovascular Disease,6.0
PT01214,Switzerland,Zurich,67.0,Male,Breast,II,,2010-10-18,2011-05-06,Radiation,Private,Alive,100.0,None,Yes,Never,Moderate,32.0,Medium,Urban,Private Insurance,18.0,Yes,No,Diabetes,2.0
PT01215,Switzerland,Geneva,59.0,Male,Pancreatic,I,2015-09-01,2015-10-22,2016-02-24,Targeted Therapy,Private,Alive,39.0,KRAS,Yes,Former,Moderate,18.3,Medium,Rural,Private Insurance,17.0,No,No,Diabetes,5.0
PT01216,Austria,Tyrol,36.0,,Breast,I,2023-07-15,2023-09-29,2024-05-10,Targeted Therapy,Public,Alive,56.0,None,Yes,Never,Moderate,28.9,Medium,Urban,Private Insurance,2.0,No,No,Obesity,8.0
PT01217,Norway,Trøndelag,,Female,Pancreatic,I,2018-01-14,2018-01-26,2018-11-11,,Public,Deceased,110.0,BRCA1,No,Former,Moderate,38.2,Low,Urban,NHS,7.0,Yes,No,Cardiovascular Disease,2.0
PT01218,Poland,Lesser Poland,26.0,Male,Leukemia,II,,2010-04-20,2011-01-10,Chemotherapy,Public,Deceased,77.0,None,No,Never,Moderate,29.7,Medium,Urban,Statutory Health Insurance,19.0,No,No,None,9.0
PT01219,Austria,Tyrol,76.0,Male,Pancreatic,IV,2017-05-30,2017-08-09,2017-09-13,Radiation,Public,Alive,32.0,EGFR,Yes,Former,Moderate,18.6,Medium,Urban,NHS,2.0,No,Yes,Hypertension,6.0
PT01220,,Dublin,27.0,Non-binary,Lung,II,2017-09-10,2018-02-01,2018-04-30,,Public,Alive,9.0,BRCA1,Yes,Former,Moderate,28.8,Low,Rural,Private Insurance,,No,No,Diabetes,5.0
PT01221,Netherlands,,75.0,Male,Ovarian,II,2021-11-29,2022-04-06,2023-01-09,Radiation,Research Institute,Deceased,81.0,None,No,Never,Moderate,19.0,High,Urban,Statutory Health Insurance,,No,No,Diabetes,3.0
PT01222,France,Île-de-France,50.0,Female,Prostate,II,2018-12-04,2018-12-16,2019-03-07,,Public,Alive,100.0,None,No,Former,None,,Low,Rural,Private Insurance,7.0,No,No,Cardiovascular Disease,6.0
PT01223,Finland,Uusimaa,78.0,Male,Breast,II,2010-11-24,2011-01-25,2011-11-25,Chemotherapy,,Alive,90.0,BRCA1,,Current,Moderate,34.2,Medium,Urban,NHS,8.0,No,No,Obesity,
PT01224,Sweden,Västra Götaland,77.0,Male,Ovarian,IV,2019-06-14,2019-09-28,2020-02-26,Targeted Therapy,Public,Alive,25.0,EGFR,Yes,Never,Moderate,20.9,Low,Urban,Private Insurance,16.0,No,Yes,Cardiovascular Disease,9.0
,Poland,Lesser Poland,31.0,Female,Colorectal,II,2015-06-21,2015-08-20,2015-10-14,Radiation,Public,Deceased,53.0,None,,Current,None,25.5,,,Private Insurance,17.0,No,No,Obesity,9.0
PT01226,Austria,Vienna,67.0,Female,Prostate,II,2010-12-12,2011-03-03,2012-01-30,Targeted Therapy,Public,Alive,58.0,KRAS,Yes,Former,None,22.4,Medium,Rural,Statutory Health Insurance,3.0,Yes,No,None,9.0
PT01227,Netherlands,Utrecht,50.0,Male,Colorectal,II,2016-06-12,2016-07-10,2017-03-13,Immunotherapy,Private,Alive,68.0,EGFR,No,Never,Moderate,26.7,Medium,Urban,Private Insurance,1.0,Yes,Yes,Obesity,2.0
PT01228,Italy,Lombardy,82.0,Male,Ovarian,III,2021-09-11,2021-11-14,2022-06-14,Radiation,Private,Alive,22.0,BRCA1,Yes,Never,None,,Medium,Urban,Statutory Health Insurance,3.0,No,No,Diabetes,5.0
PT01229,Spain,Catalonia,58.0,Male,Leukemia,II,2011-06-28,2011-10-01,2012-01-27,Radiation,Public,Alive,,None,No,Never,Heavy,24.0,High,Urban,Private Insurance,3.0,No,No,None,1.0
PT01230,Italy,Lombardy,39.0,Male,,I,2016-07-10,2016-09-20,2016-11-26,,Public,Lost to Follow-up,,KRAS,Yes,Never,,21.0,Medium,Urban,NHS,16.0,No,No,None,6.0
PT01231,Austria,Styria,67.0,Male,Prostate,I,2019-06-13,2019-10-01,2020-01-22,Targeted Therapy,Private,Alive,,EGFR,Yes,Never,Moderate,27.1,Medium,Urban,Statutory Health Insurance,17.0,Yes,No,Diabetes,5.0
PT01232,Norway,Vestland,73.0,Female,Prostate,IV,2020-02-23,2020-08-19,2021-01-03,Targeted Therapy,Public,Deceased,84.0,BRCA1,Yes,Former,Moderate,28.4,Low,,Private Insurance,4.0,,No,,4.0
PT01233,Sweden,Västra Götaland,48.0,Male,Breast,,2017-07-11,2017-08-06,2018-02-14,Radiation,Research Institute,Deceased,37.0,BRCA1,No,Former,Moderate,30.9,Low,Rural,NHS,5.0,No,Yes,None,5.0
PT01234,Sweden,Stockholm,67.0,Male,Ovarian,I,2013-09-18,2014-03-05,2014-10-17,Surgery,Public,Alive,117.0,EGFR,No,Never,Moderate,34.6,,Rural,Statutory Health Insurance,16.0,No,No,Cardiovascular Disease,2.0
PT01235,Sweden,Stockholm,75.0,Female,Lung,III,2014-12-12,2015-04-01,2016-01-08,Immunotherapy,Private,Alive,119.0,KRAS,No,Former,Moderate,20.3,Low,Urban,NHS,16.0,No,No,Cardiovascular Disease,7.0
PT01236,Switzerland,Bern,36.0,Male,Leukemia,II,2013-09-28,2014-01-18,2014-10-01,Targeted Therapy,Private,Alive,71.0,EGFR,Yes,Never,None,37.1,Medium,Rural,Statutory Health Insurance,4.0,No,No,Obesity,7.0
PT01237,Belgium,Flanders,28.0,Male,Breast,II,2017-10-24,2018-04-01,2018-05-03,Surgery,Public,Alive,97.0,BRCA1,No,Never,Moderate,33.4,Low,Urban,NHS,11.0,No,No,Diabetes,2.0
PT01238,Netherlands,Utrecht,53.0,Non-binary,Pancreatic,I,2010-07-05,2010-11-08,2011-09-30,Targeted Therapy,Private,Alive,90.0,BRCA1,No,Never,Moderate,20.4,Low,Urban,Statutory Health Insurance,8.0,No,,Obesity,8.0
PT01239,Germany,Berlin,64.0,Male,Prostate,III,2021-07-07,2021-09-16,2022-03-24,Radiation,Private,Alive,55.0,EGFR,Yes,Former,Moderate,26.3,Medium,Urban,Private Insurance,18.0,No,No,Cardiovascular Disease,1.0
PT01240,Germany,Bavaria,28.0,Female,Lung,I,2012-02-06,2012-05-29,2013-04-15,Surgery,Public,Deceased,18.0,None,No,Current,None,26.3,Low,Urban,Private Insurance,15.0,No,No,Obesity,2.0
PT01241,,Provence-Alpes-Côte d'Azur,26.0,Male,Prostate,III,2010-02-04,2010-02-09,2010-04-09,Radiation,Research Institute,Deceased,102.0,,Yes,Current,None,33.5,Medium,Urban,NHS,19.0,No,No,Obesity,3.0
PT01242,Sweden,Skåne,35.0,Male,Colorectal,I,2020-09-20,2021-02-08,2021-07-03,Chemotherapy,Private,Alive,32.0,KRAS,No,Current,Moderate,21.3,Medium,Urban,Private Insurance,,No,No,Obesity,10.0
PT01243,Spain,Andalusia,38.0,Male,Prostate,III,2014-07-04,2014-11-27,2015-06-11,Targeted Therapy,Public,Alive,31.0,BRCA1,No,Never,None,19.4,Low,Urban,Private Insurance,,No,No,Obesity,10.0
PT01244,,Algarve,25.0,Male,Leukemia,I,2019-10-26,2020-01-16,2020-05-17,Immunotherapy,Public,Alive,58.0,None,No,Never,Moderate,18.6,Medium,Urban,Private Insurance,14.0,No,No,Cardiovascular Disease,2.0
PT01245,,Berlin,,Male,Breast,I,2012-03-08,2012-07-05,2013-03-09,Surgery,Public,Deceased,39.0,BRCA1,No,Never,None,37.1,High,Urban,Private Insurance,4.0,No,No,Obesity,10.0
,Germany,North Rhine-Westphalia,80.0,Male,Prostate,I,2021-03-29,2021-05-18,2021-10-03,Chemotherapy,,Alive,87.0,EGFR,Yes,Never,Moderate,31.6,High,Urban,NHS,9.0,No,,Obesity,10.0
PT01247,Norway,Vestland,61.0,Female,Pancreatic,I,2020-01-05,2020-05-12,2020-09-07,Targeted Therapy,Public,Alive,118.0,BRCA1,No,Never,Moderate,18.5,Low,,Statutory Health Insurance,1.0,No,No,Obesity,4.0
PT01248,Spain,Madrid,32.0,Female,Colorectal,II,2014-07-18,2014-10-10,2015-05-15,Chemotherapy,Research Institute,Alive,79.0,None,No,,Moderate,,Medium,Urban,Statutory Health Insurance,12.0,,No,Diabetes,10.0
PT01249,Sweden,Skåne,31.0,Male,Colorectal,I,2010-02-07,2010-05-31,2010-12-30,Surgery,Private,Alive,88.0,BRCA1,Yes,Never,None,20.4,Medium,Rural,NHS,18.0,No,Yes,Cardiovascular Disease,3.0
PT01250,France,Provence-Alpes-Côte d'Azur,39.0,Female,Breast,IV,2015-06-02,2015-11-13,2016-07-09,Immunotherapy,Private,Deceased,119.0,EGFR,No,Never,Heavy,34.5,Low,,Statutory Health Insurance,18.0,No,No,Diabetes,1.0
PT01251,Finland,Uusimaa,69.0,Female,Colorectal,II,2012-06-05,2012-09-26,,Surgery,Public,Alive,62.0,,No,Never,Moderate,36.8,Low,Urban,Statutory Health Insurance,9.0,No,No,Hypertension,4.0
PT01252,Finland,Pirkanmaa,55.0,Female,Ovarian,II,2017-06-22,2017-10-15,2018-08-22,Immunotherapy,Public,Alive,17.0,BRCA1,No,Never,None,32.3,,Rural,Private Insurance,1.0,No,No,Diabetes,6.0
PT01253,Belgium,,88.0,Male,Breast,I,,2019-09-29,2020-04-29,Radiation,Public,Alive,93.0,KRAS,Yes,Former,Moderate,19.6,Medium,Rural,Private Insurance,,No,Yes,Cardiovascular Disease,4.0
PT01254,Italy,Veneto,56.0,Female,Leukemia,II,2022-10-19,2022-11-21,2023-05-06,Targeted Therapy,Private,Deceased,70.0,EGFR,Yes,Current,Heavy,30.5,High,Urban,NHS,17.0,No,No,Cardiovascular Disease,9.0
PT01255,Switzerland,Zurich,31.0,Male,Breast,I,2019-03-15,2019-05-23,2020-04-04,Chemotherapy,Public,Alive,14.0,EGFR,No,Current,Heavy,28.0,Medium,Rural,Statutory Health Insurance,8.0,No,Yes,Obesity,8.0
PT01256,Ireland,Munster,59.0,Male,Lung,III,2017-04-17,2017-07-22,,Radiation,Public,Alive,98.0,None,Yes,Current,Moderate,34.7,Low,Rural,NHS,12.0,No,No,Hypertension,5.0
PT01257,Switzerland,Geneva,73.0,Female,Colorectal,II,2021-08-07,2022-01-12,2022-05-28,Targeted Therapy,Private,Deceased,50.0,KRAS,No,Never,Moderate,23.9,Medium,Urban,NHS,16.0,No,No,Cardiovascular Disease,7.0
,Norway,Oslo,21.0,Female,Colorectal,III,2021-10-08,2022-01-12,2022-05-09,Chemotherapy,Private,Alive,97.0,BRCA1,Yes,Never,None,33.3,Medium,Rural,Statutory Health Insurance,5.0,No,Yes,Cardiovascular Disease,
PT01259,Ireland,Munster,69.0,Female,Pancreatic,,2019-07-08,2019-09-14,2020-02-15,Radiation,Private,Alive,104.0,BRCA1,Yes,Never,None,22.5,High,Rural,Statutory Health Insurance,,No,No,Obesity,1.0
PT01260,Norway,Trøndelag,60.0,Female,Prostate,IV,2017-10-20,2017-11-11,2018-06-25,Targeted Therapy,Public,Deceased,87.0,None,Yes,Never,None,33.6,Medium,Urban,Private Insurance,3.0,No,No,,9.0
PT01261,Netherlands,South Holland,64.0,Male,Lung,I,2019-04-01,2019-05-30,2019-10-16,Targeted Therapy,Public,Deceased,110.0,KRAS,Yes,Former,Moderate,23.8,Low,Rural,Statutory Health Insurance,4.0,No,No,Cardiovascular Disease,10.0
PT01262,Spain,Catalonia,28.0,Female,Ovarian,I,,2023-10-29,2024-10-10,Radiation,Public,Alive,49.0,KRAS,No,Never,Moderate,39.7,Medium,Urban,Statutory Health Insurance,,No,,,9.0
,,Wallonia,81.0,Male,Prostate,II,2015-12-25,2016-01-31,2016-04-17,Surgery,Research Institute,Deceased,53.0,KRAS,Yes,Former,None,38.4,High,Urban,NHS,,No,No,None,8.0
PT01264,Norway,Vestland,66.0,Male,Breast,IV,2023-05-03,2023-08-10,2024-07-26,Immunotherapy,Public,Alive,117.0,EGFR,No,Former,,29.2,Medium,Urban,Statutory Health Insurance,5.0,No,No,,3.0
PT01265,Austria,Tyrol,24.0,,Leukemia,III,2023-09-10,2023-11-05,2024-06-11,Immunotherapy,Private,,24.0,None,No,Current,Moderate,33.4,Low,Rural,Statutory Health Insurance,1.0,No,Yes,Cardiovascular Disease,9.0
PT01266,Netherlands,South Holland,20.0,Male,Pancreatic,I,2022-11-27,2023-02-21,2023-07-11,Surgery,Public,Alive,91.0,EGFR,Yes,Former,Moderate,35.9,High,Urban,Statutory Health Insurance,14.0,Yes,No,None,6.0
PT01267,Netherlands,South Holland,63.0,,Colorectal,II,2023-09-27,2023-12-01,2024-08-08,Targeted Therapy,Private,Lost to Follow-up,,EGFR,No,Current,None,33.0,Medium,Urban,NHS,7.0,No,No,Cardiovascular Disease,2.0
PT01268,Poland,Lesser Poland,41.0,Male,,IV,2017-04-26,2017-08-07,2017-11-13,Chemotherapy,Public,Alive,87.0,None,No,Never,Moderate,35.9,Medium,Urban,Private Insurance,14.0,No,No,Obesity,7.0
PT01269,Italy,Veneto,57.0,Female,Ovarian,I,,2013-08-02,2014-03-03,Surgery,Public,Lost to Follow-up,,KRAS,,Never,None,24.8,Low,Urban,,15.0,No,No,Hypertension,2.0
PT01270,,Lisbon,38.0,Male,Leukemia,I,2021-08-04,2021-11-24,2022-11-18,Targeted Therapy,Public,,106.0,,No,Former,Heavy,20.7,Medium,Urban,Private Insurance,10.0,No,No,Cardiovascular Disease,10.0
,Germany,Berlin,50.0,Male,Breast,III,2016-09-28,2017-01-03,2017-07-15,Radiation,Public,Alive,59.0,BRCA1,No,Never,None,20.7,,Urban,Private Insurance,3.0,No,No,None,10.0
PT01272,Ireland,Connacht,86.0,Female,Breast,IV,2018-11-07,2019-05-03,2020-03-19,Radiation,Public,Alive,81.0,KRAS,No,Former,None,32.2,High,Urban,,10.0,No,No,None,5.0
PT01273,Denmark,Capital Region,61.0,,Lung,III,2017-04-21,2017-06-28,2017-08-03,Targeted Therapy,Public,Deceased,,BRCA1,No,Current,None,28.3,,Rural,NHS,11.0,No,Yes,Hypertension,9.0
PT01274,Finland,Southwest Finland,,Female,,IV,2010-09-05,2011-01-20,2011-09-27,Radiation,Public,Alive,41.0,EGFR,No,Former,Moderate,36.0,Medium,,Private Insurance,8.0,No,No,None,10.0
PT01275,Italy,Veneto,32.0,Female,Colorectal,I,2011-06-10,2011-10-24,2012-06-28,Immunotherapy,Public,Alive,20.0,None,No,Never,None,19.3,High,,NHS,18.0,No,No,Hypertension,1.0
PT01276,Norway,Oslo,77.0,Female,Ovarian,II,2021-10-30,2021-12-27,2022-03-24,Surgery,Public,,14.0,BRCA1,,Former,Moderate,30.0,High,Urban,Private Insurance,10.0,No,No,Hypertension,9.0
PT01277,Ireland,Dublin,37.0,Female,Colorectal,III,2013-02-18,2013-06-04,2014-04-05,Immunotherapy,Public,Alive,14.0,,No,Never,None,21.5,Medium,Urban,Statutory Health Insurance,,No,Yes,Cardiovascular Disease,6.0
PT01278,France,Île-de-France,86.0,Male,Ovarian,III,2023-03-24,2023-05-17,2023-08-05,Targeted Therapy,Public,Alive,51.0,None,,Never,None,33.5,High,Rural,NHS,17.0,No,No,None,6.0
PT01279,Denmark,Zealand,22.0,Female,Leukemia,III,2023-03-10,2023-06-03,2024-02-02,Surgery,Private,Alive,117.0,None,No,Current,None,,High,Urban,Statutory Health Insurance,19.0,,No,Cardiovascular Disease,4.0
PT01280,Belgium,Flanders,74.0,Male,Lung,IV,2011-04-08,2011-05-26,2011-12-02,Radiation,Public,Alive,110.0,None,Yes,Never,None,23.2,Medium,Urban,Statutory Health Insurance,,No,No,Hypertension,9.0
PT01281,Ireland,Connacht,77.0,Male,Pancreatic,II,2018-02-11,2018-05-27,2018-06-26,Surgery,Public,Alive,36.0,KRAS,Yes,Current,Heavy,18.2,High,Urban,NHS,19.0,No,No,None,9.0
PT01282,Switzerland,Zurich,82.0,Male,Breast,I,2021-04-09,2021-09-12,2021-12-17,Surgery,Research Institute,Alive,60.0,None,No,Never,None,29.3,Medium,Rural,Statutory Health Insurance,15.0,Yes,,Obesity,3.0
PT01283,Norway,Vestland,71.0,,Lung,II,2015-06-02,2015-09-11,2015-11-29,Radiation,Public,Alive,75.0,None,Yes,Never,Heavy,31.3,Medium,Urban,Private Insurance,,No,No,None,6.0
PT01284,Finland,Uusimaa,43.0,Female,Colorectal,III,2019-04-24,2019-08-12,2019-10-15,Chemotherapy,Public,Lost to Follow-up,,EGFR,No,Never,Moderate,33.4,Low,Urban,Private Insurance,1.0,Yes,No,Cardiovascular Disease,4.0
,Spain,Andalusia,28.0,Female,Pancreatic,I,2022-06-10,,2023-03-10,Radiation,Private,Alive,115.0,None,No,Current,None,39.7,High,Rural,Statutory Health Insurance,7.0,No,No,Hypertension,8.0
PT01286,France,Auvergne-Rhône-Alpes,56.0,Female,Prostate,III,2015-05-18,2015-09-23,2016-09-01,Immunotherapy,Public,Deceased,63.0,BRCA1,Yes,Never,None,30.4,Medium,Rural,Private Insurance,17.0,No,No,None,4.0
PT01287,Netherlands,Utrecht,72.0,Female,Leukemia,I,2021-11-29,2022-05-07,2023-05-04,Chemotherapy,Public,Alive,119.0,BRCA1,No,Never,None,32.4,Low,Urban,,10.0,No,Yes,None,3.0
PT01288,Sweden,Västra Götaland,43.0,Female,Breast,I,2013-03-31,2013-08-19,2013-12-23,Immunotherapy,Private,Alive,108.0,BRCA1,Yes,Never,Moderate,31.0,Medium,Urban,Statutory Health Insurance,,Yes,No,Hypertension,2.0
PT01289,Portugal,Algarve,40.0,Male,Breast,II,2010-10-30,2010-12-28,2011-02-08,Targeted Therapy,Research Institute,Deceased,20.0,BRCA1,Yes,Former,Moderate,33.1,Medium,Urban,NHS,18.0,No,No,Diabetes,1.0
PT01290,Switzerland,Bern,59.0,Female,Breast,III,2012-02-16,2012-05-08,2013-03-11,Immunotherapy,Public,Deceased,45.0,EGFR,Yes,Former,,38.3,Medium,Urban,Statutory Health Insurance,14.0,No,No,Diabetes,5.0
PT01291,Portugal,Porto,81.0,Female,Prostate,II,2018-12-04,2019-05-12,2019-08-05,Surgery,Public,Alive,15.0,,No,Never,None,39.2,Low,Urban,Private Insurance,13.0,No,No,Diabetes,7.0
PT01292,Finland,Pirkanmaa,89.0,Male,Colorectal,III,2011-09-16,2011-10-19,2012-02-06,Targeted Therapy,Public,Alive,6.0,None,Yes,Former,Heavy,30.8,Medium,Urban,NHS,8.0,No,No,None,10.0
PT01293,Switzerland,Zurich,88.0,Female,Colorectal,II,2020-07-23,2020-11-18,2021-07-07,Chemotherapy,Public,Alive,77.0,KRAS,No,Never,Moderate,30.9,Medium,Urban,Private Insurance,17.0,No,No,None,6.0
PT01294,Netherlands,South Holland,33.0,Male,Lung,I,2013-12-30,2014-02-21,2014-11-28,Immunotherapy,Public,Alive,29.0,None,No,Never,None,36.3,Medium,Urban,Private Insurance,2.0,No,No,Diabetes,8.0
PT01295,Finland,Uusimaa,61.0,Female,Pancreatic,I,2019-04-10,2019-07-14,2020-03-18,Targeted Therapy,Public,Deceased,90.0,None,No,Current,Moderate,18.3,Medium,Urban,Private Insurance,,No,No,None,9.0
PT01296,Denmark,Capital Region,69.0,Female,Ovarian,III,2023-01-28,2023-05-30,2023-07-13,Immunotherapy,Public,Deceased,69.0,EGFR,No,Current,Moderate,22.2,Medium,Urban,Private Insurance,19.0,No,No,Diabetes,8.0
PT01297,Finland,Pirkanmaa,,Female,,II,,2011-07-25,,Surgery,Private,Alive,53.0,KRAS,No,Current,Moderate,21.9,Medium,Urban,NHS,15.0,Yes,No,None,3.0
PT01298,Spain,,23.0,Female,Colorectal,IV,2021-08-01,2021-11-30,2022-10-23,Surgery,Public,Alive,105.0,None,No,Never,None,19.6,Low,Rural,NHS,17.0,No,No,None,5.0
PT01299,Norway,Vestland,36.0,Female,Breast,II,2012-11-27,2013-01-02,2013-06-04,Chemotherapy,Public,,99.0,KRAS,No,Former,Moderate,25.9,Medium,Urban,,2.0,No,Yes,Hypertension,10.0
PT01300,,Algarve,76.0,Female,Prostate,II,2010-10-15,2011-02-15,2011-05-26,Radiation,Private,Deceased,55.0,None,,Current,None,34.5,Medium,Urban,Private Insurance,17.0,No,No,Cardiovascular Disease,3.0
PT01301,Norway,Oslo,67.0,Male,Colorectal,II,2019-12-19,2020-01-22,2020-08-23,Radiation,Public,Alive,8.0,EGFR,Yes,Former,None,31.1,High,Urban,NHS,11.0,No,No,Cardiovascular Disease,1.0
PT01302,Sweden,Västra Götaland,63.0,Male,Prostate,I,2013-02-17,2013-06-18,2014-01-25,Surgery,Private,Alive,75.0,KRAS,No,Never,None,23.9,Low,Urban,Private Insurance,17.0,No,No,Diabetes,6.0
PT01303,Denmark,Central Denmark,64.0,Female,Leukemia,II,2013-11-24,2014-01-24,2015-01-16,Targeted Therapy,Public,Alive,107.0,None,Yes,Former,None,37.6,Medium,Rural,Private Insurance,1.0,No,No,Hypertension,8.0
,Austria,Vienna,52.0,Female,Breast,II,2023-09-14,2023-09-17,2023-12-15,Chemotherapy,Public,Alive,69.0,EGFR,No,Former,Moderate,24.9,Low,Rural,Private Insurance,10.0,Yes,No,Diabetes,7.0
PT01305,France,Auvergne-Rhône-Alpes,50.0,Female,Leukemia,III,2011-10-20,2011-10-26,2011-12-25,Immunotherapy,,Alive,30.0,BRCA1,Yes,Former,Moderate,29.5,Medium,Rural,NHS,6.0,No,No,Obesity,3.0
PT01306,Denmark,Central Denmark,66.0,Male,Colorectal,I,2018-06-13,2018-11-08,2019-01-31,Immunotherapy,Public,Alive,61.0,KRAS,No,Never,None,18.9,Medium,Urban,Private Insurance,11.0,Yes,Yes,Diabetes,2.0
PT01307,Portugal,Lisbon,25.0,Female,Lung,I,2014-10-06,2014-10-10,2015-04-19,Targeted Therapy,Public,Alive,46.0,None,No,Former,Moderate,36.5,Low,Urban,Statutory Health Insurance,10.0,No,Yes,Hypertension,4.0
PT01308,Switzerland,Zurich,53.0,,Colorectal,I,2016-11-21,2017-03-02,2017-11-11,Radiation,Private,Alive,64.0,EGFR,No,,None,39.5,,Rural,Private Insurance,16.0,No,No,Cardiovascular Disease,8.0
PT01309,Spain,Madrid,72.0,Male,Leukemia,I,2023-08-29,2023-10-21,2024-03-30,Surgery,Public,Alive,38.0,BRCA1,Yes,Never,None,37.6,High,Urban,Statutory Health Insurance,15.0,No,No,Obesity,4.0
PT01310,Ireland,Connacht,33.0,Female,Prostate,II,2016-01-11,,2016-09-01,Surgery,Public,Alive,80.0,KRAS,No,Never,Moderate,27.0,Medium,Urban,Private Insurance,16.0,No,No,Obesity,7.0
PT01311,Italy,Lombardy,35.0,Female,Pancreatic,IV,2011-11-10,2012-01-20,2012-09-29,Chemotherapy,Research Institute,Deceased,17.0,,No,Current,Heavy,21.5,Low,Urban,Private Insurance,6.0,No,No,Hypertension,4.0
PT01312,Spain,Catalonia,62.0,Female,,III,2019-06-20,2019-12-03,2020-08-19,Surgery,Private,Alive,111.0,,Yes,,None,24.7,High,Urban,,11.0,No,,None,3.0
PT01313,Ireland,Connacht,31.0,Non-binary,Colorectal,III,2017-07-07,2017-12-18,2018-03-16,Radiation,Public,Deceased,113.0,None,No,,Moderate,38.2,Low,Urban,NHS,19.0,No,No,None,8.0
PT01314,Netherlands,South Holland,89.0,Male,Ovarian,II,2016-06-11,2016-07-15,2017-06-06,Radiation,Public,Deceased,6.0,BRCA1,No,Current,,39.4,Low,Urban,Statutory Health Insurance,8.0,No,No,Hypertension,
PT01315,Denmark,Zealand,38.0,Female,,I,2014-07-07,2014-07-13,2015-03-17,Targeted Therapy,Public,Deceased,73.0,BRCA1,Yes,Never,Moderate,19.3,Medium,Urban,Private Insurance,19.0,No,,Hypertension,8.0
PT01316,,Västra Götaland,60.0,Female,Leukemia,I,2014-08-07,2014-12-13,2015-10-21,Chemotherapy,Public,Alive,74.0,BRCA1,No,Former,Moderate,20.9,Low,Urban,NHS,6.0,Yes,No,Diabetes,8.0
PT01317,Belgium,Brussels,72.0,,Colorectal,I,2023-09-12,2024-02-05,2024-05-23,Chemotherapy,Public,Alive,104.0,None,Yes,Never,Heavy,36.1,Medium,Urban,Private Insurance,9.0,No,No,None,8.0
,Germany,Berlin,48.0,Female,Leukemia,II,,2020-12-07,2021-06-03,Surgery,Public,Alive,64.0,EGFR,No,Never,None,21.8,High,Rural,Private Insurance,13.0,No,No,,10.0
PT01319,Ireland,Dublin,89.0,Female,Leukemia,II,2017-07-04,2017-08-12,2017-12-10,Immunotherapy,Public,Alive,80.0,BRCA1,Yes,Never,Moderate,26.5,Low,Urban,NHS,10.0,No,Yes,Hypertension,8.0
PT01320,Germany,Bavaria,78.0,Male,Breast,IV,2012-05-03,2012-06-23,2013-03-05,Chemotherapy,Private,Alive,35.0,BRCA1,No,Never,Moderate,18.8,Low,Urban,NHS,6.0,No,No,Cardiovascular Disease,4.0
PT01321,Switzerland,Bern,83.0,Male,Pancreatic,IV,,2011-09-04,2012-02-19,Surgery,Public,Deceased,38.0,BRCA1,No,Current,None,22.6,Medium,Urban,Statutory Health Insurance,12.0,Yes,No,Hypertension,4.0
PT01322,Denmark,Zealand,43.0,Male,Ovarian,II,2019-04-30,2019-08-04,2019-12-25,Immunotherapy,Private,Alive,45.0,None,Yes,Former,None,21.9,Medium,Urban,Private Insurance,4.0,Yes,No,Cardiovascular Disease,3.0
PT01323,Belgium,Flanders,35.0,Female,,III,2018-01-31,2018-04-29,2018-06-19,Surgery,,Alive,90.0,BRCA1,No,Former,None,36.0,Medium,Urban,,12.0,No,No,Obesity,1.0
PT01324,Sweden,Västra Götaland,71.0,Female,Prostate,III,2023-11-12,2024-04-22,2024-06-13,Targeted Therapy,Private,Deceased,27.0,,No,Never,None,19.3,Low,Urban,Private Insurance,,No,No,Obesity,7.0
PT01325,Spain,Andalusia,,,Ovarian,I,2012-10-16,2013-01-13,2013-04-17,Chemotherapy,Public,Alive,30.0,None,No,Current,None,31.1,High,Urban,Statutory Health Insurance,8.0,No,No,Cardiovascular Disease,7.0
PT01326,Portugal,,56.0,Male,Breast,IV,2023-09-03,2023-09-27,2023-12-24,Surgery,,Deceased,103.0,KRAS,Yes,Current,Heavy,30.9,Medium,Urban,Statutory Health Insurance,15.0,No,No,Hypertension,5.0
PT01327,Spain,Andalusia,23.0,Male,Pancreatic,I,2014-05-04,2014-10-04,2015-01-30,Targeted Therapy,,Alive,112.0,BRCA1,,Current,None,38.9,Medium,Urban,Statutory Health Insurance,7.0,No,No,None,8.0
PT01328,Switzerland,Bern,57.0,Female,Leukemia,III,2023-06-13,2023-08-28,2024-04-11,Surgery,Public,Alive,9.0,KRAS,No,Former,None,20.2,Medium,Urban,Private Insurance,13.0,No,No,None,4.0
PT01329,Finland,Southwest Finland,60.0,Non-binary,Lung,II,2017-02-27,2017-06-01,2017-10-22,Radiation,Public,Alive,17.0,KRAS,Yes,Never,None,32.1,High,Urban,,2.0,No,No,Hypertension,8.0
PT01330,,Lisbon,33.0,Female,Lung,II,2015-02-15,2015-03-17,2015-05-13,Surgery,Public,Alive,9.0,KRAS,Yes,Never,,34.7,High,Urban,Statutory Health Insurance,13.0,No,No,None,1.0
,Switzerland,Geneva,70.0,Female,Breast,II,2012-12-26,2013-02-18,2013-10-15,Radiation,Public,,28.0,,No,Current,Moderate,18.2,Low,Rural,NHS,1.0,No,No,,2.0
PT01332,Switzerland,Zurich,84.0,Female,Lung,IV,2011-09-19,2012-01-12,2012-10-06,Chemotherapy,Public,Lost to Follow-up,,BRCA1,Yes,Former,None,32.2,Medium,Urban,Statutory Health Insurance,14.0,No,No,Hypertension,
PT01333,Norway,Trøndelag,71.0,Male,Leukemia,I,2021-07-09,2021-09-25,2022-07-08,Surgery,Public,Alive,107.0,BRCA1,Yes,Former,Moderate,20.5,,,Statutory Health Insurance,8.0,Yes,No,Obesity,5.0
PT01334,Norway,Oslo,49.0,Female,Ovarian,I,2023-01-19,2023-05-19,2024-03-28,Targeted Therapy,Private,Deceased,75.0,KRAS,No,Never,None,31.9,Medium,Urban,Private Insurance,6.0,Yes,Yes,Cardiovascular Disease,5.0
PT01335,France,Provence-Alpes-Côte d'Azur,76.0,Female,Colorectal,II,2018-09-14,2018-10-09,2018-12-23,,Private,Alive,63.0,None,No,Former,Moderate,24.3,Medium,Rural,Statutory Health Insurance,,No,,None,9.0
PT01336,Austria,Styria,49.0,Female,Leukemia,I,2010-01-26,2010-05-31,2011-05-28,Chemotherapy,,Deceased,115.0,None,No,Former,None,,Medium,,NHS,14.0,,No,None,10.0
PT01337,Switzerland,Bern,61.0,Female,Pancreatic,III,2018-05-07,,,,Public,Alive,102.0,BRCA1,No,Never,Moderate,28.0,Medium,Rural,Statutory Health Insurance,5.0,,No,Cardiovascular Disease,1.0
PT01338,Sweden,Skåne,30.0,Female,Colorectal,III,2011-09-14,2011-09-16,2012-03-03,Chemotherapy,Private,Alive,110.0,EGFR,No,Never,Moderate,,Medium,Urban,Statutory Health Insurance,12.0,Yes,,Cardiovascular Disease,4.0
PT01339,Sweden,Stockholm,46.0,Female,Lung,IV,2019-07-18,2019-11-06,2020-05-20,Surgery,Research Institute,Deceased,40.0,None,,Former,None,25.0,High,Rural,Private Insurance,7.0,No,Yes,None,10.0
PT01340,Switzerland,Geneva,43.0,Female,Ovarian,III,2011-12-18,2012-03-07,2012-11-04,Surgery,Public,Lost to Follow-up,,EGFR,Yes,Current,Moderate,29.6,Low,Rural,NHS,12.0,No,No,Cardiovascular Disease,1.0
PT01341,Ireland,Dublin,58.0,Non-binary,Prostate,IV,2017-04-14,2017-07-26,2018-01-30,Radiation,Private,Alive,63.0,KRAS,Yes,Former,Moderate,,High,Urban,Private Insurance,9.0,No,No,Cardiovascular Disease,1.0
PT01342,Netherlands,South Holland,37.0,Female,Prostate,III,2014-10-08,2015-02-09,2015-04-18,Surgery,Research Institute,Deceased,102.0,EGFR,Yes,Current,Moderate,38.7,Low,Urban,Private Insurance,12.0,No,Yes,Hypertension,7.0
PT01343,Ireland,Connacht,64.0,Male,Leukemia,,2018-05-31,2018-11-13,2019-03-24,Radiation,Public,Deceased,119.0,EGFR,No,,Moderate,31.1,Medium,,Statutory Health Insurance,8.0,No,No,Cardiovascular Disease,
PT01344,Ireland,Dublin,31.0,,Leukemia,I,2020-03-22,2020-07-24,,Immunotherapy,Research Institute,Alive,11.0,BRCA1,Yes,Former,Moderate,25.1,Medium,Urban,NHS,2.0,No,No,Cardiovascular Disease,9.0
PT01345,Switzerland,Zurich,68.0,Female,Lung,II,2022-03-23,2022-04-09,2023-01-27,Radiation,Research Institute,Alive,12.0,EGFR,No,Never,None,22.8,Medium,Rural,Statutory Health Insurance,13.0,Yes,No,None,4.0
PT01346,Italy,Veneto,50.0,Male,Prostate,IV,2017-08-06,2017-09-06,2018-07-30,Targeted Therapy,Private,Deceased,26.0,KRAS,No,Never,Heavy,30.7,High,Urban,Private Insurance,10.0,No,No,None,7.0
PT01347,Denmark,Zealand,41.0,Male,Prostate,III,2015-01-20,2015-05-29,2016-05-27,Targeted Therapy,Private,,,BRCA1,,Never,,39.6,High,Urban,Statutory Health Insurance,2.0,No,No,Cardiovascular Disease,8.0
PT01348,Germany,Berlin,63.0,Male,Leukemia,,2021-08-08,,2022-12-18,Surgery,Public,Deceased,20.0,None,,Never,Moderate,28.5,Medium,Urban,Statutory Health Insurance,7.0,Yes,No,None,9.0
PT01349,Italy,Veneto,83.0,Female,Pancreatic,I,2010-01-14,2010-03-25,2010-07-28,Immunotherapy,Research Institute,Alive,71.0,None,No,Current,Moderate,38.1,Medium,Urban,,1.0,No,No,,1.0
PT01350,Italy,Veneto,44.0,Female,Prostate,IV,2017-07-21,2017-08-26,2017-11-24,Targeted Therapy,Public,Deceased,92.0,None,No,Never,Heavy,29.7,Medium,Rural,Private Insurance,8.0,Yes,No,Hypertension,2.0
PT01351,Portugal,Lisbon,70.0,Male,,III,,2011-10-29,2012-04-14,Targeted Therapy,Public,Alive,72.0,EGFR,No,Current,Moderate,35.7,,Rural,NHS,19.0,Yes,No,None,3.0
PT01352,Netherlands,South Holland,26.0,Male,Breast,I,2017-11-18,,2018-11-05,Targeted Therapy,Private,Alive,17.0,BRCA1,Yes,Current,Moderate,31.0,High,Rural,Private Insurance,2.0,No,No,Hypertension,7.0
PT01353,Germany,Bavaria,25.0,Female,Prostate,I,2019-04-28,2019-07-10,2019-09-09,Surgery,Private,Deceased,54.0,EGFR,No,Never,None,30.9,,Rural,Private Insurance,4.0,No,No,Diabetes,1.0
PT01354,Denmark,Capital Region,,Male,Colorectal,I,2011-03-14,2011-07-30,2012-01-08,Chemotherapy,Private,Deceased,84.0,BRCA1,No,Never,Moderate,27.3,Medium,Urban,,3.0,No,No,Diabetes,1.0
PT01355,Ireland,Dublin,38.0,Male,Ovarian,IV,2011-01-18,2011-02-11,2011-11-02,Chemotherapy,Public,Alive,67.0,EGFR,No,Never,Moderate,33.1,High,Rural,Private Insurance,5.0,No,No,Hypertension,10.0
PT01356,Portugal,Lisbon,28.0,Female,Lung,III,,2024-03-06,2025-03-02,Chemotherapy,Public,Alive,38.0,BRCA1,No,Current,None,28.9,High,Urban,Private Insurance,8.0,Yes,No,Cardiovascular Disease,1.0
PT01357,Portugal,Algarve,55.0,Female,Ovarian,IV,2013-07-13,2013-07-15,2014-04-05,Surgery,Private,Alive,115.0,KRAS,No,Former,None,36.6,Low,Urban,NHS,14.0,No,,None,7.0
PT01358,Denmark,Capital Region,59.0,Male,Leukemia,II,2017-10-23,2017-11-12,2018-08-10,Chemotherapy,Public,Alive,66.0,,Yes,Never,None,,Low,Urban,NHS,8.0,No,Yes,Hypertension,3.0
PT01359,Finland,Southwest Finland,43.0,Female,Prostate,IV,2023-11-17,2023-12-20,2024-11-08,Radiation,Research Institute,Alive,18.0,KRAS,No,Former,None,28.8,Low,Urban,NHS,14.0,Yes,No,None,7.0
PT01360,Switzerland,Geneva,67.0,Male,Prostate,II,2015-07-31,2015-08-14,2016-05-18,Surgery,Private,Deceased,18.0,EGFR,Yes,Current,Heavy,23.8,Medium,Urban,NHS,5.0,No,,Hypertension,3.0
PT01361,Germany,North Rhine-Westphalia,82.0,Female,Pancreatic,I,2020-03-05,2020-04-29,2020-06-20,Surgery,Public,,64.0,KRAS,No,Never,Moderate,27.9,High,Urban,NHS,15.0,No,No,Diabetes,9.0
PT01362,Finland,Uusimaa,88.0,Male,Leukemia,I,2016-09-18,2016-10-25,2017-07-06,Immunotherapy,Public,Deceased,33.0,BRCA1,No,Never,None,33.5,,Urban,NHS,3.0,No,No,Diabetes,10.0
,Ireland,,72.0,Male,Colorectal,IV,2012-06-04,2012-09-17,2013-03-09,Targeted Therapy,Public,Alive,82.0,None,Yes,Never,None,29.1,High,Urban,Private Insurance,15.0,No,No,Diabetes,3.0
PT01364,Ireland,Munster,73.0,Female,Prostate,II,2019-07-27,2019-10-19,2020-09-18,Immunotherapy,Private,Alive,29.0,None,Yes,Former,Moderate,26.7,Low,Urban,NHS,9.0,No,No,Obesity,2.0
PT01365,Belgium,Wallonia,61.0,Female,Breast,I,2018-04-03,2018-07-25,2018-11-03,Chemotherapy,Public,Alive,108.0,EGFR,,Current,Moderate,18.6,Medium,Urban,NHS,16.0,No,No,Cardiovascular Disease,3.0
PT01366,Finland,Pirkanmaa,64.0,Male,Lung,I,2020-11-26,2021-04-09,2021-12-19,Surgery,,Alive,35.0,None,No,Never,Moderate,22.0,Medium,Urban,Statutory Health Insurance,7.0,No,Yes,None,7.0
PT01367,Switzerland,Zurich,33.0,Male,Leukemia,I,2021-06-06,,2022-01-30,Surgery,Private,Alive,105.0,BRCA1,Yes,Current,Moderate,36.5,Low,Urban,NHS,16.0,Yes,No,Obesity,6.0
PT01368,Spain,Madrid,48.0,Female,Prostate,IV,2010-11-05,2011-03-13,2011-05-15,Chemotherapy,Public,Alive,9.0,EGFR,No,Current,Heavy,34.8,Medium,Rural,NHS,12.0,No,Yes,Hypertension,2.0
PT01369,Sweden,Stockholm,25.0,Female,Ovarian,II,2011-12-28,2012-02-16,2012-11-25,Targeted Therapy,Public,Alive,18.0,None,Yes,Former,Moderate,19.8,Medium,Rural,NHS,11.0,No,No,,10.0
PT01370,Finland,Uusimaa,26.0,Male,Pancreatic,III,2018-07-02,2018-09-24,2018-12-25,Immunotherapy,Private,Alive,81.0,EGFR,Yes,Former,Moderate,20.3,High,Urban,Statutory Health Insurance,4.0,No,No,Hypertension,10.0
PT01371,Ireland,Munster,56.0,Female,Pancreatic,IV,,2018-04-05,2018-08-14,Targeted Therapy,Public,Lost to Follow-up,,None,Yes,Former,None,38.5,Medium,Urban,NHS,2.0,No,No,Hypertension,1.0
PT01372,Netherlands,South Holland,72.0,Male,Lung,II,2014-09-10,2014-12-05,2015-01-20,Chemotherapy,Public,Alive,6.0,KRAS,No,Never,Moderate,35.5,Medium,Urban,Private Insurance,6.0,No,No,Diabetes,3.0
PT01373,Spain,Catalonia,37.0,Female,Leukemia,III,2020-08-07,2021-02-02,2021-10-30,Immunotherapy,Private,Deceased,49.0,None,Yes,Current,None,26.9,Low,Urban,NHS,18.0,No,No,Cardiovascular Disease,8.0
PT01374,Spain,Madrid,57.0,Male,Leukemia,II,2011-12-14,,2013-04-02,Immunotherapy,Private,Alive,54.0,None,Yes,Current,Moderate,39.4,Low,Urban,Statutory Health Insurance,3.0,No,No,Obesity,9.0
PT01375,Netherlands,North Holland,78.0,Male,Leukemia,IV,2012-08-08,2012-11-16,2013-08-28,Targeted Therapy,Public,Alive,86.0,EGFR,No,Never,,39.4,Medium,Urban,Private Insurance,17.0,Yes,Yes,None,5.0
PT01376,Norway,Trøndelag,20.0,Male,Colorectal,I,2013-12-06,2014-05-27,2014-08-31,,Private,Alive,29.0,KRAS,No,Never,Moderate,39.9,Medium,Rural,Private Insurance,12.0,No,No,Cardiovascular Disease,6.0
PT01377,Sweden,Stockholm,87.0,Male,Breast,III,2022-07-02,2022-11-19,2023-09-24,Surgery,Public,Alive,39.0,EGFR,Yes,Never,Moderate,26.4,Medium,Urban,NHS,16.0,No,No,None,9.0
PT01378,Italy,Sicily,63.0,Male,Pancreatic,III,2014-03-19,2014-05-15,2015-03-06,Surgery,Private,Alive,44.0,EGFR,No,Former,None,29.7,High,Urban,Private Insurance,8.0,No,No,Diabetes,8.0
PT01379,Austria,Vienna,66.0,Male,Leukemia,I,2017-02-25,2017-07-29,2017-09-01,Targeted Therapy,Research Institute,Alive,47.0,None,Yes,Never,None,32.3,Medium,Rural,NHS,1.0,No,No,Diabetes,5.0
PT01380,Sweden,Västra Götaland,54.0,Male,Colorectal,II,2023-10-13,2023-11-07,2024-01-06,Chemotherapy,Public,,12.0,EGFR,Yes,Former,Heavy,36.0,Medium,Urban,,15.0,No,No,Cardiovascular Disease,7.0
PT01381,Netherlands,South Holland,79.0,Male,Leukemia,II,2015-12-09,,2016-06-22,Targeted Therapy,Research Institute,Deceased,28.0,KRAS,No,Former,Moderate,22.3,,Urban,NHS,9.0,No,No,Diabetes,1.0
PT01382,Norway,Vestland,71.0,Female,Leukemia,I,2016-01-07,2016-04-19,2017-02-09,Surgery,Research Institute,Alive,26.0,None,No,Former,Moderate,25.2,Medium,Urban,Private Insurance,3.0,No,No,,8.0
PT01383,Finland,Uusimaa,27.0,Male,Colorectal,II,2016-01-10,2016-04-17,2016-07-06,Immunotherapy,Public,Alive,48.0,KRAS,No,,Moderate,25.9,High,Urban,Private Insurance,3.0,,No,Obesity,9.0
PT01384,Netherlands,North Holland,60.0,Female,Breast,IV,2018-05-10,2018-07-26,2019-04-28,Chemotherapy,,Alive,65.0,KRAS,No,Current,None,36.4,High,Rural,Statutory Health Insurance,19.0,Yes,No,Obesity,3.0
PT01385,France,Auvergne-Rhône-Alpes,22.0,Male,,II,2014-07-29,2014-11-10,2015-01-26,Surgery,Private,Alive,29.0,BRCA1,No,Never,None,28.5,Medium,Urban,Statutory Health Insurance,10.0,No,No,,8.0
PT01386,Italy,Sicily,88.0,Male,Pancreatic,II,2022-10-14,2022-12-18,2023-12-16,Chemotherapy,Public,Alive,105.0,EGFR,No,Former,,30.7,Medium,Urban,NHS,,Yes,No,Cardiovascular Disease,6.0
PT01387,Denmark,Capital Region,33.0,Female,Prostate,,2018-08-01,2018-11-22,2019-05-02,Chemotherapy,Public,Lost to Follow-up,,None,Yes,Former,Moderate,35.2,Medium,Urban,Statutory Health Insurance,10.0,No,No,None,6.0
PT01388,Netherlands,Utrecht,45.0,Female,Ovarian,I,2019-03-19,2019-07-20,2020-01-01,Immunotherapy,Public,Alive,72.0,BRCA1,No,Never,Heavy,32.0,Low,Rural,Statutory Health Insurance,,No,Yes,Obesity,3.0
PT01389,Denmark,Capital Region,89.0,Male,Leukemia,II,2015-10-17,2016-02-05,2016-03-12,Surgery,Public,Alive,98.0,KRAS,No,Never,None,38.1,Low,Rural,NHS,8.0,Yes,No,Cardiovascular Disease,8.0
PT01390,Spain,,77.0,Male,Breast,IV,2010-08-13,2010-12-14,2011-05-11,Targeted Therapy,Public,Alive,33.0,BRCA1,Yes,,Moderate,21.4,High,Urban,NHS,15.0,No,No,Hypertension,9.0
PT01391,Poland,Silesian,59.0,Female,Pancreatic,IV,2012-04-26,2012-06-19,2013-05-02,Chemotherapy,Private,Alive,71.0,EGFR,No,Never,None,28.4,Medium,Urban,Statutory Health Insurance,6.0,No,No,None,5.0
PT01392,Denmark,Zealand,70.0,Female,Prostate,II,2021-02-21,2021-08-07,2022-06-10,Chemotherapy,Private,,9.0,KRAS,No,Never,None,26.5,Low,Urban,NHS,10.0,No,No,Cardiovascular Disease,2.0
PT01393,Portugal,Porto,24.0,Non-binary,Leukemia,II,2018-02-04,2018-08-02,2019-04-06,Immunotherapy,,Alive,86.0,EGFR,No,Current,None,35.9,Medium,Urban,Private Insurance,3.0,No,No,Cardiovascular Disease,5.0
PT01394,Ireland,,51.0,Female,Ovarian,II,2022-01-05,2022-01-25,2022-06-18,Surgery,Public,Alive,89.0,KRAS,Yes,Never,None,28.6,Low,Urban,NHS,2.0,,No,Hypertension,8.0
PT01395,Denmark,Zealand,20.0,Male,Prostate,III,2016-03-11,2016-06-08,2016-12-18,Chemotherapy,,Alive,41.0,BRCA1,Yes,Never,,38.3,High,Urban,Statutory Health Insurance,18.0,No,No,Cardiovascular Disease,7.0
PT01396,Austria,Tyrol,73.0,Female,Colorectal,III,2014-05-03,2014-05-14,2015-03-24,Chemotherapy,Research Institute,Deceased,62.0,None,Yes,Current,None,,Medium,Urban,Private Insurance,9.0,No,No,Obesity,6.0
PT01397,Spain,Catalonia,30.0,Female,Ovarian,III,2012-08-28,2013-01-02,2013-09-11,Radiation,Private,Alive,,KRAS,No,Never,Moderate,23.4,Medium,Rural,Private Insurance,14.0,No,No,None,8.0
PT01398,Netherlands,North Holland,72.0,Female,Pancreatic,I,2020-11-16,2021-01-07,2021-05-02,Radiation,Public,Alive,62.0,KRAS,No,Never,Heavy,30.9,High,Urban,NHS,12.0,No,No,None,8.0
PT01399,Italy,Lombardy,27.0,Female,Breast,IV,2013-05-01,2013-06-24,2014-01-28,Chemotherapy,Public,Deceased,91.0,KRAS,Yes,Never,None,19.1,Low,Urban,,,Yes,No,None,5.0
PT01400,Netherlands,South Holland,44.0,Female,Breast,I,2023-12-25,2024-03-03,2024-05-24,Immunotherapy,Private,Alive,24.0,KRAS,No,Former,None,32.5,High,Urban,Statutory Health Insurance,1.0,No,No,Hypertension,1.0
PT01401,Norway,Vestland,59.0,Female,Pancreatic,II,2014-06-27,2014-07-04,2015-06-26,Targeted Therapy,Research Institute,Alive,36.0,None,No,Never,Moderate,34.9,Low,Urban,Private Insurance,9.0,No,Yes,Cardiovascular Disease,6.0
PT01402,,Zealand,51.0,Male,Lung,IV,2015-10-23,2016-03-11,2016-04-24,Radiation,Private,Deceased,47.0,EGFR,No,Current,Moderate,23.8,Low,Rural,Private Insurance,12.0,No,No,Hypertension,6.0
PT01403,Sweden,Västra Götaland,47.0,Female,Lung,II,2022-12-04,2023-04-13,2023-09-16,Radiation,Private,Deceased,65.0,None,No,Never,None,25.8,Low,Urban,,2.0,No,No,Obesity,
PT01404,Norway,Oslo,22.0,Male,Prostate,I,2017-06-04,2017-09-15,2018-04-08,Surgery,Public,Alive,94.0,BRCA1,No,Former,Heavy,32.6,High,Rural,Statutory Health Insurance,17.0,No,No,Hypertension,3.0
PT01405,Italy,Lombardy,81.0,Male,Colorectal,I,2013-07-10,2013-12-06,2014-05-02,Targeted Therapy,Public,Deceased,35.0,None,Yes,Never,Moderate,30.3,Low,,Private Insurance,3.0,No,No,None,10.0
PT01406,Poland,Lesser Poland,46.0,,Prostate,II,2018-08-24,2018-11-01,2019-05-31,Radiation,Public,Alive,53.0,None,No,Never,Moderate,31.8,High,Urban,Statutory Health Insurance,16.0,No,No,Obesity,4.0
PT01407,Poland,,64.0,Male,Leukemia,I,2010-02-27,2010-05-29,2010-09-03,Targeted Therapy,Public,Alive,78.0,EGFR,No,Current,None,30.3,Low,Urban,Private Insurance,9.0,No,No,Diabetes,8.0
PT01408,Italy,Lombardy,,Female,Breast,II,2014-08-12,2014-11-15,2015-11-04,Targeted Therapy,Private,Lost to Follow-up,,BRCA1,Yes,Current,Moderate,28.9,High,Rural,Private Insurance,8.0,No,Yes,Obesity,
PT01409,Italy,Veneto,80.0,Female,Prostate,II,2019-07-21,2019-11-16,2020-06-24,Surgery,,Deceased,111.0,BRCA1,Yes,Never,Moderate,18.7,High,Rural,Statutory Health Insurance,14.0,No,No,Obesity,5.0
PT01410,Italy,Sicily,63.0,Male,Prostate,III,2013-07-28,2013-11-26,2014-07-07,Chemotherapy,Public,Deceased,35.0,EGFR,No,,Moderate,26.2,Low,Rural,Private Insurance,2.0,No,No,Diabetes,4.0
PT01411,Norway,Vestland,65.0,Female,Pancreatic,I,2014-06-19,2014-07-25,2015-02-17,Chemotherapy,Public,Alive,46.0,EGFR,No,Never,Moderate,31.3,Medium,Rural,Statutory Health Insurance,11.0,No,No,None,1.0
PT01412,Belgium,Flanders,33.0,,Ovarian,III,2021-03-04,2021-03-25,2021-06-09,Radiation,Research Institute,Deceased,37.0,EGFR,No,,,35.6,Low,Urban,Statutory Health Insurance,19.0,No,Yes,Obesity,1.0
PT01413,Netherlands,Utrecht,27.0,Male,Breast,II,2021-10-13,2021-12-05,2022-05-25,Surgery,Public,Alive,116.0,BRCA1,Yes,Former,None,37.0,Low,Urban,,9.0,No,Yes,Diabetes,8.0
PT01414,Austria,Vienna,67.0,Female,Breast,II,2013-03-12,2013-08-06,2013-09-13,Radiation,Research Institute,Deceased,64.0,BRCA1,No,Current,None,26.0,Medium,Urban,,11.0,No,No,Cardiovascular Disease,8.0
,Belgium,Wallonia,33.0,Female,Lung,I,2011-02-17,2011-02-20,2011-04-02,Radiation,Private,Alive,114.0,None,No,Former,Moderate,33.4,Medium,Urban,NHS,11.0,No,Yes,Cardiovascular Disease,1.0
PT01416,Finland,Southwest Finland,84.0,Male,Lung,III,2014-06-07,2014-08-27,2014-12-26,Chemotherapy,Public,Alive,53.0,None,No,Former,Moderate,19.8,Medium,Urban,Statutory Health Insurance,8.0,No,No,Cardiovascular Disease,9.0
PT01417,Switzerland,Geneva,26.0,Female,,III,2017-08-09,2017-11-11,2017-12-23,Surgery,Public,,84.0,EGFR,No,Never,Moderate,26.0,Low,Rural,NHS,10.0,No,,Obesity,8.0
PT01418,Netherlands,Utrecht,68.0,Male,Ovarian,I,2012-01-10,2012-04-19,2013-02-19,Targeted Therapy,Private,Alive,105.0,None,Yes,Former,None,21.5,High,Urban,NHS,14.0,No,No,Cardiovascular Disease,10.0
PT01419,Portugal,Algarve,,Non-binary,,III,,2023-11-10,2024-01-16,Chemotherapy,Private,Deceased,104.0,,Yes,Former,None,28.3,Medium,Rural,Statutory Health Insurance,9.0,No,No,Diabetes,9.0
PT01420,Finland,Southwest Finland,32.0,Male,Leukemia,IV,2022-05-12,2022-10-16,2023-09-18,Radiation,Public,Alive,70.0,,No,Former,Moderate,32.1,Medium,Rural,Private Insurance,15.0,No,No,Diabetes,4.0
PT01421,Netherlands,South Holland,75.0,Male,Prostate,I,2012-07-07,2012-10-31,2013-09-07,Radiation,Public,,26.0,None,Yes,Never,Moderate,38.7,Medium,Urban,NHS,8.0,No,No,None,7.0
PT01422,,Lesser Poland,75.0,Female,Ovarian,III,2016-02-27,2016-05-10,2017-03-13,Immunotherapy,Public,Deceased,41.0,KRAS,No,Current,Moderate,36.6,Low,Urban,,7.0,No,No,Hypertension,5.0
PT01423,Austria,Vienna,34.0,Female,Leukemia,II,2021-03-06,,2022-01-13,Surgery,Private,Deceased,72.0,KRAS,Yes,Former,None,21.6,High,Rural,Private Insurance,11.0,No,No,Diabetes,9.0
PT01424,Norway,Trøndelag,76.0,Male,Breast,I,2021-06-07,2021-07-27,2022-04-26,Targeted Therapy,Public,Alive,84.0,BRCA1,Yes,Never,None,34.8,Medium,Urban,NHS,5.0,No,No,Hypertension,6.0
PT01425,Switzerland,Geneva,77.0,,Pancreatic,II,2014-02-12,2014-07-09,2015-07-01,Targeted Therapy,Private,Deceased,93.0,None,Yes,Former,None,30.7,High,Rural,Private Insurance,19.0,,No,Cardiovascular Disease,3.0
PT01426,Ireland,Munster,54.0,,Leukemia,IV,2018-11-02,2019-04-01,2019-06-06,,Private,Deceased,21.0,None,Yes,Never,Moderate,36.0,High,Urban,NHS,5.0,No,No,Hypertension,7.0
PT01427,Ireland,Connacht,35.0,Female,Lung,II,2012-04-07,2012-10-03,2013-06-21,Immunotherapy,Public,Alive,63.0,BRCA1,Yes,Never,Moderate,28.5,Medium,Urban,Private Insurance,12.0,Yes,No,None,9.0
PT01428,Switzerland,Zurich,27.0,Male,Pancreatic,IV,2018-11-06,2018-12-25,2019-07-15,Immunotherapy,Public,Deceased,12.0,KRAS,No,Former,,22.4,Medium,Urban,Statutory Health Insurance,17.0,No,Yes,Obesity,6.0
PT01429,Germany,North Rhine-Westphalia,64.0,Female,Ovarian,III,2017-11-13,2018-03-16,2018-12-21,Surgery,Public,Alive,85.0,KRAS,No,Current,None,19.7,High,Urban,NHS,7.0,No,No,Cardiovascular Disease,10.0
PT01430,Finland,Uusimaa,59.0,Female,Breast,I,2014-06-06,2014-11-03,2015-04-01,Radiation,Public,Alive,33.0,EGFR,No,Never,None,23.9,Medium,Urban,Statutory Health Insurance,3.0,No,No,Cardiovascular Disease,2.0
PT01431,Ireland,Dublin,73.0,,Ovarian,I,2013-03-31,2013-07-22,2014-07-19,Radiation,Public,Alive,55.0,EGFR,No,,None,22.3,Medium,,Private Insurance,10.0,Yes,,Diabetes,4.0
PT01432,Portugal,Lisbon,33.0,Non-binary,,III,2014-08-12,2014-10-11,2014-11-23,Radiation,Public,Deceased,17.0,KRAS,No,Never,Moderate,31.4,Low,Urban,Statutory Health Insurance,7.0,No,No,Hypertension,9.0
PT01433,Denmark,Zealand,78.0,Non-binary,Leukemia,II,2011-05-25,2011-06-01,2012-03-30,Surgery,Public,Alive,30.0,KRAS,No,Former,None,32.2,Low,Urban,NHS,6.0,No,,None,4.0
PT01434,Norway,Vestland,72.0,Female,Leukemia,I,2011-11-26,,2012-09-04,Targeted Therapy,Public,Alive,35.0,,Yes,Former,Moderate,27.7,Medium,Urban,Statutory Health Insurance,15.0,No,No,None,1.0
PT01435,,Munster,46.0,Male,Ovarian,III,2018-12-24,2019-01-24,2019-08-29,Chemotherapy,Public,Alive,77.0,None,No,Former,None,,Medium,Urban,Statutory Health Insurance,10.0,No,No,Diabetes,7.0
PT01436,Finland,Southwest Finland,66.0,Female,Pancreatic,III,2020-12-30,2021-05-11,2021-08-03,Immunotherapy,,Alive,,,,Former,,37.1,Medium,Urban,Statutory Health Insurance,14.0,No,No,None,2.0
PT01437,Poland,Silesian,25.0,Female,Colorectal,III,2015-08-31,2015-12-02,2016-10-16,Targeted Therapy,Public,Deceased,65.0,None,Yes,Never,None,21.2,Medium,Urban,Statutory Health Insurance,6.0,No,Yes,Cardiovascular Disease,10.0
PT01438,France,Île-de-France,74.0,Female,Colorectal,I,2013-05-31,2013-06-07,2013-11-10,Chemotherapy,Research Institute,Lost to Follow-up,,BRCA1,Yes,Never,None,20.4,Low,Urban,Statutory Health Insurance,15.0,No,Yes,Obesity,8.0
PT01439,Belgium,Flanders,63.0,Female,Breast,I,2011-02-04,2011-06-15,2012-05-10,Targeted Therapy,Public,Deceased,47.0,KRAS,No,Former,None,19.6,High,Urban,Private Insurance,15.0,Yes,No,Cardiovascular Disease,10.0
PT01440,Norway,Oslo,37.0,Male,Pancreatic,IV,2017-02-20,2017-03-17,2017-12-30,Targeted Therapy,Public,Alive,105.0,,Yes,Never,None,28.5,Low,Rural,NHS,,No,No,,10.0
PT01441,Denmark,Capital Region,35.0,Female,Prostate,IV,2022-07-21,2022-12-30,2023-12-26,Targeted Therapy,Private,Alive,105.0,BRCA1,No,Former,Moderate,35.2,Medium,Urban,NHS,6.0,No,No,None,6.0
PT01442,Poland,Masovian,31.0,Female,Colorectal,II,2010-10-15,2010-11-17,2011-03-26,Targeted Therapy,Public,Alive,116.0,None,Yes,Current,Heavy,32.7,Medium,Urban,NHS,19.0,Yes,No,Diabetes,10.0
PT01443,Netherlands,Utrecht,39.0,Male,Ovarian,III,2013-11-04,2014-02-07,2015-01-11,Radiation,Research Institute,Deceased,60.0,,No,Current,Moderate,19.9,,Rural,Private Insurance,5.0,No,No,Diabetes,4.0
PT01444,Austria,Styria,64.0,Female,Leukemia,,2022-05-30,2022-08-26,2023-03-02,Targeted Therapy,Private,Alive,41.0,None,No,Current,None,29.1,High,Urban,Statutory Health Insurance,1.0,No,No,Diabetes,2.0
PT01445,Netherlands,North Holland,83.0,Female,Colorectal,I,2015-12-18,2016-04-22,2016-06-13,Chemotherapy,Public,Deceased,54.0,KRAS,Yes,Former,Moderate,18.9,Low,Urban,Private Insurance,16.0,No,Yes,Obesity,3.0
PT01446,Ireland,Connacht,78.0,Female,Ovarian,I,2011-03-17,2011-04-24,2011-12-09,Chemotherapy,Public,Deceased,51.0,EGFR,No,,None,20.8,Low,Urban,,16.0,Yes,No,Diabetes,4.0
PT01447,Portugal,Algarve,41.0,Male,Breast,I,2023-05-18,2023-09-05,2023-12-08,Immunotherapy,Private,Alive,99.0,BRCA1,No,Never,None,22.6,Medium,Rural,Statutory Health Insurance,15.0,No,No,Diabetes,4.0
PT01448,Ireland,Munster,66.0,Female,Breast,IV,2023-12-11,2024-04-14,2024-11-12,Surgery,Private,Alive,75.0,KRAS,No,,None,27.4,Medium,Urban,Private Insurance,13.0,No,No,Hypertension,7.0
PT01449,,,48.0,Male,Leukemia,II,2013-06-22,2013-10-26,2014-07-09,Chemotherapy,Public,Alive,40.0,EGFR,No,Never,None,26.1,Low,Urban,Statutory Health Insurance,4.0,No,No,None,6.0
PT01450,Switzerland,Geneva,64.0,Female,Leukemia,I,2016-11-17,2016-11-21,2017-04-10,Chemotherapy,Private,Alive,99.0,KRAS,Yes,Never,Heavy,33.0,Low,Urban,,,Yes,No,Hypertension,7.0
PT01451,Portugal,Algarve,28.0,Female,Leukemia,III,2010-07-05,2010-12-28,2011-04-15,Chemotherapy,,Alive,19.0,None,No,Never,Moderate,34.7,Low,Urban,Statutory Health Insurance,15.0,No,No,Hypertension,5.0
PT01452,Switzerland,Zurich,,Female,Prostate,III,2021-08-28,2021-12-07,2022-09-07,Chemotherapy,Private,Deceased,42.0,None,No,Current,Heavy,38.0,,Urban,Private Insurance,15.0,Yes,No,Hypertension,9.0
PT01453,Belgium,Wallonia,34.0,Male,Leukemia,I,2018-12-15,2019-02-14,2019-06-15,,Private,Deceased,97.0,None,No,Former,None,31.4,Low,Urban,Statutory Health Insurance,19.0,No,Yes,Hypertension,7.0
PT01454,Poland,Masovian,55.0,Female,Pancreatic,III,2016-09-14,2016-12-04,,Surgery,Public,Alive,45.0,KRAS,,Former,Heavy,23.7,Medium,Urban,Statutory Health Insurance,8.0,,No,Cardiovascular Disease,7.0
PT01455,Poland,Masovian,32.0,Non-binary,Breast,III,2019-09-14,2020-01-02,2020-02-01,Targeted Therapy,Private,Alive,57.0,BRCA1,No,Never,Moderate,29.2,Medium,Urban,Private Insurance,3.0,,Yes,Diabetes,5.0
PT01456,Netherlands,Utrecht,63.0,Male,Breast,III,2014-01-19,2014-04-07,2015-01-28,Chemotherapy,Research Institute,Alive,46.0,KRAS,No,Never,,32.1,Medium,Rural,Private Insurance,9.0,,No,Obesity,10.0
PT01457,Austria,Tyrol,55.0,Female,Colorectal,III,2023-05-19,2023-07-19,,Chemotherapy,Public,Alive,10.0,None,Yes,Current,Moderate,22.0,Medium,Urban,NHS,4.0,No,No,None,7.0
PT01458,Austria,,80.0,Female,Leukemia,I,2018-05-21,2018-09-27,2019-06-12,Immunotherapy,Public,Alive,26.0,BRCA1,No,Never,Moderate,27.2,High,Urban,Private Insurance,,No,No,,10.0
PT01459,Switzerland,Geneva,59.0,Female,Prostate,II,2022-09-15,2022-09-21,2022-12-04,Immunotherapy,Public,Deceased,60.0,EGFR,No,Current,Moderate,25.0,High,Urban,Private Insurance,5.0,,No,Cardiovascular Disease,6.0
PT01460,Finland,Southwest Finland,46.0,Male,Pancreatic,III,2016-09-26,2016-10-17,2017-02-22,Immunotherapy,Public,Deceased,54.0,EGFR,No,Current,Moderate,32.2,Medium,Urban,Statutory Health Insurance,4.0,Yes,No,Obesity,8.0
PT01461,Belgium,Flanders,20.0,Male,Lung,IV,2017-01-22,2017-04-15,2017-07-25,,Private,Deceased,66.0,BRCA1,No,Never,Moderate,20.0,High,Urban,NHS,2.0,No,No,Hypertension,8.0
PT01462,Belgium,Flanders,53.0,Female,Colorectal,I,2013-02-18,2013-03-18,2014-01-28,Targeted Therapy,Public,Deceased,11.0,EGFR,No,Current,Moderate,36.1,High,Urban,Private Insurance,16.0,Yes,No,Hypertension,7.0
PT01463,Ireland,Munster,87.0,Male,Pancreatic,I,2021-05-27,2021-10-29,2022-02-20,Radiation,Private,Alive,119.0,BRCA1,No,Current,Moderate,20.1,Medium,Urban,NHS,8.0,Yes,No,None,5.0
PT01464,Netherlands,North Holland,40.0,Male,Ovarian,IV,2011-09-27,2012-03-05,2012-10-01,Immunotherapy,Public,Deceased,56.0,None,No,Current,,36.3,Low,Urban,Private Insurance,11.0,No,No,Cardiovascular Disease,10.0
PT01465,Ireland,Munster,52.0,Female,Prostate,II,2013-07-27,2013-12-14,2014-12-01,Immunotherapy,Public,Alive,,BRCA1,,Current,Moderate,21.1,Medium,Rural,NHS,7.0,Yes,No,None,
PT01466,Spain,Catalonia,26.0,Male,Leukemia,II,2022-10-06,2022-12-10,2023-08-13,Surgery,Public,,,EGFR,No,Current,None,35.0,Low,Urban,Private Insurance,8.0,No,No,None,3.0
PT01467,Belgium,Wallonia,84.0,Female,Prostate,II,2011-06-17,2011-12-08,2012-10-29,Chemotherapy,Private,Deceased,67.0,None,Yes,,Heavy,37.1,Medium,Rural,Statutory Health Insurance,,No,,None,3.0
PT01468,Denmark,Capital Region,22.0,Female,Lung,II,2015-02-25,2015-08-12,2016-02-13,Targeted Therapy,Public,Deceased,29.0,EGFR,No,Former,Heavy,30.7,Low,Rural,NHS,4.0,No,No,Diabetes,3.0
PT01469,Finland,Southwest Finland,70.0,Female,Pancreatic,II,2017-05-21,2017-08-22,2018-08-14,Chemotherapy,Research Institute,Alive,57.0,KRAS,No,Never,Heavy,37.9,,Urban,Statutory Health Insurance,16.0,No,No,,8.0
,Sweden,Skåne,73.0,,Prostate,II,2022-09-24,2023-02-08,2023-05-13,Radiation,Private,Alive,21.0,BRCA1,No,Never,Moderate,24.4,High,Urban,Private Insurance,13.0,No,No,Hypertension,7.0
PT01471,France,Provence-Alpes-Côte d'Azur,78.0,Male,Ovarian,I,2012-08-10,2012-10-31,2013-04-21,Targeted Therapy,Public,Alive,12.0,EGFR,No,Former,Moderate,25.4,High,Rural,Private Insurance,10.0,No,No,Diabetes,2.0
PT01472,Germany,Bavaria,25.0,Male,,IV,2017-09-06,2017-11-07,2018-07-25,Radiation,Public,Alive,47.0,EGFR,Yes,Never,Heavy,26.3,Low,Urban,Statutory Health Insurance,14.0,No,No,Hypertension,5.0
PT01473,Belgium,Wallonia,48.0,Female,Lung,IV,2011-07-24,2011-11-10,2011-12-29,Chemotherapy,Public,Alive,95.0,EGFR,Yes,Never,Moderate,39.2,,Urban,NHS,5.0,No,No,Diabetes,4.0
PT01474,Germany,North Rhine-Westphalia,36.0,Male,Pancreatic,,2022-05-21,2022-10-12,2023-10-09,Surgery,Private,Alive,26.0,None,Yes,Never,Moderate,,Medium,Urban,Private Insurance,10.0,No,No,Obesity,5.0
PT01475,Ireland,Connacht,79.0,Non-binary,Lung,IV,2017-09-23,2017-12-31,2018-08-09,Immunotherapy,Public,Alive,53.0,None,No,,None,18.2,Low,Urban,NHS,14.0,No,No,Diabetes,7.0
PT01476,Poland,Lesser Poland,41.0,Female,Pancreatic,III,2018-10-21,2019-01-29,2019-12-19,Chemotherapy,Public,Alive,65.0,KRAS,No,Never,Heavy,19.1,Low,Rural,Private Insurance,18.0,No,No,Obesity,6.0
PT01477,Belgium,Wallonia,43.0,Male,Prostate,I,2012-09-06,2013-02-21,2013-08-04,Targeted Therapy,,Alive,87.0,EGFR,No,Never,Moderate,28.8,Medium,Urban,Private Insurance,18.0,No,No,Diabetes,7.0
PT01478,France,Île-de-France,70.0,Female,Ovarian,I,2021-04-23,2021-05-28,2022-01-15,Immunotherapy,Public,Alive,,EGFR,No,Former,Moderate,22.8,Medium,Urban,NHS,11.0,Yes,Yes,,3.0
PT01479,Netherlands,Utrecht,69.0,Male,Leukemia,I,,2020-01-17,2020-07-23,Targeted Therapy,Public,Alive,26.0,BRCA1,Yes,Former,Moderate,28.7,Low,Rural,Statutory Health Insurance,19.0,No,Yes,Hypertension,10.0
PT01480,Finland,Uusimaa,30.0,Male,Breast,II,2017-01-17,2017-04-10,2017-10-18,Radiation,Research Institute,Alive,57.0,EGFR,No,Former,Heavy,29.7,High,Urban,NHS,18.0,No,No,Hypertension,3.0
PT01481,Denmark,Capital Region,75.0,Female,Breast,II,2019-04-10,2019-07-10,,Targeted Therapy,Public,Alive,11.0,None,Yes,Never,Moderate,28.7,Medium,Rural,,3.0,No,No,Hypertension,3.0
PT01482,Germany,Bavaria,61.0,Female,Prostate,IV,2019-09-26,,2020-01-24,Surgery,Public,Alive,24.0,None,Yes,Current,None,27.9,Medium,Urban,Private Insurance,11.0,Yes,Yes,Obesity,2.0
,Poland,Silesian,,Female,,II,2017-11-17,2018-03-25,2018-06-13,Radiation,Private,Deceased,71.0,KRAS,No,Never,None,26.6,Medium,Urban,NHS,16.0,No,No,Cardiovascular Disease,9.0
PT01484,Italy,Veneto,88.0,Male,Breast,II,2014-10-04,2014-11-26,2015-06-27,Chemotherapy,Research Institute,Alive,24.0,BRCA1,No,Never,None,,Low,,NHS,6.0,,No,None,4.0
PT01485,Poland,Silesian,67.0,Male,Ovarian,III,,2016-11-28,2017-10-08,Immunotherapy,Public,Deceased,27.0,EGFR,No,Current,Moderate,25.1,,Rural,Private Insurance,18.0,Yes,No,Obesity,1.0
PT01486,Norway,Trøndelag,76.0,Male,Lung,I,2017-11-21,2018-05-04,2019-02-07,Immunotherapy,Public,Alive,85.0,None,No,Current,None,22.6,High,Urban,NHS,6.0,No,Yes,Obesity,8.0
PT01487,France,Île-de-France,40.0,Male,Prostate,IV,,2017-07-03,2018-06-16,Surgery,Research Institute,Alive,30.0,BRCA1,No,Never,Moderate,26.7,High,Urban,NHS,7.0,No,No,Hypertension,3.0
PT01488,Spain,Madrid,39.0,Male,Prostate,II,2023-12-21,2024-03-31,2024-11-28,Targeted Therapy,Private,,49.0,KRAS,No,Never,,30.1,Medium,Urban,NHS,2.0,No,No,Hypertension,10.0
PT01489,Finland,Uusimaa,34.0,Female,Colorectal,I,2016-12-10,,2017-12-07,Chemotherapy,Public,Alive,16.0,None,Yes,Never,None,38.7,Medium,Rural,Statutory Health Insurance,,No,Yes,Diabetes,8.0
PT01490,Finland,Uusimaa,,Female,,IV,2019-10-08,,2020-11-05,Targeted Therapy,Public,Alive,81.0,KRAS,Yes,Former,Moderate,34.0,Low,Urban,,8.0,Yes,No,Obesity,10.0
PT01491,Ireland,Dublin,70.0,Male,Colorectal,III,2016-07-28,2017-01-23,2017-02-27,Targeted Therapy,Public,Alive,33.0,KRAS,No,Former,None,38.0,Medium,Urban,NHS,5.0,Yes,No,Diabetes,1.0
PT01492,,Auvergne-Rhône-Alpes,81.0,Male,Pancreatic,II,2022-03-08,2022-07-10,2022-09-14,Surgery,Public,,71.0,EGFR,,Never,Moderate,22.8,Low,Rural,Private Insurance,10.0,,No,Cardiovascular Disease,6.0
PT01493,Finland,Southwest Finland,56.0,Female,Leukemia,II,2020-10-30,2020-11-05,2021-06-03,Radiation,Private,Alive,43.0,,Yes,Former,None,23.5,Medium,Rural,Private Insurance,5.0,Yes,No,None,2.0
PT01494,Norway,Trøndelag,25.0,Female,Prostate,III,2019-09-23,2019-12-01,2020-09-13,Radiation,Public,Alive,81.0,EGFR,No,Current,None,24.7,Medium,Urban,,7.0,Yes,No,Diabetes,7.0
PT01495,Spain,Andalusia,45.0,Female,Colorectal,I,2012-09-05,2013-02-01,2013-06-16,Surgery,Public,Deceased,30.0,,Yes,Never,None,39.3,Medium,Urban,NHS,16.0,No,No,Hypertension,7.0
PT01496,Poland,Masovian,27.0,Male,Prostate,IV,2011-02-07,2011-04-05,2011-12-12,Surgery,Public,Deceased,7.0,None,No,Never,Moderate,29.6,Medium,Rural,Statutory Health Insurance,3.0,No,No,Hypertension,1.0
PT01497,Switzerland,Zurich,23.0,Male,Lung,,2017-09-05,2018-02-08,2019-01-16,Surgery,Public,Alive,38.0,None,No,Never,Moderate,36.1,Medium,Urban,NHS,17.0,No,No,Diabetes,10.0
PT01498,Denmark,Capital Region,40.0,Female,Colorectal,II,2014-02-23,2014-05-19,2014-10-12,Targeted Therapy,Public,Deceased,18.0,KRAS,No,Current,None,35.9,Medium,Rural,Statutory Health Insurance,10.0,No,No,Hypertension,1.0
PT01499,Italy,Lombardy,50.0,Female,Prostate,III,2014-03-28,2014-04-21,2014-11-15,Targeted Therapy,Research Institute,Alive,61.0,KRAS,No,Never,Heavy,37.5,Medium,Rural,Statutory Health Insurance,15.0,No,Yes,Cardiovascular Disease,4.0
PT01500,France,Île-de-France,,Female,Leukemia,IV,2011-01-29,,2011-09-21,Chemotherapy,Public,Deceased,57.0,EGFR,No,Never,None,22.5,Medium,Rural,NHS,12.0,No,No,None,8.0
PT01501,,Sicily,44.0,Female,Pancreatic,II,2017-03-15,2017-06-15,2017-12-11,Surgery,Research Institute,Deceased,50.0,EGFR,Yes,Never,Moderate,29.4,Low,Urban,Private Insurance,13.0,,Yes,None,8.0
PT01502,Sweden,Skåne,34.0,Male,Ovarian,IV,2010-04-14,2010-06-28,,Targeted Therapy,Research Institute,Alive,55.0,KRAS,No,Current,None,31.0,Medium,Urban,Statutory Health Insurance,,No,No,Obesity,9.0
PT01503,Belgium,Flanders,54.0,Male,,III,2023-12-24,2024-01-15,2024-08-02,,Private,Alive,64.0,None,Yes,Current,Moderate,29.3,Medium,Rural,NHS,10.0,No,Yes,Cardiovascular Disease,2.0
PT01504,Ireland,Connacht,68.0,Female,,II,2014-10-10,2015-01-28,2015-12-17,Surgery,Public,Alive,69.0,KRAS,Yes,Former,Moderate,,High,Rural,NHS,12.0,No,No,Diabetes,6.0
PT01505,Spain,Catalonia,62.0,Male,Ovarian,III,2011-02-26,2011-04-01,2011-11-08,Radiation,Public,Deceased,93.0,None,Yes,Never,None,38.6,Medium,Rural,,,No,No,Hypertension,7.0
PT01506,Ireland,Dublin,60.0,Female,Colorectal,II,2022-11-27,2023-03-25,2023-05-30,Immunotherapy,Public,Alive,89.0,BRCA1,No,Current,Moderate,22.9,Low,Urban,Statutory Health Insurance,16.0,No,No,Hypertension,3.0
PT01507,Switzerland,Zurich,56.0,Male,Leukemia,,2018-09-13,2018-10-20,2019-02-26,Chemotherapy,Public,Deceased,89.0,BRCA1,No,Never,None,19.3,High,Rural,Statutory Health Insurance,,No,Yes,Hypertension,
PT01508,Denmark,Zealand,76.0,Male,Pancreatic,III,2020-05-04,2020-06-14,2021-05-03,Immunotherapy,Public,Alive,52.0,EGFR,No,,Moderate,34.2,Medium,Rural,NHS,2.0,No,No,Hypertension,9.0
PT01509,Portugal,Porto,61.0,Male,Breast,II,,2022-03-28,2023-03-19,Chemotherapy,Public,Alive,17.0,None,No,,None,29.2,,Urban,Statutory Health Insurance,12.0,No,,Obesity,2.0
PT01510,Germany,North Rhine-Westphalia,66.0,Male,Pancreatic,III,2010-10-03,2011-01-16,2011-03-17,Surgery,Public,Alive,112.0,KRAS,Yes,Never,None,38.7,Medium,Urban,Statutory Health Insurance,16.0,Yes,No,Diabetes,2.0
PT01511,France,Auvergne-Rhône-Alpes,80.0,Male,Lung,I,2010-07-13,2010-08-25,2011-07-20,Chemotherapy,Public,Alive,50.0,EGFR,Yes,Never,None,33.6,Medium,Urban,NHS,17.0,Yes,No,Diabetes,3.0
PT01512,France,Provence-Alpes-Côte d'Azur,33.0,Female,Pancreatic,II,2022-01-24,2022-02-15,2022-06-18,Targeted Therapy,Public,Alive,42.0,None,No,Never,Moderate,24.9,Low,Urban,Statutory Health Insurance,2.0,Yes,No,Cardiovascular Disease,2.0
PT01513,,Provence-Alpes-Côte d'Azur,87.0,Female,Prostate,III,2022-11-29,2023-02-28,2023-12-24,Radiation,Public,Deceased,112.0,BRCA1,Yes,Current,None,29.7,High,,Private Insurance,3.0,No,,Cardiovascular Disease,9.0
PT01514,Norway,Vestland,72.0,Male,Breast,IV,2013-01-31,2013-06-23,2013-10-28,Targeted Therapy,Public,Alive,118.0,EGFR,No,Former,Moderate,37.8,Medium,Urban,Statutory Health Insurance,4.0,No,No,Cardiovascular Disease,5.0
PT01515,Italy,Veneto,53.0,Male,Colorectal,IV,2021-01-01,2021-01-22,2021-04-13,Surgery,Private,Alive,13.0,None,No,Current,None,36.7,Low,Rural,Private Insurance,3.0,No,No,Cardiovascular Disease,5.0
PT01516,,Geneva,43.0,Non-binary,Prostate,IV,2010-09-07,2010-10-29,2011-09-21,Immunotherapy,Public,Alive,105.0,EGFR,Yes,Never,Moderate,28.3,Medium,Urban,Private Insurance,5.0,No,No,Obesity,10.0
PT01517,Sweden,Skåne,39.0,,Ovarian,I,2019-06-30,,2019-08-09,Radiation,Private,Deceased,117.0,None,No,Former,Moderate,22.9,Low,Urban,,8.0,No,No,Diabetes,6.0
,Portugal,Algarve,88.0,Male,Pancreatic,III,2017-09-30,2018-03-24,2018-12-24,Surgery,Public,Deceased,,EGFR,No,Former,None,20.3,Low,Urban,Statutory Health Insurance,13.0,No,No,Diabetes,9.0
PT01519,Switzerland,Geneva,49.0,Male,Prostate,I,2023-10-31,2024-03-25,,Targeted Therapy,Private,Alive,102.0,None,No,Never,Moderate,21.8,Low,Urban,Private Insurance,4.0,No,No,Cardiovascular Disease,5.0
PT01520,Netherlands,Utrecht,26.0,Female,Leukemia,I,2022-01-09,2022-03-21,2022-10-21,Targeted Therapy,,Alive,36.0,EGFR,No,Current,Moderate,27.7,Medium,Urban,Private Insurance,5.0,No,No,Diabetes,5.0
PT01521,Netherlands,,,Male,Prostate,I,2010-08-26,2010-12-22,2011-09-07,Chemotherapy,Research Institute,Deceased,107.0,KRAS,No,Current,None,33.8,Low,Urban,NHS,19.0,No,Yes,Cardiovascular Disease,4.0
PT01522,Norway,Trøndelag,57.0,Female,Prostate,IV,2020-03-09,2020-08-19,2021-04-07,Chemotherapy,Public,Alive,34.0,KRAS,No,Former,None,21.8,High,Urban,NHS,18.0,No,No,Diabetes,1.0
PT01523,Germany,North Rhine-Westphalia,71.0,Male,Pancreatic,I,2020-12-23,2020-12-30,2021-03-13,Immunotherapy,Private,Alive,23.0,EGFR,No,Former,None,33.0,High,Urban,Private Insurance,12.0,Yes,No,Hypertension,8.0
PT01524,Austria,Tyrol,34.0,,Lung,I,2023-06-07,2023-11-23,2024-03-29,Chemotherapy,Public,Alive,61.0,BRCA1,No,Former,None,24.7,Low,Rural,,11.0,No,No,Cardiovascular Disease,9.0
PT01525,Switzerland,Geneva,65.0,Male,Ovarian,I,2016-05-25,2016-10-10,2017-01-10,Chemotherapy,Private,Alive,25.0,KRAS,No,Never,Moderate,31.8,Medium,Urban,Statutory Health Insurance,7.0,No,No,Cardiovascular Disease,8.0
PT01526,Finland,Pirkanmaa,42.0,Female,Pancreatic,II,2017-01-28,2017-06-17,2017-12-23,Chemotherapy,Public,Alive,113.0,None,Yes,Never,None,28.7,Low,Rural,Private Insurance,,No,No,Diabetes,5.0
PT01527,Poland,Masovian,31.0,Female,Colorectal,IV,2014-11-01,2015-01-31,2015-07-22,Immunotherapy,Public,Lost to Follow-up,,None,No,Former,Heavy,37.2,Medium,Rural,NHS,14.0,No,,Obesity,4.0
PT01528,Denmark,Capital Region,63.0,Male,Ovarian,II,2020-09-22,2021-02-25,2021-03-28,Surgery,Public,Lost to Follow-up,,EGFR,Yes,Never,Moderate,38.3,Low,Urban,NHS,18.0,No,No,None,
PT01529,Italy,,34.0,Male,Breast,II,2022-08-22,,2023-04-17,Radiation,Private,Deceased,,KRAS,No,Never,None,26.5,Medium,Rural,Private Insurance,9.0,No,No,,4.0
PT01530,France,,68.0,Female,Leukemia,,2013-02-16,2013-07-12,2013-09-02,Surgery,Public,Alive,109.0,None,No,Never,Moderate,26.1,High,Rural,Statutory Health Insurance,16.0,No,Yes,,10.0
PT01531,Poland,Lesser Poland,40.0,Female,Lung,I,2015-12-07,2016-06-02,,Surgery,,Deceased,51.0,None,No,Never,None,31.5,Low,Urban,Statutory Health Insurance,3.0,No,Yes,Cardiovascular Disease,4.0
PT01532,Finland,,34.0,Male,Breast,I,2013-01-19,2013-05-26,2014-04-02,Surgery,Private,Deceased,106.0,EGFR,No,Current,None,24.5,High,Rural,Statutory Health Insurance,8.0,No,,Obesity,8.0
PT01533,Switzerland,Zurich,33.0,Female,Breast,II,2016-01-29,2016-03-14,2016-12-09,Targeted Therapy,Public,Alive,93.0,KRAS,Yes,Current,None,30.9,Medium,Rural,Statutory Health Insurance,,No,No,Diabetes,7.0
PT01534,Spain,Andalusia,61.0,Male,Ovarian,II,2023-03-12,2023-06-26,2023-12-13,Radiation,Public,Alive,6.0,KRAS,Yes,Never,Moderate,27.1,Medium,Urban,Statutory Health Insurance,8.0,,No,,10.0
PT01535,Portugal,Porto,34.0,Male,Lung,I,2013-02-13,2013-06-03,2013-12-17,Radiation,Private,Deceased,63.0,None,No,Never,None,28.5,Low,Rural,Private Insurance,2.0,No,No,Hypertension,2.0
PT01536,Germany,North Rhine-Westphalia,82.0,Male,Leukemia,III,2022-10-07,2022-12-01,2023-04-25,Targeted Therapy,Public,Alive,72.0,None,No,Never,Moderate,35.4,Medium,Urban,NHS,5.0,Yes,No,Obesity,2.0
PT01537,Belgium,Brussels,87.0,Female,Colorectal,IV,2022-07-08,2022-08-15,2022-09-23,Targeted Therapy,Research Institute,Alive,107.0,EGFR,Yes,Current,None,20.4,Low,Rural,NHS,2.0,No,Yes,Hypertension,6.0
PT01538,Belgium,Flanders,46.0,Male,Lung,I,2019-08-18,2019-08-22,2020-03-05,Chemotherapy,Public,Alive,80.0,KRAS,Yes,Never,None,21.3,Medium,,NHS,18.0,No,No,None,3.0
PT01539,Italy,Veneto,72.0,Female,Lung,I,2015-05-31,2015-06-15,2015-10-12,Targeted Therapy,Public,Alive,47.0,None,No,Current,Moderate,20.5,High,Urban,Statutory Health Insurance,10.0,Yes,No,Hypertension,
PT01540,Germany,North Rhine-Westphalia,,Female,,III,2014-05-16,2014-10-12,2015-03-01,Immunotherapy,Public,Deceased,109.0,KRAS,Yes,Never,Moderate,31.7,Medium,Rural,NHS,18.0,Yes,,None,5.0
PT01541,Denmark,Capital Region,82.0,Female,Leukemia,I,2013-02-19,2013-07-18,2014-02-12,Targeted Therapy,Private,Alive,,EGFR,Yes,Former,Moderate,37.1,Low,,Private Insurance,16.0,,No,Diabetes,5.0
,Switzerland,,72.0,Male,Lung,II,2014-06-16,2014-12-12,2015-07-13,Chemotherapy,Private,Alive,108.0,EGFR,Yes,Current,Moderate,37.8,Medium,Rural,Statutory Health Insurance,13.0,Yes,No,Hypertension,2.0
PT01543,Spain,Madrid,76.0,Male,Lung,II,2015-02-02,2015-05-21,2016-03-09,Targeted Therapy,Public,Deceased,48.0,EGFR,,Never,Moderate,29.5,High,Urban,Statutory Health Insurance,1.0,No,No,Diabetes,2.0
PT01544,Portugal,Algarve,71.0,Non-binary,Prostate,IV,2013-05-30,2013-07-04,2014-01-30,Immunotherapy,Public,Deceased,8.0,EGFR,No,Never,Heavy,32.3,Low,Urban,NHS,17.0,No,No,None,3.0
,Italy,Veneto,62.0,Female,Prostate,III,2014-01-22,2014-05-27,2014-07-08,Targeted Therapy,Research Institute,Alive,26.0,BRCA1,Yes,Former,Moderate,33.2,,Urban,,8.0,No,No,,7.0
PT01546,Poland,Silesian,26.0,Female,Prostate,I,2014-03-02,2014-03-06,2014-09-25,Surgery,Private,Alive,74.0,None,No,Former,Moderate,28.1,Low,Urban,Statutory Health Insurance,10.0,No,No,Cardiovascular Disease,9.0
PT01547,Portugal,,61.0,Male,Prostate,I,2011-01-05,2011-06-14,,Radiation,Public,Alive,70.0,None,No,Former,Heavy,32.4,Medium,Rural,NHS,14.0,Yes,No,Diabetes,9.0
PT01548,Denmark,Capital Region,23.0,Male,Lung,I,2023-04-18,,2023-11-09,Immunotherapy,Public,Deceased,115.0,KRAS,Yes,Former,None,25.8,High,Urban,Statutory Health Insurance,11.0,Yes,No,Obesity,2.0
PT01549,France,Provence-Alpes-Côte d'Azur,88.0,Female,Ovarian,II,2018-09-28,2018-11-21,2019-06-09,Immunotherapy,Research Institute,Alive,83.0,EGFR,No,Never,Moderate,31.8,Medium,Urban,NHS,19.0,Yes,No,Obesity,10.0
PT01550,Spain,Andalusia,24.0,Male,Prostate,II,2018-11-07,2018-12-07,2019-04-09,Immunotherapy,Private,Alive,119.0,EGFR,Yes,Former,Moderate,,Low,Urban,Private Insurance,18.0,Yes,No,Obesity,
PT01551,Switzerland,Zurich,60.0,Female,Breast,III,2014-11-21,,2015-03-02,Surgery,Public,Alive,73.0,BRCA1,No,Never,Moderate,21.5,High,Rural,NHS,11.0,Yes,No,None,2.0
PT01552,Norway,Trøndelag,23.0,,Ovarian,II,2011-07-29,2011-08-17,2011-11-22,Surgery,Public,Alive,24.0,KRAS,Yes,Never,None,36.6,,Urban,NHS,19.0,No,No,None,5.0
PT01553,Poland,Silesian,21.0,,Colorectal,II,,,2020-10-28,Radiation,Private,Alive,52.0,BRCA1,No,Former,None,23.8,Medium,Rural,Statutory Health Insurance,10.0,No,Yes,Cardiovascular Disease,5.0
,Finland,Pirkanmaa,86.0,Male,Prostate,,2022-03-31,2022-09-05,2023-02-15,Chemotherapy,Public,Alive,25.0,None,No,Never,None,20.3,High,Rural,Private Insurance,8.0,No,No,Diabetes,5.0
PT01555,Italy,Sicily,40.0,Male,Leukemia,I,2017-01-16,2017-05-06,2017-10-28,Radiation,Public,Deceased,117.0,None,Yes,Never,Moderate,36.3,High,Urban,NHS,18.0,No,Yes,,5.0
PT01556,France,Provence-Alpes-Côte d'Azur,89.0,Male,Colorectal,IV,2015-10-17,2015-12-01,2016-09-19,Immunotherapy,Private,Deceased,12.0,EGFR,No,Current,None,37.0,Low,Urban,NHS,19.0,,No,Hypertension,8.0
PT01557,,Zealand,,Female,Pancreatic,I,2015-03-18,2015-04-10,2015-10-25,Immunotherapy,Public,Alive,65.0,KRAS,No,Former,Heavy,19.1,High,Urban,Private Insurance,7.0,No,No,Diabetes,2.0
PT01558,Netherlands,Utrecht,88.0,Male,Pancreatic,I,2021-03-03,2021-05-18,2022-04-29,Immunotherapy,Public,Alive,53.0,None,Yes,,Moderate,38.6,Medium,Rural,NHS,2.0,No,No,None,9.0
PT01559,France,Auvergne-Rhône-Alpes,28.0,Male,Breast,I,2013-03-02,2013-03-07,2013-11-04,Radiation,Private,Alive,14.0,KRAS,No,Former,None,19.5,Medium,Rural,Statutory Health Insurance,7.0,No,No,Obesity,4.0
PT01560,Finland,Uusimaa,47.0,Female,Colorectal,II,2012-12-21,,,Chemotherapy,Public,Alive,108.0,KRAS,Yes,Former,Moderate,22.6,Medium,Rural,,,No,No,Hypertension,9.0
PT01561,Poland,Masovian,45.0,Male,,IV,2010-06-10,2010-07-23,2010-12-21,Chemotherapy,Public,Deceased,39.0,KRAS,Yes,Former,Moderate,18.1,Medium,Urban,Statutory Health Insurance,17.0,Yes,No,Obesity,9.0
PT01562,Belgium,Brussels,22.0,Male,Breast,I,2012-01-29,2012-01-31,2012-10-20,Radiation,Public,Alive,47.0,None,No,Never,None,18.3,,Urban,Private Insurance,5.0,No,No,Hypertension,
PT01563,France,Provence-Alpes-Côte d'Azur,68.0,Female,Pancreatic,II,2017-07-11,2018-01-03,2018-07-11,Immunotherapy,Public,Alive,18.0,EGFR,No,Current,Moderate,19.9,,Rural,Statutory Health Insurance,,No,Yes,Diabetes,5.0
PT01564,Poland,Masovian,36.0,,Prostate,,2012-04-09,2012-05-19,2012-10-18,Radiation,Public,Alive,73.0,,No,Never,None,37.5,Medium,Rural,Statutory Health Insurance,7.0,No,No,Diabetes,8.0
PT01565,Netherlands,South Holland,82.0,Male,Breast,III,2012-04-28,,2012-09-25,Radiation,Private,Alive,41.0,KRAS,,Never,None,19.3,Low,Urban,,14.0,No,No,,2.0
PT01566,Portugal,Lisbon,74.0,,Leukemia,III,2015-05-31,2015-09-25,2016-05-29,Targeted Therapy,Public,Alive,24.0,BRCA1,No,Former,Moderate,,Low,Urban,Statutory Health Insurance,12.0,Yes,No,Cardiovascular Disease,9.0
PT01567,Ireland,Connacht,42.0,Female,Breast,,2021-11-23,2022-05-06,2022-07-15,Targeted Therapy,Research Institute,Deceased,86.0,BRCA1,No,Current,None,30.6,Medium,Urban,Statutory Health Insurance,17.0,No,No,Diabetes,4.0
PT01568,Austria,Tyrol,53.0,Male,Lung,II,2014-03-10,2014-04-19,2014-07-02,Surgery,Private,Alive,65.0,BRCA1,Yes,Never,None,35.3,Medium,Urban,NHS,18.0,No,No,Diabetes,10.0
PT01569,Belgium,Flanders,88.0,Female,Pancreatic,IV,2016-02-28,2016-07-11,2017-04-27,Surgery,Public,Alive,94.0,None,Yes,Former,Moderate,36.3,High,Urban,NHS,8.0,No,No,None,10.0
PT01570,Germany,North Rhine-Westphalia,34.0,Non-binary,Lung,II,2017-12-02,2018-04-23,2018-06-03,Radiation,Public,Alive,19.0,KRAS,Yes,Current,Heavy,27.3,Medium,Rural,Private Insurance,3.0,No,No,Hypertension,3.0
PT01571,Portugal,,,Female,Pancreatic,II,2019-12-04,2020-04-07,2020-12-25,Targeted Therapy,Public,Deceased,10.0,EGFR,Yes,Current,Moderate,21.4,Low,Rural,NHS,15.0,Yes,No,None,1.0
PT01572,Switzerland,Zurich,22.0,,Pancreatic,III,2014-08-05,2014-11-14,2015-08-03,Immunotherapy,Public,Lost to Follow-up,,KRAS,,Former,Heavy,18.0,Medium,,NHS,19.0,No,No,Cardiovascular Disease,7.0
PT01573,Portugal,Lisbon,47.0,Male,Colorectal,II,2021-03-29,2021-05-01,2022-03-14,Surgery,Public,Alive,110.0,BRCA1,No,Never,Heavy,37.5,High,Rural,Statutory Health Insurance,12.0,No,No,None,8.0
PT01574,,Central Denmark,22.0,Female,Prostate,I,2023-03-04,2023-06-20,2024-04-18,Immunotherapy,Private,Alive,115.0,BRCA1,Yes,Never,Moderate,30.0,Low,Urban,,5.0,No,No,,2.0
PT01575,Poland,Masovian,23.0,Male,Prostate,II,2022-03-13,,2023-03-26,Immunotherapy,Private,Alive,12.0,BRCA1,Yes,Former,None,29.3,Medium,Rural,Statutory Health Insurance,15.0,No,No,Obesity,8.0
PT01576,Ireland,Connacht,50.0,Male,Pancreatic,I,2013-07-23,2014-01-10,2014-12-25,Surgery,Public,Alive,83.0,BRCA1,No,Former,Moderate,,Medium,Rural,Statutory Health Insurance,12.0,No,,,4.0
PT01577,Austria,,64.0,Female,Pancreatic,II,2015-12-12,2016-02-04,2016-05-30,Radiation,Public,Alive,102.0,EGFR,Yes,Never,Moderate,,Medium,Urban,NHS,18.0,No,No,None,4.0
PT01578,France,Auvergne-Rhône-Alpes,78.0,Male,Lung,III,2011-09-22,2011-12-27,,,Public,Deceased,81.0,None,No,Former,Moderate,39.9,High,Urban,Statutory Health Insurance,13.0,No,No,None,7.0
PT01579,Norway,,,Male,Leukemia,I,,2022-03-14,2022-09-29,Surgery,Public,Lost to Follow-up,,KRAS,Yes,Never,,30.5,Low,,NHS,10.0,No,No,Hypertension,5.0
PT01580,Sweden,Stockholm,56.0,Female,Breast,III,2010-10-05,2011-01-05,2011-09-20,Chemotherapy,,Alive,,None,Yes,Current,Moderate,19.6,High,Urban,NHS,,No,No,Diabetes,1.0
PT01581,Netherlands,North Holland,84.0,,Pancreatic,IV,2012-10-20,2013-02-21,2013-06-12,Chemotherapy,Public,Alive,9.0,BRCA1,Yes,Never,Moderate,21.8,High,Urban,Private Insurance,4.0,No,No,Diabetes,6.0
PT01582,Portugal,Lisbon,28.0,Male,Pancreatic,,2021-06-03,2021-09-06,2022-05-04,Immunotherapy,Public,Deceased,57.0,EGFR,Yes,Former,Moderate,24.6,Medium,Urban,Private Insurance,3.0,No,No,Obesity,3.0
PT01583,Belgium,Brussels,36.0,Male,,I,2022-08-27,2022-10-27,2023-05-10,Chemotherapy,Public,Deceased,61.0,EGFR,,Former,None,21.4,Medium,Rural,NHS,9.0,No,No,,
PT01584,Austria,Styria,84.0,Female,Breast,IV,2022-11-27,2023-04-17,2023-06-13,,Public,Deceased,11.0,KRAS,No,,Moderate,,Medium,Urban,NHS,17.0,,No,Hypertension,6.0
PT01585,Portugal,Porto,22.0,Male,Leukemia,III,2013-04-14,2013-10-01,2013-11-21,Targeted Therapy,Research Institute,Deceased,,BRCA1,No,Former,None,28.1,High,Urban,Statutory Health Insurance,,No,,Obesity,10.0
PT01586,Poland,Masovian,45.0,Male,Leukemia,I,2014-09-14,2014-10-02,2015-08-29,Surgery,,Alive,89.0,EGFR,Yes,Never,,27.2,Medium,Urban,Statutory Health Insurance,8.0,No,No,Cardiovascular Disease,9.0
PT01587,Ireland,Dublin,72.0,Female,Breast,II,2015-06-04,2015-09-21,2016-08-09,Surgery,Private,Alive,95.0,KRAS,Yes,Current,Moderate,34.6,Low,Urban,Private Insurance,,No,No,Hypertension,7.0
PT01588,Ireland,Connacht,50.0,Female,Pancreatic,III,2014-05-10,2014-07-21,2014-09-20,Targeted Therapy,Private,Deceased,112.0,KRAS,No,Never,None,36.1,Medium,Urban,Statutory Health Insurance,13.0,No,No,Obesity,1.0
PT01589,,Capital Region,45.0,Male,Pancreatic,II,2010-09-27,2011-01-18,2011-12-24,Immunotherapy,Public,,92.0,EGFR,No,Former,Moderate,23.8,Medium,Urban,NHS,3.0,No,Yes,None,5.0
PT01590,Portugal,Algarve,42.0,,Breast,III,2021-03-21,2021-05-08,2021-10-21,Radiation,Public,Alive,81.0,EGFR,No,Never,,19.0,High,Urban,NHS,11.0,No,No,Hypertension,2.0
PT01591,Switzerland,Bern,49.0,Male,Pancreatic,II,2017-03-05,2017-06-08,2018-04-26,Chemotherapy,,Deceased,18.0,None,Yes,Never,,21.1,Low,Rural,NHS,12.0,No,No,Obesity,2.0
PT01592,Denmark,Central Denmark,29.0,Female,Leukemia,III,2013-10-18,2014-01-10,2014-04-14,Targeted Therapy,Public,Deceased,64.0,None,Yes,Current,Moderate,36.9,Medium,Rural,NHS,9.0,No,Yes,Obesity,3.0
PT01593,Finland,Pirkanmaa,,,,II,2011-06-19,2011-11-30,2012-03-17,Chemotherapy,Private,Alive,62.0,None,No,Never,None,27.2,High,Urban,Private Insurance,4.0,No,No,Hypertension,9.0
,Italy,Lombardy,41.0,Male,Leukemia,III,2014-05-28,2014-08-23,2015-08-03,Radiation,Private,Alive,87.0,BRCA1,Yes,,None,22.9,Medium,Rural,Statutory Health Insurance,8.0,Yes,No,Diabetes,7.0
PT01595,France,Provence-Alpes-Côte d'Azur,34.0,Female,Pancreatic,IV,2016-07-26,2017-01-15,2017-10-26,Immunotherapy,Research Institute,Alive,100.0,KRAS,No,Former,Moderate,39.7,Medium,Rural,Statutory Health Insurance,3.0,No,No,Diabetes,3.0
PT01596,Ireland,Dublin,75.0,Male,,,2022-09-07,2023-01-23,2023-04-25,Chemotherapy,Public,Deceased,51.0,KRAS,No,Never,None,22.8,Medium,Urban,Statutory Health Insurance,12.0,No,No,Obesity,7.0
PT01597,Ireland,Connacht,39.0,Male,Colorectal,III,2017-12-24,2018-05-10,2018-08-23,Immunotherapy,Research Institute,Alive,119.0,,No,Never,Moderate,35.7,Low,Urban,NHS,5.0,No,Yes,Diabetes,10.0
PT01598,Austria,Vienna,66.0,Male,,I,2011-04-09,2011-09-30,2012-08-06,Radiation,Research Institute,Alive,58.0,BRCA1,,Former,Moderate,40.0,High,Urban,Statutory Health Insurance,,No,No,Cardiovascular Disease,6.0
PT01599,,Vestland,72.0,Female,Lung,I,2010-01-23,2010-06-17,2011-05-13,Immunotherapy,Public,Alive,,KRAS,No,Former,Moderate,21.1,Medium,Rural,,15.0,No,No,Hypertension,5.0
PT01600,Portugal,,72.0,Male,Ovarian,IV,2011-11-20,2011-12-23,2012-02-25,Radiation,Private,Alive,74.0,KRAS,Yes,Former,Moderate,33.0,Medium,Urban,NHS,17.0,No,No,Cardiovascular Disease,2.0
PT01601,Spain,Catalonia,20.0,Male,Leukemia,I,2021-02-18,2021-04-24,2021-08-09,Surgery,Public,Alive,,BRCA1,No,Former,None,36.3,Medium,Rural,Private Insurance,11.0,No,Yes,Cardiovascular Disease,5.0
PT01602,Austria,Tyrol,21.0,Male,Breast,I,2021-07-25,2021-12-20,2022-10-08,Chemotherapy,Public,Alive,25.0,EGFR,No,Never,Moderate,38.3,Medium,Rural,,3.0,,No,Diabetes,7.0
PT01603,Ireland,Dublin,77.0,Male,Lung,,2013-07-10,,2014-02-03,Chemotherapy,Public,Deceased,25.0,KRAS,No,Current,None,24.5,,Rural,NHS,4.0,,No,,6.0
PT01604,Belgium,Wallonia,38.0,Male,Pancreatic,II,2020-07-27,2020-12-18,2021-11-09,Radiation,Private,Alive,103.0,EGFR,No,,Moderate,19.7,Medium,Urban,Statutory Health Insurance,,No,Yes,Obesity,7.0
,Finland,Southwest Finland,81.0,Male,Prostate,III,2015-09-14,2016-02-03,2016-03-07,Radiation,Public,Alive,55.0,KRAS,Yes,Never,None,18.8,,,Statutory Health Insurance,10.0,No,No,Obesity,2.0
PT01606,Austria,Vienna,31.0,Male,Breast,I,2016-12-09,2017-04-17,2017-05-18,Targeted Therapy,Private,Alive,19.0,KRAS,No,Never,None,25.9,High,Urban,Private Insurance,6.0,No,No,None,4.0
PT01607,Netherlands,Utrecht,45.0,Male,Leukemia,,2021-06-28,2021-12-08,2022-10-24,Radiation,,Alive,20.0,EGFR,Yes,Never,Moderate,21.4,High,Urban,Private Insurance,14.0,No,No,Diabetes,4.0
PT01608,Switzerland,Bern,46.0,Female,Pancreatic,II,2012-01-07,2012-05-15,,Radiation,Public,,41.0,BRCA1,Yes,Never,None,26.0,Medium,Urban,NHS,5.0,,No,Diabetes,6.0
PT01609,Germany,Berlin,48.0,Female,Pancreatic,II,,2023-05-10,2023-10-01,Immunotherapy,Private,Deceased,35.0,BRCA1,Yes,Former,None,37.7,High,Urban,NHS,1.0,No,No,Hypertension,9.0
PT01610,Poland,Lesser Poland,34.0,Female,Prostate,II,2013-09-02,2013-11-10,2014-04-03,Immunotherapy,Public,Alive,23.0,KRAS,No,Former,Heavy,,Medium,Urban,Statutory Health Insurance,19.0,No,Yes,Hypertension,6.0
PT01611,Poland,Masovian,65.0,,Leukemia,III,2016-07-05,2016-09-18,2017-07-07,Chemotherapy,Public,Deceased,,,No,Never,,30.8,Medium,,NHS,16.0,No,No,,5.0
PT01612,Belgium,Flanders,20.0,Non-binary,Ovarian,II,2010-07-15,2010-10-19,2011-03-21,Immunotherapy,,Alive,31.0,EGFR,No,Former,Heavy,39.5,Low,Urban,NHS,6.0,No,No,Diabetes,1.0
PT01613,Spain,Madrid,79.0,Male,Breast,I,2016-09-27,2017-02-18,2017-11-24,Immunotherapy,Public,Alive,105.0,EGFR,Yes,Former,,26.4,Low,Urban,NHS,1.0,Yes,No,Obesity,5.0
PT01614,Finland,Southwest Finland,76.0,Non-binary,Pancreatic,III,2014-02-13,2014-06-14,2015-05-04,Chemotherapy,Private,Deceased,116.0,None,No,Never,Moderate,,Medium,Urban,NHS,5.0,No,No,None,7.0
PT01615,Germany,Berlin,22.0,Male,Ovarian,I,2015-10-17,2016-02-05,2016-06-04,Surgery,Public,Alive,113.0,,Yes,Never,None,38.8,Medium,Urban,Statutory Health Insurance,10.0,No,No,Obesity,1.0
PT01616,Austria,Tyrol,37.0,Male,Colorectal,I,2017-12-28,2018-03-10,2018-05-27,Targeted Therapy,Public,Lost to Follow-up,,KRAS,Yes,Never,None,30.8,Low,Urban,NHS,6.0,Yes,,None,
PT01617,Poland,Masovian,71.0,Male,Pancreatic,III,2021-01-07,2021-06-06,2022-04-04,Immunotherapy,Private,Alive,88.0,EGFR,No,Former,None,19.2,Medium,Urban,Statutory Health Insurance,15.0,Yes,No,None,8.0
PT01618,Denmark,Central Denmark,79.0,Male,Colorectal,I,2012-05-20,2012-07-11,2013-01-09,Surgery,Research Institute,Deceased,69.0,None,Yes,Never,Moderate,20.8,Low,Urban,Private Insurance,17.0,Yes,No,Hypertension,6.0
PT01619,Portugal,Porto,53.0,Female,Colorectal,II,2010-07-04,2010-12-06,2011-08-14,Targeted Therapy,Public,Alive,111.0,EGFR,No,Never,None,30.8,Medium,Urban,NHS,13.0,No,No,None,10.0
PT01620,Netherlands,South Holland,79.0,Female,,II,2014-08-17,2014-10-20,2015-04-09,Chemotherapy,Public,Alive,73.0,None,,Current,Moderate,28.6,Low,Urban,NHS,2.0,No,No,Hypertension,8.0
PT01621,Portugal,Lisbon,45.0,Non-binary,Breast,II,2013-04-27,2013-06-11,2014-02-16,Immunotherapy,Public,Alive,111.0,EGFR,,Never,Moderate,27.9,Medium,Rural,Statutory Health Insurance,2.0,,Yes,Cardiovascular Disease,2.0
PT01622,,Vienna,38.0,Female,Prostate,II,2019-12-25,2020-01-20,2020-11-05,,Public,Alive,96.0,EGFR,No,Never,Moderate,30.0,High,Urban,NHS,15.0,No,Yes,None,3.0
PT01623,Switzerland,Zurich,41.0,Male,Pancreatic,IV,2011-05-13,2011-10-01,2012-05-16,Radiation,Public,Alive,60.0,KRAS,Yes,Current,Moderate,26.0,Low,Urban,Statutory Health Insurance,16.0,No,No,Obesity,2.0
PT01624,Norway,Trøndelag,52.0,Male,Breast,II,2014-04-15,2014-09-20,2015-01-10,Immunotherapy,Public,Alive,72.0,BRCA1,Yes,Never,Moderate,36.3,High,Rural,Statutory Health Insurance,17.0,No,No,Diabetes,10.0
PT01625,Ireland,Connacht,57.0,Non-binary,Breast,,,2014-10-07,2015-06-06,Immunotherapy,Public,Lost to Follow-up,,BRCA1,,Never,None,38.8,Medium,Urban,Private Insurance,1.0,No,Yes,Hypertension,4.0
PT01626,Switzerland,,54.0,Female,Prostate,IV,2010-08-06,2010-09-05,2011-08-07,Surgery,Research Institute,Deceased,118.0,BRCA1,Yes,Current,None,24.9,Low,Urban,NHS,5.0,Yes,No,Diabetes,4.0
PT01627,France,Auvergne-Rhône-Alpes,86.0,Female,Prostate,,2022-08-26,2023-02-14,2023-10-14,Surgery,,Deceased,49.0,BRCA1,No,Former,Moderate,32.9,Medium,Urban,Private Insurance,2.0,No,No,,9.0
PT01628,Sweden,Stockholm,29.0,Male,Pancreatic,II,2013-09-23,2014-03-18,2015-01-14,Immunotherapy,Private,Alive,64.0,BRCA1,No,Current,None,26.3,High,Urban,NHS,3.0,No,No,Cardiovascular Disease,3.0
PT01629,Belgium,Wallonia,34.0,Female,Ovarian,II,2021-07-18,2021-10-28,2022-04-01,Targeted Therapy,Public,Alive,17.0,BRCA1,,,Moderate,,Medium,Urban,NHS,10.0,Yes,No,Diabetes,
PT01630,Italy,Lombardy,30.0,Female,Leukemia,II,2014-02-14,2014-02-23,2014-05-24,Chemotherapy,Private,Alive,41.0,None,Yes,Former,None,22.6,High,Urban,Private Insurance,12.0,No,No,Obesity,9.0
PT01631,Spain,Catalonia,43.0,Male,Lung,,2015-11-29,,2016-07-22,Surgery,Public,Alive,108.0,None,Yes,Never,None,23.3,Medium,Urban,Statutory Health Insurance,7.0,No,No,Obesity,4.0
PT01632,Portugal,Porto,23.0,Male,Pancreatic,I,2015-08-19,2015-11-23,2016-01-06,Targeted Therapy,Public,,7.0,EGFR,No,Current,Moderate,28.8,Low,Rural,Statutory Health Insurance,18.0,No,No,Obesity,5.0
PT01633,Austria,Tyrol,32.0,,Lung,IV,2021-10-27,2022-01-03,2022-03-13,Immunotherapy,Public,Alive,47.0,EGFR,Yes,Never,None,23.8,High,Urban,Statutory Health Insurance,11.0,No,No,Cardiovascular Disease,9.0
PT01634,Switzerland,Zurich,76.0,Female,Leukemia,II,,2012-07-19,2013-07-04,Radiation,Public,Alive,39.0,BRCA1,No,Former,None,29.3,Low,Urban,Private Insurance,,Yes,No,Cardiovascular Disease,2.0
PT01635,Belgium,Brussels,56.0,Male,Colorectal,III,2023-07-28,2023-10-25,2024-08-25,Surgery,Research Institute,,107.0,BRCA1,Yes,Never,None,18.0,Medium,Urban,Statutory Health Insurance,12.0,No,No,Cardiovascular Disease,10.0
PT01636,,Silesian,67.0,Male,Ovarian,I,2021-02-02,2021-02-23,2021-11-12,Surgery,Private,Deceased,36.0,None,No,Never,Heavy,24.9,High,Urban,Private Insurance,,No,No,Cardiovascular Disease,5.0
PT01637,Belgium,Wallonia,20.0,Male,Pancreatic,IV,2020-03-08,2020-05-25,2021-05-10,Radiation,Private,Alive,74.0,KRAS,Yes,Never,Moderate,26.6,Low,Urban,Private Insurance,4.0,No,No,Cardiovascular Disease,7.0
PT01638,Finland,Uusimaa,79.0,Female,Breast,I,2016-03-01,2016-03-31,2017-02-11,Immunotherapy,Public,Alive,25.0,KRAS,No,Former,Moderate,31.7,,Urban,Private Insurance,16.0,No,No,Diabetes,10.0
PT01639,Belgium,Flanders,31.0,Male,Prostate,III,2016-11-05,2017-01-01,2017-09-27,Surgery,Private,Lost to Follow-up,,KRAS,Yes,Current,Moderate,19.0,Medium,Urban,Private Insurance,6.0,No,No,Hypertension,2.0
PT01640,Norway,Oslo,40.0,Male,Pancreatic,II,2016-04-27,2016-06-21,2016-12-17,Immunotherapy,Research Institute,Alive,43.0,BRCA1,No,Current,Moderate,38.3,,Urban,NHS,19.0,No,Yes,Obesity,2.0
PT01641,France,Île-de-France,30.0,Female,Prostate,III,2023-08-02,2023-08-04,2023-11-03,Targeted Therapy,Private,Alive,80.0,None,No,Never,Moderate,24.8,Medium,Urban,NHS,11.0,No,No,Diabetes,8.0
PT01642,Sweden,Skåne,63.0,Female,Colorectal,III,2012-10-29,2012-12-16,2013-08-23,Surgery,Private,Alive,100.0,None,Yes,Former,Moderate,28.9,Low,Urban,Private Insurance,13.0,No,No,Diabetes,8.0
PT01643,Austria,Tyrol,77.0,Male,,I,2020-07-11,,2021-05-09,Immunotherapy,Research Institute,Lost to Follow-up,,KRAS,No,Current,Heavy,33.3,Medium,Rural,NHS,4.0,Yes,No,Cardiovascular Disease,10.0
PT01644,Switzerland,Bern,63.0,Female,Colorectal,II,2023-09-28,2024-02-16,2024-03-27,Targeted Therapy,Public,,,None,No,Current,None,26.1,High,Rural,NHS,19.0,,No,Diabetes,1.0
PT01645,France,Île-de-France,53.0,Female,Ovarian,I,2018-09-20,2018-12-18,2019-02-23,Surgery,,,9.0,KRAS,Yes,Never,Moderate,31.9,Low,Urban,Statutory Health Insurance,19.0,No,,Cardiovascular Disease,8.0
PT01646,Denmark,Central Denmark,44.0,Male,Leukemia,II,2010-12-06,2011-03-28,2011-06-30,Chemotherapy,Public,Deceased,90.0,BRCA1,No,Former,,28.9,High,Urban,Private Insurance,1.0,No,No,Cardiovascular Disease,5.0
PT01647,Netherlands,South Holland,23.0,,Colorectal,III,2015-09-26,2015-11-08,2016-06-15,Immunotherapy,Public,Alive,67.0,BRCA1,No,Never,None,28.4,Low,Urban,NHS,16.0,No,No,Diabetes,2.0
PT01648,Spain,Madrid,83.0,Female,Lung,I,2023-06-27,2023-09-10,2023-11-16,Targeted Therapy,,Alive,110.0,BRCA1,Yes,Former,Moderate,22.0,Low,Urban,Private Insurance,14.0,No,Yes,,1.0
,Norway,Oslo,35.0,Male,Pancreatic,II,2023-06-10,2023-08-23,2024-06-02,Chemotherapy,Public,Deceased,6.0,None,Yes,Never,Moderate,26.6,Low,,NHS,9.0,No,Yes,Cardiovascular Disease,9.0
PT01650,Netherlands,South Holland,29.0,Male,Colorectal,III,2011-05-04,2011-06-22,2012-04-15,,Research Institute,Alive,47.0,EGFR,Yes,Former,Moderate,22.6,Low,Rural,NHS,2.0,No,No,Obesity,7.0
PT01651,Spain,Catalonia,85.0,Female,Pancreatic,I,2013-09-07,2014-02-19,2014-11-19,Surgery,Public,Alive,56.0,BRCA1,No,Never,None,35.4,High,Urban,Statutory Health Insurance,18.0,No,No,Diabetes,3.0
PT01652,Germany,Bavaria,54.0,Female,Leukemia,IV,2012-03-01,2012-06-17,2013-04-22,Immunotherapy,Public,Alive,118.0,None,No,Never,Moderate,20.9,High,Urban,Private Insurance,19.0,No,No,None,10.0
PT01653,Norway,Oslo,25.0,Female,Ovarian,II,2019-08-18,2019-09-22,2020-08-08,Targeted Therapy,Public,,42.0,KRAS,Yes,Current,None,18.9,Medium,Rural,Private Insurance,19.0,No,No,Diabetes,4.0
PT01654,Denmark,Zealand,38.0,Male,Colorectal,I,2021-06-20,2021-07-09,,Surgery,Private,Deceased,48.0,BRCA1,Yes,Former,,26.7,Low,Urban,NHS,12.0,No,,Cardiovascular Disease,8.0
PT01655,Netherlands,Utrecht,78.0,Female,Leukemia,I,2015-01-09,2015-02-06,2015-04-19,,Public,Alive,97.0,EGFR,Yes,Current,Moderate,18.3,Medium,Urban,Private Insurance,12.0,No,Yes,Hypertension,7.0
PT01656,Poland,Lesser Poland,72.0,Male,Lung,II,2013-04-01,2013-07-16,2013-12-01,Surgery,Private,Alive,67.0,EGFR,No,Current,Moderate,25.9,Low,Rural,NHS,8.0,No,No,Hypertension,3.0
PT01657,Belgium,,27.0,Female,Ovarian,II,2021-08-04,2021-11-24,2022-04-01,Radiation,Research Institute,Deceased,56.0,KRAS,No,Never,None,35.2,Medium,Urban,Private Insurance,,No,No,Cardiovascular Disease,4.0
PT01658,Spain,Madrid,29.0,Female,Breast,I,2019-06-18,2019-10-11,2019-12-22,,Public,Alive,58.0,EGFR,No,Former,Moderate,35.6,High,Rural,Statutory Health Insurance,5.0,No,No,Obesity,4.0
PT01659,Switzerland,Bern,86.0,Female,Leukemia,I,2022-01-25,2022-07-15,2022-11-25,Chemotherapy,Public,Lost to Follow-up,,None,Yes,Former,None,26.3,Medium,Rural,NHS,5.0,Yes,No,Obesity,10.0
PT01660,Switzerland,Geneva,,Male,Breast,II,,2019-04-14,2019-11-22,Surgery,Public,Alive,6.0,KRAS,No,Never,Moderate,31.6,Low,Urban,Private Insurance,12.0,,No,None,8.0
PT01661,Spain,Madrid,,Female,Leukemia,II,2014-09-03,2015-01-19,2015-06-12,Targeted Therapy,Public,Alive,,EGFR,No,Current,None,31.7,Medium,Urban,,16.0,Yes,No,Diabetes,7.0
PT01662,Italy,Lombardy,34.0,Female,Ovarian,I,,2020-01-27,2020-04-11,Radiation,Public,Alive,21.0,EGFR,,Former,Heavy,27.5,Medium,Rural,NHS,17.0,No,No,Diabetes,3.0
PT01663,Belgium,Flanders,,Female,Colorectal,III,2011-12-04,2012-03-09,2012-06-08,Radiation,Public,Alive,7.0,BRCA1,Yes,Never,Moderate,29.9,High,Urban,Statutory Health Insurance,,No,No,None,
PT01664,Spain,,65.0,Male,,,2023-11-05,2023-11-29,2024-04-20,Surgery,Private,Alive,7.0,None,No,Former,None,31.7,High,Urban,Private Insurance,15.0,No,Yes,Obesity,3.0
PT01665,Austria,Styria,47.0,Female,Ovarian,IV,2013-06-27,2013-11-02,2014-06-17,Targeted Therapy,Private,Alive,112.0,EGFR,,Former,None,27.7,Medium,Urban,NHS,16.0,Yes,No,Hypertension,1.0
PT01666,France,Auvergne-Rhône-Alpes,45.0,Male,Leukemia,IV,2011-06-23,2011-12-12,2012-09-18,Radiation,Public,Lost to Follow-up,,EGFR,No,,Moderate,38.8,Medium,Urban,Statutory Health Insurance,8.0,No,No,Hypertension,8.0
PT01667,Poland,Silesian,29.0,Female,Pancreatic,,2020-04-11,2020-09-16,2021-01-28,Surgery,Private,Alive,63.0,BRCA1,Yes,Current,Moderate,37.0,Low,Urban,Private Insurance,10.0,No,No,Cardiovascular Disease,
PT01668,Austria,Tyrol,66.0,Female,Leukemia,I,2021-07-14,2021-11-06,2022-01-03,Immunotherapy,Public,Alive,22.0,BRCA1,No,Former,None,33.4,Low,Rural,NHS,3.0,No,No,,9.0
PT01669,Spain,Andalusia,23.0,Male,Breast,I,2018-01-18,2018-03-04,2018-09-18,Immunotherapy,Private,Alive,91.0,EGFR,No,Current,Moderate,30.4,Medium,Urban,Private Insurance,11.0,No,No,Hypertension,6.0
PT01670,Norway,Vestland,74.0,,Pancreatic,,2017-02-27,2017-06-25,2017-08-08,Immunotherapy,Public,Alive,85.0,None,Yes,Former,Moderate,33.2,Low,Urban,Statutory Health Insurance,14.0,No,No,Obesity,6.0
PT01671,Denmark,Zealand,85.0,Male,Ovarian,III,2011-05-01,2011-06-30,2011-11-28,Chemotherapy,Public,Alive,82.0,BRCA1,Yes,Never,Moderate,36.3,Low,Urban,Private Insurance,8.0,No,Yes,Diabetes,6.0
PT01672,Switzerland,Zurich,,Female,Leukemia,IV,2013-10-18,2014-02-11,2014-03-31,Targeted Therapy,Public,Alive,12.0,EGFR,No,,None,20.6,Low,Urban,Statutory Health Insurance,16.0,No,Yes,Obesity,5.0
PT01673,Switzerland,Zurich,26.0,Male,Breast,I,2012-11-15,,2013-05-12,,Public,Deceased,119.0,EGFR,Yes,,None,20.4,Low,Urban,Statutory Health Insurance,2.0,No,No,None,4.0
PT01674,Belgium,Flanders,74.0,Male,Lung,II,2012-02-23,2012-06-05,2013-04-14,Radiation,Private,Alive,,EGFR,Yes,Former,Moderate,26.3,Medium,Urban,Private Insurance,3.0,No,No,Cardiovascular Disease,10.0
PT01675,France,Île-de-France,50.0,Female,Prostate,,2018-05-18,2018-06-12,,Chemotherapy,Public,Alive,22.0,None,No,Former,None,38.8,,Urban,,7.0,No,No,,6.0
PT01676,Netherlands,South Holland,38.0,Male,Lung,II,2018-01-03,2018-04-15,2018-07-06,Immunotherapy,Public,Alive,26.0,None,Yes,,Moderate,21.0,High,Urban,Statutory Health Insurance,9.0,No,No,Obesity,8.0
PT01677,Switzerland,Geneva,47.0,Male,Breast,II,2011-09-12,2012-01-22,2012-12-14,Surgery,Public,Alive,100.0,BRCA1,No,Never,Moderate,29.3,High,Rural,NHS,1.0,No,No,None,2.0
PT01678,Poland,Masovian,47.0,Female,Colorectal,I,2022-05-07,2022-08-07,2023-07-31,Radiation,Public,Alive,84.0,BRCA1,No,Never,None,23.0,High,Rural,Private Insurance,11.0,No,No,None,8.0
PT01679,Portugal,Porto,38.0,Male,Colorectal,IV,2019-09-03,2019-10-04,2020-02-01,Chemotherapy,Public,Alive,69.0,EGFR,Yes,Never,Moderate,21.4,Medium,Rural,Statutory Health Insurance,17.0,No,No,Cardiovascular Disease,4.0
PT01680,Finland,Southwest Finland,39.0,Male,Prostate,II,2022-05-22,2022-10-16,2022-12-03,Chemotherapy,Private,Alive,48.0,BRCA1,Yes,Never,Moderate,37.3,Medium,Rural,Private Insurance,13.0,Yes,No,Diabetes,2.0
PT01681,Poland,Silesian,32.0,Male,Breast,II,2021-11-17,2021-11-19,2022-03-05,Radiation,Public,Alive,92.0,KRAS,No,Former,Heavy,33.3,Medium,Urban,Statutory Health Insurance,10.0,No,No,Hypertension,10.0
PT01682,Belgium,Flanders,62.0,Female,Pancreatic,,2019-07-07,2019-07-11,2019-12-17,Immunotherapy,,Deceased,58.0,BRCA1,Yes,Never,None,32.2,Low,Urban,Statutory Health Insurance,,No,No,Diabetes,6.0
,Belgium,Flanders,30.0,Female,Leukemia,II,,2015-02-27,2015-08-21,Surgery,Public,Alive,46.0,None,Yes,Former,Heavy,30.6,Medium,Rural,Private Insurance,1.0,No,No,Obesity,1.0
PT01684,Spain,Andalusia,67.0,Male,Lung,I,2013-01-03,2013-02-10,2013-11-11,Surgery,Public,Alive,115.0,None,Yes,Never,Moderate,33.8,Medium,Rural,Statutory Health Insurance,5.0,No,No,Hypertension,9.0
PT01685,Austria,Tyrol,34.0,,Pancreatic,I,2010-04-22,2010-05-25,2010-12-21,Surgery,Public,Deceased,31.0,None,No,,None,34.8,Low,Rural,NHS,14.0,No,No,Obesity,7.0
PT01686,Germany,Berlin,36.0,Male,Ovarian,I,2023-05-10,2023-05-28,2023-11-09,Chemotherapy,Public,Alive,99.0,BRCA1,No,Current,Moderate,26.1,Medium,Urban,Statutory Health Insurance,13.0,,Yes,None,10.0
PT01687,Poland,Lesser Poland,73.0,Female,Lung,I,,2012-12-09,2013-08-07,Immunotherapy,Public,Lost to Follow-up,,BRCA1,No,Never,Moderate,26.6,Low,Urban,Private Insurance,19.0,Yes,Yes,Hypertension,10.0
PT01688,Sweden,Skåne,69.0,Male,Prostate,II,2014-06-22,2014-11-29,2015-05-14,Radiation,Public,Deceased,80.0,None,Yes,Never,Moderate,22.3,Medium,Urban,Statutory Health Insurance,9.0,No,No,Diabetes,3.0
PT01689,Norway,Oslo,47.0,Female,Prostate,II,2010-12-26,2011-04-20,2011-12-10,Targeted Therapy,Public,Alive,107.0,None,Yes,Former,None,37.0,High,,NHS,11.0,Yes,No,None,
PT01690,Spain,Andalusia,23.0,,Ovarian,IV,2023-04-25,2023-10-03,2024-03-29,Surgery,Private,Alive,31.0,KRAS,,Former,None,21.0,Low,Urban,Private Insurance,2.0,No,Yes,Hypertension,6.0
PT01691,Denmark,,41.0,Female,Prostate,I,2012-07-07,2012-08-10,2012-10-22,Radiation,Private,Alive,75.0,EGFR,Yes,Never,Moderate,30.1,Medium,Urban,Private Insurance,10.0,Yes,No,None,3.0
PT01692,Germany,North Rhine-Westphalia,58.0,Female,Ovarian,I,2010-06-17,2010-08-07,2010-11-04,Radiation,Public,Alive,115.0,EGFR,No,Never,None,18.7,Low,Urban,NHS,14.0,No,No,Diabetes,10.0
PT01693,Netherlands,South Holland,53.0,Female,Pancreatic,IV,2019-02-04,2019-04-08,2020-03-29,Surgery,Public,Alive,72.0,KRAS,No,Former,None,29.2,Medium,Rural,,17.0,No,No,Obesity,8.0
PT01694,Ireland,Munster,63.0,Male,Pancreatic,I,,2020-10-25,,Targeted Therapy,Public,Alive,94.0,BRCA1,Yes,,Heavy,36.9,Medium,Rural,Private Insurance,17.0,,No,Obesity,10.0
PT01695,Belgium,Brussels,61.0,Female,Prostate,I,2017-09-06,2018-01-25,2018-06-29,Chemotherapy,Private,Alive,110.0,BRCA1,No,Former,Heavy,38.4,Low,Urban,Statutory Health Insurance,12.0,No,Yes,None,6.0
PT01696,Belgium,Flanders,59.0,Male,Pancreatic,I,2016-03-10,2016-05-01,2016-07-14,Chemotherapy,Public,Lost to Follow-up,,None,Yes,Never,Moderate,36.6,,Rural,NHS,7.0,Yes,No,None,6.0
PT01697,Sweden,Västra Götaland,31.0,Male,Prostate,III,2023-05-16,2023-08-17,2023-09-17,Immunotherapy,Research Institute,Alive,84.0,BRCA1,No,Never,None,34.8,Medium,Rural,Private Insurance,8.0,,No,Cardiovascular Disease,8.0
PT01698,Netherlands,North Holland,21.0,Male,Pancreatic,III,2015-02-13,2015-04-06,2015-10-14,Chemotherapy,Public,Deceased,64.0,None,Yes,Former,Heavy,21.5,High,Rural,Statutory Health Insurance,3.0,No,Yes,Obesity,9.0
,Finland,Uusimaa,47.0,Female,Prostate,II,2017-10-10,2018-03-30,2018-11-11,Radiation,Private,Alive,26.0,None,No,Never,None,31.1,,Urban,Private Insurance,19.0,No,No,Hypertension,4.0
PT01700,Sweden,,86.0,Female,Leukemia,III,2023-08-15,2023-11-29,2024-07-09,Chemotherapy,Research Institute,Alive,47.0,None,No,Current,None,20.7,Low,Urban,Private Insurance,11.0,Yes,No,Diabetes,5.0
PT01701,France,Auvergne-Rhône-Alpes,29.0,Female,Leukemia,II,2012-01-28,2012-05-05,2013-04-17,Immunotherapy,Public,Deceased,75.0,KRAS,Yes,Former,Moderate,19.8,Medium,Rural,NHS,10.0,No,Yes,Obesity,7.0
PT01702,Sweden,Stockholm,76.0,Female,Ovarian,IV,2023-02-05,2023-06-16,2023-08-31,Radiation,Private,Alive,28.0,BRCA1,No,Never,None,18.2,Medium,Urban,Private Insurance,16.0,No,Yes,Hypertension,3.0
PT01703,France,Provence-Alpes-Côte d'Azur,56.0,Male,Lung,I,2022-04-21,2022-06-19,2023-03-01,Radiation,Private,Deceased,62.0,KRAS,Yes,Former,Moderate,22.9,Low,Urban,NHS,5.0,Yes,No,None,5.0
PT01704,Germany,,,Female,Ovarian,III,2020-06-14,2020-10-19,2020-11-19,Targeted Therapy,Public,Deceased,58.0,BRCA1,No,Current,None,34.3,Medium,Urban,Private Insurance,4.0,Yes,No,Obesity,4.0
PT01705,Germany,Bavaria,59.0,Female,Lung,I,2015-05-28,2015-08-05,2016-04-02,Surgery,Public,Alive,81.0,EGFR,No,,Moderate,,Low,Urban,Statutory Health Insurance,5.0,No,No,Diabetes,4.0
PT01706,Finland,Pirkanmaa,79.0,Female,Ovarian,II,2017-06-01,2017-10-05,2018-06-06,Surgery,Private,Alive,32.0,BRCA1,Yes,Never,Moderate,21.6,Low,Urban,Private Insurance,15.0,No,No,None,4.0
PT01707,Poland,,67.0,Male,Prostate,I,2010-04-08,2010-08-16,2011-07-04,Surgery,Research Institute,Alive,67.0,KRAS,Yes,Never,None,23.5,Medium,Rural,Statutory Health Insurance,1.0,No,No,Diabetes,9.0
PT01708,Switzerland,Zurich,38.0,Non-binary,Lung,III,2018-06-04,2018-07-18,2018-11-04,Immunotherapy,Private,Deceased,84.0,EGFR,Yes,Former,None,23.9,Medium,Rural,Private Insurance,16.0,No,,Diabetes,6.0
PT01709,Switzerland,Geneva,52.0,Female,Pancreatic,III,2015-04-04,2015-08-10,2016-01-05,Chemotherapy,Research Institute,Deceased,77.0,EGFR,No,Former,None,36.1,Medium,Urban,Private Insurance,12.0,No,No,Cardiovascular Disease,7.0
PT01710,Denmark,Capital Region,63.0,Female,Prostate,II,2016-01-16,2016-02-23,2016-06-17,Surgery,Private,Alive,30.0,EGFR,No,Former,None,,Medium,Urban,,16.0,No,Yes,Obesity,3.0
PT01711,Norway,Trøndelag,56.0,Male,Leukemia,III,2010-03-28,2010-08-30,2011-08-13,Chemotherapy,Public,,48.0,KRAS,Yes,Former,Heavy,22.7,Low,Rural,,9.0,No,No,,9.0
PT01712,Spain,Madrid,55.0,Female,Colorectal,III,2014-11-02,2015-02-01,2015-04-27,Surgery,Public,Alive,53.0,BRCA1,No,Current,None,27.3,Low,Urban,Statutory Health Insurance,8.0,No,No,Obesity,8.0
PT01713,Netherlands,Utrecht,40.0,Female,Leukemia,III,2018-09-27,2019-01-31,2019-05-03,Targeted Therapy,Public,Alive,66.0,BRCA1,No,Never,None,37.5,High,Urban,Statutory Health Insurance,16.0,No,No,Diabetes,10.0
PT01714,Poland,Silesian,21.0,Male,Breast,I,2022-06-05,,2022-07-27,Chemotherapy,Public,Alive,,None,No,Never,None,34.4,Medium,Rural,Statutory Health Insurance,4.0,No,No,Diabetes,2.0
PT01715,Ireland,Munster,50.0,Male,Leukemia,II,2019-12-27,2020-06-11,2021-01-09,Immunotherapy,Private,Alive,40.0,None,Yes,Never,Moderate,32.7,High,Urban,NHS,17.0,No,No,Hypertension,6.0
PT01716,Netherlands,North Holland,49.0,Male,Breast,I,2020-01-26,2020-07-10,2021-03-31,Immunotherapy,Private,Alive,,KRAS,Yes,Never,,38.2,Medium,Urban,Statutory Health Insurance,9.0,Yes,No,None,2.0
PT01717,Denmark,Central Denmark,63.0,Female,Lung,II,2011-11-13,2012-01-15,2012-05-13,Chemotherapy,Private,Deceased,23.0,BRCA1,No,Never,Moderate,35.5,Medium,Urban,NHS,8.0,No,No,Diabetes,8.0
PT01718,Italy,Sicily,31.0,Male,,III,2021-07-18,2021-09-18,2022-01-29,Immunotherapy,Public,Alive,98.0,None,Yes,Never,,25.4,Low,Urban,Statutory Health Insurance,9.0,No,No,Cardiovascular Disease,10.0
PT01719,Denmark,Capital Region,70.0,Male,Colorectal,III,2022-07-29,2022-10-15,2023-08-19,Radiation,Research Institute,Alive,96.0,KRAS,Yes,Never,Moderate,19.2,High,Rural,Statutory Health Insurance,13.0,Yes,No,None,6.0
PT01720,Netherlands,South Holland,68.0,Female,Pancreatic,III,2022-11-21,2022-12-09,2023-09-14,Immunotherapy,Public,Alive,,BRCA1,Yes,Never,None,,Medium,Urban,Private Insurance,10.0,No,No,,5.0
PT01721,Belgium,Flanders,43.0,,Leukemia,II,2016-10-05,2017-03-11,2017-08-15,Targeted Therapy,Private,Alive,79.0,EGFR,Yes,Never,Moderate,26.4,High,Rural,Statutory Health Insurance,5.0,No,Yes,Obesity,4.0
PT01722,Italy,,43.0,Male,Pancreatic,III,2010-05-15,2010-07-25,2011-02-19,Targeted Therapy,Public,Alive,,EGFR,Yes,Never,Moderate,25.8,Low,Rural,NHS,16.0,No,Yes,Obesity,1.0
PT01723,Poland,Silesian,79.0,Male,Leukemia,II,2022-01-28,2022-02-21,2022-06-23,Chemotherapy,Public,Alive,10.0,KRAS,No,Never,Heavy,36.5,Medium,Urban,NHS,5.0,,No,Diabetes,6.0
PT01724,,Central Denmark,30.0,,Leukemia,IV,2016-02-24,2016-04-02,2016-10-30,,Public,Alive,27.0,KRAS,No,Former,Moderate,39.6,Medium,Urban,NHS,8.0,Yes,No,Obesity,5.0
PT01725,Italy,Lombardy,32.0,Female,Pancreatic,II,2020-05-17,2020-09-28,2021-05-27,Chemotherapy,Public,Deceased,61.0,KRAS,No,Never,Heavy,39.1,Medium,Rural,Statutory Health Insurance,16.0,No,Yes,Obesity,6.0
PT01726,Germany,North Rhine-Westphalia,83.0,Male,Pancreatic,III,2021-03-30,2021-08-25,2022-04-15,Surgery,Private,Alive,19.0,EGFR,No,Never,Moderate,32.5,Medium,Urban,NHS,11.0,No,No,Diabetes,6.0
PT01727,Belgium,Flanders,39.0,Female,Prostate,III,2023-08-05,2024-01-22,2024-03-28,Radiation,Private,Alive,45.0,BRCA1,Yes,Never,None,26.9,High,Urban,Statutory Health Insurance,18.0,Yes,No,Diabetes,5.0
PT01728,Ireland,Munster,47.0,Male,Leukemia,IV,2018-10-07,,2019-07-03,Chemotherapy,Private,Deceased,6.0,None,No,Current,Moderate,26.2,High,Urban,Statutory Health Insurance,19.0,No,Yes,Obesity,3.0
PT01729,Norway,Trøndelag,21.0,Non-binary,Leukemia,II,2012-01-05,2012-06-14,2012-12-06,Chemotherapy,Public,Alive,82.0,KRAS,Yes,Former,Moderate,18.5,Low,Urban,,18.0,No,No,Diabetes,10.0
PT01730,Germany,North Rhine-Westphalia,62.0,Male,Colorectal,II,2013-02-07,2013-03-25,2013-06-21,Chemotherapy,Public,Deceased,32.0,None,No,Former,Moderate,37.1,Medium,Urban,NHS,8.0,No,,Cardiovascular Disease,9.0
PT01731,Sweden,Skåne,27.0,Male,Pancreatic,II,2018-06-26,2018-10-09,2019-03-16,Chemotherapy,Public,Lost to Follow-up,,None,No,Never,Moderate,37.8,Medium,Rural,Private Insurance,18.0,No,No,Hypertension,7.0
PT01732,Poland,Silesian,,Male,Pancreatic,II,2019-07-04,2019-12-21,2020-06-08,Targeted Therapy,Private,Deceased,54.0,None,No,Former,Heavy,22.5,Medium,Urban,Private Insurance,3.0,Yes,No,Diabetes,10.0
PT01733,Denmark,Capital Region,54.0,Male,Breast,III,,2019-06-07,2019-08-08,Radiation,Public,Alive,117.0,KRAS,No,Former,Moderate,25.7,Medium,Urban,NHS,16.0,No,No,Hypertension,6.0
PT01734,,Wallonia,42.0,Female,Breast,IV,,2015-08-16,2015-10-06,Surgery,Public,Alive,63.0,None,No,Former,Moderate,31.6,Medium,Urban,Private Insurance,12.0,No,No,Obesity,8.0
PT01735,Poland,Lesser Poland,,Female,Pancreatic,I,2021-04-04,2021-05-30,2022-01-19,Radiation,,Deceased,86.0,EGFR,No,Former,Heavy,24.5,Low,Urban,NHS,9.0,No,No,Diabetes,3.0
PT01736,Italy,Lombardy,34.0,Female,Colorectal,II,2018-08-11,2018-10-27,2019-02-05,,Public,Alive,77.0,None,,Never,None,25.8,Medium,Urban,Statutory Health Insurance,5.0,Yes,No,None,
PT01737,Netherlands,South Holland,21.0,Male,Lung,IV,,2013-06-20,2014-01-16,Targeted Therapy,Private,Alive,97.0,EGFR,No,Former,None,28.1,Low,Urban,Statutory Health Insurance,2.0,No,No,Cardiovascular Disease,3.0
PT01738,Ireland,Munster,80.0,Male,,I,2013-04-02,2013-04-15,2013-11-18,Surgery,Public,Alive,31.0,None,Yes,Current,Moderate,,High,Rural,Statutory Health Insurance,17.0,No,No,None,10.0
PT01739,Sweden,Skåne,83.0,Male,,II,2010-01-07,2010-03-02,2010-05-20,Chemotherapy,Public,Alive,25.0,KRAS,No,Never,Moderate,20.4,Medium,Urban,NHS,,No,Yes,Obesity,1.0
PT01740,Switzerland,Bern,71.0,Male,Colorectal,IV,2015-10-10,2016-02-27,2017-02-12,Chemotherapy,Public,Deceased,,EGFR,Yes,Current,Moderate,34.0,Medium,Urban,NHS,2.0,No,Yes,None,5.0
PT01741,Italy,Veneto,55.0,Female,Lung,IV,2023-09-30,2023-11-04,2024-02-24,Immunotherapy,Public,Alive,19.0,EGFR,,Never,Moderate,21.5,High,Urban,NHS,1.0,No,No,None,6.0
PT01742,Finland,Pirkanmaa,86.0,Male,Breast,II,2016-12-07,2017-02-28,2017-04-22,Radiation,Public,Alive,119.0,BRCA1,No,Current,Moderate,36.9,High,Rural,Statutory Health Insurance,6.0,No,,None,4.0
PT01743,Norway,Oslo,88.0,Female,Prostate,I,2022-12-11,2022-12-20,2023-03-28,Radiation,Public,Deceased,30.0,BRCA1,Yes,Never,None,25.1,Low,Rural,Private Insurance,2.0,No,No,Hypertension,8.0
PT01744,Germany,Berlin,86.0,Female,Lung,I,2019-08-24,2019-09-06,2019-10-13,Radiation,Public,Deceased,41.0,KRAS,Yes,Never,Moderate,23.6,High,Rural,Private Insurance,,No,Yes,Hypertension,
PT01745,Norway,Trøndelag,66.0,Male,Prostate,II,2013-12-08,2013-12-30,2014-10-04,Immunotherapy,,Deceased,33.0,EGFR,No,Never,None,33.6,Medium,Urban,Statutory Health Insurance,18.0,Yes,No,None,4.0
PT01746,Italy,Sicily,21.0,Female,Lung,I,2012-07-24,2012-09-02,2013-01-08,Targeted Therapy,Public,Alive,13.0,BRCA1,No,Never,Moderate,35.0,Medium,Rural,,17.0,No,No,Obesity,8.0
PT01747,Spain,Andalusia,63.0,Male,Colorectal,I,2011-07-14,,2012-12-10,Targeted Therapy,Public,Lost to Follow-up,,BRCA1,No,Never,Heavy,24.9,Medium,Urban,Private Insurance,7.0,No,Yes,Cardiovascular Disease,4.0
PT01748,Poland,Masovian,83.0,Male,Prostate,III,2021-06-18,2021-10-13,2022-05-28,Targeted Therapy,Public,Alive,54.0,KRAS,No,Never,None,37.8,High,Urban,NHS,16.0,No,Yes,Obesity,1.0
PT01749,Netherlands,South Holland,47.0,Female,Lung,III,2011-03-22,2011-07-27,2012-07-05,Surgery,Public,Alive,102.0,EGFR,Yes,Former,None,32.6,Medium,Rural,NHS,13.0,No,,None,6.0
PT01750,Italy,Sicily,73.0,Male,Colorectal,III,2013-08-01,2014-01-17,2014-09-11,Immunotherapy,Public,Alive,11.0,EGFR,No,Never,Moderate,20.8,Medium,Urban,Private Insurance,15.0,Yes,No,Obesity,5.0
PT01751,Sweden,Västra Götaland,86.0,Male,Ovarian,I,2013-11-17,2013-11-24,,Immunotherapy,,Alive,94.0,KRAS,No,Former,Moderate,21.2,Medium,Urban,Statutory Health Insurance,,No,Yes,Obesity,1.0
PT01752,Netherlands,Utrecht,55.0,Female,Ovarian,I,2023-10-25,2023-12-19,2024-07-27,Targeted Therapy,Public,,6.0,None,No,Never,Moderate,23.0,High,Urban,NHS,13.0,No,Yes,Cardiovascular Disease,5.0
PT01753,Belgium,Wallonia,82.0,Male,,III,2015-03-21,2015-07-20,2015-09-13,Targeted Therapy,Private,Lost to Follow-up,,KRAS,No,Current,,35.2,Low,Urban,Private Insurance,14.0,No,No,Hypertension,7.0
PT01754,Netherlands,Utrecht,44.0,Female,Ovarian,III,2018-10-16,2019-01-03,2019-06-29,Targeted Therapy,Public,Alive,99.0,BRCA1,No,Never,None,38.6,Low,Rural,Private Insurance,18.0,No,No,Hypertension,7.0
PT01755,Austria,Vienna,67.0,Male,Breast,III,2010-11-26,2011-04-16,2011-05-19,,Public,Lost to Follow-up,,BRCA1,No,,Heavy,35.0,Low,Urban,Statutory Health Insurance,8.0,Yes,No,None,8.0
PT01756,Finland,Pirkanmaa,58.0,Male,Leukemia,IV,2019-04-21,2019-07-29,2019-10-31,Targeted Therapy,Private,Alive,10.0,KRAS,No,Never,None,18.5,Low,Urban,NHS,1.0,No,No,Cardiovascular Disease,9.0
PT01757,Austria,Tyrol,66.0,Female,Colorectal,IV,2020-01-27,2020-06-23,2021-02-24,Radiation,Private,Lost to Follow-up,,KRAS,No,Never,Moderate,21.3,Medium,Rural,NHS,11.0,Yes,No,None,3.0
PT01758,Spain,Andalusia,40.0,Female,,,2014-04-03,2014-04-26,2015-03-12,Targeted Therapy,Public,Deceased,78.0,KRAS,No,Never,,29.7,Medium,Urban,Statutory Health Insurance,1.0,No,No,Obesity,3.0
PT01759,Ireland,Connacht,49.0,Male,Breast,II,2018-03-22,2018-04-28,,Radiation,Private,Alive,13.0,EGFR,Yes,Current,None,30.7,Medium,Urban,Statutory Health Insurance,15.0,No,No,Cardiovascular Disease,10.0
PT01760,Denmark,Capital Region,50.0,Male,Prostate,II,2019-08-31,2019-09-20,2020-01-12,Chemotherapy,,Alive,93.0,None,No,Former,None,36.4,Medium,Urban,NHS,7.0,No,No,Obesity,4.0
PT01761,Austria,Styria,45.0,Female,Lung,III,,2017-05-09,2018-04-11,Chemotherapy,Public,Lost to Follow-up,,EGFR,No,Never,None,25.9,Low,Rural,Statutory Health Insurance,3.0,No,No,Hypertension,5.0
PT01762,Finland,Pirkanmaa,41.0,Male,,II,2017-01-27,2017-06-23,2018-04-27,,Public,Alive,94.0,BRCA1,No,Former,Moderate,36.9,High,Urban,Statutory Health Insurance,8.0,No,No,None,1.0
PT01763,Portugal,Porto,40.0,Female,Colorectal,III,2016-03-22,2016-08-15,2017-06-16,Surgery,Research Institute,,,BRCA1,No,Never,Moderate,21.5,Medium,Urban,,15.0,Yes,No,Obesity,6.0
PT01764,Italy,Sicily,20.0,Female,Pancreatic,I,2017-03-04,2017-05-11,2018-03-19,Chemotherapy,Private,Lost to Follow-up,,KRAS,Yes,Current,None,22.3,High,Urban,,15.0,No,No,Obesity,1.0
PT01765,Spain,Andalusia,56.0,Female,Ovarian,III,2014-12-20,2015-02-04,2015-08-21,Immunotherapy,Public,Alive,77.0,KRAS,No,Former,Moderate,24.3,Low,Urban,NHS,6.0,No,No,Hypertension,4.0
PT01766,Norway,Oslo,65.0,Female,Lung,I,2020-09-23,2021-03-18,2021-05-12,Immunotherapy,Public,Alive,107.0,None,No,Never,Moderate,23.4,Medium,Urban,NHS,,Yes,No,Obesity,1.0
PT01767,Norway,Trøndelag,,Female,Ovarian,II,2018-10-19,2018-11-08,,Radiation,Private,Deceased,90.0,KRAS,Yes,Never,None,35.2,Medium,Rural,Statutory Health Insurance,13.0,No,No,Hypertension,2.0
PT01768,,Porto,36.0,Female,Ovarian,IV,2020-08-23,2020-11-03,2021-06-28,Radiation,Public,Alive,24.0,BRCA1,Yes,Former,None,25.5,Medium,Rural,Private Insurance,7.0,Yes,No,Hypertension,2.0
PT01769,Netherlands,South Holland,66.0,Female,Leukemia,I,2013-05-07,2013-08-20,2013-12-11,Targeted Therapy,Public,Alive,8.0,None,No,Never,Moderate,20.5,Low,Urban,Private Insurance,6.0,No,No,Obesity,8.0
PT01770,Spain,Madrid,78.0,,Ovarian,II,2018-07-05,,2019-09-07,,Public,Alive,44.0,BRCA1,No,Former,Moderate,29.4,High,Rural,Statutory Health Insurance,1.0,No,No,Diabetes,6.0
PT01771,,Tyrol,73.0,Male,Leukemia,,2016-11-18,2017-03-02,2017-10-11,Radiation,Public,Alive,21.0,BRCA1,No,Never,Moderate,20.8,,Rural,Private Insurance,2.0,No,No,None,6.0
PT01772,Poland,Silesian,31.0,Male,Lung,,2022-10-12,2022-10-19,2023-10-12,Surgery,Public,Alive,70.0,KRAS,Yes,Former,Moderate,36.1,High,Urban,NHS,13.0,No,No,None,10.0
PT01773,Netherlands,North Holland,83.0,Female,Colorectal,III,2022-05-31,2022-07-20,2023-05-04,Immunotherapy,Private,Alive,79.0,BRCA1,Yes,Never,None,25.3,High,Rural,NHS,16.0,No,No,Cardiovascular Disease,3.0
PT01774,Norway,Oslo,25.0,,Pancreatic,IV,2023-04-15,2023-06-07,2024-01-14,Targeted Therapy,Public,Alive,75.0,BRCA1,No,Current,Moderate,28.9,Medium,Urban,Private Insurance,18.0,No,No,Obesity,8.0
PT01775,Belgium,Brussels,72.0,Male,Breast,IV,2022-10-31,2023-01-12,2023-11-22,Radiation,Private,Deceased,74.0,,No,Current,Moderate,37.4,Medium,Urban,NHS,10.0,No,No,Obesity,7.0
,Sweden,Skåne,35.0,Male,Ovarian,III,,2023-08-28,2024-03-26,Radiation,,Deceased,22.0,None,No,Never,None,26.8,Low,Urban,Private Insurance,14.0,No,No,Diabetes,5.0
PT01777,Austria,Styria,24.0,Female,Pancreatic,I,2016-12-26,,2017-06-16,Radiation,Private,Alive,26.0,EGFR,No,Former,None,20.1,Medium,Urban,NHS,7.0,No,No,Cardiovascular Disease,10.0
PT01778,Spain,Catalonia,65.0,Female,Ovarian,II,,2019-07-03,2020-01-01,Chemotherapy,Private,Alive,98.0,KRAS,Yes,Never,Moderate,37.0,Low,Urban,Statutory Health Insurance,19.0,No,No,Hypertension,5.0
PT01779,Portugal,Lisbon,33.0,Male,Ovarian,II,2023-08-24,2023-10-26,2024-09-18,,,Deceased,67.0,EGFR,,Current,None,21.0,Low,Urban,,8.0,No,Yes,Hypertension,6.0
PT01780,Austria,Tyrol,63.0,Female,Prostate,II,2016-01-07,2016-05-31,2017-03-18,Immunotherapy,Private,Alive,36.0,None,Yes,Former,Moderate,34.5,Medium,Rural,Private Insurance,11.0,No,No,Hypertension,1.0
PT01781,Austria,Styria,82.0,Non-binary,Pancreatic,,2021-05-01,2021-10-02,2022-01-18,Radiation,Private,Alive,8.0,None,No,Never,Moderate,27.7,,Urban,Private Insurance,15.0,No,No,Obesity,7.0
PT01782,Germany,Berlin,71.0,Female,Pancreatic,I,2013-08-13,2013-10-03,,Surgery,Private,Alive,43.0,None,No,Never,None,34.9,Low,Urban,Private Insurance,3.0,No,No,Cardiovascular Disease,1.0
PT01783,Austria,Styria,45.0,Female,Prostate,I,2023-09-18,2023-10-21,2024-05-26,Radiation,Public,Alive,65.0,BRCA1,No,Never,None,20.3,Low,Urban,Statutory Health Insurance,6.0,No,No,Obesity,2.0
PT01784,Austria,Styria,72.0,Male,Breast,II,2016-06-24,2016-07-20,2017-05-22,Targeted Therapy,Public,Lost to Follow-up,,BRCA1,No,Former,None,34.3,Low,Urban,Statutory Health Insurance,5.0,No,No,None,6.0
PT01785,Portugal,Porto,48.0,Female,Breast,I,2021-10-23,2021-11-14,2022-08-20,Targeted Therapy,Public,Alive,97.0,EGFR,No,Former,Moderate,31.4,Low,Urban,NHS,19.0,,No,None,1.0
PT01786,Poland,Masovian,38.0,Female,Leukemia,III,2020-05-18,2020-08-21,2021-07-30,,Public,Alive,97.0,EGFR,No,Never,Heavy,23.0,Medium,Rural,NHS,16.0,No,No,Hypertension,1.0
PT01787,Belgium,Wallonia,66.0,Female,Ovarian,II,2016-12-10,2017-02-26,2017-07-14,Targeted Therapy,Research Institute,Deceased,70.0,EGFR,Yes,Current,None,27.5,High,Rural,NHS,9.0,Yes,,Obesity,5.0
PT01788,Austria,Styria,27.0,Male,Breast,III,2016-07-03,2016-10-15,2017-02-17,Chemotherapy,Public,Deceased,,None,No,Never,None,36.9,High,Urban,NHS,18.0,No,No,Obesity,9.0
,Poland,Masovian,42.0,Male,Lung,I,2016-04-25,2016-09-17,2016-11-17,Immunotherapy,Private,Deceased,21.0,None,No,Current,Moderate,29.9,High,Urban,NHS,16.0,,No,Hypertension,4.0
PT01790,Denmark,Zealand,54.0,Male,Leukemia,IV,2017-02-26,2017-04-08,2018-01-30,Immunotherapy,Private,Alive,94.0,None,No,Never,Moderate,20.9,Medium,Urban,NHS,14.0,No,No,Hypertension,7.0
,Norway,Oslo,,Male,Colorectal,I,2021-07-16,2021-09-30,2022-06-22,Chemotherapy,Public,Alive,87.0,BRCA1,Yes,Current,Moderate,34.6,Low,Urban,Private Insurance,6.0,Yes,Yes,Hypertension,9.0
PT01792,Finland,Southwest Finland,77.0,Female,Leukemia,II,2022-01-03,2022-02-11,2022-04-01,Targeted Therapy,Research Institute,Alive,13.0,None,No,Never,Moderate,20.7,Medium,Urban,Private Insurance,14.0,No,No,None,3.0
PT01793,Germany,Berlin,,Female,Ovarian,III,2014-07-21,2014-12-29,2015-08-20,Surgery,Private,Alive,75.0,BRCA1,Yes,Never,None,25.7,Low,Urban,NHS,6.0,No,Yes,Hypertension,7.0
PT01794,Finland,Pirkanmaa,35.0,Female,Pancreatic,I,2010-08-13,2010-09-14,2011-06-08,Surgery,Public,Alive,56.0,None,No,Current,None,20.3,Medium,Urban,NHS,19.0,No,No,Hypertension,1.0
,,Southwest Finland,36.0,Female,Pancreatic,I,2023-08-30,2024-01-26,2024-03-16,Immunotherapy,Public,Alive,55.0,KRAS,No,Former,Heavy,26.7,Medium,Urban,Statutory Health Insurance,13.0,No,No,None,7.0
PT01796,Denmark,Zealand,51.0,Male,Leukemia,I,2017-09-01,2017-11-18,2018-10-14,Surgery,Public,Deceased,,EGFR,No,Former,Moderate,36.8,Low,Urban,Statutory Health Insurance,18.0,No,No,Cardiovascular Disease,2.0
PT01797,Poland,Silesian,71.0,Female,Prostate,II,2013-07-04,2013-09-08,2014-05-12,Chemotherapy,Public,Alive,23.0,KRAS,No,Never,Moderate,35.1,Medium,Rural,NHS,,Yes,No,Hypertension,10.0
PT01798,Switzerland,Zurich,,Female,Ovarian,IV,2021-11-19,2022-05-15,2022-10-12,Immunotherapy,Public,Deceased,99.0,KRAS,Yes,Never,None,38.0,Low,Urban,Statutory Health Insurance,19.0,No,Yes,Hypertension,3.0
PT01799,Portugal,Algarve,85.0,Female,Breast,II,2011-06-06,2011-08-16,2012-07-06,Radiation,Private,Alive,89.0,BRCA1,No,Former,None,29.9,Medium,Urban,Statutory Health Insurance,10.0,No,,Obesity,2.0
PT01800,Ireland,Munster,20.0,Female,Pancreatic,III,2014-06-07,,2015-04-25,Chemotherapy,Public,,87.0,EGFR,No,Never,None,32.4,Low,Rural,NHS,19.0,No,Yes,Obesity,8.0
PT01801,Portugal,Lisbon,77.0,Female,Pancreatic,II,2021-07-16,2021-10-16,2022-07-27,Chemotherapy,Private,Alive,106.0,None,Yes,Former,Moderate,31.9,Medium,Rural,Private Insurance,17.0,,No,Obesity,4.0
PT01802,Spain,Andalusia,63.0,Female,Lung,I,2020-01-31,2020-07-18,2020-08-27,Surgery,Public,Alive,34.0,KRAS,Yes,Never,Heavy,19.1,Medium,Urban,Private Insurance,13.0,No,No,Diabetes,3.0
PT01803,Germany,North Rhine-Westphalia,,,Ovarian,I,2014-05-21,2014-11-01,,,Public,Alive,80.0,KRAS,No,Former,Moderate,31.3,Medium,Urban,NHS,4.0,Yes,No,Diabetes,8.0
PT01804,France,Auvergne-Rhône-Alpes,69.0,Female,Breast,IV,2016-04-25,2016-07-08,,Surgery,Public,Deceased,87.0,EGFR,No,Current,Moderate,28.4,Low,Urban,Private Insurance,12.0,No,No,Hypertension,8.0
PT01805,Italy,Veneto,39.0,Female,Ovarian,I,2022-10-11,2023-03-27,2023-10-29,Radiation,Research Institute,Alive,38.0,KRAS,No,Current,Moderate,25.9,Medium,Rural,Statutory Health Insurance,13.0,No,No,None,2.0
PT01806,France,Auvergne-Rhône-Alpes,33.0,Male,Pancreatic,IV,2020-06-24,2020-10-13,2021-05-30,Chemotherapy,Public,Alive,8.0,BRCA1,Yes,Current,None,21.5,Medium,Urban,NHS,17.0,No,No,None,1.0
PT01807,Italy,Veneto,24.0,,Prostate,I,2013-04-30,2013-09-03,2013-11-26,Targeted Therapy,Private,Deceased,97.0,,,Never,Moderate,20.8,Low,Urban,Statutory Health Insurance,12.0,No,No,Obesity,5.0
PT01808,Finland,Southwest Finland,60.0,Female,Pancreatic,III,2012-07-31,2012-11-02,2013-09-22,Immunotherapy,,Alive,10.0,EGFR,No,Never,Moderate,29.2,Medium,Rural,Private Insurance,19.0,No,No,Cardiovascular Disease,4.0
PT01809,Austria,Vienna,59.0,Female,Breast,IV,2020-10-06,2021-01-23,2021-04-17,Surgery,Public,Deceased,85.0,EGFR,No,Former,None,21.7,Medium,,Statutory Health Insurance,7.0,No,No,Hypertension,4.0
PT01810,Austria,Tyrol,53.0,Female,,II,2013-02-27,2013-06-11,,Surgery,Private,Alive,64.0,EGFR,No,Current,Moderate,34.5,Low,Rural,Private Insurance,,Yes,No,Obesity,2.0
PT01811,Portugal,Porto,64.0,Female,Breast,III,2016-01-15,2016-07-02,2016-12-09,Chemotherapy,Research Institute,Alive,9.0,KRAS,Yes,Former,None,35.0,High,Urban,Private Insurance,1.0,No,No,Diabetes,9.0
PT01812,Spain,Madrid,46.0,Male,Ovarian,II,2020-04-07,2020-05-18,,Radiation,Private,Alive,23.0,BRCA1,Yes,Never,Moderate,24.3,High,Rural,NHS,6.0,No,Yes,Cardiovascular Disease,2.0
PT01813,Italy,Sicily,63.0,Male,Ovarian,II,2010-09-18,2010-09-23,2011-02-27,Surgery,Private,,32.0,None,No,Current,None,31.6,,Rural,Statutory Health Insurance,6.0,No,No,Obesity,6.0
PT01814,Italy,Sicily,52.0,Female,Prostate,I,2011-01-25,2011-01-31,2011-10-06,Radiation,Public,,23.0,KRAS,Yes,Former,None,19.4,Low,Urban,Statutory Health Insurance,4.0,No,No,Diabetes,
PT01815,Belgium,Brussels,52.0,Female,Lung,,2022-12-24,2023-02-24,2023-12-22,Radiation,Public,Alive,71.0,,No,Never,Moderate,38.0,Medium,Rural,Statutory Health Insurance,12.0,Yes,No,Hypertension,7.0
PT01816,Sweden,Skåne,63.0,Female,Breast,I,2021-07-29,2021-08-14,2022-05-31,,Public,Alive,11.0,BRCA1,Yes,,Moderate,31.8,Low,Rural,Statutory Health Insurance,17.0,No,Yes,None,6.0
PT01817,Italy,Lombardy,39.0,Male,,I,2011-02-12,2011-05-11,,Radiation,Public,Alive,117.0,None,No,Never,Moderate,25.8,High,Rural,Statutory Health Insurance,4.0,No,No,Hypertension,8.0
PT01818,Spain,Andalusia,,Male,Prostate,IV,2015-08-06,2015-11-24,2016-10-14,,Public,Alive,104.0,EGFR,No,Never,None,30.1,Medium,Rural,Statutory Health Insurance,17.0,No,No,Cardiovascular Disease,6.0
PT01819,,Skåne,26.0,Female,Leukemia,II,2011-07-21,2011-12-15,2012-12-01,,Public,Alive,,BRCA1,No,Never,Heavy,25.7,Low,Urban,Statutory Health Insurance,1.0,No,No,Hypertension,4.0
PT01820,Netherlands,North Holland,51.0,Male,Pancreatic,II,2023-02-03,2023-04-27,2024-01-08,Radiation,Public,Deceased,98.0,EGFR,,Former,Moderate,19.8,Medium,Urban,NHS,19.0,No,No,Hypertension,2.0
PT01821,,Île-de-France,86.0,Female,Ovarian,IV,2019-03-25,2019-07-26,2020-02-13,Immunotherapy,Private,Alive,16.0,KRAS,Yes,Never,None,23.8,Low,Rural,Private Insurance,4.0,Yes,No,None,6.0
PT01822,France,Auvergne-Rhône-Alpes,,Female,Lung,II,2015-06-03,2015-11-15,2016-08-23,Radiation,Public,Alive,43.0,EGFR,No,Never,None,18.2,Medium,Rural,NHS,18.0,No,No,Hypertension,8.0
PT01823,Norway,Oslo,43.0,Female,Lung,II,2015-05-07,2015-07-10,2015-09-01,Targeted Therapy,Public,Deceased,70.0,BRCA1,No,Never,None,35.0,Medium,Urban,Private Insurance,7.0,No,No,None,7.0
PT01824,Denmark,Zealand,89.0,,Pancreatic,III,2015-06-30,2015-10-05,2016-08-14,Targeted Therapy,Public,Alive,64.0,BRCA1,No,Former,None,39.3,Low,Rural,Statutory Health Insurance,13.0,No,,Hypertension,9.0
PT01825,Germany,North Rhine-Westphalia,73.0,Female,Ovarian,II,2020-07-05,2020-09-12,2021-02-14,Immunotherapy,Research Institute,Deceased,59.0,None,No,Former,Moderate,24.7,Medium,Urban,Statutory Health Insurance,18.0,No,No,Obesity,6.0
PT01826,Portugal,Porto,57.0,Female,Ovarian,I,2016-05-04,2016-09-16,2017-06-28,Chemotherapy,Public,Alive,26.0,EGFR,No,Never,None,33.8,Medium,Urban,,18.0,No,No,Diabetes,3.0
PT01827,Portugal,Algarve,51.0,,Breast,II,2010-04-11,2010-05-23,2011-04-06,Chemotherapy,Public,Deceased,104.0,KRAS,Yes,Never,None,29.5,Medium,Rural,Private Insurance,3.0,No,No,Obesity,6.0
PT01828,Poland,Lesser Poland,64.0,Male,Leukemia,III,2023-01-09,2023-06-11,2024-01-05,Chemotherapy,Public,Alive,13.0,KRAS,No,Never,None,18.5,Medium,Urban,Statutory Health Insurance,9.0,No,No,Hypertension,7.0
PT01829,Spain,Andalusia,80.0,Male,Lung,I,2019-06-07,2019-08-02,2019-11-19,,Public,Alive,72.0,,Yes,Never,Moderate,39.4,Low,Urban,Private Insurance,14.0,Yes,No,None,5.0
PT01830,Netherlands,Utrecht,89.0,Male,Prostate,II,2010-02-02,2010-07-27,2010-11-30,Chemotherapy,Public,Alive,20.0,KRAS,No,Former,None,39.2,Low,Urban,NHS,7.0,No,No,Obesity,
PT01831,Spain,Madrid,72.0,Female,Lung,II,2021-11-10,2022-02-03,2022-09-22,Immunotherapy,Public,Lost to Follow-up,,KRAS,No,Current,None,,Low,Rural,Private Insurance,16.0,No,No,Cardiovascular Disease,4.0
PT01832,Norway,Vestland,70.0,Female,Leukemia,I,2022-08-08,2022-11-24,2023-01-22,Chemotherapy,Public,Alive,86.0,KRAS,No,Never,Heavy,24.9,High,Urban,Statutory Health Insurance,9.0,No,No,Cardiovascular Disease,6.0
PT01833,Spain,Madrid,75.0,Non-binary,Pancreatic,III,2010-11-28,2011-05-25,2011-08-23,Immunotherapy,Public,Deceased,97.0,EGFR,Yes,Never,Moderate,20.9,Low,Urban,Statutory Health Insurance,12.0,No,No,Cardiovascular Disease,9.0
PT01834,Poland,Masovian,46.0,Female,Colorectal,I,2019-08-18,2019-11-11,2020-05-21,Immunotherapy,Public,Alive,119.0,EGFR,Yes,Current,Moderate,24.9,Medium,Rural,Statutory Health Insurance,7.0,No,No,Diabetes,2.0
PT01835,,Capital Region,57.0,Female,Pancreatic,III,2022-07-18,2022-10-17,2023-08-05,Radiation,Public,Alive,66.0,BRCA1,No,Former,None,34.2,High,Rural,Private Insurance,3.0,No,No,Hypertension,10.0
,Ireland,Connacht,81.0,,Prostate,,2021-07-17,2021-08-19,2022-02-07,Targeted Therapy,Public,Alive,105.0,BRCA1,No,Former,Moderate,28.5,Medium,Urban,,4.0,No,No,Diabetes,1.0
PT01837,Sweden,Stockholm,,Female,Lung,I,2010-06-07,2010-07-03,2010-10-06,Radiation,Public,Alive,56.0,None,No,Never,Moderate,38.2,High,Urban,Statutory Health Insurance,14.0,Yes,No,Diabetes,10.0
PT01838,Switzerland,Bern,83.0,Female,Pancreatic,I,2018-07-06,2018-07-23,2019-04-02,Radiation,Public,Alive,46.0,BRCA1,No,Current,Moderate,18.4,Medium,Rural,Private Insurance,16.0,No,No,None,8.0
PT01839,Ireland,Connacht,49.0,Female,Prostate,I,2023-07-17,2023-08-07,2024-04-12,Surgery,Private,Alive,83.0,EGFR,No,Never,,39.2,Medium,Urban,NHS,7.0,No,No,Diabetes,5.0
PT01840,Italy,Sicily,,Female,Ovarian,I,2016-01-01,2016-01-03,2016-10-31,Chemotherapy,Private,Alive,117.0,EGFR,No,Current,Moderate,39.1,Medium,Urban,Private Insurance,2.0,No,No,Obesity,1.0
PT01841,Belgium,Flanders,60.0,Female,Breast,III,2019-12-08,2020-02-25,2020-04-13,Chemotherapy,Public,Alive,22.0,None,Yes,Never,Moderate,35.3,Medium,Rural,NHS,8.0,No,No,None,2.0
PT01842,Austria,Tyrol,32.0,Female,Prostate,III,2020-05-10,2020-06-23,2021-04-18,Immunotherapy,Public,Alive,44.0,EGFR,Yes,Current,None,,Medium,Rural,Private Insurance,11.0,No,No,None,7.0
,Ireland,Munster,53.0,Female,Lung,I,2020-06-18,2020-08-28,2020-11-14,Targeted Therapy,Private,Alive,25.0,EGFR,No,Never,Heavy,25.9,Medium,Urban,Statutory Health Insurance,,No,No,,7.0
PT01844,Netherlands,Utrecht,44.0,,Breast,III,2017-05-12,2017-06-17,2018-05-19,Chemotherapy,Private,Alive,44.0,EGFR,No,Former,None,39.0,Medium,Urban,Private Insurance,14.0,No,Yes,Cardiovascular Disease,6.0
PT01845,France,Auvergne-Rhône-Alpes,85.0,Female,Breast,IV,2011-11-24,2012-01-09,2012-03-12,Chemotherapy,Public,Alive,75.0,KRAS,Yes,Never,None,33.2,High,Urban,NHS,,No,No,Obesity,9.0
PT01846,Netherlands,Utrecht,37.0,Female,Breast,I,2012-11-17,2013-05-14,2014-02-07,Targeted Therapy,Public,Deceased,75.0,None,No,Current,None,34.8,Medium,Urban,NHS,11.0,No,No,Cardiovascular Disease,1.0
,Sweden,Stockholm,24.0,Male,Colorectal,II,2023-10-24,2023-12-30,2024-04-21,Chemotherapy,Private,Alive,82.0,BRCA1,,Current,Moderate,35.8,Medium,Urban,Private Insurance,12.0,No,No,Diabetes,2.0
PT01848,Norway,Oslo,38.0,Male,Colorectal,III,2020-08-19,2020-08-22,2021-03-15,Surgery,Public,Alive,40.0,,Yes,Never,None,36.9,Medium,Rural,Private Insurance,3.0,No,No,Hypertension,
PT01849,Finland,Uusimaa,61.0,Female,Breast,I,2018-01-01,2018-04-30,2019-04-17,Chemotherapy,Public,Alive,104.0,BRCA1,No,Former,Moderate,29.0,High,Rural,NHS,7.0,No,No,None,
PT01850,Austria,Tyrol,37.0,Male,Pancreatic,III,2015-09-30,2016-03-09,2017-02-15,Surgery,Private,Deceased,115.0,EGFR,Yes,Never,Heavy,39.0,Low,Rural,Statutory Health Insurance,3.0,Yes,Yes,Cardiovascular Disease,3.0
PT01851,Portugal,Porto,51.0,Male,Pancreatic,IV,2015-11-27,2016-01-11,2017-01-08,Radiation,Public,Deceased,32.0,BRCA1,Yes,Former,Moderate,24.5,Low,Urban,Private Insurance,15.0,No,No,None,8.0
PT01852,Germany,North Rhine-Westphalia,40.0,Female,,I,2010-05-14,2010-06-08,2010-12-03,Radiation,Public,Alive,37.0,EGFR,No,Never,,35.4,Low,Rural,Private Insurance,17.0,No,No,Diabetes,9.0
PT01853,Belgium,Brussels,29.0,Female,Lung,III,2020-04-08,2020-09-20,2021-07-29,Surgery,Public,Alive,103.0,,No,Current,Heavy,20.8,Low,Urban,Private Insurance,10.0,No,No,None,3.0
PT01854,Spain,Catalonia,56.0,Female,Breast,,2015-10-29,2016-04-10,2016-10-13,Immunotherapy,Private,,8.0,None,Yes,Never,None,26.1,Medium,Urban,Statutory Health Insurance,18.0,No,No,Diabetes,10.0
PT01855,,Geneva,68.0,Male,Pancreatic,I,2023-12-21,2024-01-25,2024-10-12,Surgery,Public,Alive,37.0,BRCA1,No,Former,Moderate,,Low,Rural,NHS,9.0,No,Yes,Cardiovascular Disease,5.0
PT01856,Belgium,Flanders,32.0,Male,Breast,II,2016-07-13,2016-08-01,2017-03-25,Immunotherapy,Private,Alive,76.0,None,No,Never,Moderate,30.2,Low,Rural,Private Insurance,11.0,No,No,None,1.0
PT01857,Poland,Silesian,74.0,Male,Prostate,I,2022-05-25,,2023-01-26,Targeted Therapy,Public,Alive,39.0,KRAS,No,Current,Moderate,19.7,Low,,Private Insurance,2.0,No,No,Diabetes,10.0
PT01858,Austria,Styria,36.0,Male,Pancreatic,II,2021-06-29,2021-10-19,2022-05-02,Targeted Therapy,Private,,26.0,EGFR,Yes,Never,Moderate,26.7,High,Urban,NHS,12.0,No,No,Obesity,8.0
PT01859,Italy,Lombardy,28.0,Male,Prostate,I,2022-02-13,2022-07-09,,,Public,Alive,34.0,KRAS,No,Former,Moderate,24.9,High,Rural,Statutory Health Insurance,18.0,No,No,,8.0
PT01860,Spain,Madrid,63.0,Non-binary,Prostate,III,2022-03-30,2022-09-01,2022-10-15,Immunotherapy,Private,Alive,9.0,KRAS,No,Former,Moderate,28.2,Medium,,NHS,5.0,No,Yes,Obesity,3.0
PT01861,Belgium,Wallonia,65.0,Female,Pancreatic,II,2016-03-28,2016-06-30,2016-08-30,Radiation,Public,Alive,73.0,BRCA1,No,Current,Moderate,34.1,Medium,Urban,Statutory Health Insurance,7.0,Yes,No,Hypertension,3.0
,Sweden,Västra Götaland,27.0,Male,Leukemia,II,2014-01-14,2014-02-14,2014-04-24,Surgery,Public,Lost to Follow-up,,EGFR,No,Never,None,21.3,High,Urban,Statutory Health Insurance,16.0,Yes,No,Diabetes,
,Austria,Vienna,56.0,Male,Prostate,I,2023-04-22,2023-10-06,2024-01-19,Surgery,Private,Alive,108.0,BRCA1,Yes,Never,Heavy,33.0,Medium,Urban,Private Insurance,16.0,No,No,Obesity,4.0
PT01864,Norway,Trøndelag,38.0,Female,Pancreatic,II,2022-05-17,2022-07-23,2023-03-21,Immunotherapy,Private,Alive,6.0,EGFR,No,Never,,,Low,Urban,Private Insurance,7.0,No,No,Obesity,10.0
PT01865,Sweden,Skåne,82.0,Female,Ovarian,I,2012-11-14,2013-04-13,2013-08-11,,Public,Alive,36.0,KRAS,No,Never,Moderate,,High,Urban,NHS,10.0,No,No,Obesity,8.0
PT01866,Finland,Uusimaa,65.0,Male,Prostate,III,2011-02-20,2011-03-02,,Radiation,Private,Alive,50.0,None,Yes,,Moderate,,Medium,Urban,Statutory Health Insurance,13.0,No,No,Cardiovascular Disease,6.0
PT01867,France,Île-de-France,45.0,Female,Lung,I,2022-01-15,2022-05-12,2023-01-29,Immunotherapy,Private,Deceased,86.0,KRAS,No,Current,Moderate,36.8,High,Rural,Statutory Health Insurance,1.0,No,No,Obesity,9.0
PT01868,Belgium,Brussels,65.0,Male,Colorectal,III,2015-12-07,2015-12-15,2016-02-04,Immunotherapy,Public,Deceased,76.0,None,No,Never,Moderate,19.5,Medium,Urban,Statutory Health Insurance,17.0,Yes,Yes,Diabetes,4.0
PT01869,Ireland,Munster,65.0,Male,Colorectal,I,2016-07-06,2016-08-09,2017-02-08,Radiation,Research Institute,Alive,57.0,KRAS,Yes,Never,None,30.6,Medium,Urban,NHS,6.0,No,Yes,None,7.0
PT01870,Sweden,,,Male,Colorectal,III,2011-10-24,2012-03-18,2012-08-30,Surgery,Public,Deceased,118.0,EGFR,Yes,Never,Moderate,34.2,,Rural,Private Insurance,6.0,No,No,Obesity,4.0
PT01871,Norway,Trøndelag,82.0,Female,Ovarian,II,2022-03-13,2022-03-25,2023-02-09,Surgery,,,49.0,EGFR,Yes,Never,None,31.7,Low,Urban,Private Insurance,,No,Yes,None,9.0
PT01872,Austria,Tyrol,22.0,Male,Leukemia,II,2010-10-16,2011-01-20,2011-05-30,Chemotherapy,Public,Alive,55.0,KRAS,No,Former,Moderate,29.8,Medium,,Statutory Health Insurance,4.0,No,No,None,5.0
PT01873,Portugal,Porto,47.0,Male,Breast,III,2017-02-13,,2017-10-11,Radiation,Research Institute,Deceased,41.0,KRAS,No,Never,None,31.7,Low,Urban,Private Insurance,17.0,Yes,No,Hypertension,10.0
PT01874,Switzerland,Bern,48.0,Male,,II,2014-09-22,2014-10-09,2015-03-08,Immunotherapy,Public,Deceased,,KRAS,Yes,Current,None,25.8,Medium,Rural,NHS,10.0,No,No,,3.0
PT01875,Switzerland,,37.0,Female,Ovarian,III,2011-07-29,2011-10-13,2012-03-25,Chemotherapy,Private,Alive,28.0,KRAS,Yes,Never,None,,Medium,Urban,Statutory Health Insurance,,No,No,None,4.0
PT01876,Switzerland,Bern,54.0,Male,Lung,III,2011-12-18,2012-02-27,2012-11-01,Chemotherapy,Private,,82.0,EGFR,,Current,Moderate,26.5,Low,Urban,Statutory Health Insurance,12.0,No,No,Hypertension,1.0
,Germany,Berlin,66.0,Male,Leukemia,II,2019-05-06,2019-07-24,2020-04-12,Chemotherapy,Public,Deceased,111.0,EGFR,Yes,,None,30.8,Medium,Urban,Statutory Health Insurance,9.0,No,Yes,Diabetes,2.0
PT01878,Poland,Silesian,24.0,Male,Ovarian,IV,2021-01-05,2021-01-07,2021-09-11,Surgery,Public,Deceased,39.0,None,No,Former,None,37.5,High,Rural,Statutory Health Insurance,,No,No,Cardiovascular Disease,5.0
PT01879,Switzerland,Zurich,78.0,Male,Colorectal,III,2016-07-21,2016-08-17,2017-06-07,Targeted Therapy,Public,Alive,105.0,None,Yes,Never,Moderate,,Low,Urban,Private Insurance,19.0,Yes,No,Cardiovascular Disease,1.0
PT01880,Switzerland,Bern,78.0,Female,Leukemia,II,2021-03-04,2021-08-05,2022-04-26,Chemotherapy,Public,Alive,74.0,EGFR,No,Current,Moderate,26.9,Low,Urban,NHS,19.0,No,No,Diabetes,
PT01881,France,Auvergne-Rhône-Alpes,66.0,Male,Ovarian,I,2018-05-21,2018-10-21,2019-01-17,Immunotherapy,Private,Lost to Follow-up,,BRCA1,No,Former,Moderate,32.9,Low,Urban,NHS,14.0,No,No,Hypertension,2.0
PT01882,Finland,Southwest Finland,32.0,Male,Lung,II,2012-10-09,,2013-05-31,Surgery,Research Institute,Alive,105.0,KRAS,Yes,Never,Moderate,22.4,Low,Rural,Private Insurance,2.0,No,No,Diabetes,6.0
PT01883,Portugal,Algarve,52.0,Female,Pancreatic,,2016-06-18,2016-11-10,2017-08-12,Targeted Therapy,Research Institute,,36.0,,Yes,Current,Moderate,37.6,Medium,Rural,Statutory Health Insurance,13.0,No,Yes,Cardiovascular Disease,10.0
PT01884,Spain,Madrid,81.0,Male,Leukemia,II,2015-11-04,2016-02-07,2016-08-03,Targeted Therapy,Public,Deceased,17.0,BRCA1,No,Never,Moderate,34.7,Medium,Urban,Statutory Health Insurance,1.0,No,No,Hypertension,1.0
PT01885,Germany,North Rhine-Westphalia,35.0,Male,Colorectal,III,2015-05-01,2015-10-16,2016-05-09,Chemotherapy,Private,Alive,115.0,KRAS,No,Current,Moderate,25.7,Low,Urban,Statutory Health Insurance,1.0,No,No,Hypertension,8.0
PT01886,Ireland,Connacht,63.0,Male,Breast,III,2019-08-14,2019-08-19,2019-10-20,Chemotherapy,Private,Alive,111.0,BRCA1,No,Former,None,,Low,Urban,NHS,9.0,No,No,Diabetes,1.0
PT01887,Netherlands,Utrecht,77.0,Female,Ovarian,III,2013-09-13,2013-10-11,2014-04-03,Surgery,Private,Alive,33.0,EGFR,,Never,None,32.1,Medium,Rural,Statutory Health Insurance,17.0,No,No,Cardiovascular Disease,2.0
PT01888,Portugal,Lisbon,25.0,Female,Colorectal,III,2017-12-07,2018-02-17,2018-12-12,Chemotherapy,Public,Alive,53.0,KRAS,Yes,Former,None,39.1,Low,Urban,Statutory Health Insurance,15.0,No,No,None,7.0
PT01889,Sweden,Västra Götaland,34.0,Female,Ovarian,I,2018-06-03,2018-07-25,2019-04-21,Surgery,Public,Alive,33.0,KRAS,No,Never,Moderate,37.2,Low,Urban,Private Insurance,16.0,No,No,Obesity,2.0
PT01890,Poland,,23.0,Female,Colorectal,I,2020-09-09,,2021-12-23,Targeted Therapy,Research Institute,Deceased,12.0,KRAS,Yes,Never,None,19.7,Low,Urban,Private Insurance,11.0,No,No,Obesity,6.0
PT01891,Austria,Styria,75.0,Non-binary,Colorectal,III,2018-11-30,2019-04-13,2019-09-02,Immunotherapy,Private,Alive,,EGFR,No,,None,24.1,Medium,Urban,NHS,12.0,No,Yes,Hypertension,7.0
PT01892,Switzerland,Geneva,83.0,Female,Ovarian,II,2016-06-05,,2017-06-16,Immunotherapy,Private,Deceased,91.0,None,Yes,Former,Heavy,33.1,High,Urban,NHS,1.0,No,No,Hypertension,1.0
PT01893,Denmark,Zealand,87.0,Female,Leukemia,,2011-06-12,2011-07-19,2012-07-03,,Public,Lost to Follow-up,,EGFR,No,Never,None,29.9,High,Urban,Statutory Health Insurance,,Yes,No,None,5.0
PT01894,Italy,Sicily,53.0,Male,Lung,I,2017-04-07,2017-07-15,2017-09-22,,Public,Deceased,56.0,KRAS,,Never,Moderate,22.3,Low,Urban,Statutory Health Insurance,13.0,No,No,Diabetes,6.0
PT01895,Switzerland,Bern,75.0,Male,Colorectal,I,2018-02-22,2018-03-29,2018-10-06,Radiation,Private,Alive,93.0,None,No,,Moderate,37.1,Low,Urban,Private Insurance,15.0,No,No,Obesity,5.0
PT01896,Belgium,Wallonia,,Female,Pancreatic,II,2017-05-20,2017-09-23,2017-11-27,Immunotherapy,Public,Deceased,83.0,None,No,Never,None,39.2,High,Urban,NHS,11.0,No,No,Cardiovascular Disease,2.0
PT01897,Norway,Vestland,28.0,Non-binary,Leukemia,,2013-07-05,2013-07-22,2014-03-14,Chemotherapy,Public,Deceased,85.0,BRCA1,Yes,Former,None,26.5,Medium,Rural,Statutory Health Insurance,14.0,No,No,Cardiovascular Disease,
PT01898,Portugal,Algarve,82.0,Male,Lung,,2022-09-25,,2023-10-04,Surgery,Public,Deceased,16.0,,Yes,Never,Moderate,31.1,Low,,Private Insurance,12.0,No,No,Hypertension,2.0
PT01899,Ireland,Munster,52.0,Female,Breast,II,2018-12-24,2019-03-22,2019-08-05,Immunotherapy,Public,Alive,99.0,BRCA1,Yes,Never,Moderate,25.8,Medium,Rural,Statutory Health Insurance,4.0,No,No,Obesity,10.0
PT01900,Poland,Lesser Poland,40.0,Female,Colorectal,I,2020-12-30,2021-01-09,2021-05-03,Radiation,Public,Alive,,BRCA1,No,Current,None,22.5,Medium,Urban,Statutory Health Insurance,2.0,No,No,Diabetes,10.0
PT01901,Poland,Lesser Poland,74.0,Male,Prostate,I,2023-03-20,2023-05-10,2023-09-08,Radiation,Public,Alive,47.0,EGFR,Yes,Current,Moderate,37.8,High,Urban,Statutory Health Insurance,1.0,No,No,Hypertension,8.0
PT01902,Germany,Berlin,76.0,Male,Leukemia,,2019-01-08,2019-04-30,2020-01-08,Chemotherapy,Public,,12.0,EGFR,No,Former,Moderate,27.3,High,Rural,Statutory Health Insurance,9.0,No,No,Obesity,10.0
PT01903,Finland,Uusimaa,21.0,Female,Pancreatic,II,2020-10-11,2020-12-31,,Radiation,Public,Alive,51.0,EGFR,No,Current,Heavy,18.6,High,,NHS,16.0,Yes,No,Hypertension,1.0
PT01904,France,Provence-Alpes-Côte d'Azur,32.0,Male,Breast,IV,2012-11-10,,2013-05-03,Radiation,Research Institute,Alive,50.0,,No,Former,Moderate,25.1,Medium,Urban,NHS,13.0,No,No,Obesity,9.0
PT01905,Finland,Pirkanmaa,23.0,Female,Breast,I,2019-06-02,2019-08-05,2020-06-01,Surgery,Private,Alive,8.0,BRCA1,Yes,,None,26.7,Medium,,NHS,3.0,No,Yes,Cardiovascular Disease,1.0
PT01906,Ireland,Connacht,69.0,Female,Breast,I,2010-11-09,2010-12-12,2011-11-12,Chemotherapy,Public,Lost to Follow-up,,KRAS,Yes,Never,Moderate,21.7,Medium,Urban,Private Insurance,15.0,No,No,Hypertension,5.0
PT01907,Portugal,Porto,67.0,Female,Leukemia,III,2010-11-12,2011-02-17,2011-11-07,Targeted Therapy,Public,,84.0,KRAS,No,Never,Moderate,34.2,Low,Rural,NHS,7.0,No,No,Cardiovascular Disease,4.0
PT01908,Poland,Lesser Poland,49.0,Male,Lung,IV,2016-09-16,2016-10-03,2016-12-14,Targeted Therapy,Private,Deceased,62.0,KRAS,No,Never,None,,Medium,,Statutory Health Insurance,2.0,Yes,No,Diabetes,7.0
PT01909,Finland,Southwest Finland,48.0,Female,Prostate,I,2015-03-06,,2015-12-17,Radiation,Public,Alive,118.0,BRCA1,Yes,Never,Moderate,37.1,Medium,Urban,Statutory Health Insurance,8.0,No,Yes,Obesity,4.0
PT01910,Denmark,Capital Region,27.0,Male,Pancreatic,II,2019-11-28,2020-05-23,2020-08-25,Radiation,Public,Alive,35.0,EGFR,,,Heavy,31.4,Low,Urban,Statutory Health Insurance,15.0,No,No,,8.0
PT01911,Sweden,Skåne,31.0,Male,,I,2021-07-23,2021-11-08,2022-02-27,Surgery,Private,Alive,102.0,BRCA1,Yes,Never,Moderate,35.4,,Urban,Private Insurance,14.0,No,Yes,Hypertension,10.0
PT01912,Germany,Berlin,60.0,,Colorectal,I,2020-12-14,2021-04-20,2021-10-15,,Public,Alive,106.0,KRAS,,Former,Moderate,33.0,High,Rural,NHS,10.0,,No,Cardiovascular Disease,9.0
PT01913,Finland,Southwest Finland,45.0,Male,Prostate,III,2011-05-11,2011-05-18,2011-08-26,Chemotherapy,Private,Deceased,57.0,KRAS,Yes,Never,None,34.8,Medium,Urban,Statutory Health Insurance,14.0,No,No,Diabetes,7.0
PT01914,France,Auvergne-Rhône-Alpes,69.0,Male,Lung,IV,2012-09-07,2012-12-28,2013-12-13,Chemotherapy,Public,Alive,106.0,EGFR,Yes,Never,None,27.2,Low,Urban,Statutory Health Insurance,19.0,No,No,Diabetes,5.0
PT01915,Netherlands,South Holland,,Male,Colorectal,III,2023-04-02,2023-08-07,2024-06-10,Immunotherapy,Public,Alive,86.0,BRCA1,Yes,Never,Moderate,31.1,Low,Rural,Statutory Health Insurance,6.0,No,No,None,7.0
PT01916,Denmark,Capital Region,74.0,Female,Ovarian,IV,2023-02-17,,2023-06-27,,Public,Lost to Follow-up,,KRAS,No,Never,None,26.4,Medium,Urban,,5.0,No,Yes,Cardiovascular Disease,4.0
PT01917,Belgium,Brussels,75.0,Male,Prostate,II,2015-07-22,2015-08-22,2016-06-01,Chemotherapy,Research Institute,Alive,59.0,EGFR,No,Former,Moderate,33.8,,Urban,Private Insurance,16.0,Yes,Yes,Diabetes,2.0
PT01918,Germany,Berlin,33.0,Female,Leukemia,IV,2015-09-24,,2016-04-27,Immunotherapy,Public,Alive,53.0,KRAS,No,Former,None,24.8,Medium,Urban,,14.0,Yes,No,None,3.0
PT01919,Switzerland,Geneva,25.0,,Pancreatic,I,2023-07-03,2023-09-06,2024-08-13,Surgery,Private,Alive,89.0,EGFR,No,Current,None,,,Urban,Statutory Health Insurance,3.0,Yes,No,Obesity,6.0
PT01920,Finland,Uusimaa,80.0,Female,Ovarian,I,2023-11-08,2024-04-27,2025-02-22,Radiation,Private,Alive,38.0,None,No,Former,None,36.2,Medium,Urban,Private Insurance,9.0,No,No,Diabetes,6.0
PT01921,France,Provence-Alpes-Côte d'Azur,31.0,Female,Pancreatic,III,2023-09-16,2024-01-25,2024-08-17,Chemotherapy,Public,Alive,96.0,None,No,Never,None,22.0,Medium,Rural,Private Insurance,8.0,No,No,Obesity,8.0
PT01922,Germany,Bavaria,32.0,Male,Colorectal,II,2017-12-17,2018-02-10,2018-12-17,Targeted Therapy,Private,Deceased,106.0,BRCA1,Yes,Never,Moderate,26.8,,Urban,Statutory Health Insurance,9.0,No,No,Obesity,5.0
PT01923,Portugal,Lisbon,38.0,Male,Lung,II,2018-08-10,2018-09-27,2019-05-10,Targeted Therapy,Private,Alive,25.0,EGFR,Yes,Never,Moderate,30.6,Medium,Urban,NHS,,No,No,Cardiovascular Disease,2.0
PT01924,Spain,Madrid,63.0,Male,Prostate,III,2011-12-29,2012-03-03,2012-09-08,Chemotherapy,Public,Alive,103.0,KRAS,No,Current,None,20.9,Low,Urban,NHS,11.0,No,No,None,4.0
PT01925,Switzerland,Bern,78.0,Male,Colorectal,II,2021-06-25,2021-10-16,2022-09-11,Immunotherapy,Public,Deceased,100.0,None,Yes,Former,None,31.5,High,Urban,NHS,1.0,No,No,Cardiovascular Disease,4.0
PT01926,Ireland,Connacht,56.0,Female,Colorectal,II,2014-01-07,2014-05-02,2014-08-31,Immunotherapy,Public,Alive,10.0,KRAS,No,Never,Moderate,26.2,Medium,Urban,NHS,6.0,No,No,Obesity,7.0
PT01927,Norway,Vestland,44.0,Male,Leukemia,I,2013-01-19,2013-03-20,2013-10-03,,Public,Alive,87.0,None,No,Former,Moderate,22.7,Low,Urban,Private Insurance,6.0,No,No,Diabetes,8.0
PT01928,Austria,Vienna,35.0,Male,Colorectal,,2014-08-05,2014-08-19,2015-02-05,Chemotherapy,Private,Alive,88.0,,No,Current,Moderate,19.3,Medium,Urban,Private Insurance,3.0,No,No,Cardiovascular Disease,9.0
,Spain,Andalusia,57.0,,Prostate,II,2015-08-06,2015-11-01,2016-08-17,Chemotherapy,Private,Alive,107.0,KRAS,Yes,Never,None,30.4,High,Urban,NHS,6.0,No,No,Diabetes,4.0
PT01930,Spain,Catalonia,62.0,Female,Breast,II,2015-12-05,2016-02-24,2016-08-16,,Public,Alive,22.0,,Yes,Former,Moderate,39.4,Low,Urban,Statutory Health Insurance,,No,Yes,Cardiovascular Disease,2.0
PT01931,Germany,North Rhine-Westphalia,33.0,Female,Prostate,I,2020-11-08,2020-11-22,2021-08-17,Targeted Therapy,Research Institute,Deceased,92.0,KRAS,No,Former,None,35.0,Low,,Statutory Health Insurance,9.0,Yes,No,None,8.0
PT01932,Poland,Lesser Poland,25.0,Female,Prostate,,2018-07-12,2018-11-26,2019-03-06,Surgery,,Alive,112.0,None,No,Never,Moderate,26.7,Low,Urban,NHS,3.0,,Yes,None,6.0
PT01933,Netherlands,North Holland,42.0,Female,Leukemia,III,2021-05-29,2021-08-22,2022-03-26,Surgery,Public,Deceased,116.0,KRAS,No,Current,None,22.2,Medium,Rural,Private Insurance,14.0,No,No,Cardiovascular Disease,6.0
PT01934,Spain,Catalonia,,Female,Leukemia,,2023-04-16,2023-10-06,2023-12-09,Radiation,Private,Alive,7.0,EGFR,Yes,Current,None,34.5,,Urban,Statutory Health Insurance,9.0,No,No,,1.0
PT01935,Belgium,Flanders,31.0,Male,Pancreatic,I,2017-10-14,2017-10-16,2018-05-17,Surgery,Public,Deceased,113.0,None,No,Never,None,37.0,High,Rural,NHS,19.0,No,Yes,Diabetes,6.0
PT01936,,Catalonia,32.0,Non-binary,,I,,2018-05-05,2018-10-25,Targeted Therapy,Public,Alive,29.0,,No,Never,Moderate,25.6,Medium,Urban,NHS,16.0,Yes,No,Obesity,1.0
PT01937,Spain,Madrid,25.0,Female,Pancreatic,II,2023-03-15,2023-03-23,2024-02-23,Immunotherapy,Private,Deceased,56.0,EGFR,No,Current,Moderate,19.4,Low,Urban,Statutory Health Insurance,17.0,Yes,Yes,,9.0
PT01938,Belgium,Wallonia,82.0,Male,Colorectal,II,2010-04-17,2010-05-23,2010-11-23,Targeted Therapy,Public,Deceased,53.0,None,Yes,Current,Moderate,31.6,Medium,Rural,NHS,10.0,No,No,Cardiovascular Disease,7.0
PT01939,Portugal,Porto,57.0,Male,Pancreatic,I,2023-05-03,2023-10-15,2024-05-21,Chemotherapy,Public,Alive,49.0,BRCA1,No,Current,Heavy,20.0,Low,Urban,NHS,12.0,No,No,Obesity,2.0
,Germany,Bavaria,69.0,Female,Leukemia,III,2016-05-30,2016-06-14,2017-04-01,Chemotherapy,Public,Alive,6.0,KRAS,No,Current,None,21.8,Medium,Urban,Statutory Health Insurance,19.0,No,No,Hypertension,1.0
PT01941,France,Provence-Alpes-Côte d'Azur,71.0,Female,Colorectal,IV,2021-02-04,2021-03-10,2021-07-20,Chemotherapy,Private,Alive,57.0,BRCA1,No,Never,None,18.1,High,Urban,Private Insurance,3.0,Yes,No,None,6.0
PT01942,Sweden,Skåne,59.0,Male,Breast,I,2013-02-04,2013-07-03,2014-05-08,Surgery,Public,Alive,27.0,None,No,Never,Moderate,23.7,Medium,Urban,Private Insurance,12.0,,No,Obesity,8.0
PT01943,Italy,Sicily,27.0,Male,Lung,II,2013-01-14,2013-01-23,2013-10-22,Radiation,Public,Alive,19.0,None,No,Never,None,34.8,Medium,Urban,NHS,2.0,No,No,Hypertension,8.0
PT01944,Ireland,Dublin,80.0,Female,Leukemia,II,2019-10-22,2019-12-01,2020-03-26,Immunotherapy,Private,Deceased,108.0,EGFR,No,Current,Heavy,36.1,Medium,Rural,,,No,No,Cardiovascular Disease,8.0
PT01945,Spain,Madrid,27.0,Female,Ovarian,II,2013-06-04,2013-06-30,2013-12-09,,Private,Alive,109.0,KRAS,,Former,Moderate,38.9,Medium,Rural,Private Insurance,10.0,No,No,Hypertension,9.0
PT01946,Germany,Bavaria,53.0,Male,Leukemia,I,2017-03-26,2017-08-23,2018-04-08,Chemotherapy,Public,,82.0,KRAS,No,Current,Moderate,36.1,,Urban,Private Insurance,18.0,No,Yes,Hypertension,6.0
PT01947,Sweden,Skåne,79.0,Male,Breast,I,2018-06-01,2018-10-20,2019-02-12,Targeted Therapy,Public,Deceased,81.0,EGFR,Yes,Never,Moderate,22.6,Low,Urban,Private Insurance,3.0,No,No,None,3.0
PT01948,Belgium,Brussels,76.0,Female,Ovarian,I,2015-09-21,2015-10-16,2016-02-15,Chemotherapy,Public,Alive,76.0,None,Yes,Former,Moderate,29.5,Medium,Rural,,15.0,No,No,None,7.0
PT01949,Ireland,Dublin,65.0,Male,,II,2010-03-22,2010-07-15,2011-02-10,Targeted Therapy,Public,Alive,71.0,,Yes,Never,Moderate,30.9,Medium,Urban,Private Insurance,10.0,No,No,Diabetes,9.0
PT01950,Finland,Uusimaa,41.0,Female,Pancreatic,III,2016-12-10,2017-03-11,2017-09-15,Immunotherapy,Research Institute,Alive,72.0,EGFR,,Former,None,,High,Urban,Statutory Health Insurance,5.0,No,No,Hypertension,
PT01951,Finland,Uusimaa,59.0,Male,Pancreatic,I,2012-07-04,2012-11-24,2013-01-27,Chemotherapy,Public,Deceased,45.0,BRCA1,No,Never,Moderate,27.6,Low,Rural,NHS,14.0,Yes,No,Diabetes,8.0
PT01952,Spain,Madrid,64.0,Male,,II,2010-09-19,2010-11-03,2011-03-10,Immunotherapy,Public,Alive,41.0,,No,Never,None,24.7,Medium,Urban,NHS,14.0,Yes,No,Diabetes,9.0
PT01953,Finland,Uusimaa,74.0,Male,,II,2019-02-02,2019-02-23,2019-08-18,Chemotherapy,Private,Alive,82.0,BRCA1,Yes,Current,Moderate,34.6,High,Urban,NHS,2.0,No,No,None,10.0
PT01954,Ireland,Munster,70.0,Male,Colorectal,III,2018-04-29,2018-07-27,2018-09-28,Chemotherapy,Private,,63.0,EGFR,Yes,Never,None,19.8,Medium,Urban,Statutory Health Insurance,19.0,No,No,None,10.0
PT01955,Belgium,,24.0,Male,Leukemia,I,2023-06-05,2023-07-15,2024-03-11,Targeted Therapy,Private,Alive,,None,No,Never,None,24.1,High,Urban,Statutory Health Insurance,7.0,No,No,Hypertension,1.0
PT01956,Poland,Silesian,32.0,Male,Leukemia,II,2022-09-18,2023-03-12,2023-09-26,Radiation,Private,Alive,99.0,BRCA1,No,Never,None,20.3,Low,Rural,Statutory Health Insurance,9.0,No,No,Cardiovascular Disease,5.0
PT01957,France,Auvergne-Rhône-Alpes,47.0,Female,,III,2017-04-16,2017-07-11,2017-12-09,Targeted Therapy,Research Institute,Alive,113.0,None,No,Never,Heavy,28.2,Low,Urban,Statutory Health Insurance,5.0,No,No,,9.0
PT01958,Ireland,Munster,81.0,Male,Colorectal,III,2018-03-14,2018-05-14,2019-04-17,Surgery,Public,Alive,105.0,KRAS,No,Former,Moderate,22.2,Medium,Urban,,5.0,No,No,Cardiovascular Disease,2.0
PT01959,Sweden,Skåne,43.0,Female,Leukemia,III,2015-05-27,2015-06-10,2016-02-02,Immunotherapy,Public,,42.0,None,No,Never,Moderate,20.3,High,Urban,Statutory Health Insurance,17.0,No,No,Hypertension,3.0
PT01960,Poland,Lesser Poland,26.0,Male,,I,2015-12-15,2016-03-12,2016-08-14,Immunotherapy,Research Institute,Alive,19.0,EGFR,No,Never,None,32.5,Low,,NHS,12.0,Yes,No,Cardiovascular Disease,5.0
PT01961,Germany,Berlin,57.0,Female,Breast,III,2013-08-20,2013-10-26,2014-06-04,Radiation,Public,Alive,,BRCA1,No,Never,None,36.6,Medium,Urban,NHS,4.0,Yes,No,Diabetes,2.0
PT01962,Italy,Veneto,56.0,Male,Lung,III,2023-05-23,2023-08-07,2023-11-06,Chemotherapy,Private,Alive,,KRAS,No,Former,Moderate,22.4,Medium,Urban,Private Insurance,12.0,Yes,No,Hypertension,2.0
PT01963,Finland,Uusimaa,87.0,Male,Prostate,III,2020-08-21,2021-02-12,2021-05-07,,Public,Alive,116.0,EGFR,No,Former,Moderate,20.7,Medium,Rural,Statutory Health Insurance,18.0,Yes,Yes,Cardiovascular Disease,4.0
PT01964,Sweden,Skåne,61.0,Female,Ovarian,I,2012-04-19,2012-09-10,,Radiation,Public,Alive,45.0,BRCA1,No,Current,None,32.5,Medium,Urban,Statutory Health Insurance,17.0,No,No,Diabetes,1.0
PT01965,Denmark,Zealand,24.0,Female,Lung,I,2020-07-03,2020-09-12,2021-06-08,Surgery,Research Institute,Alive,12.0,None,No,Former,Moderate,19.0,,Urban,NHS,,No,No,None,9.0
PT01966,Belgium,Flanders,83.0,Female,Prostate,III,2019-01-27,2019-02-14,2020-01-17,Immunotherapy,Public,Alive,97.0,None,No,Never,None,23.2,,Rural,Statutory Health Insurance,1.0,No,No,Cardiovascular Disease,10.0
PT01967,Germany,Bavaria,69.0,Female,Prostate,IV,2019-12-28,2020-06-18,2021-02-26,Surgery,Research Institute,Deceased,13.0,EGFR,No,Current,Moderate,24.7,,Rural,NHS,8.0,No,No,Hypertension,2.0
PT01968,Switzerland,Geneva,34.0,Female,Ovarian,III,2011-07-02,2011-07-25,2011-09-18,Targeted Therapy,Public,Alive,84.0,None,Yes,Never,Moderate,38.2,Low,Rural,NHS,12.0,No,Yes,Obesity,10.0
PT01969,France,Auvergne-Rhône-Alpes,72.0,Male,Ovarian,III,2021-05-25,2021-06-20,2022-06-14,Immunotherapy,Public,Deceased,10.0,None,No,Former,Moderate,25.7,Medium,Rural,Private Insurance,7.0,No,No,Cardiovascular Disease,8.0
,Finland,Uusimaa,44.0,Female,Prostate,II,2020-01-15,2020-05-24,2020-08-09,Immunotherapy,Public,Alive,102.0,KRAS,No,Former,Heavy,29.7,Medium,,Private Insurance,2.0,No,No,Hypertension,9.0
PT01971,France,Provence-Alpes-Côte d'Azur,28.0,Female,Breast,II,2023-01-30,2023-06-29,2024-05-24,Chemotherapy,Public,Alive,113.0,KRAS,Yes,Never,None,,Low,Rural,NHS,19.0,No,No,Obesity,4.0
PT01972,Austria,Styria,,Non-binary,Lung,III,2017-03-11,2017-07-04,2018-05-18,Surgery,Public,Lost to Follow-up,,EGFR,No,Never,Moderate,36.6,High,Urban,Private Insurance,17.0,Yes,No,Diabetes,1.0
PT01973,Poland,,41.0,Female,Colorectal,III,,,2024-04-02,Targeted Therapy,,Deceased,48.0,,No,Never,,20.1,Low,Urban,Statutory Health Insurance,17.0,No,No,None,10.0
PT01974,Spain,Madrid,68.0,Male,Colorectal,III,2020-08-12,,2021-03-08,Radiation,Public,Alive,41.0,BRCA1,Yes,Former,Moderate,,Low,Urban,NHS,13.0,No,No,Obesity,10.0
PT01975,Portugal,Algarve,87.0,Male,Pancreatic,IV,2013-08-18,2014-01-21,2015-01-19,Targeted Therapy,Public,Deceased,118.0,EGFR,No,Current,None,34.6,Medium,Rural,Statutory Health Insurance,9.0,No,Yes,Cardiovascular Disease,8.0
PT01976,Sweden,,34.0,Female,Leukemia,II,2020-05-19,,2021-04-04,Immunotherapy,Research Institute,Alive,64.0,None,Yes,Never,None,37.3,Low,Urban,Private Insurance,11.0,Yes,Yes,Diabetes,2.0
PT01977,Norway,Trøndelag,84.0,Female,Breast,I,2017-11-11,2017-11-28,2018-08-31,Surgery,Private,Deceased,105.0,BRCA1,No,Former,Moderate,34.8,High,Rural,Private Insurance,9.0,No,No,Diabetes,2.0
PT01978,Ireland,Dublin,73.0,Female,Pancreatic,IV,2011-07-29,2011-11-18,2012-03-31,Immunotherapy,Private,Alive,8.0,BRCA1,No,Never,None,20.8,High,Urban,Private Insurance,13.0,No,No,Hypertension,5.0
PT01979,Switzerland,Zurich,49.0,Female,Pancreatic,I,2013-01-06,2013-05-01,2013-06-01,Radiation,Private,Lost to Follow-up,,,Yes,Never,None,24.6,Medium,Urban,NHS,3.0,No,Yes,Hypertension,
PT01980,Denmark,Capital Region,39.0,Male,Breast,III,2010-01-30,2010-02-01,2010-11-27,Radiation,Public,Alive,67.0,None,No,Former,None,27.3,Medium,Urban,Private Insurance,1.0,,No,Hypertension,9.0
PT01981,Belgium,Flanders,52.0,Male,Breast,IV,2013-10-07,2014-01-14,2014-07-26,Immunotherapy,Private,,27.0,BRCA1,,Never,Heavy,20.5,High,Rural,Private Insurance,6.0,No,No,Diabetes,9.0
PT01982,Finland,Southwest Finland,26.0,Male,Prostate,II,2017-09-11,2017-11-29,2018-02-01,Immunotherapy,Public,Deceased,27.0,EGFR,Yes,Never,Moderate,20.7,Low,Urban,,8.0,Yes,No,Obesity,
PT01983,Austria,Vienna,27.0,Female,Breast,III,2023-06-28,2023-10-14,2024-01-15,,Public,Deceased,101.0,KRAS,No,Current,Heavy,35.3,Medium,Urban,Private Insurance,14.0,,No,None,1.0
PT01984,Ireland,Dublin,47.0,Female,Colorectal,II,2020-10-23,2021-02-16,2021-07-01,Surgery,Public,Deceased,43.0,EGFR,,Never,Heavy,21.7,High,Urban,Statutory Health Insurance,5.0,No,No,Cardiovascular Disease,3.0
PT01985,,Vestland,64.0,Male,Breast,,2020-06-01,2020-09-18,2021-06-18,Chemotherapy,Private,Alive,55.0,KRAS,Yes,Former,Moderate,37.9,Medium,Rural,Private Insurance,12.0,No,No,None,2.0
PT01986,Ireland,Munster,30.0,Female,Ovarian,I,2022-09-05,,2023-04-09,Radiation,Private,Deceased,92.0,BRCA1,Yes,Never,Moderate,22.7,High,Urban,Private Insurance,,No,No,None,9.0
PT01987,Finland,Pirkanmaa,50.0,Male,Prostate,III,2022-03-23,2022-08-13,2023-04-04,Surgery,Public,Alive,58.0,EGFR,Yes,Former,Moderate,28.8,Medium,Urban,NHS,6.0,No,No,None,4.0
PT01988,Sweden,Skåne,31.0,Male,Lung,III,2020-03-20,2020-08-13,2020-10-24,Radiation,,Deceased,90.0,EGFR,No,Never,Heavy,22.7,Medium,Urban,NHS,1.0,Yes,No,Obesity,9.0
PT01989,Norway,Vestland,70.0,Female,Pancreatic,II,2022-01-15,2022-04-02,2023-01-22,Immunotherapy,Public,Alive,9.0,BRCA1,No,Former,Moderate,,Medium,Urban,Statutory Health Insurance,17.0,No,No,Cardiovascular Disease,10.0
PT01990,Ireland,Connacht,,Male,,III,2019-08-24,2019-10-01,2020-05-02,Radiation,Private,Deceased,84.0,KRAS,No,Former,None,29.9,Medium,Rural,Statutory Health Insurance,9.0,No,No,Cardiovascular Disease,
PT01991,Netherlands,North Holland,69.0,,Ovarian,IV,2016-06-12,2016-10-26,2016-12-27,Targeted Therapy,Public,Lost to Follow-up,,EGFR,No,,None,30.3,,Rural,,4.0,No,No,None,6.0
PT01992,Portugal,Algarve,36.0,Female,Ovarian,III,2020-04-08,2020-06-27,2020-09-18,Radiation,Public,Alive,114.0,EGFR,Yes,Current,Moderate,37.2,High,Urban,Private Insurance,15.0,No,,Cardiovascular Disease,8.0
PT01993,Italy,Sicily,54.0,Female,Pancreatic,IV,2018-08-01,,2019-09-14,Targeted Therapy,Public,Deceased,26.0,BRCA1,No,,None,21.3,Low,Rural,,14.0,No,No,Obesity,8.0
PT01994,Sweden,Västra Götaland,20.0,Male,Lung,II,2023-07-04,2023-07-30,2024-05-23,Surgery,Public,Alive,25.0,EGFR,Yes,Former,Moderate,19.9,High,Urban,NHS,13.0,Yes,No,Cardiovascular Disease,5.0
PT01995,Germany,Bavaria,48.0,Female,Leukemia,II,2013-07-23,2014-01-02,2014-07-02,Surgery,Public,Alive,89.0,KRAS,No,Former,Heavy,39.4,High,Rural,Private Insurance,15.0,No,No,Obesity,6.0
PT01996,Italy,Sicily,70.0,Female,Prostate,I,2022-08-12,2022-12-11,2023-03-12,Targeted Therapy,Public,Alive,30.0,KRAS,No,Never,None,38.2,Medium,Urban,NHS,14.0,,Yes,Hypertension,8.0
PT01997,Belgium,Flanders,83.0,Female,Pancreatic,IV,2018-05-24,2018-08-13,2019-02-26,Radiation,Public,Deceased,50.0,None,Yes,Never,None,23.6,Medium,Rural,Statutory Health Insurance,17.0,No,No,Hypertension,10.0
PT01998,Austria,Tyrol,23.0,Female,Breast,I,2012-06-05,2012-11-06,2013-10-16,Surgery,Public,Alive,69.0,EGFR,No,Never,Heavy,31.0,Medium,Urban,NHS,5.0,Yes,No,Diabetes,4.0
PT01999,Finland,Pirkanmaa,47.0,Male,,II,2014-04-08,2014-04-26,2015-04-02,Radiation,,Alive,66.0,BRCA1,Yes,Never,Moderate,33.3,Medium,Urban,Private Insurance,,Yes,No,Diabetes,10.0
PT02000,France,Provence-Alpes-Côte d'Azur,35.0,Male,Leukemia,I,2020-06-04,2020-11-23,2021-02-24,Chemotherapy,Public,Lost to Follow-up,,BRCA1,Yes,Never,None,38.4,Medium,Urban,NHS,11.0,No,Yes,Cardiovascular Disease,7.0
PT02001,,,82.0,Female,Lung,II,2018-03-05,2018-07-18,2018-10-15,Chemotherapy,Public,,,BRCA1,No,Never,None,22.6,Medium,Urban,Statutory Health Insurance,18.0,No,No,None,6.0
PT02002,,Zurich,72.0,Female,Pancreatic,IV,2020-05-12,2020-06-16,2021-04-20,Targeted Therapy,Public,Alive,100.0,KRAS,Yes,Current,Moderate,35.3,Low,Urban,Private Insurance,2.0,No,,Diabetes,
PT02003,Germany,Bavaria,36.0,Male,Pancreatic,II,2015-08-09,2015-08-21,2016-02-21,Targeted Therapy,Private,Deceased,73.0,KRAS,No,Never,Moderate,21.9,Medium,,NHS,8.0,No,No,None,2.0
PT02004,Denmark,Zealand,59.0,Male,Colorectal,IV,2023-05-23,2023-09-21,,,Private,Alive,61.0,BRCA1,No,Former,Moderate,30.3,Medium,Rural,NHS,14.0,No,No,Obesity,5.0
PT02005,Ireland,Dublin,,Female,Colorectal,II,2019-06-20,2019-10-11,2020-09-21,Chemotherapy,Public,Alive,98.0,None,No,Never,None,22.4,Low,Urban,Private Insurance,13.0,Yes,Yes,None,1.0
PT02006,Spain,Catalonia,71.0,Male,Colorectal,IV,2019-01-14,2019-02-27,2020-01-22,Chemotherapy,Public,Deceased,104.0,BRCA1,Yes,Never,Moderate,24.6,Medium,Rural,Statutory Health Insurance,6.0,Yes,No,Diabetes,10.0
PT02007,Belgium,Wallonia,77.0,Male,Pancreatic,,2019-01-12,2019-02-22,2019-05-19,Targeted Therapy,Public,Alive,99.0,BRCA1,Yes,,,29.7,Medium,Urban,Private Insurance,16.0,No,Yes,None,8.0
PT02008,Netherlands,Utrecht,56.0,Male,Pancreatic,II,2019-04-22,2019-06-15,2019-08-26,Immunotherapy,Research Institute,Alive,63.0,EGFR,Yes,Current,None,25.0,High,,NHS,16.0,No,,Obesity,10.0
PT02009,Netherlands,South Holland,80.0,Male,Colorectal,II,2021-12-21,2022-04-29,2023-04-11,Radiation,Research Institute,Alive,78.0,None,No,Former,None,39.9,Medium,Urban,Private Insurance,3.0,No,No,Diabetes,4.0
PT02010,Denmark,Zealand,53.0,Female,Prostate,II,2021-11-04,2021-11-29,2022-04-19,Radiation,Public,Deceased,42.0,EGFR,Yes,Never,Moderate,32.2,Low,Urban,Statutory Health Insurance,4.0,No,No,None,6.0
,Italy,Sicily,89.0,Male,Ovarian,I,2015-08-23,2015-11-11,2016-11-04,Surgery,Private,Alive,10.0,,Yes,Never,Moderate,36.4,Low,Urban,Private Insurance,15.0,No,No,Hypertension,8.0
PT02012,Portugal,Lisbon,36.0,Male,Ovarian,I,2014-03-07,2014-07-07,2015-03-16,Targeted Therapy,Public,Deceased,23.0,BRCA1,Yes,Never,None,22.3,Medium,Urban,NHS,1.0,No,No,Cardiovascular Disease,9.0
PT02013,Spain,Madrid,39.0,Male,Ovarian,I,2020-02-12,2020-02-27,2020-10-08,Surgery,Private,Alive,38.0,BRCA1,No,Current,Moderate,20.9,Medium,,Private Insurance,5.0,,No,Diabetes,10.0
PT02014,Denmark,Central Denmark,78.0,Male,Breast,II,2022-11-24,2023-02-07,2023-09-05,Immunotherapy,Public,Deceased,18.0,None,No,Never,Moderate,24.2,Low,Urban,Statutory Health Insurance,7.0,No,No,Obesity,10.0
,Italy,Sicily,88.0,Female,Breast,III,,2016-03-01,2016-09-17,Surgery,Public,,38.0,KRAS,No,Never,None,35.9,Medium,,NHS,7.0,No,No,Obesity,8.0
PT02016,Denmark,Capital Region,52.0,Male,Prostate,II,2015-11-27,2016-04-06,2017-01-17,Immunotherapy,Public,Alive,118.0,BRCA1,No,Never,None,22.4,High,Urban,Statutory Health Insurance,3.0,No,No,Obesity,3.0
PT02017,France,Île-de-France,,Female,Lung,III,2016-08-20,2017-02-09,2017-04-28,Surgery,Public,Deceased,45.0,None,No,Never,None,23.4,Medium,Urban,Statutory Health Insurance,1.0,No,No,Obesity,9.0
PT02018,Austria,,76.0,Male,Ovarian,IV,2017-08-26,2017-12-24,2018-03-11,Targeted Therapy,Public,Alive,106.0,KRAS,No,Never,Moderate,34.3,Medium,Rural,NHS,12.0,No,Yes,Diabetes,9.0
PT02019,Germany,Bavaria,20.0,Male,Ovarian,II,2021-08-14,2021-09-28,2022-06-11,Immunotherapy,Public,Alive,71.0,None,No,Former,None,35.6,Low,Urban,NHS,16.0,No,No,Diabetes,8.0
PT02020,Sweden,Stockholm,32.0,Male,Breast,II,2018-05-01,2018-10-27,2019-06-20,Radiation,Public,Alive,113.0,KRAS,No,Never,Moderate,30.0,,Urban,Private Insurance,17.0,Yes,Yes,Cardiovascular Disease,6.0
PT02021,,Vienna,46.0,Male,Pancreatic,I,2021-03-15,,2022-05-14,Targeted Therapy,Public,Deceased,111.0,KRAS,Yes,Former,Moderate,21.2,Medium,Rural,Private Insurance,11.0,Yes,Yes,Diabetes,2.0
PT02022,Netherlands,North Holland,89.0,Female,Leukemia,II,2018-06-06,2018-11-20,2019-06-18,Targeted Therapy,Public,Alive,17.0,BRCA1,Yes,Former,Moderate,36.4,Medium,,Statutory Health Insurance,14.0,No,No,Cardiovascular Disease,2.0
PT02023,Poland,Lesser Poland,78.0,Male,Pancreatic,III,2018-11-09,2018-11-29,,Chemotherapy,Private,Alive,98.0,EGFR,No,Current,None,30.8,Medium,Rural,,6.0,,No,Diabetes,2.0
PT02024,France,Provence-Alpes-Côte d'Azur,25.0,Female,Breast,I,2011-03-12,2011-08-05,2012-07-16,Radiation,Public,Alive,98.0,BRCA1,No,,None,38.5,Medium,Urban,,5.0,No,No,None,1.0
PT02025,Portugal,Porto,42.0,Male,Prostate,I,2013-12-28,2014-04-23,2014-09-20,Surgery,Private,Deceased,52.0,BRCA1,No,,None,22.5,Medium,Rural,Statutory Health Insurance,5.0,Yes,No,Hypertension,6.0
PT02026,Denmark,Zealand,29.0,Male,Lung,II,2016-06-30,2016-12-14,2017-04-10,Targeted Therapy,Public,Alive,53.0,KRAS,No,Current,None,21.2,High,Rural,Private Insurance,,No,,None,8.0
PT02027,Belgium,Brussels,70.0,Male,Breast,III,2016-01-14,2016-04-22,2016-08-30,Surgery,Public,Alive,28.0,None,No,Current,None,23.0,Low,Urban,Statutory Health Insurance,2.0,No,No,None,3.0
PT02028,Germany,Berlin,38.0,Female,Prostate,III,2010-04-22,2010-05-21,2010-09-26,Targeted Therapy,Public,Deceased,45.0,BRCA1,Yes,Current,Moderate,22.2,Low,Urban,Statutory Health Insurance,15.0,No,No,Cardiovascular Disease,4.0
PT02029,France,Auvergne-Rhône-Alpes,70.0,Male,Leukemia,,2018-04-23,2018-05-13,2018-07-03,Radiation,Public,Deceased,10.0,KRAS,Yes,Never,,35.7,Medium,Urban,Statutory Health Insurance,1.0,No,No,None,5.0
PT02030,Italy,Veneto,87.0,Male,,IV,2013-01-01,2013-06-20,2013-10-31,,Private,Alive,41.0,EGFR,Yes,Never,None,20.1,Medium,,Statutory Health Insurance,11.0,No,No,Cardiovascular Disease,8.0
PT02031,Austria,Styria,61.0,Male,Leukemia,I,2023-10-29,2024-01-16,2024-04-25,Surgery,Public,Alive,36.0,KRAS,No,Never,None,35.9,Medium,Rural,NHS,10.0,No,No,Diabetes,10.0
PT02032,Portugal,Porto,76.0,Male,Leukemia,I,2013-07-20,2013-10-24,2014-09-04,Surgery,,Alive,28.0,None,No,Former,Moderate,32.2,High,Rural,Private Insurance,13.0,No,No,Diabetes,1.0
PT02033,Denmark,Capital Region,87.0,Female,Ovarian,II,2012-08-15,2012-08-27,2013-08-07,Radiation,Public,Alive,21.0,BRCA1,,Never,Moderate,38.2,Medium,Urban,Statutory Health Insurance,6.0,No,No,Hypertension,3.0
PT02034,Poland,Masovian,57.0,Female,Lung,II,2023-03-25,2023-05-20,2023-08-12,Surgery,Research Institute,Alive,77.0,None,Yes,,None,28.3,Low,Urban,Statutory Health Insurance,18.0,No,No,Hypertension,1.0
PT02035,Italy,Veneto,81.0,Female,Breast,II,2023-08-09,2023-12-02,2024-05-06,Immunotherapy,Private,Deceased,14.0,None,No,Never,None,23.9,,Urban,Statutory Health Insurance,19.0,No,Yes,Obesity,1.0
PT02036,Poland,Masovian,26.0,Female,Colorectal,,2021-03-10,2021-03-22,2021-05-29,Targeted Therapy,,Alive,59.0,EGFR,No,,Moderate,37.8,Low,Urban,Private Insurance,8.0,No,No,Diabetes,9.0
PT02037,Austria,Vienna,69.0,Female,Prostate,I,2010-04-04,2010-05-27,2010-11-11,Immunotherapy,Public,Alive,71.0,KRAS,,Former,,18.2,Low,Urban,Private Insurance,5.0,No,No,Diabetes,5.0
PT02038,Portugal,,71.0,Male,,I,2017-07-29,2017-11-04,2018-04-14,Chemotherapy,Private,,23.0,BRCA1,No,Former,None,,Low,Urban,Statutory Health Insurance,15.0,No,Yes,Cardiovascular Disease,9.0
PT02039,Spain,Andalusia,45.0,Female,Breast,IV,2011-10-30,2011-11-07,2012-07-29,Chemotherapy,Private,Alive,52.0,BRCA1,Yes,Never,Heavy,31.7,Low,Urban,NHS,,No,No,Cardiovascular Disease,4.0
PT02040,France,,45.0,Male,Lung,IV,2011-05-30,2011-07-27,2012-02-02,Targeted Therapy,Public,Alive,88.0,KRAS,No,Current,None,21.6,Low,Rural,Private Insurance,12.0,No,No,Obesity,7.0
PT02041,Switzerland,Zurich,,Male,Breast,,2013-05-28,2013-06-21,2013-09-03,Surgery,Public,Alive,42.0,EGFR,Yes,Never,Moderate,24.4,Medium,Rural,NHS,10.0,No,No,Diabetes,9.0
PT02042,Finland,Pirkanmaa,28.0,Female,Prostate,I,2018-06-04,2018-09-21,2019-04-03,Radiation,Private,Alive,45.0,BRCA1,No,Current,Moderate,31.0,High,Urban,Statutory Health Insurance,11.0,No,No,Diabetes,1.0
PT02043,France,Île-de-France,80.0,Female,,I,2021-09-29,2021-11-29,2022-08-11,Chemotherapy,Private,Deceased,77.0,KRAS,No,Never,,20.1,Medium,Urban,Statutory Health Insurance,13.0,,No,Diabetes,3.0
PT02044,Finland,,39.0,Female,Leukemia,IV,2015-10-03,2016-02-09,2016-08-05,Surgery,Public,Alive,86.0,EGFR,Yes,Current,Moderate,19.3,Low,Rural,Statutory Health Insurance,1.0,No,No,Cardiovascular Disease,8.0
PT02045,Sweden,Stockholm,,Female,Breast,IV,2023-10-09,2024-01-06,2024-12-14,Radiation,Public,Deceased,74.0,None,,Current,Heavy,29.4,Low,Urban,,17.0,No,,Cardiovascular Disease,6.0
PT02046,France,Auvergne-Rhône-Alpes,,Male,Pancreatic,I,2018-04-12,2018-06-29,2019-05-31,Targeted Therapy,Public,Alive,77.0,BRCA1,Yes,Never,Heavy,18.7,,Rural,Statutory Health Insurance,7.0,No,No,None,10.0
PT02047,Switzerland,Zurich,32.0,Male,Lung,II,2012-03-22,2012-05-31,2013-05-22,Surgery,Private,Alive,79.0,None,No,Former,Moderate,35.0,High,Rural,NHS,8.0,No,No,Hypertension,6.0
PT02048,Netherlands,,31.0,Male,Lung,II,2014-03-01,2014-08-21,,Immunotherapy,Private,Alive,8.0,BRCA1,No,Former,Moderate,33.3,Medium,Rural,NHS,15.0,Yes,No,Hypertension,
PT02049,Poland,Masovian,29.0,Female,Colorectal,II,2014-01-18,2014-06-04,2015-02-12,Targeted Therapy,Public,Lost to Follow-up,,EGFR,No,Current,Moderate,38.4,High,Urban,Statutory Health Insurance,,No,No,Diabetes,8.0
PT02050,Portugal,Porto,84.0,Female,Leukemia,III,2020-07-30,2020-11-19,2021-06-14,Chemotherapy,Private,Deceased,72.0,KRAS,Yes,Former,,36.2,Low,Urban,Private Insurance,13.0,No,No,Hypertension,5.0
PT02051,Norway,Vestland,49.0,Male,Prostate,II,2015-06-25,2015-11-01,2016-10-26,Targeted Therapy,Private,Alive,100.0,EGFR,No,Never,Moderate,19.4,High,Rural,Private Insurance,14.0,Yes,No,Obesity,1.0
PT02052,Sweden,Stockholm,27.0,Male,Leukemia,IV,2012-10-28,2013-03-29,2013-10-20,Targeted Therapy,Public,Alive,96.0,EGFR,No,Never,Moderate,22.4,Medium,Rural,NHS,2.0,No,No,Cardiovascular Disease,2.0
PT02053,Ireland,Connacht,40.0,Male,Colorectal,I,2015-11-09,2016-01-08,2016-03-06,Radiation,Public,Alive,97.0,,Yes,Never,Heavy,22.4,,Urban,Private Insurance,8.0,No,,None,
PT02054,Spain,Andalusia,41.0,Female,Leukemia,III,2022-02-28,2022-08-23,2023-07-16,Chemotherapy,Public,Alive,43.0,,Yes,Never,Heavy,27.7,Medium,Urban,NHS,6.0,No,No,Diabetes,
PT02055,Germany,Bavaria,37.0,Female,Colorectal,II,2018-05-28,2018-11-11,2019-03-18,Radiation,Public,Alive,105.0,None,Yes,Current,Moderate,30.0,Low,Urban,Private Insurance,2.0,,No,None,9.0
PT02056,Norway,,85.0,Male,Leukemia,II,2010-12-17,2011-01-04,2011-08-08,Targeted Therapy,Research Institute,Deceased,32.0,None,Yes,,None,28.2,Medium,Urban,NHS,4.0,No,No,None,9.0
PT02057,Italy,Lombardy,67.0,Non-binary,Breast,III,2021-10-15,2022-01-28,2023-01-22,Surgery,Public,Alive,21.0,EGFR,No,Former,Moderate,23.0,Medium,Urban,Private Insurance,9.0,No,No,Obesity,10.0
PT02058,Denmark,Capital Region,,Female,Lung,IV,2016-04-24,2016-07-25,2017-04-04,Immunotherapy,Private,Alive,20.0,KRAS,Yes,Never,Heavy,38.1,Low,Urban,Statutory Health Insurance,2.0,No,Yes,None,9.0
PT02059,Sweden,Västra Götaland,28.0,Male,Colorectal,III,2023-02-13,2023-04-06,2023-08-21,,Public,Alive,77.0,None,No,Former,Moderate,18.8,Medium,Rural,,8.0,Yes,No,Hypertension,8.0
PT02060,Poland,Silesian,86.0,Female,Colorectal,III,2013-06-18,2013-06-20,2013-10-11,Radiation,Public,Alive,108.0,None,No,Never,None,18.7,,Rural,NHS,12.0,No,No,Hypertension,3.0
PT02061,Germany,,73.0,Male,Lung,III,2014-04-07,2014-07-17,2015-04-30,Surgery,Public,Alive,54.0,KRAS,Yes,,,34.7,Medium,Rural,Private Insurance,4.0,Yes,Yes,Cardiovascular Disease,9.0
PT02062,Spain,Madrid,45.0,Male,Pancreatic,II,2023-08-01,2024-01-12,2024-06-25,Immunotherapy,Public,Deceased,33.0,None,Yes,Never,None,24.3,Medium,Rural,Statutory Health Insurance,4.0,,No,Hypertension,10.0
PT02063,Italy,Lombardy,45.0,Male,Pancreatic,III,2012-02-25,2012-04-13,2012-09-03,Surgery,Public,Deceased,84.0,BRCA1,No,,Moderate,34.4,High,Urban,NHS,4.0,No,No,Cardiovascular Disease,7.0
PT02064,Poland,Silesian,53.0,Female,Prostate,III,2020-09-11,2021-01-06,2021-11-28,Radiation,Public,Deceased,65.0,KRAS,,Never,None,24.6,High,Urban,Private Insurance,17.0,No,No,Cardiovascular Disease,10.0
PT02065,Sweden,Västra Götaland,27.0,Female,Colorectal,II,2021-07-08,2021-10-04,2022-03-10,Chemotherapy,Public,Deceased,29.0,EGFR,No,Former,Moderate,30.5,,Urban,Statutory Health Insurance,2.0,No,No,Cardiovascular Disease,9.0
PT02066,Sweden,,29.0,Male,Breast,II,2019-05-27,2019-07-01,2019-10-27,Surgery,Public,Alive,74.0,EGFR,Yes,Never,Moderate,37.0,Medium,Urban,Statutory Health Insurance,6.0,No,No,None,9.0
PT02067,Belgium,Flanders,67.0,Female,Leukemia,III,2016-04-26,2016-07-16,2016-12-31,Surgery,,Alive,75.0,EGFR,Yes,Never,None,22.1,Medium,Urban,NHS,16.0,Yes,Yes,Obesity,
PT02068,Denmark,Capital Region,74.0,Male,Breast,III,2011-10-28,2012-01-30,2012-03-23,Chemotherapy,Public,Deceased,65.0,None,No,Former,Moderate,33.8,Low,Rural,Private Insurance,1.0,No,No,None,2.0
PT02069,Austria,Styria,73.0,Female,Colorectal,II,2011-07-15,2011-11-07,2012-01-10,Targeted Therapy,Private,Alive,60.0,,Yes,Never,Moderate,35.9,Medium,Rural,NHS,1.0,No,No,Cardiovascular Disease,9.0
PT02070,Austria,Tyrol,,Female,Prostate,III,2020-01-06,2020-03-18,2020-08-27,Targeted Therapy,Public,,10.0,KRAS,No,,Moderate,39.4,Low,Urban,NHS,12.0,Yes,Yes,Cardiovascular Disease,8.0
PT02071,Switzerland,,34.0,Male,Colorectal,III,2021-05-11,2021-10-28,2022-03-12,Targeted Therapy,Public,Alive,30.0,None,No,Current,,22.2,Low,Rural,Statutory Health Insurance,3.0,No,Yes,Obesity,10.0
PT02072,Ireland,Munster,37.0,Male,Prostate,I,2023-09-07,2023-11-26,2024-09-20,Radiation,Private,Alive,45.0,None,No,Never,Moderate,29.0,Medium,Urban,Private Insurance,12.0,No,No,Cardiovascular Disease,1.0
,Finland,Pirkanmaa,42.0,Female,Lung,III,2016-01-01,2016-02-08,2016-12-07,Targeted Therapy,,Lost to Follow-up,,EGFR,Yes,Former,None,24.5,High,Urban,Private Insurance,14.0,No,,Diabetes,1.0
,Denmark,Zealand,81.0,Male,Leukemia,I,2014-03-23,2014-08-24,2015-01-04,Radiation,Research Institute,Alive,12.0,BRCA1,No,Never,None,27.6,Medium,Urban,,16.0,No,No,Diabetes,5.0
PT02075,Spain,Andalusia,65.0,Female,Breast,I,2017-10-21,2017-11-21,2018-06-12,Chemotherapy,Public,Deceased,36.0,KRAS,Yes,Former,None,19.5,Low,Rural,Statutory Health Insurance,7.0,No,No,Diabetes,3.0
PT02076,Switzerland,Geneva,58.0,Female,Prostate,II,2011-12-19,2011-12-27,2012-09-06,Surgery,Public,Alive,66.0,BRCA1,Yes,Never,None,37.7,Medium,Urban,Statutory Health Insurance,5.0,No,,Hypertension,6.0
PT02077,Italy,Sicily,34.0,Female,Breast,IV,2018-08-06,2018-09-10,2018-12-16,Immunotherapy,Research Institute,Alive,8.0,None,No,Never,None,25.1,Medium,Rural,,,No,No,Cardiovascular Disease,8.0
PT02078,Poland,Lesser Poland,72.0,Male,Ovarian,I,2017-12-30,2018-02-02,2018-04-29,Immunotherapy,Private,Alive,57.0,KRAS,Yes,Former,Moderate,39.8,High,Rural,NHS,8.0,No,No,,5.0
PT02079,Spain,Catalonia,83.0,,Lung,III,2011-10-17,2012-03-03,2012-05-11,,Private,Alive,87.0,None,No,Former,Moderate,27.7,Medium,Urban,NHS,5.0,No,No,Hypertension,7.0
PT02080,Germany,Berlin,82.0,Male,Colorectal,II,2013-02-05,2013-07-23,2014-03-22,Radiation,Public,,69.0,BRCA1,No,Current,Moderate,25.8,,Urban,Statutory Health Insurance,1.0,No,No,Cardiovascular Disease,9.0
PT02081,,Veneto,,Female,Prostate,IV,2014-11-11,2015-02-27,2015-09-17,Surgery,Public,Alive,98.0,None,No,Former,None,29.1,Medium,Urban,NHS,11.0,No,No,Obesity,9.0
PT02082,Germany,North Rhine-Westphalia,89.0,Male,,III,,2018-12-19,2019-05-09,Chemotherapy,,Alive,70.0,BRCA1,No,Current,None,21.1,Medium,Rural,Statutory Health Insurance,2.0,Yes,No,Diabetes,1.0
PT02083,Sweden,Västra Götaland,85.0,Male,Ovarian,IV,2020-06-08,2020-10-26,,Surgery,Research Institute,Alive,61.0,KRAS,Yes,Former,Heavy,36.6,Low,Urban,NHS,10.0,No,No,None,3.0
PT02084,Denmark,,32.0,Female,Prostate,III,2014-10-16,2015-01-29,2015-12-03,Radiation,Research Institute,Alive,34.0,,Yes,Current,Moderate,35.8,High,Urban,Statutory Health Insurance,5.0,No,No,Cardiovascular Disease,4.0
PT02085,Italy,Sicily,66.0,Female,Pancreatic,III,2018-10-16,2019-03-20,2019-11-20,Surgery,Public,Lost to Follow-up,,BRCA1,,Former,Moderate,36.1,Medium,Urban,Statutory Health Insurance,7.0,No,No,Obesity,5.0
PT02086,Germany,Berlin,,Male,Colorectal,I,,2017-11-14,2018-07-02,Radiation,Public,Alive,64.0,,Yes,Former,None,27.1,Low,Urban,Private Insurance,15.0,Yes,No,Hypertension,7.0
PT02087,France,Auvergne-Rhône-Alpes,82.0,Non-binary,Colorectal,II,2016-12-11,2017-02-06,,Immunotherapy,Public,Alive,45.0,EGFR,Yes,Never,None,25.9,High,,Private Insurance,8.0,No,No,Hypertension,2.0
PT02088,Belgium,Brussels,53.0,Female,Leukemia,I,2012-12-17,2013-02-09,2013-10-15,Surgery,Private,Alive,38.0,None,No,Never,None,39.1,,Urban,Statutory Health Insurance,13.0,No,No,Diabetes,8.0
PT02089,Belgium,Flanders,48.0,Male,Leukemia,III,2021-06-15,2021-06-30,2021-11-10,Chemotherapy,Private,Alive,116.0,EGFR,Yes,Never,Moderate,30.5,Medium,Urban,Private Insurance,12.0,No,No,None,10.0
PT02090,Denmark,,56.0,Male,Lung,I,2018-04-30,2018-08-18,2018-11-06,Immunotherapy,Public,Alive,93.0,EGFR,No,Never,None,37.6,Low,Rural,Private Insurance,4.0,No,No,Obesity,4.0
PT02091,Denmark,,62.0,Female,Ovarian,I,2016-05-30,2016-11-11,2017-08-24,Chemotherapy,Public,Alive,116.0,KRAS,Yes,Never,Moderate,23.7,High,Rural,Statutory Health Insurance,6.0,No,No,Obesity,8.0
PT02092,Spain,Madrid,83.0,Female,Ovarian,IV,2018-10-07,2019-03-02,2019-06-16,Chemotherapy,Public,Deceased,40.0,EGFR,,Never,None,30.0,Low,Urban,NHS,18.0,No,No,Hypertension,4.0
PT02093,France,Provence-Alpes-Côte d'Azur,43.0,Male,Breast,III,2015-09-19,2015-11-02,2015-12-05,Radiation,Public,Alive,116.0,EGFR,No,Never,Moderate,32.8,Medium,Rural,NHS,10.0,No,Yes,Hypertension,7.0
PT02094,Switzerland,Zurich,53.0,Male,Prostate,IV,2012-12-15,2013-03-16,2014-02-19,Chemotherapy,Public,Alive,76.0,EGFR,No,Never,None,20.2,Low,Rural,Private Insurance,14.0,No,Yes,Cardiovascular Disease,9.0
PT02095,Finland,Uusimaa,67.0,Male,Lung,,2017-07-22,2017-11-01,2018-02-27,Targeted Therapy,Public,Alive,102.0,EGFR,No,Former,None,37.4,High,Rural,NHS,6.0,No,No,,5.0
PT02096,Poland,Silesian,31.0,,Breast,II,2010-10-18,2011-02-23,2011-08-09,Chemotherapy,,Alive,73.0,None,No,Never,Moderate,27.7,Medium,Rural,Statutory Health Insurance,14.0,No,No,Cardiovascular Disease,7.0
PT02097,Ireland,Munster,42.0,Male,Ovarian,I,2023-02-24,2023-05-19,2024-02-22,Surgery,Private,Deceased,40.0,KRAS,No,Never,None,35.5,Low,Urban,Statutory Health Insurance,6.0,No,No,Hypertension,10.0
PT02098,Switzerland,Bern,32.0,Male,Lung,I,2019-05-17,2019-10-13,2019-12-11,Radiation,Public,Alive,39.0,BRCA1,No,Current,Heavy,35.6,Medium,Urban,NHS,,Yes,No,,2.0
PT02099,,Silesian,64.0,Female,Pancreatic,I,2018-09-02,2018-10-01,2019-06-11,Radiation,Research Institute,Alive,79.0,BRCA1,Yes,Never,None,33.0,High,Urban,Private Insurance,4.0,,No,Cardiovascular Disease,6.0
PT02100,Ireland,Dublin,84.0,Female,Leukemia,II,2019-08-01,2019-11-16,2020-05-21,,Public,Alive,79.0,KRAS,No,Never,None,26.4,,Urban,Private Insurance,1.0,No,No,Obesity,2.0
PT02101,Norway,Vestland,66.0,Female,Leukemia,I,2023-05-27,2023-06-11,2023-07-15,Radiation,Public,Alive,106.0,KRAS,Yes,Current,Moderate,30.4,Low,Urban,Statutory Health Insurance,13.0,No,No,Diabetes,4.0
PT02102,France,Auvergne-Rhône-Alpes,77.0,Male,Colorectal,II,2012-04-23,2012-07-18,2013-05-14,Radiation,Public,Alive,25.0,BRCA1,Yes,Never,None,35.7,Medium,Urban,,9.0,No,Yes,Hypertension,3.0
PT02103,Ireland,Munster,24.0,Male,Prostate,II,2012-07-02,2012-09-27,2012-12-13,Immunotherapy,Public,Alive,49.0,None,Yes,Former,Heavy,20.3,Medium,Urban,Private Insurance,13.0,No,No,Hypertension,1.0
PT02104,Ireland,Dublin,24.0,Male,Prostate,I,2022-02-26,2022-05-05,2022-12-24,Immunotherapy,Public,Deceased,86.0,EGFR,No,Current,None,36.0,,Rural,NHS,,No,No,None,4.0
PT02105,Ireland,Connacht,79.0,Female,Prostate,III,2020-12-04,2021-03-02,,Immunotherapy,Private,Deceased,46.0,EGFR,No,,None,24.3,High,Rural,NHS,16.0,No,Yes,None,7.0
PT02106,Sweden,Västra Götaland,40.0,Female,Lung,III,2012-09-03,2012-11-06,2013-09-06,Targeted Therapy,Research Institute,Alive,82.0,KRAS,No,Current,Moderate,26.3,Low,Rural,NHS,19.0,No,No,Hypertension,3.0
PT02107,Norway,Vestland,,Male,Lung,III,2019-02-09,2019-02-23,2019-05-22,Radiation,Public,Alive,12.0,KRAS,No,Former,Moderate,24.2,Low,Urban,Private Insurance,7.0,No,No,None,6.0
PT02108,,Dublin,37.0,Male,Prostate,II,2015-09-24,2016-03-07,2016-10-03,Radiation,Public,Alive,99.0,None,Yes,Former,Moderate,,Medium,Rural,Statutory Health Insurance,12.0,No,No,Cardiovascular Disease,1.0
PT02109,Netherlands,North Holland,40.0,Female,Colorectal,IV,2013-04-15,2013-06-08,2013-12-21,Radiation,Private,Alive,,KRAS,No,Former,None,33.7,Medium,Urban,Statutory Health Insurance,9.0,No,No,Obesity,3.0
PT02110,Poland,Silesian,73.0,,Breast,IV,2014-07-07,2014-09-04,2015-06-21,Chemotherapy,Public,Deceased,16.0,EGFR,No,Never,Moderate,40.0,Low,Rural,NHS,13.0,No,No,Diabetes,1.0
PT02111,Denmark,Capital Region,29.0,Male,Pancreatic,II,2010-05-02,2010-09-07,2011-05-07,Radiation,Public,Alive,18.0,BRCA1,No,Never,None,20.1,Medium,Rural,Private Insurance,9.0,No,No,Cardiovascular Disease,10.0
PT02112,Switzerland,Bern,43.0,Female,Lung,II,2021-12-19,2022-02-12,2022-06-21,Radiation,Public,Deceased,28.0,EGFR,No,Current,Moderate,39.3,Medium,Urban,Private Insurance,19.0,No,No,None,1.0
PT02113,Spain,Andalusia,79.0,Female,Prostate,,2012-08-17,2013-02-04,2013-03-24,Surgery,Public,Deceased,79.0,None,Yes,Current,Moderate,23.0,Medium,Urban,Statutory Health Insurance,7.0,No,No,Diabetes,7.0
PT02114,Poland,Silesian,76.0,Female,Leukemia,III,2020-06-12,2020-07-21,2021-07-09,Surgery,Public,Deceased,33.0,BRCA1,No,Never,Moderate,18.4,Low,Rural,Private Insurance,7.0,No,No,None,7.0
PT02115,France,Île-de-France,,Female,Lung,II,2022-01-25,2022-04-12,2022-06-04,Radiation,Public,Alive,22.0,None,No,Former,None,22.8,Medium,Rural,NHS,7.0,No,No,Diabetes,9.0
PT02116,Sweden,Västra Götaland,41.0,Female,Breast,IV,2013-09-14,2014-02-08,2014-06-07,Chemotherapy,Public,Alive,52.0,None,Yes,Never,None,22.0,,Urban,Private Insurance,12.0,No,Yes,Obesity,6.0
PT02117,Poland,Masovian,87.0,Female,Lung,II,2011-11-19,2012-05-01,2012-10-24,Chemotherapy,Public,Alive,99.0,None,No,Never,Moderate,34.4,Medium,Rural,Private Insurance,2.0,Yes,No,Hypertension,3.0
PT02118,Norway,Oslo,53.0,Female,Breast,IV,2016-05-18,2016-07-01,,Targeted Therapy,Public,Alive,27.0,KRAS,Yes,Former,None,,Medium,Urban,Private Insurance,7.0,No,No,Cardiovascular Disease,7.0
PT02119,Sweden,Stockholm,89.0,Male,Breast,IV,2012-05-05,2012-06-20,2013-06-01,Targeted Therapy,Public,Alive,54.0,None,Yes,,None,25.8,Medium,Urban,NHS,8.0,No,Yes,Cardiovascular Disease,5.0
,Switzerland,Zurich,47.0,Male,Lung,IV,,2022-05-31,2022-07-31,Radiation,Research Institute,Alive,45.0,None,Yes,Never,Moderate,22.1,Low,Urban,Private Insurance,5.0,Yes,No,Hypertension,1.0
PT02121,Poland,Lesser Poland,58.0,Female,Breast,II,2010-01-22,2010-07-09,2010-09-21,Immunotherapy,Private,Deceased,89.0,BRCA1,,Former,Moderate,25.9,Medium,Urban,Private Insurance,14.0,No,Yes,Diabetes,7.0
PT02122,France,Île-de-France,61.0,Female,Lung,I,2015-06-28,2015-09-16,2016-06-03,Chemotherapy,Research Institute,Alive,11.0,None,No,Never,None,39.2,Low,Urban,Private Insurance,4.0,Yes,No,Diabetes,5.0
PT02123,Denmark,Central Denmark,42.0,Female,Lung,III,2020-10-27,2021-03-23,2021-08-29,Immunotherapy,Public,Alive,87.0,BRCA1,No,,Moderate,24.6,Medium,Urban,Private Insurance,6.0,No,No,Cardiovascular Disease,1.0
PT02124,Belgium,Flanders,89.0,Male,Colorectal,III,2020-08-22,2020-10-05,2021-06-16,Targeted Therapy,Private,,100.0,EGFR,No,,None,33.1,Low,Urban,Statutory Health Insurance,9.0,Yes,No,Obesity,1.0
PT02125,Belgium,Brussels,21.0,Female,Leukemia,I,2012-08-27,2012-11-29,2013-10-25,Chemotherapy,Private,,31.0,None,No,Former,Heavy,25.4,High,Rural,NHS,6.0,No,Yes,Cardiovascular Disease,7.0
PT02126,Switzerland,Geneva,43.0,Male,Pancreatic,III,2020-05-06,2020-10-01,2021-04-09,Immunotherapy,Private,Deceased,52.0,EGFR,Yes,Never,None,,High,Rural,,18.0,No,No,None,4.0
PT02127,Italy,Sicily,36.0,Female,Breast,II,2010-12-11,2011-01-24,2011-11-28,Radiation,Private,Alive,71.0,None,No,Never,None,30.7,Medium,Urban,NHS,17.0,No,,None,10.0
PT02128,Netherlands,North Holland,84.0,Male,Lung,I,2014-09-26,2015-03-16,2015-11-26,Immunotherapy,Public,Alive,50.0,BRCA1,Yes,Never,None,32.7,Low,Urban,Private Insurance,7.0,No,No,Hypertension,
PT02129,Portugal,Algarve,89.0,Male,Breast,II,2019-02-14,2019-06-05,2019-10-18,Targeted Therapy,Public,Deceased,36.0,None,Yes,Former,Moderate,18.8,Medium,Urban,Statutory Health Insurance,2.0,No,No,Diabetes,6.0
PT02130,Switzerland,Bern,,Male,Lung,IV,2021-10-05,2021-10-12,2022-01-18,Chemotherapy,Public,Alive,55.0,KRAS,No,Former,None,34.2,High,,Statutory Health Insurance,14.0,No,No,Diabetes,2.0
PT02131,Belgium,Wallonia,79.0,Female,Pancreatic,II,,2019-12-29,,Chemotherapy,Private,Alive,18.0,None,No,Never,None,23.9,High,Urban,Statutory Health Insurance,16.0,No,No,Diabetes,9.0
PT02132,Netherlands,Utrecht,69.0,Male,Ovarian,III,2019-01-21,2019-03-24,2019-11-07,Chemotherapy,Public,Alive,43.0,EGFR,No,Former,Moderate,32.2,Low,,Statutory Health Insurance,7.0,,No,Diabetes,9.0
PT02133,Germany,Berlin,31.0,,Lung,I,2011-06-24,2011-06-26,2011-12-09,Radiation,Private,Alive,104.0,EGFR,Yes,Never,Heavy,27.2,Medium,Urban,Private Insurance,15.0,No,Yes,Hypertension,8.0
PT02134,Poland,Masovian,66.0,Male,,,2016-04-12,2016-06-28,2017-03-28,Chemotherapy,Research Institute,Deceased,30.0,None,Yes,Never,Moderate,25.1,Medium,Rural,Statutory Health Insurance,6.0,No,No,None,8.0
PT02135,France,Île-de-France,86.0,Male,Leukemia,IV,,2015-10-08,2016-02-02,Immunotherapy,Public,Alive,101.0,None,Yes,Current,Heavy,25.7,High,Urban,Private Insurance,14.0,No,No,Cardiovascular Disease,4.0
PT02136,Denmark,Zealand,84.0,Female,Breast,II,2023-11-22,2023-12-30,2024-03-17,Surgery,Private,Alive,,EGFR,No,Never,Moderate,20.6,Medium,Urban,NHS,,No,No,Hypertension,1.0
PT02137,Denmark,Capital Region,46.0,Male,Leukemia,II,2019-12-18,2020-03-22,2020-05-16,Surgery,Research Institute,Alive,40.0,None,No,,None,20.9,Medium,Urban,Statutory Health Insurance,16.0,No,No,None,10.0
PT02138,Belgium,Wallonia,67.0,Male,Leukemia,III,2014-01-28,2014-06-06,2015-02-14,Radiation,,Alive,33.0,EGFR,Yes,Former,Moderate,20.6,Medium,Rural,NHS,19.0,No,No,Hypertension,2.0
PT02139,Spain,Andalusia,81.0,,Ovarian,IV,2010-10-13,2011-04-06,2012-02-12,Immunotherapy,,Alive,88.0,EGFR,No,Never,None,,High,Urban,NHS,,No,No,Cardiovascular Disease,2.0
PT02140,Italy,Lombardy,63.0,Female,Ovarian,I,2013-05-22,2013-09-06,2014-03-23,,Public,Alive,24.0,BRCA1,No,Current,None,24.2,Low,Urban,NHS,16.0,No,No,Diabetes,8.0
PT02141,Austria,Vienna,38.0,Female,Leukemia,II,2010-04-23,2010-09-11,2011-05-09,Surgery,Public,Alive,12.0,BRCA1,No,Never,Moderate,39.1,Medium,Urban,Statutory Health Insurance,5.0,No,No,None,6.0
PT02142,Ireland,Munster,78.0,Female,Leukemia,I,2022-02-20,2022-04-21,2022-09-04,Chemotherapy,Public,Alive,54.0,BRCA1,Yes,Current,None,36.1,High,Rural,Private Insurance,12.0,No,No,Obesity,1.0
PT02143,Spain,Catalonia,27.0,Female,Colorectal,II,2010-03-31,2010-05-25,2011-05-11,Surgery,Research Institute,Lost to Follow-up,,None,Yes,Never,None,25.6,Medium,Urban,NHS,19.0,No,No,Hypertension,6.0
PT02144,Finland,Southwest Finland,74.0,Male,Breast,,2017-09-07,2017-12-23,2018-12-04,Surgery,Private,Alive,88.0,KRAS,No,Current,Heavy,29.3,Medium,Urban,Private Insurance,7.0,No,No,Obesity,
PT02145,Poland,Masovian,66.0,Non-binary,Breast,IV,2014-02-08,2014-03-11,2015-02-26,Surgery,Public,Deceased,77.0,EGFR,No,Never,None,35.3,Low,Rural,Private Insurance,18.0,No,Yes,None,6.0
PT02146,Austria,Vienna,21.0,Female,Lung,,2012-11-19,2013-02-24,2014-02-10,Radiation,Research Institute,Alive,19.0,EGFR,Yes,Current,Moderate,21.2,Medium,Urban,,1.0,No,No,Hypertension,2.0
PT02147,Italy,Lombardy,58.0,Female,Breast,II,2014-04-13,2014-09-02,2015-04-24,Targeted Therapy,Public,Deceased,104.0,None,No,Current,None,22.0,Medium,Urban,NHS,11.0,No,No,Cardiovascular Disease,10.0
PT02148,Portugal,Algarve,64.0,Female,Pancreatic,IV,2010-12-23,2011-03-19,2011-11-27,Radiation,Private,Alive,13.0,KRAS,No,Current,None,26.3,,Urban,NHS,9.0,No,No,None,8.0
PT02149,Portugal,Algarve,51.0,Female,Leukemia,II,2020-03-15,2020-07-26,2020-10-06,Targeted Therapy,Private,Deceased,118.0,None,No,Current,None,29.5,Low,Urban,Statutory Health Insurance,4.0,No,No,Obesity,9.0
PT02150,Switzerland,Bern,84.0,Male,Prostate,III,2022-06-21,2022-10-18,2023-03-03,Radiation,Public,Deceased,105.0,KRAS,No,Former,Moderate,20.8,High,Urban,NHS,2.0,No,No,Diabetes,6.0
PT02151,Sweden,Skåne,57.0,Male,Ovarian,III,,2011-09-28,2011-12-28,Surgery,Public,Alive,71.0,,No,Current,Moderate,28.3,High,Urban,Statutory Health Insurance,11.0,No,No,None,4.0
PT02152,France,Île-de-France,30.0,Non-binary,Breast,II,2017-12-24,2018-03-30,2018-05-11,Chemotherapy,Public,Alive,69.0,EGFR,Yes,Never,Moderate,22.3,Medium,Rural,Private Insurance,12.0,No,No,None,10.0
PT02153,Italy,Lombardy,29.0,Female,Ovarian,I,2018-03-06,2018-03-09,2018-06-29,Immunotherapy,Private,Alive,,BRCA1,,,Moderate,37.3,High,Urban,Statutory Health Insurance,,No,No,Obesity,8.0
PT02154,Germany,Bavaria,78.0,Male,Ovarian,II,2017-03-05,2017-07-22,2018-05-27,,Public,Deceased,29.0,BRCA1,No,Never,Moderate,38.6,High,Urban,Statutory Health Insurance,16.0,No,No,Cardiovascular Disease,4.0
PT02155,Ireland,Munster,74.0,,Prostate,II,2018-12-07,2019-01-18,,Radiation,Public,Alive,20.0,EGFR,No,,Moderate,34.2,High,,Statutory Health Insurance,7.0,Yes,No,None,
PT02156,Ireland,Connacht,39.0,Female,Ovarian,I,2013-02-15,2013-07-31,2013-12-02,Chemotherapy,Research Institute,Alive,77.0,EGFR,No,Never,None,21.0,Medium,Urban,Private Insurance,7.0,No,No,Obesity,
PT02157,Portugal,Algarve,36.0,Male,Pancreatic,IV,2022-01-21,2022-06-22,2023-01-03,Immunotherapy,Public,Alive,106.0,EGFR,No,Current,Moderate,33.1,Medium,Urban,Private Insurance,9.0,No,No,Hypertension,3.0
PT02158,Poland,Masovian,87.0,Female,Colorectal,II,2022-10-04,2023-02-18,2023-03-27,Chemotherapy,Private,Deceased,8.0,KRAS,Yes,,None,29.9,Medium,Urban,Private Insurance,19.0,No,No,None,8.0
PT02159,Norway,Oslo,24.0,Female,Lung,IV,2012-11-04,2013-03-25,2014-03-03,Targeted Therapy,Public,Alive,111.0,BRCA1,Yes,Current,None,36.7,Medium,Urban,NHS,,Yes,No,Diabetes,3.0
PT02160,Sweden,Västra Götaland,79.0,Male,Lung,,2020-08-03,,2021-05-03,Targeted Therapy,Public,Alive,119.0,EGFR,No,Never,None,26.4,Low,Urban,NHS,8.0,No,Yes,Diabetes,10.0
PT02161,Norway,Oslo,42.0,Female,Lung,IV,2019-09-21,2020-02-14,2020-04-02,Immunotherapy,Research Institute,Alive,16.0,None,Yes,Never,None,39.6,High,Urban,Statutory Health Insurance,,No,No,Hypertension,7.0
PT02162,Belgium,,65.0,Male,Colorectal,,2022-11-19,2022-11-29,2023-10-10,Immunotherapy,Public,Deceased,76.0,EGFR,No,Former,None,35.6,Low,Urban,,11.0,No,No,Cardiovascular Disease,3.0
PT02163,,Veneto,71.0,Male,Leukemia,III,2010-02-24,2010-07-14,2010-10-06,Targeted Therapy,Public,Alive,44.0,KRAS,No,Never,None,22.4,Medium,Urban,Private Insurance,3.0,No,No,Cardiovascular Disease,5.0
PT02164,Denmark,Zealand,29.0,Male,,II,2013-07-25,2013-09-10,2014-04-01,Targeted Therapy,Public,,10.0,None,,Former,None,32.7,Medium,Urban,Statutory Health Insurance,18.0,No,No,Obesity,2.0
PT02165,Italy,Veneto,65.0,Female,Prostate,II,2022-05-06,2022-07-28,2023-02-08,Surgery,Public,Alive,26.0,EGFR,No,Current,Moderate,29.4,Medium,Rural,Statutory Health Insurance,10.0,No,No,Hypertension,3.0
PT02166,Poland,Silesian,47.0,Male,Breast,II,2020-09-16,2021-01-11,2021-11-09,Immunotherapy,Research Institute,Alive,27.0,BRCA1,No,Never,None,34.2,Low,Rural,Private Insurance,5.0,No,Yes,Hypertension,3.0
PT02167,Spain,Catalonia,62.0,Male,Leukemia,III,2019-06-30,2019-07-10,2019-09-14,,,Alive,101.0,BRCA1,Yes,Current,None,26.3,Medium,Urban,Private Insurance,16.0,No,No,Hypertension,8.0
PT02168,Norway,Trøndelag,45.0,Female,Lung,,2014-02-03,2014-06-12,,Targeted Therapy,Public,Deceased,43.0,EGFR,No,Current,None,18.3,Medium,Urban,,13.0,No,No,None,9.0
PT02169,Portugal,Algarve,,Male,Lung,I,2021-04-26,2021-07-06,,,Research Institute,,12.0,EGFR,No,Never,None,26.5,Medium,Urban,Statutory Health Insurance,8.0,No,No,None,7.0
PT02170,,,67.0,Female,Ovarian,IV,2020-02-21,2020-06-19,2020-08-29,Surgery,Public,Alive,95.0,BRCA1,Yes,Former,Moderate,32.5,High,Urban,Statutory Health Insurance,9.0,No,No,Hypertension,7.0
PT02171,Norway,,48.0,Female,Leukemia,IV,2023-04-28,2023-08-25,2024-06-04,Radiation,Private,Alive,96.0,,No,Never,Moderate,21.0,Medium,Urban,NHS,8.0,Yes,Yes,Diabetes,9.0
PT02172,Netherlands,North Holland,46.0,Non-binary,Prostate,II,2010-07-02,2010-11-18,2011-02-20,Targeted Therapy,Private,Alive,58.0,EGFR,No,Current,None,38.6,Medium,Rural,Statutory Health Insurance,3.0,No,No,Diabetes,3.0
PT02173,Denmark,Zealand,37.0,Female,Leukemia,I,2013-05-21,,2014-01-26,Surgery,Public,Alive,58.0,EGFR,Yes,Never,Moderate,25.4,Low,Urban,NHS,11.0,No,No,Hypertension,8.0
PT02174,Denmark,Central Denmark,,,Colorectal,III,2021-07-23,2021-07-27,2021-09-04,Surgery,Public,Deceased,48.0,KRAS,No,Never,Moderate,31.0,Low,Urban,Statutory Health Insurance,10.0,No,No,Obesity,10.0
PT02175,Finland,Uusimaa,88.0,Male,Lung,II,2021-08-06,2021-10-31,2022-05-28,Targeted Therapy,Private,,56.0,EGFR,No,Former,Moderate,20.4,Low,Rural,NHS,19.0,No,No,Cardiovascular Disease,3.0
PT02176,France,Île-de-France,40.0,Female,Prostate,III,2011-09-13,2011-09-23,2012-07-28,Chemotherapy,Public,Alive,9.0,KRAS,Yes,Never,None,18.5,Medium,Urban,Private Insurance,6.0,Yes,No,Obesity,4.0
PT02177,Norway,Trøndelag,43.0,Female,Ovarian,III,2014-03-25,2014-08-05,2014-09-24,Chemotherapy,Public,Alive,23.0,BRCA1,Yes,Former,Moderate,29.5,Medium,Urban,,6.0,No,No,None,9.0
PT02178,Sweden,Stockholm,22.0,Male,Breast,I,2021-04-20,2021-08-22,2022-03-19,Immunotherapy,Private,Alive,7.0,KRAS,Yes,Never,None,28.4,High,Urban,Private Insurance,3.0,No,No,None,1.0
PT02179,Switzerland,Bern,81.0,Female,Ovarian,III,2010-08-23,2010-11-07,2011-02-23,Targeted Therapy,Private,Deceased,63.0,EGFR,No,Never,Moderate,40.0,,Rural,NHS,2.0,No,No,None,4.0
PT02180,Finland,Southwest Finland,21.0,Female,Lung,II,2010-03-14,2010-08-19,2011-01-28,Targeted Therapy,Research Institute,Lost to Follow-up,,None,No,Never,Moderate,36.1,Low,Urban,,16.0,Yes,No,None,10.0
PT02181,Spain,Catalonia,85.0,Non-binary,Ovarian,IV,2022-07-04,2022-08-30,2023-03-11,Radiation,Public,Alive,38.0,EGFR,No,,None,33.5,Low,Rural,Statutory Health Insurance,,No,Yes,Obesity,6.0
PT02182,Denmark,Capital Region,61.0,Female,Leukemia,I,2014-11-25,2015-05-05,2015-09-26,,Public,Deceased,70.0,EGFR,No,Former,None,32.1,,Rural,Private Insurance,8.0,Yes,No,Diabetes,3.0
,Netherlands,Utrecht,53.0,,Prostate,,2011-09-20,2012-03-03,2013-01-04,Chemotherapy,Research Institute,Alive,99.0,KRAS,No,Former,,38.8,Low,Urban,NHS,7.0,No,,None,2.0
PT02184,Sweden,Stockholm,61.0,Female,Lung,IV,2011-10-30,2012-01-20,2012-04-10,,,Alive,112.0,EGFR,Yes,Former,Heavy,37.6,,Rural,Private Insurance,10.0,No,No,Diabetes,7.0
PT02185,Switzerland,Bern,39.0,Female,Breast,I,2021-01-06,2021-01-29,2021-05-22,Radiation,Private,Deceased,68.0,EGFR,No,Former,Moderate,20.2,Medium,,,19.0,No,No,Obesity,9.0
PT02186,Spain,Catalonia,87.0,Male,Breast,III,2011-08-17,2011-10-26,2012-09-03,Immunotherapy,Public,Alive,108.0,None,No,Former,None,24.9,Low,Rural,Private Insurance,6.0,Yes,No,Hypertension,7.0
PT02187,Austria,Styria,64.0,Female,,II,2017-04-20,2017-04-27,2018-03-09,Surgery,,Alive,94.0,EGFR,Yes,,None,22.7,Low,Rural,NHS,2.0,Yes,No,Obesity,7.0
PT02188,France,Provence-Alpes-Côte d'Azur,,Female,Leukemia,II,2020-06-09,2020-06-28,2021-06-01,Immunotherapy,Public,Alive,95.0,,No,Former,None,32.7,Medium,Rural,NHS,7.0,No,No,None,6.0
,Switzerland,Geneva,66.0,Non-binary,Colorectal,III,2016-05-28,2016-10-18,2017-04-17,Radiation,,Alive,36.0,BRCA1,No,Current,Moderate,36.8,Low,Urban,NHS,3.0,No,No,Cardiovascular Disease,2.0
PT02190,Ireland,Munster,24.0,Female,Leukemia,II,,2019-07-09,,Targeted Therapy,Private,Alive,,None,No,Never,None,38.9,Medium,Rural,NHS,9.0,Yes,No,Obesity,9.0
PT02191,Switzerland,Zurich,,Male,Prostate,IV,2016-03-10,2016-06-04,,Chemotherapy,Research Institute,Deceased,73.0,None,No,Current,None,39.9,Low,Urban,,16.0,No,No,Hypertension,9.0
PT02192,Austria,Styria,56.0,Female,Leukemia,I,2021-09-02,2022-02-09,2022-07-18,Targeted Therapy,Public,Alive,18.0,KRAS,Yes,Never,None,37.0,High,Rural,Statutory Health Insurance,,,No,Cardiovascular Disease,3.0
PT02193,Sweden,Västra Götaland,53.0,Female,Prostate,II,2012-08-26,2012-11-13,2013-02-13,Surgery,Public,Lost to Follow-up,,KRAS,Yes,Never,Moderate,25.5,Medium,Urban,NHS,9.0,No,No,Diabetes,4.0
PT02194,Netherlands,South Holland,89.0,Male,Pancreatic,II,2015-07-21,,2015-11-27,Chemotherapy,,Alive,32.0,BRCA1,No,Current,None,22.4,Medium,Urban,Private Insurance,8.0,No,No,Hypertension,1.0
PT02195,Norway,Oslo,37.0,Male,Pancreatic,III,2010-06-28,2010-09-06,2011-01-02,Immunotherapy,Private,Alive,62.0,None,No,Former,Moderate,24.0,,Urban,Private Insurance,11.0,No,No,Hypertension,1.0
PT02196,,Uusimaa,38.0,Female,Pancreatic,II,2015-08-14,2015-08-20,2016-06-23,Radiation,Public,Lost to Follow-up,,EGFR,Yes,Never,None,33.4,Medium,Rural,NHS,19.0,,No,None,5.0
PT02197,Poland,Silesian,59.0,Male,Colorectal,I,2022-02-18,2022-05-05,2022-11-28,Immunotherapy,,Alive,19.0,None,No,Never,,32.2,Medium,Rural,Statutory Health Insurance,3.0,No,No,Cardiovascular Disease,8.0
PT02198,Switzerland,Geneva,,Male,Pancreatic,,2010-07-14,2010-11-23,2011-11-17,Surgery,Public,Alive,57.0,EGFR,Yes,Current,None,36.5,Medium,Urban,NHS,14.0,No,No,Diabetes,9.0
PT02199,Belgium,Brussels,79.0,Male,Leukemia,II,2019-09-06,2020-01-03,2020-07-11,,Public,Alive,68.0,None,No,,,23.9,Low,Rural,Private Insurance,7.0,Yes,Yes,Diabetes,3.0
,Italy,Lombardy,61.0,Female,Breast,II,2018-01-19,2018-03-30,2018-06-10,Targeted Therapy,Private,,85.0,KRAS,Yes,Never,Moderate,30.4,Low,Urban,Statutory Health Insurance,17.0,No,No,Hypertension,6.0
PT02201,Austria,Tyrol,84.0,Female,Prostate,II,2017-09-18,2018-01-11,2018-04-05,Targeted Therapy,,Lost to Follow-up,,EGFR,No,Never,,37.9,Medium,Rural,Private Insurance,8.0,No,No,Obesity,7.0
PT02202,Spain,Andalusia,72.0,Male,Ovarian,I,2019-12-08,2020-03-18,2020-06-06,Targeted Therapy,Private,Alive,78.0,None,Yes,Former,None,19.5,Medium,Urban,Private Insurance,2.0,Yes,No,,8.0
,Spain,Catalonia,26.0,Female,Prostate,I,2013-05-16,2013-10-05,2014-04-17,Surgery,Public,Alive,99.0,None,No,Current,None,25.9,Low,,Private Insurance,2.0,No,No,Obesity,6.0
PT02204,Italy,Veneto,24.0,Female,Breast,I,2020-02-16,2020-06-06,2020-09-06,Chemotherapy,Private,,14.0,BRCA1,Yes,Never,Moderate,19.8,Low,Urban,NHS,19.0,No,No,Obesity,4.0
,Poland,Lesser Poland,43.0,Male,Ovarian,I,2015-05-14,2015-08-05,2016-07-22,Immunotherapy,Research Institute,Lost to Follow-up,,None,Yes,Never,None,34.5,Medium,,Statutory Health Insurance,1.0,,No,Hypertension,9.0
PT02206,Poland,Masovian,47.0,Male,Leukemia,I,2014-03-07,2014-03-14,2014-12-17,,Research Institute,Alive,44.0,EGFR,No,Never,None,19.2,Low,Urban,NHS,2.0,,No,Diabetes,6.0
PT02207,Denmark,Capital Region,81.0,Female,Colorectal,II,2015-12-18,2016-02-17,2017-02-07,Radiation,Public,Lost to Follow-up,,None,Yes,Never,None,38.8,Medium,Rural,Private Insurance,13.0,No,,,1.0
PT02208,Germany,Berlin,36.0,Male,Lung,III,2018-05-31,2018-09-16,2019-01-30,Radiation,Public,Alive,96.0,BRCA1,No,,None,36.4,Medium,Urban,NHS,18.0,No,Yes,Diabetes,7.0
PT02209,Switzerland,Geneva,39.0,Female,Leukemia,III,2019-08-21,2019-11-01,2020-05-25,,Research Institute,Deceased,12.0,BRCA1,Yes,Never,None,,Medium,Urban,Private Insurance,9.0,No,No,Hypertension,4.0
PT02210,Italy,Lombardy,22.0,Male,Pancreatic,I,2014-08-23,2015-01-26,2015-07-03,Targeted Therapy,Public,Lost to Follow-up,,EGFR,Yes,,Moderate,36.0,High,Urban,NHS,,No,No,Cardiovascular Disease,6.0
PT02211,Sweden,Västra Götaland,56.0,Male,Ovarian,IV,2021-04-12,2021-07-20,2022-04-30,Targeted Therapy,Private,Alive,62.0,KRAS,No,Never,Moderate,20.4,Low,Urban,Private Insurance,6.0,Yes,No,Diabetes,8.0
PT02212,Netherlands,Utrecht,34.0,Non-binary,Leukemia,III,2011-01-12,2011-03-06,2011-10-14,Chemotherapy,Research Institute,Alive,112.0,EGFR,Yes,Former,Moderate,33.4,High,Rural,Statutory Health Insurance,10.0,No,No,Cardiovascular Disease,8.0
PT02213,Germany,North Rhine-Westphalia,70.0,Male,Prostate,IV,2012-02-18,2012-05-11,2012-09-11,Immunotherapy,Public,Alive,60.0,KRAS,No,Never,None,33.3,Medium,Urban,Statutory Health Insurance,16.0,No,Yes,Hypertension,8.0
PT02214,Portugal,Algarve,67.0,Female,,II,2019-02-26,2019-08-17,2019-12-20,Targeted Therapy,Public,Alive,12.0,None,No,Former,Moderate,39.2,Low,Rural,Private Insurance,11.0,Yes,No,Diabetes,5.0
PT02215,Finland,Southwest Finland,27.0,Male,Colorectal,III,2019-11-05,2019-12-03,2020-06-26,Immunotherapy,Public,,88.0,EGFR,Yes,Never,Moderate,28.1,Low,Rural,Statutory Health Insurance,7.0,Yes,No,Cardiovascular Disease,9.0
PT02216,Portugal,Porto,32.0,Male,Pancreatic,I,2016-11-04,2016-12-20,2017-03-06,Surgery,Research Institute,Alive,108.0,EGFR,Yes,Never,Moderate,,High,Urban,NHS,11.0,Yes,No,None,4.0
PT02217,Spain,Andalusia,67.0,Male,Ovarian,III,2023-09-05,2024-02-29,2024-08-03,Radiation,Private,Deceased,85.0,KRAS,No,Former,None,30.5,Low,Urban,NHS,10.0,No,No,Hypertension,4.0
PT02218,Finland,Southwest Finland,22.0,Male,Colorectal,I,2011-08-10,,2012-10-01,Targeted Therapy,Public,Alive,21.0,EGFR,,Never,None,39.6,Medium,Urban,Statutory Health Insurance,3.0,No,No,None,
PT02219,Norway,Trøndelag,84.0,Male,Colorectal,II,2012-11-20,2013-04-24,2014-03-19,Radiation,Public,Alive,52.0,KRAS,Yes,Former,None,29.1,High,Urban,NHS,7.0,Yes,No,Cardiovascular Disease,1.0
PT02220,,Stockholm,50.0,Male,Breast,II,2018-03-19,2018-09-02,2019-05-29,Chemotherapy,Public,Alive,103.0,BRCA1,No,Current,Heavy,38.7,High,Rural,Statutory Health Insurance,14.0,No,Yes,None,3.0
PT02221,France,Île-de-France,45.0,Female,,II,2011-09-02,2011-11-25,2012-10-19,Surgery,Public,Deceased,68.0,BRCA1,Yes,Never,None,27.0,Medium,Urban,Statutory Health Insurance,9.0,No,No,Diabetes,7.0
PT02222,Denmark,Zealand,75.0,Female,Lung,II,2015-12-17,2016-01-13,2016-09-23,Targeted Therapy,Public,Alive,98.0,EGFR,No,,Moderate,,High,Urban,Statutory Health Insurance,7.0,No,No,,2.0
PT02223,Finland,Pirkanmaa,53.0,Male,Lung,I,2016-11-05,2016-12-10,2017-01-12,Targeted Therapy,Public,Alive,108.0,KRAS,No,Former,Moderate,26.3,Medium,Urban,Private Insurance,7.0,Yes,Yes,Diabetes,10.0
PT02224,Portugal,Algarve,28.0,Female,,II,2012-03-17,2012-05-03,2012-08-04,Immunotherapy,Public,Alive,101.0,KRAS,Yes,Never,Heavy,27.8,High,Urban,NHS,19.0,No,No,Cardiovascular Disease,7.0
PT02225,Austria,Tyrol,81.0,Male,,IV,2016-10-19,2016-12-10,2017-11-14,Radiation,Private,Deceased,84.0,None,No,Current,Heavy,32.4,High,Urban,Statutory Health Insurance,10.0,No,No,Obesity,2.0
PT02226,Finland,Southwest Finland,32.0,,Colorectal,IV,2017-05-23,2017-07-31,2018-04-22,Surgery,Public,Deceased,38.0,BRCA1,Yes,Never,Moderate,31.6,Low,Urban,Private Insurance,5.0,No,No,Obesity,10.0
PT02227,Ireland,Connacht,88.0,Female,Prostate,II,2013-09-13,2013-10-24,2014-08-02,Immunotherapy,Research Institute,Deceased,26.0,BRCA1,Yes,Current,None,22.1,Medium,Urban,Private Insurance,6.0,Yes,No,Obesity,8.0
,Switzerland,Bern,60.0,Male,Lung,II,2010-04-19,2010-06-08,2010-12-23,Surgery,Public,Alive,100.0,BRCA1,No,Never,Moderate,20.8,Medium,Rural,NHS,18.0,No,No,Hypertension,5.0
PT02229,Portugal,Lisbon,20.0,Female,Ovarian,I,2011-06-10,2011-07-25,2011-09-22,Surgery,Public,Lost to Follow-up,,BRCA1,No,Current,Moderate,29.4,Medium,Urban,Private Insurance,9.0,No,Yes,None,8.0
PT02230,Finland,Uusimaa,66.0,Male,Ovarian,I,2014-02-07,2014-02-27,2014-06-07,Chemotherapy,Public,Alive,44.0,BRCA1,No,Never,Moderate,,High,Rural,Private Insurance,9.0,No,No,Obesity,3.0
PT02231,Austria,Styria,23.0,Female,Leukemia,I,2012-08-07,2012-12-05,2013-08-21,Chemotherapy,Research Institute,Alive,34.0,None,No,Former,Moderate,31.6,Low,Urban,Private Insurance,15.0,,No,Cardiovascular Disease,6.0
PT02232,Switzerland,Bern,82.0,Female,Breast,II,2014-07-26,2014-08-31,2015-02-12,Immunotherapy,Public,Alive,,KRAS,,Never,Moderate,31.5,Low,,Private Insurance,13.0,Yes,No,Hypertension,9.0
PT02233,Germany,North Rhine-Westphalia,71.0,Male,Prostate,III,2018-09-20,2018-12-20,2019-04-13,Immunotherapy,Private,Deceased,50.0,BRCA1,No,Never,Moderate,22.4,Low,Rural,Private Insurance,,No,,None,5.0
PT02234,,Veneto,29.0,Male,Breast,II,2023-07-19,2023-09-27,2024-09-17,Immunotherapy,Public,Deceased,92.0,None,Yes,Current,Moderate,38.8,Medium,Urban,NHS,3.0,No,No,Diabetes,5.0
PT02235,Italy,Sicily,47.0,Female,Leukemia,I,2011-08-29,2012-01-28,2012-09-10,Surgery,Research Institute,Alive,,BRCA1,Yes,Current,Heavy,30.6,High,Urban,Private Insurance,4.0,No,No,None,2.0
PT02236,Austria,Styria,25.0,Female,Lung,II,2016-07-22,2017-01-02,2017-07-10,Targeted Therapy,Public,Alive,76.0,None,No,Former,Moderate,40.0,Low,Urban,Statutory Health Insurance,1.0,No,No,Diabetes,2.0
PT02237,France,Auvergne-Rhône-Alpes,46.0,Male,Breast,I,2014-06-13,2014-10-24,2015-06-18,Chemotherapy,Research Institute,Alive,37.0,BRCA1,No,Current,Moderate,18.9,Medium,Rural,Private Insurance,17.0,No,No,Hypertension,2.0
PT02238,Portugal,Porto,31.0,Male,Pancreatic,III,,,2024-01-22,Targeted Therapy,Private,,109.0,EGFR,No,Former,Moderate,34.7,Low,Urban,Statutory Health Insurance,10.0,Yes,No,None,
PT02239,Finland,Southwest Finland,81.0,Male,Breast,I,2022-01-20,2022-05-05,2022-12-10,Radiation,Private,Alive,48.0,,No,Never,Moderate,,Low,Urban,Private Insurance,19.0,No,No,Diabetes,8.0
PT02240,France,Île-de-France,71.0,Female,Breast,II,2023-09-15,2024-03-01,2024-11-03,Chemotherapy,Private,Deceased,35.0,KRAS,Yes,Current,None,29.4,Low,Rural,Private Insurance,,Yes,,None,3.0
PT02241,Poland,Masovian,67.0,Female,Ovarian,III,2012-11-23,2013-03-01,2013-09-01,Radiation,Public,Alive,15.0,KRAS,No,Never,Heavy,20.3,Medium,Urban,Private Insurance,12.0,No,No,None,8.0
PT02242,Germany,Berlin,86.0,Male,Leukemia,I,2013-09-30,2014-01-11,2014-06-12,Radiation,Private,Deceased,20.0,EGFR,No,Current,,21.3,Low,Urban,Statutory Health Insurance,8.0,Yes,No,Cardiovascular Disease,6.0
PT02243,,Provence-Alpes-Côte d'Azur,65.0,Male,Ovarian,I,2014-07-30,2014-12-01,2015-08-07,Immunotherapy,Public,Alive,18.0,BRCA1,No,Former,Moderate,25.0,Low,Urban,Statutory Health Insurance,8.0,Yes,No,Diabetes,2.0
PT02244,Ireland,Munster,34.0,Female,Prostate,II,2022-09-08,2023-03-05,2024-01-17,Surgery,Public,,63.0,BRCA1,,Former,None,35.1,Medium,Urban,Statutory Health Insurance,15.0,No,Yes,Diabetes,5.0
PT02245,Denmark,Central Denmark,55.0,Female,Ovarian,I,2020-03-27,2020-06-09,2021-05-26,Targeted Therapy,Public,,91.0,None,No,Former,,36.1,Medium,Urban,Statutory Health Insurance,1.0,No,No,Hypertension,8.0
PT02246,Austria,Tyrol,33.0,Female,Prostate,II,2012-07-16,2012-12-26,2013-05-09,Radiation,,Deceased,108.0,None,No,Former,None,22.0,Medium,Urban,Statutory Health Insurance,6.0,No,No,Cardiovascular Disease,1.0
PT02247,Sweden,Västra Götaland,22.0,Male,,III,2019-12-05,,2020-05-25,Immunotherapy,Public,Alive,28.0,KRAS,No,Never,,20.9,Medium,Urban,Statutory Health Insurance,14.0,No,No,Obesity,3.0
,Italy,Sicily,86.0,Female,Ovarian,II,2017-06-29,2017-12-11,2018-07-27,Surgery,Public,Alive,58.0,BRCA1,No,Current,Heavy,38.8,Medium,Urban,Private Insurance,3.0,No,No,Obesity,5.0
PT02249,Finland,Pirkanmaa,38.0,Female,Breast,,2011-12-06,2012-01-20,2012-09-17,Chemotherapy,Public,Alive,39.0,BRCA1,No,Current,,33.9,Medium,Rural,,8.0,Yes,No,None,4.0
PT02250,Italy,Sicily,73.0,Male,Breast,IV,2010-10-10,2010-11-17,2010-12-29,Radiation,Research Institute,Alive,75.0,EGFR,Yes,Former,Moderate,21.1,High,Urban,NHS,3.0,No,No,Hypertension,5.0
PT02251,Germany,North Rhine-Westphalia,88.0,Non-binary,Colorectal,II,2020-06-26,2020-10-14,2021-08-24,Immunotherapy,Research Institute,Alive,50.0,None,No,Never,Moderate,19.8,Low,Rural,Statutory Health Insurance,16.0,No,No,Diabetes,2.0
PT02252,Ireland,Munster,29.0,Female,Pancreatic,IV,2020-02-01,2020-05-12,,Immunotherapy,Public,Deceased,37.0,KRAS,No,Former,Heavy,26.5,Medium,Urban,Private Insurance,5.0,Yes,No,Hypertension,7.0
PT02253,Germany,North Rhine-Westphalia,52.0,Female,Lung,,2012-08-28,2012-11-21,2013-05-07,Immunotherapy,Public,Deceased,58.0,KRAS,No,Never,Heavy,20.5,High,Urban,NHS,15.0,No,No,None,8.0
PT02254,Norway,Oslo,32.0,Female,Lung,III,2021-02-24,2021-07-29,2021-11-11,Chemotherapy,Research Institute,Alive,107.0,None,Yes,Never,Moderate,33.6,Medium,Urban,NHS,4.0,Yes,No,None,3.0
PT02255,France,Auvergne-Rhône-Alpes,70.0,Male,Prostate,III,2011-05-04,2011-07-16,2012-02-16,Surgery,Public,Alive,81.0,None,Yes,Current,,22.0,Low,Urban,NHS,7.0,Yes,No,Diabetes,4.0
PT02256,Germany,Berlin,51.0,Male,Leukemia,IV,2018-07-04,2018-07-07,2019-03-07,Targeted Therapy,Public,Alive,36.0,BRCA1,No,Former,None,28.8,Low,Rural,Private Insurance,13.0,No,No,Diabetes,1.0
PT02257,Norway,Vestland,43.0,Male,Breast,I,2017-10-24,2017-12-22,2018-07-25,Targeted Therapy,Public,Alive,49.0,BRCA1,Yes,Current,Heavy,26.1,Medium,Urban,NHS,7.0,,Yes,Cardiovascular Disease,5.0
PT02258,Ireland,Munster,54.0,Female,Ovarian,I,2015-09-21,2015-12-30,2016-08-24,Radiation,Research Institute,Alive,84.0,BRCA1,No,Former,Moderate,31.7,Medium,Urban,Statutory Health Insurance,3.0,No,No,None,2.0
PT02259,Germany,Berlin,89.0,Male,Pancreatic,I,2010-06-19,2010-07-19,2010-10-26,Surgery,Public,Deceased,81.0,KRAS,Yes,Never,None,38.4,High,,Statutory Health Insurance,13.0,No,No,Obesity,3.0
PT02260,Finland,Pirkanmaa,59.0,Female,Lung,IV,2020-12-30,2021-01-15,2021-03-30,Radiation,Public,Alive,104.0,EGFR,No,Never,Moderate,27.2,Medium,Urban,Private Insurance,11.0,No,Yes,Obesity,10.0
PT02261,Netherlands,,,Male,Leukemia,II,2014-05-12,2014-06-10,2015-01-03,Targeted Therapy,Public,Alive,70.0,None,,Current,,28.5,High,Urban,Private Insurance,15.0,No,No,Hypertension,8.0
PT02262,,Geneva,63.0,Female,Leukemia,IV,2023-08-04,2023-11-12,2024-06-04,Chemotherapy,Private,Lost to Follow-up,,BRCA1,No,Never,None,37.0,Low,Urban,NHS,15.0,No,No,,10.0
PT02263,Switzerland,Zurich,81.0,Female,Breast,I,2011-07-20,2011-08-13,2012-06-07,Surgery,Research Institute,Lost to Follow-up,,None,No,Never,Heavy,31.9,Medium,Urban,NHS,9.0,No,Yes,Cardiovascular Disease,2.0
,,Vestland,87.0,Female,Pancreatic,I,2013-11-18,2013-11-25,2014-06-14,Surgery,Public,Deceased,113.0,BRCA1,Yes,Never,None,19.2,Medium,Urban,NHS,6.0,No,Yes,None,3.0
PT02265,,,52.0,Female,Leukemia,I,2019-03-22,2019-09-15,2020-06-14,Radiation,Private,Deceased,30.0,BRCA1,No,Never,Moderate,18.6,High,Rural,Statutory Health Insurance,18.0,No,No,Hypertension,1.0
PT02266,,Sicily,,Non-binary,Lung,II,2011-01-20,2011-05-01,2011-11-02,Radiation,Public,Alive,15.0,None,No,Never,Moderate,38.5,Medium,Urban,NHS,9.0,No,No,Obesity,5.0
PT02267,Norway,Oslo,55.0,Male,Colorectal,III,2017-03-30,2017-05-15,2017-12-19,Chemotherapy,Public,Lost to Follow-up,,KRAS,No,Former,Moderate,22.4,High,Urban,Private Insurance,12.0,No,No,Obesity,7.0
PT02268,Ireland,Munster,73.0,Male,Lung,II,2018-08-02,,2019-05-05,Surgery,Public,Deceased,38.0,EGFR,No,Current,Moderate,38.1,High,Urban,NHS,18.0,No,No,Obesity,5.0
PT02269,Switzerland,Bern,,Male,Pancreatic,IV,2021-06-08,2021-09-18,2021-12-31,Targeted Therapy,Research Institute,Alive,62.0,None,No,Former,None,27.6,Low,Rural,Statutory Health Insurance,15.0,No,No,Diabetes,6.0
PT02270,France,Provence-Alpes-Côte d'Azur,62.0,Female,Colorectal,I,2018-12-01,2019-05-03,2019-07-04,Targeted Therapy,Public,Deceased,47.0,None,Yes,Never,Moderate,,Medium,Urban,Statutory Health Insurance,18.0,Yes,No,None,6.0
PT02271,Poland,Masovian,31.0,,Ovarian,III,2010-08-26,2010-10-08,2011-05-20,Immunotherapy,Public,Alive,57.0,BRCA1,No,Never,Moderate,,,,Statutory Health Insurance,19.0,No,No,Hypertension,2.0
PT02272,Belgium,Flanders,30.0,Female,Ovarian,III,2019-06-03,2019-07-28,,Targeted Therapy,Private,Deceased,68.0,BRCA1,,Never,None,29.3,High,Rural,NHS,3.0,No,No,None,3.0
PT02273,Austria,Vienna,89.0,Male,,I,2023-03-26,2023-09-04,2024-02-14,Immunotherapy,Private,Alive,113.0,BRCA1,Yes,Never,None,,High,Rural,NHS,16.0,No,No,Obesity,1.0
PT02274,Netherlands,North Holland,31.0,Female,Lung,I,2023-07-07,2023-09-10,2024-04-18,Immunotherapy,Public,Alive,20.0,KRAS,No,Former,Moderate,32.0,Low,Urban,Private Insurance,3.0,No,No,Diabetes,7.0
PT02275,Portugal,Algarve,60.0,Female,Breast,II,2015-04-17,2015-09-20,2016-02-02,Radiation,Public,Alive,13.0,,No,Never,Moderate,35.0,High,Urban,Statutory Health Insurance,10.0,No,No,None,7.0
PT02276,Belgium,Wallonia,,Female,Pancreatic,I,2018-08-28,2018-10-08,2019-06-25,Targeted Therapy,Private,Deceased,43.0,BRCA1,No,Former,Moderate,19.4,Medium,,Private Insurance,13.0,Yes,No,Diabetes,
PT02277,Netherlands,North Holland,22.0,Female,Leukemia,IV,2017-01-20,2017-06-26,,Immunotherapy,Public,Alive,117.0,BRCA1,Yes,Former,Heavy,18.3,Medium,Rural,Private Insurance,4.0,No,No,Obesity,7.0
PT02278,Spain,Madrid,22.0,Male,Breast,IV,2021-06-15,2021-11-22,2022-01-18,,Public,Lost to Follow-up,,KRAS,Yes,Current,Moderate,33.9,High,Rural,Statutory Health Insurance,5.0,Yes,No,None,6.0
PT02279,Netherlands,South Holland,47.0,Male,Colorectal,III,2015-09-03,2015-10-07,2016-09-14,Targeted Therapy,Public,Alive,33.0,BRCA1,,Never,None,29.1,High,Urban,Private Insurance,19.0,,No,Hypertension,1.0
PT02280,Netherlands,North Holland,42.0,Female,Ovarian,III,2010-11-28,2011-01-26,2011-03-11,Targeted Therapy,Public,Deceased,77.0,None,No,Never,Moderate,35.6,Medium,Urban,Statutory Health Insurance,8.0,Yes,Yes,None,2.0
PT02281,Spain,Madrid,67.0,Male,Prostate,I,2018-07-27,2018-09-28,2019-03-28,Chemotherapy,,Alive,93.0,KRAS,Yes,Never,Moderate,21.9,Medium,Rural,Private Insurance,1.0,No,No,None,8.0
PT02282,Italy,Sicily,,Female,Prostate,I,2016-11-16,2017-04-19,2017-08-16,Immunotherapy,Private,Deceased,7.0,EGFR,No,Current,None,36.0,Medium,Urban,Private Insurance,11.0,No,No,Diabetes,10.0
PT02283,Sweden,Skåne,61.0,Female,Colorectal,III,2018-05-08,2018-05-20,2018-12-25,Targeted Therapy,Public,Alive,8.0,KRAS,No,Former,Moderate,32.6,Medium,Urban,Private Insurance,6.0,No,No,,3.0
PT02284,Germany,North Rhine-Westphalia,59.0,Female,Prostate,II,2021-09-24,2021-10-16,2022-05-26,Radiation,Private,Deceased,30.0,EGFR,Yes,Current,,23.6,Medium,Urban,NHS,4.0,No,No,Cardiovascular Disease,9.0
PT02285,Netherlands,North Holland,,Male,Pancreatic,III,2019-09-06,2019-11-01,2019-12-26,,Research Institute,Alive,39.0,BRCA1,No,Never,Moderate,38.0,Medium,Urban,NHS,6.0,No,No,Hypertension,5.0
PT02286,Belgium,Wallonia,39.0,Female,Leukemia,III,2010-12-19,2010-12-25,2011-05-13,Immunotherapy,Public,Deceased,41.0,EGFR,No,Never,None,39.3,,Urban,Statutory Health Insurance,2.0,No,No,Hypertension,1.0
PT02287,Ireland,Connacht,30.0,Male,Leukemia,II,2018-07-20,2018-08-25,,Surgery,Public,Alive,86.0,BRCA1,No,Former,Moderate,,High,Urban,NHS,4.0,No,No,None,2.0
PT02288,Norway,Vestland,46.0,Male,Pancreatic,I,2015-07-25,2015-11-28,2016-03-18,Immunotherapy,Public,Deceased,57.0,KRAS,No,Never,None,27.9,Low,Rural,NHS,11.0,No,No,Cardiovascular Disease,7.0
PT02289,Belgium,Brussels,40.0,Male,Lung,III,2012-05-09,2012-07-07,2013-03-02,Chemotherapy,Public,Deceased,24.0,,Yes,Current,Moderate,30.6,High,Urban,Statutory Health Insurance,8.0,No,No,None,3.0
PT02290,Portugal,Lisbon,32.0,Male,Leukemia,II,2018-01-05,2018-03-14,2018-05-28,Radiation,Public,Alive,98.0,EGFR,Yes,Never,Moderate,33.7,Low,Urban,Statutory Health Insurance,6.0,No,No,Obesity,10.0
PT02291,France,Provence-Alpes-Côte d'Azur,54.0,Male,Ovarian,III,2021-09-02,2021-10-24,2021-11-23,Chemotherapy,Public,Alive,67.0,None,No,Former,None,33.4,Low,Rural,Statutory Health Insurance,19.0,Yes,No,None,3.0
PT02292,Sweden,Skåne,66.0,Male,Prostate,II,2021-01-27,2021-05-27,2021-08-15,Targeted Therapy,Public,Alive,57.0,None,No,Never,Moderate,29.7,High,Rural,Private Insurance,2.0,No,No,Cardiovascular Disease,2.0
PT02293,Portugal,Lisbon,47.0,Female,Ovarian,I,2021-06-28,2021-09-13,2022-03-25,Chemotherapy,Public,Alive,88.0,None,Yes,Never,None,38.2,Medium,Urban,Statutory Health Insurance,11.0,No,Yes,Hypertension,5.0
PT02294,Ireland,Munster,40.0,Male,Pancreatic,I,2022-08-26,2022-11-14,2023-11-03,Surgery,Private,Alive,106.0,BRCA1,Yes,Former,None,21.6,Medium,Urban,Statutory Health Insurance,17.0,No,No,Hypertension,5.0
PT02295,Germany,Bavaria,37.0,Female,Breast,III,2013-03-16,2013-07-01,2014-06-20,Surgery,Public,Deceased,105.0,KRAS,No,Former,Heavy,22.4,Medium,Urban,NHS,13.0,No,,Hypertension,8.0
PT02296,Belgium,Wallonia,50.0,Male,Lung,II,2022-07-20,2023-01-15,2024-01-01,Targeted Therapy,Public,Alive,,KRAS,,Current,,33.9,Low,Rural,NHS,1.0,No,No,None,10.0
PT02297,Sweden,Västra Götaland,79.0,Male,Breast,II,2015-10-30,2016-01-28,2016-06-04,Targeted Therapy,Public,Deceased,16.0,None,Yes,Never,Moderate,34.3,Medium,Urban,Private Insurance,10.0,No,No,Hypertension,5.0
PT02298,Sweden,Skåne,56.0,Female,Ovarian,II,2017-03-12,2017-06-17,2018-04-28,Surgery,Public,Alive,14.0,BRCA1,Yes,Current,Moderate,,High,Urban,Private Insurance,4.0,No,No,Hypertension,8.0
PT02299,France,Auvergne-Rhône-Alpes,40.0,Female,Prostate,II,2023-06-19,2023-08-26,2024-06-08,Radiation,Private,Alive,106.0,KRAS,No,Never,Moderate,24.6,Low,Rural,NHS,12.0,No,No,Hypertension,2.0
PT02300,Norway,Oslo,33.0,Male,Ovarian,I,2019-12-13,2020-05-15,2020-09-21,Chemotherapy,Public,Alive,103.0,None,No,Never,Moderate,19.0,Medium,Urban,NHS,14.0,No,No,Diabetes,3.0
PT02301,Netherlands,Utrecht,79.0,Male,Breast,II,2014-05-25,2014-08-06,2014-09-29,Surgery,Public,Deceased,25.0,BRCA1,,Never,Moderate,26.5,Medium,Rural,NHS,6.0,No,Yes,Hypertension,3.0
PT02302,Italy,Sicily,42.0,Male,Prostate,I,2018-01-12,2018-02-22,2018-08-17,Targeted Therapy,Research Institute,Alive,9.0,KRAS,No,,Heavy,23.5,Low,Rural,Private Insurance,19.0,No,No,Diabetes,9.0
PT02303,Finland,Southwest Finland,48.0,Male,Leukemia,II,2010-03-13,2010-07-24,2011-04-22,Targeted Therapy,Public,Alive,,KRAS,Yes,Never,,36.3,Medium,Rural,Private Insurance,8.0,No,No,Hypertension,1.0
PT02304,Austria,Tyrol,66.0,Female,Lung,II,2016-04-11,2016-09-24,2017-01-02,Radiation,Public,Deceased,58.0,EGFR,Yes,Never,None,28.8,Medium,Urban,Private Insurance,13.0,No,Yes,Obesity,3.0
PT02305,Austria,Styria,49.0,Female,Colorectal,I,2022-10-19,2023-02-12,2023-03-27,Immunotherapy,Public,Alive,82.0,KRAS,Yes,Never,Moderate,30.4,Medium,Rural,Statutory Health Insurance,15.0,No,,Hypertension,2.0
PT02306,Netherlands,North Holland,57.0,Male,Prostate,II,2013-05-18,2013-08-19,2014-07-03,Targeted Therapy,Public,Alive,,EGFR,Yes,Current,Moderate,34.3,Low,Urban,NHS,15.0,No,No,Cardiovascular Disease,7.0
PT02307,Spain,Madrid,,Female,Pancreatic,II,2010-07-13,2010-10-23,2011-09-10,Radiation,Research Institute,Alive,15.0,None,No,Former,Moderate,24.6,,Urban,Statutory Health Insurance,1.0,No,No,None,6.0
PT02308,Finland,Pirkanmaa,34.0,Male,Pancreatic,,2022-09-08,2022-12-21,2023-11-01,Surgery,Public,Alive,114.0,BRCA1,No,Never,None,37.5,Medium,Rural,NHS,14.0,No,No,Hypertension,2.0
PT02309,Switzerland,Zurich,78.0,Female,Leukemia,IV,2022-02-14,2022-05-17,2023-01-07,Immunotherapy,,Deceased,113.0,None,Yes,Never,Heavy,26.7,Medium,Rural,Statutory Health Insurance,15.0,No,No,Obesity,2.0
PT02310,Poland,Lesser Poland,22.0,Female,Pancreatic,I,2019-10-23,2019-11-11,2020-09-04,Surgery,Public,Alive,113.0,BRCA1,No,Current,Moderate,20.4,Low,Urban,NHS,5.0,No,Yes,Diabetes,10.0
PT02311,Switzerland,Bern,29.0,Non-binary,Breast,III,2022-01-06,2022-05-04,2023-03-23,Radiation,,Alive,71.0,None,No,Former,Moderate,36.9,Medium,Urban,Statutory Health Insurance,12.0,No,,Cardiovascular Disease,6.0
PT02312,Austria,Styria,36.0,Female,Leukemia,I,2011-12-31,2012-03-05,2012-06-15,Surgery,,Alive,60.0,BRCA1,Yes,Former,Heavy,38.3,Medium,Urban,Private Insurance,4.0,No,Yes,Hypertension,3.0
PT02313,,Vestland,30.0,Female,Pancreatic,III,2010-02-05,2010-04-15,2010-08-09,Chemotherapy,Public,Deceased,115.0,None,No,Current,Moderate,22.8,Medium,Rural,Statutory Health Insurance,15.0,No,No,None,5.0
PT02314,Ireland,Connacht,,Male,Breast,,2010-09-02,2010-10-25,2011-10-11,Radiation,Public,Alive,15.0,None,No,Former,None,32.4,Medium,Urban,NHS,19.0,,No,None,5.0
PT02315,Germany,,24.0,Female,Breast,,2019-06-29,2019-11-23,2020-06-05,Immunotherapy,,Alive,52.0,BRCA1,Yes,Never,Moderate,33.1,Low,Urban,Statutory Health Insurance,17.0,Yes,,Hypertension,9.0
PT02316,Portugal,Porto,88.0,Male,Breast,III,2020-04-25,2020-06-30,2021-05-22,Targeted Therapy,Public,,71.0,KRAS,No,Never,Moderate,23.4,Low,Urban,NHS,3.0,No,Yes,None,6.0
PT02317,Sweden,Västra Götaland,83.0,,Pancreatic,I,2021-09-25,2022-03-20,2022-12-05,Surgery,,Alive,85.0,BRCA1,Yes,Never,Heavy,27.4,Medium,Rural,NHS,8.0,No,No,Hypertension,8.0
PT02318,Germany,Berlin,33.0,Female,Breast,I,2014-11-17,2015-01-22,2015-08-31,Radiation,Public,Alive,76.0,KRAS,Yes,Never,Moderate,26.7,Medium,Urban,NHS,14.0,No,No,None,4.0
PT02319,Denmark,Central Denmark,69.0,Male,Ovarian,II,2017-10-25,,2018-02-05,Surgery,Public,Deceased,78.0,KRAS,,Never,Moderate,31.8,Medium,Urban,Statutory Health Insurance,14.0,No,No,None,5.0
PT02320,Italy,Veneto,45.0,,Lung,II,2013-04-30,2013-07-19,2014-03-20,Radiation,Research Institute,Alive,116.0,BRCA1,Yes,Never,Moderate,28.8,Low,Urban,NHS,13.0,No,No,Obesity,6.0
PT02321,Germany,Bavaria,88.0,Female,Pancreatic,II,2011-09-08,2011-10-17,2012-09-15,Radiation,Private,Alive,29.0,BRCA1,Yes,Former,Moderate,32.9,Low,Rural,NHS,10.0,No,No,Cardiovascular Disease,1.0
PT02322,Spain,Andalusia,26.0,Female,Breast,,2021-05-26,2021-09-30,2022-05-04,Immunotherapy,Research Institute,Deceased,78.0,BRCA1,Yes,Never,Heavy,20.0,Medium,Urban,Statutory Health Insurance,10.0,No,No,Diabetes,6.0
PT02323,Germany,North Rhine-Westphalia,35.0,Female,Lung,II,2011-03-30,2011-05-20,2011-09-22,Surgery,Private,Alive,51.0,KRAS,Yes,Former,Moderate,24.4,Medium,Urban,Private Insurance,7.0,No,No,Obesity,5.0
,Norway,Vestland,74.0,Male,Ovarian,III,2019-01-18,2019-05-25,2020-02-23,Surgery,Public,Alive,98.0,None,No,,None,19.2,High,Rural,NHS,13.0,No,No,Hypertension,
PT02325,Denmark,Zealand,75.0,Non-binary,Colorectal,I,2014-03-12,2014-08-10,2015-02-22,Radiation,Private,Alive,13.0,KRAS,No,Never,None,30.2,Low,Rural,NHS,16.0,No,No,None,5.0
PT02326,France,Île-de-France,23.0,Male,Lung,I,2022-06-28,2022-12-06,2023-11-11,Chemotherapy,Private,Alive,17.0,BRCA1,No,Current,Moderate,27.2,Low,Urban,Statutory Health Insurance,15.0,Yes,No,Hypertension,2.0
PT02327,Netherlands,Utrecht,67.0,Female,Pancreatic,II,2014-11-11,2015-02-17,,Targeted Therapy,Public,Alive,7.0,EGFR,Yes,Never,Heavy,39.3,Medium,Urban,,10.0,No,No,Cardiovascular Disease,5.0
PT02328,France,Auvergne-Rhône-Alpes,36.0,Female,Pancreatic,II,2016-10-25,2017-03-28,2017-09-09,Targeted Therapy,Public,Deceased,14.0,None,No,Former,Heavy,24.7,Medium,Rural,Statutory Health Insurance,19.0,No,Yes,None,10.0
PT02329,Switzerland,Geneva,55.0,Female,Breast,I,2013-02-23,2013-07-18,2014-03-11,Chemotherapy,Private,Deceased,76.0,EGFR,No,Former,Heavy,24.1,Low,Urban,Private Insurance,11.0,No,No,None,5.0
PT02330,Norway,Oslo,89.0,Female,Ovarian,I,2020-02-24,2020-05-12,2021-02-14,Immunotherapy,Public,Alive,34.0,BRCA1,Yes,Never,Moderate,25.8,Low,Urban,Private Insurance,2.0,,No,Hypertension,
PT02331,Ireland,,57.0,Female,Ovarian,II,2021-07-30,2022-01-17,2022-10-27,Chemotherapy,Private,Deceased,101.0,None,No,Never,Moderate,28.6,Medium,,Statutory Health Insurance,19.0,No,No,Diabetes,7.0
PT02332,Poland,Silesian,81.0,Male,Ovarian,I,2023-08-28,2023-10-15,2024-10-07,Chemotherapy,Public,Alive,89.0,BRCA1,No,Never,Heavy,31.5,High,Urban,Private Insurance,11.0,No,No,Cardiovascular Disease,8.0
PT02333,Norway,Oslo,67.0,Male,Pancreatic,,2022-04-19,2022-07-10,2022-08-24,Immunotherapy,Private,Alive,28.0,None,Yes,Never,Moderate,25.9,High,Rural,Statutory Health Insurance,7.0,No,No,None,
PT02334,Finland,Uusimaa,29.0,Male,Colorectal,I,2015-11-08,2016-04-04,2017-02-09,Radiation,Public,Alive,94.0,KRAS,Yes,Never,Moderate,32.7,Medium,Urban,Private Insurance,4.0,No,No,Cardiovascular Disease,10.0
PT02335,Portugal,Algarve,55.0,Female,Ovarian,I,2010-03-24,2010-09-03,2011-03-11,Surgery,Private,Alive,84.0,EGFR,Yes,Former,None,33.8,Medium,Urban,Private Insurance,8.0,No,No,None,4.0
PT02336,Spain,Madrid,48.0,Female,Leukemia,,2014-03-04,2014-04-06,2015-01-24,Targeted Therapy,Private,Alive,38.0,KRAS,No,Former,Moderate,34.3,Low,Urban,Private Insurance,18.0,Yes,No,None,8.0
PT02337,Portugal,Algarve,23.0,Female,Lung,IV,2019-04-04,2019-06-24,2019-09-21,Targeted Therapy,Public,Deceased,105.0,None,Yes,Never,None,36.6,Medium,Rural,Private Insurance,2.0,No,No,Hypertension,7.0
PT02338,Finland,Pirkanmaa,63.0,Female,Leukemia,III,2017-01-23,2017-05-02,2018-02-23,Targeted Therapy,Public,Alive,99.0,BRCA1,No,Current,None,21.4,Medium,Urban,NHS,8.0,No,No,Hypertension,8.0
PT02339,Netherlands,Utrecht,75.0,Female,Colorectal,II,2023-07-08,2023-07-10,2024-02-11,Chemotherapy,Public,Alive,21.0,KRAS,Yes,Current,Moderate,34.4,High,Rural,Private Insurance,14.0,No,No,,10.0
PT02340,Ireland,Connacht,61.0,Male,Lung,I,2013-01-12,2013-06-23,,Radiation,Public,Lost to Follow-up,,BRCA1,Yes,Never,Heavy,24.5,High,Rural,Statutory Health Insurance,10.0,No,No,Hypertension,5.0
PT02341,Switzerland,Geneva,32.0,Male,Breast,,,2015-11-21,2016-02-02,Radiation,Public,Alive,14.0,BRCA1,Yes,Former,Moderate,34.0,Low,Urban,NHS,4.0,No,No,None,4.0
PT02342,Belgium,Wallonia,65.0,Male,Lung,I,2022-04-02,2022-07-01,2023-01-12,Chemotherapy,,Alive,113.0,BRCA1,Yes,Never,Moderate,18.7,Medium,Urban,Private Insurance,3.0,No,No,Diabetes,3.0
PT02343,Norway,Trøndelag,52.0,Female,Breast,III,2015-04-09,2015-08-13,2016-02-11,Immunotherapy,Private,Lost to Follow-up,,None,No,Former,Heavy,22.7,High,Rural,Statutory Health Insurance,2.0,No,No,None,8.0
PT02344,Portugal,Algarve,40.0,Male,Prostate,II,2021-10-22,2022-03-31,2022-09-28,Immunotherapy,Public,Alive,79.0,BRCA1,No,Never,Moderate,28.6,Medium,,Private Insurance,15.0,Yes,Yes,Diabetes,10.0
PT02345,Belgium,Wallonia,76.0,Female,Lung,I,2011-01-16,2011-02-06,2011-06-12,Radiation,Public,Alive,41.0,KRAS,No,Former,None,31.0,Medium,Urban,Private Insurance,1.0,No,No,Obesity,7.0
PT02346,Poland,Lesser Poland,88.0,Female,Lung,I,2011-09-29,2011-10-04,2012-05-09,Chemotherapy,Private,Alive,60.0,KRAS,Yes,,None,38.8,Low,Rural,Private Insurance,5.0,Yes,No,Cardiovascular Disease,7.0
PT02347,France,Auvergne-Rhône-Alpes,89.0,,Leukemia,III,2012-03-10,2012-04-07,2012-09-20,Targeted Therapy,Private,Alive,,KRAS,Yes,Never,Heavy,23.4,Medium,Urban,Statutory Health Insurance,17.0,No,Yes,Cardiovascular Disease,10.0
PT02348,Germany,North Rhine-Westphalia,86.0,Male,Leukemia,II,2020-05-11,2020-08-06,2021-04-09,Surgery,Public,Alive,52.0,KRAS,Yes,Former,Moderate,29.6,Medium,Urban,NHS,10.0,No,No,None,9.0
PT02349,Netherlands,North Holland,67.0,Male,Colorectal,III,2020-12-26,2021-02-12,2022-01-11,Radiation,Public,Alive,119.0,EGFR,Yes,Never,Moderate,28.8,Low,Rural,NHS,5.0,No,No,None,10.0
PT02350,Italy,Lombardy,52.0,Male,Breast,I,2016-12-30,2017-04-05,2017-11-29,Targeted Therapy,Public,Alive,19.0,EGFR,,Never,Moderate,33.2,High,Urban,NHS,8.0,No,No,Hypertension,4.0
PT02351,Poland,Lesser Poland,55.0,Female,Pancreatic,III,2010-10-10,,2011-04-08,Radiation,Research Institute,Deceased,40.0,None,Yes,Former,Moderate,23.4,Medium,Rural,Statutory Health Insurance,9.0,No,No,Obesity,5.0
PT02352,Italy,Veneto,52.0,,Leukemia,I,2021-10-19,,2022-08-12,Surgery,Private,Deceased,19.0,KRAS,Yes,Current,Moderate,38.4,Medium,Urban,NHS,17.0,Yes,No,,6.0
PT02353,Poland,Silesian,50.0,Female,Ovarian,I,2013-03-25,2013-06-16,2013-08-20,,Research Institute,Alive,6.0,KRAS,No,Never,Heavy,39.9,Low,Urban,Statutory Health Insurance,17.0,No,No,None,5.0
PT02354,Sweden,Västra Götaland,40.0,Female,Colorectal,III,2015-08-09,2016-01-24,2016-06-06,Radiation,Private,Alive,56.0,BRCA1,No,Former,None,37.5,Low,Urban,NHS,16.0,Yes,No,Diabetes,5.0
PT02355,Switzerland,Geneva,,,Breast,,2012-05-04,2012-05-10,2012-06-20,Chemotherapy,Research Institute,Alive,93.0,EGFR,Yes,Former,Moderate,33.5,High,Rural,Private Insurance,8.0,,No,Obesity,3.0
PT02356,Germany,Berlin,81.0,Female,Breast,II,2011-09-09,2012-01-29,2012-08-13,Immunotherapy,Public,Alive,81.0,EGFR,No,Current,Moderate,32.8,Medium,Urban,Statutory Health Insurance,1.0,No,No,Cardiovascular Disease,9.0
PT02357,Denmark,Central Denmark,45.0,Female,Breast,III,2018-11-05,2019-03-04,2019-11-02,Immunotherapy,Public,Deceased,53.0,KRAS,Yes,Current,Moderate,,Low,Rural,NHS,15.0,Yes,,None,1.0
PT02358,Germany,Berlin,85.0,Female,Prostate,III,2015-09-20,2016-01-23,2016-04-03,Targeted Therapy,Private,Alive,63.0,KRAS,No,Current,None,30.3,Medium,Urban,NHS,19.0,Yes,No,Hypertension,4.0
PT02359,Switzerland,Geneva,31.0,Male,Breast,II,2020-08-09,2020-10-15,2021-01-19,Chemotherapy,Public,Alive,46.0,KRAS,No,Current,Heavy,23.2,Low,Rural,Statutory Health Insurance,3.0,Yes,Yes,Obesity,6.0
PT02360,Netherlands,Utrecht,41.0,Male,Colorectal,IV,,2023-01-06,2023-07-23,Radiation,Public,Alive,78.0,,,Never,Moderate,,Medium,Urban,Private Insurance,12.0,Yes,No,Diabetes,1.0
PT02361,Poland,Lesser Poland,36.0,Male,Breast,II,2012-10-25,2013-04-10,2013-10-08,,Public,Deceased,18.0,BRCA1,,Never,Moderate,32.4,Medium,Urban,Statutory Health Insurance,4.0,No,Yes,None,8.0
PT02362,Sweden,Skåne,26.0,Male,Pancreatic,III,2012-11-10,2013-04-28,2013-12-10,Chemotherapy,Public,Alive,62.0,BRCA1,No,Former,Moderate,19.7,Low,Rural,Private Insurance,15.0,No,No,Hypertension,6.0
PT02363,Netherlands,Utrecht,87.0,Female,Pancreatic,II,2011-10-08,2011-11-01,2011-12-13,Immunotherapy,Public,Alive,31.0,EGFR,Yes,Current,None,28.9,Low,Urban,Private Insurance,3.0,No,No,None,1.0
,Spain,Catalonia,56.0,Female,Breast,II,,2013-01-16,2013-10-01,Radiation,Public,Alive,20.0,EGFR,No,Never,Moderate,27.9,Low,Rural,Private Insurance,11.0,No,No,Diabetes,2.0
PT02365,Denmark,Capital Region,57.0,Female,Colorectal,III,2021-11-16,2022-03-05,2022-09-12,Radiation,Private,Alive,113.0,BRCA1,No,Never,Moderate,20.1,Low,,Statutory Health Insurance,18.0,No,No,None,4.0
PT02366,,Berlin,30.0,Male,Lung,I,2023-10-06,2024-01-09,2024-05-20,Radiation,Private,Alive,85.0,BRCA1,Yes,Never,Moderate,26.0,High,Urban,NHS,1.0,No,No,Cardiovascular Disease,
PT02367,Denmark,Capital Region,20.0,Male,,I,2010-12-09,2011-05-12,2011-10-19,Surgery,Research Institute,Deceased,15.0,KRAS,No,Current,,22.6,High,Urban,NHS,4.0,No,No,Cardiovascular Disease,7.0
PT02368,Austria,Styria,44.0,Female,Colorectal,IV,2014-07-25,2014-08-23,2014-12-26,Chemotherapy,Public,Alive,22.0,BRCA1,Yes,Former,Heavy,19.0,High,Urban,Private Insurance,6.0,No,No,Hypertension,7.0
PT02369,Switzerland,Bern,61.0,,Leukemia,III,2016-09-30,2016-10-02,2017-06-04,Surgery,Public,Alive,109.0,BRCA1,Yes,Former,Moderate,18.5,Medium,Urban,Private Insurance,17.0,No,No,Cardiovascular Disease,4.0
PT02370,Austria,,,Male,Colorectal,II,2010-02-07,2010-03-09,2010-10-25,Surgery,Public,Alive,114.0,KRAS,Yes,Never,Moderate,24.1,Low,Rural,Private Insurance,,No,No,Diabetes,5.0
PT02371,Poland,Lesser Poland,43.0,Female,Prostate,,2022-02-18,2022-06-09,2022-11-16,Targeted Therapy,Public,Alive,15.0,BRCA1,,Former,Moderate,20.0,Medium,Urban,Private Insurance,17.0,No,No,Cardiovascular Disease,2.0
PT02372,Germany,Bavaria,72.0,,Leukemia,III,2015-12-01,2016-02-13,2016-10-01,Radiation,Public,Deceased,52.0,KRAS,No,Never,None,36.5,Medium,Urban,Statutory Health Insurance,19.0,No,No,None,1.0
PT02373,Netherlands,North Holland,75.0,Female,Pancreatic,I,2010-09-08,2010-11-23,2011-10-09,Surgery,Public,Alive,116.0,None,No,Never,Moderate,39.5,Low,Urban,NHS,5.0,No,Yes,Obesity,4.0
PT02374,Germany,North Rhine-Westphalia,,Male,Pancreatic,II,2023-09-17,2024-01-13,2024-11-13,Chemotherapy,Public,Deceased,15.0,BRCA1,No,Current,Moderate,28.2,Low,Rural,Private Insurance,2.0,No,No,Cardiovascular Disease,1.0
PT02375,Switzerland,Geneva,27.0,Female,Lung,I,2019-05-10,2019-05-29,2020-05-24,Targeted Therapy,Private,Alive,66.0,KRAS,No,Former,None,31.0,Low,Urban,Statutory Health Insurance,2.0,No,No,Hypertension,8.0
PT02376,Portugal,Porto,78.0,Female,Lung,II,2020-10-20,2020-12-13,2021-02-28,Targeted Therapy,Public,Alive,40.0,EGFR,No,Former,Heavy,38.9,Low,Urban,Statutory Health Insurance,6.0,Yes,No,Diabetes,6.0
PT02377,France,Auvergne-Rhône-Alpes,64.0,Male,Colorectal,I,2010-09-21,2011-01-19,2011-04-01,Immunotherapy,Public,Alive,110.0,KRAS,No,Current,Moderate,34.5,Medium,Urban,Private Insurance,,No,No,Diabetes,3.0
PT02378,Denmark,Capital Region,46.0,Female,Colorectal,III,2023-09-04,2024-02-02,2024-05-22,Immunotherapy,Public,Alive,13.0,KRAS,Yes,,None,29.2,Medium,Urban,Private Insurance,14.0,No,No,,10.0
PT02379,Poland,Masovian,71.0,Female,Breast,III,2022-10-21,2023-01-24,2023-05-01,Targeted Therapy,,Deceased,15.0,KRAS,No,Never,Moderate,27.4,Medium,Rural,Private Insurance,14.0,,No,Diabetes,7.0
PT02380,,Zurich,37.0,Female,Ovarian,II,2013-11-15,2013-12-18,2014-09-07,Chemotherapy,,Alive,76.0,KRAS,,Current,Moderate,34.4,Low,Rural,,10.0,No,No,Hypertension,6.0
PT02381,Italy,Sicily,35.0,Male,,I,2023-12-24,2024-02-28,2024-11-24,Surgery,Public,Alive,103.0,EGFR,Yes,Never,None,25.1,Low,Rural,NHS,2.0,No,No,Diabetes,2.0
PT02382,,Västra Götaland,85.0,Female,Breast,I,2014-06-10,2014-10-27,2015-06-12,Immunotherapy,Private,Deceased,,BRCA1,No,Current,None,34.5,Medium,Rural,Statutory Health Insurance,16.0,No,Yes,None,6.0
PT02383,Switzerland,Zurich,24.0,Male,Pancreatic,,2014-10-20,2015-01-18,2015-08-18,Surgery,,Alive,74.0,None,Yes,Former,None,19.6,High,Urban,Private Insurance,12.0,No,No,Cardiovascular Disease,6.0
PT02384,,Île-de-France,,Female,Prostate,II,2011-07-16,2011-12-09,2012-08-04,Chemotherapy,Public,Alive,86.0,None,Yes,Former,None,29.3,Low,Rural,NHS,,No,No,Diabetes,2.0
,Denmark,Capital Region,89.0,Female,Ovarian,III,2019-10-23,2019-12-27,2020-06-27,Surgery,Private,Alive,53.0,None,No,Never,None,22.0,Low,Urban,Private Insurance,,No,No,Cardiovascular Disease,1.0
PT02386,Poland,Silesian,26.0,Female,Breast,I,2013-03-03,2013-08-10,2014-02-14,Targeted Therapy,Public,Alive,25.0,BRCA1,No,Never,Heavy,34.2,Low,Urban,,16.0,No,No,Diabetes,1.0
PT02387,France,Île-de-France,69.0,Female,Pancreatic,III,2014-11-01,2015-03-13,2015-10-10,Immunotherapy,,Alive,73.0,KRAS,No,Never,Moderate,39.3,Medium,Rural,NHS,14.0,No,Yes,Diabetes,10.0
PT02388,Ireland,,33.0,Male,Colorectal,III,2021-05-19,2021-08-13,2022-03-14,Chemotherapy,Private,Alive,51.0,KRAS,No,Current,Moderate,32.4,Low,Urban,NHS,,No,No,Hypertension,1.0
PT02389,Spain,Madrid,57.0,Male,Ovarian,II,2020-07-02,2020-08-07,2020-10-31,Targeted Therapy,,Deceased,103.0,BRCA1,No,Never,None,33.9,Medium,Urban,Private Insurance,8.0,No,No,Diabetes,10.0
PT02390,Austria,,66.0,Female,Colorectal,II,2019-09-12,2020-01-04,2020-06-08,Chemotherapy,Private,Alive,41.0,EGFR,Yes,Former,Moderate,21.6,Medium,Urban,Statutory Health Insurance,11.0,No,Yes,Hypertension,4.0
PT02391,Austria,Tyrol,52.0,Female,Breast,III,2018-07-27,2019-01-04,2019-03-27,Immunotherapy,Private,Deceased,116.0,KRAS,No,Never,Heavy,30.1,Low,Urban,Private Insurance,10.0,Yes,No,Cardiovascular Disease,5.0
PT02392,Belgium,Brussels,62.0,Male,Ovarian,III,2018-12-01,2019-04-22,2019-12-07,Surgery,Public,Lost to Follow-up,,KRAS,No,Current,Heavy,35.1,High,Urban,Statutory Health Insurance,16.0,No,No,Cardiovascular Disease,7.0
PT02393,Poland,Masovian,48.0,Female,Prostate,IV,2018-07-01,2018-12-24,2019-02-25,Chemotherapy,Public,Alive,6.0,EGFR,No,Current,None,,Medium,Rural,Private Insurance,15.0,Yes,No,Cardiovascular Disease,3.0
PT02394,Austria,Vienna,76.0,Female,Pancreatic,II,2023-01-05,2023-02-11,2023-04-27,Immunotherapy,Public,Deceased,55.0,KRAS,No,Never,None,39.5,Medium,Urban,NHS,3.0,No,No,Obesity,1.0
PT02395,Poland,Lesser Poland,24.0,Female,Colorectal,IV,2021-09-04,2022-01-15,2022-09-09,Targeted Therapy,Public,Lost to Follow-up,,EGFR,No,Never,None,34.4,Medium,Urban,Statutory Health Insurance,6.0,No,No,None,6.0
PT02396,Sweden,Skåne,79.0,Male,Pancreatic,I,,2012-12-31,2013-12-25,Immunotherapy,Public,Deceased,65.0,EGFR,Yes,Never,None,30.6,Medium,Urban,Private Insurance,12.0,No,,Hypertension,9.0
PT02397,Netherlands,Utrecht,89.0,Male,Prostate,II,2017-10-28,2018-01-05,2018-03-25,Surgery,Public,Alive,109.0,BRCA1,Yes,Former,None,35.9,High,Rural,NHS,16.0,No,No,Cardiovascular Disease,5.0
PT02398,Belgium,Flanders,21.0,Non-binary,Colorectal,II,2013-01-07,2013-04-18,2013-11-30,Immunotherapy,Private,Deceased,34.0,EGFR,Yes,Current,None,23.7,Medium,Urban,NHS,5.0,No,No,None,4.0
PT02399,France,Auvergne-Rhône-Alpes,89.0,Female,Pancreatic,II,2017-06-28,2017-12-11,2018-01-20,Targeted Therapy,Research Institute,Deceased,25.0,EGFR,No,Never,,37.2,High,Urban,Private Insurance,13.0,No,No,Diabetes,8.0
PT02400,Austria,Tyrol,62.0,Female,Prostate,III,2011-01-22,2011-07-15,2012-03-31,Targeted Therapy,Research Institute,Alive,34.0,EGFR,No,Never,,35.2,Medium,Urban,Statutory Health Insurance,6.0,No,No,Obesity,9.0
PT02401,Belgium,Flanders,23.0,Male,Prostate,I,2014-06-01,2014-09-07,2014-12-31,,Public,Alive,21.0,None,No,Never,Moderate,21.7,Medium,Urban,Statutory Health Insurance,8.0,No,No,Diabetes,5.0
PT02402,Ireland,Dublin,75.0,Female,Prostate,IV,2014-04-15,2014-09-05,2015-08-31,Targeted Therapy,Public,Deceased,85.0,KRAS,Yes,Former,Moderate,36.7,Medium,Urban,Private Insurance,14.0,,Yes,Cardiovascular Disease,8.0
PT02403,Germany,Berlin,78.0,Female,Breast,II,2019-03-10,,2019-10-08,Radiation,Private,,105.0,BRCA1,,Never,Moderate,36.3,,Rural,Statutory Health Insurance,15.0,No,No,Hypertension,8.0
PT02404,Norway,Vestland,28.0,Male,Lung,IV,2016-07-04,2016-07-31,2017-02-04,Targeted Therapy,Private,Deceased,114.0,KRAS,No,Former,Moderate,38.3,High,Urban,NHS,14.0,No,No,Diabetes,3.0
PT02405,Sweden,Stockholm,22.0,Female,Pancreatic,I,2016-11-12,2017-03-04,2018-02-14,Surgery,Public,Lost to Follow-up,,KRAS,,Former,Heavy,37.8,Medium,Rural,Statutory Health Insurance,,No,No,None,8.0
PT02406,Austria,Vienna,67.0,Female,,,2016-01-10,2016-01-11,2016-03-03,Targeted Therapy,Private,Alive,45.0,BRCA1,No,Current,Moderate,25.2,Medium,Rural,Statutory Health Insurance,11.0,No,No,Diabetes,10.0
PT02407,France,Provence-Alpes-Côte d'Azur,62.0,Female,Pancreatic,II,2020-12-18,2021-05-24,2021-12-20,Chemotherapy,Public,Deceased,93.0,BRCA1,No,Former,Moderate,29.3,High,Urban,Statutory Health Insurance,,Yes,No,Hypertension,9.0
,Sweden,Stockholm,20.0,Female,Prostate,II,2017-08-04,2017-12-07,2018-03-08,Targeted Therapy,Private,,22.0,None,Yes,Never,,35.7,Medium,Urban,NHS,12.0,No,No,Diabetes,9.0
PT02409,Switzerland,Zurich,76.0,Female,Pancreatic,III,2012-03-17,2012-07-30,2012-11-10,,Public,Alive,96.0,EGFR,Yes,Former,Heavy,34.9,High,Rural,NHS,15.0,No,No,Diabetes,2.0
PT02410,Spain,Catalonia,72.0,Female,Colorectal,I,2020-05-11,2020-06-09,2020-07-25,Immunotherapy,Private,Lost to Follow-up,,BRCA1,Yes,Current,Moderate,35.8,Medium,Urban,Statutory Health Insurance,12.0,No,No,Cardiovascular Disease,3.0
PT02411,Denmark,Capital Region,35.0,Female,Pancreatic,I,2018-04-18,2018-09-24,2019-08-16,Immunotherapy,Private,Alive,109.0,KRAS,Yes,Former,Heavy,,High,Rural,Statutory Health Insurance,19.0,,No,Hypertension,3.0
PT02412,Germany,Berlin,70.0,Female,Ovarian,III,2011-10-03,2011-11-10,2012-08-20,Radiation,Public,Alive,78.0,None,No,Never,Moderate,35.5,Medium,Urban,NHS,14.0,No,No,Diabetes,5.0
PT02413,Spain,Andalusia,74.0,Male,Lung,II,2021-03-10,2021-03-18,2022-01-05,Chemotherapy,Public,Deceased,25.0,EGFR,Yes,Never,Moderate,20.2,Low,Urban,Statutory Health Insurance,17.0,No,No,Diabetes,6.0
PT02414,Austria,Vienna,20.0,Female,Colorectal,I,2018-03-15,2018-06-18,2019-05-18,Immunotherapy,Private,Alive,51.0,EGFR,Yes,Current,None,28.6,Low,Rural,Statutory Health Insurance,4.0,,No,Obesity,9.0
PT02415,Poland,Silesian,47.0,Female,Colorectal,II,2016-02-17,2016-07-31,,Immunotherapy,Public,Alive,29.0,BRCA1,Yes,Former,Heavy,19.2,Medium,Urban,Statutory Health Insurance,1.0,No,No,Diabetes,8.0
,Italy,Veneto,72.0,Male,Prostate,II,2015-10-01,2016-01-05,2016-08-02,Immunotherapy,Public,Deceased,47.0,KRAS,Yes,Current,,28.0,Low,Urban,Statutory Health Insurance,3.0,Yes,Yes,Hypertension,
PT02417,Norway,Vestland,77.0,Female,Leukemia,III,2017-03-27,2017-04-22,2017-12-25,Chemotherapy,Public,Alive,90.0,EGFR,No,Current,None,23.4,Medium,Rural,Statutory Health Insurance,7.0,No,Yes,Diabetes,1.0
PT02418,Sweden,Stockholm,79.0,Male,Ovarian,I,2016-07-16,2017-01-08,2017-05-23,Immunotherapy,Private,Alive,86.0,BRCA1,No,Never,None,29.4,Medium,Urban,NHS,12.0,No,,Cardiovascular Disease,9.0
PT02419,Italy,Veneto,78.0,Female,Lung,II,2021-04-05,2021-07-27,2021-10-19,Radiation,Public,Alive,,EGFR,No,Current,Moderate,33.7,High,Urban,Statutory Health Insurance,7.0,No,No,Obesity,9.0
,Switzerland,Geneva,41.0,Male,Colorectal,III,2021-03-09,2021-03-20,2021-09-02,Immunotherapy,Private,Deceased,55.0,BRCA1,Yes,Never,Moderate,18.7,Low,Rural,Statutory Health Insurance,10.0,No,No,Hypertension,1.0
PT02421,Sweden,Västra Götaland,27.0,Male,Leukemia,III,2010-08-30,2010-09-22,2011-08-05,Surgery,Public,Alive,36.0,KRAS,No,Never,Heavy,23.8,Medium,Urban,Statutory Health Insurance,19.0,No,No,Diabetes,9.0
PT02422,Italy,Veneto,68.0,Female,Leukemia,IV,2020-04-07,2020-09-16,2020-12-11,Radiation,Public,Alive,19.0,BRCA1,Yes,Never,Moderate,21.3,Medium,Urban,Private Insurance,,Yes,No,Cardiovascular Disease,1.0
PT02423,Belgium,Brussels,61.0,Female,Colorectal,II,2022-12-30,2023-02-01,2023-06-10,Surgery,Public,Alive,42.0,,Yes,Never,Moderate,22.0,Medium,Urban,Private Insurance,,No,No,None,3.0
PT02424,Italy,Lombardy,46.0,Female,Prostate,II,2013-12-05,2014-04-14,2014-05-18,Immunotherapy,Public,Deceased,18.0,KRAS,Yes,Never,Moderate,30.8,Low,Rural,NHS,10.0,No,,Diabetes,3.0
PT02425,Netherlands,North Holland,58.0,Female,Breast,I,2022-01-07,2022-04-30,2022-09-18,Immunotherapy,Public,Alive,,KRAS,No,Former,Heavy,19.4,Medium,Urban,NHS,8.0,No,Yes,None,9.0
PT02426,Netherlands,North Holland,44.0,Female,,II,2013-12-04,2014-02-03,2014-06-07,Chemotherapy,Private,Alive,,BRCA1,No,Never,None,33.5,Medium,Urban,Private Insurance,13.0,No,No,Cardiovascular Disease,10.0
PT02427,Austria,Styria,57.0,Female,Prostate,I,2023-01-21,2023-06-02,2024-05-15,Surgery,Private,Alive,90.0,BRCA1,No,Former,None,23.1,Low,Urban,Private Insurance,17.0,No,No,Obesity,7.0
PT02428,France,Île-de-France,43.0,,Lung,III,2013-12-10,2013-12-22,2014-08-31,Surgery,Public,Deceased,48.0,KRAS,,Former,None,39.1,Medium,Urban,NHS,5.0,No,Yes,Diabetes,6.0
PT02429,France,Île-de-France,43.0,Non-binary,Prostate,III,2021-09-17,2022-02-21,2022-09-24,Targeted Therapy,Private,Alive,11.0,None,No,Never,Moderate,38.6,Medium,Urban,Statutory Health Insurance,,No,No,Diabetes,3.0
PT02430,Finland,Southwest Finland,79.0,Male,Leukemia,II,2018-02-16,2018-06-03,2018-11-16,Targeted Therapy,Public,Deceased,84.0,EGFR,No,Current,None,34.1,Medium,Rural,NHS,17.0,No,No,Obesity,8.0
PT02431,Portugal,Lisbon,69.0,Female,Ovarian,I,2023-05-20,2023-08-31,2024-05-11,,Private,Alive,19.0,None,No,Never,Moderate,35.3,Low,Urban,Private Insurance,18.0,No,No,Cardiovascular Disease,2.0
PT02432,Netherlands,South Holland,85.0,Male,Ovarian,I,2023-01-15,2023-07-04,2024-04-09,Targeted Therapy,Public,Alive,,EGFR,,Never,,33.8,Low,Urban,Statutory Health Insurance,10.0,Yes,No,Diabetes,7.0
PT02433,Finland,Uusimaa,33.0,Female,Lung,IV,2023-03-15,2023-09-09,2023-11-03,Surgery,Public,Alive,68.0,None,No,Never,None,34.0,Medium,Urban,Private Insurance,,No,No,Obesity,5.0
PT02434,Finland,Southwest Finland,72.0,Male,Ovarian,IV,,2022-05-12,2022-12-18,Chemotherapy,Private,,14.0,BRCA1,No,Former,Moderate,22.0,Low,Urban,Statutory Health Insurance,19.0,No,No,None,10.0
PT02435,Belgium,,51.0,Female,Lung,I,,2021-10-09,2022-05-20,Targeted Therapy,Public,Alive,,KRAS,No,Never,Moderate,38.4,High,Urban,NHS,17.0,No,No,Cardiovascular Disease,6.0
PT02436,Switzerland,Bern,67.0,Female,Breast,III,2011-04-22,2011-08-25,2012-07-09,Surgery,Private,Alive,79.0,EGFR,No,Former,None,35.6,Low,Rural,NHS,6.0,No,No,None,8.0
PT02437,Finland,Pirkanmaa,58.0,Non-binary,Breast,I,2022-02-07,2022-04-05,2022-05-10,,Public,Alive,88.0,None,Yes,Never,None,30.6,High,Rural,Statutory Health Insurance,17.0,No,No,Cardiovascular Disease,8.0
PT02438,Finland,Southwest Finland,59.0,Non-binary,Colorectal,I,2019-10-06,2019-11-21,2020-11-02,Chemotherapy,Private,Lost to Follow-up,,KRAS,Yes,Current,Moderate,21.7,Medium,Rural,Private Insurance,5.0,No,No,Diabetes,6.0
PT02439,Finland,Uusimaa,61.0,Non-binary,Ovarian,I,2013-08-11,,2014-05-09,Targeted Therapy,Research Institute,Deceased,72.0,EGFR,No,,,35.1,High,Urban,NHS,14.0,No,No,Hypertension,2.0
PT02440,Switzerland,Geneva,27.0,Male,Prostate,II,2021-06-10,2021-10-27,2022-06-26,Surgery,Public,Alive,37.0,BRCA1,No,Current,Moderate,38.0,Medium,Urban,NHS,11.0,No,No,Obesity,10.0
PT02441,Italy,Lombardy,45.0,Non-binary,Colorectal,I,2020-01-06,2020-06-15,2020-09-27,Radiation,Private,Alive,6.0,None,Yes,Former,None,28.4,Medium,Urban,Statutory Health Insurance,5.0,No,Yes,None,10.0
PT02442,Denmark,Central Denmark,31.0,Male,Breast,I,2013-07-12,2013-12-07,2014-11-11,Surgery,Public,Alive,21.0,EGFR,Yes,Former,None,19.9,Low,Rural,Private Insurance,3.0,,No,None,6.0
PT02443,Belgium,Brussels,62.0,Female,Leukemia,I,2010-09-26,2010-10-01,2011-04-12,Chemotherapy,Public,,107.0,KRAS,Yes,,None,39.3,Medium,Urban,NHS,11.0,No,No,None,5.0
PT02444,Norway,Oslo,70.0,Male,Breast,II,2018-01-14,2018-03-23,2018-12-08,Immunotherapy,Private,Alive,114.0,None,Yes,Never,Heavy,,Medium,Urban,Private Insurance,,No,No,Cardiovascular Disease,4.0
PT02445,,Lesser Poland,82.0,Female,Prostate,III,2022-01-14,,2022-10-24,Targeted Therapy,Public,Alive,37.0,None,Yes,Former,Moderate,35.5,Medium,Urban,,5.0,,No,Hypertension,7.0
PT02446,Italy,Lombardy,68.0,Non-binary,Leukemia,I,2012-10-18,,2013-06-26,Chemotherapy,Public,Alive,71.0,EGFR,No,Never,None,39.7,Low,Urban,Private Insurance,18.0,No,No,Cardiovascular Disease,1.0
PT02447,Finland,Uusimaa,46.0,Female,Ovarian,IV,2010-03-31,,2010-12-12,Radiation,Private,Deceased,105.0,KRAS,Yes,Current,None,24.4,,,Statutory Health Insurance,5.0,No,No,,10.0
,,Oslo,28.0,Female,,I,2015-04-10,2015-05-07,2015-10-13,Radiation,Public,Alive,88.0,None,Yes,Former,Moderate,20.2,Medium,Rural,NHS,2.0,No,No,Diabetes,10.0
PT02449,France,Provence-Alpes-Côte d'Azur,58.0,Female,Colorectal,II,2022-03-14,2022-03-18,2022-07-26,Radiation,Private,Alive,52.0,BRCA1,Yes,Never,Moderate,35.8,High,Urban,Private Insurance,10.0,No,No,Hypertension,3.0
PT02450,Germany,Berlin,84.0,Male,Breast,I,2018-06-01,2018-10-07,2018-12-02,Radiation,,Alive,84.0,BRCA1,No,Never,Moderate,19.5,Low,Urban,Statutory Health Insurance,5.0,No,No,Diabetes,8.0
PT02451,Denmark,Central Denmark,26.0,Female,Breast,I,2018-11-22,2019-01-25,2019-03-13,Surgery,Private,Deceased,10.0,BRCA1,Yes,Current,None,29.6,Low,Urban,Private Insurance,12.0,Yes,No,Obesity,6.0
PT02452,Sweden,Västra Götaland,86.0,Female,Ovarian,I,2013-02-22,,2014-01-08,Chemotherapy,Public,Alive,19.0,None,No,Never,Moderate,34.1,Low,Rural,NHS,9.0,Yes,No,Cardiovascular Disease,2.0
PT02453,Finland,Pirkanmaa,29.0,Male,Pancreatic,I,2023-03-16,2023-09-02,2024-04-28,Radiation,,Alive,74.0,KRAS,Yes,Never,None,,Medium,Urban,NHS,15.0,No,No,None,8.0
,Poland,Silesian,72.0,Male,Colorectal,IV,2014-05-22,2014-10-26,2014-12-05,Chemotherapy,Public,Alive,16.0,KRAS,Yes,Former,Moderate,30.4,High,Rural,NHS,8.0,No,No,Obesity,1.0
PT02455,Sweden,Västra Götaland,76.0,Male,Ovarian,III,2014-12-08,2015-02-26,2015-03-31,Chemotherapy,Public,Alive,32.0,EGFR,No,Current,None,23.5,Medium,Rural,,16.0,No,No,Hypertension,5.0
,Spain,Catalonia,46.0,Female,Colorectal,IV,2010-01-05,2010-06-17,2010-10-27,Immunotherapy,Public,Alive,44.0,KRAS,No,Never,,25.0,Medium,Rural,Private Insurance,12.0,No,No,None,3.0
PT02457,Norway,Vestland,73.0,Male,Lung,I,2015-12-05,2015-12-24,2016-08-14,Surgery,Public,Alive,106.0,EGFR,No,Former,Moderate,25.9,Medium,Rural,Statutory Health Insurance,16.0,,No,Hypertension,7.0
PT02458,Finland,Southwest Finland,23.0,Male,Prostate,II,2018-05-20,2018-09-13,2019-01-03,Immunotherapy,Public,Alive,,EGFR,Yes,Never,Moderate,32.4,Medium,Rural,Private Insurance,10.0,No,No,,2.0
PT02459,France,Provence-Alpes-Côte d'Azur,42.0,Male,Lung,I,2011-03-07,,2011-08-20,Targeted Therapy,Private,,7.0,EGFR,Yes,Never,None,33.0,Low,Rural,Statutory Health Insurance,11.0,No,Yes,None,10.0
,Germany,Bavaria,67.0,Female,Lung,III,2011-01-25,2011-04-04,2012-01-10,Targeted Therapy,Private,Alive,54.0,None,Yes,Former,None,,Medium,Urban,,5.0,No,No,Obesity,1.0
PT02461,Poland,Masovian,61.0,Female,Colorectal,IV,2019-09-21,2019-10-22,2019-12-29,Targeted Therapy,Research Institute,Deceased,47.0,,No,Never,None,,Medium,Rural,Statutory Health Insurance,11.0,No,No,Diabetes,7.0
PT02462,Sweden,Västra Götaland,22.0,Female,Pancreatic,III,2019-09-13,2020-03-02,2021-02-09,Immunotherapy,Research Institute,Alive,,None,No,Never,Moderate,19.6,High,Urban,NHS,16.0,No,No,Cardiovascular Disease,6.0
PT02463,Denmark,Zealand,22.0,Female,Ovarian,,2013-10-05,2014-01-08,2014-07-09,Chemotherapy,Public,Alive,26.0,BRCA1,Yes,,Moderate,33.0,Medium,Urban,Private Insurance,4.0,No,No,Obesity,2.0
PT02464,Ireland,Connacht,47.0,Male,Ovarian,II,2023-04-02,2023-08-29,2024-08-27,Targeted Therapy,Public,Alive,118.0,None,Yes,Former,None,20.1,Medium,Urban,Statutory Health Insurance,1.0,No,Yes,Hypertension,10.0
PT02465,Sweden,Västra Götaland,82.0,Male,Prostate,I,2021-06-11,2021-09-29,,Targeted Therapy,Public,Alive,92.0,EGFR,No,Former,None,24.9,Medium,Urban,Private Insurance,2.0,No,No,None,6.0
PT02466,Netherlands,Utrecht,50.0,Female,Colorectal,I,2017-04-02,2017-09-11,2018-01-02,Immunotherapy,Public,Alive,6.0,KRAS,No,Never,,30.1,Medium,Urban,Statutory Health Insurance,1.0,No,No,Obesity,4.0
PT02467,Finland,Uusimaa,29.0,Male,,I,2019-01-12,2019-02-17,2019-05-12,Chemotherapy,Public,Alive,,KRAS,Yes,Former,None,30.1,Medium,Urban,Statutory Health Insurance,12.0,No,No,None,4.0
PT02468,Ireland,Connacht,68.0,Male,Lung,I,2011-03-29,2011-05-09,,Targeted Therapy,Research Institute,Alive,56.0,KRAS,No,Current,Moderate,29.8,Low,Urban,,19.0,No,No,Obesity,7.0
PT02469,Austria,Tyrol,40.0,Female,Ovarian,II,2010-11-19,2011-04-30,2011-08-30,Surgery,Public,Alive,40.0,EGFR,Yes,Current,Moderate,38.2,High,Urban,NHS,9.0,No,Yes,None,8.0
PT02470,Switzerland,Bern,72.0,Male,Ovarian,II,,2021-05-30,2021-10-14,,Public,Alive,40.0,EGFR,No,Never,None,27.8,,Urban,NHS,14.0,No,No,Diabetes,3.0
PT02471,Netherlands,South Holland,73.0,Female,Colorectal,II,,2015-08-16,2016-04-21,Immunotherapy,Private,,42.0,EGFR,No,Never,,21.7,Low,Urban,NHS,3.0,No,No,,6.0
PT02472,Switzerland,Geneva,76.0,Male,Breast,III,2013-02-02,2013-04-19,2013-06-24,Immunotherapy,Research Institute,Alive,52.0,KRAS,Yes,Never,Moderate,19.2,Medium,Urban,Private Insurance,5.0,No,Yes,Obesity,10.0
PT02473,Spain,Andalusia,39.0,Female,,I,2013-01-14,2013-05-18,2014-02-05,Surgery,Public,Deceased,23.0,BRCA1,No,Current,Moderate,29.3,Medium,Urban,,9.0,No,No,None,6.0
PT02474,Sweden,Västra Götaland,68.0,Male,Colorectal,I,2016-12-25,2017-01-16,2017-06-16,Chemotherapy,Public,Alive,102.0,None,Yes,Never,Moderate,31.3,High,Rural,Private Insurance,12.0,No,No,Obesity,2.0
PT02475,Denmark,Zealand,26.0,Male,Leukemia,III,2011-05-21,2011-09-19,2012-01-01,Surgery,Private,Alive,,KRAS,Yes,Never,Moderate,30.7,,Urban,Statutory Health Insurance,12.0,Yes,No,Hypertension,9.0
PT02476,France,Île-de-France,48.0,Male,Leukemia,II,2013-03-25,2013-04-16,2013-12-09,Targeted Therapy,Public,Alive,79.0,EGFR,No,,Moderate,22.2,Medium,,Private Insurance,5.0,Yes,No,Hypertension,2.0
PT02477,Switzerland,Zurich,67.0,Female,Breast,I,2011-05-11,2011-09-14,2012-08-18,Immunotherapy,Public,Alive,33.0,,No,Former,Moderate,18.9,Medium,Rural,Private Insurance,3.0,No,No,,7.0
PT02478,Netherlands,,32.0,Non-binary,Prostate,IV,2023-10-16,2024-04-06,2024-07-17,Chemotherapy,Private,Alive,63.0,None,No,Never,Heavy,37.3,Medium,Urban,,10.0,No,No,Hypertension,2.0
PT02479,Portugal,Lisbon,22.0,Male,Pancreatic,II,2011-01-21,,2011-07-29,Targeted Therapy,Public,Alive,81.0,KRAS,No,Former,None,27.8,Low,Urban,NHS,6.0,No,No,Cardiovascular Disease,5.0
PT02480,,Geneva,21.0,Female,Lung,II,2019-09-05,2019-09-15,2020-08-17,Surgery,Public,Deceased,73.0,KRAS,No,Never,None,,High,Urban,Private Insurance,5.0,No,No,None,3.0
PT02481,Portugal,Porto,35.0,Female,Ovarian,II,2019-11-24,2019-12-05,2020-10-23,Targeted Therapy,Public,Deceased,118.0,KRAS,No,Current,Moderate,,Low,Rural,NHS,16.0,Yes,No,Hypertension,5.0
PT02482,Belgium,Flanders,25.0,Non-binary,Prostate,,2023-01-24,2023-06-29,2024-05-23,Surgery,Public,Lost to Follow-up,,,No,Current,Moderate,32.4,Low,Urban,Private Insurance,15.0,No,No,Hypertension,6.0
PT02483,Belgium,Flanders,,Female,Ovarian,II,2015-03-12,2015-03-17,2015-12-06,Radiation,Public,Lost to Follow-up,,None,No,Current,None,31.5,High,,Private Insurance,12.0,No,No,,3.0
PT02484,Finland,Pirkanmaa,24.0,Male,Breast,II,2020-07-21,2020-08-02,2021-07-15,Radiation,Private,Deceased,30.0,,No,Former,None,23.1,Low,Rural,Private Insurance,3.0,No,No,Diabetes,5.0
PT02485,Portugal,Algarve,75.0,Female,Colorectal,I,2019-08-19,,2020-06-01,Immunotherapy,Private,Deceased,76.0,None,No,Never,None,36.7,Low,Urban,Private Insurance,10.0,,No,,8.0
PT02486,Sweden,,51.0,Female,Leukemia,IV,2016-05-23,2016-09-09,2016-12-15,Chemotherapy,Private,Alive,43.0,None,,Former,Moderate,19.9,Low,Urban,Private Insurance,10.0,No,No,Hypertension,9.0
PT02487,Portugal,Algarve,68.0,Male,Breast,II,,2023-12-30,2024-09-08,Immunotherapy,Private,Alive,89.0,EGFR,No,Never,Moderate,20.6,High,Urban,Private Insurance,4.0,No,No,Diabetes,7.0
PT02488,Poland,Masovian,32.0,,Prostate,III,2021-10-06,2022-01-04,2022-09-06,Targeted Therapy,Public,Deceased,60.0,None,No,Never,Moderate,26.5,Medium,Rural,Private Insurance,10.0,No,No,Obesity,9.0
PT02489,Portugal,Porto,49.0,Female,Prostate,II,2012-03-21,2012-04-19,2012-10-31,Radiation,Private,Alive,49.0,None,No,,Moderate,37.8,Medium,Urban,Private Insurance,19.0,No,No,Obesity,5.0
PT02490,Netherlands,South Holland,44.0,Female,Pancreatic,II,2012-06-01,2012-07-07,2012-10-05,Immunotherapy,Private,Alive,28.0,None,No,Current,Moderate,36.1,Low,Urban,Private Insurance,14.0,No,No,Diabetes,3.0
PT02491,Italy,Veneto,79.0,Female,Ovarian,I,2013-11-03,2013-12-08,2014-10-17,Surgery,Private,Deceased,64.0,None,No,Current,None,38.0,Medium,Urban,Private Insurance,18.0,No,No,Obesity,10.0
PT02492,Portugal,Porto,78.0,Non-binary,Breast,III,2020-05-22,2020-09-12,2020-12-20,Chemotherapy,Private,Alive,77.0,EGFR,No,,Moderate,33.4,High,Rural,Private Insurance,9.0,Yes,No,Hypertension,2.0
PT02493,,Bavaria,47.0,Female,Lung,III,2013-07-12,2013-07-20,2013-09-18,Radiation,Public,Alive,,BRCA1,No,Current,Moderate,31.7,Medium,,Private Insurance,3.0,Yes,No,Hypertension,1.0
PT02494,,Berlin,77.0,Male,Prostate,I,2012-06-16,2012-07-02,,Chemotherapy,Public,Alive,86.0,KRAS,No,Never,,35.2,Low,Rural,Private Insurance,9.0,No,No,Obesity,7.0
PT02495,Belgium,Flanders,39.0,Male,Lung,I,2016-08-01,2016-09-13,2017-02-16,Chemotherapy,Public,Deceased,34.0,KRAS,No,Current,Heavy,22.4,Medium,Urban,Statutory Health Insurance,11.0,No,No,Diabetes,3.0
PT02496,Austria,Styria,53.0,Male,Lung,IV,2013-05-01,2013-07-09,2013-12-23,Radiation,Public,Deceased,53.0,KRAS,No,Former,Heavy,20.5,Medium,Urban,Private Insurance,19.0,No,No,Hypertension,1.0
PT02497,Spain,Catalonia,24.0,Male,Ovarian,IV,2018-02-03,2018-06-27,2018-12-13,Surgery,Public,Alive,104.0,None,No,Never,None,,Low,Urban,Statutory Health Insurance,10.0,,Yes,None,
PT02498,Portugal,Lisbon,79.0,Male,Colorectal,II,2021-01-05,2021-03-02,2021-12-19,Surgery,Public,Alive,59.0,EGFR,Yes,Current,None,36.4,Medium,Urban,NHS,17.0,No,No,Hypertension,
PT02499,Sweden,,62.0,Female,Breast,II,2018-02-01,2018-03-14,2018-07-09,Surgery,Research Institute,Alive,31.0,KRAS,No,Former,None,27.3,Medium,Rural,NHS,12.0,No,No,Cardiovascular Disease,8.0
PT02500,Belgium,Brussels,76.0,Female,Breast,III,2019-10-11,,2020-06-29,Chemotherapy,Public,Alive,15.0,BRCA1,No,Current,Moderate,35.1,High,Urban,NHS,8.0,No,No,Hypertension,4.0
PT02501,Spain,Andalusia,76.0,Female,Lung,I,2012-12-24,2013-01-01,2013-12-27,Surgery,Private,Alive,,None,No,Never,Moderate,29.2,Medium,Rural,Statutory Health Insurance,5.0,No,No,Diabetes,6.0
PT02502,Switzerland,Zurich,73.0,Female,Colorectal,III,2010-11-13,2011-01-06,2011-11-07,Targeted Therapy,Research Institute,Alive,84.0,BRCA1,Yes,Never,Moderate,18.4,,Rural,,9.0,Yes,No,Diabetes,1.0
PT02503,Italy,Sicily,64.0,Female,Prostate,II,2020-06-15,2020-09-13,2021-02-09,Targeted Therapy,Research Institute,Alive,87.0,BRCA1,No,Never,Heavy,18.3,Medium,Rural,Private Insurance,3.0,No,No,Hypertension,9.0
PT02504,Norway,Oslo,56.0,Female,Prostate,III,2022-06-21,,2023-10-04,Surgery,Private,Deceased,73.0,,Yes,Current,Moderate,28.4,High,Urban,Private Insurance,3.0,No,No,None,4.0
PT02505,Italy,Sicily,67.0,Female,Breast,I,2011-01-30,2011-06-12,2011-12-22,Surgery,Public,Deceased,96.0,BRCA1,Yes,Former,None,,Low,Urban,Private Insurance,7.0,No,No,None,3.0
PT02506,Poland,Silesian,73.0,Male,Ovarian,II,2014-04-23,2014-05-02,2015-04-22,Radiation,,Lost to Follow-up,,KRAS,No,Current,Moderate,36.1,Medium,Rural,Statutory Health Insurance,18.0,No,No,None,5.0
PT02507,Netherlands,South Holland,67.0,,Ovarian,II,2020-10-28,2021-01-07,2021-06-23,Radiation,Private,,114.0,None,Yes,Former,None,31.0,Low,Rural,Private Insurance,8.0,No,No,None,2.0
PT02508,Norway,Vestland,25.0,Female,Lung,III,2012-11-28,2012-12-28,2013-09-14,Immunotherapy,Public,Deceased,74.0,BRCA1,No,Never,None,31.0,Medium,Urban,Private Insurance,13.0,Yes,No,Diabetes,2.0
PT02509,Norway,Trøndelag,53.0,Male,Colorectal,III,2016-01-06,2016-03-27,2017-02-19,Chemotherapy,Public,Deceased,75.0,None,No,Never,Moderate,39.9,Low,Urban,Private Insurance,9.0,No,No,None,8.0
PT02510,Ireland,Connacht,82.0,Female,Colorectal,IV,,2016-12-06,2017-07-25,Chemotherapy,Public,Deceased,15.0,KRAS,Yes,Never,None,18.0,Low,Urban,Statutory Health Insurance,10.0,Yes,No,,9.0
PT02511,Sweden,Stockholm,67.0,Male,Prostate,IV,2016-08-10,2016-11-13,2017-03-12,Radiation,Public,Alive,24.0,BRCA1,No,Current,Moderate,25.7,Low,Urban,Statutory Health Insurance,10.0,No,Yes,Hypertension,6.0
PT02512,France,Provence-Alpes-Côte d'Azur,42.0,Female,Prostate,II,2022-06-18,2022-08-22,2023-05-11,Targeted Therapy,Private,Alive,119.0,BRCA1,No,Never,None,38.4,Low,Urban,NHS,10.0,No,No,Obesity,4.0
PT02513,Austria,Tyrol,32.0,Non-binary,Ovarian,,2021-12-20,,2022-05-02,Immunotherapy,Public,Alive,81.0,BRCA1,No,Former,,26.4,Medium,Rural,NHS,13.0,Yes,No,Obesity,5.0
PT02514,Ireland,Munster,66.0,Male,Leukemia,III,2019-10-22,2019-12-08,2020-10-21,Radiation,Public,Deceased,64.0,KRAS,No,Former,,23.3,Medium,Rural,Private Insurance,16.0,No,No,None,5.0
PT02515,Germany,Bavaria,63.0,Female,Leukemia,IV,2021-08-29,2021-12-02,2022-06-14,Immunotherapy,Public,,29.0,BRCA1,Yes,Never,Heavy,27.6,Low,Rural,Statutory Health Insurance,14.0,No,No,None,4.0
PT02516,Norway,Vestland,51.0,Male,Lung,I,2014-07-01,2014-09-27,2015-03-16,Chemotherapy,Private,Alive,85.0,None,No,Never,Heavy,34.9,Low,Rural,NHS,10.0,No,No,Obesity,3.0
PT02517,Finland,Uusimaa,45.0,Male,Leukemia,,2023-05-28,2023-11-03,2024-02-28,Chemotherapy,Private,Alive,78.0,EGFR,No,Former,None,,Medium,Rural,Statutory Health Insurance,4.0,No,No,None,1.0
PT02518,Italy,Sicily,72.0,Male,Colorectal,I,2021-09-15,2021-11-29,2022-10-17,Chemotherapy,Public,Deceased,82.0,BRCA1,No,Never,None,25.3,Low,Urban,Statutory Health Insurance,10.0,No,No,None,2.0
PT02519,Poland,Masovian,33.0,,Leukemia,I,,2014-07-07,2014-08-24,,Public,Deceased,23.0,None,No,Former,None,20.6,High,Urban,,14.0,,No,Hypertension,2.0
PT02520,,Sicily,,Male,Breast,III,2017-12-09,2018-02-27,2019-02-13,Radiation,Public,Alive,37.0,None,No,,None,39.2,Medium,Rural,NHS,12.0,No,No,Diabetes,9.0
PT02521,Norway,Vestland,55.0,Female,Breast,III,,2015-12-12,2016-02-09,Immunotherapy,Public,Alive,113.0,BRCA1,Yes,Former,Heavy,23.1,High,Rural,Statutory Health Insurance,15.0,No,No,Obesity,5.0
PT02522,Ireland,Dublin,27.0,Male,Pancreatic,III,2014-01-18,,2014-11-18,Radiation,Research Institute,Alive,24.0,BRCA1,Yes,Never,Moderate,38.4,Low,Urban,Private Insurance,,No,No,None,8.0
PT02523,Germany,Bavaria,59.0,,Prostate,IV,2012-10-08,2013-01-13,2013-10-21,Chemotherapy,Public,Deceased,43.0,BRCA1,Yes,Never,None,26.9,Medium,Rural,NHS,,No,No,Diabetes,7.0
PT02524,Ireland,Connacht,41.0,Female,Prostate,I,2013-12-02,2013-12-08,2014-06-23,,Private,Alive,26.0,BRCA1,No,Former,Heavy,39.7,High,Urban,Private Insurance,15.0,No,No,Cardiovascular Disease,1.0
PT02525,Norway,Trøndelag,35.0,Male,Ovarian,I,2018-12-01,2019-01-15,2019-07-06,Radiation,Public,Alive,61.0,BRCA1,No,Never,Moderate,23.5,Low,Urban,,,Yes,Yes,None,2.0
PT02526,Switzerland,Geneva,,Male,Lung,,2011-04-02,2011-06-06,2012-01-19,Surgery,Public,Alive,90.0,KRAS,No,Former,Heavy,32.7,Medium,Urban,Private Insurance,19.0,No,No,None,6.0
PT02527,Norway,Trøndelag,79.0,Male,Breast,II,2023-09-20,2023-10-27,2024-02-18,Surgery,Private,,62.0,KRAS,No,Current,Moderate,36.0,High,Urban,Statutory Health Insurance,10.0,No,No,Obesity,1.0
PT02528,Netherlands,South Holland,29.0,Female,Pancreatic,I,,2018-08-21,2019-01-01,Radiation,,Alive,54.0,EGFR,Yes,Former,None,26.9,Low,Rural,NHS,16.0,No,No,Hypertension,7.0
PT02529,France,Provence-Alpes-Côte d'Azur,44.0,Female,Lung,III,2021-02-03,,2021-11-22,Chemotherapy,Private,Deceased,11.0,None,Yes,Never,None,21.2,High,Urban,Private Insurance,9.0,No,Yes,Cardiovascular Disease,4.0
PT02530,Sweden,Skåne,50.0,Male,Lung,IV,2019-10-17,2020-01-27,2020-04-03,Immunotherapy,,Alive,60.0,None,Yes,Never,None,20.1,High,Rural,Private Insurance,18.0,No,No,None,9.0
PT02531,Sweden,Västra Götaland,40.0,Male,Ovarian,III,2016-04-11,2016-07-30,2017-01-11,Surgery,Private,Alive,7.0,None,Yes,Never,Moderate,23.0,Low,Urban,Private Insurance,3.0,No,Yes,None,8.0
,Portugal,Lisbon,52.0,Male,Leukemia,III,2023-05-12,2023-10-12,2024-01-25,Radiation,Private,Alive,11.0,EGFR,Yes,Former,Moderate,19.2,,Urban,Private Insurance,7.0,No,Yes,None,1.0
,Austria,Vienna,50.0,Male,Prostate,I,2013-02-12,2013-04-03,2014-02-21,Targeted Therapy,Private,Alive,86.0,KRAS,No,Never,Moderate,37.1,Low,Rural,NHS,6.0,No,No,Obesity,8.0
PT02534,Switzerland,Bern,40.0,Female,Lung,I,2016-12-20,2017-04-22,2018-04-02,Radiation,Public,Alive,35.0,EGFR,Yes,Current,Heavy,33.5,Medium,Rural,Statutory Health Insurance,6.0,No,No,Obesity,5.0
PT02535,Spain,Andalusia,55.0,Female,Lung,IV,2013-09-22,2013-12-02,2014-04-19,Chemotherapy,Research Institute,Deceased,119.0,BRCA1,No,Former,Heavy,32.3,Medium,Urban,Statutory Health Insurance,,Yes,No,None,5.0
PT02536,Poland,Silesian,84.0,Female,Prostate,III,2018-09-26,2019-01-15,2019-04-10,Radiation,Public,Alive,60.0,KRAS,No,Former,None,33.3,Medium,Urban,Private Insurance,17.0,No,Yes,Obesity,8.0
PT02537,Sweden,,23.0,Male,Ovarian,I,2010-02-25,2010-03-28,2010-05-14,Surgery,,Lost to Follow-up,,BRCA1,Yes,Former,None,32.0,Medium,Urban,Private Insurance,7.0,No,No,Obesity,8.0
PT02538,Italy,Lombardy,87.0,Female,Prostate,II,,2022-10-24,2023-03-06,Surgery,,,16.0,EGFR,No,Never,None,18.8,Medium,Urban,Statutory Health Insurance,18.0,No,No,,3.0
PT02539,Belgium,Brussels,23.0,Female,Breast,III,2018-09-27,2019-01-20,2019-07-17,Radiation,Public,Deceased,,None,Yes,Current,Heavy,30.7,Medium,Urban,Private Insurance,,No,No,Diabetes,8.0
PT02540,Ireland,Dublin,28.0,Female,,I,2021-05-08,2021-06-25,2022-02-28,Immunotherapy,Private,Deceased,40.0,BRCA1,No,Never,Heavy,27.1,Low,Urban,,6.0,No,No,Diabetes,3.0
PT02541,France,Provence-Alpes-Côte d'Azur,49.0,Female,Leukemia,III,2019-05-30,2019-10-22,2019-11-26,Radiation,Private,Alive,78.0,EGFR,No,Never,Heavy,21.5,Medium,Urban,Private Insurance,1.0,No,Yes,Cardiovascular Disease,9.0
PT02542,France,Provence-Alpes-Côte d'Azur,64.0,Female,Breast,I,,2015-07-10,2016-01-14,Immunotherapy,Private,Deceased,94.0,KRAS,Yes,Never,None,,High,Rural,Statutory Health Insurance,5.0,No,,None,5.0
PT02543,Belgium,Wallonia,23.0,Female,Ovarian,II,2015-10-31,2016-04-09,2016-08-14,Surgery,Public,Alive,114.0,BRCA1,Yes,Never,Moderate,,Medium,Urban,Statutory Health Insurance,18.0,No,No,Cardiovascular Disease,9.0
PT02544,Austria,Tyrol,88.0,Male,Pancreatic,III,2023-08-18,2024-01-12,2025-01-02,Targeted Therapy,Public,Alive,13.0,KRAS,No,Never,None,23.6,High,Urban,Statutory Health Insurance,,No,No,Cardiovascular Disease,
PT02545,Italy,Sicily,42.0,Female,Lung,,2010-08-26,2010-09-10,2011-06-17,Immunotherapy,Public,Alive,,EGFR,Yes,Never,None,34.1,High,Urban,Private Insurance,18.0,No,No,Hypertension,5.0
PT02546,Spain,Catalonia,35.0,Male,Leukemia,I,2018-04-28,2018-10-08,2019-01-06,Radiation,Public,Deceased,95.0,BRCA1,No,Never,None,19.3,High,Urban,Private Insurance,12.0,No,No,Obesity,10.0
PT02547,Finland,Pirkanmaa,41.0,Female,,IV,2011-01-24,2011-07-20,2011-10-25,Chemotherapy,Public,Alive,107.0,,No,,Moderate,26.0,Low,Rural,Private Insurance,8.0,No,No,Cardiovascular Disease,9.0
PT02548,Austria,Tyrol,67.0,Female,Breast,III,2019-04-30,2019-10-11,2020-07-19,Chemotherapy,Research Institute,Alive,91.0,BRCA1,No,Never,None,24.1,Medium,Urban,Private Insurance,7.0,No,No,Hypertension,1.0
PT02549,Belgium,Brussels,,Female,Lung,,2011-11-16,2012-01-09,2012-12-20,Radiation,Public,Alive,29.0,BRCA1,Yes,Never,None,20.7,High,Urban,NHS,4.0,Yes,No,Obesity,7.0
PT02550,Netherlands,South Holland,79.0,Male,Breast,I,2020-11-27,2021-01-02,2021-05-23,Surgery,Public,Alive,26.0,EGFR,Yes,Never,Moderate,20.9,Medium,Urban,NHS,3.0,No,No,Hypertension,3.0
PT02551,Austria,Vienna,24.0,Male,Colorectal,II,2010-07-06,2010-08-28,2010-10-13,Surgery,Private,Alive,21.0,KRAS,No,Never,Heavy,22.7,Medium,Urban,Private Insurance,9.0,No,No,Hypertension,1.0
PT02552,Italy,Sicily,26.0,Male,Colorectal,II,2017-07-06,2017-09-18,2018-03-23,Surgery,Private,Alive,,None,Yes,Current,Moderate,18.4,Low,Urban,NHS,7.0,No,No,Diabetes,1.0
PT02553,Portugal,Lisbon,70.0,Female,Breast,I,2019-05-22,2019-07-05,2019-10-09,Radiation,Private,Alive,41.0,BRCA1,,Never,Moderate,31.1,Medium,Urban,NHS,8.0,No,Yes,Hypertension,3.0
PT02554,Denmark,,84.0,Female,Lung,II,2016-08-07,2016-09-09,2017-08-19,Chemotherapy,Private,,15.0,KRAS,Yes,Current,None,29.2,Low,Urban,Statutory Health Insurance,15.0,No,,Obesity,5.0
PT02555,Italy,Veneto,28.0,Female,Ovarian,II,2018-11-09,2019-04-30,2019-06-01,Targeted Therapy,Public,Alive,71.0,KRAS,No,Never,Moderate,36.9,Low,Rural,Statutory Health Insurance,6.0,Yes,Yes,Hypertension,8.0
PT02556,Germany,Berlin,64.0,Male,Lung,II,2019-04-12,2019-06-06,2019-10-16,Chemotherapy,Public,Alive,102.0,KRAS,Yes,Former,None,35.5,Medium,Urban,NHS,12.0,No,No,Hypertension,5.0
PT02557,,Silesian,,Female,Prostate,I,2023-11-18,2024-01-01,2024-07-03,Surgery,Public,,96.0,KRAS,No,Former,Moderate,39.5,Low,Urban,NHS,13.0,No,No,,5.0
PT02558,Germany,North Rhine-Westphalia,,Non-binary,Ovarian,I,2018-01-13,2018-03-05,2018-04-04,Radiation,Public,Deceased,22.0,BRCA1,No,Never,None,18.5,High,Rural,Statutory Health Insurance,,,Yes,Hypertension,10.0
PT02559,Switzerland,Bern,43.0,Male,,IV,2023-11-27,2024-03-05,2025-03-04,,,Alive,80.0,None,No,Never,None,29.0,Low,Urban,Private Insurance,11.0,No,No,Hypertension,8.0
PT02560,France,Île-de-France,29.0,Female,Breast,IV,2021-12-20,2022-03-16,2023-03-14,Targeted Therapy,Private,Alive,,None,,Never,Moderate,21.7,Medium,Urban,NHS,7.0,No,No,Cardiovascular Disease,2.0
PT02561,Poland,Lesser Poland,67.0,Female,Ovarian,II,2023-06-22,2023-08-12,2023-09-14,Chemotherapy,Private,Deceased,62.0,KRAS,Yes,Never,Moderate,28.3,Low,Urban,Statutory Health Insurance,12.0,No,No,Hypertension,10.0
PT02562,Portugal,Porto,54.0,Female,Leukemia,III,2020-11-13,2021-03-28,2021-11-15,Surgery,Public,Alive,15.0,BRCA1,No,Never,None,22.0,Medium,Urban,Private Insurance,8.0,No,No,Cardiovascular Disease,4.0
PT02563,Portugal,Porto,73.0,Non-binary,Ovarian,,2020-12-08,2021-04-16,2021-06-17,Targeted Therapy,Public,Alive,80.0,None,No,Former,None,19.6,High,Rural,Statutory Health Insurance,14.0,No,No,None,6.0
,Denmark,Capital Region,35.0,Male,Leukemia,I,2022-07-09,2022-11-27,2023-01-06,Surgery,Public,Alive,84.0,KRAS,No,,Moderate,36.3,Medium,Urban,NHS,16.0,No,No,None,
PT02565,Spain,Catalonia,72.0,Female,Colorectal,I,2018-11-24,2019-01-11,2019-09-01,Chemotherapy,Public,Lost to Follow-up,,,Yes,Current,Moderate,27.5,Medium,Rural,NHS,,No,No,Hypertension,7.0
PT02566,Sweden,Västra Götaland,59.0,Female,Colorectal,II,,2017-11-18,2018-07-12,Targeted Therapy,Private,Alive,71.0,EGFR,No,Never,,33.1,Medium,Urban,Statutory Health Insurance,14.0,No,No,Obesity,10.0
PT02567,Switzerland,Bern,39.0,Female,Pancreatic,II,2014-04-25,2014-08-17,2015-03-19,Surgery,Public,Alive,22.0,EGFR,No,Former,Moderate,20.5,Medium,Rural,NHS,5.0,No,No,Diabetes,7.0
PT02568,Spain,Madrid,88.0,Female,Ovarian,II,2013-06-13,2013-09-05,2014-03-07,Immunotherapy,Private,Alive,80.0,EGFR,Yes,Never,None,30.7,Medium,Urban,Private Insurance,19.0,No,No,Cardiovascular Disease,4.0
PT02569,Denmark,Central Denmark,64.0,Non-binary,Ovarian,IV,2012-11-22,2013-05-16,2013-12-13,Radiation,Public,Alive,112.0,BRCA1,Yes,Current,None,36.2,Low,Rural,Private Insurance,8.0,No,No,Hypertension,3.0
PT02570,Portugal,Lisbon,25.0,Female,Breast,III,2011-06-29,2011-08-15,2012-02-15,Chemotherapy,Private,Alive,107.0,,Yes,Former,,37.6,Low,Rural,,14.0,No,No,Obesity,8.0
PT02571,Germany,Berlin,88.0,Female,Pancreatic,IV,2010-11-26,2010-12-06,2011-08-20,,Public,Alive,37.0,None,No,Current,,24.7,Medium,,NHS,4.0,No,Yes,,1.0
PT02572,Poland,Masovian,68.0,Male,Breast,IV,2015-12-10,2016-01-05,2016-05-15,Surgery,Public,Alive,74.0,None,Yes,Never,Moderate,38.1,Medium,Urban,Private Insurance,8.0,No,No,Obesity,1.0
PT02573,Austria,Tyrol,58.0,Male,Lung,III,2014-04-28,2014-06-17,2015-01-14,Targeted Therapy,Private,Alive,23.0,,Yes,Never,Moderate,,Low,Rural,Statutory Health Insurance,18.0,Yes,No,Diabetes,5.0
PT02574,Austria,Vienna,21.0,Male,,II,2018-03-26,2018-09-17,2019-07-01,Surgery,Public,Deceased,51.0,KRAS,No,Never,,23.4,Low,Urban,Private Insurance,10.0,No,No,Diabetes,8.0
,Netherlands,North Holland,58.0,Female,Ovarian,I,2016-11-28,2017-05-19,2018-03-09,Immunotherapy,Private,Alive,106.0,BRCA1,Yes,Former,Heavy,30.1,High,Urban,,4.0,No,No,Hypertension,2.0
PT02576,Austria,Tyrol,40.0,Non-binary,Lung,II,2017-08-21,2017-12-28,2018-04-08,Immunotherapy,Public,Alive,117.0,BRCA1,No,Current,Moderate,33.1,Low,Rural,Private Insurance,15.0,No,,None,3.0
PT02577,Austria,Tyrol,59.0,Male,Lung,III,2021-07-24,2021-11-10,2022-10-25,Chemotherapy,Private,Alive,51.0,BRCA1,,Never,,19.8,High,Rural,Statutory Health Insurance,7.0,No,No,Obesity,7.0
PT02578,Switzerland,Zurich,73.0,Male,Breast,II,2017-12-25,2018-02-26,2018-11-23,Radiation,Private,Alive,119.0,None,Yes,Former,None,33.3,Medium,,Statutory Health Insurance,17.0,No,No,Obesity,4.0
PT02579,Spain,Andalusia,31.0,Female,Lung,III,2014-11-08,2015-04-02,2015-08-24,Surgery,Private,Alive,7.0,EGFR,No,Never,Heavy,34.7,High,Rural,NHS,7.0,No,No,Hypertension,7.0
,Spain,Catalonia,56.0,Female,Leukemia,IV,2015-11-09,2016-04-02,2016-07-05,Immunotherapy,Public,Alive,108.0,BRCA1,Yes,Never,,27.5,Medium,Urban,NHS,13.0,No,No,Cardiovascular Disease,5.0
PT02581,Poland,Silesian,57.0,Female,Lung,II,2015-05-11,2015-10-25,2016-08-26,Targeted Therapy,Public,Alive,32.0,EGFR,No,Current,None,37.7,Low,Rural,Private Insurance,13.0,No,Yes,None,6.0
PT02582,Netherlands,South Holland,34.0,Male,Leukemia,II,2015-09-04,2015-10-17,2016-04-06,Surgery,Public,Deceased,13.0,None,No,Former,Moderate,22.9,High,Rural,NHS,18.0,No,No,Obesity,1.0
PT02583,Portugal,Lisbon,26.0,Male,Leukemia,III,2016-07-24,2016-09-03,2017-05-07,Chemotherapy,Public,Deceased,112.0,KRAS,Yes,,Moderate,22.2,Medium,Urban,NHS,3.0,Yes,No,Diabetes,7.0
PT02584,Netherlands,Utrecht,69.0,,Leukemia,I,2017-09-16,2017-10-01,2018-04-15,Targeted Therapy,Public,Alive,97.0,BRCA1,No,Former,,31.8,Medium,Urban,Statutory Health Insurance,7.0,Yes,No,Hypertension,2.0
,Italy,Veneto,84.0,Male,Prostate,I,2012-05-22,2012-09-28,2012-11-12,Radiation,Public,Alive,33.0,EGFR,Yes,Current,Moderate,28.1,Medium,Urban,Private Insurance,11.0,No,No,Obesity,10.0
PT02586,Denmark,Capital Region,86.0,Male,Pancreatic,III,2021-11-20,2022-01-17,2022-03-22,Chemotherapy,,Alive,61.0,None,No,Former,Moderate,27.2,Medium,Urban,NHS,6.0,No,No,None,10.0
PT02587,Portugal,Lisbon,63.0,Male,Ovarian,III,2010-09-14,2010-11-07,2011-09-11,Radiation,Public,Alive,54.0,None,Yes,Former,None,31.8,Low,,NHS,4.0,Yes,No,Cardiovascular Disease,5.0
PT02588,Poland,Lesser Poland,50.0,Male,Prostate,II,2023-06-19,2023-10-30,2024-04-16,Radiation,Private,Alive,74.0,EGFR,No,Former,Moderate,26.0,Low,Rural,NHS,9.0,No,No,Diabetes,8.0
PT02589,Denmark,Capital Region,62.0,Male,Ovarian,IV,2021-01-15,2021-03-18,2021-12-12,Immunotherapy,Public,Alive,99.0,EGFR,No,Former,,39.1,Medium,Urban,Statutory Health Insurance,4.0,No,No,Obesity,2.0
PT02590,Norway,Oslo,67.0,Female,,II,2023-05-18,2023-09-22,2024-08-24,Radiation,Research Institute,Alive,112.0,EGFR,No,Current,None,37.8,Low,Rural,NHS,13.0,No,No,Obesity,9.0
PT02591,Belgium,Wallonia,80.0,Male,Lung,III,2018-12-05,2019-02-14,2019-12-15,Targeted Therapy,Public,,96.0,None,No,Never,None,24.8,Medium,Urban,Statutory Health Insurance,9.0,No,No,Hypertension,1.0
PT02592,Sweden,Skåne,29.0,Male,Pancreatic,III,2011-11-25,2012-01-10,2012-06-02,Targeted Therapy,Public,Alive,32.0,KRAS,No,Never,None,22.2,Medium,Urban,Private Insurance,1.0,No,No,Diabetes,7.0
PT02593,Sweden,Västra Götaland,48.0,Female,Ovarian,I,2023-03-28,2023-06-26,2023-10-20,Targeted Therapy,Public,Deceased,94.0,BRCA1,No,Former,Moderate,21.9,Medium,Urban,Statutory Health Insurance,15.0,No,No,Cardiovascular Disease,5.0
PT02594,Ireland,Munster,67.0,Female,Pancreatic,I,2021-01-20,2021-06-25,2021-12-10,Surgery,Private,Alive,32.0,EGFR,No,Former,None,35.1,Low,Urban,NHS,18.0,No,No,None,3.0
PT02595,Austria,Tyrol,81.0,Female,Pancreatic,IV,2023-03-08,2023-07-08,2023-09-18,Immunotherapy,Public,Alive,17.0,None,No,Never,Moderate,31.3,Medium,,Private Insurance,16.0,No,No,Obesity,8.0
PT02596,Sweden,,32.0,Female,,I,2011-07-10,2011-10-02,2012-01-08,Immunotherapy,Public,Alive,9.0,BRCA1,No,Never,Moderate,29.9,Medium,Urban,Private Insurance,4.0,No,No,Cardiovascular Disease,10.0
PT02597,Switzerland,Geneva,63.0,Female,Lung,I,,2021-04-18,2021-10-29,Targeted Therapy,Public,Alive,,None,No,Never,None,32.4,High,Urban,NHS,13.0,No,No,Diabetes,4.0
PT02598,Austria,Tyrol,66.0,Female,Prostate,II,2013-07-01,2013-11-29,2014-05-30,Surgery,Private,,62.0,None,No,Former,Moderate,34.2,Medium,Rural,Private Insurance,3.0,No,No,None,4.0
PT02599,Belgium,Wallonia,83.0,Female,Pancreatic,I,2021-07-11,,2022-06-17,Radiation,Public,Deceased,,EGFR,No,Former,Heavy,23.0,Medium,Urban,Private Insurance,4.0,No,No,Obesity,8.0
PT02600,Finland,Southwest Finland,72.0,Female,Ovarian,IV,2012-08-05,2013-01-19,2013-06-03,Radiation,Public,Alive,,EGFR,No,Never,Moderate,39.6,Low,Urban,Statutory Health Insurance,7.0,No,No,Diabetes,9.0
PT02601,Spain,Madrid,63.0,Female,Pancreatic,I,2022-07-17,2022-10-07,2023-08-22,Radiation,Research Institute,Deceased,29.0,EGFR,Yes,Never,None,25.8,Medium,Urban,NHS,18.0,No,No,Cardiovascular Disease,1.0
PT02602,Portugal,Porto,47.0,Male,,III,2021-12-22,2022-01-24,2022-05-12,Immunotherapy,Public,,41.0,EGFR,,Never,Moderate,19.7,,Rural,NHS,4.0,No,No,Obesity,8.0
PT02603,Netherlands,Utrecht,21.0,Female,Colorectal,II,2011-02-02,2011-05-02,2011-09-19,Radiation,Public,Alive,58.0,EGFR,No,Never,Moderate,36.4,Medium,Rural,NHS,5.0,No,No,Obesity,9.0
PT02604,Sweden,Västra Götaland,76.0,Female,Pancreatic,III,2010-08-10,2011-01-17,2011-11-10,Surgery,Public,,,BRCA1,Yes,Never,Moderate,29.7,Medium,Rural,Private Insurance,18.0,No,No,None,4.0
PT02605,Poland,Masovian,76.0,,Pancreatic,II,2016-06-23,2016-10-15,2017-04-10,Surgery,Public,Alive,22.0,KRAS,Yes,Never,Moderate,18.4,Low,Urban,Statutory Health Insurance,1.0,Yes,No,Diabetes,4.0
PT02606,Sweden,Västra Götaland,53.0,Male,Colorectal,II,,2015-01-02,2016-01-01,Radiation,Public,Deceased,37.0,BRCA1,,Never,None,31.4,Low,Urban,,15.0,No,No,Diabetes,6.0
PT02607,Italy,Sicily,77.0,Male,Lung,IV,2021-02-12,2021-08-10,2022-07-22,Immunotherapy,Public,Deceased,59.0,BRCA1,No,Current,None,31.6,High,Urban,Statutory Health Insurance,7.0,No,No,Diabetes,5.0
PT02608,Portugal,Lisbon,71.0,Female,Prostate,I,2020-10-29,2020-11-17,2021-02-25,Chemotherapy,Private,Alive,65.0,None,,Former,Moderate,,Low,Urban,Private Insurance,13.0,No,No,Cardiovascular Disease,10.0
PT02609,Italy,Lombardy,48.0,Male,Leukemia,II,2019-08-24,2019-08-27,2020-05-23,Targeted Therapy,Public,Deceased,60.0,BRCA1,Yes,Former,Heavy,31.1,Medium,Urban,Statutory Health Insurance,11.0,No,No,Diabetes,5.0
PT02610,Norway,Vestland,54.0,Female,Prostate,IV,,2022-06-21,,,Private,Alive,,EGFR,Yes,Never,Heavy,23.9,,Rural,NHS,5.0,Yes,No,Obesity,8.0
PT02611,Ireland,Munster,67.0,Female,Lung,III,2012-02-14,2012-05-15,2012-11-10,Radiation,Public,Alive,114.0,BRCA1,No,Current,None,40.0,Medium,Urban,NHS,18.0,No,No,Obesity,9.0
PT02612,Austria,Tyrol,,Female,Prostate,III,2010-12-06,2011-04-30,2011-08-10,Targeted Therapy,Research Institute,Alive,67.0,KRAS,Yes,Former,Moderate,28.3,Low,Rural,,,No,Yes,None,2.0
PT02613,Spain,Andalusia,,Female,Colorectal,I,2010-01-07,2010-02-19,2010-04-06,Chemotherapy,Public,Alive,64.0,EGFR,No,Never,,26.5,Medium,Urban,Private Insurance,13.0,No,No,Hypertension,2.0
PT02614,Norway,Oslo,67.0,Female,Pancreatic,I,2013-07-20,2013-12-24,2014-04-29,Radiation,Private,Deceased,81.0,,No,Never,None,18.1,Medium,Urban,Statutory Health Insurance,12.0,Yes,No,Cardiovascular Disease,2.0
PT02615,Norway,Oslo,86.0,Female,Pancreatic,I,2010-10-15,2011-01-31,2011-11-14,Radiation,Private,Alive,11.0,BRCA1,Yes,Never,None,30.5,,Rural,Statutory Health Insurance,5.0,No,No,Diabetes,8.0
PT02616,Ireland,Dublin,55.0,,Leukemia,IV,2012-06-11,2012-07-25,2013-05-13,Chemotherapy,Public,Alive,37.0,None,,Former,Heavy,28.7,Low,Rural,Private Insurance,4.0,No,Yes,Cardiovascular Disease,4.0
PT02617,Denmark,Capital Region,63.0,Female,Lung,IV,2011-12-18,2012-02-08,2012-10-17,Targeted Therapy,Private,Alive,7.0,KRAS,,Former,Heavy,38.8,Medium,,Private Insurance,8.0,No,No,Obesity,1.0
PT02618,,Oslo,79.0,Non-binary,Pancreatic,II,2021-09-19,2021-12-25,2022-02-06,Surgery,Public,,21.0,None,Yes,Current,None,25.0,Medium,Rural,NHS,11.0,No,No,Hypertension,1.0
PT02619,Belgium,Brussels,82.0,Female,Lung,I,2015-01-28,2015-02-25,2015-12-11,Radiation,Public,Deceased,114.0,KRAS,No,Former,Moderate,32.9,Low,Urban,Statutory Health Insurance,17.0,No,No,Cardiovascular Disease,4.0
PT02620,Belgium,Flanders,24.0,Non-binary,Breast,I,2011-07-24,2011-11-10,2012-05-30,Radiation,Private,Deceased,60.0,BRCA1,No,Never,Moderate,31.9,Medium,Urban,NHS,12.0,No,No,,6.0
PT02621,Poland,Masovian,59.0,Male,Ovarian,II,2022-12-02,2023-05-13,2023-12-19,Immunotherapy,Public,Deceased,96.0,BRCA1,No,Former,None,35.4,Medium,Urban,NHS,,No,No,Hypertension,3.0
PT02622,Netherlands,,38.0,Male,Leukemia,II,2011-10-05,2011-11-28,2012-09-18,Chemotherapy,Private,Alive,73.0,EGFR,Yes,Never,None,35.5,High,Rural,Statutory Health Insurance,11.0,Yes,No,Hypertension,5.0
PT02623,Germany,,66.0,Male,Ovarian,III,2020-01-21,2020-01-23,2020-04-06,Radiation,Public,Alive,33.0,,Yes,Former,None,18.1,High,Rural,Private Insurance,12.0,No,,Diabetes,2.0
PT02624,,Flanders,84.0,Male,Lung,IV,2021-03-04,2021-06-26,2022-02-26,Immunotherapy,Private,Alive,85.0,EGFR,Yes,,Moderate,37.1,Medium,Urban,Statutory Health Insurance,10.0,No,No,Hypertension,9.0
PT02625,Sweden,Västra Götaland,86.0,Female,Prostate,III,2019-02-11,2019-02-28,2020-01-23,Surgery,Research Institute,Alive,28.0,EGFR,No,Current,None,20.6,Medium,Rural,Statutory Health Insurance,17.0,Yes,No,Hypertension,5.0
PT02626,Poland,Silesian,37.0,Male,Prostate,III,2016-12-26,2017-05-21,2017-12-19,Chemotherapy,Public,,52.0,BRCA1,No,Never,Moderate,19.2,Low,Rural,NHS,6.0,No,No,Hypertension,2.0
PT02627,Denmark,Central Denmark,69.0,Non-binary,Prostate,III,2010-04-20,2010-05-18,2010-11-09,Surgery,Public,,114.0,KRAS,Yes,Never,None,,Medium,Urban,NHS,,No,Yes,Hypertension,6.0
PT02628,Austria,,49.0,Male,Prostate,III,2019-12-30,2020-01-27,2020-03-07,Immunotherapy,Public,Alive,15.0,,Yes,Never,Moderate,,Medium,Urban,Statutory Health Insurance,2.0,No,No,Cardiovascular Disease,10.0
PT02629,Poland,Silesian,85.0,Male,Lung,II,2018-10-25,2018-11-10,2019-08-08,Targeted Therapy,Private,Alive,66.0,KRAS,No,Former,None,19.0,,Urban,Statutory Health Insurance,5.0,No,Yes,Diabetes,7.0
PT02630,Norway,Vestland,24.0,,Colorectal,II,2012-01-02,,2013-01-08,Chemotherapy,Public,Deceased,87.0,BRCA1,No,Never,None,23.3,Medium,Urban,Statutory Health Insurance,6.0,Yes,No,None,1.0
PT02631,Norway,Trøndelag,61.0,Female,Leukemia,I,2021-10-19,2022-01-12,2022-06-19,Targeted Therapy,Public,Deceased,104.0,EGFR,No,Never,Moderate,29.5,Low,Urban,Statutory Health Insurance,8.0,Yes,,None,7.0
,Ireland,Munster,24.0,Male,Prostate,III,2018-05-02,2018-05-07,2018-07-28,Immunotherapy,Public,Deceased,58.0,KRAS,No,Former,Moderate,37.1,Low,Urban,NHS,12.0,No,No,Diabetes,7.0
PT02633,Poland,Masovian,69.0,Male,Lung,IV,2011-07-22,2011-09-05,2012-04-29,Chemotherapy,Public,Alive,73.0,None,No,Current,None,,Medium,Urban,Statutory Health Insurance,8.0,No,No,None,9.0
PT02634,Norway,Oslo,,Female,Pancreatic,II,2018-05-07,2018-10-19,2019-06-11,Radiation,Public,Alive,90.0,None,No,Former,Moderate,28.0,Medium,Urban,Private Insurance,2.0,No,No,Diabetes,7.0
PT02635,Ireland,Dublin,27.0,Male,Pancreatic,IV,2017-11-11,2018-01-02,2018-03-05,Immunotherapy,Private,Deceased,64.0,BRCA1,No,Never,Moderate,31.0,Low,Urban,Statutory Health Insurance,13.0,No,No,Obesity,9.0
PT02636,Finland,Uusimaa,50.0,Male,Lung,I,2013-09-19,2013-11-20,2014-03-12,Immunotherapy,,Alive,95.0,KRAS,No,Never,Moderate,,Low,Urban,NHS,6.0,No,,Hypertension,8.0
PT02637,Austria,Styria,31.0,Female,Prostate,III,2023-07-14,2023-07-19,2023-09-11,Surgery,Public,Deceased,21.0,KRAS,No,Former,Moderate,35.0,High,Urban,Private Insurance,11.0,No,No,Cardiovascular Disease,6.0
PT02638,Germany,North Rhine-Westphalia,40.0,Male,Breast,IV,2012-12-07,2013-03-24,2013-07-05,Targeted Therapy,Public,Alive,41.0,KRAS,Yes,Former,Moderate,31.7,High,Urban,Statutory Health Insurance,19.0,No,No,Hypertension,1.0
PT02639,Sweden,Stockholm,81.0,Male,Lung,III,2023-11-20,2023-12-01,2024-05-10,Chemotherapy,Public,Lost to Follow-up,,BRCA1,No,Never,None,23.4,Medium,Urban,Statutory Health Insurance,4.0,No,No,Hypertension,2.0
PT02640,Norway,Vestland,52.0,Male,Leukemia,IV,2016-02-25,2016-05-21,2016-11-18,Chemotherapy,Public,Alive,24.0,EGFR,No,Former,Moderate,28.4,Low,Urban,Statutory Health Insurance,14.0,Yes,No,Obesity,6.0
PT02641,Belgium,Flanders,45.0,Male,Leukemia,II,2016-12-30,2017-05-10,2017-12-15,Radiation,Public,Alive,26.0,KRAS,No,Never,None,36.9,High,Urban,Statutory Health Insurance,18.0,No,No,None,4.0
PT02642,Belgium,Wallonia,59.0,,Breast,,2016-07-04,2016-12-30,2017-09-03,Chemotherapy,Public,Alive,104.0,None,Yes,Former,None,24.8,High,Urban,Private Insurance,12.0,Yes,No,None,10.0
PT02643,Finland,Southwest Finland,84.0,Male,Pancreatic,I,2015-04-05,2015-06-04,2016-05-16,Radiation,Private,Lost to Follow-up,,BRCA1,No,Never,Moderate,21.2,Low,Rural,NHS,18.0,,No,None,2.0
PT02644,Ireland,Munster,78.0,Female,Pancreatic,II,2010-05-04,2010-07-09,2011-03-20,Chemotherapy,Public,Alive,44.0,KRAS,Yes,Current,None,21.4,Medium,Urban,,,Yes,No,Cardiovascular Disease,6.0
PT02645,Denmark,Capital Region,34.0,Female,Lung,IV,2010-03-16,2010-04-02,,Surgery,Private,Alive,42.0,EGFR,Yes,Never,None,35.0,Medium,Urban,Statutory Health Insurance,16.0,No,No,Obesity,2.0
PT02646,Finland,Uusimaa,20.0,Male,Breast,I,2015-06-12,2015-10-21,2016-02-03,Immunotherapy,Public,Alive,62.0,EGFR,Yes,Former,Moderate,21.6,Low,Urban,,13.0,Yes,No,Obesity,
PT02647,Italy,Sicily,30.0,Non-binary,Lung,III,2010-06-06,2010-10-15,2011-04-28,Chemotherapy,Private,Alive,26.0,BRCA1,No,Never,,19.0,Low,Urban,Statutory Health Insurance,2.0,No,No,Diabetes,10.0
PT02648,Portugal,Algarve,74.0,Male,Lung,III,2018-06-11,2018-07-21,2019-01-11,Immunotherapy,Public,Alive,90.0,BRCA1,Yes,Current,Moderate,36.8,Low,Urban,NHS,4.0,No,No,Hypertension,6.0
PT02649,Netherlands,North Holland,21.0,Male,Breast,I,2020-06-15,2020-09-03,2020-10-12,Targeted Therapy,Public,Lost to Follow-up,,KRAS,Yes,Current,None,38.5,,Urban,Private Insurance,3.0,Yes,No,Obesity,7.0
PT02650,Italy,Sicily,84.0,Male,Pancreatic,I,2021-01-21,2021-04-07,2021-10-24,Immunotherapy,Private,Alive,18.0,KRAS,No,Never,,39.7,Low,Rural,NHS,7.0,No,No,Hypertension,9.0
PT02651,Germany,Bavaria,63.0,Male,Ovarian,II,2020-02-09,2020-04-12,2021-02-24,Targeted Therapy,Public,Alive,6.0,BRCA1,No,,None,26.0,Medium,Urban,NHS,14.0,No,No,,2.0
PT02652,Ireland,Munster,35.0,Female,Colorectal,I,2020-11-23,2021-01-13,2021-03-20,Chemotherapy,Research Institute,Alive,40.0,KRAS,No,Former,Moderate,38.0,Medium,Urban,NHS,7.0,No,No,Obesity,2.0
PT02653,France,Provence-Alpes-Côte d'Azur,41.0,Male,Prostate,I,2010-03-24,2010-07-31,2010-12-27,Surgery,Private,Alive,117.0,,Yes,Current,Heavy,21.4,Medium,Urban,Statutory Health Insurance,17.0,Yes,Yes,Cardiovascular Disease,5.0
PT02654,Germany,North Rhine-Westphalia,37.0,Female,Prostate,I,2023-02-10,,2023-10-22,Surgery,Public,Lost to Follow-up,,None,No,Former,,39.8,Medium,Urban,NHS,2.0,Yes,,None,2.0
PT02655,Germany,Bavaria,66.0,Female,Prostate,I,2018-05-24,2018-05-28,2018-08-03,Immunotherapy,Public,,102.0,BRCA1,No,Current,Moderate,18.4,Low,Urban,Private Insurance,2.0,No,No,Cardiovascular Disease,3.0
PT02656,France,Île-de-France,49.0,Male,Breast,III,2016-02-12,2016-06-23,2016-08-12,Surgery,Private,Alive,107.0,EGFR,No,Current,Heavy,25.6,Medium,Rural,Statutory Health Insurance,6.0,No,No,Obesity,4.0
PT02657,Portugal,Lisbon,29.0,Female,Lung,III,,,2015-11-20,Targeted Therapy,Public,Lost to Follow-up,,BRCA1,Yes,Former,,34.4,Low,,Statutory Health Insurance,9.0,No,No,Obesity,10.0
PT02658,Switzerland,Geneva,77.0,Female,Ovarian,III,2015-09-22,2016-03-07,2016-11-09,Surgery,Public,Deceased,,,No,Never,None,31.2,Medium,Urban,Private Insurance,16.0,No,No,Diabetes,5.0
PT02659,Austria,Tyrol,81.0,Male,Ovarian,II,2021-05-31,2021-08-23,2022-05-23,Surgery,Private,Alive,58.0,KRAS,No,Current,None,26.8,Low,Urban,Statutory Health Insurance,14.0,No,No,Cardiovascular Disease,4.0
,Portugal,Algarve,25.0,,,IV,2020-12-26,2021-02-13,2021-04-26,Surgery,Public,Alive,14.0,KRAS,No,Former,Moderate,19.7,High,,,5.0,No,No,Hypertension,9.0
PT02661,Switzerland,Zurich,86.0,Male,Leukemia,IV,2015-02-21,2015-04-01,2015-08-26,Radiation,Public,Lost to Follow-up,,None,Yes,Never,None,38.9,Medium,Urban,Private Insurance,,Yes,Yes,Obesity,8.0
PT02662,Ireland,Dublin,60.0,Female,Ovarian,IV,2016-05-03,2016-09-25,2017-01-26,Radiation,Public,Alive,100.0,KRAS,No,Former,,,Medium,Urban,Statutory Health Insurance,14.0,No,No,Cardiovascular Disease,9.0
PT02663,Denmark,Capital Region,62.0,,Lung,II,2014-01-03,2014-05-26,2015-05-14,Immunotherapy,Public,Alive,91.0,EGFR,No,Current,None,,Low,Urban,Private Insurance,9.0,No,Yes,None,2.0
PT02664,Spain,Catalonia,37.0,Male,Pancreatic,IV,2020-12-06,2021-03-21,2021-11-03,,Public,Alive,62.0,BRCA1,Yes,Never,Heavy,34.6,Low,Urban,Statutory Health Insurance,5.0,,No,Diabetes,5.0
PT02665,Sweden,Västra Götaland,77.0,Female,Colorectal,III,2017-12-24,2018-05-29,2019-03-05,Chemotherapy,Private,Alive,11.0,BRCA1,Yes,Former,None,21.7,Medium,Urban,NHS,19.0,No,No,Diabetes,9.0
PT02666,Finland,,79.0,Female,Prostate,II,2019-08-26,2019-09-11,2020-04-19,Targeted Therapy,Public,Alive,53.0,None,Yes,Former,Moderate,39.2,Medium,Urban,Private Insurance,19.0,No,Yes,Hypertension,2.0
PT02667,Denmark,Central Denmark,46.0,Female,Ovarian,I,2019-03-27,2019-08-08,2020-07-22,Targeted Therapy,Private,Alive,64.0,None,Yes,Never,Moderate,19.5,Medium,Urban,Private Insurance,5.0,Yes,No,Obesity,7.0
PT02668,Denmark,Central Denmark,87.0,Male,Pancreatic,III,2013-09-03,2013-12-04,,Immunotherapy,Private,,,KRAS,No,Current,Moderate,,Low,Urban,Private Insurance,12.0,Yes,,Hypertension,2.0
PT02669,Germany,Berlin,41.0,Male,Pancreatic,I,2020-10-09,2021-03-18,2021-05-23,Radiation,Public,Alive,92.0,BRCA1,Yes,Never,None,35.0,High,Urban,Statutory Health Insurance,1.0,No,No,Obesity,10.0
PT02670,,Porto,43.0,Male,Ovarian,I,2017-05-25,2017-06-19,2017-10-05,Surgery,Private,Alive,99.0,EGFR,No,Former,None,18.4,High,Urban,Statutory Health Insurance,6.0,No,No,None,10.0
PT02671,Poland,Masovian,59.0,Female,Ovarian,II,2021-01-27,2021-03-07,2021-07-18,Radiation,Public,Alive,72.0,None,No,Never,Moderate,37.3,Medium,Rural,NHS,17.0,No,No,Obesity,7.0
PT02672,Italy,Veneto,85.0,Female,Colorectal,III,2010-02-03,2010-06-28,,Radiation,Public,Alive,,,Yes,Never,None,,Low,Urban,Private Insurance,5.0,No,No,Cardiovascular Disease,3.0
,Switzerland,Bern,59.0,Female,Prostate,IV,2015-11-16,2016-01-01,2016-09-20,Immunotherapy,Public,Alive,27.0,EGFR,No,Former,None,36.9,Medium,Urban,Statutory Health Insurance,4.0,No,No,Cardiovascular Disease,2.0
PT02674,Norway,,25.0,Male,Ovarian,,2023-02-27,2023-06-23,2023-10-03,Radiation,Public,Alive,,BRCA1,No,Current,Moderate,28.4,Medium,Rural,Statutory Health Insurance,16.0,Yes,No,Diabetes,4.0
PT02675,Portugal,Algarve,37.0,Male,Breast,III,,2013-08-25,2013-10-27,Chemotherapy,Public,Alive,20.0,None,Yes,Former,Heavy,19.2,Medium,Urban,Private Insurance,13.0,No,No,None,4.0
PT02676,Denmark,Zealand,49.0,Female,Colorectal,II,2011-02-09,2011-06-03,2011-12-11,Radiation,Private,Deceased,54.0,EGFR,No,Former,Moderate,29.9,,Urban,Private Insurance,14.0,No,No,None,2.0
PT02677,Spain,Madrid,,Female,Pancreatic,,2022-11-25,2023-01-15,2023-09-09,Chemotherapy,Public,Alive,111.0,BRCA1,,Never,,33.9,Medium,,Private Insurance,7.0,No,No,Cardiovascular Disease,6.0
PT02678,Netherlands,South Holland,81.0,Female,Ovarian,II,2015-04-09,,2016-06-17,Targeted Therapy,Private,Deceased,84.0,None,Yes,Never,None,29.8,Medium,Urban,Private Insurance,11.0,No,Yes,None,5.0
PT02679,Poland,Lesser Poland,29.0,,Lung,IV,2015-02-01,2015-02-21,2015-10-12,Targeted Therapy,Public,Alive,55.0,EGFR,No,Former,Moderate,37.8,Medium,Urban,Private Insurance,10.0,No,No,Hypertension,1.0
PT02680,Poland,Lesser Poland,32.0,Male,Prostate,II,2012-05-31,2012-08-26,2013-04-09,Immunotherapy,,Deceased,52.0,EGFR,Yes,Never,Moderate,34.6,,Urban,Private Insurance,18.0,No,No,Obesity,8.0
PT02681,Switzerland,Zurich,28.0,Female,Leukemia,II,2017-11-21,2018-04-03,2018-12-18,Surgery,Private,Deceased,,KRAS,No,Never,Moderate,20.7,High,Rural,Statutory Health Insurance,10.0,No,No,Hypertension,2.0
,Sweden,Skåne,,Non-binary,Colorectal,II,2017-12-12,2018-02-12,2018-06-21,Radiation,Private,Lost to Follow-up,,BRCA1,Yes,Never,None,19.0,Medium,Rural,,15.0,,No,None,6.0
PT02683,Spain,,58.0,Female,Pancreatic,III,2014-05-17,2014-08-28,2014-12-29,Surgery,Private,Alive,,KRAS,Yes,Former,None,26.0,Medium,Urban,NHS,14.0,No,No,Cardiovascular Disease,1.0
PT02684,Netherlands,North Holland,43.0,Female,Breast,IV,2015-04-24,2015-05-06,2015-08-06,Chemotherapy,Private,Alive,46.0,KRAS,Yes,Former,None,33.5,High,Urban,Private Insurance,11.0,No,No,None,1.0
PT02685,,Vienna,53.0,Female,Pancreatic,II,2013-05-30,2013-08-19,2014-08-17,,Private,Alive,89.0,None,Yes,Never,Moderate,36.9,Low,Urban,Statutory Health Insurance,4.0,No,,None,3.0
PT02686,France,Auvergne-Rhône-Alpes,80.0,Male,Leukemia,II,2011-03-16,2011-08-21,2012-03-31,Radiation,Public,Alive,27.0,KRAS,Yes,Former,Moderate,36.9,Low,Urban,NHS,11.0,No,,Hypertension,9.0
PT02687,Sweden,Stockholm,60.0,Female,Ovarian,III,2022-09-02,,2023-12-03,Surgery,,Alive,97.0,KRAS,No,Former,Moderate,19.5,Medium,Urban,Statutory Health Insurance,3.0,No,No,Obesity,6.0
PT02688,Finland,Uusimaa,24.0,Female,Ovarian,IV,2017-09-25,2017-09-27,2018-07-30,Surgery,,Alive,96.0,EGFR,No,Never,,35.7,Low,,NHS,5.0,No,No,Hypertension,6.0
PT02689,France,Île-de-France,69.0,Non-binary,Breast,II,2010-04-26,2010-08-29,2011-04-22,Surgery,Public,Alive,82.0,BRCA1,No,Never,Moderate,24.3,Medium,Urban,NHS,14.0,,No,Cardiovascular Disease,
PT02690,France,Île-de-France,23.0,Male,Prostate,I,2022-04-28,,2022-12-17,,Private,Alive,67.0,KRAS,No,Current,,38.2,Medium,Urban,,14.0,No,Yes,Diabetes,2.0
PT02691,Sweden,Skåne,70.0,Male,Colorectal,II,2013-07-02,2013-11-10,2014-04-26,Surgery,Research Institute,Alive,83.0,EGFR,Yes,Never,Moderate,28.9,Low,Urban,Statutory Health Insurance,10.0,No,No,Diabetes,8.0
PT02692,Spain,Catalonia,71.0,Female,Breast,II,2010-10-24,2010-11-01,2010-12-26,Radiation,Public,Deceased,15.0,EGFR,No,Current,None,21.3,Medium,Rural,Private Insurance,11.0,No,Yes,Hypertension,4.0
PT02693,Norway,Trøndelag,58.0,Male,Leukemia,II,2018-01-27,2018-03-05,2019-01-18,Radiation,Public,Lost to Follow-up,,EGFR,No,Never,None,39.8,Medium,Urban,Statutory Health Insurance,17.0,No,No,Cardiovascular Disease,9.0
PT02694,Switzerland,Geneva,27.0,Male,Pancreatic,I,2017-02-18,2017-04-14,2018-01-26,Surgery,,Deceased,79.0,KRAS,No,Never,Heavy,,Medium,Urban,Statutory Health Insurance,17.0,No,No,None,10.0
,Denmark,Zealand,64.0,Male,Leukemia,I,2012-12-30,2013-02-17,2013-09-06,Immunotherapy,Private,Alive,24.0,BRCA1,No,Never,Moderate,24.0,Low,Urban,,10.0,No,Yes,Hypertension,9.0
PT02696,Finland,Uusimaa,47.0,Female,Lung,III,,2024-01-08,2024-10-02,Chemotherapy,Public,Alive,96.0,None,No,Current,Moderate,29.6,Low,Urban,NHS,18.0,No,No,Diabetes,10.0
PT02697,Finland,Pirkanmaa,46.0,Female,Breast,IV,2023-03-05,2023-05-04,2023-07-15,Surgery,Public,Alive,93.0,None,Yes,Current,Moderate,18.6,Medium,Urban,Statutory Health Insurance,16.0,Yes,No,Obesity,10.0
,Sweden,Västra Götaland,84.0,Male,Colorectal,IV,2023-12-20,2024-03-18,2025-02-18,Immunotherapy,Public,Alive,110.0,EGFR,No,Former,Heavy,36.2,Low,,NHS,4.0,No,No,Hypertension,7.0
PT02699,Portugal,Lisbon,53.0,Female,Colorectal,III,2012-12-10,,2013-07-15,Targeted Therapy,Public,Deceased,48.0,BRCA1,Yes,Former,Heavy,,Medium,Urban,Statutory Health Insurance,10.0,Yes,No,None,5.0
PT02700,Finland,Southwest Finland,81.0,Male,Pancreatic,III,2010-01-16,2010-05-15,2010-11-07,Radiation,Private,Alive,70.0,BRCA1,No,Former,None,25.7,High,Urban,Statutory Health Insurance,17.0,No,No,Diabetes,6.0
PT02701,Sweden,Västra Götaland,81.0,Female,,I,2014-03-08,2014-08-29,2015-01-28,Targeted Therapy,Private,Deceased,32.0,EGFR,Yes,Current,None,27.7,Medium,Urban,Statutory Health Insurance,4.0,Yes,No,Hypertension,4.0
PT02702,Spain,Catalonia,57.0,Female,Ovarian,III,2010-02-20,2010-05-31,2011-04-30,Radiation,Public,Alive,13.0,KRAS,No,Never,Moderate,39.3,High,Urban,NHS,13.0,No,No,Obesity,7.0
PT02703,Finland,Pirkanmaa,45.0,Female,Pancreatic,I,2018-10-05,2018-12-07,2019-09-01,Chemotherapy,Research Institute,Alive,59.0,None,No,Former,Moderate,28.8,Medium,,NHS,11.0,No,No,Diabetes,7.0
PT02704,France,Île-de-France,43.0,Male,Lung,III,2018-11-16,2019-03-23,2019-10-29,Immunotherapy,Public,Deceased,86.0,KRAS,Yes,Current,Moderate,34.6,Medium,Urban,NHS,12.0,No,No,None,10.0
PT02705,Ireland,Connacht,58.0,Female,Leukemia,IV,2014-05-23,2014-10-30,2015-03-24,Chemotherapy,Private,Alive,110.0,KRAS,No,,Moderate,18.3,High,Urban,Statutory Health Insurance,5.0,Yes,No,Cardiovascular Disease,8.0
PT02706,Sweden,Skåne,40.0,,Pancreatic,IV,2018-04-25,2018-06-30,2019-01-02,Targeted Therapy,Research Institute,Deceased,33.0,EGFR,No,Current,None,34.6,High,Urban,NHS,1.0,No,No,None,9.0
PT02707,Netherlands,South Holland,66.0,Female,Ovarian,II,2017-08-17,2017-11-10,2018-11-06,Immunotherapy,Public,Deceased,49.0,BRCA1,No,Never,None,20.1,High,Urban,Private Insurance,17.0,No,No,Hypertension,2.0
PT02708,Italy,Lombardy,67.0,,Breast,III,2015-06-16,2015-06-20,2016-02-11,Targeted Therapy,Public,Alive,,KRAS,No,Never,None,35.5,Low,Rural,Statutory Health Insurance,10.0,,No,Cardiovascular Disease,1.0
PT02709,France,Île-de-France,32.0,Male,Pancreatic,IV,2018-02-01,2018-07-08,2018-09-28,Surgery,Public,Deceased,,BRCA1,No,Former,Moderate,38.2,High,Urban,Private Insurance,5.0,No,,Hypertension,10.0
PT02710,Belgium,Flanders,22.0,Female,,I,2012-07-20,2013-01-13,2013-05-20,Targeted Therapy,Public,Alive,102.0,EGFR,No,Former,,23.1,,Rural,Private Insurance,16.0,No,No,Cardiovascular Disease,4.0
PT02711,,Lesser Poland,51.0,Male,Breast,III,2015-07-09,2015-10-10,2015-12-06,Chemotherapy,Public,Alive,29.0,BRCA1,No,Former,Moderate,24.1,Medium,Urban,Statutory Health Insurance,19.0,No,,Cardiovascular Disease,6.0
PT02712,Germany,North Rhine-Westphalia,54.0,Male,Breast,I,2022-08-19,2022-09-11,2023-05-11,Chemotherapy,Private,Alive,70.0,EGFR,No,Never,None,35.8,Medium,Rural,Private Insurance,11.0,No,No,None,2.0
PT02713,Norway,Trøndelag,38.0,Female,,IV,2015-11-09,2016-03-19,2016-09-09,Surgery,Public,Alive,113.0,None,No,Former,Moderate,35.3,Medium,Urban,Private Insurance,3.0,No,Yes,None,8.0
PT02714,Finland,Uusimaa,33.0,Male,Leukemia,I,2021-09-29,2021-11-22,2022-08-23,Immunotherapy,Private,Alive,13.0,None,No,Current,None,35.4,Low,Urban,NHS,16.0,Yes,No,None,9.0
PT02715,Netherlands,North Holland,67.0,Non-binary,Pancreatic,I,2019-04-24,2019-09-20,2020-06-23,Targeted Therapy,Public,Alive,114.0,BRCA1,No,Former,Moderate,35.8,,Urban,NHS,3.0,No,No,None,7.0
PT02716,France,Île-de-France,87.0,Male,Leukemia,III,2012-12-23,2013-03-13,2013-05-05,Targeted Therapy,Public,Alive,7.0,None,Yes,Never,None,25.6,High,Rural,Statutory Health Insurance,10.0,No,No,Obesity,2.0
PT02717,Norway,Trøndelag,64.0,Female,Leukemia,I,2021-01-19,2021-03-04,2021-12-11,Targeted Therapy,Private,Alive,116.0,EGFR,No,Former,Moderate,38.9,High,Rural,Private Insurance,2.0,Yes,No,Diabetes,1.0
PT02718,Switzerland,Zurich,38.0,Female,Prostate,I,2010-08-14,,2012-01-05,Immunotherapy,Public,Alive,23.0,,Yes,Former,None,37.8,Medium,Urban,NHS,2.0,No,No,Diabetes,6.0
PT02719,Belgium,Wallonia,83.0,Female,Ovarian,II,2011-03-21,2011-08-13,2011-10-17,Chemotherapy,Public,,84.0,EGFR,Yes,Never,Moderate,20.8,Low,Urban,Statutory Health Insurance,4.0,No,No,Obesity,6.0
PT02720,Netherlands,Utrecht,85.0,Non-binary,Leukemia,III,2016-07-09,2016-07-21,2017-03-04,Surgery,Public,Alive,66.0,BRCA1,No,Never,Moderate,18.9,High,Urban,Private Insurance,16.0,No,No,Cardiovascular Disease,7.0
PT02721,,Stockholm,85.0,Male,Lung,I,,2021-06-06,2022-01-05,Immunotherapy,Public,Alive,47.0,None,No,Former,Moderate,38.2,High,Urban,NHS,2.0,Yes,No,Obesity,5.0
PT02722,Austria,Vienna,64.0,Female,Ovarian,III,2018-08-01,2018-10-20,2019-01-24,Surgery,Public,Lost to Follow-up,,KRAS,No,Never,Moderate,,High,,Private Insurance,3.0,No,No,Diabetes,4.0
PT02723,Sweden,Stockholm,86.0,Female,Prostate,III,2015-03-18,2015-07-22,2015-09-22,Radiation,Private,Alive,45.0,EGFR,No,,Heavy,34.3,Medium,Urban,Private Insurance,13.0,Yes,No,Cardiovascular Disease,10.0
PT02724,Sweden,Stockholm,88.0,Male,Breast,II,2022-07-29,2022-10-29,2023-05-13,Surgery,Public,Alive,9.0,KRAS,No,Former,None,32.6,Medium,Urban,Statutory Health Insurance,17.0,No,No,None,6.0
PT02725,Norway,Oslo,22.0,Female,Pancreatic,III,2020-01-03,2020-03-15,2020-10-16,Radiation,Private,Deceased,69.0,EGFR,,,Moderate,33.9,Low,Urban,Statutory Health Insurance,3.0,No,No,Diabetes,6.0
PT02726,Norway,Trøndelag,57.0,Male,Colorectal,,2019-11-13,2019-12-29,2020-02-08,Surgery,Private,Deceased,44.0,EGFR,No,Never,Moderate,31.6,Low,Urban,Private Insurance,16.0,Yes,No,None,8.0
PT02727,Ireland,Connacht,61.0,Female,Pancreatic,II,2014-01-22,,2015-01-03,Radiation,Public,Alive,84.0,None,No,,None,24.3,Medium,,Statutory Health Insurance,15.0,Yes,No,Diabetes,4.0
PT02728,Spain,Madrid,59.0,Male,Prostate,I,2010-09-02,2010-12-04,2011-03-27,Targeted Therapy,Public,Deceased,95.0,KRAS,No,Never,Moderate,,Medium,Urban,NHS,6.0,No,No,Diabetes,7.0
PT02729,Belgium,Wallonia,69.0,Female,Ovarian,I,2015-10-13,2016-02-11,2016-04-23,Immunotherapy,Private,Alive,82.0,BRCA1,Yes,Never,None,29.7,Low,Urban,Private Insurance,12.0,No,No,Cardiovascular Disease,5.0
PT02730,Finland,Pirkanmaa,54.0,Female,Prostate,II,2021-01-31,2021-02-18,2021-07-04,Targeted Therapy,Private,Alive,15.0,None,No,Former,Moderate,24.7,Medium,Urban,Private Insurance,16.0,No,Yes,,7.0
PT02731,Austria,Vienna,43.0,Male,Ovarian,II,2012-03-15,2012-04-28,,Chemotherapy,Public,Alive,106.0,BRCA1,No,Current,None,25.7,Medium,,Statutory Health Insurance,11.0,No,No,Obesity,9.0
PT02732,Switzerland,Bern,36.0,Female,Ovarian,III,2012-07-20,,2012-12-29,Immunotherapy,,Deceased,113.0,BRCA1,No,Never,,32.2,Low,Urban,Statutory Health Insurance,13.0,No,Yes,Cardiovascular Disease,7.0
PT02733,Sweden,Stockholm,59.0,Male,Breast,II,2014-10-27,2015-01-14,2015-06-08,Targeted Therapy,Public,Alive,39.0,BRCA1,Yes,Never,Moderate,36.4,Medium,Urban,NHS,13.0,No,Yes,Obesity,1.0
PT02734,Ireland,Connacht,85.0,Male,Leukemia,IV,2018-07-14,2018-09-29,2019-02-11,Surgery,Public,Alive,96.0,BRCA1,No,Former,Moderate,31.1,Medium,Rural,Private Insurance,12.0,No,No,Hypertension,8.0
PT02735,Switzerland,Bern,63.0,Male,Leukemia,I,2010-01-25,2010-06-24,2011-01-12,Immunotherapy,Public,Alive,32.0,BRCA1,No,Former,Heavy,27.6,High,Urban,Statutory Health Insurance,5.0,No,Yes,Cardiovascular Disease,10.0
PT02736,Belgium,Wallonia,42.0,Male,Prostate,I,,2022-03-14,2022-05-05,Surgery,Private,,119.0,,Yes,Current,Moderate,20.7,Low,Urban,NHS,11.0,No,,Hypertension,6.0
PT02737,Austria,Styria,25.0,Male,Leukemia,II,2010-03-15,2010-05-17,2011-04-02,Targeted Therapy,Public,Alive,50.0,None,Yes,Current,Moderate,18.4,High,Urban,Statutory Health Insurance,3.0,No,No,Cardiovascular Disease,2.0
PT02738,Netherlands,Utrecht,85.0,Female,Prostate,I,2021-08-18,2021-09-11,2022-06-08,Immunotherapy,Private,Alive,93.0,,No,Never,,19.9,High,,NHS,3.0,No,No,Hypertension,5.0
PT02739,Belgium,Brussels,40.0,Female,Pancreatic,,2021-02-22,2021-03-23,2021-07-26,Targeted Therapy,Private,Deceased,100.0,EGFR,No,Former,Moderate,19.5,Medium,Urban,Statutory Health Insurance,19.0,No,Yes,Hypertension,10.0
PT02740,Spain,Andalusia,54.0,Female,Colorectal,II,2018-08-29,2019-01-05,2019-12-10,Chemotherapy,Research Institute,Deceased,15.0,EGFR,No,,Moderate,21.6,High,Urban,Private Insurance,6.0,No,,None,5.0
,Ireland,Connacht,48.0,Male,Pancreatic,II,2021-06-19,2021-10-21,2022-03-24,Targeted Therapy,Research Institute,Alive,82.0,KRAS,Yes,Former,None,37.9,Low,Urban,NHS,7.0,No,No,Hypertension,
PT02742,Austria,Styria,26.0,Female,Colorectal,II,2017-12-29,2017-12-30,2018-09-19,Chemotherapy,Public,Alive,,BRCA1,No,Current,None,21.3,Medium,Rural,Statutory Health Insurance,,No,Yes,Cardiovascular Disease,2.0
PT02743,,South Holland,72.0,,Breast,II,2017-08-26,2017-11-07,2018-06-01,Targeted Therapy,Public,Alive,113.0,BRCA1,No,Former,Moderate,22.3,Low,Urban,Private Insurance,11.0,No,,Hypertension,3.0
PT02744,France,Auvergne-Rhône-Alpes,56.0,Male,Lung,II,2013-11-11,2013-12-02,2014-03-11,Immunotherapy,Public,Deceased,42.0,KRAS,No,Former,Heavy,31.5,High,Rural,NHS,17.0,No,Yes,Cardiovascular Disease,7.0
PT02745,France,Île-de-France,,Female,Lung,I,2019-07-19,2019-12-22,2020-08-13,Surgery,Private,Alive,8.0,None,No,Never,None,29.9,Medium,Rural,NHS,2.0,No,No,None,7.0
PT02746,Sweden,Skåne,27.0,Female,Pancreatic,I,2019-11-22,2020-04-16,2021-01-03,,Public,Alive,118.0,None,No,Never,Moderate,,Medium,Urban,Statutory Health Insurance,6.0,No,No,Obesity,8.0
PT02747,Denmark,Central Denmark,67.0,Female,Leukemia,II,,2023-05-10,2023-10-06,Targeted Therapy,Public,Deceased,20.0,EGFR,No,Never,None,23.1,Medium,Urban,Private Insurance,15.0,No,No,Hypertension,8.0
PT02748,Poland,Silesian,29.0,Male,Lung,I,,2022-05-17,2023-04-04,Targeted Therapy,Research Institute,Deceased,67.0,KRAS,No,Former,Moderate,28.6,Medium,Urban,Private Insurance,17.0,No,No,Hypertension,5.0
PT02749,France,Auvergne-Rhône-Alpes,43.0,Male,Colorectal,,2012-12-01,2013-02-05,2013-07-03,Targeted Therapy,Public,Alive,14.0,BRCA1,No,Never,Moderate,20.4,Medium,Urban,NHS,,Yes,No,Hypertension,
PT02750,Poland,Lesser Poland,66.0,Female,Breast,,2020-12-09,,2021-05-24,Radiation,Public,Deceased,72.0,EGFR,No,Current,None,,Medium,Rural,Statutory Health Insurance,19.0,No,No,Hypertension,2.0
PT02751,Spain,Andalusia,72.0,Female,Colorectal,I,2020-04-16,2020-07-13,2021-04-17,Chemotherapy,Research Institute,Alive,9.0,KRAS,No,Never,Moderate,31.3,High,Urban,Statutory Health Insurance,10.0,No,No,Obesity,3.0
,Finland,Southwest Finland,58.0,Male,Ovarian,I,2011-09-03,2011-11-04,2012-07-02,Surgery,Public,Alive,34.0,BRCA1,Yes,Never,Moderate,36.7,High,Urban,Private Insurance,11.0,No,No,Hypertension,6.0
PT02753,Italy,Veneto,86.0,Male,Prostate,II,2021-07-17,2021-08-05,2022-03-07,Chemotherapy,Public,Alive,34.0,KRAS,No,Never,Moderate,25.3,Medium,Rural,NHS,1.0,Yes,No,Obesity,10.0
PT02754,Denmark,Zealand,85.0,Female,,I,2015-01-13,2015-01-15,2016-01-06,Targeted Therapy,Research Institute,Deceased,36.0,None,Yes,Current,None,24.6,Medium,Urban,NHS,,No,No,Obesity,2.0
,,North Holland,25.0,Female,Leukemia,I,2015-09-27,2015-11-21,2016-06-25,Targeted Therapy,Public,Lost to Follow-up,,KRAS,Yes,Current,Moderate,39.0,Low,,NHS,19.0,Yes,No,None,7.0
PT02756,France,Provence-Alpes-Côte d'Azur,40.0,Female,Lung,II,2019-10-14,2020-01-01,2020-07-31,Chemotherapy,Public,Deceased,65.0,,Yes,Former,None,27.9,Medium,Urban,Private Insurance,2.0,No,No,Hypertension,9.0
PT02757,Spain,Catalonia,55.0,Male,Prostate,II,2011-04-18,2011-04-29,2011-07-08,Chemotherapy,Public,Alive,27.0,None,Yes,Never,,24.4,Low,,Statutory Health Insurance,10.0,No,No,Obesity,2.0
PT02758,Germany,North Rhine-Westphalia,22.0,Male,Lung,III,2013-03-02,2013-07-24,2013-09-19,Chemotherapy,Private,Alive,109.0,KRAS,No,Never,None,,High,Urban,NHS,13.0,No,No,None,
PT02759,Poland,Masovian,61.0,Male,Ovarian,III,2018-09-26,2018-12-20,2019-11-01,Radiation,Public,,87.0,KRAS,Yes,Current,Moderate,21.1,High,Urban,Statutory Health Insurance,19.0,No,No,Cardiovascular Disease,7.0
PT02760,Ireland,Dublin,64.0,Male,Lung,,2022-02-06,2022-03-05,2022-04-24,Chemotherapy,Public,Deceased,71.0,EGFR,No,Former,None,26.5,Medium,Urban,Private Insurance,7.0,No,No,None,10.0
PT02761,Belgium,Wallonia,63.0,Male,Lung,I,2010-02-21,2010-03-15,2010-06-26,Targeted Therapy,Public,Alive,49.0,EGFR,No,Former,Moderate,28.1,Low,Rural,Private Insurance,15.0,No,No,Obesity,3.0
PT02762,,Connacht,52.0,Female,Prostate,III,2023-10-08,2023-10-11,2024-09-11,Surgery,Public,Alive,40.0,KRAS,No,Current,Moderate,37.4,Medium,Urban,Statutory Health Insurance,16.0,Yes,No,None,
PT02763,France,Auvergne-Rhône-Alpes,79.0,Female,Lung,III,2015-12-24,2015-12-27,2016-03-01,Immunotherapy,Public,Lost to Follow-up,,EGFR,No,Former,Moderate,34.0,Medium,Urban,Statutory Health Insurance,2.0,No,No,Cardiovascular Disease,2.0
PT02764,Netherlands,South Holland,89.0,Female,,IV,2013-11-28,2014-04-26,2014-06-13,Chemotherapy,Public,,17.0,BRCA1,No,Never,None,26.6,Low,Urban,Private Insurance,5.0,No,,None,6.0
PT02765,Ireland,Connacht,45.0,Male,Leukemia,I,2016-01-26,2016-03-09,2016-12-25,Chemotherapy,Research Institute,Alive,27.0,KRAS,No,Former,None,28.2,Medium,Rural,Statutory Health Insurance,12.0,No,No,Diabetes,3.0
PT02766,Sweden,Stockholm,40.0,Male,Lung,II,2014-12-29,2015-03-28,2015-10-19,Chemotherapy,Public,Deceased,110.0,EGFR,No,Never,Heavy,38.7,High,Urban,Private Insurance,16.0,No,No,Cardiovascular Disease,1.0
PT02767,Portugal,Algarve,21.0,Male,Prostate,III,,2022-04-20,2022-06-03,Surgery,Public,Deceased,95.0,KRAS,Yes,Former,None,36.4,Medium,Urban,NHS,5.0,Yes,No,Cardiovascular Disease,10.0
PT02768,Switzerland,Geneva,66.0,Male,Prostate,III,2010-03-09,2010-06-11,2010-10-28,Chemotherapy,Public,,94.0,KRAS,No,Current,Moderate,20.6,,Rural,,5.0,No,No,Diabetes,10.0
PT02769,Denmark,Zealand,49.0,Female,Colorectal,I,2020-06-11,2020-07-20,2020-12-05,Chemotherapy,Public,Alive,37.0,BRCA1,No,Former,Moderate,25.9,High,Urban,Statutory Health Insurance,10.0,Yes,No,Obesity,2.0
PT02770,France,Provence-Alpes-Côte d'Azur,46.0,Male,Lung,III,2013-03-19,2013-08-14,,Chemotherapy,Public,Deceased,14.0,EGFR,No,Former,None,28.2,Medium,Rural,NHS,3.0,Yes,,Obesity,3.0
PT02771,Belgium,Flanders,39.0,Male,Prostate,I,2022-07-13,2022-09-16,2023-08-16,Surgery,Public,Alive,107.0,EGFR,No,Never,Moderate,22.4,Low,Urban,Statutory Health Insurance,8.0,,No,None,
PT02772,Finland,Uusimaa,69.0,Male,Pancreatic,I,2021-10-26,2022-04-07,2022-05-24,Immunotherapy,Private,Deceased,69.0,KRAS,Yes,Never,Moderate,20.8,Medium,Urban,NHS,8.0,No,No,Obesity,1.0
,Sweden,Skåne,42.0,,Lung,II,2010-09-18,2010-10-31,2011-02-21,Targeted Therapy,Public,Alive,64.0,BRCA1,Yes,Never,Moderate,25.0,Medium,Urban,NHS,1.0,No,No,Hypertension,1.0
PT02774,Sweden,Västra Götaland,32.0,Female,Breast,I,2016-05-02,2016-05-23,2016-12-31,Surgery,Public,Alive,79.0,BRCA1,No,Former,Heavy,32.6,Medium,Urban,NHS,13.0,Yes,No,Diabetes,8.0
PT02775,Spain,Catalonia,23.0,,Leukemia,III,2019-09-01,2019-09-11,2020-04-15,Chemotherapy,Public,Deceased,69.0,BRCA1,Yes,Former,None,39.1,,,Statutory Health Insurance,15.0,No,Yes,None,2.0
PT02776,France,Provence-Alpes-Côte d'Azur,,Female,Leukemia,III,2014-07-08,2014-08-22,2015-03-03,Radiation,Public,Alive,104.0,KRAS,No,Former,Heavy,39.5,Medium,Rural,Statutory Health Insurance,15.0,,No,Diabetes,
PT02777,Switzerland,Bern,39.0,Female,Pancreatic,III,2011-11-08,2012-02-09,2012-10-05,Surgery,Private,Alive,53.0,BRCA1,Yes,Current,None,37.3,Medium,Urban,Private Insurance,11.0,No,Yes,Hypertension,3.0
PT02778,France,Auvergne-Rhône-Alpes,32.0,Male,Lung,II,2020-10-14,2020-10-17,2020-12-05,Chemotherapy,Public,Deceased,58.0,EGFR,No,Former,,33.6,Medium,Urban,Private Insurance,16.0,No,No,Hypertension,
PT02779,Denmark,Zealand,,Male,Ovarian,I,,2021-12-30,2022-10-06,,Private,Alive,37.0,BRCA1,Yes,Never,None,19.6,Medium,Rural,Statutory Health Insurance,14.0,Yes,No,Cardiovascular Disease,10.0
PT02780,France,Île-de-France,66.0,Female,Leukemia,I,2015-04-20,2015-05-31,2015-10-20,Targeted Therapy,Private,Alive,59.0,None,Yes,Never,None,18.3,Low,Urban,Statutory Health Insurance,9.0,No,No,Cardiovascular Disease,10.0
PT02781,Finland,Southwest Finland,22.0,Female,Leukemia,II,2014-08-06,2014-12-05,2015-11-16,Surgery,Public,Deceased,110.0,BRCA1,No,Never,None,18.5,Medium,Urban,Statutory Health Insurance,10.0,,Yes,Cardiovascular Disease,
PT02782,Finland,Southwest Finland,20.0,Male,Ovarian,III,2013-04-07,2013-07-23,2014-07-02,Surgery,Private,Deceased,46.0,EGFR,Yes,Never,Moderate,20.2,High,Rural,Statutory Health Insurance,11.0,No,Yes,None,9.0
PT02783,Switzerland,Geneva,43.0,Male,Breast,II,2017-03-07,2017-08-23,2018-02-18,Targeted Therapy,Public,Deceased,,None,No,Never,Moderate,28.2,,Rural,Statutory Health Insurance,4.0,,No,Cardiovascular Disease,5.0
PT02784,Germany,Bavaria,54.0,Male,Leukemia,II,2011-10-28,2011-11-06,2012-10-24,Radiation,Private,Alive,60.0,EGFR,No,Former,None,18.4,Low,Urban,Statutory Health Insurance,15.0,No,No,Hypertension,2.0
PT02785,Norway,Trøndelag,33.0,Male,Leukemia,II,2023-04-25,2023-10-16,2024-07-31,Radiation,Public,Alive,99.0,None,No,Never,None,25.8,Low,Rural,Statutory Health Insurance,9.0,No,No,Cardiovascular Disease,3.0
PT02786,Switzerland,Bern,86.0,Male,Prostate,I,2014-05-21,2014-10-12,2015-02-01,Immunotherapy,Public,Alive,110.0,EGFR,No,Never,None,38.9,Medium,Urban,Statutory Health Insurance,9.0,No,No,Cardiovascular Disease,8.0
PT02787,France,Auvergne-Rhône-Alpes,32.0,Male,Leukemia,,2015-03-25,2015-07-27,2016-07-04,Immunotherapy,Public,Alive,113.0,EGFR,No,Never,Moderate,30.3,Low,Rural,Statutory Health Insurance,12.0,Yes,,Diabetes,10.0
PT02788,Portugal,Porto,66.0,Male,Lung,II,2010-07-07,2010-10-28,2011-01-23,Targeted Therapy,Public,Alive,40.0,BRCA1,Yes,Current,None,31.3,Medium,,NHS,10.0,No,No,Diabetes,9.0
PT02789,Ireland,Munster,69.0,Male,Leukemia,III,2011-12-06,2012-04-05,2012-06-27,Surgery,Research Institute,Alive,63.0,BRCA1,No,Former,None,28.8,Low,Rural,NHS,19.0,No,Yes,Cardiovascular Disease,3.0
PT02790,Austria,Vienna,,Male,Lung,III,2019-03-22,2019-05-08,2019-07-04,Chemotherapy,Public,Alive,74.0,EGFR,No,Former,None,39.6,Low,Rural,Private Insurance,16.0,Yes,No,Diabetes,7.0
PT02791,Sweden,Skåne,22.0,Female,Leukemia,I,2023-02-09,2023-07-15,2024-03-05,Radiation,Private,Alive,99.0,None,Yes,Never,Moderate,21.7,,Rural,NHS,,No,No,,3.0
PT02792,Norway,Trøndelag,70.0,Female,Lung,II,2019-06-16,2019-07-14,2019-10-08,Surgery,Research Institute,Alive,6.0,EGFR,No,Current,Heavy,39.5,Medium,Rural,NHS,3.0,No,No,Cardiovascular Disease,8.0
PT02793,Denmark,Capital Region,59.0,Female,Leukemia,III,2013-09-28,2013-12-12,2014-03-15,Immunotherapy,Public,Alive,14.0,BRCA1,No,Never,Heavy,28.3,Medium,Urban,Private Insurance,,No,No,Obesity,5.0
PT02794,Switzerland,Bern,87.0,Male,Pancreatic,I,2017-04-03,2017-07-06,2017-11-04,Radiation,Public,Deceased,,,Yes,Never,Moderate,38.4,Medium,Rural,Statutory Health Insurance,18.0,Yes,No,None,9.0
PT02795,Sweden,Västra Götaland,55.0,,Lung,III,2010-12-01,2011-04-19,2012-02-28,Chemotherapy,Public,Alive,73.0,BRCA1,Yes,Former,None,32.1,Medium,Urban,Statutory Health Insurance,19.0,No,No,Hypertension,10.0
PT02796,Belgium,Wallonia,70.0,Male,Leukemia,I,2023-03-27,2023-04-25,,,Private,Deceased,51.0,KRAS,Yes,Former,Moderate,22.5,Medium,Rural,Statutory Health Insurance,11.0,No,No,Cardiovascular Disease,2.0
PT02797,Norway,Trøndelag,20.0,Female,Ovarian,II,2016-07-12,2016-09-07,2016-10-24,Chemotherapy,Public,Alive,89.0,None,No,Never,None,35.5,Medium,,NHS,2.0,No,No,Hypertension,5.0
PT02798,Ireland,Munster,,Male,Breast,IV,2010-12-22,2011-03-06,2011-12-14,Immunotherapy,Public,Alive,93.0,None,No,Current,,20.9,Low,Urban,NHS,15.0,No,No,Hypertension,8.0
PT02799,Portugal,Algarve,26.0,Male,Prostate,II,2015-04-07,2015-08-04,2015-11-22,Chemotherapy,Public,Alive,42.0,EGFR,No,,Moderate,35.9,Medium,Urban,Private Insurance,19.0,No,,Cardiovascular Disease,3.0
PT02800,Belgium,Wallonia,71.0,Female,Prostate,II,2021-11-06,2022-01-04,2022-08-03,Radiation,Private,Alive,113.0,BRCA1,No,Never,Moderate,18.8,High,Urban,NHS,14.0,No,No,Obesity,6.0
PT02801,Norway,,30.0,Female,Prostate,I,2019-02-21,2019-03-28,2019-09-09,Targeted Therapy,Public,Deceased,82.0,,No,Former,None,21.1,High,Rural,,15.0,No,No,Hypertension,5.0
PT02802,Belgium,Brussels,46.0,Female,Ovarian,I,2012-03-06,2012-04-11,2012-08-25,Chemotherapy,Private,Lost to Follow-up,,BRCA1,No,Current,Moderate,25.9,High,Urban,NHS,16.0,No,No,Diabetes,7.0
PT02803,Italy,Lombardy,33.0,,Prostate,II,2010-07-09,2010-09-24,2011-03-06,,Public,,82.0,EGFR,Yes,Never,Moderate,19.4,High,Urban,NHS,18.0,No,No,None,2.0
PT02804,Switzerland,Geneva,65.0,Male,Ovarian,II,2021-05-06,2021-07-03,2022-02-17,Surgery,Private,Alive,24.0,,,Never,Moderate,36.0,High,Urban,Private Insurance,16.0,Yes,No,Hypertension,9.0
PT02805,Belgium,Brussels,,Male,Breast,II,2012-03-24,2012-03-26,2013-01-03,Surgery,Private,Alive,118.0,None,Yes,Never,None,27.9,Medium,Rural,Private Insurance,,No,No,Diabetes,8.0
PT02806,Poland,Lesser Poland,43.0,Female,Pancreatic,IV,2015-10-04,2015-11-01,2016-09-21,Immunotherapy,Public,Deceased,86.0,None,No,Never,None,31.6,Low,Urban,Statutory Health Insurance,7.0,No,Yes,Cardiovascular Disease,9.0
PT02807,Spain,Catalonia,,Female,Pancreatic,II,2019-05-04,2019-07-13,2020-02-06,Targeted Therapy,Public,Alive,25.0,EGFR,Yes,Former,None,20.2,Medium,Urban,Private Insurance,10.0,Yes,No,Cardiovascular Disease,9.0
PT02808,Netherlands,,37.0,Female,Breast,II,2015-12-07,2016-02-08,2016-04-24,Immunotherapy,Private,Deceased,44.0,None,No,Never,None,18.2,,Urban,Private Insurance,1.0,Yes,Yes,Hypertension,8.0
PT02809,Netherlands,North Holland,28.0,Male,Leukemia,II,2016-02-29,2016-04-29,2017-01-06,Chemotherapy,Research Institute,Deceased,20.0,KRAS,No,Never,Heavy,39.6,Medium,Rural,Private Insurance,8.0,No,No,Cardiovascular Disease,8.0
PT02810,Austria,Vienna,36.0,Female,Breast,II,2014-08-07,2014-11-05,2015-03-29,Targeted Therapy,Private,Deceased,102.0,KRAS,No,Former,None,21.2,High,Urban,Private Insurance,18.0,No,No,Cardiovascular Disease,
PT02811,Portugal,Algarve,,Male,Prostate,II,2015-08-21,2016-02-01,2017-01-21,Chemotherapy,Private,Alive,98.0,KRAS,No,Never,Heavy,36.3,,Rural,Private Insurance,12.0,No,No,Hypertension,10.0
PT02812,Denmark,Capital Region,32.0,Male,Ovarian,II,2021-12-03,2022-03-17,2022-10-28,Radiation,Private,Alive,77.0,KRAS,Yes,Current,Moderate,32.1,Low,Urban,NHS,6.0,No,No,Cardiovascular Disease,9.0
PT02813,Poland,Masovian,69.0,Female,Pancreatic,,2022-01-11,2022-05-07,2023-02-09,Targeted Therapy,Public,Deceased,26.0,EGFR,No,Former,Moderate,35.7,Medium,Rural,NHS,2.0,Yes,No,Cardiovascular Disease,
PT02814,,Auvergne-Rhône-Alpes,25.0,Female,Colorectal,II,2013-05-05,2013-06-17,2014-02-27,Surgery,Private,Deceased,59.0,KRAS,No,Never,Heavy,31.3,Medium,Urban,Private Insurance,4.0,No,No,Cardiovascular Disease,9.0
PT02815,Ireland,Munster,70.0,Male,Leukemia,II,2014-06-16,2014-11-30,2015-10-08,Radiation,Public,Alive,,None,Yes,Never,Heavy,26.6,Medium,Rural,,11.0,No,Yes,Obesity,10.0
PT02816,,Veneto,55.0,,,III,2016-07-08,2016-11-18,2017-02-09,Radiation,Public,Deceased,15.0,EGFR,Yes,,Heavy,29.6,Medium,Rural,Statutory Health Insurance,12.0,Yes,No,None,7.0
PT02817,Ireland,Connacht,44.0,Male,Pancreatic,I,2013-10-31,2014-04-27,2014-10-15,Chemotherapy,Public,Alive,54.0,EGFR,No,Never,,29.8,,Rural,Private Insurance,11.0,,No,Diabetes,5.0
PT02818,Switzerland,Bern,30.0,Male,Prostate,III,2010-05-14,2010-05-30,2011-02-16,Immunotherapy,,Alive,6.0,BRCA1,,Former,Moderate,21.9,High,Urban,Statutory Health Insurance,7.0,No,Yes,None,6.0
PT02819,Ireland,Dublin,63.0,Male,Ovarian,,2023-10-31,2023-12-22,2024-06-18,Chemotherapy,Research Institute,Alive,,BRCA1,No,Former,None,32.1,Medium,Rural,NHS,18.0,No,No,Obesity,4.0
PT02820,Sweden,,33.0,Male,Pancreatic,III,2015-12-04,2016-02-13,2016-09-26,,Public,Deceased,93.0,EGFR,No,Current,Moderate,21.8,High,Urban,Statutory Health Insurance,1.0,No,Yes,Obesity,3.0
PT02821,Netherlands,Utrecht,48.0,Male,Ovarian,III,2017-06-02,2017-06-05,2017-08-29,Targeted Therapy,Private,Alive,19.0,KRAS,Yes,Never,Moderate,29.9,Low,Rural,Private Insurance,6.0,No,No,Obesity,3.0
PT02822,Ireland,Dublin,,Non-binary,Prostate,IV,2013-07-03,2013-09-30,2014-05-27,Surgery,Private,Lost to Follow-up,,KRAS,No,Former,None,32.8,Medium,Urban,Private Insurance,2.0,No,No,Cardiovascular Disease,6.0
PT02823,Sweden,Västra Götaland,24.0,Female,Prostate,II,2011-07-07,2011-11-22,2012-11-01,Radiation,Public,Alive,33.0,EGFR,Yes,Former,Moderate,35.9,High,Urban,Private Insurance,7.0,No,No,Diabetes,1.0
PT02824,France,Île-de-France,88.0,Female,Pancreatic,III,2023-02-10,2023-04-02,2023-06-21,Immunotherapy,Public,Deceased,45.0,None,Yes,Never,None,30.0,Medium,Urban,Statutory Health Insurance,2.0,No,Yes,None,6.0
PT02825,Austria,Styria,76.0,Non-binary,Pancreatic,I,2015-09-18,2016-02-25,2016-07-31,Immunotherapy,Public,,57.0,KRAS,No,Former,Moderate,31.5,Medium,Urban,NHS,18.0,No,No,Obesity,3.0
PT02826,Denmark,Central Denmark,45.0,Female,Pancreatic,III,2020-08-30,,2021-10-23,Targeted Therapy,Public,Alive,32.0,KRAS,No,Former,None,34.0,Medium,Urban,Private Insurance,8.0,No,,Cardiovascular Disease,8.0
PT02827,Italy,Lombardy,25.0,,Breast,I,2022-07-12,2022-11-07,2022-12-18,,Private,Alive,20.0,KRAS,Yes,Never,Moderate,26.0,Medium,Urban,Private Insurance,1.0,No,No,Hypertension,4.0
PT02828,France,Auvergne-Rhône-Alpes,35.0,Male,Pancreatic,I,2018-02-21,2018-08-11,2018-10-03,Targeted Therapy,Public,Deceased,66.0,KRAS,No,Never,Moderate,19.0,High,Rural,NHS,16.0,No,Yes,Diabetes,
PT02829,Poland,Silesian,79.0,Female,Ovarian,I,2013-02-27,2013-07-17,2013-12-19,Immunotherapy,Public,Alive,94.0,KRAS,No,Never,Moderate,,Medium,Urban,Statutory Health Insurance,9.0,No,No,None,8.0
PT02830,Netherlands,Utrecht,31.0,Female,Lung,II,2021-05-21,,2022-10-22,Chemotherapy,Public,Deceased,67.0,BRCA1,No,Former,None,20.6,High,Urban,NHS,14.0,Yes,No,None,4.0
PT02831,Austria,Tyrol,22.0,Female,Leukemia,I,2012-08-12,2013-01-09,2013-07-28,Surgery,Public,Deceased,119.0,EGFR,No,Current,None,34.7,Medium,Urban,NHS,1.0,No,No,Cardiovascular Disease,10.0
,Spain,Andalusia,82.0,Female,Prostate,III,2017-01-21,2017-03-21,2017-08-02,Surgery,Public,,6.0,BRCA1,,Former,None,35.9,Low,Urban,NHS,18.0,No,No,Cardiovascular Disease,1.0
PT02833,Sweden,,83.0,Male,Pancreatic,II,,2020-07-07,2021-03-14,Radiation,Public,Alive,111.0,KRAS,No,,None,39.3,Medium,Urban,NHS,6.0,Yes,No,Cardiovascular Disease,9.0
PT02834,Norway,Trøndelag,81.0,Male,Lung,III,2018-05-27,,2018-10-07,Radiation,Private,Alive,9.0,KRAS,No,Never,Moderate,31.2,Medium,,Private Insurance,3.0,No,No,Hypertension,6.0
,Poland,Silesian,25.0,Male,Colorectal,I,2010-08-24,2010-12-07,,Chemotherapy,Public,Alive,44.0,None,Yes,Never,Moderate,28.5,Medium,Urban,NHS,18.0,Yes,No,None,8.0
PT02836,Italy,Lombardy,38.0,Male,Ovarian,I,2020-04-09,2020-05-28,2020-08-05,Chemotherapy,Public,Alive,32.0,None,Yes,Former,Moderate,38.7,Medium,Urban,Private Insurance,,Yes,No,Hypertension,2.0
PT02837,Sweden,Västra Götaland,37.0,Male,Pancreatic,,2019-12-23,2020-02-17,2020-04-19,Surgery,Private,Alive,36.0,EGFR,No,Current,Moderate,38.2,Medium,Urban,Private Insurance,7.0,No,Yes,None,9.0
PT02838,Portugal,Algarve,62.0,Male,Breast,II,2013-01-13,2013-02-13,,Radiation,Research Institute,Alive,56.0,BRCA1,No,Never,None,32.1,High,Urban,Private Insurance,18.0,No,No,Cardiovascular Disease,9.0
PT02839,Denmark,Zealand,22.0,Male,,I,2014-12-02,2015-02-10,2015-06-27,Radiation,Private,Alive,112.0,None,No,Never,Moderate,35.0,,Rural,NHS,1.0,No,No,Diabetes,3.0
PT02840,Ireland,Munster,57.0,Male,Lung,IV,2019-07-06,2019-09-20,2019-12-23,Surgery,Private,Alive,89.0,EGFR,,Never,Moderate,22.4,Medium,Rural,NHS,5.0,No,Yes,,6.0
PT02841,Poland,Lesser Poland,,Male,Ovarian,I,2013-10-22,2014-04-11,2014-07-25,Targeted Therapy,Research Institute,Alive,47.0,BRCA1,No,Former,Moderate,29.3,High,Urban,NHS,16.0,No,Yes,,9.0
PT02842,Finland,Uusimaa,63.0,Male,Pancreatic,III,2018-07-29,2018-10-18,2019-01-01,Chemotherapy,Private,Alive,68.0,BRCA1,No,Former,Moderate,25.5,Medium,Rural,NHS,5.0,No,No,Hypertension,10.0
PT02843,Sweden,Västra Götaland,82.0,Male,Lung,I,2016-01-21,2016-04-04,2016-12-24,Radiation,Research Institute,Alive,93.0,KRAS,Yes,Never,Moderate,36.1,Medium,Urban,Statutory Health Insurance,14.0,No,No,None,1.0
PT02844,Netherlands,Utrecht,61.0,Male,Prostate,IV,2023-08-18,2023-12-05,2024-04-26,Surgery,Private,Alive,86.0,None,No,Never,None,37.6,Medium,Urban,NHS,10.0,Yes,Yes,Cardiovascular Disease,8.0
PT02845,France,Provence-Alpes-Côte d'Azur,83.0,Female,Lung,II,2017-03-26,2017-03-31,2018-03-03,Chemotherapy,Private,Alive,35.0,KRAS,Yes,Former,None,26.8,Medium,Urban,NHS,3.0,Yes,,Diabetes,1.0
PT02846,Germany,North Rhine-Westphalia,73.0,Female,Lung,IV,,2018-11-07,2019-04-09,Surgery,Public,Alive,108.0,KRAS,No,Former,Moderate,28.5,Medium,Rural,,13.0,No,No,,8.0
PT02847,Norway,Vestland,,Male,Ovarian,II,,2012-12-05,2013-10-16,Targeted Therapy,Public,Deceased,12.0,BRCA1,No,Never,Moderate,23.1,Medium,Rural,NHS,5.0,No,No,Hypertension,5.0
PT02848,Denmark,Zealand,23.0,Male,Pancreatic,I,2017-12-31,2018-05-10,2018-10-29,Immunotherapy,Research Institute,Deceased,59.0,EGFR,Yes,Former,None,37.3,Low,Urban,NHS,16.0,Yes,No,Hypertension,9.0
PT02849,Finland,Uusimaa,21.0,Female,Pancreatic,II,2018-02-04,2018-07-31,2019-01-13,Radiation,,Alive,,BRCA1,No,,Moderate,21.1,Medium,Urban,Statutory Health Insurance,15.0,No,No,Hypertension,
PT02850,Norway,Trøndelag,63.0,Female,Ovarian,II,2020-06-24,2020-08-19,2021-05-22,Chemotherapy,Research Institute,Alive,64.0,BRCA1,Yes,Never,Moderate,38.2,High,Urban,NHS,3.0,No,,Hypertension,3.0
PT02851,Sweden,Stockholm,86.0,Female,Leukemia,I,2019-06-08,2019-10-22,2020-09-03,Surgery,Public,,111.0,EGFR,No,Never,,31.6,Medium,Rural,Private Insurance,10.0,No,No,Cardiovascular Disease,9.0
PT02852,Denmark,Capital Region,87.0,Male,,I,2021-01-21,2021-02-06,2021-05-18,Surgery,,Alive,,BRCA1,Yes,Current,Heavy,23.4,High,Urban,Statutory Health Insurance,10.0,Yes,Yes,Hypertension,8.0
PT02853,Sweden,Västra Götaland,81.0,Female,Leukemia,III,2010-05-01,2010-05-25,2011-04-02,Chemotherapy,Private,Alive,77.0,EGFR,,Never,Moderate,27.4,Low,Rural,NHS,3.0,No,No,Hypertension,6.0
PT02854,Spain,Madrid,20.0,Female,Breast,I,2012-08-23,2012-10-17,2012-12-27,Radiation,Public,Deceased,71.0,KRAS,Yes,Former,Moderate,20.2,Medium,Urban,Private Insurance,1.0,No,No,Hypertension,9.0
PT02855,Portugal,,36.0,Female,Breast,II,,2015-10-20,2016-08-08,Radiation,Private,Alive,111.0,EGFR,Yes,Never,None,31.1,Medium,,NHS,8.0,,No,Hypertension,6.0
PT02856,Austria,Styria,35.0,Male,Leukemia,II,2021-07-15,2021-09-13,2022-05-21,Surgery,Public,,34.0,None,No,Never,Heavy,35.8,Medium,Urban,Statutory Health Insurance,16.0,No,No,Hypertension,1.0
PT02857,France,Île-de-France,28.0,Female,Ovarian,,2020-03-08,2020-08-14,2021-06-06,Radiation,Research Institute,Alive,64.0,KRAS,No,Never,Moderate,32.3,Low,Urban,NHS,10.0,No,No,None,9.0
PT02858,Portugal,Algarve,72.0,Female,Prostate,I,2020-09-18,,2021-07-07,,Private,Alive,39.0,None,No,Current,,21.6,Medium,Rural,NHS,2.0,No,No,Hypertension,10.0
PT02859,Italy,Lombardy,78.0,Female,Ovarian,II,2022-12-18,2023-02-10,2023-04-24,Targeted Therapy,Public,Alive,58.0,BRCA1,No,Current,None,30.1,Medium,Urban,Statutory Health Insurance,10.0,No,No,Diabetes,5.0
PT02860,Norway,Oslo,28.0,Male,Lung,I,2020-06-21,2020-11-05,2021-09-19,Targeted Therapy,Public,Alive,86.0,None,No,Never,None,36.2,Medium,Rural,Statutory Health Insurance,8.0,No,,Obesity,8.0
PT02861,Austria,Styria,31.0,Female,Colorectal,I,2022-03-28,2022-09-06,2022-12-11,Immunotherapy,Public,Deceased,,BRCA1,Yes,Never,None,36.9,Low,Rural,Statutory Health Insurance,11.0,No,No,Hypertension,9.0
PT02862,Netherlands,South Holland,60.0,Male,,II,2018-09-15,2018-12-04,2019-11-09,Radiation,Research Institute,Deceased,63.0,,No,Former,None,34.4,Medium,Rural,NHS,7.0,No,Yes,None,2.0
PT02863,Norway,Trøndelag,34.0,Male,Leukemia,IV,2019-03-25,2019-08-16,2020-06-09,Surgery,Public,Alive,89.0,None,Yes,Never,Moderate,26.0,Medium,Rural,Statutory Health Insurance,19.0,,No,Diabetes,6.0
,Switzerland,Zurich,85.0,Female,Prostate,I,2019-08-06,2019-10-15,2019-12-19,Radiation,Public,Alive,107.0,None,Yes,Current,None,39.5,Medium,Urban,NHS,1.0,No,No,Hypertension,8.0
PT02865,Belgium,Brussels,30.0,Male,Lung,I,2021-01-24,2021-06-07,2021-10-01,Chemotherapy,Research Institute,Lost to Follow-up,,None,No,Former,Moderate,36.0,Medium,Rural,Statutory Health Insurance,2.0,No,No,Hypertension,8.0
PT02866,Ireland,Dublin,27.0,Female,Pancreatic,III,2015-04-08,2015-05-13,2015-07-07,Chemotherapy,Research Institute,Deceased,34.0,None,No,Current,Heavy,36.5,Medium,Rural,Statutory Health Insurance,7.0,,No,Hypertension,2.0
PT02867,Portugal,Porto,74.0,Female,Ovarian,II,2020-06-13,2020-09-26,2021-08-15,Radiation,Private,Deceased,75.0,,Yes,Never,Moderate,36.7,Medium,Rural,Statutory Health Insurance,16.0,No,No,Cardiovascular Disease,9.0
,Finland,Southwest Finland,25.0,Male,Leukemia,III,2018-06-19,2018-10-28,2019-03-06,Immunotherapy,Private,Alive,89.0,None,,Former,None,34.1,Medium,Rural,Private Insurance,14.0,No,No,Cardiovascular Disease,7.0
PT02869,Norway,Oslo,72.0,Female,Colorectal,IV,2014-11-12,2014-12-03,2015-06-01,Chemotherapy,Public,Alive,96.0,None,Yes,Never,None,29.1,Medium,Urban,Private Insurance,1.0,No,No,,9.0
PT02870,,South Holland,39.0,Female,Lung,IV,,2012-06-25,2012-12-07,Targeted Therapy,Public,Alive,75.0,KRAS,Yes,Never,Heavy,27.8,Medium,Rural,NHS,13.0,Yes,Yes,Cardiovascular Disease,5.0
PT02871,Switzerland,Zurich,58.0,Male,Leukemia,II,,2022-12-18,2023-10-13,Surgery,Research Institute,Lost to Follow-up,,KRAS,Yes,Never,Moderate,34.7,Low,Urban,,7.0,,No,Obesity,8.0
PT02872,France,Auvergne-Rhône-Alpes,53.0,Female,Pancreatic,II,2019-10-18,2020-03-24,2021-01-27,Immunotherapy,Public,Alive,54.0,BRCA1,No,Never,Moderate,28.7,High,Rural,Statutory Health Insurance,2.0,No,Yes,None,10.0
PT02873,France,Auvergne-Rhône-Alpes,76.0,Male,,IV,2014-03-19,2014-04-10,2014-08-18,Chemotherapy,Public,Deceased,11.0,KRAS,Yes,Never,None,37.8,High,Urban,Private Insurance,19.0,No,No,None,
PT02874,Switzerland,Zurich,38.0,Male,Pancreatic,I,2017-11-07,2018-03-29,2018-09-27,Surgery,Public,Alive,115.0,EGFR,No,Former,None,23.0,Medium,Rural,NHS,3.0,Yes,Yes,None,3.0
PT02875,,Bavaria,50.0,Male,Breast,II,2019-09-20,2019-12-18,2020-05-13,Targeted Therapy,Public,Alive,12.0,None,Yes,,Moderate,35.1,High,Rural,Private Insurance,2.0,No,No,Diabetes,1.0
PT02876,Spain,Catalonia,59.0,Male,Breast,II,2012-03-14,2012-05-20,2013-02-12,Chemotherapy,Private,Alive,,KRAS,Yes,Never,Moderate,23.3,High,Rural,Private Insurance,8.0,Yes,No,Cardiovascular Disease,2.0
PT02877,Sweden,,33.0,Male,Leukemia,I,2023-01-29,2023-06-11,2023-07-27,Chemotherapy,Public,,41.0,EGFR,No,Never,None,28.3,Medium,Urban,NHS,8.0,No,No,Obesity,3.0
PT02878,France,Provence-Alpes-Côte d'Azur,56.0,Non-binary,Prostate,IV,2018-12-14,2019-04-08,2019-09-16,Surgery,Private,Alive,75.0,EGFR,Yes,Former,Heavy,19.9,Low,Urban,Statutory Health Insurance,11.0,No,No,Hypertension,8.0
PT02879,Germany,Berlin,63.0,Female,Breast,III,2010-06-28,2010-08-26,2011-06-02,Surgery,Private,Alive,103.0,BRCA1,No,Former,None,28.9,Medium,Urban,Private Insurance,1.0,No,No,,6.0
PT02880,Norway,Oslo,28.0,Female,Leukemia,,2011-09-07,2012-01-22,2012-05-15,Radiation,Private,Alive,6.0,,Yes,Never,Moderate,29.6,High,Urban,Statutory Health Insurance,4.0,Yes,No,None,8.0
PT02881,Germany,Berlin,77.0,Male,Pancreatic,III,2014-10-21,2015-04-15,2015-12-12,Chemotherapy,Public,Deceased,99.0,BRCA1,No,Never,Moderate,22.0,Medium,Rural,Private Insurance,8.0,No,No,Obesity,1.0
PT02882,Spain,Catalonia,39.0,Female,Lung,II,2010-02-16,2010-05-29,2010-10-10,Targeted Therapy,Public,Alive,27.0,None,No,Former,None,25.1,Medium,Urban,Private Insurance,6.0,No,No,None,10.0
PT02883,Switzerland,Zurich,69.0,Male,Ovarian,IV,2020-02-01,2020-03-09,2020-07-15,,Private,Deceased,117.0,KRAS,No,Never,Moderate,22.7,Medium,Urban,NHS,9.0,No,No,None,5.0
PT02884,Netherlands,North Holland,39.0,Male,Pancreatic,I,2016-12-09,2017-02-15,2017-04-26,Immunotherapy,Private,Alive,86.0,BRCA1,Yes,Never,Moderate,27.5,,Urban,Private Insurance,18.0,No,No,Diabetes,3.0
,Finland,Southwest Finland,55.0,Male,Colorectal,I,2010-08-04,2010-12-30,2011-03-29,Chemotherapy,Public,Alive,47.0,KRAS,Yes,Never,Moderate,32.0,Low,Urban,NHS,3.0,No,No,Obesity,9.0
PT02886,,Oslo,46.0,Male,Breast,I,2018-01-18,2018-04-13,2018-08-07,Immunotherapy,Public,Alive,89.0,None,Yes,Never,Moderate,21.1,Low,Rural,Statutory Health Insurance,14.0,Yes,No,Cardiovascular Disease,5.0
PT02887,Spain,Madrid,51.0,Male,Ovarian,II,2017-12-09,2018-06-05,2018-08-16,,Public,Deceased,37.0,EGFR,Yes,Never,Moderate,,Medium,Rural,NHS,11.0,No,No,Cardiovascular Disease,4.0
PT02888,Norway,Trøndelag,20.0,Female,Ovarian,I,2017-11-16,2017-12-10,2018-11-12,,Public,Alive,37.0,KRAS,Yes,Never,None,30.0,Medium,Rural,Private Insurance,8.0,No,No,Obesity,4.0
PT02889,Portugal,Lisbon,36.0,Female,Ovarian,I,2023-12-23,2024-04-25,2024-06-14,Radiation,Private,Alive,11.0,None,No,Never,Moderate,,Medium,Urban,Private Insurance,15.0,No,Yes,None,
PT02890,Finland,Pirkanmaa,28.0,Male,Leukemia,IV,2013-05-21,2013-09-24,2014-03-24,Chemotherapy,Public,Alive,11.0,EGFR,No,Current,None,31.7,Low,Rural,Statutory Health Insurance,4.0,No,No,Obesity,6.0
PT02891,Spain,Catalonia,64.0,Male,Breast,IV,2012-10-04,2012-11-22,2013-04-22,Surgery,Public,Alive,77.0,,Yes,Never,Moderate,36.1,Low,Urban,NHS,8.0,No,No,None,10.0
PT02892,Switzerland,Geneva,85.0,Male,Pancreatic,III,2023-03-23,2023-08-06,2024-02-23,Surgery,Public,Alive,113.0,BRCA1,,Never,None,,Medium,,Statutory Health Insurance,,Yes,Yes,Diabetes,7.0
PT02893,Austria,Tyrol,51.0,Non-binary,Pancreatic,IV,2015-11-09,2016-01-23,2016-09-19,Surgery,,Alive,16.0,None,No,,None,22.1,,Rural,NHS,5.0,No,No,Cardiovascular Disease,1.0
PT02894,Italy,Lombardy,64.0,Female,Lung,IV,2022-01-28,2022-05-18,2022-10-27,Immunotherapy,Private,Alive,34.0,BRCA1,No,Former,Moderate,38.4,Low,Urban,Statutory Health Insurance,,No,Yes,Diabetes,2.0
PT02895,Sweden,Västra Götaland,28.0,Female,Prostate,,2015-11-30,2015-12-06,2016-10-30,Surgery,Public,Alive,38.0,KRAS,No,Current,None,32.6,Medium,Urban,Private Insurance,6.0,No,No,Obesity,5.0
PT02896,Sweden,Skåne,49.0,Female,Leukemia,II,2018-09-20,2018-10-30,2019-07-05,Immunotherapy,Public,Alive,6.0,None,No,Former,Moderate,27.1,Medium,Urban,NHS,19.0,No,No,Cardiovascular Disease,9.0
PT02897,Denmark,,57.0,Male,,IV,2011-01-09,2011-03-31,2012-03-28,,,Alive,96.0,,No,Former,None,26.0,Low,Urban,Private Insurance,2.0,Yes,No,Obesity,1.0
PT02898,France,Île-de-France,79.0,Non-binary,Colorectal,II,2013-07-10,2013-10-27,2014-01-29,Radiation,Public,Deceased,77.0,EGFR,No,Never,Moderate,34.5,Medium,Urban,Private Insurance,12.0,No,No,Cardiovascular Disease,1.0
PT02899,Norway,Oslo,20.0,Male,Leukemia,I,,2011-05-28,2011-12-02,Surgery,Private,Alive,82.0,KRAS,No,Former,Moderate,37.5,Low,Rural,NHS,8.0,No,No,Obesity,1.0
PT02900,Poland,Silesian,24.0,Male,Colorectal,II,2022-04-01,,2023-04-17,Targeted Therapy,Private,Alive,42.0,,No,Former,None,29.7,Medium,Urban,Statutory Health Insurance,10.0,No,No,Cardiovascular Disease,3.0
PT02901,Portugal,Lisbon,82.0,Female,Prostate,II,2023-06-26,2023-06-28,2023-11-18,,Public,Alive,42.0,KRAS,No,Never,Moderate,20.9,High,Urban,Private Insurance,2.0,No,Yes,Cardiovascular Disease,5.0
PT02902,Sweden,Västra Götaland,55.0,Male,Leukemia,IV,2023-06-22,2023-11-27,2024-03-09,Targeted Therapy,Public,Alive,111.0,None,Yes,Never,Moderate,37.1,Low,Urban,Statutory Health Insurance,5.0,No,No,Hypertension,5.0
PT02903,Poland,Silesian,84.0,Female,Leukemia,III,2020-09-30,2021-03-09,2022-02-12,Surgery,Public,Alive,111.0,EGFR,Yes,Former,Moderate,26.9,High,Urban,Private Insurance,17.0,No,No,Hypertension,8.0
PT02904,Norway,Oslo,43.0,Male,Ovarian,IV,2023-01-22,2023-03-13,2023-06-10,Radiation,Research Institute,Alive,,BRCA1,No,Never,Moderate,37.6,Low,Urban,NHS,,No,No,Cardiovascular Disease,9.0
PT02905,Belgium,Brussels,23.0,Female,Lung,III,2018-07-14,2018-12-05,2019-09-14,Surgery,Private,Alive,31.0,KRAS,Yes,Former,Heavy,34.9,Low,Urban,Statutory Health Insurance,,No,No,Hypertension,7.0
PT02906,Poland,Lesser Poland,,Male,Breast,II,2013-07-18,2013-10-09,2014-07-08,Immunotherapy,Research Institute,Deceased,46.0,KRAS,Yes,Never,None,25.2,High,Rural,Statutory Health Insurance,2.0,No,Yes,Hypertension,2.0
PT02907,Denmark,Central Denmark,44.0,Male,Leukemia,III,2020-11-20,,2021-05-28,Surgery,Public,Alive,,None,No,Never,Moderate,20.5,,Urban,Private Insurance,17.0,No,Yes,Cardiovascular Disease,2.0
PT02908,Portugal,Porto,26.0,Female,Prostate,I,2010-06-23,2010-12-15,2011-11-04,Chemotherapy,Public,Alive,109.0,KRAS,Yes,Current,,29.2,Medium,Rural,Statutory Health Insurance,8.0,No,No,Diabetes,8.0
PT02909,Portugal,Lisbon,32.0,Female,Leukemia,II,2021-04-24,2021-05-27,2021-10-07,Immunotherapy,Private,Alive,101.0,BRCA1,No,Former,None,19.8,Medium,Rural,Private Insurance,11.0,No,No,None,8.0
PT02910,Belgium,Brussels,87.0,Non-binary,Leukemia,III,2022-01-15,2022-05-23,2022-08-08,Targeted Therapy,Public,Deceased,47.0,KRAS,Yes,Never,None,36.2,Medium,Urban,Statutory Health Insurance,5.0,Yes,Yes,None,3.0
PT02911,Denmark,Zealand,62.0,Female,Leukemia,III,2023-08-22,2023-11-28,2024-03-16,Surgery,Private,Deceased,65.0,EGFR,Yes,Never,None,19.2,Low,Urban,Statutory Health Insurance,13.0,,,Cardiovascular Disease,2.0
PT02912,Germany,Berlin,76.0,Female,Ovarian,III,2015-09-12,,2016-04-07,Surgery,Private,Alive,93.0,BRCA1,Yes,Never,None,38.7,High,Urban,Statutory Health Insurance,9.0,Yes,No,Hypertension,3.0
PT02913,Denmark,Capital Region,55.0,Female,Leukemia,I,2020-07-01,2020-08-05,2021-06-02,Surgery,Research Institute,Deceased,8.0,EGFR,No,Former,Moderate,28.9,Medium,Rural,NHS,18.0,No,No,Diabetes,7.0
PT02914,Germany,North Rhine-Westphalia,33.0,Male,Prostate,III,2016-08-26,2016-11-19,2017-08-08,Chemotherapy,Public,Alive,18.0,KRAS,No,Never,None,28.6,Medium,Urban,NHS,7.0,Yes,Yes,Diabetes,3.0
PT02915,Italy,Sicily,46.0,Male,Lung,I,2017-08-05,2017-11-01,2018-08-11,Radiation,Private,Deceased,16.0,BRCA1,No,Never,None,36.5,Medium,Urban,NHS,5.0,,No,Obesity,2.0
PT02916,Ireland,Munster,56.0,Male,Breast,II,2011-11-24,2012-03-04,2012-08-17,Radiation,Research Institute,Alive,62.0,KRAS,No,Former,Moderate,30.0,Medium,Urban,Statutory Health Insurance,2.0,Yes,Yes,Cardiovascular Disease,10.0
PT02917,Austria,Styria,44.0,Female,Prostate,II,2022-11-04,2023-01-03,2023-07-04,Immunotherapy,Private,Alive,74.0,None,No,,Moderate,27.3,Medium,Rural,Private Insurance,16.0,No,No,Diabetes,4.0
PT02918,Portugal,,86.0,Male,Prostate,II,2018-04-18,2018-05-17,2018-08-12,Immunotherapy,Public,Alive,70.0,EGFR,,Current,Moderate,22.5,Medium,Urban,Private Insurance,16.0,No,No,None,1.0
PT02919,Switzerland,Geneva,23.0,Female,Colorectal,I,2012-05-23,2012-06-10,2013-02-14,Chemotherapy,Public,Alive,,KRAS,Yes,Never,Moderate,34.1,High,Urban,Private Insurance,10.0,,No,Obesity,9.0
PT02920,France,Auvergne-Rhône-Alpes,35.0,Female,Breast,II,2022-02-01,2022-03-21,2022-05-07,,Research Institute,Deceased,113.0,BRCA1,,Current,None,29.0,High,Rural,NHS,3.0,No,No,Cardiovascular Disease,10.0
PT02921,Finland,Southwest Finland,38.0,Female,Ovarian,III,2018-06-24,2018-07-05,2018-11-01,Chemotherapy,Public,Alive,37.0,KRAS,No,Current,None,29.1,High,Urban,Statutory Health Insurance,12.0,No,Yes,Hypertension,2.0
PT02922,Norway,Vestland,48.0,Male,Lung,II,2012-01-28,2012-06-07,2013-06-01,Targeted Therapy,Research Institute,Alive,18.0,EGFR,No,Never,None,23.6,Low,Rural,Statutory Health Insurance,7.0,No,Yes,Diabetes,5.0
PT02923,,Capital Region,70.0,Male,Pancreatic,II,2019-12-04,2020-05-22,2020-12-14,Chemotherapy,Public,Alive,,BRCA1,,Former,Moderate,21.2,Low,Urban,,4.0,,No,Obesity,5.0
PT02924,Ireland,Dublin,37.0,Female,,II,2015-10-08,2016-03-02,2016-05-14,,Private,Alive,71.0,BRCA1,No,Former,Moderate,25.0,Medium,Rural,Private Insurance,7.0,No,No,None,5.0
PT02925,Sweden,Stockholm,77.0,Male,Pancreatic,IV,2021-09-12,2021-09-28,2022-05-18,Chemotherapy,Public,Alive,26.0,BRCA1,No,Never,None,35.7,Medium,Rural,Private Insurance,3.0,No,No,Diabetes,4.0
PT02926,France,Provence-Alpes-Côte d'Azur,63.0,Male,Colorectal,IV,2014-04-15,2014-05-26,2014-10-12,Chemotherapy,Research Institute,Alive,,KRAS,Yes,Never,None,,Medium,,Statutory Health Insurance,19.0,No,,None,9.0
PT02927,Spain,Andalusia,35.0,Male,Colorectal,II,2018-07-14,2018-08-26,2019-04-05,Radiation,Public,Lost to Follow-up,,None,Yes,Current,Moderate,25.7,Medium,,Private Insurance,12.0,No,No,None,5.0
PT02928,Spain,Madrid,84.0,Male,Ovarian,II,2019-08-25,2020-02-12,2020-07-18,Surgery,,Alive,75.0,EGFR,Yes,Current,None,24.5,Low,Urban,NHS,9.0,No,Yes,Obesity,10.0
PT02929,,Catalonia,21.0,Male,Prostate,II,2010-11-05,2011-02-04,2011-03-15,Surgery,Public,Deceased,59.0,KRAS,Yes,Former,Heavy,18.1,Medium,Rural,Statutory Health Insurance,18.0,No,No,None,10.0
PT02930,Italy,Sicily,,Female,Lung,I,,2010-07-04,2011-06-17,Radiation,Public,Alive,99.0,None,Yes,Current,Moderate,18.7,High,Urban,Statutory Health Insurance,1.0,Yes,No,Diabetes,4.0
,Norway,Trøndelag,47.0,Male,Pancreatic,II,2012-08-24,,2013-01-22,Chemotherapy,Private,Alive,20.0,,No,Never,Heavy,28.6,Medium,Rural,Private Insurance,17.0,No,No,Hypertension,4.0
PT02932,Belgium,Brussels,84.0,Female,,I,2013-03-09,2013-04-29,2014-03-26,Targeted Therapy,Public,Alive,20.0,BRCA1,Yes,Never,Heavy,23.6,Low,Rural,Statutory Health Insurance,10.0,No,No,Obesity,2.0
PT02933,Portugal,Porto,24.0,,Pancreatic,,2017-09-17,2017-10-14,2018-06-25,Targeted Therapy,Private,Deceased,114.0,KRAS,No,Current,Moderate,38.6,Low,Urban,,1.0,,No,Obesity,10.0
PT02934,,Bern,41.0,Female,Lung,III,2011-01-20,2011-01-29,2011-11-12,Immunotherapy,Public,Alive,116.0,EGFR,No,Current,Moderate,30.3,Medium,Urban,NHS,7.0,Yes,No,Obesity,7.0
PT02935,Finland,Uusimaa,32.0,,Prostate,II,2020-03-08,2020-07-07,2021-03-17,Surgery,Public,Alive,14.0,EGFR,Yes,Never,None,37.8,Medium,Urban,Private Insurance,3.0,No,No,,2.0
PT02936,Sweden,Västra Götaland,84.0,Male,Pancreatic,I,2017-08-27,,2018-10-13,Immunotherapy,,Alive,81.0,None,No,Never,Moderate,22.5,Low,Urban,Statutory Health Insurance,18.0,No,No,Cardiovascular Disease,4.0
PT02937,,Sicily,35.0,Male,Lung,IV,2022-12-03,2023-05-18,2023-07-22,Chemotherapy,,Deceased,76.0,None,Yes,Former,Heavy,20.7,Low,Urban,NHS,10.0,No,Yes,Cardiovascular Disease,1.0
PT02938,Italy,Veneto,83.0,Male,Leukemia,IV,2012-11-22,2013-05-05,2014-02-19,Immunotherapy,Public,Alive,93.0,BRCA1,No,Never,None,36.3,Low,Urban,Private Insurance,,,No,Diabetes,8.0
PT02939,Poland,Silesian,51.0,Female,Colorectal,IV,2014-09-28,2014-11-27,2015-09-28,Chemotherapy,Public,Alive,26.0,EGFR,Yes,Never,Moderate,31.4,,Urban,NHS,14.0,No,No,None,8.0
PT02940,Portugal,Lisbon,70.0,Female,Ovarian,II,2019-06-05,2019-08-01,2020-05-15,Immunotherapy,Public,Alive,14.0,KRAS,No,Never,None,33.6,Medium,Rural,Statutory Health Insurance,1.0,No,Yes,Cardiovascular Disease,7.0
PT02941,Netherlands,Utrecht,77.0,Female,Colorectal,I,2014-07-28,2015-01-19,2015-11-03,Radiation,Public,Alive,101.0,None,No,Current,None,30.1,Low,,NHS,1.0,No,No,,10.0
PT02942,Portugal,Algarve,65.0,Male,Pancreatic,I,2021-02-28,2021-06-22,2022-06-12,Chemotherapy,Private,Alive,71.0,None,,,None,25.9,Medium,Rural,Statutory Health Insurance,19.0,No,No,Cardiovascular Disease,4.0
PT02943,Sweden,Skåne,71.0,Male,Colorectal,I,2021-01-10,2021-03-19,2021-12-01,Targeted Therapy,Private,Alive,76.0,BRCA1,Yes,Never,Moderate,24.3,Low,Urban,,19.0,No,Yes,Obesity,1.0
PT02944,France,Auvergne-Rhône-Alpes,82.0,Male,Ovarian,I,2020-05-02,2020-06-22,2020-10-17,Chemotherapy,Public,Alive,7.0,,No,,None,20.1,Medium,Rural,NHS,19.0,No,No,Obesity,5.0
PT02945,Spain,,79.0,Male,Colorectal,IV,2013-12-30,2014-02-26,2015-01-24,Targeted Therapy,Private,Deceased,61.0,KRAS,Yes,Never,None,19.8,Medium,Urban,Private Insurance,9.0,No,No,None,
PT02946,Germany,Berlin,84.0,,Leukemia,IV,2010-01-06,2010-02-23,2010-07-04,Targeted Therapy,Public,Alive,114.0,BRCA1,No,Never,Moderate,27.9,Low,Urban,,11.0,No,No,Cardiovascular Disease,7.0
PT02947,Italy,Lombardy,,Male,Breast,III,2023-02-08,2023-04-08,2024-02-24,Immunotherapy,Public,Alive,17.0,None,No,Former,Moderate,24.4,Low,Urban,NHS,13.0,No,No,Diabetes,3.0
PT02948,Netherlands,North Holland,76.0,Female,Lung,III,2014-06-30,2014-09-14,2014-10-21,Surgery,Private,Alive,61.0,BRCA1,No,Never,None,30.7,Medium,Rural,Statutory Health Insurance,14.0,No,No,Diabetes,5.0
PT02949,Germany,North Rhine-Westphalia,45.0,,Pancreatic,II,2020-06-26,2020-08-12,2020-12-21,Surgery,Public,Alive,84.0,KRAS,Yes,Former,Moderate,33.6,Low,Urban,Private Insurance,3.0,No,No,Diabetes,5.0
PT02950,Ireland,Connacht,,Female,Colorectal,III,2023-05-13,2023-10-03,2024-02-22,Surgery,Public,,104.0,BRCA1,No,Never,Moderate,32.4,Low,Urban,NHS,4.0,No,No,None,3.0
PT02951,Germany,North Rhine-Westphalia,65.0,Male,Lung,IV,2011-09-09,2011-12-29,2012-08-22,Targeted Therapy,Public,Deceased,56.0,,Yes,Former,None,37.4,Medium,Urban,NHS,17.0,No,,None,3.0
PT02952,Denmark,Central Denmark,66.0,Female,Lung,III,2012-06-04,2012-09-24,2012-12-07,Surgery,Private,Deceased,75.0,None,No,Current,Heavy,34.2,Low,Urban,Private Insurance,17.0,No,No,Hypertension,9.0
PT02953,Ireland,Dublin,57.0,Non-binary,Leukemia,I,2015-09-02,2015-11-13,,Chemotherapy,Public,Alive,64.0,None,Yes,Never,None,26.7,High,Rural,NHS,,No,No,None,10.0
PT02954,Portugal,,40.0,Female,Ovarian,I,2010-06-10,2010-10-09,2011-06-27,Chemotherapy,Public,Alive,76.0,BRCA1,No,Current,Moderate,25.9,Medium,Rural,Private Insurance,9.0,No,No,None,5.0
PT02955,Finland,Pirkanmaa,33.0,Female,Lung,II,2013-05-02,2013-08-05,2014-04-24,Chemotherapy,Public,Alive,16.0,EGFR,Yes,Former,Moderate,19.3,Medium,Urban,NHS,13.0,No,No,Hypertension,5.0
PT02956,Austria,Styria,21.0,Female,,II,2021-06-10,2021-06-12,2021-12-27,Targeted Therapy,Public,Alive,8.0,BRCA1,No,Former,Moderate,30.1,Low,Urban,Statutory Health Insurance,12.0,No,No,None,4.0
PT02957,Belgium,Brussels,89.0,,Colorectal,IV,,2010-09-04,2011-06-28,Targeted Therapy,Private,Alive,39.0,None,,Former,Moderate,32.9,Medium,Rural,Statutory Health Insurance,6.0,No,,Cardiovascular Disease,9.0
PT02958,Germany,Bavaria,52.0,,Pancreatic,III,2020-09-17,2020-10-27,2021-07-20,Surgery,Private,Alive,100.0,EGFR,No,Never,Moderate,25.0,Medium,Urban,Statutory Health Insurance,17.0,Yes,No,Obesity,7.0
PT02959,Italy,,25.0,Female,Lung,III,2017-05-26,2017-11-13,2018-09-02,Immunotherapy,Public,Alive,90.0,EGFR,No,Current,Moderate,36.6,Medium,Urban,NHS,12.0,No,Yes,Cardiovascular Disease,6.0
PT02960,Finland,Uusimaa,56.0,Female,Leukemia,I,2017-02-15,2017-04-04,2018-02-28,Targeted Therapy,,Alive,98.0,KRAS,No,Current,Moderate,26.0,,Rural,NHS,10.0,No,No,Diabetes,3.0
PT02961,Austria,Tyrol,33.0,Non-binary,Pancreatic,II,2022-02-26,2022-04-24,2022-08-19,Radiation,Public,Alive,24.0,EGFR,No,Current,None,25.9,Low,Urban,Private Insurance,15.0,No,No,Cardiovascular Disease,8.0
PT02962,Ireland,Dublin,56.0,Female,Pancreatic,II,2021-03-31,2021-04-12,2021-10-12,Chemotherapy,Research Institute,Lost to Follow-up,,BRCA1,Yes,Never,Moderate,25.0,Medium,Urban,Private Insurance,7.0,No,Yes,Diabetes,9.0
PT02963,Finland,Uusimaa,27.0,Male,Pancreatic,III,2019-11-15,2020-01-22,2020-06-06,Chemotherapy,Public,Deceased,12.0,KRAS,Yes,Never,None,20.1,High,Rural,NHS,18.0,No,No,Diabetes,3.0
PT02964,France,Île-de-France,32.0,,Colorectal,II,2014-04-03,2014-09-29,2015-06-02,Surgery,Private,Deceased,112.0,BRCA1,Yes,Never,Moderate,39.9,Low,Urban,NHS,19.0,Yes,No,None,10.0
PT02965,Belgium,Wallonia,59.0,Non-binary,Leukemia,IV,2011-03-26,2011-06-08,,Immunotherapy,Public,Alive,16.0,BRCA1,No,Former,Moderate,28.6,High,Urban,Private Insurance,5.0,No,,Cardiovascular Disease,4.0
PT02966,France,Auvergne-Rhône-Alpes,77.0,Male,Prostate,III,2022-10-14,2022-11-12,2023-10-19,Chemotherapy,Public,Alive,68.0,KRAS,No,Never,Heavy,38.7,,Urban,Private Insurance,19.0,No,No,Obesity,9.0
PT02967,Sweden,Stockholm,37.0,Male,Breast,III,2021-01-10,2021-04-12,2021-06-17,Targeted Therapy,Research Institute,Deceased,72.0,None,No,Current,Moderate,30.6,Low,Rural,Private Insurance,4.0,No,No,None,4.0
PT02968,Austria,Tyrol,76.0,Female,Lung,IV,2016-12-12,2017-01-10,2017-04-21,,Public,Alive,61.0,KRAS,No,Former,None,37.1,Low,Rural,Private Insurance,16.0,No,Yes,Diabetes,1.0
PT02969,Italy,Veneto,57.0,Male,Lung,IV,2017-06-02,2017-08-24,2018-01-21,Chemotherapy,Private,Alive,108.0,BRCA1,No,Current,None,31.3,Medium,Rural,Private Insurance,18.0,,Yes,Obesity,2.0
,Spain,Madrid,51.0,Male,Lung,I,2022-06-27,2022-10-20,2023-05-09,Surgery,Research Institute,Alive,48.0,BRCA1,No,Former,None,32.3,Low,Urban,NHS,17.0,No,No,Hypertension,9.0
PT02971,Spain,Andalusia,85.0,Male,Ovarian,III,2018-02-05,2018-05-23,2019-02-03,Surgery,Public,Deceased,61.0,EGFR,No,Never,None,38.9,High,Urban,NHS,8.0,No,Yes,Diabetes,
PT02972,Netherlands,North Holland,44.0,Female,Prostate,I,,2017-09-06,2018-05-10,Surgery,Public,Alive,113.0,None,No,Former,None,34.8,Low,Urban,NHS,15.0,No,No,Obesity,9.0
PT02973,Germany,Bavaria,77.0,Male,Pancreatic,II,2014-11-25,2015-03-03,2015-07-05,Targeted Therapy,Public,Deceased,,EGFR,No,Current,Heavy,21.9,High,Urban,Statutory Health Insurance,17.0,No,No,Obesity,9.0
PT02974,Ireland,Connacht,,Male,Pancreatic,I,2021-03-26,2021-05-11,2021-12-03,Surgery,Private,,65.0,KRAS,No,Former,Moderate,32.5,Medium,Urban,Statutory Health Insurance,16.0,No,Yes,Cardiovascular Disease,5.0
PT02975,Sweden,Västra Götaland,85.0,Female,Ovarian,III,2018-11-09,2018-11-29,2019-03-25,Radiation,Research Institute,Alive,38.0,EGFR,No,Never,Heavy,25.5,Medium,Urban,Statutory Health Insurance,4.0,No,No,Hypertension,5.0
PT02976,Belgium,Wallonia,49.0,Female,Breast,II,2010-11-15,2011-01-13,2011-05-24,Targeted Therapy,Private,Lost to Follow-up,,BRCA1,No,Never,None,26.9,Medium,Urban,Statutory Health Insurance,15.0,No,No,Cardiovascular Disease,4.0
PT02977,,Masovian,53.0,Non-binary,Leukemia,III,2015-12-18,2016-04-16,2017-04-04,Radiation,Public,,,EGFR,No,Former,,37.1,Low,Rural,Private Insurance,13.0,No,No,None,6.0
PT02978,Switzerland,Zurich,88.0,Male,Prostate,III,2015-11-27,2016-01-02,2016-06-06,Surgery,Public,Alive,108.0,None,No,Current,Moderate,36.8,Medium,Urban,Private Insurance,8.0,No,No,None,10.0
PT02979,France,Île-de-France,67.0,Female,Prostate,III,2016-12-28,2016-12-29,2017-04-07,Immunotherapy,Private,Alive,101.0,None,No,Never,None,25.8,Low,Rural,NHS,6.0,No,No,Diabetes,5.0
PT02980,Belgium,Brussels,,Male,Colorectal,I,2011-03-05,2011-06-03,2012-02-10,Targeted Therapy,Private,Alive,62.0,BRCA1,No,,None,38.0,Medium,Urban,Private Insurance,17.0,Yes,No,None,4.0
PT02981,Finland,Pirkanmaa,70.0,,Pancreatic,III,2021-11-18,2022-03-29,2023-01-12,Radiation,Public,Alive,57.0,EGFR,No,Never,Moderate,28.4,High,Urban,Private Insurance,6.0,No,No,Obesity,
PT02982,Austria,Vienna,32.0,Female,Prostate,II,2016-10-21,2016-12-04,2017-10-06,Targeted Therapy,Private,Alive,9.0,BRCA1,No,Former,None,24.3,Medium,Urban,Statutory Health Insurance,7.0,Yes,No,None,10.0
PT02983,Denmark,Central Denmark,50.0,Male,Prostate,II,2022-01-20,2022-03-21,2023-02-11,Radiation,Research Institute,Lost to Follow-up,,KRAS,No,Former,None,19.0,Medium,Urban,Statutory Health Insurance,9.0,No,No,Cardiovascular Disease,3.0
PT02984,France,Provence-Alpes-Côte d'Azur,58.0,Female,Lung,IV,2012-06-19,2012-10-28,2013-02-18,,Private,Alive,104.0,BRCA1,No,,Moderate,24.8,Low,Urban,NHS,16.0,No,,Obesity,8.0
PT02985,Denmark,Capital Region,82.0,Male,,,2014-06-09,2014-09-02,2015-02-12,Chemotherapy,Public,Deceased,22.0,BRCA1,Yes,Former,None,34.9,Medium,,Statutory Health Insurance,16.0,Yes,Yes,Cardiovascular Disease,3.0
,Germany,North Rhine-Westphalia,67.0,Female,Pancreatic,II,2019-04-22,2019-07-13,,Radiation,Public,Deceased,,KRAS,No,Never,None,28.6,Low,Rural,Statutory Health Insurance,13.0,No,Yes,Diabetes,2.0
PT02987,Austria,Styria,67.0,Male,Colorectal,,2012-01-19,2012-06-26,2012-08-05,Radiation,Public,,47.0,,No,Never,Moderate,22.7,Low,Rural,NHS,19.0,Yes,No,Hypertension,2.0
PT02988,France,Île-de-France,80.0,Female,Leukemia,I,2023-05-05,2023-07-05,2024-02-29,Targeted Therapy,Private,Deceased,106.0,KRAS,No,Current,,28.5,Low,Urban,Private Insurance,11.0,No,Yes,Diabetes,8.0
PT02989,Denmark,Capital Region,31.0,Male,Breast,II,,2021-11-17,2022-02-27,Immunotherapy,Public,Alive,65.0,BRCA1,,Never,Moderate,38.0,High,Urban,Private Insurance,1.0,No,Yes,Cardiovascular Disease,5.0
PT02990,Sweden,Skåne,75.0,Male,Leukemia,III,2016-08-08,2016-09-21,2017-03-09,Chemotherapy,Public,Alive,31.0,BRCA1,No,Never,None,24.4,Medium,Urban,Statutory Health Insurance,12.0,No,No,None,3.0
PT02991,Switzerland,Zurich,37.0,Non-binary,Colorectal,I,2012-10-24,2012-11-24,2013-10-06,Radiation,Private,Alive,53.0,None,Yes,Former,Moderate,33.1,Medium,Urban,Private Insurance,1.0,No,Yes,None,8.0
PT02992,Denmark,Zealand,46.0,Female,Lung,II,2021-08-15,2021-10-26,2022-05-02,Surgery,Private,Alive,69.0,BRCA1,No,Never,Moderate,20.9,Medium,Rural,NHS,16.0,No,No,Obesity,9.0
PT02993,,Provence-Alpes-Côte d'Azur,,Non-binary,,III,2018-07-30,2018-10-27,2019-05-15,Surgery,Public,Alive,,KRAS,No,Never,None,37.2,Low,Urban,Private Insurance,1.0,No,No,None,
PT02994,Switzerland,Geneva,71.0,Male,,III,,2018-04-07,2018-11-08,Targeted Therapy,Public,Deceased,103.0,EGFR,No,Current,Moderate,29.2,High,Urban,Statutory Health Insurance,18.0,No,No,Cardiovascular Disease,9.0
PT02995,Belgium,Brussels,35.0,Male,Pancreatic,III,2013-02-14,2013-04-01,2013-06-19,Immunotherapy,Private,Alive,118.0,EGFR,No,Never,Moderate,24.3,Medium,Rural,NHS,6.0,No,No,Cardiovascular Disease,
PT02996,Belgium,Flanders,77.0,Female,Pancreatic,IV,2010-08-26,2011-01-12,2011-10-15,Chemotherapy,Private,Deceased,77.0,KRAS,,Former,Moderate,36.8,Low,Urban,Statutory Health Insurance,3.0,No,No,Diabetes,6.0
PT02997,Italy,Veneto,28.0,Female,Breast,II,2023-03-19,,2024-02-23,Radiation,Private,Alive,78.0,KRAS,Yes,Former,Moderate,21.1,High,Urban,NHS,15.0,No,Yes,Cardiovascular Disease,5.0
PT02998,Finland,Pirkanmaa,45.0,Male,Breast,III,2022-06-20,2022-08-24,2022-11-02,Surgery,Public,Alive,12.0,None,,Never,None,25.8,Medium,Urban,Private Insurance,9.0,No,No,Diabetes,1.0
PT02999,France,Auvergne-Rhône-Alpes,47.0,Female,Breast,III,2016-12-07,2017-05-01,2017-09-19,Radiation,Public,Deceased,70.0,BRCA1,Yes,,Moderate,21.7,Medium,Urban,Private Insurance,15.0,,No,Cardiovascular Disease,3.0
PT03000,Sweden,Stockholm,55.0,Male,Prostate,II,2014-10-21,2015-02-14,2015-10-05,Surgery,Research Institute,Alive,57.0,KRAS,No,Never,None,37.2,Low,Urban,Statutory Health Insurance,2.0,No,No,Obesity,6.0
PT03001,Ireland,Munster,28.0,Male,Colorectal,,2023-03-03,2023-03-31,2023-11-20,Targeted Therapy,Private,Deceased,109.0,KRAS,,Never,None,27.6,Medium,Urban,Private Insurance,1.0,Yes,No,Cardiovascular Disease,8.0
PT03002,Spain,Andalusia,,Male,,IV,2014-05-30,2014-08-20,2015-03-09,Targeted Therapy,Public,Alive,,BRCA1,No,Never,None,24.5,,Rural,NHS,12.0,No,No,Diabetes,10.0
PT03003,Germany,Berlin,70.0,Female,Pancreatic,I,2018-07-16,2018-09-28,2019-03-03,Radiation,Research Institute,Deceased,21.0,EGFR,No,Former,Moderate,36.8,,Urban,Private Insurance,11.0,No,No,None,9.0
PT03004,Ireland,Munster,76.0,Female,Colorectal,III,2022-02-26,2022-03-07,2022-06-10,Targeted Therapy,,Alive,119.0,BRCA1,No,Current,,37.9,Medium,Urban,Statutory Health Insurance,13.0,No,,None,6.0
PT03005,Ireland,Munster,51.0,Female,Lung,III,2014-01-27,2014-07-08,2015-05-04,Chemotherapy,Public,Deceased,71.0,BRCA1,No,Never,Moderate,20.1,Low,Urban,NHS,6.0,No,No,None,5.0
PT03006,Italy,Veneto,86.0,Female,Pancreatic,II,2023-01-11,2023-06-08,2023-08-10,Targeted Therapy,Private,Alive,77.0,EGFR,No,Former,Moderate,31.2,Medium,Rural,NHS,,Yes,Yes,Hypertension,
PT03007,Sweden,,,Male,Leukemia,,2018-09-30,2019-02-08,2019-09-23,Chemotherapy,Public,Deceased,91.0,EGFR,Yes,Former,None,30.2,Medium,Rural,Statutory Health Insurance,11.0,No,Yes,Obesity,5.0
PT03008,Norway,Trøndelag,73.0,Female,,,2010-09-03,2011-01-10,2011-03-24,Targeted Therapy,Public,Deceased,61.0,BRCA1,No,Never,Moderate,36.3,Low,Rural,Private Insurance,1.0,No,No,Hypertension,3.0
PT03009,Switzerland,Zurich,35.0,Female,Ovarian,III,2013-07-01,2013-08-30,2014-06-08,Radiation,Public,Alive,32.0,KRAS,Yes,Former,,29.1,Medium,Urban,Statutory Health Insurance,16.0,No,No,Cardiovascular Disease,2.0
,Norway,Oslo,81.0,,Ovarian,I,2016-05-17,2016-08-22,2017-02-28,Chemotherapy,Public,Alive,23.0,KRAS,No,Current,Moderate,,Low,Urban,NHS,10.0,No,No,Hypertension,4.0
,Germany,North Rhine-Westphalia,75.0,Male,Leukemia,II,2014-04-06,2014-05-26,2015-05-25,Immunotherapy,Public,Deceased,68.0,None,Yes,Current,Heavy,39.4,Low,Urban,NHS,2.0,No,No,None,3.0
PT03012,Spain,Madrid,42.0,Female,Breast,II,2014-04-07,,2015-01-15,Radiation,Private,Deceased,85.0,EGFR,,,Moderate,30.0,Medium,Urban,NHS,16.0,No,No,None,5.0
PT03013,Belgium,Brussels,36.0,Female,Pancreatic,III,2016-02-01,2016-06-26,2017-05-17,Chemotherapy,Research Institute,,31.0,BRCA1,No,,None,32.0,Medium,Rural,Statutory Health Insurance,8.0,No,No,Diabetes,6.0
PT03014,Belgium,Wallonia,57.0,Non-binary,Leukemia,III,2016-05-21,2016-06-20,2017-04-07,Surgery,Public,,,KRAS,Yes,Current,None,19.1,Medium,Urban,Statutory Health Insurance,2.0,No,No,Obesity,9.0
PT03015,Denmark,Zealand,49.0,Non-binary,Leukemia,I,2010-11-01,2011-02-06,2011-05-21,Surgery,Public,Alive,63.0,BRCA1,Yes,Former,Moderate,35.6,Medium,Urban,Statutory Health Insurance,11.0,No,Yes,None,
PT03016,Sweden,Västra Götaland,77.0,Female,,II,2018-01-01,2018-05-31,2018-07-13,Immunotherapy,Public,Alive,6.0,EGFR,No,Current,Moderate,37.9,Low,Urban,Statutory Health Insurance,18.0,No,No,Obesity,7.0
PT03017,Belgium,Brussels,41.0,Male,Ovarian,II,2012-03-03,2012-05-23,2012-06-26,,,Deceased,101.0,BRCA1,No,Never,None,24.4,Medium,Rural,,9.0,No,No,Hypertension,3.0
PT03018,Denmark,Zealand,36.0,Female,Lung,III,2011-02-11,2011-02-20,2012-01-16,Radiation,Private,Deceased,51.0,EGFR,No,Current,Moderate,24.3,Medium,Urban,Private Insurance,6.0,Yes,No,Obesity,7.0
PT03019,,Styria,34.0,Female,Leukemia,III,2022-02-14,,2022-10-10,Chemotherapy,Public,,91.0,None,Yes,Former,Heavy,22.5,Low,Rural,NHS,4.0,No,No,Hypertension,3.0
PT03020,Sweden,Västra Götaland,67.0,Female,Pancreatic,II,2016-06-10,2016-10-26,2017-06-13,Radiation,Public,Alive,32.0,None,No,Never,None,30.0,Low,Urban,NHS,9.0,No,No,Hypertension,9.0
PT03021,Switzerland,Geneva,,Male,Lung,I,2015-07-31,2015-10-06,2016-08-29,,Research Institute,Alive,107.0,EGFR,Yes,Never,Moderate,18.5,Low,Rural,Private Insurance,7.0,No,Yes,Obesity,10.0
PT03022,Switzerland,Zurich,59.0,Male,Lung,I,,2018-02-23,2018-11-30,Targeted Therapy,Private,Alive,49.0,None,No,Never,None,20.8,Medium,Rural,Statutory Health Insurance,8.0,No,No,Obesity,5.0
,Portugal,Porto,76.0,Male,Colorectal,I,2017-06-09,2017-07-26,2018-01-26,Surgery,Public,Alive,38.0,KRAS,No,Former,Heavy,31.5,Medium,Urban,NHS,11.0,Yes,Yes,None,5.0
PT03024,Netherlands,Utrecht,77.0,Male,Ovarian,III,2017-09-21,2017-10-31,2018-06-14,Immunotherapy,Public,,99.0,EGFR,No,Current,Moderate,28.7,Medium,Urban,Private Insurance,16.0,No,Yes,Hypertension,10.0
PT03025,Spain,Andalusia,35.0,Male,Pancreatic,I,2022-09-21,2022-10-27,2023-02-02,Immunotherapy,Research Institute,Alive,88.0,EGFR,No,Never,None,34.4,Low,Urban,NHS,,No,No,Hypertension,1.0
,Norway,Vestland,47.0,Female,Pancreatic,II,2018-05-01,2018-09-25,2018-12-11,Targeted Therapy,Private,Alive,38.0,KRAS,Yes,Former,None,34.3,High,Urban,Private Insurance,7.0,No,No,Cardiovascular Disease,7.0
PT03027,Norway,Oslo,20.0,Male,Breast,III,2020-12-16,2021-03-24,2021-12-27,Immunotherapy,Private,Lost to Follow-up,,KRAS,,Never,None,27.6,High,Urban,Statutory Health Insurance,12.0,No,No,None,10.0
PT03028,Netherlands,South Holland,60.0,Male,Breast,IV,2013-09-22,2013-09-24,2014-06-12,Immunotherapy,Public,Deceased,59.0,EGFR,,Former,Moderate,32.9,High,Urban,Statutory Health Insurance,15.0,No,,Diabetes,8.0
PT03029,France,Provence-Alpes-Côte d'Azur,67.0,Male,Prostate,IV,2012-11-19,2013-05-11,2013-09-28,Surgery,Private,Alive,,None,Yes,Current,Heavy,36.9,Medium,Rural,Private Insurance,15.0,No,No,None,
PT03030,Ireland,Munster,,Male,Pancreatic,IV,2011-03-16,2011-06-07,2012-05-30,Radiation,Private,Deceased,11.0,KRAS,Yes,Never,Moderate,31.1,Medium,Urban,Statutory Health Insurance,10.0,Yes,No,None,2.0
PT03031,Spain,Andalusia,55.0,Non-binary,Ovarian,III,2021-12-02,2022-05-12,2023-03-18,Radiation,Private,Alive,53.0,BRCA1,Yes,Never,Moderate,39.3,Medium,Urban,NHS,4.0,No,No,None,2.0
PT03032,Belgium,Wallonia,52.0,Male,Lung,III,2012-02-22,2012-04-26,2012-10-08,Chemotherapy,Public,Lost to Follow-up,,BRCA1,No,Never,None,39.9,High,Urban,NHS,16.0,No,No,Hypertension,1.0
PT03033,Poland,Silesian,52.0,Male,Prostate,III,2017-02-23,2017-07-27,2017-11-11,Radiation,Private,Alive,98.0,EGFR,No,Current,None,29.3,Low,Urban,Private Insurance,14.0,No,No,Cardiovascular Disease,6.0
PT03034,Denmark,Central Denmark,42.0,Female,Pancreatic,IV,2014-12-20,2015-04-18,2016-01-03,Radiation,Public,Alive,65.0,KRAS,No,,None,23.7,High,,Private Insurance,18.0,No,Yes,None,1.0
PT03035,Switzerland,Geneva,79.0,Female,Breast,IV,2010-08-22,2010-12-11,2011-09-21,Surgery,Public,Alive,67.0,BRCA1,Yes,Never,Moderate,35.3,Low,,NHS,1.0,No,No,Obesity,
PT03036,Austria,Styria,49.0,Male,Ovarian,II,2015-09-05,2016-02-14,2016-08-21,Surgery,Public,Deceased,20.0,KRAS,No,Never,Moderate,21.8,Medium,Urban,Private Insurance,11.0,No,No,None,
PT03037,Sweden,Skåne,,Female,Breast,II,2016-08-28,2017-01-31,2017-05-01,,Public,Deceased,,BRCA1,Yes,Former,Moderate,35.0,Medium,Urban,Private Insurance,6.0,No,No,Diabetes,1.0
PT03038,Netherlands,North Holland,58.0,Female,Pancreatic,II,2022-04-16,2022-07-17,2022-11-10,Chemotherapy,Public,Alive,64.0,BRCA1,Yes,Never,Moderate,,Medium,Urban,Private Insurance,8.0,Yes,No,Cardiovascular Disease,5.0
PT03039,Switzerland,Zurich,64.0,Female,Prostate,III,2011-04-07,2011-06-24,2011-07-24,Radiation,Private,Alive,43.0,EGFR,No,Former,None,35.1,Medium,Urban,Private Insurance,6.0,No,No,Hypertension,6.0
PT03040,Germany,Berlin,31.0,Female,Breast,III,2014-10-18,,2015-03-13,Radiation,Private,Deceased,20.0,KRAS,No,Former,Moderate,24.6,Low,Urban,Statutory Health Insurance,18.0,No,Yes,Obesity,6.0
PT03041,Switzerland,Geneva,51.0,,Breast,,2012-04-18,2012-09-04,2013-03-11,Targeted Therapy,Public,Deceased,36.0,KRAS,Yes,Never,Moderate,28.0,Medium,Urban,Private Insurance,14.0,No,No,Hypertension,8.0
PT03042,Portugal,Lisbon,75.0,Male,Colorectal,II,2018-10-15,,2019-08-20,Chemotherapy,Private,Deceased,119.0,EGFR,Yes,Never,None,36.4,Medium,Urban,NHS,1.0,Yes,No,Cardiovascular Disease,8.0
PT03043,Belgium,Brussels,43.0,Male,Leukemia,II,2017-08-16,2017-09-05,2017-12-13,Radiation,Public,Deceased,70.0,KRAS,No,Former,None,25.5,Medium,Urban,Statutory Health Insurance,19.0,No,No,Diabetes,3.0
PT03044,Finland,Southwest Finland,32.0,Male,Pancreatic,IV,2021-07-07,2021-12-18,2022-04-07,Surgery,Research Institute,,25.0,KRAS,Yes,Never,Moderate,,Medium,Rural,NHS,10.0,No,No,None,1.0
PT03045,France,Auvergne-Rhône-Alpes,39.0,Male,Colorectal,I,2013-09-13,2014-01-04,2014-08-23,,Public,Deceased,34.0,BRCA1,Yes,Never,Heavy,30.7,Medium,Rural,Statutory Health Insurance,5.0,No,No,Obesity,
PT03046,Italy,,75.0,Female,Ovarian,I,2010-07-25,2010-08-10,2010-12-10,Immunotherapy,Public,Alive,117.0,BRCA1,No,,None,32.1,Medium,Urban,Statutory Health Insurance,,Yes,Yes,None,6.0
PT03047,Sweden,,72.0,Female,Leukemia,III,2012-12-30,2013-06-21,2013-09-30,Targeted Therapy,Private,Deceased,80.0,KRAS,No,Current,None,22.2,Medium,Rural,Private Insurance,1.0,No,No,Diabetes,2.0
PT03048,Germany,Bavaria,87.0,Male,Pancreatic,I,2021-10-15,2021-12-02,2022-02-26,Targeted Therapy,Public,Alive,78.0,KRAS,No,Never,Moderate,31.5,Medium,Urban,Statutory Health Insurance,16.0,No,No,Cardiovascular Disease,6.0
PT03049,Italy,Sicily,73.0,Male,Colorectal,II,2010-07-04,2010-10-25,2010-12-04,Targeted Therapy,Public,Alive,21.0,KRAS,No,,Moderate,28.6,Medium,Rural,NHS,9.0,No,No,,6.0
PT03050,Norway,Vestland,53.0,Male,,I,2017-08-24,2017-08-28,2018-02-19,Chemotherapy,Public,Alive,85.0,BRCA1,No,Never,None,35.4,Medium,Rural,Statutory Health Insurance,8.0,No,No,Obesity,7.0
PT03051,Germany,North Rhine-Westphalia,47.0,,Pancreatic,I,2023-08-27,2024-02-19,,Targeted Therapy,Private,Deceased,38.0,BRCA1,No,Current,Moderate,32.4,Medium,,Private Insurance,9.0,No,No,Diabetes,9.0
PT03052,France,Île-de-France,69.0,Female,Lung,II,2022-04-22,2022-07-29,2023-03-23,Radiation,Public,Alive,60.0,BRCA1,No,Never,None,29.0,Medium,Urban,Statutory Health Insurance,10.0,No,,Cardiovascular Disease,
PT03053,Denmark,Capital Region,21.0,Female,Prostate,II,2017-06-22,2017-10-09,2018-02-06,Chemotherapy,Public,Deceased,24.0,EGFR,Yes,Former,Moderate,36.9,,Urban,Private Insurance,9.0,No,No,None,9.0
PT03054,Finland,Pirkanmaa,45.0,Female,Pancreatic,II,2023-11-22,2024-04-26,2024-08-20,,Public,Alive,94.0,None,No,Never,None,31.2,High,Urban,Private Insurance,5.0,No,No,Hypertension,9.0
PT03055,Poland,Silesian,70.0,Female,Colorectal,I,2010-11-10,2011-04-17,2011-09-02,Surgery,Public,Alive,55.0,EGFR,No,Never,None,28.3,Low,Urban,Statutory Health Insurance,13.0,Yes,No,Diabetes,2.0
PT03056,Sweden,Västra Götaland,66.0,Female,Lung,III,2010-08-16,2010-09-14,2011-07-23,Targeted Therapy,Public,Deceased,39.0,KRAS,No,Never,Heavy,,Medium,Urban,Statutory Health Insurance,6.0,No,Yes,Cardiovascular Disease,8.0
PT03057,Switzerland,Geneva,45.0,Male,Colorectal,II,2018-06-21,2018-11-17,2019-07-09,Radiation,Research Institute,Alive,69.0,None,No,Current,None,22.5,High,Urban,Private Insurance,3.0,No,No,None,9.0
PT03058,Poland,,80.0,Female,Prostate,,2020-11-01,2020-12-13,,Chemotherapy,,Lost to Follow-up,,None,Yes,Former,None,21.3,Medium,Urban,Statutory Health Insurance,5.0,No,No,None,4.0
PT03059,Switzerland,,42.0,Female,Ovarian,I,2021-03-19,2021-07-25,2022-05-15,Radiation,Public,Alive,108.0,KRAS,Yes,Current,Moderate,36.1,Low,Urban,NHS,9.0,Yes,No,Hypertension,1.0
PT03060,Spain,Madrid,56.0,Female,Lung,II,2017-07-02,2017-08-21,2018-06-15,Targeted Therapy,Public,Alive,29.0,None,Yes,Never,Moderate,18.8,Low,Urban,Private Insurance,5.0,Yes,,Obesity,5.0
PT03061,Netherlands,South Holland,60.0,Non-binary,Pancreatic,II,2012-07-15,2012-10-12,2013-08-01,Surgery,Private,Lost to Follow-up,,BRCA1,No,Never,None,39.3,High,Urban,Statutory Health Insurance,,No,No,None,10.0
PT03062,Finland,Southwest Finland,71.0,Female,Leukemia,II,2019-02-19,2019-06-25,2019-11-15,Chemotherapy,Public,Deceased,118.0,KRAS,No,Never,,31.0,Medium,Rural,Statutory Health Insurance,6.0,Yes,Yes,Diabetes,1.0
PT03063,,Veneto,68.0,Female,Ovarian,IV,2018-07-19,2018-07-22,2019-06-28,Radiation,Private,Alive,37.0,EGFR,No,Never,None,20.5,,Urban,Private Insurance,6.0,No,Yes,Cardiovascular Disease,4.0
PT03064,Switzerland,Geneva,46.0,Female,Prostate,IV,2015-10-10,2015-11-02,2016-07-07,,Public,Alive,108.0,None,No,Former,Moderate,35.9,Medium,Urban,Private Insurance,1.0,Yes,No,Diabetes,4.0
PT03065,,Masovian,25.0,Male,,III,2016-06-13,2016-09-28,2017-06-17,Targeted Therapy,Private,Alive,8.0,None,No,Never,None,37.3,High,Rural,Statutory Health Insurance,14.0,Yes,No,,8.0
PT03066,Poland,Silesian,85.0,Female,Pancreatic,I,2011-06-21,2011-06-26,2011-10-30,Targeted Therapy,Public,Deceased,18.0,None,No,,Moderate,,High,Urban,Statutory Health Insurance,15.0,No,Yes,Diabetes,6.0
PT03067,Netherlands,Utrecht,43.0,Female,Pancreatic,III,2021-06-02,2021-06-27,2021-08-02,Immunotherapy,Public,Alive,99.0,None,No,Never,,26.0,Medium,Urban,,3.0,No,No,None,9.0
PT03068,Austria,Styria,57.0,Male,Pancreatic,I,2013-12-12,2014-01-16,2014-05-02,Immunotherapy,Private,Deceased,92.0,EGFR,No,Current,None,36.6,High,Urban,Statutory Health Insurance,17.0,Yes,No,Hypertension,
PT03069,France,Auvergne-Rhône-Alpes,47.0,Female,Lung,III,2019-04-23,,2019-12-01,Targeted Therapy,Private,Alive,99.0,KRAS,No,Current,Moderate,,Medium,Urban,Statutory Health Insurance,17.0,No,,Cardiovascular Disease,6.0
PT03070,Denmark,Central Denmark,47.0,Female,,,2019-03-07,2019-04-15,2019-11-14,Chemotherapy,Private,Alive,17.0,None,No,Current,None,29.3,Medium,Urban,,3.0,No,,Cardiovascular Disease,2.0
PT03071,Norway,Vestland,85.0,Female,Ovarian,,2018-08-13,2018-12-14,2019-04-26,Radiation,Public,Alive,67.0,BRCA1,No,Former,Moderate,,Medium,Urban,Private Insurance,13.0,No,No,Cardiovascular Disease,3.0
PT03072,Denmark,Central Denmark,80.0,Non-binary,Ovarian,IV,2011-09-01,2011-12-21,2012-04-12,Radiation,Public,Alive,50.0,KRAS,Yes,Former,None,20.8,High,Urban,NHS,14.0,No,No,None,9.0
PT03073,Switzerland,Zurich,65.0,Male,Lung,II,2011-09-04,2011-09-22,2012-08-09,Chemotherapy,Private,Alive,107.0,None,Yes,Current,Moderate,37.5,Low,Urban,Private Insurance,12.0,No,No,Cardiovascular Disease,1.0
PT03074,Finland,Pirkanmaa,88.0,Female,Leukemia,II,2012-10-17,2012-11-11,2013-02-12,Surgery,Public,Alive,29.0,EGFR,No,Current,Moderate,38.4,Medium,Rural,NHS,1.0,No,Yes,Hypertension,6.0
PT03075,Poland,Lesser Poland,62.0,Female,Lung,II,2023-05-13,2023-08-21,,Chemotherapy,Public,Lost to Follow-up,,None,No,Never,Moderate,18.3,Medium,Urban,Statutory Health Insurance,5.0,No,No,Cardiovascular Disease,5.0
PT03076,Switzerland,Bern,78.0,,Pancreatic,,2010-08-29,2011-01-05,2011-02-20,Targeted Therapy,Private,Alive,29.0,KRAS,Yes,Former,Moderate,33.0,Low,Rural,NHS,3.0,Yes,No,Cardiovascular Disease,8.0
PT03077,Italy,Sicily,21.0,Male,Colorectal,IV,2015-08-15,2015-12-30,2016-04-30,Targeted Therapy,Public,Alive,99.0,EGFR,No,,None,24.2,High,Urban,,13.0,No,No,None,1.0
PT03078,Switzerland,Geneva,34.0,Female,Breast,II,2014-05-22,2014-11-07,2015-09-09,Immunotherapy,Public,Alive,86.0,BRCA1,No,Former,Moderate,30.4,High,Urban,Private Insurance,11.0,No,No,Cardiovascular Disease,1.0
PT03079,Sweden,Stockholm,56.0,Female,Breast,I,2016-08-01,2016-11-04,2017-02-19,Radiation,Private,Deceased,20.0,BRCA1,No,Never,None,32.3,Medium,Urban,Private Insurance,11.0,Yes,No,Hypertension,7.0
PT03080,Belgium,,39.0,Female,Ovarian,III,2022-04-17,2022-05-09,2022-09-26,Immunotherapy,Research Institute,Alive,105.0,None,No,Former,Moderate,30.8,Low,Rural,NHS,3.0,No,No,Cardiovascular Disease,7.0
PT03081,Poland,Lesser Poland,54.0,Female,Ovarian,I,2013-11-15,2014-05-07,2015-04-09,Radiation,Public,Alive,55.0,None,Yes,Never,None,32.9,High,Urban,NHS,3.0,No,No,Cardiovascular Disease,3.0
PT03082,,Skåne,53.0,Male,Lung,I,2011-01-04,2011-01-24,2011-05-10,Chemotherapy,Public,Alive,93.0,None,No,Former,None,30.3,Medium,Rural,Statutory Health Insurance,12.0,Yes,No,Obesity,1.0
PT03083,Denmark,Capital Region,50.0,Male,Colorectal,II,2015-09-08,2016-01-07,2016-09-26,Surgery,Public,Alive,101.0,None,No,Former,None,34.3,,Rural,Statutory Health Insurance,12.0,Yes,No,Obesity,6.0
PT03084,Portugal,Lisbon,38.0,Male,Colorectal,III,2013-12-17,2014-05-06,2014-09-07,Radiation,Public,Alive,93.0,BRCA1,Yes,Never,Moderate,29.8,High,Urban,Private Insurance,11.0,No,No,Cardiovascular Disease,5.0
PT03085,Norway,Trøndelag,,Non-binary,Lung,II,2010-01-09,2010-05-13,2011-03-06,Surgery,Private,Alive,72.0,BRCA1,,Never,Moderate,22.5,Medium,Rural,Statutory Health Insurance,10.0,Yes,No,None,1.0
,Poland,Lesser Poland,43.0,Male,Prostate,III,2019-08-18,2019-10-21,2020-01-04,Surgery,Public,Alive,50.0,None,No,Current,None,22.4,Low,Urban,Private Insurance,4.0,No,No,Hypertension,9.0
,Denmark,Zealand,58.0,Non-binary,Leukemia,I,2022-02-16,2022-07-26,2023-07-16,Surgery,Public,Alive,70.0,BRCA1,No,Never,Heavy,32.3,Medium,Urban,NHS,14.0,Yes,No,Cardiovascular Disease,
PT03088,Finland,Pirkanmaa,73.0,Non-binary,Lung,II,,2023-12-26,2024-08-26,Chemotherapy,Public,,25.0,KRAS,Yes,Former,None,29.2,Medium,Urban,NHS,10.0,No,No,None,3.0
PT03089,Norway,,58.0,Non-binary,Pancreatic,II,,2016-08-07,2017-07-29,,Public,Alive,26.0,EGFR,Yes,Never,Moderate,25.9,Low,Urban,Statutory Health Insurance,9.0,No,No,Hypertension,7.0
PT03090,,Oslo,36.0,Male,Colorectal,IV,2011-01-28,2011-05-28,2012-03-28,Surgery,Public,,17.0,None,Yes,Never,None,30.5,Low,Urban,Statutory Health Insurance,,No,No,None,7.0
PT03091,,Stockholm,38.0,Non-binary,,I,2015-01-26,2015-03-11,2015-06-16,Targeted Therapy,Public,Lost to Follow-up,,BRCA1,No,Never,None,39.7,High,Urban,Private Insurance,19.0,No,No,,4.0
PT03092,Germany,North Rhine-Westphalia,67.0,Male,Lung,I,2012-02-18,2012-07-24,2013-06-18,Targeted Therapy,Private,Alive,105.0,BRCA1,Yes,Never,Moderate,31.9,Low,Rural,NHS,8.0,No,No,Diabetes,2.0
PT03093,Portugal,Algarve,54.0,Male,Leukemia,IV,2019-05-25,2019-06-27,2020-05-07,Radiation,Public,Alive,113.0,EGFR,Yes,Never,Moderate,33.3,Medium,Urban,NHS,8.0,No,No,None,6.0
PT03094,Sweden,Stockholm,51.0,Male,Prostate,IV,2014-08-26,2014-11-21,2015-10-03,,Public,Alive,90.0,KRAS,,Never,None,32.7,Medium,Urban,NHS,2.0,No,Yes,None,1.0
PT03095,Italy,Veneto,66.0,Female,Colorectal,III,2018-11-29,2019-03-09,2019-08-12,Radiation,Public,Alive,88.0,EGFR,Yes,Current,None,33.3,Medium,Urban,Private Insurance,12.0,No,No,Cardiovascular Disease,4.0
PT03096,Belgium,Brussels,66.0,Male,Prostate,I,2022-04-10,2022-04-23,2023-01-10,Surgery,Research Institute,Deceased,24.0,,No,Never,Moderate,22.3,Low,Urban,NHS,19.0,No,No,Hypertension,6.0
PT03097,Sweden,Skåne,83.0,Female,Ovarian,II,2018-12-16,2019-02-04,2019-09-03,Targeted Therapy,Public,Alive,106.0,None,No,Never,None,20.9,High,Urban,Private Insurance,17.0,No,Yes,,10.0
PT03098,Ireland,Connacht,65.0,Male,Prostate,II,2018-11-27,2019-04-06,2019-05-19,Immunotherapy,Public,Alive,7.0,None,No,Former,Moderate,35.2,Low,Rural,Private Insurance,7.0,No,No,Obesity,1.0
PT03099,Italy,Lombardy,54.0,Male,Colorectal,III,2019-11-21,2020-04-25,2020-09-03,Chemotherapy,Public,Alive,38.0,KRAS,No,Current,None,23.3,Low,Urban,Statutory Health Insurance,15.0,No,No,Hypertension,9.0
PT03100,Poland,Lesser Poland,36.0,Male,Ovarian,I,2017-02-25,2017-03-15,2017-09-11,Targeted Therapy,Research Institute,Alive,42.0,EGFR,Yes,Former,Heavy,18.2,Low,Rural,Statutory Health Insurance,18.0,No,No,Obesity,9.0
PT03101,Italy,Veneto,61.0,Female,Pancreatic,I,2015-01-20,2015-03-27,2016-03-15,Chemotherapy,Public,Alive,15.0,KRAS,Yes,Never,Moderate,24.6,High,Urban,Private Insurance,6.0,Yes,No,Obesity,6.0
PT03102,Sweden,Stockholm,48.0,Female,Prostate,II,2019-08-10,2020-01-31,2020-08-27,Targeted Therapy,Public,,37.0,BRCA1,No,Former,Heavy,28.2,Medium,Urban,Private Insurance,7.0,No,No,None,5.0
PT03103,,Lesser Poland,89.0,Female,Lung,,2020-08-28,2021-01-20,2021-08-15,Targeted Therapy,Public,Alive,99.0,KRAS,,Never,Moderate,23.9,Medium,Rural,Statutory Health Insurance,1.0,No,No,Diabetes,
PT03104,Finland,Pirkanmaa,36.0,Female,Lung,III,2018-07-09,2018-12-17,2019-08-16,Immunotherapy,Public,Deceased,86.0,KRAS,No,Current,Moderate,20.1,Medium,Urban,Statutory Health Insurance,3.0,No,No,Diabetes,2.0
PT03105,Switzerland,Bern,33.0,Non-binary,Leukemia,III,2021-10-27,2022-02-03,2022-04-06,Surgery,Public,Deceased,35.0,None,No,Former,None,23.5,Medium,Rural,Private Insurance,1.0,No,Yes,,4.0
PT03106,Portugal,Lisbon,43.0,Female,Lung,III,2015-02-10,2015-03-15,2015-04-22,Radiation,Private,Deceased,19.0,EGFR,No,Current,None,19.8,Medium,Urban,NHS,16.0,No,No,Hypertension,5.0
PT03107,Netherlands,South Holland,76.0,Female,Lung,II,2012-11-18,2013-02-22,2013-12-12,Targeted Therapy,Private,Alive,10.0,BRCA1,Yes,Current,None,29.8,Medium,,NHS,9.0,,Yes,Diabetes,
PT03108,Belgium,Wallonia,69.0,Female,Ovarian,IV,2012-07-15,2012-10-07,2013-05-27,Targeted Therapy,Private,Alive,41.0,KRAS,Yes,Never,None,33.1,Medium,Urban,Statutory Health Insurance,12.0,Yes,No,Cardiovascular Disease,10.0
PT03109,Italy,,76.0,Female,Ovarian,I,2020-04-30,2020-10-05,2021-07-24,Chemotherapy,Private,Alive,82.0,EGFR,No,Current,None,33.7,Low,Urban,Statutory Health Insurance,5.0,No,Yes,Cardiovascular Disease,7.0
PT03110,Austria,Styria,80.0,Female,Leukemia,I,2018-05-01,2018-05-23,2018-11-17,Surgery,Public,Alive,63.0,EGFR,Yes,Current,None,35.4,Medium,Urban,Statutory Health Insurance,,No,No,,3.0
,Denmark,Capital Region,58.0,Female,Breast,II,2021-07-27,2021-11-29,2022-03-30,Targeted Therapy,Public,Deceased,85.0,None,,Never,Heavy,19.1,High,Urban,Statutory Health Insurance,1.0,No,No,Obesity,2.0
PT03112,Poland,Lesser Poland,74.0,Female,Colorectal,I,2015-09-27,2016-03-19,2016-06-09,Targeted Therapy,Private,Alive,18.0,EGFR,Yes,Former,None,34.4,High,Urban,NHS,10.0,No,No,Obesity,8.0
PT03113,,Andalusia,55.0,Female,Lung,I,2020-07-07,2020-08-20,2020-10-03,Radiation,Public,Alive,98.0,EGFR,Yes,,None,34.4,High,Urban,NHS,16.0,Yes,No,None,6.0
PT03114,Switzerland,Geneva,56.0,Male,Leukemia,II,2012-04-06,2012-06-20,2012-09-09,Surgery,Research Institute,Alive,93.0,BRCA1,No,Former,None,29.2,Medium,Rural,Statutory Health Insurance,15.0,No,Yes,Diabetes,7.0
PT03115,Portugal,Porto,33.0,Female,Prostate,IV,2019-07-20,2019-11-11,2020-06-27,Surgery,Research Institute,Alive,23.0,EGFR,No,Never,Moderate,31.2,Medium,Urban,NHS,18.0,No,No,,1.0
PT03116,,Lesser Poland,,Male,Prostate,IV,2022-11-09,2023-04-20,2023-06-25,Targeted Therapy,Public,Alive,108.0,KRAS,,Never,Moderate,32.9,,Rural,Private Insurance,5.0,No,No,Hypertension,4.0
PT03117,Belgium,Wallonia,50.0,Female,Ovarian,II,2012-02-09,2012-03-08,2012-06-24,Surgery,Private,Alive,13.0,BRCA1,Yes,Former,None,28.9,High,Urban,Statutory Health Insurance,10.0,No,No,Obesity,2.0
,Portugal,Porto,63.0,Female,Pancreatic,I,2020-11-14,2021-04-26,2022-04-07,,Public,Deceased,74.0,EGFR,Yes,Former,None,39.8,Medium,Urban,Statutory Health Insurance,1.0,No,Yes,Obesity,5.0
PT03119,France,Île-de-France,87.0,Non-binary,Lung,I,2011-04-02,2011-04-11,2011-10-07,Radiation,Public,Alive,53.0,None,No,Never,None,19.1,Low,Urban,Private Insurance,18.0,No,No,Obesity,9.0
PT03120,France,Île-de-France,67.0,Male,Colorectal,II,2012-12-08,2013-03-25,2013-05-29,Immunotherapy,Private,Alive,83.0,BRCA1,No,Never,None,20.5,Medium,Urban,Private Insurance,17.0,No,No,Obesity,10.0
PT03121,Belgium,Brussels,76.0,Male,Leukemia,I,2017-08-07,2017-08-29,2017-12-30,Radiation,Public,Alive,8.0,BRCA1,No,Former,Moderate,24.1,Medium,Urban,Private Insurance,12.0,No,Yes,None,2.0
PT03122,,Sicily,41.0,Male,Ovarian,I,2022-09-05,2022-11-29,2023-07-07,Immunotherapy,Public,Alive,75.0,EGFR,No,Never,Moderate,30.6,Medium,Urban,Private Insurance,1.0,No,No,Obesity,4.0
PT03123,Germany,Berlin,23.0,Male,Pancreatic,III,2016-10-19,2016-11-13,2017-05-27,Radiation,Public,Deceased,114.0,None,No,Never,Heavy,38.3,Medium,Rural,Statutory Health Insurance,7.0,No,No,Obesity,2.0
PT03124,Portugal,,65.0,Female,Pancreatic,II,2016-04-17,2016-07-07,2016-09-14,Targeted Therapy,Public,Deceased,22.0,BRCA1,Yes,Current,Moderate,39.2,Medium,Urban,,1.0,Yes,No,Cardiovascular Disease,9.0
PT03125,Norway,Oslo,78.0,,Leukemia,I,2018-02-19,2018-05-09,2018-08-10,Radiation,Public,Deceased,56.0,EGFR,No,Never,Moderate,39.2,Low,Urban,Private Insurance,9.0,No,No,None,1.0
PT03126,,Porto,53.0,Female,Ovarian,,2020-10-04,2021-03-22,2021-10-21,Surgery,Private,Deceased,62.0,EGFR,No,Current,,39.0,Medium,,,3.0,No,No,None,1.0
PT03127,,North Holland,30.0,Female,Ovarian,III,2022-01-18,2022-01-25,2022-11-20,Surgery,Private,Alive,48.0,KRAS,No,Former,None,37.0,Medium,Rural,Statutory Health Insurance,10.0,Yes,No,Hypertension,6.0
PT03128,Belgium,Flanders,50.0,Male,Leukemia,II,,2014-08-29,2015-02-04,Chemotherapy,Private,Deceased,47.0,BRCA1,No,Never,Heavy,29.7,Low,Rural,,15.0,Yes,No,None,7.0
PT03129,Belgium,Wallonia,30.0,Male,Leukemia,I,2012-10-14,2012-11-16,2013-08-11,Targeted Therapy,Public,Alive,34.0,BRCA1,No,Never,Moderate,32.8,Medium,Rural,NHS,,Yes,No,Cardiovascular Disease,3.0
PT03130,,Madrid,75.0,Male,Leukemia,IV,2023-12-05,2024-03-14,2025-01-12,Surgery,Public,Alive,91.0,BRCA1,Yes,Never,Moderate,18.5,Low,Urban,Private Insurance,19.0,No,,Diabetes,8.0
PT03131,Switzerland,Geneva,57.0,Female,Colorectal,III,2021-01-25,2021-05-09,2021-08-24,Targeted Therapy,Public,Alive,110.0,BRCA1,Yes,Never,Moderate,18.6,Medium,Urban,Private Insurance,8.0,No,No,None,2.0
PT03132,Spain,Andalusia,40.0,Female,Leukemia,I,2014-01-03,2014-03-04,2015-02-23,Radiation,Research Institute,Alive,112.0,EGFR,No,Former,None,,High,Urban,NHS,13.0,No,No,Obesity,
PT03133,Sweden,Västra Götaland,,Female,Ovarian,III,2014-02-20,2014-05-12,2014-10-13,Surgery,Public,,103.0,EGFR,No,Never,None,26.1,High,Urban,NHS,6.0,No,,Obesity,1.0
PT03134,Sweden,Västra Götaland,45.0,Male,Colorectal,II,2019-07-06,2019-11-05,2019-12-13,Targeted Therapy,Public,Alive,60.0,KRAS,No,Current,Moderate,26.2,Medium,Urban,Statutory Health Insurance,13.0,Yes,Yes,None,3.0
PT03135,,Provence-Alpes-Côte d'Azur,27.0,Male,Colorectal,III,2022-03-30,2022-05-27,2023-04-10,Radiation,Public,Alive,75.0,EGFR,No,Never,Moderate,22.2,Medium,Urban,Private Insurance,9.0,,No,Hypertension,7.0
PT03136,Sweden,Skåne,27.0,Female,Colorectal,II,2019-12-18,2020-01-31,2020-07-05,Immunotherapy,Public,Deceased,48.0,None,No,Never,None,,Medium,Urban,Private Insurance,,Yes,Yes,None,
PT03137,Finland,Uusimaa,79.0,Male,Prostate,II,2014-09-18,2015-01-17,2015-09-19,,Private,Alive,65.0,None,No,,None,33.6,High,,Private Insurance,16.0,No,No,None,5.0
PT03138,Germany,North Rhine-Westphalia,53.0,Female,Breast,III,2011-11-18,,2012-05-29,Radiation,Public,Alive,46.0,EGFR,Yes,,Heavy,37.0,Low,Urban,Private Insurance,16.0,No,No,Diabetes,2.0
PT03139,Ireland,Munster,35.0,Male,Pancreatic,III,2022-03-25,2022-07-28,2023-07-09,Immunotherapy,Private,Deceased,96.0,BRCA1,Yes,Former,None,26.3,Low,Urban,Private Insurance,17.0,Yes,No,Diabetes,6.0
PT03140,,Styria,32.0,Male,Lung,I,2019-07-16,2019-12-28,2020-05-11,Targeted Therapy,,Deceased,54.0,BRCA1,Yes,Current,,,High,Urban,NHS,,No,No,None,8.0
PT03141,Italy,Veneto,41.0,,Prostate,I,2021-08-21,2022-01-21,2022-09-20,Immunotherapy,Private,,83.0,None,No,Never,None,34.1,Medium,Urban,Statutory Health Insurance,2.0,No,No,,6.0
PT03142,Italy,Veneto,46.0,Male,Ovarian,II,2019-12-12,2020-05-13,2020-07-25,Surgery,Public,Deceased,89.0,EGFR,No,Never,None,29.4,High,Urban,,10.0,No,No,Diabetes,5.0
PT03143,,Île-de-France,83.0,Female,Breast,II,2023-01-30,2023-03-28,2023-06-30,Targeted Therapy,Public,Alive,32.0,KRAS,,Never,Moderate,26.8,Medium,Urban,Statutory Health Insurance,17.0,Yes,No,Diabetes,5.0
PT03144,Switzerland,Geneva,21.0,Female,Pancreatic,I,,2019-01-04,2019-04-28,Chemotherapy,Private,Alive,8.0,KRAS,No,Never,,,Medium,Urban,Private Insurance,4.0,No,No,Obesity,9.0
PT03145,Netherlands,South Holland,45.0,Female,Prostate,III,2020-10-14,2020-12-30,2021-03-26,Chemotherapy,Research Institute,Deceased,86.0,None,No,Former,Moderate,30.4,Medium,Urban,NHS,7.0,No,No,None,8.0
PT03146,Switzerland,Zurich,88.0,Female,Pancreatic,I,2018-01-23,2018-02-04,2018-10-23,Targeted Therapy,Private,Alive,73.0,KRAS,No,Current,None,25.0,Medium,Urban,NHS,14.0,No,,Hypertension,8.0
PT03147,Norway,Trøndelag,49.0,Female,,III,2019-08-01,2019-11-17,2020-09-21,Surgery,Public,Alive,47.0,None,No,Former,,25.4,Medium,Urban,NHS,15.0,No,No,Cardiovascular Disease,8.0
PT03148,Austria,Tyrol,27.0,Male,Colorectal,,2017-12-28,2018-04-23,2018-09-01,Targeted Therapy,Public,Alive,82.0,KRAS,Yes,Current,None,22.4,Low,Urban,Statutory Health Insurance,12.0,No,Yes,Obesity,
PT03149,Germany,Bavaria,57.0,Female,Leukemia,I,2013-12-15,2014-01-12,2014-08-01,Targeted Therapy,Public,Deceased,59.0,None,No,Never,Moderate,30.5,High,Urban,NHS,13.0,No,No,Cardiovascular Disease,7.0
PT03150,Italy,Sicily,80.0,Female,Ovarian,III,2010-03-29,2010-07-23,2010-12-04,Targeted Therapy,Public,Deceased,,None,Yes,Current,Moderate,38.6,Medium,Urban,Statutory Health Insurance,15.0,No,Yes,Obesity,5.0
PT03151,Ireland,Connacht,84.0,Male,Colorectal,IV,2014-03-10,2014-04-21,2014-05-26,,Public,Alive,110.0,BRCA1,No,Former,Moderate,25.5,Low,Urban,NHS,10.0,No,No,Obesity,2.0
,Norway,,86.0,Female,Prostate,I,2018-11-14,,2019-04-06,Chemotherapy,Private,Alive,26.0,None,Yes,Current,Moderate,32.8,Medium,Urban,NHS,1.0,No,No,Cardiovascular Disease,1.0
PT03153,Portugal,Lisbon,65.0,Female,,IV,2018-09-21,2018-10-29,2018-12-24,Chemotherapy,,Lost to Follow-up,,BRCA1,Yes,Current,None,36.1,Low,Urban,NHS,15.0,No,,Cardiovascular Disease,9.0
PT03154,Spain,Madrid,62.0,Female,Lung,III,2010-01-13,2010-04-04,2010-05-21,Surgery,Public,Deceased,72.0,KRAS,No,Current,Moderate,39.2,Medium,Urban,NHS,2.0,Yes,No,Cardiovascular Disease,2.0
PT03155,Spain,Madrid,78.0,Female,Ovarian,II,2018-01-07,2018-04-26,2018-05-30,Chemotherapy,Public,Deceased,52.0,KRAS,Yes,Never,,35.7,Low,Rural,Private Insurance,6.0,No,No,Cardiovascular Disease,
PT03156,Poland,Silesian,65.0,Male,Pancreatic,I,2010-11-16,2011-03-10,2011-08-04,Surgery,Public,Deceased,94.0,EGFR,Yes,Former,None,20.1,High,,Private Insurance,19.0,No,Yes,Obesity,8.0
PT03157,Portugal,Porto,54.0,Female,Colorectal,III,2022-01-05,2022-04-23,,Surgery,Public,Alive,111.0,BRCA1,Yes,Never,Moderate,19.6,Low,Rural,NHS,11.0,No,No,Cardiovascular Disease,1.0
PT03158,Sweden,Stockholm,58.0,Male,Pancreatic,II,2023-05-01,2023-09-11,,Chemotherapy,,Lost to Follow-up,,None,No,Never,None,33.7,Medium,Urban,Private Insurance,19.0,No,No,Diabetes,9.0
PT03159,Denmark,Zealand,70.0,,Breast,III,2014-08-11,2014-11-03,2015-08-14,Targeted Therapy,Private,Deceased,113.0,EGFR,Yes,Never,Moderate,34.1,Low,Urban,Private Insurance,1.0,,No,None,6.0
PT03160,Belgium,Flanders,23.0,Female,Pancreatic,,2023-09-29,,2024-06-04,Targeted Therapy,Public,Alive,64.0,,No,Current,Moderate,37.3,Medium,Rural,Private Insurance,17.0,Yes,No,Cardiovascular Disease,3.0
PT03161,Norway,,70.0,Female,Prostate,II,2016-09-15,2017-02-25,2017-06-27,Radiation,Private,Deceased,6.0,None,Yes,Never,Moderate,35.4,Low,Rural,Private Insurance,6.0,No,No,Obesity,8.0
PT03162,Portugal,Lisbon,24.0,Male,Breast,I,2021-08-24,2021-10-11,2022-07-14,Surgery,Public,Deceased,19.0,KRAS,No,Current,None,,Medium,Rural,,9.0,No,No,None,3.0
PT03163,Sweden,Västra Götaland,74.0,Female,Ovarian,I,2011-01-19,2011-02-02,2011-11-19,Immunotherapy,Private,Alive,103.0,,No,Current,Moderate,,,,Statutory Health Insurance,4.0,No,No,Diabetes,5.0
PT03164,Finland,Pirkanmaa,39.0,Non-binary,Leukemia,I,2022-04-21,,2023-05-26,Immunotherapy,Public,Deceased,45.0,EGFR,No,Never,None,31.5,Medium,Urban,,18.0,No,No,Diabetes,4.0
PT03165,Sweden,Skåne,43.0,Female,Leukemia,IV,2013-01-01,2013-06-04,2014-03-11,Chemotherapy,Public,Alive,72.0,EGFR,,Never,None,37.8,Medium,Rural,Statutory Health Insurance,17.0,No,Yes,None,8.0
PT03166,Belgium,Flanders,55.0,Female,Pancreatic,I,,2012-12-23,2013-09-20,Chemotherapy,Public,Deceased,111.0,EGFR,No,Never,Moderate,27.9,,Rural,Private Insurance,9.0,No,No,Cardiovascular Disease,2.0
PT03167,France,Île-de-France,53.0,Female,Lung,II,2016-11-25,2017-03-14,2017-08-24,Immunotherapy,Public,Deceased,14.0,KRAS,Yes,Former,None,22.0,Low,Urban,Private Insurance,12.0,No,No,Cardiovascular Disease,9.0
PT03168,Italy,Lombardy,73.0,Male,Prostate,II,,2019-05-16,2019-08-28,Radiation,Public,Deceased,74.0,BRCA1,No,Never,Moderate,22.1,Medium,Urban,Private Insurance,5.0,Yes,No,Obesity,7.0
PT03169,Belgium,Brussels,53.0,Male,Lung,IV,2020-01-23,2020-03-05,2021-01-23,Surgery,Private,Alive,30.0,KRAS,No,Never,Moderate,18.4,Medium,Urban,Statutory Health Insurance,13.0,No,Yes,Hypertension,1.0
PT03170,Belgium,,36.0,Female,Breast,II,2010-07-13,2010-10-16,2011-07-12,Surgery,Public,Deceased,69.0,None,No,,Moderate,36.0,Medium,Urban,Statutory Health Insurance,4.0,No,No,Cardiovascular Disease,4.0
PT03171,France,Île-de-France,24.0,Female,Lung,IV,2017-10-15,2018-03-10,2018-08-22,,Public,Alive,,EGFR,No,Never,Moderate,30.8,Medium,,NHS,7.0,No,Yes,Hypertension,10.0
PT03172,Norway,Oslo,37.0,Female,Ovarian,III,2023-04-18,2023-07-30,2024-04-11,Chemotherapy,Private,Deceased,38.0,KRAS,No,Current,Heavy,28.2,High,Urban,Statutory Health Insurance,17.0,Yes,No,Cardiovascular Disease,5.0
PT03173,Spain,Madrid,74.0,Female,Breast,IV,,2013-07-26,2013-11-16,Targeted Therapy,Private,Alive,10.0,EGFR,Yes,Never,Moderate,34.4,Low,Urban,,6.0,Yes,No,Diabetes,7.0
PT03174,,Connacht,72.0,Female,Ovarian,I,2012-03-05,2012-07-08,2013-04-09,Radiation,Public,Alive,81.0,KRAS,No,Never,Moderate,25.0,High,Rural,Statutory Health Insurance,6.0,Yes,,None,1.0
PT03175,Germany,North Rhine-Westphalia,69.0,Male,Lung,I,2017-06-15,2017-09-09,2018-06-08,Surgery,Public,Alive,57.0,BRCA1,No,Former,Moderate,34.0,Medium,Urban,Statutory Health Insurance,5.0,Yes,No,None,6.0
PT03176,Norway,Oslo,64.0,Male,Leukemia,I,2014-06-15,2014-11-11,2015-03-06,Targeted Therapy,,Alive,108.0,None,No,Never,,36.9,Medium,Rural,Statutory Health Insurance,9.0,No,No,Diabetes,2.0
PT03177,Ireland,Munster,32.0,Male,,II,2017-10-12,2018-03-23,2018-08-11,Immunotherapy,Private,Alive,80.0,BRCA1,No,,Heavy,31.6,High,Urban,Private Insurance,,No,No,Cardiovascular Disease,3.0
,Germany,Berlin,35.0,Female,Lung,III,2010-04-01,2010-05-11,2010-08-17,Targeted Therapy,Private,Alive,38.0,EGFR,No,Never,Moderate,39.4,Low,Urban,Private Insurance,2.0,No,Yes,Diabetes,7.0
PT03179,Norway,Trøndelag,32.0,Male,Pancreatic,,2020-01-26,2020-05-24,2021-04-04,Immunotherapy,Public,Lost to Follow-up,,None,Yes,Never,,34.2,Low,,NHS,6.0,No,No,None,5.0
PT03180,Switzerland,Zurich,39.0,Female,Ovarian,I,2021-06-04,2021-09-23,2022-03-22,Immunotherapy,,Deceased,21.0,BRCA1,No,Never,None,27.6,Low,Urban,NHS,10.0,Yes,No,None,5.0
PT03181,Denmark,Central Denmark,85.0,Male,,III,2019-08-21,2019-09-20,2020-04-12,Surgery,Public,Alive,8.0,None,No,Current,None,31.7,,Urban,NHS,10.0,No,No,Hypertension,6.0
,,Porto,66.0,Female,,I,2013-08-13,2013-12-08,2014-07-23,Targeted Therapy,Public,Deceased,10.0,None,,Current,Moderate,20.7,Medium,Urban,Statutory Health Insurance,6.0,No,No,Cardiovascular Disease,6.0
PT03183,Germany,Bavaria,38.0,Male,Pancreatic,II,2019-06-22,2019-07-17,2019-09-26,Surgery,Private,Alive,109.0,None,Yes,Current,,38.1,Medium,Urban,Private Insurance,17.0,No,Yes,Hypertension,8.0
PT03184,Italy,Sicily,64.0,Female,Prostate,I,2016-06-27,2016-07-26,2016-09-22,Radiation,Private,Alive,67.0,KRAS,No,Never,Heavy,32.3,Low,Urban,NHS,19.0,No,Yes,Cardiovascular Disease,4.0
PT03185,Norway,Vestland,56.0,Male,Pancreatic,III,2016-10-04,2016-12-10,2017-04-03,Radiation,Private,Deceased,24.0,EGFR,No,Current,Moderate,27.0,High,Urban,NHS,4.0,No,No,None,1.0
PT03186,Finland,,73.0,Male,Leukemia,II,2017-02-06,2017-03-25,2018-03-16,Radiation,Public,Alive,117.0,BRCA1,Yes,Never,Moderate,36.8,Low,Urban,Statutory Health Insurance,16.0,Yes,No,Cardiovascular Disease,7.0
,France,Auvergne-Rhône-Alpes,25.0,Female,Ovarian,III,2014-07-16,2014-10-29,2015-07-14,Radiation,Public,Alive,16.0,EGFR,No,Former,None,19.3,Medium,Urban,Statutory Health Insurance,19.0,No,Yes,Diabetes,3.0
PT03188,Norway,,33.0,Male,Leukemia,I,2019-04-01,2019-08-24,2020-03-13,Immunotherapy,Private,Alive,90.0,None,No,Former,Heavy,29.7,High,Urban,NHS,17.0,No,No,Hypertension,1.0
PT03189,Denmark,Capital Region,23.0,Female,Colorectal,I,,2021-07-16,2021-09-24,Radiation,Private,Lost to Follow-up,,None,Yes,Never,Moderate,34.3,Medium,Rural,Statutory Health Insurance,15.0,Yes,No,None,6.0
PT03190,Netherlands,Utrecht,74.0,Female,Prostate,III,2010-12-12,2011-03-31,2011-11-16,Surgery,Public,Alive,78.0,,No,Never,Heavy,33.5,Medium,Urban,NHS,7.0,No,No,Cardiovascular Disease,3.0
PT03191,Netherlands,South Holland,53.0,Female,Lung,III,2020-08-17,2020-10-06,2021-09-19,Targeted Therapy,Private,Alive,112.0,,Yes,Never,None,18.4,Medium,Rural,NHS,6.0,No,No,Cardiovascular Disease,3.0
PT03192,Spain,Madrid,46.0,Female,Leukemia,II,2014-07-23,,2015-02-27,Targeted Therapy,Public,Alive,23.0,None,Yes,Never,Moderate,23.0,High,Urban,Statutory Health Insurance,5.0,Yes,No,,7.0
PT03193,France,Auvergne-Rhône-Alpes,26.0,Male,Lung,III,2020-08-09,2020-12-20,,Surgery,Public,Alive,17.0,None,,Never,None,36.9,Medium,Urban,Statutory Health Insurance,2.0,Yes,No,Obesity,
PT03194,Denmark,Zealand,22.0,Female,Ovarian,I,2017-08-04,2017-08-17,2018-02-09,Chemotherapy,Public,Deceased,48.0,EGFR,No,Never,Moderate,23.7,Medium,Urban,Statutory Health Insurance,3.0,No,No,Cardiovascular Disease,7.0
PT03195,Denmark,,66.0,Male,Lung,IV,2011-10-12,2011-11-20,2012-02-22,,Public,Deceased,108.0,KRAS,Yes,Never,Heavy,28.5,Low,Urban,Private Insurance,4.0,No,,Cardiovascular Disease,1.0
PT03196,Italy,Sicily,21.0,Male,Ovarian,III,2017-05-30,2017-11-19,2018-03-21,Chemotherapy,Public,Alive,92.0,KRAS,No,Former,Moderate,39.7,Low,Urban,Private Insurance,14.0,Yes,No,,4.0
PT03197,Sweden,Stockholm,44.0,Male,Breast,II,2015-03-28,2015-04-14,2015-12-01,Chemotherapy,Private,Alive,55.0,EGFR,Yes,Never,Moderate,31.1,Medium,Urban,,17.0,No,Yes,Diabetes,3.0
PT03198,Portugal,Algarve,79.0,Male,Pancreatic,IV,2020-02-03,2020-05-12,2021-03-29,Immunotherapy,Research Institute,Alive,107.0,EGFR,Yes,Current,None,30.3,Medium,Urban,Statutory Health Insurance,13.0,No,No,None,8.0
PT03199,Germany,Bavaria,43.0,Female,Lung,I,2023-04-24,2023-07-13,2024-03-08,Immunotherapy,,Alive,45.0,EGFR,No,Current,Moderate,30.7,Low,Rural,NHS,8.0,No,No,None,2.0
PT03200,,Flanders,34.0,Female,Ovarian,III,2014-12-15,2015-02-12,2015-10-19,Targeted Therapy,Private,Alive,82.0,EGFR,No,Never,Moderate,21.9,Medium,Urban,,2.0,No,No,Cardiovascular Disease,
PT03201,Ireland,Connacht,33.0,Male,Colorectal,,2018-12-05,2019-03-11,2020-02-03,Targeted Therapy,Public,Deceased,40.0,BRCA1,No,Never,None,33.1,High,,Private Insurance,15.0,No,No,Obesity,7.0
PT03202,Switzerland,Geneva,73.0,Male,Prostate,II,2015-10-14,,2016-12-01,Immunotherapy,Research Institute,Deceased,62.0,KRAS,No,Current,None,18.5,Low,Urban,Private Insurance,12.0,No,No,Cardiovascular Disease,9.0
PT03203,Portugal,Lisbon,25.0,Male,Prostate,I,2014-01-22,2014-06-07,2014-08-13,Immunotherapy,Public,Alive,61.0,KRAS,No,Never,Moderate,,Medium,Urban,Statutory Health Insurance,5.0,Yes,Yes,Obesity,8.0
PT03204,Poland,Lesser Poland,37.0,Male,Breast,III,2011-11-07,2011-12-07,2012-04-19,Targeted Therapy,Public,Alive,33.0,EGFR,Yes,Never,Heavy,24.8,Medium,Urban,Private Insurance,13.0,No,No,None,3.0
PT03205,Switzerland,,39.0,Female,Colorectal,I,2011-04-21,2011-08-30,2012-06-05,Surgery,Private,Alive,67.0,BRCA1,Yes,Current,Moderate,19.6,Low,,Private Insurance,15.0,No,,Cardiovascular Disease,10.0
PT03206,Ireland,Connacht,81.0,Male,Pancreatic,IV,2010-11-22,2011-04-16,2012-01-24,Immunotherapy,Private,Deceased,104.0,EGFR,Yes,Former,None,25.4,Low,,NHS,14.0,No,No,Diabetes,5.0
PT03207,Sweden,Skåne,59.0,Male,Colorectal,I,2018-12-08,2019-04-10,2020-02-11,Surgery,Public,Alive,92.0,KRAS,Yes,Never,Moderate,31.3,,Urban,NHS,14.0,No,No,Cardiovascular Disease,5.0
PT03208,Poland,Masovian,58.0,Female,Ovarian,III,2015-11-06,2015-12-27,2016-09-18,Radiation,Private,Deceased,,BRCA1,No,Former,Heavy,26.3,Medium,,Statutory Health Insurance,11.0,Yes,Yes,Obesity,5.0
PT03209,Finland,Pirkanmaa,71.0,Female,Prostate,II,2021-08-24,2022-01-23,2022-09-12,Surgery,Public,Deceased,13.0,None,Yes,Current,Moderate,18.5,Low,Urban,Statutory Health Insurance,19.0,No,No,Diabetes,5.0
PT03210,Italy,Sicily,51.0,Female,Colorectal,I,2013-07-20,2013-10-08,2013-12-30,Surgery,Private,Deceased,20.0,None,Yes,Never,Moderate,31.8,High,Urban,Private Insurance,7.0,No,No,None,10.0
PT03211,Ireland,Dublin,46.0,Female,Pancreatic,IV,2023-10-15,2023-12-28,2024-08-24,Immunotherapy,Private,Deceased,70.0,None,Yes,Never,Heavy,24.7,Medium,Urban,Private Insurance,14.0,No,No,None,10.0
PT03212,Sweden,Skåne,71.0,,Leukemia,III,2010-10-09,2011-02-09,2011-03-16,Radiation,Public,Alive,40.0,None,No,Never,Heavy,40.0,Low,Rural,Private Insurance,8.0,No,No,Cardiovascular Disease,9.0
PT03213,Austria,Styria,82.0,,Lung,II,2011-10-19,2012-02-07,2012-09-24,Chemotherapy,,Deceased,63.0,BRCA1,,Current,Moderate,37.8,,Urban,Statutory Health Insurance,1.0,No,No,None,10.0
PT03214,,Zealand,82.0,Male,Ovarian,I,2016-01-20,2016-05-11,2017-03-21,Surgery,Public,Alive,81.0,EGFR,No,Never,Heavy,28.7,High,Urban,Private Insurance,2.0,No,No,Hypertension,10.0
PT03215,Finland,Southwest Finland,36.0,Male,Lung,,2018-11-20,2019-05-16,2019-07-27,Radiation,Public,Deceased,14.0,KRAS,No,Former,,,Medium,Rural,Statutory Health Insurance,17.0,No,No,None,10.0
,Sweden,Västra Götaland,68.0,Female,Prostate,III,2012-06-19,2012-07-09,2013-02-18,Radiation,Public,Deceased,44.0,BRCA1,No,Never,Heavy,,Medium,Urban,Private Insurance,16.0,No,Yes,None,
PT03217,Portugal,Algarve,42.0,Female,Prostate,III,2022-02-13,,2022-12-16,Immunotherapy,Private,Alive,102.0,None,No,Never,Moderate,18.0,Medium,Urban,NHS,11.0,Yes,No,Diabetes,8.0
PT03218,Ireland,Dublin,32.0,Male,Pancreatic,III,2010-05-24,2010-06-03,2011-05-16,Radiation,Public,Deceased,26.0,BRCA1,No,Former,None,35.6,Medium,Urban,Private Insurance,17.0,Yes,No,Obesity,1.0
PT03219,Portugal,Porto,42.0,Male,Colorectal,I,2019-03-24,2019-04-02,2020-01-25,Chemotherapy,Public,Alive,100.0,KRAS,Yes,Former,None,28.8,Low,Urban,,13.0,No,No,Diabetes,8.0
PT03220,Italy,Veneto,76.0,Male,Pancreatic,IV,2020-10-08,2021-01-24,2021-09-02,Immunotherapy,Private,Alive,65.0,BRCA1,No,Never,None,25.0,High,Urban,NHS,3.0,No,No,Hypertension,10.0
PT03221,Norway,Trøndelag,81.0,Female,Breast,III,2016-10-23,2016-12-25,2017-03-11,Surgery,Private,Alive,99.0,None,No,Current,None,30.5,High,Urban,Statutory Health Insurance,15.0,No,No,Obesity,9.0
PT03222,Finland,Uusimaa,73.0,Male,,,2016-12-10,2017-01-12,2017-08-17,Immunotherapy,Private,Alive,48.0,BRCA1,No,Former,Moderate,24.7,High,,Private Insurance,14.0,No,No,None,2.0
PT03223,Portugal,Porto,39.0,Male,Ovarian,II,2013-11-14,2014-04-15,2015-02-09,Surgery,Research Institute,Deceased,68.0,EGFR,,Never,Moderate,26.4,Medium,Rural,Statutory Health Insurance,3.0,No,Yes,Cardiovascular Disease,6.0
PT03224,Netherlands,South Holland,71.0,Female,Ovarian,II,2012-11-09,2013-01-28,2013-11-14,Immunotherapy,Public,Alive,47.0,BRCA1,Yes,Never,None,19.6,,Rural,Private Insurance,12.0,No,No,Cardiovascular Disease,4.0
PT03225,Norway,Trøndelag,42.0,Male,,III,2017-01-27,2017-02-28,2017-06-06,Radiation,Private,Deceased,88.0,BRCA1,Yes,Never,None,27.7,Medium,Urban,Private Insurance,11.0,Yes,No,Diabetes,10.0
PT03226,Sweden,Västra Götaland,54.0,Male,Prostate,III,2020-01-23,2020-01-27,2020-11-09,Chemotherapy,Private,Deceased,39.0,None,Yes,Never,Moderate,21.1,Medium,Urban,,3.0,No,No,Cardiovascular Disease,6.0
PT03227,Finland,Southwest Finland,86.0,Male,Pancreatic,IV,,2011-12-29,2012-05-20,Immunotherapy,Private,Alive,114.0,None,No,,None,27.5,Low,Rural,Statutory Health Insurance,3.0,No,Yes,Hypertension,1.0
PT03228,Portugal,Porto,53.0,Male,Ovarian,II,2023-01-13,2023-05-19,2024-04-06,Targeted Therapy,Public,Deceased,22.0,KRAS,No,Never,Moderate,35.1,Low,Urban,Private Insurance,7.0,Yes,No,Cardiovascular Disease,
PT03229,Finland,Southwest Finland,52.0,Male,Pancreatic,III,2019-01-05,2019-05-04,,Radiation,Public,Alive,103.0,KRAS,Yes,Former,None,23.2,Low,Urban,NHS,10.0,No,No,Hypertension,10.0
PT03230,Poland,Masovian,65.0,Male,Colorectal,IV,2017-12-31,2018-01-22,2018-05-25,Immunotherapy,Public,Alive,70.0,KRAS,No,Never,Heavy,23.0,Low,Urban,Private Insurance,12.0,No,No,Cardiovascular Disease,4.0
PT03231,Spain,Andalusia,64.0,Female,Leukemia,I,,2010-11-20,2011-06-19,Radiation,Private,Deceased,30.0,None,No,Never,None,33.6,Low,Rural,Private Insurance,9.0,No,Yes,Obesity,1.0
PT03232,Sweden,Stockholm,38.0,,Prostate,II,2018-04-10,2018-05-06,2019-03-26,Targeted Therapy,Public,Alive,104.0,BRCA1,No,Never,None,29.8,Medium,Rural,NHS,1.0,No,No,,7.0
PT03233,Spain,Andalusia,34.0,Female,Leukemia,III,2015-08-11,2015-09-29,2016-07-07,Radiation,,Alive,63.0,BRCA1,Yes,Never,Moderate,27.2,Low,Urban,Statutory Health Insurance,2.0,No,No,Hypertension,8.0
PT03234,Poland,Masovian,85.0,Female,Pancreatic,IV,2021-03-02,2021-08-21,2021-10-09,,Private,Deceased,,EGFR,No,Never,Moderate,19.1,Medium,Urban,Statutory Health Insurance,15.0,No,No,Obesity,6.0
PT03235,Ireland,Connacht,58.0,Male,Colorectal,I,2018-06-24,2018-11-21,2019-08-27,Immunotherapy,Private,Alive,102.0,,No,Never,Heavy,28.3,Medium,Urban,Statutory Health Insurance,7.0,Yes,No,Diabetes,4.0
PT03236,Germany,Bavaria,37.0,Female,Pancreatic,I,2018-01-06,2018-04-24,2019-03-04,Radiation,Public,Alive,83.0,None,No,Never,Moderate,27.0,High,Urban,NHS,18.0,No,No,Diabetes,7.0
PT03237,Portugal,,89.0,Male,Breast,I,2015-03-10,2015-08-27,2015-10-12,,Public,Deceased,11.0,KRAS,Yes,Current,None,21.6,Medium,Urban,Private Insurance,2.0,No,No,Diabetes,6.0
PT03238,Ireland,Munster,78.0,Male,Ovarian,II,2020-11-20,2021-01-11,2021-04-01,Chemotherapy,Private,Alive,55.0,EGFR,No,Former,None,38.5,Medium,Rural,Private Insurance,9.0,No,No,Hypertension,
PT03239,Sweden,Stockholm,51.0,Male,Lung,I,2023-10-13,2024-03-06,2024-08-18,Targeted Therapy,Public,Alive,25.0,None,Yes,Never,None,,Medium,Rural,NHS,16.0,No,No,Diabetes,3.0
PT03240,Spain,Madrid,40.0,Male,Lung,II,2018-12-07,2019-04-28,2019-10-23,Surgery,Research Institute,Alive,51.0,KRAS,No,Never,None,18.0,Medium,Rural,Statutory Health Insurance,4.0,No,No,Obesity,1.0
PT03241,Italy,Sicily,59.0,Non-binary,Pancreatic,IV,2011-02-13,2011-04-18,2011-10-15,Targeted Therapy,Private,Deceased,81.0,KRAS,No,Never,,39.3,Medium,Urban,Statutory Health Insurance,13.0,No,No,Cardiovascular Disease,7.0
PT03242,Italy,Sicily,46.0,Male,Lung,III,2019-09-20,2020-03-11,2020-08-02,Radiation,Private,Alive,96.0,EGFR,Yes,Current,Moderate,28.3,Medium,Urban,Private Insurance,5.0,No,Yes,Diabetes,2.0
PT03243,Ireland,Connacht,21.0,Male,Lung,I,2019-03-30,2019-09-04,2020-06-21,Immunotherapy,Public,Alive,16.0,KRAS,No,Former,Moderate,31.7,High,Urban,Statutory Health Insurance,19.0,No,,Diabetes,2.0
PT03244,Spain,Madrid,58.0,Male,Colorectal,IV,2021-01-05,2021-05-26,2021-12-21,Surgery,Public,Alive,84.0,KRAS,No,Former,None,26.5,High,Rural,NHS,8.0,No,No,,1.0
PT03245,Austria,Styria,75.0,Male,Lung,III,2011-08-01,2012-01-02,2012-06-15,Surgery,Private,Alive,33.0,None,No,Never,Heavy,35.2,Medium,Urban,NHS,18.0,Yes,Yes,None,
PT03246,Ireland,Connacht,32.0,,Colorectal,I,2019-11-17,2020-04-25,2020-08-31,Radiation,Public,Alive,107.0,KRAS,No,Never,None,24.8,High,Urban,NHS,13.0,No,Yes,None,7.0
PT03247,Denmark,Zealand,75.0,Male,Breast,II,2021-06-09,2021-11-30,2022-11-19,Surgery,Private,Alive,7.0,BRCA1,,,Moderate,28.0,Medium,Rural,Statutory Health Insurance,6.0,No,No,None,10.0
PT03248,Finland,Southwest Finland,85.0,Male,,III,2011-08-26,2011-10-16,2012-08-29,Immunotherapy,Public,Alive,69.0,KRAS,No,Former,Moderate,27.3,Low,Rural,Statutory Health Insurance,17.0,No,No,None,
PT03249,Belgium,Brussels,75.0,Female,Prostate,III,2020-04-13,2020-05-17,2020-12-22,Radiation,Private,Deceased,19.0,BRCA1,No,Former,None,27.5,Medium,Rural,Statutory Health Insurance,7.0,No,No,Obesity,5.0
PT03250,France,Provence-Alpes-Côte d'Azur,47.0,,Prostate,II,2021-02-21,2021-06-09,2022-01-15,Targeted Therapy,Public,Alive,74.0,None,Yes,Current,None,,High,Urban,,8.0,Yes,No,Diabetes,7.0
PT03251,Italy,Sicily,83.0,Male,Ovarian,I,2012-09-14,2013-01-08,2013-09-10,Radiation,,Alive,116.0,KRAS,Yes,Former,Moderate,35.3,Medium,Rural,NHS,5.0,No,No,None,6.0
PT03252,Denmark,Capital Region,83.0,Female,Colorectal,III,2021-08-07,2021-09-04,2022-03-12,Radiation,Private,Deceased,106.0,KRAS,No,Never,None,26.6,Low,Urban,Statutory Health Insurance,12.0,No,No,Cardiovascular Disease,3.0
PT03253,Denmark,Central Denmark,75.0,Non-binary,Colorectal,II,2016-05-04,2016-05-23,2017-04-28,Surgery,Private,Deceased,79.0,BRCA1,Yes,Former,Heavy,31.8,Medium,Rural,Statutory Health Insurance,12.0,No,No,Obesity,9.0
PT03254,Norway,Vestland,60.0,Male,Colorectal,III,2021-08-05,2022-01-28,2022-12-12,Chemotherapy,Private,Alive,83.0,EGFR,,Former,Heavy,19.4,Medium,,Private Insurance,16.0,No,No,Hypertension,6.0
PT03255,Belgium,Wallonia,60.0,Male,Breast,III,2018-07-16,2018-10-22,2019-05-05,Surgery,Public,Deceased,87.0,BRCA1,Yes,Never,Moderate,19.6,High,Urban,NHS,14.0,Yes,No,Diabetes,1.0
PT03256,Ireland,Connacht,23.0,Non-binary,Leukemia,I,2012-12-19,2013-03-01,2013-12-13,Chemotherapy,Public,Alive,103.0,BRCA1,Yes,Never,None,20.3,Medium,Urban,Private Insurance,9.0,No,No,Obesity,2.0
PT03257,Norway,Vestland,76.0,Male,Colorectal,I,2017-02-21,2017-08-02,2018-04-24,Radiation,Private,Alive,86.0,BRCA1,Yes,Former,Moderate,23.0,High,Urban,Private Insurance,11.0,No,No,Obesity,4.0
,Sweden,Skåne,49.0,Female,Colorectal,I,2014-05-07,2014-08-21,2015-04-16,Radiation,Public,Alive,33.0,None,Yes,Never,Moderate,21.9,Medium,Urban,Private Insurance,18.0,Yes,Yes,Hypertension,4.0
PT03259,Netherlands,Utrecht,65.0,Male,Prostate,I,2012-12-20,2013-05-13,2014-01-26,Targeted Therapy,,Alive,43.0,BRCA1,No,Current,,28.5,Medium,Urban,NHS,19.0,No,No,Obesity,5.0
PT03260,Netherlands,Utrecht,75.0,Female,Pancreatic,I,2014-10-16,2014-12-26,2015-03-31,Surgery,Research Institute,Alive,100.0,EGFR,No,Current,None,23.9,Medium,,Private Insurance,8.0,No,No,,3.0
PT03261,Germany,,50.0,Non-binary,Ovarian,III,2018-09-02,2018-09-29,2019-06-07,Targeted Therapy,Private,Deceased,38.0,BRCA1,No,Never,Moderate,33.1,High,Urban,Private Insurance,15.0,No,No,None,4.0
PT03262,France,Île-de-France,26.0,Female,Lung,II,2014-07-14,2014-09-03,,Immunotherapy,Public,Alive,105.0,EGFR,,Former,None,35.2,Medium,Urban,Private Insurance,,Yes,No,Obesity,8.0
PT03263,Belgium,Wallonia,73.0,Male,Lung,II,2019-09-17,2019-12-10,2020-11-20,Radiation,Private,Alive,59.0,KRAS,Yes,Never,Moderate,26.9,High,Urban,NHS,15.0,No,No,Diabetes,
,Austria,Styria,27.0,,Breast,III,2010-02-09,2010-04-04,2010-10-09,Targeted Therapy,Public,,65.0,BRCA1,No,Former,Moderate,37.5,Medium,Urban,Private Insurance,1.0,,Yes,Hypertension,7.0
PT03265,Switzerland,Bern,74.0,Male,Lung,III,2013-09-12,2014-01-13,2014-10-14,Immunotherapy,Public,Alive,116.0,KRAS,No,Former,Moderate,,Medium,,NHS,13.0,No,No,Diabetes,6.0
PT03266,Netherlands,Utrecht,88.0,Female,Leukemia,IV,2015-06-18,2015-07-05,2016-04-10,Chemotherapy,Public,Alive,9.0,None,No,Never,Moderate,37.3,Low,Rural,NHS,2.0,No,Yes,Cardiovascular Disease,7.0
PT03267,Finland,Uusimaa,63.0,Female,,I,2016-09-19,2016-11-30,2017-06-13,Surgery,Public,Deceased,59.0,None,No,Current,None,28.2,High,Urban,Statutory Health Insurance,19.0,No,No,Obesity,9.0
PT03268,Sweden,Stockholm,32.0,Male,Breast,II,2012-01-14,2012-05-07,2012-11-09,Immunotherapy,Private,Deceased,106.0,KRAS,Yes,Never,Moderate,25.5,High,Rural,Private Insurance,8.0,Yes,No,None,9.0
,Belgium,Brussels,39.0,Female,Lung,I,2018-12-27,2019-04-01,2019-11-22,Surgery,,Alive,92.0,EGFR,Yes,Never,Heavy,29.8,,Urban,Private Insurance,4.0,No,No,Cardiovascular Disease,
PT03270,Portugal,Lisbon,51.0,Male,Lung,I,2021-04-26,2021-09-02,2022-01-30,Radiation,Public,,26.0,KRAS,Yes,Never,Moderate,,Low,Urban,Statutory Health Insurance,15.0,No,Yes,Diabetes,3.0
PT03271,Sweden,Skåne,79.0,Male,Pancreatic,III,2016-06-22,2016-10-05,2017-04-23,Chemotherapy,Public,Alive,30.0,BRCA1,Yes,Current,None,25.0,Low,Rural,NHS,8.0,No,No,Obesity,2.0
PT03272,Austria,,69.0,Female,Prostate,II,2013-01-11,2013-01-25,2013-06-25,Radiation,Private,,56.0,EGFR,Yes,Former,None,20.3,Low,Urban,Private Insurance,15.0,No,No,Cardiovascular Disease,2.0
PT03273,Spain,Madrid,46.0,Male,Breast,III,2019-05-21,2019-10-03,2020-08-06,Immunotherapy,Public,Alive,20.0,BRCA1,Yes,Never,Moderate,28.4,Medium,Urban,Private Insurance,16.0,No,No,None,9.0
PT03274,Poland,Silesian,44.0,Male,Prostate,II,,2011-11-25,2012-01-18,Chemotherapy,Public,Alive,83.0,KRAS,Yes,Current,None,32.1,Medium,Urban,Statutory Health Insurance,3.0,No,No,Obesity,5.0
PT03275,Portugal,Porto,71.0,Male,Breast,I,2023-06-12,2023-10-26,,Immunotherapy,Public,Alive,18.0,KRAS,Yes,Never,None,35.5,Medium,Urban,Statutory Health Insurance,3.0,No,No,None,7.0
PT03276,Finland,Southwest Finland,87.0,Female,Ovarian,IV,2022-09-09,2023-02-08,2023-06-16,Surgery,Public,Alive,119.0,BRCA1,Yes,Former,Moderate,37.1,,Rural,NHS,14.0,No,No,None,5.0
,Germany,Berlin,40.0,Female,Ovarian,I,2016-03-06,2016-07-13,2017-03-18,,Public,,66.0,None,No,Current,Moderate,21.7,High,,Private Insurance,13.0,No,No,Diabetes,2.0
PT03278,,Flanders,37.0,Non-binary,Lung,I,2020-11-29,2021-02-06,2021-09-23,Surgery,Research Institute,Alive,102.0,KRAS,Yes,Former,,26.5,Medium,Rural,Statutory Health Insurance,17.0,No,No,Cardiovascular Disease,7.0
PT03279,Portugal,Porto,58.0,Female,Prostate,I,2011-05-07,2011-06-08,2011-09-28,,Private,Alive,,BRCA1,Yes,Never,None,31.4,Medium,Rural,NHS,13.0,No,No,None,4.0
PT03280,Spain,Catalonia,34.0,Female,Prostate,IV,2022-10-24,2022-10-25,2023-08-26,Targeted Therapy,Public,Alive,112.0,KRAS,No,Current,Moderate,32.0,Low,Urban,Private Insurance,14.0,No,No,None,6.0
PT03281,Germany,Berlin,72.0,Male,Leukemia,II,2021-05-16,2021-11-02,2022-07-11,Surgery,Private,Alive,49.0,BRCA1,Yes,Never,Moderate,37.1,High,,Statutory Health Insurance,12.0,,No,None,2.0
PT03282,Spain,,,Non-binary,Ovarian,II,2014-01-22,,2014-08-05,Chemotherapy,Public,Lost to Follow-up,,KRAS,No,Current,None,29.4,High,Urban,Statutory Health Insurance,2.0,No,Yes,Diabetes,5.0
PT03283,Poland,Masovian,67.0,Female,Pancreatic,III,2015-05-04,2015-07-17,2015-12-29,Chemotherapy,Private,Alive,66.0,EGFR,No,Current,None,30.0,Low,Rural,NHS,6.0,No,Yes,Hypertension,
PT03284,Spain,Catalonia,71.0,Female,Prostate,III,,2017-02-08,2017-05-10,Immunotherapy,Public,Alive,,EGFR,,Never,Moderate,25.9,Low,Urban,Private Insurance,17.0,No,No,Diabetes,3.0
PT03285,Poland,Lesser Poland,47.0,Female,Breast,III,,2018-11-13,2019-05-27,Surgery,Public,,,None,Yes,Never,Heavy,39.1,Medium,Urban,NHS,8.0,No,No,None,4.0
PT03286,Netherlands,Utrecht,,Female,Leukemia,II,2019-08-19,2019-12-11,2020-05-19,Radiation,Private,Alive,40.0,KRAS,No,Current,Moderate,22.7,,Urban,Private Insurance,3.0,No,No,Diabetes,4.0
PT03287,Italy,Veneto,35.0,Male,Prostate,IV,2015-11-05,2016-03-31,2017-01-13,Surgery,Private,Lost to Follow-up,,BRCA1,Yes,,Moderate,34.0,Low,Rural,Statutory Health Insurance,7.0,No,No,None,5.0
PT03288,Finland,Southwest Finland,54.0,Male,Prostate,III,,2015-03-28,2016-03-02,,Public,Lost to Follow-up,,None,No,Current,Moderate,29.5,High,Rural,Private Insurance,4.0,No,No,Diabetes,7.0
PT03289,Belgium,Brussels,36.0,Female,Leukemia,II,2011-09-03,2011-11-23,2012-07-15,Chemotherapy,Public,Alive,28.0,BRCA1,No,Never,None,23.9,Medium,Urban,Private Insurance,2.0,Yes,No,Obesity,7.0
PT03290,Germany,North Rhine-Westphalia,71.0,Female,Lung,II,2013-02-21,2013-02-23,2013-09-03,Radiation,Private,Deceased,117.0,BRCA1,,Never,None,22.4,Low,Urban,NHS,13.0,No,No,Cardiovascular Disease,8.0
PT03291,Sweden,Skåne,31.0,Female,Prostate,IV,2022-12-25,2023-01-04,2023-11-29,Targeted Therapy,Public,Alive,73.0,BRCA1,,Former,Heavy,30.9,Medium,Urban,NHS,14.0,Yes,No,Obesity,8.0
PT03292,France,Auvergne-Rhône-Alpes,67.0,Male,Colorectal,III,2016-05-19,2016-08-30,2017-03-19,Radiation,Public,Deceased,117.0,KRAS,No,Never,Moderate,19.0,Low,Urban,Private Insurance,15.0,No,No,Cardiovascular Disease,8.0
PT03293,Denmark,Central Denmark,41.0,Male,,III,2017-01-05,2017-05-19,2017-12-03,Surgery,Private,Deceased,60.0,KRAS,,Never,None,39.0,Medium,Urban,Private Insurance,18.0,No,Yes,Hypertension,5.0
PT03294,Germany,Berlin,68.0,Female,Lung,III,2012-04-08,2012-06-13,2012-12-14,Radiation,Public,Alive,26.0,,Yes,Former,None,25.5,Low,Urban,NHS,9.0,No,No,Cardiovascular Disease,1.0
PT03295,Belgium,,71.0,Female,Prostate,II,2014-08-23,2014-08-31,2014-12-30,Surgery,Public,Alive,107.0,KRAS,Yes,Never,None,40.0,Medium,Urban,Private Insurance,2.0,Yes,No,None,9.0
PT03296,Finland,Pirkanmaa,20.0,Female,Lung,I,2016-01-14,2016-03-22,,Radiation,,Alive,29.0,EGFR,No,Never,Moderate,30.3,,Urban,Statutory Health Insurance,3.0,No,No,Diabetes,8.0
,Germany,North Rhine-Westphalia,85.0,Male,Breast,II,2016-03-23,2016-05-12,2016-06-15,Surgery,Public,Alive,95.0,KRAS,Yes,Former,None,24.8,Medium,Urban,Private Insurance,4.0,No,No,None,10.0
PT03298,Netherlands,North Holland,83.0,Female,Lung,II,2017-11-20,,2018-09-11,Chemotherapy,Private,Alive,66.0,KRAS,Yes,Former,,23.1,Medium,Rural,Private Insurance,13.0,No,No,Cardiovascular Disease,3.0
PT03299,Belgium,Wallonia,27.0,Female,Leukemia,I,2019-06-28,2019-08-03,2020-03-10,Chemotherapy,Private,Alive,94.0,KRAS,Yes,Former,None,34.9,High,Urban,Private Insurance,12.0,,No,,8.0
PT03300,Portugal,Lisbon,44.0,Female,Prostate,II,2010-09-23,2011-02-06,2011-04-15,,Public,Alive,13.0,None,No,Never,None,19.2,Medium,Urban,NHS,9.0,No,Yes,Cardiovascular Disease,1.0
,Germany,Berlin,85.0,Male,Lung,III,2013-07-13,2013-10-16,2013-11-24,,Public,Alive,75.0,EGFR,Yes,Former,None,35.1,Medium,Urban,Private Insurance,8.0,No,No,Obesity,9.0
PT03302,Netherlands,South Holland,89.0,Male,Colorectal,I,2019-11-30,2020-04-23,2020-07-24,Targeted Therapy,Research Institute,Alive,105.0,None,No,Never,Moderate,31.9,Medium,Rural,Statutory Health Insurance,17.0,Yes,No,Diabetes,1.0
PT03303,Portugal,Porto,70.0,Female,Breast,I,2019-04-15,2019-07-02,2020-04-21,Surgery,Public,Lost to Follow-up,,EGFR,Yes,Never,Heavy,25.7,Medium,Urban,Statutory Health Insurance,16.0,Yes,Yes,Cardiovascular Disease,10.0
PT03304,Spain,Madrid,72.0,Male,Breast,III,2011-04-18,2011-09-01,2011-12-23,Immunotherapy,Research Institute,Alive,67.0,,No,Never,Moderate,30.5,Medium,Rural,Statutory Health Insurance,15.0,No,No,,6.0
PT03305,Switzerland,Geneva,34.0,Female,Ovarian,III,2017-01-19,2017-05-21,2017-07-18,Surgery,Public,Deceased,103.0,None,Yes,,None,37.5,Medium,,Private Insurance,19.0,No,No,Obesity,7.0
PT03306,Ireland,Dublin,69.0,Female,Lung,I,,2015-06-09,2016-02-06,Chemotherapy,Public,Alive,109.0,,No,Never,Moderate,38.9,Medium,Urban,Statutory Health Insurance,,No,No,Cardiovascular Disease,
PT03307,Germany,Bavaria,57.0,Female,Leukemia,III,2018-08-21,2018-10-03,2019-06-10,Radiation,Private,Alive,8.0,KRAS,No,Never,Moderate,38.6,High,Urban,NHS,8.0,Yes,Yes,Diabetes,1.0
PT03308,Ireland,Connacht,59.0,Male,Breast,III,2012-06-08,2012-08-10,2013-06-06,Chemotherapy,Research Institute,Alive,21.0,None,Yes,Former,Moderate,29.3,Medium,Urban,NHS,3.0,No,No,Obesity,2.0
PT03309,Poland,Silesian,85.0,Male,Ovarian,II,2019-08-01,2019-10-21,2020-06-15,Immunotherapy,Private,Alive,11.0,BRCA1,No,Former,Moderate,30.9,,Urban,Private Insurance,5.0,No,Yes,Hypertension,5.0
PT03310,Denmark,Zealand,58.0,Female,Lung,II,2014-05-31,2014-09-21,2015-03-21,Radiation,Public,Alive,118.0,EGFR,Yes,Never,Moderate,22.0,Medium,Urban,Private Insurance,1.0,No,Yes,Obesity,8.0
PT03311,,Uusimaa,36.0,Female,Lung,I,2022-04-04,2022-04-16,2022-06-19,Chemotherapy,Public,Deceased,26.0,EGFR,No,Former,None,38.2,Medium,Urban,Statutory Health Insurance,14.0,No,No,Hypertension,5.0
PT03312,Sweden,Västra Götaland,26.0,Male,Breast,III,2010-07-05,2010-09-27,2010-12-26,Surgery,Public,Lost to Follow-up,,KRAS,No,Current,None,19.4,High,Urban,NHS,4.0,Yes,No,Hypertension,6.0
PT03313,Austria,Vienna,58.0,Male,Lung,II,2020-12-19,2021-03-27,2022-01-26,Surgery,Public,Alive,8.0,EGFR,,Never,Moderate,28.6,Low,Urban,Private Insurance,1.0,No,No,Cardiovascular Disease,8.0
PT03314,Denmark,Capital Region,87.0,Non-binary,Lung,II,2019-02-16,2019-04-13,2020-03-21,Radiation,Private,Alive,115.0,,No,Current,Moderate,22.6,Medium,Urban,Private Insurance,1.0,No,No,None,7.0
PT03315,Norway,Vestland,54.0,Male,Pancreatic,IV,2016-02-05,2016-03-25,2016-08-01,Targeted Therapy,Research Institute,Alive,70.0,BRCA1,No,Current,None,,Medium,Rural,Statutory Health Insurance,11.0,No,No,Cardiovascular Disease,7.0
PT03316,Norway,Trøndelag,70.0,Female,Colorectal,I,2018-10-19,2019-03-07,2019-10-25,Immunotherapy,Private,Deceased,76.0,KRAS,No,Former,Moderate,33.1,Medium,Rural,Statutory Health Insurance,14.0,No,No,Diabetes,2.0
PT03317,Finland,Pirkanmaa,66.0,Male,Lung,I,,2021-01-25,2021-10-28,Chemotherapy,Public,Alive,29.0,KRAS,,Never,Moderate,27.3,Low,Urban,Statutory Health Insurance,12.0,No,No,None,3.0
PT03318,Belgium,Brussels,55.0,Female,Pancreatic,,,2013-11-29,2014-08-07,Chemotherapy,Public,Alive,111.0,None,No,Current,,38.4,Low,Urban,,5.0,No,Yes,Diabetes,1.0
PT03319,Sweden,Västra Götaland,83.0,Female,Pancreatic,I,2017-04-27,2017-07-18,2018-02-20,Immunotherapy,Public,Alive,25.0,BRCA1,No,Never,None,32.1,High,Urban,Private Insurance,17.0,No,No,Cardiovascular Disease,1.0
PT03320,Ireland,Dublin,32.0,Female,Lung,III,2016-11-22,2016-12-28,2017-04-22,Chemotherapy,Private,Deceased,,KRAS,No,Former,None,30.5,Low,Rural,Private Insurance,5.0,No,No,Obesity,4.0
PT03321,Netherlands,Utrecht,37.0,Male,Leukemia,III,2023-12-19,2024-06-10,2024-10-05,,Private,Alive,51.0,EGFR,Yes,Former,Heavy,27.6,Medium,Urban,Statutory Health Insurance,18.0,Yes,No,Obesity,2.0
PT03322,Switzerland,Bern,40.0,Female,Breast,I,2020-04-21,2020-08-17,2021-02-04,Targeted Therapy,Private,Alive,77.0,KRAS,No,Never,None,25.7,Medium,Urban,NHS,13.0,Yes,No,None,1.0
PT03323,Switzerland,Geneva,84.0,Male,Pancreatic,I,2018-05-07,2018-10-11,2019-04-22,Radiation,Private,Alive,94.0,None,No,Former,Moderate,37.7,,Rural,Statutory Health Insurance,15.0,No,No,Cardiovascular Disease,9.0
PT03324,Ireland,Connacht,27.0,,Pancreatic,I,2015-11-25,2016-02-12,2016-07-31,Targeted Therapy,Research Institute,Alive,43.0,EGFR,No,Former,Moderate,27.2,Medium,,NHS,13.0,No,No,Cardiovascular Disease,7.0
PT03325,Italy,,67.0,Female,Ovarian,IV,2018-06-30,2018-08-10,2019-05-23,Surgery,Private,Alive,33.0,BRCA1,No,Former,None,30.8,High,Rural,Private Insurance,15.0,No,No,None,3.0
PT03326,Finland,Pirkanmaa,,Female,Leukemia,III,2019-11-28,2019-12-26,,,Private,Deceased,42.0,None,Yes,Never,Moderate,28.8,High,Rural,Private Insurance,17.0,Yes,No,Cardiovascular Disease,8.0
PT03327,Belgium,Wallonia,72.0,Male,Prostate,II,2020-07-10,2020-12-09,2021-10-03,Targeted Therapy,Public,Alive,66.0,EGFR,Yes,Never,None,31.2,High,Urban,Private Insurance,1.0,Yes,No,Cardiovascular Disease,4.0
PT03328,Ireland,Munster,46.0,Female,Leukemia,II,2011-06-05,2011-09-14,2012-03-24,Targeted Therapy,Private,Alive,30.0,KRAS,Yes,Never,None,22.7,Medium,Urban,Statutory Health Insurance,6.0,No,No,None,
PT03329,Switzerland,Zurich,38.0,Male,Ovarian,II,2014-07-03,2014-11-24,2015-01-10,Chemotherapy,Public,Lost to Follow-up,,BRCA1,No,Never,None,39.6,Medium,Urban,NHS,18.0,No,,Cardiovascular Disease,3.0
PT03330,Austria,Tyrol,42.0,,Prostate,I,2011-10-17,2011-11-08,2012-05-17,Targeted Therapy,Private,Alive,81.0,BRCA1,Yes,Former,None,26.4,Low,Urban,,6.0,No,No,Obesity,10.0
PT03331,Germany,North Rhine-Westphalia,69.0,Male,Prostate,IV,2010-02-11,2010-03-30,2010-06-19,,Private,Deceased,48.0,None,Yes,Never,None,23.9,High,Urban,Statutory Health Insurance,7.0,Yes,No,Obesity,10.0
PT03332,Germany,North Rhine-Westphalia,70.0,Male,Leukemia,III,2017-12-21,2018-01-07,2018-12-28,Surgery,Private,Alive,25.0,EGFR,No,Never,,18.8,Low,Urban,Statutory Health Insurance,14.0,,No,Hypertension,4.0
PT03333,Belgium,Brussels,62.0,Male,Colorectal,III,2020-05-12,2020-09-18,2020-12-14,Surgery,Private,Alive,87.0,None,No,Former,Moderate,36.5,Low,Rural,Statutory Health Insurance,4.0,No,No,None,4.0
PT03334,Ireland,Munster,70.0,Male,Leukemia,II,2020-10-26,2021-04-03,2022-02-09,Chemotherapy,,Alive,38.0,None,No,Never,Heavy,32.3,High,Urban,Statutory Health Insurance,9.0,No,No,Diabetes,1.0
PT03335,Poland,Silesian,88.0,Female,Pancreatic,,2014-12-29,2015-03-28,2015-09-19,Radiation,Private,Deceased,38.0,EGFR,Yes,Never,Moderate,24.6,Medium,Urban,NHS,19.0,No,No,Diabetes,6.0
PT03336,Portugal,Porto,,Male,Breast,I,2023-07-15,2023-07-27,2023-10-21,Immunotherapy,Private,Alive,106.0,EGFR,Yes,Never,Moderate,26.2,Medium,Urban,Private Insurance,15.0,No,No,Cardiovascular Disease,8.0
PT03337,Norway,Vestland,30.0,Female,Leukemia,I,,2016-05-17,2016-06-24,Radiation,Private,Alive,44.0,BRCA1,No,Former,Moderate,28.5,High,,Private Insurance,15.0,Yes,No,Cardiovascular Disease,5.0
PT03338,Portugal,Lisbon,71.0,Male,Colorectal,II,2014-02-22,2014-07-19,2015-02-25,Targeted Therapy,Public,Deceased,17.0,EGFR,No,Never,Moderate,27.2,Medium,Urban,Private Insurance,16.0,No,No,Cardiovascular Disease,4.0
PT03339,Spain,Andalusia,42.0,Female,Leukemia,I,,2023-01-24,2023-05-12,Radiation,,Alive,106.0,KRAS,Yes,Never,None,27.4,High,Rural,Statutory Health Insurance,18.0,No,No,Diabetes,
PT03340,Austria,Tyrol,68.0,Female,Colorectal,I,2020-03-25,2020-04-09,2020-10-06,Immunotherapy,Public,Alive,83.0,BRCA1,Yes,Never,Moderate,31.7,Low,,Private Insurance,18.0,No,No,None,1.0
PT03341,,Bern,57.0,Non-binary,Breast,II,2013-07-04,2013-07-29,2014-07-08,Chemotherapy,Public,,25.0,None,No,Current,Moderate,36.7,Medium,,NHS,4.0,No,No,None,6.0
PT03342,Austria,Styria,66.0,Female,Lung,IV,2023-06-26,2023-12-06,2024-07-17,Chemotherapy,Public,Alive,110.0,None,Yes,Never,Moderate,26.3,Medium,Urban,NHS,17.0,No,Yes,Obesity,6.0
PT03343,Norway,Trøndelag,26.0,Male,Colorectal,IV,2018-08-05,2018-11-21,2019-07-09,Targeted Therapy,Private,Alive,119.0,KRAS,No,Former,None,22.0,Medium,Urban,NHS,4.0,No,No,Cardiovascular Disease,8.0
PT03344,Finland,Southwest Finland,85.0,Female,Colorectal,I,2010-08-08,2010-10-02,2011-08-05,Immunotherapy,Private,Alive,23.0,EGFR,No,,Moderate,18.7,Low,Rural,Statutory Health Insurance,16.0,No,No,Obesity,6.0
PT03345,Switzerland,Zurich,81.0,Male,Pancreatic,I,2019-04-18,2019-06-20,2019-10-11,Chemotherapy,Public,,79.0,EGFR,No,Never,None,27.9,Medium,Urban,Statutory Health Insurance,13.0,No,No,Obesity,6.0
,Belgium,Brussels,48.0,Female,Colorectal,II,2020-12-23,2021-02-08,2021-11-27,Targeted Therapy,Private,Lost to Follow-up,,EGFR,Yes,Never,None,22.7,Medium,Urban,Statutory Health Insurance,,No,No,Diabetes,4.0
PT03347,Finland,Uusimaa,57.0,Male,Breast,III,2023-07-31,2023-11-24,,Radiation,Public,Deceased,22.0,EGFR,Yes,Current,None,22.8,Low,Rural,Private Insurance,11.0,No,No,Diabetes,9.0
PT03348,Italy,Lombardy,52.0,Male,Prostate,IV,2020-06-04,2020-08-07,2021-04-26,Immunotherapy,Private,Alive,10.0,None,No,Never,Heavy,19.9,Medium,Rural,Statutory Health Insurance,17.0,No,Yes,None,3.0
PT03349,France,Île-de-France,48.0,Male,Colorectal,IV,2015-07-26,2015-08-17,2016-02-13,Chemotherapy,Private,Deceased,69.0,,No,Never,None,21.4,Medium,Urban,NHS,8.0,No,No,Hypertension,6.0
PT03350,Finland,Uusimaa,42.0,Female,Ovarian,III,2014-06-18,2014-10-02,2014-12-07,Immunotherapy,Private,Deceased,33.0,KRAS,No,Former,Moderate,,High,Rural,Statutory Health Insurance,2.0,No,No,,8.0
PT03351,Germany,Bavaria,22.0,Female,Breast,I,2018-11-24,2019-02-09,2020-01-28,Chemotherapy,Public,Alive,106.0,EGFR,Yes,Former,None,33.1,Medium,Rural,NHS,17.0,No,No,Obesity,3.0
PT03352,Germany,Bavaria,64.0,Female,Pancreatic,I,2011-04-06,,2012-02-04,Chemotherapy,Public,Deceased,38.0,None,Yes,Current,Moderate,27.9,Medium,Urban,Statutory Health Insurance,11.0,No,No,None,9.0
PT03353,Sweden,Skåne,27.0,Female,Ovarian,I,2010-10-17,2011-01-05,2011-08-14,Immunotherapy,Private,Alive,43.0,EGFR,Yes,Never,None,33.8,Medium,Urban,Statutory Health Insurance,17.0,No,No,Diabetes,7.0
PT03354,Sweden,Stockholm,48.0,Male,Pancreatic,III,2013-02-09,2013-06-16,2013-08-02,Chemotherapy,Public,Alive,90.0,BRCA1,No,Current,Moderate,35.0,,Rural,Private Insurance,1.0,Yes,No,None,7.0
PT03355,Belgium,Flanders,21.0,Female,Lung,I,2016-11-18,2017-03-28,2017-10-06,,Public,Alive,44.0,None,Yes,Current,None,32.5,Low,,Private Insurance,16.0,,No,None,4.0
PT03356,Spain,Catalonia,69.0,Female,Colorectal,III,2010-08-12,2010-12-16,2011-10-20,Targeted Therapy,Public,Alive,112.0,EGFR,Yes,Never,,18.5,,Urban,Statutory Health Insurance,9.0,No,No,Cardiovascular Disease,5.0
PT03357,Netherlands,,84.0,Female,Prostate,III,2016-09-11,2017-01-03,2017-09-01,Surgery,Private,Lost to Follow-up,,None,Yes,Never,None,30.1,Medium,Rural,Statutory Health Insurance,1.0,,,,6.0
PT03358,Belgium,,39.0,Female,Breast,I,2011-03-30,2011-07-23,2012-01-03,Immunotherapy,Public,Deceased,97.0,BRCA1,No,Current,None,24.3,Low,Urban,Private Insurance,2.0,No,No,Cardiovascular Disease,2.0
PT03359,Switzerland,Geneva,71.0,Female,Lung,IV,2022-03-17,2022-08-17,2023-03-23,Immunotherapy,Private,Alive,70.0,None,No,Current,None,,High,Urban,Statutory Health Insurance,5.0,No,No,Hypertension,2.0
PT03360,Ireland,Dublin,56.0,Female,Prostate,II,2015-08-09,2015-10-09,2016-10-04,Targeted Therapy,Private,Alive,8.0,None,Yes,Never,Moderate,37.9,Medium,Rural,Statutory Health Insurance,18.0,Yes,No,None,2.0
PT03361,Austria,Vienna,46.0,Male,Lung,IV,2017-06-15,2017-06-20,2018-03-19,Radiation,Private,Lost to Follow-up,,KRAS,No,Never,Moderate,27.3,Low,Rural,NHS,16.0,No,No,Hypertension,2.0
PT03362,Denmark,Central Denmark,66.0,Male,Prostate,IV,2021-03-22,2021-04-19,,Surgery,Public,Deceased,82.0,KRAS,Yes,Former,Moderate,34.5,Medium,Rural,Private Insurance,5.0,No,No,Diabetes,1.0
PT03363,Spain,Andalusia,25.0,Male,Leukemia,I,2022-11-02,2023-01-22,2023-09-04,Radiation,Private,Alive,117.0,None,No,Never,Moderate,26.4,High,Urban,Private Insurance,6.0,No,No,,9.0
PT03364,Finland,Pirkanmaa,79.0,Male,Leukemia,II,2020-08-11,2020-08-26,2021-05-27,Immunotherapy,,Alive,31.0,BRCA1,No,Never,Moderate,,Low,,Statutory Health Insurance,18.0,No,No,Diabetes,3.0
PT03365,France,Provence-Alpes-Côte d'Azur,64.0,Male,Leukemia,I,2011-11-22,2012-03-21,2012-05-04,Surgery,Public,,114.0,KRAS,Yes,Never,Moderate,39.6,Low,Urban,,7.0,No,No,,9.0
PT03366,Italy,Sicily,63.0,Non-binary,Lung,III,2012-04-28,2012-06-05,2012-12-26,Chemotherapy,Public,Alive,,None,Yes,Never,None,21.8,Medium,Urban,NHS,9.0,No,No,Diabetes,7.0
PT03367,Switzerland,Zurich,37.0,Male,Leukemia,II,2019-04-10,2019-09-08,2020-08-14,Immunotherapy,Public,Deceased,75.0,EGFR,No,Never,Heavy,31.3,Medium,Urban,,,Yes,No,Hypertension,2.0
PT03368,Spain,Madrid,84.0,Female,Breast,IV,2022-11-15,2022-11-29,2023-04-04,Radiation,Private,Alive,119.0,,No,Former,Moderate,32.0,Medium,,Private Insurance,12.0,No,No,Obesity,8.0
PT03369,Finland,Pirkanmaa,44.0,Female,Breast,I,2023-03-18,2023-04-19,2023-06-01,Targeted Therapy,Public,Alive,94.0,BRCA1,Yes,Former,Moderate,36.6,Medium,Urban,Statutory Health Insurance,1.0,No,No,Hypertension,
PT03370,Germany,Bavaria,46.0,Male,Leukemia,III,2016-10-04,2016-11-17,2017-05-20,Chemotherapy,Private,Alive,40.0,KRAS,,Former,Moderate,21.3,Medium,Urban,Statutory Health Insurance,18.0,No,No,Diabetes,9.0
PT03371,Austria,Vienna,26.0,Male,Prostate,IV,2013-11-29,2014-03-01,2014-09-12,Surgery,Private,,24.0,KRAS,,Never,Moderate,37.9,Medium,Rural,Statutory Health Insurance,18.0,Yes,No,Diabetes,3.0
PT03372,France,Île-de-France,63.0,Female,Prostate,III,2016-05-04,2016-08-30,,Immunotherapy,Public,Deceased,55.0,KRAS,Yes,Former,Moderate,32.9,,Urban,NHS,18.0,No,No,Obesity,
PT03373,Ireland,,48.0,Female,Lung,I,2020-09-30,2021-01-24,2021-09-22,Targeted Therapy,Public,Deceased,,BRCA1,Yes,Current,Moderate,39.9,Medium,Rural,Private Insurance,11.0,No,No,Hypertension,
PT03374,France,Provence-Alpes-Côte d'Azur,63.0,Non-binary,Prostate,II,2017-02-28,2017-07-01,2017-12-07,Targeted Therapy,Private,Alive,40.0,None,Yes,Former,None,29.8,Low,Rural,Statutory Health Insurance,6.0,No,No,None,5.0
PT03375,Belgium,Wallonia,55.0,Male,Ovarian,I,2012-01-09,2012-05-04,2012-06-06,Radiation,Public,Deceased,91.0,KRAS,Yes,Current,None,31.8,Medium,Urban,NHS,9.0,Yes,No,,5.0
PT03376,Norway,Trøndelag,38.0,Female,Ovarian,I,2023-01-04,2023-04-16,2024-01-11,Targeted Therapy,Public,Alive,106.0,KRAS,Yes,Never,Moderate,22.2,Medium,Urban,Statutory Health Insurance,3.0,No,No,Diabetes,6.0
PT03377,,North Rhine-Westphalia,25.0,Male,Ovarian,II,2016-01-28,2016-02-01,2016-07-31,Radiation,Public,,16.0,None,Yes,Current,None,26.9,High,,,19.0,Yes,No,Hypertension,
PT03378,Spain,Andalusia,44.0,Female,Colorectal,I,2016-06-10,2016-10-03,,Surgery,Public,Alive,94.0,EGFR,Yes,Former,Moderate,35.3,High,Rural,Private Insurance,5.0,No,No,Obesity,3.0
PT03379,Ireland,Connacht,50.0,Female,Prostate,III,2018-11-14,2019-01-12,2019-07-07,Immunotherapy,Public,Alive,31.0,KRAS,No,Former,None,24.6,High,Urban,Private Insurance,17.0,No,No,Diabetes,3.0
PT03380,France,Île-de-France,28.0,Male,Breast,II,2012-05-24,2012-08-07,2013-03-14,Surgery,Public,Lost to Follow-up,,None,No,Never,None,38.8,Low,Rural,Private Insurance,1.0,No,No,Hypertension,6.0
,Denmark,Zealand,56.0,Male,Pancreatic,III,2010-12-01,2011-05-07,2011-11-21,Radiation,Private,Deceased,15.0,,No,,,,High,Urban,,15.0,No,No,None,1.0
PT03382,Denmark,Central Denmark,46.0,Male,Prostate,I,2013-03-24,2013-08-18,,Surgery,Private,Alive,51.0,KRAS,Yes,Never,Moderate,22.9,High,Rural,Statutory Health Insurance,17.0,Yes,No,Obesity,6.0
PT03383,Ireland,Dublin,32.0,Male,Ovarian,I,2011-09-22,2012-02-14,2012-06-14,Immunotherapy,Public,Alive,33.0,KRAS,Yes,Never,None,38.2,High,Rural,NHS,2.0,No,Yes,None,4.0
PT03384,Denmark,Central Denmark,,Female,Lung,I,2010-03-22,2010-03-26,2010-07-10,Immunotherapy,Public,Alive,88.0,BRCA1,Yes,Former,Moderate,23.1,Low,Urban,Private Insurance,13.0,Yes,No,Diabetes,9.0
PT03385,Portugal,Algarve,85.0,Male,Prostate,I,2012-06-28,2012-12-17,2013-04-03,Targeted Therapy,Public,Alive,24.0,EGFR,Yes,Former,Heavy,29.9,Medium,Urban,,17.0,No,No,Diabetes,8.0
PT03386,France,Auvergne-Rhône-Alpes,43.0,Female,Ovarian,II,2011-03-26,2011-03-30,2011-08-20,Radiation,Public,Alive,41.0,EGFR,,Never,,31.1,High,Rural,Private Insurance,19.0,No,Yes,None,6.0
PT03387,Poland,Silesian,63.0,Male,Lung,III,2018-05-29,2018-10-16,2019-01-27,Surgery,Public,Alive,111.0,None,Yes,Former,Moderate,26.5,Low,,NHS,9.0,No,Yes,,4.0
PT03388,Belgium,Wallonia,79.0,Female,Colorectal,IV,2018-02-18,2018-04-06,2018-09-07,Targeted Therapy,Public,Deceased,23.0,KRAS,,Current,Moderate,23.9,Medium,Rural,NHS,4.0,No,No,Hypertension,4.0
PT03389,,Algarve,28.0,Female,Leukemia,II,2021-03-02,2021-07-15,2022-03-13,Targeted Therapy,Research Institute,Deceased,31.0,EGFR,No,Current,,19.4,Medium,Urban,NHS,16.0,No,No,None,6.0
PT03390,Finland,Uusimaa,21.0,Female,Colorectal,I,2015-06-03,2015-10-21,2016-05-30,Surgery,Research Institute,Alive,54.0,BRCA1,No,Current,Moderate,36.8,Low,Urban,Private Insurance,9.0,No,No,Cardiovascular Disease,1.0
PT03391,,Uusimaa,75.0,Female,Breast,I,2023-01-28,2023-04-09,2023-07-23,Radiation,Public,Alive,60.0,KRAS,No,Current,Moderate,21.7,Medium,Urban,Statutory Health Insurance,4.0,,No,Obesity,2.0
PT03392,,Algarve,49.0,Male,Pancreatic,IV,2019-04-19,2019-06-12,2020-02-23,Radiation,Public,Alive,13.0,KRAS,No,Former,Moderate,23.4,Medium,Urban,,3.0,No,No,Hypertension,8.0
PT03393,Finland,Uusimaa,41.0,Female,Colorectal,III,2011-12-31,2012-03-03,2013-02-27,Immunotherapy,Public,,,,Yes,Never,None,36.3,High,Urban,Statutory Health Insurance,9.0,No,Yes,Hypertension,6.0
PT03394,Switzerland,Geneva,32.0,Male,Colorectal,III,2019-01-13,,2019-11-21,Radiation,Research Institute,Alive,77.0,None,No,Never,None,25.3,Medium,Urban,NHS,12.0,No,Yes,Obesity,2.0
PT03395,Norway,Vestland,35.0,Male,Breast,I,2018-03-31,2018-09-12,,,Public,Alive,35.0,KRAS,No,,None,32.1,Low,Urban,NHS,7.0,No,No,Cardiovascular Disease,2.0
PT03396,France,Auvergne-Rhône-Alpes,64.0,Male,Breast,I,2018-04-09,2018-06-04,2019-01-05,Immunotherapy,Public,Deceased,13.0,BRCA1,Yes,Never,Moderate,30.8,Medium,Rural,NHS,11.0,No,No,None,2.0
PT03397,France,Île-de-France,84.0,Female,Leukemia,I,2012-10-10,2012-12-22,2013-12-09,Chemotherapy,Private,Alive,41.0,KRAS,No,Current,None,35.4,Low,Rural,NHS,8.0,No,No,None,3.0
PT03398,Netherlands,Utrecht,,Female,Leukemia,IV,2023-01-28,2023-05-05,2024-04-25,Immunotherapy,Private,Alive,79.0,None,Yes,Never,None,32.3,High,,Statutory Health Insurance,2.0,No,No,Obesity,5.0
PT03399,Italy,Veneto,89.0,Female,Prostate,I,2013-08-13,2013-11-23,2014-07-25,Targeted Therapy,Public,Deceased,32.0,KRAS,No,Never,None,26.5,Low,Urban,NHS,19.0,No,Yes,Hypertension,10.0
PT03400,Belgium,Flanders,39.0,Male,Lung,III,,2019-02-27,,Surgery,Private,Deceased,110.0,EGFR,Yes,Never,Moderate,36.6,Low,Urban,Statutory Health Insurance,14.0,No,No,Hypertension,10.0
PT03401,Poland,Masovian,82.0,Male,Breast,II,,2022-09-14,2022-12-27,Surgery,Private,Alive,,KRAS,Yes,Former,None,32.1,Low,Urban,NHS,4.0,Yes,No,Cardiovascular Disease,9.0
PT03402,Netherlands,South Holland,31.0,Female,Colorectal,II,2022-10-27,2022-11-11,2023-04-05,Surgery,Public,Alive,89.0,None,No,Never,Moderate,27.9,High,Urban,NHS,1.0,No,No,Cardiovascular Disease,5.0
PT03403,Ireland,Connacht,81.0,Female,Colorectal,I,2023-07-15,2023-11-22,2024-02-08,Targeted Therapy,Public,Deceased,,KRAS,No,Current,None,26.1,Medium,Rural,NHS,14.0,,No,Diabetes,5.0
PT03404,Austria,Tyrol,61.0,Male,Leukemia,III,2017-12-18,2017-12-31,2018-12-14,Immunotherapy,Research Institute,Alive,,KRAS,No,Current,None,31.3,Low,Urban,Private Insurance,2.0,Yes,No,Hypertension,4.0
PT03405,Norway,Oslo,88.0,Female,Lung,I,,2018-05-07,2019-01-30,Surgery,Private,Alive,113.0,EGFR,No,Former,Moderate,18.4,Low,Urban,Statutory Health Insurance,8.0,No,No,None,8.0
PT03406,France,Île-de-France,77.0,Male,Ovarian,IV,2015-12-31,2016-06-24,2017-05-02,Radiation,Public,Alive,44.0,BRCA1,Yes,Former,None,34.5,Medium,Rural,Statutory Health Insurance,8.0,No,No,Obesity,6.0
PT03407,France,Provence-Alpes-Côte d'Azur,24.0,Male,Breast,I,2016-02-20,2016-07-30,2017-03-14,Chemotherapy,Public,Deceased,81.0,EGFR,Yes,Current,None,34.2,,Urban,NHS,,No,No,None,7.0
PT03408,Finland,Uusimaa,46.0,Male,,I,2017-01-13,2017-02-14,2017-05-12,Surgery,Public,Lost to Follow-up,,BRCA1,No,Current,Heavy,28.3,Medium,Urban,NHS,14.0,Yes,,Hypertension,7.0
PT03409,Portugal,Porto,47.0,Male,Ovarian,II,2019-08-06,2019-11-20,2020-04-19,Surgery,Private,Alive,115.0,KRAS,No,Never,Moderate,26.5,Medium,Urban,Private Insurance,15.0,No,No,Obesity,7.0
PT03410,Poland,Masovian,45.0,Male,Lung,III,2013-07-26,2013-08-16,2014-01-14,Chemotherapy,Public,Lost to Follow-up,,EGFR,No,Current,None,,Low,Urban,NHS,7.0,No,No,Obesity,2.0
PT03411,Switzerland,Zurich,68.0,Female,Breast,I,2012-02-29,2012-04-10,2013-01-29,Radiation,Public,Alive,115.0,None,No,Never,None,21.4,Medium,Urban,Private Insurance,14.0,,No,Obesity,2.0
PT03412,Ireland,Connacht,40.0,Female,Colorectal,II,2019-01-13,2019-04-10,2019-12-08,Chemotherapy,Public,Alive,48.0,BRCA1,No,Current,Moderate,34.3,Low,Urban,NHS,19.0,Yes,No,Hypertension,1.0
PT03413,Norway,Oslo,20.0,Female,Colorectal,I,2015-05-19,2015-11-01,2016-07-29,Surgery,Research Institute,Alive,118.0,None,Yes,Never,None,18.6,Medium,,Statutory Health Insurance,1.0,No,No,Cardiovascular Disease,10.0
PT03414,Norway,Vestland,77.0,Female,Leukemia,I,2011-02-21,2011-08-01,2012-04-28,Surgery,Private,Alive,87.0,EGFR,No,Never,Moderate,38.0,Low,Urban,Private Insurance,16.0,No,Yes,Cardiovascular Disease,1.0
PT03415,Germany,North Rhine-Westphalia,74.0,Female,Lung,III,2018-12-17,2019-05-02,2019-08-15,Immunotherapy,Public,Deceased,40.0,BRCA1,Yes,Never,Moderate,39.0,High,,Private Insurance,7.0,No,No,None,10.0
PT03416,Portugal,Algarve,45.0,Male,Colorectal,I,2013-09-06,2013-10-12,2014-05-22,Targeted Therapy,Public,Alive,56.0,BRCA1,No,Current,None,33.9,Medium,Urban,Statutory Health Insurance,12.0,Yes,Yes,Obesity,9.0
PT03417,Switzerland,Zurich,44.0,Female,Ovarian,III,2017-06-30,2017-08-02,2017-09-19,Immunotherapy,Public,Alive,43.0,BRCA1,Yes,Never,Moderate,34.5,High,Urban,Statutory Health Insurance,3.0,No,No,Diabetes,8.0
,Austria,Tyrol,52.0,Female,Lung,III,2016-08-12,2016-09-10,2017-02-08,Immunotherapy,Public,Alive,96.0,KRAS,Yes,Never,Moderate,26.1,High,Urban,Private Insurance,18.0,Yes,No,Obesity,5.0
,Ireland,Connacht,88.0,Male,Leukemia,IV,2017-03-30,2017-07-03,2017-12-21,Immunotherapy,Private,Alive,,EGFR,No,Former,None,37.3,Medium,Urban,Statutory Health Insurance,7.0,No,No,Hypertension,9.0
PT03420,Sweden,Västra Götaland,25.0,,Ovarian,,2017-02-20,2017-04-18,2017-12-21,Immunotherapy,Private,Alive,40.0,EGFR,Yes,Current,None,24.7,Medium,Rural,Private Insurance,11.0,Yes,No,Hypertension,
PT03421,Ireland,Munster,42.0,Female,Ovarian,II,2012-03-15,2012-05-26,2012-12-01,,Public,Alive,57.0,EGFR,Yes,Never,None,30.5,High,Urban,Private Insurance,5.0,No,Yes,Cardiovascular Disease,10.0
,Sweden,Västra Götaland,49.0,Female,Prostate,IV,2017-07-28,2017-10-26,2018-08-13,Radiation,Private,,101.0,BRCA1,No,Former,Heavy,34.3,Low,Urban,Statutory Health Insurance,10.0,No,No,Obesity,5.0
PT03423,Ireland,Munster,,Male,Lung,III,2015-05-07,2015-08-29,2016-01-18,Targeted Therapy,Private,Deceased,14.0,BRCA1,No,Never,None,30.9,Low,,NHS,4.0,No,,Diabetes,6.0
PT03424,Spain,Andalusia,30.0,,Pancreatic,I,2019-04-21,2019-08-14,2020-05-22,Targeted Therapy,Public,Deceased,49.0,EGFR,No,Former,Moderate,28.9,Medium,Urban,NHS,10.0,Yes,No,Cardiovascular Disease,2.0
,Finland,Southwest Finland,50.0,Female,Lung,II,2023-06-20,2023-12-08,2024-10-11,Targeted Therapy,Private,Alive,13.0,None,No,,Moderate,23.0,Medium,Urban,Statutory Health Insurance,7.0,No,No,Obesity,5.0
PT03426,France,Île-de-France,25.0,Male,Leukemia,IV,,2015-09-21,2015-11-08,Radiation,Private,Alive,77.0,,Yes,Never,Moderate,32.4,Medium,Rural,Private Insurance,10.0,No,No,None,6.0
PT03427,Germany,Bavaria,30.0,Female,Pancreatic,II,2022-01-23,2022-05-27,2023-01-28,Radiation,Public,,6.0,None,Yes,Never,Moderate,34.7,High,Rural,Private Insurance,9.0,No,No,Cardiovascular Disease,2.0
PT03428,Belgium,Brussels,31.0,Female,Prostate,III,2023-02-20,2023-07-24,2024-03-26,Radiation,Private,Alive,30.0,BRCA1,No,Never,Heavy,30.5,Medium,Urban,Private Insurance,8.0,No,No,Cardiovascular Disease,3.0
PT03429,Norway,Trøndelag,85.0,Male,Colorectal,II,2017-01-19,2017-05-15,2017-10-21,Surgery,Public,Alive,76.0,EGFR,No,Never,Moderate,36.0,Medium,Rural,Statutory Health Insurance,4.0,No,No,None,6.0
PT03430,Switzerland,Geneva,72.0,Non-binary,Breast,I,2019-03-29,2019-07-10,2020-02-26,Targeted Therapy,Private,Alive,,EGFR,Yes,Current,Moderate,31.2,Low,Rural,NHS,6.0,No,No,Cardiovascular Disease,2.0
PT03431,Poland,Masovian,55.0,,Leukemia,I,2023-02-14,2023-02-16,2023-09-14,Chemotherapy,Public,Alive,67.0,None,No,Current,Moderate,34.5,Low,Urban,Private Insurance,5.0,No,No,Hypertension,2.0
PT03432,Switzerland,Zurich,36.0,Male,Breast,I,2020-03-02,2020-05-31,2020-10-15,Immunotherapy,Private,Alive,15.0,BRCA1,No,Never,Moderate,38.5,Medium,Rural,NHS,10.0,No,No,Obesity,10.0
PT03433,Spain,Andalusia,47.0,Male,Prostate,I,2020-04-06,,2020-09-05,,Public,Alive,117.0,BRCA1,No,Current,Moderate,24.0,High,Urban,NHS,15.0,Yes,No,None,7.0
PT03434,Switzerland,Bern,41.0,Female,Pancreatic,IV,2011-08-28,2012-02-22,,Surgery,Public,Alive,105.0,BRCA1,Yes,Current,Moderate,27.9,,Urban,Private Insurance,10.0,No,No,None,4.0
PT03435,Netherlands,South Holland,26.0,Female,Prostate,III,2019-03-05,2019-04-19,2020-03-02,Immunotherapy,Research Institute,Alive,114.0,KRAS,No,Never,None,38.0,Medium,Urban,Private Insurance,5.0,Yes,No,None,7.0
PT03436,Switzerland,Geneva,34.0,Male,Lung,III,2020-05-24,2020-06-08,2021-02-03,Surgery,Research Institute,Deceased,91.0,None,Yes,Former,Moderate,28.7,Medium,Urban,Statutory Health Insurance,19.0,Yes,No,Obesity,1.0
PT03437,Netherlands,Utrecht,30.0,Male,Breast,III,2017-05-24,2017-10-06,2018-03-03,Radiation,Public,Alive,22.0,KRAS,No,Never,Moderate,18.2,Medium,Rural,NHS,1.0,No,Yes,Cardiovascular Disease,8.0
PT03438,Portugal,Lisbon,43.0,Male,Breast,II,2014-07-09,2014-12-11,2015-10-26,Surgery,Public,Alive,16.0,KRAS,No,Former,None,19.0,Low,Urban,NHS,11.0,No,No,Obesity,8.0
PT03439,Norway,Oslo,86.0,Female,Prostate,I,2022-02-03,2022-03-15,2023-03-13,Targeted Therapy,Public,Alive,52.0,EGFR,No,Never,Moderate,20.2,Medium,Urban,NHS,10.0,No,No,Obesity,4.0
PT03440,Norway,Trøndelag,49.0,Female,Pancreatic,IV,2019-09-19,2019-10-06,2019-11-24,Targeted Therapy,Public,Deceased,,EGFR,No,Current,None,27.0,Low,Urban,Private Insurance,8.0,No,Yes,Diabetes,9.0
PT03441,Sweden,Stockholm,89.0,Female,Breast,II,2010-10-31,2011-04-09,,Chemotherapy,Private,Alive,,KRAS,No,Current,Moderate,26.4,Medium,Rural,,12.0,No,No,None,10.0
PT03442,Finland,Uusimaa,85.0,Female,Ovarian,II,2011-06-03,2011-10-25,,Targeted Therapy,Public,Alive,,None,Yes,Never,Heavy,31.6,Medium,Urban,Private Insurance,19.0,No,No,None,2.0
PT03443,Finland,Southwest Finland,80.0,Female,Colorectal,IV,2023-10-02,2023-12-19,2024-08-20,Immunotherapy,Public,Alive,21.0,EGFR,Yes,Never,Moderate,22.7,Medium,Urban,,9.0,No,Yes,Cardiovascular Disease,8.0
PT03444,,,60.0,Male,Prostate,II,2021-01-13,2021-04-28,2021-08-23,Immunotherapy,Private,Deceased,30.0,None,No,Never,Moderate,27.3,,Urban,Statutory Health Insurance,16.0,No,No,None,2.0
PT03445,Italy,Sicily,70.0,Male,Lung,IV,2012-07-29,2012-10-19,2013-07-28,Targeted Therapy,Private,Alive,35.0,EGFR,No,Never,None,33.2,Medium,Urban,Private Insurance,2.0,No,No,Cardiovascular Disease,10.0
,Belgium,Brussels,63.0,,Lung,IV,2017-11-18,2018-02-12,2018-10-22,Radiation,Research Institute,Alive,,BRCA1,No,Never,None,39.8,Medium,Urban,Statutory Health Insurance,15.0,No,No,None,
PT03447,France,Provence-Alpes-Côte d'Azur,32.0,Female,Lung,I,2010-03-21,2010-06-09,2011-02-01,Targeted Therapy,Public,Alive,46.0,KRAS,No,Never,Moderate,28.4,Low,Rural,Private Insurance,16.0,Yes,No,None,8.0
PT03448,,South Holland,31.0,Male,Breast,I,2010-04-13,2010-06-01,2010-10-26,Radiation,Research Institute,Deceased,116.0,EGFR,Yes,Current,Moderate,18.1,Medium,Rural,NHS,14.0,Yes,No,Diabetes,10.0
PT03449,Finland,Uusimaa,28.0,Female,Prostate,IV,2011-12-30,2012-02-17,2012-05-24,Immunotherapy,,Alive,66.0,BRCA1,,Current,Moderate,31.6,Low,Rural,Statutory Health Insurance,5.0,No,Yes,Obesity,3.0
PT03450,Switzerland,Bern,67.0,Female,Lung,II,2021-08-08,2022-01-09,2022-09-21,Targeted Therapy,Public,Alive,54.0,None,No,Never,None,29.4,High,Urban,Private Insurance,,No,No,None,1.0
PT03451,Sweden,Stockholm,68.0,Male,Prostate,I,2016-09-16,2017-03-14,2017-06-30,Chemotherapy,Private,Alive,95.0,EGFR,No,Never,Heavy,25.8,Medium,Urban,NHS,16.0,Yes,No,Hypertension,6.0
PT03452,Denmark,Central Denmark,,Female,Breast,II,2012-08-13,2012-09-25,2013-03-20,Immunotherapy,Private,Alive,95.0,BRCA1,Yes,Never,None,25.4,High,Rural,Private Insurance,6.0,,No,Diabetes,8.0
PT03453,Switzerland,Zurich,75.0,Female,Colorectal,III,2020-01-09,,2020-05-22,Chemotherapy,Public,Alive,81.0,EGFR,No,Former,None,34.0,Low,Rural,NHS,7.0,No,No,None,6.0
PT03454,Spain,Andalusia,59.0,Male,Colorectal,III,2023-04-28,2023-07-08,2024-01-01,Immunotherapy,Public,Deceased,47.0,BRCA1,No,Never,Moderate,25.1,Medium,Urban,,11.0,No,Yes,Cardiovascular Disease,10.0
PT03455,Ireland,Connacht,43.0,Female,Colorectal,IV,2023-06-16,2023-06-25,2024-05-16,Surgery,Private,Alive,68.0,BRCA1,No,,Moderate,39.4,Low,Rural,,18.0,No,No,None,10.0
PT03456,Spain,Madrid,52.0,Male,Breast,IV,2012-01-10,2012-06-30,2012-11-28,Surgery,Public,Lost to Follow-up,,EGFR,No,Never,Moderate,20.1,Low,Rural,Statutory Health Insurance,12.0,No,No,Diabetes,5.0
PT03457,Sweden,Västra Götaland,42.0,Male,Lung,IV,2021-08-28,2021-11-26,2022-01-26,Surgery,Public,Deceased,100.0,None,No,Never,None,19.9,Medium,Rural,NHS,7.0,No,No,Diabetes,
PT03458,Spain,Andalusia,,Female,Breast,I,2011-08-17,2011-08-19,2012-02-05,Chemotherapy,Research Institute,Deceased,31.0,EGFR,Yes,Never,None,38.3,High,Rural,Private Insurance,19.0,Yes,Yes,Hypertension,10.0
PT03459,Finland,Southwest Finland,72.0,Male,Prostate,III,2019-09-20,2020-03-02,2021-02-04,Radiation,Public,Alive,,,No,Former,Moderate,27.3,Medium,Urban,NHS,18.0,No,No,Hypertension,2.0
PT03460,Belgium,Brussels,68.0,Male,Colorectal,I,2011-07-17,2011-07-20,2011-09-03,Immunotherapy,Private,Alive,33.0,,No,Former,None,28.6,Low,Urban,Private Insurance,11.0,No,Yes,Cardiovascular Disease,9.0
PT03461,France,Provence-Alpes-Côte d'Azur,68.0,,Prostate,I,2023-09-20,2024-02-16,2024-12-07,Surgery,Research Institute,Alive,75.0,KRAS,Yes,Never,Moderate,20.1,High,Rural,Statutory Health Insurance,13.0,No,No,Hypertension,8.0
PT03462,Netherlands,South Holland,79.0,Male,Breast,III,2014-08-27,2014-09-05,2015-06-10,Chemotherapy,Public,Alive,6.0,KRAS,Yes,Current,None,25.9,Medium,Urban,NHS,1.0,No,No,None,2.0
PT03463,Sweden,Skåne,84.0,Male,Leukemia,II,2011-12-26,2012-01-07,2012-08-07,Immunotherapy,Public,Alive,71.0,KRAS,No,Never,None,30.4,High,Urban,Private Insurance,12.0,Yes,No,Hypertension,10.0
PT03464,Portugal,Porto,51.0,Female,Leukemia,IV,2013-12-04,2014-05-18,2014-12-27,Surgery,Public,Alive,96.0,None,Yes,Never,None,20.0,Medium,Urban,NHS,10.0,Yes,No,Obesity,10.0
PT03465,Spain,Madrid,40.0,Male,Ovarian,I,2013-09-04,2014-02-16,2014-08-30,Surgery,Public,Alive,47.0,KRAS,Yes,Former,Moderate,,Medium,Rural,Private Insurance,17.0,No,No,Obesity,6.0
PT03466,France,Auvergne-Rhône-Alpes,37.0,Female,Breast,III,2015-03-11,2015-06-23,2015-09-13,Surgery,Public,Alive,13.0,BRCA1,No,Former,Moderate,32.3,Low,Urban,Private Insurance,3.0,No,No,Obesity,8.0
PT03467,Netherlands,South Holland,79.0,Female,Lung,I,2022-04-11,2022-06-06,2022-09-25,,,Deceased,55.0,None,No,Never,None,,Low,,Statutory Health Insurance,13.0,No,No,Cardiovascular Disease,10.0
PT03468,Sweden,Stockholm,32.0,Male,Pancreatic,I,2021-03-24,2021-07-07,2021-09-08,Radiation,Private,Alive,15.0,KRAS,Yes,Former,None,26.2,High,,Private Insurance,17.0,No,No,Obesity,
PT03469,,Zealand,43.0,Female,Prostate,II,2016-04-01,2016-06-03,2016-09-25,Surgery,Public,Alive,78.0,EGFR,No,Current,Moderate,26.4,Low,Rural,Statutory Health Insurance,18.0,No,,None,8.0
PT03470,Ireland,Munster,,Female,Breast,,2011-01-10,2011-06-13,2012-02-04,Surgery,Public,Deceased,57.0,BRCA1,Yes,Never,Moderate,37.1,Medium,Urban,NHS,13.0,No,No,Obesity,3.0
PT03471,Ireland,Munster,21.0,Male,Breast,II,2016-05-11,2016-06-26,2017-02-12,Radiation,Private,Alive,16.0,KRAS,Yes,Current,Moderate,,Low,Rural,Private Insurance,18.0,Yes,No,Obesity,2.0
PT03472,Austria,Tyrol,44.0,Male,Leukemia,IV,2013-10-26,2013-12-25,2014-03-23,Radiation,Private,Alive,9.0,None,No,Current,None,34.7,High,Urban,Private Insurance,17.0,No,No,None,8.0
PT03473,,Auvergne-Rhône-Alpes,69.0,Female,Colorectal,III,2023-09-18,2023-10-20,2023-12-13,Targeted Therapy,Public,Alive,35.0,EGFR,No,Former,None,22.2,Medium,,NHS,14.0,No,No,Hypertension,6.0
PT03474,Switzerland,Bern,33.0,Non-binary,Colorectal,I,2020-08-09,2020-11-08,2021-01-07,Surgery,Public,Deceased,42.0,,Yes,Former,None,35.0,Medium,Urban,NHS,8.0,Yes,,Cardiovascular Disease,5.0
PT03475,Finland,Pirkanmaa,25.0,Male,Pancreatic,I,2014-04-05,2014-09-27,2015-01-08,Immunotherapy,Private,Alive,108.0,KRAS,,Former,None,28.7,,Urban,Statutory Health Insurance,17.0,No,No,Diabetes,10.0
PT03476,Spain,Andalusia,49.0,Male,Lung,II,2012-07-12,,2012-10-13,Targeted Therapy,Public,Alive,96.0,None,No,Current,Moderate,25.9,Medium,Urban,NHS,5.0,No,No,,7.0
PT03477,Austria,Styria,49.0,Male,Lung,II,2012-04-20,2012-07-23,2012-12-01,Immunotherapy,Public,Alive,22.0,,No,Current,None,24.3,Low,Urban,Statutory Health Insurance,14.0,No,No,Hypertension,10.0
PT03478,Norway,Trøndelag,57.0,Male,Pancreatic,III,2014-09-27,2015-02-06,2015-09-17,Radiation,Public,Deceased,14.0,EGFR,Yes,Former,Moderate,28.7,Medium,Urban,NHS,7.0,No,No,None,7.0
PT03479,Norway,Vestland,77.0,Female,Lung,I,2021-02-24,2021-07-04,2022-03-05,Targeted Therapy,Public,Alive,116.0,BRCA1,No,Current,Moderate,33.6,Low,Urban,Statutory Health Insurance,3.0,No,No,Cardiovascular Disease,4.0
PT03480,Poland,Silesian,60.0,Male,Ovarian,III,,2023-05-07,2023-10-04,Chemotherapy,Public,Alive,11.0,KRAS,,Never,None,30.2,High,Rural,Private Insurance,8.0,Yes,Yes,Hypertension,10.0
PT03481,Denmark,Central Denmark,76.0,Male,Ovarian,I,2015-08-14,2015-10-08,2016-09-19,Targeted Therapy,Private,Alive,98.0,BRCA1,No,Never,Moderate,32.1,Medium,Urban,NHS,5.0,No,,Obesity,3.0
PT03482,Spain,Andalusia,55.0,Male,Leukemia,II,2020-09-15,,2021-05-24,Targeted Therapy,Private,Alive,,BRCA1,,Current,Moderate,38.6,Low,,Private Insurance,10.0,No,No,Obesity,9.0
PT03483,Netherlands,South Holland,83.0,Male,Breast,III,2014-03-28,2014-09-09,2014-11-10,Radiation,Public,Alive,114.0,BRCA1,No,Never,Heavy,31.7,High,Rural,Statutory Health Insurance,8.0,No,Yes,,7.0
PT03484,,Lesser Poland,35.0,Male,Lung,I,2020-11-22,2021-04-10,2022-01-05,Surgery,Public,Alive,,BRCA1,Yes,Former,Moderate,30.9,Low,Rural,Statutory Health Insurance,18.0,No,Yes,Diabetes,4.0
PT03485,Denmark,Central Denmark,33.0,Male,Leukemia,III,2016-09-19,2017-03-02,2017-06-30,Radiation,Public,Deceased,6.0,None,No,Former,Heavy,26.3,Medium,Urban,,15.0,Yes,No,Hypertension,2.0
,Netherlands,Utrecht,50.0,Male,Ovarian,III,2013-12-07,,2014-06-10,Radiation,Public,Lost to Follow-up,,,No,Never,Moderate,25.1,Low,Urban,Private Insurance,14.0,No,No,Obesity,
PT03487,Belgium,Brussels,85.0,Female,Prostate,III,2018-12-05,2019-03-16,2019-05-23,Radiation,Public,Deceased,23.0,KRAS,Yes,Never,None,29.6,Low,Urban,NHS,4.0,No,No,Hypertension,9.0
PT03488,,Île-de-France,87.0,Female,Breast,II,2016-06-22,2016-08-28,,Immunotherapy,Public,Alive,19.0,BRCA1,No,Former,Moderate,18.3,Medium,Urban,Private Insurance,6.0,No,No,Hypertension,4.0
,Italy,Lombardy,84.0,Male,Pancreatic,,2022-08-20,2022-12-10,2023-04-23,Chemotherapy,,Alive,17.0,None,No,,None,30.7,Low,Urban,,16.0,No,No,Obesity,4.0
PT03490,Ireland,Connacht,74.0,Female,Prostate,III,2012-07-12,2012-12-17,,Immunotherapy,Private,Alive,73.0,None,Yes,Former,Heavy,25.3,Medium,Urban,Statutory Health Insurance,16.0,No,No,Cardiovascular Disease,4.0
PT03491,Switzerland,Geneva,59.0,Male,Colorectal,II,2013-12-21,2014-02-16,2014-12-17,Targeted Therapy,Private,Alive,77.0,None,Yes,Never,None,35.1,Medium,Urban,NHS,6.0,Yes,No,Hypertension,8.0
PT03492,Italy,Veneto,44.0,Female,Colorectal,I,2014-03-26,2014-04-28,2014-09-03,Radiation,Public,Lost to Follow-up,,BRCA1,Yes,Former,Moderate,21.0,Medium,Rural,NHS,8.0,No,,Cardiovascular Disease,1.0
PT03493,Italy,Sicily,44.0,Male,Breast,I,2023-02-08,2023-04-14,2023-05-29,Surgery,Public,Lost to Follow-up,,EGFR,No,Never,None,33.9,Low,Urban,Statutory Health Insurance,3.0,,No,Obesity,10.0
PT03494,Ireland,Connacht,22.0,Male,,I,2023-11-16,2023-11-17,2024-02-26,Radiation,Public,Deceased,75.0,BRCA1,No,Current,Moderate,27.8,,Urban,Private Insurance,4.0,No,No,Cardiovascular Disease,9.0
PT03495,Netherlands,South Holland,88.0,,Breast,IV,2023-11-17,2024-03-27,2024-11-10,Immunotherapy,Public,Alive,65.0,None,No,Never,,27.3,Medium,Urban,,14.0,No,No,Hypertension,4.0
PT03496,Netherlands,South Holland,45.0,Male,Lung,,2020-06-10,2020-06-19,2020-10-11,Chemotherapy,Research Institute,Alive,89.0,None,Yes,Former,Moderate,19.0,High,Rural,NHS,5.0,No,No,Obesity,5.0
PT03497,Austria,Styria,59.0,Male,Pancreatic,IV,2017-12-14,2018-01-15,2018-09-19,Immunotherapy,Public,,92.0,BRCA1,No,Former,Moderate,25.6,High,Urban,NHS,5.0,Yes,No,Hypertension,8.0
PT03498,Austria,Tyrol,57.0,Female,Colorectal,,2016-03-08,2016-05-24,2016-12-24,Radiation,Public,Alive,86.0,None,Yes,Never,None,38.5,Medium,Rural,Private Insurance,11.0,No,No,None,7.0
PT03499,Italy,Sicily,57.0,Female,Ovarian,II,,2020-09-14,2021-04-04,Chemotherapy,,Deceased,70.0,None,Yes,Former,None,18.3,Low,Urban,NHS,17.0,No,No,None,6.0
PT03500,Sweden,Stockholm,87.0,Female,,IV,2022-06-09,2022-09-12,2023-06-30,Surgery,,Alive,58.0,KRAS,No,Never,Moderate,21.2,Medium,Rural,Statutory Health Insurance,5.0,No,No,Cardiovascular Disease,9.0
PT03501,Finland,Pirkanmaa,26.0,,Breast,I,2010-03-11,2010-04-01,2011-02-17,Immunotherapy,Private,Deceased,44.0,BRCA1,,Never,Moderate,35.3,Medium,Urban,NHS,7.0,No,No,Diabetes,9.0
PT03502,Germany,North Rhine-Westphalia,49.0,Female,Breast,II,2013-08-17,2013-09-09,2014-08-14,Immunotherapy,Research Institute,Deceased,107.0,EGFR,Yes,Never,None,26.9,High,Urban,NHS,8.0,Yes,,None,1.0
PT03503,France,Provence-Alpes-Côte d'Azur,38.0,Male,Pancreatic,IV,2018-08-06,2019-01-07,2019-02-09,Targeted Therapy,Public,Alive,118.0,None,Yes,Never,None,21.2,Medium,Urban,NHS,3.0,No,No,Hypertension,10.0
PT03504,Poland,Masovian,54.0,Male,Ovarian,IV,2016-05-18,2016-09-12,2017-04-04,Chemotherapy,Public,Alive,54.0,EGFR,Yes,Former,Moderate,21.8,Low,Rural,Statutory Health Insurance,12.0,No,No,Cardiovascular Disease,7.0
PT03505,Austria,Vienna,52.0,Female,Lung,III,2011-01-03,2011-04-17,2011-10-28,Immunotherapy,Public,Deceased,,EGFR,No,Current,Moderate,20.6,Medium,Rural,,7.0,Yes,No,Obesity,9.0
PT03506,Netherlands,North Holland,52.0,Female,Colorectal,IV,2015-02-27,2015-03-29,2015-12-18,Targeted Therapy,Private,Lost to Follow-up,,None,No,Former,None,19.0,High,Urban,Private Insurance,5.0,,,,1.0
PT03507,Austria,Tyrol,57.0,Female,Colorectal,III,2015-09-20,2016-01-13,2016-07-30,Surgery,Private,Deceased,7.0,BRCA1,No,Former,Heavy,39.8,,Urban,Private Insurance,16.0,Yes,No,Diabetes,3.0
PT03508,Norway,Oslo,29.0,Female,,I,2011-11-16,2012-01-24,2012-08-16,Immunotherapy,Public,Deceased,21.0,EGFR,Yes,Never,None,28.7,Low,Urban,Statutory Health Insurance,14.0,No,No,Hypertension,5.0
PT03509,Belgium,,76.0,Male,Pancreatic,III,2023-11-25,2024-04-25,2025-01-07,Immunotherapy,Public,Deceased,114.0,None,No,Never,Moderate,23.9,Medium,Urban,NHS,8.0,No,No,Diabetes,8.0
PT03510,Norway,Oslo,47.0,,Lung,IV,2014-11-09,2015-01-22,2015-08-28,Radiation,Public,Lost to Follow-up,,KRAS,No,Former,Moderate,29.4,Medium,Rural,Statutory Health Insurance,2.0,No,No,Diabetes,5.0
PT03511,Ireland,Dublin,57.0,Male,Pancreatic,II,2020-03-02,2020-05-05,2020-06-18,Immunotherapy,Private,Alive,53.0,None,No,Never,,26.1,High,,Statutory Health Insurance,17.0,No,No,None,4.0
PT03512,Germany,North Rhine-Westphalia,35.0,Female,Lung,I,2017-01-08,2017-06-20,2018-03-30,Surgery,Private,Alive,50.0,BRCA1,No,Former,Moderate,35.9,High,Urban,NHS,17.0,No,Yes,Cardiovascular Disease,3.0
PT03513,,Catalonia,40.0,Male,Colorectal,II,2020-10-16,2021-03-15,2021-06-11,Targeted Therapy,Private,Alive,31.0,KRAS,No,Current,Moderate,31.2,High,Urban,Private Insurance,14.0,No,No,Obesity,
PT03514,Portugal,Algarve,25.0,Female,Colorectal,III,2018-10-07,2018-11-15,2019-08-18,Chemotherapy,,Alive,16.0,BRCA1,No,Never,None,36.3,Medium,,NHS,6.0,Yes,No,None,8.0
PT03515,Sweden,Västra Götaland,60.0,Female,Breast,I,2015-04-05,2015-05-30,2016-04-21,Surgery,Research Institute,Alive,60.0,BRCA1,No,Former,Heavy,23.2,Medium,Urban,Statutory Health Insurance,18.0,No,No,Cardiovascular Disease,9.0
PT03516,Netherlands,North Holland,34.0,Female,Ovarian,III,2011-11-19,2011-11-26,2012-06-01,Chemotherapy,Public,Alive,102.0,KRAS,No,Current,,29.9,Medium,Rural,Private Insurance,13.0,No,Yes,Cardiovascular Disease,3.0
PT03517,Spain,Madrid,22.0,Female,Ovarian,II,2018-06-21,2018-07-30,,Surgery,Public,Deceased,18.0,BRCA1,No,Former,None,23.8,Low,Urban,Private Insurance,,No,No,Obesity,2.0
PT03518,Germany,Berlin,62.0,Non-binary,Pancreatic,III,2015-09-20,2016-02-15,2016-12-15,,Private,Alive,,None,Yes,Never,Heavy,23.5,High,Urban,Private Insurance,17.0,No,No,Hypertension,3.0
PT03519,Portugal,Porto,66.0,Female,Colorectal,II,2010-06-02,2010-09-14,2011-03-28,Radiation,Private,Alive,67.0,KRAS,No,Former,Moderate,22.0,Low,Urban,NHS,6.0,Yes,Yes,Hypertension,7.0
,Norway,Trøndelag,33.0,Non-binary,Pancreatic,I,2022-09-28,2023-01-02,,Targeted Therapy,Public,Deceased,17.0,EGFR,Yes,Current,Moderate,26.8,Medium,Urban,NHS,15.0,Yes,No,Cardiovascular Disease,1.0
PT03521,Switzerland,Geneva,85.0,Male,Pancreatic,,2021-01-11,,2021-12-30,Chemotherapy,Public,Alive,106.0,None,Yes,Former,Moderate,33.3,Medium,Rural,Statutory Health Insurance,6.0,No,Yes,Obesity,5.0
PT03522,Belgium,Wallonia,48.0,Male,Prostate,II,2012-12-06,2013-05-04,2014-02-11,Chemotherapy,Public,Alive,68.0,KRAS,Yes,,Heavy,29.2,Medium,Urban,Private Insurance,6.0,No,Yes,Hypertension,3.0
PT03523,Belgium,Wallonia,23.0,Female,Prostate,II,2020-05-18,2020-06-21,2020-11-23,Immunotherapy,Private,Deceased,116.0,BRCA1,No,Never,None,39.4,Medium,Rural,NHS,7.0,No,No,None,6.0
PT03524,Switzerland,Geneva,45.0,Non-binary,Lung,I,2021-03-22,2021-04-26,2022-04-21,Radiation,Public,Alive,8.0,EGFR,No,Never,Moderate,23.8,Medium,Urban,Private Insurance,12.0,No,No,,4.0
PT03525,Sweden,Stockholm,31.0,Male,Ovarian,II,2023-05-04,2023-08-27,2024-01-13,Targeted Therapy,Public,Alive,9.0,None,Yes,,None,33.2,Medium,Urban,Statutory Health Insurance,8.0,No,No,Hypertension,5.0
PT03526,Italy,Sicily,21.0,Male,Pancreatic,II,2012-11-25,2012-11-30,2013-05-20,Targeted Therapy,Research Institute,Alive,20.0,None,Yes,Former,,26.2,Medium,Rural,NHS,19.0,No,No,Hypertension,10.0
PT03527,Denmark,Zealand,36.0,Female,Lung,IV,2017-10-29,2017-12-24,2018-05-24,,,Alive,97.0,None,Yes,Former,Moderate,25.7,Medium,Urban,,7.0,Yes,No,Hypertension,3.0
PT03528,Portugal,Lisbon,54.0,Female,Lung,III,2021-03-15,2021-06-06,2021-07-15,Radiation,Public,,52.0,BRCA1,No,Never,None,27.5,Low,Urban,NHS,2.0,No,No,Diabetes,7.0
PT03529,Italy,Lombardy,29.0,Male,Breast,IV,2021-11-17,2021-11-24,2022-09-04,Targeted Therapy,Public,Deceased,83.0,,Yes,Former,Heavy,23.3,Medium,Rural,Statutory Health Insurance,17.0,No,,Obesity,2.0
PT03530,Belgium,Wallonia,62.0,Female,Prostate,II,2020-06-18,2020-08-10,2020-09-25,Radiation,Public,Alive,29.0,None,No,Former,Moderate,38.5,High,Urban,Statutory Health Insurance,14.0,No,No,Cardiovascular Disease,7.0
PT03531,Italy,Lombardy,,Non-binary,Prostate,II,2013-12-12,,2015-01-20,Radiation,Private,Lost to Follow-up,,KRAS,Yes,,,,Medium,Rural,NHS,16.0,No,No,Diabetes,2.0
PT03532,Germany,North Rhine-Westphalia,34.0,,Colorectal,I,2016-03-16,,2016-08-13,Targeted Therapy,Private,Alive,46.0,EGFR,No,Former,,23.8,High,Urban,NHS,16.0,No,No,Obesity,9.0
PT03533,Germany,Bavaria,54.0,Male,Prostate,,2016-02-27,2016-04-09,2016-05-11,Radiation,Public,Alive,75.0,EGFR,No,Never,None,30.9,Medium,Urban,Private Insurance,19.0,No,Yes,Hypertension,10.0
PT03534,Switzerland,Bern,79.0,Male,Colorectal,II,2022-04-17,2022-05-05,2023-01-31,Surgery,Public,Alive,80.0,None,No,Never,Moderate,21.6,Low,Urban,,7.0,No,No,,9.0
PT03535,Denmark,Capital Region,63.0,Male,Pancreatic,III,2011-08-24,2011-08-30,2012-08-05,Chemotherapy,Public,Alive,98.0,KRAS,No,Never,None,34.1,Low,Urban,,1.0,No,No,Obesity,5.0
PT03536,Finland,Uusimaa,24.0,Male,Breast,II,2012-04-15,2012-08-25,2013-03-29,Radiation,Public,Alive,21.0,EGFR,Yes,Never,Moderate,26.9,High,Urban,Private Insurance,19.0,No,No,Obesity,6.0
PT03537,Germany,Bavaria,37.0,Male,Lung,I,2011-02-04,2011-06-26,,Radiation,Research Institute,Deceased,82.0,BRCA1,No,Current,None,29.5,Low,Rural,Statutory Health Insurance,2.0,No,No,,2.0
PT03538,Poland,Silesian,40.0,Female,Lung,I,2016-05-17,,2017-03-14,Surgery,Public,Deceased,80.0,None,Yes,Former,Heavy,36.3,Low,Urban,NHS,10.0,No,No,Hypertension,3.0
PT03539,Finland,Uusimaa,70.0,Male,Pancreatic,III,2012-10-04,2013-03-28,2013-12-17,Immunotherapy,Private,Alive,103.0,None,Yes,Current,None,21.2,High,,NHS,3.0,No,No,Obesity,5.0
PT03540,Poland,Masovian,60.0,Female,Colorectal,I,2012-02-06,2012-05-13,2012-12-06,Radiation,Private,Alive,87.0,BRCA1,No,Current,Moderate,30.9,Low,Urban,NHS,8.0,No,Yes,Obesity,6.0
PT03541,Portugal,Lisbon,43.0,Female,Leukemia,I,2011-03-09,2011-05-01,2011-08-25,Targeted Therapy,Private,Alive,62.0,EGFR,No,Never,Moderate,18.7,Medium,Rural,Statutory Health Insurance,15.0,No,No,None,8.0
PT03542,Italy,Sicily,43.0,Male,,IV,2011-02-04,2011-02-25,2012-02-06,Immunotherapy,Public,Deceased,46.0,None,No,Current,None,26.8,,Rural,Statutory Health Insurance,4.0,No,No,Obesity,3.0
PT03543,France,Provence-Alpes-Côte d'Azur,57.0,Non-binary,Colorectal,III,2010-11-25,2011-04-15,2012-01-22,Immunotherapy,Public,Alive,52.0,EGFR,Yes,Former,Heavy,36.8,Medium,Urban,NHS,8.0,Yes,No,Diabetes,7.0
PT03544,Italy,Veneto,63.0,Female,Pancreatic,I,2022-12-14,2023-05-06,2024-04-10,Surgery,Research Institute,,51.0,None,No,Current,,34.0,High,Urban,,4.0,No,No,Hypertension,7.0
PT03545,Germany,,76.0,Female,Breast,I,2014-11-07,2015-02-14,2015-09-23,Targeted Therapy,Public,Alive,79.0,KRAS,No,Current,Moderate,35.3,Low,Urban,NHS,2.0,No,No,Cardiovascular Disease,5.0
PT03546,Switzerland,Bern,78.0,Male,Pancreatic,I,2014-06-01,2014-11-21,2014-12-23,Immunotherapy,Research Institute,Alive,108.0,KRAS,Yes,Never,None,27.2,Low,,Statutory Health Insurance,7.0,No,No,Diabetes,6.0
PT03547,Switzerland,Geneva,53.0,Female,Pancreatic,II,2021-06-05,2021-08-28,2022-03-03,Radiation,Public,Alive,67.0,BRCA1,No,Former,None,28.5,Medium,Urban,,17.0,No,No,Hypertension,9.0
PT03548,Germany,Berlin,42.0,Male,Prostate,III,2022-02-14,2022-08-07,2023-03-10,Surgery,Public,Alive,41.0,BRCA1,Yes,Former,None,36.5,High,Urban,,2.0,,No,Diabetes,9.0
PT03549,Portugal,Lisbon,62.0,Female,Colorectal,I,2021-08-16,2021-12-25,2022-06-13,Surgery,Private,Alive,35.0,BRCA1,No,Current,None,29.1,Medium,Urban,Statutory Health Insurance,,No,Yes,None,7.0
,Norway,Vestland,59.0,,Breast,IV,,2015-11-20,2016-11-08,Surgery,Private,Deceased,20.0,KRAS,No,Never,Moderate,31.1,Medium,Rural,Statutory Health Insurance,13.0,Yes,No,Cardiovascular Disease,9.0
PT03551,Italy,Veneto,66.0,Female,Ovarian,I,,,2018-11-10,Chemotherapy,Public,Alive,23.0,KRAS,Yes,Never,None,36.5,Low,Rural,,18.0,No,No,Diabetes,4.0
PT03552,Switzerland,Zurich,,Male,Lung,I,2021-08-16,2021-09-05,2022-08-10,Immunotherapy,Public,Alive,34.0,EGFR,No,Former,Moderate,35.9,High,,Private Insurance,12.0,No,No,,10.0
PT03553,Poland,Lesser Poland,66.0,Male,Leukemia,IV,2014-05-28,2014-06-01,2014-12-26,Targeted Therapy,Research Institute,Alive,63.0,None,No,Never,None,23.4,Medium,Rural,NHS,9.0,No,No,Obesity,6.0
PT03554,France,Île-de-France,39.0,Female,Leukemia,I,,,2019-04-01,Targeted Therapy,Public,Deceased,98.0,KRAS,,Never,None,30.9,Medium,Urban,NHS,7.0,No,No,Obesity,5.0
PT03555,Belgium,Wallonia,84.0,Female,Colorectal,IV,2010-12-28,2011-01-12,2011-11-05,Chemotherapy,Public,Alive,27.0,BRCA1,No,Former,None,22.5,Medium,Urban,Private Insurance,3.0,No,No,Cardiovascular Disease,6.0
PT03556,Austria,Vienna,87.0,Male,Pancreatic,III,2014-09-13,2014-11-09,2015-03-31,Radiation,Public,Lost to Follow-up,,BRCA1,Yes,Never,Moderate,18.9,Medium,Rural,NHS,15.0,No,No,Hypertension,5.0
PT03557,,Pirkanmaa,43.0,Male,,I,2016-08-18,2017-02-07,2017-07-06,Immunotherapy,Private,Alive,60.0,KRAS,No,Never,None,20.3,Low,Urban,Statutory Health Insurance,11.0,No,No,Diabetes,2.0
PT03558,,Andalusia,55.0,Female,Pancreatic,II,2021-06-22,2021-07-19,2021-11-14,Surgery,Research Institute,Alive,28.0,None,Yes,Never,None,28.3,High,Urban,NHS,12.0,Yes,No,None,4.0
,Switzerland,Geneva,64.0,Female,Colorectal,II,2019-06-24,2019-07-14,2019-11-26,Chemotherapy,Public,Alive,98.0,BRCA1,No,Former,None,37.6,Medium,Urban,NHS,9.0,No,No,None,2.0
PT03560,Italy,Sicily,21.0,Male,Leukemia,IV,2020-11-25,2021-03-13,2021-11-04,Chemotherapy,Public,Alive,49.0,EGFR,Yes,Never,None,28.5,Medium,Urban,NHS,14.0,Yes,No,Diabetes,9.0
PT03561,Germany,North Rhine-Westphalia,47.0,Female,Leukemia,II,2015-10-31,2016-01-18,2016-03-18,Immunotherapy,Public,Deceased,75.0,BRCA1,Yes,,Moderate,20.8,Medium,Rural,Private Insurance,17.0,Yes,Yes,Diabetes,7.0
PT03562,Poland,Lesser Poland,45.0,Female,Pancreatic,II,2022-12-12,2023-04-25,2024-02-15,Targeted Therapy,Private,,65.0,None,No,Never,None,21.1,High,Rural,Statutory Health Insurance,1.0,No,No,Hypertension,7.0
PT03563,Poland,Masovian,42.0,Male,,I,2016-09-26,2016-10-14,,Immunotherapy,Private,Alive,,EGFR,,Former,Moderate,31.7,High,Urban,Private Insurance,8.0,No,No,Cardiovascular Disease,3.0
PT03564,Ireland,Connacht,55.0,Female,Pancreatic,III,2015-08-13,2015-11-07,2016-04-05,Targeted Therapy,Public,Alive,113.0,BRCA1,Yes,Never,None,36.9,Low,Urban,Private Insurance,9.0,No,No,,4.0
PT03565,Austria,Tyrol,25.0,Female,Lung,I,2021-04-01,2021-05-20,2021-10-30,Immunotherapy,Public,Alive,93.0,KRAS,No,Never,Moderate,25.0,Low,Rural,NHS,19.0,No,No,Obesity,10.0
PT03566,Switzerland,Zurich,54.0,Female,Prostate,I,2021-08-30,2022-01-29,2022-06-30,Targeted Therapy,Public,Alive,10.0,None,No,Former,None,30.1,Medium,Urban,NHS,4.0,No,No,Cardiovascular Disease,1.0
PT03567,Ireland,Connacht,57.0,Male,Prostate,IV,2022-11-26,2022-12-07,2023-11-02,Chemotherapy,Public,Alive,110.0,,Yes,Never,None,37.6,Low,Rural,NHS,8.0,No,Yes,Diabetes,6.0
PT03568,Sweden,Stockholm,54.0,Female,Ovarian,I,2013-09-30,2014-02-23,2014-06-22,Targeted Therapy,Public,Alive,92.0,EGFR,No,Former,None,20.9,Low,Urban,Statutory Health Insurance,10.0,No,No,Diabetes,8.0
PT03569,Finland,Pirkanmaa,72.0,Male,Ovarian,I,2021-09-01,2021-10-06,2022-01-15,Immunotherapy,Research Institute,Alive,39.0,KRAS,No,Never,,21.4,High,Rural,Statutory Health Insurance,18.0,No,No,Diabetes,
PT03570,Netherlands,North Holland,57.0,Female,Leukemia,III,2018-08-13,2018-10-07,2018-12-12,Radiation,Public,Deceased,17.0,EGFR,No,Current,Moderate,26.3,Medium,Urban,NHS,7.0,No,,Obesity,2.0
PT03571,Germany,Berlin,78.0,Male,Leukemia,III,2011-10-23,2012-01-26,2012-06-04,Immunotherapy,Private,Alive,80.0,BRCA1,No,Former,Moderate,28.0,Medium,Urban,Private Insurance,16.0,Yes,No,Cardiovascular Disease,1.0
PT03572,,Lisbon,62.0,Female,Colorectal,I,2022-06-29,2022-07-27,2022-12-15,Chemotherapy,Public,Alive,72.0,EGFR,No,Current,Moderate,23.0,Medium,Urban,Private Insurance,1.0,No,No,Diabetes,2.0
PT03573,Netherlands,South Holland,23.0,Female,Colorectal,I,2011-05-31,2011-08-27,2011-10-25,Targeted Therapy,Research Institute,Alive,93.0,EGFR,Yes,Never,Moderate,,Low,Urban,Statutory Health Insurance,18.0,No,No,None,4.0
PT03574,Switzerland,Zurich,24.0,Male,Ovarian,I,2011-12-21,2012-06-02,2012-08-08,Targeted Therapy,Public,Alive,98.0,BRCA1,No,Current,,37.8,Low,Urban,Statutory Health Insurance,2.0,No,No,Obesity,6.0
PT03575,Portugal,Algarve,87.0,Female,Lung,I,2010-06-21,2010-10-08,2011-06-01,Targeted Therapy,Public,Alive,46.0,EGFR,Yes,Former,None,,Low,Urban,Statutory Health Insurance,19.0,No,No,Cardiovascular Disease,1.0
PT03576,,North Holland,64.0,Female,Leukemia,III,2014-01-09,2014-02-02,2014-08-16,Chemotherapy,Public,Deceased,,EGFR,No,,None,19.4,Low,Urban,Statutory Health Insurance,12.0,No,No,Diabetes,5.0
PT03577,Finland,Pirkanmaa,44.0,Male,Colorectal,II,2013-03-19,2013-08-27,2013-10-04,Immunotherapy,Private,Alive,13.0,,Yes,Former,None,31.3,Medium,Urban,Private Insurance,17.0,Yes,No,Cardiovascular Disease,4.0
PT03578,Germany,Berlin,30.0,Female,,III,2022-10-11,2023-02-04,2023-12-07,Targeted Therapy,Public,Alive,7.0,BRCA1,Yes,Never,None,22.7,High,Urban,NHS,12.0,No,No,Hypertension,9.0
PT03579,Germany,Berlin,48.0,Female,Prostate,II,2023-06-02,2023-11-14,,Radiation,Private,Deceased,98.0,EGFR,Yes,Never,None,32.6,High,Urban,Private Insurance,13.0,No,,Cardiovascular Disease,5.0
PT03580,Denmark,Zealand,53.0,Male,Leukemia,III,2013-03-20,,2014-07-28,Radiation,Private,Alive,63.0,EGFR,No,Former,None,30.5,,Urban,NHS,17.0,No,No,Diabetes,5.0
PT03581,Poland,Masovian,33.0,Non-binary,Breast,II,2020-04-02,2020-04-18,2021-02-16,,Public,Alive,42.0,BRCA1,No,Never,Moderate,22.9,Low,Urban,Private Insurance,14.0,No,No,Hypertension,10.0
PT03582,Austria,Vienna,43.0,Female,Leukemia,IV,2021-07-10,2021-10-30,2022-08-04,Radiation,Public,Deceased,85.0,KRAS,No,Never,Moderate,38.7,Medium,Rural,Private Insurance,14.0,Yes,No,Diabetes,
PT03583,Switzerland,Zurich,78.0,Male,Colorectal,,2015-04-26,2015-10-14,2016-03-03,Surgery,Public,Alive,65.0,EGFR,No,Former,None,28.4,Medium,Urban,Statutory Health Insurance,8.0,No,No,Obesity,10.0
PT03584,Finland,Southwest Finland,58.0,Female,Leukemia,III,2021-01-14,2021-03-28,2021-07-15,Targeted Therapy,Public,Alive,46.0,KRAS,Yes,Never,Moderate,26.6,High,Rural,Statutory Health Insurance,1.0,No,No,None,4.0
PT03585,Germany,North Rhine-Westphalia,45.0,Male,Ovarian,II,2013-10-29,2013-12-18,2014-02-03,Chemotherapy,Public,Alive,77.0,BRCA1,No,Current,Moderate,35.4,High,Rural,Private Insurance,16.0,Yes,No,None,8.0
PT03586,,Sicily,62.0,Female,,II,2021-01-04,2021-04-25,2021-08-12,,,,41.0,None,Yes,Former,Moderate,24.5,High,Rural,NHS,5.0,No,No,Hypertension,9.0
PT03587,Norway,Vestland,55.0,Female,Ovarian,III,2011-11-29,2011-12-12,2012-07-23,Chemotherapy,Research Institute,Alive,83.0,BRCA1,Yes,Former,None,31.0,Medium,Urban,NHS,3.0,Yes,No,Diabetes,6.0
PT03588,Poland,Lesser Poland,58.0,Male,Leukemia,I,2014-11-10,2015-01-20,2015-09-05,Targeted Therapy,Private,Alive,81.0,None,No,Never,Moderate,22.5,Low,Urban,NHS,4.0,Yes,Yes,None,2.0
,Denmark,,80.0,Female,Ovarian,II,2018-10-17,2019-03-29,2019-08-21,Targeted Therapy,Private,Lost to Follow-up,,None,Yes,Current,Moderate,19.3,Medium,Rural,Statutory Health Insurance,4.0,No,Yes,Hypertension,4.0
PT03590,Belgium,Flanders,35.0,Female,Colorectal,III,2019-07-06,2019-08-10,,Immunotherapy,Public,Alive,96.0,BRCA1,No,Former,None,29.0,Medium,Rural,NHS,2.0,No,No,Diabetes,7.0
,Finland,Southwest Finland,78.0,Male,Prostate,III,2021-02-15,2021-03-11,,Radiation,Public,Alive,24.0,KRAS,No,Never,Moderate,21.6,High,Rural,Private Insurance,4.0,No,No,,4.0
PT03592,Finland,,25.0,Female,Colorectal,II,2017-07-17,2017-08-25,2017-12-20,Targeted Therapy,Public,Alive,56.0,None,Yes,Never,None,25.9,Medium,Urban,Private Insurance,13.0,No,No,Hypertension,1.0
PT03593,Germany,,75.0,Female,Lung,II,2022-03-10,2022-08-04,2023-02-10,Radiation,Private,Alive,59.0,KRAS,No,,None,28.5,Medium,Urban,Private Insurance,6.0,No,No,Hypertension,9.0
PT03594,Netherlands,South Holland,27.0,Male,Ovarian,I,2021-11-13,2022-05-04,2023-04-26,Chemotherapy,Public,Alive,82.0,EGFR,No,Former,None,18.1,Medium,Urban,Private Insurance,4.0,Yes,No,Hypertension,2.0
,Portugal,Porto,46.0,Female,Colorectal,IV,,2018-09-15,2019-08-20,Radiation,Public,Alive,34.0,None,No,Never,None,,Low,Urban,Private Insurance,5.0,No,No,None,4.0
PT03596,Belgium,Wallonia,46.0,Male,Lung,II,2022-08-14,2023-02-04,2023-06-16,Immunotherapy,Private,Alive,,KRAS,No,Never,None,27.8,Low,Urban,Statutory Health Insurance,6.0,No,Yes,Cardiovascular Disease,5.0
PT03597,Poland,Masovian,65.0,Male,Leukemia,III,2017-05-04,2017-10-24,2018-09-16,Chemotherapy,Public,Deceased,13.0,BRCA1,No,,Moderate,30.0,Low,Rural,Private Insurance,11.0,No,Yes,Diabetes,5.0
PT03598,Sweden,Västra Götaland,,Female,Lung,I,2019-11-13,2020-04-21,2020-10-30,,Public,,66.0,BRCA1,Yes,Never,Moderate,36.5,Medium,Rural,Statutory Health Insurance,,No,No,Obesity,8.0
PT03599,Sweden,Stockholm,,Female,Ovarian,I,2019-02-27,2019-03-04,,Immunotherapy,Public,Alive,61.0,BRCA1,,Never,Moderate,25.2,Medium,Urban,Statutory Health Insurance,2.0,No,No,None,6.0
PT03600,,Stockholm,37.0,Female,Pancreatic,II,2013-11-30,2014-02-14,2014-09-20,Radiation,Private,Deceased,83.0,EGFR,No,Never,Moderate,38.3,Medium,Urban,Statutory Health Insurance,17.0,No,No,Obesity,3.0
PT03601,Denmark,Capital Region,31.0,Male,Leukemia,III,2015-12-02,2016-03-15,2017-02-23,Immunotherapy,Research Institute,Alive,12.0,None,No,Never,None,25.4,High,Urban,Private Insurance,1.0,No,No,Cardiovascular Disease,8.0
PT03602,Norway,Oslo,70.0,Female,Lung,II,,2024-02-15,2024-11-20,Radiation,Private,Alive,73.0,BRCA1,No,Former,Moderate,30.4,High,,NHS,10.0,No,No,None,4.0
PT03603,Austria,Vienna,58.0,Non-binary,Ovarian,I,2010-01-27,2010-04-19,2010-12-30,Chemotherapy,Private,Lost to Follow-up,,EGFR,No,Never,Moderate,19.7,High,Urban,Private Insurance,9.0,,No,Hypertension,7.0
PT03604,Netherlands,South Holland,29.0,Male,Ovarian,I,2020-04-29,2020-05-06,2020-10-06,Chemotherapy,Research Institute,Alive,118.0,BRCA1,Yes,Never,Moderate,26.8,Low,Urban,,8.0,No,No,Diabetes,4.0
PT03605,Norway,Vestland,73.0,Male,Colorectal,I,2013-12-12,2013-12-27,,Surgery,Public,Deceased,26.0,EGFR,No,Never,Moderate,35.1,Low,Urban,Private Insurance,14.0,No,No,None,10.0
PT03606,Austria,Tyrol,48.0,Female,Breast,I,2022-11-01,2023-01-13,2023-11-17,Immunotherapy,Public,Deceased,50.0,EGFR,,,Moderate,24.5,Medium,Rural,Statutory Health Insurance,6.0,No,No,Diabetes,3.0
PT03607,Spain,Catalonia,60.0,Male,Leukemia,I,2016-02-06,2016-02-26,2017-02-13,Radiation,Public,Alive,17.0,KRAS,Yes,Never,Moderate,18.2,,Rural,NHS,15.0,No,Yes,Obesity,5.0
PT03608,Spain,Catalonia,28.0,Male,Lung,III,,2011-09-18,2012-08-03,Radiation,Public,,100.0,BRCA1,Yes,,None,38.4,Medium,Urban,,10.0,No,Yes,Obesity,10.0
PT03609,Switzerland,,82.0,Female,Breast,II,2010-09-04,2010-09-08,2011-07-12,Radiation,Public,Alive,78.0,EGFR,No,Never,Moderate,18.2,High,Urban,NHS,16.0,No,No,Cardiovascular Disease,1.0
PT03610,Italy,Sicily,56.0,Non-binary,Ovarian,II,2014-03-04,2014-06-18,2014-12-22,Targeted Therapy,Public,,12.0,EGFR,No,Never,Heavy,23.9,Low,Urban,NHS,2.0,No,No,Obesity,3.0
PT03611,Sweden,Skåne,33.0,Female,Lung,IV,2016-06-22,,2016-09-02,Immunotherapy,Public,Deceased,50.0,BRCA1,Yes,Current,Moderate,37.8,,Rural,NHS,2.0,No,Yes,,5.0
PT03612,Austria,Tyrol,58.0,Female,Lung,II,2023-11-03,2024-01-07,2025-01-01,Radiation,Public,Alive,40.0,BRCA1,No,Former,Moderate,21.0,Low,Rural,Private Insurance,17.0,Yes,No,,5.0
PT03613,Poland,Lesser Poland,59.0,Female,Lung,IV,2020-11-09,2020-12-14,2021-01-22,Surgery,Private,Alive,45.0,BRCA1,No,Never,Heavy,36.9,Low,Urban,Statutory Health Insurance,9.0,No,No,None,3.0
PT03614,Belgium,Brussels,73.0,Female,Colorectal,I,2020-02-10,2020-03-25,2020-06-29,Chemotherapy,Public,Deceased,16.0,None,No,Never,None,39.0,Medium,Urban,NHS,1.0,No,No,Hypertension,7.0
PT03615,Norway,,22.0,Male,Lung,II,2023-11-30,2023-12-07,2024-06-22,Targeted Therapy,Research Institute,Lost to Follow-up,,BRCA1,No,Never,Heavy,31.7,,Urban,Statutory Health Insurance,18.0,No,No,None,1.0
PT03616,Poland,Silesian,74.0,,Breast,II,2014-11-09,2015-04-08,2015-06-26,Targeted Therapy,Private,Lost to Follow-up,,KRAS,Yes,Former,None,25.3,Medium,Urban,Statutory Health Insurance,,No,No,Diabetes,3.0
PT03617,Norway,Oslo,52.0,Male,Pancreatic,II,2018-01-16,2018-02-08,2018-07-14,Chemotherapy,Private,Alive,106.0,KRAS,No,Current,Moderate,24.8,Medium,Urban,Statutory Health Insurance,9.0,No,Yes,Obesity,10.0
,Belgium,Wallonia,38.0,Male,Lung,II,,2020-10-30,2021-06-13,Targeted Therapy,Private,Alive,47.0,EGFR,Yes,Never,Moderate,21.1,Medium,Rural,Private Insurance,4.0,No,No,None,1.0
PT03619,France,Île-de-France,53.0,,Pancreatic,I,2012-12-27,2013-03-25,2013-05-08,Surgery,Private,Alive,7.0,None,Yes,Current,None,,Medium,Urban,Statutory Health Insurance,14.0,No,No,Obesity,7.0
PT03620,,Masovian,69.0,Male,Prostate,III,2012-01-17,2012-02-06,2012-07-06,Surgery,Public,Deceased,39.0,EGFR,No,Never,None,35.5,High,Urban,Private Insurance,18.0,No,Yes,Diabetes,5.0
PT03621,Norway,,66.0,Male,Ovarian,II,2014-04-24,2014-05-26,2014-08-11,Chemotherapy,Private,Alive,59.0,BRCA1,Yes,Current,None,22.9,High,Urban,Statutory Health Insurance,18.0,No,No,Diabetes,4.0
PT03622,Italy,Sicily,65.0,Male,Leukemia,I,2022-02-27,2022-06-04,2022-10-25,Immunotherapy,Private,Deceased,104.0,None,No,Former,Moderate,,Medium,Urban,Private Insurance,11.0,No,No,Hypertension,10.0
PT03623,Netherlands,Utrecht,75.0,Female,Colorectal,II,2019-11-11,2020-04-23,2020-05-28,Targeted Therapy,Public,Deceased,107.0,KRAS,No,Never,Moderate,31.0,Low,Urban,Private Insurance,8.0,No,Yes,Obesity,5.0
PT03624,Spain,Madrid,76.0,Male,Prostate,III,2015-10-01,2016-02-24,2016-03-28,Radiation,Private,Deceased,85.0,KRAS,No,Never,Moderate,21.1,Low,Urban,NHS,9.0,No,Yes,Hypertension,6.0
PT03625,Austria,Vienna,70.0,Female,Prostate,I,2019-08-18,2019-11-23,2020-09-26,Radiation,Public,Alive,56.0,KRAS,,Current,Moderate,23.2,High,Rural,Statutory Health Insurance,4.0,Yes,No,None,5.0
PT03626,Poland,,73.0,Male,Breast,I,2020-06-02,2020-11-10,2021-05-31,Surgery,Public,Deceased,37.0,EGFR,No,Never,Moderate,21.0,Medium,Urban,Statutory Health Insurance,5.0,No,No,Diabetes,7.0
PT03627,Switzerland,Zurich,,Female,Breast,III,,2017-12-31,2018-12-16,Immunotherapy,Public,Alive,84.0,None,No,Never,Moderate,29.9,Low,Rural,Statutory Health Insurance,13.0,No,No,Hypertension,9.0
PT03628,,Utrecht,38.0,Female,Pancreatic,IV,2011-08-15,,2012-01-29,Immunotherapy,Private,Alive,79.0,KRAS,Yes,Never,Moderate,,High,Rural,Statutory Health Insurance,4.0,,No,None,
PT03629,Switzerland,Zurich,46.0,Female,Pancreatic,I,2011-11-24,2011-12-03,2012-01-16,Targeted Therapy,Research Institute,Deceased,,None,Yes,Former,Moderate,39.6,Medium,Urban,Statutory Health Insurance,6.0,No,No,None,1.0
PT03630,Spain,Andalusia,67.0,Female,Colorectal,IV,2013-03-09,2013-04-20,2013-08-18,Targeted Therapy,Private,Deceased,18.0,EGFR,No,Never,Moderate,24.1,Low,Urban,NHS,3.0,No,Yes,Hypertension,2.0
,Portugal,Porto,,Female,Colorectal,II,2020-05-20,2020-09-24,2021-05-16,Chemotherapy,Public,Alive,35.0,BRCA1,No,Former,None,33.9,High,Urban,NHS,1.0,No,Yes,Diabetes,4.0
PT03632,Spain,Madrid,70.0,Male,Leukemia,IV,,2011-06-03,2012-03-05,Surgery,Research Institute,,,EGFR,Yes,Current,Moderate,25.2,,Rural,,15.0,No,No,Cardiovascular Disease,3.0
PT03633,Poland,Silesian,26.0,Non-binary,Lung,,2016-07-10,2016-11-19,2017-08-14,Chemotherapy,Public,Alive,116.0,KRAS,No,Never,None,25.9,Medium,Urban,NHS,1.0,No,No,None,3.0
PT03634,Austria,Vienna,48.0,Female,Colorectal,IV,2011-02-09,2011-08-02,2011-09-09,Chemotherapy,Public,Alive,91.0,BRCA1,No,Former,None,24.8,Medium,Urban,Private Insurance,5.0,No,No,Diabetes,5.0
PT03635,Belgium,Flanders,62.0,Female,Colorectal,III,2022-12-26,,2023-11-21,Immunotherapy,Research Institute,Deceased,76.0,,No,Former,Moderate,20.4,Medium,Urban,Private Insurance,15.0,Yes,No,Obesity,2.0
PT03636,Denmark,Zealand,88.0,Male,Pancreatic,I,2014-01-23,2014-06-24,2015-02-25,Targeted Therapy,Private,Alive,85.0,,No,Never,None,38.4,Low,Urban,Statutory Health Insurance,6.0,No,Yes,None,
PT03637,Netherlands,Utrecht,77.0,Female,Lung,I,2015-10-24,2016-01-04,2016-08-05,Radiation,Private,Alive,50.0,EGFR,Yes,Never,Moderate,35.1,Medium,Urban,NHS,16.0,Yes,Yes,Diabetes,6.0
PT03638,Austria,Tyrol,27.0,Female,Leukemia,,2012-05-14,2012-09-15,2013-04-27,Chemotherapy,Public,Alive,102.0,KRAS,Yes,Former,Moderate,23.2,Medium,Rural,NHS,17.0,No,No,Cardiovascular Disease,3.0
PT03639,Norway,Oslo,61.0,Female,Ovarian,I,2014-05-04,2014-05-27,2014-08-03,Surgery,Public,Alive,92.0,EGFR,No,Never,Moderate,24.8,Medium,Urban,NHS,3.0,No,No,Obesity,6.0
PT03640,Finland,Pirkanmaa,61.0,Female,Ovarian,II,2010-08-05,2010-11-20,2011-01-28,Chemotherapy,Public,Alive,110.0,EGFR,Yes,Never,Moderate,27.7,Medium,Urban,Statutory Health Insurance,3.0,Yes,Yes,Obesity,1.0
PT03641,,South Holland,32.0,Male,Breast,IV,2012-01-13,,2012-06-04,Radiation,Private,Alive,102.0,BRCA1,No,Never,Moderate,35.0,Low,Urban,Private Insurance,9.0,No,,Hypertension,3.0
PT03642,Norway,Vestland,45.0,Male,Leukemia,I,2022-05-11,2022-10-01,2023-01-19,Radiation,Public,Alive,75.0,KRAS,Yes,,None,,Medium,Urban,,5.0,No,No,Hypertension,3.0
PT03643,Norway,Trøndelag,37.0,Male,Lung,II,2020-07-05,2020-08-25,2020-12-23,Surgery,Public,Deceased,51.0,None,Yes,Never,None,34.9,High,Rural,Statutory Health Insurance,8.0,No,No,,6.0
PT03644,Italy,Sicily,61.0,Male,Breast,II,2018-12-19,2019-04-21,2019-10-05,Radiation,Public,Alive,37.0,EGFR,Yes,Never,Moderate,38.9,,Urban,Private Insurance,19.0,No,No,Obesity,5.0
PT03645,Portugal,Porto,70.0,Male,,III,2023-01-04,2023-02-23,2023-09-21,Radiation,Private,Deceased,88.0,BRCA1,No,,Moderate,34.7,Medium,Urban,NHS,17.0,No,No,Cardiovascular Disease,6.0
PT03646,France,Auvergne-Rhône-Alpes,35.0,Male,Breast,I,2012-05-13,2012-11-04,2013-02-06,Radiation,Public,Alive,41.0,KRAS,Yes,Never,Heavy,22.9,Medium,Rural,NHS,12.0,No,,,6.0
PT03647,France,Provence-Alpes-Côte d'Azur,22.0,Male,Leukemia,I,2020-11-26,2021-02-17,2021-07-11,Chemotherapy,Research Institute,Alive,35.0,BRCA1,Yes,Never,None,26.3,High,Urban,NHS,,No,No,Diabetes,1.0
PT03648,Ireland,Munster,64.0,Female,Pancreatic,IV,2017-10-26,2017-11-20,2018-02-07,Surgery,Public,Alive,8.0,EGFR,Yes,Current,Moderate,34.3,Medium,Urban,Statutory Health Insurance,,No,No,Hypertension,2.0
PT03649,Belgium,Flanders,41.0,Male,Lung,III,2021-01-29,2021-03-09,2022-01-17,Chemotherapy,Private,Alive,42.0,None,Yes,Current,Moderate,20.8,,Urban,Statutory Health Insurance,2.0,No,No,None,4.0
PT03650,Belgium,Brussels,42.0,Female,Leukemia,III,2020-02-02,2020-04-10,2020-10-02,Surgery,Public,Deceased,115.0,BRCA1,Yes,Never,,23.1,High,Urban,Statutory Health Insurance,12.0,No,No,Obesity,9.0
PT03651,Spain,Andalusia,78.0,Female,Leukemia,III,2022-01-09,2022-07-02,2023-01-27,Radiation,Private,Alive,87.0,EGFR,No,Current,None,39.6,Medium,Urban,Statutory Health Insurance,18.0,Yes,No,Diabetes,2.0
PT03652,Germany,Bavaria,81.0,Female,Prostate,II,2011-03-26,2011-06-06,2011-12-13,Radiation,Public,Alive,,None,,Never,Moderate,32.6,Medium,Urban,Statutory Health Insurance,1.0,Yes,No,None,5.0
PT03653,Ireland,Dublin,87.0,Male,Colorectal,III,2015-11-21,2016-03-19,2017-01-09,Targeted Therapy,Private,Lost to Follow-up,,,No,Current,Moderate,21.9,,Urban,Private Insurance,8.0,No,No,None,2.0
PT03654,Sweden,Stockholm,73.0,Female,Ovarian,II,2013-01-20,2013-05-06,2013-09-13,Radiation,Public,Lost to Follow-up,,KRAS,No,Never,Heavy,,Medium,Rural,Private Insurance,2.0,No,No,None,1.0
PT03655,Italy,Veneto,76.0,Female,Leukemia,,2017-10-08,2017-10-21,2018-04-16,Surgery,Private,Alive,85.0,KRAS,No,Never,Heavy,39.2,Medium,Urban,,9.0,No,No,Obesity,2.0
PT03656,,Central Denmark,42.0,Non-binary,Prostate,II,2019-05-22,2019-11-04,2020-05-01,Immunotherapy,Public,Alive,9.0,KRAS,No,Never,None,29.0,Low,Rural,NHS,11.0,No,No,Hypertension,8.0
PT03657,Switzerland,Zurich,79.0,Female,Ovarian,I,2016-01-03,2016-02-08,2016-10-18,,Public,Alive,73.0,None,No,Never,None,27.3,High,Urban,Statutory Health Insurance,7.0,No,No,Obesity,5.0
PT03658,Ireland,Munster,74.0,Female,Pancreatic,II,2019-02-21,2019-08-05,2020-03-21,Radiation,Public,Alive,48.0,KRAS,No,Never,,35.5,Medium,Urban,,7.0,Yes,No,Diabetes,9.0
PT03659,France,Île-de-France,82.0,Female,Pancreatic,I,2015-12-07,2016-05-25,2017-04-10,Radiation,Private,Alive,12.0,BRCA1,Yes,Never,Moderate,32.7,Low,Rural,Statutory Health Insurance,15.0,No,No,Cardiovascular Disease,2.0
PT03660,Switzerland,Bern,,Male,Lung,II,,2014-07-05,2014-10-22,Immunotherapy,Public,Alive,117.0,KRAS,No,Former,Moderate,30.3,Low,Urban,Private Insurance,15.0,No,No,Obesity,1.0
PT03661,Netherlands,Utrecht,74.0,Male,Prostate,II,2010-09-21,2011-01-08,2011-05-25,Radiation,Public,Alive,87.0,BRCA1,No,Former,None,23.0,Medium,Urban,NHS,7.0,No,No,Hypertension,8.0
PT03662,Poland,Silesian,44.0,Female,Leukemia,III,2013-07-23,2013-11-24,2014-06-03,Targeted Therapy,Public,Alive,48.0,,Yes,Never,None,30.2,Medium,Urban,NHS,5.0,No,Yes,Cardiovascular Disease,8.0
PT03663,Poland,Masovian,45.0,Male,Lung,II,2019-05-12,2019-05-31,2019-11-24,Immunotherapy,Private,Deceased,42.0,BRCA1,No,Former,Moderate,29.9,High,Rural,Statutory Health Insurance,11.0,Yes,No,Diabetes,3.0
PT03664,Sweden,Stockholm,68.0,Male,Prostate,IV,2018-04-25,2018-06-01,,Chemotherapy,Public,Alive,104.0,EGFR,No,Never,Moderate,,Medium,Urban,Private Insurance,4.0,No,No,Hypertension,10.0
PT03665,France,Auvergne-Rhône-Alpes,82.0,Female,Leukemia,I,2017-06-05,2017-09-14,2018-08-21,,Public,Alive,71.0,EGFR,No,Current,Moderate,29.0,Low,Urban,,14.0,No,No,None,6.0
PT03666,Spain,Madrid,64.0,Male,Lung,III,2012-02-26,2012-05-21,2013-04-22,Surgery,Public,Deceased,51.0,KRAS,,Current,Moderate,31.3,Medium,Urban,NHS,3.0,Yes,No,Obesity,10.0
PT03667,Finland,Uusimaa,58.0,Female,Ovarian,III,2023-08-29,2023-10-07,2024-01-29,Targeted Therapy,Public,Lost to Follow-up,,EGFR,Yes,Former,,34.1,Low,Urban,Statutory Health Insurance,12.0,No,No,Obesity,5.0
PT03668,Netherlands,South Holland,84.0,Female,Lung,IV,2020-11-13,2021-04-16,2021-07-04,,Public,Alive,,KRAS,Yes,Never,Moderate,30.2,Medium,Rural,Statutory Health Insurance,9.0,No,No,Diabetes,
PT03669,Norway,Vestland,88.0,Male,Ovarian,II,2016-08-06,2016-09-17,2017-02-14,Radiation,Research Institute,Alive,8.0,BRCA1,No,Current,Moderate,30.3,High,Urban,Private Insurance,10.0,Yes,No,Obesity,4.0
PT03670,Denmark,Zealand,75.0,Male,Colorectal,II,2018-05-05,2018-06-27,2018-12-26,Chemotherapy,Public,Deceased,40.0,EGFR,No,,Moderate,30.5,Medium,,Private Insurance,5.0,No,No,Hypertension,1.0
,,Flanders,28.0,Male,Pancreatic,,2010-08-24,2010-10-13,2011-05-29,Immunotherapy,Public,Alive,20.0,None,No,Never,Moderate,24.0,High,Urban,Private Insurance,17.0,No,No,,
PT03672,Austria,Styria,,Male,Ovarian,I,2019-02-17,2019-06-02,2020-02-12,Targeted Therapy,Research Institute,Alive,85.0,BRCA1,No,Former,None,37.3,High,Urban,Private Insurance,3.0,No,No,Hypertension,6.0
PT03673,Denmark,Central Denmark,47.0,Male,Leukemia,II,2012-12-10,2013-03-27,2014-01-10,Radiation,Research Institute,,32.0,None,No,Former,Moderate,31.6,Medium,Urban,NHS,,No,No,Obesity,3.0
PT03674,Denmark,Capital Region,64.0,Male,Colorectal,III,2022-03-05,2022-08-09,2022-11-09,Targeted Therapy,Public,Alive,81.0,EGFR,Yes,Former,None,33.0,Low,Rural,NHS,17.0,No,No,Hypertension,4.0
PT03675,Spain,,45.0,Male,Lung,I,2022-05-10,2022-09-17,2023-07-21,Chemotherapy,Public,Deceased,74.0,EGFR,Yes,,Moderate,,Medium,Rural,NHS,10.0,No,No,None,5.0
PT03676,Norway,Vestland,47.0,Male,Lung,I,2017-11-30,2017-12-18,2018-11-25,Immunotherapy,Private,Alive,58.0,None,No,Never,None,21.2,Medium,Urban,NHS,17.0,Yes,No,None,9.0
PT03677,Sweden,Västra Götaland,59.0,Female,Prostate,I,2012-01-14,2012-03-14,2012-10-11,Radiation,Public,Deceased,72.0,KRAS,Yes,Never,None,21.5,Medium,Urban,Private Insurance,6.0,No,No,Hypertension,5.0
PT03678,Sweden,Västra Götaland,34.0,Female,Colorectal,I,2020-10-18,2021-02-11,2021-03-16,Targeted Therapy,Private,Alive,80.0,EGFR,Yes,Current,None,28.1,Medium,Urban,Private Insurance,13.0,No,No,Cardiovascular Disease,5.0
PT03679,Ireland,Dublin,25.0,Female,Breast,IV,2012-10-02,2013-02-21,2013-10-01,Chemotherapy,Research Institute,Alive,44.0,KRAS,No,Former,None,37.2,Low,Urban,NHS,5.0,No,No,Obesity,2.0
PT03680,Poland,Masovian,46.0,Female,Leukemia,IV,2010-01-13,2010-05-11,2011-02-19,Surgery,Public,Deceased,11.0,BRCA1,No,Former,Moderate,20.7,Low,Urban,Statutory Health Insurance,6.0,No,No,Hypertension,6.0
PT03681,Finland,Uusimaa,57.0,Male,Pancreatic,II,2015-01-25,2015-07-12,,Surgery,Public,Alive,19.0,BRCA1,No,Former,Moderate,29.1,Medium,Urban,Statutory Health Insurance,12.0,No,No,Cardiovascular Disease,1.0
PT03682,Austria,Styria,87.0,Female,,I,2023-06-03,2023-07-03,2023-12-30,Chemotherapy,Private,,117.0,None,Yes,Never,None,18.9,,Rural,NHS,9.0,No,No,Diabetes,6.0
PT03683,Norway,,,Male,Colorectal,IV,2019-11-13,2019-12-12,2020-01-16,Immunotherapy,Private,Alive,92.0,,No,Never,Moderate,37.2,Low,Urban,NHS,7.0,Yes,No,Obesity,9.0
PT03684,Ireland,Munster,49.0,,Lung,I,2016-03-10,2016-08-14,2017-04-15,Targeted Therapy,Private,Alive,111.0,BRCA1,No,Never,,23.8,Medium,Rural,Statutory Health Insurance,2.0,No,No,Hypertension,5.0
,Spain,Andalusia,22.0,Female,,III,2021-12-14,2022-01-02,2022-09-18,Targeted Therapy,Public,Alive,9.0,,No,Current,Moderate,25.7,Medium,Urban,Private Insurance,13.0,Yes,No,Cardiovascular Disease,8.0
PT03686,Netherlands,South Holland,81.0,Male,Leukemia,IV,2012-09-10,,,Chemotherapy,Private,Alive,21.0,KRAS,No,Former,None,21.6,Medium,Urban,Statutory Health Insurance,16.0,No,No,Hypertension,10.0
PT03687,France,Île-de-France,31.0,Male,Pancreatic,II,2023-05-02,,2024-01-29,Targeted Therapy,Private,Alive,12.0,EGFR,No,Never,Moderate,24.9,Low,Urban,Private Insurance,5.0,No,Yes,Cardiovascular Disease,6.0
PT03688,Denmark,Capital Region,49.0,Female,Ovarian,I,2015-05-14,2015-07-11,2015-11-02,Immunotherapy,Public,Deceased,32.0,BRCA1,Yes,Former,Moderate,26.6,Low,Urban,Statutory Health Insurance,16.0,No,No,Obesity,6.0
PT03689,Belgium,Wallonia,57.0,Female,Leukemia,I,2016-02-07,2016-06-02,2016-12-02,Chemotherapy,Public,Deceased,72.0,KRAS,Yes,Current,None,21.5,Medium,Urban,,18.0,Yes,No,None,6.0
PT03690,,Veneto,79.0,Male,Prostate,IV,2014-10-29,2014-12-08,2015-07-27,Surgery,Public,Deceased,8.0,KRAS,,Former,Moderate,24.2,High,Urban,Statutory Health Insurance,3.0,No,No,Diabetes,1.0
PT03691,Sweden,Västra Götaland,57.0,Male,Lung,I,2013-07-12,2013-07-21,2014-03-01,Surgery,Public,Alive,37.0,EGFR,No,Never,,33.1,Low,Urban,NHS,,No,No,Hypertension,7.0
PT03692,Sweden,Skåne,34.0,Female,Ovarian,II,2012-10-13,2013-02-11,2013-04-01,Radiation,Research Institute,Deceased,53.0,None,No,Never,None,37.1,High,Urban,Private Insurance,19.0,No,No,Hypertension,
PT03693,Sweden,Stockholm,37.0,Female,Pancreatic,III,2015-11-24,2016-03-13,2017-01-06,Surgery,Public,,73.0,BRCA1,No,Never,Moderate,32.3,High,Rural,,18.0,No,No,Hypertension,3.0
PT03694,Sweden,Stockholm,,Male,Breast,III,2022-07-19,2022-11-04,2023-08-06,Targeted Therapy,Public,Deceased,112.0,None,No,Never,Moderate,39.2,,Rural,Private Insurance,,Yes,No,Obesity,7.0
PT03695,Spain,Madrid,48.0,,Prostate,II,2022-04-27,2022-10-03,2023-01-11,Immunotherapy,Public,Alive,15.0,EGFR,No,Current,None,23.4,High,Urban,Statutory Health Insurance,11.0,Yes,No,Hypertension,6.0
PT03696,Finland,Uusimaa,79.0,Female,Breast,I,,2022-06-30,2023-02-16,Immunotherapy,Public,Deceased,6.0,BRCA1,No,Never,Moderate,26.0,Medium,Urban,Private Insurance,19.0,Yes,No,Diabetes,3.0
PT03697,Portugal,Algarve,40.0,,Colorectal,II,2011-08-31,2011-12-04,2012-02-29,Radiation,Private,Alive,,None,Yes,Never,None,25.2,Low,Urban,Private Insurance,14.0,No,No,Diabetes,5.0
PT03698,Netherlands,South Holland,36.0,Female,Leukemia,I,2021-01-27,2021-06-19,2022-04-01,Targeted Therapy,Public,Alive,99.0,None,Yes,Never,Moderate,29.7,Low,Urban,NHS,7.0,No,No,Cardiovascular Disease,1.0
PT03699,Finland,Uusimaa,37.0,Female,Pancreatic,I,2021-07-20,2021-08-23,2022-04-30,Chemotherapy,Public,Alive,33.0,BRCA1,,Current,Moderate,33.7,Medium,Urban,Private Insurance,2.0,No,No,Diabetes,2.0
PT03700,Finland,Southwest Finland,76.0,Male,Lung,III,2017-10-07,2017-12-08,2018-06-14,Radiation,Private,Deceased,48.0,EGFR,Yes,Former,None,22.7,Low,Urban,Private Insurance,12.0,No,No,Obesity,4.0
PT03701,Belgium,Brussels,56.0,Female,Breast,I,2021-04-25,2021-07-08,2021-12-20,Targeted Therapy,Public,Alive,85.0,KRAS,Yes,Never,Moderate,36.1,Medium,,Private Insurance,3.0,No,,Cardiovascular Disease,5.0
PT03702,Portugal,Porto,,Male,Lung,I,2011-12-11,2012-02-06,2012-09-30,Chemotherapy,,Alive,27.0,,No,Never,Moderate,,Low,Urban,Private Insurance,6.0,No,Yes,Cardiovascular Disease,3.0
PT03703,Switzerland,Geneva,57.0,Female,Colorectal,II,2012-02-06,2012-07-04,2013-03-28,Surgery,Private,Alive,69.0,EGFR,Yes,Former,Moderate,28.2,Low,Urban,NHS,15.0,No,No,,8.0
PT03704,Netherlands,Utrecht,31.0,Female,Breast,II,2022-08-04,2022-11-15,2023-07-20,Surgery,Public,Alive,35.0,None,Yes,Former,None,36.4,Medium,Rural,Private Insurance,17.0,No,No,Obesity,6.0
PT03705,Poland,Lesser Poland,20.0,Male,,III,2019-11-08,2020-01-01,2020-08-05,Chemotherapy,,Alive,46.0,EGFR,No,Current,Moderate,25.2,Medium,Rural,Statutory Health Insurance,10.0,No,No,Obesity,3.0
PT03706,Switzerland,Geneva,77.0,Female,Lung,III,2018-02-12,2018-07-27,2019-03-03,Radiation,Public,Deceased,44.0,KRAS,No,Never,,32.7,Low,Urban,Statutory Health Insurance,5.0,No,No,Diabetes,5.0
PT03707,Ireland,Munster,22.0,Female,Ovarian,III,2010-04-02,2010-09-17,2011-07-17,Chemotherapy,Public,Deceased,106.0,BRCA1,,Never,None,28.2,High,Urban,Statutory Health Insurance,10.0,Yes,No,Cardiovascular Disease,
PT03708,Portugal,Porto,82.0,Male,Colorectal,III,2010-04-10,2010-04-30,2011-02-07,Targeted Therapy,Public,Alive,79.0,BRCA1,No,Current,None,24.0,High,Urban,Statutory Health Insurance,,,No,Obesity,10.0
PT03709,Italy,Lombardy,40.0,Male,Prostate,III,2018-04-13,2018-07-31,2019-03-11,Chemotherapy,Public,Alive,30.0,EGFR,No,Current,None,27.9,Low,Urban,NHS,5.0,Yes,,Cardiovascular Disease,9.0
PT03710,Portugal,Porto,42.0,Male,Pancreatic,I,2011-11-17,2012-04-11,2013-03-28,Targeted Therapy,Research Institute,Deceased,16.0,EGFR,Yes,Never,None,34.7,Low,Urban,,11.0,No,No,Cardiovascular Disease,8.0
PT03711,Poland,Masovian,28.0,Female,Colorectal,II,2014-10-17,2015-04-07,2015-11-02,Targeted Therapy,Public,Deceased,92.0,KRAS,No,Current,None,32.7,Medium,Urban,NHS,7.0,No,No,Hypertension,4.0
PT03712,Netherlands,Utrecht,74.0,Non-binary,Breast,III,2020-10-23,2020-11-09,2021-10-27,Surgery,Public,Alive,27.0,EGFR,Yes,Never,Moderate,34.6,Medium,Urban,NHS,1.0,No,No,None,4.0
PT03713,Finland,Uusimaa,38.0,,Breast,I,2020-01-18,2020-02-29,2020-06-25,Targeted Therapy,Private,Alive,25.0,EGFR,No,Former,Moderate,24.9,Low,Urban,Private Insurance,5.0,No,No,Cardiovascular Disease,7.0
PT03714,Poland,Masovian,81.0,Male,Leukemia,I,2011-01-29,2011-07-04,,Immunotherapy,Private,Deceased,10.0,BRCA1,Yes,Former,Moderate,35.0,Medium,Urban,Private Insurance,6.0,Yes,No,Hypertension,9.0
PT03715,Switzerland,Bern,58.0,Female,Lung,II,2011-08-17,2011-09-07,2012-08-05,Surgery,Public,Alive,27.0,EGFR,No,Current,Moderate,26.9,,Urban,Statutory Health Insurance,18.0,,No,None,6.0
PT03716,Austria,Vienna,46.0,Male,Pancreatic,II,2017-11-21,2018-05-05,2019-04-15,,Public,Alive,86.0,None,No,Never,None,,Medium,Urban,Statutory Health Insurance,18.0,No,No,Cardiovascular Disease,1.0
PT03717,Germany,Berlin,65.0,Male,Breast,II,2012-06-04,2012-11-02,2013-10-31,Chemotherapy,Public,Deceased,23.0,BRCA1,No,,Heavy,37.3,High,Urban,NHS,3.0,Yes,No,Obesity,5.0
PT03718,Netherlands,North Holland,53.0,Female,Prostate,III,2018-05-11,2018-08-30,2019-02-01,Targeted Therapy,Public,Alive,84.0,EGFR,Yes,Former,None,33.8,Low,Rural,Statutory Health Insurance,,No,No,Cardiovascular Disease,4.0
PT03719,,Veneto,52.0,Male,Prostate,II,2011-05-20,2011-07-07,2012-02-01,Chemotherapy,Private,Deceased,99.0,None,No,Former,Moderate,33.7,High,,NHS,6.0,No,No,,9.0
PT03720,Italy,Veneto,69.0,Female,Colorectal,IV,2020-04-08,2020-06-06,2020-08-17,Targeted Therapy,Public,Lost to Follow-up,,KRAS,No,Current,Heavy,29.0,High,Rural,Private Insurance,19.0,No,No,None,7.0
PT03721,Finland,Pirkanmaa,,Female,Breast,,2014-11-13,2015-03-21,2015-11-08,Surgery,,Alive,81.0,EGFR,Yes,Never,None,30.8,Medium,Rural,Private Insurance,8.0,No,No,Diabetes,1.0
PT03722,Spain,Andalusia,59.0,Female,Pancreatic,II,2022-02-24,,2023-05-17,Immunotherapy,Research Institute,Deceased,7.0,EGFR,No,Never,None,34.6,,Urban,NHS,18.0,No,No,None,
PT03723,Norway,Oslo,77.0,Female,Pancreatic,I,2019-07-30,2019-09-20,2020-02-03,Surgery,Public,Deceased,108.0,KRAS,Yes,Former,Moderate,18.1,Low,Urban,NHS,6.0,Yes,No,Cardiovascular Disease,
PT03724,Austria,Styria,50.0,Male,Breast,II,2010-05-14,2010-05-31,2010-09-25,Radiation,,Deceased,8.0,None,Yes,Former,None,27.1,Medium,Urban,Private Insurance,2.0,No,No,None,
PT03725,Switzerland,Bern,57.0,Non-binary,Ovarian,IV,2018-01-04,2018-02-11,2018-03-26,Chemotherapy,Public,Deceased,49.0,,Yes,Current,Moderate,24.6,Low,Urban,NHS,11.0,No,No,None,2.0
PT03726,Ireland,Connacht,64.0,Female,Leukemia,II,2021-10-17,,2022-11-22,Immunotherapy,Public,Alive,83.0,None,Yes,Never,Heavy,23.6,Medium,Urban,Statutory Health Insurance,8.0,No,,Obesity,
PT03727,Norway,Vestland,60.0,Female,Leukemia,I,2011-08-08,2011-10-22,2011-12-08,Chemotherapy,,Alive,41.0,None,Yes,Never,Moderate,36.2,Medium,Rural,NHS,19.0,,Yes,Diabetes,8.0
PT03728,,Connacht,28.0,Male,Leukemia,II,2013-12-07,2014-05-17,2015-01-29,Targeted Therapy,Public,Alive,42.0,KRAS,No,Former,None,28.5,Medium,Urban,NHS,18.0,No,No,None,8.0
PT03729,Ireland,Connacht,28.0,Female,Ovarian,I,2010-12-23,2011-03-28,2011-07-12,Chemotherapy,Public,Alive,83.0,None,No,Former,Heavy,19.1,Medium,Urban,Private Insurance,13.0,No,No,Cardiovascular Disease,7.0
PT03730,Switzerland,,82.0,Female,Breast,II,2019-03-09,2019-04-22,2020-03-06,Surgery,Research Institute,Alive,28.0,KRAS,Yes,Never,Moderate,39.5,Medium,Rural,NHS,14.0,No,No,Hypertension,8.0
PT03731,Italy,Veneto,41.0,Male,Colorectal,II,2014-10-17,2015-01-13,2015-03-24,Surgery,Public,Alive,58.0,None,Yes,Former,Moderate,21.2,Medium,Urban,Statutory Health Insurance,2.0,Yes,No,Hypertension,8.0
,Norway,Trøndelag,35.0,Female,Ovarian,II,2014-08-28,2014-09-17,2015-02-12,Chemotherapy,Public,Alive,84.0,KRAS,No,Never,Moderate,27.5,Medium,Urban,NHS,18.0,Yes,No,Obesity,8.0
,Italy,Sicily,51.0,Female,Pancreatic,III,2014-09-06,2015-02-28,2015-06-12,Targeted Therapy,Public,Alive,67.0,None,No,Never,None,31.9,Medium,Rural,NHS,15.0,No,No,Hypertension,8.0
PT03734,Italy,Lombardy,85.0,Male,,III,2020-01-30,2020-04-08,2020-10-31,Targeted Therapy,Research Institute,Alive,76.0,KRAS,No,Never,None,30.4,Low,Urban,Statutory Health Insurance,15.0,No,No,Obesity,10.0
PT03735,Switzerland,Bern,33.0,Male,Colorectal,II,2011-06-21,2011-12-08,2012-08-11,Immunotherapy,Public,Alive,63.0,EGFR,Yes,Former,Moderate,27.6,Medium,Urban,NHS,9.0,No,No,Obesity,8.0
PT03736,Netherlands,,57.0,Female,Ovarian,II,2016-10-04,2017-03-07,2017-06-13,Surgery,Private,Alive,38.0,None,No,Current,Moderate,24.7,Medium,Rural,NHS,11.0,No,Yes,Hypertension,2.0
PT03737,Germany,North Rhine-Westphalia,27.0,Male,Colorectal,III,2010-05-31,2010-07-19,2011-03-18,Chemotherapy,Public,Deceased,62.0,None,No,Never,None,30.5,Medium,Rural,Statutory Health Insurance,8.0,No,No,None,4.0
PT03738,,Brussels,40.0,Female,Prostate,III,2014-10-22,2015-02-05,2016-01-04,Immunotherapy,Private,Deceased,54.0,KRAS,,Never,Moderate,36.8,Medium,,Private Insurance,4.0,No,No,Cardiovascular Disease,3.0
PT03739,France,Auvergne-Rhône-Alpes,75.0,Female,Breast,I,2016-12-25,2017-03-06,2017-04-16,Radiation,Public,Alive,43.0,EGFR,No,Current,,23.3,Medium,Urban,NHS,,No,Yes,None,10.0
PT03740,Ireland,Munster,65.0,Male,Lung,II,2012-06-06,2012-06-24,2012-11-13,Immunotherapy,Public,,81.0,EGFR,No,Never,None,19.4,Medium,Rural,,2.0,No,No,None,1.0
PT03741,Ireland,Munster,62.0,Female,Breast,II,,2018-06-25,2019-04-20,Radiation,Public,Deceased,56.0,KRAS,No,Never,Moderate,25.9,High,Urban,Statutory Health Insurance,13.0,Yes,No,Obesity,2.0
PT03742,Sweden,Västra Götaland,65.0,Female,Colorectal,I,2023-04-01,2023-07-05,2024-06-18,Radiation,Public,Alive,63.0,BRCA1,No,Former,Heavy,34.4,Low,Rural,NHS,10.0,Yes,No,Cardiovascular Disease,2.0
PT03743,Belgium,Brussels,67.0,Female,Prostate,I,2017-01-06,2017-01-15,2017-03-11,Immunotherapy,Public,Deceased,29.0,None,Yes,Never,Moderate,39.8,Medium,Urban,NHS,2.0,No,No,Cardiovascular Disease,6.0
PT03744,Portugal,Lisbon,89.0,Female,Prostate,I,2014-05-28,2014-08-02,2014-10-25,Surgery,Research Institute,Lost to Follow-up,,None,No,Former,None,32.3,High,Urban,Private Insurance,2.0,No,No,,8.0
PT03745,Germany,Bavaria,50.0,Female,Breast,III,2013-05-26,2013-07-25,2014-07-04,Immunotherapy,,Alive,,EGFR,No,Former,None,29.2,Low,Rural,Private Insurance,18.0,Yes,No,Obesity,3.0
PT03746,Switzerland,Bern,52.0,Male,Lung,II,2010-07-27,2010-11-12,2011-07-07,Immunotherapy,Research Institute,Alive,47.0,None,No,Never,None,19.7,High,,Private Insurance,4.0,No,No,Diabetes,2.0
PT03747,Sweden,Västra Götaland,63.0,Male,Ovarian,II,2020-06-29,2020-08-05,2020-11-21,Surgery,Public,Alive,76.0,BRCA1,No,Never,Moderate,25.5,Low,Urban,NHS,10.0,No,No,Cardiovascular Disease,8.0
PT03748,Ireland,Dublin,,Male,Ovarian,III,2019-03-16,2019-09-07,2020-08-25,Surgery,,Alive,25.0,KRAS,,Never,None,19.2,Low,Urban,Private Insurance,8.0,Yes,Yes,Hypertension,9.0
PT03749,,Geneva,21.0,Male,Colorectal,III,2017-12-09,2018-01-07,2018-07-06,Surgery,Public,,98.0,KRAS,Yes,Never,None,27.2,Low,Urban,Private Insurance,,No,No,Obesity,5.0
PT03750,Poland,Masovian,36.0,,Prostate,II,2019-10-28,2019-12-30,2020-12-21,Surgery,Private,,49.0,KRAS,No,Current,,28.8,Medium,Urban,Private Insurance,16.0,No,No,,3.0
PT03751,Spain,Catalonia,71.0,Male,Colorectal,II,2017-07-18,2017-08-02,2018-03-17,Surgery,Private,Deceased,59.0,None,No,Never,Moderate,24.0,Low,,NHS,9.0,No,No,Cardiovascular Disease,5.0
PT03752,Ireland,Munster,64.0,,Colorectal,I,2017-06-18,2017-06-27,2018-03-03,Surgery,Private,Alive,52.0,EGFR,No,Never,Heavy,19.5,Medium,Urban,Statutory Health Insurance,7.0,No,No,None,4.0
PT03753,Spain,Catalonia,56.0,,Pancreatic,II,2021-01-17,2021-04-07,,Immunotherapy,Public,Deceased,12.0,BRCA1,Yes,Never,None,27.4,Medium,Urban,Private Insurance,15.0,No,No,Cardiovascular Disease,9.0
PT03754,Poland,Masovian,61.0,Male,Colorectal,II,2016-03-29,2016-06-03,2017-03-20,Chemotherapy,Public,Deceased,10.0,EGFR,No,Former,Moderate,39.4,High,Urban,Private Insurance,10.0,No,No,None,7.0
PT03755,Finland,Uusimaa,63.0,Female,,II,2012-09-15,2012-09-16,2012-11-05,Chemotherapy,Private,,105.0,KRAS,,Current,None,25.1,Medium,,Private Insurance,8.0,No,No,Hypertension,5.0
PT03756,Finland,Pirkanmaa,57.0,Male,Pancreatic,II,2023-08-17,2023-12-16,2024-07-10,Chemotherapy,Private,Alive,102.0,BRCA1,No,Never,Moderate,24.9,Medium,Urban,NHS,15.0,No,No,Hypertension,8.0
,Norway,Trøndelag,25.0,Female,Colorectal,III,2017-10-30,2017-11-08,2018-02-16,Immunotherapy,Public,Deceased,57.0,,No,Never,Moderate,21.3,Low,Urban,NHS,2.0,No,No,Hypertension,2.0
PT03758,Germany,Berlin,87.0,Male,Colorectal,II,2021-10-12,2021-12-08,2022-04-10,Surgery,Public,Alive,82.0,BRCA1,Yes,Never,None,30.2,Medium,Urban,Statutory Health Insurance,6.0,Yes,No,Obesity,4.0
PT03759,Norway,Oslo,70.0,Female,,II,2014-07-08,2014-12-03,2015-07-27,Radiation,Public,Alive,37.0,None,No,Former,None,29.8,Low,Urban,Private Insurance,3.0,No,No,Hypertension,1.0
PT03760,Netherlands,South Holland,54.0,Female,Ovarian,I,2016-08-05,2016-12-04,2017-03-16,Surgery,Public,Alive,106.0,KRAS,No,Never,,26.5,Low,Urban,NHS,15.0,No,No,,3.0
PT03761,Switzerland,Bern,77.0,Female,Pancreatic,III,2016-08-17,,,Targeted Therapy,Public,Deceased,,KRAS,No,Never,Moderate,,High,Urban,NHS,14.0,No,No,Diabetes,9.0
PT03762,Poland,Lesser Poland,76.0,Male,Ovarian,IV,2013-01-29,2013-01-30,2013-11-13,Surgery,Private,Alive,32.0,KRAS,No,Former,Moderate,20.1,Medium,Rural,NHS,18.0,No,No,Obesity,3.0
PT03763,Spain,Catalonia,25.0,,Pancreatic,III,2011-06-13,2011-08-26,2012-05-09,Chemotherapy,Public,Alive,55.0,EGFR,No,Former,None,38.3,High,Urban,Private Insurance,9.0,,Yes,Hypertension,
PT03764,Switzerland,Geneva,32.0,,Lung,IV,2013-06-25,2013-08-18,,Surgery,Private,Deceased,71.0,BRCA1,Yes,Former,Moderate,27.1,Medium,Urban,Private Insurance,9.0,No,,Diabetes,9.0
PT03765,Denmark,Capital Region,78.0,Female,Leukemia,I,2013-11-20,2013-12-09,2014-10-30,Surgery,Public,Alive,116.0,BRCA1,Yes,Never,None,21.0,Medium,Urban,Private Insurance,10.0,,Yes,Hypertension,1.0
PT03766,Germany,North Rhine-Westphalia,,Male,Pancreatic,I,2021-06-05,2021-06-23,2022-02-24,Targeted Therapy,Private,Alive,82.0,BRCA1,Yes,Current,None,30.4,,Rural,NHS,14.0,,No,Hypertension,8.0
PT03767,Finland,Pirkanmaa,21.0,Male,Leukemia,II,2014-10-02,2014-10-26,2014-12-30,Radiation,,Alive,,None,Yes,Never,Moderate,33.0,Medium,Urban,Private Insurance,6.0,No,No,Diabetes,3.0
PT03768,Netherlands,South Holland,77.0,Male,Colorectal,I,2021-04-29,2021-09-03,2022-05-02,Radiation,Private,Alive,61.0,EGFR,No,Former,None,24.1,Medium,Urban,Private Insurance,5.0,No,No,Obesity,8.0
PT03769,Spain,Madrid,55.0,Male,,I,2022-01-03,2022-02-24,2022-08-22,Chemotherapy,Public,Alive,68.0,EGFR,Yes,Never,None,36.4,Medium,,NHS,14.0,,No,None,9.0
PT03770,Norway,Trøndelag,64.0,Female,Prostate,II,2013-02-22,2013-03-14,2014-01-11,,Public,Alive,35.0,EGFR,No,Former,Heavy,18.2,High,Urban,Statutory Health Insurance,14.0,,No,None,10.0
PT03771,Belgium,Flanders,28.0,Male,Breast,I,2014-03-04,2014-07-21,2014-12-12,Chemotherapy,Private,Deceased,51.0,EGFR,,,None,25.7,Medium,Rural,NHS,16.0,No,No,Cardiovascular Disease,9.0
PT03772,Ireland,Dublin,,Male,Prostate,I,2017-07-24,2017-10-05,2018-05-25,Immunotherapy,Private,Alive,75.0,EGFR,,Former,Moderate,37.3,Low,Urban,Statutory Health Insurance,12.0,No,No,Cardiovascular Disease,6.0
PT03773,Denmark,Capital Region,69.0,,Prostate,IV,2011-12-12,2011-12-28,2012-02-01,Targeted Therapy,Public,Deceased,72.0,None,Yes,Never,Moderate,32.9,Low,,Statutory Health Insurance,,No,No,None,5.0
PT03774,Switzerland,Bern,51.0,Female,Lung,I,2012-08-18,2013-01-06,2013-12-24,Surgery,Public,Deceased,56.0,BRCA1,No,Never,None,22.9,Medium,Urban,Private Insurance,8.0,No,No,Hypertension,4.0
PT03775,Denmark,Zealand,62.0,Female,Breast,I,2023-06-20,2023-06-26,2023-11-27,Targeted Therapy,Public,Deceased,99.0,EGFR,No,Never,Moderate,28.0,Low,Rural,Statutory Health Insurance,5.0,No,Yes,Diabetes,5.0
PT03776,Finland,,73.0,Non-binary,Ovarian,I,2020-02-27,2020-03-23,2021-02-23,Radiation,Private,Alive,64.0,KRAS,No,Former,None,,High,Urban,NHS,15.0,No,No,Hypertension,9.0
PT03777,Germany,Bavaria,66.0,Male,Breast,III,2010-01-05,2010-03-09,2010-10-22,Surgery,Public,Alive,88.0,KRAS,No,,None,28.4,Medium,Urban,Private Insurance,8.0,No,Yes,,7.0
PT03778,,Skåne,33.0,Female,Lung,III,2023-06-21,2023-12-13,2024-08-05,Targeted Therapy,Public,Deceased,64.0,KRAS,No,Former,None,36.4,High,Urban,Private Insurance,4.0,No,No,Diabetes,5.0
PT03779,Belgium,Brussels,67.0,Male,,I,2010-04-28,2010-05-13,2010-06-14,Targeted Therapy,Private,Alive,55.0,BRCA1,No,Current,None,19.1,Low,Urban,Private Insurance,5.0,No,No,None,
PT03780,,North Holland,74.0,Male,Prostate,I,2017-08-23,2017-10-16,2018-01-19,Chemotherapy,Private,Alive,85.0,KRAS,Yes,Never,None,23.4,Medium,Rural,Private Insurance,18.0,No,No,Cardiovascular Disease,9.0
PT03781,Netherlands,,,Male,Breast,III,2023-01-09,2023-06-29,2024-02-21,Immunotherapy,Private,Alive,73.0,None,No,Never,Heavy,18.7,Medium,Urban,Statutory Health Insurance,12.0,No,Yes,Diabetes,10.0
PT03782,Portugal,Lisbon,66.0,Male,Prostate,I,2014-04-16,2014-08-22,2015-06-25,Targeted Therapy,Public,Alive,57.0,None,No,Former,Moderate,39.8,Low,Urban,Private Insurance,5.0,No,No,Cardiovascular Disease,10.0
PT03783,Belgium,Brussels,82.0,Male,Breast,IV,2023-01-15,2023-01-29,2023-06-20,Surgery,Public,,50.0,BRCA1,Yes,Current,None,21.5,Low,Urban,NHS,16.0,No,No,None,2.0
,Spain,Madrid,,Male,Prostate,II,2019-03-27,2019-04-30,2019-10-15,Immunotherapy,Public,Alive,14.0,None,No,Current,Moderate,,Low,Urban,NHS,13.0,Yes,No,Obesity,
PT03785,Denmark,Central Denmark,28.0,,Colorectal,I,2019-02-12,2019-06-22,,Immunotherapy,Private,Alive,69.0,None,Yes,,,36.8,Medium,Rural,Private Insurance,9.0,No,No,Diabetes,3.0
PT03786,Portugal,Algarve,56.0,,Lung,IV,2023-12-30,2024-01-19,2024-12-22,Surgery,Public,Alive,13.0,None,No,Former,Heavy,29.3,Low,Urban,,12.0,Yes,No,Obesity,8.0
PT03787,Belgium,Wallonia,71.0,Non-binary,Pancreatic,II,2017-06-01,2017-09-15,2018-09-11,Immunotherapy,Public,Alive,,KRAS,Yes,Former,Heavy,38.8,,Rural,Statutory Health Insurance,2.0,Yes,No,None,6.0
PT03788,Portugal,Porto,76.0,Female,Leukemia,I,2013-03-31,2013-04-16,2013-10-30,Radiation,Public,Alive,60.0,EGFR,No,Current,Moderate,31.0,Medium,,NHS,7.0,Yes,No,Diabetes,10.0
PT03789,Switzerland,Zurich,47.0,Male,Ovarian,II,2019-03-01,,2019-10-09,Immunotherapy,Private,Lost to Follow-up,,KRAS,No,,None,33.9,Low,Urban,Statutory Health Insurance,3.0,,No,Obesity,9.0
PT03790,Finland,Uusimaa,55.0,Male,Colorectal,,2022-05-10,2022-08-21,2022-11-01,Chemotherapy,Private,Alive,95.0,KRAS,No,Never,None,31.6,Low,Rural,Private Insurance,1.0,No,No,None,4.0
,France,Auvergne-Rhône-Alpes,83.0,Male,Prostate,I,2013-02-21,2013-04-13,2014-03-09,Immunotherapy,Public,Deceased,14.0,None,Yes,Former,Moderate,34.2,Low,,Private Insurance,11.0,No,No,Diabetes,
PT03792,Italy,Lombardy,37.0,Male,Leukemia,II,2023-08-06,2023-12-15,2024-06-30,,Public,Deceased,17.0,None,No,Never,Moderate,23.9,Medium,Urban,,8.0,No,No,Diabetes,8.0
PT03793,Austria,Tyrol,54.0,Female,Pancreatic,I,2018-05-25,2018-08-10,2019-07-25,Immunotherapy,Private,Alive,97.0,None,No,Current,None,25.3,Medium,Urban,Private Insurance,8.0,No,No,Hypertension,4.0
PT03794,,Tyrol,87.0,Female,Colorectal,III,2011-09-08,2012-01-14,2012-11-09,Chemotherapy,Private,Alive,74.0,BRCA1,Yes,Never,None,31.3,Medium,Rural,Statutory Health Insurance,,No,No,Hypertension,1.0
PT03795,Denmark,Capital Region,58.0,Male,Pancreatic,II,,,2019-12-08,Chemotherapy,Public,Deceased,118.0,BRCA1,No,Never,None,36.9,Medium,Rural,Statutory Health Insurance,7.0,No,No,Hypertension,
,Austria,Styria,27.0,Male,Lung,,2012-10-23,2013-02-21,2013-05-03,Immunotherapy,Public,Deceased,,EGFR,Yes,Former,Moderate,23.0,Medium,Urban,Private Insurance,15.0,Yes,No,None,
PT03797,Italy,Lombardy,34.0,Male,Leukemia,II,2023-10-09,2023-11-24,2024-06-27,Radiation,Public,Alive,85.0,KRAS,,Never,Moderate,39.1,High,Rural,NHS,16.0,No,No,None,4.0
PT03798,Spain,Madrid,26.0,Male,Pancreatic,III,2018-05-29,2018-07-08,2018-10-30,Immunotherapy,Public,Deceased,24.0,KRAS,No,Former,None,27.8,Medium,Urban,Private Insurance,2.0,No,No,Cardiovascular Disease,5.0
PT03799,Netherlands,North Holland,36.0,Male,Leukemia,III,2012-02-01,2012-03-01,2012-04-03,Surgery,Research Institute,Deceased,92.0,None,No,Never,,21.0,High,Urban,Private Insurance,19.0,No,No,Hypertension,
PT03800,Netherlands,North Holland,83.0,Female,Lung,II,2017-03-15,2017-08-13,2018-08-04,Chemotherapy,Private,Alive,13.0,None,Yes,Current,None,37.2,Medium,Urban,Private Insurance,13.0,No,No,Obesity,5.0
PT03801,Ireland,,31.0,,Pancreatic,III,2021-12-15,2022-05-09,2023-03-19,Immunotherapy,Private,Deceased,107.0,KRAS,No,Former,Moderate,,Low,Rural,Statutory Health Insurance,19.0,Yes,No,Hypertension,2.0
PT03802,Switzerland,Bern,75.0,,Colorectal,II,2015-06-29,2015-09-30,2016-07-17,Radiation,Private,Alive,23.0,EGFR,Yes,Former,Moderate,36.1,Medium,Urban,Private Insurance,9.0,No,No,Diabetes,1.0
PT03803,Poland,Masovian,65.0,Male,Leukemia,I,2023-03-16,2023-05-24,2024-01-17,Radiation,Public,Alive,31.0,EGFR,Yes,Former,Moderate,27.6,Medium,Rural,,15.0,No,No,Diabetes,3.0
PT03804,Italy,Lombardy,66.0,Male,Ovarian,III,2011-03-10,2011-06-03,2012-03-13,Radiation,Public,,48.0,EGFR,Yes,Never,Moderate,38.8,Medium,Urban,Private Insurance,11.0,No,No,None,4.0
PT03805,Switzerland,Bern,35.0,Female,Ovarian,II,2022-08-23,2022-10-28,2023-06-08,Targeted Therapy,Public,Lost to Follow-up,,BRCA1,No,Never,None,25.3,High,Rural,,15.0,No,No,Cardiovascular Disease,9.0
PT03806,Italy,Veneto,88.0,Female,Ovarian,III,2017-12-26,,2018-09-13,,Private,Alive,31.0,BRCA1,No,Never,None,19.9,Low,Urban,Private Insurance,19.0,No,No,None,9.0
PT03807,Austria,Tyrol,21.0,Male,Pancreatic,IV,2020-11-06,2021-01-20,2021-05-22,,Public,Alive,110.0,None,No,,Moderate,25.6,Medium,Rural,Statutory Health Insurance,6.0,Yes,,None,7.0
PT03808,,Andalusia,,Female,Lung,II,2016-12-12,2017-05-12,2017-10-27,Surgery,Public,Deceased,84.0,EGFR,,Former,Moderate,26.0,,Urban,NHS,8.0,No,Yes,Obesity,10.0
PT03809,Italy,,46.0,Male,Ovarian,I,2023-06-07,2023-10-20,2024-06-23,Surgery,Public,Alive,19.0,BRCA1,No,Current,Heavy,35.6,Low,Rural,Private Insurance,14.0,Yes,No,Cardiovascular Disease,6.0
PT03810,Austria,Styria,50.0,Male,Pancreatic,IV,2013-05-07,2013-10-25,2014-07-25,Immunotherapy,Private,Alive,12.0,BRCA1,Yes,Former,Moderate,33.7,Medium,Urban,Private Insurance,7.0,No,No,Cardiovascular Disease,2.0
PT03811,Norway,Vestland,60.0,Female,Pancreatic,I,2022-05-29,2022-07-02,2022-11-11,Targeted Therapy,Public,Alive,94.0,,No,Never,Moderate,31.7,Medium,Urban,NHS,10.0,No,No,None,6.0
PT03812,Denmark,Capital Region,55.0,Female,Colorectal,II,2016-03-14,2016-06-24,2016-08-24,Targeted Therapy,Public,Alive,7.0,,Yes,Current,Moderate,22.2,Medium,Rural,Statutory Health Insurance,9.0,Yes,No,Obesity,5.0
PT03813,Italy,Sicily,66.0,Male,Prostate,I,,2014-06-27,2014-09-15,Surgery,Private,Alive,53.0,BRCA1,No,Former,,35.6,Medium,Rural,NHS,8.0,No,No,Hypertension,7.0
PT03814,Ireland,Connacht,62.0,Male,Breast,I,2023-02-15,2023-06-08,2024-03-01,,Private,Alive,75.0,None,No,Never,Heavy,18.7,Medium,Rural,Private Insurance,3.0,Yes,No,Diabetes,1.0
PT03815,Norway,Oslo,84.0,Female,Prostate,III,2012-03-02,2012-04-22,2012-06-30,Radiation,Public,Deceased,78.0,BRCA1,No,Current,Heavy,22.8,Medium,Rural,Private Insurance,18.0,No,No,Hypertension,4.0
PT03816,France,Île-de-France,69.0,Male,Prostate,II,2018-08-23,2019-02-11,2019-11-24,Chemotherapy,Public,Alive,61.0,EGFR,No,Current,None,30.1,Medium,Urban,Private Insurance,5.0,Yes,No,Hypertension,10.0
PT03817,Portugal,Lisbon,20.0,Male,Breast,III,2012-11-18,2013-01-27,2013-10-06,Immunotherapy,Private,Alive,111.0,EGFR,No,Former,None,28.5,Medium,Urban,Private Insurance,6.0,,No,None,7.0
PT03818,Germany,North Rhine-Westphalia,76.0,Female,,III,2015-09-16,2015-11-21,2015-12-26,Immunotherapy,Public,Alive,26.0,EGFR,Yes,Current,Moderate,33.2,,Urban,NHS,7.0,No,No,None,
PT03819,Belgium,Flanders,35.0,Female,Prostate,II,2016-12-29,2017-04-04,2017-08-06,Targeted Therapy,Private,Alive,80.0,KRAS,No,Never,None,35.4,High,Urban,Statutory Health Insurance,15.0,No,Yes,Hypertension,4.0
PT03820,Portugal,Porto,47.0,Male,Prostate,II,2019-11-13,2020-01-10,2020-11-06,Surgery,Public,Alive,119.0,EGFR,No,Current,Moderate,37.0,High,,NHS,10.0,Yes,No,,6.0
PT03821,Belgium,Flanders,41.0,Female,Lung,III,2014-08-09,2014-12-07,2015-05-31,Immunotherapy,Private,Deceased,12.0,KRAS,Yes,Current,Moderate,39.2,Low,Urban,NHS,19.0,No,No,Diabetes,9.0
PT03822,Switzerland,Zurich,60.0,Female,Lung,III,2016-04-26,2016-10-14,2017-10-06,Radiation,,Alive,101.0,None,No,Former,Moderate,30.2,High,Urban,Statutory Health Insurance,7.0,No,No,Cardiovascular Disease,3.0
,,Zurich,38.0,Male,Colorectal,II,2020-03-11,,2021-03-15,,Private,Alive,109.0,None,Yes,Former,Heavy,30.8,Low,Urban,NHS,19.0,No,No,None,3.0
PT03824,Belgium,Brussels,69.0,Female,Leukemia,II,,,2019-12-27,Targeted Therapy,,Alive,45.0,BRCA1,No,Never,Moderate,30.3,Low,Urban,Statutory Health Insurance,3.0,No,Yes,,9.0
PT03825,Poland,Masovian,78.0,Non-binary,Pancreatic,II,2015-07-30,2016-01-12,2016-03-30,Targeted Therapy,Public,Deceased,32.0,None,No,Never,None,37.7,High,Urban,Private Insurance,,No,No,Obesity,2.0
PT03826,Poland,Silesian,88.0,Male,Ovarian,II,2018-08-24,2019-01-27,2019-11-03,,Public,Lost to Follow-up,,KRAS,Yes,Current,Moderate,35.0,Medium,Urban,Statutory Health Insurance,4.0,No,No,Cardiovascular Disease,9.0
PT03827,Norway,Vestland,53.0,Male,Colorectal,II,2020-03-14,2020-04-24,2021-03-14,Immunotherapy,Public,Deceased,82.0,EGFR,No,Never,None,28.9,High,Rural,NHS,1.0,Yes,No,Obesity,1.0
PT03828,Ireland,Munster,58.0,Female,Lung,III,2017-05-05,2017-06-24,2017-09-19,Chemotherapy,Research Institute,Alive,7.0,None,Yes,Never,None,33.1,Low,Urban,Private Insurance,11.0,No,No,Hypertension,10.0
PT03829,Denmark,Zealand,26.0,Female,Lung,I,2015-05-19,2015-08-17,2016-04-01,Immunotherapy,Public,Deceased,18.0,BRCA1,No,Former,Moderate,24.7,High,Urban,Private Insurance,4.0,No,No,Obesity,
PT03830,France,Île-de-France,71.0,Male,Breast,IV,2016-09-25,2016-12-24,2017-07-11,Immunotherapy,Private,,,None,No,Never,Heavy,,High,Rural,Private Insurance,16.0,No,Yes,None,3.0
PT03831,Denmark,Zealand,79.0,Female,Breast,III,2011-02-26,,2012-03-31,Radiation,Research Institute,Alive,73.0,EGFR,No,Former,Moderate,,Medium,Urban,Statutory Health Insurance,19.0,Yes,No,Obesity,10.0
PT03832,Portugal,Lisbon,71.0,Female,Ovarian,I,2012-08-16,2012-12-15,2013-08-28,Radiation,Research Institute,Deceased,31.0,BRCA1,Yes,Current,None,,High,Rural,Private Insurance,,No,No,Hypertension,3.0
PT03833,Italy,Veneto,43.0,Female,Ovarian,I,2015-08-09,2015-10-29,2015-12-25,Surgery,Private,Alive,92.0,BRCA1,No,,None,,Medium,Urban,Statutory Health Insurance,10.0,Yes,No,Obesity,1.0
PT03834,France,Provence-Alpes-Côte d'Azur,45.0,Female,Lung,III,2011-08-18,2011-09-13,2012-01-09,,Public,Deceased,25.0,None,No,,None,34.7,Medium,Urban,Private Insurance,17.0,Yes,No,Obesity,1.0
PT03835,Austria,Tyrol,29.0,Male,Prostate,III,2016-01-27,2016-06-29,2016-10-28,Immunotherapy,Public,Alive,99.0,BRCA1,Yes,Former,None,29.1,Medium,Rural,Private Insurance,14.0,No,No,Diabetes,9.0
PT03836,Sweden,Skåne,36.0,Male,Ovarian,IV,2013-09-10,2013-12-26,2014-04-07,Targeted Therapy,Private,Alive,94.0,KRAS,Yes,Former,None,,High,Urban,Private Insurance,15.0,No,Yes,,5.0
PT03837,Spain,Andalusia,21.0,Female,Colorectal,I,,2018-02-28,2018-12-15,Radiation,Private,Deceased,62.0,EGFR,Yes,Current,Moderate,20.2,Medium,Rural,NHS,18.0,No,No,Obesity,4.0
PT03838,Poland,Silesian,46.0,Male,Lung,I,2010-08-16,2010-11-12,2011-10-20,Targeted Therapy,Public,Alive,32.0,KRAS,No,Never,Moderate,19.7,High,,Private Insurance,12.0,No,No,Obesity,1.0
PT03839,Austria,Tyrol,67.0,Female,Pancreatic,IV,2010-01-05,2010-04-20,2010-08-07,Immunotherapy,Private,Alive,69.0,EGFR,No,Never,Moderate,18.4,,Urban,NHS,18.0,Yes,No,Cardiovascular Disease,4.0
PT03840,,Brussels,28.0,Male,Lung,I,2010-06-01,2010-08-13,2010-10-10,Radiation,Public,Alive,25.0,BRCA1,No,Current,None,19.6,High,Urban,NHS,15.0,No,No,None,9.0
PT03841,Norway,Oslo,42.0,Male,Breast,,2016-03-18,2016-07-12,2017-04-02,Immunotherapy,Private,Lost to Follow-up,,None,Yes,Former,Moderate,34.6,Low,Urban,NHS,11.0,No,No,Cardiovascular Disease,1.0
PT03842,Portugal,Porto,46.0,Male,Colorectal,I,2021-08-23,2022-01-02,,Chemotherapy,Private,Deceased,85.0,KRAS,,Former,Heavy,35.0,Low,Urban,NHS,3.0,No,No,Obesity,5.0
PT03843,Netherlands,South Holland,62.0,Female,Colorectal,III,2019-02-12,2019-02-13,2019-08-12,Targeted Therapy,,,9.0,KRAS,No,Current,,25.8,Low,Rural,Private Insurance,1.0,No,No,None,1.0
PT03844,Denmark,Zealand,,Female,Leukemia,I,2018-06-05,2018-10-17,2019-01-11,Radiation,Private,Alive,78.0,KRAS,No,Never,Moderate,18.7,Medium,Urban,NHS,6.0,No,No,Hypertension,1.0
PT03845,Ireland,Munster,82.0,Female,Lung,III,2016-05-14,2016-06-12,2016-12-04,Radiation,Private,Alive,76.0,BRCA1,No,Never,None,20.8,Medium,Urban,Private Insurance,15.0,,Yes,Diabetes,9.0
PT03846,Italy,Lombardy,63.0,Male,Leukemia,II,2020-11-15,2021-03-26,2021-09-04,Immunotherapy,Public,Deceased,52.0,None,No,Current,None,29.2,Medium,Urban,NHS,9.0,No,No,Cardiovascular Disease,5.0
PT03847,Portugal,Algarve,58.0,Male,Breast,IV,2012-10-01,2013-02-06,2013-08-01,Immunotherapy,Public,Deceased,25.0,BRCA1,No,Never,Heavy,,Medium,Rural,NHS,2.0,No,No,,9.0
PT03848,Denmark,Zealand,59.0,Female,Leukemia,I,2023-08-17,2023-12-04,2024-08-18,Surgery,Private,Alive,46.0,EGFR,Yes,Former,None,20.7,Medium,Urban,,2.0,No,No,Cardiovascular Disease,3.0
PT03849,Denmark,Capital Region,26.0,Male,,,2020-01-09,2020-04-06,2020-11-17,Surgery,Public,Alive,110.0,EGFR,Yes,Never,None,21.4,Medium,,Private Insurance,10.0,No,No,,9.0
PT03850,Spain,Catalonia,89.0,,Lung,I,2019-08-20,,2020-05-29,Targeted Therapy,Research Institute,Alive,66.0,None,No,Former,Moderate,26.9,Medium,Urban,NHS,5.0,No,No,Hypertension,9.0
PT03851,Ireland,Connacht,44.0,Female,Lung,IV,2023-11-27,2024-04-12,2024-06-30,Radiation,Private,Alive,101.0,,No,Never,Moderate,31.5,Medium,Urban,Private Insurance,8.0,Yes,No,Hypertension,10.0
PT03852,,Stockholm,78.0,Male,Colorectal,II,2012-09-21,2012-12-11,2013-12-07,Immunotherapy,Public,Alive,70.0,BRCA1,,Former,None,26.6,Low,Urban,NHS,2.0,No,No,Hypertension,4.0
PT03853,Spain,Andalusia,32.0,Female,Ovarian,II,2014-10-03,2014-12-01,2015-09-20,Targeted Therapy,Public,Deceased,78.0,BRCA1,No,Former,None,31.8,Medium,,Statutory Health Insurance,4.0,No,No,Obesity,
PT03854,Poland,Masovian,81.0,Male,Leukemia,I,2014-06-11,2014-07-19,2015-03-18,Radiation,Private,Alive,45.0,KRAS,No,Never,Moderate,19.4,Low,Urban,Private Insurance,,No,Yes,Cardiovascular Disease,10.0
PT03855,Italy,Sicily,27.0,,Colorectal,II,2017-03-12,2017-04-23,2017-09-08,Immunotherapy,Private,Deceased,88.0,None,Yes,Never,Moderate,21.9,Medium,Rural,Statutory Health Insurance,4.0,No,No,None,1.0
PT03856,Portugal,Lisbon,64.0,Male,Pancreatic,II,2015-05-08,2015-06-27,2015-08-28,Surgery,Public,Deceased,45.0,BRCA1,Yes,Never,Moderate,19.6,Medium,Urban,Statutory Health Insurance,3.0,,No,None,6.0
PT03857,France,Île-de-France,37.0,Male,Leukemia,II,2022-11-22,2022-12-06,2023-04-16,Radiation,,Deceased,105.0,KRAS,No,Never,None,37.3,Medium,Urban,Statutory Health Insurance,1.0,No,No,Cardiovascular Disease,8.0
PT03858,Austria,Vienna,79.0,Female,Ovarian,III,2019-07-25,2019-11-28,,Immunotherapy,Private,,,KRAS,Yes,,Moderate,35.6,Low,Rural,Statutory Health Insurance,16.0,No,No,Obesity,4.0
PT03859,Belgium,Brussels,79.0,Female,Leukemia,I,2015-04-10,2015-07-19,2016-04-10,Targeted Therapy,Private,Alive,59.0,KRAS,,Former,Moderate,23.9,Medium,Urban,NHS,7.0,No,,None,4.0
PT03860,Spain,Andalusia,21.0,Female,Ovarian,III,2010-06-22,2010-12-12,2011-05-17,Targeted Therapy,Public,Alive,103.0,BRCA1,Yes,Former,None,34.6,,Rural,,1.0,No,No,None,2.0
PT03861,Ireland,Dublin,85.0,Female,Ovarian,III,2013-04-07,2013-05-10,2014-01-16,Chemotherapy,Private,Deceased,28.0,EGFR,No,Never,Moderate,35.8,Medium,Urban,NHS,15.0,Yes,No,Diabetes,
PT03862,Germany,Bavaria,,Female,Breast,IV,2013-01-31,2013-06-28,2014-02-07,Radiation,Private,Alive,70.0,None,No,Current,Moderate,,High,Urban,NHS,16.0,No,No,Cardiovascular Disease,
PT03863,Finland,Pirkanmaa,67.0,,Leukemia,III,2010-08-16,2011-01-25,2011-09-02,Targeted Therapy,Public,Deceased,41.0,None,No,Never,None,,Medium,Urban,Private Insurance,15.0,Yes,Yes,Cardiovascular Disease,2.0
PT03864,Norway,Trøndelag,75.0,Female,Colorectal,I,2019-12-23,2020-02-28,2020-06-30,Radiation,Public,Alive,61.0,None,No,Current,Moderate,39.3,High,Urban,Private Insurance,11.0,No,No,None,10.0
PT03865,Austria,Vienna,31.0,Female,Pancreatic,III,2015-06-10,2015-09-02,2016-06-16,Targeted Therapy,Private,Alive,92.0,KRAS,No,Former,None,37.6,Medium,Rural,Private Insurance,9.0,No,Yes,Cardiovascular Disease,9.0
PT03866,,,74.0,Male,Ovarian,I,2020-03-17,2020-05-23,2021-04-25,Radiation,Public,Lost to Follow-up,,BRCA1,Yes,Never,Moderate,33.6,Low,Urban,Private Insurance,5.0,Yes,No,Obesity,3.0
PT03867,Denmark,Zealand,47.0,Female,Leukemia,I,2013-05-19,2013-07-28,2013-10-09,Radiation,Public,Deceased,69.0,EGFR,Yes,Former,Moderate,18.7,Medium,Urban,NHS,9.0,No,,Diabetes,7.0
PT03868,France,Provence-Alpes-Côte d'Azur,23.0,Female,Leukemia,III,2020-04-24,2020-10-08,2021-09-18,Radiation,Private,Alive,98.0,BRCA1,No,Former,Moderate,34.2,Medium,Urban,,7.0,No,No,Obesity,5.0
PT03869,Sweden,Skåne,55.0,Male,Lung,,2022-08-22,2023-02-09,2023-05-07,Chemotherapy,Public,Alive,92.0,None,No,Former,None,31.8,Medium,Urban,NHS,5.0,No,No,Hypertension,8.0
PT03870,Portugal,Porto,69.0,Female,Lung,I,2020-03-04,2020-08-18,2020-12-20,Surgery,Private,Deceased,52.0,BRCA1,Yes,Never,None,38.8,Medium,Rural,Statutory Health Insurance,16.0,No,No,Diabetes,4.0
PT03871,Spain,Andalusia,22.0,Male,Pancreatic,I,2022-05-19,2022-09-09,2023-02-27,Radiation,,Deceased,92.0,EGFR,No,,Moderate,28.0,Medium,Urban,Private Insurance,11.0,No,No,Cardiovascular Disease,9.0
PT03872,Austria,Styria,20.0,Male,Ovarian,II,2015-10-23,2016-01-16,,Surgery,Public,Deceased,47.0,None,No,Former,None,,Low,Rural,Private Insurance,9.0,No,No,None,6.0
PT03873,Finland,,,Male,Lung,,2010-12-09,2011-04-03,2011-05-07,Surgery,Public,Alive,32.0,KRAS,No,Never,Moderate,30.5,Low,Urban,Statutory Health Insurance,3.0,No,No,Hypertension,8.0
PT03874,Denmark,,81.0,Female,Prostate,III,2022-03-25,2022-05-08,2023-02-08,,Research Institute,Alive,96.0,None,Yes,Never,Moderate,18.5,Low,Urban,Statutory Health Insurance,19.0,No,No,None,7.0
PT03875,,Zurich,67.0,Male,Lung,I,2018-01-10,2018-05-19,2018-10-18,Targeted Therapy,Public,Alive,108.0,KRAS,Yes,,None,22.7,Medium,Urban,NHS,10.0,No,No,Cardiovascular Disease,3.0
PT03876,Poland,Silesian,81.0,Female,Prostate,I,2021-10-27,2022-02-01,,Immunotherapy,Private,Alive,96.0,KRAS,No,Current,Moderate,22.0,Low,Rural,Statutory Health Insurance,9.0,Yes,No,Obesity,1.0
,Austria,Tyrol,88.0,Female,Pancreatic,II,2022-12-19,2023-02-07,2023-06-30,Surgery,Public,Alive,28.0,EGFR,No,Never,,25.8,High,Rural,NHS,13.0,No,No,Obesity,3.0
PT03878,Sweden,Västra Götaland,38.0,,Prostate,IV,2013-09-20,2014-01-18,2014-10-21,Radiation,Research Institute,Deceased,92.0,None,No,,Moderate,24.1,Low,Urban,Private Insurance,2.0,No,No,Hypertension,6.0
PT03879,France,Provence-Alpes-Côte d'Azur,53.0,Male,Pancreatic,III,2016-08-18,2016-12-12,2017-01-28,Immunotherapy,Public,Alive,90.0,EGFR,No,Former,None,,High,Rural,NHS,10.0,Yes,No,,5.0
PT03880,France,Auvergne-Rhône-Alpes,68.0,Female,Colorectal,III,2023-03-26,2023-05-27,2023-12-15,Targeted Therapy,Public,Deceased,76.0,BRCA1,No,Never,Moderate,19.6,Medium,Urban,Private Insurance,13.0,No,,None,4.0
,Finland,Pirkanmaa,66.0,Female,Lung,I,2018-09-10,2018-09-13,2019-05-28,Chemotherapy,Public,Deceased,,EGFR,No,Former,Moderate,21.4,Medium,Urban,Statutory Health Insurance,7.0,No,No,None,3.0
PT03882,Norway,Oslo,69.0,Female,Leukemia,IV,2012-01-08,2012-05-23,2013-01-30,Surgery,Private,Alive,50.0,None,No,Never,Heavy,29.1,Low,Urban,NHS,7.0,No,No,Obesity,
PT03883,Netherlands,Utrecht,45.0,Female,Ovarian,II,2022-10-05,2022-11-22,2023-07-19,Surgery,Private,Alive,89.0,EGFR,No,Former,Moderate,29.2,High,,Private Insurance,13.0,No,No,Diabetes,10.0
PT03884,Poland,Lesser Poland,75.0,Female,Breast,IV,2012-10-23,2013-02-14,2013-11-14,Targeted Therapy,Research Institute,Alive,37.0,None,Yes,,Moderate,20.1,,Urban,Private Insurance,4.0,No,Yes,,5.0
PT03885,Spain,Catalonia,33.0,Female,Ovarian,II,2022-09-14,2022-12-19,2023-01-26,Radiation,Public,Alive,44.0,EGFR,Yes,Current,,31.3,,Urban,Statutory Health Insurance,5.0,No,No,Obesity,6.0
PT03886,Poland,Masovian,44.0,Male,Leukemia,I,2013-01-08,,2013-11-24,Radiation,Private,Alive,59.0,KRAS,Yes,Former,None,39.5,,Urban,Private Insurance,19.0,No,No,None,4.0
,Austria,Vienna,23.0,Male,Lung,I,2017-05-07,2017-10-18,2018-09-10,Immunotherapy,Public,,49.0,BRCA1,Yes,Former,Moderate,26.6,High,Urban,Statutory Health Insurance,1.0,Yes,No,Obesity,2.0
PT03888,Belgium,Wallonia,51.0,Male,Leukemia,II,2023-07-16,2023-09-11,2024-08-31,Immunotherapy,Private,Alive,69.0,BRCA1,Yes,Current,,21.6,Low,Urban,Statutory Health Insurance,,No,No,None,3.0
PT03889,Germany,North Rhine-Westphalia,84.0,Male,Lung,I,2011-01-31,2011-04-26,2012-04-17,Radiation,Public,Alive,75.0,None,No,Former,None,39.9,Low,Urban,Statutory Health Insurance,11.0,Yes,No,,2.0
PT03890,Belgium,Wallonia,80.0,Female,Ovarian,IV,2018-01-18,2018-04-18,,Chemotherapy,Private,Lost to Follow-up,,None,No,Never,Moderate,29.6,Low,,Private Insurance,3.0,No,Yes,Obesity,1.0
PT03891,France,Auvergne-Rhône-Alpes,39.0,Female,Lung,I,2022-04-12,2022-08-09,,Radiation,Research Institute,Alive,87.0,None,Yes,Former,Moderate,23.3,Medium,Urban,Statutory Health Insurance,12.0,No,No,Diabetes,4.0
PT03892,Belgium,Flanders,29.0,Non-binary,Leukemia,II,2019-02-14,2019-05-03,2019-07-02,Chemotherapy,Public,Alive,11.0,EGFR,No,Current,,37.3,Medium,,Statutory Health Insurance,6.0,Yes,No,Obesity,2.0
PT03893,Italy,Sicily,53.0,Female,Prostate,I,2014-03-15,2014-09-02,2015-01-31,Targeted Therapy,Private,Alive,13.0,BRCA1,No,Current,,20.8,Medium,Urban,NHS,2.0,No,No,Obesity,5.0
PT03894,Ireland,Munster,80.0,Female,Colorectal,I,2010-02-14,2010-03-14,2011-01-12,Chemotherapy,Private,Alive,119.0,BRCA1,Yes,Never,Moderate,22.1,Medium,Rural,NHS,16.0,Yes,No,Hypertension,1.0
PT03895,Ireland,Connacht,46.0,Male,Colorectal,III,2015-06-03,2015-09-03,,Targeted Therapy,Private,Alive,71.0,BRCA1,No,Former,None,34.7,High,Rural,NHS,15.0,No,No,Diabetes,8.0
PT03896,Ireland,Dublin,59.0,Female,Colorectal,II,2015-02-08,2015-05-04,2015-11-24,Surgery,Private,Alive,45.0,BRCA1,Yes,Former,Moderate,38.0,High,Rural,Statutory Health Insurance,12.0,No,No,Diabetes,6.0
PT03897,Ireland,Munster,84.0,Male,Colorectal,,2014-12-13,2015-04-04,2016-02-20,Radiation,Public,Deceased,115.0,BRCA1,No,,Moderate,27.5,Medium,Urban,Statutory Health Insurance,6.0,No,Yes,Hypertension,7.0
PT03898,Austria,Styria,52.0,Male,Breast,I,2016-03-24,2016-07-20,2017-03-15,Immunotherapy,Public,Alive,68.0,None,No,Never,None,19.5,Medium,Urban,Statutory Health Insurance,9.0,No,No,Cardiovascular Disease,6.0
PT03899,Netherlands,South Holland,87.0,Female,Pancreatic,IV,2022-03-03,2022-08-07,2023-04-17,Surgery,Private,Alive,89.0,,Yes,Former,Heavy,31.7,,Urban,NHS,14.0,No,Yes,Hypertension,10.0
PT03900,Spain,Andalusia,28.0,Male,Lung,II,2015-12-01,2016-01-08,2016-02-25,Immunotherapy,Public,Deceased,47.0,None,No,,Moderate,34.8,High,,Private Insurance,2.0,No,No,None,1.0
PT03901,Poland,Masovian,35.0,Male,Breast,IV,2018-06-29,2018-12-08,2019-08-11,Chemotherapy,,Alive,82.0,BRCA1,No,Current,Heavy,29.6,,Urban,Private Insurance,10.0,No,No,Diabetes,4.0
,Spain,Andalusia,24.0,Female,Colorectal,I,2016-05-12,2016-07-16,2016-11-15,Radiation,Public,Alive,107.0,EGFR,No,Former,Heavy,,Medium,Urban,Private Insurance,16.0,No,,None,9.0
PT03903,Austria,Vienna,42.0,Male,Colorectal,III,2019-05-27,2019-10-22,2020-01-12,Radiation,Private,Lost to Follow-up,,None,No,Never,None,32.9,Medium,Rural,NHS,1.0,No,No,None,6.0
PT03904,Belgium,Brussels,62.0,,Ovarian,,2023-03-15,2023-04-10,2023-07-23,Radiation,Private,Alive,77.0,KRAS,No,Current,Moderate,,Low,Urban,NHS,18.0,No,,Cardiovascular Disease,2.0
PT03905,Ireland,Munster,76.0,Male,Leukemia,II,2019-08-09,2019-09-05,2020-02-13,Surgery,Private,Deceased,95.0,BRCA1,Yes,Never,,35.2,Medium,,Private Insurance,6.0,No,No,Hypertension,5.0
PT03906,France,Auvergne-Rhône-Alpes,70.0,Male,Colorectal,I,2012-03-14,2012-08-12,2012-10-26,Targeted Therapy,,Deceased,67.0,EGFR,No,Never,,18.1,Low,Urban,Private Insurance,10.0,No,No,Obesity,
PT03907,Portugal,,32.0,Male,Lung,III,2015-09-01,2015-09-23,2015-11-27,Chemotherapy,Private,Alive,79.0,,Yes,Former,Moderate,31.4,Medium,Urban,Statutory Health Insurance,2.0,No,No,None,4.0
PT03908,Netherlands,North Holland,43.0,,Ovarian,,2022-04-08,2022-09-30,2023-03-10,,Private,Alive,78.0,KRAS,No,Never,Heavy,36.6,Low,Rural,NHS,19.0,No,No,Cardiovascular Disease,7.0
PT03909,France,Île-de-France,,Male,Colorectal,II,,2011-08-15,2012-01-21,Surgery,Private,Alive,97.0,KRAS,Yes,Former,Moderate,33.0,Medium,Urban,Private Insurance,18.0,No,,Obesity,7.0
PT03910,Switzerland,Geneva,71.0,,Colorectal,,,2014-03-27,2014-10-09,Targeted Therapy,Public,Alive,12.0,BRCA1,No,Former,None,30.5,High,Rural,Statutory Health Insurance,2.0,No,No,Diabetes,8.0
PT03911,Denmark,Zealand,36.0,Male,Breast,III,2018-01-14,2018-03-24,2018-12-21,Immunotherapy,Public,Lost to Follow-up,,EGFR,No,Former,Heavy,22.9,Medium,Urban,Private Insurance,12.0,Yes,,Cardiovascular Disease,
PT03912,Spain,Madrid,56.0,Female,Lung,IV,2014-08-31,2014-11-21,2015-08-02,Immunotherapy,Private,Alive,6.0,None,Yes,Never,Moderate,30.1,Medium,Urban,Statutory Health Insurance,18.0,Yes,No,Obesity,3.0
PT03913,Spain,Andalusia,32.0,Female,Prostate,I,2021-10-26,2022-02-01,2022-12-27,Radiation,Public,Alive,102.0,BRCA1,No,Never,Moderate,35.9,Medium,Urban,NHS,5.0,Yes,Yes,Cardiovascular Disease,2.0
PT03914,Finland,Uusimaa,81.0,Female,Leukemia,II,2020-01-14,2020-01-29,2020-05-28,Surgery,Private,Deceased,48.0,BRCA1,Yes,Former,None,36.9,High,Urban,Statutory Health Insurance,15.0,No,No,Hypertension,10.0
PT03915,Denmark,Capital Region,27.0,,Prostate,,2015-07-06,2015-11-09,2016-09-30,Targeted Therapy,Private,Alive,118.0,EGFR,No,Never,Moderate,32.0,High,Urban,Statutory Health Insurance,18.0,No,No,Hypertension,5.0
PT03916,Netherlands,Utrecht,75.0,Female,Pancreatic,III,2022-10-31,2023-02-22,2023-07-23,Targeted Therapy,,Alive,18.0,BRCA1,No,Never,Moderate,39.7,Medium,Urban,Statutory Health Insurance,15.0,No,No,None,9.0
PT03917,Sweden,Stockholm,89.0,Male,Breast,IV,,2023-09-22,2024-08-10,Immunotherapy,Public,Deceased,103.0,None,Yes,Never,None,20.6,High,Urban,Statutory Health Insurance,1.0,No,No,Cardiovascular Disease,5.0
PT03918,Norway,Vestland,63.0,Female,Colorectal,,2018-11-05,,2019-12-04,Targeted Therapy,Private,Alive,16.0,,No,Never,None,33.0,Medium,Urban,Statutory Health Insurance,2.0,,No,,
PT03919,Finland,Pirkanmaa,79.0,,Leukemia,,2010-05-23,2010-07-13,2010-12-03,Immunotherapy,Public,Deceased,116.0,None,No,Current,None,19.0,Low,,NHS,3.0,No,No,Hypertension,3.0
PT03920,Netherlands,Utrecht,,Male,Pancreatic,,2015-01-24,2015-06-26,2015-08-05,Immunotherapy,Public,Alive,117.0,None,No,Never,None,36.8,High,Urban,Private Insurance,10.0,No,No,None,5.0
PT03921,Denmark,Zealand,40.0,Male,Pancreatic,IV,2021-01-03,2021-05-28,2021-12-30,Surgery,Private,Alive,98.0,None,No,Former,Heavy,35.1,Medium,Urban,Statutory Health Insurance,15.0,No,No,Diabetes,6.0
PT03922,France,Auvergne-Rhône-Alpes,61.0,Male,Lung,II,2010-02-14,2010-05-22,2010-09-06,Chemotherapy,,Alive,117.0,BRCA1,Yes,Never,Moderate,35.9,Medium,Urban,Statutory Health Insurance,6.0,Yes,No,Obesity,4.0
PT03923,France,Île-de-France,48.0,Female,Leukemia,IV,2011-03-27,2011-05-18,2011-08-25,Radiation,Public,Deceased,116.0,EGFR,Yes,Former,Heavy,26.0,High,Rural,Private Insurance,15.0,No,No,None,3.0
PT03924,Ireland,Munster,84.0,Male,Pancreatic,III,2013-06-13,2013-08-10,2014-07-04,Chemotherapy,Public,Deceased,96.0,KRAS,No,Current,Moderate,22.7,Medium,Rural,Private Insurance,18.0,No,Yes,Cardiovascular Disease,9.0
PT03925,Belgium,Flanders,36.0,Male,Breast,I,2012-09-30,2013-03-15,2013-07-26,Targeted Therapy,,Alive,40.0,,No,Never,,22.7,Low,,Statutory Health Insurance,16.0,No,Yes,Obesity,4.0
PT03926,Switzerland,Zurich,49.0,Male,Colorectal,I,2023-01-30,,2023-12-09,Chemotherapy,Public,Alive,43.0,KRAS,No,Former,Moderate,38.0,Low,Urban,Private Insurance,17.0,Yes,No,None,3.0
PT03927,Netherlands,South Holland,45.0,Female,Breast,,2019-03-06,2019-07-07,2019-12-01,Chemotherapy,Public,Alive,94.0,None,Yes,,Moderate,29.5,Medium,,Private Insurance,6.0,No,,None,7.0
PT03928,Ireland,Dublin,72.0,Male,Ovarian,III,2015-06-20,2015-07-27,2015-08-30,Immunotherapy,Public,Alive,116.0,None,Yes,Current,Moderate,22.2,Low,Urban,NHS,10.0,No,No,Hypertension,7.0
PT03929,,Dublin,38.0,Male,Pancreatic,III,2020-01-23,2020-04-07,2020-10-07,Surgery,Private,Alive,109.0,None,No,Never,None,19.7,Low,Urban,Statutory Health Insurance,3.0,No,No,Cardiovascular Disease,5.0
PT03930,Netherlands,North Holland,72.0,Female,Lung,I,2019-07-21,2019-11-06,2020-07-02,Targeted Therapy,Research Institute,Alive,50.0,KRAS,Yes,Never,None,27.2,High,Urban,Statutory Health Insurance,16.0,Yes,,Cardiovascular Disease,10.0
PT03931,Germany,Berlin,36.0,Female,Prostate,III,2023-05-21,2023-10-30,2024-09-11,Radiation,Public,Alive,,,No,Former,None,21.0,Medium,Urban,Statutory Health Insurance,19.0,No,No,None,6.0
PT03932,,Zurich,65.0,Female,Colorectal,I,2020-01-02,2020-02-06,2021-01-03,Immunotherapy,Public,Deceased,20.0,BRCA1,Yes,Current,Moderate,25.8,Medium,Rural,NHS,10.0,No,No,None,6.0
PT03933,Italy,Sicily,72.0,Female,Colorectal,III,2018-04-21,2018-05-30,2018-09-26,Radiation,Public,Alive,,None,No,Former,Moderate,21.0,Medium,Rural,NHS,,No,,None,3.0
PT03934,Poland,Masovian,,Male,Breast,,2014-02-03,2014-07-27,2014-10-14,Surgery,Public,Alive,71.0,None,No,Former,None,29.9,Medium,Urban,Statutory Health Insurance,3.0,No,No,Diabetes,5.0
PT03935,Portugal,Algarve,64.0,Male,Breast,IV,2012-12-08,2013-04-05,2013-11-22,Chemotherapy,Public,,19.0,None,No,,None,19.4,High,Urban,Statutory Health Insurance,10.0,No,No,Diabetes,8.0
PT03936,Italy,Sicily,68.0,Male,Breast,I,2021-04-05,2021-08-27,2022-02-28,Chemotherapy,Public,Alive,19.0,EGFR,,Current,Heavy,19.3,Low,Rural,Private Insurance,13.0,No,No,Cardiovascular Disease,10.0
PT03937,Belgium,Wallonia,38.0,Female,Pancreatic,IV,2021-08-15,2021-11-11,2022-03-15,Surgery,Public,Alive,115.0,BRCA1,Yes,Never,Moderate,36.0,Low,Rural,Statutory Health Insurance,8.0,No,No,Hypertension,1.0
PT03938,Austria,Tyrol,84.0,Male,Colorectal,II,2014-04-28,2014-10-04,2015-01-20,Targeted Therapy,Public,Alive,46.0,None,Yes,Never,Moderate,19.8,Low,Rural,Private Insurance,4.0,,No,None,10.0
PT03939,Switzerland,Bern,56.0,Female,Breast,II,2013-05-20,2013-06-03,2014-01-01,Immunotherapy,Public,Alive,29.0,None,Yes,Never,Moderate,39.3,Medium,Rural,Private Insurance,2.0,No,Yes,,2.0
PT03940,,,89.0,Non-binary,Ovarian,II,2014-10-06,2014-11-22,2015-10-31,Chemotherapy,Public,Deceased,10.0,,No,Former,Moderate,30.7,High,Urban,Statutory Health Insurance,,No,No,Cardiovascular Disease,6.0
PT03941,Germany,Bavaria,,Male,Leukemia,III,2012-10-12,2013-03-21,2013-10-04,Surgery,Public,Deceased,39.0,EGFR,No,Never,Moderate,24.5,Medium,Urban,,17.0,No,No,Diabetes,4.0
PT03942,Ireland,Dublin,21.0,Male,Pancreatic,IV,2023-03-06,2023-06-21,2024-01-22,Immunotherapy,Private,Alive,113.0,None,No,Never,Moderate,24.0,Medium,Rural,NHS,13.0,No,No,Diabetes,10.0
PT03943,Finland,Southwest Finland,78.0,Male,Pancreatic,II,2018-02-13,2018-05-01,2019-04-23,Immunotherapy,Public,Alive,37.0,KRAS,No,Never,None,32.6,Medium,Urban,Private Insurance,2.0,No,No,Cardiovascular Disease,1.0
PT03944,Netherlands,South Holland,24.0,Male,Leukemia,IV,2014-04-09,2014-07-20,2015-07-14,Surgery,Public,Alive,97.0,EGFR,No,Never,Moderate,37.0,High,Rural,Private Insurance,8.0,No,No,None,5.0
PT03945,,Skåne,56.0,Male,,I,2014-04-18,2014-05-05,2014-11-23,Chemotherapy,Public,Deceased,,KRAS,No,Former,Moderate,29.5,Low,Urban,Private Insurance,8.0,No,No,Hypertension,10.0
PT03946,Norway,Trøndelag,50.0,Female,Pancreatic,II,2015-06-10,2015-10-12,2016-03-27,,Public,Deceased,82.0,KRAS,Yes,Never,None,34.8,Medium,Urban,NHS,,Yes,No,Diabetes,10.0
PT03947,Norway,Oslo,67.0,Male,Colorectal,II,2014-02-19,2014-06-23,2015-02-17,Chemotherapy,Private,Alive,21.0,BRCA1,No,Never,None,38.6,Medium,Urban,Private Insurance,14.0,,No,Diabetes,10.0
PT03948,Belgium,Flanders,25.0,Male,Breast,II,2022-07-12,2022-12-23,2023-11-21,Chemotherapy,Research Institute,Alive,,BRCA1,Yes,Never,None,,Low,Urban,NHS,3.0,No,No,None,7.0
PT03949,Norway,Oslo,34.0,Male,Ovarian,IV,2020-07-23,2020-11-17,2021-07-24,Chemotherapy,,Deceased,,None,Yes,Former,Moderate,27.3,Low,Urban,Statutory Health Insurance,14.0,No,Yes,None,2.0
PT03950,Ireland,Munster,34.0,Female,Lung,III,2014-09-08,2015-02-25,2015-10-02,Chemotherapy,Public,Lost to Follow-up,,KRAS,No,Former,Moderate,20.4,Medium,Urban,Private Insurance,4.0,Yes,Yes,Diabetes,2.0
PT03951,Italy,Veneto,80.0,Female,Breast,II,2021-05-02,2021-07-23,2022-06-01,Radiation,Research Institute,Alive,92.0,KRAS,,Former,Heavy,33.2,Medium,Urban,Private Insurance,4.0,,No,Obesity,4.0
PT03952,Finland,Uusimaa,35.0,Female,Colorectal,III,2019-08-29,2020-01-23,2020-06-14,Surgery,Public,Alive,37.0,None,,Current,None,36.7,Medium,Urban,Private Insurance,11.0,No,No,None,9.0
PT03953,Spain,Catalonia,39.0,Non-binary,Leukemia,II,2023-08-11,2023-12-24,2024-02-11,Targeted Therapy,Public,Alive,81.0,None,No,Never,Moderate,18.4,High,Urban,NHS,5.0,,No,None,8.0
PT03954,Switzerland,Bern,63.0,,Colorectal,I,2020-08-04,2020-09-28,2021-01-23,Targeted Therapy,Public,Deceased,46.0,EGFR,No,Never,Heavy,32.2,Medium,Rural,Statutory Health Insurance,7.0,Yes,No,Hypertension,1.0
PT03955,Finland,Uusimaa,61.0,Male,Breast,II,2022-03-10,,2023-08-05,Radiation,Public,Alive,27.0,None,No,Never,None,19.5,Medium,Urban,Private Insurance,12.0,Yes,No,None,1.0
PT03956,Belgium,Brussels,65.0,Male,Ovarian,III,2022-07-06,2022-09-20,2023-08-12,Targeted Therapy,Public,Alive,58.0,None,Yes,Never,None,38.7,Medium,Rural,Private Insurance,13.0,No,No,Diabetes,6.0
PT03957,Belgium,Brussels,53.0,Male,Colorectal,IV,2020-01-18,2020-05-17,2021-03-04,Radiation,Public,Alive,28.0,EGFR,No,Current,Moderate,27.1,Low,Rural,,1.0,Yes,No,Cardiovascular Disease,10.0
PT03958,Portugal,Algarve,83.0,Female,Lung,I,2019-12-24,2020-01-22,2020-03-21,Radiation,Private,Deceased,40.0,BRCA1,Yes,Former,,22.1,Low,Rural,Statutory Health Insurance,8.0,No,No,Diabetes,8.0
PT03959,,Dublin,48.0,Male,Colorectal,II,2015-12-01,2016-05-11,2016-08-02,Targeted Therapy,Private,Alive,94.0,KRAS,,Former,,22.4,Medium,Rural,Private Insurance,4.0,Yes,No,Obesity,
PT03960,Sweden,Västra Götaland,22.0,Male,Prostate,I,2014-02-10,2014-07-22,2015-02-11,Targeted Therapy,Research Institute,Alive,116.0,BRCA1,Yes,Former,Moderate,20.0,Medium,Urban,Statutory Health Insurance,1.0,No,No,Hypertension,6.0
PT03961,Norway,,28.0,Female,Colorectal,I,,2012-06-19,2013-03-25,Chemotherapy,Public,Deceased,48.0,EGFR,Yes,Never,Heavy,32.5,Low,Urban,Private Insurance,2.0,Yes,No,None,1.0
PT03962,Portugal,Algarve,44.0,Female,Breast,III,2021-02-17,2021-02-19,2021-03-30,Radiation,Private,Lost to Follow-up,,BRCA1,No,Never,Moderate,37.3,Medium,Urban,Private Insurance,10.0,No,No,Diabetes,2.0
PT03963,Portugal,Lisbon,61.0,Female,Prostate,I,2019-02-08,2019-07-13,2020-05-12,Immunotherapy,Public,Deceased,67.0,KRAS,,Former,Moderate,26.4,Low,Urban,NHS,3.0,No,No,Hypertension,7.0
PT03964,Germany,Berlin,65.0,Male,Leukemia,III,2022-04-24,2022-06-10,,Surgery,Public,Alive,50.0,KRAS,No,Never,Moderate,29.7,Medium,Urban,Statutory Health Insurance,1.0,No,No,Obesity,1.0
PT03965,Italy,Sicily,78.0,Female,Breast,II,2013-08-16,2013-11-24,2014-05-07,Chemotherapy,Public,Alive,99.0,KRAS,Yes,Never,None,23.7,Medium,Rural,Private Insurance,19.0,No,No,Cardiovascular Disease,7.0
PT03966,Denmark,Central Denmark,40.0,Female,Pancreatic,I,2010-01-05,2010-03-03,2010-06-01,Radiation,Public,Alive,62.0,None,Yes,Current,Moderate,35.1,High,Urban,NHS,9.0,No,No,Obesity,
,Norway,Oslo,41.0,Male,Lung,II,2019-08-19,2019-12-19,2020-01-31,Chemotherapy,Private,Alive,99.0,KRAS,Yes,Former,Moderate,32.3,Medium,Rural,Statutory Health Insurance,2.0,No,Yes,Hypertension,6.0
PT03968,Finland,Uusimaa,48.0,Female,Colorectal,I,2013-06-12,2013-11-04,2014-08-18,Chemotherapy,Public,Alive,72.0,None,Yes,Former,,40.0,Medium,Rural,Private Insurance,11.0,No,No,Diabetes,3.0
PT03969,Denmark,Central Denmark,82.0,Female,Colorectal,IV,2015-07-28,2015-11-03,2016-09-28,Surgery,Private,Alive,60.0,None,Yes,Never,Moderate,36.7,Medium,,Private Insurance,15.0,No,No,Hypertension,10.0
PT03970,Belgium,Flanders,80.0,Male,Breast,I,2010-07-19,2010-12-20,2011-10-21,Targeted Therapy,Private,Alive,36.0,None,No,Never,Heavy,,High,Urban,NHS,16.0,No,No,Hypertension,1.0
PT03971,Germany,North Rhine-Westphalia,83.0,Male,Colorectal,I,2014-09-02,2015-01-05,2015-03-01,Targeted Therapy,Public,Alive,105.0,KRAS,Yes,Former,Moderate,36.6,Low,Urban,NHS,17.0,No,No,Hypertension,8.0
PT03972,Ireland,Munster,88.0,Female,Colorectal,III,2020-10-16,2021-03-03,,Surgery,Public,Alive,59.0,EGFR,No,Never,,19.2,Medium,Urban,NHS,14.0,Yes,No,Cardiovascular Disease,2.0
PT03973,Poland,Masovian,59.0,Male,Leukemia,IV,,2020-11-14,2021-08-16,Chemotherapy,Public,Alive,41.0,BRCA1,Yes,Never,Moderate,21.3,Medium,Urban,Statutory Health Insurance,5.0,No,Yes,Cardiovascular Disease,5.0
PT03974,Ireland,Connacht,20.0,Female,Colorectal,IV,2015-08-31,2015-09-09,2016-03-07,,Private,Alive,40.0,None,No,Current,None,26.5,Medium,Urban,NHS,14.0,No,No,Cardiovascular Disease,9.0
PT03975,Spain,Catalonia,84.0,Male,Colorectal,I,2020-04-16,2020-05-11,2021-01-03,Targeted Therapy,Public,Alive,,BRCA1,No,Never,Moderate,22.2,Low,Urban,Statutory Health Insurance,5.0,No,No,Obesity,9.0
PT03976,Switzerland,Bern,81.0,Female,Leukemia,I,2018-08-12,2019-01-07,2019-07-08,,Public,Alive,27.0,None,No,Never,Moderate,24.3,Low,Rural,Private Insurance,19.0,Yes,No,Cardiovascular Disease,6.0
PT03977,Italy,Veneto,73.0,Female,Pancreatic,III,2017-10-14,2017-10-29,2018-03-23,Radiation,Public,Alive,20.0,BRCA1,No,Never,Moderate,33.6,Medium,Rural,Private Insurance,4.0,No,No,Diabetes,3.0
PT03978,Denmark,Central Denmark,79.0,Female,Colorectal,III,2016-01-06,2016-04-28,2016-12-14,Chemotherapy,Public,Alive,92.0,None,No,Never,Heavy,30.3,Low,Rural,Private Insurance,2.0,No,,,
,Switzerland,Zurich,65.0,Male,Pancreatic,II,2011-09-17,2011-12-17,2012-07-14,Immunotherapy,Private,Deceased,77.0,None,No,Former,None,26.8,Medium,Urban,NHS,17.0,Yes,No,Diabetes,7.0
PT03980,Germany,Bavaria,,Male,Leukemia,II,2015-11-04,2016-03-22,2017-01-26,Radiation,Public,Alive,55.0,None,Yes,Never,Moderate,32.2,Medium,Rural,Statutory Health Insurance,7.0,No,No,Diabetes,9.0
,,Tyrol,41.0,,Lung,I,2017-01-22,2017-06-15,2018-01-04,Surgery,Private,Alive,29.0,None,No,Never,None,18.0,Medium,Rural,NHS,7.0,No,No,Diabetes,1.0
PT03982,Denmark,Capital Region,72.0,,Colorectal,I,2011-11-23,2012-04-21,2012-10-22,Immunotherapy,,Alive,,EGFR,No,Never,Moderate,37.3,Medium,Rural,NHS,4.0,No,Yes,None,3.0
PT03983,Belgium,Flanders,89.0,Male,Breast,II,2017-02-10,2017-07-12,2018-06-25,Chemotherapy,Private,Alive,47.0,None,Yes,Never,None,26.7,High,Urban,NHS,8.0,No,No,,10.0
PT03984,Italy,,51.0,Female,Prostate,I,2012-03-24,2012-09-04,2013-01-26,,Public,Alive,45.0,EGFR,Yes,Current,None,28.8,Low,Urban,Statutory Health Insurance,14.0,No,No,Cardiovascular Disease,8.0
PT03985,Germany,North Rhine-Westphalia,30.0,Male,Lung,I,2014-06-16,2014-11-09,,Surgery,Public,Alive,54.0,None,No,Former,Moderate,20.6,Medium,Rural,Private Insurance,14.0,Yes,Yes,Obesity,7.0
PT03986,Sweden,Skåne,29.0,Female,Colorectal,I,2022-08-22,2023-01-17,2023-07-07,Targeted Therapy,Public,Deceased,102.0,None,No,Former,Heavy,34.7,Medium,Rural,NHS,6.0,Yes,No,None,7.0
PT03987,Sweden,Skåne,58.0,Male,Breast,II,2019-11-02,2019-11-10,2020-09-13,Targeted Therapy,Private,Alive,76.0,BRCA1,No,Former,None,39.9,Medium,Urban,Statutory Health Insurance,14.0,Yes,Yes,,7.0
PT03988,,Wallonia,50.0,Female,Prostate,I,2017-01-24,2017-02-08,2017-03-25,Targeted Therapy,Public,Alive,107.0,,No,Former,Moderate,34.9,Medium,Rural,NHS,3.0,No,Yes,Hypertension,2.0
PT03989,Switzerland,Geneva,31.0,Non-binary,Leukemia,II,2020-10-07,2020-12-23,2021-06-18,Surgery,Public,Alive,105.0,EGFR,No,Never,Heavy,21.1,Low,Rural,Statutory Health Insurance,4.0,No,No,Diabetes,5.0
PT03990,Switzerland,Geneva,57.0,Male,Colorectal,IV,2010-10-23,2011-02-25,2011-12-13,Radiation,Public,Alive,119.0,None,Yes,Never,Moderate,38.5,Medium,Urban,NHS,19.0,No,No,,
PT03991,Finland,Southwest Finland,86.0,Female,Ovarian,I,2018-11-26,2019-02-12,2019-04-11,Surgery,Public,Alive,14.0,None,No,Never,None,30.9,High,Urban,Private Insurance,11.0,No,No,None,6.0
,Denmark,Central Denmark,85.0,,,III,2013-02-28,2013-04-16,2014-01-30,Immunotherapy,Research Institute,Alive,103.0,BRCA1,No,Current,None,37.1,Medium,Urban,Statutory Health Insurance,8.0,No,No,Cardiovascular Disease,6.0
PT03993,Denmark,Zealand,71.0,Female,Pancreatic,III,2020-11-24,2021-03-23,2021-08-13,Radiation,Public,Alive,48.0,None,Yes,Former,None,27.3,Medium,Urban,Statutory Health Insurance,1.0,,Yes,Obesity,7.0
PT03994,Poland,Lesser Poland,24.0,Female,Leukemia,II,2011-06-17,2011-11-16,2011-12-23,Targeted Therapy,Research Institute,Deceased,67.0,BRCA1,Yes,Current,Moderate,24.1,Medium,Rural,Statutory Health Insurance,17.0,Yes,No,Diabetes,10.0
PT03995,Netherlands,South Holland,30.0,Male,Lung,I,2012-06-06,2012-07-23,2013-06-21,Surgery,Public,Alive,25.0,None,Yes,Never,Moderate,18.5,High,Urban,NHS,8.0,,No,Diabetes,3.0
PT03996,Netherlands,Utrecht,44.0,Male,Pancreatic,I,2018-12-17,2019-01-04,2019-10-15,Chemotherapy,Private,Alive,24.0,KRAS,No,Never,None,38.9,Medium,Urban,NHS,13.0,No,No,Obesity,8.0
PT03997,,Connacht,54.0,Male,Prostate,III,2018-01-04,2018-06-13,2018-10-04,,Public,Deceased,101.0,EGFR,Yes,Former,Moderate,21.4,Medium,Urban,NHS,15.0,No,No,Diabetes,5.0
PT03998,Belgium,Flanders,54.0,Female,Pancreatic,II,2016-08-29,2017-02-15,2017-04-01,Chemotherapy,Public,Alive,119.0,None,No,Never,None,35.2,Medium,Urban,Private Insurance,14.0,No,No,Diabetes,4.0
PT03999,Sweden,Skåne,41.0,Non-binary,Ovarian,I,2019-11-07,2020-02-11,2021-01-08,Radiation,Public,Alive,26.0,BRCA1,Yes,Never,Moderate,24.1,Medium,,,4.0,No,No,Hypertension,5.0
PT04000,Denmark,Central Denmark,56.0,Female,Ovarian,III,2016-08-17,2017-01-29,2017-12-11,Targeted Therapy,Public,Deceased,95.0,EGFR,Yes,Never,Moderate,30.6,Medium,Rural,NHS,18.0,No,No,Obesity,5.0
PT04001,Netherlands,Utrecht,74.0,Male,Prostate,III,2018-11-10,2018-12-13,2019-04-17,Surgery,Research Institute,Deceased,14.0,BRCA1,Yes,Former,Moderate,36.2,Medium,Rural,Private Insurance,18.0,No,No,Hypertension,7.0
PT04002,France,Île-de-France,83.0,Female,Pancreatic,I,2022-08-24,2022-12-31,2023-05-31,Chemotherapy,Public,Alive,105.0,BRCA1,No,Current,Moderate,25.7,High,Urban,NHS,12.0,No,No,Hypertension,1.0
PT04003,Germany,Bavaria,39.0,Female,Leukemia,III,2012-04-14,2012-07-15,2013-03-27,Surgery,Private,Alive,66.0,KRAS,Yes,Never,None,27.5,Low,Urban,Statutory Health Insurance,17.0,Yes,No,Diabetes,3.0
PT04004,Germany,Bavaria,23.0,Male,Leukemia,I,2013-10-09,2014-03-13,2014-05-10,Targeted Therapy,Public,Alive,39.0,EGFR,No,Never,Moderate,21.2,Medium,Urban,Statutory Health Insurance,9.0,No,No,,2.0
PT04005,Denmark,Zealand,37.0,Male,Pancreatic,III,2019-07-13,2019-07-30,2019-11-12,Surgery,Private,Alive,113.0,None,No,Former,Moderate,27.3,Medium,Urban,NHS,17.0,No,No,Diabetes,2.0
PT04006,Ireland,Connacht,70.0,,Ovarian,,2022-08-12,2022-09-27,2023-09-15,,Public,Alive,75.0,KRAS,No,Never,Heavy,36.2,High,Urban,Private Insurance,16.0,No,No,Obesity,3.0
,Sweden,Skåne,87.0,Female,Lung,,2010-07-31,2010-10-18,2011-03-15,Immunotherapy,Public,Alive,38.0,None,Yes,Current,Moderate,37.4,Low,Urban,Statutory Health Insurance,17.0,No,No,Obesity,3.0
PT04008,Norway,Vestland,39.0,Female,Breast,I,2012-07-15,2012-10-18,2013-05-06,Surgery,Public,Deceased,84.0,KRAS,,Former,Moderate,31.9,Low,Urban,Private Insurance,1.0,No,No,Cardiovascular Disease,3.0
PT04009,Spain,Catalonia,28.0,,Ovarian,II,2017-04-26,2017-10-05,2017-12-07,Immunotherapy,Public,Deceased,87.0,None,Yes,Never,None,28.3,High,Urban,Statutory Health Insurance,4.0,Yes,No,Hypertension,9.0
PT04010,Spain,Andalusia,45.0,Male,Pancreatic,I,2021-01-15,2021-01-18,2021-11-05,Chemotherapy,Public,Alive,92.0,BRCA1,Yes,Never,Moderate,22.5,Medium,Urban,NHS,3.0,No,No,Diabetes,3.0
PT04011,Portugal,Porto,44.0,Female,Ovarian,III,2010-12-11,2011-02-05,2012-01-05,Surgery,Public,Alive,64.0,EGFR,No,Never,None,28.0,Medium,Urban,Statutory Health Insurance,5.0,No,No,Cardiovascular Disease,4.0
PT04012,Portugal,Porto,87.0,Female,Ovarian,I,2018-06-10,2018-10-28,2019-06-02,,Public,Deceased,76.0,BRCA1,Yes,Never,Moderate,35.7,Medium,Urban,Statutory Health Insurance,15.0,No,No,None,3.0
PT04013,France,Provence-Alpes-Côte d'Azur,60.0,Female,Colorectal,I,2022-02-18,2022-03-16,2022-06-04,Chemotherapy,Public,Alive,19.0,EGFR,No,Never,None,24.8,,Rural,Statutory Health Insurance,17.0,No,No,Cardiovascular Disease,8.0
PT04014,Germany,Bavaria,78.0,Female,Breast,,2014-08-29,2015-01-28,2015-03-07,Surgery,Research Institute,Alive,83.0,None,No,Never,None,35.6,Low,Urban,Private Insurance,2.0,No,No,None,4.0
PT04015,Netherlands,South Holland,,Male,Ovarian,I,2022-11-14,2023-01-13,2023-06-24,Targeted Therapy,Research Institute,Alive,58.0,KRAS,No,Former,Moderate,18.1,Low,Urban,Statutory Health Insurance,14.0,No,No,Diabetes,5.0
PT04016,Norway,Oslo,60.0,Female,Pancreatic,III,2020-07-13,2020-09-09,2021-04-18,Immunotherapy,Public,Alive,59.0,KRAS,No,Current,None,25.7,Medium,Urban,Statutory Health Insurance,16.0,,Yes,Diabetes,7.0
PT04017,Switzerland,Zurich,57.0,,Ovarian,IV,2020-12-30,2021-01-07,2021-02-21,Radiation,Public,,89.0,,Yes,Former,Moderate,39.8,High,,Statutory Health Insurance,4.0,No,No,Cardiovascular Disease,5.0
PT04018,Ireland,,38.0,Female,Prostate,III,2010-10-23,,2011-06-22,,Research Institute,Alive,103.0,EGFR,No,Former,,38.0,Medium,Urban,Private Insurance,6.0,No,No,Diabetes,10.0
PT04019,Portugal,Porto,33.0,Male,Colorectal,IV,2017-07-11,2017-10-29,2018-05-30,Radiation,Public,,99.0,BRCA1,,Former,Moderate,32.2,Medium,Rural,Statutory Health Insurance,12.0,No,No,Obesity,4.0
PT04020,Belgium,Flanders,40.0,Female,Lung,I,2022-04-11,2022-09-24,2023-05-04,Chemotherapy,Research Institute,Alive,49.0,KRAS,No,Current,Moderate,28.8,,Rural,Statutory Health Insurance,,No,No,Diabetes,5.0
PT04021,France,Île-de-France,34.0,Male,Breast,I,2014-02-05,2014-03-26,2014-07-17,Chemotherapy,Public,Alive,34.0,KRAS,No,Current,None,,Low,Rural,Private Insurance,5.0,No,Yes,Cardiovascular Disease,10.0
PT04022,France,Provence-Alpes-Côte d'Azur,22.0,Female,Breast,II,2018-06-07,2018-07-20,2019-02-09,Surgery,Private,Deceased,12.0,EGFR,Yes,Never,None,39.6,Medium,Rural,Statutory Health Insurance,15.0,No,No,None,1.0
PT04023,Spain,Andalusia,56.0,Male,Colorectal,IV,2014-04-17,2014-05-08,2014-09-06,Targeted Therapy,Public,Alive,99.0,EGFR,Yes,Former,Moderate,18.7,Low,Urban,Statutory Health Insurance,14.0,No,No,Cardiovascular Disease,8.0
PT04024,Sweden,Västra Götaland,65.0,Male,Lung,III,2015-05-30,,2016-09-02,Radiation,Private,Alive,112.0,KRAS,No,Never,Moderate,24.1,Medium,Rural,NHS,14.0,Yes,No,Hypertension,8.0
PT04025,Switzerland,Geneva,35.0,Female,Ovarian,II,2021-04-25,2021-08-02,2021-11-01,Immunotherapy,Public,Alive,99.0,BRCA1,No,Never,Moderate,39.9,Medium,Urban,NHS,12.0,No,No,Cardiovascular Disease,10.0
PT04026,Spain,Madrid,33.0,Male,Pancreatic,I,2021-09-18,2022-01-27,2022-03-30,Targeted Therapy,Public,Alive,51.0,BRCA1,Yes,Current,Moderate,31.3,Low,Rural,Statutory Health Insurance,2.0,No,No,Obesity,9.0
PT04027,Denmark,Zealand,28.0,Female,Lung,I,2021-05-28,2021-08-25,2022-02-13,Chemotherapy,Private,Alive,115.0,BRCA1,Yes,Never,Moderate,,High,Rural,Private Insurance,10.0,No,No,None,1.0
PT04028,Sweden,Stockholm,26.0,Female,Pancreatic,II,2010-08-25,2011-02-01,2011-07-03,Targeted Therapy,Public,Lost to Follow-up,,EGFR,No,Never,None,34.6,Medium,Rural,Private Insurance,13.0,Yes,No,Hypertension,3.0
PT04029,,Connacht,33.0,Female,Breast,III,2011-04-09,2011-04-30,2011-09-21,Immunotherapy,,Deceased,95.0,EGFR,Yes,Never,None,26.7,,Urban,NHS,8.0,No,Yes,Obesity,10.0
PT04030,Italy,Lombardy,,Female,Ovarian,I,2021-09-26,2021-10-10,2022-01-27,Targeted Therapy,Private,,74.0,KRAS,Yes,Former,None,,Low,Rural,Private Insurance,15.0,Yes,Yes,Obesity,9.0
PT04031,Italy,Lombardy,34.0,Female,Pancreatic,IV,2012-07-18,2012-12-01,,Surgery,Public,Alive,94.0,KRAS,No,,,21.6,High,Urban,Statutory Health Insurance,10.0,No,No,Diabetes,4.0
PT04032,Denmark,Zealand,71.0,Female,Breast,IV,2015-03-02,2015-03-09,2015-08-21,Immunotherapy,,Deceased,99.0,EGFR,No,Current,None,35.8,Medium,Rural,Statutory Health Insurance,15.0,No,No,Cardiovascular Disease,1.0
PT04033,Portugal,Lisbon,53.0,Female,Leukemia,IV,2020-09-16,2020-12-24,2021-04-27,Radiation,Public,Deceased,,BRCA1,No,Never,None,30.1,Medium,Rural,Statutory Health Insurance,,No,No,None,3.0
PT04034,France,Provence-Alpes-Côte d'Azur,20.0,Male,Colorectal,IV,2022-01-30,2022-06-09,2023-03-29,Chemotherapy,Public,Alive,51.0,KRAS,Yes,Former,None,24.3,Medium,Rural,NHS,4.0,No,Yes,Diabetes,10.0
PT04035,Sweden,Västra Götaland,88.0,Male,Ovarian,I,2011-12-19,2012-02-26,2012-08-14,,Public,Deceased,118.0,None,No,Never,Moderate,28.5,Low,Rural,NHS,3.0,No,No,,5.0
PT04036,Poland,Lesser Poland,39.0,Female,Lung,IV,,2012-04-09,2012-08-04,,,Alive,24.0,EGFR,Yes,Never,None,29.7,Medium,Urban,Private Insurance,15.0,No,No,Diabetes,10.0
PT04037,France,Île-de-France,26.0,Male,,II,2013-04-27,2013-07-02,2014-03-25,Surgery,Private,Deceased,112.0,None,No,Never,Moderate,26.0,High,Urban,Private Insurance,17.0,No,No,Cardiovascular Disease,10.0
PT04038,Norway,Vestland,26.0,Male,Colorectal,IV,2020-06-18,2020-07-06,2020-10-02,Surgery,Private,Deceased,35.0,None,Yes,Never,Moderate,24.7,Medium,Urban,Statutory Health Insurance,19.0,No,Yes,Cardiovascular Disease,3.0
PT04039,Portugal,Algarve,69.0,Male,,I,2021-02-04,2021-06-28,2022-01-18,Radiation,Public,Alive,13.0,BRCA1,No,Former,Moderate,27.8,Low,Rural,NHS,4.0,No,No,None,6.0
PT04040,Sweden,Skåne,21.0,Male,Leukemia,II,2016-03-20,2016-04-01,2016-06-29,Chemotherapy,Public,Lost to Follow-up,,,Yes,Never,Heavy,36.4,Low,Rural,NHS,11.0,No,Yes,Cardiovascular Disease,7.0
PT04041,Poland,Silesian,66.0,Female,Colorectal,I,2012-01-28,,2012-11-29,Surgery,Public,Deceased,91.0,,No,Former,None,33.7,Low,Urban,,3.0,No,Yes,Hypertension,1.0
PT04042,Ireland,Connacht,33.0,Female,Breast,I,,2019-09-09,2019-11-29,Chemotherapy,Public,Alive,99.0,None,Yes,Never,,19.8,High,Urban,NHS,12.0,No,No,Hypertension,5.0
PT04043,Belgium,Flanders,50.0,Non-binary,Colorectal,IV,2013-05-15,2013-07-08,2014-03-22,Immunotherapy,Public,Alive,,BRCA1,No,Never,Moderate,34.9,,Urban,Private Insurance,11.0,No,No,Hypertension,9.0
PT04044,Italy,Sicily,69.0,Female,Ovarian,III,2018-02-21,2018-04-02,2019-01-04,Targeted Therapy,Private,Alive,92.0,KRAS,Yes,Never,None,38.4,Low,Urban,Private Insurance,1.0,,No,Cardiovascular Disease,3.0
PT04045,Portugal,Porto,80.0,Male,,II,2016-09-13,2017-03-03,2018-02-27,Radiation,Private,Alive,65.0,None,No,Never,Moderate,39.1,Low,Urban,Statutory Health Insurance,1.0,No,No,,8.0
PT04046,Sweden,Stockholm,60.0,Male,Colorectal,II,2018-12-03,2019-05-02,2019-07-06,Surgery,Public,Deceased,93.0,,No,Former,Moderate,26.9,Medium,Rural,NHS,2.0,No,No,Cardiovascular Disease,3.0
PT04047,Finland,Southwest Finland,33.0,Male,Ovarian,III,2015-07-06,2015-07-10,2016-07-06,Targeted Therapy,Public,Alive,49.0,None,Yes,,None,38.2,Medium,Urban,NHS,7.0,Yes,No,Obesity,7.0
PT04048,Belgium,Brussels,24.0,Female,Colorectal,II,2020-01-24,2020-02-14,2020-06-21,Surgery,,Alive,113.0,EGFR,No,Current,None,21.7,High,,NHS,1.0,No,No,Obesity,4.0
PT04049,Denmark,Central Denmark,24.0,Male,Pancreatic,III,2023-12-12,2024-05-11,2024-08-17,Radiation,Public,Alive,57.0,,No,Never,Moderate,26.8,Medium,Rural,Private Insurance,6.0,No,No,Diabetes,5.0
PT04050,,Île-de-France,83.0,Male,Prostate,II,2010-03-24,2010-09-10,2011-02-27,Surgery,Public,Alive,115.0,BRCA1,No,Never,Moderate,29.1,Medium,Urban,Private Insurance,1.0,No,No,Cardiovascular Disease,
PT04051,Poland,Silesian,48.0,Female,Leukemia,III,2020-04-20,2020-07-20,2021-03-06,,Public,Alive,85.0,EGFR,,Never,Moderate,22.0,Low,Rural,Statutory Health Insurance,2.0,No,No,Cardiovascular Disease,10.0
PT04052,Switzerland,Geneva,,Female,Colorectal,IV,2013-11-01,2013-12-12,2014-10-04,Targeted Therapy,Public,Alive,13.0,KRAS,Yes,Current,Moderate,,Medium,Rural,Private Insurance,13.0,No,No,Obesity,1.0
PT04053,Finland,Uusimaa,55.0,Male,Colorectal,II,2011-10-21,2012-03-13,2012-04-19,,Public,Alive,,EGFR,No,Never,Moderate,27.0,Medium,Urban,Private Insurance,,No,No,Diabetes,8.0
PT04054,,Bavaria,38.0,Male,Prostate,II,2017-11-12,2018-02-16,2018-05-18,Radiation,Public,Deceased,47.0,EGFR,No,Never,None,20.8,Low,Urban,Private Insurance,3.0,No,,Cardiovascular Disease,2.0
PT04055,Germany,North Rhine-Westphalia,83.0,Female,Lung,IV,2013-08-30,2013-10-05,2014-03-23,,Research Institute,Alive,83.0,None,No,Former,Moderate,29.6,Medium,Rural,NHS,13.0,No,No,Diabetes,10.0
PT04056,Norway,Trøndelag,41.0,Female,Colorectal,IV,2018-10-30,2019-03-01,2020-02-26,Chemotherapy,Private,Alive,25.0,BRCA1,No,Never,Moderate,24.3,Low,Urban,NHS,3.0,No,No,Cardiovascular Disease,10.0
PT04057,Denmark,Central Denmark,53.0,Male,Ovarian,,2023-10-18,2023-11-04,2024-03-22,Targeted Therapy,Private,Alive,101.0,EGFR,Yes,Never,Heavy,38.7,High,Urban,Private Insurance,8.0,No,No,Obesity,4.0
PT04058,Portugal,Lisbon,75.0,Male,Pancreatic,II,2011-11-25,2012-02-24,2012-09-12,Radiation,Research Institute,Alive,40.0,BRCA1,Yes,Current,Heavy,36.2,Medium,Rural,Private Insurance,12.0,No,Yes,Diabetes,8.0
PT04059,Switzerland,Bern,36.0,Female,Ovarian,II,2021-11-06,2022-03-21,2022-06-16,Targeted Therapy,Private,Alive,77.0,None,No,Never,Moderate,36.0,Medium,Rural,NHS,5.0,No,Yes,Obesity,1.0
PT04060,Switzerland,Zurich,75.0,Female,Pancreatic,I,2013-02-18,2013-06-16,2013-07-23,,Research Institute,Alive,71.0,BRCA1,Yes,Never,None,32.1,Medium,Urban,Private Insurance,13.0,No,No,Cardiovascular Disease,
PT04061,Belgium,Flanders,36.0,Female,Colorectal,I,2018-12-01,2019-05-19,2019-08-20,Immunotherapy,Private,,105.0,EGFR,Yes,Former,Moderate,20.1,Medium,Rural,Private Insurance,1.0,Yes,Yes,Obesity,9.0
PT04062,Norway,,37.0,Female,Lung,III,2019-08-29,2019-12-09,,Targeted Therapy,Public,Deceased,92.0,None,Yes,Never,None,27.8,Medium,Urban,NHS,11.0,No,No,None,9.0
PT04063,Norway,Trøndelag,64.0,Female,Pancreatic,I,2015-01-27,2015-03-30,2016-03-20,Targeted Therapy,Public,Alive,54.0,None,No,Never,Moderate,32.3,Low,Rural,Statutory Health Insurance,4.0,,No,None,8.0
PT04064,Portugal,Algarve,75.0,Male,Ovarian,III,2022-04-11,2022-08-07,2023-06-10,Immunotherapy,Public,Alive,,None,No,Former,Moderate,22.4,High,Urban,NHS,1.0,No,No,Hypertension,5.0
PT04065,France,Île-de-France,69.0,Male,Ovarian,IV,2017-05-03,2017-07-26,2018-03-03,Targeted Therapy,Public,Lost to Follow-up,,KRAS,Yes,Current,None,26.9,Medium,,NHS,18.0,No,No,,8.0
PT04066,Germany,North Rhine-Westphalia,77.0,Female,Colorectal,IV,2012-05-13,2012-07-09,2013-03-17,Immunotherapy,,Deceased,97.0,KRAS,Yes,Former,None,28.6,Medium,Rural,Private Insurance,1.0,No,No,Obesity,10.0
PT04067,Switzerland,Zurich,37.0,Female,,I,2013-06-03,2013-09-10,2013-12-27,Chemotherapy,Private,Alive,,BRCA1,No,Former,Moderate,36.4,Medium,Urban,Private Insurance,19.0,Yes,No,Cardiovascular Disease,
PT04068,Norway,Vestland,26.0,Female,Colorectal,II,2013-05-03,2013-06-05,2013-08-10,,Public,,,BRCA1,Yes,Never,Moderate,26.4,Medium,Urban,Statutory Health Insurance,13.0,No,,Obesity,7.0
PT04069,Norway,Vestland,29.0,Male,Leukemia,III,2023-06-06,2023-07-02,2024-02-04,Surgery,Private,Alive,6.0,None,Yes,Never,Moderate,25.7,Low,Urban,Private Insurance,10.0,No,No,Diabetes,5.0
PT04070,,Connacht,88.0,Female,Pancreatic,II,,2013-02-11,2013-08-07,Immunotherapy,Research Institute,Deceased,56.0,BRCA1,Yes,Never,Moderate,34.0,Low,Urban,Statutory Health Insurance,18.0,Yes,No,Obesity,10.0
PT04071,France,Provence-Alpes-Côte d'Azur,22.0,Male,Breast,III,2017-12-12,,2018-05-09,Chemotherapy,Public,Lost to Follow-up,,None,Yes,Current,None,25.5,Medium,Urban,Statutory Health Insurance,9.0,No,Yes,Cardiovascular Disease,8.0
PT04072,Austria,Vienna,63.0,Female,Leukemia,IV,2022-09-07,2022-10-08,2023-03-01,Immunotherapy,Public,Alive,91.0,KRAS,Yes,Current,None,20.2,Low,Urban,NHS,16.0,No,No,Diabetes,3.0
,Portugal,Porto,89.0,Male,Lung,,2023-02-28,2023-03-27,2023-10-15,Targeted Therapy,Private,Alive,76.0,None,Yes,Never,Moderate,35.3,Medium,Urban,,,No,No,Cardiovascular Disease,5.0
PT04074,France,Auvergne-Rhône-Alpes,33.0,Female,Leukemia,II,2014-02-03,2014-03-24,2014-08-22,Chemotherapy,Public,Deceased,59.0,EGFR,Yes,Never,Moderate,26.1,,Urban,,3.0,No,No,Obesity,2.0
PT04075,Finland,Uusimaa,23.0,Female,Ovarian,II,,2016-08-06,2017-07-15,Radiation,Public,Alive,113.0,None,No,Former,Moderate,39.7,Medium,Urban,Private Insurance,2.0,No,No,Obesity,2.0
PT04076,Spain,Catalonia,37.0,,Leukemia,III,2011-01-03,2011-06-11,2012-01-30,Immunotherapy,Public,Alive,92.0,EGFR,Yes,Former,Heavy,29.1,,Urban,NHS,16.0,No,No,Obesity,6.0
PT04077,Portugal,Lisbon,71.0,Male,Prostate,II,2011-02-16,2011-07-19,2012-01-29,Targeted Therapy,Public,Alive,,KRAS,No,Former,,19.4,Low,Urban,Statutory Health Insurance,14.0,No,No,Hypertension,6.0
PT04078,Italy,Lombardy,57.0,,Lung,III,2018-06-21,2018-07-07,2019-03-15,Radiation,Private,Alive,31.0,None,Yes,Never,Moderate,34.8,Medium,Urban,Private Insurance,14.0,Yes,No,None,2.0
PT04079,,Southwest Finland,39.0,Female,Lung,IV,2010-12-20,2011-04-08,2012-01-21,Radiation,Private,Deceased,83.0,KRAS,No,Former,None,26.3,Medium,Urban,Statutory Health Insurance,18.0,No,Yes,Hypertension,3.0
PT04080,Finland,Pirkanmaa,63.0,Male,Lung,I,2014-04-15,2014-08-27,2014-12-11,Radiation,Public,Deceased,100.0,EGFR,No,Former,Moderate,20.7,Low,Rural,Private Insurance,1.0,No,No,Hypertension,5.0
PT04081,Sweden,Västra Götaland,70.0,Male,Leukemia,IV,2013-08-31,2013-11-26,2014-03-10,Surgery,Public,Alive,96.0,None,No,Never,None,30.3,Medium,,Statutory Health Insurance,10.0,Yes,No,Obesity,9.0
PT04082,Sweden,Skåne,38.0,Male,Lung,,2023-05-10,2023-08-29,2024-05-06,Targeted Therapy,Public,Alive,27.0,BRCA1,No,Former,None,23.5,Medium,Urban,Private Insurance,11.0,Yes,No,Hypertension,3.0
,Germany,North Rhine-Westphalia,87.0,Female,Pancreatic,IV,2010-11-25,,2011-11-11,Surgery,Public,Alive,54.0,KRAS,Yes,Former,None,38.7,Medium,Urban,Statutory Health Insurance,6.0,No,No,Cardiovascular Disease,7.0
PT04084,Norway,Oslo,85.0,Male,Prostate,I,2014-02-02,2014-06-27,2015-03-05,Targeted Therapy,Public,Alive,114.0,EGFR,Yes,Never,Moderate,33.4,Low,Rural,Statutory Health Insurance,11.0,No,No,Obesity,5.0
,France,Île-de-France,32.0,Male,Colorectal,I,2017-09-30,2017-10-09,2018-02-08,Targeted Therapy,Private,Deceased,51.0,KRAS,Yes,Never,Moderate,27.1,Low,Rural,Statutory Health Insurance,16.0,No,No,Obesity,1.0
PT04086,Belgium,Brussels,81.0,Female,Leukemia,II,,2014-04-26,2014-07-02,Chemotherapy,Public,Alive,105.0,None,Yes,Never,Moderate,34.9,Medium,Urban,NHS,18.0,No,No,None,2.0
PT04087,Spain,Madrid,80.0,Female,Colorectal,II,2020-03-24,2020-04-06,2020-12-25,Radiation,Private,Alive,22.0,EGFR,Yes,Current,None,28.2,,Rural,Statutory Health Insurance,12.0,Yes,Yes,Cardiovascular Disease,2.0
PT04088,Finland,Pirkanmaa,49.0,Male,Colorectal,I,2012-01-08,2012-05-22,2012-10-19,Immunotherapy,Private,Alive,113.0,None,No,Never,None,38.3,Medium,Urban,Statutory Health Insurance,1.0,No,No,Cardiovascular Disease,2.0
,Switzerland,Bern,49.0,Non-binary,Leukemia,IV,2020-08-24,2020-09-11,2020-11-28,Chemotherapy,Research Institute,Alive,99.0,None,,Current,Moderate,33.7,Medium,Urban,NHS,5.0,No,No,Diabetes,2.0
PT04090,Portugal,Porto,70.0,Female,Pancreatic,II,,2023-07-16,2023-09-17,Immunotherapy,Private,Alive,65.0,None,Yes,Former,Moderate,39.5,Low,Urban,Private Insurance,18.0,No,No,Obesity,3.0
PT04091,France,Provence-Alpes-Côte d'Azur,67.0,Female,Leukemia,IV,2014-11-30,2015-01-14,2015-07-16,Radiation,Public,Alive,90.0,BRCA1,No,Current,None,,Medium,Urban,NHS,16.0,No,No,Obesity,6.0
PT04092,,Masovian,52.0,Male,Lung,II,2013-07-26,2013-12-25,2014-06-02,Targeted Therapy,Private,Alive,13.0,None,No,Former,None,36.2,Medium,Urban,,,No,No,Hypertension,6.0
PT04093,Norway,Vestland,38.0,Female,Prostate,I,2017-04-22,2017-05-24,2017-08-17,Chemotherapy,Public,Alive,66.0,BRCA1,Yes,Never,Moderate,24.2,Medium,Urban,Private Insurance,1.0,No,Yes,Obesity,
PT04094,Belgium,Wallonia,76.0,Male,Leukemia,II,2021-08-09,2021-08-16,2021-12-23,Surgery,Public,Lost to Follow-up,,None,Yes,Never,Moderate,25.5,Low,Rural,Private Insurance,2.0,,No,Diabetes,
PT04095,Finland,Uusimaa,,Male,Colorectal,IV,2020-08-18,2020-09-07,2021-02-18,Targeted Therapy,Private,Deceased,66.0,KRAS,No,Former,None,23.3,High,Urban,Private Insurance,7.0,,No,Diabetes,6.0
PT04096,Denmark,Capital Region,60.0,Male,Leukemia,II,2023-11-20,2024-03-21,2024-05-25,Surgery,Research Institute,Deceased,7.0,KRAS,Yes,Current,Moderate,36.4,Low,Rural,NHS,12.0,No,No,Obesity,5.0
PT04097,Denmark,Central Denmark,61.0,Female,Prostate,I,2021-05-29,2021-10-23,2022-05-08,Targeted Therapy,Public,Alive,53.0,KRAS,No,Former,Moderate,37.8,Medium,Urban,Private Insurance,,Yes,Yes,Diabetes,
PT04098,Poland,Lesser Poland,71.0,Female,,IV,2011-09-30,2012-01-18,2012-09-09,Targeted Therapy,Public,Deceased,51.0,None,No,Never,None,22.3,Medium,Rural,NHS,,No,No,None,9.0
PT04099,Switzerland,Bern,23.0,Female,Pancreatic,I,2022-06-29,2022-07-13,2023-05-20,Radiation,Private,Lost to Follow-up,,BRCA1,No,Never,None,37.0,Low,Urban,NHS,6.0,No,No,Diabetes,3.0
PT04100,Finland,Southwest Finland,23.0,Male,Colorectal,III,2017-03-26,2017-09-02,2017-12-24,Chemotherapy,Research Institute,Alive,66.0,None,No,,None,39.2,High,Rural,NHS,,No,No,,7.0
PT04101,Netherlands,North Holland,,Female,Breast,II,2010-02-10,2010-02-19,2010-06-03,Immunotherapy,Public,Alive,11.0,KRAS,No,Never,None,29.7,Medium,Urban,Statutory Health Insurance,6.0,No,No,None,9.0
PT04102,Norway,Oslo,60.0,Female,Breast,II,2020-11-29,2021-03-09,2021-07-06,Radiation,Private,Deceased,18.0,KRAS,No,Never,Moderate,23.3,Medium,Rural,Private Insurance,2.0,No,No,Diabetes,8.0
PT04103,Sweden,Västra Götaland,80.0,Male,Ovarian,I,2018-01-25,2018-07-21,2018-12-18,Immunotherapy,Research Institute,Alive,34.0,EGFR,No,Never,Moderate,38.5,Low,Urban,,3.0,No,Yes,None,2.0
PT04104,Sweden,Västra Götaland,74.0,Female,Prostate,IV,2012-02-10,2012-05-10,2012-09-15,Targeted Therapy,Public,Deceased,,EGFR,No,Current,Heavy,38.3,Low,Urban,NHS,6.0,No,No,None,4.0
PT04105,Italy,Sicily,32.0,Male,Pancreatic,IV,2021-12-23,2022-03-26,2023-03-15,Surgery,Private,Alive,104.0,BRCA1,No,Former,None,20.9,Medium,Urban,Private Insurance,16.0,No,Yes,Obesity,10.0
PT04106,Netherlands,North Holland,33.0,Female,,II,2018-04-05,2018-04-21,2019-02-16,Immunotherapy,,Alive,99.0,BRCA1,No,Never,None,39.1,High,Urban,NHS,10.0,Yes,No,Diabetes,6.0
PT04107,Austria,Vienna,79.0,Male,,I,2020-02-28,2020-07-29,2020-11-10,Surgery,Private,Alive,51.0,EGFR,No,Former,Moderate,24.7,High,Urban,Statutory Health Insurance,17.0,No,No,Hypertension,7.0
PT04108,Portugal,Algarve,44.0,,Ovarian,I,2010-02-27,2010-08-04,2011-01-17,Immunotherapy,Public,Alive,39.0,BRCA1,,Former,Heavy,27.7,Medium,Rural,NHS,7.0,No,No,Obesity,6.0
PT04109,Spain,Catalonia,63.0,Non-binary,Lung,I,2021-09-03,2022-01-17,2022-11-03,Surgery,Private,Alive,89.0,KRAS,No,Never,None,30.2,Low,Urban,Private Insurance,8.0,No,No,Hypertension,9.0
PT04110,Austria,Tyrol,29.0,,Leukemia,II,2014-07-12,2014-09-29,2015-05-28,,Public,Alive,111.0,KRAS,Yes,Former,None,25.3,Low,Urban,Statutory Health Insurance,5.0,No,No,,10.0
PT04111,Switzerland,,69.0,Male,Pancreatic,II,2018-11-12,,2019-05-17,Immunotherapy,Private,Alive,20.0,BRCA1,No,Former,Moderate,19.4,Medium,Urban,Statutory Health Insurance,15.0,No,No,Cardiovascular Disease,9.0
,Italy,Veneto,63.0,Male,Colorectal,I,2010-03-23,2010-08-08,2010-12-13,Radiation,Public,Alive,79.0,KRAS,Yes,Never,None,33.8,High,Urban,NHS,19.0,No,No,Hypertension,4.0
PT04113,Netherlands,South Holland,33.0,Male,Leukemia,II,2021-07-31,2022-01-11,2022-11-22,Radiation,Public,Deceased,114.0,EGFR,Yes,Current,Moderate,34.9,,Rural,Statutory Health Insurance,18.0,No,No,Hypertension,2.0
PT04114,Spain,Andalusia,34.0,Female,Prostate,III,2014-02-17,2014-03-13,2014-06-24,Surgery,Private,Alive,29.0,KRAS,No,Former,Moderate,29.7,High,Rural,Private Insurance,19.0,Yes,No,None,5.0
PT04115,Austria,Tyrol,35.0,Female,Ovarian,IV,2010-09-19,2011-02-02,2011-07-09,Immunotherapy,Public,Alive,87.0,EGFR,No,Former,None,27.5,Low,Urban,NHS,13.0,No,No,Hypertension,2.0
PT04116,Spain,Catalonia,21.0,Male,Prostate,II,2020-02-24,2020-02-25,2020-04-26,Immunotherapy,Public,Alive,8.0,EGFR,Yes,Never,Moderate,34.0,Low,Rural,NHS,3.0,No,No,Cardiovascular Disease,4.0
PT04117,Norway,Oslo,49.0,Male,Colorectal,III,2021-04-07,2021-06-20,2022-02-20,Chemotherapy,Private,Alive,33.0,BRCA1,No,Former,Moderate,39.9,Medium,Urban,NHS,,No,No,Diabetes,
PT04118,Netherlands,South Holland,49.0,Female,Colorectal,II,2016-05-06,2016-08-25,2017-06-23,Surgery,Public,Alive,55.0,EGFR,Yes,Former,Moderate,38.5,Medium,Urban,NHS,6.0,No,No,Hypertension,9.0
PT04119,,Île-de-France,,Female,Colorectal,II,,2023-01-27,2023-05-03,Immunotherapy,Public,Lost to Follow-up,,KRAS,Yes,Current,None,30.4,Medium,Rural,Statutory Health Insurance,15.0,No,No,None,1.0
PT04120,Denmark,Capital Region,39.0,Male,Ovarian,III,2020-05-30,2020-11-07,,Targeted Therapy,Private,Alive,81.0,None,No,Never,None,36.0,Medium,Rural,Private Insurance,14.0,No,Yes,Diabetes,10.0
PT04121,Sweden,Västra Götaland,68.0,Male,Ovarian,III,2017-12-21,2018-01-21,2018-10-12,Chemotherapy,Private,Alive,102.0,EGFR,Yes,Former,Heavy,22.8,Medium,Urban,Private Insurance,6.0,No,Yes,Cardiovascular Disease,9.0
PT04122,Finland,Uusimaa,54.0,Male,Prostate,II,2011-10-31,2012-01-16,2012-07-17,Immunotherapy,Public,,21.0,EGFR,,Former,Moderate,26.2,Medium,Urban,NHS,15.0,No,No,Obesity,2.0
PT04123,Finland,Pirkanmaa,42.0,Female,Pancreatic,II,,2013-08-25,2013-10-05,Surgery,Public,Alive,54.0,None,Yes,Former,None,39.1,Low,Urban,Statutory Health Insurance,19.0,Yes,Yes,Obesity,7.0
PT04124,Germany,Bavaria,80.0,Female,Ovarian,IV,2014-10-01,2014-11-05,2015-01-10,Targeted Therapy,Public,Deceased,47.0,KRAS,Yes,Former,None,30.2,Medium,Urban,Private Insurance,13.0,No,No,Diabetes,5.0
PT04125,,Capital Region,74.0,Female,Pancreatic,III,2020-06-11,2020-11-30,,Immunotherapy,Public,,8.0,None,No,Never,None,,Medium,Urban,NHS,11.0,No,No,Obesity,1.0
PT04126,,Bern,86.0,Male,Ovarian,III,2021-01-02,2021-06-26,2022-06-03,Radiation,Public,Deceased,38.0,EGFR,No,Former,Moderate,23.3,Medium,Urban,NHS,9.0,No,No,None,10.0
PT04127,Netherlands,South Holland,27.0,Female,Leukemia,III,2022-11-29,2023-05-08,2023-06-18,Radiation,Public,Deceased,,None,Yes,Never,Moderate,28.8,Medium,Rural,NHS,2.0,No,No,Diabetes,7.0
PT04128,Portugal,,59.0,Male,Breast,I,2020-07-24,2020-08-15,2021-03-06,Targeted Therapy,Public,Alive,6.0,EGFR,No,Never,Moderate,21.7,Medium,Rural,Statutory Health Insurance,3.0,No,No,Diabetes,7.0
PT04129,Norway,Trøndelag,78.0,Male,Breast,II,2015-03-15,2015-07-28,2016-04-07,Targeted Therapy,Research Institute,Alive,56.0,KRAS,No,Never,Moderate,,Medium,Urban,Statutory Health Insurance,4.0,Yes,No,Obesity,4.0
PT04130,Germany,,51.0,Non-binary,Lung,IV,2023-12-16,2024-04-28,2024-10-29,Targeted Therapy,Private,Alive,111.0,BRCA1,No,Never,Moderate,37.2,High,,Private Insurance,7.0,No,,Hypertension,9.0
PT04131,Portugal,Lisbon,26.0,Male,Prostate,II,2016-02-10,2016-07-28,2017-07-26,Targeted Therapy,Public,Deceased,83.0,None,Yes,Never,Heavy,35.0,Low,Rural,Statutory Health Insurance,8.0,Yes,No,Diabetes,4.0
PT04132,Poland,Silesian,21.0,Male,Colorectal,I,2011-03-17,2011-03-29,2011-05-04,Surgery,Private,Alive,14.0,None,,Never,Moderate,20.7,Low,Rural,Private Insurance,18.0,No,No,Cardiovascular Disease,3.0
PT04133,Austria,Tyrol,25.0,Non-binary,Pancreatic,III,2011-08-04,2012-01-19,,Radiation,Public,Lost to Follow-up,,None,No,Never,Moderate,30.4,Low,Urban,NHS,9.0,No,Yes,Obesity,8.0
PT04134,Finland,Southwest Finland,55.0,Male,Ovarian,I,2019-02-04,2019-06-15,2019-08-21,Immunotherapy,Public,Alive,104.0,BRCA1,Yes,Never,None,26.1,Medium,Urban,Statutory Health Insurance,19.0,No,No,Cardiovascular Disease,8.0
PT04135,France,Auvergne-Rhône-Alpes,51.0,Female,Leukemia,II,2011-01-11,2011-04-21,2012-03-13,Immunotherapy,Private,Alive,21.0,KRAS,No,Never,Heavy,25.1,Medium,,Statutory Health Insurance,18.0,,No,Cardiovascular Disease,2.0
PT04136,Germany,,64.0,Female,Pancreatic,I,2020-05-29,2020-07-11,2021-04-10,Radiation,Private,Alive,78.0,KRAS,No,Former,None,35.5,Low,Rural,Private Insurance,12.0,Yes,No,Obesity,1.0
PT04137,Norway,Vestland,61.0,Female,Prostate,II,2014-12-13,2015-02-25,2015-07-27,Immunotherapy,Public,Alive,81.0,BRCA1,Yes,Former,Moderate,28.6,Low,Urban,Private Insurance,2.0,Yes,No,Obesity,10.0
PT04138,Finland,Southwest Finland,72.0,Male,Lung,III,2011-12-30,2012-01-07,2012-07-09,Radiation,Research Institute,Alive,36.0,KRAS,Yes,Current,Moderate,36.7,Low,Rural,NHS,18.0,No,Yes,Obesity,1.0
PT04139,Netherlands,South Holland,28.0,Male,Pancreatic,II,2016-09-03,2017-01-22,2017-12-15,Chemotherapy,Private,Alive,54.0,EGFR,Yes,,None,26.9,High,Urban,,8.0,No,No,Hypertension,7.0
PT04140,Switzerland,Zurich,68.0,Male,Breast,II,2021-09-15,2022-02-09,2022-11-11,Radiation,Public,Alive,11.0,EGFR,Yes,Current,None,30.0,Medium,Urban,Private Insurance,15.0,No,No,Hypertension,6.0
PT04141,Portugal,Porto,,Male,Leukemia,I,2016-08-20,2016-09-12,2016-11-21,Immunotherapy,Public,Deceased,108.0,EGFR,No,Current,,25.0,Medium,Rural,NHS,2.0,No,No,Obesity,6.0
PT04142,Belgium,Flanders,86.0,Female,Breast,II,2017-12-01,2018-01-13,2018-11-03,Chemotherapy,Public,Alive,35.0,KRAS,No,Current,None,26.8,Medium,,NHS,18.0,No,No,None,1.0
PT04143,,Veneto,30.0,Male,Leukemia,II,2016-07-04,2016-07-28,2016-12-12,Immunotherapy,Research Institute,Deceased,114.0,BRCA1,Yes,,Moderate,33.1,Medium,Urban,NHS,17.0,No,No,Cardiovascular Disease,1.0
PT04144,,Masovian,69.0,Male,Colorectal,I,2015-05-23,2015-10-01,2016-06-12,Surgery,Public,Lost to Follow-up,,None,No,Never,None,24.2,High,Rural,Statutory Health Insurance,12.0,Yes,No,,2.0
PT04145,France,Auvergne-Rhône-Alpes,54.0,Female,Leukemia,III,2016-02-26,2016-07-17,2017-02-05,Immunotherapy,Public,Alive,112.0,None,Yes,Former,None,39.9,Medium,Urban,Statutory Health Insurance,4.0,No,Yes,Diabetes,1.0
PT04146,France,Auvergne-Rhône-Alpes,34.0,Female,Ovarian,III,2017-07-06,2017-12-14,2018-04-27,Chemotherapy,Private,Deceased,50.0,BRCA1,No,Current,Moderate,36.0,Low,Urban,NHS,6.0,No,No,,1.0
PT04147,Sweden,Skåne,50.0,Female,Colorectal,I,2017-10-27,2018-01-22,2018-08-21,Radiation,Public,Alive,105.0,None,No,Never,None,20.7,High,Urban,NHS,12.0,No,No,Diabetes,8.0
PT04148,Germany,North Rhine-Westphalia,81.0,Male,,I,2014-10-26,2015-03-30,2015-07-30,Immunotherapy,Public,Deceased,94.0,None,No,Current,None,23.1,Low,Urban,Private Insurance,15.0,No,No,Obesity,3.0
PT04149,Netherlands,South Holland,,Female,Breast,I,2023-12-06,2024-04-24,2024-09-19,Radiation,Private,Alive,34.0,BRCA1,Yes,Never,Moderate,32.8,Medium,Urban,NHS,,No,No,Cardiovascular Disease,8.0
PT04150,Spain,Madrid,44.0,Female,Leukemia,II,,2015-05-13,2015-10-10,Immunotherapy,Public,Alive,57.0,EGFR,No,Never,None,21.8,High,Rural,Statutory Health Insurance,3.0,Yes,No,Obesity,9.0
PT04151,Ireland,Connacht,,,Leukemia,I,2020-01-21,2020-05-11,2020-12-13,,,Lost to Follow-up,,BRCA1,No,Former,None,18.1,Low,Urban,Statutory Health Insurance,17.0,No,No,Cardiovascular Disease,9.0
PT04152,Germany,Bavaria,20.0,Male,Lung,I,2020-06-05,2020-07-21,2021-05-15,Immunotherapy,Public,Alive,34.0,BRCA1,Yes,Former,Heavy,32.3,High,Urban,Statutory Health Insurance,7.0,Yes,Yes,Hypertension,9.0
PT04153,Netherlands,,78.0,Male,Breast,II,2015-06-06,2015-08-27,2015-10-11,Targeted Therapy,Private,Alive,91.0,KRAS,No,Current,None,23.1,Medium,Urban,Private Insurance,17.0,Yes,Yes,Diabetes,9.0
PT04154,Germany,North Rhine-Westphalia,88.0,Female,Prostate,,2017-05-01,2017-09-22,2017-11-22,Immunotherapy,Private,Alive,,None,No,Former,None,21.9,Medium,Urban,Statutory Health Insurance,4.0,No,No,Cardiovascular Disease,8.0
PT04155,Denmark,Zealand,61.0,Male,Colorectal,III,2014-08-22,2014-10-19,2015-02-20,Immunotherapy,Private,,109.0,KRAS,No,Never,Moderate,32.9,High,,Private Insurance,8.0,No,Yes,Diabetes,4.0
PT04156,Poland,Silesian,53.0,Female,Prostate,IV,2022-05-29,2022-10-18,2023-03-02,Targeted Therapy,Private,Alive,78.0,EGFR,Yes,Current,,27.0,High,Urban,NHS,4.0,No,No,,8.0
PT04157,Switzerland,Bern,85.0,Female,Lung,I,2014-10-04,2014-12-28,2015-07-20,Surgery,Public,,90.0,KRAS,No,Current,Moderate,38.7,High,Urban,Statutory Health Insurance,19.0,Yes,No,Cardiovascular Disease,
PT04158,Austria,Tyrol,37.0,Female,Prostate,I,,2010-08-05,2011-07-26,Radiation,Private,Alive,116.0,KRAS,,Current,None,23.9,Low,Urban,Private Insurance,13.0,No,No,Diabetes,6.0
PT04159,Austria,Tyrol,24.0,Male,Colorectal,I,2015-04-26,2015-05-21,,Chemotherapy,Public,Deceased,109.0,EGFR,No,Former,None,23.4,Medium,Urban,NHS,,No,,Cardiovascular Disease,10.0
PT04160,France,Île-de-France,39.0,Male,Breast,IV,2021-11-18,2022-02-28,2023-02-23,Immunotherapy,Private,Alive,16.0,KRAS,No,Current,Moderate,30.4,Medium,Rural,Statutory Health Insurance,15.0,No,No,Diabetes,2.0
PT04161,Netherlands,Utrecht,85.0,Male,Pancreatic,II,2010-06-05,2010-10-26,2010-12-31,Chemotherapy,Public,Alive,82.0,None,No,Never,Moderate,28.9,Low,Urban,Statutory Health Insurance,6.0,No,No,Obesity,3.0
PT04162,Sweden,Stockholm,81.0,Male,Lung,II,2019-06-28,2019-09-10,2019-10-31,Surgery,Private,Alive,25.0,EGFR,No,Former,None,20.1,Low,Urban,Statutory Health Insurance,17.0,No,No,Diabetes,10.0
PT04163,Ireland,Dublin,51.0,Female,Ovarian,II,2012-08-19,2013-01-24,2013-09-28,Immunotherapy,Research Institute,,79.0,,No,,None,31.4,Medium,Urban,Private Insurance,10.0,No,No,Cardiovascular Disease,9.0
PT04164,Switzerland,Geneva,77.0,Male,,III,2012-08-02,2012-09-15,2013-01-08,Targeted Therapy,Public,Alive,62.0,None,No,Never,Heavy,34.3,High,Urban,NHS,10.0,Yes,No,Obesity,2.0
PT04165,Portugal,Lisbon,69.0,Male,,,2013-07-02,2013-11-16,2014-10-27,Targeted Therapy,Research Institute,Deceased,92.0,None,No,Current,Moderate,22.3,Medium,Urban,Private Insurance,19.0,No,,,10.0
PT04166,Poland,Lesser Poland,57.0,Male,Breast,II,2013-10-17,2014-01-17,2014-03-29,Immunotherapy,Public,Alive,,EGFR,No,Former,None,23.6,Medium,,Private Insurance,12.0,No,Yes,Diabetes,5.0
PT04167,Austria,Styria,74.0,Male,Pancreatic,IV,2021-02-06,2021-04-29,2021-10-16,Targeted Therapy,Public,Alive,93.0,BRCA1,No,Current,Moderate,19.5,Medium,Rural,Statutory Health Insurance,5.0,No,No,Diabetes,4.0
PT04168,Poland,Lesser Poland,47.0,Female,Prostate,II,2020-09-24,2021-02-10,2021-10-12,Surgery,,Alive,49.0,None,No,Former,Moderate,22.2,Medium,Urban,NHS,6.0,Yes,Yes,Diabetes,5.0
PT04169,Switzerland,Zurich,41.0,,,II,2014-10-03,2015-01-13,2015-07-21,Radiation,Public,Alive,16.0,BRCA1,No,Never,Moderate,26.5,Medium,Urban,Statutory Health Insurance,13.0,No,No,Obesity,1.0
PT04170,France,Île-de-France,62.0,Female,Ovarian,II,2017-11-06,2018-01-11,2018-11-15,,Private,Alive,118.0,BRCA1,No,Current,Heavy,32.7,High,Rural,Private Insurance,19.0,No,No,None,7.0
PT04171,,Trøndelag,55.0,Male,Leukemia,III,2016-08-21,2016-09-12,2017-03-31,Surgery,Public,Alive,107.0,BRCA1,No,Never,Moderate,29.2,Medium,Urban,Private Insurance,1.0,No,,Hypertension,9.0
PT04172,Belgium,Flanders,71.0,Female,Lung,I,2021-08-19,2021-11-14,2022-05-22,Targeted Therapy,Public,Alive,38.0,BRCA1,No,Never,None,22.1,Medium,Urban,NHS,17.0,No,No,Hypertension,1.0
PT04173,Sweden,Stockholm,55.0,Female,Pancreatic,I,2020-07-05,2020-11-30,2021-08-26,Radiation,Private,Alive,96.0,KRAS,No,Never,None,20.5,Medium,Urban,,13.0,Yes,No,None,8.0
PT04174,France,Auvergne-Rhône-Alpes,47.0,Male,Colorectal,III,2017-09-20,2018-01-07,2018-07-11,Targeted Therapy,Public,Alive,64.0,KRAS,No,Current,Moderate,28.9,,Urban,Statutory Health Insurance,4.0,Yes,Yes,None,3.0
PT04175,Austria,Styria,77.0,Male,Ovarian,II,2018-10-29,2019-04-04,2019-12-21,Targeted Therapy,Public,Alive,92.0,EGFR,Yes,Current,Moderate,39.0,Low,Rural,Private Insurance,7.0,No,No,Diabetes,7.0
PT04176,Portugal,Lisbon,55.0,Female,Prostate,IV,2017-04-04,2017-07-03,2018-03-11,Chemotherapy,Research Institute,Alive,73.0,KRAS,No,Former,Moderate,,High,Rural,Private Insurance,17.0,No,No,Diabetes,5.0
PT04177,Sweden,Stockholm,89.0,Female,Pancreatic,III,2010-08-28,2010-10-08,2011-04-25,Radiation,Private,Deceased,114.0,BRCA1,No,Current,Moderate,21.4,Low,Rural,Private Insurance,2.0,No,No,Diabetes,4.0
PT04178,Germany,Bavaria,28.0,Female,Ovarian,II,2018-11-29,2019-04-01,2020-02-09,Targeted Therapy,Private,Deceased,54.0,BRCA1,Yes,Former,None,36.2,Medium,Rural,Statutory Health Insurance,11.0,No,No,Obesity,5.0
PT04179,,Provence-Alpes-Côte d'Azur,40.0,Male,Colorectal,I,2022-05-24,2022-09-13,2023-06-12,Chemotherapy,Public,Deceased,20.0,KRAS,No,Current,None,24.3,Medium,Urban,Statutory Health Insurance,2.0,Yes,No,Hypertension,8.0
PT04180,Denmark,Central Denmark,83.0,,Pancreatic,,2011-05-15,2011-08-16,2012-02-23,Surgery,Private,Alive,111.0,KRAS,Yes,Never,,20.4,High,Urban,Private Insurance,14.0,No,No,None,10.0
PT04181,Netherlands,,80.0,,Pancreatic,III,2020-08-05,2020-10-27,2021-03-19,Radiation,Research Institute,Lost to Follow-up,,BRCA1,Yes,Current,Moderate,39.8,Medium,Urban,NHS,19.0,No,No,Hypertension,4.0
PT04182,,Auvergne-Rhône-Alpes,59.0,Female,Prostate,III,2022-01-10,2022-02-27,2022-12-21,Surgery,Public,Alive,8.0,KRAS,No,Never,None,22.7,Low,Urban,Statutory Health Insurance,14.0,No,No,Hypertension,5.0
PT04183,,,75.0,Female,Lung,I,,2016-03-07,2016-07-05,Surgery,Private,Alive,72.0,BRCA1,No,Never,Moderate,25.6,Medium,Urban,Private Insurance,10.0,No,No,Diabetes,9.0
PT04184,Poland,Masovian,23.0,Female,Colorectal,IV,2019-12-08,2020-03-11,2021-01-30,Immunotherapy,Public,Alive,94.0,None,No,Never,None,22.3,Medium,Urban,Private Insurance,15.0,No,No,Cardiovascular Disease,9.0
PT04185,Switzerland,Geneva,50.0,Male,Lung,II,2013-11-30,2014-05-08,2015-04-10,Radiation,,Deceased,91.0,None,,Never,Moderate,38.9,Low,Rural,NHS,16.0,No,No,Hypertension,4.0
PT04186,Sweden,Stockholm,46.0,Female,Colorectal,I,2011-06-11,2011-09-11,,Surgery,Public,Lost to Follow-up,,BRCA1,No,Former,Moderate,33.0,Medium,Urban,NHS,3.0,No,No,Cardiovascular Disease,7.0
PT04187,Spain,Madrid,77.0,Female,Ovarian,IV,2014-12-14,2015-05-16,2016-05-04,Surgery,Public,Alive,16.0,EGFR,No,Former,None,34.3,Low,Urban,Statutory Health Insurance,8.0,No,No,None,2.0
PT04188,Netherlands,North Holland,44.0,Female,Ovarian,III,2013-04-25,2013-10-19,2014-09-30,Surgery,Public,Alive,80.0,BRCA1,No,Former,Moderate,20.3,Low,Rural,Private Insurance,14.0,No,No,Obesity,4.0
PT04189,Ireland,Dublin,88.0,Male,Prostate,II,2020-10-22,2020-12-17,2021-11-13,Targeted Therapy,Public,Alive,60.0,EGFR,Yes,Never,,32.8,,Rural,NHS,5.0,No,No,None,10.0
PT04190,Spain,Catalonia,,Male,Lung,IV,2012-11-14,2013-03-29,2013-12-16,Radiation,Public,Alive,13.0,None,No,,Moderate,29.5,Low,Urban,Statutory Health Insurance,7.0,,No,Hypertension,4.0
PT04191,Denmark,Capital Region,24.0,,Ovarian,I,2022-01-12,2022-03-23,2022-07-02,Radiation,Public,Alive,42.0,KRAS,No,Current,Moderate,28.5,Low,Rural,NHS,7.0,No,No,Obesity,2.0
PT04192,Sweden,Skåne,27.0,Female,Prostate,I,,2023-03-25,2023-08-08,Radiation,,Alive,33.0,EGFR,Yes,,Moderate,29.2,,Urban,Statutory Health Insurance,11.0,No,No,Obesity,
PT04193,,Vienna,28.0,Female,Pancreatic,III,,2013-03-21,2013-06-08,Radiation,Public,Deceased,25.0,KRAS,Yes,Current,None,31.8,Medium,Rural,NHS,16.0,No,No,Obesity,8.0
PT04194,France,Île-de-France,34.0,Female,Pancreatic,I,2011-11-07,2011-12-24,2012-01-24,Radiation,Research Institute,Alive,27.0,KRAS,No,Never,Heavy,,Low,,Statutory Health Insurance,11.0,,Yes,Hypertension,6.0
PT04195,Ireland,Munster,26.0,Female,Prostate,IV,2018-04-27,,2018-09-29,Surgery,Public,Alive,63.0,None,No,Current,Moderate,30.9,Low,Urban,NHS,1.0,No,Yes,Diabetes,1.0
PT04196,Norway,Vestland,34.0,Female,Colorectal,III,2018-12-23,2019-04-14,2019-10-31,Chemotherapy,Private,,51.0,EGFR,No,Never,Moderate,28.7,Medium,Urban,Private Insurance,16.0,Yes,No,Diabetes,1.0
PT04197,Germany,Berlin,,Male,Ovarian,II,2016-04-04,2016-08-27,2017-04-28,,Public,Deceased,117.0,,Yes,Never,Heavy,26.1,Low,Rural,Private Insurance,4.0,No,Yes,Obesity,5.0
PT04198,Norway,Oslo,58.0,Male,Pancreatic,IV,2016-02-18,2016-05-18,2016-11-01,Radiation,Public,Alive,80.0,None,No,Never,Heavy,30.1,Low,Urban,Statutory Health Insurance,4.0,Yes,No,Obesity,3.0
PT04199,Finland,Uusimaa,25.0,Male,Colorectal,I,2012-11-17,2012-12-04,2013-07-02,Targeted Therapy,Public,Alive,28.0,KRAS,Yes,Former,None,,Low,Rural,NHS,6.0,No,No,Hypertension,10.0
PT04200,Italy,Sicily,76.0,Female,Lung,II,2018-09-14,2019-02-14,2019-10-12,Chemotherapy,Research Institute,Alive,103.0,BRCA1,Yes,Never,None,21.1,Medium,Urban,Private Insurance,3.0,,No,Hypertension,9.0
PT04201,Italy,Lombardy,38.0,Male,Leukemia,IV,2019-01-08,2019-06-19,2020-04-27,Targeted Therapy,Private,Alive,39.0,BRCA1,,Never,None,19.4,High,Urban,NHS,,No,Yes,Obesity,2.0
PT04202,,Lesser Poland,82.0,Male,Pancreatic,IV,2011-03-05,2011-03-31,2011-05-01,Surgery,Public,Alive,111.0,BRCA1,Yes,Never,None,20.7,Low,,Statutory Health Insurance,17.0,No,No,Hypertension,6.0
PT04203,Germany,North Rhine-Westphalia,50.0,Female,Pancreatic,II,2015-11-02,2015-11-08,2016-05-12,Immunotherapy,Public,Alive,,KRAS,No,Never,None,32.4,Medium,Rural,Statutory Health Insurance,9.0,No,No,Hypertension,9.0
PT04204,,North Holland,29.0,Female,Breast,I,,2011-05-23,2012-04-24,Surgery,Private,Deceased,,EGFR,No,Current,Moderate,34.5,Medium,Urban,Statutory Health Insurance,14.0,No,No,Obesity,2.0
PT04205,Sweden,Stockholm,86.0,Female,Colorectal,I,2016-04-03,2016-06-23,2016-12-11,Surgery,Public,Deceased,93.0,EGFR,No,Never,None,32.8,Medium,Rural,Private Insurance,18.0,No,No,Cardiovascular Disease,2.0
PT04206,Netherlands,Utrecht,81.0,Male,Prostate,II,2020-08-02,2020-12-11,2021-02-06,Radiation,Research Institute,Alive,54.0,KRAS,No,Never,Moderate,18.2,Medium,Urban,Private Insurance,15.0,No,Yes,,2.0
PT04207,Netherlands,North Holland,22.0,Female,Breast,II,2012-04-30,2012-06-28,2013-04-10,Targeted Therapy,Private,Alive,8.0,EGFR,No,Never,Moderate,29.7,,Urban,Private Insurance,19.0,No,No,Cardiovascular Disease,9.0
,Italy,Sicily,37.0,Male,Lung,I,2017-04-13,2017-08-03,2018-06-28,Radiation,Private,Alive,35.0,None,No,Never,Moderate,18.3,Low,Urban,Statutory Health Insurance,14.0,No,No,Hypertension,5.0
PT04209,Austria,Styria,44.0,Male,Breast,II,2017-12-01,2018-02-19,2018-11-23,Surgery,Public,Deceased,28.0,None,Yes,,Moderate,19.4,Medium,Rural,Statutory Health Insurance,18.0,No,No,None,9.0
PT04210,Spain,Madrid,39.0,Male,Breast,,2012-11-24,2013-01-11,2013-05-05,Immunotherapy,Public,Alive,70.0,KRAS,Yes,Former,Heavy,19.6,Medium,Urban,NHS,5.0,No,No,Diabetes,9.0
PT04211,Spain,Andalusia,77.0,,Leukemia,II,2023-10-19,2024-03-18,2024-12-15,Chemotherapy,Research Institute,,23.0,BRCA1,No,Never,Moderate,20.3,Low,Urban,NHS,10.0,No,No,Obesity,8.0
PT04212,France,Provence-Alpes-Côte d'Azur,,Male,Leukemia,I,2015-11-15,2016-02-14,2016-10-06,Surgery,Public,,106.0,,No,Former,Moderate,18.8,Low,Urban,Statutory Health Insurance,15.0,Yes,,,4.0
PT04213,Denmark,Central Denmark,29.0,Female,Breast,IV,2019-01-18,2019-05-31,2020-03-28,Surgery,Public,Alive,57.0,None,Yes,Never,Moderate,19.4,Medium,Urban,NHS,2.0,Yes,No,Diabetes,7.0
PT04214,,Madrid,40.0,Male,Leukemia,I,2017-01-16,,2018-04-27,Surgery,Private,Deceased,72.0,EGFR,No,Never,Heavy,33.9,Medium,Urban,NHS,18.0,No,,,5.0
PT04215,Netherlands,South Holland,48.0,Female,Ovarian,III,2014-11-17,2015-02-01,2015-04-19,Targeted Therapy,Public,Alive,93.0,EGFR,No,Former,,28.8,Medium,Urban,NHS,16.0,No,Yes,Diabetes,7.0
PT04216,France,Auvergne-Rhône-Alpes,29.0,Male,Leukemia,I,2023-10-01,2023-12-25,2024-03-09,Chemotherapy,Private,Alive,30.0,BRCA1,No,Former,Moderate,39.0,Medium,Rural,NHS,1.0,No,No,Cardiovascular Disease,7.0
PT04217,,Styria,32.0,Male,Breast,II,2011-05-04,2011-05-11,2011-12-03,Immunotherapy,Research Institute,Deceased,7.0,None,No,Former,Moderate,30.3,High,Urban,NHS,12.0,,No,Obesity,1.0
PT04218,France,Provence-Alpes-Côte d'Azur,66.0,Female,Colorectal,II,2011-02-08,2011-07-03,2012-04-27,Surgery,Public,Deceased,63.0,EGFR,No,Never,None,39.3,High,Rural,Statutory Health Insurance,10.0,No,No,,10.0
,Belgium,Brussels,42.0,Female,Leukemia,II,2023-05-02,2023-05-11,2024-01-23,Chemotherapy,Public,Alive,91.0,KRAS,No,Never,Moderate,24.6,Medium,,Statutory Health Insurance,15.0,Yes,No,Diabetes,6.0
PT04220,Poland,Lesser Poland,69.0,Female,Breast,II,2011-02-07,2011-05-07,2012-02-14,Surgery,Public,Alive,78.0,None,No,Never,Moderate,27.5,Medium,Urban,NHS,15.0,,Yes,None,
PT04221,France,Provence-Alpes-Côte d'Azur,23.0,Non-binary,Colorectal,I,2020-01-06,2020-06-28,2021-03-30,Chemotherapy,Public,Alive,59.0,EGFR,Yes,Former,None,32.0,Low,Urban,Private Insurance,11.0,No,Yes,Diabetes,9.0
PT04222,Austria,Styria,86.0,Female,Pancreatic,II,2014-12-07,2015-01-13,2015-03-05,Chemotherapy,Public,Alive,21.0,BRCA1,No,Never,Moderate,31.7,Medium,Urban,NHS,5.0,No,No,Diabetes,8.0
PT04223,Portugal,Porto,72.0,,Leukemia,II,2010-07-03,2010-11-15,2011-01-05,Targeted Therapy,Public,Deceased,68.0,KRAS,No,Current,None,18.1,Low,Urban,,13.0,No,No,None,1.0
PT04224,Sweden,Stockholm,21.0,Female,Breast,I,2023-08-31,2023-09-17,,Targeted Therapy,Public,Alive,48.0,KRAS,No,Never,None,29.0,Medium,Urban,NHS,12.0,No,No,Cardiovascular Disease,
PT04225,,Oslo,87.0,Female,Leukemia,IV,2019-12-19,,2020-11-30,Chemotherapy,,Alive,110.0,,No,Never,Heavy,,High,,Statutory Health Insurance,11.0,No,Yes,Obesity,
,France,Provence-Alpes-Côte d'Azur,84.0,Male,Colorectal,IV,2014-02-25,2014-04-07,2014-12-23,Radiation,Private,Alive,49.0,BRCA1,No,Never,Moderate,,Medium,Urban,Private Insurance,6.0,No,No,Cardiovascular Disease,8.0
PT04227,Germany,Berlin,76.0,Female,Ovarian,IV,2021-05-19,2021-07-22,2022-07-18,Surgery,Research Institute,Deceased,21.0,EGFR,Yes,Current,Moderate,34.1,Medium,Urban,Statutory Health Insurance,14.0,Yes,No,Diabetes,9.0
PT04228,,Wallonia,89.0,Male,Breast,III,2014-09-05,2014-11-27,2015-08-13,Targeted Therapy,Public,Deceased,84.0,EGFR,No,Current,Moderate,35.3,Low,Urban,Private Insurance,18.0,Yes,No,Obesity,
PT04229,Finland,Southwest Finland,26.0,Male,Colorectal,I,2023-12-04,2024-01-30,2024-09-12,Chemotherapy,Private,Alive,,BRCA1,No,Current,Moderate,31.4,Low,Urban,NHS,11.0,No,No,Diabetes,6.0
PT04230,France,Île-de-France,38.0,Female,Pancreatic,II,2020-02-11,2020-03-27,2020-12-15,Radiation,Public,Alive,32.0,KRAS,No,Former,Heavy,27.0,Medium,Rural,NHS,,No,No,Cardiovascular Disease,4.0
PT04231,Austria,Styria,63.0,Male,Prostate,III,2015-05-02,2015-07-14,2016-05-29,Chemotherapy,Public,Deceased,23.0,None,No,Never,Moderate,25.6,Low,Urban,NHS,5.0,No,No,None,9.0
PT04232,Poland,Masovian,82.0,,Lung,I,2021-08-12,2021-11-29,2022-09-19,Immunotherapy,Private,Alive,12.0,None,No,Former,None,21.2,Medium,Urban,NHS,17.0,Yes,No,Cardiovascular Disease,10.0
PT04233,Sweden,Skåne,84.0,Male,Ovarian,II,2014-03-30,2014-07-18,2015-01-20,Chemotherapy,Public,Alive,91.0,BRCA1,No,,Moderate,32.0,Medium,,Statutory Health Insurance,10.0,No,,Diabetes,4.0
PT04234,Italy,Lombardy,58.0,Non-binary,Prostate,II,2021-09-18,2022-02-01,2022-03-29,Immunotherapy,Public,Alive,67.0,None,No,Never,Heavy,34.9,Medium,Urban,NHS,19.0,No,No,Obesity,1.0
PT04235,Poland,Silesian,45.0,Male,Leukemia,I,2022-01-28,2022-05-18,2023-01-26,Targeted Therapy,Public,Alive,66.0,None,No,Never,None,,Medium,Urban,NHS,6.0,No,,Cardiovascular Disease,3.0
PT04236,Norway,Vestland,63.0,Male,Colorectal,II,2020-10-23,,2021-09-28,Targeted Therapy,Public,Alive,67.0,EGFR,No,Former,None,26.3,Medium,Urban,Private Insurance,10.0,No,No,Cardiovascular Disease,7.0
PT04237,Poland,Lesser Poland,31.0,Female,Breast,IV,2023-01-07,2023-04-08,2023-08-04,Chemotherapy,Public,Alive,67.0,BRCA1,No,Current,None,27.3,Low,Rural,Statutory Health Insurance,,No,Yes,Diabetes,1.0
PT04238,Norway,Vestland,41.0,Female,Ovarian,III,2017-08-23,2017-11-18,2018-10-28,Targeted Therapy,Public,Deceased,18.0,BRCA1,Yes,Former,None,33.7,Medium,Rural,Statutory Health Insurance,17.0,,,Cardiovascular Disease,5.0
PT04239,Sweden,Stockholm,33.0,Male,Colorectal,I,2012-09-22,2013-02-07,,Chemotherapy,Public,Alive,64.0,EGFR,,Never,None,20.0,Medium,Urban,Statutory Health Insurance,19.0,No,,None,1.0
PT04240,Belgium,Flanders,49.0,Male,Leukemia,III,2017-10-27,2017-12-10,2018-10-29,Chemotherapy,Public,Alive,88.0,EGFR,Yes,Former,Moderate,23.6,Medium,Urban,,19.0,,No,Cardiovascular Disease,8.0
PT04241,Sweden,Skåne,63.0,Male,Breast,I,2011-10-14,2011-12-01,2012-06-27,Immunotherapy,Public,Deceased,31.0,KRAS,Yes,Former,None,32.2,Medium,Urban,Statutory Health Insurance,7.0,No,No,Obesity,7.0
PT04242,Belgium,Flanders,57.0,Male,Ovarian,III,2012-06-11,2012-08-21,2013-07-16,Surgery,Public,Alive,22.0,BRCA1,,Former,Moderate,39.2,Low,Rural,Statutory Health Insurance,2.0,No,No,Hypertension,2.0
PT04243,Norway,Trøndelag,78.0,Male,Prostate,IV,,2017-10-09,2017-11-30,Chemotherapy,Private,Lost to Follow-up,,None,No,Never,None,34.6,High,Urban,Private Insurance,11.0,No,Yes,None,1.0
PT04244,,Utrecht,61.0,Male,Colorectal,II,2015-06-26,2015-09-14,2016-05-02,Surgery,Public,,,None,No,Never,Heavy,,Medium,Urban,Statutory Health Insurance,4.0,No,No,None,10.0
PT04245,Spain,Catalonia,71.0,Female,Lung,III,2012-11-30,,2014-03-18,Radiation,Research Institute,Alive,22.0,KRAS,No,Never,,23.0,High,Urban,Private Insurance,1.0,Yes,Yes,Hypertension,3.0
PT04246,Portugal,Porto,82.0,Female,Ovarian,II,2016-08-27,2016-09-02,,Targeted Therapy,Public,Deceased,21.0,None,No,Current,None,25.2,Low,Rural,NHS,11.0,Yes,No,Obesity,4.0
PT04247,Italy,Sicily,80.0,Female,Pancreatic,II,2010-06-18,2010-09-06,2011-05-16,Radiation,Public,Alive,62.0,KRAS,,Current,Moderate,24.3,Medium,Urban,Statutory Health Insurance,12.0,No,No,Hypertension,5.0
PT04248,Denmark,Zealand,53.0,Male,Pancreatic,III,2010-06-20,2010-09-17,2011-09-06,Radiation,Public,Alive,18.0,None,No,Never,,34.4,Medium,Urban,Private Insurance,15.0,No,No,Diabetes,9.0
PT04249,Belgium,Flanders,58.0,Male,Leukemia,III,2020-02-07,2020-03-23,2020-10-26,Chemotherapy,Private,Alive,74.0,EGFR,,Never,Moderate,18.6,Low,Urban,Statutory Health Insurance,13.0,No,No,None,8.0
PT04250,Spain,Catalonia,60.0,Female,Leukemia,III,2012-01-09,2012-01-19,2012-10-25,Radiation,,Alive,103.0,EGFR,No,Never,Moderate,27.2,Low,Rural,NHS,17.0,No,No,Hypertension,2.0
PT04251,Netherlands,South Holland,56.0,Male,Colorectal,IV,2019-08-29,2020-01-13,2020-06-21,Chemotherapy,Research Institute,Alive,24.0,BRCA1,Yes,Former,None,35.0,Medium,Urban,Private Insurance,7.0,Yes,No,None,2.0
PT04252,Germany,Berlin,84.0,Female,Prostate,III,2019-10-03,2019-11-04,2019-12-26,Targeted Therapy,Public,Alive,98.0,None,No,Never,None,21.2,Medium,Rural,Statutory Health Insurance,10.0,Yes,No,Cardiovascular Disease,5.0
PT04253,France,Auvergne-Rhône-Alpes,,Female,,III,2013-08-10,2013-08-12,2013-10-17,Targeted Therapy,Public,Alive,98.0,KRAS,Yes,Current,Moderate,38.7,Medium,Urban,Private Insurance,5.0,No,No,Cardiovascular Disease,4.0
PT04254,France,Provence-Alpes-Côte d'Azur,27.0,Female,Lung,III,2013-07-11,2013-08-01,,Radiation,Private,Deceased,96.0,BRCA1,Yes,Former,Heavy,38.0,Low,Urban,NHS,3.0,No,No,Hypertension,3.0
PT04255,Belgium,Brussels,37.0,Male,Lung,I,2016-04-13,2016-08-22,2017-06-08,Chemotherapy,Private,Alive,81.0,EGFR,Yes,Former,Heavy,39.4,Low,Urban,Statutory Health Insurance,2.0,Yes,Yes,,7.0
PT04256,Portugal,Porto,64.0,Male,Colorectal,II,2021-08-14,2021-11-15,2022-01-24,Immunotherapy,Public,Deceased,59.0,BRCA1,Yes,,None,30.0,Low,Urban,Private Insurance,,No,No,None,7.0
PT04257,France,Provence-Alpes-Côte d'Azur,52.0,Female,Breast,II,2021-01-19,2021-05-20,2021-08-29,Immunotherapy,Private,Deceased,74.0,KRAS,Yes,Former,Moderate,21.2,Medium,Rural,NHS,13.0,No,No,Diabetes,5.0
PT04258,Netherlands,Utrecht,24.0,Female,Prostate,,2022-06-03,2022-06-26,,Surgery,Private,Alive,,None,No,Never,None,34.8,Medium,Urban,Private Insurance,5.0,No,No,None,9.0
PT04259,Denmark,Zealand,55.0,Male,Ovarian,III,2022-03-16,2022-08-28,2023-04-28,Surgery,Public,Deceased,99.0,EGFR,No,Former,Moderate,36.6,Medium,Urban,NHS,,No,No,Hypertension,9.0
PT04260,Sweden,Skåne,42.0,Non-binary,,I,2016-03-19,2016-04-24,2016-05-29,Surgery,Public,Alive,54.0,BRCA1,No,Never,Moderate,19.7,Medium,Urban,Private Insurance,7.0,Yes,No,Hypertension,1.0
,,Porto,59.0,Male,Ovarian,I,2011-10-20,2011-11-03,2012-03-30,Radiation,Public,Deceased,34.0,,No,Former,Moderate,27.8,Low,Rural,Private Insurance,17.0,No,No,,5.0
PT04262,Denmark,Central Denmark,24.0,Male,Breast,IV,2021-07-05,2021-07-20,2021-10-26,Chemotherapy,Private,Alive,64.0,EGFR,No,Never,Moderate,31.3,Medium,Urban,Statutory Health Insurance,2.0,No,No,None,2.0
PT04263,Spain,Madrid,53.0,Female,Breast,I,2018-10-07,2018-11-11,2019-02-25,Surgery,Public,Deceased,28.0,KRAS,,Never,None,32.7,,Urban,Statutory Health Insurance,6.0,No,No,Diabetes,10.0
PT04264,Italy,Lombardy,43.0,Female,Colorectal,I,2011-07-30,2011-11-27,2012-09-27,Chemotherapy,Public,Lost to Follow-up,,EGFR,No,Current,None,28.8,Low,Urban,Statutory Health Insurance,18.0,,No,Obesity,5.0
PT04265,Germany,North Rhine-Westphalia,36.0,Non-binary,Lung,II,2010-10-27,2010-11-18,2011-03-19,Radiation,Public,Alive,66.0,,No,Current,Heavy,19.1,High,Urban,NHS,6.0,No,No,Hypertension,7.0
PT04266,Spain,Catalonia,41.0,Male,Breast,III,2019-08-08,2020-01-30,2020-07-30,Chemotherapy,Private,Alive,117.0,EGFR,No,Current,Moderate,31.0,Low,Urban,Private Insurance,13.0,No,No,,1.0
PT04267,Switzerland,Zurich,34.0,Male,,II,2015-03-08,2015-04-13,2015-05-30,Chemotherapy,Public,Alive,6.0,KRAS,Yes,Never,None,20.0,Medium,Rural,,7.0,No,No,Diabetes,
PT04268,Denmark,Capital Region,34.0,Female,Lung,IV,2010-08-12,2010-08-27,2011-08-14,Radiation,Private,Alive,112.0,EGFR,Yes,Former,Moderate,19.6,Medium,Urban,Statutory Health Insurance,12.0,No,No,Hypertension,2.0
PT04269,Switzerland,Geneva,44.0,Male,Breast,I,2019-12-28,2020-04-27,2020-06-30,,Private,Lost to Follow-up,,KRAS,Yes,Current,None,19.9,Medium,Urban,Private Insurance,16.0,Yes,No,Cardiovascular Disease,6.0
PT04270,Netherlands,North Holland,72.0,Male,Breast,IV,2017-07-04,2017-10-08,2018-02-16,Chemotherapy,Private,Deceased,74.0,EGFR,No,Current,Moderate,38.8,Medium,Urban,Private Insurance,17.0,No,Yes,Obesity,3.0
PT04271,Germany,Berlin,40.0,Female,Ovarian,I,2015-02-02,2015-07-11,2016-05-06,Chemotherapy,Private,Deceased,53.0,,No,Never,Moderate,33.2,High,Rural,NHS,5.0,No,No,Diabetes,
PT04272,Norway,Trøndelag,85.0,Male,Lung,I,2020-02-12,2020-07-30,2021-07-01,Targeted Therapy,Private,Deceased,115.0,None,No,Never,None,31.6,Medium,Rural,Private Insurance,8.0,No,No,Diabetes,4.0
PT04273,Spain,Catalonia,51.0,Female,Pancreatic,II,2016-04-16,2016-07-25,2017-05-27,Targeted Therapy,Public,Alive,9.0,None,Yes,Never,Moderate,34.1,Medium,Urban,Private Insurance,2.0,Yes,No,None,8.0
PT04274,Finland,Pirkanmaa,40.0,Male,Lung,I,,2022-02-12,,Surgery,Public,Deceased,16.0,BRCA1,No,Current,Moderate,23.3,,Urban,,12.0,Yes,No,None,9.0
PT04275,,Oslo,87.0,Female,Leukemia,II,2017-11-04,2018-01-17,2018-03-22,Surgery,Public,Alive,48.0,None,No,Former,Heavy,24.9,Medium,Urban,NHS,19.0,No,No,None,8.0
PT04276,Denmark,,,Female,Ovarian,II,2019-09-15,2019-10-11,2019-11-17,Radiation,Public,Alive,19.0,None,Yes,Former,Moderate,37.9,Medium,,NHS,4.0,No,Yes,None,7.0
PT04277,,Dublin,85.0,Male,Leukemia,I,2014-08-27,2014-09-26,2015-07-11,Radiation,Public,Alive,,KRAS,Yes,Never,None,32.5,High,Urban,NHS,,Yes,No,Obesity,3.0
PT04278,Finland,Southwest Finland,33.0,Male,,IV,2019-02-17,2019-06-19,2020-05-23,Targeted Therapy,Public,Alive,,None,No,Former,None,36.3,Low,Urban,Statutory Health Insurance,18.0,No,No,Hypertension,7.0
PT04279,Denmark,Central Denmark,34.0,Male,,II,2015-08-25,2015-12-06,2016-07-22,Targeted Therapy,Private,,105.0,EGFR,Yes,Never,Moderate,38.8,Low,Urban,Private Insurance,6.0,No,No,Cardiovascular Disease,3.0
PT04280,Belgium,Flanders,39.0,Male,Prostate,IV,,2012-03-15,2012-08-31,Surgery,Public,Alive,61.0,KRAS,Yes,Current,Heavy,27.9,High,,Statutory Health Insurance,4.0,No,Yes,Cardiovascular Disease,8.0
PT04281,Finland,Pirkanmaa,53.0,Female,Leukemia,IV,2011-05-11,2011-06-11,,Targeted Therapy,Public,Alive,82.0,None,Yes,,Moderate,30.8,Low,Urban,Private Insurance,9.0,No,No,None,1.0
PT04282,Sweden,Skåne,55.0,Non-binary,Lung,I,2014-01-04,2014-04-23,2014-08-15,Chemotherapy,Private,Alive,101.0,None,No,Never,None,24.8,High,Urban,Statutory Health Insurance,15.0,No,Yes,Cardiovascular Disease,6.0
PT04283,Denmark,Central Denmark,,Female,Leukemia,II,2022-09-20,2023-01-09,2023-03-01,Chemotherapy,Private,Lost to Follow-up,,KRAS,Yes,Current,Heavy,36.4,Medium,Rural,NHS,14.0,No,No,Obesity,6.0
PT04284,Portugal,Porto,49.0,Female,Pancreatic,III,2015-09-16,2016-01-05,2016-09-25,Targeted Therapy,Public,Alive,55.0,BRCA1,No,,Moderate,28.0,High,Urban,Statutory Health Insurance,4.0,No,No,,7.0
PT04285,Sweden,Skåne,82.0,Male,Ovarian,III,2020-02-23,2020-05-15,2021-03-26,Radiation,,Alive,67.0,BRCA1,No,,,33.8,Medium,Urban,Statutory Health Insurance,6.0,No,No,None,2.0
PT04286,Ireland,Munster,54.0,Male,Colorectal,IV,2011-03-12,2011-03-14,2011-08-19,Surgery,Public,Alive,14.0,KRAS,,Current,None,30.5,Medium,Rural,Private Insurance,1.0,No,No,Hypertension,10.0
PT04287,Sweden,Stockholm,32.0,,Pancreatic,III,2016-05-29,2016-08-15,2016-11-04,Chemotherapy,Public,Alive,36.0,BRCA1,No,Current,,29.7,High,Urban,Statutory Health Insurance,17.0,No,No,None,3.0
PT04288,Sweden,Skåne,65.0,,Colorectal,I,2022-01-14,2022-06-11,,Radiation,Private,Alive,56.0,None,No,Never,Moderate,21.5,Low,Urban,Statutory Health Insurance,11.0,Yes,No,Hypertension,1.0
PT04289,Switzerland,Geneva,75.0,Female,Pancreatic,II,2014-08-25,2015-01-20,2016-01-02,Targeted Therapy,Public,Alive,55.0,BRCA1,No,Never,Moderate,33.9,Medium,Urban,Private Insurance,1.0,No,No,None,9.0
PT04290,Germany,Berlin,28.0,Male,Colorectal,IV,2020-12-25,2021-01-28,2021-03-27,Surgery,Private,Alive,110.0,KRAS,Yes,Never,None,19.2,Medium,Urban,NHS,15.0,Yes,No,Cardiovascular Disease,4.0
PT04291,Belgium,Wallonia,55.0,Female,Lung,III,2012-11-12,2013-01-11,2013-06-22,Surgery,Public,Alive,86.0,BRCA1,No,Never,Heavy,35.1,Medium,Rural,Private Insurance,9.0,No,,None,6.0
PT04292,Switzerland,Zurich,22.0,Male,Pancreatic,IV,2016-07-25,2016-08-28,2017-04-25,Radiation,Public,Lost to Follow-up,,KRAS,Yes,Former,Moderate,38.3,High,Rural,Statutory Health Insurance,4.0,No,No,Hypertension,4.0
PT04293,Norway,Oslo,38.0,Female,Ovarian,III,2012-12-25,2013-06-08,2013-07-29,Radiation,Public,Alive,82.0,,Yes,Never,None,35.6,High,Rural,Statutory Health Insurance,12.0,No,No,Hypertension,3.0
PT04294,Germany,,47.0,Female,Breast,I,2013-11-19,2014-03-26,2014-10-18,Radiation,,Alive,35.0,KRAS,No,Current,Moderate,22.2,Medium,Urban,NHS,6.0,Yes,,Diabetes,5.0
PT04295,France,Auvergne-Rhône-Alpes,42.0,Male,Colorectal,IV,2018-04-10,2018-04-29,2018-09-24,Targeted Therapy,Public,Deceased,31.0,EGFR,Yes,Never,Moderate,24.7,High,Rural,Private Insurance,,Yes,No,Obesity,9.0
PT04296,Poland,Silesian,26.0,Non-binary,Leukemia,IV,2018-05-07,2018-06-28,,Targeted Therapy,Private,Alive,115.0,,No,Former,None,22.6,High,Rural,NHS,12.0,No,No,None,7.0
PT04297,Denmark,Central Denmark,33.0,Non-binary,Breast,,2011-07-24,2011-09-06,2011-12-26,Radiation,Public,Alive,16.0,EGFR,Yes,Current,None,23.1,Medium,Urban,Private Insurance,,No,No,Cardiovascular Disease,1.0
PT04298,Spain,Catalonia,65.0,Female,Leukemia,I,2010-01-29,2010-04-25,2010-07-31,Targeted Therapy,Private,Alive,8.0,None,Yes,Current,None,35.9,Low,Urban,,15.0,No,Yes,Cardiovascular Disease,9.0
PT04299,Italy,Veneto,34.0,Female,Colorectal,II,2018-08-21,2019-01-23,2019-04-02,,Private,Alive,59.0,BRCA1,Yes,Current,Moderate,,High,Urban,Statutory Health Insurance,19.0,No,No,Diabetes,7.0
PT04300,Austria,Styria,86.0,Male,Lung,III,2019-08-08,2019-09-15,2020-01-13,Immunotherapy,Public,Alive,114.0,None,No,Never,Moderate,28.3,High,Urban,Private Insurance,17.0,No,Yes,Diabetes,10.0
PT04301,Austria,Tyrol,34.0,Female,Ovarian,II,2011-10-03,2012-01-03,2012-07-02,Targeted Therapy,Public,Alive,88.0,KRAS,Yes,Former,None,31.1,Medium,Urban,Private Insurance,16.0,No,,Diabetes,6.0
,France,Auvergne-Rhône-Alpes,70.0,Male,Ovarian,I,2018-10-10,2019-03-08,2019-11-14,Surgery,Private,Deceased,27.0,KRAS,No,Never,None,38.9,Low,Urban,NHS,1.0,No,No,Cardiovascular Disease,8.0
PT04303,Portugal,Porto,,Male,Breast,II,2021-07-12,2021-12-25,2022-04-09,Immunotherapy,Public,Deceased,54.0,BRCA1,No,Former,None,32.4,Medium,Urban,Private Insurance,13.0,No,No,Cardiovascular Disease,2.0
PT04304,Switzerland,Bern,88.0,Male,Breast,II,,2023-02-10,2023-11-01,Immunotherapy,Public,Deceased,60.0,None,No,Never,Moderate,,Low,Urban,Statutory Health Insurance,16.0,No,No,Cardiovascular Disease,10.0
PT04305,Germany,Berlin,81.0,Female,Colorectal,II,2021-06-08,2021-09-09,2022-02-26,Radiation,Research Institute,Deceased,91.0,KRAS,No,Never,None,30.0,Low,Urban,Private Insurance,5.0,No,,Obesity,5.0
PT04306,Belgium,Flanders,70.0,Male,Ovarian,III,2015-06-09,2015-11-05,2016-03-03,Radiation,Public,Alive,68.0,,No,Former,,26.1,Medium,,,1.0,No,No,None,7.0
PT04307,France,Île-de-France,82.0,Male,Ovarian,IV,,2017-05-20,2017-08-22,Surgery,Public,Alive,101.0,,No,Never,Moderate,25.8,Medium,Urban,NHS,6.0,No,No,Hypertension,2.0
PT04308,Germany,Bavaria,87.0,Male,Pancreatic,II,2023-03-10,2023-06-14,2023-12-15,Radiation,Private,Deceased,76.0,KRAS,No,Never,Moderate,33.5,Medium,Rural,NHS,2.0,Yes,Yes,,5.0
PT04309,Sweden,,35.0,Female,Colorectal,III,2021-01-14,2021-03-03,,,Public,Deceased,69.0,None,Yes,Never,None,26.1,Medium,,Private Insurance,11.0,No,,None,6.0
,Denmark,,43.0,Female,Colorectal,III,2021-05-30,2021-07-15,2021-12-30,Surgery,,Alive,93.0,BRCA1,No,Former,Heavy,32.8,Low,Urban,Statutory Health Insurance,1.0,No,No,None,6.0
PT04311,Denmark,Capital Region,25.0,Male,Ovarian,II,2015-07-23,2015-11-14,2016-07-31,,Research Institute,Alive,78.0,KRAS,No,Former,Heavy,30.0,Medium,Rural,Private Insurance,16.0,,No,Obesity,10.0
PT04312,Spain,Catalonia,76.0,Non-binary,Prostate,II,2011-04-19,2011-07-06,2011-09-15,Surgery,Public,Alive,52.0,BRCA1,No,Never,Moderate,30.2,High,,NHS,12.0,No,No,Hypertension,8.0
PT04313,Poland,Silesian,50.0,Male,Lung,II,2010-06-20,2010-08-16,2011-05-08,Radiation,Public,Alive,94.0,None,Yes,Current,None,25.2,Medium,,NHS,16.0,No,No,Obesity,1.0
PT04314,Norway,Oslo,25.0,Female,Pancreatic,II,2015-09-19,2015-11-10,2016-03-04,Radiation,Public,Alive,91.0,EGFR,No,Former,None,22.4,Low,Urban,Private Insurance,5.0,No,No,Diabetes,8.0
PT04315,Sweden,Västra Götaland,48.0,Female,Lung,IV,2018-11-19,2018-12-11,2019-06-24,Radiation,Public,Alive,29.0,None,No,,None,18.7,Medium,Urban,Statutory Health Insurance,13.0,Yes,Yes,Hypertension,10.0
PT04316,Norway,Oslo,86.0,,Ovarian,III,2016-10-07,2016-10-24,2017-06-08,Targeted Therapy,Public,Alive,49.0,None,No,Former,None,23.9,High,Urban,,12.0,Yes,No,None,6.0
PT04317,Switzerland,Bern,22.0,Male,,II,2013-05-30,2013-09-04,2013-12-04,Targeted Therapy,Public,Deceased,12.0,BRCA1,No,Never,Moderate,30.5,Low,Urban,Statutory Health Insurance,9.0,No,No,Cardiovascular Disease,3.0
PT04318,Switzerland,Zurich,47.0,Female,Prostate,IV,2012-03-08,2012-06-18,2012-08-20,Targeted Therapy,,Alive,58.0,KRAS,No,Never,None,36.3,High,Rural,Statutory Health Insurance,19.0,Yes,,Hypertension,1.0
PT04319,Belgium,Wallonia,67.0,Female,Ovarian,IV,2020-04-04,2020-04-30,2021-03-07,Surgery,Public,Alive,28.0,BRCA1,Yes,Never,None,35.6,Medium,Rural,Statutory Health Insurance,2.0,No,No,None,9.0
PT04320,Denmark,Capital Region,29.0,Female,Colorectal,IV,2016-11-02,2017-04-18,2018-01-03,Radiation,Private,Deceased,70.0,EGFR,No,Current,None,34.8,Low,Rural,NHS,16.0,No,No,None,9.0
,Ireland,Connacht,52.0,Female,Colorectal,I,2022-12-24,2023-03-05,2024-02-07,Targeted Therapy,Research Institute,Deceased,,KRAS,Yes,Current,Moderate,21.8,High,Urban,NHS,12.0,No,No,Diabetes,
PT04322,Belgium,Brussels,86.0,Male,Lung,III,2010-11-18,2011-05-16,2011-11-28,Surgery,Public,Deceased,105.0,KRAS,No,Never,Moderate,,,Urban,,,No,No,Cardiovascular Disease,5.0
PT04323,Germany,Bavaria,88.0,Female,Ovarian,III,2020-10-09,2021-03-16,2021-11-13,Immunotherapy,Public,Alive,74.0,EGFR,Yes,Current,None,23.1,High,Urban,Statutory Health Insurance,19.0,No,No,None,7.0
PT04324,Ireland,Connacht,31.0,Male,Prostate,III,2020-08-31,2020-10-11,2021-08-13,Targeted Therapy,Public,Deceased,28.0,BRCA1,Yes,Current,None,25.3,Medium,Urban,Statutory Health Insurance,4.0,No,No,None,
PT04325,France,Île-de-France,,Female,,I,2012-12-04,2013-05-14,2013-08-05,Surgery,Research Institute,Deceased,47.0,EGFR,Yes,Former,Moderate,34.3,Medium,Rural,Private Insurance,5.0,No,Yes,Cardiovascular Disease,4.0
PT04326,Italy,Lombardy,63.0,Male,Colorectal,III,2010-11-20,2011-01-09,2011-08-10,Chemotherapy,Public,Deceased,90.0,KRAS,No,Former,None,24.6,Low,Urban,Private Insurance,7.0,No,No,Obesity,8.0
PT04327,Italy,Veneto,,Female,Leukemia,II,2019-02-15,2019-08-01,2020-04-07,Targeted Therapy,Research Institute,Alive,,EGFR,No,Current,Moderate,31.8,High,Urban,,,No,No,None,3.0
PT04328,Switzerland,Bern,43.0,Male,Breast,III,2017-04-21,2017-05-19,2017-09-23,Immunotherapy,Private,Alive,71.0,KRAS,No,,Moderate,32.9,High,Rural,,12.0,No,No,Obesity,3.0
PT04329,Sweden,Stockholm,63.0,Male,Ovarian,III,2015-09-26,2016-02-19,2016-05-21,Surgery,Public,Alive,90.0,KRAS,Yes,Former,Heavy,39.2,Medium,Urban,NHS,13.0,No,No,Obesity,6.0
PT04330,Germany,Bavaria,76.0,Male,Pancreatic,I,2011-10-07,2011-12-20,2012-02-29,Targeted Therapy,Public,Deceased,119.0,,No,Current,Moderate,21.5,Low,Urban,NHS,11.0,No,No,Cardiovascular Disease,10.0
PT04331,Spain,Catalonia,35.0,Male,Colorectal,I,2020-07-11,2020-11-16,2021-08-21,Targeted Therapy,Public,Alive,23.0,EGFR,No,Never,Moderate,21.9,Low,Urban,Statutory Health Insurance,19.0,No,No,None,9.0
PT04332,Switzerland,Bern,40.0,Female,Pancreatic,III,2014-09-08,2014-11-13,2015-04-01,Chemotherapy,Public,Deceased,45.0,None,No,Never,None,28.1,Medium,Urban,NHS,15.0,No,No,None,8.0
PT04333,Italy,Veneto,,Female,Prostate,II,2017-05-04,2017-08-26,2018-02-25,Surgery,Public,Alive,23.0,EGFR,No,Former,Moderate,29.6,Low,Urban,Statutory Health Insurance,3.0,No,No,Obesity,5.0
PT04334,Ireland,Connacht,40.0,Female,Ovarian,II,2012-04-20,2012-10-08,2013-05-22,Surgery,Public,Deceased,23.0,BRCA1,Yes,Never,None,26.5,Medium,Rural,Private Insurance,4.0,No,No,Diabetes,5.0
PT04335,Portugal,Algarve,79.0,Female,Leukemia,,2010-10-30,2010-11-12,2011-05-08,Surgery,Private,Alive,84.0,KRAS,No,Never,Heavy,32.0,Medium,Rural,Statutory Health Insurance,19.0,No,No,Obesity,2.0
PT04336,Austria,Tyrol,70.0,Female,Pancreatic,IV,2018-12-06,2018-12-07,2019-08-03,Radiation,Public,Alive,64.0,None,Yes,Former,None,31.1,Low,Urban,Private Insurance,5.0,No,No,None,9.0
PT04337,Austria,Tyrol,40.0,Male,Ovarian,I,2023-04-30,2023-10-07,2024-07-05,Chemotherapy,Public,Alive,80.0,None,No,Former,None,32.5,High,Urban,NHS,7.0,No,No,Hypertension,5.0
PT04338,France,Auvergne-Rhône-Alpes,25.0,Male,Pancreatic,II,2020-04-18,2020-07-16,2020-11-29,,Public,,116.0,None,Yes,Never,Moderate,37.8,Low,Rural,Statutory Health Insurance,15.0,No,No,Obesity,10.0
PT04339,Finland,Pirkanmaa,84.0,Male,Prostate,III,2023-11-28,2023-12-08,2024-01-11,Chemotherapy,Public,Alive,81.0,KRAS,No,Never,Moderate,21.2,High,Rural,Statutory Health Insurance,14.0,No,No,Obesity,10.0
PT04340,Netherlands,South Holland,77.0,Female,Colorectal,IV,2017-03-09,2017-07-30,2018-01-19,Radiation,Public,Alive,70.0,KRAS,Yes,Current,None,35.9,Medium,Rural,Private Insurance,16.0,Yes,No,None,3.0
PT04341,Spain,Catalonia,,Male,Colorectal,,2023-07-31,2023-12-05,,Surgery,Public,Deceased,104.0,EGFR,Yes,Current,Moderate,31.3,Medium,Urban,Statutory Health Insurance,1.0,No,No,None,9.0
PT04342,Denmark,Central Denmark,84.0,Male,Breast,I,2010-12-02,2011-04-26,2012-03-01,Chemotherapy,Public,Alive,111.0,KRAS,No,Current,Moderate,,Medium,Rural,NHS,14.0,No,No,None,7.0
PT04343,Switzerland,Geneva,53.0,,Prostate,I,2015-02-22,2015-04-17,2015-10-29,Chemotherapy,Private,Deceased,37.0,EGFR,Yes,Former,Moderate,18.4,High,Rural,Statutory Health Insurance,4.0,No,No,Cardiovascular Disease,
PT04344,Sweden,Västra Götaland,75.0,Female,Leukemia,IV,2019-01-05,2019-06-05,2019-11-17,Radiation,Private,Lost to Follow-up,,EGFR,Yes,Former,Moderate,36.3,Low,Urban,Statutory Health Insurance,7.0,No,No,Hypertension,2.0
PT04345,Denmark,Capital Region,22.0,Female,,II,2015-01-27,2015-04-08,2015-09-12,,Public,,,BRCA1,Yes,Never,Moderate,,Low,Urban,Statutory Health Insurance,14.0,No,No,Diabetes,1.0
PT04346,Belgium,Brussels,61.0,Female,Ovarian,II,2023-01-08,2023-02-27,2023-06-01,Radiation,Public,Alive,15.0,KRAS,No,Never,Moderate,38.9,High,Urban,NHS,4.0,No,Yes,Cardiovascular Disease,10.0
PT04347,Poland,Silesian,81.0,,Prostate,I,2015-06-24,2015-08-22,2016-07-05,Targeted Therapy,Public,Alive,17.0,BRCA1,Yes,Never,Moderate,25.0,Low,Urban,Statutory Health Insurance,16.0,No,No,Obesity,8.0
PT04348,France,Île-de-France,25.0,,Colorectal,I,2022-11-21,2023-05-04,2023-10-08,Chemotherapy,Public,Alive,92.0,None,No,Never,,33.8,Low,Urban,,17.0,,Yes,Obesity,8.0
PT04349,Belgium,Flanders,25.0,Female,Breast,III,,2023-09-15,2024-04-28,Radiation,Public,Alive,96.0,EGFR,No,Never,Heavy,35.8,Medium,Rural,NHS,5.0,No,No,Obesity,4.0
PT04350,Italy,Veneto,82.0,Female,Colorectal,II,2015-10-31,2016-02-17,2016-06-07,Immunotherapy,Public,Alive,6.0,KRAS,Yes,Never,None,,Low,Urban,Statutory Health Insurance,11.0,No,No,Diabetes,1.0
PT04351,Denmark,Central Denmark,39.0,Male,Lung,II,2012-08-26,2012-09-27,2013-08-14,Surgery,,Deceased,102.0,KRAS,Yes,Never,Heavy,22.4,Medium,Urban,Private Insurance,9.0,Yes,No,Hypertension,6.0
,Denmark,Zealand,40.0,Male,Lung,I,2015-05-11,2015-07-03,2015-10-24,Surgery,Public,Alive,108.0,KRAS,No,Former,None,31.6,High,Urban,NHS,6.0,No,Yes,Diabetes,1.0
PT04353,Sweden,Stockholm,21.0,Male,Breast,II,2016-11-30,2017-03-18,2017-09-15,Surgery,Private,Alive,24.0,KRAS,Yes,Former,Moderate,18.8,High,Urban,Private Insurance,18.0,Yes,No,Hypertension,3.0
PT04354,Belgium,Brussels,75.0,Male,Breast,III,2016-06-04,2016-08-12,2017-03-18,,Public,Deceased,28.0,EGFR,No,Former,Moderate,19.3,Medium,Rural,Statutory Health Insurance,13.0,No,No,Obesity,5.0
PT04355,Netherlands,South Holland,29.0,,Prostate,I,2012-01-20,2012-04-12,2012-12-08,Radiation,Research Institute,Alive,16.0,KRAS,Yes,Never,None,27.1,,Urban,Statutory Health Insurance,18.0,No,No,None,3.0
PT04356,,Dublin,89.0,Male,Ovarian,IV,2017-07-06,2017-07-08,,Surgery,Public,Deceased,54.0,,,Current,None,33.3,Medium,Rural,Private Insurance,2.0,No,No,Diabetes,9.0
PT04357,Portugal,Porto,42.0,Male,Leukemia,I,2013-07-23,2013-09-04,2013-12-02,Radiation,Public,Lost to Follow-up,,KRAS,Yes,Current,Moderate,32.4,Low,Urban,,15.0,,No,Hypertension,5.0
PT04358,Portugal,Algarve,49.0,Female,Leukemia,I,2010-10-31,2010-12-10,2011-04-12,Chemotherapy,Private,Alive,73.0,BRCA1,No,Former,None,28.3,Low,Urban,Statutory Health Insurance,10.0,No,No,Obesity,6.0
PT04359,Sweden,Skåne,56.0,Female,Lung,II,2017-12-25,2017-12-29,2018-12-28,Chemotherapy,Public,Alive,72.0,KRAS,No,Current,None,31.3,,Urban,Private Insurance,15.0,Yes,,Obesity,8.0
PT04360,Ireland,Connacht,74.0,Female,Lung,IV,2021-02-17,2021-05-03,2021-09-23,Chemotherapy,Public,Alive,80.0,BRCA1,No,Current,Moderate,31.6,Medium,Urban,Statutory Health Insurance,3.0,No,No,Hypertension,3.0
PT04361,Portugal,Lisbon,68.0,Female,Lung,II,2019-02-27,2019-08-20,2020-08-12,Targeted Therapy,Public,Alive,53.0,BRCA1,No,,Heavy,36.5,High,Rural,NHS,3.0,Yes,Yes,Cardiovascular Disease,5.0
PT04362,Finland,Southwest Finland,53.0,Female,Colorectal,III,2010-02-05,2010-05-21,2010-10-21,Surgery,Public,Alive,14.0,None,,Never,Moderate,37.5,,Rural,NHS,13.0,No,Yes,Diabetes,6.0
PT04363,Norway,Vestland,63.0,Female,Leukemia,II,2022-05-15,2022-10-10,2022-12-17,Immunotherapy,Private,Deceased,29.0,None,No,Never,Moderate,26.4,Medium,Urban,NHS,2.0,No,Yes,Obesity,10.0
PT04364,Austria,Tyrol,41.0,Male,Breast,I,2019-09-20,2020-01-20,2020-11-01,,Public,Deceased,44.0,KRAS,No,Former,None,19.4,Low,Urban,Statutory Health Insurance,19.0,No,No,Diabetes,10.0
PT04365,Austria,Styria,50.0,Male,Lung,I,2016-07-13,2016-07-27,2016-09-07,Chemotherapy,Research Institute,Alive,14.0,None,Yes,Former,Heavy,23.3,Medium,Rural,NHS,6.0,No,No,None,1.0
PT04366,France,Provence-Alpes-Côte d'Azur,26.0,Male,Pancreatic,IV,2022-12-07,2023-03-16,2023-11-28,Surgery,Public,Alive,20.0,None,No,Never,None,20.1,Low,Urban,NHS,17.0,No,No,Cardiovascular Disease,10.0
PT04367,Ireland,Dublin,40.0,Female,Prostate,I,2013-12-04,2014-03-23,2014-11-01,Targeted Therapy,Private,Deceased,110.0,EGFR,Yes,Never,Moderate,35.4,Low,Urban,Statutory Health Insurance,7.0,No,No,,1.0
PT04368,Switzerland,Zurich,35.0,Non-binary,Ovarian,III,2022-06-25,2022-11-14,2023-01-24,Chemotherapy,Private,Alive,6.0,EGFR,Yes,Current,Heavy,19.3,High,Urban,,1.0,No,No,Diabetes,2.0
PT04369,Portugal,Lisbon,39.0,Non-binary,Breast,,2010-03-22,2010-09-15,2011-04-17,Targeted Therapy,Public,Alive,,KRAS,Yes,Former,Moderate,28.3,Medium,Urban,Statutory Health Insurance,10.0,Yes,No,Cardiovascular Disease,3.0
PT04370,Spain,Andalusia,62.0,Female,Ovarian,I,2014-02-11,2014-06-22,2014-08-25,Targeted Therapy,Private,Deceased,116.0,EGFR,No,Former,None,29.9,High,Urban,NHS,7.0,No,No,Cardiovascular Disease,7.0
PT04371,Germany,North Rhine-Westphalia,63.0,Male,Breast,II,2022-05-13,,2022-08-08,Targeted Therapy,Public,Lost to Follow-up,,None,No,Former,None,36.3,Low,Urban,NHS,19.0,No,No,None,7.0
PT04372,Austria,Styria,66.0,Non-binary,Breast,I,2019-08-13,2019-10-13,2020-01-25,Chemotherapy,Public,Alive,108.0,KRAS,Yes,Never,None,33.4,Medium,Rural,NHS,2.0,No,No,Hypertension,9.0
PT04373,,Andalusia,38.0,Female,Leukemia,I,2018-01-21,2018-01-23,2018-10-29,Targeted Therapy,,Alive,28.0,KRAS,No,Never,,31.2,Medium,Urban,Statutory Health Insurance,16.0,No,No,Obesity,5.0
PT04374,Netherlands,North Holland,67.0,Male,Lung,I,2012-03-05,2012-08-01,2013-01-04,Targeted Therapy,,,14.0,KRAS,Yes,Never,Moderate,,Low,Rural,NHS,17.0,No,No,None,8.0
PT04375,Netherlands,Utrecht,88.0,Female,Prostate,III,,2014-10-07,2014-11-25,Immunotherapy,Public,Alive,11.0,EGFR,No,,Moderate,28.4,High,Rural,NHS,1.0,Yes,No,Diabetes,2.0
PT04376,Belgium,,30.0,Male,Ovarian,III,2010-07-03,2010-10-02,2011-06-04,Surgery,Research Institute,Deceased,17.0,None,Yes,Former,None,37.8,High,Urban,Private Insurance,15.0,No,No,Obesity,9.0
PT04377,Spain,Catalonia,48.0,Male,Colorectal,III,2022-09-28,2023-01-24,2023-10-27,Immunotherapy,Public,Alive,113.0,EGFR,No,Never,None,21.9,High,Urban,Private Insurance,10.0,No,No,Hypertension,2.0
,Netherlands,,64.0,Female,Prostate,IV,2013-03-17,2013-08-11,2014-04-05,Surgery,Private,Alive,59.0,KRAS,Yes,Never,Moderate,39.2,Medium,Urban,NHS,19.0,No,,Obesity,5.0
PT04379,Finland,Pirkanmaa,87.0,Female,Prostate,I,2015-08-05,2015-10-20,2016-04-17,Chemotherapy,Public,Alive,115.0,KRAS,Yes,Current,,31.3,Low,Rural,NHS,14.0,No,No,,10.0
PT04380,Sweden,,55.0,Male,Pancreatic,II,2013-07-11,2014-01-04,2014-12-12,Immunotherapy,Public,Alive,20.0,EGFR,No,Never,None,23.2,Medium,,NHS,7.0,No,No,Obesity,2.0
PT04381,Switzerland,Bern,67.0,Female,Prostate,II,2020-01-25,2020-04-14,2020-10-26,Radiation,Private,Alive,8.0,None,No,Former,Moderate,34.1,Low,Urban,NHS,9.0,Yes,No,,2.0
PT04382,Poland,Masovian,34.0,Female,Colorectal,I,2023-07-07,2023-07-15,2024-06-11,Chemotherapy,Public,Alive,6.0,KRAS,Yes,Former,None,26.2,Medium,Urban,NHS,9.0,Yes,No,None,4.0
PT04383,Germany,North Rhine-Westphalia,63.0,Female,Prostate,I,2019-10-01,2020-01-10,2020-05-26,,Private,Alive,18.0,BRCA1,No,Never,None,20.2,Low,Urban,NHS,18.0,No,No,Obesity,8.0
PT04384,Spain,Catalonia,86.0,Male,Pancreatic,II,2015-02-26,2015-05-26,2015-10-30,Surgery,Private,Alive,102.0,BRCA1,Yes,Never,None,19.8,Medium,Rural,Statutory Health Insurance,10.0,No,No,Hypertension,3.0
PT04385,Finland,Pirkanmaa,,Male,Prostate,III,2010-10-09,2011-03-10,2011-09-13,Surgery,Private,Alive,80.0,None,,Current,None,30.4,Medium,Urban,Statutory Health Insurance,7.0,No,No,Diabetes,2.0
PT04386,Germany,Bavaria,33.0,Male,Ovarian,IV,2022-11-24,2023-01-10,2023-10-02,Targeted Therapy,Private,Alive,67.0,None,Yes,Former,Moderate,32.2,Medium,Urban,Private Insurance,5.0,No,Yes,Diabetes,9.0
PT04387,Denmark,Central Denmark,82.0,Non-binary,Lung,,2016-02-28,2016-05-20,2016-10-18,Radiation,Public,Lost to Follow-up,,EGFR,No,Never,Moderate,25.2,Medium,Urban,NHS,5.0,No,No,Cardiovascular Disease,1.0
PT04388,Italy,,70.0,Male,Pancreatic,III,2022-10-14,,2024-02-03,Chemotherapy,Public,Alive,85.0,,No,Never,Heavy,,Medium,Urban,NHS,6.0,No,No,,6.0
PT04389,Portugal,Algarve,77.0,Male,Lung,III,2011-02-21,2011-06-25,2012-03-13,Chemotherapy,Private,Alive,,EGFR,No,Never,Heavy,23.9,Medium,Rural,,2.0,No,No,Cardiovascular Disease,
PT04390,Netherlands,South Holland,,Female,Lung,,2010-11-13,2010-11-21,,,Private,Alive,21.0,BRCA1,No,Former,Moderate,25.6,Low,Rural,Private Insurance,4.0,No,No,Cardiovascular Disease,8.0
PT04391,Italy,Veneto,84.0,Female,Breast,I,2019-01-13,2019-06-09,2019-09-10,Surgery,Public,Alive,37.0,EGFR,No,Never,None,23.0,Low,Urban,Private Insurance,7.0,No,No,None,1.0
PT04392,France,Auvergne-Rhône-Alpes,74.0,Female,Pancreatic,IV,2018-02-11,2018-03-13,2018-04-17,Immunotherapy,Public,Alive,95.0,BRCA1,Yes,Former,Moderate,32.0,Medium,Rural,Private Insurance,18.0,Yes,No,Diabetes,1.0
PT04393,Ireland,Dublin,29.0,Female,Prostate,III,2012-12-27,2013-03-28,2014-02-07,Surgery,Public,Alive,33.0,EGFR,No,Never,Moderate,28.8,Medium,Urban,Statutory Health Insurance,6.0,No,No,None,9.0
,Denmark,Capital Region,61.0,Male,Ovarian,IV,2023-11-27,2024-04-29,2024-12-18,Surgery,Public,Alive,96.0,None,No,Never,Moderate,21.3,Medium,Urban,Statutory Health Insurance,9.0,Yes,No,Cardiovascular Disease,6.0
PT04395,Finland,Southwest Finland,30.0,Male,Ovarian,II,2017-10-15,2018-03-12,2018-07-06,Immunotherapy,Public,Lost to Follow-up,,BRCA1,No,Never,Moderate,39.4,Medium,Rural,NHS,2.0,No,No,None,5.0
PT04396,Belgium,Brussels,35.0,Female,Ovarian,II,2020-08-21,,2021-06-19,Immunotherapy,Public,Alive,110.0,KRAS,Yes,Never,Moderate,37.7,Medium,Urban,Statutory Health Insurance,4.0,No,Yes,Hypertension,4.0
PT04397,Austria,Styria,38.0,Female,Leukemia,I,2011-11-08,2012-02-21,2012-06-26,Immunotherapy,Private,Alive,86.0,EGFR,No,Never,None,35.2,Medium,Urban,NHS,10.0,No,No,,8.0
PT04398,Finland,Uusimaa,,Female,Leukemia,IV,2013-01-29,2013-04-17,2013-12-22,Surgery,Public,Alive,53.0,KRAS,No,Never,None,20.1,Low,Urban,Statutory Health Insurance,17.0,No,No,Hypertension,1.0
PT04399,Italy,Veneto,72.0,Female,Leukemia,I,2016-04-09,2016-09-29,2017-05-26,Radiation,Public,Deceased,53.0,EGFR,No,Never,None,27.6,Medium,Rural,Statutory Health Insurance,7.0,No,No,Hypertension,2.0
PT04400,Netherlands,Utrecht,27.0,Female,Ovarian,I,2013-01-18,2013-03-23,2013-08-07,Immunotherapy,Private,Alive,32.0,None,No,Current,Heavy,29.4,Medium,Rural,NHS,1.0,No,Yes,None,6.0
PT04401,Sweden,Västra Götaland,43.0,Female,Colorectal,II,2015-05-27,2015-06-26,2016-02-24,Surgery,Public,Alive,17.0,EGFR,Yes,Never,None,38.8,Medium,Urban,Private Insurance,17.0,Yes,No,Hypertension,6.0
PT04402,Germany,Berlin,27.0,Female,Ovarian,II,2018-01-27,2018-07-24,2019-01-17,Immunotherapy,Public,Alive,40.0,EGFR,Yes,,None,25.9,Medium,Rural,Statutory Health Insurance,14.0,No,No,Hypertension,8.0
PT04403,,Dublin,67.0,Female,Lung,I,,2022-01-10,2022-09-04,Radiation,Public,Alive,24.0,KRAS,No,Former,Heavy,32.7,Medium,Urban,,15.0,No,No,Obesity,7.0
PT04404,Finland,Pirkanmaa,49.0,Male,Lung,III,,2023-05-03,,Radiation,Private,Alive,102.0,EGFR,No,Never,Heavy,30.2,High,Rural,Private Insurance,17.0,No,No,,6.0
PT04405,Portugal,Lisbon,77.0,Male,Ovarian,II,2023-07-01,2023-08-28,2024-05-27,Targeted Therapy,Public,Deceased,22.0,None,Yes,Former,Moderate,35.8,Low,Urban,NHS,7.0,No,No,Diabetes,9.0
PT04406,Switzerland,Bern,74.0,Non-binary,Lung,II,2013-11-23,2013-12-24,2014-03-20,Targeted Therapy,Public,Deceased,14.0,EGFR,No,Never,Heavy,20.4,Low,Urban,Private Insurance,19.0,,No,Obesity,4.0
PT04407,Ireland,Dublin,81.0,Male,Pancreatic,I,2019-03-28,2019-06-26,,Radiation,Private,Alive,116.0,None,No,Former,,36.2,Low,Urban,Private Insurance,13.0,No,No,Diabetes,10.0
,Finland,Uusimaa,67.0,Female,Colorectal,II,2012-01-26,2012-05-05,2013-02-18,Immunotherapy,Public,Alive,51.0,None,No,Former,Moderate,32.3,Low,Rural,Private Insurance,10.0,No,No,Hypertension,6.0
PT04409,,Silesian,23.0,Male,,I,2020-04-26,2020-09-01,,Targeted Therapy,Private,Alive,17.0,EGFR,Yes,Former,None,20.4,Medium,Urban,NHS,8.0,No,Yes,Obesity,7.0
PT04410,Belgium,Brussels,56.0,Male,Breast,I,2023-05-04,2023-07-02,2023-09-03,Surgery,Public,Alive,38.0,None,No,Former,None,34.4,Medium,Urban,NHS,1.0,No,Yes,Hypertension,
PT04411,Netherlands,Utrecht,27.0,Male,Ovarian,III,2020-07-03,2020-10-22,2021-08-21,Radiation,Private,Alive,84.0,BRCA1,No,Never,None,25.3,Low,Rural,Private Insurance,8.0,No,No,Cardiovascular Disease,1.0
PT04412,Switzerland,Zurich,20.0,Male,Ovarian,II,2020-11-16,2021-03-12,2021-10-20,Immunotherapy,Public,Deceased,34.0,KRAS,No,,Moderate,19.8,High,Urban,NHS,1.0,Yes,No,None,1.0
PT04413,Norway,Oslo,89.0,,Pancreatic,I,,2021-06-12,2021-11-30,Surgery,Public,Alive,18.0,EGFR,No,Never,,,Medium,Urban,Statutory Health Insurance,5.0,,No,Diabetes,8.0
PT04414,Spain,Andalusia,66.0,Male,Lung,II,,,2023-03-09,Radiation,Private,Deceased,72.0,KRAS,Yes,Current,None,21.9,High,Urban,Private Insurance,5.0,No,No,Hypertension,4.0
PT04415,Poland,Masovian,24.0,Female,Prostate,I,2018-03-12,2018-05-17,2018-10-14,Radiation,Public,Deceased,104.0,None,,Never,Moderate,24.0,Medium,Urban,NHS,5.0,No,,None,1.0
PT04416,France,Île-de-France,69.0,Male,Leukemia,I,2011-05-07,2011-08-19,2012-05-28,Immunotherapy,Public,Alive,63.0,KRAS,Yes,Never,Moderate,40.0,Medium,Rural,Statutory Health Insurance,9.0,No,No,Cardiovascular Disease,7.0
PT04417,Norway,,43.0,Male,Ovarian,III,2011-11-15,2012-04-23,2013-01-30,Immunotherapy,Private,Deceased,90.0,BRCA1,No,Current,Moderate,,Low,Urban,NHS,11.0,No,No,Obesity,6.0
PT04418,Italy,Lombardy,66.0,Male,Breast,III,2015-05-30,2015-11-15,2016-09-03,Chemotherapy,Public,Alive,108.0,KRAS,Yes,Current,Moderate,26.4,High,Urban,Private Insurance,7.0,No,,Obesity,10.0
PT04419,Ireland,Dublin,37.0,Female,Leukemia,III,2010-10-31,2011-02-06,2012-01-17,Immunotherapy,Public,Alive,104.0,BRCA1,No,,None,32.6,Medium,Rural,Statutory Health Insurance,10.0,No,No,Cardiovascular Disease,7.0
PT04420,,Trøndelag,47.0,Female,Ovarian,II,2020-12-11,2021-02-18,2022-01-11,Surgery,Public,Deceased,,KRAS,No,Never,None,39.4,High,Rural,Private Insurance,12.0,No,No,Hypertension,4.0
,France,Île-de-France,24.0,Female,Prostate,II,2015-05-07,2015-05-12,2015-11-01,Targeted Therapy,Private,Alive,,BRCA1,Yes,Former,None,26.2,Low,Urban,NHS,5.0,No,No,Diabetes,6.0
PT04422,Belgium,Brussels,49.0,Male,Prostate,III,2019-10-10,,2020-09-17,Immunotherapy,Public,Alive,100.0,BRCA1,Yes,Never,,,High,Rural,Statutory Health Insurance,18.0,No,No,Obesity,4.0
PT04423,Poland,Silesian,20.0,Male,Leukemia,I,2020-12-18,2020-12-22,2021-07-06,Immunotherapy,Public,Alive,82.0,KRAS,No,Former,Moderate,26.9,Medium,Urban,NHS,4.0,No,No,None,6.0
PT04424,Germany,Bavaria,65.0,Female,Pancreatic,I,2013-06-14,2013-10-07,2014-02-14,Targeted Therapy,Public,Deceased,101.0,KRAS,No,Current,,21.5,High,Urban,Statutory Health Insurance,18.0,No,No,Hypertension,8.0
PT04425,Germany,North Rhine-Westphalia,88.0,Female,Breast,III,,2012-12-07,2013-02-16,Targeted Therapy,,Lost to Follow-up,,EGFR,Yes,Never,None,39.7,,Urban,NHS,17.0,No,No,,8.0
PT04426,Poland,Lesser Poland,50.0,Male,,II,2021-11-30,2022-04-19,,Radiation,Public,Alive,68.0,BRCA1,Yes,Never,None,28.4,Medium,Rural,,6.0,Yes,No,Diabetes,8.0
PT04427,Finland,Pirkanmaa,89.0,Female,Leukemia,III,2013-04-09,2013-09-21,2014-08-02,,Public,Lost to Follow-up,,KRAS,,Never,Moderate,32.5,Medium,Urban,Private Insurance,3.0,No,No,Hypertension,9.0
PT04428,Germany,Bavaria,75.0,Male,Pancreatic,I,2019-03-14,2019-06-20,2020-01-13,Targeted Therapy,Public,Deceased,87.0,EGFR,Yes,Never,Moderate,,Medium,Urban,NHS,16.0,No,,None,4.0
PT04429,Finland,Pirkanmaa,47.0,Male,Leukemia,II,2010-08-22,2010-10-16,2011-07-14,Targeted Therapy,Public,Alive,113.0,KRAS,No,Current,None,23.7,High,Urban,Statutory Health Insurance,16.0,No,,Diabetes,3.0
PT04430,Finland,Pirkanmaa,35.0,Female,Breast,IV,2017-12-30,2018-02-13,2018-10-27,Targeted Therapy,Public,Alive,23.0,None,Yes,Never,None,20.1,Medium,Rural,Statutory Health Insurance,10.0,No,,,4.0
PT04431,Sweden,Västra Götaland,73.0,Female,Colorectal,II,2014-09-15,2015-02-18,2016-01-14,Surgery,Public,Alive,15.0,BRCA1,No,Current,Moderate,35.2,Medium,Urban,Statutory Health Insurance,12.0,No,No,Hypertension,5.0
PT04432,Belgium,Flanders,72.0,Male,Breast,II,2011-05-08,2011-07-06,2012-05-17,,Private,Alive,115.0,,No,Former,Moderate,30.4,High,Urban,Private Insurance,3.0,No,,Obesity,2.0
PT04433,France,Provence-Alpes-Côte d'Azur,31.0,Male,Pancreatic,I,2018-12-27,2019-05-11,2019-07-25,Surgery,Private,Alive,85.0,,No,Never,None,22.6,Medium,Rural,NHS,15.0,No,No,None,10.0
,Spain,Catalonia,39.0,Non-binary,Leukemia,I,2015-07-08,2015-12-23,2016-03-07,Chemotherapy,,Deceased,92.0,EGFR,No,Former,Moderate,32.7,Medium,Urban,Private Insurance,10.0,No,No,,5.0
,Belgium,Brussels,53.0,Female,Lung,I,2021-11-03,2022-03-04,2022-11-13,Radiation,Public,Alive,36.0,KRAS,No,Never,None,23.4,Medium,Urban,Private Insurance,16.0,No,No,None,6.0
PT04436,Sweden,Västra Götaland,72.0,,Lung,II,2010-12-11,2011-04-15,2011-05-19,Targeted Therapy,Private,Deceased,58.0,KRAS,Yes,,None,22.7,Low,Urban,NHS,13.0,No,,Hypertension,10.0
PT04437,Italy,Lombardy,,Male,,IV,2010-09-22,2010-11-13,2011-09-04,Surgery,Private,Alive,103.0,BRCA1,No,Never,None,37.2,Medium,,Statutory Health Insurance,7.0,No,No,Diabetes,2.0
,,North Rhine-Westphalia,42.0,Female,Colorectal,IV,2019-10-16,2019-10-27,2020-03-14,Targeted Therapy,Private,Alive,49.0,None,Yes,Never,None,28.9,Low,Rural,NHS,16.0,No,No,Diabetes,1.0
PT04439,Ireland,Connacht,46.0,Male,Ovarian,III,2023-04-02,2023-07-07,2024-04-04,Targeted Therapy,Public,Alive,34.0,None,Yes,,Moderate,29.7,,Urban,Private Insurance,3.0,No,No,Hypertension,3.0
PT04440,Sweden,Skåne,36.0,Male,Ovarian,IV,,2015-01-25,2015-07-24,Targeted Therapy,,Alive,54.0,EGFR,No,Never,,,High,Urban,Statutory Health Insurance,10.0,No,No,Diabetes,9.0
PT04441,Sweden,Stockholm,67.0,Male,Pancreatic,II,2019-12-27,2020-02-15,2020-03-22,Surgery,Public,Alive,85.0,KRAS,No,Former,Moderate,28.5,High,Urban,Statutory Health Insurance,14.0,No,No,,1.0
PT04442,Switzerland,Geneva,40.0,Female,Prostate,,2011-03-05,2011-06-09,2012-05-17,Targeted Therapy,Private,Alive,62.0,,,Never,Heavy,23.3,High,Urban,Private Insurance,15.0,No,No,Diabetes,8.0
PT04443,France,Île-de-France,69.0,Male,Ovarian,I,2018-08-29,2018-12-30,2019-11-27,Radiation,Public,Alive,99.0,EGFR,No,Current,None,34.1,High,Urban,Statutory Health Insurance,18.0,No,No,Cardiovascular Disease,5.0
PT04444,France,,59.0,Female,Prostate,III,,2018-02-06,2018-12-09,Chemotherapy,Public,Alive,94.0,EGFR,No,Never,None,36.7,Low,Urban,Private Insurance,,Yes,No,Hypertension,5.0
PT04445,Germany,Bavaria,22.0,Male,Lung,I,2011-03-30,2011-08-11,2012-02-15,Immunotherapy,Private,Deceased,106.0,EGFR,Yes,Never,None,32.0,Low,Urban,NHS,12.0,No,No,Obesity,4.0
,France,Île-de-France,36.0,Male,Breast,II,2010-12-15,2011-02-03,2011-08-06,Radiation,Private,Alive,,EGFR,No,Never,Moderate,35.6,Medium,Urban,Statutory Health Insurance,13.0,Yes,No,Diabetes,1.0
PT04447,Spain,Madrid,80.0,Male,Prostate,III,2011-02-26,2011-05-19,2011-08-28,Chemotherapy,Private,Lost to Follow-up,,BRCA1,No,Former,None,18.6,Low,Urban,NHS,16.0,No,No,None,8.0
PT04448,Denmark,Central Denmark,69.0,Male,Prostate,I,2017-07-25,2017-12-03,2018-05-18,Immunotherapy,Public,Alive,53.0,BRCA1,No,Current,Moderate,28.7,Low,Rural,Private Insurance,18.0,Yes,No,Hypertension,2.0
PT04449,Portugal,Algarve,25.0,Male,Ovarian,I,2023-02-03,,,Targeted Therapy,Research Institute,Alive,88.0,None,No,Never,None,27.2,Medium,Urban,NHS,16.0,No,No,Obesity,7.0
PT04450,Norway,,,Male,Colorectal,I,2011-08-05,2011-09-02,2012-02-28,Radiation,Private,Alive,101.0,None,No,Former,Moderate,19.3,High,Urban,Statutory Health Insurance,17.0,No,,Diabetes,1.0
PT04451,Denmark,Capital Region,74.0,,Ovarian,II,2017-04-16,2017-09-23,2017-12-11,Immunotherapy,Private,Deceased,119.0,BRCA1,No,Former,Moderate,22.6,High,Urban,Private Insurance,3.0,No,No,Diabetes,1.0
PT04452,Sweden,Västra Götaland,77.0,Male,Lung,I,2021-08-29,2022-02-12,2022-06-22,,Public,Alive,106.0,EGFR,No,Never,None,27.5,Medium,,NHS,14.0,Yes,Yes,Obesity,2.0
PT04453,Norway,Trøndelag,64.0,Female,Breast,II,2016-06-09,2016-11-03,2017-05-19,Immunotherapy,Research Institute,Alive,64.0,None,No,Never,None,33.0,Medium,Rural,Statutory Health Insurance,11.0,No,No,Cardiovascular Disease,2.0
PT04454,Denmark,Capital Region,38.0,,,II,2016-06-24,2016-10-31,2017-02-03,Targeted Therapy,Public,Alive,108.0,BRCA1,No,Never,None,26.5,Medium,Urban,Private Insurance,8.0,No,No,Obesity,6.0
PT04455,Ireland,Connacht,,Female,Breast,II,2012-10-26,2013-04-05,2014-01-01,Chemotherapy,Public,Lost to Follow-up,,KRAS,Yes,Current,Moderate,33.9,Low,Urban,Private Insurance,8.0,No,No,Obesity,6.0
PT04456,Austria,Tyrol,42.0,Female,Ovarian,,2013-08-17,2013-09-19,2014-03-14,Chemotherapy,Public,Alive,17.0,BRCA1,Yes,Former,Moderate,32.8,High,Urban,NHS,11.0,No,,Cardiovascular Disease,
PT04457,Austria,Tyrol,51.0,Male,Breast,IV,2010-04-11,2010-04-22,2011-01-18,Radiation,Private,Alive,20.0,KRAS,Yes,Never,Moderate,39.2,Medium,Urban,NHS,15.0,,Yes,Obesity,5.0
PT04458,France,Provence-Alpes-Côte d'Azur,29.0,,Prostate,II,2011-02-20,2011-03-20,2011-08-12,Targeted Therapy,Private,Alive,61.0,None,No,Current,Moderate,21.1,Low,Urban,Private Insurance,8.0,No,No,None,9.0
PT04459,Switzerland,Bern,68.0,Female,Colorectal,III,2023-11-08,2023-12-25,2024-10-21,Chemotherapy,Research Institute,,84.0,KRAS,,Never,Moderate,39.4,Low,Urban,Private Insurance,16.0,No,No,Diabetes,7.0
PT04460,Portugal,Algarve,84.0,Male,Prostate,III,2013-10-15,2014-03-09,2014-08-17,Radiation,,Deceased,89.0,BRCA1,No,Former,Moderate,19.8,Medium,Urban,NHS,16.0,Yes,No,Obesity,5.0
PT04461,Portugal,Algarve,48.0,Female,Leukemia,II,2016-08-30,2016-11-12,2017-10-12,Chemotherapy,Public,Alive,65.0,KRAS,,Never,Moderate,35.9,Medium,Urban,NHS,11.0,No,Yes,Cardiovascular Disease,5.0
PT04462,Finland,Southwest Finland,78.0,Female,Breast,I,2012-11-09,2013-01-20,2013-03-28,Surgery,Private,Alive,75.0,KRAS,Yes,Former,Moderate,24.9,Medium,Rural,Statutory Health Insurance,7.0,,No,None,
PT04463,Netherlands,North Holland,64.0,Non-binary,Colorectal,II,2014-10-13,2015-02-27,2015-08-10,Targeted Therapy,Public,Alive,24.0,BRCA1,Yes,Former,Moderate,27.3,High,Rural,Private Insurance,7.0,No,No,None,5.0
PT04464,Austria,Styria,86.0,Female,,III,2022-04-19,2022-07-11,2023-02-08,Surgery,Public,Deceased,58.0,None,Yes,Former,,24.1,Medium,Rural,Private Insurance,12.0,No,No,None,6.0
PT04465,Sweden,Västra Götaland,70.0,Male,Prostate,II,2022-03-02,2022-06-24,2022-08-06,Chemotherapy,Public,Alive,,None,No,Former,Moderate,35.9,High,Urban,NHS,13.0,No,No,Cardiovascular Disease,5.0
PT04466,Italy,,30.0,Male,Leukemia,I,2013-07-12,2013-07-20,2014-03-10,Chemotherapy,Public,Deceased,67.0,None,Yes,Never,Heavy,28.5,High,Rural,NHS,8.0,No,No,Hypertension,6.0
PT04467,France,Auvergne-Rhône-Alpes,25.0,Female,Pancreatic,I,2023-04-23,2023-07-01,2023-10-23,Surgery,Private,Deceased,32.0,KRAS,No,Current,Moderate,32.8,Low,Urban,Statutory Health Insurance,2.0,No,Yes,Cardiovascular Disease,3.0
PT04468,Ireland,Connacht,86.0,Non-binary,Leukemia,II,2021-05-02,2021-07-19,2022-04-18,Targeted Therapy,Public,Alive,104.0,,No,Never,,38.9,Medium,Urban,NHS,12.0,No,No,Cardiovascular Disease,6.0
PT04469,Switzerland,,81.0,Female,Leukemia,I,2021-06-02,2021-07-17,2022-06-01,Radiation,Public,Alive,102.0,None,Yes,Current,Moderate,26.1,Low,Urban,Private Insurance,15.0,Yes,No,None,10.0
PT04470,Finland,Southwest Finland,24.0,Female,Prostate,,2021-05-11,2021-10-19,2022-04-15,Immunotherapy,Public,Alive,115.0,EGFR,,Never,None,28.6,Medium,Urban,Statutory Health Insurance,1.0,No,Yes,Hypertension,7.0
PT04471,Norway,Oslo,28.0,Male,Lung,I,2020-10-29,2021-02-13,2021-07-19,Surgery,Private,Alive,88.0,EGFR,Yes,Never,None,19.5,Medium,Urban,Statutory Health Insurance,7.0,No,No,Diabetes,8.0
PT04472,Portugal,Porto,47.0,Male,Ovarian,II,2010-02-07,2010-03-17,2011-02-28,Targeted Therapy,Public,Deceased,45.0,KRAS,No,Former,,31.2,Medium,Urban,Statutory Health Insurance,15.0,Yes,No,Diabetes,2.0
PT04473,France,Provence-Alpes-Côte d'Azur,57.0,Female,Colorectal,III,2012-02-05,2012-06-24,2013-05-17,Targeted Therapy,Private,Alive,41.0,KRAS,Yes,Never,None,25.0,,Urban,Private Insurance,9.0,No,No,None,6.0
PT04474,Portugal,,,Female,Breast,III,2020-08-13,2020-10-19,2021-01-27,Immunotherapy,Research Institute,Alive,74.0,,Yes,Never,Moderate,31.4,Medium,Urban,,14.0,No,Yes,Diabetes,7.0
PT04475,Norway,Vestland,40.0,Non-binary,,II,2016-09-30,2017-01-12,2017-05-06,Radiation,Research Institute,Alive,25.0,BRCA1,No,Former,Moderate,24.7,Medium,Urban,Statutory Health Insurance,6.0,No,No,Diabetes,10.0
PT04476,Netherlands,South Holland,81.0,Female,Prostate,I,2023-02-28,2023-08-04,2024-01-18,Radiation,Public,Alive,103.0,None,No,Never,None,20.4,Medium,Rural,Private Insurance,19.0,Yes,Yes,Hypertension,10.0
PT04477,,Madrid,65.0,Male,Pancreatic,I,2023-04-06,2023-09-03,2024-07-05,Chemotherapy,Public,Alive,53.0,EGFR,No,Never,None,24.7,Medium,Urban,NHS,10.0,No,No,Hypertension,2.0
PT04478,Norway,Vestland,89.0,Female,Colorectal,II,2017-12-01,2018-05-12,2018-10-01,,Private,Alive,76.0,EGFR,Yes,Former,None,36.1,Medium,Rural,NHS,19.0,Yes,No,Hypertension,5.0
PT04479,Netherlands,North Holland,57.0,Female,Breast,II,2010-04-26,,2010-10-05,Surgery,Private,Alive,103.0,EGFR,No,Former,None,22.0,,Rural,Private Insurance,13.0,Yes,No,None,3.0
PT04480,Germany,North Rhine-Westphalia,68.0,Female,Pancreatic,II,2010-10-06,2011-01-13,2011-05-11,Radiation,Private,Alive,60.0,EGFR,No,Never,Moderate,21.9,Medium,Urban,Private Insurance,16.0,No,No,Diabetes,10.0
PT04481,Belgium,Wallonia,58.0,Male,Colorectal,I,2011-03-30,2011-09-13,2011-12-28,Surgery,Public,Alive,63.0,KRAS,Yes,Former,Moderate,36.1,Low,Urban,NHS,1.0,Yes,Yes,Hypertension,4.0
PT04482,Norway,Oslo,49.0,Male,,IV,2018-10-19,2019-03-12,2019-08-07,Chemotherapy,Public,Alive,97.0,EGFR,Yes,Current,None,23.7,Low,Rural,Statutory Health Insurance,19.0,No,No,Cardiovascular Disease,9.0
PT04483,Italy,Veneto,40.0,Female,Ovarian,I,2022-11-17,2023-04-25,2024-03-25,Surgery,Public,Alive,44.0,EGFR,No,Never,None,25.3,Low,Urban,Statutory Health Insurance,16.0,No,No,Diabetes,8.0
PT04484,Belgium,Flanders,20.0,Male,Breast,II,2022-03-23,2022-09-16,2023-07-25,Immunotherapy,Public,Deceased,115.0,KRAS,No,,Moderate,29.9,Low,Urban,,,No,No,Hypertension,6.0
PT04485,Finland,Uusimaa,51.0,Female,Leukemia,IV,2022-03-24,2022-05-07,2023-01-20,Surgery,Private,Deceased,91.0,,,Never,None,27.3,Low,Urban,NHS,9.0,Yes,No,,7.0
PT04486,Norway,Vestland,27.0,Male,Pancreatic,III,2010-10-28,2010-12-13,2011-05-27,Chemotherapy,Public,Deceased,46.0,BRCA1,No,Former,Moderate,36.1,Low,,Statutory Health Insurance,17.0,Yes,No,None,7.0
PT04487,Poland,Masovian,,Male,Pancreatic,II,2011-12-18,2012-04-25,2012-09-24,Chemotherapy,Private,Lost to Follow-up,,None,No,Current,Moderate,30.7,Medium,Urban,NHS,18.0,,Yes,Hypertension,3.0
PT04488,Austria,Tyrol,49.0,Female,Prostate,,2023-11-15,2024-03-16,2024-10-30,Immunotherapy,Public,Alive,55.0,None,No,Never,Moderate,33.7,Medium,Urban,NHS,10.0,Yes,No,None,7.0
PT04489,Norway,Vestland,27.0,Male,Lung,IV,2013-10-07,2013-11-20,2014-01-18,Immunotherapy,Private,Alive,64.0,KRAS,Yes,Former,None,33.6,Medium,Urban,Statutory Health Insurance,2.0,No,Yes,Diabetes,5.0
PT04490,Ireland,Connacht,38.0,Female,Ovarian,I,2010-07-14,2010-10-06,2010-11-22,Radiation,Research Institute,Alive,61.0,EGFR,Yes,Never,Moderate,19.7,Medium,Urban,Private Insurance,19.0,No,No,None,1.0
PT04491,Netherlands,South Holland,78.0,Male,Leukemia,III,2013-08-21,,2014-01-07,Immunotherapy,Private,Deceased,109.0,EGFR,No,Never,Moderate,39.4,High,Urban,Statutory Health Insurance,15.0,No,No,Diabetes,
PT04492,Portugal,Lisbon,74.0,Female,Leukemia,IV,2021-12-02,2022-02-24,2022-05-02,Immunotherapy,Public,Alive,58.0,EGFR,No,Former,Moderate,19.6,Low,Urban,NHS,15.0,No,No,Diabetes,4.0
PT04493,Sweden,Västra Götaland,49.0,Male,Colorectal,I,2015-06-03,2015-09-07,,Radiation,Public,Alive,107.0,BRCA1,No,Former,Moderate,38.9,Medium,Urban,Private Insurance,,No,No,Obesity,2.0
PT04494,Germany,Berlin,55.0,Male,Pancreatic,III,,2014-05-23,2015-02-24,Immunotherapy,Private,Lost to Follow-up,,BRCA1,No,Never,Moderate,39.7,Medium,Urban,Statutory Health Insurance,9.0,No,No,Diabetes,5.0
PT04495,Finland,Uusimaa,74.0,Female,Breast,IV,2018-07-22,2018-10-02,2018-11-30,Targeted Therapy,Research Institute,Deceased,68.0,BRCA1,Yes,Never,Moderate,23.7,High,Urban,,17.0,No,No,None,2.0
PT04496,France,Auvergne-Rhône-Alpes,63.0,Female,Breast,III,2023-05-15,2023-10-23,2024-03-19,Targeted Therapy,Public,Alive,46.0,None,,Never,None,32.2,Medium,Urban,NHS,4.0,No,Yes,Hypertension,2.0
PT04497,Ireland,Munster,46.0,Male,Ovarian,II,2011-06-13,2011-12-03,2012-10-13,Targeted Therapy,Private,Alive,119.0,KRAS,Yes,Never,Moderate,19.2,Medium,Rural,NHS,17.0,Yes,No,Cardiovascular Disease,3.0
PT04498,Netherlands,Utrecht,73.0,Non-binary,Colorectal,IV,2011-05-13,2011-08-15,2011-11-26,Immunotherapy,Public,Deceased,35.0,None,No,Never,Heavy,33.0,Low,Urban,NHS,2.0,No,No,Diabetes,9.0
PT04499,Belgium,Wallonia,67.0,Female,Pancreatic,II,2014-12-16,2015-04-26,2015-08-04,Chemotherapy,Private,Alive,60.0,EGFR,Yes,Current,None,,Low,Rural,Statutory Health Insurance,12.0,Yes,Yes,Obesity,3.0
PT04500,Norway,Oslo,49.0,Female,Prostate,III,2017-10-16,2018-03-17,2019-01-13,Chemotherapy,Public,Deceased,90.0,None,No,Former,Moderate,38.7,High,Urban,Statutory Health Insurance,16.0,No,No,Cardiovascular Disease,10.0
PT04501,Austria,Styria,58.0,Female,Breast,II,2015-10-27,2016-04-03,2017-03-23,Radiation,Public,Deceased,,BRCA1,No,Never,None,32.4,High,Urban,NHS,5.0,No,No,Obesity,3.0
PT04502,Belgium,Wallonia,32.0,Male,Leukemia,I,2010-11-16,2011-01-26,2011-09-25,,Private,,45.0,EGFR,No,Former,Moderate,34.8,Medium,Rural,Statutory Health Insurance,2.0,No,No,Cardiovascular Disease,4.0
PT04503,Netherlands,South Holland,35.0,Male,Leukemia,I,2019-03-18,2019-04-27,2020-04-25,Chemotherapy,Public,Alive,78.0,None,No,Never,Moderate,38.8,Low,Urban,Private Insurance,13.0,No,No,Cardiovascular Disease,3.0
PT04504,Ireland,Dublin,63.0,Male,Pancreatic,I,2017-01-13,2017-07-10,2017-12-27,Radiation,Research Institute,Alive,41.0,BRCA1,No,Never,Moderate,36.9,Low,Urban,Private Insurance,,No,No,Hypertension,5.0
PT04505,Austria,Tyrol,46.0,Female,Breast,I,2019-04-10,2019-06-23,2020-03-16,Targeted Therapy,Private,Alive,18.0,None,Yes,Former,None,,Medium,Urban,NHS,17.0,No,Yes,None,5.0
PT04506,Portugal,Algarve,64.0,Male,Breast,I,2022-11-23,2022-12-08,2023-01-13,Radiation,Private,Alive,51.0,None,No,Current,Moderate,21.8,Medium,Rural,Private Insurance,2.0,No,No,Cardiovascular Disease,5.0
,Poland,,54.0,,Prostate,II,2022-12-09,2023-04-07,2023-12-08,Chemotherapy,Private,Deceased,102.0,KRAS,Yes,Former,None,25.1,Low,Rural,Statutory Health Insurance,17.0,,No,Obesity,7.0
PT04508,Spain,Catalonia,47.0,Male,Pancreatic,I,2017-06-09,2017-06-30,2017-10-05,Chemotherapy,Public,Alive,95.0,KRAS,No,Current,Moderate,31.0,Medium,Urban,NHS,11.0,No,No,Hypertension,4.0
PT04509,Switzerland,Bern,26.0,Male,,IV,2019-02-21,2019-03-14,2020-02-22,Radiation,Private,Alive,6.0,EGFR,No,Never,,34.4,Low,Rural,NHS,8.0,No,No,Diabetes,10.0
PT04510,Switzerland,Zurich,81.0,Female,Prostate,III,2010-09-02,2010-11-01,2011-03-15,Immunotherapy,Research Institute,Alive,65.0,EGFR,No,Former,None,23.6,,Urban,NHS,2.0,Yes,Yes,Diabetes,3.0
PT04511,Italy,Veneto,70.0,Female,Leukemia,II,2017-06-12,2017-09-26,2017-11-29,Chemotherapy,Private,Alive,7.0,BRCA1,Yes,Never,Moderate,27.9,High,Urban,Statutory Health Insurance,4.0,Yes,No,Diabetes,
PT04512,Portugal,Algarve,,Female,Prostate,II,2012-05-19,2012-07-23,2012-09-19,Chemotherapy,Public,,41.0,EGFR,No,Current,Moderate,25.9,Medium,Rural,Private Insurance,17.0,No,No,Diabetes,3.0
PT04513,Belgium,Brussels,39.0,Female,Breast,I,2013-12-30,2014-05-28,2014-10-23,Radiation,Private,Deceased,50.0,None,Yes,Never,Moderate,28.4,Medium,,NHS,8.0,No,Yes,Cardiovascular Disease,1.0
PT04514,Spain,Andalusia,57.0,Female,Lung,II,2021-04-02,2021-06-10,2021-08-12,Chemotherapy,Public,Alive,99.0,,No,Current,Moderate,25.3,Medium,,Statutory Health Insurance,2.0,No,No,Obesity,9.0
PT04515,Poland,,80.0,Non-binary,Pancreatic,III,2011-11-02,2012-02-20,2012-12-05,Immunotherapy,Private,Deceased,85.0,,No,Never,Moderate,21.5,Low,Urban,Private Insurance,16.0,No,No,None,3.0
PT04516,Finland,Southwest Finland,51.0,Male,Ovarian,III,2022-12-20,2023-01-15,2024-01-01,Immunotherapy,Research Institute,Alive,,EGFR,Yes,Former,None,28.7,Low,Urban,NHS,14.0,No,No,Diabetes,4.0
PT04517,Sweden,Stockholm,45.0,Male,Breast,I,2011-11-17,2012-01-31,2013-01-07,Radiation,Public,Deceased,20.0,EGFR,,Current,None,38.9,Medium,Urban,NHS,4.0,No,,,6.0
,Poland,Silesian,77.0,Male,Lung,,2023-10-07,2023-12-01,2024-05-10,Surgery,Public,Alive,44.0,EGFR,Yes,Never,None,20.3,Medium,Urban,Statutory Health Insurance,8.0,No,No,Cardiovascular Disease,6.0
,Belgium,Brussels,58.0,Male,Leukemia,III,2015-05-29,2015-09-19,2016-05-06,Targeted Therapy,Public,Deceased,60.0,EGFR,No,Current,Moderate,36.4,High,Rural,NHS,2.0,Yes,No,Hypertension,
PT04520,Norway,Trøndelag,39.0,Female,Pancreatic,II,2023-10-07,2023-11-22,2024-04-12,Immunotherapy,Public,Deceased,64.0,KRAS,Yes,Current,None,34.2,Medium,Urban,Private Insurance,13.0,No,No,Cardiovascular Disease,10.0
,Italy,Sicily,69.0,,Ovarian,I,2012-10-08,,,Immunotherapy,Public,,91.0,BRCA1,No,,Moderate,25.2,High,Urban,NHS,4.0,No,Yes,None,3.0
PT04522,Ireland,,71.0,Male,Colorectal,II,2013-10-16,2014-02-25,2015-01-31,Targeted Therapy,Public,Alive,84.0,KRAS,Yes,Former,Moderate,21.0,Low,,Statutory Health Insurance,15.0,No,No,Obesity,6.0
PT04523,Italy,,41.0,,Pancreatic,II,2021-05-01,2021-10-21,2021-11-25,Radiation,Research Institute,Alive,9.0,EGFR,No,Never,Moderate,38.5,High,Rural,Statutory Health Insurance,16.0,No,No,None,3.0
PT04524,Austria,Styria,72.0,Female,Leukemia,II,2012-06-29,2012-08-22,2012-10-19,Chemotherapy,Private,Alive,21.0,None,No,Never,Moderate,26.3,Medium,,Private Insurance,13.0,Yes,No,Diabetes,7.0
PT04525,Austria,Styria,85.0,Male,Leukemia,II,2013-08-10,2014-01-29,2014-08-11,Radiation,Public,Alive,110.0,EGFR,No,Never,Heavy,27.6,Low,Rural,Private Insurance,8.0,No,No,Hypertension,8.0
PT04526,Sweden,,62.0,Female,Leukemia,I,2018-07-24,2018-10-19,2018-12-24,Surgery,Public,Deceased,16.0,EGFR,No,Former,None,25.0,Low,Urban,NHS,19.0,No,,Obesity,3.0
PT04527,Germany,North Rhine-Westphalia,42.0,Female,Prostate,I,2011-07-21,2011-10-25,2012-01-25,Surgery,Private,Deceased,117.0,EGFR,No,Never,None,36.7,Low,Urban,NHS,1.0,,Yes,Hypertension,5.0
PT04528,Spain,Catalonia,83.0,Female,Ovarian,I,2020-09-22,2021-01-20,2021-10-15,Targeted Therapy,Public,Alive,101.0,BRCA1,No,Never,Moderate,23.0,Medium,Urban,NHS,11.0,No,,Hypertension,6.0
PT04529,Portugal,Lisbon,28.0,Female,Leukemia,I,2014-01-05,2014-02-10,2014-11-16,,Research Institute,Alive,27.0,BRCA1,Yes,Former,None,34.7,Low,Rural,Statutory Health Insurance,17.0,No,No,Diabetes,3.0
PT04530,Portugal,Algarve,26.0,Male,Colorectal,I,2021-07-04,2021-08-07,2022-03-09,Surgery,Research Institute,Alive,70.0,EGFR,No,Never,Moderate,23.4,High,Rural,Private Insurance,18.0,,Yes,Cardiovascular Disease,5.0
PT04531,Germany,Bavaria,60.0,Male,Breast,,2013-04-22,2013-09-03,2014-06-06,Targeted Therapy,Public,Alive,59.0,None,No,Former,Heavy,25.5,Medium,Urban,NHS,13.0,No,,Hypertension,4.0
PT04532,Belgium,Flanders,73.0,Male,Lung,I,2019-10-11,,2020-06-02,Targeted Therapy,Private,Alive,95.0,,Yes,Former,Moderate,38.3,Low,Rural,Private Insurance,3.0,No,No,Hypertension,7.0
PT04533,Switzerland,Zurich,84.0,Female,,III,2016-10-01,2016-12-26,2017-03-29,Targeted Therapy,Public,Alive,8.0,KRAS,No,Never,Moderate,31.6,Medium,Rural,Private Insurance,3.0,No,Yes,None,3.0
PT04534,Poland,Masovian,21.0,Male,Pancreatic,III,2021-05-07,2021-06-09,2022-02-16,Targeted Therapy,Public,Alive,101.0,BRCA1,No,Never,Moderate,33.2,Low,Urban,Statutory Health Insurance,7.0,No,No,Obesity,8.0
PT04535,Germany,Bavaria,23.0,Male,,II,2021-11-27,2022-01-21,2022-06-21,Targeted Therapy,Private,Alive,102.0,EGFR,No,Former,Moderate,31.8,Medium,Urban,NHS,19.0,No,No,Cardiovascular Disease,4.0
PT04536,Switzerland,Zurich,51.0,Female,,II,2020-10-01,2020-10-24,2021-04-02,Immunotherapy,Private,Deceased,102.0,None,Yes,Never,None,21.9,Medium,Urban,Private Insurance,15.0,No,No,,4.0
PT04537,,Flanders,21.0,,Leukemia,III,2018-08-07,2018-12-10,2019-11-03,Chemotherapy,Private,Deceased,71.0,None,No,Never,Moderate,32.6,Low,Rural,Statutory Health Insurance,14.0,No,No,None,8.0
PT04538,Poland,Masovian,83.0,Female,Prostate,III,2019-08-15,2019-09-28,2020-02-29,Targeted Therapy,Private,Alive,91.0,EGFR,No,Former,Moderate,29.9,High,Rural,Statutory Health Insurance,14.0,No,No,None,4.0
PT04539,Belgium,Flanders,33.0,Male,Lung,I,2020-12-24,,2021-05-27,,Research Institute,Deceased,62.0,None,No,Never,Moderate,36.2,High,Urban,NHS,12.0,No,No,Hypertension,3.0
PT04540,,Southwest Finland,39.0,Male,Leukemia,III,2017-11-17,2017-12-15,2018-11-20,Surgery,Private,Deceased,17.0,EGFR,No,Never,Moderate,39.7,,Rural,Private Insurance,9.0,No,No,None,
PT04541,Norway,Trøndelag,68.0,Male,Leukemia,II,,2014-01-04,2014-03-10,Immunotherapy,Public,Alive,71.0,None,Yes,,None,31.7,Medium,Rural,NHS,4.0,No,No,Diabetes,3.0
PT04542,Denmark,Zealand,27.0,Female,Colorectal,II,2014-04-18,2014-06-05,2014-10-20,Targeted Therapy,Private,Alive,106.0,None,No,Former,None,25.4,Medium,Urban,Private Insurance,4.0,Yes,No,Cardiovascular Disease,9.0
PT04543,Netherlands,South Holland,82.0,Male,Colorectal,,2012-01-11,,2012-10-11,Immunotherapy,Private,Deceased,13.0,KRAS,No,Current,None,36.9,Low,Urban,Private Insurance,18.0,No,Yes,Cardiovascular Disease,4.0
PT04544,Italy,Lombardy,,Female,Ovarian,,2011-12-01,2012-01-29,2012-06-09,Radiation,Research Institute,Lost to Follow-up,,EGFR,No,Current,Moderate,36.6,High,Urban,Statutory Health Insurance,17.0,No,No,Cardiovascular Disease,2.0
PT04545,Poland,Masovian,40.0,Non-binary,Colorectal,IV,2011-12-04,2012-01-16,2012-03-04,Chemotherapy,Private,Alive,86.0,None,No,Never,None,36.8,Medium,Urban,NHS,5.0,No,Yes,None,3.0
PT04546,France,Provence-Alpes-Côte d'Azur,51.0,Male,Ovarian,II,2022-01-06,2022-06-26,2023-01-28,Targeted Therapy,Private,Deceased,9.0,EGFR,Yes,Never,None,25.9,Medium,Urban,NHS,15.0,,,Diabetes,5.0
PT04547,Denmark,Zealand,27.0,Male,,II,2012-08-13,2013-01-01,2013-09-21,Chemotherapy,Public,Alive,49.0,KRAS,No,Never,Moderate,27.1,Medium,Urban,Statutory Health Insurance,,Yes,No,Diabetes,4.0
PT04548,Germany,North Rhine-Westphalia,35.0,Female,Ovarian,II,2012-05-23,2012-08-03,2012-12-04,Chemotherapy,Research Institute,,70.0,KRAS,Yes,Current,Moderate,34.9,High,Urban,Statutory Health Insurance,11.0,,No,Obesity,
PT04549,Italy,Lombardy,59.0,Female,Lung,III,2016-08-05,2016-09-17,2017-06-04,Radiation,Public,Alive,,None,No,Current,None,27.3,Medium,Urban,Statutory Health Insurance,11.0,No,No,Diabetes,6.0
PT04550,Finland,Southwest Finland,46.0,Female,Prostate,,2022-08-03,2022-08-16,2023-01-20,Chemotherapy,Private,Alive,67.0,KRAS,No,Current,Moderate,28.8,Low,Rural,Private Insurance,8.0,No,No,Hypertension,10.0
PT04551,Germany,Bavaria,37.0,Male,Breast,III,2019-04-02,2019-09-12,2020-08-21,Surgery,Research Institute,Alive,45.0,KRAS,Yes,Former,None,18.2,Medium,Urban,Statutory Health Insurance,9.0,,No,,4.0
PT04552,Netherlands,South Holland,54.0,Male,Leukemia,III,2014-12-26,2015-05-14,,Chemotherapy,Public,Alive,91.0,BRCA1,No,Never,None,,Medium,Rural,Statutory Health Insurance,2.0,,No,None,5.0
PT04553,Ireland,Dublin,71.0,Female,Leukemia,II,2022-12-28,,2024-03-09,Radiation,Research Institute,Alive,40.0,None,No,Current,None,28.5,High,Urban,Private Insurance,19.0,Yes,Yes,Cardiovascular Disease,10.0
PT04554,Denmark,Capital Region,34.0,Female,Leukemia,I,2021-06-13,2021-09-27,2022-06-25,Radiation,Private,Alive,55.0,None,No,Never,None,37.9,Medium,Rural,NHS,4.0,No,,Cardiovascular Disease,2.0
PT04555,,North Rhine-Westphalia,82.0,Male,Colorectal,I,2022-01-09,2022-06-12,2022-11-03,Targeted Therapy,Research Institute,Deceased,45.0,BRCA1,Yes,Current,Moderate,39.4,Medium,Urban,Private Insurance,7.0,Yes,No,Hypertension,5.0
PT04556,Poland,Silesian,72.0,Female,Leukemia,III,2018-11-17,2019-02-19,2019-08-19,Surgery,Public,Alive,16.0,BRCA1,No,Former,None,21.5,High,Urban,Private Insurance,13.0,,No,Obesity,3.0
PT04557,Belgium,Flanders,85.0,Female,Ovarian,IV,2013-10-11,2013-11-30,2014-04-24,Chemotherapy,Private,,71.0,KRAS,No,Current,None,19.9,High,Urban,Private Insurance,11.0,No,No,None,1.0
PT04558,Ireland,Dublin,50.0,Male,Colorectal,II,2010-10-06,2010-11-24,2011-09-11,Radiation,Public,Alive,23.0,KRAS,No,Never,Moderate,32.7,Low,Urban,Private Insurance,10.0,No,No,Obesity,5.0
PT04559,Austria,Tyrol,80.0,Female,Breast,II,2021-11-26,,2022-12-12,Radiation,Public,Deceased,78.0,None,Yes,Former,Moderate,23.6,High,Rural,NHS,1.0,No,No,Cardiovascular Disease,2.0
PT04560,Denmark,,83.0,Male,Prostate,I,2012-10-28,2013-01-26,2013-09-02,Chemotherapy,Private,Alive,75.0,KRAS,No,Never,Moderate,27.7,Medium,Urban,NHS,6.0,Yes,No,Obesity,5.0
PT04561,Netherlands,North Holland,53.0,Female,Prostate,II,2022-10-26,2023-01-25,,Chemotherapy,,Alive,39.0,EGFR,No,Former,None,18.2,Low,Urban,Statutory Health Insurance,1.0,No,No,Diabetes,1.0
PT04562,,Capital Region,74.0,Female,Ovarian,II,2013-09-05,2013-11-30,,Targeted Therapy,Private,Deceased,17.0,EGFR,No,Never,None,27.4,Low,Urban,NHS,15.0,No,No,Diabetes,2.0
PT04563,Belgium,Brussels,78.0,Male,Prostate,III,2011-08-28,2011-09-10,2012-07-27,Targeted Therapy,Private,Alive,26.0,None,Yes,Never,Moderate,39.4,Medium,Urban,Statutory Health Insurance,17.0,No,Yes,Cardiovascular Disease,4.0
PT04564,,Veneto,22.0,Female,Colorectal,,,2017-09-23,2018-08-03,Surgery,Public,Alive,65.0,EGFR,No,Former,Heavy,20.1,Medium,Rural,Statutory Health Insurance,4.0,No,No,Obesity,5.0
PT04565,Germany,Bavaria,36.0,Female,Pancreatic,III,2011-08-15,2011-08-22,2012-02-08,Targeted Therapy,Public,Deceased,95.0,BRCA1,No,Never,None,33.1,Medium,Urban,NHS,12.0,No,No,None,5.0
PT04566,Belgium,Flanders,65.0,Female,Pancreatic,I,2020-10-29,2021-04-18,2021-10-07,Targeted Therapy,Public,Deceased,15.0,None,No,Current,None,29.7,High,Rural,NHS,5.0,Yes,No,None,5.0
PT04567,Norway,Oslo,57.0,,Lung,II,2010-01-12,2010-02-23,2011-01-07,Immunotherapy,Public,Deceased,21.0,EGFR,No,Never,None,36.7,High,Urban,NHS,2.0,No,No,Cardiovascular Disease,1.0
PT04568,,North Holland,54.0,Female,Pancreatic,I,2010-05-02,,2011-06-26,Chemotherapy,Private,Alive,,KRAS,No,Never,None,32.3,Low,Urban,Private Insurance,18.0,Yes,No,Diabetes,1.0
PT04569,Portugal,Porto,20.0,Female,Lung,I,2022-05-18,2022-05-31,2022-11-20,Targeted Therapy,Private,Deceased,28.0,BRCA1,No,Never,Moderate,18.0,High,Urban,NHS,,No,No,Obesity,7.0
PT04570,Ireland,Munster,48.0,Female,Breast,I,2016-03-26,2016-04-07,2016-07-30,Immunotherapy,Public,Deceased,111.0,KRAS,Yes,Never,None,32.8,Medium,,Private Insurance,5.0,No,No,None,6.0
PT04571,Portugal,Porto,23.0,Female,Lung,II,2017-03-29,2017-05-06,2017-12-01,Immunotherapy,Private,Alive,,BRCA1,No,Current,None,36.0,Medium,Urban,Private Insurance,16.0,No,No,Diabetes,9.0
PT04572,Italy,Lombardy,80.0,Male,Breast,III,2021-02-25,2021-02-28,2021-07-08,Targeted Therapy,Public,Alive,66.0,None,Yes,Current,None,34.1,Medium,Urban,Private Insurance,18.0,No,,Diabetes,1.0
PT04573,Poland,Lesser Poland,36.0,Male,Leukemia,II,2012-05-27,2012-07-28,2013-04-20,Radiation,Public,Alive,,EGFR,No,Never,None,34.1,Medium,Urban,Private Insurance,3.0,No,Yes,Hypertension,10.0
PT04574,Belgium,Flanders,47.0,Female,Ovarian,IV,2012-02-25,2012-08-02,2013-03-24,Targeted Therapy,Public,Alive,21.0,None,No,Never,None,37.4,Medium,Rural,Statutory Health Insurance,2.0,No,No,Hypertension,
PT04575,Sweden,Stockholm,69.0,Male,Prostate,I,2015-09-08,2015-10-15,2016-08-29,Targeted Therapy,Private,Lost to Follow-up,,KRAS,No,Never,Moderate,31.3,Medium,,NHS,10.0,Yes,No,Hypertension,1.0
,Sweden,Stockholm,27.0,Female,Ovarian,II,2010-04-11,,2010-10-08,Chemotherapy,Public,Deceased,63.0,KRAS,No,,None,32.7,Low,Rural,NHS,17.0,Yes,No,Cardiovascular Disease,4.0
PT04577,Germany,Berlin,53.0,Female,Pancreatic,II,2011-01-11,2011-04-13,2012-02-14,Radiation,Public,Alive,16.0,BRCA1,Yes,Never,Moderate,29.8,Medium,Rural,NHS,15.0,No,No,Diabetes,10.0
PT04578,Portugal,Porto,78.0,Male,,I,2011-10-08,2011-12-15,2012-11-15,Surgery,Public,Deceased,89.0,BRCA1,No,Former,Moderate,38.8,Low,Urban,NHS,19.0,No,No,Hypertension,6.0
PT04579,Ireland,Connacht,37.0,Female,Breast,IV,2019-04-06,2019-06-09,2020-03-24,Targeted Therapy,Public,Alive,26.0,None,No,,None,32.8,Low,Rural,NHS,11.0,No,No,Hypertension,1.0
PT04580,Poland,Silesian,78.0,Male,Pancreatic,II,,2020-01-04,2020-10-12,Targeted Therapy,Research Institute,Alive,21.0,EGFR,No,Current,None,24.2,Medium,Rural,Private Insurance,9.0,No,No,Diabetes,2.0
PT04581,Germany,North Rhine-Westphalia,46.0,,,IV,2017-07-03,2017-07-21,2018-02-12,Chemotherapy,Public,Alive,80.0,KRAS,Yes,Former,Moderate,36.6,,Rural,Statutory Health Insurance,13.0,No,No,Diabetes,8.0
PT04582,Spain,Andalusia,35.0,Male,Colorectal,II,2019-08-30,,,Surgery,Private,Lost to Follow-up,,None,No,Never,Moderate,25.4,,Rural,Statutory Health Insurance,10.0,No,No,Hypertension,2.0
PT04583,Belgium,Wallonia,29.0,Male,Prostate,,2023-03-10,2023-08-25,2024-03-08,Immunotherapy,Public,Deceased,38.0,None,No,Former,Moderate,37.0,High,Urban,NHS,7.0,Yes,No,Hypertension,9.0
PT04584,Portugal,Lisbon,41.0,Male,Ovarian,I,2015-07-17,2015-09-13,2016-05-14,Radiation,Public,,91.0,BRCA1,No,Never,Moderate,21.8,Medium,Urban,NHS,4.0,No,No,Obesity,1.0
PT04585,Netherlands,Utrecht,35.0,Female,Leukemia,IV,2022-07-03,2022-11-03,2023-06-25,Surgery,Private,Alive,94.0,None,No,Former,,22.2,Medium,Urban,Private Insurance,12.0,No,No,,8.0
PT04586,Germany,Berlin,31.0,Male,Leukemia,I,2015-05-07,2015-06-21,2016-02-05,Targeted Therapy,Public,Alive,38.0,BRCA1,Yes,Never,None,29.5,High,,Statutory Health Insurance,10.0,No,No,None,9.0
PT04587,,Tyrol,70.0,Male,Ovarian,IV,2012-11-11,2013-01-03,2013-02-02,Immunotherapy,Private,Alive,106.0,EGFR,No,Former,None,26.1,Medium,Rural,NHS,10.0,No,No,Hypertension,4.0
PT04588,Italy,Sicily,20.0,Male,Lung,II,2015-09-29,2015-10-26,2016-05-11,Chemotherapy,Private,Deceased,103.0,KRAS,Yes,Never,,38.9,Medium,Rural,,8.0,No,Yes,Hypertension,9.0
PT04589,Norway,Oslo,46.0,Male,Pancreatic,I,2020-06-19,2020-10-15,2021-08-13,Targeted Therapy,Private,Alive,20.0,None,No,Current,None,33.7,Medium,Rural,Private Insurance,,No,No,Hypertension,6.0
PT04590,France,Auvergne-Rhône-Alpes,,Female,Leukemia,III,2023-03-15,2023-04-20,2024-02-07,Chemotherapy,Private,Alive,70.0,None,Yes,Never,Moderate,28.8,Medium,Urban,NHS,7.0,No,Yes,Cardiovascular Disease,1.0
PT04591,Spain,Madrid,31.0,Male,Prostate,,2020-08-02,2020-11-10,2021-02-14,Radiation,Private,Alive,9.0,,No,Current,Heavy,,High,,NHS,4.0,No,No,Cardiovascular Disease,4.0
PT04592,Portugal,Lisbon,49.0,Female,Pancreatic,I,2019-12-11,2020-04-30,2020-09-24,Chemotherapy,Private,Deceased,86.0,EGFR,No,Never,Heavy,38.7,High,,Private Insurance,18.0,Yes,No,Cardiovascular Disease,8.0
PT04593,Switzerland,Bern,28.0,Female,Colorectal,III,2015-07-08,2016-01-03,2016-04-27,Surgery,Public,Alive,97.0,None,Yes,,Moderate,22.8,Low,Urban,NHS,2.0,No,Yes,Diabetes,9.0
PT04594,Poland,Silesian,72.0,Female,Breast,II,2016-06-07,2016-11-30,2017-08-21,Surgery,Public,Deceased,37.0,EGFR,Yes,Never,Moderate,23.3,High,Rural,Private Insurance,,Yes,No,Hypertension,7.0
,Belgium,Brussels,80.0,Male,Breast,II,,,2020-07-22,Radiation,Private,Alive,,KRAS,No,Current,None,35.7,High,Rural,Statutory Health Insurance,15.0,Yes,Yes,Cardiovascular Disease,9.0
PT04596,Ireland,Connacht,73.0,,Leukemia,I,2011-01-19,2011-04-30,2012-02-11,Radiation,Public,Alive,,KRAS,No,Never,None,27.5,High,Urban,NHS,1.0,Yes,No,Cardiovascular Disease,10.0
PT04597,Netherlands,Utrecht,56.0,Male,Lung,I,2017-01-29,2017-05-20,2017-07-05,Radiation,Public,Alive,105.0,EGFR,No,Former,Moderate,21.3,High,Urban,Statutory Health Insurance,17.0,No,Yes,Cardiovascular Disease,9.0
PT04598,Germany,Berlin,84.0,Female,Breast,II,2011-12-04,2012-05-31,2012-09-10,Surgery,Public,Alive,88.0,KRAS,Yes,Never,None,38.2,High,Urban,Statutory Health Insurance,19.0,No,No,Obesity,1.0
PT04599,Poland,Masovian,61.0,Non-binary,Lung,II,2015-09-28,2015-10-12,2016-04-19,Targeted Therapy,Private,Alive,61.0,None,No,Never,None,34.3,Low,Rural,Statutory Health Insurance,7.0,,Yes,Obesity,5.0
,Ireland,Connacht,68.0,Female,Breast,III,2010-11-15,2011-05-05,2012-01-10,Surgery,Public,Alive,93.0,,No,Former,Moderate,26.4,Low,Rural,,5.0,No,No,Diabetes,5.0
PT04601,Poland,Silesian,23.0,Female,Lung,II,2010-01-21,2010-01-24,2010-08-23,Chemotherapy,Public,Alive,8.0,KRAS,,Never,Moderate,39.7,Medium,Rural,Private Insurance,10.0,No,No,Hypertension,1.0
PT04602,Sweden,Skåne,83.0,Non-binary,Ovarian,III,2019-08-06,2020-01-06,2020-10-10,Radiation,Private,,19.0,None,No,Never,Moderate,31.6,Low,Urban,Statutory Health Insurance,17.0,No,No,None,7.0
PT04603,Belgium,Flanders,70.0,Female,Lung,I,2011-08-15,2011-09-18,2012-02-01,Immunotherapy,Private,Alive,101.0,,No,Former,None,29.3,Medium,Rural,NHS,1.0,No,,Diabetes,5.0
PT04604,Portugal,Algarve,,,Colorectal,I,2021-03-28,2021-05-15,2021-09-22,Surgery,,Deceased,81.0,KRAS,No,Never,None,29.5,Low,Urban,Private Insurance,12.0,No,No,Diabetes,
PT04605,Belgium,Flanders,50.0,Male,Prostate,I,2016-01-06,2016-03-18,2017-02-11,Immunotherapy,Private,Alive,,None,Yes,Never,Moderate,25.6,Low,Urban,Statutory Health Insurance,3.0,No,No,Obesity,10.0
PT04606,Germany,North Rhine-Westphalia,77.0,Male,Breast,III,2013-12-31,2014-05-27,2015-03-09,Targeted Therapy,Public,Alive,39.0,BRCA1,No,Former,Moderate,25.1,Low,Urban,Statutory Health Insurance,10.0,,No,Obesity,8.0
PT04607,Sweden,Stockholm,23.0,Male,Pancreatic,III,2016-12-21,,2018-03-07,Surgery,Research Institute,Alive,100.0,BRCA1,No,Never,Moderate,39.4,Medium,Urban,Private Insurance,8.0,No,No,Obesity,10.0
PT04608,Germany,North Rhine-Westphalia,41.0,Female,Leukemia,I,2015-03-27,2015-05-01,2016-03-03,Targeted Therapy,Public,Alive,41.0,BRCA1,No,Former,Moderate,37.2,Low,Urban,Private Insurance,10.0,No,No,Diabetes,5.0
PT04609,Poland,Lesser Poland,22.0,Female,Prostate,I,2018-07-24,2018-10-29,2019-05-08,Targeted Therapy,Public,Alive,101.0,EGFR,No,Former,None,,,Urban,Private Insurance,14.0,Yes,No,None,10.0
PT04610,Portugal,Lisbon,66.0,Male,Colorectal,III,2022-01-10,2022-04-29,2023-04-26,Surgery,Research Institute,Alive,40.0,None,Yes,Never,None,38.4,High,Rural,NHS,5.0,No,No,None,5.0
PT04611,France,Île-de-France,57.0,Female,Colorectal,IV,2017-01-09,2017-04-28,2017-07-15,Surgery,Public,Deceased,,KRAS,No,Never,None,19.8,Medium,Urban,Private Insurance,13.0,No,No,Diabetes,7.0
PT04612,Spain,Andalusia,52.0,Male,Colorectal,III,2013-06-24,2013-07-27,2014-06-26,Targeted Therapy,Public,Alive,85.0,None,No,Never,None,24.3,Low,Urban,NHS,6.0,No,No,Diabetes,6.0
PT04613,Austria,Vienna,67.0,Non-binary,Leukemia,I,2010-10-09,2011-03-28,2011-10-13,Radiation,Public,Alive,6.0,BRCA1,Yes,Current,Moderate,38.2,Medium,Rural,NHS,14.0,Yes,No,Obesity,4.0
PT04614,Ireland,Dublin,84.0,Female,Breast,II,2017-09-17,2018-01-10,2018-05-11,Surgery,Public,,116.0,BRCA1,Yes,Never,Moderate,19.4,Medium,Urban,Private Insurance,15.0,Yes,No,Diabetes,2.0
PT04615,Austria,Tyrol,45.0,Female,Breast,III,2021-12-01,2022-01-24,2022-11-18,Targeted Therapy,Private,Lost to Follow-up,,BRCA1,No,Current,Moderate,38.4,Medium,Urban,Statutory Health Insurance,11.0,No,No,Diabetes,2.0
PT04616,Denmark,Central Denmark,27.0,Female,Ovarian,I,2015-01-04,2015-02-12,2015-10-29,Chemotherapy,Private,Deceased,109.0,None,No,Never,Moderate,25.8,Medium,Urban,Statutory Health Insurance,7.0,No,No,,8.0
PT04617,Belgium,Wallonia,69.0,Male,Ovarian,II,2011-07-07,2011-10-25,2012-07-30,Immunotherapy,Public,Alive,57.0,None,No,Never,Moderate,22.0,Low,Urban,NHS,13.0,No,No,Cardiovascular Disease,8.0
PT04618,Ireland,Dublin,57.0,Female,Lung,II,2020-03-28,2020-09-10,2021-05-25,Chemotherapy,Research Institute,Alive,18.0,None,Yes,Current,,21.6,Medium,Urban,Statutory Health Insurance,4.0,No,No,Hypertension,6.0
PT04619,Germany,,29.0,Male,Lung,I,2018-02-12,2018-03-22,2018-11-02,Surgery,Private,Alive,80.0,EGFR,Yes,Former,Moderate,27.1,Low,Rural,NHS,,No,No,None,1.0
PT04620,Italy,Veneto,,Male,Pancreatic,IV,,2019-09-11,2020-02-29,Surgery,Private,Alive,80.0,BRCA1,Yes,Never,None,33.4,High,Urban,Statutory Health Insurance,9.0,Yes,No,Cardiovascular Disease,6.0
PT04621,Belgium,Brussels,56.0,Female,Lung,IV,2018-01-03,2018-04-25,2018-11-24,Surgery,Public,Alive,30.0,KRAS,Yes,,None,,Low,Urban,NHS,3.0,No,No,Obesity,3.0
PT04622,,Vienna,45.0,Male,Leukemia,II,2017-09-08,2017-12-18,2018-08-19,Surgery,Public,Alive,69.0,BRCA1,No,Never,Moderate,,Medium,,NHS,14.0,Yes,No,Obesity,5.0
PT04623,Switzerland,Zurich,31.0,Non-binary,Prostate,I,2017-12-29,2018-02-14,2018-05-23,Chemotherapy,Public,Alive,10.0,BRCA1,Yes,Never,None,27.4,Low,Rural,,15.0,No,Yes,Diabetes,8.0
PT04624,Poland,Silesian,68.0,Female,Ovarian,III,2018-03-24,2018-07-28,2018-10-11,Radiation,Public,Alive,,EGFR,No,Never,Moderate,23.6,High,Urban,NHS,10.0,No,No,Hypertension,6.0
,Denmark,Capital Region,33.0,,Breast,I,,2014-06-24,2014-08-07,Targeted Therapy,Private,Deceased,,BRCA1,Yes,Current,Moderate,27.0,Low,Urban,Private Insurance,17.0,No,No,,6.0
PT04626,Switzerland,Bern,65.0,Female,Lung,I,,2016-07-24,2017-01-05,Targeted Therapy,Public,Deceased,104.0,BRCA1,No,Never,Moderate,22.3,Low,Urban,Private Insurance,5.0,No,No,Obesity,2.0
PT04627,Italy,Sicily,54.0,Male,Ovarian,II,2016-05-25,2016-07-06,2016-12-04,Targeted Therapy,Public,Alive,81.0,EGFR,Yes,Former,None,34.7,Low,Rural,Statutory Health Insurance,3.0,No,No,Diabetes,
PT04628,Italy,Veneto,48.0,Female,Leukemia,II,2016-09-22,2017-01-02,2017-08-03,Immunotherapy,Public,Alive,,EGFR,No,Never,,26.6,Medium,Urban,Private Insurance,14.0,No,No,Cardiovascular Disease,10.0
PT04629,Finland,Uusimaa,,Female,Leukemia,I,2022-01-22,2022-03-18,2023-01-08,Surgery,Public,Alive,51.0,None,No,Never,Moderate,25.8,Medium,Urban,,1.0,No,No,Hypertension,1.0
PT04630,Ireland,Connacht,63.0,Male,Pancreatic,II,2010-03-02,2010-04-30,2010-12-14,Chemotherapy,Private,Alive,82.0,EGFR,No,Never,None,31.7,High,Rural,NHS,16.0,No,No,Cardiovascular Disease,2.0
PT04631,Finland,Southwest Finland,85.0,Male,Lung,,2019-10-16,2019-12-29,2020-07-18,Chemotherapy,Research Institute,Alive,,KRAS,Yes,Never,,23.8,,Urban,Statutory Health Insurance,,No,No,Cardiovascular Disease,7.0
PT04632,Austria,Tyrol,21.0,Male,Ovarian,IV,,2017-11-19,2018-04-07,Chemotherapy,Public,Alive,81.0,BRCA1,Yes,Former,Moderate,27.1,Low,Urban,Statutory Health Insurance,19.0,No,No,Diabetes,3.0
PT04633,Netherlands,South Holland,78.0,Female,Ovarian,IV,2017-01-18,2017-06-18,2017-10-30,Radiation,Public,Alive,52.0,None,No,Never,None,19.9,Medium,Urban,Statutory Health Insurance,,No,No,Obesity,8.0
PT04634,Switzerland,Geneva,36.0,Male,Pancreatic,III,2019-04-06,2019-08-23,2020-07-04,Surgery,Research Institute,Alive,39.0,KRAS,Yes,Former,,21.0,Medium,Urban,Statutory Health Insurance,13.0,No,No,Diabetes,9.0
PT04635,Finland,Uusimaa,29.0,Male,Ovarian,II,2020-04-22,2020-05-28,2020-12-18,Targeted Therapy,Private,Alive,25.0,BRCA1,Yes,Current,None,29.5,Medium,Rural,Statutory Health Insurance,3.0,No,Yes,Hypertension,2.0
PT04636,Sweden,Stockholm,37.0,Female,Colorectal,I,,2016-04-08,2017-03-25,Targeted Therapy,Public,Deceased,44.0,EGFR,Yes,Never,Heavy,40.0,High,Urban,NHS,4.0,No,No,Diabetes,6.0
PT04637,Ireland,Munster,41.0,Female,Colorectal,III,2019-05-18,2019-08-28,2019-11-26,Surgery,Public,Deceased,57.0,None,No,Current,Heavy,30.3,Low,Urban,,12.0,No,No,None,8.0
PT04638,Belgium,Flanders,77.0,Female,Colorectal,IV,2013-01-03,2013-04-12,2014-01-30,Targeted Therapy,Private,Alive,55.0,KRAS,Yes,Former,None,28.0,Low,Urban,Statutory Health Insurance,14.0,No,,Obesity,10.0
PT04639,Italy,Lombardy,72.0,Female,Lung,I,2017-09-04,2018-01-10,2018-12-26,Targeted Therapy,Private,Alive,73.0,EGFR,No,Current,None,23.1,High,Urban,Statutory Health Insurance,8.0,No,No,Obesity,2.0
PT04640,Belgium,Brussels,20.0,Female,Leukemia,II,2018-07-05,2018-07-18,2019-05-16,Surgery,Public,Alive,46.0,None,Yes,Former,Moderate,26.1,Medium,Urban,Statutory Health Insurance,10.0,No,No,Hypertension,1.0
PT04641,Italy,Veneto,80.0,Female,Leukemia,II,2010-07-17,2010-10-24,2011-04-29,Chemotherapy,Public,Deceased,48.0,EGFR,Yes,Never,Moderate,35.5,Medium,Rural,Private Insurance,2.0,Yes,No,None,6.0
PT04642,Belgium,Brussels,50.0,,Breast,II,2015-09-23,2015-11-14,2016-07-23,Immunotherapy,Private,Alive,54.0,EGFR,No,Former,Moderate,28.2,Medium,Urban,Private Insurance,19.0,Yes,No,Diabetes,2.0
PT04643,France,Auvergne-Rhône-Alpes,50.0,Female,Ovarian,II,2017-05-12,2017-10-17,2018-03-10,Surgery,Private,Alive,76.0,None,Yes,Never,Moderate,33.2,Medium,Rural,Private Insurance,8.0,No,No,Diabetes,1.0
PT04644,Belgium,Flanders,85.0,Male,Colorectal,IV,2014-04-18,2014-09-05,2015-06-15,Targeted Therapy,Public,Alive,52.0,None,No,Current,None,25.3,Medium,Urban,Private Insurance,19.0,No,No,None,10.0
PT04645,,South Holland,38.0,Male,Lung,I,2012-05-20,,2013-09-18,Targeted Therapy,Research Institute,Alive,62.0,EGFR,No,Former,None,22.4,Medium,Rural,Statutory Health Insurance,4.0,No,No,Cardiovascular Disease,3.0
PT04646,Netherlands,North Holland,72.0,Female,Breast,II,2011-05-25,2011-10-12,2012-01-12,Immunotherapy,Public,Deceased,72.0,,No,Former,Moderate,29.7,Medium,Urban,NHS,16.0,Yes,No,,8.0
PT04647,Norway,Vestland,41.0,Male,Leukemia,IV,2016-09-29,2016-11-30,2017-02-28,Immunotherapy,Public,Alive,51.0,KRAS,No,Current,None,25.8,Medium,Urban,Private Insurance,7.0,No,Yes,Hypertension,7.0
PT04648,Austria,Vienna,42.0,Female,Ovarian,II,2021-01-16,2021-05-16,2022-02-25,Immunotherapy,Public,Alive,46.0,EGFR,No,Never,Moderate,20.5,High,Urban,NHS,8.0,No,No,Hypertension,9.0
PT04649,Germany,North Rhine-Westphalia,34.0,Male,Ovarian,IV,2016-09-22,2016-12-24,2017-04-09,Surgery,Private,Deceased,113.0,EGFR,Yes,Former,Moderate,25.6,Medium,Urban,,15.0,No,No,Hypertension,3.0
PT04650,Sweden,Västra Götaland,45.0,Male,Breast,I,2022-01-09,2022-06-25,,Chemotherapy,Research Institute,Alive,82.0,EGFR,No,Never,Moderate,,Medium,Rural,Statutory Health Insurance,,Yes,No,Obesity,3.0
PT04651,Denmark,Zealand,22.0,Female,Colorectal,IV,,2015-04-17,2016-02-28,Immunotherapy,Public,Deceased,34.0,BRCA1,No,Never,None,34.2,Low,Urban,NHS,18.0,Yes,Yes,Diabetes,5.0
PT04652,Switzerland,Bern,39.0,Female,Ovarian,I,2016-02-29,,2017-05-26,Radiation,Public,Deceased,46.0,BRCA1,No,Former,Moderate,27.3,Low,Urban,Statutory Health Insurance,17.0,No,No,Diabetes,8.0
PT04653,Portugal,Algarve,59.0,Female,Ovarian,IV,2022-10-16,2023-03-24,2024-01-19,Chemotherapy,Private,Alive,90.0,KRAS,Yes,Never,None,38.2,Medium,Urban,Statutory Health Insurance,18.0,No,No,None,2.0
PT04654,Finland,Uusimaa,58.0,Female,Ovarian,I,2023-09-20,2024-02-19,2024-08-03,Immunotherapy,,Alive,51.0,None,Yes,Never,Moderate,32.0,Medium,Urban,Private Insurance,8.0,No,Yes,Cardiovascular Disease,7.0
PT04655,Norway,Oslo,37.0,Male,Prostate,II,2012-09-11,2013-02-28,2013-12-29,Targeted Therapy,Public,Deceased,30.0,EGFR,No,Never,None,37.3,Medium,Urban,NHS,11.0,No,No,Cardiovascular Disease,9.0
PT04656,Portugal,Algarve,60.0,Female,Colorectal,II,2012-03-06,2012-07-07,2012-09-14,Surgery,Research Institute,,8.0,None,Yes,Never,None,22.4,Low,Urban,NHS,17.0,No,No,Diabetes,6.0
PT04657,Spain,Madrid,89.0,Male,Colorectal,II,2012-04-27,2012-10-21,2013-05-12,Targeted Therapy,Private,Lost to Follow-up,,EGFR,No,Former,None,36.1,Medium,Urban,Statutory Health Insurance,11.0,Yes,No,Diabetes,1.0
PT04658,Portugal,Algarve,46.0,Female,Lung,I,2013-10-23,2014-01-21,2014-06-08,Targeted Therapy,Public,Deceased,35.0,KRAS,No,,Moderate,19.8,Low,Rural,Private Insurance,10.0,Yes,No,Hypertension,4.0
PT04659,Poland,Masovian,34.0,Male,Prostate,IV,2018-03-13,2018-08-08,2019-01-15,Surgery,Public,,108.0,None,No,Never,None,34.1,Low,Urban,Statutory Health Insurance,,No,No,Obesity,4.0
PT04660,,Andalusia,56.0,Female,Ovarian,II,2022-03-16,2022-07-30,2023-01-29,Chemotherapy,Public,Alive,91.0,KRAS,No,Never,None,25.3,Low,Urban,Statutory Health Insurance,2.0,,Yes,Diabetes,5.0
PT04661,Netherlands,North Holland,77.0,Female,Pancreatic,III,2022-07-08,2022-12-16,2023-03-27,Targeted Therapy,Public,Alive,7.0,None,Yes,Current,Moderate,24.6,Low,Urban,Private Insurance,16.0,No,No,Diabetes,8.0
PT04662,Italy,Sicily,24.0,Male,Prostate,I,2022-01-17,2022-07-02,2023-06-22,Chemotherapy,Public,Alive,14.0,BRCA1,Yes,Never,Moderate,32.5,Low,Urban,Private Insurance,11.0,Yes,No,Diabetes,9.0
PT04663,Portugal,Lisbon,26.0,Female,Prostate,III,2016-02-11,2016-07-24,2016-08-27,Surgery,Public,Alive,63.0,None,No,Never,None,19.5,High,Rural,NHS,17.0,No,No,Diabetes,6.0
PT04664,Portugal,Lisbon,60.0,Male,Leukemia,II,2016-05-01,2016-06-18,2017-02-15,Immunotherapy,,Alive,9.0,BRCA1,No,Current,Moderate,39.0,Low,Rural,Statutory Health Insurance,5.0,No,No,Hypertension,2.0
PT04665,Ireland,Connacht,29.0,Male,Breast,IV,2013-12-08,2014-04-23,2015-03-01,Targeted Therapy,Public,Deceased,77.0,KRAS,No,Current,Heavy,23.1,High,Rural,NHS,6.0,No,Yes,Obesity,4.0
PT04666,Germany,Berlin,81.0,Female,Leukemia,II,2011-02-06,2011-04-07,2011-10-25,Targeted Therapy,Private,Deceased,24.0,EGFR,Yes,Current,Moderate,35.9,Medium,Rural,NHS,12.0,No,No,,6.0
PT04667,Belgium,Wallonia,45.0,Male,Pancreatic,I,2016-01-30,2016-02-23,2017-01-11,Surgery,Private,Alive,,None,No,Current,Moderate,,Low,Urban,Private Insurance,5.0,Yes,No,Cardiovascular Disease,1.0
PT04668,Belgium,,87.0,Male,Prostate,II,2012-05-27,2012-06-13,2013-02-11,Surgery,Private,Alive,19.0,EGFR,No,Never,Moderate,27.0,High,Urban,NHS,4.0,No,No,Cardiovascular Disease,5.0
PT04669,Spain,Madrid,,Female,Lung,III,2018-08-21,2018-10-25,2019-02-20,Immunotherapy,Public,Alive,6.0,EGFR,No,Former,Moderate,33.8,Medium,Urban,NHS,2.0,Yes,No,None,9.0
PT04670,Spain,Catalonia,60.0,Female,Pancreatic,III,2012-06-25,2012-12-09,2013-03-19,Surgery,Public,Alive,110.0,None,No,Never,None,25.9,Medium,Rural,Statutory Health Insurance,15.0,No,No,Hypertension,
PT04671,Ireland,Munster,84.0,Male,Ovarian,III,2022-02-28,2022-06-14,2023-06-12,Radiation,Research Institute,Alive,25.0,EGFR,No,Current,,32.7,Medium,Rural,Private Insurance,5.0,No,No,Diabetes,10.0
PT04672,Spain,Andalusia,,Female,Colorectal,I,2012-12-31,2013-02-24,2013-09-10,Radiation,Public,Deceased,88.0,None,Yes,Former,Moderate,18.1,High,Rural,NHS,,No,No,Cardiovascular Disease,6.0
PT04673,,Silesian,43.0,Female,Ovarian,II,2019-08-24,2019-11-09,2020-10-17,Surgery,Private,Alive,111.0,BRCA1,Yes,Never,Moderate,39.1,High,Rural,NHS,17.0,Yes,No,Cardiovascular Disease,6.0
PT04674,Netherlands,North Holland,46.0,Female,Colorectal,,2014-12-12,2015-02-11,2015-09-26,Immunotherapy,Public,Alive,85.0,EGFR,,Former,None,21.3,Low,Rural,Statutory Health Insurance,5.0,No,No,None,1.0
PT04675,Netherlands,South Holland,26.0,Female,,I,2014-08-04,2014-09-04,2015-01-07,Radiation,Private,Alive,79.0,KRAS,,Never,None,29.3,Medium,Rural,NHS,7.0,,No,Cardiovascular Disease,7.0
PT04676,Denmark,,31.0,,Ovarian,I,2010-07-27,2010-11-05,2011-10-19,,Private,Alive,71.0,EGFR,No,Former,,23.8,High,Urban,Private Insurance,18.0,No,No,Hypertension,9.0
PT04677,Germany,Berlin,22.0,Female,Pancreatic,III,2013-09-27,2013-10-25,,Immunotherapy,Private,Alive,70.0,BRCA1,Yes,Never,Moderate,26.4,Medium,Rural,Statutory Health Insurance,12.0,Yes,No,,6.0
PT04678,Spain,Madrid,29.0,Male,Leukemia,II,2013-11-10,2013-12-12,2014-06-14,Surgery,Research Institute,Deceased,13.0,EGFR,No,,Moderate,25.3,High,Rural,Private Insurance,17.0,No,,,3.0
PT04679,Denmark,Zealand,52.0,Male,Lung,III,2023-12-03,2023-12-10,2024-04-11,Radiation,Research Institute,Alive,14.0,EGFR,No,Never,Moderate,39.6,Low,Urban,NHS,19.0,No,No,Diabetes,4.0
PT04680,Norway,Vestland,65.0,Female,Colorectal,II,2018-01-04,2018-01-18,,,Public,Alive,44.0,BRCA1,No,,Moderate,20.9,Medium,Rural,Private Insurance,6.0,No,No,None,1.0
PT04681,Netherlands,Utrecht,78.0,Non-binary,,IV,2021-08-28,2021-11-09,2021-12-19,Targeted Therapy,Public,Alive,69.0,BRCA1,No,Former,None,21.3,Medium,Rural,Statutory Health Insurance,18.0,No,No,Hypertension,8.0
PT04682,Austria,Tyrol,71.0,Female,,IV,2015-08-26,2015-11-04,2016-03-17,Surgery,Public,Alive,111.0,BRCA1,Yes,Former,Moderate,39.4,Low,Rural,NHS,2.0,No,No,None,5.0
PT04683,Finland,,25.0,Male,Ovarian,III,2017-08-22,2018-02-17,2018-03-28,Chemotherapy,Public,Alive,62.0,None,Yes,Never,Moderate,20.9,Medium,Rural,Statutory Health Insurance,18.0,No,No,None,1.0
PT04684,Germany,North Rhine-Westphalia,21.0,Female,Breast,I,2010-09-03,2010-10-03,2011-06-10,Radiation,Public,Alive,87.0,None,No,Never,None,19.9,Medium,,Statutory Health Insurance,13.0,,No,Hypertension,8.0
PT04685,Finland,Pirkanmaa,48.0,Female,Leukemia,I,2017-02-15,2017-07-23,2017-09-10,Targeted Therapy,Research Institute,Alive,20.0,EGFR,Yes,Never,,29.2,Medium,Rural,Private Insurance,16.0,No,No,Hypertension,6.0
PT04686,Germany,North Rhine-Westphalia,59.0,Female,Leukemia,IV,2019-07-14,2019-12-05,2020-05-29,Immunotherapy,Public,Alive,111.0,KRAS,No,Never,Heavy,22.5,Medium,Rural,NHS,8.0,No,No,Obesity,10.0
PT04687,Belgium,Wallonia,80.0,Female,Prostate,II,2014-01-17,2014-06-17,2015-03-28,Radiation,,Alive,85.0,KRAS,No,Former,None,22.7,Low,Rural,NHS,19.0,No,No,Hypertension,8.0
,Germany,Bavaria,87.0,Female,Breast,III,2016-11-02,2017-04-10,2017-09-16,Radiation,Public,Alive,90.0,None,No,Current,None,36.0,Medium,Urban,,19.0,Yes,No,None,7.0
PT04689,Belgium,,87.0,Male,Breast,II,2014-01-20,2014-02-01,,Surgery,Public,Alive,116.0,BRCA1,Yes,Current,Moderate,23.2,Low,Urban,Private Insurance,9.0,No,No,Hypertension,9.0
PT04690,Ireland,Connacht,48.0,Female,Ovarian,I,2014-11-23,2014-11-26,2015-05-20,Targeted Therapy,Public,Deceased,30.0,KRAS,No,Former,Moderate,25.2,Medium,Rural,Statutory Health Insurance,17.0,No,No,Diabetes,1.0
PT04691,Austria,Tyrol,81.0,Female,Lung,II,2023-11-17,2024-01-23,2024-05-13,Radiation,Private,Alive,93.0,BRCA1,Yes,Former,None,,,Urban,Statutory Health Insurance,4.0,Yes,Yes,None,8.0
PT04692,Belgium,Brussels,79.0,Male,Ovarian,I,2014-12-18,2015-06-02,2015-07-03,Radiation,Public,Deceased,116.0,KRAS,Yes,Never,Moderate,39.8,High,Urban,NHS,12.0,No,No,None,6.0
PT04693,Sweden,Västra Götaland,,Male,Prostate,III,2021-07-13,2021-10-07,2022-09-04,Targeted Therapy,Public,Alive,21.0,,Yes,Current,Moderate,28.8,Medium,Urban,Private Insurance,13.0,No,Yes,Diabetes,5.0
PT04694,Poland,Masovian,84.0,Female,Breast,III,2018-01-02,2018-04-27,2019-01-29,Immunotherapy,Private,Alive,54.0,KRAS,Yes,Never,Moderate,32.6,High,Urban,NHS,15.0,No,No,Diabetes,3.0
PT04695,Denmark,Central Denmark,83.0,Female,Prostate,,2017-01-05,2017-04-23,2017-07-08,Surgery,Private,Alive,78.0,None,No,Never,Heavy,29.0,Medium,Rural,NHS,,No,No,Cardiovascular Disease,7.0
PT04696,Switzerland,Bern,82.0,,Prostate,III,2018-01-25,2018-06-18,2018-10-04,Radiation,Public,Deceased,107.0,None,No,Never,Moderate,22.0,Medium,Urban,NHS,4.0,No,No,Obesity,1.0
PT04697,Italy,Lombardy,67.0,Male,Colorectal,IV,2021-04-01,2021-06-22,2021-11-22,Targeted Therapy,Public,Alive,84.0,KRAS,No,Never,None,27.8,High,Urban,Private Insurance,7.0,No,No,Diabetes,
PT04698,Norway,Oslo,39.0,Male,Ovarian,III,2016-05-13,2016-05-17,2016-09-05,Chemotherapy,Public,Alive,53.0,EGFR,Yes,Never,,31.8,High,Rural,Statutory Health Insurance,13.0,No,No,Hypertension,7.0
PT04699,Spain,Catalonia,56.0,Male,Breast,II,2012-07-04,2012-07-24,2013-05-26,Immunotherapy,Private,Alive,82.0,None,Yes,Never,None,19.4,,Urban,Private Insurance,3.0,No,No,Cardiovascular Disease,5.0
PT04700,Finland,Southwest Finland,83.0,Female,Colorectal,II,2012-06-11,2012-07-26,2012-09-25,,Research Institute,Alive,65.0,KRAS,No,Never,Moderate,21.7,Medium,Rural,Private Insurance,10.0,No,No,None,3.0
PT04701,Poland,Silesian,24.0,Female,Ovarian,,2021-10-22,2022-03-12,2023-01-10,Chemotherapy,Public,Alive,66.0,BRCA1,Yes,Former,None,,Low,Urban,Statutory Health Insurance,9.0,No,No,Cardiovascular Disease,10.0
PT04702,Poland,Silesian,53.0,Female,Leukemia,II,2017-08-28,2017-12-01,2018-05-25,Immunotherapy,Public,Alive,49.0,BRCA1,Yes,Current,Moderate,19.8,Medium,Urban,Private Insurance,5.0,Yes,Yes,Obesity,
PT04703,France,Île-de-France,58.0,Female,Ovarian,IV,2022-01-07,2022-05-17,2023-03-22,Radiation,Research Institute,Alive,,KRAS,Yes,Never,None,21.6,Low,Urban,Private Insurance,11.0,No,No,Diabetes,2.0
PT04704,Austria,Tyrol,86.0,Male,Leukemia,III,2017-09-16,2017-12-19,2018-05-03,Surgery,Public,Deceased,56.0,BRCA1,Yes,Former,Moderate,23.6,Low,Urban,Private Insurance,11.0,No,No,Hypertension,4.0
PT04705,Norway,Vestland,81.0,Male,Colorectal,III,2022-07-30,2022-08-30,2023-03-05,Immunotherapy,Private,Alive,38.0,BRCA1,No,Never,None,19.2,Medium,Urban,NHS,5.0,No,No,Cardiovascular Disease,4.0
PT04706,France,Auvergne-Rhône-Alpes,43.0,Male,Leukemia,IV,2012-09-03,2012-10-01,,Immunotherapy,Public,Deceased,17.0,EGFR,No,Former,None,35.4,Low,Urban,Private Insurance,13.0,No,No,None,3.0
,Norway,Trøndelag,22.0,Male,,III,2012-01-20,2012-04-02,2013-01-02,Immunotherapy,Research Institute,Deceased,15.0,None,No,Former,,29.7,Medium,Rural,Private Insurance,6.0,No,No,Hypertension,2.0
PT04708,Sweden,Skåne,86.0,Male,Ovarian,I,2019-09-26,2019-11-24,2020-05-20,Immunotherapy,Public,Deceased,36.0,None,No,Never,None,22.5,High,Urban,NHS,19.0,No,No,Cardiovascular Disease,2.0
PT04709,,Uusimaa,69.0,Female,Lung,I,2018-09-04,2019-01-21,2019-12-20,Chemotherapy,Public,Alive,61.0,EGFR,No,Current,,20.1,High,Urban,Private Insurance,19.0,No,No,Cardiovascular Disease,7.0
PT04710,,Skåne,48.0,Female,Prostate,I,2023-02-21,2023-08-03,2024-01-08,Surgery,Public,Alive,9.0,None,No,Never,Heavy,30.6,Medium,Rural,NHS,,Yes,No,Obesity,1.0
PT04711,Spain,Madrid,51.0,Female,Lung,I,2018-04-04,2018-05-23,2018-07-13,Radiation,Public,Lost to Follow-up,,BRCA1,Yes,Former,Moderate,31.4,High,Urban,Statutory Health Insurance,12.0,,No,Diabetes,2.0
,Austria,Styria,58.0,Female,Breast,I,2019-12-06,2020-05-26,2020-08-19,Surgery,Research Institute,Alive,107.0,KRAS,Yes,Never,Moderate,33.1,,Urban,Statutory Health Insurance,4.0,Yes,No,Cardiovascular Disease,6.0
PT04713,Belgium,Brussels,28.0,Female,Lung,II,2010-09-26,2011-03-24,2011-05-30,Chemotherapy,Public,Alive,,EGFR,No,Current,Heavy,35.0,Low,Urban,NHS,8.0,No,No,Hypertension,5.0
PT04714,Italy,Sicily,33.0,Female,Lung,I,2018-04-17,2018-08-13,2018-09-30,Surgery,Private,Alive,15.0,,No,Never,None,39.4,Medium,Urban,NHS,8.0,No,No,Cardiovascular Disease,6.0
,Germany,Bavaria,87.0,Male,Leukemia,II,2012-10-08,2012-10-25,2013-06-05,Chemotherapy,Private,Deceased,72.0,KRAS,No,Former,None,36.4,High,Urban,NHS,12.0,Yes,No,Cardiovascular Disease,1.0
PT04716,Finland,Uusimaa,83.0,Non-binary,Pancreatic,IV,2015-11-06,2016-03-11,2016-07-11,Chemotherapy,Public,Alive,,None,Yes,Former,None,23.2,Low,,Private Insurance,10.0,No,No,Cardiovascular Disease,8.0
PT04717,Norway,Oslo,39.0,Male,Ovarian,III,2013-06-02,2013-10-12,2014-06-13,Chemotherapy,Public,Alive,118.0,EGFR,Yes,Never,Moderate,19.8,Low,Rural,NHS,18.0,No,Yes,None,2.0
PT04718,France,Auvergne-Rhône-Alpes,47.0,Male,Pancreatic,IV,2018-10-13,2019-03-23,2019-10-13,Chemotherapy,Private,Alive,90.0,BRCA1,No,Former,None,20.1,Low,Urban,Private Insurance,18.0,No,No,Diabetes,4.0
PT04719,Sweden,Västra Götaland,33.0,Male,Colorectal,I,2012-02-02,2012-04-23,2013-04-01,Immunotherapy,Private,Alive,43.0,None,Yes,Never,Moderate,36.4,Medium,Urban,Private Insurance,5.0,No,No,Hypertension,8.0
PT04720,Austria,Tyrol,63.0,Non-binary,Breast,II,2018-02-19,2018-06-05,2019-03-17,Surgery,Private,Alive,115.0,EGFR,No,Current,Heavy,34.7,High,Urban,NHS,17.0,No,No,Cardiovascular Disease,4.0
PT04721,Switzerland,Geneva,58.0,Non-binary,Pancreatic,II,2011-12-24,2012-03-23,2012-12-31,Targeted Therapy,Public,Alive,107.0,KRAS,No,Current,Moderate,19.0,Medium,Urban,NHS,,No,No,None,
PT04722,Poland,Silesian,47.0,,Leukemia,II,2013-11-06,,2014-07-09,Chemotherapy,Private,Alive,51.0,None,,Former,None,34.1,Medium,Urban,Private Insurance,2.0,,No,Obesity,7.0
PT04723,France,Provence-Alpes-Côte d'Azur,83.0,Female,Breast,II,2011-03-15,2011-06-07,2012-02-06,,Public,Deceased,72.0,None,Yes,,Heavy,34.2,High,Rural,Private Insurance,18.0,No,No,Obesity,8.0
PT04724,France,Auvergne-Rhône-Alpes,51.0,Female,Prostate,,2010-11-11,2010-12-23,2011-08-29,Surgery,Private,Alive,34.0,BRCA1,Yes,Never,None,36.0,Medium,Urban,Statutory Health Insurance,5.0,No,No,Hypertension,10.0
PT04725,Denmark,Capital Region,28.0,Non-binary,Colorectal,I,,2016-04-10,2016-06-06,Immunotherapy,Public,Alive,106.0,EGFR,Yes,Never,Moderate,32.4,Medium,Urban,Statutory Health Insurance,14.0,No,No,None,2.0
PT04726,Portugal,,,Female,Leukemia,III,2023-09-06,2024-02-19,2025-01-29,Radiation,Private,Alive,56.0,BRCA1,No,Never,Moderate,29.9,Low,Rural,Statutory Health Insurance,3.0,No,No,Cardiovascular Disease,4.0
PT04727,Belgium,Flanders,36.0,Female,Lung,III,2011-08-15,2012-02-02,2012-11-18,Chemotherapy,Public,Deceased,65.0,KRAS,Yes,Former,Moderate,24.6,Medium,Urban,,19.0,No,No,Cardiovascular Disease,10.0
PT04728,Italy,Lombardy,74.0,Male,Ovarian,II,2022-12-24,2023-02-10,2023-10-05,Immunotherapy,Public,Deceased,64.0,KRAS,No,Former,Moderate,19.3,Medium,Urban,NHS,16.0,Yes,No,Hypertension,10.0
PT04729,Portugal,Lisbon,29.0,Male,Prostate,I,2021-09-30,2021-11-11,2022-09-17,Immunotherapy,Public,,10.0,None,No,Current,Moderate,20.2,High,Urban,Private Insurance,6.0,No,No,Diabetes,10.0
PT04730,Poland,Masovian,25.0,Female,Lung,II,2020-01-19,2020-03-13,2020-08-18,Targeted Therapy,Private,Alive,8.0,KRAS,No,Current,Moderate,27.6,Medium,Rural,Statutory Health Insurance,13.0,No,No,,5.0
PT04731,Finland,Pirkanmaa,67.0,Male,Pancreatic,I,2015-03-25,2015-06-30,2016-01-13,Chemotherapy,Public,Alive,119.0,BRCA1,Yes,Never,None,21.9,Low,Urban,NHS,2.0,No,,None,
PT04732,Netherlands,Utrecht,86.0,Female,Ovarian,IV,2021-03-20,2021-08-12,2022-04-29,Immunotherapy,Public,Alive,69.0,None,Yes,Former,None,,Low,Rural,Private Insurance,8.0,No,No,None,7.0
PT04733,,Berlin,60.0,Female,Breast,IV,2022-03-22,2022-09-17,2023-04-01,Targeted Therapy,Private,Alive,99.0,BRCA1,No,Former,None,28.1,Medium,Rural,NHS,11.0,Yes,No,Hypertension,10.0
PT04734,Italy,Sicily,79.0,Female,Prostate,I,2016-08-20,2017-01-04,2017-05-08,Immunotherapy,Public,Alive,52.0,EGFR,No,Current,None,39.9,Medium,Urban,Statutory Health Insurance,7.0,No,No,Obesity,2.0
PT04735,Spain,Andalusia,61.0,Male,Ovarian,,2018-12-07,2018-12-15,2019-03-30,Targeted Therapy,Public,,45.0,KRAS,No,Never,None,39.4,Medium,Urban,,18.0,No,No,Diabetes,3.0
PT04736,,Styria,47.0,Female,Ovarian,II,2022-01-03,2022-04-25,2023-01-26,Targeted Therapy,Public,,13.0,BRCA1,No,Former,Moderate,34.7,High,Urban,Statutory Health Insurance,4.0,Yes,No,Hypertension,2.0
PT04737,,Pirkanmaa,32.0,Female,Leukemia,I,2023-05-28,2023-09-15,2024-04-02,Targeted Therapy,Public,Alive,113.0,None,No,Current,None,23.6,Medium,Rural,Private Insurance,11.0,No,No,Obesity,4.0
PT04738,Denmark,Central Denmark,34.0,Female,Lung,IV,2018-12-15,2019-02-23,2020-01-22,Immunotherapy,Public,Alive,61.0,BRCA1,No,Never,Moderate,35.3,Medium,Urban,Statutory Health Insurance,13.0,No,No,None,8.0
PT04739,Sweden,Skåne,55.0,Female,Pancreatic,III,2021-11-09,2022-03-26,2022-11-30,Radiation,Public,Alive,82.0,None,Yes,Never,Moderate,31.9,High,Urban,Statutory Health Insurance,3.0,No,No,Hypertension,
PT04740,Spain,Madrid,34.0,Non-binary,Lung,I,2013-06-07,2013-09-26,2014-08-15,Surgery,Research Institute,Alive,59.0,None,No,Never,Moderate,25.2,Low,Urban,NHS,,Yes,No,None,1.0
PT04741,Ireland,Dublin,75.0,Female,Breast,I,2019-01-11,2019-05-02,2020-03-06,Targeted Therapy,Public,Alive,89.0,BRCA1,No,Current,None,19.0,High,Rural,Private Insurance,19.0,No,,,5.0
PT04742,Austria,Vienna,23.0,Male,Breast,III,2013-12-24,2013-12-29,2014-10-08,Chemotherapy,Public,Alive,82.0,EGFR,No,Current,None,,Low,Urban,NHS,6.0,Yes,No,None,1.0
PT04743,Denmark,Central Denmark,71.0,Female,Pancreatic,II,2010-07-15,2010-09-25,2011-03-06,Surgery,Private,Alive,11.0,EGFR,Yes,Current,Moderate,30.9,Medium,Urban,Statutory Health Insurance,18.0,No,No,None,6.0
PT04744,Austria,Tyrol,29.0,Male,Colorectal,III,2012-02-29,2012-05-03,2013-01-23,Radiation,,Alive,79.0,KRAS,No,Former,Moderate,31.4,Medium,Urban,Private Insurance,14.0,No,No,Diabetes,10.0
PT04745,,Catalonia,64.0,Male,Pancreatic,I,2016-01-14,2016-02-18,2016-08-30,Surgery,Public,Alive,58.0,KRAS,Yes,Never,None,24.6,Medium,Rural,Statutory Health Insurance,19.0,Yes,No,,
PT04746,Germany,North Rhine-Westphalia,48.0,Male,Colorectal,I,2018-05-26,2018-07-25,2019-05-21,Surgery,Private,Alive,31.0,BRCA1,No,Never,None,33.8,Low,Urban,NHS,9.0,No,No,Obesity,7.0
PT04747,Ireland,Connacht,72.0,Female,Pancreatic,III,2019-09-24,2019-12-22,2020-08-01,Radiation,Public,Deceased,75.0,KRAS,No,Never,Moderate,33.0,Medium,Urban,NHS,3.0,No,No,Diabetes,1.0
,Denmark,,48.0,Male,Pancreatic,II,2022-03-08,2022-06-16,2023-04-17,Chemotherapy,Public,Lost to Follow-up,,BRCA1,Yes,Never,Moderate,24.7,High,Rural,Statutory Health Insurance,3.0,No,No,Diabetes,1.0
PT04749,Switzerland,Geneva,42.0,Male,Breast,I,2012-03-23,2012-05-01,2012-11-04,Targeted Therapy,Private,Alive,,BRCA1,No,Never,Moderate,34.2,Medium,Urban,NHS,12.0,Yes,No,,8.0
,Austria,Vienna,76.0,Female,,I,2023-07-02,2023-10-23,2024-01-04,Immunotherapy,Public,Deceased,33.0,BRCA1,Yes,Never,Heavy,34.4,Low,,,6.0,No,No,,2.0
PT04751,Poland,Silesian,69.0,Female,Pancreatic,II,2017-01-24,2017-06-07,2018-01-09,Chemotherapy,,Alive,81.0,KRAS,No,Never,Moderate,36.4,Low,Urban,NHS,4.0,No,Yes,Cardiovascular Disease,3.0
PT04752,Netherlands,North Holland,40.0,Male,Ovarian,III,2014-03-12,2014-06-08,2014-11-16,Chemotherapy,Private,Alive,58.0,None,No,Never,Moderate,27.4,Medium,Urban,Statutory Health Insurance,16.0,No,No,Cardiovascular Disease,3.0
PT04753,Poland,Masovian,62.0,Female,Lung,I,2011-02-09,2011-06-08,2011-12-13,Targeted Therapy,Public,Alive,,BRCA1,Yes,Former,Moderate,38.6,Medium,Urban,Private Insurance,17.0,No,Yes,Cardiovascular Disease,5.0
,Switzerland,Geneva,29.0,Female,Breast,III,2017-07-10,2017-12-06,,Chemotherapy,Public,Alive,45.0,BRCA1,Yes,Former,Moderate,39.2,,Rural,Private Insurance,17.0,No,No,Cardiovascular Disease,1.0
PT04755,Spain,Andalusia,49.0,Male,Ovarian,I,2017-10-15,2018-03-28,2019-02-17,Chemotherapy,Private,,73.0,EGFR,No,Former,Moderate,33.8,High,Urban,Private Insurance,16.0,No,,Cardiovascular Disease,9.0
PT04756,,Västra Götaland,70.0,Female,Ovarian,II,2016-05-25,2016-06-12,2016-09-25,Surgery,Public,Alive,,EGFR,No,Never,Moderate,32.4,Low,Urban,NHS,14.0,No,No,Cardiovascular Disease,9.0
PT04757,Spain,Andalusia,52.0,Female,Prostate,III,2010-03-31,2010-07-21,2010-08-27,Surgery,Public,Deceased,20.0,BRCA1,Yes,Never,None,36.1,High,Rural,Statutory Health Insurance,1.0,No,No,Hypertension,5.0
PT04758,Belgium,Wallonia,37.0,Female,Breast,III,,2013-11-07,2014-02-22,Radiation,Public,Alive,93.0,KRAS,Yes,Former,Moderate,21.0,Low,Urban,Private Insurance,18.0,No,No,Diabetes,2.0
PT04759,Switzerland,Geneva,41.0,Female,Pancreatic,I,2023-11-11,2023-11-28,,Radiation,Public,Alive,18.0,KRAS,No,Former,Heavy,35.1,Medium,Urban,NHS,4.0,No,No,Diabetes,7.0
PT04760,Norway,Oslo,83.0,Female,Leukemia,I,2019-10-14,2020-02-12,2020-04-21,Radiation,Private,Alive,72.0,EGFR,No,Former,Moderate,27.6,Medium,Urban,NHS,7.0,No,Yes,Obesity,3.0
PT04761,Finland,Pirkanmaa,40.0,Male,Leukemia,I,2014-06-06,2014-09-28,2015-02-09,Immunotherapy,Public,Deceased,,EGFR,No,Current,None,38.1,High,Urban,NHS,5.0,No,Yes,None,9.0
PT04762,Austria,,20.0,Female,Ovarian,III,2019-11-04,2020-03-17,2020-09-15,Targeted Therapy,Public,Lost to Follow-up,,BRCA1,,Former,Heavy,20.1,Medium,Urban,NHS,,No,No,Obesity,3.0
PT04763,Poland,Lesser Poland,34.0,Male,Ovarian,I,,,2015-04-15,Immunotherapy,Public,Alive,108.0,KRAS,No,Never,None,22.0,Medium,Urban,Statutory Health Insurance,4.0,No,No,None,6.0
,,Trøndelag,55.0,Male,Breast,I,2014-08-23,2015-02-12,,Immunotherapy,Private,Alive,50.0,EGFR,Yes,Former,None,26.0,Low,Urban,Private Insurance,5.0,No,No,Diabetes,5.0
PT04765,Austria,Tyrol,66.0,Male,Prostate,I,2020-02-08,2020-04-20,2021-04-11,Radiation,Private,Alive,84.0,KRAS,Yes,Never,None,39.3,Medium,Urban,NHS,10.0,No,No,Cardiovascular Disease,7.0
PT04766,Switzerland,Bern,73.0,Female,Breast,II,,2021-05-27,2021-09-20,Targeted Therapy,,Alive,31.0,None,No,Never,None,31.0,Medium,Rural,Statutory Health Insurance,16.0,No,No,None,7.0
PT04767,Austria,Tyrol,51.0,Male,Prostate,III,2018-08-29,2018-12-31,2019-07-22,Immunotherapy,Public,Alive,61.0,EGFR,Yes,Never,None,38.2,High,Urban,,19.0,No,No,Obesity,4.0
PT04768,Poland,Silesian,77.0,Male,Pancreatic,I,,2012-03-11,2012-09-10,Surgery,Public,,28.0,KRAS,No,Never,Moderate,38.6,Medium,Urban,Private Insurance,18.0,No,No,Obesity,7.0
PT04769,Ireland,Dublin,65.0,Male,Lung,II,2011-12-17,2012-06-12,2013-05-05,Immunotherapy,Public,Alive,44.0,EGFR,Yes,Former,None,18.7,Low,Urban,,3.0,No,No,Diabetes,4.0
PT04770,Switzerland,Geneva,73.0,Female,Lung,I,2016-09-07,2016-11-02,2016-12-08,,Research Institute,Alive,,None,No,Current,Moderate,34.1,Low,,Private Insurance,4.0,No,No,None,1.0
PT04771,Germany,North Rhine-Westphalia,52.0,Female,Prostate,II,2019-05-23,2019-10-07,2019-12-31,Immunotherapy,,Deceased,26.0,BRCA1,No,Never,Moderate,24.1,Medium,Urban,Private Insurance,7.0,No,No,Hypertension,7.0
PT04772,Netherlands,,58.0,Female,Ovarian,I,,2011-08-19,,Targeted Therapy,Public,Alive,19.0,KRAS,Yes,Former,None,26.7,Medium,Rural,Statutory Health Insurance,4.0,No,Yes,Obesity,1.0
PT04773,France,Provence-Alpes-Côte d'Azur,,Male,Colorectal,I,2017-09-22,2017-10-23,2018-09-17,Surgery,Public,Deceased,18.0,KRAS,Yes,Never,None,18.1,Medium,Urban,NHS,19.0,No,No,Cardiovascular Disease,8.0
PT04774,Sweden,Västra Götaland,,Male,Lung,II,2014-07-10,2014-09-13,2015-08-16,Surgery,Public,Alive,37.0,None,No,Never,Moderate,33.2,Medium,,Statutory Health Insurance,12.0,Yes,No,Cardiovascular Disease,1.0
,Spain,Catalonia,74.0,Female,Leukemia,III,2015-10-19,2016-02-01,2016-07-25,Radiation,Private,Deceased,111.0,KRAS,No,Never,None,36.7,High,Rural,Private Insurance,1.0,No,Yes,None,9.0
PT04776,Sweden,Stockholm,21.0,Female,Breast,III,2023-02-20,2023-04-22,2024-02-23,Surgery,,Alive,113.0,KRAS,Yes,Never,None,20.2,Low,Urban,Private Insurance,4.0,No,No,None,4.0
PT04777,Denmark,Capital Region,85.0,Male,Pancreatic,II,2020-04-18,2020-09-03,2021-06-19,Immunotherapy,Private,Deceased,17.0,,No,Never,Moderate,31.7,High,Rural,Statutory Health Insurance,11.0,No,No,Hypertension,7.0
PT04778,France,Île-de-France,57.0,Male,Colorectal,I,2015-09-19,2016-01-23,2016-07-27,Immunotherapy,Public,Deceased,68.0,KRAS,No,Current,None,23.6,High,Urban,NHS,15.0,No,No,Diabetes,1.0
PT04779,Belgium,Flanders,48.0,Male,Ovarian,I,2017-12-11,2018-06-07,2019-02-07,Radiation,Private,Alive,57.0,KRAS,Yes,Former,Moderate,39.6,Medium,Rural,Private Insurance,17.0,,No,,2.0
PT04780,Sweden,Stockholm,86.0,Female,Leukemia,II,2018-06-28,2018-09-13,2019-03-29,Chemotherapy,Private,Alive,79.0,EGFR,Yes,Former,Heavy,19.2,Low,Rural,Statutory Health Insurance,4.0,Yes,No,None,7.0
PT04781,Ireland,Dublin,55.0,Male,Breast,IV,2019-11-02,,2021-03-03,Surgery,Private,Alive,27.0,EGFR,No,Never,None,29.6,,Urban,,14.0,No,No,None,3.0
PT04782,Germany,Berlin,48.0,Female,Leukemia,IV,2021-12-21,2022-01-13,2022-07-30,Surgery,,Deceased,52.0,None,No,Never,None,36.4,,Urban,NHS,19.0,No,No,Diabetes,2.0
PT04783,Spain,Catalonia,56.0,Male,Colorectal,III,2020-01-04,2020-05-10,2020-08-20,Surgery,Public,Alive,30.0,KRAS,No,Current,Moderate,,High,Rural,NHS,16.0,,No,Diabetes,2.0
PT04784,Ireland,Dublin,,Male,Prostate,II,2010-07-02,2010-12-05,2011-10-01,Immunotherapy,Private,Alive,,BRCA1,No,Never,Moderate,30.1,Medium,Urban,Private Insurance,2.0,No,No,Obesity,9.0
PT04785,Denmark,Capital Region,35.0,Male,Breast,III,2023-10-14,2024-01-15,2024-04-30,Targeted Therapy,Public,Lost to Follow-up,,None,Yes,Never,Moderate,36.9,Low,Urban,NHS,8.0,,No,,
PT04786,Sweden,Skåne,,Female,Leukemia,II,2014-06-11,2014-08-08,2014-11-02,Targeted Therapy,Private,Alive,116.0,BRCA1,No,Never,None,39.6,Medium,Rural,Private Insurance,,No,No,Cardiovascular Disease,7.0
PT04787,Sweden,Stockholm,53.0,Female,Pancreatic,III,,2010-09-09,2011-01-15,Targeted Therapy,Research Institute,Deceased,98.0,KRAS,,,Moderate,20.3,Medium,Urban,NHS,4.0,No,No,Hypertension,8.0
PT04788,Norway,Vestland,,Male,Ovarian,I,2010-03-27,,2011-01-10,Radiation,Private,Deceased,76.0,None,,Never,Moderate,19.6,Low,Urban,Statutory Health Insurance,14.0,Yes,No,Cardiovascular Disease,1.0
PT04789,Norway,Trøndelag,84.0,Female,Pancreatic,I,2014-10-09,2015-02-16,2015-12-17,Radiation,Public,Alive,119.0,EGFR,Yes,Never,Heavy,36.3,Low,Urban,NHS,18.0,No,,Obesity,2.0
PT04790,Spain,Andalusia,81.0,Male,Leukemia,,2013-08-03,2014-01-21,2014-11-23,Immunotherapy,Research Institute,Deceased,,EGFR,No,Never,None,23.4,Medium,Urban,Private Insurance,4.0,No,No,Cardiovascular Disease,8.0
PT04791,Switzerland,Zurich,62.0,Female,Ovarian,II,,2012-08-10,2012-10-04,Targeted Therapy,Private,Alive,98.0,EGFR,Yes,Never,Moderate,37.3,Medium,Rural,Statutory Health Insurance,,No,No,Obesity,2.0
PT04792,Belgium,Brussels,75.0,Female,Colorectal,III,2012-11-02,2013-02-14,2013-05-10,Chemotherapy,Public,Alive,85.0,BRCA1,Yes,,None,,High,Urban,Statutory Health Insurance,14.0,No,No,Obesity,1.0
PT04793,France,Provence-Alpes-Côte d'Azur,34.0,Male,Colorectal,III,2013-11-01,2014-02-01,2014-04-02,Surgery,Private,Alive,77.0,KRAS,No,Never,Moderate,22.7,Medium,Urban,Statutory Health Insurance,11.0,No,No,Hypertension,3.0
PT04794,France,Provence-Alpes-Côte d'Azur,67.0,Female,Ovarian,,2019-07-13,2019-08-17,2019-10-15,Targeted Therapy,Private,,,BRCA1,Yes,Never,Moderate,25.1,Medium,Rural,NHS,,No,No,None,3.0
PT04795,Sweden,Västra Götaland,68.0,Female,Pancreatic,IV,2023-03-14,2023-05-27,2023-07-19,Chemotherapy,Public,Deceased,56.0,BRCA1,No,Never,None,38.0,Medium,Rural,Private Insurance,6.0,,No,Diabetes,4.0
PT04796,Spain,Madrid,63.0,Male,Pancreatic,I,2018-03-31,2018-07-20,2018-11-22,Surgery,Private,Alive,64.0,EGFR,No,Current,Moderate,34.3,Medium,Rural,Statutory Health Insurance,14.0,No,No,Obesity,2.0
PT04797,France,Île-de-France,29.0,Female,Ovarian,II,2022-11-27,2023-03-15,2023-09-18,Surgery,Research Institute,Alive,78.0,,No,Never,Moderate,18.9,Medium,Rural,Private Insurance,16.0,No,Yes,Cardiovascular Disease,3.0
PT04798,Portugal,Algarve,39.0,Male,Colorectal,II,2020-09-08,2021-01-07,2021-06-06,Radiation,Public,Deceased,25.0,None,Yes,Current,Moderate,39.8,Medium,Rural,Private Insurance,17.0,Yes,No,Cardiovascular Disease,3.0
PT04799,Sweden,Skåne,89.0,Female,Prostate,III,2011-12-26,2012-06-12,2012-12-12,Chemotherapy,Public,Alive,24.0,None,Yes,Never,Moderate,22.7,Medium,Urban,Private Insurance,2.0,No,No,Hypertension,3.0
PT04800,Finland,Pirkanmaa,27.0,Male,Lung,I,2010-07-07,2010-09-09,2010-12-29,Targeted Therapy,Public,Alive,21.0,BRCA1,Yes,,Moderate,28.7,Low,Rural,NHS,10.0,No,Yes,Hypertension,1.0
PT04801,Denmark,Capital Region,64.0,Female,Leukemia,I,2023-03-24,2023-04-11,2024-03-15,Targeted Therapy,Private,Alive,67.0,,Yes,Never,None,23.0,High,Urban,Statutory Health Insurance,9.0,No,No,Obesity,3.0
PT04802,Poland,Lesser Poland,53.0,Male,,II,2017-08-04,,2018-12-17,Immunotherapy,Public,Alive,34.0,KRAS,No,Never,None,24.1,Medium,Rural,Statutory Health Insurance,18.0,Yes,,,5.0
PT04803,Spain,Andalusia,70.0,Male,Leukemia,IV,2022-08-18,2022-10-22,2023-08-24,Chemotherapy,Public,Deceased,103.0,EGFR,No,Never,None,19.6,Medium,Urban,Private Insurance,7.0,No,No,Cardiovascular Disease,9.0
PT04804,Austria,Tyrol,23.0,Male,Pancreatic,IV,2017-01-24,2017-06-24,2017-11-26,Surgery,,Deceased,97.0,BRCA1,Yes,Former,Moderate,32.5,Medium,Rural,NHS,9.0,Yes,No,Hypertension,3.0
PT04805,Spain,Andalusia,58.0,Male,Prostate,II,2020-02-18,2020-02-22,2020-12-31,Radiation,Research Institute,Lost to Follow-up,,KRAS,Yes,Former,Moderate,,Low,Urban,Private Insurance,6.0,No,No,Obesity,3.0
PT04806,Netherlands,Utrecht,43.0,Female,Pancreatic,IV,2018-01-18,2018-01-25,2018-06-27,Immunotherapy,Public,Alive,39.0,BRCA1,No,Never,None,32.7,High,Rural,Private Insurance,13.0,Yes,Yes,Obesity,2.0
PT04807,Denmark,Central Denmark,74.0,Male,Ovarian,I,2013-02-12,2013-07-31,2013-11-18,Radiation,Private,Alive,86.0,KRAS,No,Former,,26.2,Low,Rural,Statutory Health Insurance,,No,Yes,None,10.0
PT04808,Netherlands,Utrecht,45.0,Female,Ovarian,II,2010-07-23,,2012-01-15,Surgery,Public,Alive,9.0,EGFR,Yes,Current,None,37.0,Low,Urban,Statutory Health Insurance,1.0,No,No,None,3.0
PT04809,Norway,Vestland,44.0,Male,Pancreatic,,2019-04-04,2019-08-27,2020-06-30,Surgery,Private,Deceased,60.0,KRAS,No,Former,None,29.7,Medium,Rural,Private Insurance,15.0,,No,Obesity,10.0
PT04810,Spain,Andalusia,55.0,Female,Pancreatic,I,2013-09-07,2013-11-21,2014-06-19,Radiation,Public,Alive,57.0,BRCA1,No,Current,None,39.1,,Rural,Statutory Health Insurance,4.0,Yes,No,Obesity,5.0
PT04811,Sweden,Västra Götaland,77.0,Female,Breast,I,2010-12-27,2011-02-20,2012-01-24,Immunotherapy,Public,Alive,103.0,KRAS,No,Former,Moderate,36.3,Medium,Urban,Private Insurance,18.0,Yes,No,Diabetes,5.0
PT04812,Ireland,Munster,31.0,Non-binary,Lung,,2013-02-17,2013-06-19,2013-12-27,Surgery,Public,Alive,35.0,BRCA1,Yes,Former,Moderate,30.0,Low,Urban,Private Insurance,5.0,No,No,Diabetes,4.0
PT04813,France,Provence-Alpes-Côte d'Azur,20.0,Non-binary,Pancreatic,III,2010-08-02,2010-08-29,2011-08-17,Targeted Therapy,Public,Alive,114.0,BRCA1,No,Current,Moderate,39.5,Medium,Rural,Private Insurance,9.0,No,,Cardiovascular Disease,1.0
PT04814,Norway,Vestland,69.0,,Leukemia,IV,2015-01-23,2015-06-12,2015-07-23,Targeted Therapy,Public,Alive,64.0,None,,Former,Moderate,23.0,Medium,Urban,Statutory Health Insurance,9.0,No,No,Diabetes,5.0
PT04815,Portugal,Porto,44.0,Female,Colorectal,I,2019-04-06,2019-09-28,2020-03-05,Targeted Therapy,Public,Alive,69.0,None,No,Current,None,30.8,Medium,Urban,Private Insurance,,,No,Diabetes,8.0
PT04816,Denmark,Capital Region,24.0,Male,Lung,II,2011-10-04,,2013-01-18,Immunotherapy,Public,Deceased,43.0,KRAS,No,Former,Moderate,33.4,Medium,Urban,NHS,15.0,,No,Cardiovascular Disease,9.0
PT04817,Portugal,Porto,87.0,Female,Leukemia,II,2011-08-29,2012-01-12,2012-06-14,Immunotherapy,Public,Alive,35.0,None,Yes,Never,,19.8,Low,Urban,NHS,3.0,Yes,No,None,6.0
,Spain,Catalonia,25.0,Female,Breast,IV,2011-01-01,2011-04-27,2011-11-14,Chemotherapy,Public,Alive,100.0,None,Yes,Never,Moderate,29.3,Medium,Rural,Statutory Health Insurance,10.0,No,No,Hypertension,9.0
PT04819,Norway,Oslo,45.0,Male,Pancreatic,I,2013-05-13,2013-06-05,2013-11-15,Chemotherapy,Private,Deceased,,BRCA1,Yes,Current,Moderate,21.9,Medium,Urban,Private Insurance,5.0,Yes,No,None,10.0
PT04820,Sweden,,74.0,Female,Leukemia,II,,2012-07-13,2012-09-19,Targeted Therapy,Public,Alive,101.0,EGFR,No,Never,None,32.9,Medium,Rural,Statutory Health Insurance,5.0,No,No,Obesity,6.0
PT04821,Germany,Bavaria,58.0,Male,Leukemia,I,,2022-03-03,2022-09-26,Radiation,Research Institute,Deceased,61.0,None,No,Current,Moderate,21.3,Medium,Urban,Statutory Health Insurance,5.0,Yes,Yes,,10.0
PT04822,Italy,Lombardy,28.0,Female,Leukemia,III,2017-08-03,2018-01-10,,Radiation,Public,Alive,103.0,KRAS,No,Former,Moderate,35.3,Medium,Urban,Private Insurance,3.0,No,,Diabetes,4.0
PT04823,France,Île-de-France,64.0,Male,Lung,I,2018-05-23,2018-05-29,2018-07-02,Targeted Therapy,Public,Alive,114.0,BRCA1,No,Never,Moderate,31.3,Medium,Urban,Private Insurance,3.0,No,,Cardiovascular Disease,5.0
PT04824,Germany,Bavaria,33.0,Female,Pancreatic,I,,2017-11-11,2018-02-02,Chemotherapy,Public,Alive,87.0,KRAS,No,Never,None,21.5,Low,Rural,Private Insurance,6.0,Yes,,Diabetes,4.0
PT04825,Poland,Silesian,74.0,Female,Leukemia,II,2010-03-31,2010-05-29,2011-05-03,Immunotherapy,Public,Alive,11.0,EGFR,Yes,Former,Moderate,31.6,Low,Urban,Private Insurance,9.0,No,No,Cardiovascular Disease,7.0
PT04826,Portugal,Lisbon,28.0,Non-binary,Colorectal,II,2012-09-15,2013-03-12,2014-01-01,Radiation,Private,Alive,8.0,None,No,Never,None,18.2,Medium,Urban,NHS,5.0,No,Yes,None,9.0
PT04827,Spain,Madrid,34.0,Female,,I,2016-09-06,,2017-01-03,Immunotherapy,Public,Alive,45.0,KRAS,Yes,Never,None,18.8,Low,Urban,Statutory Health Insurance,2.0,No,Yes,Hypertension,6.0
PT04828,Norway,Oslo,56.0,Female,Prostate,I,2018-10-17,2018-11-26,2019-08-03,Targeted Therapy,,Alive,,KRAS,No,Never,Heavy,22.8,High,Rural,NHS,6.0,No,No,None,7.0
PT04829,Norway,Oslo,69.0,,Colorectal,IV,2010-10-20,2011-04-12,2012-04-06,Immunotherapy,Public,Deceased,43.0,BRCA1,No,Never,Moderate,26.3,Medium,Urban,NHS,11.0,Yes,,Diabetes,7.0
PT04830,Netherlands,South Holland,40.0,Male,Breast,I,2014-01-29,2014-04-23,2015-01-18,Radiation,Research Institute,Alive,22.0,KRAS,No,Never,Moderate,21.2,Medium,Urban,NHS,4.0,No,Yes,Diabetes,9.0
PT04831,Belgium,Flanders,76.0,Male,Ovarian,I,2022-12-10,2023-05-20,2023-09-20,Chemotherapy,Private,Alive,56.0,None,No,Never,Moderate,35.3,Medium,Urban,Private Insurance,13.0,No,,None,1.0
PT04832,Poland,Lesser Poland,,Male,Lung,I,2018-09-05,2018-11-02,2019-02-08,Radiation,Public,Deceased,32.0,KRAS,No,Former,Moderate,20.5,Medium,,Private Insurance,19.0,Yes,Yes,Diabetes,4.0
PT04833,Sweden,Skåne,77.0,Male,Prostate,,2021-09-05,2021-12-30,2022-02-03,Surgery,Public,Lost to Follow-up,,BRCA1,Yes,Former,None,19.0,Medium,Urban,NHS,15.0,Yes,No,Obesity,4.0
PT04834,Austria,Styria,,Female,Lung,I,2013-12-20,2014-04-30,2014-12-21,Immunotherapy,Public,Alive,42.0,None,No,Never,Moderate,18.2,Low,Rural,,2.0,No,No,Hypertension,10.0
PT04835,Ireland,Dublin,23.0,Female,Lung,III,2023-08-26,,2023-12-28,Immunotherapy,Public,Alive,31.0,None,No,Former,None,30.4,Low,Urban,Statutory Health Insurance,19.0,No,No,,5.0
PT04836,Poland,Silesian,62.0,Female,Leukemia,IV,2012-12-26,2013-05-30,2013-08-27,Immunotherapy,Public,Alive,83.0,EGFR,No,,Moderate,30.6,Low,Urban,Statutory Health Insurance,3.0,,,Obesity,5.0
PT04837,Spain,Madrid,61.0,Male,Colorectal,II,2019-12-09,,2020-08-01,Targeted Therapy,Public,Alive,65.0,KRAS,Yes,Never,Moderate,22.1,Medium,Rural,NHS,1.0,No,No,None,9.0
PT04838,Portugal,Lisbon,22.0,Male,Prostate,I,2017-02-28,2017-04-26,2018-03-10,Targeted Therapy,Public,Alive,105.0,EGFR,No,Former,Moderate,23.8,Medium,Urban,Statutory Health Insurance,14.0,No,No,,1.0
PT04839,Sweden,Skåne,20.0,Female,,III,2010-05-31,2010-11-10,2011-07-03,Radiation,Public,Alive,93.0,EGFR,No,Never,Moderate,35.2,High,Urban,Private Insurance,16.0,Yes,No,Obesity,3.0
PT04840,Belgium,Wallonia,74.0,Male,Prostate,III,2012-09-10,2013-03-08,2013-05-16,Chemotherapy,Public,Deceased,26.0,BRCA1,No,Former,Moderate,37.7,Low,Urban,Statutory Health Insurance,6.0,No,Yes,Hypertension,7.0
PT04841,Finland,Pirkanmaa,34.0,Male,Pancreatic,III,2014-12-25,,2015-02-18,Surgery,Public,Deceased,70.0,KRAS,No,Never,Moderate,25.2,Medium,Urban,Private Insurance,7.0,No,Yes,Hypertension,10.0
PT04842,Germany,North Rhine-Westphalia,66.0,Male,Pancreatic,III,,2012-10-25,2013-02-22,Chemotherapy,Private,Alive,67.0,BRCA1,Yes,Former,,27.6,Low,Urban,NHS,8.0,No,Yes,Diabetes,10.0
PT04843,Belgium,Brussels,65.0,Male,Colorectal,I,2010-07-08,2010-12-31,2011-08-12,,Private,Alive,47.0,EGFR,No,Current,Moderate,19.5,High,,NHS,7.0,Yes,No,Obesity,7.0
PT04844,Denmark,Zealand,77.0,Male,Leukemia,III,2017-08-10,2017-10-07,2018-05-26,Surgery,Public,Alive,101.0,BRCA1,Yes,Former,None,36.6,Low,Rural,NHS,12.0,No,No,Cardiovascular Disease,2.0
PT04845,Belgium,Wallonia,58.0,Male,Prostate,I,2020-04-14,2020-06-29,2020-09-14,Targeted Therapy,Public,Deceased,68.0,KRAS,No,Former,Moderate,32.5,Low,Urban,,14.0,No,Yes,Cardiovascular Disease,3.0
PT04846,Poland,Masovian,22.0,Male,Ovarian,II,2017-01-15,2017-04-28,2018-02-17,Immunotherapy,Public,Deceased,80.0,BRCA1,Yes,,Moderate,19.7,Medium,Urban,Private Insurance,15.0,No,No,None,2.0
PT04847,Poland,Masovian,49.0,Female,Pancreatic,III,2013-04-01,2013-04-27,2014-01-26,Targeted Therapy,Public,Alive,63.0,EGFR,No,Never,Moderate,31.0,Medium,Rural,Private Insurance,17.0,Yes,No,Hypertension,9.0
PT04848,Germany,Berlin,54.0,Male,Leukemia,I,2020-09-06,2020-10-03,2021-07-21,Immunotherapy,Public,Deceased,117.0,EGFR,No,,None,20.2,Low,Urban,NHS,2.0,No,No,Cardiovascular Disease,6.0
PT04849,Finland,Uusimaa,76.0,Male,Lung,I,2019-06-02,2019-06-26,2020-06-07,Immunotherapy,Private,Deceased,86.0,KRAS,No,Former,Moderate,34.4,Low,Urban,Private Insurance,14.0,Yes,No,Hypertension,9.0
,Finland,Pirkanmaa,48.0,Female,Pancreatic,I,2017-01-08,2017-03-30,2017-05-29,Targeted Therapy,Private,Alive,67.0,KRAS,No,Never,Moderate,20.9,Medium,Urban,Private Insurance,9.0,No,No,None,7.0
PT04851,Germany,Berlin,69.0,Female,Breast,II,2023-03-04,2023-07-21,2024-05-07,Chemotherapy,Public,Deceased,72.0,EGFR,No,Former,None,28.3,Medium,Urban,Statutory Health Insurance,4.0,Yes,No,Obesity,3.0
PT04852,Switzerland,Bern,81.0,Male,Prostate,IV,2013-09-09,2013-12-04,2014-02-05,Immunotherapy,Private,Alive,106.0,EGFR,Yes,Current,None,33.6,Medium,Rural,NHS,15.0,,No,Diabetes,3.0
,Denmark,Zealand,71.0,Female,,II,2019-05-01,2019-09-14,2020-06-14,Targeted Therapy,Public,Alive,34.0,KRAS,Yes,Current,Moderate,22.0,Medium,Urban,Private Insurance,3.0,No,No,Hypertension,10.0
,Spain,Andalusia,33.0,Male,Pancreatic,III,2017-03-10,,2018-08-20,Chemotherapy,Public,Alive,24.0,,No,Current,None,20.2,Low,Rural,,12.0,No,No,Diabetes,5.0
PT04855,Italy,Sicily,54.0,Male,Colorectal,I,2020-04-10,2020-05-12,2021-03-05,Surgery,Private,Alive,112.0,KRAS,No,Never,None,,Medium,Urban,Statutory Health Insurance,2.0,No,No,Obesity,3.0
PT04856,Ireland,Munster,47.0,Non-binary,,I,2011-10-29,2011-11-27,2012-10-15,Immunotherapy,Private,Alive,102.0,BRCA1,No,Never,None,34.2,Low,Urban,Statutory Health Insurance,8.0,No,No,Diabetes,8.0
PT04857,,Lisbon,77.0,Female,Breast,I,2022-10-28,2023-02-11,2023-10-09,Chemotherapy,Public,Deceased,118.0,BRCA1,No,Current,None,25.4,Medium,Rural,Private Insurance,17.0,Yes,No,Diabetes,9.0
PT04858,,Dublin,49.0,Male,Prostate,II,2012-02-12,2012-05-18,2012-10-29,Immunotherapy,Private,Alive,108.0,KRAS,Yes,Former,Heavy,22.7,Medium,Rural,Statutory Health Insurance,13.0,Yes,No,,7.0
PT04859,Norway,Oslo,26.0,,,II,2018-10-10,2019-02-08,2019-05-12,Chemotherapy,Public,Alive,116.0,KRAS,Yes,Current,Moderate,38.3,Low,Urban,Private Insurance,,No,No,Hypertension,9.0
PT04860,Sweden,Skåne,58.0,Female,Pancreatic,IV,2023-07-21,2023-11-02,2024-08-04,Surgery,Public,Alive,10.0,KRAS,Yes,Never,Moderate,32.2,Medium,Urban,Private Insurance,1.0,No,No,None,5.0
PT04861,Italy,Sicily,88.0,Male,Prostate,II,2013-03-10,2013-07-21,2014-07-18,Immunotherapy,Private,Deceased,71.0,,Yes,Former,Moderate,29.8,Medium,Urban,NHS,8.0,No,No,Obesity,8.0
PT04862,Belgium,Flanders,54.0,Male,Colorectal,II,2023-07-25,2024-01-18,2024-11-19,Targeted Therapy,Private,Alive,14.0,BRCA1,,Former,Moderate,24.0,Low,Urban,NHS,6.0,Yes,No,Obesity,5.0
PT04863,Portugal,Lisbon,71.0,,Breast,I,2022-07-31,2022-12-19,2023-04-05,Chemotherapy,Public,Alive,46.0,KRAS,No,Former,Moderate,26.0,Medium,Urban,NHS,9.0,No,Yes,Diabetes,7.0
PT04864,,Zealand,33.0,Female,Pancreatic,I,2011-10-11,2012-02-16,2012-08-27,,Public,Lost to Follow-up,,BRCA1,No,Former,None,25.4,High,Urban,NHS,16.0,No,No,None,8.0
PT04865,Belgium,Wallonia,82.0,Male,Breast,I,2016-02-02,2016-05-01,2016-08-15,Immunotherapy,Public,Alive,30.0,BRCA1,Yes,Former,Moderate,39.0,Medium,Rural,Statutory Health Insurance,7.0,No,No,None,8.0
PT04866,Netherlands,South Holland,55.0,Female,Colorectal,III,2023-05-28,2023-07-09,2024-01-31,Surgery,Public,Deceased,89.0,BRCA1,Yes,Never,Moderate,21.0,High,Urban,Statutory Health Insurance,16.0,No,No,Cardiovascular Disease,4.0
PT04867,Sweden,Skåne,43.0,Male,Prostate,II,2023-07-18,2023-07-28,2023-12-01,Surgery,Public,Alive,80.0,KRAS,Yes,Current,Moderate,27.6,High,Rural,Statutory Health Insurance,15.0,No,No,Obesity,9.0
PT04868,Netherlands,North Holland,59.0,Male,Prostate,I,2012-11-25,2013-04-28,2013-10-13,Immunotherapy,Private,Alive,,EGFR,Yes,Former,Moderate,19.0,Medium,Urban,Private Insurance,11.0,No,No,,10.0
PT04869,Ireland,Dublin,48.0,Female,Pancreatic,II,2012-09-14,2012-10-10,2013-07-09,Immunotherapy,Private,Alive,70.0,None,No,Current,None,29.4,,Rural,Private Insurance,18.0,Yes,No,Hypertension,9.0
PT04870,Italy,Lombardy,72.0,Female,Breast,II,,2016-05-30,2017-03-06,Chemotherapy,Private,Lost to Follow-up,,KRAS,Yes,Never,None,36.6,Low,Urban,Private Insurance,7.0,Yes,No,,3.0
PT04871,Netherlands,North Holland,41.0,Male,Prostate,I,2022-12-28,2023-06-18,2024-04-22,Targeted Therapy,Public,Alive,93.0,BRCA1,No,Never,Moderate,39.3,Medium,,Private Insurance,11.0,No,Yes,Diabetes,8.0
PT04872,Ireland,Connacht,34.0,Male,Ovarian,III,,,2023-09-16,Surgery,Research Institute,Alive,,BRCA1,Yes,,Moderate,24.8,High,Urban,NHS,4.0,No,No,Cardiovascular Disease,3.0
PT04873,Denmark,Central Denmark,88.0,Female,Lung,III,2014-11-21,2014-12-30,2015-07-18,Immunotherapy,Research Institute,Alive,21.0,BRCA1,No,Former,Moderate,22.2,Medium,Urban,Statutory Health Insurance,,Yes,No,Cardiovascular Disease,8.0
PT04874,Norway,Vestland,83.0,Male,Prostate,I,2014-03-08,2014-08-26,2015-03-22,Surgery,Private,Alive,60.0,KRAS,No,Never,Moderate,31.6,Medium,Urban,Statutory Health Insurance,7.0,No,Yes,Hypertension,3.0
PT04875,Norway,Trøndelag,23.0,Male,Ovarian,III,2022-10-24,2022-12-15,,Chemotherapy,Public,Deceased,,,No,,Moderate,24.8,Medium,Rural,Statutory Health Insurance,14.0,No,No,Obesity,5.0
PT04876,Italy,Veneto,37.0,Female,Prostate,I,2021-10-29,2022-03-01,2023-01-02,Chemotherapy,Public,Lost to Follow-up,,None,Yes,Never,None,20.2,Medium,Rural,NHS,19.0,Yes,Yes,Hypertension,5.0
PT04877,Switzerland,Geneva,61.0,Female,Leukemia,III,2015-03-17,,2016-05-12,Chemotherapy,Private,Deceased,43.0,None,No,Never,Moderate,22.5,High,Urban,NHS,8.0,No,No,Cardiovascular Disease,8.0
PT04878,Sweden,Skåne,49.0,Male,Breast,IV,2016-07-31,2016-10-15,2016-12-01,Targeted Therapy,Public,Alive,48.0,BRCA1,No,,Moderate,18.5,Low,Urban,Private Insurance,16.0,No,No,Obesity,5.0
PT04879,Finland,Uusimaa,34.0,Female,Breast,II,2018-03-05,2018-06-13,2019-05-08,Radiation,Public,Deceased,13.0,EGFR,No,,None,37.5,High,Urban,NHS,6.0,No,No,Obesity,10.0
PT04880,Portugal,Algarve,89.0,Female,Ovarian,I,2015-01-25,2015-07-04,2015-11-19,Radiation,Private,Alive,58.0,EGFR,Yes,Former,None,26.3,High,Urban,Private Insurance,11.0,,No,,5.0
PT04881,Netherlands,South Holland,74.0,,Lung,II,2012-10-04,,2012-12-22,Radiation,Public,Alive,66.0,BRCA1,Yes,Current,Moderate,35.1,Low,Urban,Private Insurance,7.0,Yes,Yes,None,7.0
PT04882,Austria,Vienna,72.0,Female,Lung,I,2011-06-30,2011-08-11,2011-11-04,Targeted Therapy,Research Institute,Alive,93.0,None,,Current,Heavy,32.4,Low,Urban,Private Insurance,14.0,No,Yes,Cardiovascular Disease,4.0
PT04883,Italy,Sicily,35.0,Male,,I,2011-06-09,2011-06-11,2012-02-23,Targeted Therapy,Public,Deceased,75.0,KRAS,,Never,Moderate,22.3,High,Urban,Statutory Health Insurance,9.0,,No,Obesity,3.0
PT04884,Poland,Silesian,53.0,Male,Breast,III,2020-12-24,2021-01-26,2021-05-09,Surgery,Public,Alive,51.0,BRCA1,No,Current,None,26.7,Medium,Rural,NHS,10.0,No,,Hypertension,6.0
,Austria,Vienna,46.0,Male,Leukemia,I,2014-10-04,2015-03-27,,Surgery,Private,Alive,14.0,BRCA1,Yes,Current,Moderate,27.8,Medium,Urban,Private Insurance,3.0,No,Yes,Obesity,7.0
PT04886,Belgium,Wallonia,32.0,Male,Leukemia,I,2012-12-16,2013-02-13,2013-06-11,Chemotherapy,Public,Alive,72.0,,Yes,Never,Moderate,32.3,Medium,Rural,NHS,18.0,No,No,Hypertension,10.0
PT04887,Sweden,Skåne,46.0,Female,Colorectal,III,2015-07-15,2015-10-23,2016-04-01,Targeted Therapy,Private,Deceased,105.0,EGFR,Yes,Current,None,38.4,Medium,Rural,Private Insurance,15.0,No,No,Cardiovascular Disease,4.0
PT04888,Finland,Southwest Finland,88.0,Male,Breast,III,2013-08-31,2013-11-12,2014-10-01,Radiation,Public,Alive,28.0,KRAS,Yes,Never,Moderate,22.2,High,Urban,Private Insurance,14.0,Yes,No,None,6.0
PT04889,Spain,Madrid,50.0,Female,Colorectal,I,2015-11-29,,2017-01-28,Radiation,Public,Alive,,KRAS,No,Never,None,26.9,Low,Rural,Private Insurance,2.0,No,No,Cardiovascular Disease,10.0
PT04890,Netherlands,South Holland,22.0,Male,Prostate,III,2018-09-23,2019-03-09,2019-12-13,Surgery,Public,Alive,39.0,EGFR,No,Current,Moderate,22.5,High,Urban,Statutory Health Insurance,16.0,No,No,Hypertension,2.0
PT04891,,Algarve,49.0,,Lung,IV,2013-08-23,2013-11-16,2014-01-26,Chemotherapy,Private,Alive,107.0,EGFR,No,,None,36.1,High,Urban,Statutory Health Insurance,11.0,Yes,Yes,Obesity,10.0
PT04892,Belgium,Wallonia,40.0,Female,Colorectal,I,2012-02-10,2012-03-03,2012-11-18,Chemotherapy,Public,Alive,109.0,EGFR,,Never,None,34.2,,Urban,NHS,7.0,No,No,Diabetes,2.0
PT04893,Belgium,Flanders,25.0,Female,Pancreatic,II,2014-10-08,2014-10-25,2015-05-12,Immunotherapy,Public,Alive,,EGFR,Yes,Former,Heavy,36.2,Medium,Rural,Statutory Health Insurance,3.0,No,No,Obesity,6.0
PT04894,Sweden,Stockholm,51.0,Female,Colorectal,III,2022-01-23,2022-06-03,2023-05-14,Targeted Therapy,Public,Alive,53.0,EGFR,No,Never,Moderate,35.0,Medium,Urban,Private Insurance,13.0,No,No,Hypertension,8.0
PT04895,Spain,Andalusia,61.0,Female,Breast,III,2021-06-21,2021-07-23,2021-11-19,Radiation,,Alive,86.0,KRAS,No,,Moderate,18.6,Low,Urban,Private Insurance,10.0,No,No,Hypertension,9.0
PT04896,,Zurich,81.0,Male,Lung,I,2021-04-05,2021-05-08,2021-12-14,Radiation,Public,Alive,26.0,KRAS,No,,None,23.8,Medium,Urban,NHS,14.0,No,No,Cardiovascular Disease,5.0
PT04897,Italy,Lombardy,,Female,Lung,I,2013-09-20,2013-09-30,2014-08-02,Surgery,Private,Alive,72.0,EGFR,Yes,Never,None,25.8,High,Rural,NHS,18.0,No,Yes,Diabetes,6.0
PT04898,Ireland,Munster,58.0,Male,Leukemia,III,2018-07-31,2018-08-05,2019-01-08,Surgery,Public,Alive,43.0,None,No,Former,Heavy,35.6,,Rural,Private Insurance,14.0,No,Yes,Obesity,1.0
PT04899,Switzerland,Zurich,83.0,Female,Colorectal,IV,2017-08-28,2017-11-04,2018-04-15,Targeted Therapy,Public,Deceased,58.0,EGFR,No,Current,None,36.7,High,Rural,Private Insurance,,No,No,Diabetes,4.0
PT04900,Sweden,Skåne,49.0,,Leukemia,III,2014-05-16,2014-10-29,2015-09-09,,Public,Alive,40.0,,Yes,Former,Moderate,28.4,Medium,Urban,,4.0,No,No,Diabetes,3.0
PT04901,Finland,Pirkanmaa,82.0,Male,Colorectal,IV,2015-06-04,2015-09-14,2015-12-15,Surgery,Private,Alive,103.0,KRAS,No,Former,Moderate,39.7,Low,Urban,NHS,13.0,No,Yes,None,8.0
PT04902,Norway,Trøndelag,50.0,Male,Breast,III,2011-07-10,2011-12-26,2012-09-20,Radiation,Private,Alive,19.0,KRAS,Yes,Never,None,29.7,Medium,Urban,Statutory Health Insurance,10.0,No,No,Cardiovascular Disease,2.0
PT04903,Spain,Catalonia,59.0,Female,Breast,IV,2020-11-08,2021-01-20,2021-03-28,Targeted Therapy,Private,Alive,85.0,KRAS,No,Current,None,29.2,Low,Urban,NHS,2.0,No,,Obesity,8.0
PT04904,Austria,,52.0,Female,Prostate,III,2019-10-12,2020-03-03,2020-09-12,Radiation,Public,Alive,63.0,EGFR,Yes,Former,Moderate,29.8,Low,Urban,Statutory Health Insurance,19.0,No,No,Diabetes,6.0
PT04905,Poland,Silesian,82.0,Male,Colorectal,IV,2018-05-18,2018-07-09,2018-09-14,Radiation,Research Institute,Alive,73.0,KRAS,Yes,Never,Heavy,34.2,Low,Urban,NHS,3.0,No,No,Diabetes,7.0
PT04906,Finland,Uusimaa,44.0,Non-binary,Colorectal,I,2021-12-03,2021-12-11,2022-10-15,Surgery,Public,Alive,78.0,KRAS,Yes,Former,Moderate,26.3,,Rural,NHS,18.0,No,No,Cardiovascular Disease,1.0
PT04907,Sweden,Skåne,,Female,Lung,III,2017-07-23,2017-10-29,2018-04-27,Radiation,Private,Alive,43.0,EGFR,No,Former,Moderate,37.9,,,Statutory Health Insurance,13.0,Yes,No,Obesity,6.0
PT04908,Germany,North Rhine-Westphalia,43.0,Male,Ovarian,I,2012-04-14,2012-05-14,2012-08-09,Targeted Therapy,Public,Alive,20.0,EGFR,No,Former,Moderate,30.1,Low,Rural,Statutory Health Insurance,5.0,No,No,Obesity,1.0
PT04909,Finland,Uusimaa,,Male,Lung,I,2014-07-06,2014-09-18,2015-04-11,Surgery,Private,Alive,59.0,None,No,,None,27.5,Medium,Rural,Statutory Health Insurance,18.0,Yes,Yes,Hypertension,
PT04910,Portugal,Lisbon,58.0,Female,Ovarian,II,2018-05-18,2018-08-04,2019-05-03,Targeted Therapy,Private,Deceased,70.0,EGFR,No,Never,Moderate,23.4,Medium,Rural,NHS,1.0,No,No,Diabetes,10.0
PT04911,Italy,Sicily,65.0,Male,,II,2012-05-16,2012-09-17,2013-04-08,Chemotherapy,Public,Alive,15.0,BRCA1,No,Never,Moderate,26.1,Low,Urban,Private Insurance,4.0,No,Yes,None,9.0
PT04912,Portugal,Lisbon,29.0,Male,Prostate,I,2012-06-22,2012-12-01,2013-05-22,Targeted Therapy,Public,Deceased,16.0,KRAS,Yes,Current,None,32.5,Medium,Rural,,2.0,No,No,,2.0
PT04913,Ireland,Munster,51.0,Female,Breast,IV,2016-09-23,2017-02-11,2017-11-24,Targeted Therapy,Private,Alive,100.0,BRCA1,No,Former,Moderate,39.4,Low,Urban,Statutory Health Insurance,8.0,No,No,Cardiovascular Disease,3.0
PT04914,Norway,Vestland,55.0,Female,Colorectal,III,2023-08-24,2024-02-19,2024-06-27,Immunotherapy,Private,,41.0,BRCA1,No,Never,Moderate,30.8,Low,Urban,Private Insurance,13.0,No,No,,7.0
PT04915,Portugal,Lisbon,47.0,Female,Leukemia,IV,2010-05-23,2010-07-21,2011-03-09,Targeted Therapy,Private,Alive,103.0,EGFR,No,Never,Moderate,29.8,Low,Urban,NHS,4.0,No,No,Hypertension,5.0
PT04916,Spain,Andalusia,35.0,Male,Prostate,,2020-03-12,2020-05-13,,Radiation,Research Institute,Deceased,62.0,,No,Current,Heavy,24.7,Medium,Urban,Statutory Health Insurance,15.0,No,No,Diabetes,1.0
PT04917,Italy,Sicily,35.0,Female,Lung,II,2017-08-18,2017-09-16,2018-03-16,Radiation,Private,Alive,43.0,KRAS,No,Never,Moderate,38.3,Medium,Urban,,10.0,No,No,,5.0
PT04918,Belgium,Flanders,37.0,Non-binary,Prostate,,2019-04-14,2019-07-16,2019-10-23,Surgery,,Alive,86.0,None,,Current,Moderate,31.5,High,Rural,NHS,1.0,No,No,Diabetes,3.0
PT04919,Belgium,Wallonia,27.0,Male,Leukemia,I,2017-05-19,2017-07-20,,Chemotherapy,Public,Alive,73.0,KRAS,No,Former,None,36.7,Medium,Urban,Statutory Health Insurance,16.0,No,No,None,8.0
PT04920,Spain,Catalonia,89.0,Female,Breast,II,2017-07-22,2017-12-04,2018-09-05,Surgery,Public,Deceased,112.0,EGFR,No,,None,19.5,Low,Urban,Private Insurance,17.0,No,No,Cardiovascular Disease,6.0
PT04921,Finland,Southwest Finland,20.0,Female,Lung,III,2019-03-04,2019-08-23,2019-12-26,Targeted Therapy,Private,Deceased,42.0,KRAS,No,Former,Moderate,34.8,Medium,Urban,NHS,17.0,No,No,Diabetes,9.0
PT04922,Belgium,Brussels,81.0,Female,Pancreatic,,2020-08-25,2021-01-06,2021-04-29,,,Alive,23.0,None,No,Never,Moderate,23.8,Medium,Rural,Private Insurance,,No,No,Hypertension,2.0
PT04923,,Bern,57.0,Female,Lung,II,2020-03-22,2020-05-23,2020-10-24,Radiation,Private,Alive,44.0,BRCA1,Yes,Never,None,39.0,Medium,Urban,NHS,19.0,No,No,Diabetes,10.0
PT04924,Poland,Masovian,64.0,Male,Breast,I,2014-09-18,2014-11-25,2015-06-08,,Research Institute,Alive,41.0,KRAS,No,Former,None,21.2,Medium,Urban,NHS,2.0,No,No,Hypertension,9.0
PT04925,Austria,Tyrol,77.0,Female,Ovarian,II,2018-08-20,2018-09-06,2019-02-21,Targeted Therapy,Public,Deceased,45.0,KRAS,No,,Moderate,20.4,Low,Urban,NHS,16.0,No,No,Hypertension,2.0
PT04926,Switzerland,Bern,20.0,Female,Lung,I,2021-04-07,2021-10-01,2022-04-08,Radiation,Public,Alive,12.0,EGFR,Yes,Never,Moderate,25.6,Medium,Urban,NHS,11.0,No,No,Obesity,
PT04927,Finland,Uusimaa,51.0,Female,Leukemia,IV,2022-12-24,2023-05-25,2024-04-04,Chemotherapy,Public,Alive,81.0,BRCA1,No,Former,None,24.6,Medium,,Private Insurance,13.0,No,No,Cardiovascular Disease,3.0
PT04928,Denmark,Zealand,27.0,Non-binary,Ovarian,I,,2018-02-19,2018-06-14,Targeted Therapy,Public,Alive,24.0,BRCA1,No,Never,None,39.7,High,Urban,Statutory Health Insurance,7.0,No,No,Obesity,7.0
,Norway,Oslo,59.0,Male,Lung,II,2014-09-01,2014-10-28,2015-04-14,Immunotherapy,Public,Deceased,42.0,EGFR,No,Never,Moderate,31.7,Low,Rural,NHS,5.0,No,Yes,None,10.0
PT04930,France,Île-de-France,75.0,Male,Colorectal,I,2011-04-03,2011-09-07,2012-01-19,Chemotherapy,Private,Alive,13.0,EGFR,No,Never,Moderate,35.1,High,Rural,NHS,5.0,No,No,Diabetes,9.0
PT04931,Austria,Vienna,82.0,Male,Prostate,III,2013-06-30,2013-09-26,2014-01-11,Chemotherapy,Private,Alive,79.0,KRAS,No,Never,None,21.1,High,Urban,NHS,13.0,Yes,No,Hypertension,9.0
PT04932,Netherlands,Utrecht,,Female,Ovarian,II,2023-01-27,2023-03-30,2023-12-03,Radiation,Private,Alive,41.0,EGFR,Yes,Never,Moderate,,Low,Urban,,15.0,No,No,Diabetes,4.0
PT04933,Finland,Pirkanmaa,76.0,Male,Leukemia,I,2019-01-29,2019-05-07,2019-12-14,Surgery,Public,Deceased,76.0,KRAS,No,Never,Heavy,37.0,Low,Urban,Private Insurance,16.0,No,,Obesity,6.0
PT04934,,Trøndelag,64.0,Female,Breast,II,2014-05-28,2014-08-14,,Targeted Therapy,Public,Alive,97.0,None,Yes,Never,Moderate,38.9,Medium,Rural,,14.0,No,No,Diabetes,9.0
PT04935,Norway,Vestland,21.0,Male,Leukemia,IV,2020-08-30,2020-09-26,2021-05-09,Targeted Therapy,Private,Deceased,46.0,KRAS,No,Former,Moderate,22.8,Medium,Rural,NHS,17.0,No,No,Diabetes,9.0
PT04936,Norway,Oslo,87.0,Male,Colorectal,IV,2013-01-01,2013-05-14,2013-08-25,Surgery,Public,Alive,48.0,EGFR,No,Former,Moderate,25.1,Medium,Urban,Statutory Health Insurance,19.0,Yes,No,Hypertension,8.0
PT04937,Germany,Berlin,69.0,Male,Ovarian,I,,2011-10-29,,Targeted Therapy,Private,Deceased,87.0,EGFR,Yes,Never,None,37.2,Low,Urban,Private Insurance,,No,No,None,10.0
PT04938,Austria,Vienna,48.0,Female,Lung,III,,2014-01-05,2014-12-03,Immunotherapy,Private,Lost to Follow-up,,KRAS,,Never,Moderate,26.2,High,Rural,NHS,15.0,No,No,Hypertension,1.0
PT04939,Spain,Andalusia,29.0,Female,Lung,I,2022-12-01,2023-04-17,2024-03-03,Surgery,Public,Alive,42.0,None,No,Never,None,,Medium,Urban,Private Insurance,13.0,No,No,Hypertension,9.0
PT04940,Belgium,Brussels,46.0,Female,Pancreatic,I,2023-03-17,2023-08-08,2024-01-27,Radiation,Public,Alive,70.0,BRCA1,No,Never,None,38.7,,Rural,NHS,8.0,No,Yes,Diabetes,
PT04941,Austria,Tyrol,34.0,Female,Leukemia,II,2019-05-05,2019-05-18,,Surgery,Public,Alive,59.0,None,No,Never,Moderate,22.1,Medium,Urban,Private Insurance,14.0,No,No,Obesity,4.0
PT04942,France,Provence-Alpes-Côte d'Azur,79.0,Male,Lung,I,,2016-04-06,2016-06-12,Chemotherapy,Public,Lost to Follow-up,,BRCA1,No,Former,None,18.3,Medium,Urban,,9.0,No,No,,8.0
PT04943,Finland,Pirkanmaa,50.0,Male,Lung,III,2012-06-18,2012-11-18,2013-01-22,Radiation,Public,Alive,98.0,KRAS,No,Never,None,24.7,Medium,Urban,Statutory Health Insurance,16.0,No,No,Diabetes,
PT04944,Spain,Catalonia,40.0,Non-binary,Colorectal,IV,2011-11-29,2012-04-21,2012-09-12,Chemotherapy,Public,Alive,91.0,EGFR,Yes,Never,None,33.1,High,Urban,Statutory Health Insurance,15.0,Yes,Yes,Cardiovascular Disease,6.0
PT04945,Portugal,Lisbon,79.0,Female,Breast,I,2018-01-09,2018-02-22,2018-03-25,Radiation,,Alive,27.0,BRCA1,Yes,Never,Heavy,31.9,High,Rural,NHS,,No,No,None,2.0
PT04946,Norway,Trøndelag,77.0,Male,Pancreatic,I,2021-02-07,2021-06-03,,Surgery,Public,Alive,52.0,None,No,Never,Moderate,22.4,Medium,Urban,Private Insurance,19.0,Yes,No,Cardiovascular Disease,3.0
PT04947,Switzerland,Geneva,,Female,Pancreatic,II,2021-06-23,2021-10-19,2022-02-09,Chemotherapy,Public,Deceased,50.0,EGFR,No,Never,,28.3,Medium,Urban,NHS,3.0,No,No,None,5.0
PT04948,Ireland,Munster,65.0,Male,Pancreatic,II,2019-11-27,2020-03-01,2021-02-04,Radiation,Private,Alive,93.0,EGFR,No,Former,None,33.0,High,Urban,NHS,11.0,No,No,None,2.0
PT04949,Norway,,64.0,Male,Ovarian,IV,2019-06-03,2019-07-20,2020-04-28,Targeted Therapy,Research Institute,Deceased,30.0,EGFR,No,Current,,30.6,,Rural,NHS,12.0,No,No,Diabetes,1.0
PT04950,Netherlands,South Holland,45.0,Male,Prostate,IV,2019-05-10,2019-10-18,2020-06-29,Chemotherapy,Public,Deceased,25.0,BRCA1,No,Current,Moderate,34.0,Low,Rural,Statutory Health Insurance,19.0,No,No,Obesity,9.0
,Germany,Bavaria,70.0,Female,Leukemia,III,2018-05-09,2018-08-01,2019-07-29,Immunotherapy,Public,Alive,35.0,BRCA1,Yes,Former,None,27.7,Low,Urban,Statutory Health Insurance,19.0,No,Yes,None,7.0
PT04952,Austria,Vienna,55.0,,Breast,I,2016-10-25,,2017-10-31,Radiation,Public,Alive,56.0,None,Yes,,None,26.6,Low,Urban,Private Insurance,12.0,No,No,Hypertension,9.0
PT04953,Austria,Vienna,71.0,Male,Prostate,III,2012-03-03,2012-04-12,2012-06-05,Targeted Therapy,Public,Alive,76.0,EGFR,No,Never,None,19.3,Medium,Rural,NHS,7.0,No,No,Cardiovascular Disease,10.0
PT04954,Portugal,Algarve,70.0,Male,Breast,I,2015-09-07,2015-11-17,2016-09-11,Targeted Therapy,Public,Alive,8.0,KRAS,,Never,,,Medium,Urban,Private Insurance,15.0,No,No,Cardiovascular Disease,6.0
PT04955,Portugal,Algarve,,Male,Leukemia,IV,2019-09-14,2020-03-05,2020-11-29,Surgery,Public,Alive,75.0,EGFR,Yes,,Moderate,37.4,,Urban,NHS,17.0,No,No,None,5.0
PT04956,Switzerland,Zurich,33.0,Female,Pancreatic,I,2012-07-11,2012-10-25,2013-07-27,Surgery,Research Institute,Alive,85.0,None,No,Never,None,27.5,Medium,Urban,Statutory Health Insurance,15.0,No,No,Cardiovascular Disease,6.0
PT04957,Italy,Veneto,68.0,Male,Colorectal,,2014-01-21,2014-04-26,2014-11-18,Chemotherapy,Private,Alive,82.0,EGFR,No,Never,Moderate,36.2,Medium,Urban,NHS,12.0,Yes,No,Hypertension,1.0
PT04958,Norway,Oslo,20.0,,Colorectal,I,2012-01-12,2012-07-01,2013-01-09,Chemotherapy,Public,Alive,12.0,KRAS,No,Current,Moderate,31.7,Medium,Urban,NHS,11.0,No,No,Diabetes,10.0
PT04959,Poland,Masovian,76.0,Female,Colorectal,II,,2023-10-02,2024-06-01,Immunotherapy,Public,Alive,34.0,BRCA1,No,Never,None,23.6,Medium,Urban,Statutory Health Insurance,6.0,Yes,Yes,Obesity,9.0
PT04960,Denmark,Capital Region,36.0,Male,,III,2015-07-27,2015-09-12,2016-06-28,Targeted Therapy,Public,Lost to Follow-up,,KRAS,No,Never,None,21.9,High,Urban,Statutory Health Insurance,12.0,No,No,Hypertension,4.0
PT04961,Netherlands,Utrecht,69.0,Male,Leukemia,III,,2014-01-29,2014-10-21,Radiation,Private,Alive,60.0,KRAS,Yes,Never,None,19.1,High,Urban,NHS,7.0,No,No,Diabetes,4.0
PT04962,Spain,Madrid,33.0,Male,Lung,III,2011-01-10,2011-04-02,2011-09-23,Immunotherapy,,Alive,,KRAS,No,Never,None,32.5,Medium,,Statutory Health Insurance,19.0,No,No,Obesity,2.0
PT04963,Portugal,Lisbon,78.0,Female,Lung,II,2017-12-19,2018-06-07,2018-09-13,Immunotherapy,Public,Lost to Follow-up,,EGFR,No,Former,None,24.2,High,Rural,Statutory Health Insurance,17.0,No,No,,4.0
PT04964,Netherlands,South Holland,22.0,Female,Colorectal,I,2011-09-16,2011-09-28,,Immunotherapy,Public,Alive,7.0,BRCA1,No,Former,None,37.7,Medium,Rural,Private Insurance,9.0,Yes,No,Hypertension,9.0
PT04965,Poland,Silesian,59.0,Male,Ovarian,IV,2012-11-14,2013-02-16,2013-05-10,Radiation,Public,Deceased,93.0,BRCA1,No,Never,None,36.8,Low,Rural,Private Insurance,14.0,Yes,Yes,Cardiovascular Disease,2.0
,Portugal,Algarve,85.0,Female,Breast,III,2011-08-29,2012-02-09,2012-08-31,Immunotherapy,Public,Alive,31.0,KRAS,No,Former,None,33.8,Low,Urban,Statutory Health Insurance,14.0,No,,Cardiovascular Disease,4.0
PT04967,Poland,Silesian,53.0,Female,Lung,I,2015-10-15,2016-01-02,2016-09-10,Surgery,Public,Alive,50.0,BRCA1,Yes,Current,None,31.5,Low,Urban,,5.0,,No,None,4.0
PT04968,Poland,Silesian,28.0,Female,Breast,III,2017-01-20,2017-06-10,2018-01-02,Surgery,Private,Alive,59.0,KRAS,No,Never,Moderate,38.4,,Urban,NHS,1.0,Yes,No,Diabetes,2.0
,Finland,Southwest Finland,40.0,Male,Leukemia,,2010-10-05,2010-12-25,2011-12-19,Surgery,Public,Lost to Follow-up,,KRAS,,Never,None,36.6,Low,Urban,Private Insurance,16.0,No,No,Cardiovascular Disease,4.0
PT04970,Poland,Masovian,44.0,Male,Ovarian,III,2015-08-20,2015-12-18,2016-03-18,Immunotherapy,Research Institute,Alive,43.0,EGFR,Yes,Never,None,23.8,,Urban,NHS,4.0,No,No,Diabetes,9.0
PT04971,Netherlands,South Holland,63.0,Female,Ovarian,I,2013-03-10,2013-06-19,2013-08-03,Immunotherapy,Private,Alive,14.0,None,No,Never,None,23.7,Medium,Urban,Statutory Health Insurance,12.0,No,No,None,9.0
PT04972,Austria,Tyrol,44.0,Female,Colorectal,III,2020-08-17,2020-12-08,2021-08-03,Targeted Therapy,Private,Alive,107.0,BRCA1,No,Current,None,18.5,Low,Rural,NHS,13.0,No,No,Hypertension,5.0
PT04973,Italy,Veneto,28.0,Female,Prostate,II,2021-04-16,2021-05-13,2021-10-24,Chemotherapy,Research Institute,Deceased,105.0,,Yes,Never,Moderate,28.8,Medium,Rural,NHS,7.0,No,No,Hypertension,3.0
PT04974,Portugal,Lisbon,81.0,Male,Colorectal,III,2018-09-07,2019-02-02,2019-04-15,Targeted Therapy,Private,Alive,110.0,BRCA1,No,Never,Moderate,28.0,Low,Urban,Statutory Health Insurance,15.0,No,No,Cardiovascular Disease,6.0
PT04975,Sweden,Skåne,45.0,Male,Prostate,,2017-07-30,,2018-03-06,Surgery,Public,Alive,75.0,None,Yes,Current,Moderate,23.5,High,Urban,Statutory Health Insurance,17.0,No,No,Cardiovascular Disease,10.0
PT04976,Denmark,Zealand,76.0,,Ovarian,IV,2023-07-16,2023-09-18,2024-09-08,Chemotherapy,Public,Deceased,59.0,BRCA1,Yes,Never,Heavy,39.3,Medium,Urban,NHS,18.0,No,No,Obesity,5.0
PT04977,Denmark,Central Denmark,56.0,Female,Lung,III,2010-09-18,2010-09-27,2011-01-14,Targeted Therapy,Public,Alive,52.0,BRCA1,Yes,Never,Moderate,29.9,Low,Rural,Statutory Health Insurance,18.0,No,No,Cardiovascular Disease,10.0
PT04978,Sweden,Västra Götaland,35.0,Male,Ovarian,,2021-04-26,2021-08-22,2022-03-27,Radiation,Public,Alive,99.0,KRAS,Yes,Former,None,21.3,Low,Urban,NHS,14.0,Yes,No,None,5.0
PT04979,Netherlands,Utrecht,56.0,Male,Pancreatic,III,2019-10-06,2020-02-06,2020-07-11,Radiation,Public,Alive,83.0,EGFR,No,Former,None,36.6,High,Rural,NHS,17.0,No,No,,3.0
PT04980,Poland,,43.0,Male,Prostate,II,2020-06-15,2020-07-10,2021-06-11,Radiation,Public,Deceased,53.0,KRAS,,Former,Moderate,27.8,Medium,Rural,NHS,4.0,No,No,Hypertension,7.0
PT04981,Netherlands,North Holland,45.0,Female,Pancreatic,I,2022-06-29,2022-10-20,2022-11-25,Surgery,Private,Alive,83.0,EGFR,No,Never,Moderate,34.6,High,Urban,Private Insurance,19.0,No,No,Cardiovascular Disease,7.0
PT04982,Italy,Veneto,39.0,,Breast,II,2017-08-26,2018-01-02,2018-02-22,Chemotherapy,Private,Alive,83.0,BRCA1,No,Current,Moderate,26.0,Medium,Urban,Statutory Health Insurance,2.0,No,No,Diabetes,2.0
PT04983,Spain,Madrid,28.0,Female,Ovarian,I,2013-04-18,2013-06-16,2013-08-08,Surgery,Research Institute,Alive,29.0,None,Yes,Former,None,19.6,Low,Rural,NHS,17.0,No,No,Obesity,9.0
PT04984,Ireland,Munster,48.0,Female,Pancreatic,IV,2015-07-06,,2016-11-08,Radiation,Public,Alive,87.0,BRCA1,No,,None,39.8,Medium,Urban,NHS,8.0,No,No,Diabetes,
PT04985,Finland,Pirkanmaa,50.0,Male,Prostate,II,2014-12-16,2015-01-03,2015-10-10,Immunotherapy,Public,Deceased,7.0,None,No,Never,Moderate,36.3,Medium,Urban,Private Insurance,5.0,No,No,,9.0
PT04986,Sweden,Stockholm,38.0,Female,Lung,III,2019-11-18,,2020-07-01,Surgery,Public,Deceased,101.0,None,Yes,Never,Moderate,22.9,Medium,Rural,Private Insurance,2.0,Yes,No,Hypertension,5.0
,Italy,Lombardy,39.0,Non-binary,Lung,I,2010-10-31,2011-01-18,2011-07-29,Chemotherapy,Public,Alive,95.0,BRCA1,,Never,None,36.4,Low,Urban,NHS,4.0,No,No,Cardiovascular Disease,1.0
PT04988,Switzerland,Geneva,46.0,Female,Ovarian,III,2013-01-01,2013-06-11,2013-11-03,Surgery,Public,Deceased,36.0,BRCA1,,,Moderate,35.8,High,Rural,,17.0,No,No,Diabetes,4.0
PT04989,Netherlands,Utrecht,63.0,Female,Colorectal,II,2021-01-11,2021-02-02,2021-09-02,Chemotherapy,Research Institute,Alive,26.0,EGFR,No,Never,,35.7,Low,Urban,NHS,18.0,No,No,None,6.0
PT04990,Netherlands,North Holland,54.0,Male,,II,2019-11-28,2020-02-24,2020-11-25,Immunotherapy,Public,Alive,98.0,KRAS,No,Never,Moderate,23.5,Medium,Urban,Private Insurance,14.0,No,No,Cardiovascular Disease,3.0
PT04991,Finland,Southwest Finland,41.0,,Breast,IV,2023-10-22,2023-12-26,2024-06-03,Targeted Therapy,Public,Alive,83.0,EGFR,No,Current,Moderate,21.5,High,Rural,NHS,5.0,No,No,Obesity,1.0
PT04992,France,Île-de-France,34.0,Female,Prostate,II,2013-03-12,2013-07-29,2014-05-29,Chemotherapy,Public,Alive,110.0,KRAS,No,,None,29.3,,Urban,NHS,7.0,No,No,Diabetes,7.0
PT04993,Denmark,Capital Region,32.0,Female,Leukemia,III,2021-10-19,2022-02-03,2023-01-26,,Private,Deceased,69.0,None,No,Never,None,33.5,Medium,Urban,Private Insurance,8.0,No,No,Cardiovascular Disease,1.0
PT04994,Austria,Tyrol,23.0,Male,Lung,,2016-06-10,2016-11-11,2017-04-14,Radiation,Private,Alive,54.0,BRCA1,Yes,Never,Heavy,28.5,Low,Rural,Private Insurance,,No,No,Obesity,7.0
PT04995,Portugal,Lisbon,75.0,,Pancreatic,II,2010-12-11,,2011-11-10,Radiation,Private,Alive,52.0,BRCA1,Yes,Never,Moderate,27.3,Medium,Urban,,5.0,Yes,No,Obesity,
PT04996,Poland,,42.0,Male,Prostate,IV,2012-01-14,2012-02-21,2013-01-04,Immunotherapy,Public,Deceased,6.0,KRAS,No,Former,None,28.2,,Urban,Statutory Health Insurance,17.0,No,Yes,Diabetes,1.0
PT04997,Ireland,Connacht,53.0,Male,Colorectal,III,2014-06-10,2014-10-14,2015-08-10,Surgery,Private,Alive,39.0,None,No,Former,Moderate,39.0,Medium,Rural,Private Insurance,19.0,Yes,,None,10.0
PT04998,Netherlands,South Holland,36.0,Male,Leukemia,II,2016-12-16,2017-02-03,2017-05-12,Targeted Therapy,Private,Alive,,None,No,Former,Moderate,38.3,Low,Urban,NHS,12.0,No,Yes,Hypertension,4.0
PT04999,Finland,Uusimaa,47.0,Female,Colorectal,IV,2015-04-07,2015-07-21,2016-05-01,Targeted Therapy,Public,Alive,68.0,None,No,Current,None,38.7,Medium,Urban,Statutory Health Insurance,11.0,No,No,,2.0
PT05000,France,Auvergne-Rhône-Alpes,33.0,Male,Breast,II,2013-02-22,2013-07-17,2014-05-29,Immunotherapy,Private,Alive,,BRCA1,No,Current,Moderate,24.6,High,Rural,Statutory Health Insurance,13.0,No,No,Obesity,9.0
PT05001,Sweden,Stockholm,53.0,Male,Colorectal,II,2017-11-28,2018-01-24,2018-11-11,Targeted Therapy,Private,Deceased,68.0,EGFR,No,,Moderate,,Medium,Urban,,3.0,No,No,None,2.0
PT05002,Poland,Masovian,76.0,Female,Prostate,II,2020-10-25,2020-11-08,2021-05-03,Surgery,Public,Alive,57.0,None,Yes,Never,Moderate,,High,Urban,NHS,13.0,No,No,Cardiovascular Disease,6.0
PT05003,Denmark,Zealand,74.0,Female,Leukemia,III,2011-10-19,2012-01-10,2012-02-23,Radiation,Public,Alive,44.0,KRAS,Yes,Current,None,19.4,Low,Urban,Statutory Health Insurance,4.0,Yes,No,Obesity,4.0
PT05004,Poland,Lesser Poland,85.0,Female,Ovarian,II,2022-11-26,2022-12-04,2023-10-19,Immunotherapy,Public,Alive,81.0,None,No,Former,Moderate,38.7,Medium,Rural,Private Insurance,19.0,Yes,No,None,2.0
PT05005,Austria,Vienna,56.0,Male,Colorectal,II,,2012-03-09,2012-10-01,Targeted Therapy,,Alive,53.0,KRAS,No,,Moderate,29.0,Medium,Urban,,16.0,No,No,Diabetes,10.0
PT05006,France,Île-de-France,87.0,Female,Colorectal,IV,2014-07-28,2014-09-10,2014-12-30,Immunotherapy,Public,Deceased,8.0,KRAS,No,Former,None,30.7,Medium,Urban,NHS,7.0,No,No,Obesity,7.0
PT05007,Finland,Southwest Finland,45.0,Male,Ovarian,I,2015-07-01,2015-09-05,2016-03-26,Immunotherapy,Public,,19.0,EGFR,No,Never,Moderate,19.8,Medium,Urban,Statutory Health Insurance,10.0,No,No,Diabetes,2.0
PT05008,Italy,Sicily,,Male,Pancreatic,I,2022-08-03,2022-08-06,2022-10-25,Chemotherapy,Public,Alive,91.0,KRAS,No,Never,Moderate,38.2,Low,Urban,NHS,,Yes,No,Diabetes,8.0
PT05009,Denmark,Capital Region,86.0,Male,Pancreatic,I,2014-07-18,2014-12-06,2015-09-28,Chemotherapy,Public,Alive,31.0,KRAS,Yes,Never,Moderate,21.3,Medium,Urban,NHS,8.0,Yes,No,Hypertension,8.0
PT05010,,Masovian,71.0,Female,Breast,II,2011-08-30,2011-11-07,2011-12-10,Immunotherapy,Public,Alive,40.0,BRCA1,No,Former,Moderate,37.4,High,Rural,Private Insurance,11.0,Yes,Yes,Hypertension,1.0
PT05011,Austria,Tyrol,37.0,Male,Ovarian,II,2020-02-21,2020-05-13,2021-04-04,Chemotherapy,Private,Deceased,92.0,KRAS,No,Never,None,22.3,Low,Urban,NHS,12.0,No,No,None,9.0
PT05012,Finland,Pirkanmaa,72.0,Male,Ovarian,I,2011-03-06,2011-03-07,,Targeted Therapy,Private,Alive,108.0,None,Yes,Former,Moderate,22.1,Low,Urban,NHS,15.0,No,No,None,
PT05013,Finland,Pirkanmaa,82.0,Male,Prostate,II,2019-03-27,2019-04-17,2019-05-25,Immunotherapy,Public,Alive,9.0,,No,Current,Heavy,21.3,Low,Urban,NHS,12.0,No,No,Obesity,
PT05014,Belgium,Brussels,72.0,Female,,II,2012-10-01,2012-12-23,2013-12-08,Chemotherapy,Public,Deceased,50.0,EGFR,Yes,Former,Moderate,21.5,High,Urban,Statutory Health Insurance,17.0,No,No,Diabetes,4.0
PT05015,Belgium,Wallonia,46.0,Female,Prostate,III,2014-06-01,2014-07-27,2015-05-25,Targeted Therapy,,Deceased,31.0,BRCA1,No,Current,Moderate,32.7,Medium,Urban,NHS,19.0,No,No,Diabetes,6.0
PT05016,Germany,North Rhine-Westphalia,50.0,Female,Lung,IV,2021-06-21,2021-10-01,2022-09-18,Radiation,Public,Deceased,106.0,EGFR,No,Never,Moderate,,Low,Urban,Private Insurance,2.0,Yes,Yes,None,3.0
PT05017,Belgium,Brussels,20.0,Male,Breast,III,2016-06-20,2016-10-28,2017-08-10,Radiation,Public,Alive,112.0,BRCA1,No,Current,None,35.6,Low,Rural,NHS,8.0,No,No,Obesity,10.0
PT05018,Germany,North Rhine-Westphalia,25.0,Male,Pancreatic,I,2016-01-10,2016-02-10,2016-08-05,Immunotherapy,Public,Deceased,58.0,BRCA1,No,,None,34.0,Medium,Rural,NHS,19.0,No,No,None,4.0
PT05019,Ireland,Connacht,,Male,Ovarian,I,2015-12-28,2016-05-17,2016-12-24,Surgery,Private,Lost to Follow-up,,EGFR,No,Former,Heavy,27.1,Low,Urban,Private Insurance,18.0,No,Yes,Hypertension,8.0
PT05020,Switzerland,Zurich,53.0,Female,Breast,III,2014-06-09,2014-06-23,2014-11-23,Targeted Therapy,Public,Alive,118.0,KRAS,Yes,,Moderate,36.3,High,,Private Insurance,18.0,No,No,Hypertension,7.0
PT05021,Netherlands,North Holland,82.0,Male,Breast,,2021-10-21,2022-01-05,2022-08-26,Immunotherapy,Public,Alive,69.0,None,No,Never,,33.3,Low,Urban,Private Insurance,7.0,Yes,No,Cardiovascular Disease,3.0
PT05022,Norway,Oslo,72.0,Male,Prostate,I,2017-10-12,2017-10-25,2018-02-16,,Research Institute,Alive,31.0,EGFR,Yes,Never,Heavy,39.4,Low,Rural,Statutory Health Insurance,2.0,No,Yes,None,3.0
PT05023,Austria,Tyrol,37.0,Female,Ovarian,I,2022-03-24,2022-06-20,2022-12-24,Radiation,Public,Alive,95.0,EGFR,No,Former,Moderate,32.5,Medium,Urban,Statutory Health Insurance,14.0,Yes,No,Obesity,7.0
PT05024,Finland,Pirkanmaa,40.0,,Pancreatic,III,2012-08-29,2012-12-02,2013-01-23,Chemotherapy,Public,Alive,99.0,EGFR,Yes,Never,Moderate,31.8,High,Urban,Private Insurance,18.0,No,No,,3.0
PT05025,Italy,Sicily,38.0,Male,Pancreatic,,2016-04-07,2016-08-27,2017-01-23,Targeted Therapy,Research Institute,Deceased,34.0,BRCA1,Yes,Former,Moderate,20.3,Medium,Rural,NHS,19.0,No,No,Cardiovascular Disease,4.0
PT05026,Italy,Sicily,23.0,Male,Colorectal,II,2023-11-25,2024-03-18,2024-06-11,Immunotherapy,Public,Alive,101.0,BRCA1,Yes,Former,Moderate,37.6,Medium,Rural,Statutory Health Insurance,6.0,No,No,Cardiovascular Disease,8.0
PT05027,France,Auvergne-Rhône-Alpes,48.0,Male,,I,2014-04-08,2014-07-11,2015-06-08,Radiation,Public,Alive,66.0,EGFR,No,Never,None,31.7,Medium,Rural,Statutory Health Insurance,17.0,Yes,No,Diabetes,4.0
PT05028,Poland,Lesser Poland,44.0,Female,Prostate,III,2016-06-26,2016-11-28,2016-12-29,Targeted Therapy,Private,Alive,19.0,EGFR,No,Current,None,28.4,High,Urban,Statutory Health Insurance,19.0,No,No,Hypertension,10.0
PT05029,Austria,Tyrol,75.0,Non-binary,Prostate,III,2015-09-24,2016-01-02,2016-09-03,,Private,Alive,98.0,BRCA1,Yes,Former,None,18.2,Low,Urban,Private Insurance,15.0,No,Yes,Obesity,8.0
,,,82.0,Male,Lung,IV,2022-11-23,2023-02-01,2023-04-04,Radiation,Private,Alive,,EGFR,No,Former,Moderate,29.0,High,Urban,Statutory Health Insurance,1.0,No,No,Hypertension,6.0
PT05031,Spain,Catalonia,46.0,Male,Leukemia,III,2010-10-11,2011-02-14,2011-11-19,Immunotherapy,Private,Deceased,64.0,EGFR,No,Never,None,30.9,Medium,Urban,Private Insurance,1.0,No,,Diabetes,1.0
PT05032,Germany,North Rhine-Westphalia,79.0,Female,,II,2015-07-28,2015-11-23,2016-08-15,Immunotherapy,Private,Alive,74.0,BRCA1,No,Former,None,33.7,Medium,Urban,Private Insurance,2.0,No,No,Cardiovascular Disease,3.0
PT05033,Spain,Madrid,68.0,Female,Breast,III,2020-01-04,2020-05-10,,Surgery,Public,Alive,35.0,None,Yes,Never,Moderate,21.7,Medium,Rural,Private Insurance,3.0,No,No,Cardiovascular Disease,10.0
PT05034,Austria,Vienna,84.0,Male,Colorectal,II,2019-12-04,2020-02-12,2020-12-08,Surgery,Private,Alive,27.0,EGFR,Yes,Never,,20.1,Medium,Rural,NHS,6.0,,Yes,Hypertension,2.0
PT05035,Belgium,Flanders,57.0,Female,Pancreatic,I,2014-12-20,2015-05-12,2016-03-24,Surgery,,Alive,101.0,BRCA1,Yes,Current,Moderate,30.6,Medium,Urban,NHS,5.0,No,No,None,1.0
PT05036,France,Provence-Alpes-Côte d'Azur,71.0,Male,Ovarian,IV,2011-11-03,2011-12-29,2012-07-07,Surgery,Public,Deceased,86.0,KRAS,No,Former,Moderate,36.5,Medium,Urban,Statutory Health Insurance,9.0,No,Yes,Obesity,7.0
PT05037,Denmark,,20.0,Female,Breast,II,2015-11-05,2016-02-01,2016-12-13,Chemotherapy,Public,Alive,99.0,KRAS,No,Never,None,,Low,,Private Insurance,,No,Yes,Hypertension,5.0
PT05038,,Porto,59.0,Non-binary,Ovarian,II,2014-01-22,2014-02-04,2014-12-01,Surgery,Private,Alive,11.0,None,No,Former,None,34.8,High,Urban,NHS,16.0,No,No,None,4.0
PT05039,Austria,Vienna,40.0,Female,Pancreatic,,2016-06-04,2016-10-17,2017-04-12,Chemotherapy,Research Institute,Alive,10.0,None,No,Current,Moderate,25.9,Medium,Rural,Statutory Health Insurance,15.0,No,No,Obesity,8.0
PT05040,Sweden,Västra Götaland,34.0,Female,Colorectal,IV,2010-01-14,2010-05-03,2010-09-15,,Private,Alive,46.0,BRCA1,Yes,Never,None,22.4,Medium,Rural,Private Insurance,10.0,No,No,Cardiovascular Disease,3.0
PT05041,,Skåne,69.0,Male,Colorectal,II,2012-01-26,2012-06-23,2012-08-22,Chemotherapy,Private,Alive,105.0,None,Yes,Never,Heavy,23.8,High,Rural,Statutory Health Insurance,4.0,No,No,Cardiovascular Disease,4.0
PT05042,Finland,Southwest Finland,67.0,Female,Lung,I,2010-06-18,2010-09-28,2011-07-12,Radiation,Public,,91.0,EGFR,Yes,Current,Moderate,22.6,Low,Urban,Private Insurance,14.0,No,No,Cardiovascular Disease,
PT05043,Norway,Oslo,51.0,Female,Prostate,II,2016-03-29,2016-07-09,2017-05-03,Surgery,Public,Alive,52.0,KRAS,No,Never,Moderate,38.0,Medium,Urban,NHS,15.0,,No,None,7.0
PT05044,France,Île-de-France,,Female,Ovarian,IV,2013-02-08,2013-06-30,2014-04-26,Chemotherapy,Public,Alive,,EGFR,Yes,Former,None,38.4,Medium,Rural,NHS,18.0,Yes,Yes,None,7.0
PT05045,Poland,Masovian,87.0,Male,Prostate,I,2017-04-15,2017-04-18,2017-06-11,Radiation,Public,Alive,82.0,EGFR,Yes,Former,Moderate,30.7,Medium,Urban,Statutory Health Insurance,,No,No,Diabetes,6.0
PT05046,Ireland,Connacht,64.0,Female,Prostate,IV,2023-03-18,2023-05-20,2024-05-15,Surgery,Private,Alive,119.0,EGFR,Yes,Current,Moderate,32.1,Medium,Rural,Statutory Health Insurance,17.0,No,No,Diabetes,9.0
PT05047,Portugal,Algarve,51.0,Female,Leukemia,I,2010-08-28,2011-02-15,2011-04-13,,Public,Deceased,107.0,BRCA1,No,Never,None,37.4,Medium,Urban,NHS,8.0,No,No,Hypertension,8.0
PT05048,Sweden,Skåne,23.0,Male,Prostate,II,2016-04-06,2016-07-24,2016-12-05,Immunotherapy,Public,Alive,58.0,KRAS,Yes,Current,Moderate,25.0,Medium,Rural,Statutory Health Insurance,7.0,No,No,None,2.0
PT05049,Poland,Masovian,84.0,,Leukemia,II,2021-12-14,,2022-10-19,Radiation,Public,Alive,45.0,KRAS,No,Never,None,23.8,Medium,Rural,Private Insurance,5.0,No,No,Diabetes,2.0
PT05050,Netherlands,South Holland,84.0,Male,Pancreatic,I,2017-01-31,2017-03-27,2017-11-24,Surgery,Public,Alive,113.0,EGFR,No,Never,Moderate,37.7,Medium,Urban,,5.0,No,No,Cardiovascular Disease,3.0
PT05051,Switzerland,Bern,,Female,Breast,IV,2013-08-02,2013-11-28,2014-07-01,Targeted Therapy,Public,Alive,66.0,EGFR,Yes,Never,None,22.1,Medium,Urban,Private Insurance,7.0,No,No,Diabetes,2.0
PT05052,Austria,Styria,73.0,Female,Ovarian,III,2011-03-19,,2012-02-03,Immunotherapy,Public,Alive,85.0,BRCA1,Yes,Never,None,40.0,Medium,Urban,NHS,9.0,No,No,Diabetes,6.0
PT05053,Germany,Bavaria,66.0,Female,Leukemia,I,2011-12-26,2012-04-28,2012-12-03,Chemotherapy,Public,Alive,19.0,KRAS,No,Current,None,35.5,Low,Urban,Private Insurance,13.0,No,Yes,None,8.0
PT05054,Poland,Silesian,25.0,Male,Colorectal,,2012-06-26,2012-09-25,2013-01-06,Immunotherapy,Public,Deceased,27.0,KRAS,Yes,Current,None,37.5,Medium,Urban,NHS,3.0,,No,Obesity,1.0
PT05055,Poland,Masovian,85.0,Female,Lung,III,2014-03-07,2014-05-15,2014-09-12,Surgery,Public,Alive,73.0,BRCA1,No,Never,Moderate,23.8,Low,Urban,Statutory Health Insurance,17.0,No,No,Obesity,10.0
PT05056,Netherlands,South Holland,28.0,Female,Ovarian,I,2016-08-14,2017-02-03,2017-04-25,Radiation,Public,Alive,116.0,EGFR,No,Former,Heavy,36.7,Medium,Rural,Statutory Health Insurance,9.0,,No,Diabetes,5.0
PT05057,Norway,,87.0,Male,Lung,IV,2013-02-17,2013-04-13,2014-02-22,Targeted Therapy,,Alive,,KRAS,No,Never,None,25.9,Medium,Urban,Statutory Health Insurance,4.0,No,No,Hypertension,7.0
PT05058,Italy,Sicily,42.0,Male,Colorectal,I,2010-03-16,2010-05-30,2010-10-03,Surgery,Public,Alive,8.0,EGFR,Yes,Never,None,27.4,Medium,Urban,NHS,5.0,No,No,Diabetes,5.0
PT05059,Denmark,Central Denmark,62.0,Male,Pancreatic,I,2016-10-06,2016-12-05,,Radiation,Public,Lost to Follow-up,,None,No,Former,Moderate,32.2,,Urban,Private Insurance,12.0,No,,Cardiovascular Disease,4.0
PT05060,Ireland,Connacht,,Female,Ovarian,I,2010-03-11,2010-04-22,2010-10-06,Surgery,Private,Lost to Follow-up,,None,No,Current,None,39.1,Medium,Urban,Statutory Health Insurance,18.0,No,No,Cardiovascular Disease,4.0
PT05061,Norway,Vestland,44.0,Male,Breast,,2023-04-03,2023-09-22,2024-03-12,Targeted Therapy,Public,Deceased,72.0,EGFR,,Former,Moderate,29.9,Low,Urban,Private Insurance,2.0,No,No,Diabetes,2.0
PT05062,Italy,Sicily,54.0,Male,Lung,II,2021-02-17,2021-07-01,2022-05-08,Radiation,Public,Alive,78.0,,,Never,Moderate,31.3,Low,Urban,Private Insurance,7.0,No,No,Hypertension,9.0
PT05063,Italy,Sicily,,,Ovarian,IV,2010-05-12,2010-07-20,2011-02-23,Targeted Therapy,Private,Alive,43.0,KRAS,No,Current,Moderate,,Medium,Rural,Private Insurance,5.0,No,No,Cardiovascular Disease,5.0
PT05064,Denmark,Zealand,37.0,Female,Colorectal,I,2013-01-26,2013-02-17,2013-04-02,Radiation,Research Institute,Alive,12.0,None,No,Current,None,23.1,Low,Urban,Statutory Health Insurance,15.0,No,No,Hypertension,2.0
PT05065,Poland,Masovian,46.0,Male,Lung,I,2021-06-29,2021-09-02,,Immunotherapy,Public,Alive,18.0,KRAS,Yes,Former,None,28.6,High,Rural,Statutory Health Insurance,14.0,No,No,Cardiovascular Disease,5.0
PT05066,Finland,Southwest Finland,34.0,Male,Leukemia,I,2013-04-05,,2013-11-13,Surgery,Public,Alive,101.0,KRAS,Yes,Never,Moderate,37.3,High,Urban,Statutory Health Insurance,17.0,No,Yes,None,4.0
PT05067,Finland,,88.0,Male,Pancreatic,III,2013-02-02,2013-05-01,2013-10-06,Chemotherapy,Public,Alive,60.0,None,No,Never,None,36.2,Medium,Rural,NHS,11.0,,,Diabetes,8.0
PT05068,,Brussels,34.0,Male,Lung,III,2011-08-21,2012-01-16,2012-06-07,Chemotherapy,Private,Alive,119.0,,No,Former,Moderate,19.3,Medium,Urban,,15.0,Yes,Yes,Hypertension,5.0
PT05069,Denmark,Capital Region,61.0,Male,Pancreatic,III,2014-04-22,2014-06-08,2014-10-02,Surgery,Public,Alive,7.0,EGFR,No,Current,None,19.2,Medium,Urban,Private Insurance,10.0,,No,Hypertension,7.0
,Netherlands,,53.0,Female,Pancreatic,I,2011-11-03,2012-04-27,2013-01-07,Chemotherapy,Private,Deceased,113.0,KRAS,No,Current,Moderate,,Medium,Urban,Private Insurance,12.0,No,Yes,Hypertension,2.0
PT05071,Germany,Berlin,67.0,Female,Leukemia,III,2022-12-14,2023-01-07,2023-07-18,Targeted Therapy,Private,Alive,42.0,BRCA1,Yes,Former,Moderate,,Low,Rural,NHS,1.0,No,No,Diabetes,10.0
PT05072,,Utrecht,27.0,Female,Ovarian,III,2023-09-29,2023-12-10,2024-05-11,Chemotherapy,Research Institute,,115.0,BRCA1,Yes,Never,None,25.7,Medium,Urban,Private Insurance,5.0,No,No,None,6.0
PT05073,Netherlands,South Holland,29.0,Female,Pancreatic,II,2020-03-04,2020-06-10,2020-10-24,Surgery,Private,Alive,113.0,BRCA1,Yes,Never,None,32.9,Low,Urban,NHS,19.0,No,No,Diabetes,1.0
PT05074,Belgium,Wallonia,24.0,Male,Leukemia,II,2019-02-20,,2019-09-05,Immunotherapy,Public,Alive,82.0,None,No,Former,,32.6,Low,Urban,NHS,2.0,,No,Cardiovascular Disease,7.0
PT05075,Finland,Southwest Finland,67.0,Female,Lung,III,2020-08-02,2020-09-26,2021-08-15,Surgery,Public,Deceased,98.0,KRAS,Yes,Former,Moderate,33.5,High,Urban,NHS,17.0,No,No,Obesity,10.0
PT05076,Poland,Masovian,45.0,Male,Lung,II,2017-12-09,2018-04-04,2018-12-28,Surgery,Public,Alive,82.0,BRCA1,No,Current,Moderate,19.9,High,Urban,Statutory Health Insurance,3.0,No,No,Hypertension,8.0
PT05077,Austria,Tyrol,42.0,Male,Pancreatic,I,2016-04-27,2016-07-13,2016-09-21,Radiation,Public,Alive,55.0,None,No,Former,Moderate,31.2,High,Urban,Private Insurance,14.0,No,No,Obesity,7.0
PT05078,Belgium,,81.0,Female,Leukemia,II,2016-09-29,2017-01-15,2017-07-03,Chemotherapy,Research Institute,Deceased,25.0,None,No,Current,Heavy,28.6,Medium,Rural,Private Insurance,6.0,No,Yes,None,8.0
PT05079,Belgium,Wallonia,32.0,Female,Lung,II,2020-12-04,2021-04-30,2021-10-14,Chemotherapy,Public,Alive,54.0,EGFR,No,Never,Moderate,35.7,Low,Urban,Private Insurance,15.0,Yes,No,Cardiovascular Disease,5.0
PT05080,Netherlands,Utrecht,28.0,Female,Pancreatic,I,2019-09-03,2019-10-31,2020-05-02,,Private,Alive,16.0,None,Yes,Current,Heavy,21.4,Low,Urban,Private Insurance,18.0,No,No,Diabetes,1.0
PT05081,Poland,Masovian,39.0,Female,Ovarian,,2017-07-11,2017-12-12,2018-09-01,Targeted Therapy,Private,Alive,109.0,None,Yes,Current,None,33.5,Low,Rural,Private Insurance,9.0,No,No,Cardiovascular Disease,8.0
PT05082,,Dublin,76.0,Non-binary,Breast,IV,2017-02-03,2017-05-15,2018-05-05,Targeted Therapy,Public,Deceased,55.0,None,Yes,Current,Moderate,34.8,Medium,,Statutory Health Insurance,16.0,No,Yes,Obesity,5.0
PT05083,Sweden,Västra Götaland,43.0,Female,Prostate,II,2018-04-19,2018-07-19,,Radiation,Private,Alive,46.0,KRAS,No,Never,None,39.7,Low,Urban,Statutory Health Insurance,5.0,Yes,No,Obesity,5.0
PT05084,Belgium,Wallonia,52.0,Female,Ovarian,II,2019-04-05,2019-07-02,2020-04-23,Chemotherapy,,Deceased,78.0,EGFR,No,Current,None,31.5,Medium,Urban,Statutory Health Insurance,1.0,Yes,No,Cardiovascular Disease,3.0
PT05085,Sweden,Västra Götaland,39.0,Female,Ovarian,III,2014-09-08,2015-03-02,2015-12-10,Targeted Therapy,Public,Alive,9.0,None,No,Former,None,23.7,Low,Rural,NHS,6.0,No,No,Cardiovascular Disease,8.0
PT05086,Netherlands,South Holland,79.0,Male,Prostate,III,2021-05-07,2021-09-26,2022-08-01,Targeted Therapy,Public,Alive,48.0,BRCA1,,Never,Moderate,36.6,,Urban,Private Insurance,,No,No,Obesity,7.0
,Portugal,Lisbon,67.0,Male,Colorectal,II,,2022-10-15,2023-09-22,Immunotherapy,Public,Alive,84.0,BRCA1,Yes,Never,Moderate,,High,,NHS,7.0,No,No,None,8.0
PT05088,Sweden,Stockholm,83.0,Female,Pancreatic,III,2010-06-21,2010-10-26,2011-01-03,Targeted Therapy,Public,,105.0,BRCA1,No,Never,,18.8,,Urban,Private Insurance,13.0,,,Hypertension,10.0
PT05089,Poland,Silesian,,Male,Prostate,III,2023-10-05,,2025-01-11,Chemotherapy,Private,Alive,,KRAS,No,Never,Moderate,34.7,Medium,Urban,NHS,1.0,Yes,No,Diabetes,3.0
PT05090,Italy,Veneto,36.0,Male,Breast,I,2018-04-26,,2019-02-16,Immunotherapy,Research Institute,Alive,7.0,None,Yes,Never,None,33.2,,Urban,Statutory Health Insurance,14.0,,No,Hypertension,6.0
PT05091,Spain,Catalonia,33.0,Male,Pancreatic,II,2019-04-25,2019-05-10,2019-08-15,Immunotherapy,Public,Alive,17.0,None,No,Former,Moderate,23.3,Medium,Rural,NHS,13.0,No,No,None,7.0
PT05092,Ireland,Munster,38.0,Male,Prostate,I,2021-03-25,2021-09-14,2022-06-03,Chemotherapy,Public,Alive,90.0,EGFR,No,Former,None,31.0,Low,Urban,NHS,2.0,No,No,Diabetes,9.0
PT05093,Austria,Vienna,78.0,,Prostate,IV,2013-05-12,2013-11-01,2014-03-04,Radiation,Public,Alive,117.0,None,No,Current,Heavy,29.6,Low,Urban,Private Insurance,18.0,No,No,Obesity,5.0
PT05094,Norway,Vestland,86.0,Female,Breast,I,2016-08-13,2016-08-16,2017-04-09,,Research Institute,Alive,35.0,KRAS,No,Former,Moderate,23.8,High,Urban,,18.0,No,No,Obesity,4.0
PT05095,Belgium,Wallonia,63.0,Female,Leukemia,I,2011-12-23,2012-04-10,2013-03-06,Targeted Therapy,Private,Deceased,49.0,KRAS,No,Former,None,28.2,Low,Urban,Statutory Health Insurance,17.0,No,Yes,Diabetes,9.0
PT05096,,Styria,51.0,Non-binary,Prostate,II,2019-11-29,2020-04-16,2021-02-26,Radiation,Public,Deceased,119.0,EGFR,No,Current,Heavy,22.3,Low,Urban,Statutory Health Insurance,14.0,No,No,Diabetes,10.0
PT05097,Italy,Veneto,30.0,Female,Ovarian,IV,2012-07-19,2012-07-28,2013-06-15,Surgery,Private,Deceased,92.0,KRAS,No,Never,None,21.5,Low,Rural,NHS,10.0,No,No,None,7.0
,Germany,Bavaria,21.0,Female,Colorectal,II,2016-05-17,2016-05-21,2016-10-11,Chemotherapy,Research Institute,Alive,80.0,BRCA1,Yes,Current,Moderate,38.7,Medium,Urban,Private Insurance,16.0,No,,Cardiovascular Disease,8.0
PT05099,Ireland,Munster,87.0,Female,Ovarian,III,2012-12-14,2013-04-06,2013-06-17,Targeted Therapy,Public,Deceased,41.0,BRCA1,No,Never,None,30.6,Medium,Urban,Private Insurance,8.0,No,No,Diabetes,8.0
PT05100,Switzerland,Geneva,36.0,Male,Prostate,III,,2019-10-03,2020-01-25,Radiation,Public,,,BRCA1,No,Never,Moderate,35.8,Medium,Urban,Statutory Health Insurance,1.0,Yes,No,Diabetes,6.0
PT05101,,Andalusia,59.0,Male,Prostate,III,2018-02-13,2018-05-04,2018-09-09,Surgery,Public,Alive,76.0,None,Yes,Former,Moderate,25.4,Low,Rural,Private Insurance,3.0,No,No,Obesity,3.0
PT05102,Switzerland,Zurich,65.0,Male,Breast,III,2019-09-20,2020-02-01,2020-11-16,Chemotherapy,Public,Deceased,55.0,None,No,Never,None,25.4,Low,Rural,Private Insurance,18.0,No,No,Hypertension,3.0
PT05103,Netherlands,North Holland,23.0,,Breast,I,2016-10-11,2017-04-01,2017-11-15,Immunotherapy,Public,Alive,77.0,KRAS,No,Current,None,29.0,Medium,Urban,NHS,19.0,No,No,Obesity,7.0
PT05104,Italy,Veneto,57.0,,Pancreatic,IV,2014-03-16,2014-03-21,2014-08-19,Immunotherapy,Public,Alive,27.0,None,Yes,Never,Moderate,36.8,High,Urban,Statutory Health Insurance,17.0,No,No,Hypertension,9.0
PT05105,Austria,Tyrol,82.0,Female,Colorectal,III,2011-02-17,2011-04-07,2011-06-04,Immunotherapy,Private,Lost to Follow-up,,KRAS,Yes,Never,None,38.9,Medium,Urban,Private Insurance,16.0,No,No,Hypertension,4.0
PT05106,Poland,Silesian,48.0,Female,Lung,IV,2012-04-18,2012-07-10,2012-11-15,Chemotherapy,Public,Alive,41.0,BRCA1,No,Current,None,19.1,Medium,Rural,NHS,,No,No,Diabetes,6.0
PT05107,Spain,Madrid,38.0,Male,,III,2020-02-05,2020-04-14,2020-08-17,,Public,Alive,107.0,None,Yes,Never,None,28.3,Medium,Urban,Private Insurance,17.0,No,No,None,3.0
PT05108,Austria,Styria,48.0,Male,Lung,IV,2012-10-23,2013-03-28,2013-12-26,Chemotherapy,Public,Alive,8.0,KRAS,No,Former,Moderate,37.3,Medium,Urban,Private Insurance,16.0,Yes,Yes,,9.0
PT05109,Ireland,Connacht,54.0,Female,Colorectal,,,,2020-10-31,Immunotherapy,Public,Alive,83.0,None,Yes,Never,Moderate,30.0,High,Rural,NHS,7.0,No,,Cardiovascular Disease,8.0
PT05110,Poland,Lesser Poland,89.0,Male,Prostate,II,2023-02-02,2023-07-19,2024-06-01,Chemotherapy,Private,Deceased,32.0,None,Yes,Never,None,27.9,Medium,Urban,Statutory Health Insurance,13.0,No,Yes,None,
PT05111,Italy,Sicily,,Female,Pancreatic,II,2017-10-06,2018-03-17,2018-12-04,Targeted Therapy,Public,Alive,105.0,BRCA1,No,Current,,21.3,,Urban,Statutory Health Insurance,12.0,No,Yes,None,4.0
PT05112,Italy,Sicily,65.0,Female,Prostate,I,,2010-03-13,2010-08-10,Surgery,Research Institute,Deceased,95.0,None,No,Never,None,27.8,Medium,Urban,Statutory Health Insurance,18.0,No,No,Cardiovascular Disease,9.0
PT05113,Denmark,Central Denmark,63.0,Female,Ovarian,III,2011-08-13,2011-10-06,2011-11-21,Targeted Therapy,Public,Alive,12.0,BRCA1,Yes,Current,None,34.3,Low,Urban,NHS,12.0,No,No,Hypertension,7.0
PT05114,Spain,Madrid,67.0,Male,Pancreatic,I,2017-01-21,2017-05-05,2017-10-21,Immunotherapy,Public,Deceased,42.0,KRAS,Yes,Never,,32.9,Low,Urban,Private Insurance,16.0,No,Yes,Hypertension,7.0
PT05115,Germany,,71.0,Female,Lung,I,2018-09-04,2018-11-23,2018-12-23,Surgery,Private,Deceased,60.0,EGFR,Yes,Never,Moderate,27.7,Medium,Urban,NHS,7.0,No,No,Obesity,3.0
PT05116,Ireland,Dublin,27.0,Female,Ovarian,III,2015-07-28,2015-10-09,2016-05-09,Targeted Therapy,Research Institute,Alive,49.0,EGFR,No,Former,Moderate,34.9,,Rural,NHS,19.0,No,No,Obesity,4.0
PT05117,Portugal,Lisbon,74.0,Non-binary,Colorectal,IV,2021-02-20,2021-08-04,2021-09-25,Chemotherapy,Research Institute,Alive,77.0,,No,Never,None,,Low,Rural,Private Insurance,13.0,No,No,Hypertension,2.0
PT05118,Portugal,Algarve,85.0,Female,Colorectal,III,2023-11-26,2024-05-05,2024-06-10,Radiation,Private,Deceased,109.0,BRCA1,No,Former,Moderate,24.0,High,Rural,NHS,5.0,No,No,Diabetes,1.0
PT05119,Spain,Andalusia,,Female,Breast,III,2012-02-16,2012-08-11,2013-08-09,Chemotherapy,Research Institute,Alive,65.0,KRAS,No,Former,None,21.0,High,Urban,Statutory Health Insurance,15.0,No,No,Obesity,7.0
PT05120,,Southwest Finland,50.0,Male,Lung,II,2010-05-28,2010-05-29,2010-08-19,Immunotherapy,Private,Deceased,64.0,KRAS,Yes,Current,Moderate,32.7,Low,Urban,Private Insurance,2.0,No,Yes,Diabetes,6.0
PT05121,Ireland,Dublin,67.0,Female,Pancreatic,IV,2010-02-16,2010-08-10,2011-04-28,Radiation,Public,Alive,57.0,,No,Never,Heavy,21.9,Medium,Urban,Private Insurance,9.0,No,No,Diabetes,2.0
PT05122,,Vienna,80.0,Female,Breast,II,2013-06-21,2013-12-03,2014-09-21,Surgery,Private,Alive,9.0,BRCA1,No,Current,Moderate,,Medium,Urban,Statutory Health Insurance,19.0,No,No,Cardiovascular Disease,7.0
PT05123,Netherlands,South Holland,71.0,,,IV,2014-02-10,2014-06-27,2014-11-01,Radiation,Public,Alive,,None,No,Former,Moderate,24.1,Low,Urban,Private Insurance,11.0,No,No,Diabetes,1.0
PT05124,Austria,Styria,57.0,Male,Ovarian,I,2014-06-07,2014-06-25,2015-02-03,Surgery,Public,Alive,7.0,BRCA1,No,Never,Moderate,38.9,Medium,Urban,NHS,19.0,Yes,Yes,Obesity,3.0
PT05125,Austria,Tyrol,55.0,Male,,III,2014-07-23,2014-11-02,2015-08-11,Targeted Therapy,Public,Alive,22.0,KRAS,Yes,Former,None,33.0,High,Rural,Statutory Health Insurance,2.0,No,No,Diabetes,7.0
PT05126,Belgium,Flanders,74.0,Female,Breast,III,2021-01-23,2021-04-18,2021-12-12,Targeted Therapy,Private,Alive,90.0,EGFR,No,Former,None,38.4,High,Rural,Statutory Health Insurance,18.0,No,No,Hypertension,3.0
PT05127,Sweden,Västra Götaland,32.0,Male,Colorectal,II,2018-03-23,,2018-12-23,Targeted Therapy,Private,Deceased,105.0,EGFR,No,Current,,23.4,Medium,Urban,NHS,1.0,No,No,Cardiovascular Disease,1.0
PT05128,Sweden,Västra Götaland,56.0,Male,Colorectal,III,2015-07-16,2015-11-08,2015-12-12,Targeted Therapy,,Alive,,EGFR,Yes,Never,None,31.5,Low,Urban,Statutory Health Insurance,10.0,Yes,No,Obesity,1.0
PT05129,Portugal,Lisbon,66.0,Female,Prostate,III,2010-07-29,2010-09-30,2011-04-11,Targeted Therapy,Public,Alive,35.0,None,No,Former,None,32.8,,Urban,NHS,8.0,No,No,Obesity,5.0
PT05130,Norway,,41.0,Female,Prostate,IV,2021-09-22,,2022-08-20,Radiation,Public,Alive,53.0,BRCA1,No,Former,None,38.9,Low,Urban,Statutory Health Insurance,18.0,,No,Hypertension,4.0
PT05131,France,Auvergne-Rhône-Alpes,58.0,Male,Colorectal,I,2013-04-02,2013-07-23,2013-12-21,Surgery,Public,Lost to Follow-up,,KRAS,No,,Moderate,28.3,Medium,Urban,Statutory Health Insurance,10.0,No,Yes,Hypertension,10.0
PT05132,Norway,Oslo,77.0,Male,Colorectal,I,2018-05-12,2018-10-05,2019-03-22,Targeted Therapy,Public,Deceased,112.0,EGFR,No,Former,None,32.1,Medium,Urban,NHS,2.0,No,Yes,None,1.0
,Finland,,49.0,Male,Ovarian,I,2010-02-04,2010-07-19,2011-01-13,Targeted Therapy,Private,Alive,7.0,KRAS,Yes,Never,Heavy,37.3,Medium,Rural,Private Insurance,17.0,No,No,Hypertension,10.0
PT05134,Finland,Uusimaa,37.0,Male,Breast,I,2015-08-06,2015-08-26,2015-10-29,Surgery,Public,Deceased,84.0,EGFR,Yes,Former,Moderate,,Medium,,Statutory Health Insurance,6.0,No,No,Hypertension,3.0
PT05135,Ireland,Connacht,37.0,Male,Prostate,I,2013-06-30,2013-10-01,2014-08-17,Radiation,Public,Deceased,109.0,None,Yes,Never,Moderate,38.0,Medium,Rural,Statutory Health Insurance,,No,No,Hypertension,10.0
PT05136,Italy,Sicily,58.0,Female,Colorectal,III,2022-07-07,2022-08-12,2022-10-15,Targeted Therapy,Public,Alive,71.0,KRAS,Yes,Never,Moderate,25.2,Medium,,NHS,18.0,No,No,Hypertension,7.0
PT05137,Portugal,Porto,45.0,Female,Lung,II,2023-04-17,2023-04-21,2023-11-03,Radiation,Private,Deceased,32.0,EGFR,No,Current,Moderate,27.4,,Urban,Private Insurance,12.0,No,No,Hypertension,3.0
PT05138,Switzerland,Geneva,26.0,Female,Lung,III,2022-07-02,2022-10-30,2023-09-13,Targeted Therapy,Public,Alive,26.0,,Yes,Current,Moderate,29.1,High,Urban,NHS,1.0,No,No,Hypertension,6.0
PT05139,Spain,Andalusia,88.0,Male,Prostate,II,2018-02-02,2018-05-22,,Radiation,Public,Alive,94.0,BRCA1,Yes,Former,Moderate,33.8,Medium,Rural,NHS,3.0,Yes,No,Hypertension,6.0
PT05140,Norway,Trøndelag,84.0,Female,Lung,II,2010-09-21,2010-12-08,2011-11-26,Immunotherapy,Public,Deceased,98.0,BRCA1,Yes,Never,None,21.5,High,Rural,Private Insurance,11.0,Yes,No,None,5.0
PT05141,Sweden,Västra Götaland,65.0,Female,Pancreatic,I,2013-02-02,2013-02-19,2013-11-07,Targeted Therapy,Research Institute,Alive,10.0,EGFR,No,Former,None,33.1,Low,Urban,NHS,4.0,No,,Obesity,1.0
PT05142,Germany,Berlin,37.0,Male,Breast,,2019-01-05,2019-02-23,2020-01-25,Targeted Therapy,Research Institute,Alive,,BRCA1,Yes,Never,Moderate,20.1,,Urban,Private Insurance,8.0,No,Yes,Diabetes,3.0
PT05143,Portugal,Lisbon,,Male,Prostate,III,2023-04-25,2023-08-12,2024-05-15,Chemotherapy,Private,Alive,30.0,None,Yes,Former,Moderate,26.4,Low,Urban,NHS,4.0,No,No,Diabetes,7.0
PT05144,Sweden,Stockholm,44.0,Female,Pancreatic,II,2011-02-11,2011-06-07,2012-04-25,Chemotherapy,Private,Deceased,111.0,KRAS,No,Never,None,31.6,Low,Urban,Statutory Health Insurance,15.0,No,No,Obesity,9.0
PT05145,Finland,Southwest Finland,27.0,Female,Colorectal,II,2017-05-17,2017-05-27,2017-08-06,Radiation,,Alive,30.0,None,Yes,Never,Moderate,21.1,Low,Rural,Statutory Health Insurance,19.0,No,No,None,7.0
,Belgium,Brussels,51.0,Male,Ovarian,I,2013-05-14,2013-10-18,,Chemotherapy,Public,Alive,53.0,BRCA1,No,,Moderate,32.7,High,Urban,NHS,10.0,No,No,Diabetes,6.0
PT05147,Netherlands,South Holland,36.0,Female,Ovarian,III,2015-10-13,2016-02-10,2016-04-09,Radiation,Private,Alive,16.0,BRCA1,No,Current,Moderate,39.0,,,NHS,9.0,No,No,Obesity,
PT05148,France,Auvergne-Rhône-Alpes,67.0,Female,Pancreatic,III,2018-04-05,2018-08-06,2019-02-14,Targeted Therapy,Private,Deceased,102.0,,Yes,Never,Heavy,39.0,Medium,Urban,Statutory Health Insurance,8.0,Yes,No,Cardiovascular Disease,2.0
PT05149,Sweden,Stockholm,82.0,Female,Lung,,2012-05-21,2012-08-05,2012-10-01,,Public,Alive,114.0,KRAS,No,Never,Heavy,30.9,High,Urban,NHS,10.0,No,No,Diabetes,7.0
PT05150,Finland,Pirkanmaa,59.0,Male,Breast,I,2021-04-26,2021-08-27,2022-03-17,Immunotherapy,Public,Alive,24.0,None,No,Never,,29.4,High,Urban,NHS,12.0,Yes,No,Hypertension,9.0
PT05151,,Brussels,34.0,Female,Colorectal,I,2023-04-18,2023-09-02,2024-07-31,Immunotherapy,Public,Alive,,BRCA1,No,Former,Moderate,27.6,,Rural,NHS,9.0,No,No,Cardiovascular Disease,7.0
PT05152,Germany,Berlin,25.0,Male,Leukemia,I,2023-01-13,2023-04-13,2024-03-18,Chemotherapy,Private,Alive,23.0,KRAS,No,Never,Heavy,28.0,,Urban,Private Insurance,6.0,No,No,None,4.0
PT05153,Finland,Pirkanmaa,82.0,Female,Breast,I,2021-10-27,2022-03-25,2022-09-24,Targeted Therapy,Private,Alive,119.0,EGFR,Yes,Former,Moderate,30.5,Low,Urban,NHS,18.0,Yes,No,Diabetes,3.0
PT05154,Finland,Uusimaa,27.0,Female,Lung,I,2023-04-28,2023-04-29,2024-01-09,Radiation,Private,Deceased,12.0,None,Yes,Former,Moderate,27.6,Medium,Rural,Private Insurance,9.0,No,No,None,6.0
PT05155,France,Île-de-France,,Male,Breast,I,,2011-09-29,2012-03-01,Chemotherapy,Private,Alive,92.0,EGFR,No,Former,Moderate,27.4,Medium,Urban,Private Insurance,13.0,No,Yes,Hypertension,5.0
PT05156,Norway,Oslo,,Female,Ovarian,II,2019-10-18,2019-10-24,2020-04-27,Immunotherapy,Public,Alive,9.0,KRAS,No,Former,Heavy,24.3,Medium,Urban,Private Insurance,4.0,No,No,Hypertension,6.0
PT05157,,Zealand,,Male,Leukemia,II,2022-10-19,2023-02-07,2024-01-13,Surgery,Private,Deceased,26.0,BRCA1,No,Former,None,32.9,Medium,Urban,Private Insurance,18.0,No,No,None,5.0
PT05158,Ireland,Dublin,32.0,Female,Leukemia,II,2020-06-29,2020-11-22,2021-07-03,Radiation,Public,Alive,46.0,EGFR,No,Never,None,37.2,High,Urban,Private Insurance,19.0,No,No,Hypertension,5.0
PT05159,Switzerland,Bern,43.0,Male,Breast,II,2021-11-09,2022-02-18,2023-02-08,Surgery,Private,Alive,82.0,None,Yes,Former,None,18.7,Medium,Urban,NHS,5.0,,No,Hypertension,6.0
PT05160,Poland,Masovian,59.0,Female,Ovarian,III,2015-11-12,2016-03-30,2017-02-26,Chemotherapy,Public,Alive,96.0,KRAS,Yes,Never,Moderate,39.2,High,Urban,Statutory Health Insurance,17.0,Yes,No,Cardiovascular Disease,3.0
PT05161,Austria,Tyrol,33.0,Male,Colorectal,III,,2018-02-25,2018-12-14,Chemotherapy,,Deceased,11.0,KRAS,No,Former,Moderate,33.9,High,Urban,NHS,1.0,No,No,None,8.0
PT05162,Netherlands,South Holland,89.0,,Ovarian,I,2017-11-26,2018-04-24,2018-08-06,Surgery,Public,Deceased,82.0,EGFR,Yes,Current,,18.2,Medium,Urban,NHS,17.0,Yes,No,Obesity,6.0
PT05163,Portugal,Porto,81.0,Female,Pancreatic,III,2022-12-28,2023-04-14,2023-09-13,Chemotherapy,Public,Lost to Follow-up,,None,No,Never,Moderate,20.2,Low,Rural,Private Insurance,6.0,No,No,Diabetes,9.0
PT05164,Switzerland,Bern,80.0,Female,Colorectal,,2021-04-04,2021-07-19,2021-11-05,Chemotherapy,Research Institute,Alive,68.0,None,Yes,Current,None,38.5,Medium,Rural,Private Insurance,17.0,Yes,Yes,Cardiovascular Disease,7.0
PT05165,Sweden,Stockholm,20.0,Male,Leukemia,II,,2013-11-08,2014-04-20,Targeted Therapy,Public,Alive,23.0,,No,Former,None,,Medium,Urban,NHS,16.0,No,No,None,8.0
PT05166,Switzerland,Geneva,85.0,Female,Prostate,I,2010-12-30,2011-01-01,2011-10-16,Radiation,Public,Alive,32.0,None,No,Current,None,19.3,Medium,Urban,Statutory Health Insurance,,No,No,Hypertension,3.0
PT05167,Portugal,Lisbon,51.0,Male,Prostate,IV,2012-01-14,2012-05-06,2012-09-05,Immunotherapy,Public,Deceased,92.0,EGFR,No,Current,None,25.4,Low,Rural,Private Insurance,15.0,No,No,None,2.0
,Belgium,Brussels,32.0,Female,Colorectal,IV,2019-07-02,2019-11-11,2020-04-05,Targeted Therapy,,Deceased,51.0,KRAS,No,Former,None,37.5,Medium,Urban,Statutory Health Insurance,11.0,No,No,Diabetes,2.0
PT05169,Germany,Bavaria,52.0,,Prostate,I,,2016-12-22,2017-07-07,Chemotherapy,Public,Deceased,51.0,,No,Never,None,36.8,Medium,Urban,Private Insurance,8.0,No,No,None,4.0
PT05170,Portugal,Algarve,51.0,Female,Colorectal,I,2020-02-02,2020-02-14,2020-03-31,Immunotherapy,,Deceased,100.0,None,Yes,Current,None,22.2,Low,Urban,Statutory Health Insurance,,No,No,Diabetes,6.0
PT05171,Netherlands,Utrecht,75.0,Female,Lung,III,2016-02-12,2016-05-05,2017-01-19,Chemotherapy,Public,Deceased,90.0,BRCA1,No,Current,Moderate,27.3,Medium,Urban,Statutory Health Insurance,2.0,No,No,Hypertension,7.0
PT05172,Portugal,Lisbon,43.0,Male,Colorectal,II,2021-01-24,2021-04-17,2022-03-15,Radiation,Public,Alive,94.0,BRCA1,No,Current,None,34.6,Medium,Urban,Statutory Health Insurance,4.0,No,No,Cardiovascular Disease,2.0
PT05173,Austria,Styria,23.0,Female,Lung,,2011-04-15,2011-07-17,2011-08-26,Chemotherapy,Public,Deceased,50.0,None,Yes,Current,Moderate,33.1,Medium,Urban,Statutory Health Insurance,14.0,No,,Obesity,1.0
PT05174,Spain,Madrid,42.0,Male,,,2010-11-08,2010-12-17,2011-03-17,Surgery,Public,Alive,48.0,EGFR,Yes,Never,None,20.2,Medium,Urban,Private Insurance,7.0,No,No,Cardiovascular Disease,7.0
,Italy,Sicily,48.0,Non-binary,Leukemia,IV,2017-10-18,2018-03-29,2018-12-28,Surgery,Public,Alive,85.0,EGFR,No,Never,Moderate,,High,Urban,NHS,2.0,Yes,No,Diabetes,4.0
PT05176,Norway,Trøndelag,40.0,Female,Prostate,I,2018-08-16,2018-10-14,2019-01-21,Surgery,Public,,55.0,EGFR,No,Former,None,18.6,Medium,Urban,Statutory Health Insurance,13.0,Yes,No,Cardiovascular Disease,4.0
PT05177,Netherlands,North Holland,49.0,Female,Pancreatic,I,,2023-01-11,2023-12-13,Surgery,Public,Alive,85.0,BRCA1,,Never,Heavy,26.0,High,Urban,Statutory Health Insurance,13.0,,No,Obesity,6.0
PT05178,France,Île-de-France,39.0,Female,Pancreatic,IV,2015-12-10,2016-02-20,2016-11-16,Immunotherapy,Public,Alive,108.0,KRAS,Yes,Never,,29.4,Low,Urban,Private Insurance,19.0,Yes,No,Diabetes,9.0
PT05179,Finland,Pirkanmaa,35.0,Male,Ovarian,I,2021-11-02,2022-03-16,2023-03-09,Surgery,Public,Alive,,KRAS,Yes,Former,None,18.9,High,Urban,NHS,7.0,No,Yes,None,7.0
PT05180,Ireland,Munster,86.0,Female,Ovarian,I,2012-09-15,2013-02-22,2013-10-03,Chemotherapy,Research Institute,Alive,118.0,None,No,Former,None,36.6,Medium,Urban,Private Insurance,5.0,Yes,No,Obesity,8.0
PT05181,Denmark,Central Denmark,68.0,Male,Leukemia,IV,2013-12-02,,2014-12-18,Targeted Therapy,Private,Alive,38.0,EGFR,No,Never,None,27.1,Low,Rural,Statutory Health Insurance,14.0,Yes,No,Obesity,4.0
PT05182,Italy,Veneto,,Female,Breast,I,2021-04-03,2021-06-17,2022-05-25,Chemotherapy,Public,Alive,97.0,KRAS,No,Current,None,26.9,,Urban,Private Insurance,5.0,No,No,None,3.0
PT05183,,North Holland,63.0,Female,Breast,I,2010-08-02,2010-09-12,2011-03-29,Chemotherapy,Public,Lost to Follow-up,,BRCA1,No,Never,Moderate,20.4,Low,Urban,Statutory Health Insurance,12.0,No,No,None,3.0
PT05184,Spain,Madrid,44.0,Male,Pancreatic,II,2022-11-12,2023-01-23,2023-10-11,Chemotherapy,Private,Deceased,35.0,None,Yes,Former,Moderate,28.5,High,Urban,NHS,7.0,No,No,None,9.0
PT05185,,Vienna,42.0,Male,Pancreatic,,2021-05-10,2021-08-06,2021-12-07,Chemotherapy,Public,Alive,6.0,KRAS,No,Never,None,19.9,Low,Urban,Statutory Health Insurance,1.0,,No,Diabetes,5.0
PT05186,Norway,Trøndelag,78.0,Male,Ovarian,III,2023-10-05,2024-03-08,2024-08-16,Targeted Therapy,Private,Alive,74.0,None,No,Former,Moderate,21.3,Low,Urban,Private Insurance,7.0,No,No,Cardiovascular Disease,5.0
PT05187,Poland,Lesser Poland,20.0,Non-binary,Leukemia,IV,2021-05-15,2021-07-07,2021-08-12,Surgery,Private,Deceased,,None,No,Never,Moderate,36.4,Low,Urban,NHS,4.0,No,No,Hypertension,10.0
PT05188,Ireland,Connacht,,Male,Colorectal,II,2013-08-05,2013-12-06,2014-03-27,Radiation,,Alive,80.0,BRCA1,No,Former,Heavy,33.0,Low,Rural,NHS,2.0,No,,Cardiovascular Disease,4.0
PT05189,,Capital Region,71.0,Female,Colorectal,II,2018-10-26,2018-11-06,2019-04-20,Immunotherapy,Private,Alive,77.0,BRCA1,Yes,Current,None,31.1,Low,,Statutory Health Insurance,3.0,No,No,Cardiovascular Disease,7.0
PT05190,Switzerland,Zurich,77.0,Female,Prostate,II,2016-09-21,2016-12-17,2017-04-04,Targeted Therapy,Public,Deceased,100.0,BRCA1,No,Former,Moderate,29.2,Medium,Urban,Private Insurance,19.0,,No,Obesity,10.0
PT05191,Germany,North Rhine-Westphalia,60.0,Male,Leukemia,III,2022-09-02,2023-01-30,2023-03-10,Targeted Therapy,Private,Alive,90.0,BRCA1,No,Former,Moderate,28.4,Low,Urban,Statutory Health Insurance,1.0,No,No,None,8.0
PT05192,Norway,Trøndelag,63.0,Female,Breast,III,2019-06-03,2019-06-08,2019-10-25,Targeted Therapy,Public,Alive,94.0,BRCA1,,Former,Moderate,38.9,High,Urban,Private Insurance,12.0,No,Yes,Diabetes,1.0
PT05193,Portugal,Algarve,23.0,Female,Leukemia,IV,2016-08-01,2016-11-21,2017-08-28,Immunotherapy,Public,Alive,23.0,None,Yes,Former,Moderate,39.8,Medium,,NHS,14.0,No,No,None,5.0
PT05194,Italy,Veneto,87.0,Male,Leukemia,,2011-12-01,2012-05-11,2012-12-20,Chemotherapy,Public,Alive,17.0,None,Yes,Former,Moderate,26.5,High,Urban,Private Insurance,13.0,No,No,None,2.0
PT05195,Denmark,Zealand,26.0,Female,Ovarian,II,2014-04-16,2014-06-17,2014-10-30,Immunotherapy,Public,Alive,17.0,BRCA1,Yes,Current,Moderate,18.3,Medium,Urban,NHS,3.0,No,No,Cardiovascular Disease,6.0
PT05196,Sweden,Skåne,65.0,Male,Prostate,II,2023-01-22,2023-06-30,2024-02-21,Targeted Therapy,Public,Deceased,104.0,,No,Former,Moderate,38.0,,Rural,Private Insurance,19.0,No,No,Cardiovascular Disease,9.0
PT05197,Portugal,Lisbon,28.0,Male,Colorectal,III,2013-08-02,2013-09-18,,Chemotherapy,Public,Alive,69.0,BRCA1,No,Former,None,25.0,Low,Urban,NHS,17.0,No,No,Cardiovascular Disease,5.0
PT05198,Spain,Catalonia,,Female,Pancreatic,I,2022-08-18,2022-09-24,2023-06-06,Targeted Therapy,Private,Alive,34.0,None,No,Never,Moderate,38.3,Medium,Urban,NHS,6.0,No,No,None,9.0
PT05199,Sweden,Stockholm,52.0,Male,Breast,I,2011-11-12,2012-03-02,2013-02-17,Radiation,,Deceased,83.0,None,No,Current,Moderate,29.7,Medium,Rural,,10.0,No,Yes,Hypertension,3.0
,Germany,North Rhine-Westphalia,23.0,Female,Prostate,IV,2014-09-05,2014-10-01,2015-07-17,Surgery,Private,Alive,82.0,KRAS,Yes,Former,Moderate,39.2,Low,Urban,Statutory Health Insurance,2.0,No,No,Obesity,3.0
PT05201,Norway,Trøndelag,84.0,Female,Breast,II,,2023-04-28,2023-08-24,Surgery,Research Institute,Alive,24.0,KRAS,No,Never,None,29.3,,Rural,Statutory Health Insurance,15.0,No,No,Hypertension,6.0
PT05202,France,Provence-Alpes-Côte d'Azur,53.0,Female,Breast,II,2020-09-05,2020-11-05,2021-02-11,Targeted Therapy,Public,Alive,89.0,None,No,Never,Moderate,27.5,,Urban,Statutory Health Insurance,2.0,No,No,Diabetes,2.0
PT05203,Germany,North Rhine-Westphalia,83.0,Male,Colorectal,II,2015-12-05,2016-05-19,2017-04-22,Chemotherapy,Public,Alive,7.0,EGFR,Yes,,None,,Medium,Urban,NHS,18.0,Yes,Yes,None,6.0
PT05204,Denmark,Central Denmark,,Male,,III,2021-12-13,2022-04-20,2022-11-18,Radiation,Private,Alive,17.0,,No,Never,None,33.8,High,Urban,NHS,14.0,No,No,Cardiovascular Disease,5.0
PT05205,Netherlands,North Holland,74.0,Male,Pancreatic,I,2014-11-23,2015-05-02,2015-07-17,Radiation,Private,Alive,49.0,None,No,Current,None,36.5,Medium,Urban,,,No,No,Diabetes,10.0
PT05206,Poland,Silesian,28.0,Female,Ovarian,III,2011-12-19,2012-02-26,2013-01-03,Chemotherapy,Public,Alive,79.0,EGFR,No,Former,None,19.7,Medium,Urban,NHS,8.0,No,Yes,Diabetes,10.0
PT05207,Switzerland,Geneva,36.0,Female,Colorectal,II,2011-12-22,2012-04-26,2012-10-18,Chemotherapy,Public,Deceased,41.0,BRCA1,Yes,Never,Moderate,31.5,Low,Urban,Private Insurance,4.0,No,Yes,Obesity,10.0
PT05208,Spain,Madrid,40.0,Male,Prostate,IV,2018-11-09,2019-03-16,2020-02-15,Radiation,Public,Alive,22.0,KRAS,No,Current,Moderate,32.7,High,Rural,Private Insurance,14.0,No,No,Cardiovascular Disease,9.0
PT05209,Portugal,Porto,79.0,Male,Lung,II,2020-07-24,2020-12-24,2021-05-23,Surgery,Public,Alive,12.0,BRCA1,No,Former,None,20.9,Medium,Rural,NHS,4.0,Yes,No,Diabetes,2.0
PT05210,Ireland,Munster,32.0,Male,Prostate,IV,2015-12-28,2016-01-30,2016-05-05,Surgery,Public,Deceased,106.0,None,No,Never,None,24.6,Medium,Rural,NHS,3.0,No,No,Hypertension,8.0
PT05211,Denmark,Zealand,22.0,Male,Prostate,II,2020-11-02,2021-01-05,2021-02-05,Radiation,Public,Alive,105.0,BRCA1,Yes,Never,,,High,,Statutory Health Insurance,7.0,No,No,Obesity,1.0
PT05212,Switzerland,Zurich,87.0,,Lung,IV,2020-04-10,2020-09-01,2021-06-02,Immunotherapy,Public,Lost to Follow-up,,None,No,Never,Moderate,23.0,Medium,Urban,Private Insurance,,Yes,No,Obesity,5.0
PT05213,Norway,Vestland,23.0,Female,Breast,IV,2021-08-10,2022-02-03,2022-06-13,Radiation,Private,Alive,23.0,BRCA1,Yes,Never,None,35.1,Medium,Urban,NHS,5.0,No,No,Diabetes,10.0
PT05214,Austria,Vienna,26.0,Female,Leukemia,II,2016-03-19,2016-06-20,2016-12-07,Targeted Therapy,Private,Deceased,,,No,Never,Heavy,18.6,Medium,Rural,Statutory Health Insurance,2.0,No,Yes,None,6.0
PT05215,Sweden,Skåne,45.0,Male,Lung,II,2012-02-20,2012-06-22,2013-01-05,Immunotherapy,Private,Alive,82.0,BRCA1,Yes,Former,None,22.0,Medium,Urban,Statutory Health Insurance,19.0,No,No,Hypertension,4.0
PT05216,Spain,Madrid,43.0,Female,Leukemia,II,2023-08-28,2023-09-12,2023-10-23,Chemotherapy,Public,Deceased,65.0,BRCA1,Yes,Former,Heavy,19.1,Medium,Rural,Private Insurance,3.0,No,No,Obesity,4.0
PT05217,,Vestland,29.0,Male,Breast,III,2011-09-22,2011-10-12,2011-12-23,Radiation,Research Institute,Alive,109.0,None,No,Never,Moderate,27.0,Medium,,Private Insurance,18.0,No,No,Cardiovascular Disease,4.0
PT05218,France,Île-de-France,32.0,Female,Lung,II,2022-05-28,2022-06-19,2022-09-28,Radiation,Public,Alive,17.0,EGFR,No,Former,Heavy,22.5,Medium,,Private Insurance,3.0,No,No,Cardiovascular Disease,7.0
PT05219,Norway,Vestland,63.0,Male,Colorectal,II,2020-09-26,2020-10-06,2021-09-29,Immunotherapy,Private,Alive,84.0,KRAS,No,Current,Moderate,23.7,Medium,Rural,NHS,12.0,,No,Hypertension,3.0
PT05220,Germany,Bavaria,58.0,Female,Prostate,III,2018-06-05,2018-09-09,2018-10-12,Radiation,Private,Deceased,53.0,KRAS,No,Current,None,29.1,Low,Urban,Statutory Health Insurance,3.0,No,No,Diabetes,9.0
PT05221,Denmark,Capital Region,38.0,Female,Lung,III,2019-01-26,2019-07-01,2020-01-11,Targeted Therapy,Public,Alive,56.0,None,No,Current,Moderate,29.4,Medium,Urban,Private Insurance,8.0,No,Yes,Obesity,1.0
PT05222,Germany,,70.0,Male,Lung,I,2018-07-24,2018-12-08,2019-06-19,Surgery,Private,,106.0,EGFR,,Never,Heavy,22.7,Medium,Urban,NHS,6.0,Yes,No,Obesity,8.0
PT05223,Belgium,Wallonia,38.0,Female,Breast,I,2016-08-27,2016-09-27,2016-11-27,Radiation,Public,Alive,72.0,BRCA1,Yes,Never,Moderate,36.7,Low,Urban,NHS,6.0,No,No,Obesity,6.0
PT05224,Germany,North Rhine-Westphalia,71.0,Female,Colorectal,I,2019-09-12,2019-12-17,2020-07-18,Surgery,Public,Alive,65.0,BRCA1,Yes,Former,Moderate,25.4,Low,Urban,Statutory Health Insurance,4.0,No,No,Diabetes,2.0
PT05225,Sweden,Västra Götaland,66.0,Male,Lung,I,2018-08-09,2018-10-22,2019-04-09,Chemotherapy,Public,Alive,15.0,KRAS,No,Former,Heavy,26.3,High,Urban,Statutory Health Insurance,10.0,No,No,Obesity,4.0
PT05226,Denmark,Capital Region,49.0,Male,Colorectal,II,2014-06-18,2014-11-24,2015-10-06,Chemotherapy,Private,Alive,28.0,BRCA1,No,Current,None,,Medium,Urban,Statutory Health Insurance,17.0,No,No,Cardiovascular Disease,7.0
PT05227,,Skåne,65.0,Female,Leukemia,III,2014-01-13,2014-03-29,2014-10-12,,Research Institute,Alive,9.0,BRCA1,No,Never,Moderate,27.5,Low,Urban,Private Insurance,,Yes,No,Obesity,8.0
PT05228,Norway,Oslo,40.0,Female,Lung,II,2011-04-25,2011-10-13,2012-01-13,Chemotherapy,Private,,113.0,BRCA1,,Current,None,22.8,Medium,Rural,Private Insurance,8.0,No,Yes,None,5.0
PT05229,Sweden,Västra Götaland,67.0,Female,Colorectal,I,2015-09-01,2015-11-14,2016-07-21,Radiation,Research Institute,Alive,30.0,EGFR,No,Never,Heavy,19.9,Medium,Urban,NHS,3.0,No,Yes,Diabetes,1.0
PT05230,Austria,Styria,81.0,Female,Prostate,II,2011-07-15,2011-11-29,2012-08-24,Surgery,Research Institute,Deceased,70.0,BRCA1,No,Never,Moderate,32.7,Medium,Urban,Private Insurance,6.0,No,No,Obesity,5.0
PT05231,Finland,Pirkanmaa,77.0,Female,Breast,IV,2017-05-19,2017-06-30,2018-06-05,Immunotherapy,Public,Deceased,66.0,BRCA1,Yes,Former,,22.2,Medium,Urban,NHS,14.0,No,No,Obesity,1.0
PT05232,Poland,Silesian,37.0,Female,Pancreatic,II,2017-04-13,,2018-05-17,Radiation,Public,Deceased,,EGFR,No,Former,None,35.5,Medium,Urban,Private Insurance,7.0,No,No,Hypertension,8.0
PT05233,Poland,Silesian,78.0,Female,Colorectal,IV,2017-07-22,2018-01-16,2018-09-21,Immunotherapy,Private,Alive,74.0,None,Yes,Never,Moderate,37.7,Medium,Urban,Statutory Health Insurance,13.0,Yes,No,Obesity,10.0
PT05234,Denmark,Capital Region,67.0,Male,Breast,I,2015-06-27,2015-12-09,2016-09-04,Surgery,Public,Alive,52.0,None,Yes,Never,Moderate,29.2,Medium,Rural,NHS,14.0,Yes,Yes,Cardiovascular Disease,7.0
PT05235,Sweden,Västra Götaland,82.0,Female,Pancreatic,,2021-07-18,2021-10-10,2022-08-30,Surgery,Public,Alive,32.0,None,Yes,Never,Moderate,,Medium,Urban,Private Insurance,9.0,Yes,No,Cardiovascular Disease,8.0
PT05236,Norway,Trøndelag,31.0,Male,Lung,III,2017-08-18,2018-01-10,,Immunotherapy,Private,Deceased,67.0,KRAS,No,Current,Moderate,19.6,Medium,Urban,NHS,19.0,No,No,Hypertension,6.0
PT05237,France,,53.0,Male,Lung,II,,2021-05-31,2021-12-18,Radiation,Public,Alive,76.0,EGFR,Yes,Former,Moderate,32.5,High,Rural,Statutory Health Insurance,13.0,No,No,None,8.0
PT05238,France,Auvergne-Rhône-Alpes,80.0,Female,Leukemia,III,,2014-01-03,2014-02-21,Immunotherapy,Public,Alive,54.0,EGFR,Yes,Current,Moderate,38.1,Medium,Urban,NHS,8.0,No,No,None,2.0
PT05239,Ireland,Dublin,72.0,Male,Breast,IV,2023-04-09,2023-05-21,2023-09-23,Radiation,Private,Deceased,66.0,None,No,Never,None,18.0,Low,Urban,Private Insurance,13.0,No,Yes,None,5.0
PT05240,Ireland,Munster,44.0,Male,Prostate,I,2023-05-17,2023-08-31,,Radiation,Public,Deceased,93.0,EGFR,Yes,Never,Moderate,22.8,Medium,Rural,NHS,16.0,No,Yes,Hypertension,1.0
PT05241,Norway,Vestland,81.0,,Ovarian,III,2012-06-13,2012-10-30,2013-09-18,Immunotherapy,Public,Alive,92.0,BRCA1,No,Never,Moderate,25.3,Low,Rural,NHS,1.0,No,No,Hypertension,6.0
PT05242,France,Île-de-France,23.0,Female,,III,2012-10-03,2013-02-07,2013-05-23,Surgery,Public,Alive,77.0,KRAS,No,Former,None,36.0,High,Urban,Private Insurance,11.0,Yes,No,Cardiovascular Disease,1.0
PT05243,Denmark,Central Denmark,32.0,Non-binary,Colorectal,IV,2021-09-22,2021-12-04,2022-09-26,Targeted Therapy,Private,Alive,35.0,None,No,Current,None,20.4,Low,Rural,Private Insurance,2.0,Yes,No,Diabetes,9.0
PT05244,Netherlands,Utrecht,61.0,Female,Prostate,II,2011-06-02,2011-11-22,,Chemotherapy,Public,Deceased,36.0,BRCA1,No,Never,Moderate,27.7,Medium,Urban,Private Insurance,,No,No,Diabetes,7.0
PT05245,Sweden,,68.0,Female,Pancreatic,I,2012-09-27,2013-03-19,2013-12-04,Targeted Therapy,Private,Alive,21.0,None,Yes,Never,None,22.1,,Urban,NHS,10.0,No,No,None,8.0
PT05246,Belgium,Brussels,75.0,Male,Breast,II,2020-04-05,2020-09-09,,Surgery,Research Institute,Deceased,,EGFR,,Never,,38.1,Low,Urban,NHS,19.0,No,No,Diabetes,7.0
PT05247,Switzerland,Geneva,66.0,Male,Lung,IV,2011-10-02,2012-03-12,2013-01-07,Chemotherapy,Private,Alive,70.0,,Yes,Never,Moderate,22.6,Medium,Rural,NHS,13.0,No,Yes,Obesity,3.0
PT05248,Norway,Oslo,27.0,Male,Breast,I,2011-12-31,2012-04-04,2012-06-14,Immunotherapy,Research Institute,Alive,16.0,None,Yes,Former,Moderate,24.9,High,Urban,Private Insurance,8.0,No,No,None,7.0
PT05249,Portugal,Lisbon,74.0,Male,Breast,I,2023-01-01,2023-04-01,2023-12-19,Targeted Therapy,Research Institute,Alive,67.0,KRAS,No,Former,,30.2,High,Urban,Private Insurance,16.0,Yes,No,Cardiovascular Disease,5.0
PT05250,Norway,Vestland,37.0,Male,Lung,II,2011-03-09,2011-07-08,2012-06-27,Radiation,Public,Alive,43.0,KRAS,Yes,Never,None,19.8,Medium,Urban,Private Insurance,3.0,No,No,Diabetes,2.0
PT05251,Germany,North Rhine-Westphalia,54.0,Male,Pancreatic,III,2020-10-12,2020-11-01,2020-12-13,Surgery,Private,Alive,92.0,EGFR,,Current,None,27.4,Medium,Urban,Statutory Health Insurance,13.0,No,No,Hypertension,2.0
,Portugal,Lisbon,51.0,Male,Breast,II,2017-09-11,2017-11-22,2018-01-26,Surgery,Public,Alive,101.0,EGFR,Yes,Never,Heavy,24.9,High,Urban,NHS,3.0,No,No,Diabetes,10.0
PT05253,Spain,Catalonia,43.0,Female,Prostate,I,2018-01-16,2018-03-27,2018-07-09,Surgery,Public,Alive,101.0,BRCA1,No,,Moderate,37.1,Medium,Urban,NHS,8.0,No,No,Cardiovascular Disease,7.0
PT05254,Denmark,,26.0,Female,,III,2021-06-28,2021-11-21,2022-05-08,Targeted Therapy,Private,,98.0,BRCA1,No,,Heavy,35.5,Low,Urban,NHS,9.0,No,No,None,6.0
PT05255,Italy,Sicily,32.0,Female,Ovarian,I,2013-01-26,2013-05-23,2013-10-23,Radiation,Public,Alive,,,No,Never,Moderate,38.4,High,Urban,,5.0,Yes,No,Cardiovascular Disease,1.0
PT05256,Spain,Andalusia,88.0,Female,Colorectal,I,2023-07-15,,2024-08-03,Targeted Therapy,Public,Alive,64.0,EGFR,No,Former,Moderate,24.1,High,Rural,,8.0,Yes,Yes,Obesity,3.0
PT05257,France,Provence-Alpes-Côte d'Azur,61.0,Male,Breast,II,2016-05-15,2016-06-09,,Radiation,,Alive,24.0,EGFR,,Former,Moderate,35.9,Medium,Urban,Private Insurance,11.0,No,No,,7.0
PT05258,Ireland,,50.0,Female,,II,2015-02-22,2015-04-29,2015-11-01,Chemotherapy,Public,Deceased,14.0,KRAS,No,Never,Moderate,,High,Urban,Statutory Health Insurance,16.0,No,No,Cardiovascular Disease,9.0
PT05259,Finland,Uusimaa,,Male,Lung,II,2019-05-10,2019-06-07,,Immunotherapy,Public,Alive,101.0,EGFR,No,Never,None,20.5,Low,Rural,Statutory Health Insurance,18.0,No,No,Diabetes,3.0
,Ireland,Connacht,51.0,Female,Leukemia,I,2018-01-21,2018-04-20,2018-09-21,Surgery,Private,Alive,,KRAS,,,,,Low,Urban,Statutory Health Insurance,18.0,No,No,Obesity,6.0
PT05261,Finland,Pirkanmaa,71.0,Female,Pancreatic,II,2014-06-03,2014-06-23,2015-05-30,Radiation,Public,Alive,74.0,BRCA1,No,Former,,39.4,Low,Rural,,3.0,No,No,Obesity,
PT05262,Belgium,Flanders,39.0,Female,Breast,III,2022-05-23,2022-08-01,2023-03-27,Targeted Therapy,Private,Alive,28.0,EGFR,No,Former,None,36.3,High,Urban,Private Insurance,10.0,No,No,Diabetes,5.0
PT05263,France,Provence-Alpes-Côte d'Azur,,Female,Breast,II,2012-11-28,,2013-06-09,Targeted Therapy,Public,Alive,115.0,EGFR,No,Never,None,32.5,Medium,Urban,NHS,15.0,No,No,None,1.0
PT05264,Italy,Veneto,78.0,Female,Leukemia,II,2016-10-08,2016-10-24,2017-03-02,Surgery,Private,Alive,60.0,None,Yes,Never,None,29.3,High,Urban,NHS,2.0,No,No,Hypertension,5.0
PT05265,Germany,Berlin,33.0,Female,Colorectal,I,2022-05-22,2022-11-01,2023-08-09,Surgery,Public,Alive,90.0,KRAS,No,,None,33.6,Medium,Urban,Private Insurance,9.0,No,No,None,4.0
PT05266,Germany,Bavaria,63.0,Male,Pancreatic,I,2022-06-17,2022-09-25,2023-06-16,Surgery,Public,Alive,25.0,EGFR,No,Never,None,35.6,Medium,Urban,Private Insurance,15.0,No,,Hypertension,
PT05267,Portugal,Lisbon,67.0,Female,Colorectal,IV,2011-06-03,2011-08-20,2012-04-09,Chemotherapy,Public,Alive,18.0,EGFR,Yes,Current,Moderate,28.9,Medium,,Statutory Health Insurance,10.0,No,No,Obesity,
PT05268,Belgium,Wallonia,62.0,Male,Ovarian,II,2019-05-18,2019-06-01,2020-04-23,,Private,Alive,114.0,None,No,Current,Moderate,34.3,Medium,Rural,Private Insurance,19.0,No,No,Cardiovascular Disease,4.0
PT05269,Spain,Andalusia,35.0,Female,Leukemia,II,2010-07-29,2010-08-22,2010-11-19,Radiation,Public,Alive,62.0,KRAS,Yes,Never,None,21.4,Medium,Rural,NHS,2.0,Yes,No,Diabetes,10.0
PT05270,Belgium,Brussels,54.0,Male,,IV,,2023-01-22,2023-11-03,Surgery,Private,Deceased,25.0,BRCA1,No,Never,Moderate,26.7,High,,NHS,3.0,No,No,Obesity,7.0
PT05271,Ireland,Munster,72.0,Male,Ovarian,,2023-08-30,2023-10-07,2023-12-31,Radiation,Public,Alive,52.0,KRAS,No,Never,Moderate,19.2,Medium,Urban,Private Insurance,2.0,No,No,None,8.0
PT05272,Spain,Madrid,53.0,Female,Breast,III,2012-05-16,2012-08-06,2013-05-21,Targeted Therapy,Private,Alive,82.0,KRAS,No,Never,Heavy,34.9,Medium,Urban,Private Insurance,18.0,No,No,Hypertension,7.0
PT05273,Finland,Southwest Finland,22.0,,Prostate,III,2020-10-15,2020-10-24,2021-05-08,Immunotherapy,,Alive,12.0,None,No,Former,None,22.7,Medium,Urban,NHS,16.0,No,Yes,None,4.0
PT05274,Denmark,Zealand,87.0,Female,Colorectal,I,2010-06-25,2010-10-24,2011-01-04,Immunotherapy,Public,Lost to Follow-up,,BRCA1,No,Never,Moderate,21.6,High,Urban,Statutory Health Insurance,14.0,No,No,None,1.0
,Poland,Masovian,24.0,Male,Colorectal,IV,2023-04-19,2023-06-17,2023-11-30,Radiation,Private,Alive,39.0,None,No,Former,Moderate,27.6,Low,Urban,Private Insurance,17.0,No,No,Hypertension,7.0
PT05276,Italy,Sicily,29.0,Female,Pancreatic,IV,2019-08-31,2019-10-21,2020-08-19,Targeted Therapy,Private,Alive,61.0,EGFR,No,Former,Heavy,29.8,Medium,Rural,Statutory Health Insurance,14.0,No,No,None,8.0
PT05277,Belgium,,71.0,Female,Ovarian,I,2010-08-05,2010-11-22,2011-08-28,Targeted Therapy,Private,Alive,58.0,None,Yes,Never,,21.6,Medium,,Statutory Health Insurance,11.0,No,No,Diabetes,4.0
PT05278,Belgium,Wallonia,48.0,Female,,III,2017-12-20,2018-02-09,2018-03-31,Chemotherapy,Public,,,None,Yes,Never,Moderate,26.0,High,Urban,Private Insurance,17.0,No,No,None,6.0
PT05279,Italy,Veneto,50.0,Male,Colorectal,II,2011-08-27,,2012-03-16,Surgery,Private,Deceased,58.0,BRCA1,No,Never,Moderate,,Medium,Urban,Private Insurance,19.0,Yes,No,Hypertension,8.0
PT05280,Finland,Southwest Finland,85.0,Male,Lung,III,2014-10-09,2014-12-10,2015-01-31,Targeted Therapy,Public,,86.0,None,No,Current,None,20.0,Low,Urban,NHS,1.0,No,Yes,None,9.0
PT05281,Austria,Vienna,88.0,Female,Leukemia,I,2019-01-17,2019-01-27,2019-11-21,Surgery,Research Institute,Alive,68.0,EGFR,No,Current,None,25.0,Medium,Urban,NHS,16.0,No,No,Diabetes,4.0
PT05282,Sweden,Västra Götaland,56.0,Male,Lung,II,2012-03-30,2012-09-12,2013-04-10,Surgery,Public,Alive,35.0,EGFR,No,Former,,23.7,Medium,Urban,NHS,19.0,No,No,Obesity,1.0
PT05283,Switzerland,Zurich,46.0,Male,Colorectal,I,2012-11-27,2013-04-07,2014-01-07,Radiation,Public,Alive,73.0,EGFR,Yes,Never,None,33.9,Medium,Urban,Private Insurance,7.0,Yes,Yes,Cardiovascular Disease,8.0
PT05284,Austria,Vienna,,Female,Pancreatic,II,2016-10-07,,2018-02-17,Surgery,Private,Deceased,9.0,BRCA1,,Never,Moderate,21.6,Medium,Rural,,15.0,No,No,Obesity,9.0
PT05285,Denmark,Capital Region,87.0,Female,Breast,I,2019-07-03,2019-12-19,2020-07-19,Radiation,Public,Deceased,119.0,EGFR,No,Former,Moderate,28.9,Medium,Rural,Private Insurance,6.0,No,No,None,4.0
PT05286,Spain,Madrid,78.0,Male,Colorectal,II,2018-04-01,2018-08-24,2019-02-09,Immunotherapy,Research Institute,Deceased,42.0,EGFR,No,Never,Moderate,25.2,Low,Urban,Private Insurance,11.0,No,No,None,7.0
PT05287,Germany,Bavaria,83.0,Male,Breast,III,2018-02-03,2018-05-01,2018-06-02,Targeted Therapy,Private,Alive,44.0,EGFR,Yes,Never,Moderate,33.9,High,Urban,Statutory Health Insurance,10.0,No,Yes,None,10.0
PT05288,Norway,Oslo,63.0,Male,Pancreatic,IV,2017-03-11,2017-05-23,2017-11-10,Radiation,Private,Alive,41.0,None,Yes,Never,Moderate,39.2,Medium,Urban,NHS,15.0,No,Yes,Diabetes,3.0
,Portugal,Lisbon,68.0,Female,Breast,I,2010-07-04,2010-09-25,,Chemotherapy,Public,Alive,20.0,KRAS,No,Current,None,37.0,Medium,Rural,Private Insurance,1.0,No,No,Obesity,4.0
,Finland,Uusimaa,72.0,Male,,IV,2019-06-11,2019-09-12,2020-05-30,Radiation,Private,Alive,91.0,None,Yes,Never,None,29.4,Medium,Urban,NHS,12.0,No,No,Hypertension,9.0
,Germany,Bavaria,68.0,Non-binary,Colorectal,II,2011-08-25,2011-09-09,,Surgery,Public,Alive,80.0,,No,Former,Moderate,36.8,,Urban,Private Insurance,16.0,No,No,Cardiovascular Disease,6.0
PT05292,Germany,Bavaria,85.0,Male,Breast,III,2013-08-02,2013-11-16,2014-02-24,Chemotherapy,Private,Lost to Follow-up,,None,No,Current,Moderate,33.6,Low,Urban,NHS,19.0,No,No,Diabetes,3.0
PT05293,Portugal,Algarve,82.0,Male,Lung,II,2013-10-03,2014-01-11,2014-08-22,Surgery,Public,Alive,41.0,KRAS,No,Former,None,22.2,Low,Urban,Statutory Health Insurance,9.0,No,No,,4.0
PT05294,Portugal,Algarve,44.0,Female,Lung,IV,2017-07-29,2017-10-13,2017-12-07,Chemotherapy,Public,,101.0,None,No,Never,Moderate,33.2,Medium,Rural,Statutory Health Insurance,14.0,No,No,Cardiovascular Disease,9.0
PT05295,Sweden,Västra Götaland,23.0,Male,Pancreatic,III,2022-08-31,2022-11-17,2023-06-08,Radiation,Public,Deceased,24.0,EGFR,Yes,Never,Heavy,,Medium,Urban,Statutory Health Insurance,2.0,No,Yes,Obesity,3.0
PT05296,Poland,Silesian,70.0,Female,Lung,II,2012-10-09,2013-03-01,2013-10-02,Surgery,Private,Alive,21.0,KRAS,Yes,Never,Heavy,22.5,Medium,Rural,NHS,11.0,,No,Hypertension,7.0
PT05297,Netherlands,South Holland,30.0,Female,Ovarian,II,2015-01-29,2015-05-24,2016-04-30,Radiation,Private,Alive,79.0,,No,Former,Moderate,39.4,Low,,,5.0,No,Yes,Obesity,2.0
PT05298,Norway,Oslo,36.0,Male,Prostate,IV,2010-01-07,2010-04-12,2010-09-01,Targeted Therapy,Private,Deceased,112.0,None,Yes,Former,None,35.9,High,,NHS,16.0,No,No,None,5.0
PT05299,Finland,Pirkanmaa,85.0,Female,Breast,III,2010-07-07,2010-11-17,2011-08-13,Chemotherapy,Public,Alive,86.0,None,No,Never,None,34.9,Medium,Urban,Private Insurance,6.0,No,No,None,6.0
PT05300,Switzerland,Geneva,89.0,Male,Prostate,II,2021-01-28,2021-03-13,2022-02-25,Immunotherapy,Public,Alive,112.0,None,No,Never,,39.5,Low,,Private Insurance,2.0,No,No,None,1.0
PT05301,Ireland,Connacht,88.0,Male,Prostate,I,2014-06-12,2014-06-15,2015-02-01,Immunotherapy,,Alive,48.0,EGFR,Yes,Former,Moderate,39.7,Medium,Urban,NHS,7.0,Yes,Yes,Diabetes,4.0
PT05302,Netherlands,North Holland,48.0,Male,Ovarian,III,2013-02-13,2013-04-01,2013-12-14,Radiation,Public,Deceased,11.0,EGFR,Yes,Former,Moderate,28.5,Medium,Urban,NHS,1.0,No,No,Hypertension,6.0
PT05303,,Sicily,39.0,Female,Breast,IV,2010-03-04,2010-08-09,2011-07-26,Chemotherapy,Private,Alive,117.0,KRAS,No,Never,None,29.1,Medium,Rural,NHS,18.0,Yes,No,Obesity,6.0
PT05304,Netherlands,South Holland,46.0,Male,,I,2011-03-17,2011-03-29,2011-09-16,Chemotherapy,Public,Alive,,KRAS,No,Never,Moderate,36.7,Low,,Private Insurance,11.0,No,No,Hypertension,4.0
PT05305,Netherlands,South Holland,27.0,,Pancreatic,IV,2013-09-29,2013-10-14,2014-03-30,Radiation,Public,Alive,102.0,EGFR,No,,Moderate,31.9,Medium,Rural,NHS,16.0,No,Yes,Obesity,2.0
PT05306,Denmark,Zealand,80.0,Female,Pancreatic,I,,2012-01-23,,Immunotherapy,Private,Alive,89.0,KRAS,No,Former,None,19.7,Medium,Urban,Private Insurance,19.0,No,No,,9.0
PT05307,Poland,Masovian,47.0,Male,Breast,IV,2011-01-14,2011-02-11,2012-01-26,Targeted Therapy,Research Institute,Alive,19.0,EGFR,No,Never,Heavy,33.2,High,Rural,NHS,9.0,No,Yes,Cardiovascular Disease,10.0
PT05308,Netherlands,South Holland,89.0,Male,Leukemia,III,2013-06-09,2013-12-03,2014-04-30,Immunotherapy,Private,Deceased,112.0,BRCA1,No,,Moderate,28.4,Medium,Urban,Statutory Health Insurance,16.0,Yes,No,Cardiovascular Disease,5.0
PT05309,Finland,Pirkanmaa,22.0,Female,Leukemia,II,2016-10-23,2017-01-18,2017-11-20,Surgery,Public,Alive,33.0,BRCA1,Yes,Never,None,19.3,Medium,,Private Insurance,2.0,No,No,Hypertension,9.0
PT05310,Netherlands,South Holland,88.0,,Ovarian,II,2016-09-07,2017-03-01,2017-10-13,Immunotherapy,Public,Alive,109.0,KRAS,No,Never,,38.1,Medium,Rural,Statutory Health Insurance,11.0,No,No,Hypertension,4.0
PT05311,Poland,Lesser Poland,26.0,Female,Breast,III,2020-10-21,2021-01-04,2021-10-25,Surgery,Public,Deceased,11.0,BRCA1,No,Former,Moderate,23.1,Medium,Urban,Private Insurance,3.0,No,No,Diabetes,10.0
PT05312,Ireland,Connacht,79.0,Female,Breast,II,2012-01-07,2012-04-10,2012-09-23,Surgery,Private,Deceased,24.0,BRCA1,Yes,Never,Moderate,,Medium,Urban,Private Insurance,11.0,Yes,No,Diabetes,5.0
PT05313,France,Auvergne-Rhône-Alpes,23.0,Male,Breast,IV,2019-03-02,2019-03-14,2019-08-10,Targeted Therapy,Public,Alive,112.0,None,No,Current,Moderate,29.0,Low,Urban,Statutory Health Insurance,3.0,No,No,Cardiovascular Disease,5.0
PT05314,Switzerland,Geneva,24.0,Female,Lung,III,2012-05-23,2012-07-16,2012-10-22,Targeted Therapy,Public,Alive,11.0,None,Yes,Current,None,32.2,Medium,Rural,,8.0,No,No,None,3.0
PT05315,Poland,Lesser Poland,30.0,Female,,II,2023-02-21,2023-05-15,2023-08-14,Immunotherapy,Public,Alive,112.0,EGFR,Yes,Never,Moderate,23.8,High,,NHS,5.0,No,No,Obesity,2.0
PT05316,Italy,Sicily,34.0,Female,Pancreatic,IV,2018-11-13,2018-12-15,2019-06-06,Radiation,Private,Alive,10.0,,No,Former,None,39.7,Medium,Rural,Statutory Health Insurance,1.0,Yes,No,,5.0
PT05317,Poland,Silesian,83.0,Female,Pancreatic,II,2010-04-09,2010-08-16,2011-04-28,Immunotherapy,Public,Alive,71.0,EGFR,Yes,Never,None,19.0,Low,,Statutory Health Insurance,,No,No,None,10.0
PT05318,Denmark,Central Denmark,32.0,Female,Colorectal,III,2016-09-25,2017-02-16,2017-07-16,Targeted Therapy,Public,Deceased,53.0,KRAS,No,Former,Moderate,37.0,Medium,Rural,Statutory Health Insurance,11.0,No,No,Hypertension,10.0
PT05319,,Masovian,26.0,Female,Leukemia,III,2019-01-13,2019-01-24,2019-02-26,Surgery,,Alive,,BRCA1,No,Never,Moderate,19.5,High,Urban,Private Insurance,5.0,No,No,Obesity,5.0
PT05320,Austria,,25.0,Female,Leukemia,IV,2011-02-18,2011-05-26,2011-10-21,Surgery,Public,Alive,19.0,EGFR,Yes,Former,Heavy,38.0,High,Rural,Statutory Health Insurance,2.0,Yes,No,Obesity,5.0
PT05321,Switzerland,Geneva,75.0,Male,Ovarian,I,2010-11-10,2011-01-04,2011-05-14,Radiation,Public,Alive,83.0,KRAS,No,Never,Moderate,38.0,High,Urban,Statutory Health Insurance,8.0,No,Yes,Cardiovascular Disease,2.0
PT05322,France,Auvergne-Rhône-Alpes,83.0,Female,Breast,II,2016-07-01,2016-12-12,2017-08-30,Immunotherapy,Public,Deceased,,EGFR,No,Never,,26.1,Medium,Urban,Private Insurance,9.0,No,No,Obesity,8.0
PT05323,,Provence-Alpes-Côte d'Azur,69.0,Male,Leukemia,II,2014-11-21,2014-12-21,2015-07-10,Radiation,Private,Deceased,,KRAS,No,,,31.2,,Urban,Private Insurance,5.0,No,No,Diabetes,4.0
,Norway,Oslo,49.0,Male,Breast,II,2013-12-03,2014-02-09,2014-10-02,Radiation,Private,Alive,45.0,EGFR,,Former,,36.8,Low,Urban,Statutory Health Insurance,1.0,No,No,Diabetes,3.0
PT05325,Norway,Vestland,41.0,Male,Breast,II,2022-05-16,2022-07-11,2023-03-16,Immunotherapy,Private,Alive,93.0,BRCA1,Yes,Never,,25.0,,Rural,NHS,14.0,No,,Cardiovascular Disease,2.0
,Denmark,Capital Region,44.0,Male,Leukemia,III,2021-11-04,2022-02-01,2022-06-23,,Public,Alive,35.0,,,Current,Moderate,20.9,Low,Rural,Statutory Health Insurance,13.0,No,No,Cardiovascular Disease,6.0
PT05327,Switzerland,Zurich,47.0,Male,Leukemia,II,2014-05-14,2014-08-20,2015-08-16,Immunotherapy,Research Institute,Alive,80.0,BRCA1,No,Never,Moderate,38.2,Medium,Urban,Private Insurance,,No,Yes,None,7.0
PT05328,Denmark,Zealand,,Female,Colorectal,II,2023-01-25,2023-02-11,2023-11-15,Radiation,Public,Deceased,83.0,None,Yes,Never,Moderate,19.6,Medium,Rural,Statutory Health Insurance,9.0,No,No,Obesity,4.0
PT05329,,Provence-Alpes-Côte d'Azur,86.0,Male,Ovarian,I,2019-10-24,2020-04-02,2020-10-10,,Private,Alive,27.0,None,Yes,Former,Moderate,20.9,Medium,Urban,NHS,4.0,No,No,Obesity,9.0
PT05330,Denmark,Zealand,24.0,Female,Prostate,I,2023-03-05,2023-08-10,2024-05-25,Radiation,Private,Alive,8.0,BRCA1,No,Never,Moderate,21.9,Medium,Urban,Statutory Health Insurance,12.0,No,No,None,
PT05331,Sweden,Skåne,84.0,Male,,III,2010-12-04,2010-12-17,2011-11-18,,,Alive,34.0,None,No,Never,,31.6,Low,Urban,Private Insurance,11.0,Yes,Yes,Cardiovascular Disease,9.0
PT05332,France,Auvergne-Rhône-Alpes,34.0,Male,Colorectal,I,2021-11-20,2022-04-09,2022-12-28,Radiation,Public,,53.0,BRCA1,No,,None,25.0,Medium,Urban,Statutory Health Insurance,13.0,No,No,Obesity,4.0
PT05333,France,Auvergne-Rhône-Alpes,86.0,Male,Leukemia,I,,2011-11-13,2012-02-08,Surgery,Research Institute,Alive,115.0,None,No,Former,Moderate,30.3,Low,Urban,NHS,18.0,No,No,Cardiovascular Disease,9.0
PT05334,Netherlands,Utrecht,59.0,Male,Ovarian,II,2021-10-09,2021-11-10,2022-05-08,Immunotherapy,Private,Alive,13.0,BRCA1,No,Former,Moderate,35.1,Medium,Urban,Private Insurance,12.0,No,No,Hypertension,3.0
PT05335,France,Île-de-France,88.0,Female,Pancreatic,I,2013-05-01,2013-07-27,2013-09-13,Targeted Therapy,Public,Alive,54.0,EGFR,,Current,Moderate,31.3,Medium,Rural,Statutory Health Insurance,9.0,No,Yes,,1.0
PT05336,Netherlands,South Holland,62.0,Female,Ovarian,I,2020-09-15,2020-12-17,2021-08-21,Surgery,Public,Alive,12.0,None,No,Never,Moderate,38.0,Medium,Urban,Statutory Health Insurance,18.0,Yes,Yes,Obesity,5.0
PT05337,Poland,Lesser Poland,20.0,Male,Colorectal,IV,2019-05-24,2019-06-27,2019-08-15,Immunotherapy,Private,Alive,29.0,KRAS,Yes,Never,None,20.2,Medium,Rural,NHS,2.0,No,No,Obesity,1.0
PT05338,Poland,Lesser Poland,41.0,Male,Pancreatic,III,2023-01-22,2023-04-15,2024-01-13,Surgery,Research Institute,Deceased,10.0,,No,Former,Moderate,38.3,High,Urban,Statutory Health Insurance,16.0,No,No,Cardiovascular Disease,6.0
PT05339,Poland,Masovian,,Female,Leukemia,II,2012-01-06,2012-01-18,2012-03-01,Immunotherapy,Private,Alive,89.0,EGFR,No,Never,,28.7,Medium,,Statutory Health Insurance,12.0,No,No,Cardiovascular Disease,10.0
PT05340,Italy,Lombardy,45.0,Male,Lung,II,2019-02-08,2019-02-12,2019-12-14,Chemotherapy,Private,Alive,69.0,,No,Never,Heavy,19.3,Low,Urban,NHS,18.0,Yes,Yes,Hypertension,7.0
PT05341,Ireland,Munster,37.0,Male,Breast,IV,2016-05-20,2016-08-17,2017-07-13,Targeted Therapy,Research Institute,Alive,10.0,None,Yes,Current,Moderate,,High,Rural,NHS,17.0,Yes,No,Cardiovascular Disease,9.0
PT05342,Poland,Silesian,67.0,Female,Prostate,I,2016-03-15,2016-08-16,2017-07-14,Chemotherapy,Private,Alive,54.0,None,No,Former,Moderate,20.5,Low,Rural,Statutory Health Insurance,7.0,No,No,Obesity,2.0
PT05343,Sweden,Stockholm,28.0,Male,Pancreatic,II,2022-10-13,2023-01-03,2023-09-28,Chemotherapy,Research Institute,Deceased,75.0,KRAS,Yes,Current,Moderate,32.8,Low,Urban,NHS,5.0,,No,Obesity,10.0
PT05344,Ireland,Dublin,,Non-binary,Lung,II,2019-12-03,2020-04-09,2021-03-17,Immunotherapy,Public,Deceased,97.0,BRCA1,No,Former,Heavy,24.2,High,Rural,NHS,1.0,No,No,Cardiovascular Disease,6.0
PT05345,Ireland,Munster,28.0,Female,Pancreatic,III,2010-07-01,2010-12-06,2011-02-04,Radiation,Private,Alive,20.0,BRCA1,Yes,Never,Moderate,,Low,Rural,Private Insurance,6.0,No,Yes,,10.0
PT05346,Switzerland,Geneva,42.0,Male,Breast,IV,2023-11-18,2024-03-19,2024-07-26,Radiation,Private,Deceased,64.0,BRCA1,No,Never,None,36.5,Medium,Urban,Statutory Health Insurance,10.0,Yes,No,None,3.0
PT05347,Netherlands,South Holland,64.0,,,II,2023-10-16,2024-03-26,2024-06-09,Radiation,,Alive,95.0,None,No,Never,Moderate,27.4,Medium,Urban,Private Insurance,10.0,No,No,,4.0
,Switzerland,Geneva,21.0,Female,Ovarian,II,2010-07-27,,2011-07-29,Radiation,Public,Alive,114.0,EGFR,,Never,None,31.6,High,Rural,Statutory Health Insurance,7.0,No,,Obesity,2.0
PT05349,Sweden,Stockholm,33.0,Male,Prostate,III,2016-10-06,2017-03-14,2017-05-23,Targeted Therapy,Research Institute,Alive,26.0,EGFR,Yes,Former,Moderate,33.5,Low,Urban,Private Insurance,13.0,No,,Cardiovascular Disease,9.0
PT05350,Sweden,,57.0,Female,Colorectal,IV,2013-04-08,2013-06-03,2013-10-05,Chemotherapy,Public,Alive,90.0,KRAS,Yes,Former,,30.2,Medium,Urban,NHS,,,No,Cardiovascular Disease,7.0
PT05351,Switzerland,Bern,59.0,Female,Breast,IV,2021-08-05,2021-10-06,2022-01-25,Surgery,Public,Alive,14.0,EGFR,No,Never,None,35.1,Low,Urban,Private Insurance,12.0,No,,Cardiovascular Disease,10.0
PT05352,Switzerland,Geneva,82.0,Male,Prostate,III,2021-11-28,2021-12-29,2022-05-16,Targeted Therapy,Private,Lost to Follow-up,,BRCA1,No,Current,Moderate,29.0,Medium,Urban,NHS,15.0,Yes,No,None,5.0
,Austria,Tyrol,35.0,Female,Pancreatic,IV,2013-04-04,2013-04-28,2013-11-02,Immunotherapy,Public,Alive,52.0,KRAS,No,Current,Moderate,27.2,High,Urban,Statutory Health Insurance,6.0,No,Yes,Cardiovascular Disease,5.0
PT05354,Ireland,Munster,25.0,Male,,I,2022-10-09,2022-12-17,2023-03-03,Targeted Therapy,Public,,113.0,KRAS,No,Never,None,34.5,Low,Urban,Statutory Health Insurance,7.0,Yes,No,Cardiovascular Disease,6.0
PT05355,Portugal,Lisbon,22.0,Male,Pancreatic,II,2014-07-17,2015-01-12,2015-02-28,Targeted Therapy,Private,Deceased,46.0,KRAS,Yes,Never,Heavy,22.6,Medium,Rural,Private Insurance,6.0,No,No,Diabetes,6.0
PT05356,Norway,Trøndelag,33.0,Female,Ovarian,I,2011-03-02,2011-06-08,2012-01-25,Immunotherapy,Public,Alive,61.0,BRCA1,Yes,Never,Moderate,38.7,Medium,Urban,NHS,3.0,No,No,Cardiovascular Disease,9.0
PT05357,Netherlands,South Holland,85.0,Female,Pancreatic,I,2019-10-18,2019-10-27,2020-08-14,Surgery,Public,Alive,79.0,BRCA1,Yes,Never,Moderate,24.6,Medium,Urban,Private Insurance,1.0,No,No,Obesity,7.0
PT05358,Italy,Lombardy,86.0,Female,Pancreatic,III,2013-11-30,2013-12-08,2014-02-13,Chemotherapy,Public,Alive,53.0,KRAS,No,Former,None,18.9,Medium,Urban,Private Insurance,17.0,Yes,No,Obesity,
PT05359,Ireland,Dublin,50.0,Male,Leukemia,IV,2023-10-09,2024-01-24,2024-08-13,Targeted Therapy,Research Institute,,67.0,KRAS,Yes,Current,None,29.9,Medium,Urban,NHS,19.0,No,No,Diabetes,7.0
PT05360,Germany,Bavaria,52.0,Female,Breast,III,2023-11-13,2024-04-25,2024-06-21,Immunotherapy,Public,Alive,94.0,,No,Never,None,24.6,Medium,Rural,Private Insurance,19.0,Yes,No,Hypertension,6.0
PT05361,Switzerland,Geneva,20.0,Male,Ovarian,III,2023-04-20,2023-07-22,2023-09-07,Immunotherapy,Public,Alive,90.0,EGFR,Yes,Never,None,21.5,Medium,Rural,Statutory Health Insurance,1.0,No,No,Diabetes,
PT05362,Austria,Tyrol,63.0,Female,Breast,I,2011-07-23,2011-09-30,2011-11-07,Surgery,Public,Alive,103.0,BRCA1,No,Never,Moderate,35.2,Low,Urban,Private Insurance,11.0,No,No,Obesity,9.0
PT05363,Switzerland,Bern,34.0,Female,Colorectal,III,2017-03-11,2017-04-26,,Targeted Therapy,Public,Alive,36.0,EGFR,Yes,Former,Heavy,31.0,Low,Rural,Statutory Health Insurance,5.0,Yes,No,Hypertension,6.0
PT05364,Poland,Masovian,56.0,Female,Ovarian,II,2010-08-19,2011-01-04,2011-12-17,Immunotherapy,Research Institute,Deceased,71.0,None,No,Former,None,31.0,High,Urban,Private Insurance,12.0,No,No,Hypertension,1.0
PT05365,France,Auvergne-Rhône-Alpes,46.0,Female,Colorectal,III,2012-09-21,,2013-03-11,Surgery,Private,Alive,111.0,BRCA1,No,Never,Heavy,29.3,High,Urban,Private Insurance,7.0,No,No,None,6.0
PT05366,Poland,Lesser Poland,67.0,Female,,II,2014-07-15,2014-09-27,2015-02-04,Surgery,Public,Alive,109.0,BRCA1,No,Former,Moderate,32.2,High,Rural,NHS,9.0,Yes,No,Hypertension,10.0
PT05367,Finland,Uusimaa,46.0,Non-binary,Leukemia,II,2021-01-22,2021-05-29,2021-09-29,Immunotherapy,Private,Alive,21.0,KRAS,Yes,Former,Moderate,38.3,High,Urban,Private Insurance,18.0,No,No,Diabetes,6.0
,Poland,,31.0,Non-binary,Breast,,2012-02-29,2012-07-17,2012-10-12,Immunotherapy,Public,Lost to Follow-up,,BRCA1,No,Never,None,25.3,Medium,Urban,NHS,1.0,No,Yes,None,3.0
PT05369,France,Île-de-France,86.0,Female,Ovarian,II,2017-03-10,2017-07-04,,Targeted Therapy,Public,Alive,40.0,,No,Never,Moderate,32.0,Medium,Rural,Private Insurance,6.0,No,No,Cardiovascular Disease,1.0
PT05370,Portugal,Lisbon,49.0,,Colorectal,I,2012-11-02,2012-11-10,2013-03-25,Targeted Therapy,Public,Deceased,54.0,KRAS,Yes,Former,Moderate,35.2,High,Urban,Private Insurance,5.0,No,Yes,None,4.0
PT05371,Netherlands,North Holland,85.0,Female,Ovarian,,2022-02-25,2022-05-04,,Chemotherapy,Private,Deceased,119.0,EGFR,No,Current,Moderate,22.5,Low,Rural,,1.0,No,No,Hypertension,2.0
PT05372,Belgium,Brussels,26.0,Female,Prostate,II,2014-06-01,2014-10-25,2015-06-17,Immunotherapy,Public,Alive,36.0,KRAS,Yes,Current,None,34.2,Medium,Rural,NHS,13.0,Yes,No,None,9.0
PT05373,Netherlands,North Holland,53.0,Male,Pancreatic,III,2010-12-05,2011-04-12,2011-06-07,,Private,Alive,81.0,None,Yes,Never,Moderate,26.4,Medium,Urban,NHS,18.0,No,No,,9.0
PT05374,,Île-de-France,51.0,,Pancreatic,III,2011-08-09,2011-12-09,2012-10-19,,Public,Alive,59.0,KRAS,No,Current,Heavy,36.5,Medium,Urban,Statutory Health Insurance,7.0,No,No,Cardiovascular Disease,
PT05375,Ireland,Connacht,58.0,Female,Breast,IV,2011-02-26,2011-03-01,2011-05-14,Chemotherapy,Public,Alive,28.0,EGFR,No,Never,Moderate,24.5,High,Urban,Private Insurance,15.0,Yes,No,Cardiovascular Disease,9.0
PT05376,Denmark,Zealand,,Female,Pancreatic,III,2013-08-06,2013-11-22,2014-01-26,Immunotherapy,Private,Deceased,111.0,None,No,Former,None,33.2,Low,Urban,Statutory Health Insurance,12.0,No,No,Obesity,7.0
,Belgium,Brussels,62.0,Female,Pancreatic,II,2013-08-06,2013-12-27,2014-11-27,Surgery,Public,,113.0,BRCA1,Yes,Never,None,29.2,Medium,Urban,NHS,14.0,No,No,Obesity,10.0
PT05378,Austria,Tyrol,22.0,Male,Prostate,III,2020-07-09,2020-11-14,2021-01-20,Radiation,Private,Alive,107.0,BRCA1,No,Former,None,34.5,High,Urban,Private Insurance,16.0,No,Yes,Diabetes,10.0
PT05379,Ireland,Connacht,65.0,Male,Lung,II,2013-03-23,2013-07-21,2014-04-15,Targeted Therapy,Private,Deceased,22.0,None,No,Former,Moderate,35.9,High,Urban,Statutory Health Insurance,6.0,Yes,No,None,6.0
PT05380,Germany,Berlin,51.0,Female,Leukemia,I,,2014-11-29,2015-03-12,Radiation,Public,Deceased,113.0,BRCA1,No,Never,Moderate,20.7,Medium,Urban,Private Insurance,13.0,No,No,None,6.0
PT05381,Austria,Vienna,62.0,Female,Colorectal,III,2014-07-25,2014-10-03,2015-07-31,Immunotherapy,Private,Alive,19.0,KRAS,Yes,Never,Moderate,23.8,Low,Urban,Statutory Health Insurance,11.0,No,No,Hypertension,2.0
PT05382,Germany,North Rhine-Westphalia,22.0,Male,Lung,I,,2021-11-23,2022-06-19,,Private,Alive,102.0,BRCA1,No,Never,Heavy,23.7,Medium,Rural,NHS,5.0,No,No,Diabetes,2.0
PT05383,Italy,Sicily,82.0,Female,Colorectal,,2022-05-26,2022-09-03,2023-03-18,Chemotherapy,Private,Alive,,EGFR,No,,None,19.0,Medium,Rural,NHS,12.0,No,No,Hypertension,10.0
PT05384,Norway,Trøndelag,59.0,Female,,III,2011-05-30,2011-07-01,2012-04-06,Targeted Therapy,,Alive,53.0,BRCA1,,Former,Moderate,39.1,Medium,Urban,NHS,16.0,No,No,Diabetes,8.0
PT05385,Poland,Silesian,37.0,Male,Pancreatic,III,2019-02-12,2019-02-18,2019-10-18,Chemotherapy,Private,Alive,,None,No,Former,Moderate,30.3,Medium,Urban,Statutory Health Insurance,18.0,No,No,Cardiovascular Disease,4.0
PT05386,Ireland,Dublin,86.0,,Colorectal,III,2022-08-03,2022-12-25,2023-08-31,Surgery,Private,Alive,28.0,None,No,Never,Heavy,22.9,Low,Urban,Private Insurance,6.0,Yes,No,Diabetes,10.0
PT05387,Austria,Vienna,81.0,Male,Leukemia,I,2012-09-15,2012-10-01,2013-07-04,Surgery,Private,Alive,53.0,None,No,Former,Heavy,,Medium,,Private Insurance,4.0,No,No,Hypertension,8.0
PT05388,Italy,,29.0,Male,Breast,IV,2022-05-10,2022-05-24,2022-11-20,Surgery,Public,Alive,54.0,None,Yes,Former,Moderate,36.2,High,Urban,Private Insurance,8.0,No,No,None,7.0
PT05389,Finland,Southwest Finland,71.0,Male,Prostate,,2021-06-27,2021-08-28,2022-08-13,Surgery,Private,,66.0,None,No,Never,None,21.5,Medium,Urban,NHS,4.0,No,No,,10.0
,Ireland,Connacht,65.0,Male,Lung,III,,2014-04-13,2015-03-13,Immunotherapy,Research Institute,Deceased,36.0,None,,Never,Heavy,32.3,Medium,Rural,Private Insurance,19.0,No,No,Obesity,10.0
PT05391,Germany,Berlin,74.0,Male,Prostate,III,2023-08-15,2023-08-23,2024-03-21,Immunotherapy,Public,Alive,109.0,None,No,Current,None,21.3,High,Urban,Statutory Health Insurance,18.0,No,No,Hypertension,5.0
PT05392,Italy,Sicily,,Female,Prostate,II,2017-06-18,2017-10-29,2018-04-17,Immunotherapy,Private,Alive,10.0,None,No,Former,Moderate,36.7,Medium,Urban,Statutory Health Insurance,2.0,,No,Cardiovascular Disease,9.0
PT05393,Italy,Lombardy,79.0,Female,Colorectal,I,2016-01-06,2016-04-03,2016-07-24,Chemotherapy,Private,Alive,72.0,KRAS,No,,Moderate,23.3,Medium,,Statutory Health Insurance,16.0,No,No,Cardiovascular Disease,3.0
PT05394,Ireland,Munster,45.0,Female,Breast,III,2015-07-08,2015-08-18,2016-02-15,Chemotherapy,Private,Alive,43.0,EGFR,No,Never,Moderate,31.3,High,Rural,Private Insurance,9.0,Yes,No,Diabetes,9.0
PT05395,Finland,Southwest Finland,46.0,Male,,III,2011-03-27,2011-07-16,2011-11-26,Radiation,Public,Deceased,33.0,EGFR,No,Never,Moderate,18.4,Medium,Urban,Statutory Health Insurance,2.0,No,No,Diabetes,4.0
PT05396,Portugal,Algarve,57.0,Female,Prostate,,2011-06-18,2011-08-16,2012-03-09,Targeted Therapy,Private,Deceased,36.0,None,No,,Moderate,18.0,Low,Urban,Statutory Health Insurance,12.0,No,No,None,4.0
PT05397,Netherlands,North Holland,41.0,Female,Pancreatic,III,2017-12-25,2018-01-03,2018-06-04,Chemotherapy,Research Institute,Alive,63.0,KRAS,Yes,Current,None,33.0,Medium,Urban,Statutory Health Insurance,3.0,No,No,Cardiovascular Disease,4.0
PT05398,Switzerland,Geneva,45.0,Female,Ovarian,II,2023-03-12,2023-04-23,2023-11-03,Radiation,Private,Deceased,59.0,KRAS,No,Former,None,19.2,Low,Rural,Statutory Health Insurance,17.0,No,Yes,Obesity,3.0
PT05399,Belgium,,88.0,Female,Leukemia,II,2023-07-31,2023-08-18,2024-04-20,Surgery,Public,Deceased,22.0,BRCA1,No,Never,Heavy,22.7,Medium,Rural,NHS,11.0,No,No,Diabetes,9.0
PT05400,,,54.0,Female,Breast,II,2014-03-24,2014-05-09,2015-03-16,Surgery,Public,Alive,27.0,None,No,Former,None,38.7,Medium,Urban,NHS,,No,No,Hypertension,4.0
PT05401,Finland,Pirkanmaa,85.0,Female,Breast,I,2012-03-29,2012-07-30,2013-04-21,Chemotherapy,Public,Alive,69.0,KRAS,No,Former,Moderate,32.2,Low,Rural,Statutory Health Insurance,13.0,Yes,No,None,3.0
PT05402,Netherlands,Utrecht,70.0,Female,Pancreatic,I,2014-08-17,2015-02-09,2015-11-24,Immunotherapy,Private,Deceased,116.0,KRAS,No,Current,Moderate,,High,Rural,Statutory Health Insurance,11.0,No,No,Hypertension,2.0
PT05403,France,Provence-Alpes-Côte d'Azur,37.0,,Prostate,III,,2016-05-10,2016-09-21,Radiation,Private,Alive,18.0,None,No,Never,Heavy,32.8,Low,Urban,Private Insurance,9.0,No,No,Obesity,5.0
PT05404,Belgium,Flanders,62.0,,Colorectal,I,2014-01-12,2014-02-18,2014-09-06,Targeted Therapy,Public,Deceased,118.0,,No,Current,Heavy,39.9,High,Urban,Private Insurance,6.0,No,No,None,10.0
,Finland,Southwest Finland,31.0,Male,Pancreatic,I,2016-01-11,2016-03-25,2017-03-18,Radiation,Public,Alive,49.0,EGFR,Yes,Current,Moderate,27.6,High,Urban,Private Insurance,6.0,Yes,No,Diabetes,6.0
PT05406,Switzerland,Zurich,22.0,Male,Leukemia,IV,2010-09-03,2010-09-23,2010-12-26,Immunotherapy,Public,Alive,90.0,BRCA1,Yes,Never,None,29.2,High,Urban,Statutory Health Insurance,13.0,Yes,No,None,2.0
PT05407,Ireland,Dublin,26.0,Male,Lung,I,2012-03-25,2012-09-07,2012-12-12,Immunotherapy,Private,Alive,52.0,,Yes,Current,None,29.8,Medium,Urban,NHS,8.0,No,No,None,10.0
,Ireland,Connacht,25.0,Female,Colorectal,III,2018-07-12,2018-12-28,2019-06-17,Chemotherapy,Public,Alive,90.0,EGFR,Yes,Never,None,21.5,High,Rural,Private Insurance,1.0,No,,Obesity,1.0
PT05409,Norway,Vestland,64.0,Male,Breast,IV,2011-01-28,2011-05-20,2012-04-01,Immunotherapy,Public,Alive,11.0,EGFR,No,Never,Moderate,29.7,Low,Urban,Private Insurance,10.0,No,No,Cardiovascular Disease,7.0
PT05410,France,,58.0,Non-binary,Pancreatic,II,2021-08-29,2021-12-31,2022-08-13,Immunotherapy,Public,Alive,15.0,EGFR,No,Never,None,31.9,Low,Urban,NHS,8.0,No,,Diabetes,10.0
PT05411,Belgium,,70.0,Female,Colorectal,III,2022-06-28,2022-11-23,2023-06-28,Targeted Therapy,Private,Alive,63.0,BRCA1,Yes,Current,Moderate,28.8,Low,Urban,NHS,3.0,Yes,No,Hypertension,3.0
PT05412,France,Auvergne-Rhône-Alpes,28.0,Male,Lung,IV,2022-08-13,2023-01-11,2023-05-21,,Public,Deceased,45.0,KRAS,No,Never,None,28.1,Low,Rural,NHS,8.0,No,,Cardiovascular Disease,10.0
PT05413,Ireland,,42.0,Female,Ovarian,IV,2013-03-16,2013-05-05,2013-11-05,Surgery,Private,Alive,19.0,None,,Never,Heavy,22.8,Medium,Urban,Private Insurance,9.0,No,No,Hypertension,4.0
PT05414,France,Île-de-France,31.0,Male,Ovarian,II,2023-07-15,2023-11-25,2024-05-05,Immunotherapy,Public,Alive,28.0,None,No,Never,Moderate,30.8,Low,Rural,NHS,11.0,No,No,None,1.0
PT05415,Belgium,Flanders,,Non-binary,,II,2018-11-02,2019-01-14,2019-04-20,Surgery,Public,Alive,76.0,BRCA1,No,Never,None,30.1,Medium,Urban,,3.0,No,No,Obesity,8.0
PT05416,Norway,,59.0,Female,Ovarian,II,2017-01-06,2017-02-18,2017-10-17,Targeted Therapy,Public,Alive,93.0,BRCA1,No,Never,Moderate,38.4,Medium,Rural,NHS,17.0,No,No,Hypertension,7.0
PT05417,France,Auvergne-Rhône-Alpes,73.0,Male,Ovarian,III,,2016-05-08,2016-11-22,Chemotherapy,Public,Alive,20.0,None,,Never,None,26.1,Medium,Urban,Private Insurance,3.0,No,No,,3.0
PT05418,Austria,Tyrol,26.0,Female,Pancreatic,IV,2019-10-24,2020-02-06,2020-06-22,Surgery,Public,Lost to Follow-up,,None,Yes,Never,Moderate,33.4,Low,Urban,Statutory Health Insurance,16.0,Yes,No,None,6.0
PT05419,Portugal,Algarve,36.0,Female,Leukemia,III,2019-02-23,2019-03-31,2019-05-01,Chemotherapy,Public,Deceased,92.0,BRCA1,No,Never,Moderate,35.2,High,Urban,Private Insurance,5.0,No,No,Obesity,8.0
PT05420,Netherlands,Utrecht,69.0,Male,Lung,II,2016-06-01,2016-09-10,2016-11-21,Chemotherapy,Public,Alive,10.0,KRAS,Yes,Never,,35.4,Medium,Urban,NHS,4.0,No,Yes,Diabetes,3.0
PT05421,Poland,Silesian,43.0,,Lung,II,2016-06-19,2016-06-22,2016-11-27,Surgery,Public,Deceased,46.0,EGFR,,Former,Moderate,30.4,Medium,Rural,NHS,,Yes,No,Obesity,10.0
PT05422,Portugal,Lisbon,21.0,Female,Ovarian,II,2017-03-01,2017-04-06,2017-10-28,Radiation,Private,Alive,25.0,EGFR,No,Former,Heavy,31.7,Medium,Urban,NHS,10.0,No,No,Diabetes,4.0
PT05423,Austria,Tyrol,52.0,Male,Prostate,I,,2017-03-21,2018-01-25,Immunotherapy,Private,Alive,57.0,None,No,Never,None,35.6,High,Urban,NHS,18.0,No,No,None,6.0
PT05424,Italy,Veneto,40.0,Female,Breast,III,2013-02-16,2013-04-02,2013-07-30,Targeted Therapy,Public,Deceased,15.0,KRAS,No,Never,None,18.6,High,Urban,Private Insurance,6.0,No,No,Hypertension,5.0
PT05425,Finland,Uusimaa,72.0,Male,Prostate,I,2017-01-25,2017-05-05,2018-04-22,Chemotherapy,Public,Alive,,BRCA1,No,Former,Moderate,22.7,High,Urban,,8.0,No,No,Obesity,10.0
PT05426,Spain,Catalonia,65.0,Female,,II,2019-12-14,2020-05-19,2021-02-24,Radiation,Research Institute,Deceased,118.0,BRCA1,No,Former,Moderate,29.6,Medium,Urban,Private Insurance,3.0,,,Cardiovascular Disease,6.0
PT05427,Sweden,Skåne,64.0,Male,,III,2022-07-06,,2023-04-10,,Public,Deceased,32.0,KRAS,No,Former,None,,,Urban,Statutory Health Insurance,8.0,No,No,Cardiovascular Disease,
PT05428,France,Auvergne-Rhône-Alpes,28.0,Non-binary,Prostate,I,2023-03-17,2023-07-31,,Radiation,Research Institute,Deceased,56.0,BRCA1,No,Current,Moderate,22.0,Low,Urban,NHS,1.0,No,No,,3.0
PT05429,Germany,North Rhine-Westphalia,,Female,Breast,IV,2011-08-11,2011-10-23,2012-06-13,Targeted Therapy,Private,Deceased,112.0,BRCA1,Yes,Never,Moderate,37.1,High,Urban,Private Insurance,11.0,No,No,None,
PT05430,Portugal,Algarve,70.0,Male,Breast,I,2013-04-04,2013-09-01,2013-11-25,Radiation,Public,Deceased,115.0,None,Yes,Never,Moderate,,Medium,Urban,Private Insurance,3.0,No,No,None,2.0
PT05431,Spain,Andalusia,54.0,Male,Lung,IV,2022-07-12,2022-09-19,2022-12-16,Targeted Therapy,Research Institute,Deceased,65.0,EGFR,Yes,Former,Moderate,26.3,Low,Urban,NHS,19.0,Yes,No,Obesity,
PT05432,Ireland,Dublin,72.0,Male,Pancreatic,II,2010-03-02,2010-08-21,2011-05-07,Immunotherapy,Public,Alive,100.0,EGFR,No,Never,Moderate,21.3,Low,Urban,Private Insurance,15.0,No,Yes,None,4.0
PT05433,Netherlands,South Holland,,Female,Prostate,I,2015-01-15,2015-07-03,,Radiation,Public,Alive,11.0,None,No,Never,None,30.3,High,Rural,Statutory Health Insurance,4.0,No,No,Obesity,3.0
PT05434,Austria,Tyrol,,Male,Leukemia,,2013-07-26,2014-01-06,2014-03-30,Chemotherapy,Public,Alive,117.0,None,No,Never,Moderate,35.3,Medium,Rural,NHS,4.0,No,,Hypertension,4.0
PT05435,France,Île-de-France,44.0,Female,Lung,,2022-10-28,2023-04-04,2024-01-09,Immunotherapy,Private,Deceased,82.0,None,No,Former,Moderate,24.9,,Urban,Private Insurance,13.0,Yes,No,None,3.0
PT05436,France,Île-de-France,,Female,Ovarian,II,2021-10-14,2021-12-02,2022-02-16,,Public,Lost to Follow-up,,None,No,Former,None,28.9,Low,Urban,Statutory Health Insurance,10.0,No,No,Diabetes,8.0
PT05437,Netherlands,South Holland,36.0,Female,Colorectal,III,2010-02-06,2010-05-26,2010-11-17,Chemotherapy,Public,Deceased,,None,No,Never,None,21.9,High,Rural,Private Insurance,15.0,No,No,None,10.0
PT05438,Portugal,Porto,55.0,Male,Prostate,IV,,2013-06-30,2014-02-23,Immunotherapy,Private,Alive,21.0,EGFR,No,Former,None,23.7,Low,Urban,Private Insurance,6.0,No,No,Hypertension,1.0
PT05439,Sweden,Stockholm,40.0,Male,Prostate,I,2023-03-24,2023-04-10,2023-06-24,Immunotherapy,Public,Alive,22.0,BRCA1,No,Never,None,,Medium,Rural,NHS,17.0,No,No,Hypertension,10.0
PT05440,France,Provence-Alpes-Côte d'Azur,37.0,Male,Lung,III,2018-02-07,2018-07-15,2018-12-09,Targeted Therapy,Public,Deceased,51.0,EGFR,No,Former,Moderate,39.3,Medium,Rural,Private Insurance,1.0,No,No,Hypertension,7.0
PT05441,Austria,,79.0,Female,Pancreatic,I,2013-11-21,2014-03-25,2014-11-26,Radiation,Public,Alive,116.0,EGFR,No,Former,Moderate,31.5,Medium,Urban,,,No,Yes,None,2.0
PT05442,Norway,Oslo,37.0,Female,Prostate,II,2019-02-06,2019-02-10,2019-07-11,Targeted Therapy,Private,Alive,100.0,KRAS,Yes,Never,Moderate,31.9,High,Urban,Statutory Health Insurance,5.0,No,Yes,Cardiovascular Disease,3.0
PT05443,France,Auvergne-Rhône-Alpes,20.0,Female,,I,2011-05-22,2011-11-01,,Surgery,Research Institute,Deceased,15.0,BRCA1,,Never,None,37.4,Medium,Rural,Statutory Health Insurance,2.0,No,No,Cardiovascular Disease,8.0
PT05444,Switzerland,Geneva,33.0,Male,,II,2014-06-03,2014-08-26,2014-10-12,Surgery,Private,,,None,No,Former,,,High,Urban,NHS,18.0,No,No,Diabetes,2.0
PT05445,Norway,Oslo,27.0,Female,Pancreatic,I,2013-06-21,2013-11-13,2014-10-13,Targeted Therapy,Public,Alive,36.0,KRAS,No,Never,None,35.9,Low,Urban,NHS,15.0,No,No,None,2.0
PT05446,Germany,Bavaria,,Male,Colorectal,II,2023-06-27,2023-11-09,2024-06-18,Targeted Therapy,Public,Alive,64.0,BRCA1,Yes,Current,Moderate,36.9,Medium,Urban,Private Insurance,6.0,Yes,No,Diabetes,5.0
,Sweden,Skåne,70.0,Male,Leukemia,II,2012-08-30,2012-12-11,,,Public,Alive,44.0,KRAS,No,Former,None,33.3,,Urban,NHS,1.0,No,No,Diabetes,3.0
PT05448,Norway,Oslo,79.0,Female,Colorectal,III,2011-03-26,2011-07-21,2011-11-24,Immunotherapy,Private,Lost to Follow-up,,None,No,Former,Moderate,18.8,Low,Urban,Statutory Health Insurance,15.0,No,Yes,Hypertension,
PT05449,Spain,Andalusia,53.0,Male,Ovarian,III,2021-07-17,2021-09-17,2022-03-18,Surgery,Private,Alive,111.0,KRAS,No,Former,None,38.4,High,Urban,Statutory Health Insurance,19.0,No,No,Diabetes,5.0
PT05450,Poland,Masovian,55.0,Female,Leukemia,II,2019-04-04,2019-06-01,2020-04-06,Immunotherapy,Public,Deceased,11.0,KRAS,Yes,Never,None,31.0,High,Rural,Private Insurance,11.0,No,No,Hypertension,
PT05451,Portugal,Algarve,81.0,Female,Colorectal,I,2022-12-13,2023-06-03,2023-08-06,Chemotherapy,Public,Alive,115.0,EGFR,Yes,Never,Heavy,22.9,Medium,Rural,NHS,17.0,No,No,None,7.0
PT05452,Germany,North Rhine-Westphalia,20.0,Female,Leukemia,IV,2010-07-31,,2011-02-10,Chemotherapy,Public,Deceased,89.0,None,No,,Moderate,28.7,Low,Urban,NHS,9.0,No,No,Obesity,8.0
PT05453,Italy,Veneto,61.0,Male,Pancreatic,II,2016-05-20,2016-09-03,2017-06-29,Immunotherapy,Private,Alive,54.0,None,Yes,Current,Heavy,30.5,Low,Rural,NHS,2.0,No,No,Diabetes,5.0
PT05454,Spain,Madrid,20.0,Male,Colorectal,I,2019-11-11,2020-01-22,2020-08-01,Chemotherapy,Research Institute,Alive,110.0,EGFR,No,,Moderate,19.8,Low,,Statutory Health Insurance,19.0,No,No,Hypertension,2.0
PT05455,Norway,Vestland,73.0,Male,Colorectal,II,,2013-04-16,2013-06-18,Surgery,Public,Alive,26.0,EGFR,No,Never,Moderate,31.0,Medium,Rural,Private Insurance,17.0,No,No,Obesity,9.0
PT05456,Poland,Lesser Poland,66.0,Male,Lung,III,2013-12-17,2013-12-23,2014-01-28,Surgery,Private,Alive,,BRCA1,No,Current,Heavy,31.6,Medium,Rural,Statutory Health Insurance,5.0,No,No,Obesity,5.0
PT05457,Austria,Styria,58.0,Non-binary,Colorectal,I,2018-04-05,,2019-01-06,Chemotherapy,Public,Alive,30.0,None,Yes,Former,Moderate,35.5,Low,Urban,NHS,5.0,No,No,Diabetes,6.0
PT05458,Netherlands,Utrecht,49.0,Female,Leukemia,I,2014-03-13,2014-06-07,2015-01-10,Surgery,Public,Alive,44.0,KRAS,No,Former,None,38.3,High,Rural,Statutory Health Insurance,,No,No,Cardiovascular Disease,3.0
PT05459,Portugal,Porto,26.0,Male,,III,2018-02-01,2018-05-23,,Chemotherapy,Public,Alive,,KRAS,No,Former,Moderate,28.2,Medium,Urban,Private Insurance,5.0,No,No,,7.0
,Italy,Veneto,41.0,Female,Leukemia,II,2015-01-08,2015-06-05,2016-03-29,Radiation,Public,Deceased,112.0,BRCA1,Yes,Former,None,24.1,Low,Urban,Private Insurance,2.0,Yes,No,Cardiovascular Disease,10.0
PT05461,Norway,Vestland,69.0,Female,Colorectal,II,2016-08-04,2016-10-07,2017-07-23,,Public,Alive,39.0,None,No,Current,Heavy,32.9,Medium,Urban,Private Insurance,19.0,No,No,Cardiovascular Disease,4.0
PT05462,Spain,Catalonia,64.0,Male,Colorectal,IV,2019-01-19,,2019-09-08,Immunotherapy,Public,,77.0,BRCA1,Yes,Never,None,21.3,High,,NHS,11.0,No,No,Hypertension,1.0
PT05463,Sweden,Stockholm,29.0,Male,Leukemia,,2022-12-25,2023-05-09,2023-09-23,Chemotherapy,,Alive,19.0,EGFR,Yes,Former,Moderate,20.2,Low,Urban,Private Insurance,2.0,No,No,None,6.0
PT05464,,Provence-Alpes-Côte d'Azur,33.0,Male,Pancreatic,III,2013-09-18,2014-01-14,2014-07-03,Radiation,Public,Deceased,62.0,KRAS,Yes,Current,None,35.2,Medium,Urban,Private Insurance,6.0,No,No,None,10.0
PT05465,Norway,Vestland,65.0,Non-binary,Pancreatic,II,2016-03-03,2016-03-27,2016-11-26,Radiation,Public,Alive,54.0,KRAS,,Current,None,37.0,High,Rural,Statutory Health Insurance,16.0,Yes,No,Hypertension,1.0
PT05466,Belgium,,25.0,Female,Ovarian,I,2020-12-11,2021-04-13,2021-06-14,Surgery,Public,,92.0,EGFR,Yes,Current,None,35.9,Low,Urban,Private Insurance,10.0,Yes,No,Hypertension,1.0
PT05467,Denmark,Capital Region,40.0,Female,Pancreatic,I,2015-11-07,2015-11-15,2016-01-06,Immunotherapy,,Deceased,81.0,EGFR,No,Former,None,37.6,Medium,Urban,Statutory Health Insurance,8.0,No,No,Cardiovascular Disease,5.0
PT05468,Belgium,Brussels,81.0,Male,Prostate,III,2012-07-24,2012-09-29,2013-01-03,Immunotherapy,Public,Alive,89.0,EGFR,No,Current,None,24.1,Low,Urban,Private Insurance,17.0,No,No,None,9.0
PT05469,Switzerland,Zurich,38.0,Female,Lung,I,2013-01-27,2013-02-07,2013-08-15,Radiation,Public,Alive,65.0,BRCA1,Yes,Never,None,31.8,Low,,Statutory Health Insurance,13.0,Yes,Yes,Cardiovascular Disease,2.0
PT05470,Ireland,Connacht,81.0,Male,Lung,II,2014-02-18,2014-05-29,2014-06-30,Radiation,Research Institute,Alive,93.0,KRAS,No,Never,None,31.5,Medium,Urban,Statutory Health Insurance,5.0,No,Yes,None,9.0
PT05471,Denmark,Capital Region,72.0,Non-binary,Pancreatic,IV,2011-12-12,2012-02-16,2012-07-18,Immunotherapy,Public,Deceased,82.0,BRCA1,Yes,Never,Moderate,19.0,Low,Urban,,6.0,No,,Diabetes,10.0
PT05472,Spain,Catalonia,43.0,Female,Colorectal,III,2012-09-20,2013-01-27,2014-01-03,Surgery,Public,Alive,38.0,KRAS,No,Never,Moderate,18.6,Medium,Urban,NHS,2.0,No,No,Diabetes,9.0
PT05473,Poland,Lesser Poland,75.0,,Lung,II,2010-02-24,2010-03-03,2010-10-14,Targeted Therapy,Public,Alive,39.0,EGFR,Yes,Former,Moderate,37.3,Medium,Urban,NHS,4.0,Yes,No,None,3.0
PT05474,Portugal,Algarve,81.0,Female,Leukemia,I,2014-06-29,2014-07-23,,Surgery,Public,Alive,37.0,BRCA1,Yes,Never,Moderate,18.4,Medium,Urban,Statutory Health Insurance,10.0,No,No,Diabetes,8.0
PT05475,Belgium,Wallonia,53.0,Female,Colorectal,II,2016-06-19,2016-11-06,2017-01-06,Targeted Therapy,Public,,,KRAS,No,Current,Moderate,34.1,High,Urban,Statutory Health Insurance,11.0,No,No,Hypertension,10.0
PT05476,Portugal,Porto,41.0,Female,Lung,II,2018-09-11,2018-11-13,2019-05-06,Immunotherapy,Private,Alive,111.0,KRAS,,Never,None,27.4,Medium,,Statutory Health Insurance,10.0,Yes,No,Obesity,1.0
PT05477,Denmark,Capital Region,87.0,Male,Breast,IV,2014-10-23,2015-01-03,2015-04-15,,,,60.0,BRCA1,Yes,Current,Moderate,18.9,High,Rural,Statutory Health Insurance,2.0,No,No,Obesity,3.0
PT05478,Poland,Lesser Poland,76.0,Male,Lung,,2012-02-15,2012-07-05,2013-04-21,Immunotherapy,Private,Deceased,34.0,KRAS,Yes,Former,None,36.7,Medium,Urban,,8.0,No,No,Diabetes,8.0
PT05479,Switzerland,Geneva,29.0,Female,Pancreatic,II,2010-12-22,2011-03-20,2012-01-20,Chemotherapy,Public,Alive,32.0,BRCA1,No,Never,Heavy,26.6,Medium,Urban,NHS,17.0,No,No,Hypertension,7.0
PT05480,,Zurich,85.0,Female,Leukemia,I,2019-06-13,2019-10-07,2020-07-21,Chemotherapy,Public,Alive,107.0,BRCA1,No,Never,Moderate,34.2,Low,Urban,Private Insurance,1.0,No,No,Obesity,10.0
PT05481,Spain,Catalonia,27.0,Male,Lung,IV,2017-07-05,2017-07-29,2018-04-15,Chemotherapy,Public,Alive,82.0,EGFR,No,Former,Heavy,,Medium,Urban,NHS,5.0,Yes,No,Hypertension,2.0
PT05482,Switzerland,Geneva,57.0,Female,Ovarian,III,2011-07-18,2011-08-25,2012-04-05,Immunotherapy,Public,Alive,118.0,None,Yes,Current,Moderate,37.1,Medium,Urban,Statutory Health Insurance,8.0,No,No,None,9.0
PT05483,Spain,Andalusia,81.0,Male,Prostate,II,2016-07-22,2016-08-01,2017-06-19,Radiation,Public,Alive,91.0,EGFR,Yes,Former,None,29.0,High,Urban,Private Insurance,8.0,No,No,Cardiovascular Disease,1.0
PT05484,Spain,Andalusia,47.0,Female,Pancreatic,II,2017-12-02,2018-05-09,2019-01-29,Immunotherapy,Research Institute,Deceased,76.0,EGFR,Yes,Current,Moderate,34.6,Medium,Urban,NHS,14.0,No,No,None,5.0
PT05485,Sweden,,29.0,Male,Ovarian,II,2023-09-27,2023-12-24,2024-11-08,,Public,Alive,76.0,EGFR,No,Former,Moderate,31.2,High,Urban,NHS,14.0,No,No,Obesity,10.0
PT05486,Sweden,Västra Götaland,64.0,Male,Ovarian,IV,2014-03-07,2014-04-03,2014-06-04,Surgery,,Alive,98.0,BRCA1,Yes,Never,Moderate,35.2,Low,Urban,Statutory Health Insurance,15.0,Yes,No,Hypertension,7.0
PT05487,Norway,,84.0,Female,Prostate,I,2021-04-13,2021-05-13,2021-12-10,Targeted Therapy,Public,Alive,109.0,BRCA1,No,Former,None,20.4,,Urban,Statutory Health Insurance,19.0,Yes,No,Cardiovascular Disease,3.0
PT05488,Ireland,Connacht,86.0,,Colorectal,III,2021-06-19,2021-10-25,2022-08-09,Surgery,Public,Deceased,19.0,EGFR,No,Former,Moderate,25.8,High,Urban,NHS,9.0,No,No,Diabetes,9.0
PT05489,Italy,Lombardy,28.0,Female,Prostate,I,2016-07-04,,2017-05-22,,Private,Alive,7.0,BRCA1,No,Former,None,,Medium,,Private Insurance,15.0,Yes,Yes,Hypertension,5.0
PT05490,Netherlands,South Holland,24.0,Female,Leukemia,IV,2014-04-11,2014-04-13,2014-10-05,Surgery,Public,Alive,12.0,EGFR,Yes,Never,Moderate,20.5,High,Urban,NHS,12.0,No,No,Hypertension,
PT05491,Germany,Berlin,,Male,Breast,II,2018-04-08,2018-04-16,2018-09-23,Radiation,Public,Alive,86.0,KRAS,Yes,Former,Moderate,37.7,High,Urban,Private Insurance,13.0,Yes,No,None,7.0
PT05492,Spain,Madrid,31.0,Male,Breast,I,2022-11-11,2023-04-05,2023-08-05,Surgery,Private,Alive,38.0,EGFR,No,Current,None,23.9,Low,,Statutory Health Insurance,8.0,No,No,,2.0
PT05493,Portugal,Algarve,77.0,Female,Colorectal,I,2022-02-24,2022-04-13,2022-09-22,Immunotherapy,Public,Alive,27.0,KRAS,Yes,Current,None,35.1,Medium,Urban,NHS,8.0,No,No,Diabetes,8.0
PT05494,Netherlands,Utrecht,40.0,Male,Colorectal,II,2018-01-23,,2018-05-05,Targeted Therapy,Public,Lost to Follow-up,,None,No,Never,None,28.7,Low,Urban,Private Insurance,16.0,No,No,Obesity,9.0
PT05495,Spain,Andalusia,,Female,Prostate,I,2020-12-05,2021-04-25,2021-12-14,Chemotherapy,Private,Alive,19.0,KRAS,No,Former,None,37.5,High,Urban,NHS,17.0,No,No,Hypertension,3.0
PT05496,Netherlands,North Holland,84.0,Female,,III,2011-06-26,2011-11-22,2012-01-06,Radiation,Public,Alive,59.0,BRCA1,No,Current,Moderate,34.1,Low,Urban,Statutory Health Insurance,14.0,No,No,Cardiovascular Disease,5.0
PT05497,Netherlands,Utrecht,22.0,Female,Leukemia,I,2017-01-17,2017-05-04,2017-08-14,,Public,Alive,6.0,EGFR,Yes,Former,Moderate,34.7,Low,Urban,Statutory Health Insurance,11.0,No,No,Obesity,5.0
PT05498,Switzerland,Geneva,88.0,Female,Prostate,I,2013-02-27,2013-07-07,2014-01-30,Radiation,Public,Alive,77.0,KRAS,No,Never,,28.7,High,Urban,Private Insurance,10.0,No,No,Cardiovascular Disease,1.0
PT05499,Denmark,Zealand,83.0,Male,Leukemia,II,2019-10-30,2020-03-05,2020-12-05,Chemotherapy,Private,Lost to Follow-up,,EGFR,No,Former,Moderate,26.6,Medium,Urban,Private Insurance,8.0,No,,Diabetes,10.0
,Netherlands,,68.0,Female,Leukemia,II,2014-10-13,2015-01-05,2015-08-07,Chemotherapy,Public,Alive,,KRAS,Yes,Current,,28.3,Medium,,NHS,15.0,No,No,Diabetes,2.0
PT05501,France,Auvergne-Rhône-Alpes,36.0,Non-binary,Breast,II,2013-03-18,2013-08-16,2013-11-10,Chemotherapy,Private,Deceased,13.0,BRCA1,No,Former,None,,Low,Urban,NHS,4.0,No,No,Cardiovascular Disease,4.0
PT05502,Ireland,Munster,51.0,Male,,II,2013-07-23,2013-08-08,2013-12-01,Chemotherapy,Private,Alive,34.0,BRCA1,No,Former,Moderate,19.3,Medium,Urban,Statutory Health Insurance,12.0,Yes,No,None,8.0
PT05503,Ireland,,89.0,Non-binary,Leukemia,II,2020-03-21,2020-08-09,2020-09-24,Chemotherapy,Private,Alive,86.0,BRCA1,No,,None,20.3,Medium,Rural,NHS,4.0,No,No,Hypertension,6.0
PT05504,Portugal,Algarve,40.0,Female,Lung,II,2018-12-12,2019-04-23,2020-04-07,Immunotherapy,Research Institute,Alive,96.0,None,Yes,Former,Moderate,24.4,Medium,Rural,Private Insurance,1.0,No,Yes,Cardiovascular Disease,3.0
PT05505,Spain,Madrid,26.0,Male,Leukemia,I,2022-05-02,,2023-04-11,Surgery,Private,Alive,50.0,KRAS,No,Never,Heavy,27.1,Low,Rural,NHS,15.0,No,No,Cardiovascular Disease,2.0
PT05506,Poland,Masovian,26.0,Male,Breast,,2023-08-19,2023-12-11,2024-07-18,Chemotherapy,,Alive,13.0,EGFR,No,Current,Moderate,19.5,High,Urban,NHS,7.0,No,Yes,None,5.0
PT05507,France,Île-de-France,46.0,Female,Pancreatic,I,2010-03-12,2010-05-16,2010-12-26,Targeted Therapy,Private,Alive,,BRCA1,No,Never,Heavy,28.6,Medium,Urban,Private Insurance,1.0,No,No,Hypertension,8.0
PT05508,Finland,Southwest Finland,,Male,Prostate,III,2013-05-07,2013-06-02,2013-07-06,Targeted Therapy,Private,Alive,56.0,KRAS,No,Never,Heavy,30.8,Medium,Urban,Statutory Health Insurance,5.0,No,No,Hypertension,3.0
PT05509,Germany,Berlin,47.0,Male,Leukemia,II,2022-09-15,2022-10-15,2023-05-07,Chemotherapy,Public,Lost to Follow-up,,EGFR,Yes,Never,None,39.1,Medium,Urban,NHS,14.0,No,No,Cardiovascular Disease,2.0
PT05510,Denmark,Zealand,85.0,Male,Lung,II,2023-06-16,2023-10-12,2024-03-21,Radiation,Private,Alive,113.0,None,Yes,Never,Moderate,20.3,High,Urban,Statutory Health Insurance,16.0,No,No,None,2.0
PT05511,Denmark,Central Denmark,66.0,Male,Colorectal,III,2011-08-25,,2012-01-27,Chemotherapy,Public,Alive,99.0,KRAS,Yes,Never,Moderate,35.8,Medium,Urban,Statutory Health Insurance,7.0,No,No,Cardiovascular Disease,9.0
PT05512,Denmark,Central Denmark,29.0,Male,Prostate,II,2014-01-28,2014-06-25,2015-01-23,Immunotherapy,Private,Alive,28.0,EGFR,No,Never,Moderate,34.1,Low,Urban,Statutory Health Insurance,10.0,No,No,Obesity,10.0
PT05513,Poland,Silesian,52.0,Female,Colorectal,II,,2018-09-22,,Surgery,Private,Alive,84.0,KRAS,No,Former,Moderate,34.4,High,Urban,NHS,11.0,No,Yes,Diabetes,5.0
PT05514,Italy,Sicily,26.0,Male,Lung,I,2023-08-21,2023-12-24,2024-05-11,Targeted Therapy,Private,Alive,65.0,KRAS,Yes,Former,None,36.6,Medium,Urban,Private Insurance,2.0,No,No,Obesity,4.0
PT05515,Italy,Lombardy,22.0,Non-binary,,III,2017-12-04,2018-01-25,2018-04-30,Chemotherapy,Private,Alive,46.0,KRAS,No,Never,Moderate,39.2,,Rural,NHS,7.0,Yes,Yes,Diabetes,9.0
PT05516,Portugal,Lisbon,33.0,Male,Pancreatic,III,2014-12-17,2015-03-10,2015-07-17,,Private,Lost to Follow-up,,,No,Never,None,32.1,Medium,Urban,Private Insurance,10.0,No,No,Hypertension,7.0
PT05517,Spain,Madrid,63.0,Male,Ovarian,III,2023-10-27,2024-01-26,2025-01-16,Surgery,Public,Alive,19.0,KRAS,No,Never,None,37.5,High,Urban,Statutory Health Insurance,5.0,No,No,Hypertension,6.0
PT05518,Poland,Masovian,65.0,Male,Breast,IV,2014-11-08,2015-03-26,2015-12-08,Chemotherapy,Private,,32.0,KRAS,No,Current,None,20.8,Medium,Urban,Statutory Health Insurance,14.0,No,Yes,Cardiovascular Disease,7.0
PT05519,Ireland,Dublin,80.0,Male,Pancreatic,III,2010-01-01,2010-06-19,2011-03-07,Surgery,Research Institute,Alive,72.0,EGFR,Yes,Never,None,23.2,Medium,Rural,Statutory Health Insurance,4.0,No,No,Diabetes,3.0
,Netherlands,South Holland,55.0,Male,Ovarian,III,2022-09-19,2022-11-19,2023-08-10,Targeted Therapy,Private,Alive,17.0,KRAS,No,,None,26.3,Medium,Rural,Statutory Health Insurance,1.0,,No,Hypertension,3.0
PT05521,Netherlands,South Holland,32.0,Female,Prostate,II,2023-11-12,2024-03-02,2024-12-20,Chemotherapy,Private,,112.0,None,Yes,Former,Moderate,19.7,Medium,Urban,Private Insurance,18.0,Yes,No,Obesity,1.0
PT05522,Switzerland,Bern,35.0,Female,Leukemia,II,2015-12-22,2015-12-24,2016-02-27,Radiation,Research Institute,Lost to Follow-up,,BRCA1,No,Never,Moderate,22.9,Medium,Urban,Statutory Health Insurance,6.0,No,No,Obesity,10.0
PT05523,Sweden,Västra Götaland,24.0,Male,Leukemia,IV,2019-02-06,2019-04-28,2020-02-19,,Public,Deceased,72.0,,No,Current,None,39.6,High,Rural,NHS,13.0,No,No,,2.0
PT05524,Italy,Sicily,57.0,Male,,IV,2023-08-05,2023-12-18,2024-06-20,Targeted Therapy,Public,Alive,45.0,KRAS,No,Never,Moderate,,Medium,Urban,NHS,12.0,No,No,Diabetes,10.0
PT05525,France,,69.0,Male,Breast,II,2017-08-09,2017-10-08,2017-11-08,Chemotherapy,Research Institute,Deceased,70.0,KRAS,No,Never,None,33.8,Medium,Rural,Private Insurance,8.0,No,No,Cardiovascular Disease,4.0
PT05526,Denmark,Zealand,57.0,Female,Leukemia,II,2022-08-22,2022-11-10,2023-02-25,Chemotherapy,Private,Alive,,EGFR,Yes,Never,Moderate,29.8,High,Urban,NHS,12.0,No,No,Obesity,7.0
PT05527,Netherlands,North Holland,75.0,Female,Pancreatic,IV,2012-06-27,2012-10-18,2013-04-12,Chemotherapy,Public,,23.0,None,Yes,Former,Moderate,23.0,Low,Urban,Private Insurance,3.0,No,No,Diabetes,5.0
PT05528,Switzerland,Bern,82.0,Male,Ovarian,II,2015-04-07,2015-05-04,,Immunotherapy,Public,,,,No,Never,None,20.7,Medium,Rural,Private Insurance,2.0,,,Hypertension,3.0
PT05529,Belgium,Brussels,67.0,Male,Leukemia,I,2015-06-10,2015-06-11,,Immunotherapy,Private,Alive,64.0,BRCA1,No,Former,None,29.5,High,Rural,Private Insurance,7.0,No,No,Diabetes,4.0
PT05530,Belgium,Flanders,78.0,Female,Breast,III,2021-01-25,2021-04-21,2021-11-16,Targeted Therapy,Private,Deceased,17.0,BRCA1,Yes,Never,Moderate,32.5,Medium,Urban,Statutory Health Insurance,,No,No,None,5.0
PT05531,Spain,Madrid,63.0,Male,Breast,I,2015-01-12,2015-06-16,,Surgery,,Deceased,22.0,,No,Former,Moderate,30.4,High,Rural,NHS,3.0,No,No,Hypertension,5.0
PT05532,Finland,Uusimaa,74.0,Female,Lung,II,2019-12-21,,2020-11-19,Chemotherapy,Public,Alive,27.0,EGFR,Yes,Never,Moderate,28.1,Medium,Rural,Private Insurance,6.0,Yes,Yes,Cardiovascular Disease,
PT05533,Belgium,Wallonia,74.0,Male,Ovarian,III,2011-05-16,2011-07-15,2012-06-06,Chemotherapy,Private,Alive,111.0,KRAS,Yes,Never,Moderate,18.5,Medium,Rural,NHS,5.0,No,No,Diabetes,7.0
PT05534,Norway,Vestland,20.0,Female,Colorectal,I,2014-12-28,2015-02-19,2015-12-08,,Research Institute,Alive,19.0,KRAS,Yes,Former,Moderate,31.2,Medium,Urban,NHS,8.0,No,No,None,6.0
PT05535,Netherlands,North Holland,27.0,Non-binary,Ovarian,IV,,2013-09-29,2014-08-22,Radiation,Private,Alive,46.0,EGFR,No,Never,Heavy,29.5,Medium,Urban,NHS,7.0,No,Yes,Cardiovascular Disease,6.0
PT05536,Poland,Lesser Poland,23.0,Non-binary,Breast,,2021-11-25,2022-04-26,2022-11-26,Immunotherapy,Private,Alive,13.0,KRAS,Yes,Never,Moderate,24.2,Low,Rural,Statutory Health Insurance,8.0,Yes,No,Diabetes,
PT05537,Spain,Catalonia,72.0,Female,Ovarian,III,2018-01-31,2018-03-07,2019-01-02,Surgery,Public,Alive,22.0,None,No,Never,None,35.5,Low,Rural,Private Insurance,16.0,No,No,Cardiovascular Disease,8.0
PT05538,Italy,Lombardy,,,Lung,IV,2014-06-15,2014-07-18,2014-12-09,Chemotherapy,Public,Alive,84.0,EGFR,Yes,Former,Moderate,33.2,Low,Rural,Private Insurance,5.0,No,No,Diabetes,8.0
PT05539,Ireland,Connacht,56.0,Female,Ovarian,II,2013-05-12,2013-10-04,2014-08-29,Chemotherapy,Public,Alive,11.0,EGFR,No,Former,None,39.4,Low,Urban,Statutory Health Insurance,9.0,No,No,None,10.0
PT05540,Finland,Uusimaa,68.0,Male,Breast,II,2015-08-18,2015-10-26,2016-01-01,Targeted Therapy,Public,Alive,76.0,None,No,Current,None,29.0,Low,Rural,Statutory Health Insurance,4.0,,No,,7.0
PT05541,Belgium,Flanders,86.0,Non-binary,Prostate,III,2015-11-26,2016-05-07,2017-02-16,Radiation,Public,Alive,,BRCA1,No,Former,Moderate,,Low,Rural,,7.0,Yes,,Obesity,1.0
PT05542,Germany,North Rhine-Westphalia,38.0,Female,Pancreatic,II,2015-02-21,2015-06-08,2016-02-26,Targeted Therapy,,Alive,101.0,None,Yes,Never,None,38.4,Low,Urban,Statutory Health Insurance,2.0,No,No,Obesity,7.0
PT05543,Poland,Silesian,20.0,Male,Pancreatic,II,2021-02-13,2021-08-07,2022-07-03,Radiation,Public,Alive,117.0,KRAS,No,Never,Moderate,28.1,Medium,Rural,Statutory Health Insurance,5.0,No,Yes,Diabetes,1.0
PT05544,Switzerland,Bern,48.0,Male,Prostate,III,2017-11-04,2018-02-10,2018-11-09,Radiation,Research Institute,Lost to Follow-up,,KRAS,No,Never,Moderate,,Medium,Rural,Private Insurance,11.0,Yes,No,Cardiovascular Disease,10.0
PT05545,Sweden,Stockholm,52.0,Female,Prostate,III,2017-01-14,2017-04-20,2017-10-24,,Public,Alive,48.0,None,Yes,Never,Moderate,29.1,Medium,Urban,Private Insurance,4.0,No,No,,2.0
PT05546,Poland,Masovian,71.0,Non-binary,Breast,III,2013-10-28,2014-01-25,2014-09-23,Radiation,,,14.0,EGFR,No,Never,Moderate,27.2,High,Urban,NHS,1.0,No,No,Obesity,1.0
PT05547,Portugal,Algarve,60.0,Female,Leukemia,III,,2022-06-07,2023-04-23,Targeted Therapy,Public,Alive,,BRCA1,No,Never,Heavy,,Low,Urban,Statutory Health Insurance,11.0,No,No,Cardiovascular Disease,4.0
PT05548,Sweden,Västra Götaland,42.0,Male,Leukemia,III,,2021-11-18,2022-02-16,Chemotherapy,Public,Deceased,47.0,BRCA1,Yes,Former,None,20.7,Low,Urban,,8.0,No,Yes,Cardiovascular Disease,1.0
PT05549,Finland,Uusimaa,24.0,Male,Prostate,III,2018-02-17,2018-07-17,2018-12-26,Chemotherapy,Private,Alive,50.0,,Yes,Former,Moderate,20.5,Medium,,NHS,14.0,Yes,No,Hypertension,3.0
PT05550,Denmark,Central Denmark,76.0,Male,Colorectal,II,2023-12-29,2024-01-25,2024-06-11,Targeted Therapy,Public,Alive,44.0,None,Yes,Former,Moderate,,Medium,,,18.0,No,No,Obesity,1.0
PT05551,Belgium,Flanders,25.0,Female,Pancreatic,I,2019-10-30,2020-02-19,2021-02-16,,Private,Lost to Follow-up,,BRCA1,No,Current,Moderate,29.7,Low,,NHS,13.0,No,No,Obesity,10.0
PT05552,Sweden,Skåne,68.0,Non-binary,Lung,III,2015-03-07,2015-06-05,2016-04-26,Surgery,,Alive,71.0,KRAS,No,Current,None,39.7,Low,Urban,Statutory Health Insurance,11.0,No,No,Hypertension,9.0
PT05553,Denmark,Capital Region,41.0,,Prostate,I,2013-06-27,2013-07-12,2014-05-21,Radiation,Private,Alive,69.0,None,Yes,Never,Moderate,27.6,Low,Rural,Private Insurance,5.0,No,Yes,Hypertension,6.0
PT05554,France,Auvergne-Rhône-Alpes,23.0,,Pancreatic,IV,2016-02-24,2016-08-06,2017-01-20,Targeted Therapy,Public,Deceased,87.0,KRAS,No,Former,Moderate,21.5,Medium,Rural,NHS,13.0,No,Yes,,2.0
PT05555,Switzerland,Bern,83.0,Female,Lung,III,2020-02-28,2020-06-16,2020-11-10,Radiation,Private,Alive,66.0,KRAS,Yes,Never,Moderate,24.2,Medium,Urban,NHS,18.0,No,No,Diabetes,10.0
PT05556,Germany,Berlin,56.0,Female,Ovarian,III,2010-02-06,2010-03-19,2010-08-20,Radiation,Public,Alive,43.0,EGFR,No,Former,,35.6,Medium,Rural,NHS,1.0,Yes,No,Diabetes,5.0
PT05557,Norway,Oslo,50.0,Female,Lung,IV,2018-01-19,2018-07-11,2019-02-05,Radiation,Private,Deceased,71.0,None,Yes,Former,None,36.1,High,,NHS,4.0,No,No,Hypertension,7.0
PT05558,Austria,Tyrol,56.0,Female,Prostate,III,2011-02-25,2011-08-15,2012-04-22,Targeted Therapy,Private,Deceased,84.0,EGFR,No,Never,Moderate,20.6,Medium,,Private Insurance,12.0,No,No,Hypertension,8.0
,Netherlands,North Holland,64.0,Male,Leukemia,I,2018-06-07,2018-06-19,2018-12-25,Chemotherapy,Private,Alive,16.0,KRAS,No,Never,,39.7,High,Urban,Statutory Health Insurance,,Yes,No,Cardiovascular Disease,8.0
PT05560,Netherlands,Utrecht,27.0,Female,Colorectal,II,2021-07-17,2021-10-21,2022-06-11,Immunotherapy,Public,,8.0,KRAS,Yes,Never,None,25.8,Medium,Urban,NHS,7.0,No,No,Cardiovascular Disease,7.0
PT05561,France,Provence-Alpes-Côte d'Azur,59.0,Male,Pancreatic,I,2023-04-02,2023-04-06,2023-06-19,,Public,Deceased,14.0,EGFR,Yes,Never,None,25.9,Medium,Urban,Private Insurance,1.0,Yes,,Hypertension,9.0
PT05562,Switzerland,Bern,24.0,Male,Prostate,II,2020-06-05,2020-10-02,2020-11-16,Targeted Therapy,Public,Alive,114.0,BRCA1,No,Never,None,24.3,High,Urban,NHS,6.0,Yes,No,Hypertension,2.0
PT05563,Belgium,Wallonia,47.0,Female,Lung,II,,2016-08-21,2016-12-18,Surgery,Public,Alive,48.0,EGFR,No,Never,Heavy,34.9,Low,Urban,NHS,3.0,No,No,Obesity,1.0
PT05564,Ireland,Connacht,,Female,Pancreatic,III,2016-03-30,2016-08-07,2017-06-23,Immunotherapy,Private,,92.0,BRCA1,No,Former,Moderate,38.6,Low,Urban,Statutory Health Insurance,9.0,,No,Diabetes,2.0
PT05565,Sweden,Stockholm,21.0,Female,Breast,II,2016-05-23,2016-07-08,2016-11-19,Immunotherapy,Public,Deceased,68.0,BRCA1,No,Former,None,33.7,High,Rural,Private Insurance,19.0,No,No,Diabetes,8.0
PT05566,Norway,Vestland,82.0,Male,Ovarian,II,2012-01-08,2012-03-23,,Radiation,,Alive,114.0,None,Yes,Never,Moderate,20.1,Medium,Urban,Statutory Health Insurance,10.0,No,No,Hypertension,10.0
PT05567,Switzerland,Zurich,70.0,Female,Breast,II,2013-11-19,2014-03-25,2014-08-13,Targeted Therapy,Public,Alive,112.0,EGFR,No,Never,None,35.0,Medium,Urban,Statutory Health Insurance,16.0,No,No,Obesity,4.0
PT05568,Poland,Masovian,50.0,Female,Pancreatic,II,2022-06-14,2022-10-29,2023-06-30,Chemotherapy,Private,Lost to Follow-up,,KRAS,Yes,Former,Moderate,35.1,,Urban,Private Insurance,6.0,No,,Hypertension,2.0
PT05569,Ireland,Dublin,26.0,Male,Pancreatic,I,2015-08-04,2015-12-18,2016-07-12,Targeted Therapy,Public,Alive,15.0,EGFR,No,Former,None,32.3,Medium,Urban,Statutory Health Insurance,,,No,None,3.0
PT05570,Belgium,Flanders,49.0,Female,Lung,I,2014-11-21,2015-01-18,,Targeted Therapy,Private,Lost to Follow-up,,EGFR,Yes,Current,Moderate,22.2,Low,Urban,NHS,18.0,,No,Diabetes,5.0
PT05571,Switzerland,Bern,77.0,Male,Prostate,III,2012-11-28,2013-03-11,2013-11-21,Immunotherapy,Private,Deceased,106.0,BRCA1,No,Never,None,29.0,Low,Urban,Private Insurance,4.0,,No,Diabetes,4.0
PT05572,Norway,Oslo,22.0,Male,Leukemia,II,2019-10-09,2019-12-11,2020-02-24,Radiation,Public,Deceased,93.0,KRAS,Yes,Never,Moderate,18.7,Medium,Urban,Private Insurance,8.0,No,No,,6.0
PT05573,Switzerland,Bern,,Female,Prostate,I,2023-11-09,2024-03-31,2024-06-25,Targeted Therapy,Private,Alive,37.0,KRAS,Yes,Former,Moderate,,High,Rural,Statutory Health Insurance,11.0,No,No,Diabetes,3.0
PT05574,Italy,Veneto,75.0,Male,Colorectal,II,2011-01-07,2011-03-21,2012-01-05,Chemotherapy,Private,Alive,,EGFR,No,Never,None,32.8,Medium,Urban,Statutory Health Insurance,9.0,No,No,Cardiovascular Disease,2.0
PT05575,Finland,Southwest Finland,29.0,Male,Pancreatic,III,2017-02-09,2017-07-29,2017-10-18,Radiation,,Alive,108.0,EGFR,Yes,Never,Moderate,26.0,Medium,Rural,,14.0,No,No,Obesity,2.0
PT05576,Sweden,Stockholm,80.0,Male,Breast,III,2012-09-29,2013-03-26,2013-09-02,Radiation,Private,,12.0,KRAS,Yes,Never,Moderate,21.5,Low,Rural,NHS,8.0,No,No,,7.0
PT05577,Finland,Pirkanmaa,69.0,,Lung,IV,2016-11-28,2017-03-02,2017-05-23,Chemotherapy,Private,Deceased,98.0,KRAS,No,Current,None,20.4,High,Urban,Statutory Health Insurance,2.0,No,No,None,2.0
PT05578,France,Auvergne-Rhône-Alpes,66.0,Male,Leukemia,III,2022-04-28,2022-10-24,2023-02-13,Chemotherapy,Public,Alive,50.0,EGFR,No,Never,Moderate,34.8,Medium,Urban,Private Insurance,11.0,,No,Obesity,9.0
PT05579,Poland,,20.0,Male,Ovarian,II,2013-11-19,2014-04-21,2014-06-07,Chemotherapy,Public,Alive,51.0,None,No,Never,None,24.2,Medium,Urban,NHS,1.0,No,No,Hypertension,7.0
PT05580,Sweden,,76.0,Male,Prostate,I,2022-10-21,2023-03-20,2023-09-08,Targeted Therapy,Research Institute,Alive,65.0,KRAS,No,Current,Moderate,39.2,High,Rural,NHS,5.0,No,No,Hypertension,10.0
PT05581,Italy,Veneto,57.0,Male,Colorectal,I,2018-10-07,2018-10-29,2019-09-29,Radiation,Private,Alive,34.0,None,Yes,Current,Moderate,34.3,Medium,Urban,Statutory Health Insurance,18.0,No,Yes,None,9.0
PT05582,Austria,Tyrol,81.0,Male,Prostate,III,2011-09-19,2011-12-22,2012-02-17,Radiation,Public,Deceased,69.0,BRCA1,Yes,Former,Moderate,25.8,Low,Urban,Statutory Health Insurance,6.0,Yes,No,None,4.0
PT05583,France,Île-de-France,89.0,Male,Ovarian,II,2014-12-27,2015-04-23,2016-03-19,Surgery,Public,Alive,78.0,KRAS,No,Former,Moderate,25.5,Medium,Urban,Private Insurance,3.0,No,No,Hypertension,10.0
PT05584,Netherlands,Utrecht,84.0,Female,Colorectal,,2022-02-23,,2022-09-27,Surgery,Private,Alive,111.0,BRCA1,Yes,Current,None,21.1,Low,Urban,Private Insurance,19.0,No,No,Hypertension,8.0
PT05585,France,Provence-Alpes-Côte d'Azur,81.0,Female,Prostate,I,2021-10-17,2021-12-20,2022-05-14,Surgery,Private,,51.0,EGFR,,Former,Moderate,,High,Urban,,,No,No,Cardiovascular Disease,2.0
PT05586,Sweden,Skåne,75.0,Male,,II,2018-02-09,2018-07-09,2019-07-01,Targeted Therapy,Research Institute,Alive,7.0,None,No,Never,None,28.9,,Urban,Private Insurance,4.0,No,Yes,,4.0
PT05587,Norway,Vestland,86.0,Female,Leukemia,I,2014-07-05,2014-11-23,2015-08-30,Targeted Therapy,Public,Alive,8.0,BRCA1,No,Current,None,36.1,Low,Urban,Private Insurance,,No,No,Hypertension,7.0
PT05588,Spain,Andalusia,36.0,Non-binary,Lung,III,2015-06-23,2015-11-25,2016-04-15,Chemotherapy,Public,Alive,110.0,None,No,,Moderate,24.1,Medium,Urban,Private Insurance,16.0,Yes,No,Obesity,9.0
PT05589,Finland,Uusimaa,27.0,Female,Leukemia,I,2017-03-20,2017-05-06,2017-09-06,Targeted Therapy,Public,,97.0,KRAS,No,Never,None,25.5,Medium,Urban,Statutory Health Insurance,5.0,No,Yes,Obesity,3.0
PT05590,Norway,Oslo,79.0,Male,Colorectal,III,2016-06-01,2016-08-31,2016-09-30,Radiation,Private,Alive,89.0,BRCA1,No,Never,None,28.5,High,Urban,Private Insurance,5.0,Yes,No,Obesity,10.0
PT05591,France,Île-de-France,59.0,Female,Lung,I,2018-08-26,2018-09-16,2019-04-16,Radiation,Research Institute,Alive,47.0,None,Yes,Former,None,33.5,Low,Rural,NHS,,No,,Obesity,8.0
,Belgium,Flanders,81.0,Male,Ovarian,II,2012-10-06,2012-11-06,2013-10-15,Immunotherapy,Public,Alive,73.0,KRAS,No,Current,Heavy,36.9,Low,Urban,NHS,16.0,No,No,None,9.0
PT05593,Ireland,Munster,60.0,Male,Leukemia,I,2023-09-18,2024-01-17,2024-07-13,Immunotherapy,Public,Deceased,67.0,None,Yes,Current,None,39.0,High,Urban,NHS,10.0,No,No,Obesity,10.0
PT05594,Switzerland,Zurich,31.0,Male,Breast,I,2018-10-24,2018-12-01,2019-02-24,Targeted Therapy,Public,Lost to Follow-up,,BRCA1,No,Never,Moderate,19.1,Low,Urban,Statutory Health Insurance,1.0,No,,None,8.0
PT05595,Poland,Masovian,73.0,Male,Ovarian,I,2021-05-13,2021-06-21,2021-09-28,Immunotherapy,Private,Alive,35.0,KRAS,Yes,Current,Moderate,36.6,High,Urban,NHS,11.0,No,No,None,10.0
,,Algarve,30.0,Female,Colorectal,,2017-09-13,2018-02-24,2018-08-17,Targeted Therapy,Public,Deceased,36.0,EGFR,No,,Moderate,20.8,Medium,Rural,,16.0,No,No,,3.0
PT05597,Italy,Veneto,79.0,,Ovarian,II,2020-03-29,2020-07-07,2020-10-22,Chemotherapy,Private,Alive,46.0,EGFR,No,Former,Moderate,39.6,High,Rural,Private Insurance,13.0,Yes,No,None,3.0
PT05598,Portugal,Algarve,87.0,Female,Ovarian,,2023-08-17,2023-08-28,2024-02-08,Chemotherapy,Public,Alive,27.0,None,No,Never,Moderate,19.0,,Urban,Statutory Health Insurance,,No,Yes,None,6.0
PT05599,Austria,,65.0,,Lung,I,2021-01-21,2021-03-31,2021-07-17,Immunotherapy,Public,Alive,78.0,KRAS,No,Former,Moderate,24.9,Low,Urban,Private Insurance,15.0,No,No,Cardiovascular Disease,5.0
PT05600,Italy,Lombardy,57.0,Male,Colorectal,I,2020-07-01,,2021-07-27,Targeted Therapy,Private,Deceased,14.0,None,No,Former,None,40.0,Medium,Urban,NHS,19.0,No,No,Hypertension,5.0
PT05601,France,Île-de-France,80.0,Male,Lung,,2014-12-05,2014-12-10,2015-09-13,Immunotherapy,Public,Alive,36.0,BRCA1,No,Current,Moderate,23.5,Medium,Rural,Statutory Health Insurance,2.0,No,No,Hypertension,8.0
PT05602,Sweden,Stockholm,36.0,Male,Colorectal,III,2017-11-24,2017-12-14,2018-07-07,Radiation,Public,Alive,21.0,EGFR,No,Former,Moderate,36.8,High,Rural,NHS,2.0,No,No,Obesity,7.0
PT05603,Portugal,Algarve,85.0,Non-binary,,I,2013-08-15,2013-10-17,2013-11-25,Targeted Therapy,Research Institute,Deceased,40.0,BRCA1,Yes,Former,Heavy,36.4,High,Rural,NHS,7.0,Yes,No,Cardiovascular Disease,5.0
PT05604,Belgium,Wallonia,55.0,Female,Ovarian,III,2017-02-22,2017-04-08,2017-12-14,Surgery,Public,Alive,27.0,KRAS,Yes,Current,Moderate,23.8,High,Rural,Statutory Health Insurance,2.0,No,No,Hypertension,3.0
PT05605,,,26.0,Non-binary,Leukemia,III,2011-12-26,2012-06-13,2012-11-16,Radiation,Private,Alive,115.0,BRCA1,No,Never,None,29.1,High,Urban,Private Insurance,2.0,No,No,,5.0
PT05606,Switzerland,Geneva,35.0,Female,Prostate,II,2016-08-08,2016-08-21,2016-10-30,Targeted Therapy,Public,Alive,57.0,EGFR,Yes,Never,None,19.7,High,Urban,NHS,10.0,Yes,No,None,9.0
PT05607,Sweden,Västra Götaland,33.0,Male,Ovarian,II,2013-08-08,2013-12-23,2014-07-30,Immunotherapy,Public,Alive,64.0,KRAS,No,Never,Moderate,,Medium,Urban,Private Insurance,5.0,No,No,Cardiovascular Disease,7.0
PT05608,Austria,Vienna,44.0,Male,Prostate,I,2013-11-13,2014-03-26,2014-08-09,Immunotherapy,Public,Alive,100.0,None,No,Never,None,25.9,Medium,Urban,Private Insurance,10.0,No,No,Obesity,8.0
PT05609,Sweden,Stockholm,23.0,Female,Prostate,I,2023-04-11,2023-09-24,2024-04-04,Immunotherapy,Public,Deceased,18.0,KRAS,No,Never,None,37.9,Medium,Urban,NHS,15.0,No,No,Diabetes,2.0
PT05610,Austria,Vienna,48.0,Male,Ovarian,IV,2019-09-13,2019-12-16,2020-07-10,Targeted Therapy,Public,Deceased,,BRCA1,Yes,Never,None,32.6,High,Urban,Statutory Health Insurance,10.0,No,No,Diabetes,2.0
PT05611,Austria,Tyrol,75.0,Female,Lung,I,,2014-09-28,2015-01-17,Immunotherapy,Private,Alive,118.0,KRAS,No,Never,None,31.3,Medium,Urban,NHS,6.0,No,Yes,Obesity,5.0
PT05612,Germany,Berlin,25.0,Male,Leukemia,I,2011-03-02,2011-06-02,2011-07-06,Targeted Therapy,Public,Alive,56.0,,Yes,Never,,38.9,Low,Urban,Private Insurance,19.0,No,No,Obesity,9.0
PT05613,,Catalonia,20.0,Male,Ovarian,IV,2020-10-24,2021-02-02,2021-08-24,,Public,Alive,44.0,BRCA1,No,Never,Moderate,,Medium,Rural,Private Insurance,19.0,No,No,Hypertension,8.0
PT05614,Germany,Berlin,58.0,Female,Pancreatic,III,,2022-09-25,2023-09-22,Immunotherapy,Public,Alive,64.0,BRCA1,No,,Heavy,39.9,Medium,Urban,Statutory Health Insurance,16.0,No,No,Cardiovascular Disease,4.0
,Germany,Berlin,20.0,,Lung,II,2010-10-31,2011-03-01,2012-01-20,Chemotherapy,Private,Deceased,44.0,BRCA1,No,Former,None,28.1,Low,Urban,NHS,4.0,No,No,None,4.0
PT05616,Norway,Trøndelag,82.0,,Ovarian,III,2010-04-14,,2011-06-08,Chemotherapy,Private,Alive,,EGFR,No,Current,None,22.3,Medium,Urban,Private Insurance,6.0,No,No,Obesity,1.0
PT05617,Netherlands,South Holland,76.0,Female,,III,2010-12-30,2011-06-19,2011-11-13,Radiation,Private,Alive,94.0,EGFR,Yes,Never,Heavy,27.3,Medium,Urban,NHS,7.0,No,No,None,6.0
PT05618,Austria,Tyrol,86.0,Male,Lung,III,2022-10-07,2023-03-25,2023-11-09,Targeted Therapy,Public,Alive,53.0,BRCA1,No,Former,Moderate,27.3,Low,Urban,Statutory Health Insurance,16.0,Yes,No,Hypertension,7.0
PT05619,Netherlands,North Holland,84.0,Female,Ovarian,I,2017-10-18,2018-04-08,2018-05-24,Immunotherapy,Public,Alive,70.0,BRCA1,Yes,Never,Moderate,35.1,Medium,Rural,Statutory Health Insurance,12.0,Yes,Yes,Hypertension,8.0
PT05620,Netherlands,North Holland,84.0,Male,Lung,II,2017-06-16,2017-11-20,2018-03-04,Immunotherapy,Public,Alive,55.0,EGFR,No,Current,None,23.9,High,Rural,Private Insurance,,No,Yes,Obesity,10.0
PT05621,Finland,Southwest Finland,40.0,Male,Ovarian,I,2020-10-23,2020-12-30,2021-05-29,Immunotherapy,Public,Alive,51.0,EGFR,No,Never,None,29.6,Low,Rural,Private Insurance,5.0,Yes,No,Cardiovascular Disease,5.0
PT05622,Austria,Vienna,49.0,Female,Pancreatic,I,2013-01-13,2013-02-07,2013-12-15,Chemotherapy,Private,Alive,40.0,None,Yes,Never,Moderate,26.9,Low,Rural,Statutory Health Insurance,8.0,Yes,No,Obesity,10.0
PT05623,Ireland,,52.0,Male,,II,2016-08-12,2016-08-26,2016-11-02,Surgery,Public,Deceased,68.0,EGFR,No,Former,None,28.0,Medium,Urban,NHS,2.0,No,No,Obesity,6.0
PT05624,Norway,Trøndelag,67.0,Female,Lung,III,2015-03-13,2015-05-14,2015-12-24,Targeted Therapy,Public,Alive,80.0,EGFR,No,Current,Moderate,20.2,Low,Rural,NHS,10.0,,Yes,Cardiovascular Disease,5.0
PT05625,Germany,Bavaria,41.0,Female,Leukemia,I,2023-03-14,2023-08-06,2024-02-04,Radiation,Public,Alive,103.0,BRCA1,Yes,Never,Moderate,30.4,Medium,Urban,Private Insurance,10.0,No,No,Hypertension,3.0
PT05626,Spain,Andalusia,73.0,Male,Ovarian,II,2011-12-16,2012-04-11,2013-01-10,Radiation,Public,Alive,87.0,KRAS,,Never,Heavy,31.9,,Urban,NHS,6.0,No,No,Hypertension,3.0
PT05627,Sweden,Västra Götaland,23.0,Female,Prostate,III,2017-11-12,2018-04-08,2018-08-31,Radiation,Private,Alive,36.0,EGFR,,Former,Moderate,19.1,High,Urban,NHS,5.0,Yes,No,None,9.0
PT05628,France,Île-de-France,74.0,Female,Colorectal,II,2013-04-17,2013-09-21,2013-11-30,Targeted Therapy,Private,Alive,65.0,BRCA1,Yes,Current,None,20.9,Low,Urban,Statutory Health Insurance,11.0,No,No,Hypertension,5.0
PT05629,Italy,,63.0,Male,Lung,IV,2010-04-02,2010-07-11,2010-11-21,Targeted Therapy,Public,Deceased,21.0,KRAS,Yes,Current,Moderate,19.6,High,Urban,Statutory Health Insurance,10.0,,No,Hypertension,
PT05630,Denmark,Zealand,31.0,Female,Ovarian,III,2014-03-04,2014-05-09,2015-02-10,Radiation,Research Institute,Alive,56.0,EGFR,No,Current,None,22.5,Medium,Rural,NHS,6.0,No,Yes,Obesity,10.0
PT05631,Spain,Madrid,71.0,Female,Leukemia,IV,2022-12-03,,2023-08-06,Radiation,Public,Deceased,115.0,EGFR,No,Never,Moderate,19.5,Medium,Urban,NHS,9.0,No,No,Obesity,6.0
PT05632,Austria,Vienna,84.0,Female,Breast,II,,2021-02-02,2021-11-24,Immunotherapy,Research Institute,Deceased,99.0,EGFR,Yes,,,27.1,Low,Urban,Statutory Health Insurance,5.0,No,No,,1.0
PT05633,Netherlands,South Holland,84.0,Female,Colorectal,III,2010-06-18,2010-07-16,2011-07-09,Surgery,Public,Alive,60.0,None,No,Former,Moderate,23.7,Low,Rural,Private Insurance,4.0,Yes,No,Hypertension,9.0
PT05634,Austria,Styria,,Female,Lung,IV,2013-08-12,2013-10-10,2014-04-06,Chemotherapy,Public,Alive,,None,No,Never,Moderate,34.3,Medium,Urban,Private Insurance,4.0,Yes,,None,1.0
PT05635,Spain,Andalusia,37.0,Non-binary,Lung,III,2016-02-19,2016-02-27,2016-10-16,Targeted Therapy,Public,,30.0,BRCA1,Yes,Never,None,38.4,Medium,,Private Insurance,11.0,No,No,Cardiovascular Disease,8.0
PT05636,Belgium,Brussels,66.0,Female,Ovarian,III,2012-05-19,2012-05-29,2012-07-22,Surgery,Research Institute,Alive,33.0,BRCA1,Yes,Never,Moderate,29.6,Medium,Rural,NHS,8.0,No,No,Hypertension,8.0
PT05637,Austria,Tyrol,85.0,Male,Colorectal,II,2017-07-29,2017-08-19,2018-06-22,Radiation,Public,Deceased,29.0,KRAS,Yes,Never,Moderate,25.9,Medium,Rural,Private Insurance,2.0,No,No,Hypertension,1.0
PT05638,Germany,Bavaria,68.0,Male,Colorectal,I,2019-03-12,2019-04-16,2019-05-26,Radiation,Private,Alive,103.0,KRAS,No,Current,None,30.3,Low,Urban,NHS,,No,No,Hypertension,1.0
PT05639,Belgium,Brussels,41.0,Male,Lung,IV,2019-01-01,2019-01-05,2019-10-22,Radiation,Public,Deceased,26.0,None,No,Former,None,21.2,Medium,Rural,NHS,19.0,No,No,Hypertension,3.0
PT05640,Portugal,Algarve,45.0,Female,Leukemia,III,2012-09-01,2012-11-25,2012-12-30,Radiation,Research Institute,Alive,,BRCA1,Yes,Never,None,35.7,Medium,Rural,Statutory Health Insurance,12.0,No,No,Obesity,5.0
PT05641,Italy,Lombardy,28.0,Female,Breast,III,2022-03-15,2022-04-09,2022-12-19,Immunotherapy,Public,Alive,16.0,BRCA1,No,Former,Moderate,30.0,Medium,Rural,Statutory Health Insurance,11.0,Yes,No,Diabetes,3.0
PT05642,Germany,Berlin,40.0,Male,Ovarian,I,2021-05-01,2021-05-21,2022-03-18,Targeted Therapy,Private,Alive,58.0,EGFR,Yes,Former,None,18.6,Medium,Rural,Statutory Health Insurance,14.0,No,Yes,,1.0
PT05643,Portugal,Algarve,82.0,Male,Leukemia,II,2016-02-07,2016-05-13,2017-02-14,Radiation,Public,Alive,96.0,None,Yes,Never,Heavy,28.9,Low,Urban,Statutory Health Insurance,10.0,No,No,Diabetes,3.0
PT05644,Norway,Trøndelag,25.0,Male,Pancreatic,II,2017-01-02,2017-04-08,2017-06-22,Radiation,,Deceased,78.0,EGFR,Yes,Current,None,31.7,Medium,Urban,Statutory Health Insurance,8.0,No,No,Diabetes,9.0
PT05645,France,Île-de-France,33.0,Male,Prostate,III,2016-11-14,2017-03-21,2017-05-03,Targeted Therapy,Public,Alive,21.0,None,Yes,Never,Moderate,,Low,Urban,Private Insurance,17.0,Yes,Yes,Obesity,6.0
PT05646,Ireland,Munster,52.0,Female,Prostate,IV,2016-05-22,2016-06-13,2016-08-05,Chemotherapy,Public,Lost to Follow-up,,EGFR,No,Former,None,26.4,Medium,Urban,NHS,14.0,No,No,Diabetes,1.0
PT05647,Sweden,Stockholm,43.0,Female,Prostate,I,2013-08-13,2013-10-01,2014-07-11,Immunotherapy,Public,Alive,16.0,None,No,Never,Moderate,24.1,High,Urban,Statutory Health Insurance,3.0,No,No,Obesity,7.0
PT05648,Denmark,Zealand,70.0,Non-binary,Lung,III,2014-04-29,2014-07-27,2015-07-23,Immunotherapy,Research Institute,Deceased,19.0,EGFR,No,Never,None,28.7,Medium,Urban,Statutory Health Insurance,6.0,No,No,None,7.0
PT05649,Spain,Andalusia,21.0,Male,Ovarian,I,2015-03-24,2015-03-30,2016-01-15,Surgery,Public,Alive,48.0,EGFR,Yes,Former,Moderate,28.4,Low,Rural,NHS,9.0,Yes,No,Obesity,10.0
PT05650,Portugal,Lisbon,34.0,Female,Ovarian,II,2014-11-20,2015-05-18,2016-02-18,Immunotherapy,Research Institute,Deceased,84.0,EGFR,,Current,,37.4,Medium,Rural,,8.0,No,No,Cardiovascular Disease,10.0
PT05651,Ireland,Dublin,54.0,Female,Breast,II,2015-03-31,2015-09-02,2016-07-04,Surgery,Public,Alive,91.0,None,No,Current,Moderate,37.5,High,Rural,,12.0,No,Yes,Cardiovascular Disease,8.0
PT05652,Spain,Andalusia,55.0,,Breast,III,2018-02-28,2018-07-24,2018-12-12,Chemotherapy,Public,Alive,111.0,EGFR,No,Current,,24.0,,Urban,NHS,1.0,No,No,Hypertension,5.0
PT05653,Ireland,Connacht,58.0,Female,Ovarian,IV,2010-09-14,2010-09-26,2011-05-14,Targeted Therapy,Public,Alive,47.0,None,No,Current,Moderate,34.3,Low,Urban,NHS,18.0,Yes,No,Hypertension,9.0
PT05654,Germany,North Rhine-Westphalia,23.0,Male,Pancreatic,II,2013-05-25,2013-06-22,2014-05-19,Radiation,Public,Alive,91.0,EGFR,No,Never,Moderate,20.9,Medium,Urban,Statutory Health Insurance,8.0,No,No,Hypertension,4.0
PT05655,Spain,Madrid,83.0,Male,Lung,II,2017-01-13,2017-02-01,2017-06-15,Surgery,Private,Deceased,94.0,EGFR,No,Current,Moderate,26.1,Medium,Urban,Statutory Health Insurance,12.0,No,No,Hypertension,8.0
PT05656,Germany,North Rhine-Westphalia,25.0,Female,Lung,III,2012-01-20,2012-03-03,2012-11-15,Immunotherapy,Public,Alive,91.0,EGFR,Yes,Current,,26.1,Medium,Urban,NHS,2.0,No,No,,9.0
PT05657,Portugal,Algarve,76.0,Female,Lung,II,2019-02-05,2019-05-15,2019-12-17,Radiation,Public,Alive,72.0,EGFR,Yes,Never,Moderate,36.6,Medium,Urban,Statutory Health Insurance,3.0,No,No,Hypertension,6.0
PT05658,Denmark,Central Denmark,49.0,Female,Breast,IV,2018-12-31,2019-05-23,2019-12-08,Chemotherapy,Public,Deceased,108.0,BRCA1,Yes,Former,Moderate,19.6,,Rural,Private Insurance,4.0,No,No,Cardiovascular Disease,8.0
PT05659,Germany,Berlin,86.0,Male,Lung,IV,2023-01-05,2023-02-10,2023-09-14,Targeted Therapy,Public,Alive,35.0,EGFR,No,,None,29.3,Medium,Rural,Statutory Health Insurance,18.0,No,No,None,7.0
PT05660,Netherlands,North Holland,34.0,Female,Colorectal,I,2012-01-04,2012-04-10,2012-06-19,,Private,Alive,70.0,KRAS,,Former,Moderate,27.6,High,Urban,Statutory Health Insurance,10.0,No,No,Obesity,1.0
PT05661,Germany,Berlin,36.0,Male,Colorectal,II,2016-07-14,2016-10-07,2017-09-24,Immunotherapy,Public,Deceased,50.0,,Yes,Never,None,31.1,High,Urban,Statutory Health Insurance,19.0,No,No,Diabetes,3.0
PT05662,Belgium,Wallonia,37.0,Non-binary,Colorectal,I,2021-11-02,2021-12-14,2022-04-05,Radiation,Public,Alive,8.0,BRCA1,No,Former,None,37.1,Low,,NHS,19.0,No,No,None,4.0
PT05663,Sweden,Skåne,38.0,Female,Lung,II,,,2014-08-28,Radiation,Public,Alive,52.0,BRCA1,Yes,Current,None,19.6,Medium,Urban,NHS,18.0,No,No,Cardiovascular Disease,8.0
PT05664,,Pirkanmaa,88.0,Female,Colorectal,III,2016-08-10,2016-12-14,2017-06-08,Radiation,Private,Deceased,86.0,BRCA1,Yes,Never,Moderate,39.6,Medium,Rural,NHS,19.0,No,,Cardiovascular Disease,3.0
PT05665,Belgium,Brussels,43.0,Female,Ovarian,I,2017-12-15,,2019-01-28,Targeted Therapy,Public,Alive,102.0,,No,Never,Heavy,32.5,Medium,Urban,Private Insurance,14.0,No,No,None,10.0
PT05666,Denmark,Capital Region,67.0,Male,Pancreatic,IV,2016-11-01,2016-12-01,2017-05-26,Surgery,Research Institute,Alive,82.0,KRAS,No,Never,Moderate,34.8,High,Rural,Statutory Health Insurance,3.0,Yes,No,Diabetes,8.0
PT05667,Austria,Tyrol,49.0,Male,Lung,II,2016-12-29,,2017-12-13,Targeted Therapy,Private,,66.0,BRCA1,No,Current,None,26.8,Medium,Urban,NHS,13.0,No,No,Hypertension,4.0
PT05668,Spain,Catalonia,34.0,Male,Pancreatic,IV,2020-02-22,2020-08-14,2021-02-26,Immunotherapy,Public,Deceased,61.0,BRCA1,Yes,Never,Moderate,38.7,Low,Urban,NHS,16.0,No,Yes,None,7.0
PT05669,Portugal,Algarve,66.0,Male,Colorectal,I,2015-10-11,2015-11-10,2016-08-21,Surgery,Private,,13.0,,Yes,Current,None,25.3,Medium,Rural,Statutory Health Insurance,12.0,No,No,Obesity,8.0
PT05670,Portugal,Lisbon,63.0,Female,,III,2019-04-26,2019-08-13,2020-04-21,Chemotherapy,Private,Alive,,KRAS,Yes,Former,None,35.0,Low,Rural,Statutory Health Insurance,2.0,No,,Hypertension,7.0
PT05671,Austria,Styria,46.0,Male,Leukemia,III,2021-09-22,2021-12-19,2022-04-21,Chemotherapy,Private,Deceased,62.0,KRAS,No,Never,Moderate,36.1,Low,Urban,Private Insurance,14.0,Yes,No,None,5.0
PT05672,Poland,Masovian,83.0,Female,Prostate,I,2014-03-09,2014-06-03,2014-12-10,Targeted Therapy,,Alive,31.0,BRCA1,Yes,Never,Heavy,33.1,High,Urban,Private Insurance,8.0,No,,Hypertension,9.0
PT05673,,,60.0,Male,Leukemia,II,2012-04-30,2012-06-06,2013-03-10,Targeted Therapy,Research Institute,Deceased,75.0,BRCA1,No,Never,None,34.7,Low,Rural,Private Insurance,2.0,No,No,Obesity,10.0
PT05674,Portugal,Algarve,87.0,Female,Prostate,IV,2016-04-20,2016-07-19,2017-05-12,Targeted Therapy,Public,Deceased,81.0,KRAS,No,Never,Moderate,21.2,Medium,Urban,Private Insurance,7.0,No,No,None,6.0
PT05675,Finland,Uusimaa,24.0,Female,Prostate,II,2022-10-19,2023-03-18,2023-09-21,Chemotherapy,Public,Alive,13.0,EGFR,No,Never,Moderate,20.5,Medium,Urban,Private Insurance,6.0,No,Yes,Diabetes,9.0
PT05676,Netherlands,North Holland,72.0,Male,Colorectal,II,2022-01-27,2022-05-04,2022-08-11,Chemotherapy,Public,Lost to Follow-up,,EGFR,No,Former,Moderate,30.3,Medium,Urban,NHS,2.0,No,No,Obesity,6.0
PT05677,Ireland,Connacht,27.0,Male,Prostate,IV,2019-12-03,2019-12-27,2020-07-13,Surgery,Public,Deceased,98.0,KRAS,Yes,Never,None,25.5,Medium,Urban,NHS,2.0,Yes,Yes,Hypertension,1.0
PT05678,Norway,Oslo,41.0,Male,Prostate,I,2019-01-09,2019-03-19,2020-01-03,Surgery,Public,Deceased,25.0,BRCA1,Yes,Never,Moderate,36.9,Medium,Urban,NHS,2.0,No,No,Diabetes,8.0
PT05679,Sweden,Skåne,26.0,Female,Leukemia,II,2022-05-24,2022-08-20,2023-04-21,Targeted Therapy,Private,Alive,114.0,BRCA1,Yes,Former,Moderate,22.9,High,Urban,Private Insurance,9.0,No,No,Obesity,1.0
PT05680,Ireland,Dublin,41.0,Female,Prostate,III,2013-10-11,2014-01-18,2014-12-29,Radiation,Public,Alive,18.0,KRAS,No,,None,32.7,Low,Urban,Statutory Health Insurance,18.0,No,No,Cardiovascular Disease,8.0
PT05681,Denmark,Central Denmark,65.0,Male,Lung,III,2019-07-31,2019-11-30,2020-03-16,Surgery,Private,Alive,50.0,KRAS,,Never,None,23.4,Low,Urban,,18.0,Yes,No,Cardiovascular Disease,7.0
PT05682,Portugal,Porto,49.0,,Pancreatic,I,2013-11-16,2014-02-10,2014-09-20,Chemotherapy,Public,Alive,13.0,BRCA1,No,Never,None,21.7,Medium,Urban,Statutory Health Insurance,19.0,Yes,No,Diabetes,2.0
PT05683,Netherlands,North Holland,35.0,Male,Ovarian,II,2016-03-19,2016-08-27,2017-07-30,Immunotherapy,Public,,23.0,KRAS,Yes,Never,Moderate,22.3,Medium,Rural,NHS,15.0,No,No,Hypertension,7.0
PT05684,Switzerland,Zurich,24.0,Female,Pancreatic,III,2017-09-08,,2018-03-10,Radiation,Public,Alive,,KRAS,No,Current,Heavy,24.4,Low,Rural,Private Insurance,2.0,No,Yes,Diabetes,
PT05685,Austria,Tyrol,86.0,Male,Lung,II,2014-12-05,2014-12-17,,Chemotherapy,Private,Alive,89.0,KRAS,No,Never,Moderate,36.1,Medium,Urban,Private Insurance,10.0,Yes,No,None,4.0
PT05686,Denmark,Zealand,42.0,Female,Ovarian,III,2019-11-18,2019-12-18,2020-02-20,Radiation,Public,Alive,38.0,KRAS,No,Former,Heavy,39.9,Low,,Statutory Health Insurance,14.0,Yes,No,Diabetes,
PT05687,Denmark,Capital Region,80.0,Female,Colorectal,I,2017-09-14,2018-02-02,2019-01-27,,Private,Alive,13.0,BRCA1,Yes,Former,Heavy,29.4,Medium,Urban,Private Insurance,18.0,No,No,Obesity,5.0
PT05688,Germany,Berlin,24.0,Female,Ovarian,III,2015-06-26,2015-07-02,2016-04-28,Targeted Therapy,Research Institute,Deceased,117.0,BRCA1,No,Former,Moderate,20.7,Medium,Urban,Statutory Health Insurance,5.0,No,,,5.0
PT05689,Spain,Madrid,42.0,Male,Ovarian,II,2015-10-21,2016-02-23,2016-08-31,Radiation,Public,Alive,81.0,None,Yes,Never,Moderate,35.5,Low,Urban,Statutory Health Insurance,6.0,No,No,Diabetes,3.0
PT05690,Portugal,Lisbon,44.0,Male,Leukemia,IV,2023-12-04,2023-12-15,2024-11-15,Immunotherapy,Public,Lost to Follow-up,,BRCA1,No,Current,Moderate,20.6,Medium,Urban,NHS,,No,Yes,Obesity,10.0
PT05691,Italy,Veneto,27.0,Female,Ovarian,I,2011-04-01,2011-08-07,2012-07-18,Immunotherapy,Public,Alive,71.0,None,No,Never,Heavy,23.4,Medium,Rural,Private Insurance,1.0,No,No,None,3.0
PT05692,Spain,Madrid,40.0,Male,Ovarian,II,,2018-12-15,2019-04-02,Radiation,Public,Alive,21.0,EGFR,Yes,Never,Moderate,39.0,,,Private Insurance,18.0,Yes,No,Obesity,9.0
PT05693,Denmark,Zealand,21.0,Male,Breast,I,,2023-01-18,2023-12-28,Radiation,Public,Alive,119.0,BRCA1,No,Former,Moderate,22.7,Low,Urban,NHS,5.0,Yes,No,Obesity,7.0
PT05694,Italy,Veneto,41.0,Female,Pancreatic,II,2017-11-24,2017-12-04,2018-05-09,Radiation,Public,Alive,112.0,KRAS,Yes,Current,Moderate,30.5,Medium,Rural,Statutory Health Insurance,12.0,Yes,Yes,Hypertension,2.0
PT05695,Spain,Catalonia,87.0,Male,Leukemia,I,,2012-08-12,2012-09-14,Radiation,Private,Alive,48.0,EGFR,No,Former,Moderate,37.9,High,Rural,Private Insurance,5.0,No,No,Obesity,4.0
PT05696,Austria,Tyrol,83.0,Male,Pancreatic,III,2014-08-12,2014-11-04,2015-10-26,,Public,Alive,106.0,EGFR,Yes,,None,33.7,Medium,Rural,NHS,8.0,,Yes,,6.0
PT05697,Switzerland,Zurich,38.0,Female,Breast,IV,2017-01-09,2017-06-28,2018-01-29,Chemotherapy,Private,Alive,16.0,EGFR,Yes,Current,None,35.0,Medium,Urban,NHS,17.0,No,No,Diabetes,9.0
PT05698,Sweden,Skåne,72.0,Female,Prostate,I,2019-05-03,2019-10-22,2020-01-21,Surgery,,Alive,86.0,None,Yes,Never,Moderate,23.5,Low,Rural,Private Insurance,6.0,No,No,,6.0
,Finland,Southwest Finland,71.0,Male,Breast,I,2015-09-17,2016-02-11,2016-12-17,Targeted Therapy,Private,Alive,113.0,KRAS,Yes,Never,Moderate,36.4,Low,Rural,Statutory Health Insurance,1.0,No,No,Cardiovascular Disease,9.0
,Germany,Berlin,66.0,Female,Prostate,IV,2016-06-24,2016-10-02,2017-09-23,Radiation,Research Institute,Deceased,99.0,KRAS,No,Never,None,24.7,High,Urban,Statutory Health Insurance,4.0,No,No,None,4.0
,Germany,Bavaria,73.0,Female,Pancreatic,II,2010-05-20,2010-06-04,2011-04-10,Immunotherapy,,,49.0,EGFR,Yes,Never,Moderate,29.2,,Urban,NHS,13.0,No,No,None,10.0
PT05702,Switzerland,Bern,63.0,Male,Ovarian,II,2011-03-03,2011-05-27,2011-10-26,Targeted Therapy,Private,Deceased,13.0,EGFR,No,Never,Heavy,28.5,Medium,Urban,Private Insurance,9.0,No,No,Cardiovascular Disease,1.0
PT05703,Norway,Trøndelag,26.0,Female,Leukemia,I,,2018-01-20,2019-01-06,Surgery,Public,Alive,92.0,EGFR,No,Former,None,28.8,High,Urban,,9.0,No,No,Obesity,
PT05704,Denmark,Central Denmark,20.0,Female,Leukemia,II,2015-07-11,2015-07-16,2016-05-22,Surgery,Private,Alive,79.0,EGFR,No,Never,None,,Low,Urban,Private Insurance,,No,No,,5.0
PT05705,Germany,Berlin,82.0,Male,Colorectal,,2013-05-03,2013-07-28,2014-04-11,Targeted Therapy,Public,Alive,75.0,KRAS,Yes,Never,Moderate,27.3,High,,Statutory Health Insurance,6.0,No,No,Obesity,4.0
PT05706,Austria,Vienna,58.0,Female,Pancreatic,III,,2021-11-20,2022-06-20,Immunotherapy,Research Institute,Alive,70.0,None,Yes,,None,36.4,Medium,,Statutory Health Insurance,,No,Yes,Hypertension,2.0
PT05707,Poland,Lesser Poland,38.0,Male,Colorectal,II,2015-03-28,2015-08-31,2016-02-07,Immunotherapy,Private,Alive,80.0,BRCA1,No,Former,None,38.1,Medium,Rural,Statutory Health Insurance,1.0,No,No,None,8.0
PT05708,Germany,Berlin,50.0,Female,Ovarian,III,2022-09-11,2022-10-19,2023-04-23,Immunotherapy,Private,Alive,110.0,EGFR,No,Current,Moderate,37.1,Medium,Rural,NHS,16.0,No,No,Cardiovascular Disease,7.0
PT05709,Belgium,Flanders,43.0,Female,Pancreatic,II,2020-01-30,2020-06-21,2021-01-22,Chemotherapy,,Alive,92.0,EGFR,No,Never,Moderate,38.2,High,Urban,Statutory Health Insurance,6.0,No,Yes,Diabetes,5.0
PT05710,Poland,Silesian,88.0,Male,Ovarian,II,2016-09-02,2016-09-21,2017-06-12,Immunotherapy,Public,Alive,72.0,EGFR,No,Never,Moderate,22.5,Medium,Rural,Statutory Health Insurance,19.0,No,No,Obesity,5.0
PT05711,Spain,Madrid,84.0,Female,Prostate,I,2013-12-23,2014-06-04,2014-11-29,Surgery,Public,Alive,83.0,EGFR,Yes,Never,None,34.9,Medium,Urban,,13.0,No,Yes,Cardiovascular Disease,10.0
PT05712,Finland,Uusimaa,52.0,Female,Pancreatic,IV,2014-09-14,2014-09-29,2014-12-10,Radiation,,Deceased,82.0,None,No,Never,None,27.8,High,Rural,NHS,,No,No,Cardiovascular Disease,5.0
PT05713,Belgium,Brussels,78.0,Male,Pancreatic,II,2016-01-09,2016-05-02,,Radiation,Private,Alive,25.0,None,No,Never,Moderate,35.7,Medium,Urban,Private Insurance,19.0,Yes,No,Obesity,3.0
PT05714,Sweden,Skåne,52.0,Female,Prostate,I,2018-09-10,2018-12-07,2019-11-26,Surgery,Public,Alive,104.0,KRAS,,Current,Moderate,26.6,Medium,Rural,Statutory Health Insurance,8.0,No,,Obesity,7.0
PT05715,Finland,Southwest Finland,51.0,Male,Lung,I,2013-11-29,2014-05-23,,Immunotherapy,,Alive,54.0,BRCA1,No,Never,Moderate,31.2,Low,Urban,NHS,15.0,No,No,Diabetes,10.0
PT05716,Norway,Trøndelag,78.0,Female,Ovarian,I,2013-08-04,2013-12-30,2014-11-02,Radiation,Public,Alive,20.0,EGFR,No,,Moderate,20.5,High,Urban,Statutory Health Insurance,15.0,No,No,Diabetes,7.0
PT05717,Sweden,Västra Götaland,60.0,,Lung,I,2012-01-17,,2012-03-01,Surgery,Private,Alive,10.0,None,No,Former,Moderate,29.3,Medium,Rural,,6.0,No,Yes,Obesity,2.0
,Spain,Catalonia,31.0,Female,Pancreatic,II,2017-08-21,2017-08-26,2018-02-21,Immunotherapy,Public,Alive,58.0,BRCA1,Yes,Never,Moderate,24.2,High,Rural,NHS,11.0,Yes,No,Diabetes,9.0
PT05719,Poland,Lesser Poland,30.0,Female,Lung,II,2018-07-04,2018-11-20,2019-09-17,Chemotherapy,Public,Alive,46.0,EGFR,Yes,Never,,28.7,Medium,Rural,NHS,17.0,No,No,Diabetes,2.0
PT05720,Finland,Uusimaa,38.0,Female,Leukemia,IV,2017-12-24,2018-04-21,2018-10-31,Radiation,Public,Alive,90.0,BRCA1,,Never,Moderate,,Low,Urban,Private Insurance,12.0,Yes,No,None,6.0
PT05721,Netherlands,Utrecht,73.0,Female,Pancreatic,I,2012-01-24,2012-05-06,2012-11-29,Immunotherapy,Public,Alive,54.0,BRCA1,Yes,Never,None,24.3,Low,Urban,Statutory Health Insurance,,No,No,Diabetes,6.0
PT05722,Norway,Trøndelag,76.0,Female,Breast,III,2011-04-29,2011-07-29,2011-10-24,Immunotherapy,Research Institute,Deceased,115.0,BRCA1,No,Former,Moderate,35.6,High,Urban,Statutory Health Insurance,,No,No,Hypertension,10.0
PT05723,Poland,Lesser Poland,61.0,Female,,II,,,2020-06-19,Radiation,Private,Alive,106.0,KRAS,Yes,Never,Moderate,35.9,Medium,Rural,Private Insurance,17.0,Yes,No,Diabetes,3.0
PT05724,Switzerland,Zurich,50.0,Female,Colorectal,I,2011-01-23,2011-06-20,2011-10-14,Immunotherapy,Private,Alive,80.0,,Yes,Never,None,36.9,Medium,Urban,Statutory Health Insurance,12.0,No,No,None,10.0
PT05725,Spain,Madrid,71.0,Male,Prostate,IV,2014-11-24,2014-12-15,2015-07-11,Targeted Therapy,Research Institute,Deceased,76.0,None,No,Former,Heavy,19.9,Low,Rural,NHS,11.0,No,No,Obesity,6.0
PT05726,Norway,Oslo,21.0,Female,Pancreatic,III,2011-06-29,2011-08-19,2011-12-04,Targeted Therapy,Public,Alive,81.0,BRCA1,Yes,Former,Moderate,18.1,Medium,Urban,Statutory Health Insurance,5.0,Yes,No,None,8.0
PT05727,France,Auvergne-Rhône-Alpes,57.0,Female,Breast,III,2017-12-16,2018-05-23,2018-08-07,Chemotherapy,,Alive,73.0,EGFR,No,Current,Moderate,32.0,Medium,Urban,Private Insurance,18.0,Yes,No,Obesity,9.0
PT05728,Switzerland,,51.0,Female,Prostate,III,2018-02-13,2018-08-08,2019-01-18,Surgery,Public,Alive,28.0,EGFR,No,Never,Moderate,19.2,Medium,Urban,Private Insurance,6.0,No,No,Hypertension,2.0
PT05729,Ireland,Connacht,29.0,Non-binary,Colorectal,IV,2017-07-09,2017-07-10,2018-01-08,Targeted Therapy,Public,Deceased,31.0,None,Yes,Never,None,27.1,Medium,Rural,Private Insurance,19.0,No,No,Cardiovascular Disease,
PT05730,Switzerland,Bern,27.0,Male,Colorectal,II,2022-10-21,2023-04-02,2024-01-25,Targeted Therapy,Private,Alive,53.0,None,No,Never,Moderate,37.9,High,Urban,Private Insurance,4.0,No,Yes,Hypertension,1.0
PT05731,Norway,Oslo,39.0,Male,Breast,I,2013-03-07,2013-08-08,2013-12-30,Chemotherapy,Research Institute,Alive,65.0,KRAS,No,Never,None,23.7,Low,Urban,NHS,3.0,No,No,Hypertension,7.0
PT05732,Poland,,39.0,Male,Colorectal,I,2021-07-28,2021-08-06,2021-10-27,Targeted Therapy,Private,Alive,71.0,KRAS,No,Current,None,23.9,Low,Urban,Private Insurance,19.0,No,,Diabetes,1.0
PT05733,Netherlands,North Holland,28.0,Female,Leukemia,III,,2019-05-29,2020-02-24,,Public,Deceased,21.0,KRAS,No,Never,None,30.8,Low,Urban,Statutory Health Insurance,2.0,No,No,None,2.0
PT05734,Switzerland,Bern,34.0,Female,Colorectal,III,2014-07-17,2015-01-01,2015-12-19,Radiation,Public,Alive,,BRCA1,Yes,Never,Moderate,39.7,Low,Urban,Private Insurance,15.0,No,No,None,5.0
,Denmark,Capital Region,82.0,,Ovarian,III,2022-03-20,2022-04-10,2023-02-20,Chemotherapy,Public,,80.0,None,No,Current,Moderate,20.3,Low,Rural,Statutory Health Insurance,17.0,,No,None,7.0
PT05736,Austria,Tyrol,40.0,Male,Breast,I,2011-02-25,2011-05-16,2011-08-20,Immunotherapy,Public,Alive,92.0,KRAS,No,Never,Heavy,39.1,Medium,Rural,Private Insurance,15.0,No,No,None,3.0
PT05737,Austria,Styria,24.0,Female,Breast,IV,2022-05-17,2022-10-04,2023-05-04,Immunotherapy,Public,,56.0,BRCA1,No,Never,Moderate,32.0,Medium,Urban,NHS,18.0,No,,Diabetes,1.0
PT05738,Ireland,Connacht,54.0,Female,,II,2014-12-14,2015-01-20,2015-10-07,Surgery,Public,Alive,28.0,EGFR,Yes,Never,Moderate,34.7,Medium,Rural,,13.0,Yes,No,None,10.0
PT05739,Switzerland,Bern,87.0,Female,Colorectal,III,2020-12-01,2021-03-02,2022-01-10,,Public,Alive,56.0,EGFR,Yes,Current,Moderate,21.9,Medium,Urban,NHS,1.0,No,No,Diabetes,5.0
PT05740,Sweden,Skåne,67.0,Male,Colorectal,I,2021-02-17,2021-04-29,2021-11-07,Targeted Therapy,Private,Alive,114.0,None,Yes,Current,Moderate,31.2,Low,Urban,Private Insurance,16.0,No,No,Hypertension,3.0
PT05741,Netherlands,Utrecht,81.0,Female,Pancreatic,IV,2016-01-19,2016-06-19,2016-10-30,Targeted Therapy,Research Institute,Alive,60.0,,Yes,Never,None,21.4,Medium,Urban,Statutory Health Insurance,7.0,No,No,Obesity,3.0
PT05742,Finland,Pirkanmaa,54.0,Non-binary,Pancreatic,II,2021-06-22,2021-12-17,2022-06-27,Immunotherapy,Private,,99.0,EGFR,No,Former,None,28.7,Low,Rural,Statutory Health Insurance,12.0,No,No,Hypertension,1.0
PT05743,Germany,North Rhine-Westphalia,89.0,Non-binary,Breast,II,2013-03-31,2013-07-19,2014-06-19,Chemotherapy,,,,BRCA1,No,Current,Moderate,27.4,High,Rural,Statutory Health Insurance,14.0,No,No,None,10.0
PT05744,Norway,Vestland,40.0,Female,Pancreatic,IV,2023-07-02,2023-10-14,2024-08-24,Radiation,Research Institute,Alive,108.0,None,No,Never,Moderate,34.5,Medium,Urban,Statutory Health Insurance,14.0,No,No,Obesity,4.0
PT05745,Austria,Tyrol,58.0,Female,Prostate,IV,2014-12-25,2015-04-13,2016-02-07,Surgery,Public,Alive,,BRCA1,Yes,Former,Moderate,26.1,High,Urban,Statutory Health Insurance,15.0,No,Yes,Hypertension,1.0
PT05746,Ireland,,53.0,Male,Ovarian,I,2022-06-25,2022-11-28,2023-01-25,Targeted Therapy,Private,Lost to Follow-up,,KRAS,Yes,Never,Moderate,19.6,Low,Urban,Private Insurance,7.0,,No,Hypertension,6.0
PT05747,Netherlands,North Holland,34.0,Male,Prostate,IV,2012-07-19,2012-07-23,2012-11-04,Surgery,Public,Alive,89.0,KRAS,No,Former,Moderate,38.8,Low,Urban,Statutory Health Insurance,17.0,Yes,No,Diabetes,5.0
PT05748,France,Provence-Alpes-Côte d'Azur,25.0,,Leukemia,III,2023-01-29,2023-06-18,2024-05-25,Immunotherapy,Public,Alive,85.0,None,Yes,Never,None,21.2,Medium,Rural,NHS,5.0,No,Yes,Diabetes,6.0
PT05749,France,Île-de-France,85.0,Male,Ovarian,I,2019-04-10,2019-06-16,2019-11-04,Chemotherapy,Public,Lost to Follow-up,,None,No,Former,None,26.4,,Rural,NHS,2.0,No,Yes,Hypertension,10.0
PT05750,Sweden,Västra Götaland,,Male,,I,2013-09-15,2014-02-27,2014-12-01,Immunotherapy,Research Institute,Alive,118.0,KRAS,No,Former,Moderate,29.4,High,Rural,NHS,8.0,No,No,Obesity,3.0
PT05751,Portugal,Lisbon,68.0,Male,Breast,,2011-10-19,2011-10-23,2012-09-23,Radiation,Private,Alive,16.0,KRAS,Yes,Former,None,37.5,Medium,Rural,Private Insurance,18.0,No,Yes,Obesity,3.0
PT05752,Poland,Lesser Poland,20.0,,Prostate,II,2013-04-20,2013-05-05,2014-04-23,,Public,Alive,51.0,None,No,Current,None,,Low,Rural,Statutory Health Insurance,18.0,Yes,No,Obesity,5.0
PT05753,Finland,Southwest Finland,84.0,Female,Prostate,III,2017-11-07,2018-04-12,2019-01-12,Radiation,Public,Deceased,100.0,KRAS,No,Never,Moderate,32.9,High,Urban,NHS,3.0,No,No,Diabetes,2.0
PT05754,Austria,Vienna,47.0,,Leukemia,I,2011-04-01,2011-05-08,2011-08-03,Radiation,Public,Lost to Follow-up,,EGFR,Yes,Never,Moderate,,Medium,Rural,NHS,,No,No,None,3.0
PT05755,Poland,Lesser Poland,39.0,Female,Ovarian,III,2023-09-24,2024-02-08,2024-07-26,Chemotherapy,Public,Lost to Follow-up,,KRAS,No,Never,None,35.3,High,Urban,NHS,7.0,,No,None,3.0
PT05756,France,Auvergne-Rhône-Alpes,67.0,Female,Pancreatic,III,2021-12-19,2022-01-02,2022-12-22,Radiation,Public,Alive,93.0,EGFR,No,Never,Moderate,37.2,High,Urban,Statutory Health Insurance,6.0,No,No,Cardiovascular Disease,
PT05757,Spain,Madrid,84.0,Male,,III,2015-09-16,2016-01-17,2016-10-15,Surgery,Public,Deceased,63.0,KRAS,No,Never,,22.7,Low,,Private Insurance,16.0,No,No,Diabetes,2.0
PT05758,Netherlands,North Holland,70.0,Male,Breast,IV,2016-10-26,2017-02-14,2018-02-02,Targeted Therapy,Private,Alive,31.0,None,No,Never,Moderate,31.5,,Urban,Statutory Health Insurance,1.0,No,No,Hypertension,5.0
PT05759,Netherlands,South Holland,62.0,Female,Ovarian,III,2012-05-24,2012-09-27,2013-08-14,Chemotherapy,,Deceased,71.0,EGFR,,Current,Moderate,29.5,High,Urban,Statutory Health Insurance,12.0,No,Yes,None,3.0
PT05760,Ireland,Connacht,,Female,Prostate,I,2018-07-05,2018-09-25,2019-07-01,Immunotherapy,Public,Alive,62.0,KRAS,Yes,Former,Moderate,30.7,Medium,Urban,Statutory Health Insurance,4.0,No,No,Hypertension,10.0
PT05761,Norway,Vestland,44.0,Male,Breast,III,2021-05-26,2021-07-15,2021-12-21,Immunotherapy,Private,Alive,84.0,EGFR,Yes,Never,None,36.8,Medium,Urban,NHS,11.0,Yes,,Hypertension,4.0
PT05762,Poland,Lesser Poland,60.0,Male,Leukemia,IV,2013-12-04,2014-02-20,2015-01-06,Targeted Therapy,Public,Alive,50.0,None,No,Never,Moderate,24.5,Low,Urban,Statutory Health Insurance,8.0,No,No,Obesity,8.0
PT05763,Italy,Lombardy,83.0,Male,Colorectal,I,2022-03-14,2022-04-08,2022-09-09,Immunotherapy,Private,Deceased,114.0,KRAS,No,Current,Moderate,24.6,Medium,Urban,Private Insurance,5.0,No,No,None,3.0
PT05764,Austria,Tyrol,80.0,Male,Leukemia,IV,2018-09-28,2018-11-06,2019-08-26,Targeted Therapy,Public,Deceased,106.0,KRAS,No,,Heavy,33.8,Low,Urban,Statutory Health Insurance,11.0,No,No,Cardiovascular Disease,4.0
PT05765,Poland,Silesian,31.0,Male,Prostate,I,2020-03-27,2020-04-22,2020-12-08,Surgery,Private,Alive,27.0,None,Yes,Never,Moderate,29.1,Low,Urban,Private Insurance,15.0,No,Yes,Diabetes,10.0
PT05766,Ireland,Munster,88.0,Female,Breast,II,2021-01-12,,2022-01-20,Immunotherapy,,Alive,31.0,BRCA1,No,Former,None,31.2,Medium,Rural,NHS,15.0,Yes,No,Obesity,4.0
PT05767,Netherlands,South Holland,33.0,Female,Pancreatic,III,2023-10-23,2023-12-14,2024-07-18,Immunotherapy,Public,Alive,54.0,BRCA1,No,Never,Moderate,35.1,Medium,Urban,NHS,12.0,No,No,,6.0
PT05768,Portugal,Porto,53.0,Female,Pancreatic,III,2011-07-29,2011-10-07,2011-12-19,Surgery,Public,Alive,73.0,EGFR,Yes,Current,None,26.2,Medium,Rural,Private Insurance,18.0,Yes,No,,3.0
PT05769,Ireland,Munster,67.0,Male,Prostate,III,2012-12-31,2013-06-03,2013-07-12,Immunotherapy,Public,Alive,11.0,None,No,Never,Heavy,25.0,Medium,Urban,Private Insurance,3.0,,No,Hypertension,2.0
PT05770,Switzerland,Zurich,80.0,Female,Leukemia,II,2017-12-05,2018-01-22,2018-02-25,Immunotherapy,Private,Deceased,27.0,EGFR,Yes,Never,Moderate,27.1,Medium,Urban,Private Insurance,17.0,No,No,Diabetes,5.0
PT05771,France,Provence-Alpes-Côte d'Azur,54.0,Male,Leukemia,III,2015-06-12,2015-08-05,2016-02-25,Surgery,Research Institute,Deceased,43.0,KRAS,Yes,Current,Moderate,18.6,Medium,Rural,Statutory Health Insurance,16.0,No,No,Hypertension,7.0
PT05772,,Connacht,84.0,Male,Lung,III,2010-10-17,2011-02-09,2011-08-16,Surgery,Public,Alive,28.0,KRAS,Yes,Former,None,36.0,Medium,Urban,NHS,7.0,No,No,Hypertension,5.0
PT05773,Denmark,Central Denmark,78.0,Female,Leukemia,II,2016-10-03,2017-03-21,2017-12-19,Surgery,Private,Deceased,69.0,KRAS,No,Current,Moderate,,Medium,Rural,NHS,17.0,No,No,Obesity,8.0
PT05774,Norway,Vestland,55.0,Female,Prostate,II,2014-05-08,2014-09-01,2014-10-29,Immunotherapy,Private,Alive,94.0,KRAS,No,Current,Moderate,27.2,High,Urban,NHS,11.0,No,No,Diabetes,3.0
PT05775,Portugal,Lisbon,38.0,Male,Ovarian,III,2014-01-18,2014-05-27,2014-11-26,Targeted Therapy,Private,Deceased,72.0,,No,Never,None,35.3,Medium,Urban,Private Insurance,7.0,No,Yes,,
PT05776,Poland,,61.0,Female,Ovarian,II,2012-03-15,2012-07-07,2012-11-08,Targeted Therapy,Public,Deceased,25.0,KRAS,No,Current,None,22.5,Medium,,NHS,12.0,No,No,Cardiovascular Disease,2.0
PT05777,Poland,,88.0,Female,Breast,,2011-09-04,2011-09-25,,Chemotherapy,Public,Alive,38.0,BRCA1,Yes,Never,Moderate,21.3,Medium,Urban,Private Insurance,15.0,Yes,No,Cardiovascular Disease,3.0
PT05778,Ireland,Dublin,38.0,Female,Breast,I,2011-04-17,2011-08-05,2012-08-03,Chemotherapy,Private,Alive,117.0,None,No,Never,None,38.0,Medium,Rural,NHS,10.0,No,No,Obesity,1.0
PT05779,,Styria,58.0,Female,Lung,III,2015-05-24,2015-08-04,2015-12-03,Immunotherapy,Research Institute,Alive,118.0,None,No,Current,Heavy,38.3,High,Rural,Statutory Health Insurance,16.0,,No,Hypertension,3.0
PT05780,Austria,Vienna,88.0,Non-binary,Pancreatic,I,2022-03-23,2022-08-23,,Immunotherapy,Public,Alive,25.0,None,No,Former,None,35.5,Medium,Rural,NHS,11.0,No,Yes,Diabetes,5.0
PT05781,Switzerland,Geneva,71.0,Female,Prostate,II,2011-02-14,2011-03-04,2011-11-24,Targeted Therapy,Public,Deceased,,EGFR,No,Former,None,21.3,Low,Urban,Private Insurance,7.0,Yes,No,Diabetes,1.0
PT05782,Netherlands,South Holland,31.0,Female,Leukemia,I,2014-06-14,2014-06-29,2015-06-25,Radiation,Private,Alive,81.0,EGFR,Yes,Never,Moderate,36.2,Medium,Urban,Statutory Health Insurance,15.0,No,No,None,5.0
PT05783,Belgium,Brussels,66.0,Male,Colorectal,I,2020-11-03,2020-12-15,,,Public,Alive,49.0,BRCA1,No,Former,None,38.6,Low,Rural,Private Insurance,11.0,No,No,Obesity,4.0
,Sweden,Stockholm,55.0,Male,Breast,II,2019-10-15,2019-11-04,2020-02-26,Targeted Therapy,Public,Alive,88.0,EGFR,No,Current,Moderate,36.8,,Urban,Private Insurance,13.0,No,No,None,
PT05785,Norway,Vestland,82.0,,Prostate,II,2010-06-10,2010-06-26,2011-04-05,Immunotherapy,Private,Alive,,KRAS,Yes,Former,Moderate,26.8,Low,Urban,Private Insurance,2.0,No,No,Cardiovascular Disease,6.0
PT05786,Austria,Tyrol,70.0,Female,Ovarian,II,2017-06-18,2017-10-31,2018-07-08,Chemotherapy,Public,Alive,30.0,EGFR,No,Current,None,20.0,Medium,Rural,Statutory Health Insurance,8.0,No,,None,3.0
PT05787,Portugal,Lisbon,62.0,Male,Lung,I,2020-08-02,2020-11-05,2021-08-10,Chemotherapy,Research Institute,Alive,118.0,EGFR,,Former,Heavy,26.4,High,Urban,Private Insurance,4.0,No,No,,
PT05788,Poland,Masovian,53.0,Non-binary,Colorectal,IV,2021-04-01,2021-07-03,,Chemotherapy,Public,,54.0,BRCA1,No,,Moderate,18.1,High,Rural,Statutory Health Insurance,1.0,Yes,No,Hypertension,4.0
PT05789,Sweden,Skåne,,Male,,I,2019-07-11,2019-09-30,2020-08-27,Immunotherapy,Public,Deceased,87.0,None,No,Never,None,29.4,High,Urban,Private Insurance,7.0,No,No,Hypertension,7.0
,Switzerland,Geneva,37.0,Female,Prostate,IV,2015-06-10,2015-10-21,2015-12-09,,Public,Alive,20.0,EGFR,Yes,Former,Moderate,18.2,,Urban,Statutory Health Insurance,16.0,No,No,None,3.0
PT05791,France,Provence-Alpes-Côte d'Azur,80.0,Male,Leukemia,III,2015-02-22,2015-07-18,2015-12-18,Radiation,Public,Alive,107.0,KRAS,Yes,Never,Moderate,30.3,High,Urban,Statutory Health Insurance,10.0,No,No,Cardiovascular Disease,8.0
PT05792,Italy,Veneto,76.0,Female,Pancreatic,I,2019-05-20,2019-08-06,2020-01-28,Immunotherapy,Public,Alive,32.0,KRAS,No,Never,Moderate,27.9,Low,Rural,NHS,13.0,No,No,,4.0
PT05793,Belgium,Flanders,24.0,Female,Ovarian,II,2019-01-31,2019-05-06,2020-01-20,Chemotherapy,,Deceased,110.0,BRCA1,Yes,,None,25.6,High,Rural,Statutory Health Insurance,3.0,No,No,Obesity,1.0
PT05794,France,Auvergne-Rhône-Alpes,43.0,Male,Breast,IV,2022-06-01,2022-10-25,2023-10-24,Surgery,Public,Lost to Follow-up,,BRCA1,No,Former,Moderate,24.6,Medium,Urban,NHS,10.0,Yes,Yes,Diabetes,4.0
PT05795,Denmark,Capital Region,83.0,Male,Ovarian,III,2011-02-25,2011-04-30,2011-07-29,Targeted Therapy,,Alive,93.0,None,No,Never,None,36.2,Low,Urban,Statutory Health Insurance,17.0,Yes,No,Cardiovascular Disease,9.0
PT05796,Austria,Vienna,78.0,Female,,I,2020-08-29,2021-01-29,2021-06-28,Immunotherapy,Public,Alive,,KRAS,No,Current,None,29.2,Medium,Urban,NHS,18.0,No,No,None,9.0
PT05797,Norway,Oslo,57.0,Female,Lung,II,2011-05-15,2011-06-10,2012-03-21,Chemotherapy,Public,Alive,26.0,EGFR,No,Current,Moderate,24.3,Medium,Urban,NHS,10.0,No,No,Diabetes,8.0
PT05798,Germany,Berlin,52.0,Female,Breast,II,2010-09-03,2011-01-25,2011-09-15,Radiation,Private,Alive,109.0,EGFR,,Former,Heavy,33.0,Low,Urban,NHS,18.0,No,No,Hypertension,6.0
PT05799,Ireland,Connacht,29.0,Non-binary,Colorectal,III,2022-02-28,2022-05-16,2022-06-19,Chemotherapy,Private,Deceased,106.0,BRCA1,No,Former,Moderate,31.2,High,Rural,Private Insurance,9.0,No,No,Obesity,3.0
PT05800,France,Provence-Alpes-Côte d'Azur,56.0,Male,Breast,IV,2011-04-25,2011-06-22,2012-05-30,Chemotherapy,Public,Deceased,84.0,KRAS,No,Never,Moderate,25.0,Medium,Urban,NHS,10.0,No,No,Diabetes,7.0
PT05801,Denmark,Central Denmark,30.0,Female,Ovarian,I,2013-08-26,2013-11-30,2014-03-16,Immunotherapy,Public,Lost to Follow-up,,KRAS,Yes,Never,,39.7,Medium,Urban,Statutory Health Insurance,6.0,No,,Diabetes,7.0
PT05802,Denmark,Capital Region,43.0,Female,Leukemia,II,2017-01-11,2017-06-15,2018-05-26,Radiation,Public,Alive,31.0,KRAS,No,Never,None,35.1,High,Urban,Statutory Health Insurance,7.0,No,No,Hypertension,10.0
PT05803,Italy,Sicily,,Non-binary,Pancreatic,I,2021-09-05,2022-03-01,,Surgery,Private,Alive,15.0,KRAS,No,Never,Heavy,33.2,Medium,Rural,Private Insurance,8.0,No,No,Cardiovascular Disease,5.0
PT05804,Germany,Bavaria,39.0,Female,Prostate,IV,,2021-09-01,,Immunotherapy,Public,Deceased,72.0,EGFR,No,Current,,20.1,Medium,Urban,NHS,10.0,No,No,Cardiovascular Disease,
PT05805,Sweden,Skåne,29.0,Female,Ovarian,,2012-01-28,2012-04-08,2012-12-01,Targeted Therapy,Public,Alive,108.0,EGFR,Yes,Never,Moderate,21.1,Low,Rural,Statutory Health Insurance,6.0,No,No,Diabetes,5.0
PT05806,Ireland,Munster,66.0,Female,Prostate,IV,2015-10-12,2016-02-12,2017-01-02,Radiation,,Alive,,None,No,Never,Moderate,30.7,Medium,Urban,,19.0,No,No,Cardiovascular Disease,10.0
PT05807,Norway,Vestland,66.0,Male,Prostate,II,2010-04-19,,2011-05-26,Surgery,Public,Alive,43.0,None,Yes,Never,None,38.1,High,Rural,NHS,2.0,No,No,Cardiovascular Disease,4.0
,Austria,Tyrol,34.0,Male,Ovarian,III,2012-01-16,2012-03-02,2012-09-27,Surgery,Research Institute,Alive,60.0,BRCA1,No,Never,Moderate,28.3,Medium,Rural,Statutory Health Insurance,13.0,No,Yes,None,7.0
PT05809,Spain,Andalusia,63.0,Female,Ovarian,I,2014-02-25,2014-03-05,2014-12-17,Radiation,Public,Alive,74.0,BRCA1,Yes,Former,None,,Low,Urban,Statutory Health Insurance,6.0,No,No,Cardiovascular Disease,3.0
PT05810,Finland,Southwest Finland,81.0,Female,Ovarian,IV,,,2015-01-24,Targeted Therapy,Public,Alive,93.0,BRCA1,No,Never,Heavy,29.8,High,Rural,Private Insurance,3.0,Yes,No,Diabetes,2.0
PT05811,Norway,Trøndelag,25.0,Female,Lung,II,2022-05-10,2022-10-03,2023-03-20,Chemotherapy,Public,Alive,109.0,KRAS,Yes,Never,None,38.7,Medium,Urban,Private Insurance,4.0,No,Yes,,1.0
,Spain,Andalusia,85.0,Female,Lung,III,2013-09-10,2013-10-16,2013-11-25,Immunotherapy,Private,,,BRCA1,Yes,Former,Heavy,30.5,Low,Urban,Private Insurance,4.0,,No,Obesity,7.0
PT05813,Belgium,Flanders,23.0,Male,Prostate,I,2019-01-25,2019-04-23,,,Private,Alive,74.0,BRCA1,No,Former,Moderate,36.6,Medium,Rural,NHS,9.0,No,No,None,10.0
PT05814,Denmark,Zealand,42.0,Female,,III,2011-12-11,2012-04-08,2012-06-04,Surgery,Private,Deceased,37.0,EGFR,No,Never,Moderate,36.9,Medium,Urban,Private Insurance,11.0,,No,Hypertension,1.0
PT05815,Netherlands,North Holland,32.0,Male,Leukemia,II,2019-10-28,2019-12-09,2020-05-05,Targeted Therapy,Public,Lost to Follow-up,,KRAS,Yes,Never,None,22.5,High,Rural,,9.0,No,No,None,2.0
PT05816,Switzerland,Geneva,50.0,Male,Colorectal,I,2022-11-27,,2023-12-12,Chemotherapy,Public,Alive,,BRCA1,No,Current,Heavy,29.8,Medium,Urban,,7.0,Yes,Yes,None,4.0
PT05817,Sweden,Skåne,35.0,Male,Ovarian,II,2021-11-26,2022-04-14,2022-05-20,,Public,Alive,53.0,BRCA1,Yes,Never,Moderate,19.5,High,Rural,Statutory Health Insurance,1.0,,No,Hypertension,4.0
PT05818,Germany,North Rhine-Westphalia,60.0,Female,Ovarian,II,2012-01-08,2012-03-07,2012-08-26,Targeted Therapy,Private,Deceased,32.0,None,,Current,Moderate,21.1,Medium,,Statutory Health Insurance,5.0,No,Yes,Obesity,6.0
PT05819,Germany,Bavaria,20.0,Male,Prostate,I,2016-12-26,2017-02-13,2017-03-21,Surgery,Public,Deceased,81.0,KRAS,No,Former,Heavy,26.9,Low,Rural,NHS,8.0,No,Yes,None,5.0
PT05820,Germany,Bavaria,31.0,Female,Leukemia,I,2016-01-11,2016-04-24,,Targeted Therapy,Public,Alive,37.0,,No,,Moderate,19.5,High,Urban,,6.0,No,No,Cardiovascular Disease,3.0
PT05821,Netherlands,South Holland,75.0,,Lung,II,2022-11-07,2023-03-15,2023-05-03,Immunotherapy,Public,Deceased,108.0,EGFR,No,Current,None,20.8,Low,Urban,Statutory Health Insurance,18.0,No,,None,8.0
PT05822,,Berlin,69.0,Male,Breast,II,2013-12-12,2014-02-24,2014-03-28,Radiation,Public,Alive,41.0,None,Yes,Never,None,22.9,Low,Rural,Statutory Health Insurance,6.0,No,No,None,10.0
PT05823,Belgium,Flanders,39.0,Female,Breast,II,2011-11-15,2011-12-15,2012-02-02,Surgery,Public,,60.0,None,No,Never,None,33.7,Medium,Urban,Statutory Health Insurance,10.0,No,No,None,8.0
PT05824,Sweden,Skåne,85.0,,Leukemia,II,2015-04-05,2015-05-03,2016-02-22,Radiation,Private,Deceased,75.0,BRCA1,Yes,Never,None,20.5,Low,Urban,Private Insurance,15.0,Yes,Yes,Obesity,4.0
PT05825,France,Auvergne-Rhône-Alpes,55.0,Male,Colorectal,I,2016-01-17,2016-04-19,2016-12-31,Targeted Therapy,Private,Alive,113.0,EGFR,No,Never,,35.1,,,Private Insurance,2.0,No,No,None,
PT05826,,Sicily,57.0,Male,Leukemia,I,2019-03-06,2019-09-01,2020-05-05,Chemotherapy,Research Institute,Alive,18.0,None,No,Never,Heavy,30.3,Medium,Urban,NHS,,No,Yes,None,
PT05827,Belgium,Flanders,41.0,Female,Colorectal,III,2016-01-29,2016-02-25,2016-09-06,,Public,Alive,55.0,EGFR,Yes,Former,None,39.6,Medium,Urban,Statutory Health Insurance,2.0,Yes,Yes,Hypertension,4.0
PT05828,Austria,Styria,80.0,Male,Ovarian,I,,2021-04-04,2021-06-23,Targeted Therapy,Public,Alive,100.0,KRAS,No,Former,Heavy,19.7,Low,Rural,NHS,10.0,Yes,Yes,Hypertension,3.0
PT05829,Germany,North Rhine-Westphalia,69.0,Female,Pancreatic,III,2019-05-09,2019-08-15,2020-03-01,Targeted Therapy,Public,Alive,,KRAS,Yes,Former,Moderate,35.6,Low,Urban,NHS,13.0,No,No,Hypertension,
PT05830,Switzerland,Geneva,78.0,Male,Colorectal,II,2010-09-28,2010-11-19,2011-01-17,Chemotherapy,Public,Alive,34.0,KRAS,Yes,Never,None,28.4,Low,Urban,NHS,17.0,No,Yes,Hypertension,8.0
PT05831,France,Provence-Alpes-Côte d'Azur,39.0,Male,Breast,IV,2015-03-05,2015-08-14,2016-05-13,Targeted Therapy,Private,Alive,15.0,BRCA1,Yes,Never,Moderate,19.0,Low,Urban,NHS,4.0,No,No,Obesity,4.0
PT05832,Denmark,,55.0,Male,Lung,I,,2023-05-17,2023-07-30,Immunotherapy,Public,Alive,44.0,KRAS,No,Never,None,36.4,High,Rural,NHS,19.0,No,No,Cardiovascular Disease,7.0
PT05833,Ireland,Munster,34.0,Female,Prostate,III,2023-12-16,2024-01-29,2024-09-29,Chemotherapy,Public,Alive,108.0,None,No,Never,None,29.4,,Urban,Private Insurance,12.0,No,,Hypertension,9.0
PT05834,Spain,Madrid,81.0,Female,Ovarian,II,2013-07-03,2013-11-12,2014-01-03,Surgery,Public,Alive,8.0,None,No,Never,None,27.3,Medium,Urban,Statutory Health Insurance,1.0,,No,Cardiovascular Disease,3.0
PT05835,Sweden,Skåne,22.0,Male,Lung,I,2020-12-08,2021-01-25,2021-04-17,Surgery,Public,Alive,114.0,EGFR,Yes,,Moderate,32.2,Low,Urban,Private Insurance,10.0,No,Yes,Hypertension,8.0
PT05836,Ireland,Connacht,24.0,Female,Prostate,I,2019-06-27,2019-10-03,2019-12-13,Radiation,Public,Alive,87.0,BRCA1,Yes,Current,Moderate,26.5,Medium,Rural,Statutory Health Insurance,10.0,No,No,Cardiovascular Disease,5.0
PT05837,Sweden,Skåne,75.0,Female,Pancreatic,II,2017-10-01,2017-10-17,2018-04-28,,Public,Alive,53.0,None,,Never,None,28.3,High,Urban,NHS,16.0,No,No,Cardiovascular Disease,4.0
PT05838,Italy,Veneto,50.0,Female,Breast,II,2014-04-17,2014-06-03,2014-10-14,Immunotherapy,Private,Alive,98.0,None,No,Never,Moderate,25.1,Low,Urban,Statutory Health Insurance,,Yes,No,None,6.0
PT05839,Finland,Southwest Finland,54.0,Male,Ovarian,II,2015-07-31,2015-11-18,,,Private,Alive,47.0,EGFR,Yes,Former,None,24.1,Medium,,Private Insurance,3.0,Yes,No,Diabetes,1.0
PT05840,France,Île-de-France,89.0,Male,Prostate,IV,2012-03-04,2012-05-18,2012-11-17,Targeted Therapy,Private,,52.0,,Yes,Never,Moderate,27.9,Medium,Urban,Private Insurance,4.0,No,No,Obesity,5.0
PT05841,Sweden,Stockholm,45.0,Female,Pancreatic,II,2012-10-27,2012-11-11,2013-11-02,Immunotherapy,Public,Alive,31.0,KRAS,No,Never,None,27.5,Low,Rural,NHS,2.0,,No,None,
PT05842,Finland,Pirkanmaa,20.0,Male,Ovarian,II,2012-05-09,2012-08-19,,Immunotherapy,Private,Alive,37.0,None,No,Former,None,20.2,Medium,Urban,Private Insurance,14.0,No,Yes,Diabetes,3.0
PT05843,Denmark,Central Denmark,26.0,Male,Colorectal,III,2022-06-01,2022-09-03,2022-11-14,Targeted Therapy,,Alive,32.0,EGFR,Yes,Never,Moderate,24.1,Medium,Rural,Statutory Health Insurance,6.0,No,No,Obesity,6.0
PT05844,Ireland,,55.0,Female,Leukemia,III,2011-07-05,2011-11-26,2012-02-17,Chemotherapy,Public,Alive,80.0,EGFR,Yes,Former,Heavy,21.3,Medium,Urban,Statutory Health Insurance,17.0,No,No,Diabetes,7.0
,Ireland,Dublin,44.0,Male,Ovarian,I,2014-04-15,2014-08-22,2015-07-25,Targeted Therapy,,Alive,110.0,None,No,Never,None,25.0,Medium,Rural,Statutory Health Insurance,16.0,No,No,Hypertension,10.0
PT05846,Poland,Masovian,78.0,Male,Ovarian,III,2011-11-09,2012-04-10,2012-05-22,Radiation,,,75.0,KRAS,Yes,Never,Moderate,29.2,Medium,Urban,Private Insurance,13.0,Yes,No,None,7.0
PT05847,Poland,Masovian,80.0,Male,Prostate,II,2011-04-07,2011-06-10,2011-10-29,Radiation,Public,Deceased,100.0,EGFR,No,Current,Moderate,30.5,High,Urban,Private Insurance,14.0,Yes,No,Obesity,10.0
PT05848,Norway,Oslo,48.0,,Lung,I,2014-03-03,2014-06-03,2014-08-27,Surgery,,Alive,13.0,BRCA1,Yes,Former,Heavy,36.3,Medium,Urban,NHS,3.0,,No,Obesity,6.0
PT05849,Belgium,Brussels,37.0,Male,Breast,I,2013-05-19,2013-07-01,2013-11-11,Chemotherapy,Private,Alive,113.0,None,No,Never,None,28.7,Medium,Urban,Private Insurance,11.0,No,Yes,None,4.0
PT05850,Ireland,Connacht,60.0,Female,Breast,I,2013-02-10,2013-02-24,2013-09-16,Immunotherapy,Public,Alive,93.0,EGFR,No,Current,Moderate,22.3,Medium,Urban,Private Insurance,10.0,Yes,No,Diabetes,8.0
PT05851,Norway,Oslo,38.0,Female,Ovarian,II,2021-07-14,2022-01-06,2022-12-23,Surgery,Public,Lost to Follow-up,,,Yes,Never,None,28.1,Low,Rural,NHS,15.0,No,No,Hypertension,5.0
PT05852,,Dublin,23.0,Female,Ovarian,I,2022-10-03,2022-12-10,2023-03-17,,Public,Alive,23.0,EGFR,No,Never,None,39.0,Medium,Rural,NHS,,,No,Diabetes,9.0
,Sweden,Stockholm,84.0,Male,,II,2016-02-27,2016-03-12,2016-04-23,Immunotherapy,Public,Deceased,78.0,KRAS,No,Current,Moderate,36.9,Medium,Urban,Statutory Health Insurance,10.0,No,Yes,None,5.0
,Italy,Sicily,60.0,Male,Leukemia,II,2010-05-04,2010-09-24,2011-08-05,Immunotherapy,Public,Alive,27.0,None,Yes,Current,Moderate,33.5,High,Urban,NHS,9.0,No,No,Diabetes,7.0
PT05855,Italy,Sicily,34.0,Female,Colorectal,III,2021-08-22,2022-01-14,2023-01-10,Targeted Therapy,Public,Deceased,112.0,EGFR,No,Never,Moderate,26.9,,Urban,Statutory Health Insurance,14.0,No,Yes,Obesity,5.0
PT05856,,Algarve,73.0,Male,,III,2022-05-02,2022-08-02,2023-02-08,Radiation,Private,Alive,68.0,EGFR,No,Former,None,24.2,Medium,Urban,Statutory Health Insurance,9.0,No,No,Diabetes,6.0
PT05857,Denmark,Zealand,83.0,Female,Colorectal,III,2022-06-28,2022-11-13,2023-05-27,Immunotherapy,Research Institute,Alive,,None,Yes,Never,None,28.0,Low,Urban,NHS,12.0,No,Yes,Cardiovascular Disease,4.0
PT05858,Denmark,Zealand,34.0,Female,Breast,IV,2023-04-12,2023-04-29,2024-03-22,Targeted Therapy,Private,Alive,79.0,EGFR,Yes,Never,None,32.7,High,Urban,Private Insurance,12.0,Yes,No,Hypertension,5.0
PT05859,Norway,Vestland,69.0,Female,Colorectal,IV,2023-04-30,2023-09-13,2024-06-27,Radiation,Research Institute,Deceased,6.0,,Yes,Former,None,37.5,Medium,Urban,NHS,6.0,Yes,No,Diabetes,4.0
PT05860,Ireland,Dublin,41.0,Male,Ovarian,IV,2020-10-05,2020-10-07,2020-12-18,Chemotherapy,Private,Alive,8.0,,No,,None,38.8,Medium,Urban,Private Insurance,1.0,Yes,No,,2.0
PT05861,Poland,Masovian,37.0,Female,Ovarian,I,2020-05-04,2020-07-08,2021-07-01,Chemotherapy,Private,Alive,113.0,KRAS,No,Former,Heavy,34.9,Medium,Urban,NHS,2.0,No,No,Obesity,4.0
PT05862,Belgium,Brussels,21.0,Male,Pancreatic,I,2017-11-24,2018-03-23,2018-11-06,Chemotherapy,Public,,95.0,EGFR,Yes,Never,Moderate,31.9,Low,Rural,Statutory Health Insurance,4.0,No,No,None,2.0
PT05863,Italy,Veneto,55.0,Male,Leukemia,II,2023-12-18,,2024-09-03,Immunotherapy,Public,Alive,61.0,EGFR,Yes,Never,None,19.5,Low,Urban,Statutory Health Insurance,11.0,No,No,Obesity,7.0
PT05864,Sweden,Skåne,39.0,Female,Breast,,2022-04-17,2022-08-02,2022-12-01,Radiation,Public,Deceased,12.0,EGFR,No,Never,None,32.0,Medium,,Private Insurance,3.0,No,No,Diabetes,2.0
PT05865,Sweden,Stockholm,35.0,,Colorectal,I,2015-09-29,2016-01-24,2016-03-25,Radiation,Public,Alive,32.0,None,No,Current,Moderate,34.5,Low,Urban,Statutory Health Insurance,4.0,No,No,Hypertension,10.0
PT05866,Finland,Southwest Finland,86.0,Female,Prostate,I,2017-08-04,2018-01-15,2018-10-28,Chemotherapy,Public,Alive,20.0,KRAS,No,Former,Moderate,36.6,Low,Urban,Private Insurance,3.0,No,No,Cardiovascular Disease,
PT05867,Spain,Madrid,49.0,Female,Prostate,,2014-12-07,,2015-02-19,Surgery,Private,Alive,92.0,EGFR,Yes,Current,Moderate,27.6,Medium,Rural,NHS,10.0,No,Yes,None,10.0
PT05868,Poland,Silesian,,Female,Pancreatic,II,2020-01-22,2020-06-12,2021-04-19,Radiation,Private,Alive,90.0,BRCA1,Yes,Current,Moderate,18.6,Medium,Rural,Private Insurance,5.0,No,Yes,,2.0
PT05869,Austria,,85.0,Male,Colorectal,II,2010-05-24,2010-08-06,2011-03-28,Radiation,Public,Deceased,115.0,KRAS,Yes,Never,Moderate,21.5,Medium,Urban,NHS,18.0,No,No,,
PT05870,Poland,Lesser Poland,45.0,Male,Prostate,I,2010-06-15,2010-07-07,2011-01-02,Targeted Therapy,Public,Alive,82.0,KRAS,Yes,Never,None,26.3,Medium,Rural,Statutory Health Insurance,11.0,No,No,Cardiovascular Disease,
PT05871,Spain,Andalusia,76.0,Female,Leukemia,III,2018-08-05,2018-08-21,2019-02-05,Chemotherapy,Public,Alive,37.0,None,No,Never,Moderate,33.1,Medium,Urban,Statutory Health Insurance,12.0,No,Yes,Cardiovascular Disease,2.0
PT05872,Denmark,Zealand,88.0,Male,Lung,II,2010-03-10,2010-08-26,2011-07-02,Surgery,Research Institute,Alive,54.0,EGFR,No,Never,,29.2,Medium,Rural,NHS,10.0,No,No,Hypertension,9.0
PT05873,Portugal,Algarve,21.0,Female,Leukemia,I,,2017-04-11,,Targeted Therapy,Research Institute,Alive,89.0,EGFR,No,Never,Moderate,,Medium,,Private Insurance,7.0,No,No,Diabetes,5.0
PT05874,Denmark,Central Denmark,75.0,Male,Pancreatic,IV,2010-01-25,2010-04-29,2010-11-17,Surgery,Public,Alive,117.0,None,No,Current,None,30.6,Low,Rural,NHS,3.0,No,No,Cardiovascular Disease,10.0
PT05875,Spain,Andalusia,81.0,Male,Leukemia,III,2020-10-03,2021-03-09,2021-09-18,,Private,Alive,74.0,EGFR,No,Current,Moderate,38.7,Medium,Urban,NHS,2.0,Yes,Yes,,8.0
PT05876,,Pirkanmaa,53.0,Male,Colorectal,III,2016-06-15,2016-11-18,2017-03-29,Surgery,Public,Lost to Follow-up,,None,No,Never,None,35.3,,Rural,NHS,8.0,Yes,,Hypertension,2.0
PT05877,Switzerland,Zurich,75.0,Female,Ovarian,IV,2021-03-31,2021-06-25,2022-05-10,Immunotherapy,Public,Deceased,110.0,BRCA1,No,Never,Heavy,35.9,Medium,Urban,NHS,12.0,Yes,,None,8.0
PT05878,Ireland,Dublin,74.0,Female,Leukemia,II,2011-07-31,2011-09-01,2012-07-14,Radiation,Private,Alive,37.0,,Yes,Current,None,33.3,Low,Urban,,17.0,No,No,Hypertension,2.0
PT05879,Sweden,Stockholm,39.0,Male,Colorectal,III,2021-11-08,2021-11-19,2022-03-30,Radiation,Private,Alive,58.0,None,Yes,Former,None,19.8,Low,Urban,,9.0,,No,None,10.0
PT05880,France,Auvergne-Rhône-Alpes,69.0,Male,Breast,I,2017-11-22,2018-04-25,2018-10-24,Targeted Therapy,Public,Deceased,116.0,None,No,Former,None,39.6,High,Urban,NHS,14.0,No,Yes,Diabetes,2.0
PT05881,Finland,Pirkanmaa,44.0,Female,Colorectal,III,2023-09-22,2024-02-28,2024-07-27,Surgery,Public,Alive,33.0,EGFR,Yes,Never,None,19.5,High,Urban,Private Insurance,6.0,No,No,Diabetes,3.0
PT05882,Portugal,Algarve,44.0,Male,Pancreatic,I,2011-08-14,2011-09-03,2011-11-28,Surgery,Public,Alive,110.0,KRAS,No,Never,Moderate,25.8,Low,Urban,NHS,4.0,No,No,Cardiovascular Disease,7.0
PT05883,Belgium,Brussels,72.0,Female,Colorectal,I,2014-07-26,2014-10-18,2015-03-03,Radiation,Public,Alive,97.0,KRAS,Yes,Never,None,35.8,Medium,Rural,Private Insurance,4.0,No,No,,1.0
PT05884,Germany,Bavaria,33.0,Female,Breast,II,2013-07-22,2014-01-07,2014-10-02,Surgery,Private,Alive,81.0,EGFR,No,Current,None,24.9,Medium,Urban,Private Insurance,11.0,No,Yes,None,7.0
PT05885,Switzerland,Geneva,79.0,Non-binary,Ovarian,I,2022-11-22,2023-01-28,2023-03-19,Surgery,Private,Alive,75.0,KRAS,No,Never,None,31.9,Medium,Rural,Statutory Health Insurance,2.0,No,No,Hypertension,1.0
,Portugal,Lisbon,62.0,Female,,II,2021-08-18,2021-10-01,2022-01-11,Surgery,Private,Alive,95.0,None,No,Never,Heavy,37.7,Medium,Rural,Statutory Health Insurance,12.0,Yes,No,None,4.0
PT05887,Italy,Sicily,,Male,Pancreatic,II,2019-08-25,2019-11-28,2020-01-17,Chemotherapy,Public,Alive,86.0,BRCA1,No,Never,None,35.9,,,Statutory Health Insurance,1.0,No,No,Cardiovascular Disease,9.0
PT05888,,Lombardy,88.0,Non-binary,Breast,III,2016-03-13,2016-06-27,2017-05-20,Chemotherapy,Private,Alive,41.0,BRCA1,Yes,Never,None,30.4,Low,Urban,Private Insurance,3.0,No,No,Diabetes,4.0
PT05889,Spain,Andalusia,82.0,Female,Colorectal,I,2023-01-07,2023-05-22,2023-07-01,Chemotherapy,Public,Alive,67.0,BRCA1,No,Former,None,29.3,High,Urban,,12.0,No,No,Obesity,
PT05890,Finland,Southwest Finland,21.0,Female,Pancreatic,I,2020-07-30,2020-11-01,2021-01-27,Targeted Therapy,,Alive,15.0,EGFR,No,Former,Moderate,22.7,Medium,Urban,Private Insurance,7.0,No,No,Cardiovascular Disease,2.0
PT05891,France,Île-de-France,73.0,Male,Prostate,III,2022-01-23,2022-03-18,2022-12-12,Surgery,Public,Alive,95.0,KRAS,No,Never,Heavy,31.1,Medium,Rural,Private Insurance,14.0,Yes,No,Cardiovascular Disease,9.0
PT05892,Denmark,Capital Region,35.0,Female,Colorectal,III,2021-08-15,2021-11-05,2022-09-27,Chemotherapy,Public,Alive,85.0,KRAS,No,Never,Moderate,33.2,Medium,Rural,Private Insurance,6.0,Yes,No,Hypertension,5.0
PT05893,Spain,Madrid,74.0,Female,Breast,I,,2019-09-11,2020-01-04,Chemotherapy,Public,Alive,,KRAS,Yes,Never,Heavy,31.4,Medium,Urban,Statutory Health Insurance,16.0,No,No,None,2.0
PT05894,Denmark,,62.0,Female,Colorectal,II,2019-03-01,2019-04-03,2019-09-23,Immunotherapy,Public,,85.0,KRAS,No,Never,None,23.2,Low,Urban,Statutory Health Insurance,5.0,No,No,Hypertension,6.0
PT05895,Finland,Pirkanmaa,80.0,Male,Ovarian,,2018-04-07,2018-08-20,2019-05-01,Targeted Therapy,Private,Alive,19.0,EGFR,No,Former,Heavy,37.0,Medium,Rural,NHS,2.0,No,No,Diabetes,5.0
PT05896,Spain,Madrid,57.0,Male,Breast,I,2013-04-19,2013-09-24,2014-05-05,Chemotherapy,Private,Alive,30.0,KRAS,No,Current,None,29.8,Medium,Urban,Statutory Health Insurance,9.0,No,No,None,4.0
PT05897,Ireland,Dublin,64.0,Non-binary,Leukemia,II,2020-08-12,2020-08-23,2021-01-02,Chemotherapy,Private,Alive,70.0,None,No,Former,Moderate,,Low,Urban,,3.0,No,Yes,Diabetes,10.0
PT05898,Finland,Uusimaa,70.0,Female,Lung,II,2016-03-01,2016-05-10,2017-04-30,,Public,Alive,44.0,EGFR,Yes,Never,None,21.3,Medium,Urban,Statutory Health Insurance,2.0,Yes,No,Obesity,
PT05899,Norway,Trøndelag,61.0,Male,Lung,IV,2022-06-26,2022-07-17,2023-01-24,Immunotherapy,Private,Alive,48.0,None,No,Former,None,36.9,Medium,Rural,NHS,12.0,No,No,Hypertension,1.0
PT05900,Netherlands,North Holland,43.0,Female,Pancreatic,I,,,2013-08-29,Immunotherapy,Public,Deceased,85.0,,No,,None,24.8,Medium,Urban,NHS,5.0,No,,Cardiovascular Disease,5.0
PT05901,Poland,Masovian,49.0,Male,Breast,II,,2022-06-22,2022-09-07,Targeted Therapy,Public,Alive,102.0,BRCA1,No,Former,None,30.4,Medium,Rural,NHS,15.0,No,Yes,Cardiovascular Disease,6.0
PT05902,Denmark,Capital Region,56.0,Male,Lung,IV,2021-08-15,2021-11-29,2022-08-19,Surgery,Public,Alive,91.0,EGFR,No,Current,Moderate,28.3,Medium,Urban,NHS,2.0,No,No,Hypertension,6.0
PT05903,France,Île-de-France,72.0,Male,Prostate,,2013-07-24,2013-10-25,2014-09-12,Surgery,Private,Alive,116.0,EGFR,Yes,Current,Moderate,29.3,Medium,Urban,Private Insurance,16.0,No,No,Hypertension,4.0
PT05904,Spain,Andalusia,82.0,Male,Pancreatic,II,2020-12-22,2021-01-26,2021-03-18,Targeted Therapy,,Deceased,97.0,KRAS,No,,Heavy,33.6,Medium,Urban,Statutory Health Insurance,10.0,No,No,Diabetes,8.0
PT05905,Austria,Tyrol,30.0,Male,Prostate,I,2010-02-04,2010-03-23,2010-09-03,Surgery,Private,Deceased,55.0,None,No,Never,None,34.8,Medium,Rural,NHS,1.0,No,No,Cardiovascular Disease,7.0
PT05906,Italy,Lombardy,42.0,Male,Lung,IV,2010-01-01,2010-01-13,2010-08-05,Radiation,Research Institute,Alive,28.0,None,No,Former,Moderate,39.3,Medium,Urban,Private Insurance,1.0,No,,Diabetes,7.0
PT05907,Spain,Andalusia,69.0,,Breast,III,2016-11-20,2016-12-27,2017-12-24,Surgery,Public,Deceased,7.0,KRAS,Yes,Never,None,33.4,High,Urban,Private Insurance,16.0,No,Yes,Cardiovascular Disease,9.0
PT05908,Belgium,Brussels,74.0,Female,Pancreatic,III,2017-04-04,2017-05-18,2018-02-13,Immunotherapy,Research Institute,Alive,20.0,None,No,Current,None,24.9,Low,Urban,Statutory Health Insurance,10.0,Yes,No,Cardiovascular Disease,8.0
PT05909,Portugal,Porto,74.0,Female,Prostate,I,2015-04-25,2015-05-17,2015-07-02,Immunotherapy,Research Institute,,49.0,KRAS,Yes,Never,None,32.3,Medium,Rural,Private Insurance,11.0,Yes,No,Diabetes,7.0
,Norway,Vestland,23.0,Female,Ovarian,I,2012-10-17,2013-03-05,2013-12-18,Chemotherapy,Private,Deceased,49.0,None,No,Former,,30.8,Medium,Urban,Private Insurance,18.0,No,No,Cardiovascular Disease,2.0
PT05911,Ireland,Connacht,73.0,Male,Lung,II,2010-04-02,2010-06-28,2011-02-10,Immunotherapy,Public,Deceased,68.0,BRCA1,Yes,Never,None,29.8,Medium,Urban,Private Insurance,9.0,No,No,Cardiovascular Disease,9.0
PT05912,Norway,Vestland,80.0,Male,Colorectal,I,2022-11-03,2022-12-28,2023-04-12,Radiation,Public,Alive,111.0,None,Yes,Never,Moderate,18.2,High,Urban,NHS,9.0,,No,Diabetes,5.0
PT05913,Belgium,Brussels,24.0,Female,Prostate,III,2020-08-27,2020-09-06,2021-04-26,Radiation,Public,Deceased,116.0,BRCA1,No,Never,Moderate,35.8,Medium,Rural,Private Insurance,3.0,No,,Diabetes,3.0
PT05914,Ireland,Dublin,37.0,Non-binary,Leukemia,II,2015-11-17,2016-05-05,2017-01-22,Radiation,Public,Alive,42.0,EGFR,Yes,Never,Heavy,38.5,Low,Urban,Private Insurance,12.0,,,Cardiovascular Disease,3.0
PT05915,Denmark,Zealand,63.0,Male,Pancreatic,III,2021-03-17,2021-07-12,2022-05-12,Chemotherapy,Private,Deceased,10.0,EGFR,No,Current,,24.0,High,,Private Insurance,9.0,No,No,Obesity,3.0
PT05916,Denmark,Capital Region,50.0,Male,Prostate,I,2017-01-01,2017-03-22,2017-09-26,Surgery,Public,Deceased,37.0,EGFR,Yes,Current,None,19.5,High,,NHS,3.0,,No,,9.0
PT05917,Belgium,Flanders,40.0,Female,Pancreatic,II,2014-05-08,2014-07-23,2014-12-14,Chemotherapy,Public,Deceased,107.0,None,Yes,Never,Moderate,,Low,Urban,Statutory Health Insurance,4.0,No,No,None,4.0
PT05918,Sweden,Stockholm,66.0,Female,Lung,III,2015-02-20,2015-08-17,2016-05-30,Immunotherapy,Public,Alive,92.0,None,No,Never,None,39.9,Low,Urban,NHS,2.0,Yes,No,Diabetes,4.0
PT05919,Austria,Styria,49.0,Male,Lung,II,2020-01-12,2020-06-20,2021-03-13,Radiation,Public,Deceased,28.0,BRCA1,No,Never,None,32.1,Medium,Urban,NHS,6.0,No,No,Hypertension,5.0
PT05920,Switzerland,Bern,74.0,Female,Pancreatic,III,2020-08-31,2020-11-27,2021-04-01,Chemotherapy,Research Institute,Deceased,102.0,,Yes,Never,Moderate,26.2,Medium,Urban,Private Insurance,10.0,No,No,Diabetes,1.0
PT05921,Poland,Lesser Poland,87.0,Female,Lung,I,2023-11-30,2024-03-06,2024-08-10,Chemotherapy,Private,Alive,75.0,EGFR,No,Former,Moderate,24.0,Low,Urban,Statutory Health Insurance,7.0,No,No,None,7.0
PT05922,Poland,Lesser Poland,88.0,Non-binary,Breast,III,2023-11-13,2023-12-01,2024-09-29,Radiation,Private,Alive,53.0,EGFR,Yes,Never,Moderate,39.7,Medium,Urban,Private Insurance,19.0,Yes,No,None,5.0
,Switzerland,Geneva,60.0,Male,Pancreatic,IV,2019-05-08,2019-08-27,2020-08-01,Targeted Therapy,Public,Alive,38.0,KRAS,No,Never,Moderate,22.1,Medium,Rural,Statutory Health Insurance,2.0,No,No,Hypertension,1.0
,Belgium,Wallonia,64.0,Non-binary,Breast,II,2012-08-19,2012-11-12,2013-08-28,Radiation,Private,Alive,110.0,,No,Never,None,,,Urban,,3.0,No,Yes,Cardiovascular Disease,2.0
PT05925,,Brussels,49.0,Male,Pancreatic,II,2021-11-20,2022-01-24,2023-01-22,Targeted Therapy,Private,Alive,25.0,None,Yes,Current,Moderate,27.5,Low,Urban,Statutory Health Insurance,10.0,No,No,Hypertension,9.0
PT05926,Netherlands,South Holland,,Female,Colorectal,I,2017-10-19,2018-02-19,2018-06-06,Radiation,,,7.0,BRCA1,No,Current,Heavy,26.1,Low,,NHS,16.0,No,No,Cardiovascular Disease,2.0
PT05927,Germany,North Rhine-Westphalia,64.0,Female,Colorectal,III,2019-09-14,2019-12-31,2020-11-14,Surgery,Private,Alive,89.0,None,Yes,Never,None,21.6,High,Urban,Private Insurance,9.0,No,No,Hypertension,7.0
PT05928,Netherlands,North Holland,64.0,Female,Prostate,II,2021-12-23,2022-05-25,2022-12-16,Targeted Therapy,Research Institute,Alive,92.0,None,No,Former,Moderate,34.0,Medium,Rural,,1.0,No,No,,6.0
PT05929,Belgium,Wallonia,74.0,Female,Lung,I,,2018-01-23,2018-06-28,Targeted Therapy,Public,Alive,95.0,,Yes,Current,Moderate,39.6,Low,Urban,Private Insurance,4.0,No,No,Hypertension,8.0
PT05930,Belgium,Flanders,78.0,Male,Colorectal,III,2012-05-02,2012-06-02,2013-01-15,Chemotherapy,Public,Alive,59.0,None,Yes,Never,None,23.3,Low,Urban,Private Insurance,4.0,Yes,No,None,4.0
PT05931,Ireland,,24.0,Male,Lung,III,2019-10-22,2020-03-17,2020-11-05,Targeted Therapy,Research Institute,Alive,31.0,EGFR,Yes,Never,None,31.2,Low,Rural,Private Insurance,11.0,No,Yes,None,
PT05932,Poland,Silesian,51.0,Female,Prostate,IV,2022-05-24,2022-08-21,2022-11-03,Immunotherapy,Private,Alive,7.0,BRCA1,Yes,Never,Moderate,23.1,Low,Rural,Private Insurance,17.0,Yes,No,Cardiovascular Disease,4.0
PT05933,Denmark,,25.0,Female,Breast,II,2016-10-25,2017-02-15,2017-08-27,Chemotherapy,Private,,71.0,None,No,Never,Moderate,28.8,,Urban,Private Insurance,12.0,No,No,Hypertension,9.0
PT05934,Finland,Pirkanmaa,45.0,Male,Colorectal,II,2020-06-28,2020-07-16,2020-11-20,Chemotherapy,Public,Alive,102.0,KRAS,,Never,None,35.7,Medium,Rural,NHS,4.0,No,No,Diabetes,5.0
PT05935,Portugal,Algarve,56.0,Female,Leukemia,IV,2019-09-03,,2021-01-12,Surgery,Public,Alive,79.0,EGFR,Yes,Never,Moderate,28.8,Medium,Urban,Statutory Health Insurance,11.0,No,,None,8.0
PT05936,Finland,Pirkanmaa,32.0,Male,,II,,2016-07-10,2017-04-08,Chemotherapy,Private,Deceased,33.0,KRAS,Yes,Current,Heavy,36.3,Medium,Rural,Private Insurance,1.0,No,No,None,5.0
,Norway,Vestland,88.0,Male,Leukemia,III,2016-10-28,2016-11-04,2017-04-25,Chemotherapy,Public,Alive,20.0,EGFR,Yes,Current,Moderate,30.6,Medium,Urban,Statutory Health Insurance,16.0,No,No,None,6.0
PT05938,Denmark,Capital Region,44.0,Male,Ovarian,III,2016-03-20,2016-03-21,2016-09-03,Immunotherapy,Research Institute,Alive,87.0,None,Yes,Current,Heavy,,Low,Urban,Statutory Health Insurance,18.0,No,No,Diabetes,4.0
PT05939,Portugal,Algarve,32.0,Female,Leukemia,,2023-06-04,,2023-12-10,Chemotherapy,Private,Deceased,108.0,EGFR,No,Former,Moderate,29.8,Medium,Urban,Private Insurance,14.0,No,Yes,Diabetes,10.0
PT05940,Italy,Lombardy,39.0,Male,Leukemia,I,2010-09-26,2011-01-03,2011-10-28,Targeted Therapy,Public,Alive,96.0,EGFR,Yes,Former,None,34.2,Low,Urban,Private Insurance,15.0,No,No,Hypertension,10.0
PT05941,Norway,Oslo,79.0,Female,Leukemia,I,2017-05-22,2017-08-17,2018-03-03,Surgery,Public,,106.0,KRAS,No,Former,Moderate,22.7,Medium,Rural,Private Insurance,6.0,No,No,,7.0
PT05942,Netherlands,,40.0,Male,Leukemia,II,2019-04-26,2019-07-15,2019-11-29,Immunotherapy,Public,Alive,57.0,BRCA1,Yes,Current,Moderate,22.9,High,Rural,Statutory Health Insurance,17.0,,No,None,1.0
PT05943,Netherlands,Utrecht,80.0,Male,Colorectal,II,2021-03-01,2021-04-29,2021-07-11,Radiation,Public,Alive,44.0,BRCA1,No,Never,Moderate,25.9,High,Rural,Private Insurance,17.0,No,No,Obesity,2.0
PT05944,,Porto,45.0,Female,Leukemia,III,2011-03-09,2011-04-12,2011-08-05,Radiation,Public,Alive,113.0,KRAS,No,Former,None,22.8,Medium,Rural,Private Insurance,16.0,No,No,Obesity,4.0
PT05945,Spain,Catalonia,73.0,Female,Pancreatic,II,2012-03-13,2012-07-30,2013-06-10,Radiation,Public,Alive,81.0,EGFR,,Current,None,18.3,Low,Rural,Private Insurance,9.0,No,,Cardiovascular Disease,6.0
PT05946,Spain,Catalonia,61.0,Male,Pancreatic,I,2023-10-06,2023-10-14,2024-01-28,Immunotherapy,Private,Alive,19.0,KRAS,Yes,Former,None,22.8,Low,Rural,Statutory Health Insurance,16.0,No,No,Cardiovascular Disease,7.0
PT05947,Italy,Lombardy,30.0,Male,Leukemia,II,,2023-12-02,2024-08-29,Radiation,Public,Alive,36.0,BRCA1,Yes,Current,Moderate,28.8,Medium,Urban,NHS,1.0,No,No,Obesity,3.0
PT05948,Finland,Pirkanmaa,56.0,Female,Ovarian,I,2013-07-27,2013-09-18,2014-05-29,Targeted Therapy,Public,Deceased,78.0,BRCA1,Yes,Never,None,32.7,Medium,Urban,Private Insurance,14.0,No,No,Hypertension,10.0
PT05949,Denmark,Central Denmark,30.0,Male,Prostate,I,2018-01-07,2018-05-30,2019-05-08,Radiation,Public,Lost to Follow-up,,BRCA1,Yes,Never,,30.2,Medium,Urban,Statutory Health Insurance,9.0,Yes,No,Hypertension,3.0
PT05950,Austria,,46.0,Female,Colorectal,I,2022-10-08,2022-11-05,2023-05-16,Radiation,Research Institute,Alive,51.0,EGFR,No,Former,Moderate,22.2,Low,Urban,Statutory Health Insurance,17.0,No,No,Hypertension,10.0
PT05951,Germany,Bavaria,53.0,Male,Pancreatic,II,2012-01-13,2012-06-03,2012-11-01,Surgery,Public,Lost to Follow-up,,BRCA1,,Never,Moderate,20.9,Medium,Urban,Private Insurance,19.0,No,Yes,Diabetes,7.0
PT05952,Ireland,Munster,57.0,,Prostate,I,2011-11-14,2012-02-12,2012-09-05,Radiation,Public,,45.0,None,Yes,Never,Heavy,36.2,,Rural,Private Insurance,11.0,Yes,No,Hypertension,5.0
PT05953,Switzerland,Zurich,80.0,Female,Lung,I,2018-05-17,2018-07-13,2019-02-14,Radiation,Private,Alive,64.0,KRAS,No,Current,None,35.1,Low,Urban,Private Insurance,10.0,,No,None,2.0
PT05954,France,Île-de-France,72.0,Female,Leukemia,III,2015-01-24,2015-03-02,2015-11-30,Chemotherapy,Public,Deceased,31.0,EGFR,No,Former,,23.3,Medium,Urban,NHS,7.0,No,No,Hypertension,4.0
PT05955,Netherlands,South Holland,84.0,Male,Breast,I,2013-07-25,2013-07-27,2014-04-03,Targeted Therapy,,,,BRCA1,No,Never,None,29.5,Low,Rural,Statutory Health Insurance,19.0,Yes,No,Diabetes,4.0
PT05956,France,Île-de-France,22.0,Male,Ovarian,I,2014-12-01,2015-05-12,2015-10-23,Immunotherapy,Private,Lost to Follow-up,,BRCA1,,Never,None,32.8,Medium,Urban,Statutory Health Insurance,4.0,No,No,None,4.0
PT05957,Ireland,Dublin,86.0,Male,Ovarian,IV,2012-06-14,2012-07-18,2012-09-20,Surgery,,Deceased,,EGFR,Yes,Never,None,33.3,Low,Rural,Statutory Health Insurance,17.0,Yes,No,Obesity,5.0
PT05958,Denmark,,47.0,Female,Ovarian,III,2023-10-07,2023-12-04,2024-06-17,Immunotherapy,Public,Alive,21.0,BRCA1,Yes,Current,Moderate,28.0,Low,Rural,NHS,14.0,No,No,Obesity,2.0
PT05959,France,Île-de-France,,Female,Leukemia,I,2011-04-26,2011-07-08,2012-04-24,Radiation,Public,Alive,7.0,EGFR,No,Current,None,28.6,Medium,Rural,Private Insurance,,No,No,Obesity,6.0
,Germany,Bavaria,71.0,Male,Leukemia,I,,2021-05-08,2022-05-06,Chemotherapy,Public,Alive,86.0,EGFR,No,Never,Moderate,28.6,,Rural,NHS,3.0,Yes,No,Obesity,1.0
PT05961,Italy,Lombardy,49.0,Male,Prostate,III,2010-10-18,2011-02-12,2011-10-19,Radiation,Private,Deceased,98.0,BRCA1,Yes,Never,None,30.5,High,Rural,Statutory Health Insurance,9.0,No,Yes,,2.0
PT05962,Belgium,Wallonia,77.0,Male,Ovarian,II,2017-05-18,2017-09-11,2017-12-14,Radiation,Public,Alive,101.0,EGFR,Yes,Former,Moderate,28.3,Medium,Urban,NHS,2.0,No,,Obesity,
PT05963,Italy,Veneto,73.0,Male,Ovarian,I,2020-06-07,2020-09-29,2021-02-15,Surgery,Public,Alive,68.0,EGFR,No,Former,None,28.6,Medium,Rural,NHS,13.0,No,Yes,Obesity,7.0
PT05964,Switzerland,Geneva,88.0,Male,Ovarian,,2015-05-29,2015-06-28,2015-08-05,Surgery,Public,Alive,30.0,KRAS,Yes,Never,None,36.0,Low,Urban,Private Insurance,1.0,No,No,Diabetes,10.0
PT05965,Italy,Sicily,34.0,Female,Lung,IV,2020-12-28,2021-03-21,2021-10-18,Immunotherapy,Public,Deceased,72.0,BRCA1,Yes,Never,None,22.5,Low,Urban,Private Insurance,7.0,No,No,Hypertension,6.0
PT05966,Norway,Trøndelag,57.0,Male,Prostate,II,2010-07-09,2010-10-24,2011-01-04,Radiation,Public,Alive,46.0,None,No,Current,None,,Medium,Urban,NHS,10.0,No,No,Hypertension,1.0
PT05967,Sweden,Stockholm,33.0,Male,Colorectal,II,,,2011-08-08,,Public,Alive,60.0,BRCA1,Yes,Never,Moderate,33.2,Medium,Urban,NHS,8.0,No,No,Diabetes,4.0
PT05968,Switzerland,Bern,,Female,Ovarian,I,2010-09-16,2011-01-14,2011-12-15,Radiation,Public,Deceased,107.0,EGFR,No,Never,None,30.1,Medium,Rural,NHS,4.0,No,No,Cardiovascular Disease,3.0
PT05969,Ireland,,78.0,Male,Lung,I,2012-04-06,2012-09-05,,Surgery,Public,Alive,104.0,BRCA1,Yes,Current,None,24.5,Low,Urban,Statutory Health Insurance,1.0,No,No,Hypertension,5.0
PT05970,Denmark,Central Denmark,27.0,Male,Pancreatic,II,2016-08-16,2017-01-06,2017-12-20,Chemotherapy,Private,Deceased,8.0,KRAS,No,Former,None,20.2,Medium,Rural,NHS,14.0,No,No,Hypertension,2.0
PT05971,Austria,Tyrol,38.0,Male,Lung,IV,2015-01-05,2015-06-04,2016-03-13,Immunotherapy,Research Institute,Alive,32.0,,No,,Moderate,32.7,Medium,Urban,Private Insurance,16.0,No,No,None,4.0
PT05972,Poland,Lesser Poland,51.0,Male,Lung,I,2018-04-05,2018-09-12,2019-05-30,Immunotherapy,Private,Deceased,19.0,KRAS,No,Former,None,33.6,Medium,Urban,Statutory Health Insurance,16.0,No,No,None,5.0
PT05973,Netherlands,Utrecht,48.0,Female,Prostate,IV,2015-11-23,2016-02-06,2016-07-20,Targeted Therapy,Public,Deceased,38.0,KRAS,Yes,Never,Moderate,19.4,Medium,Rural,NHS,13.0,No,,None,8.0
PT05974,Belgium,Brussels,60.0,Female,Leukemia,I,2013-12-20,2014-03-23,2014-10-06,Targeted Therapy,Public,,,BRCA1,Yes,Current,Moderate,33.9,Low,Urban,Private Insurance,7.0,Yes,No,Cardiovascular Disease,6.0
PT05975,Belgium,Flanders,64.0,Male,,II,2018-01-03,,2019-01-16,Chemotherapy,Public,,90.0,EGFR,Yes,Never,Heavy,36.1,Low,Rural,Statutory Health Insurance,15.0,No,No,Hypertension,7.0
PT05976,Netherlands,North Holland,32.0,Male,Leukemia,I,2019-02-15,2019-05-14,2020-02-21,Targeted Therapy,Public,Alive,15.0,EGFR,No,Never,None,37.7,Low,Rural,Statutory Health Insurance,11.0,Yes,No,Hypertension,6.0
PT05977,Switzerland,Geneva,46.0,Male,Leukemia,II,2018-07-15,2018-10-06,2018-12-21,Chemotherapy,Public,Deceased,58.0,KRAS,,Former,Moderate,,Medium,Urban,Private Insurance,1.0,No,No,None,7.0
PT05978,Austria,Vienna,38.0,Female,Leukemia,II,2022-12-23,2023-02-16,2023-08-06,Radiation,Research Institute,Deceased,86.0,KRAS,Yes,Never,Moderate,31.0,Low,Urban,NHS,17.0,No,No,Cardiovascular Disease,9.0
PT05979,France,Île-de-France,45.0,Female,Colorectal,III,2019-11-07,2020-03-19,2021-01-23,,Private,Alive,76.0,KRAS,No,Never,Moderate,39.6,Low,Rural,NHS,4.0,No,No,None,4.0
,Finland,Uusimaa,72.0,Female,Breast,II,2016-05-03,2016-10-19,2017-02-10,Targeted Therapy,Public,Alive,96.0,BRCA1,Yes,Never,Moderate,30.1,Medium,Urban,NHS,9.0,No,Yes,Diabetes,7.0
PT05981,Netherlands,South Holland,70.0,Male,Pancreatic,II,2023-10-31,2023-12-27,2024-04-27,,Public,Deceased,100.0,EGFR,Yes,Never,None,32.8,High,Urban,Private Insurance,16.0,Yes,,Obesity,5.0
PT05982,Finland,Southwest Finland,56.0,Male,Lung,III,2014-04-07,,2014-12-04,Chemotherapy,Public,Alive,45.0,None,No,Former,Moderate,33.1,Medium,Urban,Private Insurance,14.0,,No,Hypertension,6.0
PT05983,Denmark,Zealand,28.0,Female,Breast,I,2014-09-13,2015-02-26,2015-05-18,Immunotherapy,Public,Deceased,,,Yes,Never,None,34.2,Low,Urban,Statutory Health Insurance,2.0,No,No,Obesity,1.0
,Finland,Southwest Finland,71.0,,Colorectal,II,2019-06-30,2019-07-01,2020-04-15,Targeted Therapy,Public,Alive,29.0,None,No,,Moderate,35.0,Medium,Urban,NHS,11.0,No,No,Cardiovascular Disease,4.0
PT05985,Portugal,Porto,73.0,Female,Ovarian,I,2013-03-18,2013-05-17,2013-10-11,Radiation,Public,Alive,15.0,EGFR,No,Former,None,30.4,Medium,,Statutory Health Insurance,2.0,No,No,Diabetes,10.0
PT05986,France,Île-de-France,22.0,Male,Ovarian,II,2016-05-16,2016-07-31,2016-10-14,Surgery,Public,Deceased,54.0,BRCA1,No,Current,Moderate,34.9,Medium,Rural,Private Insurance,11.0,No,No,None,5.0
PT05987,Belgium,Wallonia,88.0,Female,Leukemia,III,2022-08-26,2022-10-11,2023-04-15,Chemotherapy,Private,Alive,33.0,KRAS,Yes,Current,None,23.6,Low,Rural,Private Insurance,3.0,No,Yes,Cardiovascular Disease,3.0
PT05988,Belgium,Wallonia,27.0,Female,Ovarian,I,2017-12-21,2017-12-25,2018-08-04,Chemotherapy,Public,Alive,111.0,,No,Never,Moderate,29.4,Low,Rural,Statutory Health Insurance,8.0,Yes,No,Diabetes,10.0
PT05989,Norway,Oslo,33.0,Female,,IV,2014-02-16,2014-03-03,2014-07-06,Radiation,Public,Deceased,38.0,KRAS,Yes,Current,None,21.9,Medium,Urban,Statutory Health Insurance,,Yes,No,Hypertension,10.0
PT05990,Spain,Andalusia,22.0,Male,Pancreatic,IV,2015-05-19,2015-08-08,2016-05-20,Radiation,Public,Alive,52.0,,No,Never,Moderate,27.4,High,Urban,Private Insurance,12.0,No,No,Hypertension,3.0
PT05991,Germany,Berlin,43.0,Female,Pancreatic,II,2023-05-26,2023-09-19,2024-09-06,Chemotherapy,Public,Alive,,BRCA1,No,Former,Moderate,26.6,Medium,Rural,Private Insurance,19.0,Yes,No,None,3.0
PT05992,Ireland,Munster,32.0,Male,Colorectal,I,2018-08-02,2018-08-14,2019-03-18,Chemotherapy,Public,Alive,49.0,BRCA1,No,Never,None,,Low,Rural,NHS,7.0,No,No,None,4.0
PT05993,Spain,Madrid,62.0,Female,Ovarian,III,2022-05-15,2022-05-16,2023-02-01,Radiation,Public,Alive,98.0,BRCA1,No,Never,Moderate,24.2,Medium,,,15.0,No,No,Obesity,
PT05994,,Wallonia,48.0,Male,Breast,IV,,2020-06-03,2021-03-13,,Private,Deceased,32.0,EGFR,,Never,None,,High,Rural,Statutory Health Insurance,6.0,No,No,Diabetes,4.0
PT05995,Switzerland,Bern,70.0,Female,Lung,I,2012-06-23,2012-07-23,2012-11-07,Radiation,Public,Alive,80.0,KRAS,Yes,Current,Heavy,28.0,Medium,Rural,Statutory Health Insurance,,Yes,No,None,8.0
PT05996,Netherlands,Utrecht,61.0,Female,Prostate,,2023-03-15,2023-07-27,2024-02-21,Targeted Therapy,Public,Deceased,79.0,EGFR,No,Former,Moderate,38.3,Medium,Urban,Statutory Health Insurance,4.0,No,No,None,3.0
PT05997,Denmark,Zealand,50.0,Male,Prostate,IV,2018-10-05,2018-12-17,2019-09-20,Chemotherapy,Private,Alive,34.0,BRCA1,,Never,Moderate,26.9,Medium,Rural,NHS,9.0,No,No,None,5.0
PT05998,Italy,Lombardy,82.0,Female,Pancreatic,II,2016-05-30,2016-07-19,2017-07-17,Chemotherapy,Public,Alive,113.0,None,No,Never,Heavy,28.1,Medium,Rural,NHS,18.0,No,No,Hypertension,2.0
PT05999,Germany,Bavaria,45.0,Male,Lung,III,2019-04-22,2019-08-30,2020-05-31,Radiation,Private,Alive,83.0,BRCA1,No,Never,None,35.1,Low,Urban,NHS,7.0,Yes,No,Hypertension,6.0
PT06000,Denmark,Zealand,37.0,Male,Leukemia,II,2017-10-22,2017-10-28,2018-04-05,Immunotherapy,Private,Alive,90.0,KRAS,No,Former,None,19.9,Low,Urban,Private Insurance,15.0,No,,None,10.0
PT06001,Norway,Vestland,76.0,Male,Colorectal,II,2013-02-19,2013-05-05,2013-06-24,Surgery,Public,Deceased,45.0,None,No,Never,Moderate,38.3,High,Urban,Statutory Health Insurance,3.0,No,No,,5.0
PT06002,,Zealand,26.0,Male,Ovarian,II,2019-11-04,,2020-12-12,Chemotherapy,Public,Alive,94.0,KRAS,,Current,Heavy,28.9,Low,Rural,NHS,11.0,No,No,None,
PT06003,Ireland,,67.0,Female,Leukemia,I,2011-01-19,2011-04-21,2011-08-04,Targeted Therapy,Public,Alive,12.0,EGFR,No,Never,Moderate,34.2,High,Urban,,,No,No,Obesity,1.0
PT06004,France,Auvergne-Rhône-Alpes,79.0,Male,Pancreatic,III,2015-06-10,2015-08-26,2016-03-02,Surgery,Research Institute,,84.0,BRCA1,No,Never,None,33.6,Medium,Urban,,,Yes,Yes,None,2.0
,France,Auvergne-Rhône-Alpes,52.0,Female,Colorectal,I,2016-05-19,2016-11-01,2017-05-18,Immunotherapy,Public,Alive,77.0,EGFR,Yes,Never,Moderate,24.7,,Urban,,12.0,No,No,None,9.0
PT06006,Ireland,Munster,22.0,Female,Prostate,II,2017-09-12,2017-11-27,2018-09-30,Targeted Therapy,Research Institute,Alive,106.0,BRCA1,No,Current,None,40.0,Medium,Urban,Statutory Health Insurance,6.0,No,No,None,5.0
PT06007,Italy,Sicily,23.0,Female,Pancreatic,IV,2012-08-24,2012-11-15,2013-05-03,Radiation,Public,Alive,91.0,BRCA1,No,Former,Moderate,18.9,Medium,Urban,Private Insurance,12.0,No,No,Obesity,
PT06008,Norway,Trøndelag,23.0,Female,Pancreatic,I,2023-07-09,2023-07-27,2024-07-03,Immunotherapy,Private,Alive,82.0,BRCA1,Yes,Former,Heavy,38.5,Medium,Rural,Statutory Health Insurance,16.0,Yes,No,Cardiovascular Disease,1.0
PT06009,Norway,Oslo,61.0,Male,Lung,II,2011-09-11,2012-02-05,2012-03-13,Radiation,Private,Alive,44.0,EGFR,No,Former,Moderate,20.1,Low,Urban,,13.0,No,No,Cardiovascular Disease,2.0
PT06010,Sweden,Stockholm,28.0,Female,Breast,II,2012-10-16,2013-03-21,2013-09-22,Targeted Therapy,Public,Alive,30.0,BRCA1,No,Former,None,,High,Urban,Private Insurance,6.0,No,No,Hypertension,
PT06011,Finland,Uusimaa,70.0,Male,Pancreatic,I,2015-05-08,2015-05-20,2016-04-26,Targeted Therapy,Public,Deceased,33.0,None,Yes,Current,None,37.8,Medium,Urban,Private Insurance,2.0,No,Yes,None,1.0
PT06012,Netherlands,Utrecht,36.0,Female,Breast,III,2021-01-27,2021-03-20,2021-10-16,Radiation,Public,Alive,56.0,KRAS,No,Never,Moderate,22.7,Low,Urban,NHS,14.0,,No,Obesity,5.0
PT06013,Austria,Vienna,36.0,Female,Lung,II,2010-07-25,2010-10-20,2011-06-20,Surgery,Public,Alive,85.0,KRAS,No,Never,None,19.4,Low,Urban,Statutory Health Insurance,14.0,No,Yes,,9.0
PT06014,Finland,Uusimaa,39.0,Female,,II,2020-05-20,2020-08-28,2021-04-18,Chemotherapy,Research Institute,Alive,76.0,None,Yes,Never,Moderate,,Medium,Urban,NHS,,No,No,Obesity,9.0
PT06015,Belgium,Wallonia,33.0,Male,Ovarian,I,2011-10-01,2011-10-23,2012-07-19,Chemotherapy,Public,Alive,54.0,EGFR,Yes,Never,None,24.3,Medium,Urban,NHS,7.0,No,No,Cardiovascular Disease,2.0
PT06016,Portugal,Algarve,41.0,Female,Pancreatic,I,2019-11-27,2020-03-08,2020-04-23,Targeted Therapy,Research Institute,Alive,62.0,BRCA1,Yes,Never,None,26.8,High,Urban,Statutory Health Insurance,5.0,No,Yes,Diabetes,
PT06017,Austria,Styria,71.0,Female,Prostate,I,2010-03-05,2010-08-25,2011-06-27,Immunotherapy,Public,Alive,75.0,KRAS,No,Never,Moderate,27.9,Low,Urban,NHS,16.0,No,No,Hypertension,5.0
PT06018,Spain,,46.0,Female,Colorectal,I,2018-06-16,2018-08-17,2018-11-05,Radiation,Public,Deceased,20.0,,No,Former,Moderate,32.9,High,Rural,Statutory Health Insurance,17.0,No,No,Obesity,2.0
PT06019,Finland,Uusimaa,62.0,Male,Ovarian,II,2020-06-29,2020-08-10,2021-04-08,Immunotherapy,Public,Alive,104.0,BRCA1,Yes,Current,Moderate,34.1,High,Urban,Private Insurance,6.0,No,No,Diabetes,5.0
PT06020,Spain,Madrid,22.0,Female,Breast,II,2018-09-12,2018-11-18,2019-02-09,Radiation,Private,Deceased,7.0,None,No,Never,None,25.4,Medium,Rural,Statutory Health Insurance,1.0,No,No,Diabetes,4.0
PT06021,Belgium,Wallonia,27.0,Male,Prostate,I,2020-10-03,2021-02-17,2022-01-28,Immunotherapy,Private,Alive,17.0,BRCA1,No,Former,Heavy,37.9,Medium,Urban,Statutory Health Insurance,7.0,No,No,Hypertension,10.0
,Denmark,Central Denmark,29.0,Female,Ovarian,I,,2020-07-01,2020-09-12,Radiation,Public,Alive,,KRAS,Yes,Current,None,22.7,Medium,Rural,Private Insurance,6.0,No,No,None,9.0
PT06023,Finland,Southwest Finland,48.0,Female,Pancreatic,II,2020-06-02,2020-11-07,2021-11-04,Targeted Therapy,Research Institute,Lost to Follow-up,,KRAS,No,Never,None,34.7,Medium,Urban,NHS,7.0,No,No,None,10.0
PT06024,Italy,Veneto,59.0,Male,Lung,III,2021-11-02,2022-04-05,2022-12-23,Surgery,Public,Alive,58.0,KRAS,No,Never,None,33.9,,Rural,Private Insurance,10.0,No,No,Cardiovascular Disease,2.0
PT06025,Sweden,,84.0,Male,Leukemia,III,2023-02-19,2023-05-24,2023-07-21,Chemotherapy,,Alive,,None,Yes,Never,None,29.5,Medium,Urban,Private Insurance,,No,No,Hypertension,3.0
PT06026,,Madrid,40.0,Female,Prostate,I,2021-01-06,2021-05-08,2021-11-24,Immunotherapy,Public,Alive,65.0,KRAS,No,Never,None,39.4,Low,Urban,Statutory Health Insurance,11.0,No,Yes,Cardiovascular Disease,8.0
PT06027,Belgium,Flanders,43.0,Male,Prostate,IV,2011-01-30,2011-05-05,2011-08-03,,Private,Deceased,71.0,BRCA1,Yes,Former,Heavy,28.3,Medium,Urban,NHS,19.0,Yes,No,Hypertension,3.0
PT06028,Austria,Styria,79.0,Male,Leukemia,IV,2013-05-21,2013-09-25,2013-12-24,Immunotherapy,Public,Alive,48.0,EGFR,Yes,Current,Heavy,36.9,Low,Rural,Statutory Health Insurance,9.0,No,No,Diabetes,5.0
PT06029,Ireland,Dublin,45.0,Female,Pancreatic,II,,2017-09-03,2018-08-26,Targeted Therapy,Public,Deceased,39.0,BRCA1,Yes,Never,Moderate,19.4,High,Urban,NHS,18.0,No,Yes,None,5.0
PT06030,Poland,Silesian,28.0,Female,Prostate,III,2015-02-03,2015-03-29,2015-05-17,Targeted Therapy,Public,Alive,33.0,EGFR,No,Never,None,26.8,Low,Urban,NHS,7.0,No,No,Obesity,9.0
,Germany,Berlin,39.0,Female,Breast,II,,2013-02-19,2013-05-15,Immunotherapy,Public,Alive,10.0,BRCA1,No,Former,None,22.7,Medium,Urban,Statutory Health Insurance,18.0,No,No,Diabetes,10.0
PT06032,Finland,Southwest Finland,75.0,Male,Pancreatic,IV,2019-07-05,2019-09-01,2020-03-24,Immunotherapy,Private,Alive,40.0,,Yes,Current,Moderate,36.9,High,Rural,Private Insurance,8.0,No,No,Diabetes,6.0
PT06033,Ireland,Munster,55.0,Male,Breast,II,2022-09-23,2022-12-31,2023-12-25,Immunotherapy,Public,Alive,21.0,EGFR,Yes,Former,None,27.4,Medium,Urban,Statutory Health Insurance,8.0,No,No,Cardiovascular Disease,9.0
PT06034,Netherlands,Utrecht,55.0,Female,Breast,,2017-08-01,2017-08-20,2018-05-25,Targeted Therapy,Public,Alive,43.0,KRAS,No,Former,None,29.6,Medium,Urban,NHS,11.0,Yes,,Hypertension,3.0
PT06035,Germany,North Rhine-Westphalia,41.0,Female,Prostate,I,2010-11-29,2011-05-10,2011-12-29,Surgery,Private,Alive,111.0,KRAS,No,Former,None,32.6,Medium,Urban,NHS,8.0,No,Yes,Cardiovascular Disease,9.0
PT06036,,Lombardy,20.0,Female,Pancreatic,II,2022-02-12,2022-07-04,,Surgery,Public,,104.0,BRCA1,Yes,Never,Heavy,26.9,Medium,Urban,NHS,4.0,No,Yes,Hypertension,7.0
PT06037,Ireland,Dublin,88.0,Female,Prostate,III,2018-02-05,2018-02-27,2018-05-13,Immunotherapy,Private,Alive,51.0,EGFR,No,Never,None,26.0,Medium,Rural,NHS,13.0,Yes,No,Obesity,2.0
,Netherlands,Utrecht,56.0,Male,Prostate,III,2013-07-12,2013-11-30,2014-02-12,Radiation,Private,Alive,49.0,None,No,Never,Moderate,25.4,Medium,Urban,Statutory Health Insurance,1.0,No,No,Hypertension,10.0
PT06039,Ireland,Munster,32.0,Male,Pancreatic,III,2016-01-28,2016-05-30,2016-08-09,Surgery,,Alive,49.0,KRAS,Yes,Never,Moderate,35.0,Medium,Urban,Statutory Health Insurance,,Yes,No,Hypertension,7.0
PT06040,Finland,,62.0,Female,Pancreatic,IV,2015-08-11,2015-10-06,2015-11-12,Targeted Therapy,,,10.0,BRCA1,Yes,Never,None,39.7,,Urban,Private Insurance,8.0,No,,None,10.0
PT06041,Finland,Uusimaa,56.0,Female,Pancreatic,III,2012-05-25,2012-07-06,2012-08-18,Targeted Therapy,,Alive,51.0,None,No,Never,None,25.2,Low,Urban,Statutory Health Insurance,9.0,Yes,No,Obesity,5.0
PT06042,Austria,Styria,44.0,Female,Ovarian,III,2017-12-18,2018-02-22,2018-11-07,Targeted Therapy,Private,Deceased,109.0,BRCA1,Yes,Former,None,32.8,High,Urban,NHS,7.0,No,No,None,2.0
PT06043,Ireland,Munster,40.0,Female,,II,2016-04-07,2016-09-24,2017-08-01,Chemotherapy,Public,Alive,51.0,BRCA1,No,Never,Moderate,37.3,Medium,Urban,Statutory Health Insurance,14.0,No,No,Obesity,3.0
PT06044,Austria,Vienna,60.0,Female,Lung,II,,2022-11-27,2023-04-07,Chemotherapy,,Alive,82.0,KRAS,Yes,Current,None,39.6,High,Urban,Private Insurance,6.0,No,No,None,7.0
PT06045,Spain,Andalusia,61.0,Female,,II,2020-07-23,2020-08-21,2021-07-13,Targeted Therapy,Public,Alive,70.0,None,No,Former,Moderate,30.7,Medium,Urban,Private Insurance,13.0,,Yes,Cardiovascular Disease,3.0
PT06046,France,Île-de-France,61.0,Male,Leukemia,III,2021-02-04,2021-07-08,2022-03-31,Surgery,Public,Alive,34.0,BRCA1,Yes,Current,None,,Medium,Rural,Statutory Health Insurance,17.0,No,No,Obesity,3.0
PT06047,Netherlands,Utrecht,21.0,Non-binary,Pancreatic,,2022-11-10,2023-04-10,2023-06-07,Chemotherapy,Private,Alive,7.0,BRCA1,No,Never,Moderate,30.0,High,Urban,NHS,9.0,No,No,Obesity,4.0
PT06048,France,Île-de-France,87.0,,Prostate,I,2015-12-29,2016-02-03,2016-09-10,Radiation,Public,Alive,68.0,KRAS,No,Former,Moderate,32.4,Low,Urban,Statutory Health Insurance,13.0,No,No,Diabetes,5.0
PT06049,Switzerland,Zurich,27.0,Male,Leukemia,I,2019-04-28,2019-08-24,2020-06-17,Immunotherapy,Public,Deceased,86.0,None,Yes,,None,28.5,Medium,Urban,NHS,13.0,No,No,Obesity,5.0
PT06050,Belgium,Flanders,80.0,Female,Ovarian,,2023-02-04,2023-02-13,2024-01-11,Chemotherapy,Public,Alive,41.0,None,,,Moderate,24.8,Medium,Urban,NHS,18.0,No,No,Cardiovascular Disease,8.0
PT06051,Norway,Trøndelag,33.0,Male,Colorectal,I,2022-04-14,2022-07-08,2023-03-10,Chemotherapy,Public,Deceased,43.0,None,No,Former,None,24.9,Medium,Urban,Statutory Health Insurance,9.0,No,No,Hypertension,2.0
PT06052,,Oslo,40.0,Female,Breast,I,2012-12-14,2013-01-25,2013-10-29,Surgery,Public,Alive,119.0,EGFR,Yes,Former,Moderate,35.6,Medium,Urban,Statutory Health Insurance,14.0,Yes,Yes,Diabetes,4.0
PT06053,Germany,Berlin,43.0,Female,Lung,II,2022-07-22,2022-09-27,2023-07-30,Surgery,Private,Deceased,119.0,BRCA1,No,Never,None,39.2,Low,Urban,NHS,15.0,,No,Diabetes,9.0
PT06054,Ireland,Munster,69.0,,Leukemia,I,2013-09-17,2013-09-24,2013-11-04,Radiation,Private,Alive,93.0,,No,Never,None,33.1,Medium,Rural,Statutory Health Insurance,3.0,No,No,Cardiovascular Disease,10.0
PT06055,France,Auvergne-Rhône-Alpes,64.0,Female,Ovarian,II,2010-09-27,2010-10-20,2011-03-04,Radiation,Private,Alive,23.0,None,Yes,Never,None,28.0,Medium,Urban,Private Insurance,16.0,Yes,No,None,3.0
PT06056,Portugal,Algarve,83.0,Female,Breast,I,2022-03-16,2022-08-23,2022-10-15,Radiation,Public,Alive,13.0,None,Yes,Former,None,25.0,High,Rural,NHS,14.0,No,No,None,3.0
PT06057,Denmark,Capital Region,83.0,Female,Lung,I,2021-08-11,2021-09-03,2022-07-06,Radiation,Public,Alive,33.0,BRCA1,Yes,Never,Heavy,21.6,Medium,Urban,NHS,2.0,No,Yes,,3.0
PT06058,Sweden,Västra Götaland,45.0,Female,Pancreatic,III,,2011-08-28,2011-09-30,Chemotherapy,Private,Alive,9.0,BRCA1,No,,None,24.6,Low,Urban,NHS,9.0,No,No,Obesity,3.0
PT06059,Netherlands,North Holland,51.0,Male,Ovarian,III,2013-02-26,2013-05-06,2014-03-12,Radiation,Private,Alive,43.0,EGFR,Yes,Former,None,18.4,Medium,Urban,Private Insurance,7.0,No,No,None,8.0
PT06060,,Vienna,76.0,Male,Breast,I,,2011-01-23,2011-03-01,Radiation,Private,Alive,87.0,KRAS,No,Current,Heavy,25.4,Medium,Urban,Statutory Health Insurance,11.0,No,No,Hypertension,4.0
PT06061,Poland,Lesser Poland,72.0,Female,Ovarian,III,2014-07-05,2014-07-15,2015-01-24,,Public,Alive,69.0,None,Yes,Former,None,21.9,High,Urban,Statutory Health Insurance,14.0,No,No,Diabetes,5.0
PT06062,Finland,Southwest Finland,52.0,Female,Prostate,III,2018-05-31,,2019-06-13,Chemotherapy,,Alive,116.0,EGFR,Yes,Current,Moderate,18.6,Low,,NHS,9.0,No,Yes,Obesity,4.0
PT06063,Belgium,Brussels,71.0,Male,Prostate,III,2019-06-01,2019-06-03,2019-10-24,Chemotherapy,Public,Lost to Follow-up,,KRAS,No,Never,,20.6,,Urban,Statutory Health Insurance,1.0,No,No,Obesity,8.0
PT06064,Austria,Tyrol,37.0,Male,Pancreatic,II,2017-01-29,2017-06-07,2017-08-25,Chemotherapy,Public,Alive,77.0,None,No,Former,None,37.8,High,Rural,NHS,19.0,No,No,Hypertension,6.0
PT06065,Belgium,Brussels,54.0,Male,Breast,I,2014-07-10,2014-09-02,2015-05-27,Immunotherapy,Research Institute,Alive,63.0,None,No,Never,Moderate,24.0,Medium,Rural,Statutory Health Insurance,13.0,No,No,Diabetes,3.0
PT06066,Italy,Veneto,31.0,Female,Pancreatic,III,2018-07-03,2018-07-22,2019-05-31,Radiation,,Deceased,68.0,BRCA1,No,Never,None,29.8,Medium,Urban,Private Insurance,11.0,Yes,No,Hypertension,6.0
PT06067,Ireland,Connacht,70.0,,Pancreatic,II,2022-01-31,2022-05-08,2022-08-07,Radiation,Private,Alive,25.0,EGFR,No,Never,None,23.5,Medium,Urban,Private Insurance,15.0,No,No,Diabetes,8.0
PT06068,Norway,Oslo,29.0,Male,Lung,I,2020-06-12,2020-07-10,2020-12-13,Radiation,Private,Alive,65.0,None,Yes,Never,Moderate,32.4,,Urban,Statutory Health Insurance,4.0,No,No,None,3.0
PT06069,Austria,Tyrol,71.0,Female,Breast,II,2022-10-25,2023-03-07,2023-11-12,Surgery,Public,Alive,114.0,BRCA1,Yes,Former,Moderate,21.5,Low,Rural,NHS,15.0,,No,Diabetes,7.0
PT06070,,Provence-Alpes-Côte d'Azur,53.0,Male,Colorectal,III,2017-02-23,2017-05-10,,Surgery,Public,Alive,40.0,KRAS,No,Current,None,27.9,Low,Rural,NHS,8.0,Yes,No,Diabetes,
PT06071,Norway,Vestland,86.0,Female,Pancreatic,II,2018-12-27,2019-06-03,2020-04-27,Surgery,Public,Alive,86.0,BRCA1,No,Never,None,22.9,Medium,Urban,Private Insurance,12.0,No,Yes,None,3.0
PT06072,France,Provence-Alpes-Côte d'Azur,58.0,Female,Lung,I,2014-10-17,2014-11-05,,Immunotherapy,Public,Alive,42.0,KRAS,No,Current,Moderate,30.0,,Urban,NHS,5.0,No,No,Diabetes,9.0
PT06073,Portugal,Algarve,27.0,Female,Lung,III,2017-02-13,2017-05-28,2017-07-04,Radiation,Public,Alive,80.0,KRAS,No,Never,None,20.2,Medium,Urban,Private Insurance,,No,No,Cardiovascular Disease,1.0
PT06074,Austria,Tyrol,48.0,Male,Breast,IV,2022-01-24,2022-03-07,2022-08-08,Chemotherapy,Public,Alive,68.0,BRCA1,No,Former,Moderate,30.9,Medium,Rural,NHS,15.0,No,No,Diabetes,8.0
PT06075,Spain,Catalonia,41.0,Male,Leukemia,II,2018-02-19,2018-07-22,2018-11-18,Chemotherapy,Public,Deceased,117.0,EGFR,No,Never,Moderate,34.1,High,Rural,Private Insurance,5.0,No,No,Hypertension,6.0
PT06076,Finland,Southwest Finland,89.0,Female,Ovarian,II,2021-06-21,2021-07-26,2022-04-25,Targeted Therapy,Private,Deceased,40.0,None,No,Current,None,27.9,Medium,Rural,NHS,6.0,No,No,None,6.0
PT06077,Poland,Silesian,,Male,Pancreatic,III,2021-09-24,2021-10-03,2022-05-15,Surgery,Public,Deceased,57.0,BRCA1,Yes,Never,None,38.9,Low,Urban,Statutory Health Insurance,14.0,No,No,None,2.0
PT06078,Italy,Lombardy,62.0,Non-binary,Pancreatic,I,2022-12-26,2023-02-03,2023-06-18,Immunotherapy,Research Institute,Alive,23.0,None,No,Never,Moderate,22.7,Low,Urban,Statutory Health Insurance,12.0,No,No,Obesity,10.0
PT06079,Belgium,Flanders,68.0,Female,Breast,III,2014-10-08,,2015-07-08,Targeted Therapy,Private,Alive,62.0,EGFR,No,Former,Moderate,20.2,Medium,Urban,Statutory Health Insurance,17.0,No,Yes,Cardiovascular Disease,7.0
PT06080,Germany,North Rhine-Westphalia,48.0,Male,Leukemia,III,2019-10-26,2019-11-10,2020-02-18,Immunotherapy,Private,Deceased,,KRAS,No,Former,Moderate,19.9,Medium,Urban,Private Insurance,15.0,No,No,None,2.0
PT06081,Sweden,Stockholm,50.0,Female,Lung,II,,2014-06-12,2014-08-12,Chemotherapy,Public,Deceased,25.0,BRCA1,Yes,Never,None,25.3,High,Urban,NHS,10.0,No,No,Cardiovascular Disease,1.0
PT06082,Spain,Catalonia,72.0,Male,Ovarian,I,2020-06-21,2020-12-12,2021-06-25,Radiation,Public,Alive,116.0,BRCA1,No,Current,Moderate,,,Rural,NHS,7.0,No,No,Obesity,4.0
PT06083,Belgium,Brussels,53.0,Female,Prostate,I,2020-07-08,2020-12-20,2021-08-18,Chemotherapy,Public,,,EGFR,,Never,None,18.2,Low,Rural,Private Insurance,13.0,Yes,,Diabetes,8.0
PT06084,Belgium,Flanders,57.0,Non-binary,Pancreatic,III,2023-11-16,2024-02-14,2024-03-24,Chemotherapy,Private,Alive,64.0,EGFR,Yes,Never,Moderate,23.0,Low,Urban,Statutory Health Insurance,18.0,Yes,No,Cardiovascular Disease,1.0
PT06085,Poland,Silesian,76.0,Male,Prostate,I,2021-06-21,2021-10-24,2022-10-23,Surgery,Public,Alive,73.0,KRAS,No,Never,None,23.2,High,Urban,Statutory Health Insurance,9.0,No,,Hypertension,10.0
PT06086,Switzerland,Geneva,,Female,Ovarian,II,2016-06-19,2016-08-18,2017-04-02,Chemotherapy,Public,Alive,31.0,EGFR,Yes,Never,None,20.8,,,Private Insurance,7.0,No,No,Hypertension,10.0
PT06087,France,Auvergne-Rhône-Alpes,21.0,Male,Pancreatic,II,2015-05-21,2015-07-22,2016-04-23,Immunotherapy,Research Institute,Alive,18.0,EGFR,Yes,Current,Moderate,26.5,Medium,Rural,NHS,10.0,No,No,Diabetes,2.0
PT06088,Spain,Madrid,31.0,Female,Ovarian,,2019-12-24,2020-01-24,2020-09-26,Radiation,Public,Alive,26.0,None,No,Never,Moderate,39.1,Low,Urban,,17.0,No,No,Cardiovascular Disease,6.0
PT06089,Finland,Pirkanmaa,54.0,Male,Breast,II,2010-12-26,2011-01-25,2011-07-02,Surgery,,Alive,109.0,EGFR,No,Former,Moderate,38.2,Medium,Urban,Private Insurance,18.0,No,Yes,Cardiovascular Disease,4.0
PT06090,Poland,Masovian,89.0,Male,Pancreatic,II,2012-09-08,2012-11-13,2013-06-28,Targeted Therapy,Public,Alive,93.0,None,,Current,Heavy,18.4,Low,Urban,Statutory Health Insurance,3.0,Yes,No,Diabetes,8.0
PT06091,Belgium,Flanders,40.0,Non-binary,Leukemia,III,2014-12-15,2014-12-22,2015-12-19,Chemotherapy,,Alive,100.0,None,Yes,Current,None,36.0,High,Rural,NHS,12.0,No,,Diabetes,8.0
PT06092,Sweden,Stockholm,80.0,Male,Pancreatic,I,2022-04-21,2022-09-26,2023-01-08,Surgery,Public,Alive,115.0,BRCA1,No,Former,Heavy,22.9,Medium,Urban,Statutory Health Insurance,15.0,No,No,Diabetes,9.0
PT06093,Germany,North Rhine-Westphalia,54.0,Female,Breast,I,2022-09-07,2023-02-15,2023-06-14,Surgery,Private,Deceased,105.0,EGFR,No,Never,Moderate,29.8,Medium,Urban,NHS,14.0,No,No,Diabetes,4.0
PT06094,Italy,Sicily,67.0,Female,Ovarian,III,2011-01-29,2011-05-21,2012-03-26,Surgery,Private,Alive,60.0,None,No,Former,Moderate,28.3,Medium,Urban,NHS,4.0,No,No,Hypertension,4.0
PT06095,Italy,Sicily,34.0,Female,Colorectal,III,2013-10-11,,,Immunotherapy,Public,Alive,,KRAS,,Never,Moderate,39.6,Low,Urban,Private Insurance,16.0,No,No,None,2.0
PT06096,Sweden,Skåne,34.0,Female,Breast,III,2010-02-17,2010-06-08,2011-05-11,Targeted Therapy,Private,Alive,88.0,EGFR,No,Never,None,31.2,High,Urban,Statutory Health Insurance,4.0,No,No,Diabetes,3.0
PT06097,France,Île-de-France,25.0,Female,Breast,I,2013-12-26,2014-02-02,2014-03-15,Surgery,Public,Alive,102.0,BRCA1,No,Current,None,31.9,Low,,Statutory Health Insurance,15.0,No,No,Hypertension,2.0
PT06098,Sweden,Västra Götaland,87.0,Male,Breast,I,2017-07-11,2017-12-05,2018-02-18,Immunotherapy,Public,Alive,104.0,None,No,,Moderate,38.6,Low,Urban,NHS,15.0,No,No,Hypertension,5.0
PT06099,Germany,North Rhine-Westphalia,41.0,Female,Breast,II,2015-10-02,2016-02-16,2016-07-31,Targeted Therapy,Research Institute,Alive,28.0,EGFR,No,Current,None,21.5,,Rural,Private Insurance,11.0,No,Yes,Hypertension,2.0
PT06100,Ireland,Connacht,51.0,Female,Leukemia,IV,2016-04-07,2016-07-02,2017-05-28,Radiation,Private,Alive,75.0,EGFR,No,Current,Heavy,28.9,Medium,Urban,Statutory Health Insurance,19.0,Yes,Yes,Obesity,4.0
PT06101,Italy,Sicily,41.0,Male,Pancreatic,IV,2018-07-28,2019-01-04,2019-11-21,Immunotherapy,Private,Alive,49.0,EGFR,No,Never,None,20.7,Low,Urban,,15.0,Yes,,None,9.0
PT06102,Norway,Vestland,46.0,Male,Leukemia,III,2013-04-24,2013-09-29,2014-03-14,Surgery,Public,Deceased,31.0,EGFR,No,Former,,20.4,Low,Rural,Statutory Health Insurance,15.0,No,No,Obesity,1.0
PT06103,Netherlands,North Holland,34.0,Female,Leukemia,I,2013-03-10,2013-07-22,2013-11-25,Chemotherapy,Research Institute,Alive,70.0,KRAS,Yes,Former,Heavy,33.7,Medium,Urban,Statutory Health Insurance,14.0,No,No,Diabetes,10.0
PT06104,Poland,Masovian,63.0,Non-binary,Colorectal,III,,2024-04-18,2024-10-26,Immunotherapy,Public,Alive,81.0,None,,Never,None,,High,Urban,Private Insurance,,No,No,None,5.0
PT06105,Germany,North Rhine-Westphalia,28.0,Female,Colorectal,IV,2015-07-16,2015-10-03,2016-01-28,Radiation,Public,Deceased,119.0,KRAS,Yes,Former,Moderate,20.5,Medium,Rural,Statutory Health Insurance,1.0,No,No,Cardiovascular Disease,5.0
PT06106,Italy,Veneto,53.0,Female,Pancreatic,I,2012-12-16,2013-05-13,2013-08-03,Targeted Therapy,Public,Alive,56.0,KRAS,No,Never,Moderate,29.5,High,Urban,NHS,2.0,No,No,Cardiovascular Disease,10.0
PT06107,Poland,Lesser Poland,34.0,Male,Pancreatic,II,2022-06-12,2022-07-12,2022-11-27,Radiation,Public,Deceased,79.0,EGFR,Yes,Current,None,38.9,Medium,Rural,,1.0,,No,None,8.0
PT06108,Poland,Masovian,81.0,Female,Ovarian,II,2019-09-10,2019-09-28,2019-12-11,Targeted Therapy,,Alive,95.0,None,No,Current,Moderate,21.1,,Urban,NHS,11.0,Yes,No,Hypertension,10.0
PT06109,Italy,Lombardy,64.0,,Breast,I,2022-05-26,2022-10-23,2023-05-01,Immunotherapy,Public,Deceased,32.0,None,No,Never,None,21.6,High,Urban,Private Insurance,1.0,No,No,Cardiovascular Disease,1.0
PT06110,Poland,Silesian,,Male,Leukemia,II,2014-08-31,2014-11-27,2015-10-07,Targeted Therapy,Public,Alive,42.0,EGFR,No,Former,Heavy,32.7,High,Urban,Statutory Health Insurance,9.0,Yes,No,,7.0
PT06111,Italy,Lombardy,38.0,Male,Colorectal,IV,2023-07-14,2023-10-17,2024-09-14,Surgery,Private,Deceased,,EGFR,Yes,Former,Moderate,23.0,Medium,Urban,Statutory Health Insurance,14.0,No,No,Cardiovascular Disease,8.0
PT06112,Finland,Pirkanmaa,35.0,Male,,IV,2019-05-05,2019-10-29,2020-02-17,Immunotherapy,Private,Alive,45.0,,No,Never,None,,Low,Urban,Private Insurance,3.0,No,No,Cardiovascular Disease,6.0
PT06113,Switzerland,Zurich,27.0,Female,Breast,IV,2014-03-18,2014-04-05,2015-03-15,Chemotherapy,Private,Alive,32.0,EGFR,Yes,Never,None,,Medium,,Private Insurance,3.0,Yes,No,Obesity,6.0
PT06114,Portugal,Porto,52.0,Male,Ovarian,II,2016-02-08,2016-04-09,2017-03-22,Radiation,Public,Alive,70.0,EGFR,No,Current,Moderate,18.2,,Urban,Private Insurance,6.0,No,No,Diabetes,5.0
PT06115,Norway,Oslo,37.0,Male,Lung,II,2013-08-18,2013-11-08,2014-08-19,Radiation,Public,Alive,65.0,KRAS,Yes,Never,Moderate,25.1,High,Rural,Statutory Health Insurance,3.0,No,,Diabetes,6.0
PT06116,Norway,Trøndelag,54.0,,Leukemia,III,2010-07-02,2010-09-18,2011-08-04,Immunotherapy,Public,Deceased,61.0,,No,Former,Moderate,30.8,High,Rural,NHS,7.0,No,Yes,Hypertension,3.0
PT06117,Finland,Uusimaa,62.0,Male,Breast,II,2021-01-10,2021-05-25,2022-05-04,Chemotherapy,Public,Alive,117.0,KRAS,Yes,Former,Heavy,29.3,High,Urban,Statutory Health Insurance,4.0,Yes,No,None,1.0
PT06118,Ireland,Munster,69.0,Male,Pancreatic,I,2014-03-14,2014-07-27,2015-02-28,Immunotherapy,Private,Alive,83.0,None,No,Former,None,30.0,Low,Urban,,9.0,Yes,No,Cardiovascular Disease,
PT06119,Germany,Bavaria,22.0,Female,Breast,III,2019-07-18,2019-09-21,2020-01-17,Surgery,Public,Alive,57.0,None,Yes,,,33.2,Low,Urban,Statutory Health Insurance,4.0,No,No,Diabetes,10.0
PT06120,Spain,Catalonia,78.0,Male,Lung,,2010-06-05,2010-07-15,2010-09-07,Surgery,,Alive,106.0,EGFR,,Current,None,35.8,Medium,Urban,Private Insurance,2.0,No,No,Hypertension,9.0
PT06121,Ireland,Dublin,47.0,Female,Pancreatic,I,2015-11-15,2016-03-10,2016-05-31,Chemotherapy,Public,Alive,58.0,KRAS,No,Never,Moderate,,High,Urban,Statutory Health Insurance,5.0,Yes,Yes,None,1.0
PT06122,Netherlands,North Holland,65.0,Female,Prostate,I,2023-10-12,2023-11-05,2024-02-20,Immunotherapy,Private,Alive,19.0,None,No,Current,Moderate,34.5,Medium,Urban,Private Insurance,11.0,No,No,Obesity,7.0
PT06123,Italy,Sicily,83.0,Female,Colorectal,IV,2013-10-24,2014-04-02,2014-08-23,Chemotherapy,Research Institute,Deceased,37.0,KRAS,Yes,Never,Moderate,19.7,Low,Urban,Statutory Health Insurance,16.0,Yes,No,Obesity,9.0
PT06124,Denmark,Capital Region,89.0,Female,Colorectal,I,,2023-05-27,2024-05-02,Chemotherapy,Private,Alive,101.0,EGFR,Yes,Never,Moderate,33.4,Medium,Urban,Private Insurance,10.0,No,No,None,8.0
PT06125,Spain,Madrid,66.0,Male,Lung,II,2012-05-07,2012-09-21,2013-07-05,Surgery,Private,Deceased,88.0,EGFR,Yes,Never,Moderate,36.4,Low,Rural,Statutory Health Insurance,9.0,No,No,Hypertension,2.0
PT06126,Denmark,,33.0,Male,Ovarian,IV,2021-09-17,2021-10-26,2022-04-18,Surgery,Public,Alive,77.0,None,No,Never,Heavy,38.5,Medium,Rural,NHS,18.0,Yes,Yes,Obesity,
PT06127,Netherlands,South Holland,26.0,Male,Lung,II,2020-12-21,2021-05-01,,Chemotherapy,Public,Alive,40.0,None,Yes,Current,Moderate,32.1,Medium,Urban,Statutory Health Insurance,16.0,No,No,Cardiovascular Disease,5.0
PT06128,Denmark,Zealand,50.0,Non-binary,Ovarian,I,2023-04-21,2023-08-07,2024-07-05,Chemotherapy,Private,,54.0,EGFR,Yes,Never,None,24.9,Medium,Urban,Statutory Health Insurance,7.0,No,Yes,,6.0
PT06129,Poland,Lesser Poland,70.0,Male,Ovarian,II,2018-02-27,2018-05-07,2018-09-15,Targeted Therapy,Public,Alive,19.0,BRCA1,No,Current,Moderate,32.4,Low,Urban,Statutory Health Insurance,13.0,No,Yes,Hypertension,1.0
PT06130,Portugal,Porto,48.0,Female,Colorectal,I,2022-10-23,2022-10-30,2023-09-14,Surgery,,Alive,64.0,KRAS,Yes,Former,Heavy,21.9,Medium,Urban,NHS,13.0,No,,Obesity,4.0
PT06131,Switzerland,Bern,34.0,Female,Prostate,I,2020-01-16,2020-06-04,2020-12-19,Chemotherapy,Public,Alive,10.0,None,No,Former,None,33.3,Medium,Rural,NHS,6.0,Yes,No,None,3.0
PT06132,Norway,Vestland,44.0,Female,Prostate,IV,2023-08-17,2023-09-09,2024-01-11,Targeted Therapy,Public,Deceased,,None,No,Current,None,37.3,,Urban,Statutory Health Insurance,19.0,No,No,Diabetes,10.0
PT06133,Ireland,Dublin,80.0,Female,,I,2022-01-21,2022-04-20,2023-02-05,Chemotherapy,Private,Deceased,37.0,KRAS,No,Former,Moderate,39.0,Low,Urban,Private Insurance,19.0,Yes,Yes,Diabetes,5.0
PT06134,France,Auvergne-Rhône-Alpes,60.0,Female,Lung,III,2014-08-27,2014-09-13,2015-07-01,Targeted Therapy,Private,Alive,93.0,KRAS,No,Never,Heavy,22.1,Medium,Urban,Statutory Health Insurance,2.0,No,No,Hypertension,10.0
PT06135,France,Provence-Alpes-Côte d'Azur,,,Lung,II,2019-11-26,2020-02-12,2020-04-09,Chemotherapy,Private,Alive,27.0,KRAS,Yes,Former,Moderate,31.6,Medium,Rural,,11.0,No,No,Hypertension,10.0
,,Dublin,23.0,Female,,I,2015-10-02,2015-12-06,2016-05-19,Immunotherapy,Private,Deceased,66.0,BRCA1,Yes,Never,None,39.6,Low,Urban,Statutory Health Insurance,4.0,No,,Hypertension,6.0
PT06137,Denmark,Capital Region,76.0,Male,Pancreatic,II,2016-03-13,,2016-11-12,Surgery,Public,Alive,26.0,KRAS,No,Never,Moderate,31.8,High,,Private Insurance,3.0,No,No,Cardiovascular Disease,8.0
PT06138,Netherlands,Utrecht,50.0,Female,Colorectal,I,2011-12-15,2012-01-12,2012-11-10,Chemotherapy,Research Institute,Deceased,38.0,BRCA1,Yes,Former,None,38.7,High,Rural,,9.0,No,No,None,1.0
PT06139,Poland,Masovian,22.0,Female,Colorectal,II,2015-09-17,2015-11-14,2016-07-22,Radiation,Public,Alive,84.0,KRAS,No,Never,Moderate,27.7,High,Rural,NHS,6.0,No,,Cardiovascular Disease,2.0
PT06140,Ireland,Dublin,86.0,Male,Colorectal,II,2013-12-22,2014-01-09,2014-06-10,Radiation,Private,Lost to Follow-up,,BRCA1,Yes,Former,,35.4,Medium,Urban,Private Insurance,11.0,Yes,,Hypertension,
PT06141,Poland,Lesser Poland,69.0,Female,Prostate,I,,2014-02-16,2014-06-17,Targeted Therapy,,Alive,56.0,KRAS,No,Former,Moderate,19.9,Medium,Urban,NHS,11.0,No,Yes,None,3.0
PT06142,Belgium,Brussels,36.0,Female,Colorectal,III,,2023-09-26,2023-11-05,,Public,Alive,53.0,BRCA1,Yes,Never,Moderate,22.6,Low,Urban,NHS,18.0,No,No,Hypertension,4.0
PT06143,Netherlands,Utrecht,79.0,Female,Breast,I,,2011-04-14,2011-05-19,Targeted Therapy,Private,Alive,20.0,KRAS,Yes,Never,None,,Medium,Rural,Statutory Health Insurance,13.0,Yes,No,Cardiovascular Disease,5.0
PT06144,Belgium,Brussels,85.0,Female,Pancreatic,II,2012-10-25,2012-12-28,2013-09-11,Surgery,Private,Alive,8.0,BRCA1,No,Never,Moderate,19.2,High,Urban,Statutory Health Insurance,8.0,No,,Cardiovascular Disease,4.0
PT06145,,Central Denmark,43.0,Female,Colorectal,III,2011-11-22,2011-12-29,2012-02-18,Radiation,Research Institute,Alive,99.0,BRCA1,No,Never,None,27.8,Medium,Rural,Statutory Health Insurance,17.0,No,No,Diabetes,7.0
PT06146,Austria,Tyrol,51.0,,,II,2020-12-24,2020-12-27,2021-08-28,Radiation,Public,Alive,62.0,EGFR,No,Never,None,36.8,Medium,Urban,Statutory Health Insurance,14.0,No,No,Hypertension,10.0
PT06147,Italy,Veneto,38.0,Male,Pancreatic,IV,2019-10-20,2019-11-03,2020-09-11,Targeted Therapy,Public,Deceased,61.0,None,Yes,,Heavy,24.1,High,Rural,Statutory Health Insurance,3.0,Yes,Yes,None,5.0
PT06148,Portugal,Lisbon,85.0,Female,Prostate,III,2017-09-28,2018-02-10,2018-07-04,Immunotherapy,Private,Deceased,110.0,KRAS,Yes,Never,Moderate,,High,Urban,Statutory Health Insurance,12.0,Yes,No,None,5.0
PT06149,Austria,Tyrol,79.0,Female,Lung,IV,2019-08-26,2020-01-18,2020-09-17,Radiation,Public,Deceased,67.0,EGFR,Yes,Former,Moderate,34.7,High,Rural,NHS,16.0,Yes,,Cardiovascular Disease,2.0
PT06150,Sweden,Skåne,85.0,Male,Pancreatic,I,2010-07-19,2010-10-10,2011-03-29,Surgery,Private,Alive,23.0,BRCA1,Yes,Never,Moderate,23.8,Low,Urban,NHS,11.0,No,No,Obesity,3.0
PT06151,Belgium,Brussels,34.0,Male,Breast,IV,2012-02-15,2012-07-31,2013-02-24,Chemotherapy,Public,Alive,,None,Yes,Never,Moderate,31.4,,Rural,Private Insurance,13.0,No,No,Obesity,7.0
PT06152,Austria,Styria,54.0,Male,Prostate,III,2010-08-14,2010-12-25,2011-01-24,Chemotherapy,Private,Alive,77.0,EGFR,Yes,Current,Moderate,21.5,High,Urban,Statutory Health Insurance,19.0,Yes,No,Obesity,10.0
PT06153,France,Île-de-France,88.0,Non-binary,Leukemia,III,2022-07-03,2022-09-20,2022-11-17,Chemotherapy,Public,Deceased,88.0,EGFR,No,Never,Moderate,26.9,Medium,Rural,Statutory Health Insurance,19.0,No,No,Obesity,
PT06154,Switzerland,Zurich,46.0,Male,Pancreatic,IV,2015-08-28,2015-10-19,2016-09-10,Radiation,Public,Alive,61.0,BRCA1,Yes,Never,Moderate,30.0,Medium,Urban,NHS,7.0,No,No,Diabetes,9.0
PT06155,,North Rhine-Westphalia,26.0,Male,Ovarian,II,2014-11-14,2015-03-03,2016-01-11,Immunotherapy,,Alive,53.0,EGFR,No,,Moderate,39.9,High,Urban,Private Insurance,12.0,No,No,Cardiovascular Disease,5.0
PT06156,Denmark,Zealand,25.0,Female,Pancreatic,IV,2011-09-21,2011-10-17,2012-09-26,Radiation,Public,Deceased,96.0,EGFR,No,Never,Moderate,36.8,Medium,Urban,NHS,14.0,No,No,Hypertension,7.0
PT06157,Italy,,,Male,Lung,II,2015-08-20,2016-02-03,2016-06-16,Surgery,Research Institute,,10.0,EGFR,Yes,Never,Moderate,18.3,Low,Rural,Statutory Health Insurance,17.0,Yes,No,,5.0
PT06158,France,Auvergne-Rhône-Alpes,77.0,Female,Colorectal,II,2010-02-10,2010-08-02,2011-02-09,Radiation,Private,Alive,114.0,EGFR,No,Never,Heavy,32.0,Medium,Urban,NHS,,No,No,Hypertension,3.0
PT06159,Netherlands,North Holland,68.0,Male,Prostate,II,2015-09-23,,2016-02-16,Radiation,Private,Alive,95.0,BRCA1,No,Never,None,,Medium,Rural,,13.0,No,No,None,4.0
PT06160,Norway,Trøndelag,36.0,Male,Leukemia,I,2016-02-23,,2016-12-01,Radiation,Public,Deceased,19.0,BRCA1,No,Former,None,30.1,Medium,Urban,NHS,17.0,No,No,Hypertension,3.0
PT06161,Finland,Southwest Finland,61.0,Female,Prostate,II,2010-10-26,2011-03-26,2011-06-15,Radiation,Public,Deceased,46.0,EGFR,Yes,Never,None,18.6,High,,Statutory Health Insurance,15.0,Yes,No,Hypertension,1.0
PT06162,Belgium,,59.0,Female,Colorectal,IV,2021-10-14,2021-11-23,2022-02-24,Surgery,Private,Alive,65.0,KRAS,No,Former,None,24.2,Low,Rural,Private Insurance,7.0,No,No,Hypertension,6.0
PT06163,Ireland,Connacht,65.0,Male,Prostate,III,2011-04-04,2011-05-06,2011-06-08,Radiation,Public,Alive,55.0,KRAS,Yes,Never,None,22.5,Medium,Rural,Statutory Health Insurance,12.0,No,No,Hypertension,6.0
PT06164,Poland,Masovian,89.0,Female,Leukemia,III,2012-05-28,2012-09-06,2012-10-23,Immunotherapy,Public,Deceased,68.0,EGFR,No,Current,Moderate,18.8,Low,Rural,Private Insurance,19.0,No,No,Diabetes,2.0
PT06165,,Provence-Alpes-Côte d'Azur,87.0,Male,Prostate,III,2014-12-16,,2015-01-28,,Public,Alive,70.0,BRCA1,,Current,None,37.5,,Urban,Private Insurance,7.0,No,No,Obesity,9.0
,Denmark,Capital Region,20.0,Female,Breast,II,2012-02-28,2012-05-19,2013-03-14,,Private,Alive,37.0,None,Yes,Never,Moderate,30.9,Low,Rural,Private Insurance,8.0,No,No,Diabetes,2.0
PT06167,Sweden,Skåne,71.0,Male,Breast,I,2020-08-31,2020-11-23,2021-03-31,Immunotherapy,Private,Alive,96.0,None,No,Former,Heavy,23.7,Medium,Urban,Statutory Health Insurance,3.0,No,No,Cardiovascular Disease,7.0
PT06168,Netherlands,Utrecht,54.0,Non-binary,Colorectal,I,,2011-07-11,2012-06-06,Chemotherapy,Private,Alive,,EGFR,No,Current,None,37.4,Low,Rural,NHS,15.0,No,,Cardiovascular Disease,4.0
PT06169,Netherlands,Utrecht,88.0,,Ovarian,I,2013-12-21,2014-03-06,2014-10-15,Chemotherapy,,Lost to Follow-up,,None,No,Never,Moderate,36.7,Medium,Urban,Private Insurance,14.0,No,No,Hypertension,7.0
PT06170,,Berlin,24.0,Male,Ovarian,III,2019-05-09,2019-06-20,2020-05-31,Surgery,Public,Alive,23.0,BRCA1,Yes,Former,None,23.0,Medium,Rural,NHS,19.0,No,,None,3.0
PT06171,Spain,Catalonia,36.0,Male,Leukemia,III,2017-02-08,2017-05-16,2017-07-18,Targeted Therapy,,Alive,46.0,KRAS,No,Current,None,23.1,Medium,Rural,NHS,16.0,No,No,Obesity,9.0
PT06172,Ireland,Connacht,72.0,Female,Leukemia,I,2022-08-08,2023-01-22,2024-01-12,Radiation,Private,Lost to Follow-up,,None,No,Never,Moderate,22.0,High,Urban,Private Insurance,19.0,No,No,Cardiovascular Disease,1.0
PT06173,Spain,,71.0,Male,Leukemia,I,2019-10-30,2020-02-10,2020-05-14,Surgery,Public,Alive,112.0,EGFR,Yes,Former,Moderate,22.2,Medium,Rural,Statutory Health Insurance,9.0,No,No,Hypertension,
PT06174,Poland,,33.0,Male,Leukemia,II,2010-11-26,2011-01-12,2011-07-23,Radiation,Public,Deceased,80.0,EGFR,No,Former,None,34.1,Medium,Rural,Private Insurance,13.0,Yes,No,Diabetes,7.0
PT06175,Spain,Andalusia,48.0,Male,Leukemia,I,2018-05-13,2018-10-26,2019-05-19,Radiation,Public,Deceased,75.0,BRCA1,Yes,,Moderate,23.3,Medium,Rural,NHS,11.0,No,No,None,8.0
PT06176,Sweden,Stockholm,27.0,Female,Ovarian,II,2016-12-10,2016-12-28,2017-03-14,Chemotherapy,Private,Alive,56.0,None,Yes,Current,Heavy,36.3,High,Rural,NHS,6.0,No,Yes,None,4.0
PT06177,Switzerland,Geneva,20.0,Female,Lung,I,2023-06-11,,2024-02-15,Targeted Therapy,Public,Alive,98.0,BRCA1,Yes,Former,Moderate,39.3,Low,Urban,Private Insurance,9.0,No,No,Diabetes,6.0
PT06178,Finland,Southwest Finland,48.0,Male,Prostate,II,2012-10-16,2013-01-29,2013-10-06,Radiation,Public,Alive,41.0,KRAS,No,Current,Moderate,,Medium,Urban,,4.0,Yes,No,Hypertension,8.0
PT06179,Denmark,Zealand,55.0,Female,Pancreatic,IV,,2019-11-20,2019-12-30,Surgery,Private,Alive,10.0,KRAS,Yes,Never,Heavy,29.6,Low,,NHS,7.0,No,No,Obesity,1.0
PT06180,Poland,Lesser Poland,70.0,Female,Leukemia,II,2020-06-18,2020-09-14,2021-04-21,Chemotherapy,Public,Alive,116.0,EGFR,No,Former,Moderate,18.8,Low,Urban,Private Insurance,12.0,No,,Cardiovascular Disease,3.0
PT06181,Ireland,Connacht,56.0,Male,Ovarian,III,2022-05-27,2022-11-01,2023-02-24,,Public,Alive,39.0,EGFR,Yes,Never,Moderate,25.3,Medium,Urban,NHS,12.0,Yes,No,None,3.0
,Ireland,Munster,88.0,Female,Pancreatic,III,2015-01-02,2015-01-06,2015-03-09,Chemotherapy,Public,Alive,20.0,None,Yes,Former,Moderate,38.6,Medium,Urban,Statutory Health Insurance,15.0,No,Yes,Obesity,
PT06183,Norway,Trøndelag,72.0,Female,Breast,II,2021-04-04,2021-04-11,2021-08-13,Chemotherapy,Private,Alive,14.0,None,No,Never,Heavy,26.1,High,Rural,Private Insurance,15.0,No,,Diabetes,8.0
PT06184,Portugal,Porto,71.0,Female,Ovarian,III,2011-09-12,2011-11-08,2012-11-01,Surgery,Public,Alive,102.0,BRCA1,No,Never,None,33.2,Low,Urban,NHS,2.0,No,No,Diabetes,8.0
PT06185,Germany,Bavaria,31.0,,Pancreatic,II,2011-11-20,2011-12-20,2012-07-17,Surgery,Public,Alive,86.0,KRAS,No,Never,None,29.8,Medium,Urban,NHS,1.0,Yes,Yes,None,6.0
PT06186,Ireland,Dublin,71.0,Non-binary,Ovarian,I,2015-10-14,2016-04-03,2017-02-10,,Private,Deceased,106.0,KRAS,No,Never,Moderate,30.9,Medium,,Statutory Health Insurance,1.0,Yes,No,Obesity,6.0
PT06187,Norway,Oslo,20.0,,Pancreatic,I,2022-10-15,2023-03-21,2023-05-12,Radiation,Public,Lost to Follow-up,,EGFR,No,Never,None,39.9,Medium,Rural,,3.0,No,,Obesity,3.0
PT06188,Norway,Vestland,26.0,Female,Ovarian,III,2012-03-30,2012-06-28,2012-09-14,Chemotherapy,Public,Deceased,16.0,None,Yes,Former,None,36.1,Medium,Urban,Statutory Health Insurance,14.0,No,No,Hypertension,5.0
PT06189,Sweden,Stockholm,36.0,Female,Prostate,II,2016-03-01,2016-04-06,2017-04-02,Immunotherapy,Public,Alive,47.0,None,Yes,Former,Moderate,38.2,,Urban,Statutory Health Insurance,14.0,No,,None,9.0
PT06190,Netherlands,Utrecht,62.0,Male,Pancreatic,II,2016-04-20,2016-07-28,2017-04-04,Surgery,Public,Alive,107.0,KRAS,Yes,Never,Moderate,32.7,High,Urban,NHS,15.0,Yes,No,None,10.0
PT06191,Spain,Madrid,36.0,Female,Colorectal,I,2019-12-23,2020-04-14,2020-05-15,Targeted Therapy,Public,Alive,68.0,BRCA1,No,Never,Moderate,26.9,High,,NHS,15.0,No,No,Obesity,3.0
PT06192,Belgium,Brussels,78.0,Female,Ovarian,I,2017-04-14,2017-10-07,2018-01-21,Chemotherapy,Public,,46.0,BRCA1,No,,Moderate,26.3,,Rural,Private Insurance,18.0,No,No,None,4.0
,Belgium,Brussels,22.0,Male,Colorectal,III,2016-02-21,,2016-12-04,Targeted Therapy,Private,Deceased,66.0,BRCA1,No,Current,Moderate,39.3,Medium,,Private Insurance,2.0,No,No,Hypertension,8.0
PT06194,Austria,Styria,48.0,Male,Ovarian,III,2016-04-17,,2016-10-19,Targeted Therapy,Public,Alive,35.0,KRAS,Yes,Current,Moderate,24.6,Medium,Urban,NHS,8.0,Yes,No,Diabetes,9.0
PT06195,Sweden,Stockholm,41.0,Male,Leukemia,II,2019-09-25,2020-02-14,2020-08-06,Chemotherapy,Public,Alive,,None,No,Current,None,22.1,Medium,,,,Yes,No,Hypertension,4.0
PT06196,Belgium,Brussels,57.0,Female,Lung,I,2012-08-12,2012-12-03,2013-10-27,Immunotherapy,Private,Alive,18.0,None,,Current,None,20.9,Medium,Rural,Statutory Health Insurance,15.0,No,No,Cardiovascular Disease,2.0
,Finland,Uusimaa,73.0,Female,Ovarian,IV,2020-10-16,2021-01-24,2021-05-30,Immunotherapy,Public,Alive,80.0,BRCA1,Yes,Former,None,30.0,Medium,Urban,Private Insurance,2.0,No,No,None,10.0
PT06198,Denmark,Zealand,69.0,Female,Lung,III,2023-01-01,2023-04-15,2024-03-24,Chemotherapy,Private,Deceased,118.0,EGFR,No,Never,Moderate,33.6,Medium,Rural,,2.0,No,No,None,10.0
PT06199,Switzerland,Geneva,88.0,Male,Prostate,III,2021-12-19,2022-04-10,2022-12-09,Radiation,Public,Alive,12.0,KRAS,No,Never,None,28.8,Low,Rural,Private Insurance,13.0,No,No,Obesity,5.0
PT06200,,Zurich,49.0,Female,Lung,I,2013-06-01,2013-07-06,2014-06-22,Targeted Therapy,Private,Alive,63.0,KRAS,Yes,Never,Heavy,37.8,Medium,Urban,NHS,8.0,No,No,Cardiovascular Disease,4.0
PT06201,Switzerland,,42.0,Female,Pancreatic,II,2022-09-09,2023-02-05,2023-05-19,Immunotherapy,Public,Alive,47.0,None,No,Current,Moderate,34.2,High,Rural,Statutory Health Insurance,4.0,No,No,Hypertension,2.0
PT06202,Portugal,Lisbon,66.0,Male,Colorectal,IV,2013-06-27,2013-11-19,2014-10-09,Chemotherapy,Public,Deceased,,BRCA1,No,Never,Moderate,21.8,Low,Urban,Private Insurance,7.0,No,Yes,Hypertension,4.0
PT06203,Netherlands,North Holland,40.0,Male,Leukemia,II,2010-01-13,2010-04-05,2010-05-30,Surgery,Public,Deceased,50.0,None,Yes,Current,None,39.0,High,Rural,Private Insurance,4.0,No,No,Cardiovascular Disease,3.0
PT06204,,Pirkanmaa,39.0,Male,,III,2022-11-19,2022-12-21,2023-08-29,Surgery,Public,Alive,90.0,None,No,Never,None,32.4,High,Urban,Statutory Health Insurance,2.0,Yes,Yes,Obesity,3.0
PT06205,Poland,Masovian,42.0,Female,Pancreatic,III,2016-02-18,2016-07-18,2017-03-07,Chemotherapy,Research Institute,Alive,76.0,KRAS,No,Never,Moderate,21.8,Medium,Urban,Statutory Health Insurance,10.0,No,Yes,Obesity,1.0
PT06206,Norway,Vestland,87.0,Female,Colorectal,I,2011-11-29,2012-04-11,2013-02-12,Radiation,Private,Alive,27.0,EGFR,Yes,Never,None,27.7,,,Statutory Health Insurance,16.0,No,No,Hypertension,8.0
PT06207,Norway,,40.0,Non-binary,Colorectal,III,2015-08-29,2015-09-27,,Surgery,Public,Deceased,118.0,EGFR,No,Never,None,28.1,Medium,Urban,NHS,1.0,No,Yes,Obesity,2.0
PT06208,Netherlands,North Holland,40.0,Male,Prostate,I,2016-07-14,2016-09-15,2017-02-06,Radiation,Public,Alive,101.0,None,No,Never,None,31.9,Medium,Urban,NHS,10.0,No,No,Obesity,4.0
PT06209,Belgium,Brussels,20.0,Female,Pancreatic,,2022-10-19,2023-02-21,2023-12-13,Chemotherapy,Public,Deceased,9.0,KRAS,No,Former,None,39.0,High,Urban,Private Insurance,2.0,No,No,Cardiovascular Disease,1.0
PT06210,Switzerland,Geneva,34.0,Female,Ovarian,IV,2015-09-05,2015-12-10,2016-04-27,Chemotherapy,Public,Alive,84.0,None,Yes,Former,Moderate,26.6,High,Rural,NHS,13.0,No,No,Cardiovascular Disease,4.0
PT06211,Ireland,Connacht,36.0,Male,Lung,IV,2018-06-05,2018-08-25,2019-02-23,Targeted Therapy,Public,Alive,44.0,KRAS,Yes,Never,None,30.9,Medium,Urban,Statutory Health Insurance,2.0,No,No,Obesity,10.0
PT06212,Italy,Sicily,70.0,Male,Breast,III,2018-10-18,,2019-07-24,Chemotherapy,Public,Alive,115.0,KRAS,No,Current,None,26.6,Low,Rural,NHS,7.0,Yes,No,None,8.0
,,Munster,82.0,Female,Breast,II,2020-06-10,2020-08-07,2021-01-06,Radiation,Private,Alive,90.0,KRAS,No,Never,Heavy,37.8,Medium,Rural,Private Insurance,6.0,No,Yes,Obesity,9.0
PT06214,Norway,,33.0,,Ovarian,III,2012-11-16,2013-04-24,2013-12-14,Immunotherapy,Public,Deceased,106.0,KRAS,Yes,Former,None,39.1,,Rural,Private Insurance,2.0,No,No,Diabetes,1.0
PT06215,Sweden,Västra Götaland,78.0,Male,Lung,III,2015-11-23,2016-04-21,2017-04-07,Surgery,Public,Alive,46.0,EGFR,Yes,Former,Heavy,34.3,Medium,Urban,Private Insurance,10.0,No,,Cardiovascular Disease,
PT06216,Denmark,Zealand,69.0,Male,Ovarian,I,2020-10-02,2021-03-06,2021-12-11,Surgery,Private,Deceased,46.0,,No,Current,None,23.7,Medium,Rural,NHS,9.0,No,No,Hypertension,9.0
PT06217,Portugal,Lisbon,53.0,Female,Leukemia,I,2017-10-02,2018-01-28,2018-07-10,Targeted Therapy,Public,Deceased,107.0,None,No,Former,Moderate,31.6,Medium,Rural,Private Insurance,9.0,No,No,Cardiovascular Disease,2.0
PT06218,Sweden,Västra Götaland,25.0,Non-binary,Lung,II,2016-06-08,2016-09-01,2017-06-09,,Public,Alive,46.0,EGFR,No,Never,Moderate,23.6,Medium,Urban,NHS,15.0,No,No,None,3.0
PT06219,Denmark,Capital Region,68.0,Female,Leukemia,I,2018-08-15,2018-11-07,2018-12-07,Radiation,,Alive,33.0,EGFR,Yes,Former,Moderate,30.6,Medium,,Private Insurance,9.0,No,No,None,10.0
PT06220,Portugal,Porto,25.0,Male,Breast,IV,2018-06-17,2018-09-12,2019-07-22,Radiation,Public,Alive,48.0,KRAS,No,Current,Moderate,26.6,Low,Rural,Statutory Health Insurance,7.0,Yes,No,Hypertension,5.0
PT06221,Germany,Bavaria,88.0,Male,Pancreatic,II,2019-12-21,2020-01-06,2020-09-05,,Research Institute,Deceased,69.0,EGFR,Yes,Current,Moderate,34.8,Medium,Urban,NHS,3.0,No,No,Hypertension,9.0
PT06222,France,Auvergne-Rhône-Alpes,26.0,Male,Prostate,I,2017-05-13,2017-05-19,2017-10-19,Chemotherapy,Private,Deceased,11.0,EGFR,,Never,Moderate,37.7,Medium,Urban,Private Insurance,17.0,No,No,Obesity,6.0
PT06223,Norway,Vestland,70.0,Female,Colorectal,II,2010-06-23,2010-06-30,2011-02-11,Immunotherapy,Public,Alive,71.0,KRAS,Yes,Never,None,18.3,Low,Rural,NHS,10.0,No,No,Diabetes,7.0
PT06224,Norway,Vestland,20.0,Female,Pancreatic,IV,2013-11-25,2013-12-09,2014-01-27,Surgery,Private,Alive,36.0,BRCA1,Yes,Former,None,38.1,Medium,Urban,Private Insurance,18.0,No,Yes,Diabetes,5.0
PT06225,Ireland,Dublin,32.0,Female,Breast,IV,2020-09-08,2020-09-11,2021-09-07,Immunotherapy,Research Institute,Alive,96.0,EGFR,No,Current,Moderate,23.7,Medium,Urban,Statutory Health Insurance,9.0,No,No,Cardiovascular Disease,4.0
PT06226,Ireland,Dublin,62.0,Male,Breast,I,2011-03-25,2011-05-13,2012-04-20,Targeted Therapy,Public,Deceased,14.0,KRAS,No,Former,Heavy,33.9,Medium,Urban,NHS,17.0,No,No,Obesity,10.0
PT06227,Norway,Vestland,46.0,,Breast,III,,2014-01-26,2014-08-12,Chemotherapy,Private,Lost to Follow-up,,KRAS,No,,None,22.9,High,Rural,Private Insurance,10.0,No,No,Diabetes,3.0
PT06228,Austria,Tyrol,22.0,Female,Colorectal,II,2021-06-05,2021-07-04,2021-11-08,Immunotherapy,Public,,6.0,None,Yes,Former,None,25.6,High,Urban,Private Insurance,9.0,No,No,Obesity,
PT06229,Belgium,Wallonia,77.0,Non-binary,Leukemia,II,2016-10-22,2017-03-03,2017-08-25,Chemotherapy,Public,Deceased,20.0,EGFR,No,Never,Moderate,31.5,Low,Urban,Statutory Health Insurance,5.0,No,No,Cardiovascular Disease,7.0
PT06230,Poland,Masovian,36.0,Female,Prostate,III,2012-02-21,2012-08-07,2013-02-14,Immunotherapy,Research Institute,Lost to Follow-up,,None,,Never,Heavy,21.5,Medium,Rural,,16.0,Yes,No,Diabetes,7.0
PT06231,Ireland,Dublin,64.0,Female,Pancreatic,I,2019-10-09,2020-03-26,2020-06-29,Surgery,Public,Alive,28.0,None,Yes,Never,Moderate,23.1,Medium,Rural,NHS,13.0,,Yes,,6.0
PT06232,Netherlands,Utrecht,77.0,Female,Pancreatic,II,2010-06-21,2010-11-18,2011-08-19,Radiation,Private,,22.0,None,No,,Heavy,28.5,Medium,Rural,Private Insurance,6.0,No,No,None,6.0
PT06233,Norway,Vestland,75.0,Male,Prostate,II,2020-04-27,2020-09-06,2021-08-22,Immunotherapy,Public,,63.0,BRCA1,No,Former,Moderate,20.6,Medium,Urban,Statutory Health Insurance,1.0,No,No,None,4.0
PT06234,Poland,Silesian,73.0,Non-binary,Prostate,I,2016-08-05,2016-12-04,2017-05-08,Radiation,Research Institute,Deceased,76.0,None,Yes,Current,Moderate,21.0,Low,Urban,,13.0,No,No,Diabetes,4.0
PT06235,Austria,Styria,,Male,Leukemia,I,2016-04-02,2016-04-25,2016-12-30,,Public,Alive,109.0,EGFR,Yes,Never,Moderate,32.7,Low,Urban,Private Insurance,17.0,No,,,4.0
PT06236,Sweden,Västra Götaland,73.0,Female,Pancreatic,I,2011-03-09,2011-06-19,2012-04-26,Radiation,Public,Alive,72.0,KRAS,Yes,Former,Moderate,40.0,Medium,Urban,Private Insurance,9.0,No,No,None,1.0
PT06237,Finland,Southwest Finland,46.0,Non-binary,Lung,III,2017-08-17,2017-12-27,2018-02-24,Targeted Therapy,,Alive,103.0,KRAS,No,,None,39.7,Medium,Urban,Statutory Health Insurance,17.0,No,No,Obesity,3.0
PT06238,Norway,Vestland,64.0,Male,Lung,I,2023-07-17,2023-08-04,2023-11-27,Surgery,Public,,58.0,KRAS,Yes,Current,None,29.0,High,Urban,Statutory Health Insurance,9.0,,No,Cardiovascular Disease,1.0
PT06239,Denmark,Central Denmark,50.0,Female,Prostate,II,2015-02-03,2015-02-04,2016-01-31,Radiation,Private,Lost to Follow-up,,KRAS,No,Current,Heavy,34.7,Medium,Urban,NHS,2.0,,No,Obesity,8.0
PT06240,Ireland,Connacht,55.0,Female,Breast,II,2013-09-12,2013-10-14,2014-07-26,Surgery,Private,,88.0,KRAS,No,Never,None,31.7,Medium,Urban,,,No,No,Diabetes,8.0
PT06241,Ireland,Munster,80.0,Female,Breast,IV,2020-09-24,2021-02-20,2021-11-01,Immunotherapy,Public,Deceased,35.0,KRAS,No,Former,None,18.1,Medium,Rural,NHS,4.0,No,No,Diabetes,1.0
PT06242,,,56.0,,Colorectal,III,2017-04-28,2017-10-11,2018-09-02,Surgery,Public,,,None,Yes,Former,Moderate,37.8,,Urban,Private Insurance,19.0,No,Yes,Hypertension,9.0
PT06243,,,86.0,Female,Lung,IV,2011-07-03,2011-12-04,2012-08-29,Chemotherapy,Public,Alive,60.0,KRAS,No,Former,None,35.3,,Urban,NHS,9.0,,No,Obesity,5.0
PT06244,Portugal,Lisbon,55.0,Female,Breast,I,2023-11-09,2023-12-20,2024-10-01,Radiation,Public,Alive,47.0,EGFR,No,Current,None,23.0,Low,Rural,Private Insurance,9.0,Yes,No,Cardiovascular Disease,3.0
PT06245,Portugal,Algarve,24.0,Male,Ovarian,III,2019-10-15,2020-04-09,2020-09-18,Immunotherapy,Private,Alive,119.0,None,No,Former,None,39.3,Medium,Rural,,2.0,No,No,,10.0
PT06246,Italy,Lombardy,65.0,Male,Prostate,I,,2020-03-12,2020-08-21,,Public,Lost to Follow-up,,None,Yes,Never,None,26.3,Low,Urban,NHS,16.0,No,No,Obesity,5.0
PT06247,,Skåne,71.0,,Colorectal,III,2010-06-16,2010-09-17,,Radiation,Private,Alive,108.0,BRCA1,No,Former,Moderate,26.6,Low,Urban,Private Insurance,6.0,No,No,None,1.0
PT06248,Denmark,Central Denmark,68.0,Female,Lung,II,2019-08-14,2019-12-09,2020-10-15,Immunotherapy,Public,Deceased,53.0,None,No,Never,None,32.7,High,Urban,NHS,17.0,No,No,Diabetes,9.0
PT06249,France,Auvergne-Rhône-Alpes,25.0,Male,Colorectal,III,2020-04-18,2020-10-04,2021-09-03,Immunotherapy,Private,Alive,116.0,BRCA1,No,Never,None,32.4,Medium,Urban,NHS,11.0,No,No,Cardiovascular Disease,1.0
PT06250,Denmark,Central Denmark,29.0,Female,Breast,II,2016-07-28,2016-11-01,2017-10-22,Targeted Therapy,Public,Alive,87.0,BRCA1,Yes,Former,None,32.8,High,,Private Insurance,3.0,No,Yes,Cardiovascular Disease,9.0
PT06251,Italy,Veneto,42.0,Male,Prostate,I,2018-09-06,2018-11-04,,Targeted Therapy,Private,Alive,28.0,KRAS,Yes,Never,Moderate,18.5,Medium,Rural,Statutory Health Insurance,17.0,,Yes,None,3.0
PT06252,Ireland,Connacht,36.0,Female,Ovarian,III,2014-07-06,2014-11-15,2015-10-27,,Public,Alive,,BRCA1,No,Former,None,25.4,Low,Rural,Private Insurance,,No,No,Diabetes,10.0
PT06253,Austria,Vienna,63.0,Male,Prostate,IV,2018-09-25,2019-02-13,,Surgery,Private,Deceased,9.0,KRAS,,Current,Moderate,18.3,Low,Rural,NHS,3.0,No,,Diabetes,8.0
PT06254,Sweden,Västra Götaland,60.0,Female,Prostate,I,2020-04-03,2020-06-03,2020-12-16,Chemotherapy,Public,Deceased,111.0,None,No,Never,None,25.5,Low,Rural,Statutory Health Insurance,8.0,No,Yes,Hypertension,
PT06255,Denmark,Zealand,34.0,Female,Breast,IV,2022-03-07,2022-04-27,2022-08-12,Chemotherapy,Private,Alive,104.0,EGFR,Yes,Never,None,36.5,Medium,Rural,NHS,6.0,No,No,Hypertension,4.0
PT06256,Portugal,Lisbon,63.0,Female,Ovarian,I,2017-03-06,2017-08-16,2018-03-10,Surgery,Private,Deceased,78.0,EGFR,No,Never,None,23.8,Low,Urban,Statutory Health Insurance,12.0,Yes,,Cardiovascular Disease,5.0
PT06257,,Connacht,77.0,Female,Ovarian,III,2019-04-25,2019-07-25,2020-05-19,Targeted Therapy,Private,Alive,80.0,KRAS,Yes,Current,Moderate,21.9,Low,Urban,Statutory Health Insurance,7.0,No,No,Hypertension,6.0
PT06258,Poland,Masovian,69.0,Female,Leukemia,IV,2023-03-28,2023-06-01,,,Public,Alive,70.0,BRCA1,No,Never,Moderate,38.3,High,Urban,Statutory Health Insurance,,No,Yes,Cardiovascular Disease,
PT06259,Norway,Vestland,71.0,Female,Pancreatic,I,2011-06-27,2011-08-15,2012-01-28,Targeted Therapy,Private,Deceased,15.0,KRAS,No,Current,Moderate,23.0,Medium,Urban,NHS,2.0,No,No,Diabetes,3.0
PT06260,Sweden,,89.0,Female,Pancreatic,II,,2014-02-25,2014-10-03,Immunotherapy,Public,Alive,116.0,KRAS,Yes,Current,None,28.5,Low,Urban,NHS,9.0,No,Yes,Hypertension,6.0
PT06261,Finland,Uusimaa,87.0,Male,Prostate,II,2019-10-25,2020-02-05,2020-11-22,Surgery,Public,Alive,100.0,None,No,Never,None,25.4,Medium,Rural,Private Insurance,18.0,No,No,Cardiovascular Disease,4.0
PT06262,Belgium,Brussels,82.0,,Pancreatic,II,2011-07-22,2011-12-11,2012-04-20,Targeted Therapy,Public,,19.0,KRAS,Yes,Former,None,19.9,Low,Urban,NHS,5.0,No,No,None,6.0
PT06263,Netherlands,South Holland,77.0,Female,Leukemia,III,2019-09-09,2020-02-21,2020-07-04,Surgery,Private,Alive,97.0,EGFR,No,Former,None,23.0,Medium,Urban,NHS,15.0,No,No,,9.0
PT06264,Belgium,Brussels,42.0,Male,,III,2017-07-08,,2018-07-01,Radiation,Public,Alive,116.0,None,Yes,Never,Moderate,31.8,High,Rural,NHS,14.0,No,No,Obesity,1.0
PT06265,Portugal,Porto,63.0,Female,Leukemia,IV,2020-01-23,,2021-05-28,Surgery,Public,Alive,41.0,None,No,Former,None,19.8,Low,Urban,NHS,7.0,No,No,Obesity,4.0
PT06266,Germany,Berlin,63.0,Female,Lung,I,2015-04-25,2015-07-26,2015-11-29,Surgery,Research Institute,Alive,93.0,BRCA1,No,Never,Moderate,18.9,Medium,Urban,NHS,8.0,No,Yes,,9.0
PT06267,Denmark,Capital Region,71.0,Non-binary,Pancreatic,II,,2023-07-05,2024-05-29,Targeted Therapy,Private,,33.0,None,No,Former,None,21.5,Medium,Urban,Statutory Health Insurance,13.0,No,No,Cardiovascular Disease,8.0
PT06268,Portugal,Porto,86.0,Female,Ovarian,II,2014-10-27,2014-12-28,2015-01-31,Surgery,Private,Alive,64.0,EGFR,No,Former,None,,High,Rural,Statutory Health Insurance,13.0,No,No,Hypertension,10.0
PT06269,France,Auvergne-Rhône-Alpes,47.0,Male,Lung,IV,2016-02-08,2016-02-11,2016-07-30,Radiation,Public,,9.0,BRCA1,No,Former,Moderate,33.7,Low,Rural,NHS,14.0,No,No,Diabetes,10.0
PT06270,Spain,Andalusia,86.0,Male,Prostate,I,2020-10-20,2020-11-28,2021-05-19,Immunotherapy,,Alive,83.0,EGFR,No,Never,Moderate,28.7,Medium,Rural,Statutory Health Insurance,5.0,No,,Cardiovascular Disease,
PT06271,Finland,Pirkanmaa,37.0,Male,Ovarian,IV,2017-05-25,2017-06-13,2018-03-06,Chemotherapy,Public,Alive,74.0,KRAS,Yes,Current,Moderate,29.0,Medium,Rural,NHS,14.0,Yes,No,Hypertension,1.0
,France,Auvergne-Rhône-Alpes,,,,II,2012-10-25,2013-02-07,2013-09-08,Immunotherapy,Public,Deceased,101.0,BRCA1,No,Never,None,26.2,Medium,Urban,Statutory Health Insurance,5.0,No,No,Diabetes,7.0
PT06273,Ireland,Connacht,70.0,Female,Colorectal,III,2022-04-08,2022-07-15,2023-03-02,Surgery,Public,Deceased,,None,Yes,Current,Moderate,35.3,Medium,Urban,Statutory Health Insurance,,No,No,Obesity,4.0
PT06274,Spain,,79.0,Male,Breast,II,2020-02-21,2020-06-28,2020-08-26,Radiation,Public,Deceased,103.0,None,No,Former,None,18.9,Medium,Rural,NHS,13.0,No,No,Diabetes,4.0
PT06275,Poland,Lesser Poland,68.0,Female,Lung,IV,2012-01-12,2012-06-27,2013-06-03,Radiation,Public,Alive,42.0,EGFR,No,Former,Heavy,,Low,Urban,Statutory Health Insurance,19.0,Yes,,Hypertension,2.0
PT06276,Germany,Berlin,34.0,Female,Lung,II,2014-11-11,2014-11-21,2015-04-23,Immunotherapy,Public,Lost to Follow-up,,EGFR,Yes,,Moderate,39.1,High,Rural,Statutory Health Insurance,10.0,No,Yes,Cardiovascular Disease,10.0
PT06277,Portugal,Lisbon,87.0,Female,,III,2016-02-13,,2017-07-25,Targeted Therapy,,Deceased,67.0,BRCA1,Yes,Current,Heavy,30.6,High,Urban,NHS,4.0,No,No,None,7.0
PT06278,Germany,North Rhine-Westphalia,,Male,Prostate,III,2014-06-02,2014-10-08,2015-03-11,Chemotherapy,Private,Alive,95.0,EGFR,Yes,Never,Moderate,34.2,Medium,Rural,NHS,12.0,No,No,Cardiovascular Disease,1.0
PT06279,Switzerland,Geneva,70.0,Male,Ovarian,II,2019-09-07,2019-12-05,2020-11-01,Surgery,Research Institute,Alive,119.0,KRAS,Yes,Former,Moderate,21.3,High,Urban,Private Insurance,16.0,Yes,,None,6.0
PT06280,Austria,Styria,67.0,Male,Ovarian,I,2011-07-12,2011-12-10,2012-10-18,Surgery,Private,Alive,,EGFR,No,Former,,30.6,Low,Urban,Statutory Health Insurance,19.0,No,No,Hypertension,5.0
PT06281,Norway,Trøndelag,20.0,Male,Ovarian,III,2021-07-12,2021-09-09,2022-07-28,Immunotherapy,Private,Alive,97.0,None,Yes,Never,Moderate,24.9,High,Urban,Statutory Health Insurance,4.0,No,No,Obesity,6.0
PT06282,Sweden,Stockholm,,Non-binary,Breast,I,2013-09-29,2013-12-21,2014-12-15,Radiation,Public,Alive,,KRAS,Yes,,None,33.6,High,Rural,NHS,,Yes,,Hypertension,5.0
PT06283,Netherlands,Utrecht,72.0,Female,Lung,III,2012-05-07,2012-08-17,2012-11-27,Radiation,Public,Lost to Follow-up,,,No,Former,Moderate,22.0,,Rural,Private Insurance,5.0,No,,Hypertension,4.0
PT06284,Norway,Trøndelag,50.0,Male,Breast,III,2018-04-10,2018-09-05,2019-06-12,Targeted Therapy,Public,Deceased,98.0,BRCA1,,Never,None,30.7,Medium,Urban,Private Insurance,12.0,,No,None,9.0
PT06285,Ireland,Connacht,37.0,Female,Lung,II,2021-11-13,2022-05-05,2022-10-08,Chemotherapy,Public,Alive,58.0,KRAS,Yes,Never,Moderate,29.3,Medium,Rural,NHS,8.0,No,No,Obesity,7.0
PT06286,Switzerland,Geneva,31.0,Male,,II,2014-12-16,2015-01-29,2015-12-16,Surgery,Private,Alive,41.0,,,Never,Moderate,34.0,High,Urban,NHS,3.0,No,No,None,4.0
PT06287,Germany,Bavaria,67.0,Female,Ovarian,III,2016-06-14,2016-07-02,2017-03-10,Immunotherapy,Private,Deceased,31.0,BRCA1,No,Never,Moderate,32.7,Medium,Urban,Private Insurance,16.0,No,No,Diabetes,8.0
PT06288,Switzerland,Bern,49.0,Male,Leukemia,III,2021-02-17,2021-04-06,2022-04-01,,Private,Alive,91.0,BRCA1,No,Current,Moderate,34.3,High,Rural,Private Insurance,11.0,No,No,Cardiovascular Disease,1.0
PT06289,Denmark,Capital Region,26.0,Female,,III,2021-05-20,2021-08-03,2022-02-01,Chemotherapy,Private,Deceased,104.0,EGFR,No,,Moderate,38.3,High,Urban,Statutory Health Insurance,9.0,,Yes,,6.0
PT06290,Ireland,Connacht,22.0,Male,Ovarian,I,2023-02-23,2023-02-24,2024-02-19,Surgery,Public,Alive,33.0,,No,Never,Heavy,30.6,Medium,Rural,Private Insurance,13.0,No,No,None,6.0
PT06291,Ireland,Dublin,82.0,Male,Ovarian,IV,2019-06-02,2019-11-09,2020-09-30,Chemotherapy,Public,,66.0,EGFR,Yes,Former,None,26.8,Low,Rural,,7.0,Yes,No,Diabetes,5.0
PT06292,Switzerland,Zurich,25.0,Male,Colorectal,II,2019-08-08,2019-11-13,2020-06-12,Surgery,Research Institute,Deceased,113.0,KRAS,No,Former,Moderate,29.0,Low,Urban,NHS,5.0,No,No,Hypertension,9.0
PT06293,Denmark,Capital Region,34.0,Male,,,2022-01-05,2022-01-12,2022-04-20,Chemotherapy,Private,Alive,27.0,None,Yes,Former,None,33.2,High,Urban,Statutory Health Insurance,,Yes,No,None,3.0
PT06294,Netherlands,North Holland,62.0,Female,Lung,I,2012-01-17,2012-04-21,2012-12-25,Chemotherapy,Public,Alive,55.0,BRCA1,No,Former,None,23.2,Medium,,NHS,18.0,,No,Obesity,4.0
PT06295,Switzerland,Zurich,37.0,Male,Pancreatic,I,2010-08-29,2010-11-27,2011-02-21,Immunotherapy,Public,Alive,40.0,EGFR,Yes,Never,None,22.2,High,Rural,Statutory Health Insurance,4.0,No,No,Diabetes,3.0
PT06296,Belgium,Flanders,41.0,Female,Leukemia,II,2023-09-30,2024-01-08,2024-02-09,Targeted Therapy,,Alive,87.0,KRAS,No,Former,Moderate,20.0,High,Urban,Statutory Health Insurance,14.0,No,No,Cardiovascular Disease,8.0
PT06297,Sweden,Stockholm,80.0,Female,Leukemia,II,2013-02-26,2013-08-19,2014-07-18,Radiation,Public,Alive,74.0,None,No,Never,None,26.8,High,Rural,,11.0,No,No,Cardiovascular Disease,9.0
PT06298,Norway,Vestland,80.0,Female,Breast,IV,2012-08-10,2013-01-09,2013-04-07,Chemotherapy,Research Institute,Alive,98.0,BRCA1,No,Former,Moderate,19.7,Medium,Urban,NHS,5.0,No,No,None,10.0
PT06299,Sweden,Stockholm,72.0,Female,Ovarian,I,2020-10-14,,2021-11-08,Immunotherapy,Public,Lost to Follow-up,,EGFR,No,Former,Heavy,20.5,Low,Urban,Private Insurance,14.0,No,No,None,5.0
PT06300,Denmark,Capital Region,45.0,Male,Pancreatic,,2017-01-18,2017-05-06,2017-12-04,Radiation,Public,Alive,16.0,KRAS,Yes,Never,Moderate,37.4,Medium,Rural,NHS,10.0,No,Yes,,5.0
PT06301,Netherlands,North Holland,59.0,Female,Breast,I,2019-01-14,2019-06-27,2019-10-13,Targeted Therapy,Public,Alive,,BRCA1,No,Never,None,31.2,Low,Urban,Statutory Health Insurance,13.0,No,No,Cardiovascular Disease,4.0
PT06302,Italy,Veneto,27.0,,,I,2018-10-21,2018-12-10,2019-12-07,,Public,Alive,43.0,None,Yes,Never,Moderate,39.0,Medium,Urban,Private Insurance,10.0,No,Yes,Diabetes,7.0
PT06303,Germany,Bavaria,40.0,Female,Colorectal,II,2023-03-31,2023-05-16,2023-11-30,Chemotherapy,Public,Alive,64.0,KRAS,No,Current,None,26.1,Low,Rural,Statutory Health Insurance,8.0,No,No,Cardiovascular Disease,3.0
PT06304,Portugal,Algarve,62.0,Female,Pancreatic,,2010-06-25,2010-07-18,2010-10-29,Surgery,Private,Alive,50.0,BRCA1,,Current,None,26.0,High,Urban,Statutory Health Insurance,15.0,No,No,Diabetes,6.0
PT06305,Sweden,Stockholm,40.0,Female,Pancreatic,II,2012-12-12,2012-12-24,2013-03-22,Targeted Therapy,Public,Alive,49.0,KRAS,No,Former,Heavy,36.8,Medium,Rural,Statutory Health Insurance,15.0,No,No,None,8.0
PT06306,Austria,Styria,22.0,Male,Colorectal,I,2010-12-01,2011-05-06,2011-11-13,Immunotherapy,Private,Alive,30.0,EGFR,No,,Moderate,30.7,Medium,Rural,Statutory Health Insurance,2.0,No,No,Hypertension,4.0
PT06307,Switzerland,Zurich,50.0,Female,Prostate,I,2023-09-04,2023-11-04,2024-01-02,Chemotherapy,Public,Deceased,,KRAS,Yes,Never,Moderate,30.4,Medium,Urban,NHS,6.0,No,No,,8.0
,Netherlands,North Holland,46.0,Female,Ovarian,I,2023-01-07,2023-02-10,2023-06-08,Targeted Therapy,Public,Alive,25.0,BRCA1,Yes,Never,None,30.3,Medium,Rural,NHS,6.0,No,No,Obesity,6.0
PT06309,Ireland,Munster,46.0,Male,Leukemia,III,2019-01-25,2019-04-29,2020-04-10,Chemotherapy,Public,Lost to Follow-up,,BRCA1,Yes,Never,None,35.9,High,Urban,Private Insurance,2.0,No,No,Hypertension,10.0
PT06310,Portugal,Lisbon,,Female,Leukemia,III,2022-06-05,2022-09-14,2022-12-22,Surgery,Public,Deceased,59.0,None,Yes,Former,None,32.8,Medium,Urban,Private Insurance,5.0,No,No,Hypertension,3.0
PT06311,Netherlands,Utrecht,52.0,Male,Breast,III,2014-09-27,,2015-09-20,Targeted Therapy,Public,Alive,18.0,None,Yes,Current,None,22.2,Medium,Urban,NHS,1.0,No,No,Obesity,7.0
,Switzerland,Zurich,63.0,Male,Leukemia,IV,2020-07-20,2020-11-17,2021-03-26,Chemotherapy,Public,Alive,40.0,None,Yes,Current,None,33.5,Medium,Rural,Private Insurance,7.0,Yes,No,Diabetes,3.0
PT06313,Denmark,Capital Region,62.0,Female,Breast,IV,2023-04-24,2023-10-04,2024-02-06,Immunotherapy,Public,Deceased,17.0,KRAS,No,Never,Moderate,29.9,,Rural,NHS,3.0,No,No,Diabetes,1.0
PT06314,Ireland,Connacht,,Female,Pancreatic,II,2014-09-21,2015-03-16,2016-01-17,Targeted Therapy,Public,Deceased,68.0,EGFR,No,Former,Heavy,20.6,Low,Urban,Private Insurance,15.0,Yes,No,Diabetes,4.0
PT06315,France,,84.0,Female,Pancreatic,II,2012-03-13,2012-04-19,2012-06-09,Surgery,Public,Alive,9.0,None,Yes,Current,Heavy,25.0,Low,Urban,Private Insurance,,No,No,None,2.0
PT06316,Sweden,Västra Götaland,36.0,Female,Prostate,IV,2012-06-30,2012-08-10,2012-11-29,Radiation,Private,Alive,41.0,,Yes,Never,None,34.8,Medium,Urban,NHS,8.0,No,No,Obesity,10.0
PT06317,France,Auvergne-Rhône-Alpes,34.0,Male,Ovarian,III,2021-05-29,2021-10-10,2022-06-16,Radiation,Public,Alive,99.0,KRAS,Yes,Never,None,38.4,Low,Urban,Private Insurance,6.0,No,No,Diabetes,3.0
PT06318,Austria,Tyrol,53.0,Female,Pancreatic,I,2018-02-26,2018-07-04,2019-05-08,Chemotherapy,Private,,98.0,KRAS,Yes,Never,None,28.4,Medium,Urban,Private Insurance,15.0,,No,Cardiovascular Disease,3.0
PT06319,,Porto,23.0,Male,Ovarian,II,2023-10-31,2024-01-25,2024-05-07,Targeted Therapy,Private,,87.0,KRAS,Yes,Former,None,33.7,High,Urban,Private Insurance,16.0,No,,,6.0
PT06320,Ireland,Dublin,47.0,,Colorectal,IV,2019-08-06,,2020-02-08,,Research Institute,Lost to Follow-up,,EGFR,No,Current,Moderate,19.1,,Rural,,16.0,No,No,Diabetes,10.0
,Finland,Southwest Finland,21.0,,Prostate,III,2018-05-26,2018-07-04,2019-04-29,Surgery,Public,Deceased,110.0,None,No,Never,Moderate,29.3,Medium,,NHS,15.0,No,No,Obesity,3.0
PT06322,Austria,Vienna,36.0,Female,Colorectal,I,2010-12-02,2010-12-06,2011-05-31,Radiation,Private,Alive,98.0,KRAS,No,Never,Moderate,29.1,Medium,Urban,Private Insurance,13.0,No,,Obesity,8.0
PT06323,Portugal,Algarve,77.0,Female,Colorectal,IV,2022-05-12,2022-10-03,2023-09-22,Immunotherapy,Public,Alive,14.0,KRAS,No,Never,Moderate,39.9,Medium,,NHS,19.0,No,No,Diabetes,3.0
PT06324,Spain,,28.0,Female,Breast,IV,2020-08-16,2020-10-07,2021-07-13,Radiation,Public,Alive,79.0,EGFR,Yes,Former,None,39.9,High,Urban,NHS,5.0,No,No,Hypertension,
PT06325,Belgium,Wallonia,50.0,Female,Ovarian,I,2021-11-11,2022-03-04,2022-09-25,Targeted Therapy,Public,Alive,15.0,KRAS,Yes,Never,None,28.4,Low,Urban,Statutory Health Insurance,15.0,Yes,No,None,8.0
PT06326,Netherlands,Utrecht,85.0,Male,Colorectal,IV,2015-07-09,2015-07-28,2015-11-30,Immunotherapy,Private,Alive,58.0,BRCA1,Yes,Never,Moderate,21.6,Medium,Urban,Statutory Health Insurance,5.0,No,,Diabetes,2.0
PT06327,Norway,Trøndelag,81.0,Female,Ovarian,IV,2020-01-08,2020-04-09,2021-04-03,Immunotherapy,Private,Alive,13.0,KRAS,Yes,Never,Moderate,29.2,Low,Rural,NHS,7.0,No,No,,10.0
PT06328,Italy,Veneto,38.0,Male,Prostate,I,2022-08-07,2022-12-06,2023-05-17,Surgery,Private,Alive,64.0,KRAS,No,Never,None,32.9,,Urban,Private Insurance,10.0,No,No,Hypertension,7.0
PT06329,Austria,Vienna,,Male,Lung,III,2023-11-25,2023-12-12,2024-08-03,Chemotherapy,Private,Alive,118.0,BRCA1,Yes,Current,None,34.3,,Urban,NHS,8.0,No,Yes,Diabetes,2.0
PT06330,Poland,Silesian,47.0,Female,Pancreatic,II,2011-02-03,2011-07-26,2012-04-14,Chemotherapy,Private,Deceased,24.0,KRAS,Yes,Never,Moderate,22.0,Low,Urban,NHS,5.0,No,No,Cardiovascular Disease,10.0
PT06331,France,,69.0,Female,Breast,III,2017-04-12,2017-08-20,,Surgery,,Alive,49.0,KRAS,Yes,Never,None,34.6,Low,Urban,Statutory Health Insurance,14.0,No,No,None,9.0
PT06332,Portugal,Lisbon,84.0,,Ovarian,IV,2019-04-18,2019-08-26,2020-08-20,Targeted Therapy,Research Institute,Alive,49.0,BRCA1,Yes,Former,Moderate,38.9,High,Urban,Private Insurance,5.0,No,No,Diabetes,
PT06333,Italy,Veneto,22.0,Female,Pancreatic,II,2021-03-21,2021-06-17,2021-12-30,Targeted Therapy,Private,Alive,39.0,KRAS,No,Never,Moderate,21.8,Low,Urban,Statutory Health Insurance,4.0,No,No,Hypertension,3.0
PT06334,,Connacht,71.0,Female,Colorectal,II,2018-12-01,2019-01-25,2020-01-04,Chemotherapy,Private,Alive,58.0,BRCA1,No,Never,Moderate,28.5,Low,Urban,Private Insurance,13.0,No,No,None,9.0
PT06335,Italy,Veneto,29.0,Female,Colorectal,IV,2010-01-16,2010-04-17,2011-01-08,Radiation,Private,,,,Yes,Never,Moderate,37.0,Medium,Rural,NHS,,No,No,Obesity,6.0
PT06336,Denmark,Zealand,40.0,Male,Leukemia,IV,2021-12-23,2021-12-27,2022-09-20,Surgery,Private,Alive,92.0,BRCA1,Yes,Current,None,24.7,Low,Urban,NHS,3.0,No,No,,8.0
PT06337,France,Île-de-France,56.0,Male,Ovarian,I,2014-04-26,2014-08-27,2014-12-28,Radiation,Public,Alive,116.0,None,No,Never,Moderate,19.5,Low,Urban,Private Insurance,5.0,No,No,Obesity,4.0
,Netherlands,South Holland,34.0,Male,Breast,,2023-11-07,2024-02-15,,Surgery,Public,Deceased,7.0,,Yes,Former,Moderate,39.4,Low,Urban,NHS,4.0,No,No,,1.0
PT06339,Netherlands,North Holland,28.0,Male,Breast,I,2018-01-13,2018-06-02,2019-02-25,Surgery,Public,Alive,65.0,KRAS,Yes,Current,Moderate,33.8,Medium,Urban,Private Insurance,7.0,No,No,Cardiovascular Disease,9.0
PT06340,Poland,Silesian,63.0,Male,Prostate,II,2011-01-13,2011-03-14,2011-11-01,Chemotherapy,Private,Deceased,51.0,EGFR,Yes,Former,,21.3,Medium,Urban,NHS,13.0,Yes,No,Hypertension,7.0
PT06341,Switzerland,Geneva,58.0,Non-binary,Lung,III,2013-10-11,2013-11-09,2014-07-10,Chemotherapy,Public,Alive,20.0,None,,Never,Moderate,28.0,Medium,Urban,NHS,19.0,No,No,Cardiovascular Disease,8.0
PT06342,France,Provence-Alpes-Côte d'Azur,24.0,Female,Prostate,III,2019-01-27,2019-03-14,2020-01-03,Radiation,,Alive,,BRCA1,Yes,Former,Moderate,,Medium,Urban,Statutory Health Insurance,10.0,No,Yes,Diabetes,1.0
PT06343,France,Provence-Alpes-Côte d'Azur,44.0,Female,Prostate,III,2012-01-24,2012-04-30,2012-09-13,Targeted Therapy,Public,Alive,117.0,BRCA1,No,Never,Moderate,38.2,High,Rural,Statutory Health Insurance,13.0,Yes,No,Hypertension,8.0
PT06344,Sweden,Skåne,75.0,Male,Prostate,I,2013-07-31,2013-09-18,2014-07-15,Immunotherapy,Public,Deceased,12.0,BRCA1,Yes,Never,None,24.4,Medium,Rural,NHS,15.0,,No,Hypertension,10.0
,,Silesian,83.0,Male,Lung,I,2014-07-17,2014-11-14,2015-10-25,,Private,Alive,66.0,KRAS,No,Never,Moderate,36.0,Low,Urban,Private Insurance,17.0,No,No,Diabetes,6.0
PT06346,,Utrecht,71.0,Male,Prostate,IV,2022-05-30,2022-10-23,2022-12-26,Surgery,Public,Alive,40.0,KRAS,No,Never,Moderate,18.0,High,Urban,NHS,3.0,No,No,,1.0
PT06347,Germany,Berlin,28.0,Female,Pancreatic,I,2023-01-27,,2023-06-16,Immunotherapy,Private,Deceased,40.0,KRAS,No,Never,None,37.3,Medium,Rural,Private Insurance,19.0,Yes,No,Diabetes,5.0
PT06348,Belgium,Flanders,29.0,Male,Breast,I,2022-08-26,2022-11-08,2022-12-08,Immunotherapy,Public,,74.0,BRCA1,Yes,Current,Moderate,34.7,High,Urban,Private Insurance,1.0,No,No,None,6.0
PT06349,Poland,Masovian,29.0,Female,Lung,III,2010-02-23,2010-07-25,2010-10-09,Immunotherapy,,Alive,54.0,EGFR,No,Never,Heavy,38.7,Low,Urban,NHS,6.0,No,No,Obesity,4.0
PT06350,France,Île-de-France,81.0,Female,Colorectal,III,2015-08-23,2015-09-09,2016-01-25,Immunotherapy,,Alive,88.0,None,Yes,Current,Moderate,26.7,Medium,Urban,NHS,1.0,No,No,Obesity,3.0
PT06351,Portugal,Algarve,79.0,Female,Leukemia,II,2019-12-22,2020-04-07,2020-08-25,Immunotherapy,Public,Deceased,100.0,KRAS,Yes,,Moderate,39.3,Medium,Rural,NHS,6.0,No,No,Hypertension,3.0
PT06352,Ireland,Connacht,38.0,Male,Leukemia,I,2010-03-21,2010-06-25,2011-03-26,Radiation,Private,Alive,7.0,None,No,Former,Moderate,35.5,Medium,Urban,NHS,9.0,No,No,Hypertension,5.0
PT06353,Spain,Catalonia,57.0,Female,Ovarian,IV,2016-11-28,2017-02-25,2017-12-25,Chemotherapy,Public,Alive,39.0,EGFR,Yes,Former,None,21.1,Medium,Urban,Statutory Health Insurance,2.0,,No,Cardiovascular Disease,6.0
PT06354,Austria,Vienna,25.0,Female,Pancreatic,IV,2018-07-16,2018-09-06,2018-10-31,Chemotherapy,Public,Alive,113.0,KRAS,No,Former,None,23.1,Low,Urban,Statutory Health Insurance,3.0,No,Yes,Diabetes,3.0
PT06355,Portugal,Porto,34.0,Female,Breast,I,2019-11-12,2020-01-22,,Surgery,Public,Alive,115.0,BRCA1,Yes,Former,,35.7,High,Urban,NHS,14.0,No,Yes,Diabetes,3.0
PT06356,Italy,Sicily,66.0,Male,Leukemia,II,2010-10-13,2010-11-02,2011-04-26,Targeted Therapy,Public,Alive,18.0,KRAS,Yes,Never,Moderate,28.1,Low,Rural,Statutory Health Insurance,14.0,No,No,Diabetes,7.0
PT06357,Germany,North Rhine-Westphalia,64.0,Male,Pancreatic,I,2019-06-01,2019-11-05,2020-10-18,Radiation,Private,Alive,69.0,BRCA1,No,Never,Heavy,34.7,Medium,,Statutory Health Insurance,14.0,No,No,Obesity,6.0
PT06358,Italy,Veneto,24.0,Male,Pancreatic,III,,2014-07-18,2014-09-26,Immunotherapy,Public,Alive,40.0,EGFR,No,Current,Heavy,28.1,Low,Rural,Private Insurance,15.0,No,No,Obesity,8.0
PT06359,Belgium,Wallonia,72.0,Non-binary,Leukemia,II,2012-08-01,2013-01-26,2013-09-22,Chemotherapy,,Alive,103.0,KRAS,Yes,Former,None,31.7,Medium,Urban,Private Insurance,16.0,No,No,Hypertension,9.0
PT06360,Spain,Andalusia,85.0,Female,Leukemia,III,2010-08-16,2010-12-13,2011-02-23,Surgery,Public,Deceased,83.0,None,No,Never,None,25.4,Medium,Urban,Statutory Health Insurance,3.0,No,No,Cardiovascular Disease,10.0
PT06361,Switzerland,Geneva,81.0,Non-binary,Pancreatic,II,2015-05-31,2015-09-26,2016-06-05,Immunotherapy,Private,Deceased,,None,Yes,Never,None,28.4,High,Urban,Statutory Health Insurance,18.0,No,No,Hypertension,
PT06362,Finland,Uusimaa,42.0,,Pancreatic,,2016-01-28,2016-06-19,2017-05-08,Surgery,Public,Alive,106.0,KRAS,Yes,Former,Heavy,36.6,Low,Urban,Private Insurance,8.0,No,No,Hypertension,10.0
PT06363,Portugal,Algarve,63.0,Male,Colorectal,IV,2014-03-01,2014-08-07,2015-05-13,Immunotherapy,Research Institute,Alive,31.0,KRAS,No,Current,None,29.0,Medium,Urban,Private Insurance,1.0,Yes,No,Diabetes,1.0
PT06364,Poland,Masovian,71.0,Female,Leukemia,II,2019-01-30,2019-02-12,2019-08-15,Immunotherapy,Private,Alive,,KRAS,No,Never,Moderate,33.1,Medium,Urban,NHS,10.0,No,No,Obesity,1.0
PT06365,Switzerland,Bern,65.0,Male,Prostate,III,2015-06-08,2015-08-03,2016-02-25,Chemotherapy,Public,Alive,111.0,None,No,Current,None,22.5,Low,Rural,NHS,8.0,No,No,Diabetes,1.0
PT06366,Poland,Masovian,38.0,Female,Pancreatic,II,2019-06-27,2019-07-16,2020-06-21,Chemotherapy,Public,Alive,12.0,None,No,,Moderate,33.1,Low,Urban,NHS,13.0,No,No,Obesity,3.0
PT06367,Spain,Madrid,66.0,Female,Breast,I,2022-08-25,2022-11-03,2023-05-28,Immunotherapy,Private,Alive,105.0,BRCA1,No,Former,Moderate,20.3,Low,Rural,Private Insurance,,No,No,Hypertension,5.0
PT06368,,Uusimaa,71.0,Female,Breast,II,2014-10-17,2015-03-22,2015-11-18,Chemotherapy,Public,Alive,44.0,None,,Never,Moderate,31.4,Medium,Urban,Private Insurance,13.0,Yes,,Cardiovascular Disease,10.0
PT06369,,Catalonia,43.0,Female,Ovarian,II,2020-03-12,2020-08-09,2021-03-14,Radiation,Private,Deceased,90.0,EGFR,Yes,Former,Moderate,30.0,Low,Urban,Private Insurance,11.0,Yes,Yes,Hypertension,10.0
PT06370,Italy,Veneto,36.0,Female,Pancreatic,II,2016-06-03,2016-11-06,2017-03-02,Immunotherapy,,Alive,84.0,None,No,Never,Moderate,27.2,Medium,Urban,Private Insurance,18.0,No,Yes,Obesity,9.0
PT06371,,Lombardy,65.0,Non-binary,Breast,III,2013-12-31,2014-03-21,2015-02-25,Chemotherapy,Research Institute,Alive,18.0,KRAS,No,Never,Moderate,36.2,Low,Urban,Statutory Health Insurance,15.0,No,No,,
PT06372,Germany,,83.0,Male,Colorectal,II,2022-07-10,2022-11-01,2023-06-22,Surgery,Public,Alive,,None,Yes,Current,Moderate,30.8,Medium,Urban,Private Insurance,2.0,Yes,,None,8.0
PT06373,,Vestland,47.0,Female,Ovarian,IV,2013-04-23,2013-05-26,2013-10-19,Surgery,Public,Alive,103.0,None,Yes,Former,Moderate,23.6,Medium,Urban,Private Insurance,17.0,,No,None,2.0
PT06374,Finland,Southwest Finland,69.0,Female,Colorectal,II,2020-05-23,2020-09-14,2021-05-28,,Research Institute,Deceased,95.0,None,No,Never,Moderate,29.2,Medium,Urban,NHS,18.0,No,No,Diabetes,1.0
PT06375,Portugal,Lisbon,83.0,Non-binary,,I,2016-11-13,2017-05-05,2017-08-04,Targeted Therapy,Private,Alive,9.0,EGFR,No,Never,None,35.5,Medium,Urban,NHS,,No,No,Obesity,2.0
PT06376,Finland,Southwest Finland,47.0,Female,Ovarian,I,2016-10-17,2017-04-11,2017-08-18,Surgery,Private,Deceased,103.0,,Yes,Former,Heavy,36.9,High,Rural,Statutory Health Insurance,11.0,No,No,Obesity,9.0
PT06377,Sweden,Västra Götaland,75.0,Non-binary,Leukemia,IV,2014-07-26,2014-11-18,2015-06-05,Surgery,,Lost to Follow-up,,EGFR,No,Never,Moderate,24.8,Medium,,Private Insurance,16.0,,No,Diabetes,4.0
PT06378,Norway,Vestland,78.0,Female,Prostate,I,2014-02-05,2014-04-09,2014-10-11,Radiation,Public,,89.0,EGFR,Yes,Former,None,19.7,,Urban,NHS,14.0,No,Yes,Cardiovascular Disease,10.0
PT06379,Belgium,Flanders,24.0,Male,Leukemia,I,,2017-11-09,2018-01-14,Radiation,Public,Alive,24.0,None,No,Never,Moderate,23.6,Medium,Urban,Private Insurance,16.0,No,No,Hypertension,3.0
PT06380,Poland,Lesser Poland,73.0,Female,Breast,I,2022-11-30,2023-02-25,2023-12-27,Targeted Therapy,Research Institute,Deceased,106.0,KRAS,No,Never,None,37.6,,Urban,Statutory Health Insurance,1.0,No,No,Diabetes,8.0
PT06381,Denmark,,63.0,Female,Ovarian,II,2013-12-02,2013-12-03,2014-02-05,Radiation,,Deceased,36.0,KRAS,Yes,Never,Moderate,32.6,Low,Urban,Statutory Health Insurance,10.0,No,Yes,Hypertension,1.0
PT06382,France,Provence-Alpes-Côte d'Azur,61.0,Female,Prostate,II,2015-04-05,2015-07-07,2016-06-27,Chemotherapy,Public,Deceased,88.0,KRAS,No,Former,Heavy,39.2,Medium,Rural,NHS,13.0,No,No,Obesity,8.0
PT06383,Austria,,76.0,Male,Breast,I,2012-07-18,2012-11-01,2013-08-19,,Public,Lost to Follow-up,,KRAS,Yes,Current,Moderate,18.9,,Urban,NHS,13.0,Yes,Yes,Diabetes,3.0
PT06384,Denmark,Capital Region,66.0,Female,Prostate,II,2022-04-10,2022-08-19,2022-10-06,Chemotherapy,Private,Alive,48.0,,No,Never,Moderate,25.7,Low,Urban,Private Insurance,12.0,No,Yes,Hypertension,10.0
PT06385,Austria,Vienna,44.0,Male,Pancreatic,II,2019-05-06,2019-07-29,,Targeted Therapy,Public,Alive,69.0,EGFR,No,Current,Moderate,27.0,Medium,Urban,Statutory Health Insurance,12.0,No,No,Hypertension,6.0
PT06386,Sweden,Skåne,63.0,Female,Lung,III,2015-04-25,2015-08-10,2016-06-06,Chemotherapy,Private,Alive,7.0,None,Yes,Former,Moderate,25.3,Medium,Rural,Private Insurance,6.0,No,No,Obesity,6.0
PT06387,Ireland,Munster,34.0,Male,Colorectal,III,2021-10-19,2022-02-12,2022-04-06,Chemotherapy,Public,Alive,95.0,EGFR,No,Former,None,23.6,Low,Urban,Private Insurance,2.0,No,No,Diabetes,4.0
PT06388,Netherlands,South Holland,70.0,Female,Ovarian,III,2011-08-15,2011-08-20,2012-02-06,Chemotherapy,Private,Deceased,27.0,,Yes,Former,None,28.1,Medium,,NHS,9.0,No,Yes,Obesity,4.0
PT06389,Ireland,Connacht,72.0,Male,Colorectal,II,2011-01-01,2011-06-23,2011-11-18,,Public,Alive,86.0,BRCA1,No,Former,Moderate,32.9,High,Urban,Private Insurance,5.0,,No,None,8.0
PT06390,Germany,Berlin,53.0,Male,Ovarian,I,2016-01-31,2016-02-12,2016-03-21,Surgery,Private,Alive,93.0,None,Yes,Never,Moderate,22.0,Medium,Urban,Statutory Health Insurance,12.0,No,No,Obesity,10.0
PT06391,Denmark,Capital Region,27.0,Female,Pancreatic,III,2010-09-30,2010-11-17,2011-06-02,Chemotherapy,Public,Deceased,81.0,EGFR,No,Never,None,35.4,Medium,Rural,NHS,6.0,No,,Hypertension,8.0
PT06392,Poland,Masovian,89.0,Male,Breast,II,2019-12-01,2019-12-15,2020-10-02,Immunotherapy,Public,Alive,27.0,BRCA1,No,Never,Heavy,22.7,,Rural,Private Insurance,11.0,Yes,No,Obesity,8.0
PT06393,Finland,Southwest Finland,40.0,Male,,II,2019-12-22,2020-02-13,,Surgery,Public,Alive,109.0,EGFR,Yes,Former,None,39.3,Medium,Urban,Private Insurance,2.0,No,No,Obesity,8.0
PT06394,Belgium,Brussels,26.0,Male,Lung,IV,2022-07-22,2022-09-05,2023-07-19,Surgery,Private,Alive,89.0,BRCA1,No,Former,None,35.2,Medium,Urban,Private Insurance,12.0,Yes,No,Obesity,7.0
PT06395,Portugal,Algarve,75.0,Female,Leukemia,IV,2011-08-25,2012-02-01,2012-04-30,Immunotherapy,Private,Alive,72.0,BRCA1,Yes,Never,None,25.1,Medium,Urban,NHS,10.0,No,No,Obesity,9.0
PT06396,France,Auvergne-Rhône-Alpes,68.0,Female,Ovarian,IV,2018-08-09,2019-01-14,2019-04-04,Targeted Therapy,Public,Alive,20.0,BRCA1,No,Never,Moderate,30.9,High,Urban,NHS,11.0,No,Yes,None,3.0
PT06397,Germany,North Rhine-Westphalia,61.0,Male,Prostate,IV,2011-09-04,2011-09-16,2011-11-24,Targeted Therapy,Private,Alive,,BRCA1,No,Never,Moderate,26.4,High,Urban,,19.0,Yes,No,None,3.0
PT06398,Switzerland,Geneva,42.0,Female,Pancreatic,IV,2010-11-23,2011-03-03,2012-03-01,Surgery,Private,Alive,19.0,EGFR,Yes,Never,None,40.0,Medium,Rural,Private Insurance,7.0,No,Yes,Hypertension,5.0
PT06399,Netherlands,Utrecht,71.0,Male,Lung,III,2014-09-03,2014-11-25,2015-09-17,Radiation,Public,Alive,117.0,BRCA1,Yes,Current,Heavy,28.5,Medium,Urban,Private Insurance,2.0,No,No,Cardiovascular Disease,8.0
PT06400,Spain,Andalusia,72.0,Female,Pancreatic,I,2022-03-01,2022-04-14,2023-04-07,Targeted Therapy,Private,Alive,79.0,EGFR,No,Current,Moderate,32.9,Medium,Urban,Statutory Health Insurance,3.0,Yes,No,None,8.0
PT06401,Sweden,Skåne,35.0,Female,Lung,IV,2021-09-01,2022-02-01,2022-03-18,Targeted Therapy,Public,Deceased,25.0,BRCA1,No,Never,,32.0,High,Urban,NHS,,No,No,Hypertension,
PT06402,France,Provence-Alpes-Côte d'Azur,56.0,Non-binary,Breast,IV,2018-01-06,2018-06-25,2019-05-01,Chemotherapy,Public,Alive,28.0,BRCA1,No,Current,Heavy,24.6,Medium,,NHS,15.0,No,No,Cardiovascular Disease,5.0
PT06403,Sweden,Stockholm,37.0,Female,Breast,I,2023-04-10,2023-05-01,2023-12-18,Chemotherapy,,Deceased,59.0,BRCA1,Yes,Never,Moderate,26.5,Medium,Rural,Statutory Health Insurance,,No,No,Hypertension,4.0
PT06404,Norway,Oslo,39.0,Male,Leukemia,II,2015-10-10,2015-12-15,2016-04-06,Targeted Therapy,Private,Alive,78.0,EGFR,No,Former,None,29.1,Low,Rural,Statutory Health Insurance,15.0,Yes,No,Diabetes,4.0
PT06405,Sweden,Stockholm,65.0,Male,Ovarian,I,2015-05-19,2015-08-28,2016-07-19,Radiation,Public,Alive,108.0,KRAS,No,Former,Moderate,23.5,Medium,Urban,Private Insurance,10.0,No,No,Obesity,5.0
PT06406,Netherlands,North Holland,,Female,Ovarian,IV,2013-04-24,2013-05-15,2013-08-17,Chemotherapy,Public,Alive,67.0,EGFR,No,Former,None,22.4,Medium,Urban,NHS,18.0,No,Yes,None,3.0
PT06407,Norway,Trøndelag,82.0,Male,Pancreatic,II,2022-03-18,2022-04-13,2022-10-19,Radiation,Private,Alive,67.0,None,Yes,Former,None,39.3,Medium,Urban,Statutory Health Insurance,,,No,Cardiovascular Disease,2.0
PT06408,Portugal,Porto,22.0,Male,Pancreatic,I,2012-10-20,2013-03-29,2013-08-09,Surgery,Research Institute,Deceased,69.0,None,No,Never,None,24.2,Medium,Urban,NHS,2.0,No,No,Hypertension,10.0
PT06409,France,Île-de-France,65.0,Male,Leukemia,I,2014-10-21,2014-11-07,2015-05-31,Radiation,Private,Alive,79.0,KRAS,No,Never,Moderate,,Low,Urban,NHS,16.0,No,No,None,7.0
PT06410,Poland,Silesian,68.0,Male,,,2015-09-13,2015-09-17,2015-12-09,Chemotherapy,Public,Alive,58.0,None,No,,Moderate,36.1,High,Rural,Private Insurance,14.0,Yes,No,Diabetes,3.0
PT06411,Denmark,Capital Region,20.0,Female,Colorectal,III,2022-04-28,2022-06-06,2022-11-07,Immunotherapy,Public,Deceased,109.0,KRAS,Yes,,Moderate,,High,Urban,Private Insurance,3.0,Yes,No,Hypertension,6.0
PT06412,,Munster,41.0,Male,,II,2018-01-23,2018-02-07,2018-05-22,Radiation,Private,Deceased,66.0,EGFR,No,Never,None,21.4,Medium,Urban,NHS,,,No,Obesity,3.0
PT06413,Switzerland,Geneva,33.0,Male,,II,,2015-04-03,2015-09-01,Targeted Therapy,Private,Alive,58.0,,No,Former,Heavy,,Low,Urban,NHS,8.0,No,No,,3.0
,Poland,Lesser Poland,64.0,Female,Breast,I,2015-09-07,2016-01-27,2016-04-06,Radiation,Private,Alive,8.0,BRCA1,No,Never,None,21.7,Low,Urban,Statutory Health Insurance,3.0,No,No,Diabetes,2.0
PT06415,Sweden,Stockholm,25.0,Male,,I,2021-01-11,2021-04-11,2021-07-10,Radiation,Private,Alive,17.0,BRCA1,Yes,Former,Moderate,30.5,High,Urban,Statutory Health Insurance,14.0,No,No,None,10.0
PT06416,,Pirkanmaa,84.0,Non-binary,Pancreatic,II,2021-07-03,2021-08-19,2022-01-30,Radiation,Private,Alive,25.0,EGFR,No,Never,None,36.1,Medium,Urban,Private Insurance,11.0,No,No,Hypertension,2.0
,Switzerland,Bern,40.0,,Prostate,II,2020-08-05,2020-12-13,2021-04-23,Targeted Therapy,Private,Alive,30.0,KRAS,No,Never,None,34.2,High,Rural,Private Insurance,17.0,No,Yes,Obesity,8.0
PT06418,Italy,Lombardy,23.0,Female,Prostate,II,2014-12-28,2015-03-28,2015-06-18,Radiation,Public,Deceased,94.0,EGFR,Yes,Current,Heavy,26.5,Medium,Urban,Statutory Health Insurance,11.0,No,No,None,2.0
PT06419,Belgium,Wallonia,,Male,Colorectal,II,2018-09-14,2018-11-19,2019-08-03,Immunotherapy,Public,Alive,33.0,BRCA1,No,Never,Moderate,30.8,High,Rural,Private Insurance,8.0,Yes,Yes,Obesity,2.0
PT06420,Sweden,Stockholm,49.0,Male,Pancreatic,I,2013-06-10,2013-12-03,2014-04-11,Targeted Therapy,Public,Alive,21.0,KRAS,No,Current,None,33.5,Medium,Urban,Private Insurance,2.0,No,No,Obesity,6.0
PT06421,Denmark,,,Male,Breast,IV,2010-07-15,2011-01-07,2011-12-19,Immunotherapy,Private,Deceased,56.0,None,No,Former,Moderate,18.2,Low,Urban,Statutory Health Insurance,4.0,No,No,Diabetes,4.0
PT06422,Netherlands,North Holland,53.0,Female,Pancreatic,I,2018-05-15,2018-08-04,2018-10-07,Immunotherapy,Private,Alive,45.0,KRAS,Yes,Former,None,,Medium,Urban,NHS,18.0,No,No,Obesity,8.0
PT06423,Portugal,Lisbon,39.0,Female,Pancreatic,I,2021-10-07,2021-10-25,,Immunotherapy,Public,Alive,26.0,KRAS,No,Never,Moderate,35.2,High,Rural,Statutory Health Insurance,15.0,No,Yes,Diabetes,
PT06424,Italy,Sicily,73.0,Female,Lung,I,2015-11-27,2016-05-24,2017-05-08,Targeted Therapy,Public,Deceased,76.0,EGFR,No,Former,,34.3,High,Urban,,16.0,No,No,Hypertension,2.0
PT06425,,Utrecht,44.0,Male,Colorectal,I,2022-09-13,2023-01-23,2023-07-10,Chemotherapy,Private,Alive,81.0,EGFR,No,Current,None,39.2,Medium,Rural,Private Insurance,17.0,No,Yes,Diabetes,7.0
PT06426,Belgium,Brussels,34.0,Male,Lung,I,2010-02-10,2010-05-02,2010-10-08,Targeted Therapy,Public,Alive,117.0,KRAS,Yes,Never,None,18.2,Medium,Urban,NHS,7.0,No,Yes,Cardiovascular Disease,10.0
PT06427,Netherlands,North Holland,57.0,Male,,II,2020-06-11,2020-11-19,2021-10-10,Radiation,Public,Alive,111.0,,Yes,Current,Moderate,36.1,Medium,Urban,NHS,17.0,No,No,Hypertension,4.0
PT06428,Sweden,Stockholm,42.0,Male,Prostate,III,,2024-01-24,2024-06-07,Immunotherapy,Public,Alive,104.0,None,No,Former,None,28.3,Medium,Urban,Private Insurance,1.0,Yes,,Hypertension,3.0
PT06429,Portugal,Algarve,71.0,Male,Lung,I,2011-11-13,2011-11-26,2012-04-02,Radiation,Research Institute,Deceased,87.0,None,No,Never,Moderate,34.7,High,Urban,Statutory Health Insurance,4.0,No,No,,4.0
PT06430,Netherlands,South Holland,85.0,Non-binary,Prostate,II,2017-10-30,2018-01-09,2018-10-27,Immunotherapy,Public,Alive,87.0,KRAS,No,Current,Moderate,18.7,Medium,Rural,Statutory Health Insurance,3.0,No,No,,1.0
PT06431,Ireland,Connacht,,Female,Ovarian,IV,2016-09-28,2016-11-25,2017-01-14,Immunotherapy,Public,Alive,16.0,BRCA1,No,Never,None,19.3,Medium,Urban,Private Insurance,11.0,No,No,None,2.0
PT06432,Poland,Masovian,76.0,Female,Leukemia,I,2015-07-31,,2016-06-13,,Private,Alive,37.0,EGFR,No,Current,,20.8,Medium,Urban,NHS,15.0,No,No,Cardiovascular Disease,7.0
PT06433,Italy,Lombardy,71.0,Female,Ovarian,III,2016-08-16,2016-11-28,2017-06-28,Surgery,Public,Deceased,102.0,EGFR,Yes,Never,Moderate,22.1,Medium,Rural,Private Insurance,7.0,Yes,No,None,2.0
PT06434,Denmark,Central Denmark,54.0,Female,Prostate,I,2014-08-02,2014-09-13,2015-04-21,Immunotherapy,Public,Deceased,52.0,BRCA1,Yes,Former,Moderate,21.1,Medium,Urban,Statutory Health Insurance,9.0,No,No,Hypertension,3.0
PT06435,Spain,Catalonia,33.0,Male,Pancreatic,I,,2018-01-25,2018-12-28,Surgery,Private,Alive,50.0,,No,Former,Moderate,25.5,High,Urban,NHS,19.0,No,No,Hypertension,3.0
PT06436,Switzerland,Zurich,33.0,Female,Ovarian,II,2010-12-30,2011-04-09,2012-02-25,Targeted Therapy,Research Institute,,102.0,EGFR,No,Never,None,24.8,High,Urban,Private Insurance,17.0,No,No,Hypertension,
PT06437,Switzerland,Bern,52.0,Female,Prostate,I,2016-11-23,2017-02-20,,Immunotherapy,Public,Alive,84.0,EGFR,No,,,22.8,Low,Urban,Statutory Health Insurance,19.0,No,No,Cardiovascular Disease,3.0
PT06438,Denmark,Capital Region,71.0,Male,Ovarian,IV,2011-05-15,2011-09-01,2012-06-01,,Public,,23.0,EGFR,,Never,Moderate,21.4,Medium,Rural,Statutory Health Insurance,11.0,Yes,Yes,Diabetes,7.0
PT06439,,Auvergne-Rhône-Alpes,20.0,,,I,2018-05-12,2018-09-03,2018-10-11,Targeted Therapy,Public,Lost to Follow-up,,EGFR,Yes,Current,Heavy,32.8,Low,Urban,NHS,14.0,No,No,Obesity,9.0
PT06440,Norway,Trøndelag,53.0,Non-binary,Colorectal,II,2016-10-06,2016-11-15,2017-04-16,Radiation,Public,Alive,91.0,None,,Former,None,28.5,Low,Rural,Statutory Health Insurance,16.0,No,Yes,Obesity,3.0
PT06441,Netherlands,Utrecht,38.0,Female,Pancreatic,,2011-08-02,2011-11-04,2012-01-04,Radiation,Public,Alive,11.0,,Yes,Never,Heavy,38.9,Low,Urban,Private Insurance,,No,No,Obesity,1.0
PT06442,Norway,Vestland,,Male,Ovarian,I,2020-07-31,2020-11-10,2021-03-31,Surgery,Public,Alive,64.0,KRAS,No,Never,Moderate,36.1,Low,Urban,NHS,2.0,No,No,Obesity,8.0
PT06443,France,Auvergne-Rhône-Alpes,23.0,Female,Pancreatic,III,2013-06-11,2013-07-02,2014-02-28,,Public,Alive,,EGFR,Yes,Current,None,34.5,Medium,Rural,NHS,7.0,No,No,None,5.0
,,Flanders,55.0,Male,Pancreatic,II,2018-02-20,2018-05-14,2019-02-26,Immunotherapy,Research Institute,Deceased,11.0,BRCA1,Yes,Never,Heavy,19.9,Medium,Rural,Private Insurance,10.0,Yes,No,Cardiovascular Disease,4.0
PT06445,Denmark,Capital Region,77.0,Female,Colorectal,III,2023-10-21,2024-03-30,2025-01-30,Surgery,Public,Alive,20.0,EGFR,No,Former,Heavy,38.0,High,Rural,NHS,,,Yes,Hypertension,9.0
PT06446,Netherlands,South Holland,51.0,Male,Breast,III,2020-11-29,2021-03-20,2022-03-12,Radiation,Private,Alive,107.0,KRAS,Yes,Never,None,39.4,High,Rural,NHS,18.0,No,No,Diabetes,4.0
PT06447,Norway,Trøndelag,28.0,Male,Ovarian,II,2018-03-08,2018-04-19,2018-09-11,Immunotherapy,Public,Alive,99.0,None,Yes,Never,Heavy,19.6,Low,Urban,NHS,1.0,No,Yes,Diabetes,5.0
PT06448,Spain,Andalusia,86.0,Female,Breast,II,2014-03-05,2014-04-11,2015-01-03,Radiation,Private,Alive,66.0,BRCA1,Yes,Current,None,36.4,Medium,Rural,Statutory Health Insurance,5.0,Yes,No,Cardiovascular Disease,10.0
PT06449,Denmark,Zealand,39.0,Female,Ovarian,I,2022-03-12,2022-07-19,2023-02-08,Surgery,Public,Alive,35.0,EGFR,Yes,Never,Moderate,27.2,Low,Urban,Statutory Health Insurance,8.0,No,No,Hypertension,2.0
PT06450,Switzerland,Zurich,81.0,Female,Prostate,I,2021-07-23,2021-10-08,2021-11-27,Radiation,Public,Alive,51.0,KRAS,Yes,Former,None,25.0,Medium,Urban,NHS,6.0,No,No,Hypertension,10.0
PT06451,Belgium,Brussels,77.0,,Leukemia,I,2010-09-09,2011-02-10,2012-01-03,Radiation,Private,Alive,115.0,BRCA1,No,Never,Moderate,32.9,Medium,Urban,NHS,7.0,No,No,None,6.0
PT06452,Germany,North Rhine-Westphalia,,Female,Breast,IV,2011-01-17,2011-05-10,2011-10-31,Targeted Therapy,Private,Alive,101.0,,No,,None,24.9,Medium,Rural,Statutory Health Insurance,4.0,No,No,Obesity,4.0
PT06453,Spain,Andalusia,86.0,Male,Prostate,II,2014-12-10,2015-01-18,2015-03-28,Surgery,Public,Deceased,89.0,BRCA1,No,Current,Moderate,20.4,Medium,Urban,Statutory Health Insurance,14.0,No,Yes,Obesity,1.0
PT06454,Finland,Pirkanmaa,67.0,Male,Colorectal,I,2015-06-11,2015-07-28,2015-10-23,Immunotherapy,Private,Deceased,22.0,KRAS,No,Never,Moderate,33.4,Low,Urban,NHS,11.0,,No,Cardiovascular Disease,3.0
PT06455,Poland,Lesser Poland,27.0,Female,Breast,I,2023-03-06,2023-05-01,2023-09-22,Radiation,Research Institute,Alive,,None,Yes,Former,Moderate,32.4,Medium,Urban,Private Insurance,18.0,No,No,Obesity,7.0
PT06456,Denmark,Zealand,34.0,,Breast,I,2016-11-04,2017-02-22,2017-05-04,Radiation,Public,Deceased,80.0,None,Yes,,Heavy,35.3,,Urban,Private Insurance,10.0,No,No,Obesity,7.0
PT06457,Sweden,Västra Götaland,51.0,Male,Pancreatic,I,2017-03-27,2017-08-30,2018-08-07,Chemotherapy,Public,Alive,119.0,KRAS,No,Never,None,30.3,Low,Urban,Private Insurance,17.0,No,Yes,Obesity,3.0
PT06458,Finland,Southwest Finland,72.0,Male,Ovarian,II,2010-01-24,2010-04-05,2010-06-09,Surgery,Private,Deceased,112.0,EGFR,Yes,Never,Moderate,35.6,Medium,Urban,NHS,2.0,No,No,None,
PT06459,Belgium,Wallonia,86.0,Male,Pancreatic,I,2010-12-19,2011-04-08,2012-01-15,Surgery,Public,Alive,89.0,None,No,Former,Heavy,18.2,Medium,Urban,Private Insurance,18.0,No,No,Hypertension,5.0
PT06460,Italy,,23.0,,Prostate,I,2023-02-12,2023-08-04,,Immunotherapy,,Alive,110.0,EGFR,Yes,Never,Moderate,,,,Private Insurance,19.0,No,,Cardiovascular Disease,1.0
PT06461,Sweden,Skåne,49.0,Non-binary,Pancreatic,III,2021-03-12,2021-05-16,2021-06-24,Targeted Therapy,Public,Alive,89.0,KRAS,No,Former,Moderate,27.6,Low,Urban,Statutory Health Insurance,19.0,No,No,Hypertension,6.0
PT06462,Austria,,32.0,Female,Prostate,IV,2022-08-16,2022-08-20,2023-02-17,Immunotherapy,Private,Alive,13.0,None,Yes,Never,None,30.6,Medium,Rural,Statutory Health Insurance,,No,No,None,3.0
PT06463,Norway,Oslo,40.0,Female,Lung,II,2012-02-10,2012-04-11,2013-04-09,Surgery,Private,Deceased,55.0,KRAS,Yes,Current,Heavy,37.6,Medium,Urban,NHS,15.0,No,No,Obesity,7.0
PT06464,Italy,Lombardy,60.0,Female,Ovarian,III,2023-01-06,2023-06-26,2023-12-20,Radiation,,Deceased,22.0,,No,Former,None,35.1,High,Urban,Private Insurance,4.0,No,Yes,,5.0
PT06465,Italy,,38.0,Female,Lung,I,2017-11-21,2018-03-06,2018-05-26,Targeted Therapy,Public,Alive,62.0,None,No,Former,None,32.3,Low,Urban,Private Insurance,3.0,Yes,Yes,Obesity,5.0
PT06466,Ireland,Connacht,,Male,Leukemia,III,2014-10-14,2015-03-10,2015-12-11,Targeted Therapy,,Alive,63.0,KRAS,Yes,Current,None,,High,Urban,NHS,13.0,No,No,Diabetes,4.0
PT06467,,Bavaria,82.0,Female,Ovarian,I,2012-11-16,2013-02-10,2013-12-06,Surgery,Public,Alive,81.0,None,Yes,Former,Moderate,23.5,High,Urban,Statutory Health Insurance,15.0,No,No,,10.0
PT06468,Belgium,Flanders,39.0,Male,Breast,III,2011-09-14,2011-12-23,2012-04-03,Surgery,,Deceased,101.0,BRCA1,Yes,Current,None,25.7,Medium,Urban,Statutory Health Insurance,8.0,No,No,Hypertension,2.0
PT06469,Italy,Sicily,83.0,Female,Lung,IV,2010-01-19,2010-05-28,2011-03-03,Immunotherapy,Public,Alive,91.0,KRAS,Yes,Current,Heavy,38.5,Low,Urban,Statutory Health Insurance,10.0,No,Yes,None,2.0
PT06470,France,Île-de-France,56.0,Male,,III,2017-01-19,2017-06-15,2017-12-23,Chemotherapy,Public,Deceased,32.0,KRAS,,,None,35.0,Medium,Urban,Private Insurance,6.0,No,No,Cardiovascular Disease,1.0
PT06471,Switzerland,Geneva,50.0,Female,Pancreatic,III,2012-03-04,2012-04-24,2012-08-15,Surgery,Private,Alive,,KRAS,No,Never,None,29.0,Low,Urban,Private Insurance,3.0,Yes,No,Hypertension,9.0
PT06472,Germany,North Rhine-Westphalia,37.0,Female,Pancreatic,II,,2019-04-29,2020-04-15,Surgery,Private,,106.0,EGFR,No,Current,Moderate,34.7,Medium,Urban,NHS,15.0,No,No,Obesity,5.0
PT06473,Ireland,Connacht,39.0,Non-binary,Breast,I,2020-03-28,2020-05-30,2020-10-18,Immunotherapy,Private,Alive,56.0,BRCA1,No,Former,Moderate,23.8,Medium,Urban,NHS,2.0,No,No,Diabetes,7.0
PT06474,Portugal,Lisbon,30.0,Female,Ovarian,III,2015-03-18,2015-04-16,2015-08-26,Surgery,Public,Alive,52.0,BRCA1,Yes,Never,Heavy,21.3,Medium,Urban,NHS,5.0,No,No,None,8.0
PT06475,Italy,Lombardy,63.0,Male,Lung,II,2022-09-12,2023-02-06,2023-03-19,Immunotherapy,Public,Alive,62.0,KRAS,Yes,Never,None,30.9,High,Urban,NHS,12.0,No,No,Obesity,3.0
PT06476,Denmark,Central Denmark,83.0,Female,Leukemia,I,2022-11-26,2023-01-08,2023-12-01,Surgery,Private,Alive,55.0,EGFR,Yes,Former,Moderate,27.3,Low,Urban,Private Insurance,3.0,Yes,No,Obesity,10.0
PT06477,Germany,Bavaria,53.0,Male,Leukemia,II,2015-04-25,2015-07-04,2016-03-16,Radiation,Public,Lost to Follow-up,,,No,Never,None,28.1,,Urban,Statutory Health Insurance,18.0,No,No,Hypertension,8.0
PT06478,Denmark,Central Denmark,84.0,Male,Leukemia,III,2013-04-21,,2014-02-15,,Public,Alive,95.0,,Yes,Never,Moderate,21.7,Medium,Urban,Private Insurance,,No,Yes,Diabetes,2.0
PT06479,Netherlands,North Holland,74.0,Male,Leukemia,I,2021-03-04,2021-03-27,2021-09-09,Chemotherapy,Public,Deceased,36.0,KRAS,,Former,None,26.0,Low,Urban,Private Insurance,4.0,No,No,None,1.0
PT06480,Finland,Pirkanmaa,,Male,Pancreatic,III,2010-06-14,2010-06-15,2010-09-03,Targeted Therapy,Public,Alive,34.0,EGFR,No,Never,None,39.4,High,Urban,Private Insurance,3.0,No,No,Cardiovascular Disease,1.0
PT06481,Italy,Lombardy,57.0,Female,Pancreatic,,2020-04-15,,2020-08-20,Immunotherapy,Public,Alive,100.0,EGFR,Yes,Never,Moderate,19.7,Medium,Rural,Private Insurance,18.0,No,No,,7.0
PT06482,Ireland,Munster,28.0,Female,Pancreatic,I,2017-12-21,2018-01-15,2018-07-13,Chemotherapy,Private,Alive,29.0,None,Yes,Former,,39.6,High,Urban,,6.0,No,No,Diabetes,9.0
PT06483,Norway,Vestland,36.0,Female,Ovarian,II,2018-09-01,2019-01-11,2019-06-26,Immunotherapy,Public,Alive,68.0,,Yes,Former,Moderate,31.4,Medium,Rural,Statutory Health Insurance,18.0,No,No,None,6.0
PT06484,Portugal,Porto,71.0,Male,,IV,2013-04-26,2013-08-13,2014-01-05,Chemotherapy,Public,Alive,73.0,KRAS,Yes,Current,Moderate,27.1,High,Urban,Private Insurance,19.0,No,No,Hypertension,9.0
PT06485,Spain,Andalusia,37.0,Male,Leukemia,IV,,2018-12-12,2019-03-14,Immunotherapy,Public,Alive,115.0,EGFR,Yes,Former,None,18.0,Medium,Urban,NHS,19.0,No,No,Diabetes,9.0
PT06486,Portugal,Algarve,82.0,Male,,,2014-01-21,2014-01-22,2015-01-15,Immunotherapy,Research Institute,Alive,83.0,EGFR,No,Never,Moderate,27.6,,Rural,Private Insurance,10.0,No,No,Cardiovascular Disease,2.0
PT06487,Austria,Styria,52.0,Male,Pancreatic,II,2014-02-04,2014-03-16,2015-01-22,Targeted Therapy,Research Institute,Alive,82.0,BRCA1,Yes,Never,None,27.9,Medium,Urban,,13.0,No,No,Obesity,4.0
PT06488,Switzerland,Bern,23.0,Male,Leukemia,I,2014-11-28,2014-12-19,2015-05-13,Surgery,Private,Alive,28.0,BRCA1,No,Former,Moderate,23.2,Medium,Urban,NHS,7.0,No,No,Cardiovascular Disease,3.0
PT06489,Finland,,71.0,Male,Lung,I,2016-08-16,2017-02-03,2018-01-01,,Public,Alive,13.0,None,No,Never,Moderate,36.9,High,Urban,Statutory Health Insurance,16.0,No,No,,6.0
PT06490,Portugal,Porto,28.0,Female,Ovarian,I,2020-03-16,2020-08-01,2021-07-25,Immunotherapy,Public,Deceased,18.0,KRAS,Yes,Current,Moderate,,Medium,Urban,NHS,4.0,No,Yes,Hypertension,7.0
PT06491,Netherlands,South Holland,83.0,Female,Breast,IV,2010-12-31,2011-03-07,2012-01-14,Targeted Therapy,Public,Alive,6.0,,Yes,Never,None,20.4,High,,NHS,8.0,No,No,Hypertension,6.0
,Switzerland,Geneva,49.0,Female,,IV,2021-07-16,,2021-10-05,Immunotherapy,Public,Alive,68.0,KRAS,No,Former,None,36.5,High,Urban,Statutory Health Insurance,15.0,No,No,Cardiovascular Disease,4.0
PT06493,France,Provence-Alpes-Côte d'Azur,27.0,Male,Pancreatic,III,2011-02-13,2011-06-17,2011-12-29,Immunotherapy,Public,Alive,32.0,BRCA1,No,Former,Moderate,32.4,Medium,Rural,Private Insurance,14.0,No,Yes,None,
PT06494,Austria,Tyrol,,Female,Lung,II,2010-12-29,2011-05-19,2011-09-21,Radiation,Public,,86.0,KRAS,No,Current,Moderate,19.1,Low,Rural,NHS,10.0,No,No,Obesity,6.0
PT06495,Germany,North Rhine-Westphalia,82.0,Female,Breast,I,2019-06-03,2019-09-02,2020-03-18,Radiation,Research Institute,Alive,46.0,None,No,Current,None,19.6,High,Urban,Statutory Health Insurance,19.0,No,No,Obesity,9.0
PT06496,Switzerland,Geneva,20.0,Male,Prostate,II,2023-11-02,2024-02-23,2025-02-09,Radiation,Private,Alive,14.0,KRAS,No,Current,Moderate,39.4,High,Rural,NHS,13.0,Yes,No,Hypertension,9.0
PT06497,Poland,Lesser Poland,34.0,Male,Pancreatic,III,2022-02-05,2022-06-11,2023-01-10,Targeted Therapy,Public,Alive,32.0,KRAS,No,Current,Moderate,37.1,High,Urban,Private Insurance,2.0,No,No,Obesity,7.0
PT06498,Austria,Vienna,57.0,Male,Breast,II,2012-01-28,2012-02-07,2012-07-22,Immunotherapy,Private,Alive,95.0,EGFR,Yes,Never,None,37.4,Low,Urban,NHS,11.0,No,No,Cardiovascular Disease,6.0
PT06499,Austria,Vienna,61.0,Male,Colorectal,III,2019-03-20,2019-08-05,2019-10-24,Targeted Therapy,Public,,118.0,KRAS,No,Never,Moderate,20.1,Low,Urban,Statutory Health Insurance,18.0,No,No,None,10.0
,Netherlands,South Holland,65.0,Male,Pancreatic,III,2019-09-22,2019-11-08,2020-07-22,Targeted Therapy,Private,Alive,26.0,EGFR,Yes,Never,Moderate,,Low,Rural,NHS,19.0,No,No,Cardiovascular Disease,4.0
PT06501,Norway,Trøndelag,72.0,,Leukemia,III,2018-03-11,2018-03-20,2018-07-04,Chemotherapy,Private,Deceased,112.0,BRCA1,,Current,Moderate,39.7,Medium,Urban,Statutory Health Insurance,10.0,No,No,Hypertension,9.0
PT06502,Norway,Vestland,45.0,Male,Ovarian,II,2011-03-24,2011-05-09,2012-01-19,Surgery,Public,Alive,51.0,EGFR,No,Former,Moderate,39.8,High,Urban,Statutory Health Insurance,1.0,No,,Cardiovascular Disease,4.0
PT06503,Netherlands,Utrecht,80.0,Male,Lung,III,2018-10-07,,2019-09-26,Chemotherapy,Public,Deceased,53.0,EGFR,No,Former,Moderate,28.3,Low,,NHS,10.0,Yes,No,None,4.0
PT06504,Poland,Lesser Poland,86.0,Female,Breast,I,2017-07-14,2017-10-25,2018-05-05,Surgery,Public,Alive,73.0,EGFR,,Never,,34.1,Medium,Urban,Private Insurance,5.0,No,No,Diabetes,4.0
PT06505,Poland,,73.0,Male,Lung,III,2014-11-27,2015-03-31,2015-05-15,Chemotherapy,Public,Alive,19.0,BRCA1,,Never,,34.2,Medium,Rural,Private Insurance,,No,No,,2.0
PT06506,Poland,Silesian,,Female,Leukemia,,2016-07-17,2016-09-23,2017-04-08,Immunotherapy,Public,Deceased,47.0,KRAS,Yes,Never,Moderate,39.8,High,Rural,Statutory Health Insurance,19.0,Yes,No,Cardiovascular Disease,10.0
PT06507,France,Auvergne-Rhône-Alpes,45.0,Male,Prostate,I,2022-07-07,2022-10-24,2023-10-13,Targeted Therapy,Public,Deceased,114.0,KRAS,No,Former,Moderate,35.2,Medium,Rural,Statutory Health Insurance,3.0,No,No,None,9.0
PT06508,,Central Denmark,79.0,Male,Ovarian,I,2010-10-18,2010-12-25,2011-01-31,Chemotherapy,Private,Alive,,BRCA1,No,Never,Moderate,25.1,Low,Rural,Statutory Health Insurance,10.0,No,No,Hypertension,1.0
PT06509,,Silesian,58.0,Female,Leukemia,I,2010-06-21,2010-10-31,2011-05-09,Chemotherapy,Public,Deceased,80.0,KRAS,No,Former,Moderate,32.5,Low,Rural,NHS,14.0,No,No,,8.0
PT06510,Switzerland,Bern,55.0,,Prostate,IV,2010-10-28,2011-02-10,2011-10-19,Immunotherapy,Private,Alive,67.0,KRAS,No,Former,Moderate,28.6,Low,Urban,NHS,14.0,No,No,None,3.0
PT06511,Italy,Sicily,40.0,Male,Lung,II,2018-09-02,2019-01-09,2019-07-23,Targeted Therapy,Public,Alive,9.0,None,No,Never,None,27.7,Medium,Urban,Private Insurance,16.0,Yes,No,Obesity,10.0
PT06512,Poland,,60.0,Female,Prostate,IV,2020-11-20,,2021-12-25,Surgery,Research Institute,Alive,64.0,KRAS,No,Never,Moderate,28.4,Medium,Urban,Private Insurance,3.0,No,No,Obesity,8.0
PT06513,Germany,North Rhine-Westphalia,,Female,Pancreatic,I,2018-04-03,2018-09-03,,Chemotherapy,Public,Alive,39.0,None,Yes,Current,,,Medium,Urban,NHS,16.0,No,No,None,5.0
PT06514,Poland,Masovian,45.0,Male,Prostate,I,2016-04-23,2016-09-07,2016-10-26,Surgery,Public,Alive,10.0,KRAS,,Former,Moderate,25.5,Medium,Urban,NHS,1.0,No,No,Hypertension,3.0
PT06515,Portugal,Porto,82.0,Male,Prostate,II,,2014-11-07,2015-01-27,Radiation,Public,Alive,37.0,BRCA1,Yes,Former,Moderate,32.5,Low,Urban,NHS,6.0,No,No,Obesity,9.0
PT06516,Switzerland,Zurich,55.0,Female,Pancreatic,II,2011-05-30,2011-08-20,2012-08-04,Chemotherapy,Public,Lost to Follow-up,,KRAS,Yes,Former,None,39.4,Medium,Urban,Statutory Health Insurance,3.0,Yes,No,Diabetes,1.0
PT06517,Norway,Trøndelag,43.0,Male,Prostate,III,2011-11-10,2012-04-12,2012-07-16,Targeted Therapy,Public,Lost to Follow-up,,KRAS,Yes,Never,Moderate,,Medium,Urban,Statutory Health Insurance,15.0,No,No,None,1.0
PT06518,Portugal,Lisbon,40.0,Male,Pancreatic,II,2020-11-23,2021-01-18,2021-11-18,Radiation,Private,Alive,85.0,None,No,Never,Moderate,,High,Urban,NHS,7.0,No,Yes,None,2.0
PT06519,Austria,Tyrol,37.0,Male,Pancreatic,III,2019-05-15,2019-07-03,2020-03-21,Radiation,Public,Alive,97.0,EGFR,No,Current,Heavy,21.1,High,,Private Insurance,6.0,No,Yes,Cardiovascular Disease,6.0
PT06520,Austria,Tyrol,34.0,Female,Ovarian,II,2023-09-17,2023-11-21,2024-09-21,Chemotherapy,Public,Deceased,71.0,EGFR,No,Current,Moderate,36.9,Low,Urban,NHS,10.0,Yes,No,Hypertension,4.0
PT06521,Belgium,Wallonia,25.0,Female,Prostate,II,2016-03-02,2016-03-11,2017-02-11,Chemotherapy,,Alive,40.0,KRAS,,Never,Heavy,36.3,,Urban,NHS,18.0,No,No,Cardiovascular Disease,9.0
PT06522,Poland,Masovian,62.0,Female,Pancreatic,II,,2023-06-25,2023-12-13,Radiation,Public,Alive,13.0,EGFR,Yes,Never,None,22.6,Medium,Urban,Statutory Health Insurance,3.0,No,No,None,3.0
PT06523,Germany,Bavaria,50.0,Female,Breast,III,2010-12-10,2011-04-01,2011-08-30,Chemotherapy,Public,Alive,62.0,None,Yes,Never,None,20.2,Medium,Urban,NHS,13.0,No,No,Hypertension,2.0
PT06524,Switzerland,Zurich,47.0,Non-binary,Prostate,III,2010-01-29,2010-06-17,2011-02-06,Targeted Therapy,Public,Alive,30.0,KRAS,Yes,Never,None,20.8,High,Urban,NHS,4.0,No,No,None,
PT06525,Poland,Silesian,27.0,Female,Prostate,II,,2019-09-14,2020-01-12,Targeted Therapy,Public,Deceased,28.0,KRAS,No,Former,Heavy,37.7,High,Urban,Private Insurance,3.0,No,No,Obesity,4.0
PT06526,Ireland,Munster,48.0,Female,Leukemia,I,2015-11-23,2016-02-16,2016-07-16,Radiation,Research Institute,Deceased,41.0,EGFR,,Former,Moderate,28.6,High,Rural,Private Insurance,16.0,No,Yes,Hypertension,8.0
PT06527,Poland,Lesser Poland,40.0,,Leukemia,III,2010-04-17,2010-05-23,2010-12-25,Chemotherapy,Public,Deceased,30.0,None,Yes,Current,Moderate,34.5,High,Urban,Statutory Health Insurance,11.0,No,No,,6.0
PT06528,Belgium,Flanders,77.0,Male,Ovarian,,2021-06-29,2021-12-06,2022-03-25,Radiation,Public,Deceased,22.0,KRAS,No,Never,Heavy,28.7,Medium,Urban,Private Insurance,14.0,No,Yes,Obesity,9.0
PT06529,Switzerland,Zurich,79.0,Female,Ovarian,I,2017-02-12,2017-05-06,2017-11-07,Targeted Therapy,Public,Alive,68.0,EGFR,No,Never,Heavy,37.2,Low,Urban,Statutory Health Insurance,18.0,No,No,Diabetes,1.0
PT06530,Netherlands,Utrecht,69.0,Female,Ovarian,III,2019-03-15,2019-08-25,2020-06-08,Chemotherapy,Research Institute,Alive,119.0,BRCA1,Yes,Current,None,,High,Rural,Private Insurance,7.0,No,Yes,Cardiovascular Disease,10.0
PT06531,Italy,Lombardy,50.0,Female,Leukemia,II,2011-05-05,2011-09-14,2012-02-17,Targeted Therapy,Public,Alive,69.0,EGFR,Yes,Former,None,37.1,Medium,Urban,Statutory Health Insurance,2.0,No,No,None,6.0
PT06532,Belgium,Flanders,66.0,Female,Prostate,II,2020-04-18,2020-06-19,2020-07-22,Chemotherapy,Public,Deceased,95.0,None,No,Never,None,23.9,Medium,Urban,Private Insurance,5.0,No,No,Diabetes,2.0
PT06533,Austria,Vienna,53.0,Female,Leukemia,IV,,,2022-03-26,Immunotherapy,Public,Deceased,115.0,BRCA1,Yes,Never,,19.4,Medium,Urban,Private Insurance,18.0,No,No,Obesity,5.0
PT06534,,Capital Region,,Female,Breast,III,2018-10-28,2019-03-13,,Targeted Therapy,Public,Alive,42.0,,No,Never,Moderate,24.3,High,Urban,Statutory Health Insurance,7.0,No,No,Hypertension,5.0
,Finland,Pirkanmaa,86.0,Female,Lung,III,2010-10-05,2011-02-01,2011-10-19,Surgery,Public,Deceased,90.0,BRCA1,No,Current,Moderate,31.6,Low,Urban,Private Insurance,3.0,No,No,Hypertension,5.0
PT06536,Poland,Lesser Poland,71.0,Male,Leukemia,II,2021-02-28,,2022-03-19,Chemotherapy,Private,Alive,10.0,,No,Never,Moderate,37.0,Medium,Urban,Statutory Health Insurance,15.0,Yes,No,Obesity,4.0
PT06537,Italy,Sicily,26.0,Male,Pancreatic,I,2013-10-05,2013-12-13,2014-03-12,Immunotherapy,Public,Alive,29.0,,No,Current,None,24.0,Medium,Urban,Private Insurance,19.0,No,No,Hypertension,3.0
PT06538,Denmark,Central Denmark,38.0,Female,Leukemia,III,2011-09-20,2011-12-23,2012-10-30,Immunotherapy,Private,Alive,79.0,EGFR,Yes,Never,None,19.7,Low,Urban,Statutory Health Insurance,10.0,,No,Hypertension,4.0
PT06539,Germany,Berlin,34.0,Male,Breast,IV,2017-05-19,2017-07-21,2017-12-16,Immunotherapy,Public,Alive,71.0,None,No,Current,None,27.5,Medium,Urban,Private Insurance,8.0,No,No,Obesity,6.0
PT06540,Netherlands,South Holland,67.0,Male,Pancreatic,III,,2013-05-16,2014-04-16,,Public,Deceased,95.0,None,No,Current,None,38.5,High,Urban,Statutory Health Insurance,14.0,No,No,Hypertension,4.0
PT06541,Finland,Uusimaa,33.0,Male,Pancreatic,I,2022-03-19,2022-06-26,2023-04-19,Surgery,Research Institute,Deceased,78.0,None,Yes,Never,Heavy,27.6,Low,Urban,Private Insurance,6.0,No,No,None,6.0
PT06542,Poland,Lesser Poland,22.0,Female,Pancreatic,II,2011-11-09,2011-12-16,2012-05-31,Immunotherapy,Public,Alive,53.0,KRAS,Yes,Never,None,25.1,Medium,Urban,Statutory Health Insurance,2.0,No,No,,7.0
PT06543,Denmark,Capital Region,69.0,Male,Pancreatic,II,2020-03-06,2020-03-10,,Radiation,Public,Alive,35.0,EGFR,No,Current,Moderate,33.3,Medium,Rural,NHS,2.0,No,No,Cardiovascular Disease,10.0
PT06544,Belgium,Wallonia,,Female,Colorectal,II,2019-03-16,2019-05-11,2020-01-25,Chemotherapy,Public,Alive,44.0,KRAS,Yes,Former,None,27.2,Medium,Urban,Private Insurance,6.0,Yes,No,Obesity,1.0
PT06545,Belgium,Flanders,25.0,Female,Colorectal,I,2019-04-25,2019-06-07,2020-02-11,Chemotherapy,Public,Deceased,,KRAS,No,Current,Moderate,33.4,Low,Urban,Private Insurance,11.0,No,No,None,10.0
PT06546,Sweden,Skåne,68.0,,Pancreatic,I,2016-09-08,2016-09-29,2016-12-02,Surgery,Private,Alive,68.0,KRAS,Yes,Former,Moderate,,Medium,Urban,Statutory Health Insurance,18.0,No,No,None,2.0
PT06547,Sweden,Västra Götaland,42.0,,Pancreatic,,2011-07-09,2011-09-05,,Surgery,Public,Alive,101.0,KRAS,No,Never,None,28.1,Low,Urban,Statutory Health Insurance,9.0,No,No,Diabetes,4.0
PT06548,Norway,Oslo,39.0,Female,Pancreatic,III,2012-03-13,2012-08-04,2012-12-31,Targeted Therapy,Private,Alive,62.0,EGFR,No,Current,Heavy,19.8,Medium,Urban,Statutory Health Insurance,2.0,No,No,Diabetes,6.0
PT06549,Switzerland,Geneva,79.0,Female,Breast,,2013-03-08,2013-04-30,2014-03-01,Radiation,Public,Alive,77.0,None,No,Former,Heavy,33.3,High,Urban,,9.0,Yes,No,Hypertension,3.0
PT06550,Finland,Uusimaa,64.0,Male,Leukemia,IV,2011-02-28,2011-03-18,2012-01-09,Chemotherapy,Public,Alive,66.0,None,Yes,Former,None,34.7,Medium,Urban,NHS,13.0,No,No,Cardiovascular Disease,1.0
PT06551,Netherlands,North Holland,80.0,Male,Lung,II,2013-06-30,2013-08-26,2014-06-10,Immunotherapy,Public,Deceased,8.0,None,Yes,,None,21.1,Medium,Urban,Private Insurance,1.0,No,Yes,Hypertension,10.0
PT06552,Ireland,Dublin,75.0,Male,Ovarian,IV,2011-02-20,2011-05-26,,Immunotherapy,Private,Alive,9.0,KRAS,No,Never,None,19.4,Medium,Rural,NHS,12.0,No,No,None,1.0
PT06553,Netherlands,South Holland,21.0,Male,Pancreatic,III,2018-03-12,2018-08-25,2019-06-28,Chemotherapy,Research Institute,Alive,94.0,EGFR,No,Current,Moderate,27.0,Medium,Urban,Statutory Health Insurance,1.0,No,No,Obesity,4.0
PT06554,Netherlands,North Holland,64.0,Male,,IV,2015-06-29,2015-10-30,2016-09-14,Radiation,Public,Alive,54.0,BRCA1,No,Never,Moderate,36.3,Low,Urban,Statutory Health Insurance,19.0,Yes,No,Cardiovascular Disease,8.0
PT06555,Germany,Berlin,59.0,Male,Leukemia,I,2017-07-07,2017-08-08,2018-05-01,,,,96.0,KRAS,Yes,Former,None,23.0,Low,Urban,NHS,5.0,No,No,None,10.0
PT06556,France,Île-de-France,43.0,Female,Breast,I,2022-10-17,2023-02-06,2023-11-06,Immunotherapy,Research Institute,Alive,21.0,None,No,Never,None,30.7,High,,Private Insurance,2.0,No,No,,10.0
PT06557,Sweden,Västra Götaland,48.0,Female,Ovarian,,2017-11-03,2017-11-22,2017-12-30,,Public,Deceased,28.0,KRAS,No,Former,Moderate,22.1,Medium,Rural,NHS,10.0,,No,Hypertension,7.0
PT06558,Finland,Southwest Finland,86.0,Female,Breast,IV,2015-07-06,2015-09-28,,Immunotherapy,Public,Alive,116.0,None,No,Never,None,32.4,Medium,Urban,Statutory Health Insurance,19.0,No,No,None,6.0
PT06559,,Zurich,87.0,Female,Pancreatic,III,2021-09-15,,2022-08-31,Targeted Therapy,,Alive,31.0,BRCA1,No,Never,None,22.3,Medium,Urban,,9.0,Yes,No,Obesity,
PT06560,Belgium,Wallonia,85.0,Female,Ovarian,III,2015-01-05,2015-03-20,2015-09-07,Chemotherapy,Research Institute,Lost to Follow-up,,EGFR,No,Never,Moderate,25.9,Low,Urban,NHS,1.0,Yes,No,Cardiovascular Disease,
PT06561,France,Auvergne-Rhône-Alpes,73.0,Female,Prostate,II,2021-10-19,2022-03-22,2022-12-20,Radiation,Public,Alive,84.0,EGFR,Yes,Never,Moderate,33.9,Low,Urban,Private Insurance,3.0,Yes,No,None,10.0
PT06562,Netherlands,South Holland,72.0,Male,Breast,III,2021-08-19,2021-12-07,2022-04-19,Immunotherapy,Public,,31.0,None,No,Never,Moderate,32.2,,Urban,NHS,9.0,No,No,Obesity,2.0
PT06563,Finland,,68.0,Male,Prostate,III,2023-10-16,2024-01-06,2024-08-08,Surgery,Private,Alive,30.0,EGFR,No,Never,Heavy,27.6,High,Rural,Private Insurance,12.0,No,No,None,5.0
PT06564,Denmark,Capital Region,51.0,Female,Ovarian,III,,2021-04-06,2021-06-10,Surgery,Public,Alive,47.0,EGFR,No,Former,Moderate,25.7,Low,Rural,NHS,9.0,No,No,None,5.0
PT06565,France,Provence-Alpes-Côte d'Azur,80.0,Female,Ovarian,III,2020-08-07,2021-01-27,2021-08-05,Targeted Therapy,Public,Alive,80.0,KRAS,Yes,Never,None,37.6,Medium,Rural,Private Insurance,7.0,,,Obesity,9.0
PT06566,,Provence-Alpes-Côte d'Azur,61.0,Male,Breast,I,2014-06-06,2014-06-21,2014-09-22,,Public,Deceased,82.0,BRCA1,Yes,Never,Moderate,21.2,High,Urban,Private Insurance,13.0,No,No,,1.0
PT06567,Sweden,Skåne,20.0,Male,Prostate,III,2014-07-02,2014-11-25,2015-05-14,Targeted Therapy,,Alive,49.0,BRCA1,No,Current,None,28.5,High,Urban,Statutory Health Insurance,18.0,No,Yes,Hypertension,6.0
PT06568,Netherlands,North Holland,82.0,Female,Prostate,II,2017-08-31,2017-10-01,2018-04-10,Targeted Therapy,Public,Alive,6.0,BRCA1,No,Never,,28.9,Medium,Urban,,11.0,No,No,Diabetes,3.0
PT06569,Portugal,Porto,54.0,Male,Pancreatic,IV,2014-12-09,2015-05-01,,Radiation,Public,Deceased,41.0,BRCA1,Yes,Never,Moderate,25.3,Low,Urban,NHS,2.0,Yes,No,Cardiovascular Disease,5.0
PT06570,Finland,Uusimaa,70.0,Male,Pancreatic,III,2012-08-11,2012-11-21,2013-04-10,Radiation,Public,Alive,100.0,BRCA1,Yes,Never,None,37.0,Medium,Urban,NHS,1.0,No,Yes,Obesity,8.0
PT06571,Portugal,Lisbon,64.0,Female,,III,2019-01-28,2019-02-12,2019-09-29,Chemotherapy,Private,Deceased,27.0,None,No,Never,Heavy,18.2,High,Urban,NHS,18.0,No,No,None,8.0
PT06572,Italy,Veneto,84.0,Female,Leukemia,,2023-05-16,2023-07-20,2024-05-18,Immunotherapy,Private,Alive,105.0,KRAS,No,Current,None,36.5,Low,Rural,Private Insurance,,No,No,Diabetes,8.0
PT06573,,Provence-Alpes-Côte d'Azur,33.0,,Prostate,I,2018-10-13,,2019-05-24,Surgery,Private,Alive,10.0,KRAS,No,Never,None,23.4,High,Rural,Private Insurance,2.0,No,No,Obesity,4.0
PT06574,Portugal,Algarve,22.0,Female,Colorectal,I,2013-03-28,2013-09-18,2013-11-04,Immunotherapy,Private,Alive,114.0,EGFR,No,Former,Moderate,18.3,Medium,Rural,NHS,13.0,Yes,Yes,Cardiovascular Disease,6.0
PT06575,Germany,Berlin,43.0,Female,Breast,III,2021-08-18,2021-11-01,2022-09-02,Immunotherapy,Public,Alive,24.0,None,No,Never,,29.4,High,Urban,Statutory Health Insurance,9.0,No,No,Hypertension,2.0
PT06576,Italy,Veneto,84.0,Female,Pancreatic,II,2012-06-27,2012-10-07,2013-07-23,Targeted Therapy,Public,Alive,117.0,KRAS,No,Never,None,23.9,Medium,Urban,NHS,12.0,No,Yes,Cardiovascular Disease,3.0
PT06577,Ireland,Dublin,67.0,Male,Lung,II,2019-12-05,2020-04-27,2020-06-17,Surgery,Private,Alive,100.0,None,Yes,Former,None,27.8,Medium,Urban,Statutory Health Insurance,3.0,No,No,Diabetes,3.0
PT06578,Switzerland,Bern,29.0,Male,Ovarian,IV,2022-02-16,2022-03-18,2022-11-19,Radiation,Private,,,EGFR,No,Former,Moderate,24.9,Medium,Urban,Private Insurance,6.0,,No,Diabetes,3.0
,Norway,Oslo,32.0,Female,Breast,II,2011-04-08,2011-05-19,2012-01-04,Immunotherapy,Private,Alive,92.0,KRAS,No,Former,None,24.7,Medium,Urban,Statutory Health Insurance,2.0,No,No,None,7.0
PT06580,Norway,Oslo,33.0,,Leukemia,I,2014-02-01,2014-04-09,2015-01-28,Targeted Therapy,Private,,66.0,None,No,Never,Moderate,34.4,Low,Urban,NHS,2.0,No,No,,9.0
PT06581,Norway,Oslo,29.0,Male,Leukemia,II,2012-11-15,2012-12-02,2013-07-06,Radiation,Public,Alive,91.0,KRAS,No,Current,Moderate,35.9,Low,Urban,NHS,18.0,No,No,Cardiovascular Disease,3.0
PT06582,,Zurich,59.0,Male,Prostate,I,2018-11-12,2018-12-08,2019-10-22,Targeted Therapy,Public,Deceased,62.0,BRCA1,,Never,None,,Medium,Rural,Statutory Health Insurance,6.0,No,No,Diabetes,2.0
PT06583,Belgium,Flanders,42.0,Male,Leukemia,II,2019-05-31,2019-09-26,,Immunotherapy,Public,Alive,100.0,None,Yes,Former,Heavy,29.7,High,Urban,,2.0,Yes,No,Diabetes,4.0
PT06584,Finland,Pirkanmaa,74.0,,Pancreatic,,,2023-08-15,2023-11-18,Immunotherapy,Public,Alive,26.0,None,No,Former,None,31.8,High,Urban,NHS,2.0,No,No,Obesity,5.0
PT06585,Austria,Styria,,,Leukemia,IV,2022-06-01,2022-09-10,2023-01-14,Immunotherapy,Public,Alive,,EGFR,No,Never,Moderate,39.4,High,Urban,NHS,13.0,No,No,Cardiovascular Disease,8.0
PT06586,Netherlands,Utrecht,61.0,Male,Breast,II,2022-04-17,2022-07-21,2023-06-06,Surgery,Private,Alive,58.0,None,No,Never,None,24.3,High,Urban,Private Insurance,14.0,No,No,Diabetes,1.0
PT06587,Italy,Lombardy,85.0,Male,Ovarian,I,2019-09-09,2019-11-06,2020-03-07,Surgery,Private,Deceased,65.0,EGFR,No,,None,20.0,Medium,Urban,Private Insurance,13.0,No,Yes,Diabetes,10.0
PT06588,Germany,Bavaria,66.0,Female,Colorectal,II,2010-09-24,2010-12-28,2011-07-05,Immunotherapy,Private,Alive,66.0,EGFR,No,Current,None,34.2,Low,Rural,Statutory Health Insurance,1.0,No,No,Cardiovascular Disease,2.0
PT06589,Austria,Styria,,Female,,III,2014-04-08,2014-07-19,,Surgery,Private,Alive,80.0,None,Yes,Current,Heavy,25.3,Medium,Urban,Private Insurance,5.0,No,No,None,5.0
PT06590,Germany,Bavaria,37.0,Male,Ovarian,II,2015-12-09,2016-04-18,2016-09-11,Targeted Therapy,Public,Alive,17.0,EGFR,Yes,Never,Moderate,25.5,High,Urban,Private Insurance,12.0,No,No,None,3.0
PT06591,Norway,Trøndelag,37.0,Female,Ovarian,II,2015-02-28,,2016-01-23,Targeted Therapy,Public,Deceased,47.0,None,Yes,Never,Moderate,38.7,Low,Urban,Statutory Health Insurance,13.0,No,No,Obesity,10.0
PT06592,France,Île-de-France,43.0,Female,Prostate,IV,2022-12-22,2023-04-27,2023-06-30,Chemotherapy,Public,Alive,94.0,EGFR,Yes,Never,None,24.0,Medium,Urban,NHS,4.0,Yes,No,Hypertension,3.0
PT06593,France,Île-de-France,42.0,Female,Ovarian,II,2019-09-10,2020-01-01,2020-11-21,Radiation,Private,Alive,53.0,KRAS,Yes,Current,Moderate,18.5,Medium,Urban,Private Insurance,7.0,No,No,,3.0
PT06594,Netherlands,Utrecht,31.0,Male,Leukemia,II,2017-11-06,2018-04-11,2019-03-01,Targeted Therapy,Public,Alive,90.0,BRCA1,No,Never,Moderate,19.8,Low,Urban,Statutory Health Insurance,1.0,No,No,None,9.0
PT06595,Denmark,Central Denmark,42.0,Female,Leukemia,III,2021-09-18,2022-01-28,2022-03-18,,Private,Deceased,76.0,KRAS,No,Never,Heavy,35.3,High,Urban,Statutory Health Insurance,17.0,No,No,Diabetes,9.0
PT06596,Ireland,Dublin,40.0,,Colorectal,II,2016-12-21,2017-06-07,2018-02-06,Chemotherapy,,Alive,100.0,KRAS,No,Former,Moderate,36.2,Low,Urban,Statutory Health Insurance,17.0,No,No,Obesity,3.0
PT06597,Austria,Tyrol,83.0,,Ovarian,I,2019-08-20,2019-11-30,2020-02-20,Chemotherapy,Public,Alive,80.0,KRAS,,Current,Heavy,27.8,High,Urban,NHS,18.0,Yes,No,,
PT06598,Austria,Styria,53.0,Male,Prostate,I,2018-11-23,2019-01-19,2019-07-07,Radiation,Private,Deceased,70.0,BRCA1,Yes,Former,Moderate,22.8,Medium,,,10.0,No,No,Diabetes,2.0
PT06599,Belgium,Brussels,21.0,,Leukemia,IV,2015-10-19,2016-04-11,2016-09-23,Immunotherapy,Private,,83.0,None,Yes,,Moderate,34.6,Low,Rural,Statutory Health Insurance,6.0,Yes,No,None,3.0
PT06600,Portugal,Algarve,88.0,Female,Prostate,IV,2014-12-05,2015-05-16,2015-11-30,Radiation,Public,Deceased,52.0,EGFR,Yes,Current,,21.3,Medium,Urban,Statutory Health Insurance,16.0,No,No,Obesity,3.0
PT06601,Portugal,Porto,50.0,Male,Pancreatic,,2010-05-03,2010-10-23,2011-03-23,Targeted Therapy,Private,Alive,28.0,None,No,Never,Moderate,21.0,Medium,Urban,,16.0,No,,Obesity,3.0
PT06602,Switzerland,,87.0,Male,Breast,II,2011-01-27,2011-02-28,2011-08-15,,Private,Alive,105.0,None,No,Former,Heavy,19.8,Medium,Rural,Statutory Health Insurance,17.0,No,No,Obesity,6.0
PT06603,France,Auvergne-Rhône-Alpes,89.0,Female,Pancreatic,I,2019-01-12,2019-07-03,2019-08-27,Targeted Therapy,Private,Deceased,48.0,None,Yes,Never,Moderate,19.7,Medium,Urban,NHS,14.0,No,No,,4.0
PT06604,Netherlands,North Holland,38.0,Male,Leukemia,III,2023-09-20,2023-12-26,2024-08-26,Targeted Therapy,Public,Alive,74.0,BRCA1,No,Former,None,28.0,Medium,Urban,Statutory Health Insurance,19.0,,No,None,10.0
PT06605,Switzerland,Zurich,32.0,Female,Leukemia,I,2016-08-12,2016-12-29,2017-03-06,Targeted Therapy,Public,Alive,45.0,EGFR,No,Never,None,22.7,Medium,Rural,Statutory Health Insurance,5.0,No,No,Diabetes,8.0
,Norway,Vestland,84.0,Male,Leukemia,I,2022-06-20,2022-07-26,2023-01-04,Immunotherapy,Private,Deceased,61.0,EGFR,Yes,Never,Moderate,23.9,High,Rural,NHS,16.0,,No,Diabetes,5.0
PT06607,Portugal,Algarve,25.0,Male,Colorectal,III,2021-01-23,2021-06-13,2022-04-26,Immunotherapy,Public,Alive,74.0,BRCA1,No,Former,None,29.8,Medium,Urban,NHS,3.0,No,Yes,Diabetes,2.0
PT06608,Norway,Trøndelag,46.0,Female,Colorectal,II,2018-08-10,2018-10-06,2019-05-20,Chemotherapy,Research Institute,,71.0,BRCA1,No,Current,Moderate,27.9,Low,Urban,Statutory Health Insurance,10.0,No,No,Hypertension,8.0
PT06609,Poland,Masovian,71.0,Male,Leukemia,I,2017-01-03,2017-06-05,2017-10-24,Surgery,Public,Deceased,43.0,None,Yes,Current,Moderate,24.2,Low,Urban,Private Insurance,5.0,Yes,Yes,Cardiovascular Disease,2.0
PT06610,,Utrecht,67.0,Non-binary,Leukemia,III,2012-12-31,2013-06-14,2013-12-03,Immunotherapy,Research Institute,Alive,,EGFR,Yes,Never,Moderate,39.4,Medium,Rural,Statutory Health Insurance,1.0,No,No,Hypertension,7.0
PT06611,Poland,Masovian,87.0,Female,Breast,III,2017-08-03,2017-11-01,2018-10-04,Immunotherapy,Public,Alive,86.0,KRAS,Yes,Current,Moderate,,Medium,Urban,Statutory Health Insurance,12.0,No,No,None,5.0
PT06612,Finland,Uusimaa,63.0,Female,Breast,III,2021-05-04,,2021-11-09,Chemotherapy,Public,Deceased,10.0,EGFR,Yes,Former,Moderate,31.6,Low,Rural,Private Insurance,19.0,No,No,None,10.0
PT06613,Ireland,Dublin,36.0,Female,Prostate,IV,2022-11-02,2023-02-19,2023-08-14,Chemotherapy,Public,Alive,83.0,BRCA1,Yes,Never,,38.1,High,Urban,Statutory Health Insurance,18.0,No,No,Cardiovascular Disease,8.0
PT06614,Finland,Southwest Finland,57.0,Female,Ovarian,II,2018-03-07,2018-04-02,,Chemotherapy,Research Institute,Alive,105.0,,No,Former,None,18.8,High,,,11.0,Yes,,Cardiovascular Disease,5.0
PT06615,Portugal,Algarve,29.0,Male,Prostate,I,2012-02-12,2012-02-25,2012-06-14,Radiation,Public,Alive,65.0,,No,Never,Moderate,32.0,Medium,Urban,,3.0,,No,None,6.0
PT06616,Netherlands,South Holland,,Female,Colorectal,I,2022-07-14,2022-09-24,2022-11-07,Targeted Therapy,Public,Deceased,52.0,KRAS,No,Never,None,36.7,High,Urban,Statutory Health Insurance,3.0,No,No,None,
PT06617,Poland,Silesian,,Male,Lung,II,2013-04-13,2013-10-09,2014-08-03,Immunotherapy,Public,Alive,115.0,,No,Former,Moderate,18.9,Medium,Urban,Private Insurance,5.0,No,No,Cardiovascular Disease,8.0
PT06618,Netherlands,Utrecht,25.0,Male,Breast,I,2013-12-21,2014-02-06,2014-10-08,Targeted Therapy,Public,Alive,97.0,EGFR,No,Never,Moderate,33.7,Medium,Urban,NHS,16.0,No,No,None,2.0
PT06619,Norway,Vestland,71.0,,Prostate,II,2023-01-03,2023-05-08,2023-06-29,Surgery,Private,Deceased,81.0,EGFR,Yes,Never,Moderate,35.2,Medium,Urban,Private Insurance,19.0,No,Yes,Cardiovascular Disease,6.0
PT06620,Belgium,Wallonia,34.0,Female,Ovarian,I,2016-04-03,2016-09-11,2017-04-18,Chemotherapy,Private,Deceased,,None,Yes,Current,Moderate,19.5,Medium,Urban,Private Insurance,6.0,Yes,No,Diabetes,8.0
PT06621,Switzerland,Zurich,87.0,Male,Ovarian,II,2018-04-27,2018-10-14,2019-08-20,Surgery,Public,Alive,45.0,EGFR,No,,None,19.1,High,Urban,Statutory Health Insurance,2.0,No,No,Obesity,3.0
PT06622,France,Île-de-France,76.0,Male,Breast,I,2013-03-09,2013-07-15,2014-01-20,,Public,Alive,29.0,EGFR,Yes,Never,Moderate,28.7,Low,Rural,Statutory Health Insurance,17.0,No,No,Diabetes,4.0
PT06623,Germany,North Rhine-Westphalia,75.0,Female,Breast,II,2010-03-05,2010-04-05,2010-09-30,Chemotherapy,Public,Lost to Follow-up,,,No,Current,None,33.6,High,Urban,Private Insurance,4.0,No,No,Cardiovascular Disease,10.0
PT06624,Italy,Lombardy,26.0,Male,Pancreatic,III,2016-05-15,2016-10-30,2017-09-08,Surgery,Public,Alive,23.0,KRAS,No,Current,Moderate,26.7,Low,Urban,Statutory Health Insurance,13.0,No,No,,9.0
PT06625,Netherlands,Utrecht,70.0,Female,,II,2010-02-19,2010-06-15,2010-10-13,Targeted Therapy,Research Institute,Alive,80.0,EGFR,No,Former,None,36.1,Medium,Urban,Private Insurance,16.0,No,No,Cardiovascular Disease,8.0
PT06626,,Algarve,77.0,Female,Breast,,2021-10-20,2022-03-13,2022-08-05,,Public,Alive,115.0,KRAS,No,Former,Moderate,36.2,High,Rural,Private Insurance,12.0,No,,Hypertension,9.0
PT06627,Italy,Lombardy,83.0,Male,Pancreatic,IV,2014-08-02,2014-09-27,,Radiation,Research Institute,,94.0,BRCA1,No,Current,Moderate,21.5,Medium,Urban,Statutory Health Insurance,6.0,Yes,,Cardiovascular Disease,5.0
PT06628,Portugal,Lisbon,45.0,,Ovarian,III,2016-10-14,2016-12-27,2017-06-14,Immunotherapy,,Alive,88.0,None,No,Former,None,19.6,High,Urban,NHS,7.0,Yes,No,Cardiovascular Disease,
PT06629,France,Auvergne-Rhône-Alpes,77.0,Female,Lung,II,2011-05-20,2011-06-25,2011-08-13,,Public,,73.0,KRAS,Yes,Current,None,24.8,Low,Urban,,9.0,No,No,Hypertension,7.0
PT06630,Norway,Oslo,50.0,Male,Ovarian,II,2014-05-11,2014-08-15,2015-07-17,Targeted Therapy,Public,Alive,67.0,EGFR,No,Never,Moderate,,Low,Rural,Private Insurance,8.0,No,No,None,4.0
PT06631,Germany,Bavaria,85.0,Male,Pancreatic,III,2021-11-23,2022-02-11,2022-06-05,,,Lost to Follow-up,,KRAS,No,Never,Moderate,35.6,Medium,Urban,,5.0,No,Yes,Hypertension,10.0
PT06632,,Île-de-France,32.0,Male,Ovarian,,2012-01-04,2012-02-21,2012-06-30,Targeted Therapy,Public,Alive,12.0,EGFR,No,Never,Moderate,29.7,Low,Rural,,4.0,No,Yes,Diabetes,10.0
PT06633,Ireland,Dublin,37.0,Male,,I,2017-10-23,,2018-08-08,Surgery,Public,Alive,87.0,None,No,Never,,32.5,Low,Urban,Statutory Health Insurance,10.0,Yes,No,Hypertension,7.0
PT06634,Belgium,Flanders,32.0,Male,Lung,,2011-04-13,2011-04-28,2012-04-24,Surgery,Private,Deceased,20.0,None,Yes,Current,Moderate,34.7,Medium,Urban,NHS,16.0,No,No,Obesity,1.0
PT06635,Sweden,Västra Götaland,43.0,Female,Breast,II,2017-09-09,2018-01-30,2018-03-25,Surgery,Public,Alive,111.0,KRAS,No,Never,Heavy,37.0,Medium,Urban,Private Insurance,13.0,No,No,None,7.0
PT06636,Denmark,Zealand,76.0,Female,Breast,I,2011-05-25,2011-10-21,2011-12-20,Chemotherapy,Private,Alive,117.0,None,Yes,Former,Moderate,30.7,Medium,Rural,Private Insurance,4.0,No,No,None,10.0
PT06637,Poland,Lesser Poland,48.0,Female,Prostate,,2017-08-05,2017-10-08,2018-06-01,Surgery,Public,Deceased,84.0,None,No,Never,Moderate,31.2,High,,Private Insurance,12.0,No,No,,10.0
PT06638,Italy,Veneto,75.0,Female,,I,2017-10-28,2018-03-12,2018-09-25,Immunotherapy,Public,Alive,71.0,KRAS,No,,Moderate,32.9,High,Urban,Private Insurance,9.0,No,No,Cardiovascular Disease,1.0
PT06639,Spain,Madrid,73.0,Male,Ovarian,,2018-11-04,2018-12-26,2019-04-01,Immunotherapy,Private,Alive,110.0,None,No,Never,None,31.7,Medium,Urban,Private Insurance,1.0,No,No,Obesity,8.0
PT06640,Portugal,Algarve,24.0,Male,Breast,I,2018-09-01,2018-09-20,,Chemotherapy,Public,,41.0,EGFR,Yes,Current,Heavy,37.7,Medium,Rural,Private Insurance,13.0,No,Yes,Diabetes,5.0
PT06641,France,Auvergne-Rhône-Alpes,54.0,Female,Breast,,2014-02-18,2014-06-23,2014-08-02,Surgery,Private,Alive,64.0,KRAS,No,Never,Moderate,19.7,Medium,Urban,Statutory Health Insurance,17.0,No,Yes,Cardiovascular Disease,
PT06642,Sweden,Skåne,38.0,Female,Prostate,III,2021-02-21,,2021-11-28,Surgery,Public,Alive,76.0,None,Yes,Former,Moderate,24.4,Medium,Rural,Private Insurance,7.0,No,No,Cardiovascular Disease,7.0
PT06643,Norway,Trøndelag,74.0,Female,Lung,II,2019-08-12,2020-02-02,2020-07-20,,Private,Deceased,34.0,EGFR,Yes,Former,Moderate,18.6,High,Urban,Statutory Health Insurance,18.0,No,No,Hypertension,2.0
PT06644,Denmark,Central Denmark,88.0,Female,Prostate,II,2010-06-15,2010-07-23,2011-05-10,Radiation,Public,,30.0,None,Yes,Never,Heavy,37.1,High,Rural,Statutory Health Insurance,17.0,Yes,,Cardiovascular Disease,8.0
PT06645,Finland,Pirkanmaa,63.0,Female,Ovarian,II,2019-08-28,2020-01-16,2021-01-05,Immunotherapy,Public,Alive,60.0,EGFR,No,Never,Moderate,28.9,Medium,Rural,NHS,10.0,No,No,None,10.0
PT06646,Italy,Sicily,57.0,,Ovarian,II,2019-06-04,2019-07-18,2020-03-16,Targeted Therapy,Private,Alive,26.0,BRCA1,No,Never,Moderate,36.2,Medium,Urban,Statutory Health Insurance,9.0,No,,None,8.0
PT06647,Germany,Bavaria,81.0,Female,Breast,III,,2014-04-01,2014-06-16,Immunotherapy,Public,Deceased,54.0,EGFR,Yes,Never,None,30.9,,,Statutory Health Insurance,13.0,No,No,Cardiovascular Disease,5.0
PT06648,Norway,Trøndelag,41.0,Female,Leukemia,I,2020-12-17,2021-01-21,2021-03-27,Chemotherapy,Public,Alive,17.0,BRCA1,No,Never,None,20.5,Medium,Urban,Private Insurance,8.0,No,Yes,Cardiovascular Disease,6.0
PT06649,Italy,Lombardy,59.0,Non-binary,Breast,II,2013-11-15,2014-03-26,2014-07-15,Surgery,Public,Alive,13.0,BRCA1,Yes,,,19.7,,Urban,Private Insurance,19.0,No,No,None,10.0
PT06650,Sweden,Stockholm,45.0,Female,Prostate,IV,2013-10-07,2014-01-26,2014-04-09,Radiation,Public,Alive,90.0,,No,,None,18.9,Medium,Rural,Private Insurance,18.0,Yes,No,Hypertension,5.0
PT06651,Norway,Oslo,24.0,Female,Pancreatic,I,2018-08-20,2019-01-11,,Immunotherapy,Public,Alive,46.0,BRCA1,No,Never,Moderate,24.3,High,Urban,Statutory Health Insurance,12.0,No,No,None,5.0
PT06652,Switzerland,Geneva,73.0,Female,Pancreatic,I,2018-05-18,2018-11-07,2019-03-03,Chemotherapy,Public,Alive,29.0,BRCA1,Yes,Never,Moderate,38.3,Medium,Rural,,14.0,Yes,No,Hypertension,3.0
PT06653,Belgium,Wallonia,68.0,Female,Prostate,I,2010-03-04,2010-07-26,2010-09-28,Targeted Therapy,Public,Alive,41.0,EGFR,No,Never,Moderate,34.5,High,Rural,NHS,18.0,No,No,,2.0
PT06654,Belgium,Flanders,22.0,Non-binary,Colorectal,I,,2017-10-22,2018-10-03,Immunotherapy,Research Institute,Deceased,7.0,None,Yes,Never,Moderate,24.8,Medium,Urban,NHS,10.0,No,No,Obesity,2.0
PT06655,Norway,Oslo,57.0,,Ovarian,I,,2021-02-07,2021-10-03,Surgery,Public,Deceased,34.0,None,No,Former,None,25.9,Low,Urban,Private Insurance,9.0,No,Yes,Hypertension,8.0
PT06656,,Andalusia,33.0,Female,Pancreatic,I,2022-09-25,2023-03-10,2023-09-21,Surgery,Public,Alive,18.0,BRCA1,No,Never,None,30.7,High,Urban,Statutory Health Insurance,19.0,Yes,No,Obesity,7.0
PT06657,Sweden,Skåne,66.0,Male,Leukemia,I,2020-07-24,2020-08-17,2021-03-14,Radiation,,Alive,94.0,KRAS,No,Never,Moderate,37.3,Low,Urban,Private Insurance,12.0,Yes,No,Diabetes,4.0
PT06658,Belgium,Flanders,33.0,Female,Prostate,II,2016-01-05,2016-07-01,2016-08-01,Chemotherapy,Public,Deceased,12.0,KRAS,Yes,Never,None,34.8,Medium,Urban,Private Insurance,8.0,No,No,Diabetes,4.0
PT06659,Portugal,Porto,57.0,Female,Pancreatic,I,,2014-07-09,2015-02-18,Targeted Therapy,Private,Lost to Follow-up,,None,No,Former,None,37.4,Medium,Rural,Private Insurance,16.0,Yes,No,Cardiovascular Disease,1.0
PT06660,Portugal,Algarve,83.0,Female,Pancreatic,III,2022-01-21,2022-03-19,2022-05-10,Targeted Therapy,Public,Alive,116.0,None,No,Never,Moderate,18.3,Medium,Urban,NHS,15.0,,No,None,4.0
PT06661,Switzerland,Zurich,63.0,Male,Lung,III,2015-01-03,2015-05-06,2015-06-30,Chemotherapy,Private,Deceased,,,No,Never,Moderate,39.5,,,Private Insurance,15.0,No,No,Obesity,1.0
PT06662,Germany,,89.0,Female,Breast,II,2010-04-08,2010-06-03,2010-08-01,Radiation,Public,Deceased,105.0,KRAS,Yes,Current,None,23.4,Medium,Urban,Statutory Health Insurance,,Yes,No,Obesity,9.0
PT06663,Austria,Vienna,84.0,Male,Pancreatic,IV,2013-08-18,2013-11-12,2014-09-12,Surgery,Public,Lost to Follow-up,,KRAS,Yes,Former,Moderate,25.2,High,Urban,Statutory Health Insurance,11.0,No,No,,8.0
PT06664,Belgium,Wallonia,44.0,Female,Pancreatic,III,2023-04-12,2023-06-17,2023-12-30,Targeted Therapy,Private,Alive,64.0,BRCA1,No,Former,Moderate,32.2,Medium,Rural,Statutory Health Insurance,4.0,No,Yes,Obesity,8.0
PT06665,Netherlands,Utrecht,35.0,Male,Lung,III,2019-06-18,2019-09-04,2020-01-01,Chemotherapy,Private,Deceased,63.0,BRCA1,No,Current,Moderate,36.0,Medium,Urban,Statutory Health Insurance,2.0,No,Yes,Hypertension,5.0
PT06666,Netherlands,South Holland,34.0,Female,Ovarian,I,2018-09-11,2018-12-12,2019-08-22,Radiation,Public,Alive,105.0,EGFR,Yes,Never,Moderate,25.5,Medium,Urban,Statutory Health Insurance,18.0,Yes,No,Obesity,5.0
PT06667,Finland,Pirkanmaa,22.0,Male,Prostate,III,,2017-06-07,2017-10-20,Surgery,Public,Alive,16.0,KRAS,,Current,Heavy,33.2,Medium,Rural,Statutory Health Insurance,4.0,Yes,No,None,6.0
PT06668,Poland,Lesser Poland,86.0,Male,Prostate,IV,2015-07-18,2015-10-28,2015-12-24,Chemotherapy,Public,Alive,34.0,KRAS,Yes,Former,Heavy,38.3,Low,Urban,NHS,10.0,No,No,None,6.0
PT06669,Norway,,56.0,Female,Lung,I,2018-03-01,2018-05-21,2018-10-24,Radiation,Private,Alive,22.0,BRCA1,No,Never,,29.9,Medium,Urban,Private Insurance,8.0,No,No,Cardiovascular Disease,4.0
PT06670,Denmark,Capital Region,74.0,Male,Lung,III,2011-11-10,2012-01-22,2012-04-21,Immunotherapy,Research Institute,Alive,18.0,None,Yes,Never,None,30.1,Low,Rural,Private Insurance,18.0,No,No,None,10.0
PT06671,Poland,Silesian,57.0,Female,,III,2013-07-29,2013-09-29,2014-04-22,Chemotherapy,Public,Alive,14.0,None,Yes,,Moderate,33.5,High,Rural,Statutory Health Insurance,11.0,No,No,None,1.0
PT06672,Norway,Oslo,82.0,Female,Breast,II,2018-06-29,2018-07-13,2018-11-14,Targeted Therapy,Public,Alive,99.0,BRCA1,No,Never,None,20.8,,Rural,NHS,7.0,No,No,None,1.0
PT06673,Germany,North Rhine-Westphalia,20.0,Non-binary,Lung,II,2014-11-25,2014-12-16,2015-04-20,Chemotherapy,Public,Alive,47.0,EGFR,No,Never,None,33.7,High,Urban,NHS,7.0,No,Yes,,6.0
PT06674,Sweden,Stockholm,38.0,Male,Breast,I,2020-11-18,2021-04-30,2021-10-17,Surgery,Public,Deceased,14.0,None,No,Current,Moderate,21.5,Medium,Urban,Private Insurance,16.0,No,No,None,4.0
PT06675,Ireland,Munster,71.0,Female,,I,2018-02-14,2018-03-16,2018-07-09,Chemotherapy,Public,Alive,26.0,KRAS,No,Never,None,39.1,Low,Rural,Private Insurance,7.0,No,No,Hypertension,6.0
PT06676,Switzerland,Zurich,49.0,Male,Leukemia,I,2017-12-06,2018-05-22,2018-10-21,Surgery,Public,Alive,83.0,KRAS,No,Never,Moderate,22.0,Low,Urban,NHS,10.0,,No,Diabetes,
PT06677,Switzerland,Geneva,74.0,Female,Prostate,II,2023-10-23,2023-11-17,2024-07-19,Radiation,Public,Alive,32.0,BRCA1,No,Former,None,28.0,High,Urban,Private Insurance,8.0,No,,Obesity,3.0
PT06678,Germany,Bavaria,33.0,Female,Lung,III,2018-10-26,2019-04-16,2019-08-31,Immunotherapy,Public,,60.0,EGFR,Yes,Former,Moderate,35.5,Medium,Rural,NHS,16.0,Yes,No,Hypertension,10.0
PT06679,Sweden,Västra Götaland,32.0,Male,Leukemia,IV,2013-01-04,2013-04-13,2013-11-07,Surgery,Private,Deceased,40.0,None,Yes,Current,,25.0,Low,Urban,Statutory Health Insurance,13.0,Yes,,None,5.0
PT06680,Belgium,Flanders,46.0,Male,Prostate,II,2023-11-26,2024-04-08,,Radiation,,,96.0,None,No,Former,Moderate,,Low,Urban,NHS,7.0,No,No,Diabetes,7.0
PT06681,,Auvergne-Rhône-Alpes,28.0,Male,Colorectal,I,2022-04-30,2022-09-08,2023-02-11,Radiation,Private,Alive,45.0,None,Yes,Former,Heavy,19.5,Low,Rural,Statutory Health Insurance,19.0,No,No,Cardiovascular Disease,10.0
PT06682,Finland,Uusimaa,60.0,,Prostate,I,2020-01-01,2020-06-13,2021-02-03,Immunotherapy,Private,Alive,94.0,EGFR,No,Former,Moderate,34.2,Low,Urban,Statutory Health Insurance,9.0,,No,Cardiovascular Disease,5.0
PT06683,Germany,Bavaria,67.0,Male,Lung,IV,2022-09-19,2023-01-09,2023-10-28,,Research Institute,Alive,17.0,None,No,Current,Moderate,20.3,Low,Urban,NHS,4.0,No,No,Cardiovascular Disease,1.0
PT06684,Germany,Bavaria,31.0,Female,Leukemia,II,2014-07-29,2014-11-17,2015-02-21,Targeted Therapy,Public,,77.0,KRAS,No,Never,Heavy,34.0,Medium,Urban,Private Insurance,19.0,No,No,None,7.0
PT06685,Denmark,Central Denmark,29.0,Female,Leukemia,III,2018-10-08,2019-02-14,2019-07-31,Chemotherapy,Public,Alive,34.0,EGFR,Yes,Current,None,20.7,Medium,Urban,NHS,7.0,No,No,None,3.0
PT06686,Sweden,Västra Götaland,25.0,Non-binary,Leukemia,I,2011-05-28,2011-11-06,2012-07-17,Targeted Therapy,Public,Deceased,10.0,BRCA1,No,Never,None,20.9,Medium,Rural,Private Insurance,15.0,No,No,None,1.0
PT06687,Netherlands,North Holland,53.0,Female,Prostate,II,2012-12-19,2013-02-22,2013-05-23,Chemotherapy,Public,Alive,65.0,EGFR,Yes,Former,None,34.0,Medium,Urban,Private Insurance,,No,No,None,3.0
PT06688,Ireland,Munster,71.0,Male,Breast,,2023-09-07,2023-10-03,2024-02-11,Surgery,Private,Alive,107.0,None,Yes,Former,Moderate,25.2,Medium,Urban,NHS,10.0,No,No,None,6.0
PT06689,Portugal,Lisbon,60.0,Female,Ovarian,I,2015-02-06,2015-02-24,2016-01-12,Surgery,Public,Deceased,24.0,KRAS,No,Former,Moderate,24.5,High,Urban,Private Insurance,9.0,No,,Hypertension,2.0
PT06690,Denmark,Zealand,25.0,Female,Breast,III,2019-11-24,2020-05-06,2020-06-19,Chemotherapy,Public,Alive,40.0,,,Never,Moderate,24.4,Medium,Rural,Statutory Health Insurance,2.0,No,No,Cardiovascular Disease,1.0
PT06691,Netherlands,,21.0,Female,Prostate,II,2014-12-05,2015-04-18,2015-07-06,Immunotherapy,Private,Alive,51.0,BRCA1,Yes,Former,None,30.9,Medium,Urban,Private Insurance,11.0,No,No,None,5.0
PT06692,Belgium,Brussels,,Male,Lung,II,2020-11-02,2021-04-23,2022-02-06,Immunotherapy,Private,Alive,51.0,EGFR,Yes,Former,None,29.1,Medium,Rural,Private Insurance,2.0,No,No,None,4.0
PT06693,Germany,Bavaria,36.0,Male,Prostate,III,2021-03-26,2021-05-05,2021-09-12,Targeted Therapy,Private,Alive,50.0,KRAS,No,Current,Moderate,19.7,High,Rural,Statutory Health Insurance,9.0,Yes,No,Cardiovascular Disease,1.0
PT06694,Switzerland,Bern,35.0,,,II,2023-10-04,2023-11-03,2023-12-12,Surgery,Public,Alive,44.0,KRAS,Yes,,None,32.3,High,Urban,NHS,19.0,Yes,No,Diabetes,4.0
PT06695,Spain,Catalonia,47.0,,Prostate,I,2020-12-22,2021-03-10,2021-12-08,Surgery,Private,Alive,46.0,BRCA1,Yes,Never,None,34.6,Low,Rural,Statutory Health Insurance,7.0,No,No,Cardiovascular Disease,7.0
PT06696,Ireland,Dublin,29.0,Male,Leukemia,IV,2015-05-31,2015-08-13,2016-01-12,Immunotherapy,Public,Alive,116.0,None,No,Former,Moderate,21.5,High,Urban,Statutory Health Insurance,6.0,No,No,Hypertension,8.0
PT06697,Netherlands,South Holland,29.0,Female,Lung,I,,2013-04-04,2013-09-30,Radiation,Public,Alive,116.0,EGFR,No,Former,None,23.1,Low,Rural,Statutory Health Insurance,10.0,No,Yes,Hypertension,6.0
PT06698,Norway,Vestland,29.0,Female,Ovarian,III,2013-12-28,2014-06-10,2014-12-15,Immunotherapy,Public,Alive,94.0,,No,Never,Heavy,35.5,High,Urban,NHS,12.0,No,Yes,Obesity,7.0
,Italy,Lombardy,47.0,Female,Lung,III,2011-10-16,,2012-10-11,Immunotherapy,Public,Deceased,23.0,BRCA1,No,Never,None,,High,Urban,NHS,4.0,No,No,Cardiovascular Disease,3.0
PT06700,Ireland,Munster,43.0,Female,Colorectal,I,2020-05-21,2020-10-26,2021-10-22,Radiation,Public,Deceased,64.0,EGFR,Yes,Never,Moderate,25.2,Medium,Urban,NHS,19.0,No,No,Cardiovascular Disease,
PT06701,Italy,Lombardy,38.0,Male,Ovarian,II,2011-04-28,2011-06-15,2012-01-31,Targeted Therapy,Public,Alive,92.0,BRCA1,Yes,Never,Moderate,25.2,Medium,Urban,NHS,,No,No,Cardiovascular Disease,2.0
PT06702,,Munster,87.0,Female,Prostate,I,2014-07-19,2014-10-05,2015-08-14,Chemotherapy,Public,Deceased,109.0,BRCA1,No,Never,None,39.3,Low,Rural,,,No,No,None,3.0
PT06703,Poland,Silesian,75.0,Female,Pancreatic,II,2016-12-13,2017-04-03,2017-08-08,Targeted Therapy,Public,Deceased,35.0,None,Yes,Never,Heavy,27.1,High,Urban,NHS,15.0,Yes,No,Obesity,8.0
PT06704,Switzerland,Zurich,86.0,,Pancreatic,III,2019-04-16,2019-07-12,2020-03-19,Radiation,Research Institute,Alive,70.0,BRCA1,Yes,Never,Moderate,34.0,Low,Urban,Statutory Health Insurance,12.0,Yes,No,Diabetes,3.0
PT06705,Ireland,Connacht,61.0,Female,Ovarian,I,2012-08-08,2012-08-25,2013-04-19,Radiation,Public,Alive,95.0,EGFR,No,Current,None,23.2,Medium,,NHS,8.0,No,No,,9.0
PT06706,France,Île-de-France,31.0,Male,Ovarian,I,2011-02-16,2011-03-15,2012-01-13,,Public,,,KRAS,No,Never,None,28.4,Medium,Rural,NHS,13.0,No,No,Obesity,4.0
PT06707,Poland,Lesser Poland,37.0,Female,Ovarian,II,2010-12-20,2011-04-07,2012-04-04,Chemotherapy,Public,Deceased,89.0,EGFR,Yes,Never,None,38.3,High,Rural,Statutory Health Insurance,14.0,No,Yes,Cardiovascular Disease,4.0
,Poland,Lesser Poland,42.0,Male,Pancreatic,II,2016-10-15,2017-02-18,2017-05-05,Targeted Therapy,Public,Alive,110.0,EGFR,Yes,Former,Moderate,19.6,Medium,Urban,Private Insurance,12.0,No,No,None,6.0
PT06709,Netherlands,North Holland,25.0,Male,Leukemia,III,,2021-08-11,2022-01-02,Surgery,Public,Deceased,46.0,BRCA1,Yes,Never,,19.9,Medium,,NHS,14.0,No,No,Cardiovascular Disease,2.0
PT06710,Italy,Lombardy,72.0,Male,,III,2021-03-04,2021-08-05,2022-03-06,Surgery,Private,Alive,90.0,None,No,Never,Moderate,32.7,Low,Rural,NHS,,No,No,Obesity,1.0
PT06711,Austria,Tyrol,61.0,Female,Prostate,III,2021-07-28,2022-01-15,2022-02-24,Surgery,Private,Alive,60.0,EGFR,,Current,Moderate,19.3,Medium,Rural,Statutory Health Insurance,9.0,Yes,No,None,2.0
PT06712,Sweden,Stockholm,85.0,Male,Colorectal,III,2013-01-03,,2013-08-26,Chemotherapy,Research Institute,Deceased,64.0,KRAS,Yes,Never,None,28.0,Medium,Urban,Private Insurance,14.0,Yes,No,Diabetes,
PT06713,Germany,Berlin,49.0,Female,Colorectal,,2013-09-09,2013-10-03,2014-09-27,Chemotherapy,Public,Alive,50.0,EGFR,No,Never,None,27.9,High,Urban,Private Insurance,16.0,No,No,Diabetes,5.0
PT06714,Spain,Catalonia,28.0,Male,,II,2019-09-20,2020-02-15,2020-10-22,Radiation,Public,Alive,89.0,BRCA1,No,Former,Moderate,23.1,Medium,Urban,Private Insurance,10.0,No,No,Hypertension,5.0
PT06715,Netherlands,South Holland,61.0,Female,Pancreatic,II,2015-05-28,2015-06-05,2015-08-27,Immunotherapy,Private,Alive,72.0,BRCA1,No,Never,None,30.6,Medium,Rural,Statutory Health Insurance,5.0,Yes,No,None,1.0
PT06716,Finland,Uusimaa,53.0,Female,Prostate,IV,2012-10-20,2012-11-19,2013-02-15,Chemotherapy,Public,Deceased,22.0,BRCA1,No,Current,None,31.5,,Urban,Private Insurance,10.0,Yes,No,None,3.0
PT06717,Spain,Madrid,59.0,Male,Ovarian,II,2021-08-26,2021-12-30,2022-08-09,Immunotherapy,Private,Deceased,96.0,,Yes,Never,Moderate,19.9,Low,Urban,NHS,10.0,,No,Obesity,1.0
PT06718,France,,,Male,Ovarian,IV,2020-07-22,2020-08-09,2020-10-09,Surgery,Public,Alive,87.0,,No,Never,,,,Urban,NHS,17.0,No,No,Cardiovascular Disease,2.0
PT06719,Norway,Oslo,48.0,Female,Prostate,III,2013-11-19,,2014-07-29,Surgery,Public,Alive,108.0,EGFR,No,,Moderate,37.0,Medium,Urban,Private Insurance,,Yes,No,Obesity,10.0
PT06720,Austria,,69.0,Male,Ovarian,III,2022-03-10,2022-07-10,2022-12-18,Immunotherapy,Research Institute,Alive,79.0,EGFR,No,Current,None,26.8,Medium,,Private Insurance,18.0,No,No,None,3.0
PT06721,Portugal,Porto,68.0,Female,Breast,,2012-11-21,2013-03-27,2013-11-19,Targeted Therapy,Public,Alive,,EGFR,Yes,Former,Moderate,18.3,Medium,Rural,NHS,13.0,,No,Cardiovascular Disease,5.0
PT06722,Sweden,Skåne,80.0,Female,Colorectal,II,2018-01-15,2018-05-06,2019-01-03,Radiation,Public,Alive,28.0,EGFR,No,Never,None,29.2,Medium,Urban,NHS,3.0,No,Yes,Diabetes,8.0
PT06723,Germany,Bavaria,65.0,Male,Lung,II,2016-12-05,2017-02-26,2017-09-22,Radiation,Public,Lost to Follow-up,,EGFR,Yes,Never,Moderate,18.5,Medium,Rural,Statutory Health Insurance,4.0,Yes,Yes,None,1.0
PT06724,France,Auvergne-Rhône-Alpes,65.0,Male,Pancreatic,I,2015-03-25,2015-08-13,2016-07-17,Targeted Therapy,Public,Alive,,,,Never,None,38.0,Low,Rural,Private Insurance,12.0,No,Yes,Cardiovascular Disease,1.0
PT06725,Sweden,Stockholm,36.0,Male,Pancreatic,IV,2014-07-06,2014-12-29,2015-06-02,Immunotherapy,Research Institute,Alive,13.0,BRCA1,Yes,Former,Heavy,27.8,,Urban,Statutory Health Insurance,12.0,Yes,No,Hypertension,4.0
PT06726,Netherlands,Utrecht,85.0,Male,Breast,III,2017-09-21,2018-02-22,2018-08-08,Immunotherapy,,,108.0,None,No,Never,None,18.4,High,Urban,Statutory Health Insurance,12.0,,,Diabetes,1.0
PT06727,France,Auvergne-Rhône-Alpes,24.0,Male,Leukemia,III,2012-05-06,2012-09-07,2013-06-08,Chemotherapy,Public,Alive,106.0,EGFR,Yes,,Moderate,28.5,Medium,Urban,Statutory Health Insurance,,No,No,Obesity,4.0
PT06728,Ireland,Connacht,73.0,Male,Lung,II,2023-05-24,2023-10-08,2024-05-17,Surgery,Public,Alive,70.0,EGFR,No,Current,Moderate,30.7,Medium,Urban,Statutory Health Insurance,13.0,No,No,Hypertension,5.0
PT06729,Austria,Styria,35.0,Male,Lung,I,2018-03-29,2018-07-05,2019-05-05,Surgery,Public,Alive,65.0,KRAS,No,Former,Moderate,37.9,Low,Rural,Statutory Health Insurance,5.0,No,No,None,7.0
PT06730,Norway,Vestland,,Male,Lung,III,2012-03-12,2012-05-04,2012-10-15,Immunotherapy,,Alive,12.0,None,No,Current,,23.0,Medium,Urban,Statutory Health Insurance,9.0,No,No,None,3.0
PT06731,Norway,Vestland,27.0,Non-binary,Ovarian,II,2010-12-08,2011-03-13,,Chemotherapy,Private,Alive,9.0,KRAS,No,Never,Moderate,30.6,Medium,Rural,NHS,8.0,No,No,,7.0
PT06732,Denmark,Zealand,57.0,Female,Colorectal,IV,2022-04-29,2022-08-29,2022-11-04,Chemotherapy,Public,Alive,33.0,BRCA1,Yes,Former,Moderate,29.7,Medium,Urban,Statutory Health Insurance,5.0,No,No,,8.0
,Poland,Masovian,73.0,Female,Leukemia,III,2013-10-28,2014-02-11,2014-07-25,,Public,Alive,24.0,None,No,Former,Moderate,20.4,Medium,Urban,Private Insurance,12.0,Yes,No,None,3.0
PT06734,Italy,Lombardy,34.0,Male,Breast,I,2013-08-02,2013-10-12,2014-07-03,Radiation,Private,Deceased,11.0,KRAS,No,Never,Moderate,39.2,Low,Urban,NHS,12.0,No,No,Cardiovascular Disease,9.0
PT06735,Poland,Silesian,69.0,Male,Ovarian,III,2011-07-31,2011-12-15,2012-03-20,Immunotherapy,Public,Lost to Follow-up,,BRCA1,No,Former,Moderate,24.8,,Urban,NHS,16.0,No,No,None,8.0
PT06736,Ireland,Munster,75.0,Female,Leukemia,III,2021-10-26,2022-02-07,2022-05-22,Radiation,Private,Deceased,31.0,KRAS,No,Never,Moderate,33.9,Medium,Rural,Statutory Health Insurance,14.0,No,No,None,2.0
PT06737,,Central Denmark,28.0,Female,Pancreatic,II,2021-01-11,2021-06-14,2022-04-03,Chemotherapy,Private,Lost to Follow-up,,KRAS,No,Former,,35.3,Low,Rural,Private Insurance,12.0,No,No,Diabetes,9.0
PT06738,Denmark,,27.0,Male,Breast,II,2016-01-04,2016-04-28,2016-08-25,Targeted Therapy,Research Institute,Alive,45.0,None,Yes,Former,Moderate,33.2,Low,Urban,NHS,6.0,No,No,Obesity,1.0
PT06739,Austria,Styria,,Male,Ovarian,I,2021-02-02,2021-07-13,2021-11-21,Surgery,Public,Alive,106.0,KRAS,No,Never,Moderate,20.6,Medium,Urban,Private Insurance,,No,Yes,Cardiovascular Disease,1.0
PT06740,Poland,Silesian,70.0,Female,Colorectal,I,2013-04-18,2013-09-26,2013-10-28,Immunotherapy,Public,Alive,24.0,None,Yes,Never,Moderate,26.3,Medium,Urban,,18.0,No,No,Hypertension,9.0
PT06741,Switzerland,Bern,76.0,Female,Pancreatic,III,2011-05-06,2011-09-04,2012-01-04,Radiation,Public,Deceased,86.0,EGFR,No,Former,Moderate,36.2,High,,NHS,2.0,No,Yes,Cardiovascular Disease,3.0
PT06742,Ireland,Connacht,87.0,Male,,I,2023-12-25,2024-06-10,2024-07-21,Radiation,Public,Alive,98.0,KRAS,No,Never,Moderate,36.1,Medium,Rural,NHS,10.0,No,No,Diabetes,8.0
PT06743,,Central Denmark,50.0,Female,Lung,III,2015-10-30,,,Chemotherapy,Research Institute,Deceased,118.0,EGFR,Yes,Former,None,23.4,Medium,Urban,NHS,6.0,Yes,,Hypertension,3.0
PT06744,France,,22.0,Female,Leukemia,II,2023-08-06,2024-01-09,2024-07-27,Radiation,Public,Alive,26.0,BRCA1,No,Former,Moderate,29.8,Medium,Urban,Private Insurance,14.0,No,No,None,8.0
PT06745,Germany,,,Non-binary,Pancreatic,IV,2016-10-17,2016-12-10,2017-08-30,Surgery,Public,Alive,10.0,KRAS,No,,Moderate,36.1,High,Urban,Private Insurance,4.0,Yes,No,Hypertension,8.0
PT06746,Austria,Styria,48.0,Female,Ovarian,IV,2019-03-15,2019-06-21,2020-05-19,Immunotherapy,,Deceased,22.0,EGFR,Yes,Never,None,31.5,Medium,Rural,Statutory Health Insurance,14.0,No,No,Hypertension,8.0
PT06747,,North Holland,29.0,Male,Ovarian,III,2012-01-10,2012-02-28,2012-05-12,Radiation,Private,Alive,43.0,BRCA1,No,Former,Moderate,22.7,High,Urban,NHS,11.0,No,No,Hypertension,6.0
PT06748,Norway,Vestland,31.0,Female,Colorectal,II,2011-05-25,2011-09-06,2011-10-30,Targeted Therapy,Private,Alive,67.0,BRCA1,No,Former,None,35.6,Medium,Urban,NHS,11.0,No,Yes,None,10.0
PT06749,Finland,Pirkanmaa,65.0,,Colorectal,II,2011-08-17,2011-12-07,2012-01-09,Targeted Therapy,Private,Lost to Follow-up,,None,No,Former,Moderate,36.3,Low,Urban,,9.0,Yes,,None,2.0
PT06750,Netherlands,North Holland,49.0,Female,Colorectal,I,2016-12-02,2017-04-15,2017-12-30,Immunotherapy,Public,Deceased,110.0,EGFR,No,Former,None,38.2,Medium,Urban,NHS,9.0,No,Yes,,3.0
PT06751,Poland,Lesser Poland,51.0,Female,Breast,I,2020-01-16,2020-02-18,2020-09-29,Targeted Therapy,Private,,45.0,BRCA1,No,Never,Moderate,36.4,High,Rural,Statutory Health Insurance,11.0,Yes,,None,6.0
PT06752,Belgium,Flanders,66.0,Female,Leukemia,II,2012-01-25,2012-06-06,2012-12-08,Targeted Therapy,Public,Lost to Follow-up,,EGFR,No,Never,Moderate,31.9,Medium,Urban,NHS,1.0,No,No,None,7.0
PT06753,Denmark,Zealand,82.0,Male,,III,2014-01-02,2014-05-28,2014-10-14,,Private,Deceased,12.0,KRAS,No,Former,None,28.2,Medium,Urban,NHS,11.0,No,No,Obesity,9.0
PT06754,,Geneva,45.0,Male,Ovarian,I,2021-02-11,2021-06-22,2022-01-02,Targeted Therapy,Public,Alive,32.0,None,No,,None,40.0,Low,Rural,Private Insurance,17.0,No,No,Cardiovascular Disease,8.0
PT06755,Poland,Silesian,22.0,Female,Lung,II,2022-02-28,2022-06-06,2023-05-30,Radiation,Public,Lost to Follow-up,,BRCA1,Yes,Never,Moderate,39.6,Medium,Urban,NHS,4.0,Yes,No,Obesity,1.0
,Germany,North Rhine-Westphalia,42.0,Male,Prostate,II,2018-03-22,2018-07-22,2018-10-20,Surgery,,,36.0,None,No,Never,Moderate,28.5,Medium,Rural,Statutory Health Insurance,8.0,,Yes,Hypertension,4.0
,Norway,Vestland,69.0,Male,Colorectal,IV,2010-04-15,2010-04-17,2010-12-11,Chemotherapy,Private,Alive,103.0,EGFR,Yes,Current,None,34.7,Medium,Urban,Private Insurance,16.0,No,No,Obesity,6.0
PT06758,Belgium,Flanders,55.0,Male,Pancreatic,I,2014-05-12,2014-07-16,2014-12-17,Radiation,Public,Deceased,67.0,EGFR,Yes,Never,Moderate,25.4,Medium,Urban,Private Insurance,17.0,No,No,Cardiovascular Disease,8.0
PT06759,Switzerland,Zurich,32.0,Female,Lung,I,2023-05-16,2023-06-20,2024-05-21,Chemotherapy,Public,Alive,31.0,BRCA1,Yes,Current,,22.3,Medium,Urban,Statutory Health Insurance,3.0,No,No,Diabetes,10.0
PT06760,Austria,Styria,48.0,Male,Colorectal,IV,2020-04-10,2020-10-06,2021-08-18,Radiation,Research Institute,Alive,75.0,None,Yes,Never,None,38.0,Medium,Rural,,6.0,No,No,Diabetes,5.0
PT06761,Portugal,Porto,57.0,Female,Lung,I,2020-06-19,2020-08-26,,Radiation,Public,Alive,36.0,EGFR,No,Former,None,18.9,Low,Urban,NHS,3.0,Yes,No,Hypertension,7.0
PT06762,Portugal,Porto,24.0,Male,Leukemia,III,2017-10-13,2017-11-17,2018-07-13,Immunotherapy,Research Institute,Alive,17.0,KRAS,No,Never,Moderate,34.3,High,Rural,Private Insurance,18.0,No,Yes,Obesity,6.0
PT06763,Norway,Vestland,,Male,Prostate,III,2011-01-28,2011-04-10,2011-12-29,Radiation,Public,Alive,20.0,KRAS,No,Never,Moderate,36.6,Low,Urban,NHS,1.0,No,No,Hypertension,6.0
PT06764,,Lombardy,33.0,Male,Colorectal,II,2015-07-26,2016-01-14,2016-03-26,Targeted Therapy,Public,Alive,63.0,EGFR,Yes,Never,,33.9,Low,Rural,Statutory Health Insurance,1.0,No,Yes,Cardiovascular Disease,2.0
PT06765,,North Rhine-Westphalia,27.0,Male,Breast,II,2023-08-17,2023-09-15,,Targeted Therapy,Private,Alive,6.0,EGFR,No,Current,Moderate,37.4,Low,Urban,Statutory Health Insurance,10.0,,No,Obesity,7.0
PT06766,Austria,Tyrol,67.0,Female,Breast,IV,2021-10-23,2022-04-05,2023-01-10,Radiation,Public,Alive,67.0,BRCA1,No,Former,Moderate,24.0,Medium,Urban,Private Insurance,1.0,No,No,Cardiovascular Disease,6.0
PT06767,Austria,Vienna,32.0,Female,Lung,I,2016-01-10,2016-03-28,2016-10-10,Surgery,Public,Alive,64.0,KRAS,No,Current,None,35.3,High,Rural,Private Insurance,5.0,No,No,Diabetes,10.0
PT06768,Netherlands,,43.0,Female,Ovarian,I,2011-11-21,2012-01-02,2012-08-11,,Private,Alive,95.0,KRAS,Yes,Former,,33.7,Low,Urban,Private Insurance,13.0,No,No,Cardiovascular Disease,3.0
PT06769,Ireland,Dublin,84.0,Male,Leukemia,II,2023-03-01,2023-06-22,2023-09-26,Chemotherapy,Public,Deceased,42.0,EGFR,No,Former,None,39.7,Low,Urban,Statutory Health Insurance,15.0,No,No,Hypertension,5.0
PT06770,Italy,Lombardy,53.0,Female,Pancreatic,II,2014-07-19,2014-10-21,2015-06-14,Surgery,Private,Deceased,11.0,,No,Former,Moderate,38.1,Medium,Urban,Private Insurance,12.0,No,No,None,7.0
PT06771,Portugal,Porto,70.0,Male,Ovarian,II,2020-04-04,2020-07-27,2021-07-15,Chemotherapy,Public,Alive,29.0,EGFR,No,Never,None,19.4,Low,Urban,,9.0,,Yes,None,10.0
PT06772,Germany,Bavaria,22.0,Male,Colorectal,IV,2020-11-06,2020-11-13,2021-01-17,Radiation,Public,Alive,52.0,EGFR,No,Never,Moderate,20.9,Medium,Urban,NHS,11.0,,No,Obesity,8.0
PT06773,Poland,Lesser Poland,77.0,Female,Prostate,IV,2013-11-03,2014-03-24,2015-02-02,Radiation,Public,,69.0,None,Yes,Never,Moderate,40.0,Low,Urban,Private Insurance,8.0,,No,,8.0
PT06774,Austria,Tyrol,74.0,Female,,I,2023-10-17,2023-11-08,2024-09-11,Radiation,Private,Deceased,41.0,None,No,Never,Moderate,31.5,Medium,Urban,Statutory Health Insurance,4.0,No,No,Diabetes,5.0
PT06775,France,Auvergne-Rhône-Alpes,61.0,Male,Lung,II,2017-04-26,2017-06-22,2018-01-12,Targeted Therapy,Private,Deceased,113.0,BRCA1,No,Never,Moderate,20.1,Medium,,NHS,3.0,No,No,Obesity,10.0
,Finland,Southwest Finland,40.0,Male,Leukemia,I,2020-09-29,2021-03-21,2021-04-30,Surgery,Public,Alive,88.0,,Yes,Former,None,25.2,Low,Urban,NHS,12.0,Yes,No,None,1.0
PT06777,Spain,Catalonia,29.0,Female,Prostate,IV,2021-06-19,2021-06-21,2021-08-08,Chemotherapy,Public,Lost to Follow-up,,None,No,Current,None,26.4,Medium,Urban,Statutory Health Insurance,5.0,No,No,Diabetes,6.0
PT06778,Italy,Lombardy,76.0,Male,Leukemia,II,2018-11-27,2019-01-23,2019-08-30,Immunotherapy,Public,Alive,61.0,EGFR,Yes,Former,Moderate,19.6,,Rural,Statutory Health Insurance,5.0,Yes,Yes,Hypertension,10.0
PT06779,Denmark,Zealand,44.0,Female,Colorectal,II,2019-03-04,2019-06-30,2019-10-09,Surgery,Private,Alive,87.0,KRAS,Yes,Former,Moderate,31.7,Low,Urban,Statutory Health Insurance,2.0,No,No,Obesity,9.0
PT06780,Switzerland,,75.0,Non-binary,Lung,III,2019-02-13,2019-05-08,2020-03-31,Chemotherapy,Public,,107.0,EGFR,Yes,Never,Moderate,38.8,High,Urban,NHS,11.0,No,No,,1.0
PT06781,Belgium,Wallonia,57.0,Female,Prostate,II,2016-06-07,,2016-12-03,Immunotherapy,Public,Alive,85.0,KRAS,No,Never,Moderate,33.5,Medium,Urban,Statutory Health Insurance,8.0,No,No,Diabetes,1.0
PT06782,Switzerland,Bern,80.0,Male,Lung,I,2022-07-20,2022-08-23,2023-02-05,Surgery,Research Institute,Alive,22.0,EGFR,No,Current,Moderate,36.9,Low,Urban,Private Insurance,,No,No,None,10.0
PT06783,Sweden,Västra Götaland,66.0,Female,Pancreatic,,2020-06-22,2020-08-05,2021-04-29,Surgery,Research Institute,Alive,,BRCA1,Yes,Never,,38.3,Low,Urban,Statutory Health Insurance,4.0,No,,Obesity,1.0
PT06784,Netherlands,South Holland,73.0,Male,Colorectal,III,2022-07-16,2022-09-23,2023-07-30,Radiation,Public,Alive,9.0,KRAS,No,Former,Moderate,,Medium,Rural,Statutory Health Insurance,5.0,No,No,,9.0
PT06785,Austria,Styria,,Male,Prostate,III,2022-12-27,,2023-12-31,Surgery,Private,Lost to Follow-up,,EGFR,Yes,Current,None,35.8,Medium,Rural,Private Insurance,11.0,No,No,None,3.0
PT06786,Spain,Catalonia,87.0,Female,Pancreatic,III,2011-07-05,2011-10-07,2012-03-25,Chemotherapy,Public,,85.0,EGFR,No,,None,29.4,Low,Urban,NHS,1.0,No,No,Cardiovascular Disease,9.0
PT06787,Portugal,Algarve,23.0,Male,Pancreatic,I,2015-04-29,2015-06-01,2016-05-16,Radiation,Public,Alive,14.0,EGFR,No,Former,Heavy,19.5,Low,Urban,Statutory Health Insurance,12.0,No,No,Obesity,
PT06788,Spain,Madrid,85.0,Male,Pancreatic,II,2010-10-30,2011-01-14,2011-07-20,Surgery,Private,Deceased,92.0,EGFR,Yes,Current,Moderate,19.2,Low,,NHS,13.0,No,Yes,,5.0
PT06789,,North Holland,62.0,Female,Prostate,III,2011-02-22,2011-05-02,2011-12-18,Radiation,Public,Deceased,79.0,KRAS,No,Never,Moderate,34.8,Medium,Rural,NHS,16.0,No,No,Cardiovascular Disease,6.0
PT06790,Portugal,Porto,81.0,Female,Lung,IV,2015-10-17,2016-02-23,,Immunotherapy,Public,Deceased,95.0,EGFR,Yes,Never,Moderate,23.6,Medium,Urban,,7.0,,No,Hypertension,9.0
PT06791,Austria,Tyrol,23.0,Male,Leukemia,I,2015-10-06,2016-03-17,2016-07-19,Chemotherapy,Private,Alive,114.0,None,No,Current,,27.0,Medium,Urban,Statutory Health Insurance,13.0,Yes,No,Diabetes,2.0
PT06792,Poland,Silesian,84.0,Male,Leukemia,I,2021-10-06,2021-10-31,2022-08-30,Immunotherapy,Public,Alive,105.0,EGFR,No,Current,None,35.7,Medium,Urban,Private Insurance,12.0,,No,Cardiovascular Disease,6.0
PT06793,Denmark,Central Denmark,81.0,Male,Pancreatic,III,2017-03-31,2017-08-10,2018-01-17,Chemotherapy,Public,Deceased,115.0,None,,Never,Heavy,31.6,Medium,Urban,Statutory Health Insurance,16.0,Yes,No,Hypertension,2.0
PT06794,Belgium,,21.0,Male,Breast,II,2012-04-09,2012-06-21,2013-03-24,Targeted Therapy,Public,Alive,44.0,None,Yes,Never,None,35.6,Low,Urban,Statutory Health Insurance,13.0,Yes,No,Hypertension,
PT06795,Netherlands,South Holland,28.0,Female,Breast,I,2018-07-08,2018-11-03,2019-01-06,Immunotherapy,Public,Alive,72.0,EGFR,Yes,Former,None,30.1,Low,Urban,Private Insurance,3.0,No,No,None,5.0
PT06796,Germany,Berlin,76.0,Female,Prostate,II,2013-02-11,2013-06-04,2013-11-12,Targeted Therapy,Private,,89.0,KRAS,Yes,Never,Heavy,22.5,Medium,Urban,Private Insurance,6.0,No,No,Obesity,3.0
PT06797,Switzerland,Bern,64.0,Female,Lung,IV,2014-10-06,2015-01-29,2015-12-21,Radiation,Public,,86.0,BRCA1,Yes,Never,,35.2,Medium,,Private Insurance,8.0,Yes,Yes,,3.0
PT06798,Italy,Lombardy,37.0,Male,Prostate,III,2015-12-23,2016-04-26,2017-04-25,Immunotherapy,Public,Alive,115.0,BRCA1,No,Current,None,33.5,High,Rural,NHS,19.0,No,,Diabetes,3.0
PT06799,Poland,Masovian,67.0,Male,Lung,II,2017-12-20,2018-03-24,2018-08-14,Surgery,Public,Deceased,52.0,None,Yes,Former,Moderate,29.1,Medium,Rural,,7.0,Yes,No,None,6.0
PT06800,Poland,Silesian,61.0,Male,Colorectal,III,,2023-09-06,2024-01-03,Chemotherapy,Public,Alive,33.0,None,No,Former,Moderate,30.3,Medium,Urban,Statutory Health Insurance,13.0,No,No,Hypertension,2.0
PT06801,Denmark,,60.0,,Breast,I,2021-02-06,2021-06-24,2022-03-03,Surgery,Public,Alive,6.0,,,Former,Moderate,19.2,Medium,Rural,Statutory Health Insurance,12.0,No,No,Diabetes,3.0
PT06802,Norway,Vestland,77.0,Male,Prostate,II,2023-10-25,2024-03-21,2025-01-30,Surgery,Public,Alive,41.0,EGFR,No,Former,Moderate,33.6,Medium,Urban,Statutory Health Insurance,12.0,No,No,Diabetes,1.0
PT06803,,Oslo,61.0,Male,Ovarian,II,2017-03-27,2017-05-06,2017-08-30,,Public,Alive,94.0,BRCA1,No,Current,Moderate,34.4,Low,Rural,Private Insurance,5.0,No,No,Obesity,9.0
PT06804,Denmark,Zealand,54.0,Male,Colorectal,II,2012-02-26,2012-05-11,2013-01-17,Radiation,Private,Alive,102.0,BRCA1,Yes,Former,None,32.7,Medium,Rural,Statutory Health Insurance,11.0,No,No,Diabetes,5.0
PT06805,Austria,Styria,57.0,Female,Leukemia,IV,2016-12-24,2017-01-08,2017-10-31,Surgery,Research Institute,Alive,55.0,BRCA1,Yes,Never,None,27.8,High,Rural,NHS,12.0,No,No,Diabetes,2.0
PT06806,Spain,Andalusia,86.0,Female,Breast,I,2018-11-21,2019-03-17,2019-05-18,Surgery,Private,Alive,90.0,None,No,Never,None,,High,Rural,,10.0,,No,Diabetes,1.0
PT06807,Spain,Catalonia,60.0,Female,Lung,I,2021-09-06,2022-02-09,,Surgery,Public,Deceased,99.0,None,No,Never,,32.3,Medium,Urban,Statutory Health Insurance,16.0,No,No,Obesity,3.0
PT06808,Denmark,,69.0,Male,Pancreatic,IV,2016-10-03,2017-01-19,2017-10-13,Chemotherapy,Private,Alive,82.0,BRCA1,No,Never,None,34.7,Medium,Urban,NHS,10.0,No,No,None,
PT06809,,Uusimaa,,Female,Leukemia,I,2019-11-18,2019-12-23,2020-01-26,,Private,Alive,44.0,KRAS,Yes,,Moderate,26.2,Low,Urban,Statutory Health Insurance,4.0,No,Yes,Obesity,9.0
PT06810,Ireland,Dublin,38.0,Non-binary,Leukemia,II,2015-08-31,2015-09-07,2016-04-10,Immunotherapy,Public,,55.0,EGFR,Yes,Former,None,27.0,Low,Urban,Private Insurance,1.0,No,No,Hypertension,10.0
PT06811,Finland,Pirkanmaa,36.0,Male,Colorectal,II,2016-05-26,2016-11-12,2017-08-16,Radiation,Public,Alive,,BRCA1,Yes,Never,Moderate,21.8,Medium,Urban,Private Insurance,7.0,No,Yes,Obesity,8.0
PT06812,Portugal,Porto,84.0,Female,Ovarian,IV,2017-04-23,2017-05-31,2017-10-06,Surgery,Public,Alive,58.0,KRAS,No,Current,None,32.2,High,Urban,Statutory Health Insurance,15.0,No,No,Diabetes,10.0
,Ireland,Connacht,75.0,Female,Prostate,II,2014-12-22,2015-02-24,2015-05-15,Immunotherapy,Public,Deceased,11.0,KRAS,No,Never,Moderate,35.1,Medium,Urban,NHS,3.0,No,Yes,Obesity,3.0
PT06814,Norway,Trøndelag,60.0,Female,Pancreatic,II,2015-11-25,2016-01-21,2016-04-24,Immunotherapy,Public,Alive,88.0,KRAS,No,Never,Moderate,31.2,Medium,Urban,NHS,11.0,No,Yes,Obesity,5.0
PT06815,Portugal,Lisbon,61.0,Male,Prostate,II,2014-12-08,2015-03-26,2015-11-06,Immunotherapy,Public,Alive,15.0,BRCA1,Yes,Never,None,32.2,Medium,Urban,Statutory Health Insurance,5.0,No,No,Hypertension,1.0
,Austria,Styria,25.0,Male,Colorectal,IV,2014-12-16,2015-05-22,2015-08-17,Radiation,Public,Alive,21.0,None,No,Never,None,37.2,Medium,Urban,Private Insurance,15.0,No,No,None,7.0
PT06817,,South Holland,88.0,Female,Leukemia,III,2018-03-12,2018-07-14,2019-02-04,Surgery,Private,Deceased,82.0,KRAS,No,Never,None,38.2,Low,Urban,Statutory Health Insurance,4.0,No,No,Diabetes,2.0
PT06818,Norway,Trøndelag,59.0,Male,Breast,I,2015-04-06,2015-06-28,2016-01-29,Surgery,Public,Deceased,27.0,EGFR,Yes,Never,Moderate,32.9,Medium,Rural,Private Insurance,7.0,No,Yes,Diabetes,
PT06819,Finland,Uusimaa,60.0,Female,Leukemia,III,2022-11-30,2023-04-13,2023-10-24,Targeted Therapy,Public,Deceased,71.0,EGFR,Yes,Never,Moderate,21.7,Low,Rural,Statutory Health Insurance,16.0,No,No,Cardiovascular Disease,9.0
PT06820,Germany,Berlin,28.0,Female,Colorectal,III,2017-10-01,2017-12-21,2018-06-03,Chemotherapy,Private,Alive,47.0,KRAS,No,Never,Moderate,20.6,High,Rural,NHS,5.0,No,No,,2.0
PT06821,Austria,Tyrol,27.0,Male,Leukemia,III,2019-04-26,2019-04-28,2019-07-26,Radiation,,Alive,,BRCA1,No,Current,Moderate,36.4,Medium,Urban,Statutory Health Insurance,9.0,No,No,Obesity,9.0
PT06822,Norway,Trøndelag,63.0,Female,Pancreatic,III,2011-12-29,2012-06-13,2013-05-23,Targeted Therapy,Public,Alive,10.0,None,No,Never,Moderate,32.3,Low,Rural,Statutory Health Insurance,16.0,No,No,Cardiovascular Disease,
PT06823,Italy,Veneto,77.0,Female,Leukemia,,2021-07-29,2021-12-10,2022-10-24,Targeted Therapy,Public,Lost to Follow-up,,BRCA1,No,Never,Moderate,22.8,Medium,Urban,NHS,2.0,No,No,Diabetes,
PT06824,France,Île-de-France,86.0,Male,Leukemia,III,,2022-03-07,2022-10-01,Targeted Therapy,Public,Alive,99.0,None,No,Former,Moderate,22.6,High,Urban,NHS,9.0,No,No,None,3.0
PT06825,Netherlands,South Holland,32.0,Male,Leukemia,III,2010-08-09,2011-01-02,2011-06-03,Radiation,Private,Alive,42.0,BRCA1,No,,Moderate,19.2,High,Urban,NHS,2.0,Yes,No,,1.0
PT06826,Netherlands,South Holland,38.0,Female,Breast,I,2023-05-10,2023-07-19,2024-07-16,Chemotherapy,Public,Deceased,91.0,EGFR,No,Current,Heavy,29.1,High,Urban,NHS,9.0,No,No,Hypertension,2.0
PT06827,Belgium,Wallonia,68.0,Female,Lung,I,2017-12-06,2018-02-20,2019-01-09,,Private,Alive,56.0,KRAS,No,Former,None,20.6,Low,Urban,NHS,16.0,No,No,Obesity,9.0
PT06828,Portugal,Lisbon,49.0,Male,Lung,I,2020-07-14,2020-12-11,2021-09-10,Chemotherapy,Public,Alive,87.0,None,No,Never,Moderate,26.5,Low,Urban,NHS,12.0,No,No,Cardiovascular Disease,8.0
PT06829,Spain,Andalusia,85.0,Male,Prostate,III,2021-06-04,2021-08-21,2022-07-27,Chemotherapy,Private,,98.0,EGFR,No,Former,None,22.4,Low,Rural,NHS,,Yes,,Diabetes,7.0
PT06830,Sweden,Västra Götaland,78.0,Female,Lung,,2017-04-06,2017-04-19,2018-02-24,Surgery,Research Institute,,24.0,EGFR,No,Former,Moderate,34.0,Low,Urban,NHS,,No,No,Diabetes,2.0
PT06831,Sweden,Västra Götaland,72.0,Female,Lung,II,2020-10-25,2021-01-06,2021-11-29,Targeted Therapy,Public,Alive,9.0,None,No,Former,Moderate,18.1,Low,Rural,NHS,16.0,No,No,Hypertension,5.0
PT06832,Netherlands,Utrecht,71.0,Male,Lung,III,2022-11-01,2023-02-23,2023-06-09,Targeted Therapy,Public,,77.0,KRAS,No,Never,None,26.3,Low,Urban,Statutory Health Insurance,14.0,No,No,Cardiovascular Disease,3.0
PT06833,Belgium,Flanders,50.0,Female,,III,2013-09-28,2014-01-12,2014-05-08,,Public,Alive,32.0,BRCA1,Yes,Current,None,19.0,Medium,Urban,Statutory Health Insurance,2.0,No,No,Diabetes,9.0
PT06834,Norway,Trøndelag,34.0,Male,Leukemia,IV,2010-11-28,2010-12-08,2011-03-27,Surgery,,Alive,60.0,BRCA1,Yes,Former,Moderate,,Medium,Urban,,4.0,No,No,Obesity,1.0
PT06835,Spain,Catalonia,39.0,Male,Ovarian,I,2017-06-18,2017-07-15,2017-11-06,Immunotherapy,Public,Deceased,98.0,EGFR,No,Former,Moderate,20.1,Medium,Urban,Private Insurance,10.0,,No,Diabetes,7.0
PT06836,Ireland,Connacht,24.0,Female,Leukemia,II,2013-11-05,2013-11-19,2014-09-18,Radiation,Public,Alive,113.0,None,No,Never,None,,Medium,Rural,NHS,11.0,No,No,Diabetes,3.0
PT06837,Netherlands,South Holland,26.0,Male,Pancreatic,III,2012-08-15,2012-08-24,2013-06-14,Surgery,Public,Alive,102.0,BRCA1,Yes,Never,None,35.2,High,Urban,NHS,18.0,No,No,Hypertension,3.0
PT06838,Netherlands,Utrecht,37.0,Female,,I,2019-08-13,2019-12-28,2020-05-16,Targeted Therapy,Public,Deceased,12.0,None,Yes,Never,Moderate,30.0,High,Urban,Private Insurance,14.0,No,No,Diabetes,9.0
PT06839,Portugal,Algarve,75.0,Male,Ovarian,II,,2016-10-09,2017-08-07,Immunotherapy,Private,Alive,66.0,,No,,None,21.1,High,Urban,Statutory Health Insurance,8.0,No,Yes,Obesity,1.0
PT06840,Sweden,Skåne,64.0,Female,Leukemia,II,2011-06-13,2011-07-18,2012-06-22,Surgery,Public,Alive,104.0,BRCA1,Yes,Never,Moderate,26.6,Medium,Urban,Statutory Health Insurance,11.0,Yes,No,Diabetes,9.0
PT06841,Finland,Uusimaa,47.0,Male,Leukemia,III,2012-05-17,2012-10-18,2013-09-22,Surgery,Public,,73.0,None,No,Current,Moderate,38.1,High,Urban,Statutory Health Insurance,18.0,No,No,None,6.0
,,Connacht,69.0,Male,Lung,II,2015-04-21,2015-10-07,2016-02-18,Chemotherapy,Public,Deceased,31.0,None,No,Never,None,27.3,Medium,Urban,Private Insurance,6.0,No,No,Diabetes,7.0
PT06843,Netherlands,Utrecht,21.0,Female,Breast,II,2012-01-11,2012-04-29,2013-02-17,Surgery,Private,Deceased,64.0,None,No,Current,Moderate,38.9,Low,Urban,NHS,,No,No,Cardiovascular Disease,8.0
PT06844,Netherlands,South Holland,87.0,Female,Breast,II,2013-07-30,2013-11-13,,Surgery,Private,Alive,82.0,EGFR,No,,Moderate,38.2,High,Rural,Statutory Health Insurance,,No,No,Hypertension,7.0
PT06845,Italy,Veneto,43.0,Female,Lung,I,2019-05-10,2019-09-08,2020-02-20,Targeted Therapy,Private,Alive,80.0,None,No,Never,Moderate,26.7,Low,Rural,NHS,16.0,No,No,None,2.0
PT06846,Poland,Lesser Poland,67.0,Female,Ovarian,IV,2014-10-24,2014-12-30,2015-08-06,Radiation,Research Institute,Deceased,44.0,KRAS,No,Never,Moderate,32.3,Medium,Urban,Statutory Health Insurance,2.0,No,No,None,7.0
PT06847,Belgium,Flanders,64.0,Female,Lung,II,2013-06-10,2013-07-10,2014-04-17,Immunotherapy,Public,Alive,39.0,,No,Never,None,35.3,,Rural,NHS,1.0,No,No,None,10.0
PT06848,,Vienna,77.0,Female,Breast,II,2020-10-16,2020-11-14,2021-07-15,Radiation,Public,Alive,30.0,BRCA1,Yes,Never,Moderate,22.0,Low,Urban,Private Insurance,5.0,Yes,Yes,Diabetes,1.0
PT06849,France,Île-de-France,55.0,Female,Colorectal,I,2013-10-07,2013-12-30,2014-05-30,Surgery,Private,Alive,,None,No,Never,Moderate,29.7,Low,Urban,Statutory Health Insurance,11.0,No,No,Obesity,
,Netherlands,Utrecht,21.0,Female,Lung,II,2011-12-17,2012-02-23,2013-01-22,Targeted Therapy,Public,Deceased,41.0,EGFR,Yes,Never,None,20.3,Low,Rural,Private Insurance,14.0,Yes,No,Diabetes,8.0
PT06851,Sweden,Skåne,37.0,Female,Lung,,2011-03-09,2011-03-23,2012-03-12,Targeted Therapy,Private,Deceased,110.0,None,,Never,None,29.1,Medium,Urban,Statutory Health Insurance,9.0,No,No,Hypertension,6.0
PT06852,Ireland,Dublin,68.0,Female,Breast,IV,2019-04-09,2019-07-27,2020-03-30,Targeted Therapy,Public,Alive,110.0,KRAS,Yes,Never,Moderate,20.8,Low,Rural,Private Insurance,19.0,No,No,,5.0
PT06853,Ireland,,27.0,Male,Ovarian,II,2018-05-08,2018-06-16,2019-01-01,Targeted Therapy,Research Institute,Alive,71.0,BRCA1,,Former,None,35.0,Medium,Urban,NHS,14.0,No,No,Obesity,7.0
PT06854,Italy,,77.0,,Colorectal,I,2015-07-11,2015-08-01,2016-05-14,Chemotherapy,Public,Deceased,94.0,BRCA1,No,Former,Moderate,31.5,Medium,Urban,Private Insurance,7.0,,No,Diabetes,1.0
PT06855,Poland,Masovian,34.0,Male,,II,2010-09-14,2010-11-24,2011-05-31,Surgery,Public,Alive,101.0,KRAS,No,Former,None,32.2,Medium,Rural,,17.0,No,Yes,None,2.0
PT06856,Poland,Silesian,36.0,Male,Colorectal,II,2017-10-07,2017-10-13,2018-01-26,Chemotherapy,Public,Alive,70.0,None,Yes,Former,None,23.4,High,Urban,Private Insurance,6.0,No,No,Hypertension,
PT06857,Denmark,Central Denmark,42.0,Male,Prostate,III,2016-04-23,2016-06-02,2017-04-02,,Public,Deceased,102.0,None,No,Never,None,31.4,High,Urban,NHS,2.0,No,No,Hypertension,4.0
PT06858,Poland,Silesian,85.0,Female,Colorectal,II,,2016-06-17,,Surgery,Private,Deceased,11.0,BRCA1,No,Former,Moderate,34.5,High,Rural,Private Insurance,5.0,No,No,Diabetes,9.0
PT06859,Belgium,Brussels,89.0,Female,Lung,III,2020-07-09,2020-11-18,2021-08-14,Targeted Therapy,Public,Alive,18.0,None,Yes,Current,Moderate,24.8,Medium,Rural,Private Insurance,7.0,No,No,Hypertension,9.0
PT06860,Finland,Uusimaa,46.0,Female,,III,2021-10-08,2022-03-19,2022-06-21,Immunotherapy,Private,Alive,22.0,KRAS,Yes,Current,None,38.8,Medium,Urban,Statutory Health Insurance,14.0,No,Yes,Obesity,9.0
PT06861,Sweden,Stockholm,56.0,Male,Breast,I,2015-07-31,2015-10-28,2016-10-09,Targeted Therapy,Private,Lost to Follow-up,,KRAS,Yes,Never,None,26.3,Medium,Urban,Private Insurance,4.0,No,No,Hypertension,8.0
PT06862,Denmark,Zealand,68.0,Male,Pancreatic,III,2023-02-05,2023-02-27,2023-10-02,Targeted Therapy,Public,Alive,85.0,KRAS,No,Former,None,25.9,Medium,Urban,,5.0,No,No,,3.0
PT06863,Denmark,,83.0,Female,Lung,III,2021-06-09,2021-08-04,2021-12-09,Chemotherapy,Research Institute,Alive,43.0,EGFR,Yes,Never,Heavy,26.5,Low,Urban,Statutory Health Insurance,4.0,Yes,No,Obesity,6.0
PT06864,Denmark,Capital Region,53.0,Male,Pancreatic,II,2014-01-09,2014-02-24,2014-12-22,Radiation,Research Institute,Deceased,91.0,,Yes,Never,Moderate,37.9,Medium,Rural,Private Insurance,9.0,Yes,No,Diabetes,9.0
PT06865,Denmark,Zealand,37.0,Male,Breast,IV,2012-11-14,2013-03-14,2013-07-26,Targeted Therapy,Private,Alive,48.0,EGFR,No,Former,Heavy,24.8,Low,Urban,Private Insurance,,No,Yes,None,5.0
PT06866,,Zealand,83.0,Male,Pancreatic,III,2021-04-06,2021-09-08,2022-02-19,Surgery,Research Institute,Alive,46.0,KRAS,No,Never,,31.5,High,Urban,Statutory Health Insurance,12.0,No,Yes,Cardiovascular Disease,8.0
PT06867,Belgium,Brussels,63.0,Female,Colorectal,II,2019-10-09,2020-01-07,2021-01-03,Surgery,Public,Alive,76.0,BRCA1,No,Former,Moderate,23.8,Low,Urban,NHS,9.0,No,,Cardiovascular Disease,3.0
PT06868,Netherlands,Utrecht,36.0,Male,Breast,IV,2012-08-18,2012-12-12,2013-07-25,Surgery,,Deceased,7.0,None,No,Never,None,35.1,Medium,Urban,Private Insurance,,Yes,No,Cardiovascular Disease,2.0
PT06869,Austria,Tyrol,78.0,Male,Lung,III,2021-04-09,2021-09-19,2022-06-06,Chemotherapy,Public,Alive,6.0,KRAS,No,Never,Moderate,39.7,Medium,Urban,Statutory Health Insurance,1.0,No,No,Hypertension,8.0
PT06870,Germany,North Rhine-Westphalia,32.0,Female,Leukemia,II,2013-03-17,2013-08-08,2014-03-27,Immunotherapy,Research Institute,Alive,24.0,EGFR,No,Current,Moderate,39.4,Medium,Urban,Private Insurance,15.0,No,No,Obesity,3.0
PT06871,,Berlin,71.0,Male,Lung,II,,2017-08-21,2017-12-20,Immunotherapy,Private,Alive,21.0,KRAS,Yes,Never,None,20.6,Medium,Urban,Private Insurance,19.0,No,No,Diabetes,5.0
PT06872,,Styria,,Female,Ovarian,,2018-03-04,2018-07-30,2018-10-14,Immunotherapy,Research Institute,Alive,39.0,KRAS,Yes,Never,Moderate,35.8,Low,Urban,Statutory Health Insurance,9.0,No,Yes,None,4.0
PT06873,Portugal,Algarve,61.0,Male,Prostate,I,2012-01-06,2012-01-21,2012-03-01,Targeted Therapy,Public,Alive,98.0,None,No,Former,Moderate,32.2,High,Urban,NHS,16.0,No,No,Obesity,2.0
PT06874,Sweden,Stockholm,83.0,Male,Breast,II,2011-09-25,2012-01-13,2012-07-22,Targeted Therapy,Public,Deceased,77.0,KRAS,Yes,Current,Moderate,34.6,Medium,Urban,Private Insurance,4.0,Yes,No,Obesity,1.0
PT06875,Netherlands,South Holland,85.0,Female,Lung,II,2022-06-08,2022-07-02,2022-09-20,,Public,Deceased,95.0,KRAS,Yes,Never,Moderate,26.4,Medium,Rural,NHS,16.0,No,No,Obesity,10.0
,,Munster,53.0,Female,Colorectal,II,2010-10-14,2011-01-02,2011-02-05,Radiation,Public,Alive,16.0,KRAS,No,Never,,25.6,Medium,Urban,NHS,,No,No,None,9.0
PT06877,Austria,Styria,83.0,Female,Colorectal,III,2023-08-04,2023-09-17,2024-08-15,Radiation,Private,Alive,79.0,KRAS,No,Never,None,27.5,Low,Urban,NHS,1.0,No,No,None,7.0
PT06878,Spain,Madrid,52.0,Female,Ovarian,II,2023-01-13,2023-06-04,2024-04-15,Chemotherapy,Public,Alive,73.0,,No,Never,Moderate,39.9,Low,Rural,Statutory Health Insurance,13.0,No,No,Diabetes,9.0
PT06879,Germany,North Rhine-Westphalia,31.0,Male,Pancreatic,I,2013-09-10,2013-11-22,2014-03-16,Immunotherapy,Private,Alive,56.0,None,,Former,None,,,Rural,Private Insurance,12.0,No,No,None,1.0
PT06880,Ireland,Dublin,38.0,Male,Lung,IV,2021-08-14,2021-12-02,2022-10-23,Targeted Therapy,Public,Deceased,103.0,KRAS,No,Never,Moderate,38.2,High,Rural,Private Insurance,2.0,Yes,No,Obesity,9.0
PT06881,Denmark,Zealand,28.0,Male,Pancreatic,III,,2016-09-13,2017-07-05,Radiation,Public,,54.0,BRCA1,Yes,Former,None,29.8,High,Urban,Private Insurance,17.0,No,No,Diabetes,9.0
PT06882,Switzerland,Geneva,36.0,Female,Prostate,IV,2021-11-02,2022-04-01,2022-12-16,Chemotherapy,Private,Deceased,28.0,EGFR,Yes,Former,None,32.5,High,Rural,Private Insurance,19.0,No,Yes,None,2.0
,Italy,Sicily,69.0,Female,Breast,I,2022-01-19,2022-06-28,2023-05-28,Radiation,Public,Alive,7.0,BRCA1,Yes,Current,None,19.9,Medium,,NHS,3.0,No,Yes,None,10.0
PT06884,Switzerland,Bern,58.0,Female,Prostate,,2010-06-28,,,Targeted Therapy,Research Institute,Alive,102.0,KRAS,No,,Moderate,36.2,Low,Urban,NHS,14.0,No,No,Obesity,5.0
PT06885,Italy,Lombardy,60.0,Male,Leukemia,III,2015-03-27,2015-07-20,2016-03-19,Radiation,Public,Deceased,,EGFR,No,,Moderate,20.0,Low,Urban,Private Insurance,19.0,No,Yes,,8.0
PT06886,Switzerland,Bern,29.0,Female,Ovarian,II,2014-02-08,2014-03-05,2014-10-28,Chemotherapy,Public,Deceased,59.0,EGFR,Yes,Former,None,33.1,Low,Urban,Private Insurance,7.0,Yes,No,Obesity,5.0
PT06887,Netherlands,North Holland,31.0,Female,Pancreatic,III,2015-06-21,2015-12-15,2016-11-19,Chemotherapy,Private,Alive,25.0,BRCA1,Yes,Never,,32.0,Medium,Rural,,16.0,No,No,Cardiovascular Disease,7.0
PT06888,Norway,Trøndelag,34.0,Female,Lung,I,2022-05-10,2022-06-02,2023-04-17,Radiation,Private,Deceased,82.0,EGFR,Yes,Current,Moderate,39.8,Medium,Rural,Statutory Health Insurance,7.0,No,No,None,9.0
PT06889,Germany,Bavaria,,Female,Pancreatic,II,2017-04-11,2017-05-18,2018-02-07,Targeted Therapy,Research Institute,Deceased,72.0,None,No,Never,None,37.3,Medium,Urban,Private Insurance,1.0,No,No,Obesity,9.0
PT06890,Denmark,Capital Region,23.0,Female,Prostate,III,2017-04-29,,2017-07-03,,Private,Deceased,98.0,KRAS,Yes,Never,Moderate,26.5,Low,Urban,NHS,1.0,,Yes,None,10.0
PT06891,Spain,Catalonia,55.0,Male,Ovarian,II,2015-12-11,2016-02-09,2016-07-20,Immunotherapy,Public,Alive,,EGFR,No,Former,Moderate,37.9,Low,Urban,NHS,9.0,No,No,Hypertension,6.0
PT06892,Netherlands,North Holland,84.0,Male,Leukemia,III,2016-05-21,2016-07-19,2016-11-29,Chemotherapy,Public,Lost to Follow-up,,None,,Former,None,19.7,Low,,Statutory Health Insurance,14.0,No,No,Cardiovascular Disease,3.0
PT06893,Netherlands,North Holland,66.0,Male,Prostate,I,2020-12-03,2021-05-03,2021-07-13,Surgery,Public,Deceased,75.0,None,No,Never,Moderate,24.0,Low,Rural,Private Insurance,19.0,No,No,Obesity,
PT06894,Italy,Sicily,58.0,,Leukemia,III,2017-07-17,2017-08-19,2018-01-26,Radiation,Public,Deceased,19.0,BRCA1,No,Never,None,38.5,Medium,Urban,Statutory Health Insurance,18.0,No,No,None,4.0
PT06895,Belgium,Flanders,57.0,Male,Ovarian,II,2015-08-13,2015-09-21,2016-04-28,Immunotherapy,Public,Lost to Follow-up,,None,Yes,Never,None,29.7,Low,Rural,Statutory Health Insurance,10.0,Yes,No,None,7.0
PT06896,Finland,Southwest Finland,63.0,Male,Colorectal,II,2010-09-19,2011-02-19,2011-12-14,Targeted Therapy,Private,Alive,73.0,BRCA1,No,Current,None,24.7,,Urban,Statutory Health Insurance,18.0,No,No,None,4.0
PT06897,Belgium,Brussels,70.0,,Colorectal,II,2014-02-03,2014-04-07,2015-01-05,Immunotherapy,Private,Alive,95.0,BRCA1,Yes,Former,Heavy,22.1,Low,Urban,,5.0,No,No,Obesity,10.0
PT06898,France,Auvergne-Rhône-Alpes,45.0,Female,Lung,II,2010-11-28,2011-02-25,2011-05-26,Chemotherapy,Research Institute,Deceased,81.0,BRCA1,No,Former,Moderate,27.0,Medium,Urban,NHS,17.0,No,Yes,Diabetes,9.0
PT06899,Netherlands,North Holland,55.0,Female,Prostate,III,2021-12-05,2022-03-18,2022-09-21,Chemotherapy,Public,,66.0,KRAS,No,Never,None,38.4,Low,Urban,Private Insurance,11.0,No,No,None,8.0
PT06900,Sweden,Skåne,88.0,Female,Colorectal,III,2017-09-20,2017-12-14,2018-11-14,Surgery,Public,Deceased,43.0,None,,,None,38.5,Medium,Urban,NHS,6.0,No,No,Cardiovascular Disease,5.0
PT06901,Netherlands,North Holland,20.0,Male,Pancreatic,II,2022-06-09,2022-11-15,2023-02-21,Immunotherapy,Private,Alive,63.0,BRCA1,No,Former,None,31.6,Low,Urban,NHS,1.0,No,No,Diabetes,6.0
PT06902,Italy,Lombardy,72.0,Male,Ovarian,II,,2023-06-19,2024-05-07,Chemotherapy,Public,Alive,97.0,KRAS,No,Former,Moderate,20.0,Medium,Rural,Private Insurance,6.0,No,No,Hypertension,2.0
PT06903,Portugal,Porto,25.0,Male,Breast,II,2017-03-01,2017-06-12,2017-10-14,Targeted Therapy,Public,Alive,46.0,EGFR,No,Never,Moderate,27.4,Medium,Urban,Private Insurance,8.0,No,No,Cardiovascular Disease,
PT06904,Poland,Lesser Poland,56.0,Non-binary,Ovarian,III,2017-03-27,2017-07-14,2018-04-17,Targeted Therapy,Public,Deceased,11.0,BRCA1,No,Never,Moderate,30.3,Medium,Urban,Private Insurance,5.0,No,No,Cardiovascular Disease,1.0
PT06905,Ireland,Dublin,21.0,Female,Pancreatic,II,2021-10-05,2022-03-20,2023-01-01,Immunotherapy,Private,Alive,107.0,EGFR,Yes,Former,Moderate,34.3,,Rural,Statutory Health Insurance,19.0,Yes,Yes,Hypertension,1.0
PT06906,Denmark,Zealand,88.0,Male,Colorectal,II,2023-01-16,2023-03-28,2023-06-22,Immunotherapy,Private,Alive,,KRAS,No,Former,Moderate,38.1,Low,Urban,Statutory Health Insurance,13.0,No,No,Cardiovascular Disease,6.0
PT06907,,Zealand,60.0,Female,Colorectal,II,,2013-06-03,2014-03-22,Surgery,Private,Alive,9.0,BRCA1,,Never,Moderate,39.9,High,Urban,Private Insurance,6.0,No,,Obesity,10.0
,Poland,Lesser Poland,70.0,Male,Prostate,I,2010-10-21,2011-01-06,2011-08-31,Immunotherapy,Private,Alive,77.0,None,Yes,Current,None,27.0,,Urban,Private Insurance,9.0,No,No,Obesity,5.0
PT06909,Italy,Lombardy,66.0,Female,Leukemia,I,,2018-03-31,2018-05-28,Targeted Therapy,Public,Deceased,49.0,BRCA1,No,Former,Heavy,37.4,Low,Urban,NHS,4.0,Yes,,Cardiovascular Disease,3.0
,Austria,Styria,32.0,Male,,I,2021-06-12,2021-06-20,,Immunotherapy,Public,Deceased,100.0,BRCA1,No,Never,Heavy,36.2,High,Urban,Private Insurance,10.0,Yes,No,Hypertension,10.0
PT06911,Denmark,Zealand,88.0,Male,Breast,II,,2010-11-02,2011-05-12,Chemotherapy,Public,Alive,101.0,KRAS,Yes,Never,Moderate,30.8,Medium,Urban,Private Insurance,18.0,Yes,No,Obesity,6.0
PT06912,Ireland,Connacht,85.0,Female,Leukemia,I,2013-03-07,2013-04-02,2013-08-07,Chemotherapy,Private,Alive,9.0,BRCA1,Yes,,Moderate,30.5,Low,Rural,NHS,8.0,Yes,No,Cardiovascular Disease,4.0
PT06913,Sweden,Skåne,78.0,Female,Prostate,II,2011-02-15,2011-07-03,2012-01-21,Immunotherapy,Public,Alive,33.0,BRCA1,No,Never,Moderate,39.6,Low,Urban,NHS,14.0,No,No,Diabetes,8.0
PT06914,Germany,North Rhine-Westphalia,87.0,Female,Colorectal,I,2011-05-24,2011-08-23,2012-01-26,Radiation,Private,Alive,12.0,BRCA1,No,Never,Moderate,26.3,Low,Urban,NHS,15.0,No,No,Diabetes,4.0
PT06915,France,Île-de-France,78.0,,Leukemia,II,2020-10-30,2020-12-25,2021-05-03,Immunotherapy,Public,Alive,14.0,None,No,Former,,27.6,Low,Urban,NHS,10.0,Yes,Yes,Cardiovascular Disease,4.0
PT06916,Denmark,Zealand,29.0,Male,Ovarian,I,2019-01-03,2019-05-15,2019-08-23,Surgery,Public,Deceased,72.0,EGFR,No,Former,None,29.1,Low,Rural,Private Insurance,2.0,No,No,None,6.0
PT06917,Spain,Andalusia,32.0,Male,Ovarian,III,2022-11-27,,2023-10-14,Targeted Therapy,,Deceased,58.0,KRAS,Yes,Former,Moderate,33.8,Medium,Urban,Statutory Health Insurance,18.0,No,No,Hypertension,10.0
PT06918,Germany,Berlin,21.0,Non-binary,Ovarian,IV,2015-11-10,2015-12-11,2016-12-08,Targeted Therapy,Public,Alive,102.0,BRCA1,Yes,Never,,29.5,Medium,Urban,NHS,2.0,No,No,Obesity,9.0
PT06919,Poland,Lesser Poland,34.0,,Breast,III,2023-05-12,2023-05-29,2023-09-19,Immunotherapy,Public,Alive,25.0,KRAS,No,Never,None,31.2,Low,Urban,Statutory Health Insurance,4.0,Yes,No,Diabetes,6.0
PT06920,Ireland,Munster,65.0,Female,Breast,II,,2014-03-10,2014-11-23,Radiation,Private,Alive,24.0,KRAS,No,Never,None,26.4,High,Urban,NHS,19.0,No,No,None,9.0
PT06921,Belgium,Wallonia,76.0,Male,Ovarian,III,2017-03-03,2017-04-09,2018-02-21,Targeted Therapy,Private,Deceased,21.0,BRCA1,Yes,Never,Heavy,,Low,Urban,NHS,15.0,,No,None,6.0
PT06922,Spain,Madrid,29.0,Female,Ovarian,I,2023-04-29,2023-09-01,2024-06-06,Radiation,Public,Alive,8.0,BRCA1,,Current,Moderate,31.4,Medium,Rural,NHS,14.0,No,No,None,8.0
PT06923,Denmark,Zealand,41.0,Male,Ovarian,I,2015-05-31,2015-10-26,2016-02-29,Targeted Therapy,Public,Alive,11.0,BRCA1,No,Current,None,31.6,Medium,Rural,Private Insurance,14.0,No,No,Obesity,9.0
PT06924,Ireland,Munster,27.0,Female,Colorectal,I,2011-12-08,2012-01-24,2012-09-27,Chemotherapy,Public,Alive,107.0,EGFR,No,Never,Moderate,24.8,Medium,Rural,Private Insurance,5.0,No,No,Cardiovascular Disease,1.0
PT06925,Austria,Styria,40.0,,Colorectal,I,2013-07-22,2013-09-11,2014-04-20,,Public,Alive,98.0,KRAS,No,Never,None,31.6,Medium,Urban,NHS,13.0,,No,Diabetes,1.0
PT06926,Poland,Masovian,41.0,Female,Lung,I,2018-01-30,2018-05-24,2018-12-05,Targeted Therapy,Public,Alive,119.0,KRAS,No,Never,,31.6,Medium,Urban,Statutory Health Insurance,18.0,No,No,Diabetes,
PT06927,Poland,Lesser Poland,64.0,Female,Pancreatic,II,2020-07-25,2020-09-21,2020-11-01,,Private,Alive,,BRCA1,Yes,Never,Moderate,25.9,High,Rural,NHS,15.0,Yes,Yes,Cardiovascular Disease,10.0
PT06928,Norway,Trøndelag,59.0,Male,Leukemia,,2018-07-05,2018-08-18,2019-03-26,Chemotherapy,Public,Alive,103.0,EGFR,No,Former,None,34.1,Medium,Rural,Private Insurance,3.0,No,No,Hypertension,9.0
,Switzerland,Zurich,41.0,Male,Colorectal,IV,2022-12-03,2023-03-11,2023-10-14,Radiation,Public,Alive,83.0,None,No,Never,Moderate,31.0,,Urban,NHS,1.0,Yes,No,None,2.0
PT06930,Ireland,Munster,49.0,Female,Lung,IV,2012-01-11,2012-01-22,2012-11-22,Surgery,Public,Deceased,31.0,EGFR,No,Never,Moderate,20.2,High,Urban,NHS,14.0,No,No,Diabetes,4.0
PT06931,Denmark,Zealand,81.0,Male,Prostate,IV,2021-10-02,2021-10-14,2022-07-12,Radiation,Public,Alive,39.0,BRCA1,Yes,Current,Moderate,28.3,High,Urban,NHS,15.0,No,No,Cardiovascular Disease,7.0
PT06932,Sweden,Västra Götaland,64.0,Female,Ovarian,I,,2021-01-20,2022-01-06,Radiation,Public,Deceased,14.0,EGFR,No,Former,Heavy,37.3,Medium,Rural,NHS,16.0,No,,Hypertension,4.0
PT06933,Belgium,Brussels,54.0,Female,Breast,IV,2016-05-26,2016-07-19,2016-09-04,Targeted Therapy,Public,Alive,60.0,None,No,Never,Moderate,34.8,Medium,Rural,Statutory Health Insurance,5.0,Yes,No,Diabetes,7.0
,Switzerland,Bern,61.0,Female,Leukemia,III,2023-04-24,2023-05-28,2024-03-14,Chemotherapy,Public,Alive,38.0,EGFR,No,Never,None,21.1,,,Statutory Health Insurance,5.0,No,No,Cardiovascular Disease,6.0
PT06935,Portugal,Lisbon,24.0,Female,Pancreatic,IV,2013-12-05,2014-05-12,2014-08-15,Surgery,Private,Lost to Follow-up,,BRCA1,No,Former,None,39.0,High,Urban,Statutory Health Insurance,8.0,Yes,No,Obesity,1.0
PT06936,,Berlin,46.0,Female,Prostate,II,2013-08-14,2014-01-04,2014-04-12,Chemotherapy,Private,Lost to Follow-up,,None,No,Never,None,23.5,High,Urban,Private Insurance,13.0,No,No,Obesity,9.0
PT06937,Portugal,,89.0,Female,Leukemia,III,2012-10-07,2013-02-20,2013-07-26,Chemotherapy,Research Institute,Alive,,EGFR,Yes,Never,Moderate,25.6,High,Urban,Statutory Health Insurance,19.0,No,,None,1.0
PT06938,Italy,Veneto,81.0,Male,Leukemia,I,2021-06-15,2021-09-23,2022-02-24,Targeted Therapy,Private,Alive,24.0,KRAS,Yes,Former,Moderate,22.5,Low,Urban,Private Insurance,15.0,No,Yes,Cardiovascular Disease,3.0
PT06939,Norway,Vestland,,Female,Colorectal,I,2010-06-25,2010-12-10,2011-04-20,Radiation,Research Institute,Alive,78.0,KRAS,No,Current,Heavy,34.0,High,Urban,Statutory Health Insurance,13.0,No,Yes,Diabetes,2.0
PT06940,Poland,Silesian,27.0,Female,Lung,I,2016-05-14,,2017-02-03,Chemotherapy,Public,Alive,44.0,KRAS,Yes,Former,Moderate,30.3,High,Urban,Statutory Health Insurance,3.0,Yes,No,None,2.0
PT06941,Poland,Masovian,37.0,Male,Leukemia,IV,2013-08-13,2013-08-18,2014-02-13,Radiation,Public,Alive,11.0,None,No,Never,Moderate,30.6,Medium,Urban,Private Insurance,14.0,No,No,Obesity,9.0
PT06942,Norway,Vestland,34.0,Female,Pancreatic,I,2016-10-07,2016-10-27,2017-01-29,Chemotherapy,Public,Alive,28.0,None,,Current,Moderate,33.2,Low,Urban,Private Insurance,16.0,Yes,No,Hypertension,2.0
PT06943,Netherlands,South Holland,,Female,,I,2013-12-10,2014-04-07,2014-12-20,Surgery,Public,Deceased,62.0,None,No,Never,Moderate,31.0,Medium,Rural,NHS,10.0,Yes,Yes,Hypertension,4.0
PT06944,Germany,Berlin,72.0,Female,Pancreatic,IV,,2021-06-09,2021-09-23,Immunotherapy,Private,Deceased,114.0,None,No,Never,,25.5,Medium,Rural,Statutory Health Insurance,1.0,,No,,2.0
PT06945,Sweden,Skåne,63.0,Male,Leukemia,I,2010-07-28,2010-11-24,2011-07-02,Immunotherapy,Public,Lost to Follow-up,,EGFR,Yes,Former,Moderate,38.3,Medium,Rural,Private Insurance,7.0,Yes,No,Diabetes,8.0
PT06946,Sweden,Skåne,51.0,Female,Pancreatic,IV,2010-09-05,2011-01-30,2011-07-19,Immunotherapy,,Alive,14.0,BRCA1,No,Never,Moderate,30.7,Medium,Urban,Statutory Health Insurance,3.0,Yes,No,Diabetes,5.0
PT06947,Germany,North Rhine-Westphalia,47.0,Male,Pancreatic,III,2019-06-12,2019-11-01,2020-03-24,Targeted Therapy,Public,Alive,95.0,BRCA1,Yes,Never,None,34.1,Low,Urban,Statutory Health Insurance,5.0,Yes,No,Obesity,2.0
PT06948,Spain,Madrid,58.0,Female,Ovarian,I,2017-12-04,,2018-05-12,Targeted Therapy,Public,Alive,15.0,None,Yes,Never,Moderate,21.4,Medium,Urban,NHS,3.0,No,No,None,3.0
,Portugal,Lisbon,51.0,Male,Lung,I,2020-05-02,2020-07-21,2021-04-16,Radiation,Public,Deceased,75.0,KRAS,No,Never,None,26.0,Medium,Urban,NHS,6.0,No,No,None,7.0
PT06950,Germany,Berlin,37.0,Female,Breast,II,2012-02-29,2012-03-10,2012-06-06,Targeted Therapy,Public,Alive,19.0,EGFR,,Former,Heavy,35.1,Low,Urban,NHS,19.0,,No,Obesity,
,Switzerland,Bern,89.0,Male,Leukemia,IV,2021-03-04,2021-06-19,2021-11-09,Immunotherapy,Public,Deceased,22.0,EGFR,No,Former,None,25.4,Low,Rural,NHS,2.0,Yes,No,Cardiovascular Disease,9.0
PT06952,Poland,Lesser Poland,30.0,Male,Prostate,IV,2021-04-06,2021-09-03,2021-12-23,Targeted Therapy,Private,Alive,73.0,KRAS,No,Never,Moderate,34.0,Medium,Rural,NHS,11.0,No,Yes,Obesity,2.0
PT06953,Netherlands,North Holland,51.0,Male,Ovarian,II,2016-03-10,2016-07-21,,Immunotherapy,Public,Alive,116.0,None,No,Never,,28.8,High,Urban,NHS,13.0,No,No,Cardiovascular Disease,4.0
PT06954,Sweden,Stockholm,39.0,Male,,,2014-10-13,2014-11-06,2015-08-19,Chemotherapy,Public,Alive,83.0,BRCA1,No,Never,None,35.6,,Urban,NHS,11.0,No,No,Diabetes,1.0
PT06955,Switzerland,Zurich,59.0,Female,Breast,II,2017-01-05,2017-05-28,2018-05-16,Immunotherapy,Public,Deceased,29.0,EGFR,Yes,Never,Moderate,34.3,Low,Rural,Statutory Health Insurance,7.0,No,,Cardiovascular Disease,9.0
PT06956,Ireland,Munster,27.0,Female,Pancreatic,III,2013-01-22,2013-04-20,2013-05-28,Immunotherapy,Public,Alive,18.0,KRAS,Yes,Former,Moderate,23.6,Low,Urban,Private Insurance,13.0,No,No,Obesity,
PT06957,France,Auvergne-Rhône-Alpes,54.0,Male,Breast,,2012-05-06,2012-10-07,2012-11-08,Surgery,Public,Alive,64.0,BRCA1,No,Former,None,21.3,Low,Rural,NHS,9.0,No,No,,5.0
PT06958,Poland,Masovian,88.0,Male,Colorectal,I,2018-02-17,2018-04-13,2019-02-01,Surgery,Private,Deceased,106.0,EGFR,No,Former,Moderate,26.1,High,Urban,Private Insurance,11.0,Yes,No,Cardiovascular Disease,9.0
PT06959,Switzerland,Bern,40.0,Male,Colorectal,III,2017-10-25,2018-01-31,2019-01-20,Surgery,Research Institute,Deceased,70.0,KRAS,Yes,Never,Moderate,23.8,Low,Rural,Private Insurance,19.0,,Yes,Obesity,5.0
,Norway,Oslo,43.0,Female,Leukemia,II,,2013-04-01,2014-02-02,Surgery,Private,Alive,43.0,EGFR,No,Former,Moderate,25.8,High,Urban,Private Insurance,8.0,No,Yes,Hypertension,1.0
PT06961,Netherlands,Utrecht,36.0,Male,Ovarian,I,2018-10-08,2019-03-28,2019-08-05,Immunotherapy,Private,Alive,102.0,None,No,Former,Heavy,19.5,Medium,Urban,Private Insurance,18.0,No,No,,10.0
PT06962,,Madrid,37.0,Male,Prostate,,2010-10-25,,2011-08-02,Radiation,Private,Deceased,22.0,EGFR,No,,Moderate,28.0,,Rural,NHS,2.0,Yes,No,Obesity,8.0
PT06963,Belgium,Wallonia,31.0,Male,Colorectal,II,2012-09-24,2013-03-16,2013-07-03,Surgery,Public,Deceased,19.0,None,No,Never,Moderate,32.7,Medium,Rural,Private Insurance,9.0,No,No,Hypertension,9.0
PT06964,Portugal,Lisbon,35.0,Male,Pancreatic,II,2017-10-15,2017-11-09,2018-04-20,Targeted Therapy,Private,Deceased,86.0,BRCA1,Yes,Former,None,25.7,High,Urban,Statutory Health Insurance,16.0,Yes,Yes,Obesity,3.0
PT06965,Italy,Lombardy,23.0,Male,Lung,III,2018-10-07,2019-02-28,2019-05-07,Targeted Therapy,Private,Deceased,51.0,BRCA1,No,Never,Moderate,33.0,Low,Urban,NHS,18.0,No,Yes,Cardiovascular Disease,4.0
PT06966,Austria,Tyrol,53.0,Male,Lung,II,2017-04-17,2017-05-16,2017-06-17,Targeted Therapy,Public,Alive,21.0,,No,Former,None,32.7,Medium,Rural,NHS,11.0,Yes,No,Diabetes,1.0
PT06967,Sweden,Stockholm,65.0,Female,Pancreatic,III,2019-02-24,2019-04-29,2019-06-23,Immunotherapy,Research Institute,Alive,76.0,None,Yes,Never,Moderate,19.6,Medium,Rural,Statutory Health Insurance,14.0,No,No,Diabetes,
PT06968,France,Auvergne-Rhône-Alpes,50.0,Female,Breast,IV,2016-05-04,2016-09-10,2017-06-30,Chemotherapy,Research Institute,Deceased,111.0,EGFR,No,Former,Moderate,35.9,Low,Urban,NHS,9.0,No,No,Diabetes,6.0
PT06969,Sweden,Skåne,44.0,Male,Pancreatic,III,2022-08-01,2022-12-03,2023-02-22,Chemotherapy,Public,Deceased,52.0,BRCA1,No,Current,Moderate,20.4,Medium,,NHS,3.0,No,No,Obesity,2.0
PT06970,Denmark,Central Denmark,43.0,Female,Breast,III,2019-09-29,2020-03-20,,Surgery,Public,Alive,81.0,KRAS,No,Never,None,29.1,Medium,Rural,Private Insurance,7.0,No,No,Obesity,8.0
PT06971,Ireland,Dublin,84.0,Male,Breast,III,2012-07-02,2012-10-19,2013-04-21,Targeted Therapy,Public,,28.0,None,No,Former,Moderate,37.6,Medium,Urban,Statutory Health Insurance,18.0,No,No,Obesity,1.0
,Finland,Uusimaa,44.0,,Lung,II,2021-10-22,2021-11-17,2022-07-18,Surgery,Public,Alive,109.0,BRCA1,No,,Moderate,38.2,,Urban,Private Insurance,12.0,Yes,Yes,None,
PT06973,Italy,,47.0,Male,Colorectal,I,2019-05-22,2019-08-15,,Immunotherapy,Public,Alive,117.0,KRAS,No,Never,None,26.8,Medium,Urban,NHS,8.0,No,No,Hypertension,6.0
PT06974,France,Provence-Alpes-Côte d'Azur,55.0,Female,Pancreatic,II,2022-12-25,2023-02-13,2023-04-26,Targeted Therapy,Public,Alive,11.0,KRAS,No,Current,Moderate,18.0,Medium,Rural,Statutory Health Insurance,7.0,No,No,Diabetes,7.0
PT06975,Spain,Andalusia,25.0,Female,Colorectal,III,2012-10-01,2013-03-05,2013-04-30,Surgery,Public,Alive,112.0,EGFR,Yes,Never,,,High,Urban,NHS,7.0,Yes,No,None,4.0
PT06976,Poland,Silesian,85.0,Male,Leukemia,II,2013-08-02,2013-11-10,2014-01-23,Radiation,Private,Deceased,43.0,None,No,Never,Moderate,39.9,Medium,Urban,Statutory Health Insurance,10.0,No,No,Diabetes,10.0
PT06977,Germany,North Rhine-Westphalia,,Female,Prostate,II,2017-02-06,2017-07-19,2018-06-15,Immunotherapy,Private,Deceased,35.0,BRCA1,No,Former,,32.7,Medium,Urban,NHS,9.0,Yes,No,Cardiovascular Disease,3.0
PT06978,France,Provence-Alpes-Côte d'Azur,67.0,Female,Lung,,2017-08-02,2017-10-21,2017-12-22,Immunotherapy,Public,Alive,27.0,BRCA1,No,Former,Moderate,22.6,High,Rural,Statutory Health Insurance,16.0,No,No,Cardiovascular Disease,7.0
PT06979,Norway,Vestland,89.0,Female,,I,2023-11-12,2023-12-11,2024-05-15,Immunotherapy,Public,Alive,6.0,KRAS,No,Never,None,29.9,High,Urban,Private Insurance,11.0,Yes,No,Diabetes,8.0
PT06980,Finland,Uusimaa,86.0,Male,Breast,III,2019-04-26,2019-09-08,2020-01-10,Radiation,Research Institute,Alive,119.0,BRCA1,Yes,Former,None,30.3,Medium,Rural,Statutory Health Insurance,10.0,No,No,Obesity,3.0
PT06981,Italy,Veneto,67.0,Male,Prostate,II,2017-07-03,2017-09-03,2018-07-13,Chemotherapy,Public,Deceased,72.0,KRAS,No,Current,Moderate,34.6,High,Urban,NHS,6.0,No,No,Diabetes,2.0
PT06982,Poland,Silesian,84.0,Female,Breast,II,2023-05-12,2023-07-22,2023-12-07,Chemotherapy,Public,Alive,109.0,EGFR,No,Current,,36.6,Medium,Rural,Statutory Health Insurance,6.0,Yes,Yes,Diabetes,9.0
PT06983,Germany,North Rhine-Westphalia,63.0,Male,Prostate,II,2012-07-10,2012-11-14,2013-03-04,Radiation,Public,,45.0,BRCA1,No,Never,Moderate,36.6,Low,Urban,Private Insurance,1.0,No,,Obesity,3.0
PT06984,Belgium,Flanders,82.0,Female,Prostate,I,2014-09-17,2014-10-21,2015-05-17,Chemotherapy,Public,Deceased,6.0,EGFR,No,Never,None,37.0,Medium,,Statutory Health Insurance,3.0,Yes,No,Cardiovascular Disease,9.0
PT06985,France,Auvergne-Rhône-Alpes,65.0,Male,,II,2018-05-27,2018-11-19,,Radiation,Research Institute,,106.0,EGFR,No,Never,None,37.7,Medium,Rural,Private Insurance,7.0,No,No,Cardiovascular Disease,4.0
PT06986,Netherlands,South Holland,38.0,Female,Ovarian,II,2018-09-19,2019-01-30,2019-04-04,Surgery,Private,Alive,105.0,KRAS,Yes,Never,Moderate,26.2,,Urban,Private Insurance,2.0,No,No,Cardiovascular Disease,3.0
PT06987,Denmark,Zealand,83.0,,Leukemia,II,2014-02-24,2014-06-21,2015-04-08,Radiation,Public,Alive,102.0,None,No,Never,Heavy,26.3,Medium,Urban,NHS,9.0,No,No,Cardiovascular Disease,2.0
PT06988,Sweden,Västra Götaland,69.0,Male,Leukemia,III,2019-11-19,2019-11-27,2020-08-03,Chemotherapy,Private,Deceased,53.0,BRCA1,Yes,Never,None,28.2,Low,Urban,NHS,5.0,No,No,Hypertension,9.0
PT06989,Italy,Sicily,,,Breast,II,2016-04-28,2016-06-10,2017-01-11,Radiation,Public,Deceased,107.0,BRCA1,No,,Moderate,33.6,Medium,Urban,Statutory Health Insurance,6.0,,No,None,7.0
PT06990,Sweden,Västra Götaland,60.0,Male,Lung,III,,2023-03-10,2023-08-14,Radiation,Public,Deceased,114.0,,No,Never,Moderate,18.5,Low,Urban,Private Insurance,12.0,No,No,Cardiovascular Disease,8.0
PT06991,Spain,Andalusia,26.0,Male,Leukemia,III,2020-07-19,2020-07-20,2021-05-15,Targeted Therapy,Public,Alive,44.0,KRAS,Yes,Never,None,26.8,High,Urban,Private Insurance,19.0,No,,Diabetes,6.0
PT06992,Finland,Pirkanmaa,28.0,Male,Lung,,2017-06-29,2017-08-06,2018-03-24,Radiation,Public,Alive,49.0,EGFR,No,Never,Moderate,19.8,Low,Rural,NHS,8.0,,No,Obesity,4.0
PT06993,Italy,Sicily,23.0,Male,Breast,I,2013-02-07,2013-02-14,2014-01-21,Chemotherapy,Public,Alive,54.0,,No,Former,Moderate,32.4,Low,Urban,NHS,15.0,No,No,Diabetes,2.0
PT06994,Portugal,Algarve,68.0,Male,Lung,I,2014-02-11,2014-05-03,2014-08-19,Immunotherapy,Public,Alive,66.0,,Yes,Never,None,24.7,Medium,,Private Insurance,1.0,No,No,Diabetes,
PT06995,Norway,Trøndelag,25.0,Female,Prostate,IV,2022-12-03,,2024-02-09,Surgery,,Alive,118.0,KRAS,No,Never,None,19.4,Low,Urban,NHS,10.0,,No,Diabetes,3.0
PT06996,Switzerland,Geneva,40.0,Male,Prostate,IV,2014-06-25,2014-07-19,2015-01-12,Radiation,Public,Alive,117.0,BRCA1,No,Never,Moderate,20.4,Medium,Urban,Statutory Health Insurance,18.0,No,No,Cardiovascular Disease,8.0
PT06997,Poland,Lesser Poland,34.0,Male,Breast,I,2014-12-15,2015-01-19,2015-09-19,Chemotherapy,Public,Alive,80.0,KRAS,No,Never,None,37.7,Medium,Rural,NHS,3.0,No,No,Cardiovascular Disease,3.0
PT06998,Poland,Lesser Poland,86.0,Male,Lung,II,2010-09-24,2010-11-05,2011-04-07,Chemotherapy,Public,Deceased,59.0,None,Yes,Former,Moderate,36.7,Medium,Urban,,3.0,No,No,Diabetes,10.0
PT06999,Spain,Catalonia,85.0,Male,Ovarian,IV,2023-05-06,2023-06-19,2023-12-10,Targeted Therapy,Public,Deceased,115.0,KRAS,No,Former,Moderate,34.5,Low,Urban,NHS,8.0,No,No,Diabetes,5.0
PT07000,Spain,Madrid,75.0,Female,Ovarian,III,2011-10-30,2011-11-03,2012-04-22,Chemotherapy,Private,Alive,101.0,None,Yes,Never,None,24.1,Medium,Rural,Statutory Health Insurance,9.0,No,Yes,Cardiovascular Disease,8.0
PT07001,Finland,Pirkanmaa,87.0,Male,Lung,II,2010-02-23,,2010-08-05,Immunotherapy,Public,Alive,24.0,EGFR,Yes,Never,Heavy,,Low,Urban,Private Insurance,,Yes,No,None,3.0
PT07002,Ireland,Munster,51.0,Female,Breast,I,2017-09-22,2018-01-19,2018-10-07,Chemotherapy,Public,Alive,26.0,KRAS,Yes,Never,Heavy,38.7,Low,,NHS,14.0,No,No,None,1.0
PT07003,Switzerland,Zurich,85.0,Male,Ovarian,I,2020-10-20,2021-01-05,2021-07-13,Immunotherapy,Public,Lost to Follow-up,,KRAS,No,Never,None,37.2,Medium,Urban,Statutory Health Insurance,13.0,No,No,Diabetes,3.0
PT07004,Portugal,Porto,48.0,Female,Leukemia,III,2022-04-18,2022-05-12,2023-01-28,Surgery,Research Institute,Alive,80.0,BRCA1,No,Current,None,33.3,High,,Statutory Health Insurance,18.0,No,No,Obesity,5.0
PT07005,Spain,Catalonia,85.0,Male,Colorectal,III,2022-08-13,2022-10-23,2023-01-31,Radiation,Public,Alive,91.0,BRCA1,No,Never,Heavy,35.5,Medium,Rural,NHS,16.0,Yes,No,None,2.0
PT07006,Netherlands,South Holland,53.0,Male,Leukemia,II,2012-03-11,2012-08-05,2013-07-13,Surgery,Public,Alive,24.0,None,No,Never,None,18.5,Medium,Rural,NHS,18.0,No,No,None,6.0
PT07007,Netherlands,,46.0,Female,Pancreatic,I,2022-02-07,2022-06-10,2023-01-26,,Public,Alive,33.0,EGFR,No,Current,None,34.0,High,Rural,Private Insurance,18.0,Yes,No,Diabetes,8.0
PT07008,Germany,North Rhine-Westphalia,79.0,Male,Colorectal,IV,2021-06-23,2021-09-22,2022-07-16,Surgery,Private,,,EGFR,No,Never,Moderate,28.6,Medium,Urban,Private Insurance,11.0,No,No,,8.0
PT07009,Austria,Vienna,58.0,Female,Lung,III,2015-07-20,2016-01-14,2016-02-15,Immunotherapy,Public,Alive,95.0,KRAS,Yes,Former,None,22.2,Medium,Rural,Statutory Health Insurance,4.0,Yes,No,None,6.0
PT07010,Germany,Bavaria,63.0,Female,Colorectal,I,2010-06-23,2010-11-16,2011-05-07,Radiation,Private,,24.0,BRCA1,No,Current,Moderate,,Low,Urban,NHS,9.0,No,Yes,,2.0
PT07011,Spain,Madrid,55.0,Male,Ovarian,I,,2022-05-31,2022-11-13,Radiation,Private,Alive,20.0,KRAS,No,Current,Heavy,37.1,Low,Urban,Statutory Health Insurance,10.0,,No,None,4.0
PT07012,Finland,Southwest Finland,38.0,,Colorectal,II,2010-02-24,2010-07-30,2010-10-16,Surgery,,Alive,10.0,BRCA1,No,Current,Moderate,36.5,Medium,Urban,Statutory Health Insurance,10.0,No,No,Obesity,1.0
PT07013,France,Île-de-France,64.0,Non-binary,Lung,I,2011-12-11,2012-05-16,2012-12-03,Targeted Therapy,Private,Alive,17.0,EGFR,Yes,Current,None,27.0,Low,Rural,NHS,14.0,No,No,Diabetes,1.0
PT07014,Portugal,Algarve,40.0,Female,Prostate,I,2014-06-29,2014-09-10,2014-12-29,Targeted Therapy,Public,Alive,114.0,EGFR,Yes,Former,Heavy,22.9,Low,Urban,Statutory Health Insurance,2.0,No,No,Cardiovascular Disease,6.0
PT07015,Poland,Masovian,42.0,Female,Colorectal,I,2014-12-20,2015-04-02,2015-10-04,Surgery,Research Institute,Alive,28.0,BRCA1,No,,Moderate,32.4,Low,,Statutory Health Insurance,,No,No,Cardiovascular Disease,6.0
PT07016,Switzerland,Zurich,46.0,Male,,IV,2014-09-10,2014-12-22,,Chemotherapy,Private,Deceased,54.0,KRAS,Yes,Never,Heavy,29.0,Low,Rural,,4.0,No,,Obesity,1.0
,Portugal,Algarve,38.0,Female,Ovarian,III,2016-06-07,2016-08-31,2017-07-29,Surgery,Private,Alive,86.0,EGFR,,Never,None,32.9,Low,Urban,Statutory Health Insurance,14.0,Yes,No,Diabetes,3.0
PT07018,Sweden,Västra Götaland,60.0,Female,Breast,I,2018-12-21,2019-06-12,2019-08-01,Immunotherapy,Public,Deceased,16.0,None,Yes,Current,None,27.1,Low,Rural,Statutory Health Insurance,5.0,No,Yes,Obesity,9.0
PT07019,Norway,Oslo,45.0,Male,Leukemia,IV,2021-10-25,2022-02-04,2022-04-24,Immunotherapy,Public,Alive,100.0,EGFR,No,Never,Moderate,,Medium,Urban,NHS,6.0,Yes,No,Cardiovascular Disease,2.0
PT07020,France,Île-de-France,47.0,Non-binary,Lung,III,2022-05-21,,2023-04-25,Chemotherapy,Public,Deceased,46.0,None,,Never,Heavy,39.1,Medium,Urban,Statutory Health Insurance,2.0,,,,9.0
,Netherlands,Utrecht,83.0,Male,Lung,II,2021-08-07,2021-09-21,2022-02-11,Targeted Therapy,Public,Deceased,63.0,BRCA1,No,,Moderate,35.5,Medium,Urban,Statutory Health Insurance,5.0,Yes,No,Obesity,1.0
PT07022,France,Provence-Alpes-Côte d'Azur,87.0,Female,Colorectal,IV,2016-11-07,2017-02-04,2017-11-21,Immunotherapy,Public,Alive,117.0,KRAS,No,Never,Moderate,,Medium,Urban,NHS,15.0,No,No,None,2.0
PT07023,Sweden,Stockholm,70.0,Male,Prostate,II,2021-08-24,2022-01-25,2022-11-13,Immunotherapy,Research Institute,Alive,77.0,BRCA1,Yes,Former,Moderate,21.6,Medium,Rural,Private Insurance,8.0,No,No,Diabetes,8.0
PT07024,Germany,Berlin,67.0,Male,Prostate,III,2010-04-15,2010-06-24,2011-05-12,Radiation,Private,,45.0,EGFR,Yes,Former,Moderate,27.6,High,Rural,Private Insurance,6.0,No,No,None,1.0
PT07025,Spain,Madrid,29.0,Female,Leukemia,II,2017-08-21,2017-10-09,2018-07-19,Radiation,Private,Alive,27.0,KRAS,Yes,Never,Moderate,27.7,High,Rural,NHS,17.0,No,No,Diabetes,7.0
PT07026,Netherlands,South Holland,58.0,Male,,II,2015-05-04,2015-08-31,2015-12-05,Chemotherapy,Public,Alive,101.0,KRAS,No,Never,Heavy,36.1,Medium,Rural,Statutory Health Insurance,7.0,No,No,Diabetes,6.0
PT07027,Spain,Catalonia,38.0,Male,Ovarian,I,2022-01-02,2022-03-27,2022-08-06,Immunotherapy,Private,Alive,15.0,BRCA1,No,Never,Moderate,18.5,High,Rural,,5.0,No,No,Hypertension,9.0
PT07028,Switzerland,Zurich,83.0,Male,Prostate,II,2022-12-11,2023-05-06,2024-03-13,Surgery,Public,Deceased,44.0,BRCA1,No,Never,Moderate,,Medium,Rural,Statutory Health Insurance,17.0,No,No,Cardiovascular Disease,8.0
PT07029,France,Auvergne-Rhône-Alpes,38.0,Female,Pancreatic,II,2013-04-23,2013-06-02,2013-08-21,Targeted Therapy,,Alive,107.0,,No,Never,None,25.4,Medium,Rural,NHS,10.0,No,No,Diabetes,2.0
PT07030,Italy,Sicily,81.0,Non-binary,Prostate,IV,2021-12-23,2022-01-10,2022-08-03,Chemotherapy,Private,Alive,56.0,None,No,Never,None,,High,Rural,,17.0,Yes,No,Obesity,
PT07031,Spain,Andalusia,32.0,Male,Prostate,III,2018-03-15,2018-05-01,2019-04-23,Surgery,Public,Alive,50.0,BRCA1,No,Former,None,26.4,Medium,Urban,NHS,6.0,Yes,No,Obesity,7.0
,Spain,Madrid,44.0,Male,Colorectal,I,2021-10-30,2021-10-31,2022-07-30,Surgery,Private,Alive,,KRAS,No,Former,Moderate,22.7,Medium,,NHS,12.0,No,No,Obesity,9.0
PT07033,Italy,Veneto,61.0,Male,Ovarian,I,2015-03-22,2015-08-30,,Chemotherapy,Private,Alive,104.0,None,No,Never,None,39.6,,Rural,NHS,12.0,Yes,No,Diabetes,3.0
PT07034,Germany,Berlin,58.0,Female,,IV,2020-08-29,2020-10-07,,Chemotherapy,Public,Deceased,,,No,Never,Moderate,29.4,Medium,Urban,NHS,4.0,No,No,Obesity,9.0
PT07035,Italy,Sicily,49.0,Male,Leukemia,II,2014-09-07,2014-12-28,2015-03-15,,Research Institute,Deceased,23.0,BRCA1,Yes,,None,31.9,Low,Urban,NHS,5.0,No,No,Diabetes,8.0
PT07036,Spain,,24.0,Male,Pancreatic,II,2018-11-23,2018-12-16,,Targeted Therapy,Public,Alive,102.0,BRCA1,No,Current,Heavy,36.1,Medium,,Private Insurance,7.0,No,No,None,8.0
PT07037,Switzerland,,37.0,Male,Pancreatic,III,2021-06-11,2021-06-25,,Immunotherapy,,Alive,46.0,None,No,Never,None,29.3,Medium,Urban,Private Insurance,17.0,Yes,No,None,2.0
PT07038,Spain,Catalonia,40.0,Female,Lung,IV,2014-05-11,2014-10-30,2015-03-02,Surgery,Public,Alive,82.0,BRCA1,No,Never,None,27.9,Medium,Urban,Private Insurance,11.0,No,No,None,5.0
PT07039,,Västra Götaland,69.0,Female,Prostate,III,2015-11-10,2015-12-17,2016-09-26,Immunotherapy,Private,Alive,108.0,,No,Never,,30.9,Low,Urban,Statutory Health Insurance,16.0,No,No,Diabetes,2.0
PT07040,Sweden,Skåne,25.0,Female,Prostate,I,,2010-03-20,2010-07-13,Immunotherapy,Public,Alive,74.0,BRCA1,No,Former,Heavy,21.4,,Urban,Private Insurance,19.0,No,No,Obesity,10.0
PT07041,Italy,Sicily,,Male,Breast,II,2020-03-22,2020-06-06,2020-10-08,Targeted Therapy,Research Institute,Alive,58.0,KRAS,No,Former,None,35.9,Medium,Urban,,15.0,No,No,Cardiovascular Disease,3.0
PT07042,Switzerland,Bern,85.0,Female,Ovarian,III,2019-12-25,2020-06-07,2020-08-21,Radiation,,Alive,69.0,BRCA1,No,Current,Heavy,32.0,Low,Urban,NHS,3.0,Yes,No,None,
PT07043,Belgium,Flanders,20.0,Female,Prostate,IV,2014-07-13,2014-12-16,2015-02-19,Targeted Therapy,Private,,105.0,KRAS,,Current,None,38.6,High,Rural,Private Insurance,7.0,No,No,None,3.0
PT07044,Portugal,Algarve,76.0,Male,Leukemia,IV,2011-04-24,2011-08-25,2011-10-03,Immunotherapy,Research Institute,Deceased,51.0,None,No,Never,None,34.5,High,Urban,Statutory Health Insurance,13.0,No,Yes,Cardiovascular Disease,2.0
PT07045,Spain,Madrid,49.0,Male,Pancreatic,II,2021-07-05,2021-07-12,2022-04-11,Radiation,Private,Alive,30.0,BRCA1,Yes,Current,None,24.4,Low,Urban,Private Insurance,1.0,No,No,Diabetes,1.0
PT07046,Poland,Lesser Poland,77.0,Male,Prostate,III,2020-10-02,2021-01-19,2021-03-16,Surgery,Public,Alive,73.0,BRCA1,Yes,Current,None,36.1,Medium,Urban,Private Insurance,2.0,No,No,Cardiovascular Disease,9.0
PT07047,,Västra Götaland,71.0,Female,Breast,I,2020-02-15,2020-06-15,2020-10-01,Targeted Therapy,Public,Lost to Follow-up,,None,Yes,Former,Moderate,20.1,,Urban,Private Insurance,17.0,No,No,Cardiovascular Disease,8.0
PT07048,Norway,Oslo,56.0,Female,,I,2016-04-03,2016-08-26,2017-02-10,Chemotherapy,Private,Alive,52.0,EGFR,No,Never,,20.6,Medium,Urban,Private Insurance,6.0,Yes,,Cardiovascular Disease,1.0
PT07049,Sweden,Västra Götaland,67.0,Female,Leukemia,II,2015-07-08,2015-12-20,2016-02-19,Surgery,Public,,34.0,None,Yes,Never,,37.8,Low,Rural,NHS,2.0,Yes,No,Diabetes,1.0
PT07050,Ireland,Munster,20.0,Male,Colorectal,IV,2017-01-20,2017-02-03,2017-07-30,Radiation,Private,Alive,29.0,None,No,Current,None,21.4,Low,Urban,Statutory Health Insurance,17.0,No,No,Cardiovascular Disease,6.0
,Belgium,Wallonia,,Male,Lung,I,2014-06-16,2014-12-12,2015-02-25,,Research Institute,Alive,111.0,KRAS,No,Current,Moderate,19.9,Low,Urban,Private Insurance,10.0,No,No,,5.0
PT07052,Finland,Southwest Finland,65.0,Non-binary,Breast,II,2022-12-08,2023-02-01,2023-05-01,Chemotherapy,Public,Lost to Follow-up,,BRCA1,No,Current,Moderate,39.5,Medium,Urban,Private Insurance,11.0,No,No,Hypertension,3.0
PT07053,Sweden,Skåne,86.0,Male,,IV,2013-11-11,2014-01-07,2014-04-14,,Public,Alive,90.0,BRCA1,Yes,Never,Moderate,27.1,Low,Urban,NHS,7.0,No,Yes,Hypertension,9.0
PT07054,Norway,Trøndelag,21.0,Female,Lung,II,2013-05-27,2013-05-31,2013-07-16,Targeted Therapy,Private,Alive,63.0,KRAS,Yes,Former,None,34.4,Medium,Rural,Statutory Health Insurance,18.0,Yes,No,,9.0
PT07055,Norway,Vestland,75.0,Female,Pancreatic,I,2013-03-18,2013-05-06,2013-08-08,Targeted Therapy,Private,Deceased,110.0,KRAS,Yes,Former,None,34.5,High,Rural,Private Insurance,16.0,No,No,Obesity,1.0
PT07056,Italy,Lombardy,36.0,Male,Lung,III,2015-10-03,2015-12-23,2016-07-24,Immunotherapy,Public,Alive,80.0,BRCA1,Yes,Never,Moderate,24.2,Low,Urban,Private Insurance,19.0,No,No,Obesity,5.0
PT07057,Italy,Veneto,41.0,Male,Lung,III,2015-02-25,2015-04-01,2016-01-30,Immunotherapy,Public,Deceased,32.0,EGFR,No,Current,,20.2,High,Urban,Statutory Health Insurance,5.0,Yes,No,None,5.0
PT07058,Germany,Bavaria,46.0,Female,Breast,II,2018-09-20,2019-01-08,2019-02-11,Surgery,Public,Deceased,117.0,EGFR,No,,None,21.5,Medium,Urban,Statutory Health Insurance,15.0,No,Yes,None,
PT07059,Denmark,Zealand,74.0,Male,Colorectal,IV,2011-03-03,2011-08-10,,Chemotherapy,Private,Alive,53.0,KRAS,Yes,Never,None,26.8,Low,Urban,Private Insurance,17.0,No,No,Obesity,1.0
PT07060,Finland,Pirkanmaa,51.0,Female,Prostate,I,2016-12-20,2017-04-01,2017-06-24,Surgery,Private,Alive,106.0,BRCA1,Yes,Never,Moderate,39.1,Low,Urban,NHS,18.0,Yes,No,Cardiovascular Disease,1.0
PT07061,Finland,Pirkanmaa,,Male,Lung,IV,,2013-12-07,,Radiation,Public,Alive,46.0,EGFR,Yes,Former,Heavy,26.4,High,Urban,Private Insurance,6.0,No,No,None,8.0
PT07062,Ireland,,47.0,Female,Pancreatic,III,2011-05-26,2011-06-05,2011-12-31,Radiation,Public,Alive,79.0,,No,Former,Moderate,37.8,Medium,Rural,,10.0,Yes,No,Obesity,9.0
PT07063,Norway,Oslo,47.0,Female,Ovarian,II,2011-03-17,2011-07-08,2011-08-25,Immunotherapy,Public,Lost to Follow-up,,BRCA1,Yes,Never,None,35.7,Low,Urban,NHS,12.0,No,No,Diabetes,5.0
PT07064,,Munster,44.0,Female,Prostate,III,2014-07-14,2014-07-16,2014-12-23,Surgery,Public,Alive,16.0,None,No,Never,Moderate,29.8,Medium,Rural,NHS,6.0,No,No,Diabetes,7.0
PT07065,Spain,Catalonia,45.0,Female,Pancreatic,I,2020-01-23,2020-03-26,2020-06-30,Radiation,Private,Alive,48.0,None,No,Current,Moderate,20.4,Low,Urban,Private Insurance,1.0,No,No,Cardiovascular Disease,6.0
PT07066,France,Auvergne-Rhône-Alpes,36.0,Female,Prostate,I,2023-09-27,2024-01-25,2024-12-04,Immunotherapy,Public,Alive,78.0,EGFR,No,Never,Moderate,33.9,High,Urban,Statutory Health Insurance,19.0,No,No,Diabetes,7.0
PT07067,,South Holland,26.0,Male,Lung,IV,2017-08-01,2017-12-23,2018-07-21,Surgery,Research Institute,Deceased,111.0,None,No,Former,None,33.3,Medium,Urban,Private Insurance,5.0,Yes,No,Diabetes,10.0
PT07068,Finland,Pirkanmaa,,Male,Leukemia,I,2018-05-03,2018-05-19,2018-10-31,Chemotherapy,Public,,8.0,None,No,Former,Moderate,28.2,Medium,Urban,NHS,13.0,Yes,Yes,Cardiovascular Disease,8.0
PT07069,Norway,Trøndelag,,Male,Ovarian,I,2017-04-11,2017-08-20,2018-01-29,Radiation,Private,Deceased,54.0,EGFR,Yes,Never,None,28.5,High,Urban,Statutory Health Insurance,18.0,No,,Obesity,3.0
PT07070,,Catalonia,39.0,Male,Prostate,II,2023-05-18,2023-06-05,2023-09-06,Radiation,Private,Deceased,,BRCA1,No,Never,Moderate,19.0,,Rural,Statutory Health Insurance,5.0,No,No,Cardiovascular Disease,8.0
PT07071,Italy,Sicily,57.0,Male,Leukemia,I,2019-11-17,2019-12-29,2020-02-23,Chemotherapy,Private,Alive,49.0,BRCA1,No,Current,None,26.0,,Urban,NHS,14.0,No,No,None,4.0
PT07072,Sweden,Västra Götaland,77.0,Male,Colorectal,IV,2011-01-31,2011-07-10,2012-05-23,,Public,Deceased,11.0,EGFR,No,,Heavy,27.4,Low,Urban,NHS,3.0,No,No,None,9.0
PT07073,France,,35.0,Non-binary,Prostate,IV,2018-08-13,2018-12-15,2019-11-23,Radiation,,Lost to Follow-up,,EGFR,No,Current,None,21.9,Medium,Rural,NHS,8.0,No,No,Hypertension,5.0
PT07074,Sweden,Västra Götaland,,Female,Breast,II,2012-04-07,2012-05-27,2013-05-09,Chemotherapy,Private,Alive,53.0,KRAS,No,Current,None,22.4,Medium,,Private Insurance,3.0,Yes,Yes,Obesity,6.0
PT07075,Finland,Southwest Finland,,Male,Pancreatic,II,2019-10-31,2020-04-25,2021-03-02,Immunotherapy,Private,Alive,94.0,None,No,Never,Heavy,23.9,Low,Urban,NHS,,No,No,Cardiovascular Disease,3.0
PT07076,,Trøndelag,70.0,Non-binary,Ovarian,II,2018-03-24,2018-03-27,2018-12-04,Targeted Therapy,Public,Alive,76.0,EGFR,No,Never,Moderate,29.2,Medium,Rural,NHS,17.0,No,No,Diabetes,
PT07077,Austria,Styria,35.0,Male,Colorectal,I,2022-10-05,2022-12-16,2023-10-11,Immunotherapy,Public,Alive,32.0,None,No,Never,Moderate,19.6,High,Rural,Private Insurance,17.0,Yes,No,Cardiovascular Disease,7.0
PT07078,Netherlands,,79.0,Male,Colorectal,I,2012-03-02,2012-06-26,2012-08-26,Radiation,Private,,,EGFR,,Former,None,28.8,Low,Urban,Private Insurance,11.0,No,No,None,1.0
PT07079,Belgium,Brussels,59.0,Female,Ovarian,I,2011-05-18,2011-09-20,2012-08-11,Immunotherapy,Private,Alive,55.0,None,No,Current,Moderate,25.9,Medium,Rural,Private Insurance,4.0,No,No,Hypertension,3.0
PT07080,Austria,,86.0,Male,Leukemia,II,2020-08-28,2021-01-02,2021-10-07,Radiation,Public,Alive,91.0,BRCA1,Yes,,Moderate,29.3,,Urban,Private Insurance,6.0,No,No,Cardiovascular Disease,7.0
PT07081,Spain,Madrid,21.0,Female,Lung,III,,2023-05-14,2023-11-01,Immunotherapy,Research Institute,Alive,88.0,BRCA1,Yes,Former,None,30.2,Medium,Urban,Private Insurance,7.0,No,Yes,Diabetes,7.0
PT07082,Portugal,Algarve,,Male,Pancreatic,IV,2022-02-16,2022-05-11,,Targeted Therapy,Private,Alive,99.0,EGFR,No,Former,None,36.3,Medium,Rural,Private Insurance,2.0,No,No,None,1.0
,Denmark,Central Denmark,71.0,Male,Breast,III,2022-07-23,2023-01-11,2023-08-04,Immunotherapy,Public,Alive,91.0,None,No,Never,Heavy,26.1,High,Urban,NHS,15.0,No,No,Diabetes,6.0
PT07084,Spain,Catalonia,43.0,Male,Ovarian,III,2015-08-11,2016-01-11,2016-11-29,Targeted Therapy,Public,Alive,28.0,EGFR,Yes,Never,None,36.3,High,Rural,NHS,19.0,Yes,No,Cardiovascular Disease,7.0
PT07085,Portugal,Algarve,21.0,Female,Ovarian,II,2017-04-28,2017-05-21,2017-07-22,Radiation,Private,Alive,81.0,None,No,Never,Moderate,20.0,Low,Urban,,2.0,No,No,Diabetes,2.0
PT07086,Austria,Tyrol,84.0,Female,Breast,IV,2019-05-02,2019-09-17,2020-01-21,Immunotherapy,Research Institute,Lost to Follow-up,,EGFR,Yes,Current,Heavy,18.6,High,Urban,Statutory Health Insurance,3.0,Yes,Yes,Cardiovascular Disease,3.0
PT07087,Portugal,Algarve,39.0,Female,Leukemia,IV,2016-02-13,2016-06-30,2016-08-22,Chemotherapy,Public,Alive,71.0,EGFR,No,Former,Moderate,22.0,High,,Private Insurance,8.0,No,No,Obesity,4.0
PT07088,Denmark,Zealand,53.0,Female,Leukemia,IV,2021-01-04,2021-06-14,2021-08-08,Targeted Therapy,Public,Alive,34.0,KRAS,No,Never,Heavy,30.3,High,Urban,Statutory Health Insurance,5.0,No,No,Diabetes,2.0
PT07089,Denmark,Capital Region,60.0,Male,Colorectal,I,2019-08-04,,2020-01-03,Surgery,Private,Lost to Follow-up,,KRAS,No,Former,Moderate,35.3,High,Rural,Statutory Health Insurance,12.0,No,No,None,8.0
PT07090,Spain,Andalusia,60.0,Female,,III,2019-11-20,,2020-10-30,Targeted Therapy,Research Institute,Alive,98.0,KRAS,No,Former,None,39.2,Medium,Rural,Private Insurance,12.0,No,No,None,3.0
PT07091,Norway,Vestland,42.0,Male,Leukemia,III,2021-01-27,2021-05-04,2021-09-05,Immunotherapy,Public,Alive,19.0,KRAS,Yes,Never,None,23.9,Medium,Rural,NHS,,No,No,Cardiovascular Disease,5.0
PT07092,Switzerland,Zurich,57.0,Male,Lung,I,2015-12-11,2016-02-23,2016-10-28,Targeted Therapy,Private,Alive,78.0,KRAS,No,Never,Heavy,25.3,Medium,Urban,Statutory Health Insurance,7.0,No,No,None,2.0
PT07093,Portugal,Lisbon,,Female,Colorectal,IV,2022-09-22,2022-10-19,2023-04-07,Immunotherapy,Public,Deceased,114.0,KRAS,Yes,Never,Heavy,23.6,Low,,NHS,17.0,,No,Hypertension,5.0
PT07094,Norway,Vestland,86.0,Male,Colorectal,I,2013-05-27,2013-11-06,2014-07-17,Radiation,Public,Alive,111.0,None,Yes,Never,Moderate,24.9,High,Urban,NHS,9.0,No,No,None,10.0
PT07095,Belgium,Flanders,81.0,Male,Colorectal,I,2013-12-10,,2014-12-15,Radiation,Private,Deceased,95.0,,Yes,Never,Moderate,26.7,Low,Urban,Private Insurance,3.0,No,No,Diabetes,1.0
PT07096,,Vienna,31.0,Female,Breast,,2020-07-04,2020-11-27,2021-06-09,Chemotherapy,Public,Deceased,34.0,BRCA1,No,Never,Moderate,31.5,Medium,Urban,Private Insurance,7.0,Yes,No,Obesity,2.0
PT07097,Italy,Lombardy,49.0,Female,Pancreatic,II,2013-04-24,2013-05-01,2013-07-28,Surgery,Public,Deceased,10.0,EGFR,Yes,Former,Moderate,30.2,Medium,Rural,Statutory Health Insurance,17.0,Yes,No,Cardiovascular Disease,9.0
PT07098,Portugal,Lisbon,84.0,Female,Pancreatic,IV,2019-12-15,2019-12-25,2020-10-21,,Public,Alive,91.0,BRCA1,No,Former,Moderate,19.3,High,Urban,Statutory Health Insurance,2.0,No,No,Hypertension,10.0
PT07099,Austria,Styria,60.0,Male,Breast,II,2018-12-21,2019-01-17,2019-12-07,Chemotherapy,Public,Lost to Follow-up,,KRAS,Yes,Never,Moderate,29.6,Medium,Urban,Statutory Health Insurance,12.0,No,No,,7.0
PT07100,Sweden,Västra Götaland,39.0,Male,Colorectal,II,2022-02-18,2022-04-27,2022-12-12,Surgery,Public,Alive,64.0,None,No,Current,None,35.0,Medium,Urban,Statutory Health Insurance,11.0,No,No,Hypertension,1.0
,Germany,Berlin,25.0,Female,Lung,III,2020-08-09,2020-09-26,2021-01-15,,Public,Deceased,98.0,EGFR,No,Never,Moderate,32.5,Medium,Urban,NHS,5.0,No,No,Hypertension,
PT07102,Netherlands,Utrecht,23.0,Female,Prostate,,2011-01-25,2011-05-12,2012-02-15,Radiation,Research Institute,Alive,82.0,KRAS,Yes,Former,None,32.4,High,Urban,NHS,6.0,No,No,Hypertension,3.0
PT07103,Austria,Styria,,Female,Colorectal,III,2014-08-30,2014-11-05,2015-08-26,Surgery,Private,Alive,23.0,EGFR,No,,None,20.0,High,Urban,Private Insurance,6.0,No,No,Obesity,8.0
PT07104,Finland,Uusimaa,70.0,Non-binary,Leukemia,,2014-03-16,2014-06-13,2014-10-12,Radiation,Public,Alive,76.0,EGFR,Yes,Never,Moderate,29.4,Medium,Urban,Statutory Health Insurance,11.0,No,No,Hypertension,7.0
PT07105,Switzerland,Zurich,57.0,Female,Ovarian,II,2015-06-21,,2016-09-24,Immunotherapy,Private,Alive,82.0,BRCA1,Yes,Former,Moderate,23.8,Medium,Urban,Private Insurance,10.0,No,No,,1.0
PT07106,Sweden,Skåne,20.0,Male,Ovarian,IV,2014-12-03,2015-05-20,2015-09-01,Surgery,Public,Lost to Follow-up,,None,No,Former,None,34.9,Low,Urban,Private Insurance,2.0,No,No,Obesity,1.0
PT07107,Switzerland,Geneva,27.0,Female,Pancreatic,II,2023-11-16,2024-01-26,2024-12-30,Chemotherapy,Public,Alive,66.0,,Yes,Former,None,19.2,Medium,Urban,Statutory Health Insurance,19.0,No,Yes,None,5.0
PT07108,Netherlands,Utrecht,82.0,Female,Ovarian,III,2021-10-31,2021-12-16,2022-01-28,Immunotherapy,Private,Deceased,114.0,None,No,Former,Moderate,31.4,Medium,Urban,Statutory Health Insurance,18.0,No,No,Diabetes,2.0
PT07109,Norway,Trøndelag,52.0,Female,Prostate,IV,2015-01-19,2015-04-27,2015-12-27,Chemotherapy,Public,,117.0,BRCA1,Yes,Never,Moderate,21.0,Medium,Urban,Private Insurance,15.0,No,No,Cardiovascular Disease,6.0
PT07110,Italy,Sicily,34.0,Male,Breast,III,2017-01-04,,2017-07-23,Radiation,Private,Alive,53.0,KRAS,No,Never,Moderate,,Low,Urban,NHS,1.0,Yes,No,Obesity,3.0
PT07111,Belgium,Wallonia,50.0,Female,,II,2010-01-29,2010-02-09,2010-07-21,Radiation,Private,Alive,105.0,BRCA1,No,Never,None,18.8,Medium,Urban,NHS,14.0,No,No,Cardiovascular Disease,6.0
PT07112,Ireland,Munster,40.0,Female,Prostate,I,2022-11-13,2023-05-11,2024-01-20,Immunotherapy,Private,Alive,90.0,None,No,,Moderate,29.2,Medium,Rural,NHS,6.0,No,No,Diabetes,7.0
PT07113,Spain,Catalonia,22.0,Female,Pancreatic,III,2023-11-09,2023-12-11,2024-09-05,Immunotherapy,Public,Alive,97.0,KRAS,No,Never,None,32.4,High,Urban,Private Insurance,14.0,No,Yes,Hypertension,6.0
PT07114,Norway,Vestland,85.0,Female,Pancreatic,IV,2012-09-07,2012-11-18,2013-08-31,Surgery,Public,Alive,49.0,None,No,Never,None,25.6,Medium,Urban,Private Insurance,14.0,No,No,Obesity,
PT07115,Spain,Andalusia,54.0,Male,Leukemia,,2018-05-13,2018-10-08,2019-03-28,Chemotherapy,Private,Alive,43.0,EGFR,Yes,Former,Moderate,38.7,Medium,Urban,Private Insurance,11.0,No,No,Hypertension,3.0
PT07116,Germany,Berlin,60.0,Male,Breast,,2019-10-24,2020-03-05,2020-11-28,Targeted Therapy,,Deceased,8.0,EGFR,No,Current,Moderate,27.4,Medium,Rural,Statutory Health Insurance,10.0,Yes,No,Obesity,9.0
PT07117,Denmark,Zealand,78.0,Male,Breast,II,2023-12-27,2024-05-01,2024-07-24,Radiation,Public,,33.0,None,Yes,Never,None,24.7,High,Rural,NHS,16.0,Yes,No,Diabetes,3.0
PT07118,Switzerland,Bern,35.0,Male,,III,2014-07-17,2015-01-02,2015-02-17,Targeted Therapy,Public,Deceased,59.0,EGFR,No,Never,None,35.9,High,Urban,Private Insurance,7.0,No,No,Hypertension,6.0
PT07119,Austria,Styria,75.0,,Lung,I,2023-03-14,2023-03-27,2023-05-04,Targeted Therapy,Public,Lost to Follow-up,,BRCA1,Yes,Never,Moderate,22.6,,Rural,NHS,13.0,No,Yes,Obesity,5.0
PT07120,Poland,Masovian,64.0,Male,Leukemia,IV,2023-02-06,2023-06-08,2024-03-31,Immunotherapy,Public,Deceased,50.0,None,No,Former,None,35.6,High,Rural,Private Insurance,7.0,No,No,None,5.0
PT07121,Portugal,Lisbon,78.0,Female,Colorectal,IV,2023-09-14,2023-12-21,2024-05-20,Chemotherapy,Public,Alive,91.0,KRAS,No,Never,Moderate,37.0,Low,Urban,NHS,3.0,No,No,Diabetes,4.0
PT07122,Denmark,Capital Region,69.0,Male,,II,2017-02-17,2017-06-28,2018-06-14,Targeted Therapy,Research Institute,,48.0,None,Yes,Never,Moderate,23.9,Low,Urban,NHS,10.0,No,No,None,6.0
PT07123,France,Île-de-France,31.0,Male,Lung,I,2020-11-05,2021-03-28,2021-06-02,Chemotherapy,Research Institute,Alive,112.0,KRAS,No,Never,None,33.0,Low,Urban,NHS,16.0,No,No,Diabetes,4.0
PT07124,Portugal,Algarve,31.0,Male,Ovarian,III,2016-05-15,2016-08-20,2017-07-24,Immunotherapy,Public,Alive,38.0,None,Yes,Former,,27.8,High,Urban,Statutory Health Insurance,7.0,No,No,Cardiovascular Disease,6.0
PT07125,Sweden,Stockholm,52.0,Female,Breast,I,2012-04-19,2012-06-14,2012-12-29,Targeted Therapy,Public,Alive,119.0,None,No,Never,Moderate,30.5,Medium,Urban,Private Insurance,5.0,No,No,None,10.0
PT07126,Netherlands,Utrecht,68.0,Male,Lung,II,2016-08-11,2016-12-13,2017-12-11,Targeted Therapy,Public,Alive,18.0,None,No,Former,None,,High,Urban,,9.0,No,Yes,Obesity,8.0
,Finland,Uusimaa,40.0,,Breast,I,,2022-08-03,2023-05-19,Radiation,Private,Alive,46.0,EGFR,No,Never,Moderate,22.4,,Urban,Private Insurance,9.0,Yes,No,Obesity,2.0
PT07128,Belgium,Wallonia,79.0,Female,Pancreatic,II,2011-02-01,2011-03-19,2011-06-27,Targeted Therapy,Public,Alive,62.0,None,No,Current,Moderate,36.8,Low,,Private Insurance,,No,No,Cardiovascular Disease,9.0
PT07129,Sweden,Stockholm,71.0,Non-binary,Colorectal,II,2011-01-20,2011-05-17,2011-07-02,Surgery,Public,Alive,114.0,KRAS,No,Never,Moderate,39.7,Low,Urban,Statutory Health Insurance,14.0,No,No,Hypertension,1.0
PT07130,Norway,Vestland,73.0,Female,Breast,III,2019-10-23,2020-04-16,2020-08-25,Immunotherapy,Public,Alive,106.0,None,,Never,Moderate,29.4,Low,Rural,,4.0,No,Yes,Cardiovascular Disease,4.0
PT07131,Netherlands,North Holland,58.0,Male,Lung,III,2020-11-22,,2021-11-09,Surgery,Public,Alive,10.0,EGFR,Yes,Former,None,20.8,Low,Urban,NHS,7.0,No,No,None,6.0
PT07132,Germany,Bavaria,68.0,Male,Colorectal,,2017-02-18,2017-05-26,2018-03-29,Targeted Therapy,Public,Deceased,105.0,BRCA1,Yes,Never,None,34.2,Low,Rural,Private Insurance,19.0,No,Yes,Obesity,1.0
PT07133,Spain,Madrid,83.0,Non-binary,Lung,I,2021-12-07,2022-05-20,2023-04-10,Targeted Therapy,Public,Alive,109.0,EGFR,No,Never,None,21.6,Medium,Urban,Private Insurance,2.0,No,Yes,Diabetes,7.0
PT07134,Norway,Trøndelag,45.0,Female,Lung,I,2018-09-02,2019-01-31,2019-10-24,Surgery,Research Institute,Deceased,13.0,EGFR,No,Former,Moderate,18.9,High,Urban,Statutory Health Insurance,9.0,No,No,Hypertension,6.0
PT07135,Switzerland,Zurich,26.0,Female,Prostate,II,2012-08-01,2012-09-25,2013-02-05,Radiation,Private,Alive,71.0,KRAS,Yes,Never,Moderate,28.3,Medium,Urban,NHS,13.0,No,No,Cardiovascular Disease,3.0
PT07136,Italy,Sicily,,Male,Breast,I,2023-12-04,2024-01-27,2024-07-07,Radiation,Public,Alive,49.0,None,No,Never,Moderate,32.9,Low,Rural,Private Insurance,9.0,No,No,None,6.0
PT07137,Netherlands,Utrecht,,Male,Breast,I,2014-11-21,2015-03-26,2015-05-03,Surgery,Public,Deceased,48.0,BRCA1,No,Never,None,29.0,Medium,Urban,Statutory Health Insurance,4.0,No,No,Hypertension,2.0
PT07138,France,Provence-Alpes-Côte d'Azur,59.0,Male,Lung,II,2012-04-26,2012-06-30,2012-09-27,Surgery,Public,Alive,110.0,BRCA1,No,Former,Heavy,22.3,Low,Rural,Statutory Health Insurance,1.0,No,Yes,Diabetes,5.0
PT07139,Denmark,,66.0,Female,Ovarian,II,2014-01-21,2014-03-13,2015-01-12,Immunotherapy,Private,Deceased,86.0,BRCA1,No,Never,None,,,Urban,NHS,13.0,Yes,No,Diabetes,5.0
PT07140,Belgium,Wallonia,27.0,Male,Pancreatic,I,,2018-12-20,2019-05-21,Radiation,Private,Alive,9.0,EGFR,Yes,Former,Moderate,21.6,Medium,Rural,Private Insurance,12.0,No,No,None,1.0
PT07141,Poland,Masovian,73.0,Non-binary,Breast,II,2013-10-18,2014-02-23,2015-01-08,,Research Institute,Lost to Follow-up,,KRAS,No,Never,Moderate,38.1,Medium,Rural,Private Insurance,15.0,Yes,No,Cardiovascular Disease,1.0
PT07142,Sweden,Stockholm,28.0,Male,Leukemia,II,2016-01-15,2016-06-11,2016-11-12,Targeted Therapy,Public,Deceased,24.0,BRCA1,No,Never,Moderate,27.5,Low,Urban,,14.0,No,No,Cardiovascular Disease,8.0
PT07143,Belgium,Flanders,22.0,Female,Pancreatic,I,2013-07-04,2013-10-03,2014-01-11,Targeted Therapy,Public,Deceased,39.0,EGFR,No,Never,Moderate,25.0,Medium,Urban,Statutory Health Insurance,18.0,No,No,Cardiovascular Disease,3.0
PT07144,Germany,North Rhine-Westphalia,73.0,Male,Pancreatic,IV,,2014-10-29,2015-05-12,Surgery,Public,,67.0,EGFR,Yes,Never,None,35.3,Low,Urban,NHS,16.0,Yes,Yes,Cardiovascular Disease,3.0
PT07145,Denmark,Zealand,,Female,Pancreatic,I,2015-06-06,2015-07-08,2015-09-07,Chemotherapy,Research Institute,Deceased,86.0,KRAS,No,Current,Moderate,,High,Urban,NHS,12.0,No,,Obesity,5.0
PT07146,Portugal,Lisbon,67.0,Male,Breast,I,2010-11-09,2011-02-20,2011-09-11,Radiation,Public,Deceased,94.0,EGFR,No,,None,21.0,,Rural,NHS,14.0,No,No,,3.0
PT07147,Spain,Madrid,66.0,Female,Pancreatic,I,2020-07-26,2020-09-21,2020-11-14,Radiation,Private,Lost to Follow-up,,None,Yes,Former,None,20.4,Low,Urban,NHS,13.0,No,No,Hypertension,
PT07148,Germany,Berlin,87.0,Female,Pancreatic,I,2015-12-05,2016-01-03,2016-12-17,Radiation,Public,Alive,10.0,EGFR,Yes,Never,Moderate,23.9,Medium,Urban,Statutory Health Insurance,5.0,No,No,Hypertension,7.0
PT07149,Spain,,82.0,Male,Colorectal,IV,2014-08-27,,2015-08-26,Surgery,Private,Alive,86.0,KRAS,No,Current,Moderate,34.8,Medium,Rural,NHS,2.0,No,No,None,5.0
PT07150,Ireland,Munster,35.0,Female,Breast,I,2018-05-27,,2019-07-20,Surgery,,Deceased,16.0,EGFR,Yes,Former,None,27.9,Medium,Urban,Private Insurance,12.0,Yes,No,Hypertension,
PT07151,Belgium,Brussels,24.0,,Pancreatic,III,2014-11-14,2015-03-16,2016-03-04,Targeted Therapy,Public,Alive,63.0,EGFR,No,Never,Moderate,22.1,Low,Urban,NHS,8.0,No,No,None,2.0
PT07152,Netherlands,Utrecht,30.0,Female,Ovarian,II,2021-09-09,2022-02-19,2022-07-24,Targeted Therapy,Public,Alive,21.0,EGFR,No,Former,,18.9,Medium,Rural,NHS,6.0,No,No,Obesity,
PT07153,Poland,Masovian,48.0,Female,Leukemia,III,2020-02-20,2020-05-09,2021-03-19,Radiation,Private,Alive,85.0,BRCA1,No,Never,Moderate,26.2,Low,Urban,Statutory Health Insurance,10.0,No,No,Hypertension,3.0
PT07154,Finland,Uusimaa,89.0,Female,Pancreatic,IV,2012-01-19,2012-05-05,2012-12-07,Targeted Therapy,Public,Alive,75.0,None,No,Former,None,23.2,Low,Urban,Statutory Health Insurance,10.0,Yes,No,Obesity,10.0
PT07155,Norway,Oslo,67.0,Male,Lung,III,2014-12-13,2015-02-03,2015-08-10,Targeted Therapy,Public,Alive,107.0,,Yes,Never,None,38.9,High,Rural,NHS,3.0,No,No,Hypertension,6.0
PT07156,Spain,Madrid,34.0,Male,Breast,I,2014-03-14,2014-08-04,2014-09-28,Radiation,Public,Alive,108.0,EGFR,No,Never,None,22.4,Low,Rural,Statutory Health Insurance,,No,Yes,Cardiovascular Disease,4.0
PT07157,Germany,Berlin,53.0,Non-binary,Colorectal,III,2020-05-24,2020-08-21,2020-11-21,Surgery,Research Institute,Alive,87.0,,No,Current,None,33.5,Low,Urban,NHS,12.0,No,No,Cardiovascular Disease,9.0
PT07158,Finland,Uusimaa,,Female,Leukemia,II,2016-03-31,2016-09-26,2017-01-18,Targeted Therapy,Public,Alive,115.0,EGFR,No,Current,Moderate,23.0,Low,Urban,NHS,7.0,No,No,Diabetes,5.0
PT07159,Italy,Lombardy,81.0,Male,Prostate,II,2019-05-16,2019-06-16,2020-02-26,Surgery,Public,Deceased,8.0,KRAS,Yes,Current,None,,Low,Rural,Statutory Health Insurance,15.0,No,No,Obesity,6.0
PT07160,Denmark,Zealand,21.0,Female,Lung,III,2016-01-19,2016-04-12,2016-11-04,Chemotherapy,Public,Alive,23.0,None,No,,Moderate,18.2,Low,Urban,Private Insurance,14.0,No,,Obesity,8.0
PT07161,,Zealand,38.0,Male,Lung,IV,2020-01-11,2020-06-03,2021-05-13,,Public,Alive,115.0,,No,Former,Heavy,23.9,Low,Rural,NHS,2.0,No,No,Hypertension,6.0
PT07162,Norway,Trøndelag,68.0,Female,Lung,I,2017-07-01,2017-12-12,2018-09-06,Immunotherapy,Public,Alive,12.0,None,No,Never,,38.0,Medium,Urban,,2.0,No,No,Hypertension,2.0
PT07163,Spain,Madrid,47.0,Female,Leukemia,III,2010-10-19,2010-11-27,2011-02-11,Immunotherapy,Private,Alive,80.0,EGFR,Yes,Never,Heavy,23.2,Medium,Rural,Private Insurance,2.0,No,No,Obesity,1.0
PT07164,Netherlands,North Holland,67.0,Female,Breast,I,2021-07-24,2021-12-10,2022-10-13,Radiation,Public,Alive,52.0,KRAS,Yes,Never,None,,Low,Urban,Statutory Health Insurance,11.0,No,No,Cardiovascular Disease,7.0
PT07165,Norway,,56.0,Male,Breast,II,2017-07-03,2017-11-28,2018-07-07,Immunotherapy,Public,Alive,20.0,None,No,Former,Moderate,23.3,Low,Urban,Private Insurance,10.0,No,No,None,6.0
,Portugal,Lisbon,68.0,Male,Pancreatic,IV,2015-05-05,2015-06-30,2016-01-19,Chemotherapy,Public,Alive,106.0,KRAS,No,Never,None,33.7,Medium,Urban,Statutory Health Insurance,3.0,No,No,Cardiovascular Disease,2.0
PT07167,Italy,Veneto,67.0,Male,Pancreatic,II,,2017-02-18,2017-08-26,Surgery,Public,Alive,67.0,None,No,Current,None,34.9,Medium,Rural,NHS,10.0,Yes,No,Diabetes,9.0
PT07168,Austria,Tyrol,,Female,Breast,I,2017-09-28,2017-11-14,2018-07-14,Surgery,Public,Deceased,83.0,EGFR,No,Former,None,22.6,Low,Urban,NHS,1.0,No,No,Diabetes,5.0
PT07169,Poland,,79.0,Male,Ovarian,II,2010-06-30,2010-07-06,2010-11-03,Targeted Therapy,Research Institute,Alive,28.0,BRCA1,No,Former,None,,Medium,Urban,,15.0,No,No,Cardiovascular Disease,9.0
PT07170,Finland,Uusimaa,48.0,Male,Pancreatic,III,2013-03-16,2013-07-03,2014-03-23,Targeted Therapy,Public,Lost to Follow-up,,KRAS,No,Current,None,20.9,Medium,Urban,Statutory Health Insurance,16.0,Yes,No,None,3.0
PT07171,Poland,Masovian,77.0,Female,Ovarian,II,2017-07-06,2017-08-10,2018-02-20,Targeted Therapy,Private,Alive,41.0,None,Yes,Former,None,28.8,Medium,Urban,Statutory Health Insurance,18.0,No,No,Obesity,4.0
PT07172,France,Provence-Alpes-Côte d'Azur,67.0,Female,Breast,I,2013-02-09,2013-06-25,2014-06-12,Surgery,Public,Alive,22.0,EGFR,No,,Heavy,26.9,Low,Urban,NHS,6.0,No,No,Diabetes,3.0
PT07173,Spain,,42.0,Female,Lung,II,2014-09-07,2014-11-17,2015-06-14,Surgery,Private,Alive,27.0,EGFR,No,Never,,20.2,Medium,Urban,Statutory Health Insurance,4.0,Yes,No,Hypertension,
PT07174,Spain,Catalonia,46.0,Female,Prostate,IV,2016-06-02,,2016-11-24,Targeted Therapy,Private,Deceased,29.0,BRCA1,Yes,Current,Heavy,20.6,Medium,Urban,Private Insurance,19.0,No,No,Hypertension,2.0
PT07175,,Masovian,26.0,Male,Lung,III,2023-02-08,2023-08-05,2023-10-07,Surgery,Public,Alive,32.0,None,No,Current,None,30.3,Low,Rural,Private Insurance,7.0,,No,Diabetes,8.0
PT07176,Portugal,Porto,68.0,Female,Ovarian,III,2022-10-02,2023-02-02,2023-09-08,Chemotherapy,Private,Lost to Follow-up,,BRCA1,Yes,Never,Moderate,39.8,Medium,Urban,Statutory Health Insurance,5.0,No,No,None,5.0
PT07177,Poland,Silesian,73.0,Female,Pancreatic,III,2020-11-18,2021-04-11,2022-04-02,Targeted Therapy,Private,,22.0,None,No,Never,None,38.4,Low,Urban,NHS,15.0,Yes,No,,
PT07178,Portugal,Algarve,87.0,Male,Prostate,I,2019-08-05,2019-08-14,2020-04-20,Immunotherapy,Public,Deceased,28.0,EGFR,Yes,Never,None,37.5,,Urban,Private Insurance,,No,No,Obesity,2.0
PT07179,Italy,,,Female,Prostate,II,2020-10-25,2021-01-08,2021-07-29,Targeted Therapy,Public,Alive,76.0,KRAS,No,Never,None,19.7,Medium,Urban,Private Insurance,14.0,No,No,Hypertension,6.0
PT07180,Portugal,Lisbon,78.0,Male,Breast,II,,2016-08-15,2017-03-01,Immunotherapy,,Alive,6.0,None,No,Former,Moderate,20.5,Medium,Urban,Private Insurance,11.0,No,No,None,6.0
PT07181,Belgium,Brussels,63.0,Male,,I,2011-01-25,2011-03-17,2011-06-20,Radiation,,Deceased,55.0,BRCA1,No,Former,Moderate,33.6,Low,Urban,Statutory Health Insurance,7.0,No,No,None,8.0
,Austria,Tyrol,45.0,Female,Leukemia,,2018-05-17,2018-07-02,2019-04-25,Immunotherapy,Public,Alive,68.0,EGFR,No,Former,Moderate,37.5,Medium,Urban,Private Insurance,10.0,No,No,None,7.0
PT07183,Switzerland,Geneva,42.0,Female,Colorectal,III,2022-08-31,2022-11-10,2023-09-06,Chemotherapy,Public,Deceased,55.0,BRCA1,Yes,Never,Moderate,24.6,,,Private Insurance,11.0,No,No,Hypertension,6.0
PT07184,Poland,Silesian,27.0,Female,Prostate,I,2010-06-08,2010-10-26,2011-03-30,Surgery,Private,Alive,96.0,KRAS,No,Current,None,29.0,Low,Urban,Private Insurance,7.0,No,No,Cardiovascular Disease,1.0
PT07185,Switzerland,Bern,72.0,Female,Colorectal,II,,2014-10-10,2015-07-13,Chemotherapy,Private,Alive,,BRCA1,No,Never,Moderate,26.6,Medium,Urban,NHS,3.0,No,No,Obesity,9.0
PT07186,Sweden,Västra Götaland,33.0,Female,Pancreatic,I,2023-10-27,2024-02-19,,Radiation,Public,Alive,42.0,KRAS,No,Former,Moderate,21.0,Low,Urban,NHS,4.0,Yes,No,Cardiovascular Disease,6.0
PT07187,France,Auvergne-Rhône-Alpes,26.0,Female,Prostate,I,2019-09-21,2019-10-12,2020-07-26,Chemotherapy,Research Institute,Lost to Follow-up,,KRAS,No,Never,None,27.2,Low,Urban,NHS,4.0,No,No,None,8.0
PT07188,Germany,Bavaria,28.0,Female,Lung,II,2010-08-18,2010-08-23,2011-05-17,Chemotherapy,Public,Alive,114.0,EGFR,No,Never,None,27.3,Low,Rural,Statutory Health Insurance,7.0,,No,Diabetes,
PT07189,France,Île-de-France,22.0,Female,Pancreatic,III,2014-09-22,2014-09-28,2015-08-27,Radiation,Private,Alive,20.0,EGFR,No,Never,Moderate,32.0,Low,Urban,Statutory Health Insurance,12.0,No,No,Cardiovascular Disease,4.0
PT07190,Spain,Andalusia,36.0,Male,Lung,I,2019-05-02,2019-06-14,2019-10-12,Chemotherapy,Public,Alive,115.0,KRAS,Yes,Current,,34.5,Medium,Urban,Private Insurance,12.0,No,No,Diabetes,3.0
PT07191,Ireland,Munster,63.0,Male,Pancreatic,I,2023-02-09,2023-03-07,2023-11-07,Radiation,Private,,61.0,EGFR,No,Current,Moderate,35.3,Low,,Statutory Health Insurance,7.0,No,No,Hypertension,1.0
PT07192,Denmark,Zealand,65.0,Male,Breast,III,2021-07-30,2021-10-31,,Surgery,Public,Alive,87.0,KRAS,Yes,Never,Moderate,21.6,Low,Urban,Statutory Health Insurance,9.0,No,No,Cardiovascular Disease,10.0
PT07193,Finland,Uusimaa,77.0,Female,Ovarian,,2023-10-24,2023-12-17,2024-06-18,,Public,Alive,61.0,EGFR,No,,None,,High,Urban,Statutory Health Insurance,1.0,No,No,Hypertension,9.0
PT07194,Norway,Vestland,,Female,Pancreatic,III,2014-08-08,2014-12-14,2015-11-11,Surgery,Private,Deceased,73.0,KRAS,No,Never,Moderate,23.1,Medium,Urban,Private Insurance,13.0,No,Yes,None,8.0
PT07195,,Flanders,33.0,Female,Leukemia,I,2013-07-19,2013-11-27,2014-06-08,Surgery,Public,Deceased,34.0,KRAS,Yes,Never,Moderate,35.0,Medium,Urban,NHS,3.0,No,No,Diabetes,9.0
PT07196,Sweden,Västra Götaland,28.0,Male,Lung,III,2017-01-24,2017-06-12,2017-12-03,Surgery,Public,Alive,92.0,EGFR,Yes,Former,None,28.9,Medium,Urban,NHS,17.0,No,No,Diabetes,6.0
PT07197,Ireland,Connacht,,Female,Pancreatic,II,2020-08-12,2020-09-06,2021-08-02,Chemotherapy,Public,Alive,48.0,None,Yes,Never,Moderate,25.9,Medium,Urban,Private Insurance,2.0,No,No,Cardiovascular Disease,6.0
PT07198,Ireland,Connacht,21.0,Male,Leukemia,III,2018-03-04,2018-07-22,,Surgery,Private,Alive,91.0,EGFR,No,Never,None,37.2,Low,Rural,,3.0,Yes,No,Hypertension,9.0
,Denmark,Central Denmark,53.0,Male,Breast,I,2023-06-18,2023-08-22,2024-01-27,Radiation,Private,Deceased,25.0,EGFR,No,Never,Heavy,37.1,Low,Rural,Private Insurance,5.0,No,Yes,Cardiovascular Disease,9.0
PT07200,Finland,Southwest Finland,38.0,Female,Pancreatic,I,2014-12-29,2015-01-02,2015-11-03,Radiation,Research Institute,Alive,91.0,BRCA1,Yes,Never,Moderate,38.4,Medium,Urban,Private Insurance,4.0,Yes,No,None,9.0
PT07201,Portugal,Lisbon,58.0,Female,Ovarian,III,2016-05-17,2016-09-21,2017-05-05,Radiation,Private,Alive,17.0,EGFR,No,Never,None,30.6,Medium,Urban,Private Insurance,18.0,No,No,None,
PT07202,Poland,Masovian,32.0,Female,Leukemia,I,2010-12-25,2011-06-05,2012-01-12,Radiation,Private,Alive,114.0,KRAS,No,Current,Moderate,32.9,Low,Rural,Statutory Health Insurance,1.0,Yes,No,Obesity,6.0
PT07203,Norway,Vestland,24.0,Male,Ovarian,I,2012-10-09,2013-01-26,2014-01-16,Surgery,Public,Deceased,104.0,None,,Never,None,27.4,Low,Rural,Private Insurance,10.0,No,No,Diabetes,6.0
PT07204,Netherlands,North Holland,69.0,Male,Pancreatic,II,2017-12-04,2017-12-20,2018-09-30,Immunotherapy,Public,Alive,95.0,EGFR,No,Never,Moderate,37.8,Medium,Urban,Statutory Health Insurance,3.0,No,No,Cardiovascular Disease,4.0
PT07205,Belgium,Wallonia,42.0,Female,Lung,,2017-05-19,2017-10-08,2017-12-29,Targeted Therapy,Public,Alive,19.0,KRAS,Yes,Never,Moderate,28.7,Medium,,NHS,11.0,No,No,Hypertension,3.0
PT07206,France,Île-de-France,48.0,Male,Lung,III,2021-03-20,2021-06-30,2021-11-15,Immunotherapy,Public,,66.0,EGFR,No,Never,Moderate,34.2,Medium,Rural,Private Insurance,3.0,No,No,None,10.0
PT07207,Portugal,Lisbon,45.0,Male,Colorectal,III,2021-01-24,2021-05-17,2021-10-01,Chemotherapy,Research Institute,Deceased,113.0,KRAS,No,Current,Moderate,36.6,Medium,Urban,NHS,1.0,Yes,No,None,1.0
PT07208,Netherlands,North Holland,76.0,Male,Colorectal,II,2016-06-20,2016-09-02,2017-04-08,Surgery,Private,Deceased,89.0,KRAS,No,Never,,27.5,Medium,Urban,Private Insurance,13.0,No,No,Hypertension,7.0
PT07209,Austria,Vienna,,Female,Pancreatic,II,2013-06-23,2013-08-15,2014-08-09,Immunotherapy,,Deceased,105.0,None,No,Former,None,36.5,High,Urban,Statutory Health Insurance,16.0,No,No,Hypertension,1.0
PT07210,Portugal,Algarve,47.0,Non-binary,Colorectal,IV,2013-06-17,2013-10-13,2014-08-19,Surgery,Research Institute,Alive,81.0,BRCA1,No,Never,None,37.5,Medium,Rural,Private Insurance,8.0,Yes,No,Cardiovascular Disease,6.0
PT07211,Denmark,,81.0,Female,Pancreatic,II,2019-02-26,2019-04-30,2019-06-27,Radiation,Private,Alive,66.0,None,No,Never,Moderate,18.2,,Urban,Private Insurance,12.0,,No,Diabetes,9.0
PT07212,Ireland,Munster,,Non-binary,Pancreatic,III,2012-04-27,2012-09-15,2013-02-06,Chemotherapy,Research Institute,Alive,14.0,None,Yes,Former,None,27.6,Low,Rural,Private Insurance,13.0,No,No,Diabetes,5.0
PT07213,Spain,Madrid,78.0,Female,Ovarian,I,2023-05-17,2023-07-01,2023-09-03,,Public,Deceased,102.0,BRCA1,Yes,Never,Heavy,39.0,Low,Urban,Statutory Health Insurance,10.0,No,No,Obesity,7.0
PT07214,Denmark,Zealand,50.0,Female,Leukemia,IV,2016-06-19,2016-11-27,2017-10-25,Targeted Therapy,Public,Alive,93.0,KRAS,No,Current,Moderate,19.2,Low,Urban,Private Insurance,10.0,No,No,Cardiovascular Disease,9.0
,Finland,Uusimaa,89.0,Female,Lung,I,2019-12-20,,2020-08-27,Radiation,Public,Alive,78.0,KRAS,No,Never,Moderate,27.7,Medium,Urban,Statutory Health Insurance,,No,No,,2.0
PT07216,Austria,Styria,68.0,,Breast,,,2016-06-11,2016-11-14,Radiation,Public,Alive,,KRAS,No,Never,None,35.9,Medium,Urban,Private Insurance,16.0,No,Yes,Obesity,5.0
PT07217,Belgium,Brussels,24.0,Male,Prostate,II,2011-05-13,2011-10-01,2012-08-27,Chemotherapy,Public,Alive,99.0,EGFR,Yes,Never,Moderate,28.6,,Urban,Statutory Health Insurance,14.0,No,No,Diabetes,1.0
PT07218,Italy,Veneto,50.0,Female,Lung,III,2015-12-09,2016-02-28,2016-05-03,Radiation,Public,,74.0,EGFR,No,Current,Heavy,34.0,Medium,Urban,Private Insurance,,No,No,Diabetes,5.0
PT07219,Spain,Madrid,,Male,Colorectal,II,2016-08-08,2016-10-20,2017-01-28,Radiation,Private,Alive,13.0,EGFR,,Former,Heavy,36.9,Medium,,Statutory Health Insurance,13.0,No,No,Hypertension,2.0
PT07220,France,Provence-Alpes-Côte d'Azur,34.0,Male,Pancreatic,III,2014-03-02,2014-07-21,2015-06-17,Immunotherapy,Public,Alive,84.0,None,,Never,None,22.5,Medium,Urban,Statutory Health Insurance,6.0,No,No,Cardiovascular Disease,7.0
PT07221,Belgium,Brussels,71.0,Female,Colorectal,I,2021-08-27,2021-09-12,2022-01-17,Radiation,Public,Alive,50.0,KRAS,No,Current,Moderate,22.7,Medium,Urban,Private Insurance,8.0,No,No,None,3.0
PT07222,Switzerland,Geneva,88.0,Male,Leukemia,II,2011-10-26,2012-04-01,2012-08-05,Chemotherapy,Research Institute,Deceased,,KRAS,Yes,Current,None,34.4,Medium,Urban,,3.0,No,No,,6.0
PT07223,France,Provence-Alpes-Côte d'Azur,30.0,Non-binary,Colorectal,III,2012-08-24,2013-02-07,2013-04-03,Surgery,Private,Alive,25.0,EGFR,Yes,Former,,25.9,Medium,Urban,Private Insurance,13.0,Yes,No,Hypertension,1.0
PT07224,Switzerland,Zurich,62.0,Female,Leukemia,I,2011-07-04,2011-10-09,2012-05-01,Chemotherapy,Private,Alive,63.0,None,Yes,Never,None,24.6,Low,Urban,Private Insurance,11.0,,No,Obesity,8.0
PT07225,Switzerland,Zurich,89.0,Male,Breast,I,2012-12-09,2013-03-23,2013-10-14,Chemotherapy,Private,Alive,84.0,None,No,,Moderate,31.5,Low,Urban,Private Insurance,13.0,No,Yes,None,8.0
,Poland,Masovian,42.0,Female,Pancreatic,II,2023-04-05,2023-06-08,2023-07-20,Surgery,Public,Alive,91.0,BRCA1,No,Never,None,39.3,Medium,Urban,Private Insurance,3.0,No,Yes,Diabetes,2.0
PT07227,Finland,Southwest Finland,59.0,Female,Colorectal,IV,2015-11-07,2016-01-16,2016-07-21,Immunotherapy,Public,Alive,101.0,None,No,Current,None,22.0,Medium,Rural,Private Insurance,16.0,No,No,Hypertension,7.0
PT07228,Portugal,Algarve,82.0,Male,Leukemia,I,2012-06-11,2012-10-29,2013-07-09,Targeted Therapy,Public,Alive,75.0,BRCA1,No,Never,Moderate,33.7,High,Urban,NHS,,No,No,Obesity,3.0
PT07229,Ireland,,21.0,Female,Colorectal,I,2017-07-31,2017-12-08,2018-08-19,Targeted Therapy,Public,Alive,107.0,None,Yes,Never,None,32.8,High,Urban,Private Insurance,12.0,No,No,Diabetes,2.0
PT07230,Poland,Lesser Poland,66.0,Female,Leukemia,,2013-06-02,2013-11-10,2014-06-21,Chemotherapy,Private,Alive,116.0,BRCA1,Yes,Never,Moderate,34.7,Low,Urban,NHS,4.0,No,No,Hypertension,3.0
PT07231,Spain,Andalusia,49.0,Male,,I,2016-08-30,2017-01-20,2017-06-23,Immunotherapy,Public,Alive,38.0,None,No,Never,Moderate,29.8,High,Rural,Statutory Health Insurance,19.0,No,Yes,Obesity,10.0
PT07232,Portugal,Algarve,35.0,Male,Pancreatic,II,2013-04-05,2013-06-25,2013-07-31,Immunotherapy,Public,Alive,66.0,BRCA1,No,Former,None,35.0,Medium,Urban,Statutory Health Insurance,14.0,No,No,Cardiovascular Disease,9.0
PT07233,Finland,Pirkanmaa,78.0,Male,Pancreatic,III,2014-10-04,2015-03-16,2016-02-20,Immunotherapy,Private,Alive,16.0,BRCA1,No,Never,None,18.1,Medium,Rural,NHS,18.0,Yes,Yes,Diabetes,9.0
PT07234,France,Île-de-France,66.0,Male,Lung,I,2011-10-16,2012-01-19,2012-11-29,,Private,Alive,97.0,None,Yes,Never,None,30.7,Low,Rural,Private Insurance,7.0,Yes,No,Diabetes,5.0
PT07235,Austria,Styria,49.0,Male,Leukemia,III,2010-12-03,2011-04-05,2011-12-28,Chemotherapy,,Deceased,8.0,BRCA1,Yes,Never,None,20.9,High,Urban,NHS,5.0,No,No,Obesity,9.0
PT07236,Italy,Lombardy,28.0,Female,Prostate,II,2022-10-30,2022-12-07,2023-03-01,Radiation,Public,Alive,115.0,None,No,Never,,31.6,Low,Urban,NHS,8.0,No,No,Obesity,9.0
PT07237,Portugal,,84.0,,Breast,,,2011-04-22,2011-12-25,Targeted Therapy,Public,Alive,54.0,BRCA1,No,Current,None,34.5,Medium,Rural,Private Insurance,10.0,No,No,Obesity,5.0
,Italy,Sicily,78.0,Female,Lung,IV,2013-06-25,2013-10-12,,Targeted Therapy,Public,Alive,62.0,BRCA1,Yes,Never,None,27.7,Medium,Rural,Private Insurance,18.0,No,No,Cardiovascular Disease,
PT07239,Finland,Uusimaa,83.0,Male,Breast,II,2022-07-19,2022-10-08,2023-04-25,Surgery,Public,Alive,72.0,EGFR,Yes,Never,Heavy,32.9,Low,Rural,NHS,13.0,No,Yes,Hypertension,8.0
PT07240,Spain,Catalonia,27.0,Male,Lung,II,2015-01-06,2015-01-13,2015-02-17,Chemotherapy,Public,Alive,34.0,KRAS,Yes,Never,Moderate,39.3,Medium,Rural,NHS,10.0,No,No,Hypertension,3.0
PT07241,Ireland,Dublin,71.0,Female,Colorectal,III,2014-02-09,2014-04-06,2015-01-24,Targeted Therapy,Public,Alive,16.0,EGFR,Yes,Never,Moderate,,Medium,Urban,Statutory Health Insurance,18.0,No,No,None,4.0
,Poland,Silesian,37.0,Female,Leukemia,II,,2016-04-08,2017-04-01,Chemotherapy,Public,Alive,106.0,KRAS,No,Former,Moderate,,Medium,Urban,Statutory Health Insurance,6.0,No,No,Hypertension,2.0
PT07243,Finland,Pirkanmaa,77.0,Female,Colorectal,I,2014-11-03,2015-04-20,,Chemotherapy,Public,Alive,114.0,None,,Current,None,22.5,Medium,Urban,,14.0,No,Yes,Cardiovascular Disease,5.0
PT07244,Poland,Silesian,68.0,Male,Breast,IV,2022-09-13,2022-11-13,2023-02-25,Immunotherapy,Public,Alive,60.0,KRAS,No,Current,None,32.2,Low,Urban,Statutory Health Insurance,9.0,No,Yes,,8.0
,France,Provence-Alpes-Côte d'Azur,51.0,Female,Pancreatic,II,2012-03-15,2012-05-19,2013-01-19,Surgery,Research Institute,Alive,112.0,KRAS,Yes,Never,None,28.6,Medium,Urban,Private Insurance,4.0,,No,Obesity,5.0
PT07246,Belgium,Flanders,67.0,Male,Breast,I,2015-06-16,2015-09-17,2016-09-06,Chemotherapy,Private,Alive,101.0,BRCA1,No,Current,Moderate,,High,Urban,NHS,10.0,No,No,Obesity,2.0
,,Stockholm,64.0,Male,Lung,III,2023-01-31,,2023-07-04,Targeted Therapy,Public,Alive,55.0,KRAS,Yes,Never,Moderate,20.3,Medium,Urban,Private Insurance,7.0,No,No,None,9.0
PT07248,Spain,Catalonia,73.0,Male,Breast,II,2018-09-16,2019-03-05,2019-10-04,Targeted Therapy,Public,Alive,20.0,None,No,Former,Heavy,24.6,Low,Urban,Private Insurance,,No,No,Hypertension,4.0
PT07249,Spain,Madrid,65.0,Female,Leukemia,I,2016-04-30,2016-10-10,2017-01-27,Surgery,Public,Alive,9.0,None,Yes,Never,Moderate,40.0,Low,Urban,Statutory Health Insurance,10.0,No,No,Diabetes,10.0
PT07250,France,Île-de-France,50.0,Male,Breast,I,2022-01-03,,2022-11-26,Chemotherapy,Public,Alive,37.0,EGFR,Yes,Never,None,25.4,Medium,Urban,Statutory Health Insurance,18.0,No,No,Diabetes,1.0
PT07251,Austria,Vienna,56.0,Female,Colorectal,I,2021-08-11,2021-08-17,,Immunotherapy,Public,Alive,57.0,KRAS,No,Never,Moderate,19.9,Medium,Rural,NHS,3.0,No,,Hypertension,6.0
PT07252,Netherlands,Utrecht,35.0,,Pancreatic,IV,2011-06-13,2011-06-21,2011-11-01,Surgery,Private,Alive,112.0,None,No,Never,,25.7,Medium,Urban,Statutory Health Insurance,12.0,,No,,3.0
PT07253,Netherlands,North Holland,,Female,Leukemia,IV,2016-07-13,2016-12-23,2017-12-01,,Private,,67.0,None,No,Former,None,22.7,Low,Urban,NHS,15.0,No,No,None,4.0
PT07254,Portugal,,65.0,Male,Breast,II,2014-05-08,2014-06-30,2015-06-04,Surgery,Private,,103.0,EGFR,No,Current,None,25.8,Medium,Urban,NHS,4.0,Yes,No,,1.0
PT07255,Switzerland,Bern,80.0,Male,Prostate,III,2020-11-26,2020-12-15,2021-01-22,Immunotherapy,Private,Deceased,79.0,EGFR,No,Never,Moderate,29.2,High,Urban,,19.0,No,No,Cardiovascular Disease,6.0
PT07256,Denmark,Capital Region,65.0,Male,Prostate,II,2014-07-03,2014-07-12,2015-06-13,Radiation,Private,Alive,99.0,EGFR,No,Former,Moderate,,Medium,Urban,NHS,10.0,No,No,Diabetes,9.0
PT07257,Norway,Vestland,,Male,Pancreatic,III,2014-05-12,2014-10-20,2015-04-05,Radiation,Research Institute,Alive,46.0,BRCA1,,Former,Moderate,,Low,Rural,NHS,12.0,No,No,,
PT07258,Spain,Madrid,81.0,Female,Colorectal,,2020-03-20,2020-03-28,2020-06-14,Radiation,Research Institute,Alive,87.0,BRCA1,No,Never,Moderate,34.5,Low,Urban,Private Insurance,2.0,Yes,No,Hypertension,9.0
PT07259,Switzerland,Zurich,54.0,,Lung,II,2019-11-18,,2020-06-30,Immunotherapy,Public,Alive,22.0,,No,Never,Heavy,18.3,Medium,Urban,NHS,16.0,Yes,No,Cardiovascular Disease,4.0
PT07260,Switzerland,Bern,,Female,Lung,I,2010-03-19,2010-08-26,2011-06-16,Immunotherapy,Public,Alive,10.0,EGFR,Yes,,None,20.3,High,,Statutory Health Insurance,19.0,,No,None,8.0
PT07261,Finland,Uusimaa,64.0,Female,Pancreatic,I,2021-06-26,2021-07-19,2022-02-07,Surgery,Public,Deceased,77.0,None,Yes,Former,None,27.1,Low,Urban,NHS,3.0,No,,None,6.0
PT07262,Germany,North Rhine-Westphalia,87.0,Female,Breast,I,2017-05-17,2017-10-26,2018-09-02,Targeted Therapy,Research Institute,Deceased,109.0,EGFR,Yes,Never,Moderate,36.7,Medium,Urban,Private Insurance,11.0,No,,Hypertension,5.0
PT07263,,Veneto,66.0,Male,Leukemia,I,2013-08-31,2013-11-26,2014-07-05,Immunotherapy,Public,Alive,115.0,EGFR,No,Former,Moderate,30.5,Medium,Urban,NHS,7.0,No,No,Obesity,8.0
PT07264,Netherlands,,49.0,Non-binary,Pancreatic,IV,2019-01-08,2019-07-01,2020-01-08,Immunotherapy,Public,Alive,74.0,None,Yes,,None,32.2,High,Urban,Statutory Health Insurance,19.0,No,No,Diabetes,3.0
PT07265,Ireland,Dublin,43.0,Male,Lung,IV,2018-04-12,2018-09-19,2019-06-02,Radiation,Public,Deceased,86.0,EGFR,No,Current,Moderate,19.1,Low,Urban,Private Insurance,16.0,No,No,Cardiovascular Disease,6.0
PT07266,Switzerland,Geneva,85.0,Female,Prostate,III,2023-08-12,2023-12-19,2024-05-24,Radiation,Private,Alive,108.0,EGFR,No,Never,None,36.3,Medium,Rural,NHS,10.0,No,No,Hypertension,7.0
PT07267,Switzerland,Zurich,62.0,Female,Lung,I,2017-09-21,,2017-11-23,Radiation,Private,Alive,44.0,EGFR,No,Current,Moderate,25.3,Low,Urban,Private Insurance,4.0,No,No,Cardiovascular Disease,5.0
PT07268,Portugal,Porto,53.0,Female,Prostate,II,2023-05-07,2023-08-22,2023-12-13,Targeted Therapy,Public,Lost to Follow-up,,EGFR,No,Never,None,21.7,Low,Rural,NHS,10.0,Yes,,Obesity,
PT07269,Poland,Lesser Poland,42.0,Male,Lung,II,2020-09-30,2021-01-20,2021-09-22,Radiation,Public,Lost to Follow-up,,BRCA1,No,Former,Moderate,19.0,Medium,Urban,Private Insurance,5.0,Yes,No,Cardiovascular Disease,10.0
PT07270,France,Île-de-France,80.0,Female,Colorectal,II,2015-09-19,2015-10-13,2016-04-28,Radiation,Private,Alive,111.0,None,Yes,Former,None,37.0,Low,Urban,Statutory Health Insurance,13.0,No,No,Diabetes,10.0
PT07271,Belgium,Flanders,56.0,Female,Pancreatic,I,2022-07-08,2022-11-15,,Targeted Therapy,Public,Alive,96.0,KRAS,Yes,,Moderate,,Medium,Urban,Statutory Health Insurance,9.0,No,,Cardiovascular Disease,3.0
PT07272,Portugal,Porto,32.0,Female,Leukemia,II,2013-02-11,2013-07-07,,Radiation,Public,Alive,37.0,EGFR,No,Never,,34.8,High,Urban,NHS,7.0,No,No,None,2.0
PT07273,Ireland,Connacht,26.0,Female,Pancreatic,I,2011-11-10,,2013-01-01,Surgery,Private,Alive,12.0,BRCA1,,Current,Moderate,29.8,Medium,Rural,NHS,2.0,No,No,Obesity,4.0
,Poland,Silesian,61.0,Male,Ovarian,,2023-07-05,2023-10-19,2024-09-11,Surgery,Private,Deceased,91.0,BRCA1,No,Never,Moderate,30.6,Medium,,NHS,19.0,No,No,Hypertension,1.0
PT07275,Belgium,Brussels,57.0,Male,Breast,III,2022-09-02,2022-12-11,2023-02-19,Chemotherapy,Public,Alive,81.0,None,No,Current,None,39.2,Medium,Urban,Statutory Health Insurance,10.0,No,Yes,Obesity,2.0
PT07276,Portugal,Algarve,71.0,Non-binary,Prostate,II,2010-08-18,2010-10-13,2010-11-29,Surgery,Public,Alive,55.0,None,No,Former,None,32.7,Medium,Urban,Private Insurance,8.0,No,No,Diabetes,
PT07277,Netherlands,North Holland,63.0,Female,Lung,III,2017-09-29,2017-12-30,2018-08-05,Targeted Therapy,Public,Alive,93.0,EGFR,Yes,Never,Moderate,31.0,Low,Rural,Statutory Health Insurance,3.0,No,No,None,9.0
PT07278,Spain,Madrid,83.0,Female,Breast,I,2015-10-25,2015-11-26,2016-07-12,,,Alive,54.0,BRCA1,No,Never,Moderate,30.2,Medium,Rural,NHS,14.0,No,No,None,8.0
PT07279,,Provence-Alpes-Côte d'Azur,32.0,Male,Prostate,I,2016-05-01,2016-07-17,2016-10-07,Chemotherapy,Public,Alive,48.0,EGFR,Yes,Former,Moderate,29.8,Low,Urban,Private Insurance,8.0,No,No,Hypertension,5.0
PT07280,Switzerland,Zurich,47.0,Male,Pancreatic,II,2023-12-06,2024-02-14,2024-06-02,,Public,Alive,,None,No,Never,Moderate,39.2,Low,Urban,Statutory Health Insurance,10.0,Yes,No,Cardiovascular Disease,1.0
PT07281,Portugal,Algarve,20.0,,Prostate,III,2019-02-15,2019-05-19,2020-04-21,Immunotherapy,Public,Alive,76.0,KRAS,Yes,Former,Moderate,25.6,Medium,Urban,Private Insurance,17.0,No,No,Obesity,2.0
PT07282,Germany,Bavaria,62.0,Female,Colorectal,I,2013-10-24,2013-11-03,2014-08-28,Surgery,Public,Alive,117.0,BRCA1,Yes,Never,Moderate,18.7,High,Urban,Statutory Health Insurance,18.0,Yes,No,Hypertension,5.0
PT07283,Finland,Southwest Finland,61.0,Male,Lung,II,2020-03-24,2020-07-25,2021-06-01,Chemotherapy,Public,Alive,86.0,BRCA1,No,Never,None,20.3,,Rural,NHS,18.0,No,No,Hypertension,9.0
PT07284,Austria,Tyrol,69.0,Male,Ovarian,I,2015-07-18,2016-01-02,2016-05-22,Immunotherapy,Private,Alive,25.0,KRAS,No,Former,,35.5,Low,Urban,NHS,16.0,Yes,No,None,
PT07285,Denmark,Zealand,79.0,Female,Pancreatic,I,,2021-08-22,2021-12-19,Immunotherapy,Public,Alive,96.0,KRAS,,Current,None,38.3,,Urban,Private Insurance,16.0,No,No,Hypertension,3.0
PT07286,Netherlands,South Holland,20.0,Female,Ovarian,I,2014-07-19,2014-08-22,2015-05-25,Immunotherapy,Private,Deceased,50.0,KRAS,Yes,Former,None,19.6,High,Urban,NHS,4.0,No,No,Cardiovascular Disease,4.0
PT07287,Denmark,Central Denmark,70.0,Male,Breast,III,2010-08-18,2010-11-10,2011-02-03,Surgery,Private,Deceased,79.0,None,,Never,None,20.1,Medium,Urban,,18.0,No,Yes,None,4.0
PT07288,Norway,Trøndelag,35.0,Female,Lung,II,2017-05-17,2017-09-05,2018-04-11,Surgery,Public,Alive,75.0,None,No,Never,None,20.1,Medium,,Statutory Health Insurance,5.0,Yes,Yes,Cardiovascular Disease,9.0
PT07289,,,58.0,Female,Pancreatic,III,2014-06-10,2014-07-13,2015-01-07,Chemotherapy,Public,Deceased,53.0,BRCA1,No,Former,None,21.9,Medium,Urban,Private Insurance,2.0,No,No,Diabetes,6.0
PT07290,Portugal,Algarve,34.0,Male,Ovarian,I,2014-04-28,2014-07-25,2015-05-14,Surgery,Public,Alive,37.0,None,Yes,Never,Moderate,20.7,Low,,Statutory Health Insurance,5.0,Yes,No,Diabetes,3.0
PT07291,Finland,Southwest Finland,52.0,,Lung,I,2020-05-15,2020-08-20,2021-05-01,Surgery,Private,Alive,13.0,KRAS,Yes,Former,Moderate,26.2,High,Urban,Private Insurance,3.0,No,Yes,None,9.0
PT07292,Denmark,Zealand,72.0,Female,Leukemia,III,2010-10-08,2010-12-04,2011-07-13,Targeted Therapy,Private,Alive,49.0,None,No,Never,Moderate,26.9,Low,Rural,NHS,,,No,Obesity,1.0
PT07293,Finland,,36.0,Male,Prostate,I,2016-11-20,2017-04-19,2018-04-11,Surgery,Private,Alive,67.0,EGFR,No,Current,Moderate,29.5,,,Private Insurance,5.0,No,No,Hypertension,5.0
PT07294,Norway,Vestland,25.0,Male,Ovarian,I,2022-08-31,2023-02-23,2023-06-02,Chemotherapy,,Lost to Follow-up,,EGFR,Yes,Never,None,35.3,Medium,Urban,Private Insurance,,No,No,Hypertension,8.0
PT07295,Norway,Oslo,50.0,Male,Prostate,II,2016-09-21,2016-10-23,2016-11-27,Surgery,Public,Alive,113.0,BRCA1,No,Current,None,30.8,High,Rural,NHS,11.0,,Yes,None,2.0
PT07296,France,Île-de-France,88.0,Female,Leukemia,III,2021-10-28,2022-03-02,2022-04-22,Surgery,Private,Lost to Follow-up,,,Yes,Never,Moderate,,High,,Statutory Health Insurance,17.0,No,No,,7.0
PT07297,Italy,Veneto,59.0,Male,Leukemia,III,2012-02-08,2012-05-26,2012-12-15,Targeted Therapy,Private,Alive,88.0,None,Yes,Former,Moderate,35.7,Low,Urban,Statutory Health Insurance,5.0,No,No,Diabetes,10.0
PT07298,,Île-de-France,49.0,Male,Lung,I,2018-06-14,2018-12-04,2019-04-07,Chemotherapy,Private,Alive,,KRAS,No,,Heavy,34.4,Medium,Rural,Statutory Health Insurance,1.0,No,,Obesity,1.0
PT07299,Italy,Lombardy,88.0,Female,Prostate,II,2011-06-30,2011-07-02,2012-02-05,Immunotherapy,Public,Alive,27.0,EGFR,Yes,Never,Moderate,34.9,,Urban,Private Insurance,17.0,No,,Hypertension,4.0
PT07300,Norway,Vestland,26.0,Male,Breast,III,2018-11-26,2019-01-24,2020-01-06,Targeted Therapy,,Alive,40.0,None,Yes,Never,None,30.6,Low,Rural,NHS,5.0,No,No,Cardiovascular Disease,9.0
PT07301,Germany,Berlin,,Non-binary,Colorectal,II,2021-08-17,2021-09-19,,Surgery,Public,Deceased,33.0,KRAS,Yes,Former,None,27.2,Medium,Urban,NHS,4.0,Yes,No,Hypertension,1.0
PT07302,Norway,Trøndelag,23.0,,Pancreatic,I,2023-04-25,2023-07-30,2023-11-22,Radiation,Public,Alive,,BRCA1,Yes,Never,Moderate,21.7,Medium,Urban,Statutory Health Insurance,16.0,No,No,,2.0
PT07303,Portugal,Lisbon,69.0,Female,Leukemia,III,2010-01-14,2010-04-29,2010-07-24,Targeted Therapy,Public,Alive,11.0,KRAS,No,Never,Moderate,38.9,Low,Urban,Statutory Health Insurance,7.0,No,No,Diabetes,7.0
PT07304,Austria,Vienna,22.0,Male,Breast,III,2013-11-02,2013-11-16,2014-04-06,Targeted Therapy,Public,Alive,17.0,EGFR,Yes,Never,Moderate,37.1,Medium,Urban,,1.0,No,No,Obesity,
PT07305,Austria,Vienna,,Male,Breast,I,2016-03-04,2016-05-02,2016-10-31,Chemotherapy,Private,Alive,102.0,KRAS,No,Former,Moderate,23.5,Medium,Rural,Private Insurance,4.0,,No,Cardiovascular Disease,8.0
PT07306,Portugal,,84.0,Male,Lung,III,2017-04-20,2017-05-05,2018-04-28,,Public,Alive,55.0,BRCA1,No,Former,Moderate,25.1,Low,Rural,Statutory Health Insurance,11.0,Yes,,Diabetes,9.0
PT07307,Ireland,Dublin,46.0,Non-binary,Leukemia,II,2017-08-14,2018-01-20,2018-07-21,Immunotherapy,Public,Deceased,103.0,KRAS,No,Never,None,19.4,Low,Urban,NHS,7.0,No,No,Hypertension,
PT07308,Switzerland,Zurich,69.0,Male,Breast,III,2023-05-08,2023-06-06,2023-10-06,Immunotherapy,Public,Deceased,66.0,None,No,Former,Moderate,34.4,Low,,NHS,9.0,No,No,Cardiovascular Disease,4.0
PT07309,Norway,Trøndelag,36.0,Female,Colorectal,I,2013-01-03,2013-04-25,2013-11-01,Targeted Therapy,Public,Alive,55.0,EGFR,No,Current,Moderate,32.5,High,Urban,Statutory Health Insurance,14.0,No,No,Hypertension,3.0
PT07310,Denmark,Zealand,51.0,Female,Breast,I,,,2019-03-05,Radiation,Research Institute,Alive,81.0,BRCA1,,,Moderate,35.3,Medium,Urban,Statutory Health Insurance,5.0,No,No,Cardiovascular Disease,1.0
PT07311,Netherlands,North Holland,70.0,Female,Colorectal,II,2011-03-07,2011-07-08,2011-12-04,Chemotherapy,Private,Alive,42.0,EGFR,No,Former,Moderate,,Medium,Urban,Statutory Health Insurance,19.0,No,No,Diabetes,10.0
PT07312,Poland,Masovian,36.0,Male,Ovarian,II,2012-03-05,2012-04-21,2012-10-08,Radiation,Public,Alive,105.0,None,No,Current,Moderate,20.4,High,Urban,Statutory Health Insurance,11.0,No,No,Diabetes,
PT07313,Poland,Silesian,53.0,Female,Colorectal,II,2020-11-10,2021-01-07,2021-12-19,Immunotherapy,Public,Alive,72.0,EGFR,No,Never,Moderate,36.7,Low,Rural,Private Insurance,15.0,No,No,None,1.0
PT07314,Denmark,Central Denmark,54.0,Female,Colorectal,III,2019-08-09,2019-11-10,2020-08-05,Targeted Therapy,Private,Lost to Follow-up,,EGFR,No,Never,Moderate,33.1,Medium,Urban,NHS,17.0,Yes,No,Obesity,2.0
PT07315,France,Île-de-France,43.0,Male,Leukemia,II,2010-07-27,2010-10-20,2011-03-15,Immunotherapy,,Deceased,105.0,KRAS,Yes,Never,Moderate,24.6,Medium,Urban,NHS,19.0,No,No,None,2.0
PT07316,Netherlands,North Holland,73.0,Female,Ovarian,III,2015-11-22,2016-04-29,2016-09-19,Radiation,Private,Alive,108.0,EGFR,No,Former,None,27.8,Medium,Urban,Private Insurance,10.0,No,Yes,Diabetes,6.0
PT07317,Belgium,Wallonia,37.0,Non-binary,,I,2016-11-16,2017-01-08,2017-03-05,Immunotherapy,Public,Alive,66.0,None,No,Former,Moderate,27.2,Medium,Rural,NHS,,No,No,Hypertension,9.0
PT07318,Ireland,Munster,69.0,Non-binary,,III,2022-07-02,2022-09-26,2023-08-31,Surgery,Private,,97.0,None,No,Never,None,28.6,Medium,Urban,Private Insurance,2.0,Yes,No,,9.0
PT07319,Belgium,Wallonia,65.0,Male,Ovarian,II,2011-08-03,2011-10-06,2012-08-19,Chemotherapy,Public,Lost to Follow-up,,None,Yes,Never,None,26.3,Medium,Urban,NHS,17.0,No,Yes,Obesity,6.0
PT07320,Switzerland,Bern,67.0,Female,Breast,I,2021-11-24,2022-02-14,2022-10-24,Radiation,Public,Deceased,16.0,BRCA1,Yes,Never,Moderate,39.0,Low,Rural,Statutory Health Insurance,10.0,No,No,Cardiovascular Disease,4.0
PT07321,Germany,North Rhine-Westphalia,52.0,Male,Ovarian,I,2022-11-12,2022-11-14,2023-05-18,Surgery,,Alive,85.0,BRCA1,No,Never,,25.7,Medium,Rural,Statutory Health Insurance,17.0,Yes,Yes,Hypertension,4.0
PT07322,Norway,Oslo,46.0,Male,,I,2017-10-01,2017-11-30,2018-07-30,Immunotherapy,Private,Alive,59.0,None,No,Current,None,26.6,Low,,Private Insurance,11.0,No,,Obesity,10.0
PT07323,Norway,Oslo,20.0,Male,Ovarian,II,2022-04-26,2022-07-19,2023-02-13,Chemotherapy,Public,Alive,72.0,EGFR,Yes,Never,Moderate,36.7,Low,Urban,Private Insurance,4.0,Yes,No,Obesity,8.0
PT07324,Spain,Madrid,78.0,Male,Prostate,II,2017-07-29,2018-01-21,2018-12-01,Chemotherapy,Public,Alive,91.0,KRAS,No,Never,None,18.2,Medium,Rural,NHS,9.0,Yes,Yes,Hypertension,8.0
PT07325,Sweden,Västra Götaland,29.0,Female,Breast,IV,2018-03-08,2018-04-25,,Chemotherapy,,Alive,,KRAS,No,Current,Moderate,35.2,Low,Rural,Private Insurance,2.0,No,No,Hypertension,10.0
PT07326,France,,44.0,Female,Pancreatic,IV,2021-03-29,2021-07-25,2022-02-28,Targeted Therapy,Public,Alive,54.0,BRCA1,Yes,Never,Heavy,23.1,High,Urban,,11.0,No,No,Cardiovascular Disease,7.0
PT07327,Austria,Vienna,76.0,Male,,,2014-06-22,2014-11-01,,Chemotherapy,Private,Deceased,84.0,KRAS,No,Current,Heavy,30.9,High,Urban,NHS,,No,No,None,2.0
,Ireland,Munster,85.0,Male,Ovarian,II,2021-03-18,2021-04-13,2022-04-06,Surgery,Public,Alive,104.0,None,No,Current,Moderate,23.7,Medium,Urban,Private Insurance,5.0,No,No,,6.0
PT07329,Austria,Vienna,34.0,Male,Ovarian,III,2014-03-01,2014-05-24,2015-05-05,Radiation,Private,Alive,89.0,,Yes,Never,Moderate,37.2,High,Rural,Statutory Health Insurance,9.0,No,No,,5.0
PT07330,Norway,Vestland,47.0,Non-binary,Prostate,I,2019-07-14,2019-12-11,2020-06-07,Surgery,Private,Deceased,48.0,EGFR,No,Never,Moderate,38.3,Low,Urban,Private Insurance,12.0,No,No,None,1.0
PT07331,Sweden,Skåne,32.0,,Prostate,II,2019-03-03,2019-08-21,2020-04-06,Immunotherapy,Public,Alive,73.0,EGFR,No,Current,,22.0,Low,Urban,Private Insurance,17.0,No,No,Hypertension,1.0
PT07332,Poland,Silesian,33.0,Male,Lung,II,2010-04-06,2010-04-26,2011-04-03,Targeted Therapy,Public,Deceased,98.0,,Yes,Former,,37.4,High,Urban,Private Insurance,13.0,No,No,None,1.0
PT07333,Norway,Vestland,85.0,Female,Leukemia,I,2020-08-20,2020-11-21,2021-02-03,Targeted Therapy,Private,Alive,89.0,BRCA1,Yes,Current,None,20.9,High,Rural,Private Insurance,10.0,No,No,Cardiovascular Disease,1.0
PT07334,,Brussels,,Male,,I,2019-08-12,2019-09-29,2020-01-17,Immunotherapy,Public,Alive,34.0,BRCA1,No,Current,None,27.7,Medium,Urban,Private Insurance,10.0,No,No,Hypertension,5.0
PT07335,Netherlands,North Holland,44.0,Female,Leukemia,II,2014-03-12,2014-07-11,2015-03-12,Radiation,Private,Alive,19.0,BRCA1,No,Former,Moderate,18.4,Medium,Urban,Private Insurance,9.0,No,No,,10.0
PT07336,Finland,Uusimaa,73.0,Non-binary,Lung,I,2023-05-08,2023-08-11,2024-04-27,Targeted Therapy,Research Institute,Deceased,6.0,BRCA1,Yes,Never,None,,Medium,Rural,Private Insurance,6.0,No,No,Hypertension,3.0
PT07337,Sweden,Västra Götaland,31.0,Male,Breast,III,,2011-11-07,,Immunotherapy,Public,Alive,23.0,KRAS,No,Former,Moderate,19.8,Low,Urban,Statutory Health Insurance,,Yes,No,Obesity,2.0
PT07338,,Silesian,28.0,Female,Prostate,IV,2023-07-09,2023-12-07,2024-05-26,Immunotherapy,Public,Alive,86.0,BRCA1,No,Never,Moderate,32.5,High,Rural,Statutory Health Insurance,4.0,No,No,None,7.0
PT07339,Netherlands,South Holland,50.0,Male,Breast,I,2019-07-19,2019-09-18,2020-05-21,Immunotherapy,Public,Alive,20.0,None,No,Never,Moderate,32.8,Low,Urban,Private Insurance,16.0,No,No,Diabetes,8.0
PT07340,Finland,,72.0,Male,Leukemia,II,2021-07-28,2021-10-16,2022-04-09,Immunotherapy,Public,Alive,94.0,BRCA1,Yes,Never,None,20.6,Low,Rural,Private Insurance,14.0,Yes,No,Obesity,10.0
PT07341,,Masovian,62.0,Female,Prostate,III,2015-11-16,2015-12-05,2016-06-11,,Private,Alive,18.0,BRCA1,No,Never,Moderate,35.6,Medium,Urban,Statutory Health Insurance,,No,No,Hypertension,9.0
PT07342,Sweden,Stockholm,57.0,Non-binary,Prostate,I,2012-11-25,2012-12-08,2013-06-21,Radiation,Public,Deceased,102.0,BRCA1,Yes,Never,None,22.8,,Urban,Statutory Health Insurance,6.0,No,No,Diabetes,
PT07343,Belgium,Wallonia,61.0,Male,Leukemia,IV,2018-04-06,2018-08-14,2019-01-06,,Public,Alive,29.0,EGFR,Yes,Never,,24.6,Medium,Urban,Statutory Health Insurance,12.0,No,No,Diabetes,8.0
PT07344,Ireland,Connacht,67.0,Female,Breast,IV,2014-11-08,2015-05-06,2015-07-27,Chemotherapy,Public,Deceased,39.0,EGFR,No,Never,None,20.5,Low,Rural,Private Insurance,12.0,No,No,Cardiovascular Disease,1.0
PT07345,Netherlands,Utrecht,86.0,Female,Prostate,I,2015-06-18,2015-09-01,2016-02-20,Chemotherapy,Research Institute,Alive,16.0,BRCA1,No,Never,,36.4,Medium,Urban,Private Insurance,12.0,,No,Hypertension,6.0
PT07346,Poland,Lesser Poland,85.0,Male,Pancreatic,I,2014-07-25,2014-07-26,2015-06-25,Surgery,Private,Alive,106.0,,Yes,Never,None,29.0,Medium,Rural,Statutory Health Insurance,14.0,No,No,Hypertension,6.0
PT07347,Switzerland,Bern,35.0,Male,Ovarian,IV,,2017-12-20,,,Private,Alive,67.0,EGFR,Yes,Never,None,36.8,Low,Urban,NHS,17.0,No,No,Hypertension,2.0
PT07348,Switzerland,Bern,35.0,Female,Breast,IV,2021-04-16,2021-09-01,2022-06-26,Chemotherapy,Public,Alive,52.0,KRAS,No,Current,None,27.4,High,Urban,Statutory Health Insurance,8.0,Yes,No,Hypertension,8.0
PT07349,Sweden,Skåne,50.0,Female,Breast,II,2017-06-09,2017-06-12,,Surgery,Public,Alive,30.0,BRCA1,No,Never,None,26.6,Low,Urban,Statutory Health Insurance,15.0,No,Yes,Diabetes,
PT07350,Sweden,,77.0,Male,Breast,I,2011-06-06,2011-06-14,2012-01-21,Surgery,Private,Lost to Follow-up,,None,No,,Moderate,28.1,Medium,Urban,Private Insurance,10.0,,No,Obesity,7.0
PT07351,Ireland,Connacht,47.0,Non-binary,Prostate,III,2012-07-11,2012-09-29,2013-03-24,Immunotherapy,Public,Alive,110.0,None,No,Never,None,28.7,Low,Rural,,13.0,No,Yes,Obesity,9.0
PT07352,Ireland,Munster,23.0,Female,Colorectal,I,2021-01-13,2021-06-26,2021-10-18,Targeted Therapy,Public,Alive,37.0,KRAS,No,Former,Moderate,26.4,Low,Rural,Statutory Health Insurance,1.0,No,No,Hypertension,8.0
PT07353,Italy,Lombardy,29.0,Male,Ovarian,IV,2021-07-06,2021-10-21,2022-01-14,Chemotherapy,Public,,70.0,KRAS,Yes,Former,None,28.2,Medium,Urban,Private Insurance,4.0,Yes,No,Cardiovascular Disease,1.0
PT07354,Ireland,Munster,,Female,Lung,III,2023-06-27,2023-08-06,2024-06-23,Targeted Therapy,Public,Alive,34.0,None,No,Former,Heavy,28.6,Medium,Rural,Private Insurance,16.0,No,No,,8.0
PT07355,France,Île-de-France,37.0,Male,Leukemia,III,2017-04-09,,2017-12-19,Surgery,Public,Alive,46.0,EGFR,Yes,Never,Heavy,,Medium,Urban,Statutory Health Insurance,15.0,No,No,Cardiovascular Disease,2.0
PT07356,Switzerland,Zurich,66.0,Female,Breast,I,2023-01-06,2023-06-30,2023-08-07,Targeted Therapy,Public,Alive,80.0,EGFR,,Never,None,31.9,Medium,Urban,NHS,2.0,No,No,Diabetes,7.0
PT07357,Germany,Berlin,51.0,Female,Prostate,III,2013-04-19,2013-08-16,2014-01-24,Targeted Therapy,Public,Alive,27.0,None,No,Never,Moderate,36.8,High,Rural,NHS,2.0,No,No,Diabetes,
PT07358,France,Provence-Alpes-Côte d'Azur,49.0,Female,Leukemia,,2021-10-15,2021-10-23,2022-01-31,Immunotherapy,Private,Deceased,81.0,EGFR,No,Former,Moderate,28.7,Low,Urban,Private Insurance,2.0,No,No,Cardiovascular Disease,10.0
PT07359,Spain,Catalonia,55.0,Male,Colorectal,I,2018-07-18,2018-09-30,2019-05-08,Surgery,Private,Deceased,6.0,BRCA1,No,,Moderate,30.9,Low,Rural,Private Insurance,,No,No,Diabetes,5.0
PT07360,,Tyrol,28.0,Female,Pancreatic,II,2014-02-05,,2014-11-30,Radiation,Private,Lost to Follow-up,,KRAS,No,Current,Moderate,,Medium,Urban,Statutory Health Insurance,12.0,No,No,None,9.0
,Portugal,Algarve,55.0,Female,Colorectal,II,2023-01-14,2023-02-10,2023-11-13,Chemotherapy,Public,,21.0,KRAS,Yes,Current,,24.3,Medium,Urban,Statutory Health Insurance,10.0,No,Yes,Obesity,1.0
PT07362,Portugal,Porto,48.0,Male,Prostate,III,2023-05-01,2023-08-04,2024-07-17,Immunotherapy,Public,Alive,21.0,EGFR,Yes,Current,None,35.6,Low,Rural,NHS,14.0,No,No,Diabetes,1.0
PT07363,Poland,Masovian,35.0,Male,Breast,IV,,2011-04-05,2011-07-04,Immunotherapy,Private,Deceased,108.0,EGFR,,Former,None,25.4,Low,Urban,Private Insurance,14.0,No,No,Hypertension,8.0
PT07364,Finland,Southwest Finland,40.0,Female,Colorectal,II,2020-12-05,,2022-03-10,Radiation,Public,Deceased,8.0,BRCA1,Yes,Never,Heavy,33.9,High,Rural,,11.0,No,No,None,
PT07365,France,Provence-Alpes-Côte d'Azur,83.0,Female,Ovarian,II,2014-01-04,2014-01-10,2014-05-09,Immunotherapy,Public,Alive,106.0,BRCA1,No,Current,None,18.6,Low,Rural,Private Insurance,5.0,No,No,Cardiovascular Disease,3.0
PT07366,Spain,Catalonia,85.0,Male,Colorectal,II,2018-09-28,,2019-08-16,Surgery,Public,Alive,105.0,None,No,Current,None,30.3,Medium,Rural,Statutory Health Insurance,1.0,Yes,No,Obesity,9.0
PT07367,Spain,Catalonia,78.0,Male,Colorectal,II,2015-07-28,2016-01-01,2016-03-15,Immunotherapy,Public,Deceased,99.0,EGFR,No,Never,Moderate,39.7,Medium,Rural,Private Insurance,13.0,No,,Hypertension,7.0
,Finland,Pirkanmaa,47.0,Male,,III,2019-10-31,2019-11-29,2020-09-23,Immunotherapy,Private,,8.0,EGFR,Yes,Former,None,33.7,High,Rural,Statutory Health Insurance,18.0,Yes,Yes,Obesity,2.0
PT07369,Denmark,Central Denmark,74.0,,Pancreatic,II,,2011-10-13,2012-01-22,Radiation,Public,Alive,104.0,EGFR,No,Never,Moderate,33.4,Low,Urban,NHS,8.0,No,No,Cardiovascular Disease,5.0
PT07370,Sweden,Västra Götaland,50.0,,Prostate,IV,2011-05-04,2011-07-22,2011-10-11,Chemotherapy,Research Institute,Alive,57.0,KRAS,No,Never,None,28.6,Low,Urban,Statutory Health Insurance,9.0,No,No,None,1.0
PT07371,Italy,Sicily,52.0,Male,Leukemia,III,2020-07-04,2020-09-08,2021-04-06,Chemotherapy,Private,Alive,36.0,BRCA1,No,Current,Moderate,24.2,,Urban,Private Insurance,13.0,No,No,Diabetes,5.0
PT07372,Germany,Bavaria,79.0,Male,Lung,I,2013-11-27,2013-12-09,2014-11-10,Targeted Therapy,Private,Alive,40.0,,No,Current,Heavy,27.1,Medium,,NHS,5.0,,No,,7.0
PT07373,Belgium,Brussels,60.0,Female,Prostate,I,2014-05-19,2014-06-01,2014-11-07,Surgery,Private,Alive,55.0,EGFR,Yes,Never,Moderate,29.3,Medium,Urban,Statutory Health Insurance,13.0,No,No,Diabetes,10.0
PT07374,Finland,Southwest Finland,65.0,Male,Breast,II,2015-01-09,2015-04-27,2015-07-13,Radiation,Public,Alive,81.0,None,Yes,,Moderate,33.7,Medium,Rural,NHS,3.0,No,Yes,Diabetes,9.0
PT07375,Poland,Lesser Poland,68.0,Female,Prostate,II,,2023-06-29,2024-01-31,Chemotherapy,Private,Alive,118.0,BRCA1,Yes,Former,Moderate,21.6,Low,Urban,NHS,13.0,No,No,Cardiovascular Disease,9.0
PT07376,Sweden,Västra Götaland,84.0,Female,Prostate,II,2012-11-06,2013-04-22,2014-04-09,Radiation,Public,Alive,99.0,EGFR,,Current,None,26.1,Medium,Rural,NHS,,Yes,No,Cardiovascular Disease,1.0
PT07377,Belgium,Wallonia,61.0,Female,Pancreatic,I,,2010-05-21,2010-09-07,Targeted Therapy,Public,Alive,94.0,KRAS,No,Former,None,,Medium,Urban,NHS,10.0,Yes,No,Obesity,8.0
PT07378,Sweden,Västra Götaland,42.0,Female,Lung,IV,2017-06-05,2017-11-25,2018-05-10,,Private,Alive,28.0,BRCA1,Yes,Never,Moderate,18.2,Medium,Urban,Private Insurance,11.0,No,Yes,Diabetes,5.0
PT07379,Italy,Veneto,46.0,Male,Lung,I,2017-12-24,2018-06-11,2018-10-21,Radiation,,Deceased,86.0,BRCA1,Yes,Current,None,36.1,High,Urban,Private Insurance,15.0,No,No,,5.0
PT07380,Netherlands,South Holland,51.0,Male,Lung,III,,2010-05-10,2010-06-10,Surgery,Private,Alive,109.0,EGFR,No,Former,None,19.2,Medium,Rural,Private Insurance,12.0,No,Yes,Diabetes,5.0
PT07381,France,Provence-Alpes-Côte d'Azur,22.0,Female,Leukemia,I,2010-07-06,2010-12-24,2011-04-07,Surgery,Public,Alive,70.0,,Yes,Never,Moderate,35.1,Medium,Urban,NHS,2.0,No,No,Cardiovascular Disease,7.0
PT07382,Austria,,79.0,Female,Prostate,II,2012-01-20,2012-03-22,2012-11-27,Targeted Therapy,Research Institute,Alive,86.0,EGFR,Yes,Current,None,39.8,Low,Urban,Statutory Health Insurance,1.0,No,No,None,4.0
PT07383,Portugal,Lisbon,36.0,Male,Pancreatic,II,2023-11-06,2024-03-16,2025-01-09,Chemotherapy,Public,Deceased,110.0,KRAS,Yes,Former,None,34.4,High,Urban,NHS,14.0,No,No,Cardiovascular Disease,7.0
PT07384,Finland,Pirkanmaa,51.0,Male,Breast,,2017-10-02,2017-10-11,2018-07-19,Chemotherapy,Public,Alive,112.0,KRAS,Yes,Never,,29.8,Medium,Rural,Statutory Health Insurance,11.0,No,No,Cardiovascular Disease,8.0
PT07385,Ireland,Dublin,26.0,Female,Lung,,2016-08-06,2017-01-25,2018-01-04,Surgery,Public,Alive,114.0,KRAS,Yes,Never,Moderate,,Low,Rural,Private Insurance,11.0,No,No,Obesity,1.0
PT07386,Sweden,,88.0,Male,Ovarian,III,2022-06-24,2022-10-27,2023-09-24,Targeted Therapy,Private,Alive,64.0,None,No,Never,Moderate,19.3,Low,Urban,Private Insurance,13.0,No,No,Obesity,2.0
PT07387,Switzerland,Bern,77.0,Male,Lung,II,2011-10-31,2012-04-10,2012-10-20,Immunotherapy,Private,Alive,40.0,BRCA1,Yes,Current,Heavy,26.9,Medium,Urban,Private Insurance,9.0,No,No,Obesity,9.0
PT07388,Austria,Styria,59.0,Male,Ovarian,III,2017-07-16,2017-08-04,2017-10-05,Surgery,Public,Deceased,68.0,EGFR,Yes,Former,Moderate,27.1,Low,Urban,Statutory Health Insurance,11.0,,No,Diabetes,6.0
PT07389,Poland,Masovian,67.0,Female,Prostate,III,2023-05-06,2023-08-04,2024-03-11,Surgery,,Alive,23.0,BRCA1,Yes,Never,Moderate,,Low,Rural,Private Insurance,12.0,,No,Obesity,10.0
PT07390,Poland,Lesser Poland,70.0,Female,Breast,IV,2015-08-12,2015-11-07,2016-07-28,Radiation,Research Institute,Alive,15.0,,No,Former,None,26.8,Low,Urban,Private Insurance,14.0,No,No,Obesity,7.0
PT07391,Austria,Styria,76.0,Female,Pancreatic,III,2019-09-17,2019-10-05,2019-11-21,,Research Institute,,52.0,BRCA1,No,Never,Moderate,24.4,High,Rural,NHS,6.0,No,No,Diabetes,5.0
PT07392,Belgium,Flanders,56.0,Male,Lung,I,2023-01-01,2023-06-24,,Immunotherapy,Public,Alive,38.0,,No,Never,Moderate,19.2,Medium,Urban,Statutory Health Insurance,14.0,No,No,Diabetes,3.0
PT07393,Ireland,Dublin,74.0,Male,Prostate,IV,2010-07-01,,2010-11-16,Targeted Therapy,Public,Deceased,11.0,None,Yes,Former,,27.9,High,Urban,Private Insurance,3.0,No,No,Diabetes,5.0
PT07394,Switzerland,Bern,60.0,Male,Colorectal,IV,2018-11-16,2019-05-04,2020-03-16,Targeted Therapy,Public,Alive,26.0,KRAS,No,Current,None,28.6,Medium,Urban,Statutory Health Insurance,11.0,No,No,Cardiovascular Disease,8.0
PT07395,Ireland,Munster,39.0,Female,Pancreatic,III,2012-09-03,2013-01-07,2013-08-01,Surgery,Public,Alive,52.0,KRAS,No,,Moderate,33.4,Medium,Urban,NHS,6.0,No,No,Obesity,9.0
PT07396,Spain,Catalonia,52.0,Female,Ovarian,II,2016-06-12,2016-07-31,2016-11-10,Surgery,Public,Alive,35.0,None,No,Never,Moderate,30.1,High,Urban,NHS,10.0,Yes,Yes,Cardiovascular Disease,4.0
,Austria,Vienna,59.0,Non-binary,Leukemia,I,2018-01-02,2018-04-14,2019-02-07,,Public,Alive,95.0,None,Yes,Former,None,37.9,Low,Urban,NHS,5.0,No,No,Cardiovascular Disease,8.0
PT07398,France,,53.0,Male,Pancreatic,,2015-09-28,2015-12-11,2016-11-24,Radiation,Public,Deceased,76.0,EGFR,No,Current,None,25.7,,,Statutory Health Insurance,14.0,No,Yes,Hypertension,10.0
PT07399,Germany,Bavaria,81.0,Female,Prostate,IV,,2014-06-05,,Immunotherapy,Public,Alive,26.0,None,Yes,,Moderate,22.9,,Urban,Statutory Health Insurance,12.0,No,,Diabetes,9.0
PT07400,Italy,Lombardy,38.0,Female,Lung,III,2013-08-01,2013-12-17,2014-06-01,Immunotherapy,Public,Alive,107.0,,No,Former,Moderate,19.5,Medium,Urban,Statutory Health Insurance,19.0,No,No,Hypertension,8.0
PT07401,Denmark,Central Denmark,62.0,Male,Pancreatic,III,2011-01-15,2011-04-10,2011-08-26,Targeted Therapy,Public,Alive,116.0,EGFR,No,Former,None,26.5,Medium,Urban,Private Insurance,15.0,Yes,Yes,Diabetes,7.0
PT07402,Sweden,Västra Götaland,88.0,Male,Breast,,2015-01-30,2015-07-15,2016-06-12,Surgery,Public,,119.0,None,No,Never,None,19.1,,Rural,Statutory Health Insurance,8.0,No,No,Cardiovascular Disease,10.0
PT07403,Belgium,Brussels,82.0,Female,Ovarian,II,2023-05-19,2023-06-26,2024-05-28,Targeted Therapy,Public,Alive,50.0,,No,Never,Moderate,28.6,High,Urban,Private Insurance,14.0,No,No,Diabetes,
PT07404,Netherlands,North Holland,29.0,Female,Colorectal,III,2022-08-05,2023-01-27,2023-06-14,Surgery,Public,Deceased,102.0,None,No,Never,Heavy,37.7,Medium,Rural,Private Insurance,11.0,Yes,No,None,5.0
PT07405,Norway,Vestland,32.0,Male,,I,2023-05-12,2023-09-24,2024-03-08,Targeted Therapy,Private,,55.0,BRCA1,No,Never,Moderate,29.8,Medium,Urban,NHS,16.0,No,No,Hypertension,8.0
PT07406,Sweden,Skåne,24.0,Non-binary,Breast,,2011-07-10,2011-07-22,2011-12-06,Targeted Therapy,Public,Alive,8.0,BRCA1,Yes,Current,None,32.4,Low,,NHS,4.0,Yes,No,Cardiovascular Disease,3.0
PT07407,,Pirkanmaa,77.0,Female,Breast,III,2022-10-12,2022-12-03,2023-02-02,Radiation,Private,Alive,81.0,BRCA1,No,Former,Moderate,37.4,Low,Urban,Statutory Health Insurance,7.0,No,No,Obesity,1.0
PT07408,Denmark,Capital Region,78.0,Male,Prostate,,2013-05-07,2013-08-20,2014-02-03,Radiation,Public,Deceased,38.0,EGFR,Yes,Current,Moderate,21.0,Medium,Rural,NHS,3.0,Yes,No,,9.0
PT07409,Belgium,Brussels,78.0,Male,Prostate,I,2010-04-19,2010-09-27,2011-01-27,Targeted Therapy,Public,Alive,93.0,EGFR,No,Never,Moderate,30.1,Low,Urban,Statutory Health Insurance,2.0,No,No,Obesity,9.0
PT07410,France,,34.0,Male,Pancreatic,III,2010-03-06,,2011-02-04,Surgery,Private,Alive,76.0,BRCA1,No,Never,None,25.9,High,Rural,Private Insurance,8.0,No,No,Obesity,1.0
PT07411,Sweden,Västra Götaland,20.0,Male,Ovarian,I,2018-10-06,2018-10-30,2019-02-05,Targeted Therapy,Public,Deceased,63.0,BRCA1,No,Former,Moderate,30.9,High,Urban,Statutory Health Insurance,,No,No,Diabetes,5.0
PT07412,Netherlands,Utrecht,57.0,Male,Leukemia,II,,2016-10-27,2017-08-19,Surgery,Public,Deceased,77.0,None,No,Never,Heavy,20.9,Low,Rural,Statutory Health Insurance,12.0,,No,Cardiovascular Disease,6.0
PT07413,France,Auvergne-Rhône-Alpes,,Male,Ovarian,III,,2014-01-03,2014-08-06,Chemotherapy,Public,Alive,,None,Yes,Never,Moderate,,High,Rural,Statutory Health Insurance,17.0,No,No,Diabetes,3.0
PT07414,Belgium,Flanders,71.0,Non-binary,Colorectal,III,2015-11-05,2016-01-26,2016-12-04,Immunotherapy,Public,Alive,42.0,None,,Former,None,33.5,Medium,Rural,Private Insurance,9.0,Yes,Yes,,8.0
PT07415,Sweden,Stockholm,20.0,Female,Pancreatic,IV,2021-02-14,2021-03-09,,Targeted Therapy,Public,Alive,59.0,None,Yes,Former,Moderate,30.6,Low,Urban,Statutory Health Insurance,6.0,No,Yes,None,3.0
PT07416,Austria,Styria,30.0,Female,Breast,II,2020-10-02,2020-12-12,2021-04-26,Chemotherapy,Public,Alive,40.0,EGFR,No,Never,Moderate,34.3,Low,Urban,NHS,6.0,Yes,No,,4.0
PT07417,Germany,Bavaria,77.0,Male,Pancreatic,II,2019-06-28,,2020-07-29,Targeted Therapy,Research Institute,Alive,68.0,KRAS,No,Current,Moderate,27.8,High,Urban,Private Insurance,11.0,Yes,Yes,Diabetes,2.0
PT07418,Ireland,Connacht,59.0,Male,Ovarian,III,2016-11-02,2017-02-28,2017-10-07,Radiation,Public,Alive,12.0,,No,Former,Heavy,21.7,,Urban,NHS,9.0,No,Yes,Diabetes,
PT07419,Germany,,79.0,Male,Lung,II,2018-02-24,2018-07-17,2018-12-31,Immunotherapy,Public,Alive,9.0,EGFR,No,Former,Heavy,23.1,Medium,Urban,Private Insurance,8.0,Yes,No,Diabetes,4.0
PT07420,Portugal,Algarve,63.0,Female,Pancreatic,II,,2012-02-18,2012-12-25,Targeted Therapy,Public,Deceased,39.0,,No,Never,None,34.9,High,Urban,Private Insurance,16.0,No,No,Cardiovascular Disease,2.0
PT07421,Sweden,Västra Götaland,25.0,Male,Ovarian,II,2011-04-16,2011-09-19,2011-11-30,Radiation,Public,Alive,44.0,None,Yes,Never,Moderate,25.7,Medium,Rural,NHS,1.0,Yes,No,Obesity,1.0
PT07422,Switzerland,Geneva,47.0,Male,Pancreatic,II,2014-07-24,2014-10-23,2015-07-12,Radiation,Research Institute,Deceased,91.0,BRCA1,Yes,Never,Heavy,27.0,Medium,Urban,Statutory Health Insurance,2.0,No,No,Diabetes,9.0
PT07423,Portugal,Porto,50.0,Female,Ovarian,II,,2020-07-09,2021-06-30,Chemotherapy,Private,Alive,38.0,BRCA1,,Never,Moderate,36.3,Low,Urban,NHS,13.0,No,Yes,None,2.0
PT07424,Portugal,,27.0,Female,Breast,II,2020-12-04,2020-12-25,2021-05-15,Radiation,,Alive,80.0,BRCA1,No,Current,Heavy,22.8,,Urban,,8.0,No,No,Cardiovascular Disease,9.0
PT07425,Germany,North Rhine-Westphalia,24.0,Female,Pancreatic,II,2023-04-23,2023-05-20,2024-05-18,Chemotherapy,Public,Alive,,EGFR,No,Former,Heavy,35.9,Low,Urban,Statutory Health Insurance,6.0,No,No,Diabetes,5.0
PT07426,Denmark,Capital Region,73.0,Male,Colorectal,IV,2010-04-20,2010-10-12,,Surgery,Public,Alive,111.0,BRCA1,Yes,Never,Moderate,20.6,,Rural,Statutory Health Insurance,3.0,No,Yes,Hypertension,10.0
PT07427,Ireland,Connacht,36.0,Male,Breast,II,2020-08-16,2020-10-11,2021-07-04,Surgery,Research Institute,Alive,20.0,EGFR,,Never,Heavy,21.2,Low,Urban,Statutory Health Insurance,9.0,No,No,Obesity,
PT07428,Finland,Pirkanmaa,57.0,Female,Prostate,I,2022-01-07,2022-05-12,,Surgery,Public,Deceased,97.0,KRAS,No,Former,,25.8,High,Urban,Statutory Health Insurance,11.0,No,No,Obesity,7.0
PT07429,Ireland,Connacht,28.0,Female,Prostate,II,2016-03-12,2016-06-26,2017-05-22,Surgery,Public,Deceased,35.0,None,No,Current,,36.0,,Rural,Statutory Health Insurance,18.0,,No,Diabetes,9.0
PT07430,Sweden,Skåne,33.0,Male,Pancreatic,II,2012-08-17,2013-01-06,2013-08-12,Targeted Therapy,Public,Alive,111.0,EGFR,No,Never,None,33.9,Medium,Rural,Statutory Health Insurance,12.0,,No,Cardiovascular Disease,5.0
PT07431,Ireland,Munster,45.0,Male,Pancreatic,IV,2014-04-09,2014-04-30,2015-01-02,Chemotherapy,Public,,118.0,BRCA1,Yes,Never,Moderate,34.8,Medium,Urban,Private Insurance,8.0,No,No,None,5.0
PT07432,Ireland,Connacht,81.0,Female,Colorectal,III,2013-01-21,2013-02-04,2013-09-20,Surgery,Private,Alive,49.0,None,No,Never,Moderate,22.1,Low,,NHS,10.0,No,No,Diabetes,5.0
PT07433,Switzerland,Zurich,44.0,Non-binary,Ovarian,III,2011-11-12,2012-02-27,2012-10-15,Radiation,Public,Alive,28.0,BRCA1,No,Never,Moderate,39.5,Medium,Urban,Statutory Health Insurance,12.0,,No,Cardiovascular Disease,8.0
PT07434,Sweden,Västra Götaland,,Female,Ovarian,,2012-11-17,2013-01-26,2013-04-12,Chemotherapy,Private,Deceased,73.0,KRAS,No,Former,Moderate,20.1,High,,Private Insurance,14.0,No,Yes,None,5.0
PT07435,Norway,Vestland,52.0,Female,Leukemia,,2020-05-01,2020-05-29,2021-03-09,Targeted Therapy,Public,Deceased,83.0,BRCA1,No,Former,,20.4,High,Urban,Statutory Health Insurance,,Yes,No,None,5.0
PT07436,France,Auvergne-Rhône-Alpes,22.0,Female,Breast,I,2021-12-10,2022-04-02,,Surgery,Public,Alive,88.0,None,No,,Heavy,25.9,Low,Rural,Private Insurance,17.0,No,No,,7.0
PT07437,Poland,Masovian,30.0,Male,Colorectal,II,2023-09-01,2024-02-13,2024-10-29,Chemotherapy,Private,Alive,93.0,BRCA1,No,Never,Moderate,29.7,High,Urban,NHS,3.0,No,Yes,Obesity,5.0
PT07438,Norway,Vestland,77.0,Male,Pancreatic,,2021-12-29,2022-04-10,2023-02-18,Immunotherapy,Private,Deceased,62.0,KRAS,Yes,Current,None,34.6,Medium,Urban,Statutory Health Insurance,4.0,No,Yes,None,3.0
PT07439,Italy,Veneto,83.0,Female,Pancreatic,II,2015-05-05,2015-07-11,2016-02-16,Surgery,Private,Alive,50.0,None,Yes,Never,Moderate,32.5,Medium,Rural,Private Insurance,,No,No,Cardiovascular Disease,
PT07440,Netherlands,South Holland,37.0,Female,Pancreatic,III,2022-11-08,2023-03-12,2023-05-05,Chemotherapy,Public,Alive,105.0,KRAS,Yes,Former,Moderate,37.5,Low,Rural,NHS,16.0,No,Yes,Obesity,3.0
PT07441,Germany,Berlin,66.0,Female,Pancreatic,II,2023-01-15,2023-02-17,2023-07-06,Surgery,Public,Deceased,76.0,None,Yes,Former,Moderate,31.2,Medium,Urban,Private Insurance,19.0,No,No,Cardiovascular Disease,9.0
PT07442,Sweden,Stockholm,63.0,Female,Lung,III,2015-04-13,2015-04-25,2016-02-08,Immunotherapy,Private,,23.0,,No,Former,None,19.6,Low,Urban,Statutory Health Insurance,10.0,Yes,No,Cardiovascular Disease,4.0
PT07443,Sweden,Stockholm,,Non-binary,Pancreatic,II,2015-08-30,2016-01-17,2016-04-24,Radiation,Private,Alive,112.0,None,No,Former,Moderate,28.3,Medium,Urban,Statutory Health Insurance,,No,No,Hypertension,2.0
PT07444,Italy,Lombardy,69.0,Female,Pancreatic,II,2020-07-02,,2021-03-30,Radiation,Public,Alive,50.0,BRCA1,Yes,Never,,35.0,Medium,Urban,Statutory Health Insurance,5.0,No,No,Diabetes,6.0
PT07445,Portugal,Algarve,88.0,Male,Lung,II,2015-03-24,2015-09-03,2016-06-20,Immunotherapy,Public,Alive,54.0,None,No,Never,None,28.6,Low,Urban,Statutory Health Insurance,7.0,Yes,No,Hypertension,
PT07446,Portugal,Algarve,48.0,Male,Leukemia,III,2013-10-03,2014-01-14,,Chemotherapy,Public,Alive,20.0,BRCA1,No,Former,Moderate,20.8,High,Urban,Private Insurance,3.0,No,Yes,Cardiovascular Disease,7.0
PT07447,Sweden,Skåne,86.0,Male,Ovarian,III,2021-05-08,2021-05-20,2021-07-24,Targeted Therapy,Private,Alive,52.0,None,No,,Moderate,33.4,High,Urban,NHS,16.0,No,No,Diabetes,1.0
,Italy,Veneto,21.0,Female,Prostate,,2015-10-16,2015-11-04,2016-10-30,Surgery,Private,,118.0,KRAS,Yes,Former,None,34.0,Medium,Rural,Statutory Health Insurance,1.0,No,No,None,2.0
PT07449,Netherlands,South Holland,44.0,,Pancreatic,III,2018-02-08,2018-05-14,2018-09-08,Targeted Therapy,Private,,10.0,BRCA1,No,Current,Moderate,34.8,,Urban,NHS,1.0,No,No,Cardiovascular Disease,5.0
PT07450,Denmark,Central Denmark,38.0,Non-binary,Ovarian,II,2018-09-06,2018-11-04,2019-06-06,Surgery,Private,Deceased,110.0,BRCA1,No,Never,Moderate,25.6,Medium,Urban,Private Insurance,12.0,No,No,Cardiovascular Disease,3.0
PT07451,Germany,Berlin,59.0,Non-binary,Pancreatic,I,2023-01-09,2023-05-06,2023-11-09,Targeted Therapy,Research Institute,Deceased,105.0,BRCA1,No,Current,Moderate,33.1,Medium,Rural,NHS,14.0,,No,Cardiovascular Disease,10.0
PT07452,Switzerland,,21.0,Female,Colorectal,III,2015-06-16,2015-06-29,2016-04-01,Surgery,Private,Alive,67.0,BRCA1,No,Never,None,34.2,Medium,Urban,Statutory Health Insurance,1.0,No,No,None,2.0
PT07453,Sweden,Stockholm,84.0,Male,Breast,,2018-11-06,2018-11-25,2019-10-15,Radiation,Public,Alive,89.0,EGFR,Yes,Never,Moderate,26.5,Low,,Private Insurance,13.0,No,No,None,2.0
PT07454,Netherlands,South Holland,81.0,Male,Colorectal,II,2021-04-16,2021-09-27,2022-08-12,Surgery,Public,Alive,12.0,KRAS,No,Never,None,27.2,Medium,Urban,Statutory Health Insurance,3.0,No,No,Cardiovascular Disease,6.0
PT07455,,Provence-Alpes-Côte d'Azur,73.0,Male,Pancreatic,I,2016-11-18,2017-03-30,2017-06-25,Surgery,Private,Alive,79.0,BRCA1,No,Never,Moderate,28.8,Medium,Urban,Statutory Health Insurance,19.0,No,No,Cardiovascular Disease,10.0
PT07456,Finland,Southwest Finland,64.0,Male,Leukemia,II,2015-02-05,2015-02-18,2015-10-17,Immunotherapy,Public,Deceased,70.0,None,No,Never,Moderate,31.4,Medium,Urban,NHS,3.0,No,No,None,7.0
PT07457,Netherlands,Utrecht,68.0,Male,Colorectal,I,2013-05-06,2013-07-29,2014-03-30,Immunotherapy,Private,Alive,103.0,BRCA1,No,Former,Moderate,24.7,High,Rural,Statutory Health Insurance,8.0,No,No,Diabetes,2.0
PT07458,Italy,Lombardy,88.0,Male,Leukemia,IV,2016-05-02,2016-09-13,2017-07-29,Surgery,Public,Alive,92.0,BRCA1,No,Never,Moderate,21.6,Medium,Urban,Statutory Health Insurance,12.0,No,Yes,None,2.0
PT07459,Netherlands,South Holland,57.0,Female,Leukemia,III,2012-02-09,2012-03-24,2012-09-05,Surgery,Public,Alive,99.0,KRAS,Yes,,Moderate,23.4,High,Urban,NHS,2.0,Yes,No,Hypertension,8.0
PT07460,Finland,Southwest Finland,23.0,Male,,I,2019-10-03,2019-12-18,2020-11-10,Chemotherapy,Public,Lost to Follow-up,,KRAS,No,Never,Heavy,29.8,Medium,Urban,Private Insurance,2.0,No,No,None,3.0
PT07461,,Bern,36.0,Male,Leukemia,I,2013-12-03,2014-03-22,2015-03-05,Radiation,Public,Alive,111.0,,No,Never,Moderate,34.4,High,Rural,Private Insurance,15.0,No,No,Hypertension,10.0
PT07462,Portugal,Lisbon,72.0,Female,Colorectal,III,2015-05-12,,2016-05-11,Surgery,,Deceased,45.0,EGFR,Yes,Never,Moderate,37.2,Low,Urban,Private Insurance,4.0,No,No,Hypertension,3.0
PT07463,Ireland,Connacht,72.0,Non-binary,Lung,III,2016-04-23,2016-09-06,2017-04-13,Surgery,Public,Lost to Follow-up,,EGFR,No,Never,None,37.7,Low,Rural,,2.0,No,No,Cardiovascular Disease,6.0
PT07464,France,Île-de-France,50.0,,Breast,II,2013-09-21,2014-03-01,2014-07-19,Radiation,Public,Alive,88.0,None,No,Former,None,30.6,Medium,Rural,Private Insurance,3.0,No,No,Diabetes,2.0
,Finland,Pirkanmaa,41.0,Female,Leukemia,III,2023-07-25,2023-11-23,2024-09-23,Chemotherapy,Public,Alive,62.0,None,No,Current,,37.0,Low,Urban,Private Insurance,,Yes,No,Diabetes,
PT07466,Denmark,Capital Region,30.0,Female,Ovarian,III,2013-06-10,2013-08-01,2014-02-26,Immunotherapy,,Alive,38.0,None,No,Never,None,23.7,High,Urban,,12.0,No,No,Obesity,7.0
PT07467,France,Provence-Alpes-Côte d'Azur,53.0,Female,Pancreatic,,2010-03-14,2010-06-25,2010-10-16,Immunotherapy,Public,Alive,103.0,None,Yes,Never,Moderate,27.7,Low,Rural,Private Insurance,12.0,No,Yes,None,1.0
PT07468,Belgium,,34.0,Female,Prostate,IV,2013-03-28,2013-07-23,2013-11-13,Radiation,Public,Alive,85.0,EGFR,No,Former,None,22.8,Medium,Urban,NHS,3.0,No,No,Diabetes,2.0
PT07469,Spain,Madrid,29.0,Male,Leukemia,II,2011-04-28,2011-07-27,2012-06-22,Surgery,Public,Alive,39.0,EGFR,Yes,Current,None,21.0,High,Urban,Private Insurance,14.0,No,No,Obesity,3.0
PT07470,France,Île-de-France,72.0,Female,Ovarian,I,2013-05-24,2013-08-15,2013-11-14,Immunotherapy,Private,Alive,35.0,KRAS,No,Never,None,32.7,Medium,Urban,Private Insurance,5.0,No,No,Cardiovascular Disease,10.0
PT07471,Norway,Trøndelag,67.0,Male,Colorectal,II,2016-02-21,2016-03-05,2016-08-19,Surgery,Public,Alive,29.0,KRAS,No,Never,None,23.2,Medium,Rural,Statutory Health Insurance,15.0,Yes,No,Hypertension,5.0
,Belgium,Flanders,50.0,Female,,I,,,2020-01-14,Targeted Therapy,,Alive,101.0,None,Yes,Never,Moderate,30.4,Medium,Urban,Statutory Health Insurance,11.0,No,No,None,9.0
PT07473,Italy,Veneto,56.0,Male,Prostate,II,,2011-06-25,2011-12-17,Surgery,Private,Alive,41.0,BRCA1,No,Never,Moderate,19.6,Low,Urban,NHS,4.0,No,No,Diabetes,10.0
PT07474,France,Île-de-France,47.0,Female,Ovarian,III,,2012-07-15,2013-06-26,Immunotherapy,Public,Alive,21.0,KRAS,No,Never,Moderate,,Medium,Rural,Private Insurance,17.0,Yes,No,,3.0
PT07475,,Trøndelag,50.0,Non-binary,Lung,I,2015-01-10,2015-04-15,2016-03-28,Surgery,Private,Deceased,88.0,EGFR,No,Former,None,24.7,High,Urban,Private Insurance,,No,No,Cardiovascular Disease,1.0
PT07476,Poland,,89.0,Male,Colorectal,IV,2017-02-02,2017-07-07,2017-11-02,Surgery,Public,Alive,109.0,BRCA1,No,Never,Moderate,26.7,,Rural,Private Insurance,19.0,No,No,None,10.0
PT07477,France,Provence-Alpes-Côte d'Azur,33.0,Non-binary,Colorectal,III,2012-03-14,2012-09-02,2013-06-13,Chemotherapy,Public,Deceased,63.0,KRAS,No,,None,23.6,,Urban,Statutory Health Insurance,8.0,Yes,No,None,9.0
PT07478,Netherlands,Utrecht,35.0,Male,Pancreatic,I,2021-07-03,2021-09-10,2022-05-06,Chemotherapy,Public,Alive,118.0,BRCA1,Yes,,None,33.9,Medium,Urban,Statutory Health Insurance,15.0,No,No,Cardiovascular Disease,2.0
PT07479,Portugal,Algarve,44.0,Male,Colorectal,II,,2021-07-24,2022-05-10,Surgery,Public,Alive,8.0,KRAS,No,Former,None,19.4,High,Rural,Statutory Health Insurance,9.0,,No,Obesity,10.0
PT07480,Sweden,Stockholm,58.0,Male,Prostate,II,2018-03-22,2018-09-03,2019-06-10,Radiation,Public,Alive,86.0,None,Yes,,Moderate,30.2,Low,Urban,Private Insurance,17.0,,No,None,3.0
PT07481,Spain,,85.0,Non-binary,Ovarian,I,2017-07-25,2017-10-04,2017-11-23,,Public,Alive,36.0,None,Yes,Never,Moderate,18.6,Medium,Rural,Private Insurance,2.0,Yes,No,Cardiovascular Disease,7.0
,,Utrecht,57.0,Female,Colorectal,I,2017-09-20,2018-01-02,2018-05-11,Radiation,Private,Alive,,BRCA1,Yes,Former,Moderate,37.9,High,Urban,NHS,6.0,No,Yes,Diabetes,9.0
PT07483,Netherlands,South Holland,60.0,Female,Lung,I,2018-07-22,2018-09-16,2019-07-17,Radiation,Research Institute,Deceased,17.0,EGFR,No,Current,Moderate,,Low,Urban,Statutory Health Insurance,16.0,No,No,None,2.0
PT07484,Belgium,Wallonia,59.0,Female,Breast,II,,2018-11-21,2019-05-20,Immunotherapy,Public,Deceased,43.0,EGFR,Yes,Former,Moderate,33.0,Low,Urban,Statutory Health Insurance,8.0,Yes,No,Diabetes,1.0
PT07485,Norway,Trøndelag,83.0,Non-binary,Breast,I,2010-11-06,2011-01-01,2011-12-21,Radiation,Public,Alive,51.0,None,Yes,Current,Moderate,33.4,Medium,Urban,Statutory Health Insurance,16.0,Yes,No,Diabetes,8.0
PT07486,Spain,Andalusia,35.0,Female,Leukemia,I,2020-06-24,2020-12-11,2021-06-19,Immunotherapy,Public,Alive,99.0,None,No,Former,Moderate,29.8,Low,Urban,Statutory Health Insurance,8.0,Yes,Yes,None,4.0
PT07487,,Geneva,78.0,Male,Breast,IV,2022-09-27,2023-02-15,2023-11-10,Radiation,Public,Alive,109.0,EGFR,No,Never,,20.5,Low,Rural,Private Insurance,4.0,No,No,Hypertension,2.0
PT07488,Norway,Vestland,30.0,Male,Prostate,I,2018-02-08,2018-03-14,2018-05-17,Surgery,Public,Alive,67.0,None,,Never,Moderate,27.2,Low,Urban,Statutory Health Insurance,6.0,Yes,No,Obesity,10.0
PT07489,Netherlands,South Holland,20.0,Male,Breast,II,,2016-06-14,2017-05-24,Radiation,Research Institute,Alive,75.0,KRAS,No,Former,Moderate,34.5,Low,Urban,Statutory Health Insurance,19.0,No,No,None,2.0
PT07490,Germany,Bavaria,32.0,Female,Prostate,I,2011-03-11,2011-08-20,2011-10-30,,Research Institute,Alive,82.0,None,No,,Moderate,39.6,Medium,Rural,NHS,13.0,Yes,Yes,Obesity,2.0
PT07491,Poland,Silesian,49.0,Male,Prostate,I,2018-07-21,2018-09-12,2019-02-15,Surgery,Private,Alive,58.0,BRCA1,No,Never,None,24.8,Medium,Urban,Private Insurance,,No,No,Obesity,5.0
PT07492,Austria,Tyrol,88.0,Male,Leukemia,III,2012-04-29,2012-05-02,2013-01-04,Chemotherapy,Public,Alive,39.0,,Yes,Never,Heavy,32.0,Medium,Rural,Statutory Health Insurance,8.0,No,No,Diabetes,2.0
PT07493,Italy,Veneto,37.0,Female,,I,2010-04-17,,2010-10-23,Targeted Therapy,Public,Alive,10.0,None,No,Never,None,39.6,High,Urban,Statutory Health Insurance,16.0,No,No,Obesity,7.0
PT07494,Poland,Silesian,32.0,Male,Leukemia,I,2017-04-25,2017-08-10,2018-03-30,Targeted Therapy,Public,Alive,91.0,EGFR,Yes,Current,Heavy,30.6,Medium,Urban,Private Insurance,16.0,No,No,Hypertension,2.0
PT07495,Belgium,Brussels,51.0,,Colorectal,II,2010-04-30,2010-08-07,2010-10-24,Surgery,Public,Alive,78.0,EGFR,No,Former,Moderate,35.7,High,Rural,NHS,3.0,No,No,Cardiovascular Disease,9.0
PT07496,,Trøndelag,,Male,Lung,I,2018-04-23,2018-05-30,2019-04-21,Targeted Therapy,Public,Alive,38.0,BRCA1,No,Never,None,31.0,Medium,Urban,NHS,2.0,No,Yes,None,1.0
PT07497,Switzerland,Geneva,,Male,Ovarian,II,2023-03-03,2023-07-15,2024-07-11,Targeted Therapy,Private,Deceased,32.0,EGFR,No,Never,Heavy,27.5,Medium,Urban,NHS,15.0,No,,,1.0
PT07498,Norway,Oslo,70.0,,,I,2015-03-08,2015-08-04,2016-03-26,Radiation,Private,Deceased,17.0,BRCA1,No,Never,None,32.9,Low,Rural,Statutory Health Insurance,,No,No,None,7.0
PT07499,Denmark,Central Denmark,46.0,Male,Colorectal,II,2015-12-02,2016-01-16,2016-05-29,Targeted Therapy,Public,Alive,117.0,KRAS,Yes,Former,None,37.0,Medium,Urban,Private Insurance,14.0,No,No,Cardiovascular Disease,1.0
PT07500,Sweden,Stockholm,79.0,,Pancreatic,I,2020-03-05,2020-07-16,2020-10-02,Targeted Therapy,Public,Deceased,23.0,,,Former,Moderate,35.2,High,Rural,Private Insurance,12.0,No,No,None,6.0
PT07501,Ireland,Connacht,,Male,Ovarian,IV,2012-01-30,2012-02-02,2012-05-12,Targeted Therapy,Public,Alive,52.0,BRCA1,No,Former,None,37.3,,Urban,Private Insurance,5.0,No,No,None,4.0
PT07502,Spain,Madrid,72.0,Male,Ovarian,II,2014-07-05,2014-07-25,2014-11-15,Chemotherapy,Public,Lost to Follow-up,,None,No,Never,None,38.9,High,Urban,Statutory Health Insurance,16.0,No,No,Diabetes,2.0
PT07503,Sweden,Skåne,52.0,Female,Ovarian,II,2022-06-16,2022-08-16,2023-03-07,Targeted Therapy,Public,Alive,47.0,BRCA1,No,Current,None,34.4,Medium,Urban,Statutory Health Insurance,12.0,Yes,No,Diabetes,4.0
PT07504,Germany,Bavaria,60.0,Female,Colorectal,III,2023-11-04,2024-04-15,2025-03-30,Radiation,Public,Alive,78.0,BRCA1,No,Current,None,36.4,Medium,Rural,Statutory Health Insurance,8.0,Yes,No,Diabetes,6.0
PT07505,Sweden,Västra Götaland,38.0,Female,Leukemia,III,2010-08-20,2011-01-27,2011-11-04,Immunotherapy,Public,Alive,94.0,None,,,Heavy,23.8,Medium,Urban,Statutory Health Insurance,12.0,No,No,Diabetes,10.0
PT07506,Ireland,Connacht,60.0,Female,Leukemia,III,2014-05-14,2014-10-08,2015-04-10,Chemotherapy,Public,,35.0,EGFR,Yes,Former,Moderate,21.5,Medium,Urban,NHS,4.0,No,No,Diabetes,4.0
PT07507,Germany,Bavaria,61.0,Female,Ovarian,,2011-07-16,2011-12-06,2012-10-20,Radiation,Public,Alive,42.0,None,Yes,Never,Heavy,26.5,Medium,Urban,Private Insurance,8.0,No,No,None,9.0
PT07508,Spain,Catalonia,42.0,Male,,II,2014-12-12,2015-02-24,2015-10-25,Surgery,Public,Alive,47.0,KRAS,Yes,Former,None,24.8,Medium,Rural,NHS,17.0,No,No,Diabetes,8.0
PT07509,Austria,Tyrol,52.0,Female,Lung,II,2012-05-25,2012-07-21,2013-02-26,Radiation,Private,Alive,21.0,BRCA1,,Never,Moderate,27.1,Medium,Rural,Statutory Health Insurance,2.0,Yes,No,Cardiovascular Disease,10.0
PT07510,Finland,Southwest Finland,39.0,,Lung,III,2014-06-27,2014-11-28,,Immunotherapy,Public,Alive,32.0,None,No,Former,,21.1,Low,Urban,Statutory Health Insurance,17.0,,No,Cardiovascular Disease,6.0
PT07511,Norway,Oslo,44.0,Male,Ovarian,IV,2012-09-19,2012-11-28,2013-07-10,,Public,Alive,28.0,KRAS,No,Never,None,27.3,High,Rural,Statutory Health Insurance,16.0,No,No,None,6.0
PT07512,Netherlands,Utrecht,71.0,Male,Lung,I,2020-03-24,2020-07-13,2021-01-13,Immunotherapy,Public,Alive,75.0,KRAS,No,Current,None,36.0,Medium,Urban,NHS,8.0,No,Yes,Cardiovascular Disease,6.0
PT07513,Austria,Tyrol,31.0,Male,Ovarian,II,2014-04-06,2014-07-05,2014-08-10,Surgery,Research Institute,Deceased,100.0,EGFR,No,Current,Moderate,,Low,Urban,NHS,9.0,No,No,Cardiovascular Disease,5.0
PT07514,Denmark,Central Denmark,51.0,Male,Lung,III,2021-12-02,2022-04-11,2022-09-10,Surgery,Research Institute,Deceased,111.0,KRAS,Yes,Never,Moderate,23.6,Medium,Urban,Private Insurance,13.0,No,No,Diabetes,2.0
PT07515,Belgium,,52.0,Male,Ovarian,I,2023-03-12,2023-04-30,2024-03-03,Surgery,Public,Alive,83.0,BRCA1,No,Current,None,26.7,Low,Urban,Private Insurance,2.0,Yes,No,Cardiovascular Disease,6.0
PT07516,Netherlands,Utrecht,87.0,Male,Leukemia,IV,2016-10-12,2017-04-06,2017-09-09,Radiation,Research Institute,Alive,32.0,KRAS,Yes,Never,None,30.8,Low,Urban,Private Insurance,3.0,No,Yes,Cardiovascular Disease,9.0
PT07517,Finland,Southwest Finland,34.0,Female,Prostate,II,2019-10-12,2020-03-20,2020-11-20,Radiation,Private,Deceased,22.0,KRAS,No,Never,Moderate,27.6,Medium,Urban,Statutory Health Insurance,2.0,Yes,No,Obesity,4.0
PT07518,Belgium,Flanders,70.0,Female,Leukemia,III,2011-11-08,2012-03-18,2012-12-14,Targeted Therapy,Private,Alive,112.0,None,Yes,Never,Heavy,18.7,Low,Urban,Statutory Health Insurance,16.0,No,No,Diabetes,8.0
PT07519,Netherlands,Utrecht,25.0,Female,Prostate,I,2020-04-14,2020-09-09,2021-03-21,Surgery,Public,Alive,11.0,EGFR,No,Former,,32.0,Medium,Urban,Private Insurance,12.0,No,No,Hypertension,5.0
PT07520,Ireland,Munster,88.0,Female,Leukemia,I,2011-03-01,2011-06-03,2012-05-11,Immunotherapy,Public,Alive,83.0,KRAS,No,,Moderate,33.7,Low,Urban,Private Insurance,7.0,No,Yes,None,10.0
PT07521,Italy,Sicily,88.0,Male,Pancreatic,I,2014-05-20,2014-11-01,2014-12-11,Surgery,Public,Deceased,88.0,BRCA1,No,Never,None,20.5,High,Urban,Statutory Health Insurance,4.0,No,No,None,4.0
PT07522,Austria,Vienna,54.0,Female,Leukemia,I,2013-09-02,2013-12-20,2014-10-08,Chemotherapy,Public,Alive,15.0,BRCA1,No,Never,None,18.3,Medium,Urban,NHS,6.0,No,No,Hypertension,7.0
PT07523,Switzerland,Zurich,53.0,,Lung,II,2011-09-22,2012-02-17,2013-02-02,Radiation,Private,Deceased,50.0,BRCA1,Yes,Never,Moderate,30.2,Medium,Urban,Statutory Health Insurance,2.0,No,No,Diabetes,7.0
PT07524,Italy,Lombardy,82.0,Male,,III,2021-07-31,2021-09-29,2022-08-11,Surgery,Private,,61.0,EGFR,Yes,Never,Heavy,37.1,High,Urban,NHS,8.0,No,No,Obesity,10.0
PT07525,Switzerland,Bern,87.0,Male,Colorectal,II,2018-03-28,,2018-09-17,Targeted Therapy,Private,Alive,36.0,EGFR,Yes,Former,Moderate,34.5,Low,Rural,NHS,8.0,No,No,Diabetes,2.0
PT07526,Netherlands,Utrecht,37.0,Male,Pancreatic,I,2015-08-28,2015-11-17,2016-11-06,Surgery,Public,Lost to Follow-up,,BRCA1,No,Former,Moderate,29.0,Medium,Rural,Statutory Health Insurance,3.0,Yes,No,Hypertension,10.0
PT07527,Finland,Pirkanmaa,45.0,Male,Colorectal,I,2022-03-22,2022-05-03,2023-02-10,Targeted Therapy,Public,Alive,96.0,KRAS,No,Never,,25.7,,Urban,NHS,2.0,No,No,Hypertension,4.0
PT07528,Italy,Veneto,80.0,Male,Pancreatic,III,2010-06-17,2010-11-15,2011-07-31,Radiation,Public,Alive,108.0,EGFR,Yes,Current,None,18.6,Low,Rural,Statutory Health Insurance,2.0,No,No,Hypertension,10.0
PT07529,Italy,Veneto,67.0,Male,Colorectal,II,2020-12-19,2021-06-06,2022-05-10,Radiation,Research Institute,Alive,45.0,KRAS,No,Former,Moderate,35.2,Medium,Urban,NHS,1.0,No,No,Cardiovascular Disease,1.0
PT07530,Italy,,50.0,Male,Lung,IV,,2021-03-09,2021-06-14,Targeted Therapy,Private,Deceased,8.0,KRAS,No,Never,None,23.0,,Urban,Statutory Health Insurance,1.0,No,No,Hypertension,5.0
,Switzerland,Geneva,53.0,Male,,III,2010-01-17,2010-02-13,2010-04-29,Chemotherapy,Public,Alive,52.0,None,,Never,None,39.7,Medium,Urban,NHS,14.0,Yes,Yes,Obesity,8.0
PT07532,Netherlands,Utrecht,26.0,,Ovarian,III,2014-03-26,,2015-05-03,Radiation,Public,Alive,97.0,None,No,Current,Moderate,19.6,Low,Urban,Statutory Health Insurance,17.0,No,No,Hypertension,5.0
PT07533,France,Provence-Alpes-Côte d'Azur,26.0,,Leukemia,I,2014-03-11,2014-09-01,2015-08-28,,Public,Alive,118.0,EGFR,No,Former,Moderate,37.6,Medium,Rural,Private Insurance,12.0,No,No,Obesity,1.0
PT07534,Poland,Lesser Poland,66.0,Male,Lung,III,2020-06-10,2020-06-27,2020-12-28,Radiation,Public,,117.0,KRAS,No,Former,Moderate,23.4,Low,Urban,Private Insurance,,No,No,Hypertension,4.0
PT07535,Belgium,Brussels,27.0,Female,Ovarian,I,2014-02-06,2014-05-30,2015-04-05,Surgery,Public,Alive,29.0,KRAS,No,Never,None,37.8,Low,Rural,NHS,5.0,No,No,Obesity,10.0
PT07536,Belgium,Wallonia,20.0,Female,Colorectal,II,2011-06-27,2011-11-04,2011-12-15,Immunotherapy,Private,Alive,106.0,BRCA1,No,Former,None,27.6,High,Urban,Private Insurance,,,No,Diabetes,6.0
PT07537,France,,22.0,Male,Lung,II,2011-12-28,2012-01-12,2012-08-16,Chemotherapy,Public,Alive,16.0,KRAS,Yes,Never,Moderate,23.1,Medium,Urban,NHS,19.0,,No,Hypertension,1.0
PT07538,Finland,Southwest Finland,72.0,Female,Leukemia,II,2011-01-14,2011-05-12,2011-06-27,Immunotherapy,Public,Alive,80.0,KRAS,Yes,Never,None,20.4,Low,Urban,NHS,3.0,No,Yes,Diabetes,6.0
PT07539,Sweden,Skåne,57.0,Male,Lung,I,2022-02-22,2022-08-10,2023-01-14,Chemotherapy,Public,Alive,36.0,EGFR,No,Current,Moderate,20.8,High,Rural,Private Insurance,16.0,,,Diabetes,3.0
PT07540,Denmark,Capital Region,70.0,Male,Colorectal,II,2021-10-12,2021-12-24,2022-05-21,Surgery,Public,Alive,52.0,EGFR,No,Never,Moderate,38.7,Medium,Urban,NHS,11.0,,No,Hypertension,10.0
PT07541,Belgium,Brussels,34.0,Male,Lung,I,,2019-08-09,2019-09-16,Targeted Therapy,Public,Alive,83.0,KRAS,Yes,Current,None,24.2,,Urban,NHS,1.0,No,No,Diabetes,6.0
PT07542,Spain,Madrid,86.0,Female,Pancreatic,I,2019-06-26,2019-07-04,2020-02-29,Targeted Therapy,Public,Alive,48.0,KRAS,Yes,Never,None,39.4,Low,Urban,NHS,,No,No,Diabetes,3.0
PT07543,Germany,Berlin,83.0,Male,Breast,III,2012-04-25,2012-07-10,,Targeted Therapy,Public,Alive,16.0,None,No,Never,None,36.3,Medium,Rural,Private Insurance,16.0,No,Yes,Diabetes,4.0
PT07544,Ireland,Dublin,87.0,Female,Colorectal,IV,2020-07-19,2020-12-01,2021-01-28,Surgery,Public,Alive,113.0,EGFR,No,Former,,34.3,High,Urban,,3.0,No,No,Obesity,3.0
PT07545,Poland,Lesser Poland,24.0,Male,Leukemia,III,2023-03-15,2023-05-21,2023-10-14,Immunotherapy,Research Institute,Deceased,61.0,KRAS,No,Former,Moderate,33.8,Medium,Urban,NHS,18.0,No,No,Obesity,2.0
PT07546,Norway,Oslo,29.0,Female,Prostate,II,2011-11-05,2012-04-07,2012-09-24,Radiation,,Deceased,11.0,BRCA1,No,Former,None,37.6,,Rural,Private Insurance,7.0,No,No,Obesity,10.0
PT07547,Austria,Vienna,27.0,Male,Lung,I,2019-08-22,2019-08-25,,Targeted Therapy,Research Institute,Lost to Follow-up,,None,No,Current,,23.0,Low,Urban,Private Insurance,6.0,No,,Cardiovascular Disease,4.0
PT07548,Norway,Vestland,31.0,Male,Pancreatic,,2018-04-28,2018-10-19,2019-07-09,Radiation,Public,Deceased,6.0,KRAS,No,Former,Moderate,37.9,Low,Urban,Statutory Health Insurance,4.0,No,No,,
PT07549,Sweden,Skåne,,Female,Lung,I,2015-08-20,2015-12-30,,Immunotherapy,Private,Deceased,81.0,,No,Former,Moderate,27.9,Medium,Urban,Statutory Health Insurance,16.0,No,No,Cardiovascular Disease,8.0
PT07550,Finland,Pirkanmaa,78.0,Female,Colorectal,IV,2022-03-04,2022-07-06,2023-01-15,Radiation,Public,Deceased,7.0,KRAS,No,Never,None,34.6,Low,Urban,,,No,No,None,8.0
PT07551,France,Île-de-France,86.0,Male,Pancreatic,II,2012-01-08,2012-06-30,2013-01-30,Radiation,,Deceased,41.0,KRAS,No,Former,Moderate,35.4,Medium,Urban,NHS,11.0,No,No,None,8.0
PT07552,Poland,Silesian,69.0,Female,,III,2020-11-02,2020-11-16,2021-08-31,Radiation,Public,Alive,78.0,None,Yes,Former,Moderate,36.4,Low,,Private Insurance,16.0,No,No,Diabetes,1.0
PT07553,Norway,Trøndelag,42.0,Female,Breast,III,2021-10-22,2022-03-02,2022-09-12,Surgery,Public,Alive,85.0,KRAS,No,Former,None,27.9,Medium,Urban,Statutory Health Insurance,17.0,No,No,Diabetes,8.0
PT07554,Denmark,Capital Region,59.0,Male,Leukemia,III,2019-06-12,2019-10-31,2019-12-19,Immunotherapy,,Alive,46.0,EGFR,No,Current,None,23.6,Low,Urban,Private Insurance,19.0,Yes,No,Obesity,7.0
PT07555,Germany,Bavaria,37.0,Non-binary,Pancreatic,IV,2014-09-21,2015-02-04,2016-01-29,Radiation,Public,Deceased,111.0,None,Yes,Never,Moderate,,Low,Urban,NHS,7.0,No,Yes,Hypertension,6.0
PT07556,Italy,Lombardy,40.0,Female,Pancreatic,I,2017-04-07,2017-08-15,2018-06-18,Targeted Therapy,Research Institute,Alive,103.0,KRAS,No,Never,,19.4,Medium,Rural,,15.0,No,No,Cardiovascular Disease,3.0
PT07557,Austria,Vienna,,Male,Lung,II,2012-11-27,2013-03-09,2013-09-03,Targeted Therapy,Public,Alive,70.0,None,Yes,Never,Moderate,30.7,Medium,Rural,Private Insurance,1.0,No,Yes,Diabetes,8.0
PT07558,Spain,Madrid,57.0,Male,Lung,IV,2022-10-28,2023-02-21,2023-11-02,Immunotherapy,Research Institute,Deceased,38.0,BRCA1,,Current,None,34.9,Medium,Urban,Private Insurance,17.0,No,No,Obesity,3.0
PT07559,Portugal,Algarve,60.0,Female,Prostate,II,2013-08-11,2013-09-26,2014-02-02,Surgery,Private,Deceased,71.0,KRAS,Yes,Current,None,37.3,Medium,Rural,Statutory Health Insurance,19.0,No,No,Diabetes,5.0
PT07560,France,Provence-Alpes-Côte d'Azur,61.0,Male,,I,2012-04-09,2012-05-10,2012-06-21,Radiation,Private,Alive,98.0,BRCA1,,Never,,20.6,Low,Rural,NHS,10.0,No,No,Diabetes,6.0
PT07561,Ireland,Munster,28.0,Male,Pancreatic,I,2019-10-26,2020-01-25,2020-10-31,Surgery,Public,Alive,111.0,None,No,Never,Moderate,28.2,Medium,Urban,NHS,15.0,No,No,Hypertension,9.0
,Portugal,Algarve,42.0,Male,Lung,III,2018-10-27,2018-12-01,2019-01-07,Immunotherapy,,Deceased,78.0,EGFR,Yes,Current,None,33.2,High,Urban,Statutory Health Insurance,5.0,No,No,Obesity,4.0
PT07563,Finland,Pirkanmaa,30.0,Female,Lung,I,2019-04-08,2019-06-09,2019-12-14,Chemotherapy,Public,Deceased,13.0,BRCA1,No,Never,Moderate,38.0,Medium,Urban,Private Insurance,1.0,No,Yes,Hypertension,10.0
PT07564,Spain,Madrid,50.0,Male,Ovarian,IV,2023-12-25,2024-06-16,2025-04-02,Targeted Therapy,Private,Alive,97.0,EGFR,Yes,Never,Heavy,31.9,Medium,Urban,Statutory Health Insurance,19.0,No,No,None,3.0
PT07565,Finland,Southwest Finland,45.0,Female,Breast,I,2015-11-18,2016-04-18,2016-09-22,Radiation,Research Institute,Deceased,8.0,EGFR,No,Former,None,23.2,High,Urban,NHS,1.0,,Yes,None,3.0
PT07566,Netherlands,Utrecht,49.0,Male,Prostate,III,2013-07-26,,2014-04-18,Radiation,Public,Alive,49.0,EGFR,Yes,Never,Moderate,21.0,,Urban,Statutory Health Insurance,14.0,Yes,No,Hypertension,2.0
PT07567,Germany,Berlin,53.0,Male,Ovarian,III,2018-06-03,2018-09-01,,Immunotherapy,Private,Alive,16.0,,Yes,Former,Moderate,27.0,Medium,Urban,Private Insurance,16.0,No,No,Hypertension,10.0
PT07568,Spain,,65.0,Female,Lung,II,2023-02-27,2023-04-12,2023-10-11,Immunotherapy,Public,Alive,6.0,None,Yes,Never,Moderate,21.7,Medium,Urban,NHS,14.0,No,No,Obesity,9.0
PT07569,Poland,Silesian,88.0,,Lung,II,2015-05-15,2015-08-22,2015-10-03,Surgery,Research Institute,Alive,53.0,None,No,Current,None,33.4,Medium,Urban,Private Insurance,14.0,No,Yes,Obesity,9.0
PT07570,Belgium,Wallonia,24.0,Male,Leukemia,IV,2014-08-28,,2014-12-18,Targeted Therapy,Private,Deceased,75.0,,No,,Heavy,29.6,Low,Urban,,11.0,No,No,None,4.0
,Ireland,Munster,80.0,Male,Pancreatic,III,2018-04-09,2018-07-26,2019-01-05,Surgery,Public,Alive,47.0,BRCA1,No,Current,Moderate,23.4,Low,Rural,NHS,7.0,No,No,,3.0
PT07572,Netherlands,South Holland,57.0,Male,,III,2012-10-21,2013-01-17,2013-04-05,Immunotherapy,Private,Alive,82.0,,Yes,Former,None,31.6,Medium,Urban,NHS,3.0,No,No,Hypertension,2.0
,France,Île-de-France,47.0,Female,Breast,,2011-08-23,2012-02-13,2012-12-05,Targeted Therapy,Private,Alive,50.0,EGFR,No,Former,None,20.1,Medium,Rural,NHS,,No,No,,9.0
PT07574,Italy,Lombardy,45.0,Male,Lung,I,2013-12-12,2014-01-14,,Immunotherapy,Private,Alive,96.0,KRAS,Yes,Never,Moderate,31.9,Medium,Urban,Private Insurance,12.0,No,No,None,1.0
PT07575,,Porto,80.0,Female,Pancreatic,I,2021-03-29,,2022-02-18,Surgery,Public,Alive,92.0,BRCA1,No,Current,None,32.7,Medium,Rural,NHS,3.0,No,No,,10.0
PT07576,Austria,Vienna,42.0,Female,Lung,,2016-08-19,2016-11-28,2017-03-05,Surgery,Private,Alive,39.0,BRCA1,No,Current,None,18.4,Low,Rural,Private Insurance,3.0,No,No,Cardiovascular Disease,3.0
PT07577,Finland,Southwest Finland,65.0,Male,Ovarian,III,2011-10-08,2012-03-23,2012-10-06,Surgery,Public,Deceased,112.0,BRCA1,No,,Moderate,32.8,High,Rural,Private Insurance,8.0,Yes,Yes,Obesity,5.0
PT07578,Switzerland,Zurich,49.0,Male,Colorectal,II,2015-06-15,2015-08-12,2016-05-15,Chemotherapy,Public,Alive,37.0,KRAS,Yes,Never,None,25.1,Medium,Rural,Statutory Health Insurance,14.0,No,No,None,5.0
PT07579,France,Auvergne-Rhône-Alpes,86.0,Male,Lung,III,2018-10-02,2019-01-25,2019-06-07,,Public,Alive,66.0,EGFR,Yes,Never,Moderate,19.0,Medium,Rural,NHS,10.0,No,Yes,None,10.0
PT07580,Finland,Pirkanmaa,52.0,Male,Prostate,I,2019-03-27,2019-04-22,2019-12-21,Radiation,Public,Alive,98.0,None,No,Never,None,27.4,Medium,Rural,Statutory Health Insurance,1.0,No,No,,9.0
PT07581,Ireland,Connacht,22.0,,Pancreatic,II,,2023-04-27,2023-10-31,Surgery,Research Institute,Alive,11.0,KRAS,Yes,Never,None,25.9,Medium,Urban,NHS,11.0,No,No,Cardiovascular Disease,8.0
,Switzerland,Zurich,88.0,Female,Pancreatic,IV,2014-07-05,2014-09-18,,Immunotherapy,Public,Alive,109.0,None,No,Never,None,33.5,,Urban,NHS,2.0,Yes,No,None,1.0
PT07583,Ireland,Munster,61.0,Female,Colorectal,IV,2018-08-08,2018-11-09,2019-03-19,Surgery,Private,Alive,83.0,None,No,Never,None,33.3,Medium,Urban,NHS,6.0,No,No,Cardiovascular Disease,10.0
PT07584,Poland,Silesian,81.0,Male,Prostate,IV,2021-10-29,2021-12-25,2022-05-17,,Public,Deceased,83.0,KRAS,No,Current,Moderate,27.5,Low,Urban,Statutory Health Insurance,9.0,No,Yes,None,10.0
PT07585,Poland,Lesser Poland,77.0,Female,Prostate,III,2014-10-21,2014-12-30,2015-12-12,Immunotherapy,Public,Deceased,102.0,None,Yes,Never,Heavy,32.5,Medium,Urban,NHS,12.0,No,Yes,,2.0
PT07586,France,Auvergne-Rhône-Alpes,76.0,Male,Pancreatic,III,2012-01-21,2012-04-03,2012-10-15,Targeted Therapy,Public,Alive,115.0,KRAS,No,,Moderate,36.8,Medium,Rural,NHS,1.0,No,Yes,None,1.0
PT07587,Finland,Uusimaa,20.0,Male,,IV,2012-04-22,2012-04-30,2012-06-28,Chemotherapy,Public,Alive,93.0,EGFR,No,Never,Moderate,19.3,Low,Urban,Statutory Health Insurance,12.0,Yes,No,None,9.0
PT07588,Austria,,79.0,Female,Lung,III,2019-05-08,2019-08-07,2019-10-07,Immunotherapy,Public,Alive,67.0,BRCA1,No,Current,Heavy,21.3,High,Urban,NHS,1.0,No,No,Cardiovascular Disease,7.0
PT07589,Germany,North Rhine-Westphalia,88.0,Female,,IV,2019-05-22,2019-09-25,2020-02-17,Immunotherapy,Research Institute,Alive,40.0,BRCA1,No,Former,None,28.3,Low,Urban,NHS,,No,No,Obesity,3.0
PT07590,Germany,North Rhine-Westphalia,78.0,Male,Lung,I,2019-08-12,2019-09-15,2020-01-23,Radiation,Public,Deceased,16.0,BRCA1,Yes,Never,Moderate,36.5,Low,Urban,Private Insurance,13.0,No,No,Obesity,7.0
PT07591,Norway,Oslo,65.0,Female,Lung,IV,2016-04-22,2016-06-30,2016-10-24,Surgery,Public,Alive,19.0,None,No,Never,None,29.1,High,Urban,Statutory Health Insurance,10.0,No,Yes,Hypertension,1.0
PT07592,Norway,Oslo,53.0,Female,Ovarian,II,2017-06-07,2017-06-17,2017-07-28,Chemotherapy,Public,Deceased,114.0,None,No,Current,None,22.0,Medium,Urban,NHS,11.0,No,No,Diabetes,10.0
PT07593,Spain,Catalonia,44.0,Female,Breast,I,2014-02-14,2014-03-08,2014-12-27,Chemotherapy,Public,Deceased,50.0,EGFR,No,Never,Moderate,,Medium,Urban,Private Insurance,2.0,No,No,Cardiovascular Disease,4.0
PT07594,Germany,North Rhine-Westphalia,61.0,Male,Breast,I,2013-11-28,2014-04-17,,Targeted Therapy,Private,,31.0,KRAS,Yes,Former,None,22.9,Low,Urban,Statutory Health Insurance,4.0,No,No,Hypertension,9.0
PT07595,Spain,Madrid,,Female,Prostate,IV,2020-07-21,2020-12-25,2021-03-24,Immunotherapy,Public,Alive,117.0,EGFR,No,Current,None,36.2,Medium,Urban,Statutory Health Insurance,15.0,No,No,Diabetes,6.0
PT07596,Belgium,Flanders,44.0,Female,Prostate,II,2017-07-05,2017-12-11,2018-09-26,Immunotherapy,Private,Alive,95.0,EGFR,Yes,Never,Moderate,40.0,Medium,Urban,NHS,4.0,Yes,No,,8.0
PT07597,Netherlands,South Holland,73.0,Female,Pancreatic,IV,2021-02-23,2021-03-01,2021-08-14,Radiation,Public,Alive,45.0,,Yes,Never,Moderate,31.4,Medium,Urban,,4.0,No,No,Obesity,6.0
PT07598,Italy,Lombardy,86.0,Female,Ovarian,I,2018-12-19,2019-04-08,2020-01-29,Chemotherapy,Public,Alive,39.0,None,,Never,,22.3,Medium,Urban,NHS,11.0,Yes,Yes,Obesity,8.0
PT07599,Poland,Masovian,34.0,Non-binary,Ovarian,II,2017-02-21,2017-02-28,2017-11-19,Surgery,Research Institute,Alive,84.0,EGFR,No,Never,None,29.0,High,Urban,Private Insurance,4.0,No,No,Hypertension,7.0
PT07600,Germany,Berlin,23.0,Male,,II,2016-07-02,2016-10-07,2017-07-18,,Private,Alive,97.0,None,No,,None,32.9,,Urban,Private Insurance,8.0,No,No,None,1.0
PT07601,France,Île-de-France,57.0,Male,Lung,II,2016-09-30,2017-01-18,,Targeted Therapy,Private,Alive,100.0,KRAS,No,Never,Moderate,21.0,Medium,Urban,NHS,9.0,No,Yes,Cardiovascular Disease,7.0
PT07602,Spain,Catalonia,39.0,Male,Pancreatic,III,2020-06-02,2020-06-15,2021-02-25,Targeted Therapy,Public,Alive,71.0,EGFR,,Never,Moderate,39.5,Medium,Urban,Private Insurance,15.0,No,No,Cardiovascular Disease,5.0
PT07603,Finland,Southwest Finland,42.0,Male,Lung,III,2020-10-10,2020-12-12,2021-04-18,Targeted Therapy,Public,Alive,27.0,None,No,,None,39.1,Low,Urban,Statutory Health Insurance,5.0,No,No,None,5.0
PT07604,Norway,Trøndelag,56.0,Male,Breast,,2013-10-15,2013-11-08,,Chemotherapy,Private,Alive,46.0,EGFR,Yes,Current,Moderate,29.1,Medium,Urban,NHS,3.0,No,No,Obesity,8.0
PT07605,Netherlands,South Holland,81.0,Female,Breast,I,2019-11-30,2020-03-03,2020-04-26,Immunotherapy,Public,Alive,64.0,None,No,Former,None,36.0,Medium,Rural,Private Insurance,8.0,No,No,Diabetes,7.0
PT07606,France,Auvergne-Rhône-Alpes,27.0,,,I,2018-12-21,2019-03-28,2019-06-27,Chemotherapy,Public,Alive,104.0,EGFR,No,Never,None,39.8,Medium,Urban,NHS,7.0,No,No,None,7.0
PT07607,Sweden,Stockholm,,Female,Pancreatic,IV,2018-01-29,2018-04-23,2018-08-14,Surgery,,Deceased,87.0,KRAS,Yes,Never,Heavy,32.7,Low,Rural,,10.0,Yes,No,Diabetes,9.0
PT07608,France,Provence-Alpes-Côte d'Azur,64.0,Female,,II,2010-10-07,2010-10-26,2010-12-18,Targeted Therapy,Private,Alive,113.0,EGFR,No,Former,Heavy,30.9,Low,Urban,Private Insurance,15.0,No,No,None,9.0
PT07609,Austria,Tyrol,52.0,Male,Colorectal,II,2020-11-22,2021-02-13,2021-09-27,Chemotherapy,Private,Alive,37.0,BRCA1,Yes,Never,Moderate,31.4,Medium,Urban,Private Insurance,15.0,No,No,Obesity,4.0
PT07610,Spain,Catalonia,26.0,Female,Ovarian,II,2016-03-20,2016-06-16,2016-09-19,,Public,Deceased,40.0,BRCA1,No,,Moderate,29.7,High,Rural,Private Insurance,16.0,No,No,Cardiovascular Disease,6.0
PT07611,Italy,Veneto,,Male,Colorectal,III,2015-11-26,2016-02-03,,Radiation,Private,Deceased,116.0,None,No,Current,Moderate,37.9,High,Rural,Private Insurance,1.0,No,,None,5.0
PT07612,Denmark,Central Denmark,24.0,Female,Breast,I,2011-11-15,2012-04-13,2013-02-01,Targeted Therapy,Public,Alive,,None,Yes,Never,Moderate,21.0,Medium,Urban,NHS,10.0,No,No,Hypertension,
PT07613,Poland,Masovian,34.0,Female,Breast,I,2011-08-25,2011-10-24,2012-07-14,Immunotherapy,Private,Alive,9.0,KRAS,No,Former,Moderate,28.6,Low,Urban,NHS,5.0,No,No,Obesity,8.0
PT07614,Sweden,Stockholm,40.0,Male,Colorectal,III,2015-08-06,2015-08-28,2016-02-09,Immunotherapy,Public,Deceased,99.0,KRAS,No,Former,Heavy,18.3,Medium,Urban,Private Insurance,8.0,No,No,None,4.0
PT07615,Sweden,Västra Götaland,36.0,Male,Colorectal,IV,2014-03-13,2014-06-13,2014-11-15,Immunotherapy,Private,Alive,119.0,None,No,Former,None,37.6,High,Urban,Statutory Health Insurance,9.0,No,No,Obesity,1.0
PT07616,Norway,Trøndelag,75.0,Male,Prostate,III,2012-08-18,2013-01-10,2013-05-15,Surgery,Public,Deceased,81.0,EGFR,,Former,None,24.9,High,Urban,Private Insurance,17.0,No,No,Diabetes,9.0
,Finland,,69.0,Female,Colorectal,I,2018-06-05,2018-09-08,,Chemotherapy,Public,Alive,106.0,None,Yes,Never,Heavy,28.4,Low,Rural,NHS,13.0,No,No,Cardiovascular Disease,5.0
PT07618,France,Île-de-France,26.0,Female,,II,2011-05-22,2011-11-13,2012-11-03,,Private,Alive,,BRCA1,Yes,Never,Moderate,32.1,Medium,Rural,NHS,13.0,No,No,Diabetes,7.0
PT07619,Norway,Trøndelag,69.0,Male,Colorectal,IV,2014-12-28,2015-05-12,2015-07-18,Targeted Therapy,Public,Alive,58.0,BRCA1,No,Never,,20.7,Low,,NHS,18.0,No,No,Cardiovascular Disease,9.0
PT07620,Switzerland,Geneva,79.0,Female,Leukemia,II,2013-04-09,2013-09-01,2014-02-25,Targeted Therapy,Public,,,BRCA1,No,Never,None,34.5,Low,Urban,Statutory Health Insurance,1.0,Yes,No,Obesity,5.0
PT07621,,North Rhine-Westphalia,26.0,Male,Colorectal,II,,2012-10-06,2012-12-21,,Public,Lost to Follow-up,,,No,Current,None,29.2,Low,Urban,Statutory Health Insurance,15.0,No,No,Obesity,
PT07622,France,Île-de-France,59.0,Male,Breast,II,2016-05-04,2016-06-02,2016-09-18,Radiation,Research Institute,Alive,90.0,,No,Former,Moderate,19.5,High,Urban,Statutory Health Insurance,13.0,Yes,No,Diabetes,9.0
PT07623,Finland,Uusimaa,64.0,Non-binary,Breast,IV,2021-09-28,2021-10-02,2021-11-28,,Private,Alive,36.0,BRCA1,No,Never,None,21.3,Medium,Urban,,13.0,No,,Obesity,2.0
PT07624,Portugal,Lisbon,78.0,Male,Ovarian,III,2017-09-04,2017-12-17,2018-10-20,Radiation,Private,Deceased,,None,Yes,Never,Moderate,31.1,Low,Urban,NHS,2.0,No,No,Obesity,10.0
PT07625,Switzerland,Geneva,74.0,Female,Leukemia,III,2017-09-08,2018-01-04,2018-09-22,Chemotherapy,Private,Alive,19.0,,No,Former,Moderate,,High,Urban,NHS,12.0,No,No,Diabetes,1.0
PT07626,Austria,Vienna,83.0,Female,Lung,I,2015-10-19,2015-11-04,2016-03-25,Immunotherapy,Public,Alive,78.0,None,No,Current,Moderate,38.0,Medium,Urban,NHS,8.0,No,No,None,2.0
PT07627,Ireland,,84.0,Non-binary,Colorectal,II,2018-09-26,2018-12-15,2019-07-11,Radiation,Public,Alive,38.0,BRCA1,Yes,Current,Moderate,32.6,Medium,,Private Insurance,18.0,No,No,Hypertension,4.0
PT07628,Denmark,Capital Region,73.0,,Colorectal,II,2020-05-16,2020-08-10,2021-06-15,Immunotherapy,Private,Deceased,,BRCA1,Yes,Former,None,,Medium,,Statutory Health Insurance,2.0,Yes,Yes,Diabetes,6.0
PT07629,Portugal,Lisbon,59.0,Male,Leukemia,I,2022-08-11,2022-10-25,2023-07-07,Immunotherapy,Public,Alive,23.0,BRCA1,Yes,Never,Moderate,33.9,Low,Urban,Private Insurance,,Yes,Yes,Hypertension,8.0
PT07630,Poland,Masovian,72.0,Male,Ovarian,IV,2012-01-04,2012-02-14,2012-05-26,Surgery,Research Institute,Alive,21.0,EGFR,No,Current,None,29.3,Low,Urban,Statutory Health Insurance,7.0,No,No,Diabetes,9.0
PT07631,France,Île-de-France,63.0,Female,,II,2022-06-22,2022-08-21,2022-11-19,Radiation,Public,Alive,,EGFR,No,,None,,High,Rural,Private Insurance,1.0,No,No,Hypertension,3.0
PT07632,Poland,Lesser Poland,82.0,Female,Prostate,I,2014-07-20,2014-09-16,2014-10-17,Targeted Therapy,Public,Alive,113.0,KRAS,No,Current,Moderate,39.5,Medium,Rural,Private Insurance,14.0,,No,Diabetes,10.0
PT07633,Poland,Masovian,21.0,Male,Ovarian,IV,2022-06-20,2022-10-10,2023-02-05,Surgery,Public,Alive,17.0,EGFR,No,Former,Moderate,37.8,Medium,Rural,Private Insurance,1.0,Yes,No,None,6.0
PT07634,Denmark,Central Denmark,40.0,Female,Lung,I,2022-10-07,2022-11-16,2022-12-19,Targeted Therapy,Public,Deceased,19.0,EGFR,No,Current,None,21.9,Low,Urban,NHS,13.0,No,No,None,10.0
PT07635,,,69.0,Male,,III,2021-04-27,2021-06-24,2022-03-12,Immunotherapy,Private,Deceased,109.0,BRCA1,No,Former,Heavy,22.5,Low,Urban,Private Insurance,2.0,No,No,Hypertension,4.0
PT07636,Netherlands,South Holland,71.0,Male,Colorectal,III,2012-08-27,2013-02-16,2013-05-14,Surgery,Public,Alive,106.0,KRAS,Yes,Former,None,23.8,High,Rural,NHS,16.0,No,No,None,4.0
PT07637,Switzerland,Bern,28.0,Male,Colorectal,IV,2010-09-19,2010-12-05,2011-05-10,Targeted Therapy,Public,Alive,99.0,EGFR,No,Current,Moderate,34.1,Low,Rural,NHS,13.0,,No,Cardiovascular Disease,9.0
PT07638,Portugal,Lisbon,39.0,Male,Ovarian,III,2021-09-19,2021-11-06,2022-08-31,Targeted Therapy,Public,Alive,90.0,KRAS,No,Never,None,38.6,Medium,,Private Insurance,3.0,No,No,Cardiovascular Disease,3.0
PT07639,Switzerland,Geneva,37.0,Male,Breast,,2022-08-21,2022-11-19,,Chemotherapy,,Deceased,,None,Yes,Former,None,20.8,,Urban,NHS,1.0,No,No,Hypertension,2.0
PT07640,Netherlands,South Holland,49.0,Male,Pancreatic,II,2019-11-09,2019-11-20,2020-07-30,Surgery,Public,Alive,29.0,,No,Never,Heavy,39.9,Medium,Urban,Private Insurance,12.0,No,No,Hypertension,8.0
PT07641,Portugal,Porto,84.0,Female,Prostate,II,2020-11-03,2020-12-29,2021-07-01,Surgery,Public,Lost to Follow-up,,EGFR,Yes,Never,Moderate,25.1,Low,Urban,Statutory Health Insurance,7.0,No,No,,
PT07642,Germany,Berlin,43.0,Female,Ovarian,IV,2011-01-21,2011-02-13,2011-04-13,Immunotherapy,Public,Alive,18.0,EGFR,Yes,Current,,25.6,High,Urban,Statutory Health Insurance,7.0,No,No,Cardiovascular Disease,6.0
PT07643,Poland,Masovian,66.0,Male,Pancreatic,I,2021-11-27,2021-12-30,2022-05-18,Immunotherapy,Public,Deceased,57.0,BRCA1,No,,None,29.7,High,Urban,NHS,17.0,No,,None,2.0
PT07644,Germany,Berlin,63.0,Female,Leukemia,III,2012-10-31,2013-02-24,2013-12-02,Surgery,Public,Alive,115.0,EGFR,No,Former,None,20.1,High,Rural,Private Insurance,10.0,No,No,Diabetes,7.0
PT07645,,Brussels,48.0,Female,Pancreatic,I,2014-03-20,2014-04-17,2015-03-30,,Public,Deceased,97.0,BRCA1,Yes,Former,Heavy,,Low,Urban,NHS,17.0,No,Yes,Hypertension,2.0
PT07646,Ireland,Dublin,87.0,Male,Breast,I,2014-12-12,2015-04-06,2015-11-14,Chemotherapy,Public,Alive,86.0,EGFR,No,Former,Moderate,18.4,Low,Urban,Private Insurance,5.0,No,No,Obesity,4.0
PT07647,Denmark,Zealand,36.0,Female,Breast,I,2021-05-26,2021-10-05,2021-11-14,Immunotherapy,Private,Alive,79.0,KRAS,,Current,Moderate,18.2,Medium,Urban,Private Insurance,18.0,No,No,Obesity,8.0
PT07648,Norway,Oslo,24.0,Female,Prostate,I,2016-10-10,2017-04-07,2017-05-23,,Public,Alive,82.0,BRCA1,Yes,Never,Moderate,39.4,Low,Urban,NHS,15.0,Yes,No,Diabetes,4.0
PT07649,Ireland,Dublin,69.0,Female,Colorectal,IV,2015-08-19,2016-01-04,2016-07-06,Targeted Therapy,Private,Alive,112.0,EGFR,Yes,Never,Moderate,26.8,High,Urban,NHS,19.0,No,No,Cardiovascular Disease,3.0
PT07650,Germany,North Rhine-Westphalia,59.0,Female,Lung,IV,2022-09-07,,2023-03-24,,Private,,102.0,None,Yes,Former,None,23.5,Low,Urban,NHS,6.0,No,,Hypertension,6.0
PT07651,Switzerland,Geneva,65.0,Female,Pancreatic,II,2014-05-20,2014-05-29,2015-02-11,Chemotherapy,Public,Alive,76.0,EGFR,No,Current,,,Medium,Urban,Private Insurance,6.0,No,No,Obesity,10.0
PT07652,Spain,Madrid,70.0,Male,Ovarian,III,2020-02-05,2020-02-23,2021-01-08,Surgery,Public,Alive,106.0,EGFR,No,Former,None,28.9,Low,Urban,,7.0,No,No,Diabetes,3.0
PT07653,Norway,Trøndelag,30.0,Female,Ovarian,II,2023-02-12,2023-05-05,,Chemotherapy,Public,Alive,74.0,KRAS,No,Current,Moderate,37.7,Medium,Urban,NHS,12.0,No,No,Cardiovascular Disease,7.0
PT07654,France,Provence-Alpes-Côte d'Azur,31.0,Male,Leukemia,III,2012-03-11,2012-08-26,2013-03-04,Surgery,Research Institute,,102.0,None,No,Current,Moderate,34.4,High,Rural,Private Insurance,18.0,Yes,No,Obesity,8.0
PT07655,Sweden,Skåne,32.0,,Prostate,III,2015-09-01,2015-11-06,2016-01-29,Immunotherapy,Public,Lost to Follow-up,,EGFR,No,Never,None,21.8,Low,Urban,,5.0,No,Yes,None,10.0
PT07656,Finland,Southwest Finland,83.0,Male,Lung,I,2018-12-20,2019-01-11,2019-09-05,Targeted Therapy,Private,Deceased,103.0,KRAS,No,Never,Moderate,25.5,Low,Urban,Statutory Health Insurance,11.0,No,Yes,Obesity,5.0
PT07657,Finland,Southwest Finland,27.0,Male,Prostate,II,2021-08-21,2021-11-09,2022-11-04,Targeted Therapy,Private,Alive,19.0,None,Yes,Former,Moderate,27.3,Medium,Urban,NHS,18.0,No,No,None,
PT07658,Poland,,84.0,Female,Prostate,III,2019-11-04,2020-02-13,2020-05-04,Immunotherapy,Private,Deceased,90.0,EGFR,Yes,Current,Heavy,39.8,Low,Urban,Statutory Health Insurance,4.0,No,Yes,Cardiovascular Disease,10.0
PT07659,Portugal,Porto,28.0,Male,Prostate,IV,2017-10-28,2018-02-01,2018-03-21,Targeted Therapy,Public,Alive,87.0,KRAS,Yes,Never,Heavy,35.1,High,Urban,Private Insurance,7.0,Yes,No,Obesity,1.0
PT07660,Ireland,Connacht,21.0,Female,Prostate,III,2014-01-25,2014-04-09,2015-01-05,Targeted Therapy,Public,Deceased,83.0,,No,Current,,28.8,High,Urban,Statutory Health Insurance,10.0,Yes,No,Cardiovascular Disease,
PT07661,Spain,Madrid,32.0,Male,Colorectal,IV,,2021-09-18,2022-04-23,Radiation,,Alive,96.0,KRAS,,Never,Heavy,23.4,Medium,,NHS,11.0,,No,Hypertension,1.0
PT07662,Poland,Masovian,21.0,Female,Ovarian,III,2023-03-08,2023-08-17,2023-09-25,Radiation,Public,Deceased,44.0,EGFR,No,Never,Heavy,21.4,Medium,Rural,NHS,,No,No,Cardiovascular Disease,10.0
PT07663,Spain,Catalonia,87.0,Male,Breast,II,2023-04-21,2023-10-14,2024-09-29,,Public,Alive,107.0,BRCA1,No,Never,None,21.8,Medium,Urban,Statutory Health Insurance,18.0,No,No,None,2.0
,Austria,Styria,67.0,Male,Ovarian,IV,2021-05-15,2021-05-31,2021-07-06,Surgery,Private,Alive,53.0,EGFR,Yes,Never,Moderate,25.3,Low,Urban,NHS,11.0,No,Yes,None,4.0
PT07665,Portugal,Lisbon,22.0,Male,Ovarian,II,2010-12-05,2011-01-23,2011-05-22,Radiation,Public,Alive,31.0,KRAS,No,Never,Moderate,29.6,Medium,Urban,NHS,12.0,No,Yes,None,4.0
PT07666,Netherlands,North Holland,87.0,Female,Pancreatic,II,2010-10-01,2011-01-07,2011-07-23,Immunotherapy,Private,Alive,33.0,BRCA1,No,Never,Moderate,21.8,Low,Urban,NHS,8.0,No,No,Hypertension,4.0
PT07667,Ireland,Connacht,25.0,Female,Prostate,III,2020-11-05,2021-02-14,2021-09-29,Radiation,Private,Alive,,EGFR,No,Never,Heavy,34.2,Medium,,Private Insurance,3.0,Yes,No,Hypertension,
PT07668,Switzerland,Geneva,24.0,Female,Lung,I,2015-03-08,2015-05-10,2015-06-19,Immunotherapy,Public,Deceased,18.0,None,Yes,Never,None,38.6,Low,Urban,NHS,12.0,Yes,No,Cardiovascular Disease,2.0
PT07669,Germany,North Rhine-Westphalia,22.0,Non-binary,Pancreatic,II,2020-04-14,2020-09-29,,Radiation,Public,,104.0,KRAS,Yes,Former,,29.6,High,Urban,Private Insurance,8.0,No,No,Diabetes,10.0
PT07670,France,Provence-Alpes-Côte d'Azur,29.0,Female,Lung,III,2022-05-26,2022-07-21,2023-01-06,Targeted Therapy,Private,Alive,91.0,KRAS,Yes,Never,Moderate,26.0,,Urban,Private Insurance,10.0,No,No,None,8.0
PT07671,Denmark,Zealand,62.0,Female,Lung,II,2016-09-04,2016-12-11,2017-08-17,Radiation,Public,Alive,,None,Yes,Former,None,33.4,Medium,Urban,Private Insurance,16.0,Yes,No,None,9.0
PT07672,Spain,Andalusia,38.0,Male,Breast,IV,2015-04-06,2015-07-23,2016-02-27,Immunotherapy,Public,Alive,8.0,KRAS,No,Never,None,33.2,Low,Urban,Statutory Health Insurance,14.0,No,No,Cardiovascular Disease,7.0
PT07673,Italy,Lombardy,33.0,Male,Breast,IV,2019-05-07,2019-07-23,2020-07-15,Immunotherapy,,Deceased,116.0,BRCA1,No,Former,None,36.0,Low,Urban,NHS,12.0,No,No,Obesity,9.0
PT07674,Spain,Catalonia,40.0,Male,Lung,II,2013-07-07,2013-12-30,2014-06-28,Immunotherapy,Public,Alive,55.0,None,No,Never,Moderate,38.5,Medium,Urban,Statutory Health Insurance,10.0,No,Yes,None,7.0
PT07675,Portugal,Algarve,62.0,Male,Colorectal,II,2021-03-15,2021-04-21,2022-03-12,Radiation,Private,Alive,90.0,EGFR,No,Never,Moderate,25.5,High,Rural,Private Insurance,2.0,No,No,Obesity,1.0
PT07676,Switzerland,Zurich,47.0,Female,Breast,III,2016-01-31,2016-06-19,2017-02-01,Surgery,Public,Alive,6.0,EGFR,Yes,Current,None,20.9,High,Urban,Private Insurance,10.0,No,No,Hypertension,10.0
PT07677,Germany,North Rhine-Westphalia,40.0,Female,Breast,II,,2015-01-15,2015-12-16,Immunotherapy,Public,Alive,104.0,None,Yes,Former,Moderate,37.9,High,Urban,NHS,14.0,No,No,Diabetes,4.0
PT07678,Italy,Sicily,55.0,Female,Colorectal,I,2018-12-11,2019-03-19,2019-06-20,Surgery,,Alive,57.0,,Yes,Current,None,22.0,High,Urban,Private Insurance,16.0,No,No,Obesity,4.0
PT07679,Austria,Vienna,43.0,Female,Prostate,III,2019-08-14,2019-09-15,2020-03-09,Radiation,Private,Alive,,BRCA1,No,Never,None,25.8,Medium,Rural,NHS,6.0,No,No,Diabetes,2.0
PT07680,Spain,Andalusia,73.0,Non-binary,Breast,,2019-04-02,2019-07-19,2020-03-16,Surgery,Private,Deceased,15.0,EGFR,No,Never,Moderate,27.3,Low,Rural,Statutory Health Insurance,8.0,No,No,Diabetes,7.0
PT07681,Ireland,Connacht,57.0,Female,Pancreatic,I,2022-01-21,2022-06-21,2023-04-20,Surgery,Public,Deceased,93.0,EGFR,No,Never,Moderate,36.9,Medium,Urban,Private Insurance,18.0,No,No,None,7.0
,Italy,Lombardy,36.0,Male,Lung,III,2017-03-27,2017-06-09,2017-10-13,Immunotherapy,Public,Deceased,68.0,,Yes,,Moderate,30.9,Medium,Urban,Private Insurance,19.0,No,No,,6.0
PT07683,,Connacht,41.0,Male,Lung,III,2011-07-10,2011-09-20,2012-01-20,Radiation,,Alive,116.0,None,No,Former,Moderate,31.2,Medium,Urban,Statutory Health Insurance,1.0,No,No,Cardiovascular Disease,3.0
PT07684,Germany,Berlin,64.0,Male,Colorectal,I,2016-03-04,2016-03-25,2017-03-18,Immunotherapy,Private,Deceased,57.0,KRAS,No,Former,Heavy,35.0,Medium,Urban,Statutory Health Insurance,,No,No,Hypertension,3.0
PT07685,France,Auvergne-Rhône-Alpes,80.0,Male,Lung,III,2013-02-14,2013-07-04,2014-05-29,Targeted Therapy,Private,Alive,13.0,EGFR,,Never,None,40.0,Medium,Urban,Private Insurance,9.0,No,No,Hypertension,9.0
PT07686,Portugal,Porto,30.0,,Ovarian,I,2020-06-01,2020-11-25,2021-11-03,Chemotherapy,Public,,63.0,None,No,Never,Heavy,,Medium,Urban,NHS,6.0,No,No,Hypertension,9.0
PT07687,Austria,Tyrol,80.0,Female,Leukemia,I,2014-11-21,2015-03-04,2015-06-03,Surgery,Public,Alive,54.0,KRAS,No,Former,Moderate,20.9,Medium,Rural,Private Insurance,17.0,No,No,Cardiovascular Disease,
PT07688,Sweden,Skåne,57.0,Male,Lung,III,2013-01-18,2013-07-12,2013-11-09,Radiation,Public,Deceased,9.0,None,Yes,Former,Heavy,39.7,,Urban,NHS,10.0,No,No,Hypertension,10.0
PT07689,Switzerland,Zurich,85.0,Female,Colorectal,IV,,2018-10-03,2019-09-06,Surgery,Private,Alive,39.0,KRAS,No,Former,None,33.9,Low,Urban,Private Insurance,14.0,No,No,Hypertension,
PT07690,Netherlands,North Holland,52.0,Female,Colorectal,I,2023-10-25,2023-12-26,2024-03-25,Radiation,Public,Alive,37.0,None,Yes,Never,None,32.0,Medium,Urban,NHS,5.0,Yes,No,Hypertension,10.0
PT07691,Denmark,Capital Region,62.0,Male,Colorectal,IV,2019-11-25,2020-01-02,2020-12-02,Immunotherapy,Public,Alive,113.0,KRAS,Yes,Never,Heavy,26.7,Low,Urban,Statutory Health Insurance,6.0,No,No,Hypertension,4.0
PT07692,Spain,Madrid,50.0,Male,Ovarian,I,2013-05-25,2013-08-31,2013-11-22,,Research Institute,Alive,30.0,None,No,Never,Moderate,39.8,High,Rural,NHS,12.0,No,Yes,Obesity,3.0
PT07693,Italy,Lombardy,54.0,Female,Pancreatic,I,2020-08-28,2020-12-16,2021-11-08,Chemotherapy,Public,Deceased,36.0,KRAS,No,Never,None,24.9,Medium,Rural,NHS,12.0,No,Yes,Obesity,8.0
PT07694,Finland,Southwest Finland,56.0,Female,Leukemia,I,2010-03-12,2010-08-13,2011-03-17,Chemotherapy,Public,Deceased,107.0,EGFR,,Never,Moderate,38.9,Low,Urban,Statutory Health Insurance,11.0,Yes,No,None,2.0
PT07695,Netherlands,South Holland,66.0,Male,Ovarian,I,2021-04-18,2021-05-28,2022-03-17,Chemotherapy,Private,Deceased,15.0,EGFR,Yes,Former,Moderate,25.8,Medium,Urban,Statutory Health Insurance,18.0,No,No,Cardiovascular Disease,9.0
PT07696,Ireland,Connacht,42.0,Male,Breast,II,2017-11-08,2018-04-01,2018-12-24,Surgery,Public,Alive,40.0,KRAS,No,Former,Moderate,21.1,Low,Urban,NHS,8.0,No,No,Obesity,4.0
,Spain,Andalusia,55.0,Male,Prostate,IV,,2023-02-07,2023-12-02,Radiation,Research Institute,Alive,45.0,EGFR,No,Current,None,31.8,Medium,Rural,Statutory Health Insurance,1.0,No,Yes,None,1.0
PT07698,France,Auvergne-Rhône-Alpes,59.0,Male,Lung,I,2014-03-25,2014-09-19,2015-05-05,Targeted Therapy,Private,Alive,82.0,KRAS,Yes,Former,Moderate,,Low,Rural,Statutory Health Insurance,1.0,No,Yes,Hypertension,4.0
PT07699,Norway,Vestland,34.0,Female,Pancreatic,II,2023-12-08,2024-01-06,2025-01-04,Radiation,Public,Alive,65.0,BRCA1,No,Never,Moderate,38.8,Low,Urban,NHS,2.0,No,No,,1.0
PT07700,Denmark,Central Denmark,56.0,Male,Breast,III,2016-06-28,2016-10-15,2017-09-08,Surgery,Private,Alive,83.0,EGFR,No,Former,None,36.0,Low,Urban,Private Insurance,16.0,Yes,No,,10.0
PT07701,France,Auvergne-Rhône-Alpes,23.0,Male,Colorectal,II,2016-08-14,2017-01-27,2017-10-31,Immunotherapy,Public,Alive,73.0,KRAS,No,Former,Moderate,26.7,Medium,Urban,NHS,4.0,No,No,Obesity,8.0
PT07702,Finland,Pirkanmaa,41.0,Male,Breast,III,2013-03-25,2013-09-05,2014-06-17,Targeted Therapy,Public,Alive,105.0,BRCA1,No,Never,None,35.1,Medium,Urban,Statutory Health Insurance,5.0,No,No,Diabetes,8.0
PT07703,Germany,Berlin,41.0,Female,Ovarian,II,2023-12-20,2024-03-14,2024-09-18,Targeted Therapy,Public,Alive,8.0,EGFR,Yes,Former,None,,Medium,Urban,NHS,10.0,No,No,Obesity,10.0
PT07704,Norway,Oslo,36.0,Male,Breast,I,2017-06-06,2017-06-16,2018-06-13,Targeted Therapy,Public,Alive,72.0,None,No,Current,Moderate,22.0,Low,Urban,Private Insurance,2.0,No,Yes,Obesity,6.0
,Sweden,Skåne,57.0,Male,Leukemia,III,2013-01-11,2013-07-05,2014-05-25,Surgery,Research Institute,Alive,8.0,EGFR,No,Former,Heavy,30.6,Medium,Urban,NHS,3.0,No,No,Obesity,1.0
PT07706,Denmark,Capital Region,43.0,Female,Colorectal,I,2016-09-18,2017-03-09,2017-07-10,Chemotherapy,Public,,69.0,None,No,Never,Moderate,24.2,Medium,Rural,Statutory Health Insurance,12.0,Yes,No,None,
PT07707,Poland,Silesian,25.0,Male,Pancreatic,I,2022-11-22,2023-03-18,2023-10-16,Chemotherapy,Private,Deceased,53.0,None,No,Never,None,32.8,Medium,Urban,Statutory Health Insurance,12.0,No,No,Hypertension,5.0
PT07708,Belgium,Flanders,87.0,Male,Pancreatic,II,2019-03-06,2019-06-22,,Chemotherapy,Public,Lost to Follow-up,,BRCA1,Yes,Current,Moderate,33.1,High,Urban,NHS,17.0,Yes,No,Diabetes,6.0
PT07709,Italy,Sicily,25.0,Male,Colorectal,II,2010-10-08,2010-10-15,2011-05-28,Radiation,Private,Alive,58.0,EGFR,No,Never,Moderate,31.6,Medium,Rural,Statutory Health Insurance,10.0,No,,,1.0
PT07710,Finland,Uusimaa,45.0,Female,Lung,III,2014-09-12,2014-10-01,2015-01-03,Chemotherapy,Public,Lost to Follow-up,,None,No,Current,Heavy,33.5,Low,Rural,Statutory Health Insurance,12.0,No,No,Cardiovascular Disease,6.0
PT07711,Austria,Styria,,Non-binary,Pancreatic,II,,2013-05-08,2014-03-29,Targeted Therapy,Private,Alive,13.0,BRCA1,No,Never,None,24.8,Medium,Urban,NHS,9.0,Yes,No,Cardiovascular Disease,8.0
PT07712,Norway,Oslo,57.0,Male,Pancreatic,II,2015-12-17,2016-01-19,2016-09-08,Chemotherapy,Private,Alive,52.0,EGFR,Yes,Current,Moderate,22.8,Low,Rural,NHS,10.0,No,No,Hypertension,6.0
PT07713,France,Provence-Alpes-Côte d'Azur,62.0,Male,Lung,II,2022-01-22,2022-06-23,2022-10-06,Targeted Therapy,Public,Deceased,,BRCA1,Yes,Never,None,18.2,High,Urban,,9.0,No,Yes,,6.0
PT07714,Finland,Southwest Finland,72.0,Male,Lung,II,2015-06-11,2015-07-04,2016-03-01,Targeted Therapy,Public,Alive,32.0,None,Yes,Current,Heavy,32.5,High,Urban,Private Insurance,16.0,Yes,No,Hypertension,5.0
PT07715,Netherlands,Utrecht,34.0,Female,Ovarian,IV,2022-07-17,2022-10-11,2023-07-12,Radiation,Public,Alive,78.0,None,Yes,Never,Moderate,30.9,High,Urban,Private Insurance,,Yes,No,Diabetes,7.0
PT07716,Finland,Pirkanmaa,75.0,Female,Pancreatic,IV,2018-09-14,2018-12-23,,Chemotherapy,Private,Deceased,,EGFR,Yes,Former,Moderate,25.3,Medium,Urban,Statutory Health Insurance,12.0,No,No,Hypertension,10.0
PT07717,Finland,Uusimaa,75.0,Female,Pancreatic,II,2018-04-10,2018-07-29,2018-09-26,Immunotherapy,Private,Alive,25.0,KRAS,Yes,Never,None,25.6,Low,Urban,Statutory Health Insurance,17.0,No,No,None,8.0
PT07718,Belgium,,50.0,Female,Pancreatic,I,2018-05-29,2018-10-25,2019-07-28,Chemotherapy,Private,Lost to Follow-up,,EGFR,,Former,Moderate,22.7,Medium,Urban,Statutory Health Insurance,2.0,No,Yes,Cardiovascular Disease,5.0
PT07719,Austria,Vienna,76.0,Female,Lung,II,2014-03-09,2014-05-30,2015-02-19,Immunotherapy,Private,Deceased,105.0,None,Yes,Current,Moderate,25.6,Medium,Urban,Private Insurance,15.0,No,,Cardiovascular Disease,9.0
PT07720,Spain,Catalonia,70.0,Female,,I,2017-10-10,2018-01-20,2018-08-14,Radiation,Private,Lost to Follow-up,,BRCA1,No,Never,Moderate,24.7,Medium,Rural,Statutory Health Insurance,12.0,No,No,Diabetes,
PT07721,Poland,,43.0,Female,Breast,II,2021-12-27,2022-03-28,2022-07-28,,Public,Alive,15.0,None,Yes,Never,Moderate,39.4,Medium,Urban,NHS,15.0,Yes,No,Diabetes,9.0
PT07722,Portugal,Algarve,77.0,Male,Breast,I,2013-02-04,2013-03-13,2013-09-27,Radiation,Private,Deceased,33.0,BRCA1,Yes,Never,Moderate,,Medium,Urban,NHS,,No,No,Hypertension,8.0
PT07723,Ireland,Munster,23.0,Male,Lung,III,2019-04-28,2019-06-16,2019-10-09,Radiation,Private,Lost to Follow-up,,KRAS,No,Former,None,30.8,Low,Urban,NHS,15.0,No,No,Hypertension,10.0
PT07724,Netherlands,Utrecht,29.0,Female,Lung,I,2023-08-06,2024-01-06,2024-05-23,Immunotherapy,Public,Alive,73.0,,Yes,Former,Moderate,18.5,Medium,Urban,Private Insurance,16.0,Yes,No,Cardiovascular Disease,9.0
PT07725,Norway,Vestland,,Female,Lung,IV,2021-12-05,2022-01-13,2022-12-13,,Public,Deceased,57.0,KRAS,No,Former,Moderate,36.2,Medium,Urban,NHS,5.0,No,No,Hypertension,
PT07726,Austria,Styria,34.0,Female,Prostate,I,2019-01-15,2019-02-14,2019-08-19,Targeted Therapy,Research Institute,Alive,7.0,BRCA1,No,Current,Moderate,34.6,Low,Urban,Private Insurance,18.0,No,Yes,Diabetes,8.0
PT07727,Netherlands,,82.0,Male,Lung,III,2015-04-14,2015-05-27,2015-11-01,Radiation,Private,Lost to Follow-up,,EGFR,Yes,Never,Moderate,29.3,Low,Urban,Statutory Health Insurance,18.0,No,No,Hypertension,2.0
PT07728,Finland,Pirkanmaa,38.0,Female,Ovarian,IV,2021-10-26,2021-11-27,2022-10-09,Radiation,Research Institute,Alive,43.0,,Yes,Never,Moderate,35.1,,Rural,Private Insurance,4.0,No,,Hypertension,1.0
PT07729,Switzerland,Geneva,82.0,,Prostate,I,2011-11-24,2012-03-29,2013-02-04,Immunotherapy,Private,Alive,6.0,None,No,Never,None,21.6,High,Urban,Statutory Health Insurance,18.0,No,No,Hypertension,6.0
PT07730,Switzerland,Zurich,75.0,Female,Lung,,2016-09-11,2016-12-15,,Radiation,Public,Alive,48.0,None,Yes,Never,Heavy,27.8,Low,Rural,Private Insurance,15.0,No,Yes,Obesity,8.0
PT07731,Belgium,Brussels,40.0,Male,Colorectal,II,2011-12-15,2012-06-09,2012-07-16,Radiation,Public,Alive,63.0,None,No,,None,23.3,Low,,Statutory Health Insurance,6.0,No,No,Cardiovascular Disease,9.0
PT07732,Germany,Berlin,53.0,Male,Leukemia,IV,2017-10-15,2017-10-17,2017-12-25,Chemotherapy,Private,Deceased,69.0,None,Yes,Current,,31.0,Medium,Urban,NHS,5.0,No,No,Hypertension,8.0
PT07733,Belgium,Wallonia,36.0,,Pancreatic,,2022-12-09,2023-01-25,2023-09-11,Targeted Therapy,Private,Alive,8.0,BRCA1,,,Moderate,31.7,Low,Urban,Statutory Health Insurance,13.0,No,No,Diabetes,7.0
PT07734,Poland,Masovian,37.0,Female,Pancreatic,I,2022-12-08,2023-03-17,2023-08-27,Targeted Therapy,Public,,74.0,KRAS,Yes,Never,Moderate,39.7,Medium,Rural,Statutory Health Insurance,3.0,Yes,No,None,4.0
PT07735,Portugal,Porto,85.0,Female,Breast,III,2017-07-19,2017-08-11,2018-01-30,Targeted Therapy,Public,Alive,13.0,BRCA1,No,Never,Moderate,18.4,Low,Rural,NHS,,Yes,No,Obesity,7.0
PT07736,Netherlands,North Holland,70.0,Male,Colorectal,I,2014-09-26,2015-02-07,2015-12-10,Radiation,Public,Deceased,21.0,EGFR,Yes,Never,Moderate,,Low,,Private Insurance,2.0,No,No,Obesity,6.0
PT07737,France,Provence-Alpes-Côte d'Azur,84.0,Male,Leukemia,I,2015-01-02,2015-03-28,2015-11-10,Targeted Therapy,Public,Alive,81.0,None,Yes,Never,None,38.8,Medium,Rural,Private Insurance,17.0,Yes,No,Diabetes,1.0
PT07738,Belgium,Brussels,62.0,Female,Pancreatic,,2014-03-02,2014-04-12,2015-03-17,Chemotherapy,Private,Deceased,89.0,BRCA1,No,Never,Heavy,39.3,High,Rural,NHS,7.0,No,Yes,None,10.0
PT07739,Finland,Southwest Finland,76.0,,Pancreatic,I,2010-10-28,2010-12-09,2011-08-25,Surgery,Private,Alive,19.0,EGFR,Yes,Current,None,30.5,Low,Urban,Statutory Health Insurance,19.0,No,,Hypertension,7.0
PT07740,Ireland,Connacht,29.0,Non-binary,Prostate,,2021-03-16,2021-05-27,2021-09-24,Surgery,Private,Alive,97.0,None,Yes,Current,Moderate,30.5,Medium,Rural,Statutory Health Insurance,10.0,No,Yes,Diabetes,8.0
PT07741,Sweden,Skåne,56.0,Female,Breast,II,2012-10-25,2013-04-10,2013-08-23,Chemotherapy,,Alive,38.0,EGFR,No,Never,Moderate,27.3,Medium,Urban,Statutory Health Insurance,16.0,No,No,Cardiovascular Disease,7.0
PT07742,Norway,Trøndelag,67.0,Male,Prostate,III,2020-09-23,2021-02-08,2021-06-04,Surgery,Public,Deceased,48.0,EGFR,,Current,Moderate,22.7,Low,Urban,Private Insurance,14.0,No,No,Hypertension,8.0
PT07743,Denmark,Central Denmark,88.0,Female,Ovarian,II,2014-12-25,2015-04-16,2016-02-14,Surgery,Public,Alive,47.0,None,Yes,Never,Moderate,19.6,Medium,Urban,Private Insurance,8.0,No,No,Diabetes,7.0
PT07744,Belgium,Wallonia,75.0,Male,Ovarian,IV,2021-04-15,2021-06-04,2021-10-03,Immunotherapy,Public,Deceased,51.0,,,Never,Moderate,26.4,Low,Rural,Statutory Health Insurance,17.0,No,No,Hypertension,3.0
PT07745,Ireland,Connacht,55.0,Female,Prostate,I,2014-09-07,2014-11-21,,Radiation,Public,Deceased,52.0,None,No,Never,None,25.6,Low,Urban,Statutory Health Insurance,17.0,No,No,Cardiovascular Disease,7.0
PT07746,Denmark,Central Denmark,50.0,Male,Breast,I,2018-09-22,2019-02-05,2019-04-09,Immunotherapy,Research Institute,Alive,116.0,BRCA1,Yes,Current,None,30.2,Medium,Urban,Statutory Health Insurance,6.0,,No,Diabetes,3.0
PT07747,Denmark,,74.0,Non-binary,Leukemia,III,2022-04-01,2022-04-02,2022-06-28,Immunotherapy,Private,Alive,93.0,EGFR,No,Former,Moderate,25.6,High,Urban,Private Insurance,12.0,Yes,No,Cardiovascular Disease,4.0
PT07748,Italy,Lombardy,57.0,Female,Breast,IV,2021-06-24,2021-06-25,2022-02-08,Chemotherapy,Public,Alive,7.0,EGFR,No,Former,Moderate,27.5,Medium,Rural,NHS,2.0,No,No,Hypertension,
PT07749,Portugal,,34.0,Female,Lung,III,2013-03-05,2013-04-01,2013-12-29,Surgery,Public,Lost to Follow-up,,BRCA1,No,Former,Moderate,31.3,High,Rural,Private Insurance,14.0,No,No,Hypertension,4.0
PT07750,Finland,Pirkanmaa,35.0,Male,Prostate,II,2011-01-23,2011-05-12,2012-02-25,Chemotherapy,,Alive,107.0,BRCA1,No,Never,Moderate,33.5,High,Urban,,14.0,No,No,Obesity,1.0
PT07751,France,Provence-Alpes-Côte d'Azur,72.0,Male,Lung,I,2015-03-19,2015-07-22,2016-02-14,Targeted Therapy,Private,Deceased,110.0,KRAS,No,Never,Moderate,18.3,High,Urban,NHS,6.0,No,No,Cardiovascular Disease,10.0
PT07752,Norway,Vestland,75.0,Female,Breast,I,2021-08-30,2022-02-22,2022-04-13,Immunotherapy,Private,Alive,75.0,BRCA1,No,Current,None,22.6,Medium,Urban,Private Insurance,3.0,No,No,Diabetes,6.0
,Belgium,Brussels,26.0,Female,Breast,II,2015-03-14,2015-04-06,2015-07-04,Surgery,Private,Alive,38.0,KRAS,No,Never,None,22.2,Low,Urban,Private Insurance,8.0,Yes,No,Hypertension,1.0
PT07754,Switzerland,Zurich,76.0,Male,Pancreatic,II,2013-12-09,2014-05-30,2014-12-16,Radiation,Research Institute,Alive,74.0,,,Former,None,27.2,High,Urban,Statutory Health Insurance,8.0,No,No,Diabetes,6.0
PT07755,Poland,Silesian,74.0,Male,Ovarian,II,2023-10-20,2024-04-05,2024-06-18,Immunotherapy,Public,Alive,64.0,KRAS,Yes,Never,Moderate,19.8,Low,Urban,NHS,7.0,No,No,Obesity,4.0
PT07756,Austria,Tyrol,71.0,Male,Leukemia,II,2023-01-29,2023-06-17,2023-08-27,Surgery,Public,Alive,49.0,BRCA1,No,Never,None,37.8,Medium,Rural,,3.0,No,No,Cardiovascular Disease,10.0
PT07757,Denmark,Zealand,23.0,Female,Prostate,III,2012-09-28,2013-01-15,2013-08-09,Targeted Therapy,Public,Deceased,93.0,EGFR,No,Current,None,27.3,Medium,Urban,Statutory Health Insurance,,No,No,None,6.0
PT07758,Austria,Vienna,62.0,Male,Ovarian,III,2013-03-05,2013-07-22,2014-03-04,Chemotherapy,Public,Deceased,33.0,BRCA1,No,Never,Moderate,36.3,High,Urban,NHS,14.0,No,No,Diabetes,9.0
PT07759,Sweden,Stockholm,,Male,,I,2021-08-24,2021-12-02,2022-01-03,Surgery,Private,Alive,53.0,,No,Never,None,38.3,High,Urban,Private Insurance,14.0,No,No,,8.0
PT07760,Italy,Veneto,49.0,Male,Breast,II,2012-03-23,2012-07-03,2013-05-23,Surgery,Public,Alive,69.0,KRAS,No,Never,Moderate,22.5,Medium,Rural,NHS,4.0,No,No,Obesity,4.0
PT07761,Belgium,Flanders,,Male,Pancreatic,,2013-10-21,2013-11-21,2014-02-06,Immunotherapy,Public,Alive,102.0,KRAS,Yes,Former,None,28.9,High,Urban,NHS,6.0,No,No,Cardiovascular Disease,3.0
PT07762,Finland,Southwest Finland,26.0,Male,Colorectal,I,2018-03-30,2018-05-24,2018-11-18,Surgery,Private,Lost to Follow-up,,EGFR,Yes,Former,Moderate,39.3,High,Rural,Private Insurance,7.0,Yes,No,Hypertension,6.0
PT07763,,Île-de-France,55.0,Non-binary,Prostate,III,2016-07-24,2016-12-23,2017-09-08,Targeted Therapy,,Lost to Follow-up,,BRCA1,Yes,Current,None,36.1,Medium,Urban,Private Insurance,7.0,No,No,Cardiovascular Disease,2.0
PT07764,Germany,North Rhine-Westphalia,54.0,Male,Lung,III,2022-04-17,2022-06-18,2022-08-04,Radiation,Public,Deceased,118.0,BRCA1,No,Former,Moderate,18.9,Low,Rural,Private Insurance,11.0,No,No,Cardiovascular Disease,10.0
PT07765,Belgium,Flanders,58.0,Female,Prostate,III,2013-09-09,,2014-11-02,Targeted Therapy,Public,Lost to Follow-up,,,Yes,Former,None,39.3,Medium,Urban,Statutory Health Insurance,9.0,No,No,Hypertension,7.0
PT07766,,Andalusia,55.0,Male,Ovarian,I,2018-03-15,2018-06-19,2018-11-01,Surgery,Public,Alive,63.0,EGFR,Yes,Never,Moderate,18.5,Medium,Urban,Private Insurance,4.0,No,No,Cardiovascular Disease,3.0
PT07767,Austria,Styria,39.0,,Leukemia,IV,2014-03-18,2014-04-27,2014-11-05,Radiation,Private,Deceased,23.0,EGFR,Yes,Never,None,18.7,Medium,Urban,Statutory Health Insurance,3.0,No,No,Hypertension,2.0
PT07768,Finland,Pirkanmaa,68.0,Male,Colorectal,I,2023-07-10,,2023-12-20,Targeted Therapy,Public,Alive,94.0,EGFR,No,Never,Moderate,32.2,Low,Urban,NHS,15.0,Yes,No,Cardiovascular Disease,3.0
PT07769,Spain,Andalusia,78.0,Female,Pancreatic,IV,2014-01-26,2014-02-12,2014-07-13,Radiation,Public,Deceased,42.0,None,,Current,None,31.9,Medium,Urban,Private Insurance,18.0,No,No,Obesity,6.0
PT07770,Denmark,Central Denmark,68.0,Female,Ovarian,II,2018-08-13,2019-02-07,2019-06-19,Immunotherapy,Private,Alive,34.0,BRCA1,No,Current,None,36.2,High,Rural,NHS,1.0,No,No,Hypertension,1.0
,Austria,Styria,45.0,Male,,I,2014-11-18,2015-02-25,2015-09-28,Surgery,Public,Deceased,57.0,EGFR,No,Never,Moderate,24.7,High,Rural,Statutory Health Insurance,7.0,No,No,Obesity,2.0
PT07772,Sweden,Västra Götaland,55.0,Male,Lung,I,2016-12-23,2017-01-04,2017-09-13,,Public,Alive,66.0,None,No,Never,Moderate,28.6,,Rural,NHS,14.0,No,No,Diabetes,6.0
PT07773,Finland,Southwest Finland,62.0,Female,Ovarian,I,2014-10-17,2015-03-09,2015-05-23,Chemotherapy,Public,Lost to Follow-up,,BRCA1,No,Never,None,36.8,,Urban,Statutory Health Insurance,9.0,No,No,Cardiovascular Disease,1.0
PT07774,Austria,Vienna,62.0,Non-binary,Pancreatic,II,,2015-12-21,2016-05-24,Immunotherapy,Public,Alive,82.0,EGFR,,Never,Moderate,,Medium,Urban,NHS,11.0,No,No,Cardiovascular Disease,5.0
PT07775,Finland,Pirkanmaa,52.0,Male,Lung,IV,2016-02-14,2016-02-27,2016-08-22,Surgery,,Alive,58.0,EGFR,No,Never,None,27.3,Medium,Rural,NHS,19.0,No,No,None,10.0
PT07776,Germany,Berlin,64.0,Female,Breast,II,,2024-01-23,2024-03-18,Immunotherapy,Public,Deceased,118.0,None,No,Never,Moderate,36.7,High,Urban,Statutory Health Insurance,2.0,Yes,No,Obesity,9.0
PT07777,Denmark,Central Denmark,64.0,,Ovarian,III,2019-10-05,2020-01-19,2020-07-05,Chemotherapy,Public,Alive,85.0,,Yes,Current,Moderate,28.6,,Urban,Private Insurance,14.0,No,No,Cardiovascular Disease,2.0
PT07778,Switzerland,Bern,34.0,Male,Prostate,IV,2022-03-19,2022-04-07,2022-11-16,Surgery,Public,Alive,82.0,,Yes,Never,None,29.7,Medium,Urban,NHS,6.0,No,No,Cardiovascular Disease,2.0
PT07779,Spain,Andalusia,36.0,Male,Ovarian,,2016-12-23,2017-02-18,2017-10-21,Immunotherapy,Public,Alive,25.0,None,No,Never,Moderate,30.9,Low,,Private Insurance,4.0,Yes,No,,7.0
PT07780,Netherlands,Utrecht,31.0,Male,Ovarian,II,2023-09-24,2023-12-25,2024-02-29,Immunotherapy,Public,Alive,72.0,KRAS,Yes,Former,None,26.2,Medium,,Private Insurance,13.0,No,No,Cardiovascular Disease,4.0
PT07781,Germany,Bavaria,41.0,Female,Leukemia,IV,2016-02-03,2016-04-03,2016-12-03,Radiation,Public,Alive,107.0,EGFR,No,Former,Moderate,24.3,Medium,Urban,Statutory Health Insurance,11.0,No,No,None,7.0
PT07782,Switzerland,Geneva,42.0,Male,Breast,I,2022-12-08,2023-05-10,,Radiation,Private,Deceased,,BRCA1,Yes,Never,None,32.9,High,Urban,NHS,8.0,No,No,Obesity,9.0
PT07783,Switzerland,Geneva,31.0,Female,Prostate,II,2012-08-27,2012-12-09,2013-05-01,Immunotherapy,Public,Alive,63.0,,Yes,Current,Heavy,21.5,Low,Rural,Private Insurance,4.0,No,Yes,None,7.0
PT07784,Austria,,87.0,Female,Lung,III,2010-09-30,2011-02-09,2012-01-07,Radiation,Public,Deceased,108.0,BRCA1,No,Former,None,29.0,High,Urban,Statutory Health Insurance,15.0,No,No,Diabetes,1.0
PT07785,Belgium,Brussels,,Male,Leukemia,I,2014-05-06,2014-09-10,2015-03-12,Surgery,Private,Alive,19.0,KRAS,Yes,,Moderate,25.0,Medium,Urban,Statutory Health Insurance,17.0,Yes,Yes,None,4.0
PT07786,Finland,Southwest Finland,32.0,Male,Lung,III,2017-09-25,2018-01-04,2018-11-10,Radiation,Public,Alive,17.0,KRAS,Yes,Former,None,26.4,Low,Urban,Private Insurance,1.0,Yes,No,Obesity,8.0
PT07787,Germany,,76.0,Female,Pancreatic,I,2019-08-20,2020-01-02,2020-11-03,Surgery,,Alive,38.0,,Yes,Never,None,28.2,Medium,Urban,,16.0,No,No,None,4.0
PT07788,Denmark,Capital Region,74.0,Male,Lung,I,2016-07-16,2016-09-22,,Surgery,Research Institute,Lost to Follow-up,,KRAS,Yes,Never,Moderate,22.5,High,Rural,Private Insurance,5.0,,,Cardiovascular Disease,
PT07789,Ireland,Dublin,47.0,Male,Colorectal,I,,2021-03-31,,Surgery,Private,Alive,86.0,None,Yes,Never,None,28.8,High,Urban,Statutory Health Insurance,17.0,No,No,,7.0
PT07790,,Pirkanmaa,63.0,,Prostate,IV,2022-08-06,2022-11-22,2023-02-24,Surgery,,Alive,87.0,KRAS,Yes,Never,None,34.2,High,,NHS,11.0,No,Yes,Hypertension,10.0
PT07791,Sweden,Skåne,38.0,Male,Breast,IV,2023-07-28,2024-01-17,,Immunotherapy,Private,Alive,,None,,Current,None,23.2,Medium,Urban,Private Insurance,17.0,No,No,None,6.0
PT07792,Germany,North Rhine-Westphalia,65.0,Female,Ovarian,I,2020-06-17,2020-11-01,2021-10-26,Targeted Therapy,Public,Deceased,17.0,EGFR,No,Never,None,36.8,Low,Urban,Private Insurance,,No,No,Hypertension,2.0
PT07793,,Berlin,22.0,Female,Colorectal,I,2017-08-16,2017-12-15,2018-04-12,Targeted Therapy,Research Institute,Deceased,50.0,BRCA1,No,Current,Moderate,27.6,High,Urban,NHS,11.0,No,No,Hypertension,6.0
PT07794,Netherlands,Utrecht,39.0,Male,Pancreatic,II,2011-09-21,2011-09-30,2012-01-23,Surgery,Public,Deceased,31.0,BRCA1,No,Current,Moderate,34.4,Low,Urban,NHS,6.0,No,Yes,None,3.0
PT07795,Ireland,Munster,44.0,Female,Prostate,II,2021-11-24,2022-04-04,2022-12-28,Targeted Therapy,Private,Deceased,33.0,KRAS,Yes,Never,Moderate,33.0,,Urban,NHS,,No,No,Hypertension,6.0
PT07796,Spain,Catalonia,,Female,Pancreatic,IV,2022-08-13,2022-10-29,2023-06-15,Surgery,,Alive,,,No,Never,Moderate,27.0,Medium,Rural,Private Insurance,6.0,No,No,Obesity,2.0
PT07797,France,Provence-Alpes-Côte d'Azur,80.0,Male,Prostate,IV,2010-12-11,2011-02-12,2011-06-26,Targeted Therapy,Public,Alive,106.0,KRAS,No,Current,None,35.9,Medium,Urban,Private Insurance,1.0,No,No,Obesity,1.0
PT07798,Italy,Veneto,74.0,Male,Prostate,III,2022-09-17,2023-01-14,2023-04-17,Chemotherapy,Private,Alive,17.0,KRAS,No,Never,None,,Medium,Urban,NHS,17.0,No,No,Cardiovascular Disease,8.0
PT07799,Germany,Berlin,54.0,Non-binary,Leukemia,II,2011-07-10,2011-10-11,2012-05-31,Radiation,Private,Deceased,62.0,,No,Never,None,23.7,Medium,Rural,Private Insurance,1.0,No,No,Cardiovascular Disease,1.0
,Switzerland,Zurich,78.0,Female,Colorectal,I,2023-12-01,2024-04-09,2024-10-31,Targeted Therapy,Public,Alive,9.0,None,Yes,Never,Moderate,18.3,Medium,Urban,NHS,11.0,No,No,Cardiovascular Disease,10.0
PT07801,Finland,Pirkanmaa,58.0,Male,Breast,I,2020-12-24,2021-06-01,2021-08-08,Surgery,Public,Alive,89.0,BRCA1,Yes,Current,None,35.4,Medium,Urban,NHS,12.0,No,No,Hypertension,5.0
PT07802,Austria,Vienna,76.0,Male,Colorectal,II,2017-12-29,2018-02-05,2018-07-24,Radiation,Public,Alive,62.0,BRCA1,Yes,Never,None,21.0,Medium,Urban,Statutory Health Insurance,,No,No,Cardiovascular Disease,3.0
PT07803,Spain,Catalonia,86.0,Male,Pancreatic,II,2011-04-05,2011-04-12,2011-09-27,Radiation,Private,Deceased,15.0,BRCA1,Yes,,None,27.0,Medium,Rural,Private Insurance,17.0,Yes,No,Cardiovascular Disease,6.0
PT07804,Spain,Madrid,53.0,Male,Lung,III,2017-08-20,2017-12-02,2018-02-17,Immunotherapy,Public,Alive,54.0,EGFR,Yes,Current,None,,Low,Rural,NHS,7.0,Yes,No,Hypertension,5.0
PT07805,Switzerland,Bern,60.0,Female,Pancreatic,II,2017-09-12,2018-01-28,2018-07-12,Immunotherapy,Public,Alive,50.0,KRAS,No,Current,Moderate,39.3,Medium,Urban,NHS,17.0,No,No,Diabetes,10.0
PT07806,Sweden,Västra Götaland,41.0,Male,Prostate,I,2016-12-10,2017-02-25,2018-01-27,Targeted Therapy,Private,Alive,52.0,BRCA1,Yes,Never,Moderate,,Medium,Urban,Private Insurance,1.0,No,Yes,None,5.0
PT07807,France,Auvergne-Rhône-Alpes,46.0,Male,Lung,II,2018-07-13,2018-07-14,2018-11-21,Immunotherapy,Private,Alive,79.0,KRAS,No,Former,None,37.1,Low,Urban,NHS,19.0,No,No,Hypertension,
PT07808,Germany,,40.0,Female,Colorectal,IV,2016-12-24,,2017-10-27,Surgery,Research Institute,Deceased,108.0,EGFR,No,Former,Heavy,29.8,Medium,,Private Insurance,19.0,No,No,Cardiovascular Disease,10.0
PT07809,Spain,,60.0,Female,Breast,III,2023-09-26,2024-02-26,2024-10-20,Immunotherapy,Research Institute,Deceased,33.0,KRAS,No,Former,Moderate,20.9,High,Urban,Statutory Health Insurance,5.0,No,Yes,None,4.0
PT07810,France,Provence-Alpes-Côte d'Azur,50.0,Male,Lung,I,2010-03-01,2010-06-03,2011-01-28,Chemotherapy,Public,Alive,17.0,EGFR,No,Never,None,,Low,Urban,Statutory Health Insurance,17.0,No,Yes,None,7.0
PT07811,Denmark,Zealand,46.0,Male,,IV,2022-10-17,2022-12-22,2023-05-08,Targeted Therapy,Private,Deceased,27.0,KRAS,No,Former,None,37.0,Medium,Urban,NHS,6.0,No,No,Hypertension,4.0
PT07812,Sweden,Västra Götaland,56.0,Non-binary,Ovarian,II,2018-09-21,2018-12-30,,Radiation,Public,Alive,69.0,EGFR,No,Never,Moderate,39.1,High,Urban,Private Insurance,8.0,Yes,,Obesity,8.0
PT07813,Ireland,Connacht,85.0,Female,Leukemia,II,2014-11-30,2015-02-14,2015-05-25,Radiation,Public,Alive,90.0,KRAS,No,Former,None,32.5,High,Rural,Private Insurance,2.0,No,No,Hypertension,6.0
PT07814,Denmark,Zealand,73.0,Male,Colorectal,II,2022-03-03,2022-03-08,2022-07-13,Chemotherapy,Private,Alive,50.0,BRCA1,Yes,Current,None,35.7,Medium,Urban,NHS,8.0,No,Yes,None,3.0
PT07815,Finland,Pirkanmaa,,Male,Lung,II,2015-05-19,2015-07-14,2015-11-29,Surgery,Public,Alive,20.0,BRCA1,No,Never,Moderate,,Medium,Urban,Private Insurance,4.0,No,No,Obesity,10.0
PT07816,Ireland,Munster,61.0,Male,Colorectal,II,2023-01-22,2023-03-05,2023-09-14,Radiation,Private,Lost to Follow-up,,EGFR,No,Current,Moderate,39.2,,Urban,Private Insurance,15.0,No,No,Hypertension,8.0
PT07817,Denmark,Zealand,55.0,Female,Breast,III,2014-02-02,2014-03-23,2015-02-01,Chemotherapy,Public,Alive,85.0,KRAS,Yes,Never,None,35.8,Medium,Urban,NHS,1.0,No,Yes,None,4.0
PT07818,Italy,Sicily,29.0,Male,Lung,II,2023-01-24,2023-03-11,2023-07-08,,Public,Alive,69.0,EGFR,No,Former,Moderate,26.0,Medium,Urban,Private Insurance,16.0,,No,Hypertension,5.0
PT07819,,Provence-Alpes-Côte d'Azur,78.0,Male,Breast,I,2017-02-09,2017-04-21,2017-08-03,Targeted Therapy,Public,Alive,108.0,BRCA1,No,Never,None,28.5,Medium,Urban,,16.0,No,No,Obesity,8.0
PT07820,Poland,Silesian,59.0,Male,Pancreatic,I,2021-08-04,,,Chemotherapy,Public,Alive,,KRAS,No,Current,Moderate,23.4,High,Urban,Statutory Health Insurance,14.0,No,Yes,None,5.0
PT07821,Netherlands,North Holland,73.0,Male,Lung,III,2023-06-15,2023-08-21,2023-09-22,Chemotherapy,Research Institute,Alive,55.0,EGFR,No,Former,Moderate,21.4,Medium,Urban,Statutory Health Insurance,4.0,No,No,None,8.0
PT07822,Germany,Bavaria,58.0,Female,Ovarian,III,2017-04-19,2017-08-29,2018-08-11,Immunotherapy,Public,Alive,84.0,BRCA1,Yes,Current,Moderate,25.8,Medium,Rural,Private Insurance,15.0,No,No,Obesity,8.0
PT07823,Netherlands,North Holland,26.0,Male,Prostate,II,2021-06-08,2021-08-09,2021-09-18,Surgery,Private,Alive,84.0,BRCA1,No,Former,None,32.8,,Urban,Statutory Health Insurance,8.0,No,No,Diabetes,10.0
PT07824,Finland,,23.0,Male,Leukemia,I,2022-01-16,2022-05-08,2022-08-18,Immunotherapy,,Alive,92.0,None,No,Current,Moderate,31.1,Medium,Urban,NHS,2.0,No,No,Cardiovascular Disease,8.0
PT07825,Germany,North Rhine-Westphalia,34.0,Female,Leukemia,I,2018-05-28,2018-08-16,,Immunotherapy,Public,Alive,87.0,None,Yes,,Moderate,34.5,Low,Urban,Statutory Health Insurance,12.0,No,Yes,Cardiovascular Disease,6.0
PT07826,Austria,Vienna,67.0,Female,Leukemia,II,2016-09-22,2016-10-19,2017-03-15,Radiation,Research Institute,Alive,98.0,BRCA1,No,Former,Moderate,37.7,Medium,Urban,Private Insurance,12.0,No,No,Hypertension,7.0
PT07827,Poland,Masovian,25.0,Male,Breast,I,2017-07-30,2017-10-24,2018-05-28,Chemotherapy,Research Institute,Alive,48.0,None,No,Never,Moderate,19.1,Medium,Urban,Private Insurance,19.0,No,No,Obesity,1.0
PT07828,Netherlands,North Holland,54.0,Female,Colorectal,II,2016-08-09,2016-10-15,2017-07-27,Chemotherapy,Public,Alive,38.0,EGFR,,Current,Moderate,23.5,Medium,Urban,Private Insurance,4.0,Yes,No,None,7.0
PT07829,Ireland,Dublin,87.0,Male,Ovarian,III,2018-05-21,2018-09-11,2018-12-21,Immunotherapy,Private,Alive,98.0,None,Yes,Current,Moderate,35.2,Medium,Urban,Statutory Health Insurance,16.0,No,No,None,9.0
PT07830,Sweden,Västra Götaland,77.0,Female,Leukemia,I,2015-11-07,2016-03-08,2016-11-05,Immunotherapy,Public,Lost to Follow-up,,KRAS,Yes,Never,Moderate,38.3,Medium,Rural,,19.0,No,,None,9.0
PT07831,Germany,Berlin,38.0,Female,Pancreatic,III,2021-11-19,2022-04-13,2022-07-23,Chemotherapy,,Deceased,,EGFR,Yes,Former,None,38.6,Low,Rural,Private Insurance,19.0,No,No,Obesity,7.0
PT07832,Denmark,Central Denmark,81.0,Female,,III,2014-12-09,,2016-01-11,Chemotherapy,,Deceased,22.0,None,No,Former,,22.1,Medium,Rural,Private Insurance,6.0,No,No,None,7.0
PT07833,,Pirkanmaa,29.0,Female,Lung,I,2013-01-01,2013-02-27,,Chemotherapy,Public,Alive,,None,No,Never,None,20.2,Medium,Urban,NHS,14.0,,No,Hypertension,2.0
PT07834,Denmark,Zealand,44.0,Male,,III,2020-04-06,2020-05-06,2021-02-21,Surgery,Research Institute,Deceased,48.0,KRAS,Yes,Never,Heavy,38.5,High,Urban,Statutory Health Insurance,9.0,No,No,None,4.0
PT07835,Finland,Pirkanmaa,63.0,Female,Breast,,2010-07-30,2010-12-21,2011-10-23,Immunotherapy,Private,Alive,63.0,EGFR,No,Never,None,19.5,Low,Urban,Statutory Health Insurance,13.0,Yes,No,Diabetes,5.0
PT07836,Denmark,Capital Region,77.0,Male,Lung,III,2011-06-18,2011-10-10,2012-07-13,Immunotherapy,Private,Lost to Follow-up,,EGFR,No,Never,Moderate,32.6,Medium,Rural,Statutory Health Insurance,7.0,No,Yes,None,4.0
PT07837,Spain,Andalusia,44.0,Male,Lung,I,2012-07-29,2012-11-28,2013-03-24,Radiation,Public,Alive,14.0,EGFR,Yes,Current,None,26.8,,Urban,,9.0,Yes,No,Diabetes,10.0
PT07838,Italy,Sicily,59.0,Female,Ovarian,II,2020-10-12,2021-01-24,2021-09-20,Radiation,Public,Alive,26.0,KRAS,Yes,Current,,24.1,Low,Urban,Private Insurance,,No,No,Obesity,8.0
PT07839,Italy,Sicily,89.0,Female,Prostate,II,2013-06-19,2013-09-30,2014-06-05,Targeted Therapy,,Alive,109.0,None,No,Former,None,24.0,Low,,Statutory Health Insurance,3.0,No,No,Cardiovascular Disease,5.0
PT07840,Austria,Styria,29.0,Non-binary,Prostate,I,2010-01-12,2010-06-16,2010-11-23,Chemotherapy,Public,Alive,,EGFR,No,Former,None,25.9,High,Rural,Statutory Health Insurance,1.0,No,No,Obesity,2.0
PT07841,Italy,Lombardy,85.0,Male,Colorectal,I,2015-06-25,2015-09-07,2016-06-12,Chemotherapy,Public,Alive,68.0,KRAS,No,Never,Moderate,26.0,Medium,Rural,NHS,13.0,No,No,Diabetes,7.0
PT07842,Finland,Pirkanmaa,44.0,Male,Colorectal,II,2011-06-01,2011-09-07,2012-06-30,Targeted Therapy,Public,Deceased,78.0,KRAS,No,Current,None,35.9,Medium,Urban,Private Insurance,1.0,No,No,Cardiovascular Disease,9.0
PT07843,Sweden,Västra Götaland,30.0,Male,Colorectal,II,2023-05-22,2023-11-13,2024-03-05,Immunotherapy,Public,Alive,,BRCA1,No,Current,Heavy,29.7,Medium,Urban,Statutory Health Insurance,17.0,No,No,Hypertension,5.0
PT07844,,Sicily,55.0,Female,Lung,IV,2022-03-01,2022-03-15,2022-05-02,Chemotherapy,Private,Alive,32.0,KRAS,Yes,Current,Moderate,38.7,Medium,Rural,NHS,16.0,No,Yes,Cardiovascular Disease,8.0
PT07845,Sweden,Västra Götaland,68.0,Male,Prostate,I,,2016-01-07,2016-02-28,Radiation,Private,Alive,83.0,BRCA1,Yes,Never,Moderate,32.1,High,Urban,Private Insurance,9.0,No,No,Diabetes,4.0
,Sweden,Skåne,67.0,Male,Pancreatic,II,2014-09-21,2015-03-07,2015-05-26,Surgery,Public,Alive,41.0,BRCA1,No,Never,Heavy,27.0,Medium,Urban,Private Insurance,14.0,Yes,No,Hypertension,7.0
PT07847,Italy,Sicily,26.0,Male,,II,2015-12-24,2016-02-17,2016-12-10,Immunotherapy,Private,Alive,64.0,BRCA1,Yes,Former,None,29.7,Medium,Urban,Statutory Health Insurance,9.0,No,No,None,7.0
PT07848,Austria,Vienna,70.0,Female,Colorectal,I,2022-06-08,2022-07-04,2022-11-02,Surgery,Private,Alive,100.0,None,Yes,Former,Moderate,38.7,High,Urban,NHS,18.0,No,No,Diabetes,4.0
PT07849,Belgium,Flanders,36.0,Male,Pancreatic,III,2010-06-22,2010-08-05,2011-03-07,Surgery,Private,Alive,51.0,EGFR,Yes,Former,Moderate,36.4,Medium,Urban,NHS,13.0,No,No,Obesity,1.0
PT07850,Italy,Veneto,51.0,Female,Leukemia,I,2021-08-25,2021-11-02,2022-09-17,Targeted Therapy,Public,Deceased,104.0,None,No,Never,Moderate,38.3,Low,,,4.0,Yes,No,Obesity,8.0
PT07851,Poland,Silesian,45.0,,Lung,III,2014-12-20,2015-01-27,2015-11-02,Surgery,Public,Lost to Follow-up,,None,Yes,Former,Moderate,33.6,Low,Rural,Private Insurance,17.0,No,Yes,Hypertension,4.0
PT07852,,Wallonia,41.0,Male,Breast,,2014-08-03,2014-10-22,2015-02-08,Chemotherapy,Public,Alive,35.0,KRAS,No,Never,Moderate,31.9,High,Urban,NHS,13.0,No,No,Hypertension,2.0
PT07853,Denmark,Zealand,32.0,Male,Lung,I,2010-01-04,2010-01-16,2010-12-30,Targeted Therapy,Public,Alive,87.0,,No,Former,Heavy,23.4,Low,Urban,Statutory Health Insurance,7.0,No,Yes,Diabetes,7.0
PT07854,Spain,Catalonia,31.0,Non-binary,Pancreatic,III,2014-05-30,2014-09-12,2015-02-20,Radiation,Public,Deceased,22.0,BRCA1,Yes,Never,None,25.8,Low,Urban,Private Insurance,1.0,No,Yes,Hypertension,2.0
PT07855,Belgium,Flanders,20.0,Male,Colorectal,II,2017-08-25,2017-12-11,2018-08-31,Surgery,Public,Alive,110.0,None,Yes,Never,,19.3,Medium,Urban,Statutory Health Insurance,15.0,No,No,Hypertension,9.0
PT07856,Netherlands,North Holland,52.0,Male,Pancreatic,II,2016-08-17,2016-09-03,2017-08-08,Chemotherapy,Public,Alive,86.0,KRAS,No,Never,Moderate,30.7,Low,Urban,Statutory Health Insurance,12.0,No,No,Diabetes,1.0
PT07857,Switzerland,Bern,33.0,Female,Pancreatic,I,2021-12-26,2022-01-20,2022-02-24,Chemotherapy,Private,Alive,57.0,EGFR,No,Never,Moderate,32.1,High,Rural,NHS,1.0,No,No,Cardiovascular Disease,10.0
PT07858,Sweden,Skåne,83.0,Male,Ovarian,I,2017-08-22,2017-11-18,,Radiation,Public,Deceased,119.0,BRCA1,No,Former,Moderate,34.5,Low,Rural,NHS,9.0,No,No,None,7.0
PT07859,Ireland,Connacht,62.0,Female,Lung,II,2016-05-19,2016-10-05,2017-01-10,Targeted Therapy,Public,Alive,52.0,BRCA1,Yes,Current,Moderate,36.8,Low,Urban,Statutory Health Insurance,14.0,No,No,Hypertension,1.0
,Finland,Uusimaa,77.0,Male,Colorectal,I,2014-02-09,2014-07-05,2014-08-16,Targeted Therapy,Private,Deceased,97.0,BRCA1,No,Never,None,24.5,Medium,Rural,NHS,18.0,No,No,None,1.0
PT07861,Norway,Oslo,60.0,Male,Lung,II,2021-11-09,2022-04-22,2022-12-08,Targeted Therapy,Public,Alive,93.0,None,Yes,Current,None,21.9,Medium,Urban,NHS,7.0,No,No,Diabetes,3.0
PT07862,Italy,Lombardy,87.0,Male,Colorectal,,2014-09-22,2014-09-25,2015-08-13,Radiation,Research Institute,Alive,42.0,BRCA1,Yes,Never,None,,Medium,Urban,Statutory Health Insurance,8.0,No,No,Obesity,1.0
PT07863,Norway,Vestland,58.0,Male,Ovarian,IV,2020-10-03,2020-12-25,2021-08-17,Radiation,Public,Lost to Follow-up,,BRCA1,Yes,Former,None,29.9,Medium,Urban,Statutory Health Insurance,8.0,Yes,No,Diabetes,8.0
PT07864,Portugal,Porto,20.0,Female,Prostate,,2022-02-20,2022-05-01,2023-01-14,,Public,Deceased,104.0,EGFR,No,Never,Moderate,23.9,Low,Urban,Statutory Health Insurance,10.0,No,No,Cardiovascular Disease,4.0
PT07865,Portugal,Lisbon,60.0,Female,Prostate,III,2011-04-01,2011-06-27,,Targeted Therapy,Public,Alive,97.0,BRCA1,No,Never,Heavy,22.3,Medium,Urban,Statutory Health Insurance,9.0,No,No,Obesity,9.0
PT07866,Belgium,Flanders,64.0,Female,,III,2020-11-13,2021-01-23,2022-01-03,Surgery,,Alive,19.0,None,No,Never,None,30.2,Medium,Urban,Private Insurance,18.0,No,No,Obesity,3.0
PT07867,Netherlands,North Holland,32.0,Female,Ovarian,IV,2015-04-03,2015-07-23,2016-05-16,Radiation,Public,Deceased,41.0,BRCA1,Yes,Never,Moderate,31.2,Medium,,Statutory Health Insurance,5.0,No,No,Cardiovascular Disease,8.0
PT07868,Finland,Pirkanmaa,28.0,Male,Ovarian,I,2013-10-14,2014-01-30,2014-06-03,Radiation,Research Institute,Alive,40.0,BRCA1,Yes,Never,Heavy,21.1,Low,Urban,Statutory Health Insurance,19.0,No,No,Cardiovascular Disease,7.0
PT07869,Belgium,Brussels,82.0,Male,Ovarian,I,2022-05-03,2022-05-12,2022-11-29,Targeted Therapy,Private,Deceased,63.0,None,No,Current,Moderate,29.5,Low,Urban,Statutory Health Insurance,14.0,,No,None,8.0
PT07870,Finland,Pirkanmaa,,Female,,I,2015-06-12,2015-10-18,2016-08-26,Radiation,Public,Alive,55.0,BRCA1,Yes,Former,Moderate,20.1,Medium,Rural,NHS,5.0,No,No,Diabetes,3.0
PT07871,Austria,Vienna,73.0,Female,Prostate,II,2011-07-12,2011-11-11,2012-04-17,Surgery,Research Institute,Alive,11.0,EGFR,No,Former,None,35.3,High,Urban,NHS,4.0,,No,Hypertension,2.0
,Poland,Lesser Poland,66.0,Male,Ovarian,I,2022-06-24,2022-08-10,2022-09-16,Targeted Therapy,Public,Alive,67.0,KRAS,,Former,None,30.9,Medium,Urban,NHS,10.0,No,No,None,6.0
PT07873,Austria,Styria,58.0,Female,Prostate,,2021-09-26,2022-03-23,2023-03-10,Radiation,Private,Alive,67.0,EGFR,No,Never,None,31.1,Medium,Rural,Statutory Health Insurance,2.0,Yes,No,Obesity,5.0
PT07874,Italy,Veneto,45.0,Male,Leukemia,II,2020-12-04,2021-02-06,2021-11-12,Radiation,Private,Alive,43.0,EGFR,,Never,Moderate,,Low,,Statutory Health Insurance,16.0,No,Yes,Diabetes,3.0
PT07875,Denmark,Central Denmark,20.0,Female,Lung,IV,2013-03-14,2013-07-01,2013-10-05,Immunotherapy,Public,Alive,90.0,EGFR,Yes,,None,22.7,Low,Urban,Private Insurance,,No,No,None,2.0
PT07876,Norway,Trøndelag,33.0,Female,Pancreatic,IV,2013-09-29,2014-01-19,2014-11-18,Immunotherapy,Public,Deceased,97.0,BRCA1,No,Never,,22.1,High,Rural,Statutory Health Insurance,15.0,No,No,Cardiovascular Disease,7.0
PT07877,Poland,,84.0,Female,Ovarian,III,2020-02-05,2020-03-23,2020-05-26,Chemotherapy,Public,Alive,14.0,KRAS,No,Former,None,24.9,Low,Urban,Private Insurance,7.0,Yes,,Hypertension,10.0
PT07878,Denmark,Zealand,88.0,Male,Prostate,II,2014-05-19,2014-08-02,2015-06-27,,Research Institute,Lost to Follow-up,,,No,Former,None,30.8,Low,Urban,NHS,11.0,Yes,No,Obesity,7.0
PT07879,Belgium,Flanders,86.0,Female,Leukemia,,2010-06-06,2010-10-09,2011-02-13,Radiation,Public,Alive,18.0,None,Yes,Former,Moderate,36.1,Medium,Urban,Private Insurance,11.0,Yes,No,Diabetes,7.0
PT07880,Ireland,,,Female,Ovarian,IV,2019-04-03,2019-05-15,2019-10-18,Immunotherapy,Public,Deceased,85.0,BRCA1,No,Former,Moderate,39.8,High,Urban,NHS,12.0,No,No,Cardiovascular Disease,2.0
PT07881,Belgium,Brussels,,Male,Leukemia,IV,2023-08-30,2023-10-18,2024-02-09,Chemotherapy,Private,Alive,116.0,EGFR,No,Never,Moderate,,Low,Rural,NHS,12.0,No,Yes,Diabetes,5.0
PT07882,Belgium,Brussels,77.0,Male,Lung,III,2023-07-29,2023-08-28,,Targeted Therapy,Private,Alive,116.0,BRCA1,No,Current,None,28.8,Low,Urban,Private Insurance,12.0,Yes,Yes,None,5.0
PT07883,Italy,Sicily,72.0,Non-binary,Lung,I,2012-11-13,2012-11-21,,Immunotherapy,Public,Alive,111.0,EGFR,No,Never,Moderate,30.7,Medium,Urban,Private Insurance,6.0,No,No,None,3.0
PT07884,Norway,Vestland,76.0,Male,Colorectal,I,2012-07-19,2012-12-31,2013-09-26,Surgery,Private,,118.0,KRAS,No,Never,Heavy,24.2,Medium,Urban,Statutory Health Insurance,2.0,No,Yes,Diabetes,9.0
PT07885,Belgium,Flanders,37.0,Male,Colorectal,IV,,2013-04-24,2014-03-21,Surgery,Research Institute,Alive,28.0,KRAS,Yes,Current,None,,Medium,Urban,,,No,No,None,6.0
PT07886,France,Provence-Alpes-Côte d'Azur,35.0,Male,Prostate,I,2013-07-05,2013-07-13,2013-09-20,Surgery,Public,Deceased,101.0,None,,Never,Moderate,21.1,Medium,Urban,Statutory Health Insurance,2.0,Yes,No,Cardiovascular Disease,5.0
PT07887,Portugal,Algarve,,Female,Breast,I,2023-01-09,2023-05-17,2024-01-23,Surgery,Research Institute,Alive,115.0,KRAS,Yes,Never,Moderate,29.4,High,Rural,Statutory Health Insurance,1.0,Yes,No,Obesity,3.0
,Italy,Lombardy,32.0,Female,Colorectal,II,2013-02-02,2013-02-13,2014-01-20,,Public,Alive,38.0,KRAS,No,Former,Moderate,21.9,High,Urban,Private Insurance,6.0,No,No,Hypertension,4.0
PT07889,Portugal,Algarve,64.0,Female,Breast,I,2020-01-01,2020-05-01,2020-11-01,Targeted Therapy,Public,Lost to Follow-up,,KRAS,No,Current,Moderate,19.2,Medium,Rural,Private Insurance,16.0,No,No,,5.0
PT07890,Switzerland,Bern,62.0,Male,Pancreatic,IV,2015-09-14,2016-01-13,2016-07-08,Surgery,Public,Alive,59.0,,No,Former,Heavy,22.0,Medium,,NHS,12.0,No,No,None,10.0
PT07891,Portugal,Porto,73.0,Female,Colorectal,I,2022-02-21,2022-08-02,2023-03-25,Targeted Therapy,Public,Alive,50.0,KRAS,Yes,Never,Moderate,26.5,Medium,Rural,NHS,2.0,,No,Hypertension,5.0
,Denmark,Central Denmark,,Female,Pancreatic,I,2023-03-09,2023-08-23,2024-07-30,Chemotherapy,Research Institute,Alive,53.0,None,No,Former,None,23.0,Medium,Urban,Statutory Health Insurance,,,No,Diabetes,9.0
PT07893,Germany,Berlin,28.0,Female,Leukemia,IV,2013-03-22,2013-08-13,2013-09-23,Chemotherapy,Public,Alive,90.0,,No,Current,None,22.8,Low,Urban,Statutory Health Insurance,8.0,No,No,Hypertension,4.0
PT07894,Denmark,Capital Region,67.0,Male,Leukemia,II,2011-05-21,2011-07-31,2012-04-26,Radiation,Public,Alive,73.0,None,No,Former,Heavy,23.4,Medium,Urban,NHS,7.0,No,No,Cardiovascular Disease,2.0
PT07895,Italy,Veneto,37.0,Female,,IV,2010-08-13,2010-12-23,2011-02-13,Immunotherapy,Public,Alive,66.0,KRAS,No,Never,None,37.5,Medium,Urban,Statutory Health Insurance,13.0,No,No,Hypertension,6.0
PT07896,,Central Denmark,30.0,Male,Leukemia,II,2020-07-05,2020-10-09,2020-11-19,Surgery,Public,Alive,104.0,EGFR,No,Former,None,19.8,,Urban,NHS,7.0,No,No,Obesity,3.0
PT07897,,Bavaria,81.0,Male,Pancreatic,III,2021-02-04,2021-05-16,2021-10-09,Targeted Therapy,Research Institute,,111.0,KRAS,No,Current,Moderate,25.1,Medium,Urban,Statutory Health Insurance,19.0,No,No,Diabetes,7.0
PT07898,Norway,Vestland,38.0,Female,Breast,I,2010-06-29,2010-12-20,2011-05-06,Targeted Therapy,Private,Alive,57.0,KRAS,Yes,Never,None,26.7,Medium,Urban,NHS,12.0,No,No,,3.0
,Spain,Catalonia,43.0,Non-binary,Prostate,II,2022-05-12,2022-06-03,2022-12-21,Immunotherapy,Private,Lost to Follow-up,,BRCA1,No,Former,Moderate,24.2,Medium,Rural,NHS,16.0,No,No,Diabetes,3.0
,Portugal,Algarve,32.0,Male,Pancreatic,I,2013-08-21,2013-09-03,2013-11-10,Chemotherapy,Private,Alive,51.0,EGFR,Yes,Never,Moderate,26.4,Low,Urban,Private Insurance,7.0,No,No,,1.0
,Denmark,Capital Region,65.0,Non-binary,Colorectal,,2023-01-04,2023-03-27,2023-06-06,Immunotherapy,Public,Alive,49.0,KRAS,No,Never,Heavy,31.8,Medium,Urban,Statutory Health Insurance,3.0,Yes,No,None,8.0
PT07902,Germany,North Rhine-Westphalia,72.0,Male,Colorectal,I,2012-01-12,2012-06-30,2013-03-08,Targeted Therapy,Public,Alive,80.0,EGFR,No,Current,Heavy,21.1,Low,Urban,Private Insurance,16.0,No,No,Hypertension,1.0
PT07903,France,Auvergne-Rhône-Alpes,48.0,Female,Breast,I,2022-01-27,2022-07-08,2022-09-23,Immunotherapy,Public,Deceased,54.0,BRCA1,Yes,Former,None,25.9,Medium,Rural,Private Insurance,2.0,No,Yes,Diabetes,7.0
PT07904,France,Auvergne-Rhône-Alpes,55.0,Male,Pancreatic,IV,,2020-09-07,2021-08-25,Chemotherapy,Research Institute,Alive,42.0,EGFR,Yes,Never,Heavy,,Medium,Urban,Private Insurance,15.0,No,No,Obesity,3.0
PT07905,Germany,Berlin,36.0,Male,Leukemia,II,2010-11-04,2011-04-10,2011-06-13,Chemotherapy,Private,Alive,46.0,,No,Current,Moderate,34.1,Medium,Rural,Statutory Health Insurance,9.0,Yes,Yes,Obesity,10.0
PT07906,Netherlands,Utrecht,,Female,,III,2013-06-20,2013-10-24,2014-08-05,Surgery,Public,Alive,27.0,KRAS,Yes,Former,Moderate,37.0,Medium,Rural,Private Insurance,9.0,No,No,Obesity,8.0
PT07907,Norway,Vestland,43.0,Female,Colorectal,III,2013-06-22,,2014-11-01,Surgery,Public,Alive,47.0,KRAS,Yes,Former,Moderate,30.2,Medium,Rural,NHS,,No,No,Cardiovascular Disease,4.0
PT07908,Germany,Berlin,73.0,Female,,I,2020-01-29,2020-05-03,2021-02-28,Surgery,Research Institute,Alive,63.0,BRCA1,No,Former,None,19.3,Medium,Urban,NHS,5.0,No,No,None,2.0
PT07909,Spain,Madrid,20.0,Female,Prostate,I,2018-04-17,2018-04-28,2018-06-14,Chemotherapy,Public,Alive,57.0,EGFR,Yes,Never,Moderate,27.8,Medium,Urban,Statutory Health Insurance,12.0,Yes,No,Diabetes,1.0
PT07910,Norway,Oslo,86.0,Female,Lung,IV,2021-01-30,2021-04-03,2021-12-12,Targeted Therapy,Public,Alive,58.0,None,Yes,Never,Heavy,27.2,High,Urban,Private Insurance,6.0,Yes,No,None,10.0
PT07911,Finland,Uusimaa,25.0,Female,Prostate,I,2012-11-19,2013-03-01,2013-08-04,Surgery,Public,Deceased,54.0,EGFR,Yes,Former,Moderate,35.6,Medium,Rural,Private Insurance,7.0,Yes,No,Obesity,10.0
PT07912,Sweden,Skåne,74.0,Male,Pancreatic,,2014-07-02,2014-08-22,2015-08-18,Immunotherapy,Private,Alive,,KRAS,No,Former,Moderate,19.2,Medium,Rural,Private Insurance,17.0,Yes,No,Hypertension,10.0
PT07913,Finland,Southwest Finland,57.0,Male,,III,2015-07-22,2015-09-07,2016-07-30,Targeted Therapy,Private,Deceased,67.0,KRAS,Yes,Current,Moderate,39.4,Low,Urban,NHS,12.0,No,No,Obesity,5.0
PT07914,Norway,Trøndelag,52.0,Male,Lung,I,2023-10-05,2023-10-09,2023-11-09,Radiation,Public,Alive,41.0,None,No,Former,Heavy,22.7,High,Urban,NHS,2.0,Yes,No,Obesity,8.0
PT07915,Sweden,Skåne,27.0,Male,Ovarian,,2017-08-05,2017-08-12,2017-11-02,Surgery,Public,Alive,57.0,EGFR,No,Never,None,36.0,High,Urban,Private Insurance,8.0,No,No,Obesity,9.0
PT07916,Germany,Bavaria,,Female,Breast,II,2015-07-19,2015-10-14,2016-06-17,Radiation,Public,Lost to Follow-up,,KRAS,,Never,None,35.4,Low,Rural,Statutory Health Insurance,16.0,No,Yes,Diabetes,2.0
PT07917,Germany,Bavaria,74.0,Male,,IV,2015-07-24,2015-08-24,2015-11-21,Surgery,Public,Alive,46.0,EGFR,No,,None,34.9,,Urban,Private Insurance,7.0,No,No,Cardiovascular Disease,5.0
PT07918,Netherlands,South Holland,67.0,Male,Lung,I,2018-03-28,2018-07-24,2018-09-26,Targeted Therapy,Research Institute,Alive,42.0,KRAS,Yes,Former,Heavy,20.8,Low,Urban,Statutory Health Insurance,4.0,No,No,Obesity,10.0
PT07919,Germany,Bavaria,75.0,Male,,I,2017-04-17,2017-07-12,2018-01-18,Radiation,Research Institute,Deceased,24.0,BRCA1,No,Never,None,19.8,Medium,Rural,Private Insurance,1.0,No,No,Diabetes,1.0
PT07920,Ireland,Connacht,29.0,,Prostate,III,2015-07-02,2015-08-01,,Chemotherapy,Public,Deceased,109.0,EGFR,No,,Moderate,27.8,Medium,Rural,NHS,6.0,No,No,Diabetes,9.0
PT07921,Belgium,Wallonia,71.0,Male,Leukemia,II,2022-07-30,2023-01-03,2023-08-11,Surgery,Public,Deceased,111.0,None,No,Never,None,34.3,Low,Urban,Statutory Health Insurance,14.0,No,No,Obesity,6.0
PT07922,Portugal,Porto,69.0,Male,Prostate,II,2014-07-21,2014-09-02,2015-06-18,Immunotherapy,Private,Lost to Follow-up,,None,Yes,Current,None,33.0,,Urban,NHS,11.0,No,No,Cardiovascular Disease,6.0
,Germany,North Rhine-Westphalia,53.0,Female,Prostate,III,2019-05-08,2019-08-01,2020-06-02,Radiation,Public,Alive,63.0,BRCA1,Yes,Former,None,35.1,Medium,Rural,Private Insurance,2.0,No,Yes,Obesity,8.0
PT07924,Spain,Andalusia,55.0,Female,Lung,III,2010-02-02,2010-07-02,2010-11-20,Immunotherapy,Public,Alive,29.0,EGFR,No,Never,Moderate,20.6,Low,Urban,NHS,,No,No,Cardiovascular Disease,5.0
PT07925,Norway,Trøndelag,80.0,Male,Breast,II,2016-03-31,2016-09-23,2017-03-03,Radiation,Public,Alive,68.0,BRCA1,Yes,Former,None,27.4,High,Rural,Private Insurance,18.0,No,No,Cardiovascular Disease,3.0
PT07926,Norway,Oslo,35.0,Female,,I,2011-06-14,2011-09-26,2012-01-28,Targeted Therapy,Private,Alive,105.0,BRCA1,,Current,Heavy,28.2,Medium,Rural,NHS,18.0,Yes,No,Obesity,5.0
PT07927,Ireland,Munster,37.0,Male,Prostate,,2023-08-23,2024-02-15,2025-01-21,Immunotherapy,Research Institute,Alive,60.0,KRAS,No,Never,Heavy,23.3,High,Urban,NHS,5.0,,No,Diabetes,4.0
PT07928,Ireland,Connacht,66.0,,Pancreatic,I,2023-06-16,2023-10-06,2024-07-02,Surgery,Public,Alive,9.0,None,Yes,Current,None,30.7,High,Rural,Private Insurance,4.0,Yes,No,None,3.0
PT07929,Denmark,Zealand,51.0,Male,Lung,IV,2022-05-21,2022-10-18,2023-08-03,Chemotherapy,Public,Alive,30.0,None,No,Current,Heavy,18.9,,Urban,NHS,9.0,Yes,No,None,4.0
PT07930,Poland,Masovian,62.0,,Pancreatic,I,2013-07-13,2013-12-15,2014-05-25,Targeted Therapy,Public,,66.0,EGFR,Yes,Former,Heavy,35.1,High,Rural,Private Insurance,11.0,Yes,Yes,Diabetes,8.0
PT07931,Germany,Bavaria,59.0,Non-binary,Pancreatic,III,2023-12-19,2024-02-20,2024-11-11,Radiation,Public,Alive,36.0,KRAS,Yes,Never,Heavy,22.7,,Rural,NHS,15.0,No,No,Hypertension,7.0
PT07932,Norway,Trøndelag,,Female,Ovarian,II,2013-08-11,2013-08-15,,Surgery,Private,Alive,26.0,,No,Former,Moderate,34.3,Low,Urban,Statutory Health Insurance,1.0,No,No,Cardiovascular Disease,5.0
PT07933,Spain,Catalonia,54.0,Male,Prostate,I,2014-01-03,2014-04-03,2015-01-01,Radiation,Public,Deceased,99.0,BRCA1,No,Never,Moderate,19.6,Medium,Urban,Statutory Health Insurance,14.0,No,No,Diabetes,4.0
PT07934,,Geneva,88.0,Female,Ovarian,,2014-05-04,2014-09-03,2014-11-26,Immunotherapy,Public,Deceased,10.0,EGFR,Yes,Never,Moderate,28.9,Low,Rural,NHS,4.0,No,No,Hypertension,6.0
PT07935,Norway,Trøndelag,69.0,Male,Pancreatic,I,2011-07-24,2011-07-27,2012-03-09,Immunotherapy,Private,Alive,73.0,KRAS,Yes,Never,None,22.9,Medium,Urban,NHS,2.0,No,,Diabetes,8.0
PT07936,Belgium,Brussels,31.0,Female,Ovarian,I,2010-05-31,2010-08-20,2010-12-10,Chemotherapy,Public,Alive,101.0,None,No,Never,,26.6,High,Urban,Private Insurance,13.0,No,No,Diabetes,8.0
PT07937,Switzerland,Bern,77.0,,Leukemia,,2023-08-14,2024-01-29,2024-12-11,Immunotherapy,Public,Alive,10.0,KRAS,No,Never,Moderate,37.5,Medium,Urban,Statutory Health Insurance,1.0,No,No,Hypertension,3.0
PT07938,Netherlands,North Holland,82.0,Non-binary,Breast,IV,2010-12-11,2011-03-04,2012-02-10,Targeted Therapy,Public,Alive,118.0,EGFR,Yes,Former,None,27.8,High,,Statutory Health Insurance,1.0,No,No,Diabetes,1.0
PT07939,Portugal,Lisbon,68.0,Female,Prostate,I,2014-07-18,2014-10-08,2015-05-16,Radiation,Private,Alive,21.0,None,Yes,Never,None,24.0,Low,Urban,NHS,2.0,No,No,None,3.0
PT07940,Netherlands,North Holland,55.0,Female,Pancreatic,IV,2012-07-22,2012-12-25,2013-08-28,Radiation,Public,Alive,96.0,BRCA1,No,Former,Moderate,24.7,Medium,,Private Insurance,11.0,No,No,None,2.0
PT07941,Netherlands,South Holland,73.0,Female,Breast,I,2022-11-30,2023-03-27,2023-12-26,Targeted Therapy,Research Institute,Alive,17.0,None,No,Never,None,32.0,Low,Urban,Private Insurance,4.0,No,Yes,Obesity,9.0
PT07942,Poland,Silesian,66.0,Male,Ovarian,III,2021-08-16,2022-01-06,2022-10-28,Immunotherapy,Public,Alive,70.0,None,No,Never,None,34.2,High,Rural,Private Insurance,8.0,No,Yes,Hypertension,9.0
PT07943,Netherlands,North Holland,51.0,Male,Breast,IV,2023-04-03,2023-05-24,2023-07-24,Immunotherapy,Research Institute,Alive,71.0,KRAS,No,Never,None,18.9,Low,Urban,Private Insurance,8.0,No,No,Diabetes,8.0
PT07944,Poland,Silesian,72.0,Female,Leukemia,IV,2021-12-11,2022-05-14,2023-02-28,Targeted Therapy,Public,Alive,77.0,EGFR,No,Never,Moderate,29.0,High,Urban,Statutory Health Insurance,7.0,Yes,No,Obesity,4.0
PT07945,Switzerland,Zurich,51.0,Female,Leukemia,I,2021-08-13,2021-09-17,2022-03-22,Chemotherapy,Public,Alive,48.0,BRCA1,No,Never,Moderate,27.3,Medium,,Statutory Health Insurance,19.0,Yes,No,Cardiovascular Disease,7.0
PT07946,Spain,Andalusia,81.0,Female,Colorectal,III,2023-09-08,2024-01-12,2024-06-24,Surgery,Research Institute,Alive,103.0,KRAS,Yes,Never,Moderate,26.5,Medium,Urban,NHS,5.0,No,Yes,None,9.0
PT07947,Germany,Bavaria,56.0,Female,Breast,I,2014-02-17,2014-05-08,2015-02-19,Surgery,Private,Alive,114.0,KRAS,Yes,Current,Moderate,27.0,Medium,Rural,NHS,6.0,No,No,Hypertension,10.0
PT07948,Poland,Silesian,57.0,Female,Prostate,II,2019-10-16,2019-10-31,2020-08-21,Immunotherapy,Public,Deceased,30.0,BRCA1,Yes,Former,,,Medium,Urban,Private Insurance,10.0,No,No,None,2.0
PT07949,Denmark,Zealand,49.0,Female,Leukemia,III,2016-12-26,2017-05-08,2017-07-29,Surgery,Public,Lost to Follow-up,,EGFR,Yes,Never,,40.0,Medium,Urban,Private Insurance,5.0,No,No,None,9.0
PT07950,France,Île-de-France,,Male,Prostate,II,2012-10-08,2013-03-31,2014-03-07,Surgery,Public,Alive,103.0,BRCA1,No,Never,None,39.5,Medium,Urban,Statutory Health Insurance,,Yes,No,Hypertension,2.0
PT07951,Ireland,Dublin,51.0,Female,Breast,II,2021-05-29,2021-06-22,2021-08-30,,Public,Lost to Follow-up,,BRCA1,No,Never,Moderate,33.5,Low,Urban,NHS,7.0,,No,None,3.0
PT07952,France,Provence-Alpes-Côte d'Azur,85.0,Male,Leukemia,I,2016-04-27,2016-04-29,2016-11-30,Immunotherapy,Private,Alive,51.0,None,,Never,Moderate,23.3,Medium,Urban,Statutory Health Insurance,7.0,Yes,No,Hypertension,8.0
PT07953,Switzerland,Geneva,70.0,Male,Colorectal,I,2023-02-13,2023-07-27,2024-04-28,Radiation,Private,Alive,117.0,BRCA1,Yes,Current,Moderate,18.2,Low,,Private Insurance,2.0,No,No,,7.0
PT07954,Poland,Masovian,30.0,Male,Breast,I,2012-05-10,2012-06-24,2012-10-07,Immunotherapy,Public,Deceased,6.0,None,Yes,Former,Moderate,35.1,Medium,Urban,Private Insurance,2.0,Yes,No,Diabetes,8.0
PT07955,Spain,Catalonia,78.0,Non-binary,Prostate,IV,2013-12-05,2014-03-10,2014-07-09,Immunotherapy,Public,Alive,83.0,EGFR,No,Current,None,28.6,Low,Rural,Statutory Health Insurance,2.0,No,No,Obesity,5.0
PT07956,Spain,Andalusia,,Male,Colorectal,I,2013-12-10,2014-03-14,2014-11-19,Chemotherapy,Public,Alive,37.0,EGFR,No,Former,None,24.2,Medium,Urban,NHS,,Yes,No,Cardiovascular Disease,6.0
PT07957,Netherlands,Utrecht,56.0,Female,Breast,III,2019-05-10,2019-09-10,2020-05-01,Chemotherapy,Public,Alive,66.0,EGFR,No,Never,None,27.3,Medium,Urban,Private Insurance,8.0,No,No,Cardiovascular Disease,5.0
,Switzerland,Zurich,68.0,Female,Leukemia,III,2020-10-28,2020-12-04,2021-04-26,Immunotherapy,Public,Deceased,34.0,BRCA1,Yes,Never,None,34.4,Medium,Urban,Statutory Health Insurance,5.0,Yes,No,Cardiovascular Disease,
PT07959,Finland,Southwest Finland,38.0,Female,Pancreatic,II,2022-07-15,2022-11-10,2023-03-01,Targeted Therapy,Public,Deceased,53.0,None,Yes,Never,,19.0,High,Rural,NHS,9.0,No,No,Cardiovascular Disease,1.0
PT07960,Portugal,Porto,74.0,Female,,III,2014-01-01,2014-03-27,2014-12-08,Targeted Therapy,Private,Alive,88.0,KRAS,No,Never,None,29.2,Medium,Urban,NHS,9.0,No,No,None,5.0
PT07961,Portugal,Algarve,59.0,Female,Lung,III,2010-06-11,2010-10-29,2010-12-19,Chemotherapy,Public,Alive,99.0,KRAS,No,Current,None,26.4,Medium,Rural,Statutory Health Insurance,13.0,No,Yes,Hypertension,2.0
,Norway,Vestland,26.0,Male,Prostate,II,2011-10-01,2012-01-31,2012-09-25,Chemotherapy,Public,Alive,28.0,EGFR,Yes,Former,Moderate,22.6,Medium,Urban,NHS,8.0,No,No,Cardiovascular Disease,7.0
PT07963,Italy,Lombardy,24.0,Male,Leukemia,II,2012-11-23,2013-05-05,2014-03-02,Radiation,,Deceased,74.0,KRAS,Yes,Former,Moderate,37.7,Medium,Urban,,12.0,No,No,None,5.0
PT07964,Finland,Southwest Finland,61.0,Non-binary,Leukemia,IV,2013-12-24,2014-05-23,2015-05-12,Chemotherapy,Private,Deceased,92.0,KRAS,No,Never,Moderate,33.9,Medium,Urban,NHS,4.0,No,No,Cardiovascular Disease,3.0
PT07965,Germany,North Rhine-Westphalia,67.0,Male,,IV,2023-03-20,2023-07-15,2023-12-19,Surgery,Public,Deceased,104.0,EGFR,No,Never,Moderate,34.6,Medium,Rural,Private Insurance,6.0,Yes,Yes,None,7.0
PT07966,Spain,Madrid,26.0,Female,Pancreatic,III,2017-08-16,2017-10-27,2018-07-31,Immunotherapy,Public,Deceased,58.0,,Yes,Never,Moderate,33.1,Low,Urban,Private Insurance,15.0,Yes,No,Cardiovascular Disease,5.0
PT07967,Italy,Lombardy,30.0,Female,Colorectal,I,2019-03-22,2019-08-24,2020-06-21,Immunotherapy,Public,Alive,76.0,BRCA1,No,Never,None,24.8,Medium,Rural,,12.0,No,No,Obesity,5.0
PT07968,Denmark,Zealand,68.0,Male,Leukemia,II,2021-09-07,2021-12-16,2022-07-22,Immunotherapy,Private,Alive,100.0,BRCA1,No,Former,None,18.6,Medium,Urban,Private Insurance,4.0,Yes,,Diabetes,5.0
PT07969,Austria,Styria,49.0,Female,Ovarian,II,2018-11-10,2018-11-17,2019-11-12,Radiation,Public,Deceased,83.0,None,Yes,Never,Moderate,31.1,Medium,Urban,Private Insurance,14.0,Yes,No,None,3.0
PT07970,Finland,Uusimaa,60.0,Female,Colorectal,III,2021-10-04,2021-10-07,2022-09-01,Radiation,,,96.0,,No,Never,None,,Medium,Rural,NHS,10.0,No,No,Cardiovascular Disease,7.0
PT07971,Poland,,22.0,Male,Colorectal,III,2015-09-29,2015-10-03,2016-06-16,Surgery,Private,Alive,119.0,KRAS,Yes,Former,Moderate,24.1,Medium,Urban,NHS,8.0,Yes,No,Hypertension,3.0
PT07972,Germany,Berlin,59.0,Non-binary,Colorectal,II,2014-01-05,2014-01-13,2014-12-05,,Private,Alive,109.0,KRAS,No,Former,None,32.9,Medium,Urban,Statutory Health Insurance,9.0,No,No,Hypertension,4.0
PT07973,Portugal,Porto,70.0,Female,Pancreatic,III,2022-02-12,2022-03-29,2022-12-19,,Public,Alive,,None,Yes,Never,Moderate,25.8,Medium,,Private Insurance,1.0,No,No,Hypertension,7.0
PT07974,Italy,Lombardy,51.0,Male,Breast,I,2022-01-07,2022-06-04,2023-02-22,Chemotherapy,Public,Alive,113.0,KRAS,Yes,Current,Moderate,39.5,Medium,Rural,,17.0,No,No,Cardiovascular Disease,5.0
PT07975,Austria,Tyrol,,Female,Lung,,2016-05-16,2016-09-26,2017-04-26,Immunotherapy,Public,Deceased,31.0,None,No,Never,None,37.9,Medium,Rural,NHS,16.0,No,No,Cardiovascular Disease,4.0
PT07976,France,Île-de-France,39.0,Male,Prostate,I,2022-03-18,2022-09-08,2023-06-23,Surgery,Research Institute,Alive,76.0,EGFR,No,Never,Moderate,19.0,Medium,Urban,Statutory Health Insurance,,No,No,None,1.0
PT07977,Sweden,Skåne,54.0,Female,,III,2021-01-24,2021-04-03,2021-08-01,Radiation,Public,Alive,26.0,,No,Never,None,,Low,Urban,Statutory Health Insurance,8.0,No,Yes,None,9.0
PT07978,Switzerland,Bern,43.0,Male,Leukemia,I,2017-03-03,2017-04-07,2017-08-23,Radiation,Private,Alive,93.0,KRAS,No,Current,Moderate,30.2,High,Urban,,16.0,No,No,Diabetes,2.0
PT07979,Austria,Tyrol,59.0,Female,Lung,I,2021-08-20,2022-01-10,2022-10-06,Radiation,,Deceased,86.0,BRCA1,Yes,Former,Moderate,18.6,Medium,Urban,Statutory Health Insurance,,No,No,Obesity,2.0
PT07980,Belgium,Brussels,71.0,Female,Prostate,I,2014-10-21,2014-11-07,2014-12-19,Surgery,,Alive,65.0,BRCA1,Yes,Never,None,27.8,High,Rural,Private Insurance,8.0,Yes,No,Cardiovascular Disease,8.0
PT07981,Poland,Masovian,58.0,Female,Breast,IV,2011-11-29,2012-02-13,2012-09-08,Surgery,Public,Deceased,60.0,None,,Current,None,26.9,,Rural,Statutory Health Insurance,,No,No,Hypertension,10.0
PT07982,Germany,Bavaria,87.0,Female,Leukemia,III,2020-11-01,2021-04-24,2021-11-21,Surgery,Private,Alive,112.0,KRAS,,Never,None,32.4,Low,Rural,Statutory Health Insurance,15.0,No,No,Diabetes,8.0
PT07983,Switzerland,Geneva,80.0,Male,Breast,II,2021-12-16,2022-06-05,2022-11-27,Targeted Therapy,Private,Alive,78.0,BRCA1,No,Never,Moderate,27.7,Medium,Rural,,8.0,Yes,No,Hypertension,5.0
,Belgium,,,Female,Leukemia,III,2016-10-26,2017-02-25,,Immunotherapy,Private,Alive,84.0,BRCA1,No,Never,Heavy,21.3,Medium,Rural,Statutory Health Insurance,15.0,No,,Obesity,5.0
PT07985,Switzerland,Bern,81.0,Female,Prostate,III,2011-05-28,2011-08-15,2011-12-19,Targeted Therapy,Public,Alive,,,Yes,,Moderate,21.9,Medium,Urban,NHS,13.0,No,No,Obesity,1.0
PT07986,Denmark,Capital Region,21.0,Female,Breast,III,2012-03-19,2012-06-18,2013-02-11,Targeted Therapy,Private,Alive,73.0,BRCA1,Yes,Current,Moderate,26.4,Low,Urban,Private Insurance,11.0,No,Yes,None,
PT07987,Netherlands,North Holland,25.0,Male,Prostate,II,2012-11-04,2013-02-26,2013-05-10,Chemotherapy,Public,Alive,93.0,None,Yes,Never,,23.4,High,,,4.0,No,No,None,10.0
,Sweden,Stockholm,62.0,Female,,I,2011-06-28,2011-07-20,2012-04-08,,Public,Alive,100.0,None,No,Former,Moderate,36.5,Low,,Statutory Health Insurance,9.0,No,No,Hypertension,1.0
PT07989,Germany,Bavaria,59.0,Female,Pancreatic,I,2020-05-04,2020-09-18,2021-01-18,Radiation,Private,Alive,17.0,None,Yes,Current,None,40.0,Low,Rural,NHS,14.0,No,No,Cardiovascular Disease,7.0
PT07990,France,Provence-Alpes-Côte d'Azur,58.0,Female,Lung,I,2023-11-15,2024-01-01,2024-06-14,Targeted Therapy,Public,Alive,113.0,EGFR,Yes,Former,,35.4,Low,Urban,Private Insurance,1.0,,No,Cardiovascular Disease,7.0
,Norway,,47.0,Female,Leukemia,III,2016-04-20,2016-04-23,2016-11-02,Chemotherapy,Public,Alive,13.0,None,No,Never,Moderate,25.3,Low,Rural,Statutory Health Insurance,13.0,No,No,Hypertension,5.0
PT07992,Norway,Trøndelag,82.0,Male,Colorectal,I,2023-04-04,2023-05-05,2023-07-02,Targeted Therapy,Public,Alive,,BRCA1,No,Never,Moderate,28.2,Medium,Rural,Statutory Health Insurance,14.0,No,No,Diabetes,8.0
PT07993,Ireland,Dublin,83.0,Female,Colorectal,II,2011-12-11,2011-12-24,2012-08-26,Immunotherapy,Public,Alive,118.0,KRAS,Yes,Never,Moderate,28.0,Low,Urban,Statutory Health Insurance,12.0,No,No,Obesity,6.0
PT07994,Ireland,Connacht,31.0,Female,Breast,II,2013-08-06,2013-08-08,2013-10-06,Targeted Therapy,Public,Alive,48.0,BRCA1,No,Current,Moderate,38.2,Medium,Urban,Statutory Health Insurance,1.0,No,No,Cardiovascular Disease,9.0
PT07995,Finland,Uusimaa,60.0,,Prostate,I,2022-01-19,2022-05-10,,Radiation,Research Institute,,14.0,EGFR,Yes,Current,,31.2,Medium,Urban,NHS,4.0,No,No,Obesity,7.0
PT07996,Switzerland,Bern,48.0,Female,Lung,IV,2021-09-07,2021-09-14,2022-05-21,Surgery,Public,Alive,22.0,KRAS,No,Former,Moderate,33.7,Medium,Urban,NHS,11.0,Yes,No,Cardiovascular Disease,7.0
PT07997,Switzerland,,42.0,Female,,IV,2022-02-10,2022-03-11,2022-05-26,Radiation,Public,Alive,21.0,None,Yes,Never,Moderate,24.9,High,Urban,NHS,12.0,Yes,No,Diabetes,8.0
PT07998,France,Île-de-France,70.0,Male,Breast,I,2021-08-19,2021-12-29,2022-07-08,Targeted Therapy,Public,Alive,56.0,BRCA1,No,Former,Moderate,19.0,High,Urban,Statutory Health Insurance,9.0,Yes,No,Hypertension,3.0
PT07999,Switzerland,Bern,64.0,Male,Prostate,III,2017-07-18,2017-11-27,2018-05-19,Targeted Therapy,Public,Deceased,40.0,EGFR,No,Current,Moderate,22.9,Medium,Urban,NHS,1.0,,No,None,9.0
PT08000,Netherlands,Utrecht,41.0,Male,Pancreatic,II,2022-11-16,,2023-11-16,Surgery,Private,,57.0,EGFR,No,Former,None,21.2,Medium,Rural,NHS,11.0,No,No,Obesity,5.0
PT08001,Netherlands,North Holland,29.0,Male,Colorectal,III,2014-11-08,2015-04-06,2015-07-18,Radiation,Public,Deceased,82.0,EGFR,No,Never,Moderate,28.0,Medium,Urban,Statutory Health Insurance,2.0,No,No,Hypertension,2.0
PT08002,Portugal,Porto,26.0,Male,,I,2013-12-10,2014-06-01,2014-07-29,Radiation,Private,Deceased,17.0,None,,Never,None,30.3,Medium,Rural,NHS,4.0,No,No,Hypertension,7.0
PT08003,Netherlands,Utrecht,34.0,Male,Leukemia,I,2022-01-24,2022-05-31,2023-03-06,Targeted Therapy,Public,Deceased,99.0,EGFR,No,Current,Moderate,22.0,Low,Rural,Private Insurance,7.0,No,No,Diabetes,6.0
PT08004,Norway,Oslo,65.0,Male,Leukemia,IV,2019-01-29,2019-07-04,2019-12-01,Immunotherapy,Private,Alive,72.0,KRAS,No,Never,Heavy,26.9,Low,Urban,NHS,11.0,No,No,Cardiovascular Disease,2.0
PT08005,Germany,Berlin,80.0,Non-binary,Leukemia,IV,2011-02-13,2011-02-21,2011-04-06,Chemotherapy,,Deceased,74.0,None,No,Never,None,,Medium,Rural,NHS,5.0,No,No,Cardiovascular Disease,4.0
PT08006,Sweden,Västra Götaland,,Female,Breast,II,2023-03-08,2023-04-19,2023-12-24,Targeted Therapy,Private,Lost to Follow-up,,KRAS,Yes,Former,Heavy,24.2,Medium,Urban,NHS,16.0,,No,Obesity,2.0
PT08007,Switzerland,Bern,70.0,Male,Leukemia,IV,2022-12-06,2023-04-30,2024-03-31,Targeted Therapy,,Alive,106.0,EGFR,Yes,,Moderate,27.1,Medium,Urban,Private Insurance,8.0,No,No,Cardiovascular Disease,1.0
,Ireland,Munster,57.0,Female,Breast,III,2021-11-12,2022-03-29,2023-03-05,Chemotherapy,Research Institute,Deceased,18.0,None,No,Former,Moderate,18.3,High,Urban,Private Insurance,6.0,No,Yes,Diabetes,1.0
PT08009,Finland,,31.0,Female,,I,2016-09-19,2016-12-12,2017-06-29,Surgery,Research Institute,Deceased,18.0,KRAS,No,Never,Moderate,26.8,Low,Rural,Private Insurance,2.0,No,No,None,3.0
PT08010,Finland,Southwest Finland,85.0,,Prostate,II,2014-05-02,2014-07-10,2015-01-30,Targeted Therapy,Private,Alive,33.0,None,No,Former,None,31.9,Medium,Urban,Private Insurance,3.0,No,,Obesity,7.0
PT08011,Belgium,Flanders,73.0,Male,Colorectal,I,2013-05-06,2013-08-13,2014-07-28,Immunotherapy,Private,Alive,52.0,None,No,Former,Moderate,28.5,Medium,Rural,Private Insurance,9.0,No,,Cardiovascular Disease,5.0
,Denmark,Zealand,58.0,Male,Ovarian,III,2011-07-17,2011-08-27,2012-01-20,Surgery,Public,Alive,49.0,KRAS,No,Current,Heavy,30.5,Medium,Rural,Private Insurance,10.0,No,No,Hypertension,10.0
PT08013,Sweden,Västra Götaland,58.0,Male,Ovarian,IV,2020-05-05,2020-10-09,2020-11-09,Surgery,Public,Alive,,EGFR,No,Current,Heavy,35.1,Low,Urban,Statutory Health Insurance,9.0,Yes,No,Cardiovascular Disease,9.0
PT08014,Netherlands,South Holland,49.0,Male,Breast,II,2021-06-14,2021-08-07,2021-10-07,Surgery,Public,Alive,74.0,,Yes,Current,None,40.0,Medium,Rural,NHS,5.0,Yes,No,Diabetes,8.0
PT08015,Netherlands,North Holland,67.0,Female,Prostate,III,2014-10-22,2015-03-31,2016-03-04,Targeted Therapy,Private,Alive,25.0,None,No,Former,None,,Medium,Urban,Private Insurance,15.0,Yes,No,Obesity,1.0
,Austria,Vienna,50.0,Female,Pancreatic,III,2017-10-08,2018-02-06,2018-12-30,Surgery,Public,Alive,97.0,EGFR,No,Never,None,21.8,Low,Urban,Statutory Health Insurance,10.0,No,,Obesity,
PT08017,Italy,Veneto,44.0,Female,Leukemia,I,2012-01-15,2012-02-27,,Radiation,Public,Alive,41.0,None,No,Never,Moderate,39.5,Medium,Rural,Private Insurance,4.0,No,No,Hypertension,9.0
PT08018,,,87.0,Male,Colorectal,II,2011-01-05,,2012-01-03,Targeted Therapy,Private,Alive,50.0,KRAS,No,Former,Heavy,24.3,Low,Urban,Statutory Health Insurance,9.0,No,Yes,None,1.0
PT08019,Poland,Lesser Poland,70.0,Female,Pancreatic,II,2015-09-23,2016-01-16,,Targeted Therapy,Public,Deceased,117.0,BRCA1,No,Never,None,23.8,Low,Urban,Private Insurance,12.0,No,No,Hypertension,
PT08020,Finland,Uusimaa,32.0,Female,Breast,II,2013-08-13,2013-11-21,2014-05-03,Chemotherapy,Public,Alive,87.0,BRCA1,Yes,Former,None,37.1,Low,Urban,Statutory Health Insurance,8.0,Yes,No,Cardiovascular Disease,8.0
PT08021,Germany,Berlin,82.0,Non-binary,Leukemia,IV,2011-04-11,2011-04-27,,Surgery,Public,Alive,62.0,BRCA1,No,Never,Heavy,37.6,High,Urban,NHS,15.0,No,No,Hypertension,6.0
,,Lesser Poland,61.0,Male,Prostate,I,2019-07-26,2019-12-22,2020-10-08,Targeted Therapy,Research Institute,Alive,92.0,KRAS,No,Never,Moderate,25.4,Medium,Rural,NHS,8.0,No,No,Cardiovascular Disease,2.0
PT08023,,Styria,73.0,Female,Lung,II,,2024-02-26,2024-07-03,Immunotherapy,Public,Deceased,96.0,None,No,Former,Moderate,32.2,Medium,Urban,Private Insurance,6.0,No,No,None,3.0
PT08024,Switzerland,Geneva,86.0,Female,Prostate,III,2011-04-18,2011-09-19,2012-03-23,Immunotherapy,Public,Alive,7.0,None,No,Never,None,33.2,High,Urban,Private Insurance,11.0,No,No,,4.0
PT08025,Finland,Southwest Finland,75.0,Female,Breast,I,2013-07-20,2013-11-28,2014-07-09,Targeted Therapy,Public,Lost to Follow-up,,BRCA1,No,Former,None,29.5,Low,Rural,Private Insurance,7.0,Yes,No,Obesity,9.0
PT08026,Sweden,Skåne,38.0,Female,Lung,II,,2021-10-01,2022-01-12,Targeted Therapy,Public,Alive,47.0,KRAS,Yes,Never,,31.1,High,Urban,Statutory Health Insurance,13.0,No,Yes,Cardiovascular Disease,6.0
PT08027,Germany,Berlin,65.0,Male,Lung,I,2010-08-24,2010-11-21,2011-10-03,Immunotherapy,,Alive,109.0,BRCA1,Yes,Former,Moderate,,Low,Urban,NHS,12.0,No,No,Diabetes,4.0
PT08028,Portugal,Porto,34.0,Female,Leukemia,II,2019-06-26,2019-09-18,2019-12-28,Immunotherapy,Private,Alive,,BRCA1,,Never,Moderate,33.5,Medium,Urban,NHS,16.0,No,No,None,
PT08029,Sweden,Stockholm,51.0,Male,Prostate,III,2014-08-06,2014-09-22,2015-08-12,Radiation,Public,Alive,36.0,EGFR,No,Never,Heavy,37.6,,Rural,Private Insurance,11.0,No,No,Diabetes,3.0
PT08030,Finland,Uusimaa,68.0,Female,Breast,I,2021-11-07,2022-03-05,2023-02-10,Immunotherapy,Private,Alive,87.0,BRCA1,No,Former,Moderate,37.0,Low,Urban,Statutory Health Insurance,,Yes,No,None,3.0
PT08031,Netherlands,Utrecht,40.0,Male,Pancreatic,III,2010-09-23,2011-03-06,2011-08-07,Radiation,Private,Alive,,KRAS,No,Former,None,35.9,Medium,Rural,Statutory Health Insurance,16.0,No,Yes,Obesity,2.0
PT08032,Netherlands,North Holland,84.0,Male,Pancreatic,II,2016-08-01,2016-09-05,2017-03-09,Targeted Therapy,Public,Alive,116.0,None,No,Former,Moderate,21.4,Medium,Urban,Private Insurance,6.0,No,No,Cardiovascular Disease,9.0
PT08033,France,Île-de-France,89.0,Female,Lung,I,2010-05-19,2010-11-06,2011-01-05,Surgery,Research Institute,Alive,92.0,BRCA1,No,,Moderate,34.8,Medium,Urban,NHS,17.0,No,No,None,2.0
PT08034,Spain,Madrid,46.0,Female,Leukemia,II,2022-09-17,2023-02-25,2023-04-08,Surgery,Private,,85.0,KRAS,Yes,Former,None,21.6,Medium,Urban,NHS,3.0,No,No,Hypertension,6.0
PT08035,Belgium,Flanders,42.0,Male,Pancreatic,IV,2013-09-27,2013-10-02,2014-01-10,Chemotherapy,Public,Deceased,31.0,None,Yes,Former,Moderate,35.6,High,Urban,Statutory Health Insurance,17.0,No,No,None,5.0
PT08036,Italy,Lombardy,66.0,Non-binary,Lung,I,2015-05-07,2015-05-11,2015-07-30,Radiation,Public,Alive,30.0,EGFR,No,Former,Moderate,25.1,Low,Urban,Statutory Health Insurance,15.0,No,No,None,9.0
PT08037,Poland,Lesser Poland,31.0,Female,Ovarian,II,2010-03-14,2010-05-11,2010-08-13,Immunotherapy,Public,Deceased,106.0,KRAS,No,Former,None,21.0,Medium,Urban,Statutory Health Insurance,5.0,No,Yes,Hypertension,6.0
PT08038,Spain,Madrid,85.0,Male,Prostate,III,2010-06-12,2010-09-27,2010-12-10,,Private,Alive,40.0,EGFR,No,Never,None,34.0,Low,Rural,Private Insurance,9.0,No,Yes,None,
PT08039,Switzerland,Geneva,24.0,Male,Pancreatic,II,2010-08-11,2011-02-05,2011-06-27,Chemotherapy,,Alive,116.0,EGFR,Yes,Never,None,28.2,Medium,Rural,Private Insurance,,No,No,Cardiovascular Disease,4.0
PT08040,France,Provence-Alpes-Côte d'Azur,28.0,Female,Colorectal,I,2010-07-04,2010-12-06,2011-02-26,,Private,Alive,91.0,EGFR,No,Current,Moderate,30.1,High,Rural,Private Insurance,3.0,No,No,Hypertension,6.0
PT08041,Netherlands,South Holland,39.0,Male,Ovarian,II,2010-04-05,2010-08-21,2011-06-28,Radiation,Public,Alive,78.0,EGFR,Yes,Current,None,36.9,Low,Urban,Private Insurance,10.0,No,No,Diabetes,3.0
PT08042,Portugal,Algarve,82.0,Female,Breast,III,2020-08-08,2020-12-09,2021-04-27,Immunotherapy,Public,Alive,39.0,BRCA1,No,Never,Heavy,26.1,Medium,Urban,Private Insurance,16.0,No,Yes,Diabetes,3.0
PT08043,Austria,Tyrol,49.0,Male,Ovarian,IV,2011-11-15,2012-01-16,2012-07-07,Targeted Therapy,Public,Alive,50.0,KRAS,No,Never,None,,Low,Rural,,6.0,Yes,No,Diabetes,9.0
,Spain,Catalonia,35.0,Male,Colorectal,I,2019-04-04,2019-08-04,2020-05-27,Targeted Therapy,Research Institute,Alive,28.0,None,No,Former,Moderate,26.8,High,Urban,Private Insurance,18.0,,No,Hypertension,8.0
,Ireland,Dublin,24.0,Female,Prostate,II,2012-09-02,2013-01-28,2013-10-30,Targeted Therapy,Public,Alive,111.0,BRCA1,No,Former,Moderate,31.9,Medium,Rural,Statutory Health Insurance,16.0,Yes,No,Cardiovascular Disease,
PT08046,Netherlands,South Holland,48.0,Male,Colorectal,I,,2018-11-26,2019-09-23,Chemotherapy,Private,Alive,96.0,None,Yes,Never,Moderate,22.9,Low,Urban,Statutory Health Insurance,14.0,No,No,Cardiovascular Disease,3.0
PT08047,France,Provence-Alpes-Côte d'Azur,66.0,Male,Prostate,III,2020-02-11,2020-03-30,,Radiation,Private,Deceased,79.0,None,No,Current,Moderate,35.5,Medium,Urban,Statutory Health Insurance,6.0,No,No,Obesity,3.0
PT08048,Ireland,Connacht,41.0,Male,Prostate,I,2016-12-19,2017-06-14,,Chemotherapy,Public,Alive,21.0,None,Yes,Former,Moderate,37.4,Medium,Urban,Private Insurance,8.0,No,No,Hypertension,7.0
PT08049,Portugal,Algarve,76.0,Male,Leukemia,I,2018-11-07,2018-12-03,2019-03-25,Immunotherapy,Public,Deceased,9.0,None,No,Former,None,38.0,High,Urban,Private Insurance,14.0,No,No,Obesity,7.0
PT08050,Italy,Veneto,54.0,Male,Ovarian,III,2010-03-02,2010-07-02,2010-10-15,Surgery,Private,Alive,59.0,None,No,Former,None,31.6,Medium,Rural,Private Insurance,13.0,Yes,No,Hypertension,6.0
PT08051,Austria,Styria,79.0,Female,Colorectal,I,2013-12-31,2014-06-12,2014-12-10,Chemotherapy,Private,Lost to Follow-up,,EGFR,Yes,Never,Moderate,38.6,Medium,Urban,,13.0,No,No,Cardiovascular Disease,9.0
PT08052,Switzerland,Bern,89.0,Female,Lung,II,,2011-05-25,2011-10-15,Immunotherapy,Public,Lost to Follow-up,,BRCA1,No,Never,Moderate,21.0,Medium,,Private Insurance,4.0,No,No,Obesity,7.0
PT08053,Switzerland,Bern,79.0,Male,Prostate,IV,2021-07-12,2021-09-15,2021-12-11,Immunotherapy,Research Institute,Deceased,100.0,None,,Never,Moderate,30.3,Low,Urban,NHS,14.0,Yes,No,Diabetes,10.0
PT08054,Netherlands,Utrecht,77.0,Male,Ovarian,IV,2021-03-02,2021-06-29,2022-01-11,Immunotherapy,Public,Deceased,73.0,EGFR,Yes,Current,Moderate,27.8,Medium,Rural,NHS,8.0,Yes,No,Diabetes,3.0
,Italy,Veneto,22.0,Male,Colorectal,I,2023-09-16,2024-02-17,2024-11-29,Surgery,Public,Deceased,116.0,None,No,Never,Moderate,39.6,Low,Urban,Private Insurance,6.0,No,No,Diabetes,3.0
PT08056,Belgium,Flanders,53.0,Male,Lung,II,2022-09-24,2022-09-30,2023-01-25,Targeted Therapy,Public,Alive,,None,No,Former,Moderate,20.0,High,Urban,NHS,2.0,No,No,Cardiovascular Disease,8.0
PT08057,Poland,Lesser Poland,64.0,Female,Breast,II,2019-12-31,2020-02-19,2020-09-24,Radiation,Private,Deceased,,EGFR,Yes,Former,None,26.8,High,Urban,NHS,6.0,No,Yes,Hypertension,4.0
PT08058,Denmark,Capital Region,69.0,Male,Lung,II,2013-03-20,2013-05-08,2013-07-24,Chemotherapy,Public,Alive,19.0,KRAS,No,Never,Moderate,21.6,Medium,Rural,Statutory Health Insurance,4.0,No,No,Cardiovascular Disease,2.0
PT08059,Poland,Silesian,21.0,Male,Colorectal,IV,2017-02-08,2017-03-26,2017-06-25,Surgery,Private,Deceased,85.0,None,Yes,Former,Moderate,25.8,Medium,Rural,,12.0,No,No,Obesity,9.0
,France,Auvergne-Rhône-Alpes,34.0,Female,Colorectal,III,2021-08-06,2021-11-04,,Immunotherapy,Public,Deceased,116.0,BRCA1,Yes,Never,None,37.2,Low,Urban,Private Insurance,19.0,No,No,Obesity,9.0
PT08061,Portugal,Algarve,56.0,Male,Lung,III,2020-06-03,2020-10-30,2021-06-24,Surgery,Public,Deceased,88.0,EGFR,No,Never,Moderate,23.0,Low,Urban,Statutory Health Insurance,4.0,No,No,Obesity,4.0
,Belgium,Flanders,34.0,,Lung,I,,2011-08-09,2011-11-15,Chemotherapy,Private,Lost to Follow-up,,KRAS,No,Former,Heavy,28.9,High,Urban,Statutory Health Insurance,9.0,No,No,None,1.0
PT08063,Poland,Silesian,79.0,Female,Pancreatic,,2015-04-15,2015-05-10,2015-08-16,Radiation,Private,Alive,8.0,KRAS,Yes,Former,,22.5,Medium,Urban,NHS,9.0,Yes,No,Cardiovascular Disease,8.0
PT08064,Belgium,Flanders,83.0,Male,Prostate,II,2012-06-15,2012-09-19,2012-12-09,Chemotherapy,Public,Deceased,47.0,EGFR,,Former,None,39.5,High,Rural,Statutory Health Insurance,12.0,No,,Obesity,7.0
PT08065,France,Île-de-France,71.0,Female,Colorectal,I,2021-10-10,2022-02-12,2022-06-28,Surgery,Public,,115.0,KRAS,,Current,Moderate,19.7,,,NHS,9.0,Yes,No,Obesity,6.0
PT08066,Netherlands,Utrecht,42.0,Female,Prostate,I,2016-05-31,2016-09-13,2016-11-27,Immunotherapy,Private,Alive,72.0,KRAS,Yes,Never,None,36.7,Medium,Urban,Statutory Health Insurance,,Yes,No,Cardiovascular Disease,10.0
PT08067,Ireland,Munster,56.0,Male,Prostate,,2017-12-18,2018-02-19,2018-08-12,Immunotherapy,Private,Alive,,BRCA1,Yes,Former,,38.5,High,Urban,NHS,13.0,No,No,Cardiovascular Disease,4.0
PT08068,,Southwest Finland,,Female,Ovarian,I,2017-06-11,2017-09-02,2017-12-25,Targeted Therapy,Public,Alive,25.0,None,No,Former,None,35.1,Medium,Urban,,1.0,No,No,Cardiovascular Disease,2.0
PT08069,Netherlands,North Holland,76.0,Female,Breast,I,2023-09-10,2023-11-15,2024-01-13,,Private,Deceased,60.0,KRAS,Yes,Never,Moderate,26.1,Low,Urban,Statutory Health Insurance,9.0,No,No,Diabetes,5.0
PT08070,Spain,Andalusia,44.0,Non-binary,Ovarian,I,2018-11-30,2019-05-12,2019-12-04,Radiation,Private,,71.0,BRCA1,No,Current,None,26.7,,Rural,Statutory Health Insurance,17.0,No,No,Diabetes,4.0
PT08071,Poland,Lesser Poland,56.0,Female,Colorectal,I,2010-01-18,2010-04-08,2010-06-09,Radiation,Private,Alive,89.0,BRCA1,Yes,Former,Moderate,18.7,Medium,Rural,,12.0,,No,Obesity,8.0
PT08072,Germany,North Rhine-Westphalia,59.0,Female,Prostate,II,2020-09-11,,2021-09-22,Targeted Therapy,,Deceased,58.0,None,Yes,Former,Moderate,22.3,Low,Rural,Statutory Health Insurance,18.0,No,No,Diabetes,7.0
PT08073,Portugal,Algarve,65.0,Male,Breast,II,2022-11-30,2023-01-19,2023-10-09,Targeted Therapy,Public,Alive,31.0,EGFR,No,Never,Moderate,38.5,High,Urban,NHS,7.0,Yes,No,Obesity,1.0
,Finland,Pirkanmaa,79.0,Female,Pancreatic,II,2022-12-22,2023-05-23,2023-12-05,Chemotherapy,Public,Alive,24.0,EGFR,No,,,34.0,Medium,Urban,NHS,16.0,No,No,Obesity,10.0
,Ireland,Connacht,38.0,Male,Prostate,IV,2021-02-28,2021-06-03,2022-02-17,Chemotherapy,Private,Alive,68.0,None,No,Former,None,30.1,Low,Urban,Statutory Health Insurance,16.0,No,No,Hypertension,10.0
PT08076,Portugal,Algarve,28.0,Male,Prostate,II,2011-06-26,2011-11-24,2012-08-28,Immunotherapy,Public,Alive,119.0,KRAS,Yes,Current,Moderate,39.8,Medium,,NHS,19.0,No,No,Diabetes,5.0
PT08077,Netherlands,Utrecht,88.0,Female,Pancreatic,III,2010-07-17,2010-10-06,2011-05-22,Immunotherapy,Public,Alive,38.0,KRAS,No,Never,,34.7,High,Urban,Private Insurance,5.0,No,No,Cardiovascular Disease,8.0
PT08078,Sweden,Skåne,24.0,Female,Colorectal,IV,2013-06-19,2013-09-24,2013-11-29,Targeted Therapy,Research Institute,Deceased,116.0,None,Yes,Never,Moderate,31.5,Low,Rural,NHS,17.0,No,,Hypertension,1.0
PT08079,Denmark,Capital Region,45.0,Male,Ovarian,I,2023-05-16,,2023-08-05,Chemotherapy,Public,Alive,103.0,BRCA1,No,Never,None,29.4,Medium,,NHS,13.0,No,No,None,7.0
PT08080,Finland,Pirkanmaa,38.0,Female,,II,2012-09-03,2012-12-12,2013-04-13,Targeted Therapy,Public,Alive,33.0,None,No,Never,None,28.2,High,Urban,NHS,7.0,No,Yes,Obesity,7.0
PT08081,Poland,Masovian,49.0,Female,Pancreatic,II,2011-09-01,2011-11-03,,Targeted Therapy,Research Institute,Alive,53.0,EGFR,,Never,Moderate,36.8,Medium,Urban,NHS,,Yes,No,None,2.0
PT08082,France,,67.0,Male,Lung,II,2011-04-10,2011-06-12,2012-04-12,Radiation,Public,Alive,58.0,BRCA1,No,Never,Moderate,28.6,Medium,Urban,NHS,18.0,No,No,Obesity,8.0
PT08083,Poland,Lesser Poland,35.0,Male,Colorectal,I,2012-10-24,2012-11-12,,Targeted Therapy,Private,Alive,61.0,EGFR,Yes,,None,27.6,Medium,Rural,NHS,18.0,No,No,Hypertension,
PT08084,Austria,Styria,37.0,Male,Ovarian,,2013-06-15,2013-11-11,,Immunotherapy,Public,Alive,54.0,EGFR,No,Former,Moderate,23.1,Medium,Rural,Private Insurance,6.0,No,No,Diabetes,6.0
PT08085,Belgium,Brussels,75.0,Male,Lung,I,2017-02-12,2017-03-23,2017-09-05,Radiation,Public,Deceased,83.0,BRCA1,Yes,Current,Moderate,32.0,Medium,Urban,Private Insurance,7.0,No,,Diabetes,3.0
PT08086,Finland,Uusimaa,40.0,Female,Ovarian,IV,2018-02-04,2018-05-19,2019-01-01,Chemotherapy,Public,Alive,68.0,None,No,Never,Moderate,18.7,Medium,Urban,NHS,18.0,No,No,Cardiovascular Disease,1.0
PT08087,Italy,,50.0,Male,Leukemia,III,2015-07-23,2015-10-14,2016-08-14,Immunotherapy,Research Institute,Lost to Follow-up,,,Yes,Never,None,23.6,Medium,Urban,Statutory Health Insurance,16.0,Yes,No,None,
PT08088,Ireland,Munster,20.0,Male,Lung,II,2019-04-24,2019-09-25,2019-12-27,Surgery,Private,Alive,19.0,EGFR,Yes,Never,None,29.6,Medium,Urban,NHS,6.0,Yes,Yes,Cardiovascular Disease,3.0
PT08089,Switzerland,Zurich,22.0,Female,Ovarian,I,2014-12-23,2015-04-07,2015-09-03,Chemotherapy,Public,Alive,,None,No,Never,Moderate,24.8,Low,Urban,NHS,,Yes,No,Hypertension,7.0
PT08090,Ireland,Munster,44.0,,Pancreatic,II,2010-08-29,2011-02-24,2011-08-07,Surgery,Private,Alive,58.0,KRAS,No,Never,Moderate,29.3,Medium,Rural,Statutory Health Insurance,18.0,Yes,No,Hypertension,5.0
PT08091,France,Provence-Alpes-Côte d'Azur,27.0,Male,Prostate,,2017-10-27,2017-12-26,2018-05-06,Immunotherapy,Public,Alive,31.0,KRAS,No,Never,Heavy,23.2,Medium,Urban,NHS,6.0,Yes,No,Hypertension,7.0
PT08092,France,Provence-Alpes-Côte d'Azur,84.0,Male,Prostate,I,2020-08-17,2020-11-07,2021-02-08,Chemotherapy,Public,Alive,38.0,None,Yes,Never,None,36.9,Medium,Urban,NHS,7.0,Yes,Yes,Hypertension,
PT08093,Austria,Vienna,81.0,Male,Breast,III,2023-12-22,2024-03-23,2025-02-19,Surgery,Public,Alive,74.0,None,Yes,Former,None,20.5,Medium,Urban,NHS,16.0,No,No,Diabetes,4.0
PT08094,Ireland,Connacht,26.0,Female,Pancreatic,II,2014-10-28,2015-02-27,2015-11-09,Surgery,,Deceased,111.0,,No,Former,Moderate,22.9,Medium,Urban,Private Insurance,15.0,No,No,None,9.0
PT08095,Italy,Veneto,26.0,Female,Ovarian,II,2013-03-28,2013-07-30,2014-06-27,Chemotherapy,Public,Alive,71.0,KRAS,,Former,None,28.2,Medium,Urban,,1.0,No,No,Hypertension,10.0
PT08096,Portugal,Algarve,27.0,Female,Colorectal,,2015-09-22,2015-12-28,2016-08-05,Targeted Therapy,Research Institute,Alive,78.0,EGFR,No,Never,Moderate,27.7,Medium,Urban,NHS,18.0,No,No,Diabetes,6.0
PT08097,Austria,Tyrol,38.0,,Breast,I,2015-04-25,2015-09-06,2016-08-23,Immunotherapy,Public,Deceased,24.0,BRCA1,Yes,Former,Heavy,32.8,High,Urban,NHS,8.0,No,No,,7.0
PT08098,Austria,Styria,36.0,Female,Prostate,II,2018-01-01,2018-05-16,2018-12-04,Immunotherapy,Public,Alive,,BRCA1,Yes,Never,None,33.5,Low,Urban,NHS,1.0,Yes,Yes,Hypertension,3.0
PT08099,Germany,North Rhine-Westphalia,30.0,Male,Prostate,II,2011-02-17,2011-06-30,2012-04-27,Radiation,Private,Alive,64.0,,No,Former,Moderate,32.4,Low,Rural,,18.0,No,Yes,Obesity,2.0
,Belgium,Wallonia,68.0,Male,Breast,II,2018-10-29,2019-01-28,2019-09-08,Chemotherapy,Private,Alive,96.0,BRCA1,Yes,Current,,32.0,Medium,Rural,Private Insurance,15.0,No,No,None,6.0
PT08101,Spain,Madrid,30.0,Male,Pancreatic,III,2013-01-08,2013-05-24,2013-10-26,Immunotherapy,,Lost to Follow-up,,None,No,Former,,27.9,Medium,Urban,Private Insurance,9.0,No,Yes,Obesity,1.0
PT08102,,Flanders,60.0,,Leukemia,IV,2018-10-14,2019-01-24,2019-09-14,Surgery,Public,Alive,,KRAS,No,Former,Moderate,27.8,Low,Urban,Private Insurance,12.0,No,No,None,3.0
PT08103,Germany,North Rhine-Westphalia,81.0,Female,Lung,,2013-11-10,2014-04-20,2015-01-04,Chemotherapy,Private,Deceased,106.0,EGFR,No,,Moderate,20.0,High,Rural,NHS,12.0,No,,Obesity,7.0
PT08104,Denmark,Zealand,71.0,Female,Ovarian,II,2010-06-14,2010-11-01,2011-10-28,Surgery,Public,Alive,106.0,None,Yes,Former,None,18.1,Medium,Urban,Statutory Health Insurance,13.0,,,Diabetes,2.0
PT08105,Belgium,Wallonia,85.0,Female,Ovarian,II,2023-02-26,2023-06-07,2023-08-02,Chemotherapy,Public,Alive,83.0,KRAS,No,,None,36.8,,Urban,Statutory Health Insurance,19.0,No,Yes,Cardiovascular Disease,1.0
PT08106,Italy,Veneto,87.0,Male,Leukemia,III,2023-05-02,2023-09-04,2024-01-01,Surgery,Public,Alive,8.0,BRCA1,No,Current,None,18.2,Medium,Rural,Statutory Health Insurance,19.0,No,Yes,None,4.0
PT08107,Denmark,Zealand,86.0,Male,Leukemia,III,2012-12-07,2013-01-13,2013-03-30,Surgery,Private,Alive,63.0,BRCA1,No,Former,Moderate,37.9,High,Rural,NHS,1.0,No,Yes,Hypertension,9.0
PT08108,Germany,,59.0,Female,Leukemia,I,,2013-07-17,2013-12-08,Chemotherapy,Public,Alive,26.0,BRCA1,No,Never,Moderate,22.6,High,Urban,Private Insurance,10.0,No,No,None,1.0
PT08109,Germany,North Rhine-Westphalia,24.0,Female,Ovarian,I,2011-01-03,2011-01-20,2011-03-30,Radiation,Public,Deceased,51.0,None,No,Current,Moderate,,High,Urban,Statutory Health Insurance,15.0,Yes,No,Obesity,7.0
PT08110,France,Île-de-France,,Female,Pancreatic,IV,2016-12-29,2017-02-04,2017-05-13,,Public,Deceased,106.0,None,No,Former,None,38.5,Low,Rural,Private Insurance,16.0,No,No,Cardiovascular Disease,7.0
PT08111,Denmark,Capital Region,56.0,Male,Leukemia,I,2011-09-05,2012-03-02,2012-09-07,Chemotherapy,Public,Alive,45.0,KRAS,No,Never,None,26.4,Medium,Urban,NHS,18.0,No,No,Hypertension,
PT08112,Poland,Masovian,30.0,Female,Lung,III,2010-03-18,2010-08-22,2010-12-29,Targeted Therapy,,Alive,77.0,EGFR,No,Current,Moderate,35.7,Medium,Urban,NHS,2.0,Yes,No,Diabetes,3.0
PT08113,Finland,Southwest Finland,,Male,Colorectal,III,2017-07-17,2017-07-20,,Targeted Therapy,Private,Alive,75.0,None,No,Former,Moderate,30.7,Medium,Rural,Statutory Health Insurance,4.0,No,No,Obesity,4.0
PT08114,Ireland,Munster,72.0,Female,Breast,II,2018-12-17,2019-05-20,2020-02-17,,Public,Lost to Follow-up,,BRCA1,No,Never,,27.5,Low,,Statutory Health Insurance,19.0,No,No,Cardiovascular Disease,8.0
PT08115,Switzerland,Geneva,80.0,Male,Leukemia,III,2021-05-26,2021-09-07,2022-09-01,Chemotherapy,Public,Alive,71.0,EGFR,No,Never,Moderate,21.5,Medium,Urban,Private Insurance,12.0,No,No,,9.0
PT08116,Norway,Vestland,86.0,Female,Leukemia,I,2012-11-17,2013-03-18,2013-05-23,Radiation,Private,Alive,62.0,EGFR,No,Never,Moderate,21.7,Medium,Urban,Statutory Health Insurance,,No,No,Diabetes,3.0
PT08117,Italy,Veneto,32.0,Male,Breast,IV,2018-03-03,2018-04-17,2018-10-06,Surgery,Research Institute,Deceased,11.0,KRAS,No,Never,Moderate,24.8,Medium,Urban,Statutory Health Insurance,3.0,Yes,No,Hypertension,2.0
,Germany,Berlin,30.0,Female,Ovarian,I,2015-10-06,2016-02-17,2017-02-11,,,Alive,64.0,KRAS,Yes,Never,Moderate,37.7,Medium,Urban,NHS,6.0,,No,Cardiovascular Disease,9.0
PT08119,Portugal,Porto,30.0,Female,Ovarian,II,2013-05-11,2013-08-18,2014-06-08,Radiation,Research Institute,,44.0,EGFR,No,Never,,22.1,Medium,Rural,NHS,9.0,No,No,Cardiovascular Disease,9.0
PT08120,Ireland,Munster,26.0,Male,Breast,II,2022-10-07,2023-03-03,2023-06-22,Surgery,Public,Deceased,80.0,EGFR,Yes,Former,None,,Low,Urban,NHS,19.0,No,No,Cardiovascular Disease,4.0
PT08121,Austria,Vienna,36.0,Male,Ovarian,III,2018-08-21,2018-09-03,,Targeted Therapy,Private,Alive,74.0,KRAS,No,Never,Moderate,20.4,Medium,,Statutory Health Insurance,9.0,No,Yes,None,7.0
PT08122,Ireland,Munster,,Female,Ovarian,I,2013-06-28,2013-08-24,2014-07-30,Radiation,,Alive,79.0,None,No,Never,,35.9,High,Rural,Private Insurance,3.0,No,,None,1.0
PT08123,Germany,Berlin,33.0,Male,Colorectal,II,2016-07-17,2016-09-28,2017-03-13,Surgery,Public,Alive,,EGFR,Yes,Never,None,19.5,High,Urban,Statutory Health Insurance,2.0,Yes,No,Hypertension,4.0
PT08124,Austria,Tyrol,82.0,Male,Prostate,I,2022-06-01,2022-08-23,2023-08-07,Immunotherapy,Public,Alive,,EGFR,No,Never,Moderate,22.9,Low,Urban,Statutory Health Insurance,19.0,Yes,No,Cardiovascular Disease,6.0
PT08125,Netherlands,Utrecht,83.0,Non-binary,Colorectal,II,2012-05-21,2012-08-14,2012-10-23,Targeted Therapy,Private,Alive,108.0,EGFR,No,Former,Moderate,23.1,Medium,Rural,Statutory Health Insurance,10.0,No,No,Obesity,3.0
PT08126,Poland,Masovian,84.0,Female,Prostate,III,,2015-11-06,2016-09-01,Surgery,Public,Alive,43.0,BRCA1,No,Never,Moderate,36.1,Medium,Rural,NHS,4.0,No,No,Hypertension,2.0
PT08127,,Provence-Alpes-Côte d'Azur,53.0,Male,Pancreatic,I,2015-12-21,2016-01-02,2016-03-07,Immunotherapy,Public,Alive,76.0,BRCA1,,Current,Moderate,30.9,Medium,,Statutory Health Insurance,12.0,No,No,Diabetes,1.0
PT08128,Portugal,Algarve,28.0,Female,Lung,III,2020-10-15,2021-03-21,2021-06-23,Radiation,Private,Deceased,105.0,,Yes,Current,,32.0,Medium,Rural,Statutory Health Insurance,11.0,No,No,Hypertension,7.0
PT08129,Ireland,Munster,56.0,Female,Ovarian,III,2016-10-12,2017-01-17,2017-03-20,Immunotherapy,Public,Deceased,116.0,KRAS,Yes,Never,Heavy,36.0,Medium,Urban,NHS,6.0,Yes,No,Hypertension,5.0
PT08130,Spain,Catalonia,49.0,Female,Colorectal,IV,2014-04-17,2014-06-21,2014-09-23,Targeted Therapy,Public,,87.0,None,Yes,Current,None,34.8,Medium,Urban,Private Insurance,4.0,No,No,Cardiovascular Disease,10.0
PT08131,Ireland,Dublin,60.0,Female,Lung,III,2016-05-04,2016-06-22,2016-11-21,Chemotherapy,Research Institute,Alive,79.0,None,No,Never,None,18.4,Low,Urban,Private Insurance,6.0,,No,Hypertension,9.0
PT08132,Denmark,Capital Region,64.0,Female,,II,2015-11-25,2016-03-31,,Radiation,Public,Alive,62.0,None,No,Never,None,25.0,Medium,Urban,Private Insurance,1.0,No,No,Hypertension,3.0
PT08133,Switzerland,Zurich,66.0,Male,Colorectal,II,2021-05-24,2021-10-03,2022-04-26,Immunotherapy,Private,Alive,12.0,BRCA1,Yes,Current,Moderate,24.3,High,Rural,NHS,18.0,No,No,Cardiovascular Disease,8.0
PT08134,Finland,Uusimaa,,Female,Pancreatic,IV,2012-12-11,2013-01-08,2013-04-21,Surgery,Public,Alive,41.0,KRAS,No,Former,None,35.6,Medium,Urban,NHS,10.0,No,No,Hypertension,6.0
PT08135,Belgium,Wallonia,33.0,Male,Breast,IV,2015-07-29,2015-09-17,2016-03-20,Chemotherapy,Research Institute,Alive,100.0,KRAS,No,Never,Moderate,18.2,Medium,Rural,NHS,7.0,No,Yes,None,7.0
PT08136,Italy,,67.0,Male,Pancreatic,II,2011-01-25,2011-02-06,2011-03-23,Chemotherapy,Private,Deceased,55.0,None,No,Never,None,18.4,High,Urban,Statutory Health Insurance,4.0,No,No,,9.0
PT08137,France,Auvergne-Rhône-Alpes,,Female,,IV,2023-03-18,2023-06-09,2023-08-03,Radiation,Public,Alive,77.0,None,Yes,Former,Moderate,22.4,Medium,Rural,Private Insurance,16.0,No,No,None,10.0
PT08138,Germany,North Rhine-Westphalia,53.0,Male,Leukemia,III,2017-06-27,2017-07-15,2018-02-07,Immunotherapy,Research Institute,Alive,45.0,EGFR,No,Never,None,23.1,Medium,Rural,NHS,14.0,No,No,Cardiovascular Disease,10.0
PT08139,Poland,Masovian,65.0,Female,Breast,IV,2018-02-04,2018-05-22,2018-08-13,Targeted Therapy,,Alive,79.0,KRAS,No,Never,None,21.6,Low,Urban,NHS,18.0,,No,Cardiovascular Disease,2.0
PT08140,Germany,North Rhine-Westphalia,78.0,Female,Ovarian,III,2020-07-29,2020-11-17,2021-07-10,Immunotherapy,Public,Alive,45.0,BRCA1,No,Never,Heavy,19.9,Low,Urban,Statutory Health Insurance,3.0,Yes,No,None,2.0
PT08141,Denmark,Zealand,89.0,Male,Pancreatic,IV,2019-10-05,2020-01-24,2020-07-12,Immunotherapy,Public,Deceased,56.0,BRCA1,Yes,Never,None,32.5,Medium,Urban,Private Insurance,13.0,Yes,No,Cardiovascular Disease,1.0
PT08142,Norway,Trøndelag,,Male,Leukemia,IV,2021-03-01,2021-07-13,2022-02-20,Radiation,Public,Alive,97.0,None,Yes,Never,Moderate,21.5,Low,Rural,NHS,14.0,Yes,No,Obesity,4.0
,France,Auvergne-Rhône-Alpes,43.0,Female,Prostate,I,2017-01-12,2017-03-21,2018-02-04,Radiation,Private,Alive,95.0,KRAS,No,Never,None,32.0,Low,Rural,Private Insurance,10.0,No,No,None,1.0
PT08144,Ireland,,,Female,Leukemia,IV,2010-12-28,2011-03-14,2011-11-05,Surgery,Public,Deceased,25.0,BRCA1,No,Never,None,28.1,Low,Urban,Statutory Health Insurance,1.0,No,No,None,10.0
PT08145,Portugal,Algarve,23.0,Female,Ovarian,II,2010-02-28,,2010-05-20,Targeted Therapy,Public,Alive,7.0,EGFR,No,Former,Heavy,36.9,Medium,Urban,Private Insurance,7.0,No,Yes,None,3.0
PT08146,Spain,Madrid,20.0,Female,Prostate,II,2022-07-17,2022-12-20,2023-06-26,Radiation,Private,Deceased,115.0,EGFR,No,Former,,23.9,Low,Urban,NHS,,Yes,No,None,1.0
PT08147,Switzerland,Bern,53.0,Male,Leukemia,III,2013-01-29,2013-03-10,2014-01-01,Surgery,Public,,92.0,EGFR,Yes,Former,Moderate,39.7,Medium,Urban,Private Insurance,19.0,No,Yes,Obesity,2.0
PT08148,Germany,Berlin,28.0,Male,Leukemia,III,2014-11-16,2015-02-22,2015-05-31,Chemotherapy,Public,Alive,28.0,None,Yes,Never,Moderate,30.2,Medium,,NHS,16.0,Yes,No,Hypertension,5.0
,Spain,Andalusia,82.0,Female,Lung,IV,2010-12-06,2011-01-23,2011-10-17,Surgery,Public,Alive,86.0,KRAS,No,Never,Moderate,39.2,Low,Rural,Private Insurance,18.0,,No,None,3.0
PT08150,Finland,Southwest Finland,29.0,Male,Lung,II,2022-07-18,2022-12-27,2023-02-26,Targeted Therapy,Public,Alive,46.0,BRCA1,,,Moderate,32.3,Medium,Urban,NHS,17.0,Yes,No,None,4.0
PT08151,Switzerland,Zurich,29.0,Female,Ovarian,II,2017-06-29,2017-09-29,2018-07-21,Surgery,Public,Alive,62.0,KRAS,No,Never,Moderate,23.2,Low,Urban,Statutory Health Insurance,13.0,No,Yes,Hypertension,8.0
PT08152,Denmark,Zealand,69.0,Male,Breast,I,2012-11-05,2013-04-16,2013-09-25,Surgery,,,26.0,BRCA1,Yes,Never,None,24.6,Medium,Urban,Private Insurance,1.0,No,No,Obesity,8.0
PT08153,Netherlands,Utrecht,63.0,Female,Pancreatic,II,2010-05-01,2010-06-27,2011-05-05,Radiation,Private,Alive,44.0,None,No,Former,Moderate,21.5,Low,Urban,Statutory Health Insurance,9.0,No,No,None,7.0
PT08154,Sweden,Västra Götaland,67.0,Female,Ovarian,III,2020-06-10,2020-07-09,2021-01-21,Targeted Therapy,Public,Alive,31.0,KRAS,No,Current,None,27.4,Medium,Urban,Private Insurance,,Yes,No,Cardiovascular Disease,5.0
PT08155,Switzerland,Bern,,Female,Lung,II,2012-01-15,2012-04-14,2013-02-14,Surgery,Public,Alive,100.0,BRCA1,Yes,Never,Moderate,25.2,Low,Urban,Private Insurance,16.0,No,Yes,Diabetes,7.0
PT08156,Portugal,Lisbon,43.0,Female,Prostate,II,2022-04-09,2022-08-11,2022-09-25,Immunotherapy,Public,Alive,77.0,KRAS,No,Never,None,23.5,High,Rural,,18.0,No,No,None,7.0
PT08157,Ireland,,77.0,Female,Lung,I,2022-06-10,2022-09-16,2023-07-27,Surgery,Public,Alive,56.0,EGFR,No,Former,Moderate,22.4,Medium,Urban,Private Insurance,8.0,No,No,None,3.0
PT08158,Norway,Oslo,83.0,Non-binary,Breast,III,2018-01-30,,2018-11-13,Chemotherapy,Research Institute,Deceased,76.0,KRAS,Yes,Former,Moderate,36.4,Low,Urban,Statutory Health Insurance,15.0,No,,,3.0
PT08159,Belgium,Wallonia,75.0,Female,Colorectal,I,2020-10-29,2021-01-30,2021-06-10,Chemotherapy,Public,Alive,26.0,None,No,Never,None,36.5,High,Urban,,19.0,No,No,Hypertension,10.0
PT08160,Ireland,,31.0,Female,Prostate,III,2012-10-19,2013-02-03,2013-07-07,Surgery,Private,Alive,63.0,BRCA1,Yes,Never,,29.9,,Urban,NHS,7.0,Yes,Yes,Diabetes,1.0
PT08161,Belgium,,54.0,Female,Colorectal,II,2023-08-01,2023-11-13,2024-02-21,Surgery,Private,Alive,55.0,BRCA1,Yes,Never,Moderate,31.3,Medium,,NHS,9.0,No,No,,6.0
PT08162,Italy,Sicily,25.0,Female,Prostate,I,2019-03-16,2019-08-07,2020-04-02,Immunotherapy,Public,Deceased,28.0,KRAS,No,Current,Moderate,27.2,Medium,Urban,NHS,10.0,No,No,Cardiovascular Disease,10.0
PT08163,Switzerland,Zurich,84.0,Male,Pancreatic,IV,2014-11-11,2015-02-11,2015-06-03,Surgery,Private,Deceased,82.0,None,No,Current,Heavy,31.8,Medium,Urban,,11.0,No,No,Obesity,10.0
PT08164,Italy,Veneto,79.0,Male,Pancreatic,II,,2015-08-29,2016-04-23,,Private,Alive,47.0,KRAS,Yes,Current,Moderate,35.3,Medium,Urban,NHS,19.0,No,,Cardiovascular Disease,4.0
PT08165,Sweden,Skåne,87.0,Male,Pancreatic,II,2018-04-21,2018-07-17,2018-08-29,Targeted Therapy,Private,Alive,47.0,None,No,Current,Moderate,,Low,Urban,NHS,17.0,No,No,Hypertension,1.0
PT08166,Portugal,Lisbon,48.0,Male,Breast,III,2017-04-09,2017-07-11,2018-06-02,Immunotherapy,Public,Deceased,97.0,None,No,Never,None,35.4,Medium,Urban,Statutory Health Insurance,2.0,No,No,Diabetes,7.0
PT08167,Denmark,Capital Region,57.0,Male,Lung,III,2011-08-11,2011-11-03,2012-02-14,Surgery,Public,Alive,,BRCA1,Yes,Never,None,37.6,Medium,Urban,NHS,6.0,No,No,Cardiovascular Disease,4.0
PT08168,Sweden,Stockholm,,Male,Colorectal,III,2015-07-24,2015-10-13,2016-04-28,Radiation,Public,Alive,,EGFR,No,Never,Moderate,39.8,Medium,Urban,NHS,4.0,No,No,None,6.0
PT08169,France,Provence-Alpes-Côte d'Azur,27.0,Female,Colorectal,III,2011-01-18,2011-06-21,2012-01-08,Surgery,Public,Alive,101.0,KRAS,No,Never,None,39.2,High,Urban,Private Insurance,5.0,No,No,Diabetes,5.0
PT08170,Spain,Andalusia,82.0,Female,Lung,II,2011-11-21,2011-12-30,2012-12-22,Immunotherapy,Public,Deceased,25.0,BRCA1,No,,,23.5,Low,Rural,Private Insurance,9.0,No,No,None,3.0
,Poland,Silesian,32.0,Male,Breast,II,2010-07-23,2010-08-25,2011-06-22,Immunotherapy,Public,Alive,67.0,KRAS,No,Never,Moderate,31.4,High,Rural,NHS,,No,No,Hypertension,7.0
PT08172,Italy,Sicily,46.0,Male,Lung,I,2021-03-05,2021-05-22,2021-10-24,Chemotherapy,Public,Alive,18.0,EGFR,Yes,Never,None,25.9,Medium,Urban,Statutory Health Insurance,16.0,No,No,Diabetes,8.0
PT08173,Sweden,Stockholm,37.0,Female,Leukemia,IV,2021-04-14,2021-05-15,2021-07-07,Chemotherapy,Public,Alive,47.0,BRCA1,Yes,Never,Moderate,33.4,Medium,Rural,Private Insurance,7.0,No,No,None,3.0
PT08174,Norway,Vestland,37.0,Female,Leukemia,IV,2015-02-20,2015-03-13,2016-01-13,Surgery,Public,Alive,71.0,None,No,Former,Moderate,22.4,Low,Urban,Private Insurance,8.0,No,Yes,Hypertension,5.0
PT08175,,Central Denmark,81.0,Female,Pancreatic,II,2014-08-28,2015-02-22,2015-09-26,Targeted Therapy,Public,Alive,48.0,None,Yes,Never,Moderate,24.1,,Urban,Statutory Health Insurance,14.0,Yes,No,Diabetes,5.0
PT08176,Portugal,Lisbon,33.0,Non-binary,Leukemia,I,2014-05-10,2014-09-15,2015-09-06,Radiation,Public,Deceased,88.0,BRCA1,No,Former,Moderate,39.3,Low,Urban,Private Insurance,5.0,Yes,No,Cardiovascular Disease,3.0
PT08177,Austria,Tyrol,30.0,Non-binary,Colorectal,I,,2012-09-28,2013-03-11,Chemotherapy,Public,Alive,54.0,BRCA1,Yes,Never,Moderate,31.4,High,Rural,NHS,15.0,No,No,Cardiovascular Disease,9.0
PT08178,Denmark,Zealand,36.0,Male,Pancreatic,III,2021-12-18,2022-03-18,2022-09-26,Chemotherapy,Public,Alive,84.0,None,No,Never,None,22.4,Medium,Urban,Statutory Health Insurance,7.0,No,No,,5.0
PT08179,Denmark,Central Denmark,70.0,Male,Colorectal,I,2015-08-27,2016-01-15,2016-11-05,Targeted Therapy,Public,,96.0,None,Yes,Never,Moderate,26.7,Medium,,Private Insurance,18.0,No,No,Hypertension,1.0
PT08180,Sweden,Stockholm,33.0,Female,Breast,III,2014-01-27,2014-03-26,2014-10-07,Immunotherapy,Public,Alive,17.0,KRAS,Yes,Current,Heavy,25.9,Low,Urban,NHS,9.0,No,Yes,None,6.0
PT08181,,Algarve,76.0,Male,Prostate,IV,2016-06-03,2016-11-22,2017-10-05,Surgery,Public,Deceased,45.0,BRCA1,,Current,Moderate,23.1,High,Urban,NHS,19.0,No,Yes,None,4.0
,Belgium,Flanders,25.0,Female,Lung,,2017-03-25,2017-04-26,2018-04-08,Surgery,Public,Alive,79.0,BRCA1,No,Former,Moderate,19.3,High,Rural,Statutory Health Insurance,9.0,No,No,Hypertension,8.0
PT08183,Finland,Southwest Finland,76.0,Female,Ovarian,I,2012-11-16,2013-01-14,2013-05-21,Radiation,Public,Deceased,97.0,BRCA1,No,Former,None,39.5,Medium,Rural,Statutory Health Insurance,4.0,,Yes,Obesity,9.0
PT08184,Portugal,Porto,23.0,Female,Ovarian,IV,2015-08-06,2015-11-17,2016-08-24,Targeted Therapy,Private,Alive,73.0,BRCA1,Yes,Former,None,26.2,High,Urban,Private Insurance,,No,No,Hypertension,6.0
PT08185,Austria,Styria,30.0,,Ovarian,III,2021-09-18,2021-12-08,2022-04-04,Targeted Therapy,Public,Alive,9.0,BRCA1,Yes,Never,None,30.0,,Urban,NHS,,No,,None,1.0
PT08186,Sweden,Stockholm,30.0,Female,Prostate,,2019-10-28,2020-04-18,2020-09-14,Targeted Therapy,,Alive,97.0,None,No,Former,Moderate,26.9,High,Urban,Private Insurance,18.0,Yes,No,Cardiovascular Disease,4.0
PT08187,Finland,Uusimaa,27.0,Female,Colorectal,II,2019-04-27,,2020-01-08,Immunotherapy,,Alive,47.0,KRAS,Yes,Former,None,33.6,Medium,Urban,Statutory Health Insurance,16.0,No,No,,7.0
PT08188,Sweden,Stockholm,78.0,Female,,III,2014-05-27,2014-07-27,2014-10-05,Targeted Therapy,Public,Alive,113.0,None,Yes,Former,Moderate,34.4,Medium,Urban,Private Insurance,2.0,No,No,Diabetes,3.0
PT08189,Austria,Styria,40.0,Male,Colorectal,IV,2022-05-13,2022-06-22,2022-09-06,Immunotherapy,,Deceased,98.0,EGFR,Yes,Current,Moderate,37.8,Medium,Urban,Statutory Health Insurance,14.0,No,Yes,Cardiovascular Disease,3.0
PT08190,Netherlands,North Holland,84.0,Female,Breast,I,2023-06-01,,2024-06-04,Surgery,Private,Alive,17.0,EGFR,No,Never,Moderate,25.0,Medium,Rural,Private Insurance,10.0,No,No,Hypertension,
PT08191,Norway,Vestland,43.0,Female,Pancreatic,I,2022-06-01,2022-11-10,2023-05-28,Immunotherapy,Research Institute,Alive,118.0,None,No,Never,None,39.6,Medium,,Private Insurance,7.0,No,,Hypertension,10.0
PT08192,Italy,Lombardy,49.0,Female,,II,2012-10-17,2013-02-07,2013-03-12,Surgery,Public,Alive,27.0,EGFR,No,Never,None,35.5,Medium,Urban,NHS,9.0,No,Yes,Diabetes,5.0
PT08193,Denmark,Zealand,76.0,Female,Colorectal,IV,2011-06-07,2011-09-04,2011-10-04,Radiation,Public,Alive,73.0,None,,Former,Moderate,22.2,Medium,Rural,NHS,3.0,No,No,Diabetes,2.0
PT08194,Austria,Tyrol,36.0,Female,Leukemia,,2011-07-25,2011-08-06,2012-05-28,Targeted Therapy,Research Institute,Alive,94.0,BRCA1,No,Never,None,29.1,Medium,Urban,NHS,18.0,No,No,Cardiovascular Disease,10.0
PT08195,Spain,Madrid,78.0,Male,Ovarian,,2023-03-03,2023-07-24,2023-12-12,Radiation,Public,Alive,119.0,None,No,Never,Moderate,25.5,Medium,Urban,Private Insurance,1.0,No,Yes,Hypertension,9.0
PT08196,Italy,Sicily,50.0,Male,Leukemia,II,2019-02-22,2019-06-09,2019-07-19,Targeted Therapy,Public,Alive,77.0,None,,Never,Heavy,29.3,Low,Urban,NHS,12.0,No,No,Hypertension,3.0
,France,Provence-Alpes-Côte d'Azur,83.0,Female,Colorectal,IV,2021-07-10,2021-07-19,2021-08-31,Radiation,Public,Alive,98.0,KRAS,No,Current,Moderate,24.8,Medium,Rural,NHS,15.0,No,No,None,6.0
PT08198,Portugal,Algarve,67.0,Female,Prostate,III,2016-09-18,2017-02-13,2017-06-13,Chemotherapy,Public,,76.0,EGFR,No,Never,None,23.3,,Rural,NHS,13.0,No,No,None,9.0
PT08199,Belgium,Brussels,42.0,Male,Pancreatic,IV,2019-07-06,2019-10-03,2020-06-08,Chemotherapy,Private,Deceased,13.0,,Yes,Never,Moderate,34.3,Low,Urban,NHS,6.0,No,No,Hypertension,3.0
PT08200,France,Provence-Alpes-Côte d'Azur,89.0,Female,,IV,,2019-01-10,2019-10-15,Immunotherapy,Private,,23.0,KRAS,No,Never,None,29.4,Low,Rural,NHS,19.0,No,No,Cardiovascular Disease,1.0
PT08201,Denmark,Zealand,49.0,Male,Breast,I,2012-04-26,2012-06-14,2012-09-24,Radiation,Research Institute,Alive,95.0,BRCA1,No,Never,Moderate,30.1,Medium,Urban,NHS,12.0,No,No,Obesity,4.0
PT08202,,Provence-Alpes-Côte d'Azur,74.0,Male,Ovarian,III,2019-04-16,2019-04-30,2020-04-08,Targeted Therapy,Public,Deceased,65.0,BRCA1,No,Never,Moderate,27.3,Medium,Urban,Private Insurance,5.0,No,,Cardiovascular Disease,10.0
PT08203,Norway,Oslo,,Female,Colorectal,I,2013-08-27,2014-01-07,2014-07-01,Surgery,Private,Alive,78.0,KRAS,No,Former,Moderate,38.1,Medium,Rural,Statutory Health Insurance,17.0,No,No,,1.0
PT08204,Poland,Silesian,31.0,Male,Breast,III,2017-12-07,2018-04-12,2018-07-11,Immunotherapy,Public,Alive,66.0,BRCA1,No,Former,Moderate,19.0,Medium,Urban,Statutory Health Insurance,12.0,No,Yes,Hypertension,9.0
PT08205,Poland,Masovian,79.0,Male,Lung,III,2015-03-27,2015-05-14,2016-03-18,Immunotherapy,Private,Alive,105.0,EGFR,No,Former,Moderate,35.2,Low,Urban,Statutory Health Insurance,8.0,No,No,Diabetes,
,Belgium,,71.0,Male,Breast,IV,2010-10-27,2010-12-23,2011-02-17,Chemotherapy,Public,Deceased,36.0,KRAS,Yes,Former,Moderate,35.7,Medium,Urban,Statutory Health Insurance,16.0,Yes,No,Hypertension,4.0
PT08207,Austria,Styria,46.0,Female,Leukemia,IV,2023-07-30,2023-10-31,2024-09-15,Radiation,Private,Deceased,118.0,EGFR,No,Never,None,26.6,High,Rural,NHS,11.0,No,No,Hypertension,5.0
PT08208,Ireland,Dublin,31.0,Male,Colorectal,I,2012-12-21,2013-02-19,2013-04-11,Radiation,Private,Deceased,11.0,None,Yes,Never,,19.5,Medium,,Private Insurance,11.0,Yes,No,None,2.0
,Norway,Vestland,32.0,Male,Lung,I,2010-03-25,2010-06-14,2010-07-24,Immunotherapy,Private,Alive,105.0,,Yes,Current,,35.2,Low,Urban,NHS,14.0,No,No,Cardiovascular Disease,5.0
PT08210,Austria,Styria,81.0,Male,Ovarian,II,2021-02-08,2021-03-23,2021-08-23,Chemotherapy,Private,Alive,84.0,BRCA1,No,Never,None,27.9,Low,Urban,Private Insurance,7.0,Yes,Yes,Diabetes,6.0
PT08211,Ireland,Dublin,48.0,Male,Breast,IV,2013-10-08,2013-12-29,2014-05-31,Surgery,Public,,23.0,EGFR,Yes,Former,Moderate,31.6,Medium,Urban,NHS,12.0,,No,Cardiovascular Disease,2.0
PT08212,Netherlands,Utrecht,54.0,Male,Ovarian,III,2014-08-20,2014-11-19,2015-06-22,Chemotherapy,Private,Alive,118.0,EGFR,No,Never,None,,Medium,Urban,NHS,12.0,No,No,Obesity,6.0
PT08213,Belgium,Wallonia,79.0,Male,Leukemia,IV,2019-10-15,2019-12-18,2020-04-23,Radiation,Private,Alive,59.0,None,No,Never,Moderate,21.7,Low,Rural,NHS,3.0,No,No,Obesity,
PT08214,Denmark,Zealand,48.0,Male,Pancreatic,III,2012-07-12,,2012-10-27,,Public,Alive,45.0,,No,Former,Heavy,26.0,High,Rural,Statutory Health Insurance,11.0,No,No,Obesity,
PT08215,Netherlands,North Holland,50.0,Female,Prostate,I,2023-08-26,2023-08-27,2024-02-04,Immunotherapy,,Alive,56.0,BRCA1,No,Never,Moderate,33.2,Medium,Rural,NHS,2.0,No,Yes,Diabetes,2.0
PT08216,Poland,Masovian,80.0,Male,Breast,I,2014-02-07,2014-06-05,2015-01-14,Surgery,Public,Alive,113.0,KRAS,No,Never,None,25.5,Medium,Urban,NHS,3.0,No,No,Diabetes,5.0
PT08217,Finland,Southwest Finland,21.0,Male,Ovarian,I,2023-09-20,2023-11-23,2024-11-07,Immunotherapy,Private,Alive,79.0,BRCA1,No,Never,Heavy,26.1,High,Urban,NHS,15.0,No,No,Obesity,9.0
PT08218,Austria,Styria,52.0,Male,Leukemia,III,2015-07-20,2015-09-30,2016-03-23,Chemotherapy,Public,Alive,77.0,EGFR,Yes,Former,Moderate,34.3,Low,Urban,Private Insurance,7.0,Yes,No,None,4.0
PT08219,Denmark,Zealand,81.0,Male,Pancreatic,IV,2022-08-04,2022-10-28,2023-10-07,Surgery,Private,Alive,94.0,,Yes,Never,None,34.4,High,Rural,NHS,13.0,No,No,None,6.0
PT08220,Germany,Bavaria,78.0,Female,Pancreatic,II,2020-08-06,2020-08-30,2021-07-04,Targeted Therapy,Public,Deceased,103.0,KRAS,No,,None,31.2,Medium,Urban,Statutory Health Insurance,,No,No,Hypertension,6.0
PT08221,Finland,Pirkanmaa,59.0,Male,Leukemia,IV,2023-02-11,,2024-04-05,Radiation,Public,Alive,41.0,None,No,Never,Heavy,27.1,Low,Urban,Private Insurance,19.0,,No,Diabetes,6.0
PT08222,Germany,Berlin,68.0,Male,Leukemia,II,2015-11-17,2016-01-15,2016-10-14,Immunotherapy,Public,,,None,No,Former,None,26.5,Medium,Rural,NHS,17.0,No,No,None,2.0
PT08223,France,Auvergne-Rhône-Alpes,51.0,Male,Ovarian,II,2014-09-22,2015-01-02,2015-09-22,Surgery,Public,Alive,11.0,,Yes,Current,Moderate,24.4,High,Rural,Private Insurance,4.0,Yes,No,Hypertension,5.0
PT08224,Finland,,57.0,Female,Leukemia,II,2023-09-15,2024-02-24,,Surgery,Public,Alive,28.0,BRCA1,No,Former,Heavy,19.7,High,Rural,Private Insurance,3.0,,No,Hypertension,5.0
PT08225,Portugal,Algarve,,Male,Prostate,II,2017-09-11,,2018-09-27,Targeted Therapy,Research Institute,Alive,53.0,BRCA1,No,Current,None,19.0,High,Urban,Statutory Health Insurance,15.0,No,No,Cardiovascular Disease,3.0
PT08226,Norway,Trøndelag,73.0,Female,Colorectal,IV,2016-04-13,2016-08-05,2017-02-18,Chemotherapy,Public,Alive,105.0,None,No,Never,Heavy,38.3,Low,Rural,NHS,3.0,,Yes,Cardiovascular Disease,3.0
PT08227,Netherlands,Utrecht,32.0,Male,Leukemia,II,2016-05-01,2016-05-06,2016-11-30,Targeted Therapy,Public,Deceased,25.0,None,No,Never,Moderate,20.8,Low,Urban,NHS,8.0,No,Yes,Cardiovascular Disease,5.0
PT08228,Denmark,Central Denmark,58.0,Male,Colorectal,I,2014-05-12,2014-08-29,2015-05-18,Surgery,Private,Alive,66.0,BRCA1,Yes,Current,None,31.5,Medium,Rural,NHS,8.0,No,Yes,None,4.0
PT08229,,Porto,42.0,Female,Pancreatic,III,2011-03-01,2011-07-03,2011-12-30,Radiation,Public,Alive,92.0,BRCA1,Yes,Never,None,24.0,Medium,Urban,Private Insurance,7.0,No,,Cardiovascular Disease,4.0
PT08230,Italy,Sicily,33.0,Female,Prostate,IV,2023-05-23,2023-09-19,2024-03-07,Surgery,Private,Alive,60.0,None,No,,Moderate,,Medium,Urban,Private Insurance,5.0,No,No,Obesity,2.0
PT08231,Belgium,Brussels,36.0,Female,Ovarian,III,,2016-08-04,2017-05-17,Surgery,Private,Alive,92.0,,Yes,Never,Moderate,33.3,Medium,Urban,NHS,11.0,Yes,Yes,,5.0
PT08232,Spain,Catalonia,43.0,,Pancreatic,I,2017-10-10,2017-12-21,2018-12-17,Surgery,Private,Deceased,41.0,BRCA1,No,Never,Moderate,35.3,Medium,Urban,NHS,18.0,No,No,Obesity,7.0
PT08233,Netherlands,South Holland,77.0,Female,Prostate,I,2023-07-15,2023-10-17,2024-04-01,Targeted Therapy,Private,Alive,115.0,KRAS,No,Current,,20.0,Medium,Rural,Statutory Health Insurance,4.0,No,,Obesity,5.0
PT08234,Belgium,Flanders,82.0,Male,Pancreatic,I,2010-03-03,2010-07-19,2011-03-29,Targeted Therapy,,Alive,50.0,BRCA1,Yes,Current,Moderate,20.3,Low,Urban,NHS,10.0,No,No,Cardiovascular Disease,9.0
PT08235,France,,53.0,Female,Lung,I,2023-11-07,2024-01-31,2024-03-22,Immunotherapy,Private,Deceased,91.0,BRCA1,Yes,Never,Moderate,35.8,,Urban,Statutory Health Insurance,9.0,Yes,Yes,Diabetes,7.0
,Poland,Lesser Poland,70.0,Female,Lung,IV,2019-09-29,2020-03-21,2020-07-17,Immunotherapy,Research Institute,Alive,92.0,BRCA1,Yes,Former,None,38.5,,Urban,Private Insurance,12.0,Yes,No,None,2.0
,Norway,Oslo,,Male,Leukemia,I,2014-11-20,2015-01-11,2015-11-03,Immunotherapy,Private,Deceased,47.0,None,No,Former,Moderate,23.7,Medium,Urban,Private Insurance,15.0,No,No,Cardiovascular Disease,3.0
PT08238,France,Auvergne-Rhône-Alpes,40.0,Female,Colorectal,II,2017-12-26,2018-05-07,2018-08-19,Surgery,Private,Alive,78.0,KRAS,Yes,Never,Moderate,24.8,Low,Urban,NHS,2.0,No,Yes,Cardiovascular Disease,7.0
PT08239,Denmark,Zealand,56.0,Female,Pancreatic,,,2019-06-18,2019-10-15,Immunotherapy,Public,Alive,34.0,EGFR,Yes,Never,None,38.2,Low,Urban,Private Insurance,9.0,Yes,No,Cardiovascular Disease,2.0
PT08240,Finland,Southwest Finland,26.0,Male,Prostate,,2011-05-30,2011-09-12,2012-07-09,Immunotherapy,Research Institute,Alive,26.0,None,No,Never,Heavy,35.4,Low,Urban,Private Insurance,14.0,No,No,None,6.0
PT08241,Spain,Madrid,32.0,,Breast,I,2023-04-06,2023-10-01,2024-04-04,Chemotherapy,Public,Alive,107.0,KRAS,No,Former,Heavy,23.2,High,Rural,Statutory Health Insurance,14.0,Yes,No,None,4.0
PT08242,Switzerland,Geneva,49.0,Female,Lung,II,2022-11-26,2023-04-26,2023-10-30,Targeted Therapy,Public,Alive,67.0,EGFR,Yes,Never,None,30.8,High,,Private Insurance,9.0,No,No,None,3.0
PT08243,Poland,Lesser Poland,50.0,Male,Lung,I,2010-04-09,2010-08-13,,Immunotherapy,Public,Deceased,42.0,,No,Former,Moderate,24.9,Medium,Rural,Statutory Health Insurance,6.0,No,No,None,
PT08244,Norway,Oslo,24.0,Female,Pancreatic,I,2010-11-19,2011-03-12,2011-06-14,Targeted Therapy,Public,Alive,42.0,KRAS,No,Current,Moderate,27.7,Low,Urban,Private Insurance,17.0,No,Yes,None,4.0
PT08245,Norway,Vestland,51.0,Male,Ovarian,II,2017-03-24,2017-04-23,2017-05-28,Radiation,Private,Alive,35.0,None,No,Current,Moderate,33.5,Medium,Rural,Private Insurance,2.0,No,No,Obesity,8.0
PT08246,Italy,Lombardy,35.0,Female,Breast,II,2021-08-21,2021-12-22,2022-04-07,Chemotherapy,Public,Alive,72.0,BRCA1,Yes,Current,None,23.5,Low,Urban,NHS,14.0,No,No,Diabetes,3.0
PT08247,Portugal,Lisbon,,Female,Colorectal,I,2022-09-12,2022-12-09,2023-04-08,Radiation,Public,Deceased,38.0,KRAS,No,Never,None,19.6,,Urban,Statutory Health Insurance,15.0,No,No,Diabetes,8.0
PT08248,Denmark,Capital Region,83.0,Female,Colorectal,II,2020-01-31,2020-02-25,2021-01-10,Targeted Therapy,Public,Alive,119.0,,No,Current,Moderate,39.8,High,Rural,Statutory Health Insurance,12.0,No,No,Diabetes,2.0
PT08249,Poland,Masovian,63.0,Male,Colorectal,I,2021-08-12,2021-09-11,2022-02-15,Targeted Therapy,Public,Deceased,66.0,None,Yes,Current,None,27.4,Low,Urban,Statutory Health Insurance,10.0,No,No,Obesity,5.0
,,Västra Götaland,59.0,Female,Leukemia,IV,2018-02-21,,2018-12-31,Radiation,,Deceased,,None,No,Former,Moderate,34.1,Medium,Urban,NHS,18.0,Yes,No,None,4.0
PT08251,Portugal,Porto,56.0,Male,Leukemia,II,2014-02-06,2014-04-21,2014-12-31,Immunotherapy,Private,Alive,108.0,,Yes,Former,Moderate,39.9,Medium,Rural,Statutory Health Insurance,10.0,No,No,Cardiovascular Disease,10.0
PT08252,Spain,Catalonia,35.0,Male,Ovarian,IV,2023-07-31,2023-12-02,2024-11-10,Chemotherapy,Private,Alive,48.0,EGFR,No,Former,,18.8,,Urban,Private Insurance,2.0,No,No,None,9.0
PT08253,Italy,Veneto,62.0,Male,Pancreatic,I,2017-07-12,2017-11-28,,Targeted Therapy,Private,Deceased,85.0,None,Yes,Current,Moderate,27.8,Medium,Rural,NHS,12.0,Yes,No,Diabetes,4.0
PT08254,Poland,Silesian,82.0,Female,Breast,III,2023-05-17,2023-07-29,2024-02-17,Surgery,Public,Alive,33.0,EGFR,No,,Moderate,18.4,Medium,Urban,NHS,6.0,No,No,Cardiovascular Disease,4.0
PT08255,Germany,Berlin,34.0,Female,Pancreatic,II,2015-04-16,2015-09-27,2016-03-24,Chemotherapy,Private,Alive,25.0,EGFR,Yes,Never,Moderate,32.3,Medium,Urban,NHS,8.0,No,No,,7.0
PT08256,Denmark,Capital Region,63.0,Male,Prostate,I,2021-12-01,2022-03-23,2022-10-26,Radiation,Private,Deceased,48.0,BRCA1,Yes,Never,Moderate,21.7,,Rural,Statutory Health Insurance,5.0,No,No,Hypertension,10.0
PT08257,Poland,Masovian,28.0,Female,Breast,III,2011-03-15,2011-03-20,2011-07-12,Targeted Therapy,Public,Alive,79.0,EGFR,No,Current,None,,Low,Urban,Statutory Health Insurance,6.0,,No,Cardiovascular Disease,5.0
PT08258,Switzerland,Zurich,84.0,Male,Prostate,III,2011-06-21,2011-09-05,2012-02-01,Targeted Therapy,Public,Alive,33.0,EGFR,Yes,Never,None,37.2,Medium,Rural,NHS,4.0,No,Yes,Obesity,9.0
PT08259,Switzerland,Zurich,63.0,Non-binary,Breast,IV,2016-02-01,2016-06-22,2017-06-11,Radiation,Public,Alive,114.0,None,,Former,Moderate,32.4,Medium,Urban,Statutory Health Insurance,19.0,Yes,No,None,6.0
PT08260,Switzerland,Geneva,39.0,Female,Leukemia,III,2011-12-14,2012-05-10,2012-10-29,Surgery,Public,Deceased,105.0,EGFR,Yes,Never,Moderate,21.5,Low,Rural,Statutory Health Insurance,19.0,No,Yes,Hypertension,9.0
PT08261,,Pirkanmaa,89.0,Male,Colorectal,I,2016-12-13,2017-01-02,2017-12-03,Surgery,Public,Alive,13.0,None,No,Former,None,25.6,Medium,Urban,Private Insurance,,No,No,Hypertension,5.0
PT08262,Germany,North Rhine-Westphalia,52.0,Male,Lung,II,2021-10-24,2022-04-14,2023-01-08,Targeted Therapy,Public,Alive,108.0,None,No,Never,None,39.6,Low,Urban,Statutory Health Insurance,4.0,No,No,Obesity,7.0
PT08263,Portugal,Algarve,25.0,,Ovarian,II,2021-05-15,2021-08-23,2022-04-21,,Public,Deceased,93.0,EGFR,Yes,Never,Moderate,24.9,Medium,Urban,Private Insurance,12.0,No,No,Hypertension,5.0
PT08264,France,Auvergne-Rhône-Alpes,50.0,Male,Breast,I,2023-04-01,2023-04-26,2023-11-25,Surgery,Public,Alive,70.0,BRCA1,No,Former,None,39.9,High,Urban,Statutory Health Insurance,6.0,No,No,Diabetes,6.0
PT08265,Sweden,Stockholm,85.0,Female,Breast,III,2017-07-29,2018-01-14,2018-08-22,Surgery,Public,Alive,22.0,EGFR,Yes,Former,Moderate,36.1,High,Urban,Private Insurance,18.0,Yes,No,Hypertension,3.0
PT08266,Germany,North Rhine-Westphalia,,Male,Ovarian,II,2012-09-16,2013-01-04,2013-02-28,Immunotherapy,Public,Deceased,65.0,BRCA1,No,Former,Heavy,29.7,Medium,Rural,NHS,1.0,Yes,No,,3.0
PT08267,Netherlands,Utrecht,47.0,Non-binary,Lung,IV,2021-02-19,2021-06-26,2021-11-27,Surgery,Private,Alive,25.0,BRCA1,Yes,Never,Moderate,36.7,Medium,Urban,Statutory Health Insurance,5.0,No,No,Cardiovascular Disease,7.0
PT08268,Finland,Southwest Finland,87.0,,Ovarian,II,2010-10-29,2011-01-06,2011-10-04,Immunotherapy,Public,Alive,18.0,BRCA1,Yes,Current,None,39.4,Medium,Rural,Private Insurance,17.0,No,Yes,Diabetes,5.0
PT08269,Italy,Veneto,84.0,Female,Breast,II,2012-10-09,2013-01-08,2013-11-16,Radiation,Private,Deceased,18.0,KRAS,,Former,Moderate,24.4,Medium,Urban,Statutory Health Insurance,17.0,Yes,No,,8.0
PT08270,Spain,Madrid,,Male,Ovarian,I,2019-12-30,2020-01-01,2020-10-31,Chemotherapy,Private,Alive,110.0,KRAS,Yes,Former,Moderate,20.6,,Urban,NHS,9.0,No,No,None,9.0
PT08271,France,Provence-Alpes-Côte d'Azur,77.0,Female,Colorectal,I,2010-09-04,2011-01-22,2011-03-29,Chemotherapy,Private,Lost to Follow-up,,EGFR,No,Current,Moderate,19.8,Medium,Rural,Statutory Health Insurance,13.0,No,No,,1.0
PT08272,Germany,North Rhine-Westphalia,66.0,Female,,III,2015-08-26,2015-09-23,2016-08-09,Radiation,Public,Alive,36.0,None,No,Former,None,31.4,Low,Urban,NHS,16.0,No,No,None,8.0
PT08273,Spain,Andalusia,85.0,,Lung,IV,2013-09-20,2013-11-03,2014-07-11,Surgery,Private,Alive,27.0,EGFR,Yes,Current,Moderate,25.2,High,,NHS,8.0,No,Yes,None,8.0
PT08274,Belgium,Wallonia,71.0,Female,Lung,II,2021-10-16,2022-03-06,2023-02-17,Chemotherapy,Public,Lost to Follow-up,,None,No,Never,Moderate,26.5,High,Rural,Statutory Health Insurance,7.0,No,No,None,9.0
PT08275,France,Île-de-France,55.0,Male,Colorectal,III,2014-05-29,2014-08-22,,Radiation,Public,Alive,20.0,KRAS,No,Never,Moderate,21.4,Medium,Rural,Private Insurance,10.0,No,Yes,Diabetes,4.0
PT08276,France,Provence-Alpes-Côte d'Azur,20.0,Male,Colorectal,,2019-11-11,2019-12-24,2020-09-25,Chemotherapy,Private,Alive,84.0,None,No,Former,Heavy,19.9,High,Rural,Statutory Health Insurance,6.0,No,No,Cardiovascular Disease,6.0
PT08277,Germany,Bavaria,58.0,Female,Lung,IV,,2013-01-05,2013-06-11,Surgery,Public,Deceased,103.0,BRCA1,Yes,Former,None,25.0,High,Urban,Private Insurance,7.0,No,Yes,Cardiovascular Disease,8.0
PT08278,Denmark,Central Denmark,20.0,,,I,2021-07-16,2021-11-29,2022-04-14,Immunotherapy,Public,Alive,52.0,BRCA1,No,Never,Heavy,21.8,Medium,Rural,Statutory Health Insurance,12.0,No,No,Hypertension,2.0
PT08279,Belgium,Brussels,33.0,Female,Pancreatic,II,2014-04-01,2014-08-03,2015-04-12,Radiation,Private,Alive,41.0,EGFR,Yes,Never,Moderate,19.5,Medium,Urban,Statutory Health Insurance,17.0,No,No,None,7.0
PT08280,Belgium,Flanders,42.0,Male,Colorectal,II,2018-11-30,2019-02-02,2020-02-01,Chemotherapy,Public,Alive,101.0,BRCA1,No,Never,None,18.9,Medium,,Statutory Health Insurance,6.0,No,No,Cardiovascular Disease,9.0
PT08281,Netherlands,Utrecht,62.0,Female,Pancreatic,II,2014-03-19,2014-07-14,2015-01-20,Surgery,Public,Alive,18.0,BRCA1,No,Former,None,19.3,Low,Urban,Statutory Health Insurance,14.0,No,No,Cardiovascular Disease,1.0
PT08282,Spain,Madrid,41.0,Male,Colorectal,I,2014-02-24,2014-03-08,2015-01-19,Chemotherapy,Research Institute,Alive,89.0,EGFR,No,Former,None,33.8,,Urban,Private Insurance,13.0,No,Yes,None,7.0
PT08283,Poland,Masovian,79.0,Male,,II,2022-08-07,,2023-06-29,Surgery,Private,Alive,30.0,EGFR,No,Never,None,31.4,Medium,Urban,Private Insurance,5.0,No,No,Diabetes,7.0
PT08284,,Porto,,Female,Breast,III,2020-02-24,2020-04-08,2021-01-04,Surgery,Public,Alive,58.0,None,Yes,Never,Moderate,33.2,,Urban,Private Insurance,13.0,No,Yes,Diabetes,10.0
PT08285,Germany,Berlin,75.0,Male,Prostate,I,,2014-11-25,2015-04-23,Surgery,,Alive,91.0,EGFR,Yes,Former,None,36.0,,Urban,Private Insurance,19.0,No,No,Hypertension,9.0
PT08286,Finland,Uusimaa,21.0,Female,Lung,III,2011-03-13,2011-04-01,2011-05-06,Surgery,Public,Alive,72.0,EGFR,Yes,,Moderate,31.7,High,Rural,Statutory Health Insurance,9.0,,Yes,None,1.0
PT08287,Ireland,Connacht,58.0,Female,Ovarian,III,2012-03-13,2012-07-16,2012-12-14,Radiation,Private,Deceased,46.0,EGFR,No,Never,None,28.5,Medium,Rural,,15.0,No,No,,3.0
PT08288,Netherlands,North Holland,70.0,Female,Prostate,IV,2021-06-30,2021-08-29,2022-02-19,Immunotherapy,Public,Alive,34.0,KRAS,No,Never,Moderate,36.0,Medium,Urban,Private Insurance,9.0,Yes,No,Hypertension,8.0
PT08289,Norway,Trøndelag,38.0,Female,Colorectal,II,2023-02-22,2023-07-27,2024-05-09,Radiation,Private,Alive,46.0,EGFR,No,Current,None,31.8,Low,Urban,Private Insurance,1.0,No,No,Cardiovascular Disease,9.0
PT08290,Switzerland,Geneva,81.0,Female,Colorectal,I,2012-04-04,2012-08-03,2012-11-20,Chemotherapy,Research Institute,Deceased,73.0,EGFR,Yes,Never,Moderate,33.4,Medium,Urban,Statutory Health Insurance,12.0,No,No,Diabetes,3.0
PT08291,Norway,Oslo,86.0,Male,Breast,II,2020-06-02,2020-11-04,2021-10-10,Radiation,Research Institute,Deceased,87.0,None,Yes,Current,Moderate,27.5,Medium,Urban,NHS,14.0,No,No,Obesity,10.0
PT08292,Switzerland,,82.0,Female,Colorectal,I,2010-10-31,2010-11-14,2011-04-03,Radiation,Public,Deceased,59.0,None,No,Current,,27.9,Low,Rural,Statutory Health Insurance,17.0,Yes,No,,2.0
PT08293,Spain,Andalusia,,Female,Ovarian,III,,2011-10-08,2012-07-14,Chemotherapy,Research Institute,Deceased,45.0,EGFR,No,Current,None,27.8,Low,,Private Insurance,10.0,No,No,Hypertension,6.0
PT08294,Belgium,Flanders,80.0,Female,Prostate,,2010-03-28,2010-05-31,2011-03-24,Immunotherapy,Public,Deceased,26.0,EGFR,No,Never,None,24.3,Medium,Rural,NHS,3.0,No,Yes,None,5.0
PT08295,Switzerland,Geneva,26.0,Female,Lung,II,2019-01-11,2019-06-12,2019-08-31,Radiation,Public,Deceased,100.0,BRCA1,Yes,Current,Moderate,31.6,Medium,Urban,Private Insurance,4.0,No,No,Cardiovascular Disease,9.0
PT08296,Poland,Silesian,69.0,Male,Lung,I,2019-02-02,2019-06-12,2019-08-28,Surgery,Public,Alive,103.0,KRAS,,Never,Moderate,27.7,High,Urban,NHS,1.0,No,No,Hypertension,3.0
PT08297,Austria,Vienna,65.0,Male,Ovarian,I,2019-10-17,2020-01-20,2020-08-03,Radiation,Private,Alive,22.0,BRCA1,No,Current,Moderate,19.0,Low,Urban,Statutory Health Insurance,9.0,No,No,,
PT08298,Portugal,Algarve,33.0,Male,Pancreatic,IV,2020-06-17,,2021-02-22,Chemotherapy,Private,Alive,95.0,None,Yes,Never,Heavy,33.4,Medium,Rural,Statutory Health Insurance,18.0,No,No,Cardiovascular Disease,3.0
PT08299,Portugal,Porto,88.0,Non-binary,,IV,2012-11-15,2013-01-12,2013-05-26,Immunotherapy,Private,Alive,94.0,KRAS,No,Never,None,29.1,Low,Urban,Private Insurance,17.0,No,No,None,8.0
PT08300,Ireland,Dublin,84.0,Male,Ovarian,II,2019-11-11,2020-02-13,2020-05-22,Radiation,Research Institute,Alive,9.0,EGFR,No,Former,Moderate,22.2,Medium,Urban,Statutory Health Insurance,11.0,Yes,No,Diabetes,2.0
,Netherlands,North Holland,84.0,Female,Prostate,I,2021-07-28,2021-09-08,2022-02-03,Radiation,Public,Deceased,65.0,BRCA1,No,Current,None,19.3,Low,Rural,Private Insurance,,No,No,Obesity,5.0
PT08302,Spain,Catalonia,76.0,Male,Colorectal,IV,2023-04-28,2023-04-29,2023-05-29,Chemotherapy,Public,Alive,108.0,KRAS,No,Never,None,22.2,Low,Urban,Private Insurance,8.0,No,No,Hypertension,10.0
PT08303,Austria,,81.0,Female,Leukemia,IV,2018-03-03,2018-07-31,2019-06-27,Targeted Therapy,Private,Deceased,97.0,,No,Never,Heavy,29.2,Medium,Urban,NHS,1.0,Yes,No,Diabetes,3.0
PT08304,Germany,Berlin,39.0,Male,Breast,IV,2018-07-18,2018-11-01,2019-02-01,Targeted Therapy,Private,Alive,43.0,KRAS,Yes,Former,Moderate,19.4,Medium,Rural,Statutory Health Insurance,11.0,No,No,None,3.0
PT08305,Norway,,45.0,Male,Breast,II,2023-06-21,2023-09-01,2023-11-28,Radiation,Public,Alive,71.0,KRAS,No,Former,Moderate,31.5,Medium,Urban,Private Insurance,,Yes,No,Diabetes,4.0
PT08306,,,63.0,Male,Leukemia,I,2011-06-12,2011-10-31,2012-09-27,Surgery,Research Institute,Alive,57.0,KRAS,No,Never,None,24.0,Low,Urban,Statutory Health Insurance,13.0,Yes,No,Hypertension,10.0
PT08307,Germany,Berlin,,Female,Ovarian,I,2010-02-03,2010-03-13,2011-01-08,Radiation,Public,Alive,72.0,None,No,Never,Moderate,39.2,Low,Rural,NHS,9.0,No,No,None,3.0
PT08308,Finland,Pirkanmaa,89.0,Male,Lung,IV,2015-09-11,2015-11-26,2016-02-09,Targeted Therapy,,Deceased,34.0,None,,Never,None,35.4,Low,Urban,Statutory Health Insurance,11.0,No,No,Obesity,
PT08309,Austria,Vienna,81.0,Female,Pancreatic,IV,2010-01-10,2010-03-03,2010-06-20,Radiation,Public,,,BRCA1,Yes,Never,None,20.4,Low,Urban,Private Insurance,6.0,No,No,,8.0
,Portugal,Lisbon,64.0,Male,Lung,II,2014-09-24,2015-01-13,2015-04-02,Surgery,Public,Alive,33.0,BRCA1,No,Never,,33.7,Medium,Urban,NHS,10.0,No,Yes,Hypertension,2.0
PT08311,Denmark,Zealand,30.0,Female,Lung,II,2017-08-10,2017-10-29,,Immunotherapy,Private,Alive,65.0,BRCA1,Yes,Never,,36.3,Medium,Rural,Private Insurance,11.0,No,,Hypertension,10.0
,Belgium,Flanders,53.0,Male,Leukemia,III,2019-05-14,2019-08-06,2020-06-06,Radiation,Public,Alive,107.0,BRCA1,No,Former,Moderate,,Medium,Urban,Private Insurance,,No,No,Cardiovascular Disease,7.0
,Germany,North Rhine-Westphalia,65.0,Female,Colorectal,III,2018-11-02,2019-02-18,2019-11-03,Chemotherapy,Private,Alive,96.0,EGFR,No,Never,None,30.0,Low,Rural,,11.0,No,,None,3.0
PT08314,Poland,Lesser Poland,51.0,,Colorectal,III,2018-06-26,2018-12-03,2019-11-30,Surgery,Public,Deceased,12.0,None,No,Never,Moderate,37.0,High,Urban,Private Insurance,12.0,No,Yes,Hypertension,9.0
,Denmark,Capital Region,24.0,Female,Pancreatic,III,2021-01-27,2021-07-01,2021-10-10,,Private,,,EGFR,Yes,Former,Moderate,34.8,Medium,Urban,Statutory Health Insurance,3.0,No,No,Obesity,5.0
PT08316,Germany,Bavaria,82.0,Male,Pancreatic,I,2013-03-22,2013-06-28,2014-01-12,Targeted Therapy,Private,Alive,26.0,EGFR,Yes,Former,Moderate,30.5,Medium,Rural,NHS,19.0,No,Yes,Cardiovascular Disease,9.0
PT08317,Germany,North Rhine-Westphalia,48.0,Female,Prostate,,2022-12-07,,2023-12-24,Radiation,,Alive,43.0,None,,Former,Moderate,27.3,Medium,Urban,NHS,7.0,No,No,,10.0
PT08318,Denmark,Zealand,67.0,Female,Prostate,III,2013-06-27,2013-08-28,2013-11-20,,Research Institute,Alive,83.0,None,Yes,Former,None,18.0,High,Urban,NHS,14.0,No,No,Hypertension,
PT08319,Netherlands,Utrecht,35.0,Male,Lung,III,2016-10-12,2016-10-15,2017-07-01,Chemotherapy,Public,Deceased,49.0,BRCA1,No,Never,Moderate,31.5,Medium,Urban,NHS,9.0,No,No,None,2.0
PT08320,Italy,Veneto,44.0,Male,Leukemia,I,2019-10-18,2020-01-07,2020-03-23,Immunotherapy,Public,Deceased,92.0,EGFR,No,Never,Heavy,23.4,,Urban,NHS,6.0,No,No,Cardiovascular Disease,7.0
PT08321,Finland,Pirkanmaa,48.0,Female,Pancreatic,I,2016-05-30,2016-10-03,2017-01-18,Targeted Therapy,Research Institute,Deceased,57.0,None,No,Never,None,23.0,High,Urban,Statutory Health Insurance,18.0,No,Yes,Diabetes,2.0
PT08322,Norway,Vestland,71.0,Female,Breast,III,2022-06-06,2022-09-05,2023-08-06,Radiation,Public,Alive,,None,No,Never,Moderate,21.1,High,Urban,NHS,5.0,No,No,Hypertension,10.0
PT08323,Sweden,Västra Götaland,65.0,Male,Colorectal,,2022-01-01,2022-04-14,2023-02-16,,Public,Alive,,EGFR,,Former,Heavy,33.0,Low,Urban,Statutory Health Insurance,11.0,No,No,None,8.0
PT08324,Germany,Bavaria,44.0,Female,Ovarian,II,,2016-09-29,2016-12-28,Surgery,Public,Deceased,98.0,EGFR,No,Never,None,32.9,High,,Statutory Health Insurance,9.0,,No,Hypertension,4.0
PT08325,Sweden,Västra Götaland,42.0,,Leukemia,III,2018-08-09,2018-11-12,2018-12-18,,Public,Deceased,78.0,BRCA1,No,Former,None,27.2,Medium,Urban,Statutory Health Insurance,4.0,Yes,Yes,Obesity,3.0
PT08326,Denmark,Central Denmark,53.0,Male,Pancreatic,III,2016-01-20,2016-02-20,2016-12-16,Surgery,Public,Deceased,114.0,None,No,Former,None,28.3,Low,Rural,Private Insurance,8.0,No,No,None,7.0
PT08327,Portugal,Algarve,,Male,Prostate,,2017-03-20,2017-09-06,,Targeted Therapy,Research Institute,Alive,56.0,EGFR,No,Never,Moderate,34.7,Low,Rural,Private Insurance,13.0,No,No,Cardiovascular Disease,9.0
PT08328,France,,53.0,Female,Pancreatic,I,2019-05-08,2019-07-05,2019-08-12,Chemotherapy,Public,Alive,28.0,,Yes,Former,None,21.4,Medium,Urban,Private Insurance,6.0,No,No,None,2.0
PT08329,Ireland,Munster,51.0,Male,Colorectal,II,2015-07-21,2015-09-02,2016-05-01,Immunotherapy,Public,Alive,74.0,EGFR,,Former,None,23.1,Medium,Urban,Private Insurance,17.0,No,No,Diabetes,4.0
PT08330,Switzerland,Bern,48.0,Female,Pancreatic,I,2022-12-10,2023-05-19,2023-11-29,Radiation,Research Institute,Alive,19.0,KRAS,No,Never,Moderate,38.7,,Urban,NHS,15.0,No,No,Hypertension,2.0
PT08331,Belgium,Brussels,28.0,Female,Colorectal,III,2023-05-27,2023-11-01,2024-07-18,Chemotherapy,Public,Alive,20.0,BRCA1,Yes,Current,None,40.0,Medium,Urban,NHS,9.0,Yes,No,Hypertension,6.0
PT08332,Ireland,Connacht,85.0,Male,Leukemia,III,2015-06-23,2015-09-14,2016-08-23,Chemotherapy,Private,Alive,20.0,None,No,Never,None,29.3,Medium,Urban,NHS,3.0,No,No,None,4.0
PT08333,Netherlands,South Holland,76.0,Female,Pancreatic,I,2022-11-18,2023-03-25,2023-09-26,Immunotherapy,Public,Deceased,40.0,KRAS,Yes,,None,28.2,High,Urban,Private Insurance,2.0,No,No,Obesity,8.0
PT08334,Portugal,Lisbon,58.0,Female,Pancreatic,I,2012-10-21,2013-03-26,2013-05-09,Targeted Therapy,Private,Deceased,16.0,None,,Never,Moderate,19.8,High,Urban,Private Insurance,3.0,Yes,No,Obesity,4.0
PT08335,Germany,North Rhine-Westphalia,26.0,Male,Prostate,I,2014-06-10,2014-07-25,2014-12-19,Immunotherapy,Public,Alive,98.0,KRAS,Yes,Former,,32.8,Medium,Urban,Statutory Health Insurance,4.0,Yes,,Diabetes,8.0
PT08336,Spain,Madrid,88.0,Male,Leukemia,II,2022-07-08,2022-11-23,2023-03-20,Immunotherapy,Private,Alive,42.0,None,No,Never,Heavy,28.3,Medium,Urban,NHS,11.0,No,,None,10.0
PT08337,Finland,Southwest Finland,27.0,Non-binary,Breast,I,2018-03-31,2018-08-22,2018-09-24,Immunotherapy,Research Institute,Lost to Follow-up,,BRCA1,Yes,Current,None,29.8,Medium,Urban,NHS,13.0,No,No,Diabetes,1.0
PT08338,Spain,Madrid,37.0,,Colorectal,III,2012-06-29,,2013-08-30,Surgery,Public,Alive,77.0,None,No,Former,Moderate,38.5,Medium,Rural,NHS,14.0,No,No,Obesity,5.0
PT08339,Germany,Berlin,68.0,Male,Ovarian,,2011-09-07,2011-09-17,2012-02-07,Radiation,,Alive,119.0,KRAS,No,Never,Moderate,38.3,Medium,Urban,Statutory Health Insurance,9.0,No,No,None,3.0
PT08340,Norway,Oslo,35.0,Male,Ovarian,III,2021-03-04,2021-05-17,2022-01-28,Immunotherapy,Research Institute,Alive,26.0,KRAS,Yes,Former,Moderate,38.2,Medium,Urban,,14.0,No,No,Obesity,10.0
PT08341,Norway,Vestland,40.0,Male,Leukemia,IV,2022-05-15,2022-08-15,2023-07-24,Radiation,Public,Alive,20.0,None,No,Never,Moderate,20.2,Medium,Urban,Private Insurance,3.0,No,No,Obesity,8.0
PT08342,Belgium,Wallonia,29.0,Male,Ovarian,II,2012-10-01,2012-10-13,2013-04-03,,Public,Alive,,None,No,Never,Moderate,26.4,Medium,Rural,,19.0,No,Yes,Obesity,6.0
PT08343,France,Provence-Alpes-Côte d'Azur,23.0,Male,Leukemia,IV,2018-10-28,2019-04-02,2019-12-31,Targeted Therapy,Public,Alive,81.0,None,No,Never,Moderate,32.6,Medium,Urban,Private Insurance,3.0,No,No,None,3.0
PT08344,Italy,Veneto,63.0,Female,Ovarian,I,2012-10-12,2012-10-30,2012-11-30,Targeted Therapy,Public,Alive,102.0,None,No,Former,Moderate,21.0,Medium,Urban,Statutory Health Insurance,8.0,No,No,Cardiovascular Disease,8.0
PT08345,Sweden,Västra Götaland,27.0,Female,Breast,I,2019-07-19,2019-12-22,2020-05-23,Immunotherapy,Public,Alive,116.0,EGFR,No,Never,None,38.7,Medium,Rural,NHS,11.0,No,No,None,4.0
PT08346,Spain,Andalusia,74.0,Male,Leukemia,II,2010-01-07,2010-02-04,2011-01-24,Chemotherapy,Public,Alive,108.0,EGFR,No,Current,None,30.7,High,Rural,Statutory Health Insurance,10.0,No,,,4.0
,France,Provence-Alpes-Côte d'Azur,38.0,Female,Colorectal,II,2023-11-17,2023-12-01,2024-07-18,Radiation,Public,Alive,13.0,None,No,Never,None,31.1,High,Urban,Private Insurance,13.0,No,No,Hypertension,5.0
PT08348,Switzerland,Geneva,83.0,Male,Ovarian,I,2020-04-23,2020-05-01,,Targeted Therapy,Private,Alive,29.0,EGFR,No,,Moderate,,Medium,Urban,NHS,1.0,No,No,Diabetes,1.0
PT08349,Denmark,Central Denmark,59.0,Male,Lung,II,2019-09-08,2019-12-17,2020-03-23,Surgery,Private,Deceased,37.0,None,Yes,Never,Heavy,18.4,Low,Urban,Statutory Health Insurance,19.0,No,Yes,None,9.0
PT08350,Germany,Berlin,70.0,Female,Lung,II,2021-07-01,2021-07-04,2021-12-27,Chemotherapy,Public,Alive,76.0,BRCA1,Yes,,Moderate,32.2,Low,Rural,NHS,12.0,No,Yes,Cardiovascular Disease,6.0
PT08351,Norway,Trøndelag,28.0,Male,Prostate,IV,2021-02-02,2021-06-19,2022-04-08,,Public,Alive,30.0,KRAS,Yes,Former,None,22.7,High,Rural,Statutory Health Insurance,6.0,No,,Obesity,9.0
PT08352,Austria,Vienna,,Male,Breast,II,2016-11-16,2017-01-02,2017-11-14,Chemotherapy,,Alive,,BRCA1,No,Never,Moderate,36.0,Medium,Urban,NHS,10.0,No,No,Diabetes,4.0
PT08353,Austria,Styria,75.0,Female,Prostate,II,,2020-02-16,2020-12-11,Radiation,Research Institute,Alive,106.0,KRAS,Yes,Never,None,19.1,Medium,Urban,Private Insurance,,No,No,None,1.0
PT08354,Finland,Southwest Finland,63.0,Male,,IV,2017-12-05,2018-05-22,2018-07-19,Chemotherapy,Research Institute,Alive,51.0,BRCA1,Yes,,Moderate,21.8,Medium,Urban,Private Insurance,19.0,No,Yes,Cardiovascular Disease,8.0
PT08355,Belgium,Wallonia,78.0,Female,Breast,III,2020-05-28,2020-08-13,2021-01-26,,Research Institute,Alive,86.0,KRAS,No,Never,None,35.2,Medium,Urban,Statutory Health Insurance,16.0,No,No,Diabetes,4.0
PT08356,Finland,Uusimaa,34.0,Male,Leukemia,II,,2020-12-05,2021-04-14,Chemotherapy,Private,Alive,100.0,KRAS,No,Former,Moderate,18.3,Medium,Rural,Private Insurance,12.0,No,No,Cardiovascular Disease,3.0
PT08357,Belgium,Brussels,87.0,Male,Leukemia,II,2016-08-10,2016-12-09,2017-11-29,Targeted Therapy,Public,Lost to Follow-up,,KRAS,Yes,Former,Moderate,23.3,High,Urban,NHS,2.0,No,No,Obesity,6.0
PT08358,Austria,Vienna,89.0,Female,Colorectal,III,2015-04-01,2015-08-31,2016-05-20,Surgery,Research Institute,Deceased,15.0,,No,Current,None,34.0,Low,Rural,NHS,1.0,No,No,None,8.0
PT08359,Spain,Andalusia,80.0,Female,Pancreatic,,,2021-09-30,2022-08-26,,Private,Deceased,112.0,EGFR,No,Never,None,33.3,High,Urban,Statutory Health Insurance,10.0,No,No,,4.0
PT08360,Norway,Vestland,42.0,Male,Lung,I,2016-04-09,2016-08-21,2017-08-15,Targeted Therapy,Private,Alive,55.0,KRAS,,Never,Moderate,22.5,Medium,Urban,NHS,16.0,No,No,Obesity,5.0
PT08361,Germany,Berlin,66.0,Female,Leukemia,II,2021-10-25,2022-04-22,2022-07-14,,Private,Deceased,119.0,None,No,Current,Moderate,35.4,Low,Rural,Statutory Health Insurance,6.0,No,No,Cardiovascular Disease,3.0
PT08362,Portugal,Lisbon,36.0,Female,Breast,III,2015-03-07,2015-05-06,2016-03-31,Immunotherapy,Public,Deceased,61.0,,No,Current,Moderate,27.2,Medium,Urban,NHS,11.0,Yes,Yes,Obesity,9.0
PT08363,Portugal,Porto,76.0,Female,Pancreatic,I,2021-04-23,2021-07-07,2022-04-21,Targeted Therapy,Public,Alive,77.0,KRAS,Yes,Former,,33.4,Medium,Urban,NHS,4.0,No,No,Hypertension,4.0
PT08364,Denmark,Central Denmark,73.0,Male,Pancreatic,I,2020-07-30,2021-01-03,2021-04-18,Chemotherapy,Public,Alive,6.0,None,No,Never,None,28.2,High,Urban,Statutory Health Insurance,17.0,Yes,No,Diabetes,10.0
PT08365,Switzerland,Geneva,71.0,Female,Leukemia,I,2011-11-06,2011-11-22,2012-10-08,Radiation,Public,Alive,14.0,EGFR,No,Current,Moderate,18.2,Low,Urban,NHS,10.0,No,,Obesity,5.0
PT08366,Germany,Berlin,41.0,Female,Prostate,,2017-12-19,2018-03-14,2018-08-29,Chemotherapy,Public,Alive,111.0,KRAS,Yes,Never,Heavy,18.1,Medium,Urban,Statutory Health Insurance,15.0,No,,Diabetes,3.0
PT08367,Finland,Southwest Finland,58.0,Female,Prostate,III,2015-03-16,2015-05-10,2016-02-01,Surgery,Public,Alive,53.0,None,No,Never,Moderate,39.8,Medium,Urban,Statutory Health Insurance,15.0,Yes,No,Obesity,4.0
PT08368,Finland,Uusimaa,32.0,Female,Prostate,III,2020-10-17,2021-03-23,2021-08-16,Radiation,Private,,31.0,None,No,,Moderate,22.5,Low,Urban,Private Insurance,13.0,No,No,Hypertension,2.0
PT08369,Sweden,Västra Götaland,85.0,Male,Pancreatic,II,2022-05-01,2022-07-18,2022-09-26,Radiation,Public,Alive,15.0,None,No,Never,Moderate,36.9,Low,Rural,Private Insurance,16.0,Yes,No,Obesity,1.0
PT08370,France,Provence-Alpes-Côte d'Azur,71.0,Female,Prostate,IV,2021-03-23,2021-05-17,2022-05-09,Surgery,Private,Deceased,95.0,None,No,Never,Moderate,23.0,Medium,,Statutory Health Insurance,10.0,No,No,Cardiovascular Disease,7.0
PT08371,Ireland,Connacht,33.0,Female,Prostate,II,2022-03-15,2022-08-31,2023-04-22,Surgery,Public,Deceased,63.0,BRCA1,No,,None,27.9,Low,Urban,Private Insurance,1.0,No,No,Diabetes,5.0
PT08372,Sweden,Västra Götaland,82.0,Female,Pancreatic,II,2018-04-26,2018-05-05,2018-09-18,Surgery,Research Institute,Alive,50.0,KRAS,Yes,Never,None,39.7,Low,Urban,NHS,18.0,No,No,None,7.0
PT08373,Belgium,Flanders,47.0,,Colorectal,IV,2011-08-13,2011-08-19,2011-12-30,Surgery,Public,Deceased,23.0,EGFR,Yes,Never,,21.0,Medium,Urban,NHS,2.0,No,No,Cardiovascular Disease,10.0
PT08374,Sweden,Skåne,65.0,Female,Prostate,IV,2015-03-05,2015-06-15,2015-11-29,Immunotherapy,Public,Deceased,64.0,EGFR,No,Former,Moderate,30.2,Low,Rural,Statutory Health Insurance,17.0,No,No,Obesity,5.0
PT08375,Finland,Pirkanmaa,47.0,Male,Colorectal,III,2016-07-10,2016-12-14,2017-02-22,Radiation,Public,Alive,62.0,BRCA1,No,Never,Moderate,26.0,Medium,Urban,NHS,5.0,No,,Cardiovascular Disease,10.0
PT08376,Sweden,,21.0,Male,Colorectal,IV,2019-03-17,2019-08-10,2020-03-07,Immunotherapy,Public,Deceased,72.0,None,No,Former,Moderate,30.5,Low,Urban,NHS,11.0,Yes,No,Cardiovascular Disease,7.0
PT08377,Denmark,Capital Region,36.0,,,II,2016-05-21,2016-06-14,2016-07-17,Immunotherapy,Public,Alive,33.0,BRCA1,No,,Moderate,29.5,Medium,Rural,,13.0,Yes,No,Diabetes,2.0
PT08378,Germany,,78.0,,Pancreatic,,2012-11-25,2013-01-15,2013-02-23,Chemotherapy,Private,Deceased,86.0,None,No,Former,Moderate,20.9,Low,Urban,NHS,16.0,No,Yes,Obesity,4.0
PT08379,Austria,Tyrol,71.0,Female,,II,2019-04-19,2019-05-06,2019-07-23,Radiation,Public,Deceased,20.0,BRCA1,Yes,,Heavy,30.5,Medium,Urban,Private Insurance,15.0,No,No,Diabetes,1.0
PT08380,Denmark,Zealand,23.0,,Prostate,,2011-01-30,2011-02-20,2011-06-03,Radiation,Research Institute,Alive,40.0,EGFR,Yes,Never,None,26.0,Low,Urban,Statutory Health Insurance,11.0,Yes,No,Obesity,2.0
PT08381,France,Auvergne-Rhône-Alpes,22.0,Male,Breast,III,2011-07-21,2011-10-12,2011-12-28,Radiation,Private,Alive,47.0,None,No,Never,Moderate,23.7,Low,Rural,NHS,1.0,No,No,Diabetes,9.0
PT08382,Portugal,Porto,56.0,Female,Lung,II,2012-12-08,2013-02-08,2013-07-11,Radiation,Public,Alive,30.0,KRAS,,Never,Moderate,21.1,High,Urban,Private Insurance,4.0,No,No,Diabetes,7.0
PT08383,Germany,North Rhine-Westphalia,43.0,Female,Colorectal,IV,2016-11-15,2017-02-14,2017-08-13,Surgery,Private,Alive,18.0,KRAS,No,Current,None,32.7,Medium,Urban,Statutory Health Insurance,7.0,No,No,Obesity,5.0
PT08384,Austria,Styria,54.0,Female,Ovarian,II,2016-07-30,2016-11-24,2017-04-02,Targeted Therapy,Public,,,BRCA1,Yes,Current,None,33.8,Low,,Statutory Health Insurance,19.0,No,No,None,3.0
PT08385,Germany,Bavaria,21.0,Female,Lung,I,2015-10-04,2015-12-18,2016-10-17,Chemotherapy,Public,Deceased,104.0,None,No,Never,Moderate,36.0,Medium,Urban,Private Insurance,19.0,No,No,Obesity,10.0
PT08386,France,Provence-Alpes-Côte d'Azur,52.0,Male,Colorectal,I,2019-04-07,2019-08-02,2020-03-18,Chemotherapy,Private,Alive,62.0,None,No,Former,Heavy,36.0,Low,Urban,Private Insurance,3.0,Yes,No,,4.0
PT08387,Poland,Masovian,29.0,Male,Prostate,,2023-07-09,2023-09-01,2024-05-05,Surgery,Public,Deceased,66.0,BRCA1,No,Current,Moderate,39.9,,Urban,NHS,14.0,,No,Cardiovascular Disease,10.0
PT08388,Sweden,Stockholm,81.0,Male,Lung,III,2021-12-04,2022-04-22,2022-09-24,Immunotherapy,Private,Alive,91.0,None,Yes,Current,Moderate,23.3,,Urban,NHS,3.0,No,No,Hypertension,1.0
PT08389,Spain,Madrid,62.0,Male,Pancreatic,III,2023-08-13,2024-01-31,2024-08-26,,Public,Alive,87.0,EGFR,No,,Moderate,30.4,High,Rural,NHS,19.0,No,No,Obesity,1.0
PT08390,Denmark,Capital Region,88.0,Male,Leukemia,III,2012-07-03,2012-11-01,2013-07-16,Chemotherapy,Public,Alive,90.0,BRCA1,Yes,Never,Moderate,30.6,Medium,,NHS,14.0,Yes,No,Cardiovascular Disease,9.0
PT08391,Switzerland,Geneva,78.0,Female,Lung,III,,2013-06-01,2014-03-24,Immunotherapy,Private,,16.0,BRCA1,Yes,,Heavy,29.8,Low,Urban,Statutory Health Insurance,2.0,No,No,Cardiovascular Disease,4.0
PT08392,Spain,Madrid,28.0,Male,Colorectal,IV,2023-09-09,2024-02-07,2024-11-21,Radiation,Public,Alive,118.0,EGFR,Yes,Former,None,25.8,Medium,Urban,Private Insurance,,No,No,Diabetes,3.0
PT08393,Belgium,Wallonia,,Female,Pancreatic,,2019-06-24,2019-10-23,2020-07-30,Targeted Therapy,Public,,,KRAS,No,Former,None,21.9,Medium,Urban,,5.0,No,No,Diabetes,9.0
PT08394,France,Provence-Alpes-Côte d'Azur,82.0,Male,Colorectal,II,2020-09-28,,2021-07-17,Targeted Therapy,Public,Alive,62.0,KRAS,No,Current,Heavy,30.7,Medium,Urban,NHS,17.0,No,No,Diabetes,3.0
PT08395,Switzerland,Zurich,71.0,Male,Breast,I,2016-05-06,2016-06-15,2016-12-06,Radiation,Private,Alive,48.0,KRAS,No,Never,Moderate,21.3,,Rural,Private Insurance,2.0,No,No,Cardiovascular Disease,8.0
PT08396,Norway,Oslo,42.0,Female,Ovarian,IV,2012-08-23,2012-09-01,2012-12-12,Chemotherapy,Public,Alive,118.0,None,No,Never,None,18.3,Medium,Urban,Private Insurance,12.0,No,No,Hypertension,10.0
PT08397,Finland,Southwest Finland,49.0,Male,Ovarian,IV,2019-09-02,2020-02-01,2020-03-31,Targeted Therapy,Private,Deceased,52.0,None,No,Never,Moderate,32.5,Low,Urban,Private Insurance,2.0,No,No,None,8.0
PT08398,Poland,,62.0,Female,Lung,III,2013-02-23,2013-05-10,,Surgery,Public,Deceased,47.0,BRCA1,Yes,Never,None,27.7,Medium,Urban,Statutory Health Insurance,18.0,,No,None,7.0
PT08399,Germany,North Rhine-Westphalia,87.0,Male,Leukemia,II,2016-02-11,2016-04-27,2016-06-03,Surgery,Private,Alive,9.0,EGFR,,Never,Moderate,39.1,High,Urban,NHS,7.0,Yes,No,Diabetes,2.0
PT08400,Sweden,Skåne,40.0,Male,Prostate,,2010-12-31,2011-05-10,2011-11-24,Surgery,Public,Deceased,67.0,None,No,Former,Moderate,25.5,High,Urban,Private Insurance,,No,No,None,1.0
PT08401,Austria,Vienna,62.0,Female,Breast,II,,2020-02-01,2020-03-06,Targeted Therapy,Public,Alive,30.0,BRCA1,Yes,Never,Moderate,39.8,Low,,Private Insurance,18.0,No,No,Cardiovascular Disease,2.0
PT08402,France,,26.0,Male,Lung,I,2023-03-09,2023-03-13,2024-03-01,Chemotherapy,Private,Alive,39.0,EGFR,No,Never,None,18.2,Medium,Rural,Private Insurance,2.0,No,No,Diabetes,10.0
PT08403,Norway,Trøndelag,35.0,Male,Breast,II,2012-10-28,2012-12-28,2013-09-21,Immunotherapy,Public,Alive,61.0,EGFR,No,Former,Moderate,19.3,Medium,Urban,Statutory Health Insurance,18.0,No,No,Cardiovascular Disease,5.0
PT08404,Portugal,Lisbon,42.0,Male,Lung,I,2011-10-16,2012-02-19,2012-08-18,Chemotherapy,Public,Alive,115.0,KRAS,No,Former,Moderate,32.6,Medium,Urban,NHS,12.0,No,No,Diabetes,2.0
PT08405,Austria,Styria,77.0,Female,Ovarian,IV,2020-05-23,2020-06-28,2021-06-26,Immunotherapy,Public,Deceased,74.0,KRAS,No,Current,Moderate,32.0,Low,Urban,NHS,1.0,No,No,None,10.0
PT08406,Italy,,50.0,,Prostate,II,2020-08-03,2020-09-13,2020-12-20,Targeted Therapy,Public,Deceased,46.0,EGFR,Yes,Former,,29.9,Low,Urban,Private Insurance,5.0,No,Yes,Hypertension,10.0
PT08407,Norway,Trøndelag,88.0,Male,Prostate,,2021-03-10,2021-06-21,2022-04-02,Radiation,Public,Alive,38.0,BRCA1,No,Never,Moderate,22.2,Low,Urban,NHS,17.0,No,No,Diabetes,7.0
PT08408,Sweden,Skåne,25.0,Female,Ovarian,III,2018-10-09,2019-03-24,2020-03-14,Immunotherapy,Research Institute,Deceased,49.0,None,No,Former,Heavy,20.1,Medium,Rural,Private Insurance,13.0,No,,Hypertension,3.0
PT08409,Netherlands,North Holland,84.0,Female,Leukemia,I,2022-02-05,2022-04-28,2022-08-14,Immunotherapy,Public,Alive,76.0,EGFR,No,Former,Heavy,19.3,Medium,Rural,Statutory Health Insurance,10.0,No,No,None,6.0
PT08410,Spain,Madrid,78.0,Male,Breast,I,2023-09-11,2024-02-01,,Chemotherapy,Private,Deceased,97.0,None,Yes,Current,Moderate,35.0,Medium,Urban,NHS,13.0,,No,Obesity,9.0
PT08411,Poland,Masovian,47.0,Male,Leukemia,IV,,2016-01-07,2016-11-19,Targeted Therapy,Public,Alive,113.0,EGFR,Yes,Never,None,37.4,Medium,Urban,NHS,2.0,No,No,Obesity,9.0
PT08412,,Connacht,37.0,Male,Lung,III,2023-05-23,2023-08-28,2023-11-25,Chemotherapy,Private,Alive,89.0,KRAS,Yes,Never,None,36.1,Medium,Urban,Private Insurance,16.0,No,No,Diabetes,10.0
PT08413,Portugal,Algarve,,Female,Prostate,I,2014-01-29,2014-07-06,2014-12-10,Targeted Therapy,,Alive,79.0,None,Yes,Never,None,21.3,Medium,Rural,NHS,4.0,No,,Hypertension,6.0
PT08414,Finland,Southwest Finland,26.0,Male,Prostate,I,2023-04-02,2023-04-27,2023-11-12,Immunotherapy,Public,Alive,35.0,KRAS,No,Never,None,35.2,Medium,Urban,NHS,13.0,No,No,Obesity,1.0
PT08415,Denmark,Capital Region,56.0,Female,Colorectal,III,2020-08-10,2020-08-14,,Radiation,Private,Alive,72.0,None,,Former,None,39.6,High,Urban,Statutory Health Insurance,11.0,No,No,Diabetes,3.0
PT08416,Austria,Tyrol,64.0,Female,Colorectal,II,2023-08-24,2023-09-11,2023-11-06,Targeted Therapy,Public,Alive,33.0,BRCA1,Yes,Former,None,31.5,High,Urban,Private Insurance,14.0,No,No,Obesity,2.0
PT08417,Norway,Trøndelag,35.0,Male,Ovarian,I,2019-12-18,2020-06-08,2020-10-19,Immunotherapy,Private,Alive,100.0,None,No,Never,None,26.4,Low,Urban,NHS,9.0,No,No,Hypertension,7.0
PT08418,Ireland,Munster,33.0,Female,Leukemia,III,2013-07-01,2013-10-29,2013-12-02,Radiation,Private,Alive,45.0,KRAS,,Never,Moderate,20.1,Medium,Urban,NHS,3.0,No,No,Cardiovascular Disease,1.0
PT08419,Italy,Veneto,30.0,Male,Breast,III,2023-03-16,2023-06-21,2023-11-24,Chemotherapy,Public,Alive,108.0,None,,Never,None,24.7,High,Urban,Private Insurance,6.0,Yes,No,Obesity,
PT08420,Portugal,Lisbon,53.0,Male,Ovarian,,2023-06-08,2023-08-31,2024-08-02,Chemotherapy,Public,Deceased,36.0,EGFR,Yes,Current,Heavy,30.9,Medium,Urban,Statutory Health Insurance,4.0,,No,None,7.0
PT08421,Norway,Vestland,79.0,Male,Lung,IV,2022-02-11,2022-04-25,2022-08-07,Targeted Therapy,Public,Deceased,,,No,Never,Moderate,27.2,Low,Urban,Private Insurance,17.0,No,,Diabetes,8.0
PT08422,Poland,Masovian,32.0,Male,Leukemia,III,2019-03-25,2019-05-29,2020-02-13,Targeted Therapy,Public,Alive,100.0,,No,Former,Moderate,29.3,Medium,Rural,Statutory Health Insurance,16.0,No,No,Obesity,9.0
PT08423,Austria,Tyrol,58.0,Female,Prostate,IV,2016-08-14,,2017-09-11,Targeted Therapy,Public,Alive,23.0,,No,Current,Heavy,33.0,Low,Urban,NHS,9.0,No,No,Hypertension,8.0
PT08424,Poland,Silesian,63.0,Female,Prostate,,2020-03-31,2020-04-27,2021-04-13,Chemotherapy,Public,Deceased,15.0,BRCA1,Yes,Never,,27.5,High,Urban,NHS,9.0,No,No,Hypertension,10.0
PT08425,Switzerland,Bern,47.0,Male,Prostate,I,2010-09-16,2010-12-13,2011-05-26,Targeted Therapy,Private,Deceased,37.0,KRAS,Yes,Current,Moderate,22.3,Medium,Urban,Private Insurance,19.0,No,,Hypertension,2.0
PT08426,France,Provence-Alpes-Côte d'Azur,59.0,Non-binary,Lung,I,2022-03-31,2022-08-31,2023-03-27,Immunotherapy,Public,Alive,117.0,KRAS,Yes,Never,Heavy,,Low,Urban,Statutory Health Insurance,,No,No,Cardiovascular Disease,10.0
PT08427,Norway,Oslo,35.0,Male,Ovarian,II,2010-05-25,2010-11-03,2011-03-26,,Public,Alive,77.0,BRCA1,No,Former,Moderate,27.2,Medium,Rural,Private Insurance,6.0,No,No,Obesity,6.0
PT08428,Netherlands,North Holland,69.0,Male,,IV,2018-07-08,2018-08-27,2019-06-09,Surgery,Public,Alive,90.0,KRAS,No,Never,Moderate,37.4,Medium,Urban,Private Insurance,,,No,,1.0
PT08429,Portugal,Porto,47.0,Male,Lung,IV,2017-07-16,2017-12-01,2018-11-27,Targeted Therapy,Public,Deceased,90.0,KRAS,Yes,Former,,,Low,Urban,NHS,17.0,No,No,None,1.0
PT08430,Spain,Catalonia,87.0,Female,,III,2011-12-10,2012-03-28,2012-12-27,Immunotherapy,Private,Alive,,None,No,Never,Moderate,23.2,High,Urban,,6.0,No,Yes,Obesity,2.0
PT08431,Norway,Trøndelag,79.0,Non-binary,Prostate,II,2010-09-03,2010-12-01,2011-06-25,Immunotherapy,Public,Alive,,None,Yes,Current,None,29.0,Low,Urban,Private Insurance,11.0,No,Yes,Diabetes,9.0
PT08432,Netherlands,Utrecht,31.0,Female,Colorectal,III,2022-02-15,2022-06-26,2022-08-14,Immunotherapy,Public,Alive,90.0,KRAS,No,Never,Moderate,22.8,Medium,Urban,NHS,2.0,Yes,Yes,Obesity,4.0
PT08433,Netherlands,Utrecht,35.0,Female,Leukemia,II,2014-05-31,2014-08-25,2014-11-04,Radiation,,,100.0,None,No,Current,Moderate,21.0,Medium,Urban,Private Insurance,16.0,No,No,Hypertension,3.0
PT08434,Italy,Lombardy,72.0,Male,Colorectal,I,,2017-12-26,2018-06-17,Immunotherapy,,Alive,,EGFR,No,Former,Moderate,35.1,Medium,Urban,NHS,18.0,No,No,Cardiovascular Disease,9.0
PT08435,France,Île-de-France,73.0,Male,Leukemia,II,2021-12-22,2022-04-11,2023-01-07,Chemotherapy,Public,Alive,98.0,None,No,Current,Moderate,27.4,Low,Rural,Private Insurance,5.0,No,No,Cardiovascular Disease,3.0
PT08436,Denmark,Zealand,68.0,Female,Ovarian,II,2013-10-19,,2014-04-19,Chemotherapy,Public,Alive,83.0,EGFR,No,Current,Heavy,19.2,Low,Urban,Statutory Health Insurance,12.0,No,Yes,Cardiovascular Disease,6.0
PT08437,France,Provence-Alpes-Côte d'Azur,55.0,Female,Prostate,I,2019-08-25,2019-11-21,2020-03-18,Immunotherapy,Public,,,BRCA1,Yes,Former,Moderate,36.0,Medium,Urban,Statutory Health Insurance,19.0,No,No,Obesity,1.0
,Netherlands,North Holland,81.0,Male,Colorectal,I,2014-10-01,2014-11-26,2015-03-18,Surgery,Private,Alive,14.0,,Yes,Former,Moderate,38.6,High,Urban,NHS,14.0,Yes,No,None,4.0
PT08439,Switzerland,Geneva,45.0,Female,,I,2010-09-09,2011-02-11,2011-12-09,Radiation,,Deceased,16.0,,No,Former,Heavy,25.5,Medium,Rural,NHS,19.0,No,No,Diabetes,1.0
PT08440,,Zealand,75.0,Male,Leukemia,III,2018-01-22,2018-04-22,2018-11-13,Chemotherapy,Public,Alive,76.0,BRCA1,Yes,Never,Moderate,28.9,High,Urban,Statutory Health Insurance,14.0,No,No,None,5.0
PT08441,Netherlands,Utrecht,41.0,Male,Pancreatic,I,2015-06-29,2015-11-20,2016-03-17,Chemotherapy,Public,Lost to Follow-up,,EGFR,No,Former,Moderate,34.7,High,Urban,Private Insurance,16.0,No,No,None,10.0
PT08442,Belgium,Flanders,88.0,Female,Pancreatic,III,2019-01-27,2019-03-06,2020-02-09,Chemotherapy,Private,Alive,10.0,None,Yes,,Moderate,18.8,Low,Rural,Private Insurance,11.0,No,No,Cardiovascular Disease,9.0
PT08443,Norway,Vestland,68.0,Female,Colorectal,II,2013-06-30,2013-10-13,,Radiation,Public,Alive,77.0,KRAS,No,Current,None,38.2,Medium,Urban,NHS,17.0,Yes,No,None,5.0
PT08444,Poland,Lesser Poland,21.0,Male,Colorectal,II,2012-10-24,2012-11-16,2013-05-20,Immunotherapy,,Alive,110.0,None,Yes,Never,Heavy,40.0,High,Urban,,3.0,No,No,,
,Poland,Silesian,72.0,Male,Ovarian,III,2013-10-28,2014-01-19,2014-09-06,Radiation,,Alive,64.0,KRAS,No,Current,Moderate,29.1,Medium,Rural,Statutory Health Insurance,12.0,Yes,No,None,8.0
PT08446,Austria,Styria,,Female,,II,2013-12-19,2014-03-17,2014-11-11,Immunotherapy,Private,Alive,72.0,None,No,Never,Moderate,29.7,Medium,Urban,Private Insurance,1.0,No,,,6.0
PT08447,Denmark,Capital Region,39.0,Female,Leukemia,II,2013-04-17,2013-06-09,2013-12-06,Targeted Therapy,Public,Alive,38.0,EGFR,Yes,Never,None,29.4,Low,Rural,Private Insurance,6.0,No,Yes,None,1.0
PT08448,Sweden,Västra Götaland,49.0,Female,Leukemia,IV,2010-01-12,2010-06-08,2011-04-19,Chemotherapy,Private,Deceased,88.0,None,No,Never,None,36.1,Medium,Urban,Private Insurance,5.0,Yes,No,Hypertension,5.0
PT08449,Netherlands,South Holland,86.0,Female,Breast,II,2013-08-09,2013-08-13,2013-12-16,Surgery,Public,Alive,52.0,EGFR,No,Never,,29.5,Medium,Rural,Statutory Health Insurance,13.0,Yes,No,Cardiovascular Disease,4.0
PT08450,,Vestland,78.0,Male,Leukemia,IV,2012-02-09,2012-07-15,2013-03-04,Radiation,Private,Alive,117.0,BRCA1,No,Never,None,32.4,Medium,Rural,Statutory Health Insurance,6.0,No,Yes,Diabetes,2.0
PT08451,Ireland,Dublin,85.0,Non-binary,Prostate,II,2016-04-25,2016-10-15,2017-07-15,Radiation,Public,Deceased,37.0,KRAS,No,Never,,32.3,Low,Urban,,11.0,No,No,Cardiovascular Disease,10.0
PT08452,Netherlands,South Holland,22.0,Female,Colorectal,I,2022-05-22,2022-09-04,,Chemotherapy,Private,Alive,46.0,None,,Never,Moderate,29.7,Medium,Urban,NHS,4.0,No,No,Hypertension,2.0
PT08453,Poland,Lesser Poland,75.0,Male,Ovarian,III,2013-09-18,2013-10-09,2013-12-03,Chemotherapy,Public,Alive,14.0,None,Yes,Never,None,38.4,Medium,Urban,Statutory Health Insurance,3.0,,No,Diabetes,5.0
PT08454,Belgium,Flanders,36.0,Male,Breast,I,2018-09-19,2018-11-12,2019-09-13,Surgery,Private,Lost to Follow-up,,None,No,Never,None,36.8,Medium,Urban,Statutory Health Insurance,10.0,No,No,None,2.0
PT08455,Sweden,Skåne,71.0,Male,,I,2015-05-28,2015-10-01,2016-08-25,Surgery,Private,Alive,16.0,KRAS,No,Former,None,19.6,Low,Urban,Statutory Health Insurance,18.0,,Yes,Cardiovascular Disease,2.0
PT08456,Belgium,Wallonia,26.0,Male,Ovarian,I,2016-03-03,2016-06-20,2017-04-19,Chemotherapy,Private,Alive,40.0,KRAS,Yes,Never,Moderate,27.0,Medium,Urban,NHS,10.0,No,No,,9.0
PT08457,Sweden,Stockholm,24.0,Female,Colorectal,I,2016-03-19,2016-05-10,2016-11-17,Immunotherapy,Private,Deceased,17.0,KRAS,Yes,Never,,30.9,Low,Urban,Private Insurance,19.0,,,None,6.0
PT08458,Finland,Southwest Finland,73.0,Female,Leukemia,III,2012-11-02,2013-03-28,2013-08-04,Chemotherapy,Public,,17.0,EGFR,Yes,Former,None,35.3,High,Urban,NHS,11.0,Yes,Yes,Obesity,9.0
PT08459,Poland,Masovian,80.0,Female,Lung,,2016-12-27,2017-05-21,,Surgery,Public,Lost to Follow-up,,None,,Never,None,25.9,Medium,Rural,Private Insurance,10.0,,No,Obesity,8.0
PT08460,Netherlands,Utrecht,,Male,Colorectal,IV,,2017-05-16,2018-01-13,Chemotherapy,Private,,103.0,KRAS,No,Never,None,31.5,High,Urban,Statutory Health Insurance,16.0,No,Yes,Diabetes,2.0
PT08461,Norway,Vestland,86.0,Female,Pancreatic,I,2014-10-21,2015-02-05,2015-06-04,Surgery,Research Institute,Deceased,55.0,BRCA1,No,Never,Moderate,27.6,High,Rural,Private Insurance,6.0,No,No,Diabetes,5.0
PT08462,Austria,Styria,78.0,Male,Leukemia,III,2018-12-31,2019-06-01,2019-11-19,Targeted Therapy,Public,Alive,56.0,None,No,Former,Moderate,20.7,Low,Urban,Statutory Health Insurance,9.0,No,No,Hypertension,8.0
PT08463,Finland,Southwest Finland,66.0,Male,Pancreatic,I,2021-01-21,2021-05-14,2021-09-10,Immunotherapy,Public,Alive,41.0,KRAS,No,Never,Moderate,39.9,Medium,Urban,NHS,16.0,No,Yes,None,4.0
PT08464,Portugal,Lisbon,67.0,Female,,III,2022-08-23,2023-01-04,2023-03-15,Surgery,Private,Deceased,103.0,KRAS,No,Former,Moderate,32.9,Low,Urban,Private Insurance,9.0,No,No,Cardiovascular Disease,
PT08465,Netherlands,Utrecht,83.0,Male,,IV,2020-05-28,2020-10-30,2021-02-27,Radiation,Public,Lost to Follow-up,,BRCA1,No,,Heavy,24.5,High,Urban,NHS,1.0,No,No,Hypertension,9.0
PT08466,Italy,Veneto,69.0,Female,Leukemia,I,2013-02-18,2013-08-12,2013-10-02,Radiation,Public,Alive,35.0,,No,Former,Moderate,32.4,Medium,Rural,Statutory Health Insurance,6.0,Yes,No,Obesity,6.0
PT08467,Austria,Styria,60.0,Female,Breast,IV,2014-08-26,2015-02-16,2015-08-02,Immunotherapy,Public,Deceased,46.0,None,Yes,Never,Moderate,24.0,Low,Rural,NHS,9.0,No,,Hypertension,1.0
,Austria,Tyrol,41.0,Female,Pancreatic,III,2016-06-10,2016-09-09,2016-11-27,Immunotherapy,Private,Alive,8.0,EGFR,Yes,Former,Moderate,33.8,Low,Urban,Statutory Health Insurance,,No,No,None,6.0
PT08469,Netherlands,South Holland,73.0,Male,Lung,III,2010-08-08,2010-11-07,,Radiation,Private,Alive,103.0,BRCA1,No,Current,Moderate,23.2,Medium,Urban,Statutory Health Insurance,10.0,No,No,Diabetes,7.0
,Sweden,Stockholm,24.0,Female,Ovarian,III,2014-06-21,2014-12-01,2015-09-28,Targeted Therapy,Public,Alive,54.0,EGFR,Yes,Never,None,39.3,Medium,Rural,Private Insurance,12.0,No,No,Cardiovascular Disease,5.0
PT08471,Denmark,Central Denmark,36.0,Non-binary,Lung,III,2011-09-03,2012-01-21,2013-01-07,Targeted Therapy,Research Institute,Alive,60.0,None,No,Never,Moderate,30.0,Low,Urban,NHS,9.0,No,No,Obesity,3.0
PT08472,France,Auvergne-Rhône-Alpes,60.0,Female,Lung,IV,2021-07-31,2021-08-29,2022-06-30,Surgery,Public,Deceased,37.0,KRAS,No,Current,Moderate,35.7,Medium,Urban,Private Insurance,3.0,No,No,Cardiovascular Disease,8.0
PT08473,Switzerland,Geneva,54.0,Female,Pancreatic,III,2023-06-25,2023-08-21,2024-03-30,Immunotherapy,Research Institute,Alive,84.0,KRAS,No,Current,,33.5,High,Urban,Private Insurance,12.0,No,Yes,Cardiovascular Disease,1.0
PT08474,Finland,Uusimaa,59.0,,Prostate,II,2023-07-16,2023-09-09,2024-07-23,Radiation,Public,Alive,,EGFR,No,Never,None,37.1,Low,Urban,Private Insurance,17.0,No,No,Hypertension,10.0
PT08475,Switzerland,Zurich,41.0,Male,Lung,III,2021-08-13,2022-01-25,2022-07-11,Immunotherapy,Public,Alive,56.0,KRAS,No,Never,None,36.4,Low,,NHS,13.0,No,No,Obesity,10.0
PT08476,,Skåne,67.0,Female,Colorectal,II,2018-09-20,2018-11-30,2019-11-05,Radiation,Public,Alive,108.0,None,No,Never,Heavy,19.3,Low,Urban,Statutory Health Insurance,12.0,No,No,None,6.0
PT08477,Denmark,Capital Region,72.0,Female,Ovarian,IV,2011-03-09,2011-05-01,2011-07-14,Radiation,Public,Deceased,111.0,BRCA1,No,Former,None,24.5,Low,Urban,NHS,1.0,Yes,No,None,3.0
PT08478,France,Île-de-France,29.0,Female,Prostate,IV,,2019-06-14,2020-01-16,Surgery,Research Institute,Deceased,54.0,EGFR,Yes,Never,None,30.3,Medium,Urban,Private Insurance,8.0,No,Yes,Obesity,1.0
PT08479,Spain,Catalonia,37.0,Female,Leukemia,II,2018-07-03,2018-07-24,2019-06-05,Immunotherapy,Private,Alive,78.0,EGFR,No,Never,Moderate,36.3,Medium,Urban,Statutory Health Insurance,1.0,No,No,Hypertension,6.0
PT08480,Spain,Catalonia,68.0,Male,Breast,III,2010-03-03,2010-06-15,2010-11-14,Targeted Therapy,Private,Deceased,95.0,None,No,Current,None,37.3,Low,Urban,NHS,1.0,No,No,Obesity,8.0
PT08481,Norway,Trøndelag,49.0,Male,Prostate,IV,2021-06-14,2021-06-28,2021-10-23,Immunotherapy,Public,Deceased,68.0,None,Yes,Current,None,26.8,Medium,Rural,Private Insurance,5.0,Yes,No,Hypertension,5.0
PT08482,Sweden,Västra Götaland,38.0,Female,Ovarian,I,2012-06-09,2012-08-01,2013-01-15,Radiation,Public,Deceased,27.0,BRCA1,No,Never,Heavy,34.5,Medium,Rural,NHS,3.0,,No,None,6.0
PT08483,Spain,Andalusia,74.0,Male,Ovarian,II,2020-02-24,2020-06-18,2021-04-05,Targeted Therapy,Public,Deceased,43.0,None,No,Current,Moderate,32.1,Medium,Rural,Private Insurance,14.0,No,No,None,6.0
PT08484,Denmark,Central Denmark,79.0,Male,Breast,II,2020-09-26,2020-12-31,2021-09-06,Radiation,,Deceased,,EGFR,No,Never,Moderate,38.2,Medium,Urban,NHS,13.0,No,No,Cardiovascular Disease,7.0
PT08485,Netherlands,North Holland,40.0,Male,Prostate,III,2018-02-20,2018-06-27,2018-12-02,Immunotherapy,Public,Alive,38.0,None,Yes,Never,Moderate,37.1,High,Rural,Statutory Health Insurance,1.0,,No,,4.0
PT08486,Denmark,Zealand,45.0,Male,Leukemia,II,2013-09-01,2013-11-25,2014-08-31,Radiation,Research Institute,Alive,19.0,EGFR,No,Never,Moderate,23.4,,Rural,Private Insurance,7.0,No,Yes,Diabetes,4.0
PT08487,Belgium,Wallonia,47.0,Female,,III,2022-04-22,2022-07-25,2023-07-19,Chemotherapy,Public,Lost to Follow-up,,EGFR,No,Current,Moderate,25.5,High,Urban,NHS,1.0,No,Yes,Hypertension,8.0
PT08488,Netherlands,North Holland,58.0,Female,Ovarian,II,,2018-04-25,2018-09-18,Targeted Therapy,Public,Alive,74.0,KRAS,Yes,Never,Moderate,24.0,High,Urban,,11.0,No,No,Hypertension,8.0
PT08489,,Lombardy,52.0,Male,Prostate,I,,2016-10-25,,Surgery,Research Institute,Alive,15.0,None,Yes,Never,None,29.4,Low,Urban,Private Insurance,18.0,,No,None,5.0
PT08490,Netherlands,North Holland,59.0,Male,Ovarian,I,2023-04-21,2023-10-05,2024-01-05,Chemotherapy,Private,Alive,49.0,KRAS,Yes,Current,None,19.5,Medium,Urban,,3.0,No,No,,7.0
PT08491,Switzerland,Geneva,48.0,,Breast,I,2015-09-14,2015-12-24,2016-04-05,Radiation,Public,,30.0,None,Yes,Never,Moderate,,Medium,Urban,Private Insurance,1.0,No,,Hypertension,7.0
PT08492,Netherlands,North Holland,39.0,Male,Lung,I,2012-02-17,2012-08-04,2012-09-22,Immunotherapy,Private,Alive,89.0,EGFR,Yes,Current,Moderate,38.3,Low,Rural,Private Insurance,16.0,Yes,No,Cardiovascular Disease,5.0
,Portugal,Lisbon,39.0,Male,Ovarian,II,2023-10-09,,2024-05-30,Radiation,Research Institute,Alive,57.0,None,,Former,None,34.8,Medium,Rural,NHS,15.0,Yes,No,Diabetes,7.0
PT08494,Spain,Madrid,31.0,Female,Lung,III,2013-11-07,2014-04-12,2014-10-20,Surgery,Private,Alive,80.0,KRAS,No,Never,Moderate,25.3,,,NHS,8.0,No,No,Diabetes,7.0
PT08495,Switzerland,Geneva,44.0,Male,Pancreatic,I,2020-04-15,2020-04-17,2020-11-26,Immunotherapy,Research Institute,Alive,56.0,BRCA1,No,,Moderate,27.7,Medium,Urban,Statutory Health Insurance,1.0,No,No,Diabetes,6.0
PT08496,Sweden,Västra Götaland,44.0,Female,Lung,III,2017-07-20,2017-08-11,2018-03-22,Targeted Therapy,Public,Alive,56.0,None,Yes,Never,None,33.6,Low,Urban,NHS,7.0,No,No,Obesity,8.0
PT08497,Ireland,Dublin,23.0,Female,Colorectal,II,2014-10-13,2015-02-18,2015-07-27,Targeted Therapy,Public,Alive,39.0,EGFR,,Never,,38.5,Medium,Urban,NHS,9.0,No,No,Obesity,7.0
PT08498,Switzerland,Bern,23.0,,Lung,I,2019-10-08,2020-01-12,2020-12-16,Radiation,Private,Alive,21.0,BRCA1,No,Former,None,35.0,Medium,Urban,Statutory Health Insurance,13.0,No,No,Obesity,7.0
PT08499,Netherlands,South Holland,28.0,Male,Lung,II,,,2016-12-25,Chemotherapy,Public,Alive,,EGFR,No,Never,,39.6,High,Urban,Private Insurance,19.0,No,No,None,3.0
PT08500,Austria,Tyrol,34.0,Female,Leukemia,,2016-08-18,2016-11-06,2017-07-30,Immunotherapy,Private,Alive,62.0,BRCA1,No,Current,Moderate,39.8,Medium,Urban,Private Insurance,10.0,Yes,Yes,None,5.0
PT08501,Portugal,Porto,45.0,Male,Breast,I,2010-02-22,2010-03-30,2010-11-23,Chemotherapy,Research Institute,,105.0,None,No,Current,None,22.2,Medium,Urban,Statutory Health Insurance,1.0,No,No,,9.0
PT08502,,Auvergne-Rhône-Alpes,51.0,Female,Breast,I,2021-12-02,2022-02-21,2023-01-02,Radiation,Public,Lost to Follow-up,,None,Yes,Current,Moderate,,Medium,Urban,Private Insurance,2.0,Yes,No,,10.0
PT08503,Norway,Trøndelag,71.0,Male,Lung,IV,2015-12-20,2016-02-07,2016-11-26,,Public,Deceased,58.0,,No,Former,None,36.4,High,Rural,NHS,19.0,No,No,Hypertension,6.0
PT08504,Denmark,Central Denmark,51.0,Female,Breast,III,,2014-10-04,2015-04-21,Targeted Therapy,Public,Deceased,57.0,EGFR,Yes,Never,Moderate,37.6,High,Urban,NHS,16.0,Yes,,Hypertension,1.0
PT08505,Sweden,Skåne,28.0,Male,Prostate,II,2019-06-29,2019-07-22,2020-04-14,Targeted Therapy,Public,Deceased,33.0,BRCA1,,Never,None,28.0,Medium,Urban,NHS,9.0,No,No,Diabetes,6.0
PT08506,Denmark,Capital Region,32.0,Female,Pancreatic,III,2022-11-04,2023-02-13,2023-08-18,Radiation,Public,Alive,79.0,KRAS,No,Former,Moderate,19.4,High,Urban,Private Insurance,15.0,No,No,Cardiovascular Disease,3.0
PT08507,Germany,Berlin,75.0,Female,Ovarian,III,2012-07-16,2012-12-19,2013-03-09,Immunotherapy,Private,Deceased,93.0,EGFR,No,Never,,21.7,High,Rural,Statutory Health Insurance,7.0,Yes,No,Hypertension,7.0
PT08508,Italy,Veneto,63.0,Non-binary,Lung,III,2021-11-23,2022-03-12,2022-08-08,Radiation,Research Institute,Deceased,53.0,EGFR,Yes,,None,20.6,Medium,Urban,Statutory Health Insurance,19.0,No,No,None,9.0
PT08509,Belgium,Brussels,49.0,Female,Pancreatic,II,2020-12-30,2021-04-14,,Targeted Therapy,Private,Lost to Follow-up,,EGFR,No,Current,None,21.9,Low,Urban,Private Insurance,6.0,No,No,Hypertension,7.0
PT08510,Finland,Pirkanmaa,35.0,,Lung,II,2023-01-02,2023-03-15,2023-09-04,Surgery,Public,Alive,78.0,KRAS,Yes,Current,Moderate,19.8,Medium,Rural,Statutory Health Insurance,6.0,No,No,,5.0
PT08511,Germany,North Rhine-Westphalia,31.0,Male,Colorectal,III,2013-12-17,2014-01-19,2014-06-18,Chemotherapy,Private,Alive,11.0,BRCA1,No,Never,None,20.6,Medium,Urban,NHS,10.0,Yes,No,Obesity,2.0
PT08512,Sweden,Skåne,85.0,Male,Pancreatic,I,2017-05-23,2017-09-26,2017-12-14,Radiation,Research Institute,Alive,42.0,EGFR,Yes,Former,None,33.5,Low,Rural,NHS,19.0,No,No,Hypertension,
PT08513,France,Auvergne-Rhône-Alpes,,Female,Prostate,IV,2023-10-20,2023-12-27,2024-03-06,Surgery,Public,Alive,,None,No,Never,Heavy,18.7,Low,Urban,,14.0,Yes,Yes,Diabetes,9.0
PT08514,Finland,Southwest Finland,32.0,Female,Lung,II,2010-12-06,2011-02-15,2011-11-05,Targeted Therapy,Private,Deceased,66.0,BRCA1,Yes,,None,37.0,Low,Rural,Private Insurance,8.0,No,No,Cardiovascular Disease,5.0
PT08515,Austria,Styria,43.0,Female,Lung,,2016-08-18,2016-08-29,2016-11-20,Radiation,Public,Alive,100.0,EGFR,No,Former,Moderate,36.3,Medium,Urban,Private Insurance,3.0,No,No,Cardiovascular Disease,6.0
PT08516,Germany,Bavaria,31.0,Male,Breast,IV,2023-08-21,2024-01-04,,Targeted Therapy,Private,Alive,105.0,None,Yes,Current,None,31.6,Medium,Urban,Statutory Health Insurance,1.0,No,No,None,10.0
PT08517,Finland,Uusimaa,79.0,Female,Lung,I,2020-10-21,2020-11-10,2021-10-21,Targeted Therapy,Public,Deceased,46.0,BRCA1,No,,Moderate,38.2,Medium,Urban,Private Insurance,3.0,No,No,None,4.0
PT08518,France,Auvergne-Rhône-Alpes,79.0,Female,Pancreatic,I,2017-01-07,2017-03-10,2018-02-27,Radiation,Research Institute,Lost to Follow-up,,EGFR,Yes,Never,Moderate,20.0,High,Rural,Private Insurance,5.0,No,No,Diabetes,
PT08519,Ireland,Connacht,20.0,Non-binary,Pancreatic,III,2019-02-22,2019-08-12,2020-08-10,Surgery,Public,Deceased,57.0,None,Yes,Current,None,23.6,Low,Urban,Private Insurance,6.0,Yes,Yes,Obesity,2.0
PT08520,Switzerland,Zurich,62.0,Female,Lung,II,,2021-03-26,2021-05-17,Radiation,Public,Alive,39.0,KRAS,Yes,Former,Moderate,28.6,Medium,Rural,,,No,No,None,3.0
PT08521,Poland,Silesian,74.0,,Lung,III,2013-10-12,2014-01-12,2014-09-21,Targeted Therapy,Public,Alive,14.0,None,No,Never,None,21.0,Low,Rural,Private Insurance,3.0,Yes,No,Hypertension,2.0
PT08522,Ireland,Connacht,59.0,Male,Lung,I,2023-07-14,2023-09-27,2024-01-28,Immunotherapy,Private,Deceased,34.0,KRAS,Yes,Former,None,31.8,Medium,Urban,Statutory Health Insurance,7.0,No,No,Diabetes,
PT08523,,Zealand,83.0,Male,,II,2016-06-13,2016-10-05,2017-09-26,Targeted Therapy,Private,Alive,46.0,BRCA1,No,Current,None,36.3,Low,Urban,NHS,13.0,No,No,Cardiovascular Disease,4.0
PT08524,Poland,Lesser Poland,53.0,Female,Prostate,I,2020-10-13,2021-02-11,2021-12-13,Radiation,Public,Alive,107.0,BRCA1,Yes,Current,None,36.7,Low,Rural,NHS,11.0,Yes,Yes,Cardiovascular Disease,
PT08525,Italy,Lombardy,53.0,Female,Ovarian,III,,2011-09-01,2011-11-08,Surgery,Public,Alive,115.0,BRCA1,Yes,Current,None,24.6,Medium,Rural,Private Insurance,,No,No,Cardiovascular Disease,4.0
PT08526,Austria,Vienna,67.0,Male,Pancreatic,I,2014-07-30,2014-12-15,2015-09-29,Targeted Therapy,Public,Deceased,6.0,KRAS,No,Never,Moderate,21.3,Low,Urban,NHS,,Yes,No,Diabetes,4.0
PT08527,Norway,Trøndelag,52.0,Male,Colorectal,II,2017-08-11,2018-01-26,2018-11-10,Surgery,Private,Deceased,119.0,KRAS,No,Current,None,35.1,Medium,Rural,NHS,,No,No,Cardiovascular Disease,2.0
PT08528,Austria,Vienna,87.0,Male,Ovarian,III,2020-04-23,2020-04-27,2021-02-13,Surgery,Research Institute,Alive,69.0,None,Yes,Current,Moderate,25.8,Medium,Urban,Statutory Health Insurance,15.0,No,No,None,3.0
PT08529,Belgium,Flanders,49.0,Female,Breast,IV,2016-12-13,2017-03-25,2017-10-24,Chemotherapy,Public,Alive,17.0,EGFR,Yes,Never,Moderate,32.4,Low,Urban,NHS,2.0,No,Yes,,1.0
PT08530,Portugal,Algarve,48.0,Male,Leukemia,III,2011-10-01,,2012-05-29,Surgery,Public,Alive,28.0,KRAS,No,Former,None,19.7,Medium,Urban,,10.0,No,No,None,5.0
PT08531,Austria,Tyrol,42.0,Male,Lung,II,2017-05-09,2017-08-27,2017-12-04,Targeted Therapy,Public,,6.0,BRCA1,No,,None,28.8,Medium,Urban,Statutory Health Insurance,1.0,No,No,Hypertension,1.0
PT08532,Netherlands,South Holland,53.0,Male,Pancreatic,II,,2021-08-12,2022-02-24,,Public,Deceased,100.0,KRAS,No,Former,None,24.6,Low,Rural,,15.0,No,No,Obesity,5.0
PT08533,Poland,Lesser Poland,34.0,Male,Ovarian,III,2023-02-24,2023-03-18,,Radiation,Private,Alive,107.0,,No,Former,Moderate,32.9,Medium,Rural,Private Insurance,12.0,No,No,Diabetes,3.0
PT08534,Portugal,Lisbon,72.0,Female,Breast,IV,2013-10-06,2014-01-17,2014-11-01,Radiation,Public,Alive,30.0,None,Yes,Never,None,31.4,,Urban,Statutory Health Insurance,14.0,No,No,Diabetes,6.0
PT08535,Switzerland,Bern,36.0,Female,,IV,2014-09-23,,2015-09-03,Surgery,Public,Deceased,43.0,EGFR,No,Never,None,28.0,Medium,Urban,Private Insurance,,Yes,No,Hypertension,3.0
PT08536,Norway,Trøndelag,83.0,Male,Leukemia,IV,2011-10-19,2012-02-09,2012-11-22,Immunotherapy,Private,Alive,9.0,BRCA1,,Never,Heavy,38.5,Medium,Urban,NHS,15.0,No,No,Diabetes,1.0
PT08537,Ireland,Connacht,80.0,Female,Ovarian,III,2018-02-10,2018-07-09,2019-04-16,Targeted Therapy,Private,Lost to Follow-up,,BRCA1,No,Current,Heavy,30.0,Medium,Urban,Private Insurance,17.0,No,No,None,1.0
PT08538,Denmark,Central Denmark,76.0,Male,Lung,I,2023-06-15,2023-10-28,2024-08-28,Surgery,Research Institute,Alive,48.0,KRAS,No,Never,None,18.3,Medium,Urban,Private Insurance,19.0,No,No,Cardiovascular Disease,6.0
PT08539,Denmark,Capital Region,56.0,Non-binary,Pancreatic,III,2017-11-15,2017-11-22,,Radiation,Public,Alive,95.0,BRCA1,No,Never,Moderate,29.5,Medium,Urban,NHS,3.0,Yes,No,,4.0
PT08540,Austria,Tyrol,26.0,Male,Lung,III,2011-08-03,2011-10-19,,Targeted Therapy,Public,Alive,66.0,KRAS,Yes,Never,None,19.3,High,Rural,Private Insurance,14.0,No,No,None,9.0
PT08541,Netherlands,Utrecht,27.0,Male,Leukemia,IV,2010-06-09,2010-07-02,2011-05-02,Chemotherapy,Private,Alive,37.0,BRCA1,,Current,Heavy,39.1,Medium,Rural,NHS,16.0,Yes,Yes,Obesity,3.0
PT08542,Netherlands,Utrecht,87.0,Female,Colorectal,IV,2019-10-13,2020-01-11,2020-08-10,Radiation,Private,Alive,33.0,BRCA1,No,Never,None,34.3,High,Urban,NHS,14.0,No,No,Hypertension,2.0
PT08543,Finland,Uusimaa,40.0,Male,Ovarian,II,2014-01-29,2014-02-16,,Chemotherapy,Research Institute,Alive,38.0,None,Yes,Never,Moderate,18.2,High,Urban,Private Insurance,2.0,No,No,None,7.0
PT08544,Denmark,Zealand,80.0,,Leukemia,III,2017-12-05,2018-04-01,2018-11-29,Targeted Therapy,Public,Alive,32.0,BRCA1,Yes,Current,Moderate,28.7,Medium,Rural,NHS,8.0,No,,None,5.0
PT08545,Italy,Veneto,48.0,Female,Leukemia,I,2020-10-03,2020-12-13,2021-02-23,,Private,,6.0,EGFR,No,Never,Moderate,,Medium,Urban,NHS,1.0,No,No,Cardiovascular Disease,6.0
PT08546,Switzerland,Geneva,44.0,Female,Pancreatic,II,2016-12-20,2017-02-24,2017-08-05,Surgery,Public,Alive,13.0,BRCA1,,Former,None,35.6,Low,Urban,NHS,13.0,,No,Obesity,7.0
PT08547,Italy,Sicily,77.0,Male,Ovarian,II,2011-04-09,,2012-01-20,Surgery,Public,Deceased,90.0,BRCA1,Yes,Never,Moderate,24.0,Medium,Urban,Statutory Health Insurance,8.0,No,No,Diabetes,2.0
PT08548,Sweden,,33.0,Female,Prostate,,2016-07-17,2016-12-11,2017-05-01,Immunotherapy,Public,Deceased,28.0,BRCA1,,Never,None,32.9,Medium,Urban,Private Insurance,1.0,Yes,No,Obesity,2.0
PT08549,Portugal,Algarve,85.0,Female,Lung,IV,2011-05-23,2011-10-12,2012-05-17,Surgery,Private,Alive,37.0,,No,Never,Heavy,34.9,High,Urban,Statutory Health Insurance,10.0,No,No,Obesity,10.0
PT08550,Norway,Oslo,73.0,Female,Ovarian,III,2013-07-31,2013-08-25,2014-04-01,Surgery,Public,Alive,8.0,BRCA1,No,Never,Moderate,32.3,Low,Rural,NHS,1.0,No,No,Obesity,5.0
PT08551,Sweden,Stockholm,86.0,Female,Pancreatic,I,2012-10-18,2012-11-20,2013-03-03,Chemotherapy,Private,Alive,49.0,None,No,Never,None,37.7,Low,Rural,NHS,10.0,No,No,None,1.0
PT08552,Belgium,Wallonia,49.0,Female,Lung,II,2017-03-07,2017-08-30,2018-04-07,Surgery,Public,Alive,59.0,BRCA1,Yes,Current,None,,Medium,Rural,Private Insurance,2.0,No,No,Obesity,4.0
PT08553,Belgium,Brussels,37.0,Male,,III,,2018-02-20,2018-08-18,Chemotherapy,Public,Deceased,11.0,KRAS,No,Never,None,34.4,Low,Urban,NHS,8.0,,,Obesity,
PT08554,Switzerland,Geneva,73.0,Male,Ovarian,I,2018-01-21,2018-05-23,2019-04-11,Surgery,Private,Deceased,75.0,EGFR,No,Never,Moderate,31.3,Low,Urban,NHS,15.0,No,No,None,5.0
PT08555,Ireland,Dublin,40.0,Male,Colorectal,I,2023-02-13,2023-06-05,2023-10-04,Surgery,Public,Alive,54.0,KRAS,No,Never,Heavy,39.3,Medium,Urban,NHS,10.0,No,No,Obesity,8.0
PT08556,Spain,Andalusia,72.0,Male,Prostate,IV,2019-04-17,2019-08-03,2020-01-19,Radiation,Private,Alive,64.0,KRAS,Yes,Never,Moderate,33.0,Low,Rural,Private Insurance,2.0,Yes,No,Cardiovascular Disease,3.0
PT08557,Austria,,35.0,Female,Prostate,I,2017-10-14,2018-02-24,2018-07-06,Immunotherapy,Public,Alive,62.0,BRCA1,Yes,Current,Moderate,27.5,Low,Urban,Private Insurance,7.0,No,Yes,None,10.0
PT08558,Finland,Southwest Finland,47.0,Male,Prostate,I,2011-10-28,2012-02-18,2012-10-06,Radiation,Public,Deceased,94.0,KRAS,Yes,Never,Moderate,20.6,Low,Rural,Statutory Health Insurance,9.0,No,No,Hypertension,3.0
PT08559,Switzerland,Bern,23.0,Male,Colorectal,II,2019-12-23,2020-05-20,2021-02-13,Surgery,Private,Deceased,66.0,BRCA1,Yes,Former,Moderate,32.0,Medium,Urban,Private Insurance,14.0,No,No,Diabetes,9.0
PT08560,Belgium,Wallonia,74.0,Male,Leukemia,IV,2012-02-07,2012-04-06,2012-07-05,Chemotherapy,Private,Alive,61.0,KRAS,Yes,Current,None,39.1,Low,Urban,NHS,3.0,Yes,Yes,Hypertension,1.0
PT08561,Norway,Vestland,34.0,Male,Pancreatic,III,2023-12-01,2024-03-30,2024-08-05,Surgery,Public,Lost to Follow-up,,KRAS,Yes,Former,Moderate,25.3,Low,Urban,NHS,16.0,No,No,Cardiovascular Disease,8.0
PT08562,Sweden,Stockholm,83.0,Female,Lung,IV,2016-02-09,2016-04-26,2017-03-25,Targeted Therapy,Public,Alive,46.0,KRAS,,,Moderate,32.5,Medium,Urban,NHS,19.0,No,No,Cardiovascular Disease,5.0
PT08563,Spain,Madrid,84.0,Male,Lung,III,2011-01-19,2011-02-02,2011-10-25,Targeted Therapy,,Alive,19.0,BRCA1,No,Current,Moderate,35.3,Low,Urban,Private Insurance,10.0,No,No,Diabetes,5.0
PT08564,Poland,Silesian,35.0,Female,Pancreatic,II,2021-04-13,2021-06-06,2022-02-22,Targeted Therapy,Private,Alive,88.0,,No,Current,None,37.3,Medium,Urban,,1.0,Yes,Yes,Cardiovascular Disease,9.0
PT08565,Austria,Vienna,39.0,Male,Breast,IV,2023-09-22,2024-03-13,2024-11-26,Targeted Therapy,Research Institute,Deceased,82.0,EGFR,,Current,None,34.8,High,Urban,Statutory Health Insurance,,No,No,Diabetes,10.0
PT08566,Ireland,Dublin,83.0,Female,Colorectal,II,2013-08-30,2014-02-24,2014-11-24,Surgery,Public,Deceased,42.0,EGFR,No,Never,None,27.1,Low,Urban,Statutory Health Insurance,13.0,No,Yes,Diabetes,8.0
PT08567,Finland,Uusimaa,52.0,Non-binary,Colorectal,II,2015-09-17,2016-03-04,2016-11-07,Targeted Therapy,Public,Alive,46.0,EGFR,Yes,Never,,18.2,Medium,Urban,NHS,12.0,No,No,None,10.0
,Finland,Uusimaa,88.0,Female,Prostate,II,2022-01-15,2022-04-17,2023-03-20,Immunotherapy,Private,Lost to Follow-up,,EGFR,No,Never,Moderate,,Low,Urban,Private Insurance,18.0,Yes,No,Obesity,3.0
PT08569,Poland,Silesian,88.0,Female,Ovarian,III,2021-01-25,2021-06-01,2021-08-15,Surgery,Public,Alive,35.0,BRCA1,Yes,Former,Moderate,30.2,Medium,Rural,NHS,19.0,No,No,Obesity,3.0
PT08570,Belgium,Flanders,77.0,Female,Ovarian,IV,2021-02-11,2021-06-20,2021-09-13,Radiation,Public,Alive,97.0,KRAS,Yes,Current,Moderate,27.3,High,Urban,Statutory Health Insurance,2.0,No,No,Cardiovascular Disease,2.0
PT08571,Ireland,Dublin,58.0,Female,Pancreatic,II,2013-10-24,2014-03-03,2015-01-11,Surgery,Public,Lost to Follow-up,,None,Yes,Never,None,31.9,Medium,Rural,Private Insurance,4.0,No,No,Hypertension,7.0
PT08572,Denmark,Zealand,55.0,Female,Breast,II,2015-11-18,2016-01-29,2016-10-02,Chemotherapy,Private,Alive,47.0,None,Yes,,Heavy,18.9,High,Rural,,1.0,Yes,No,None,4.0
PT08573,Ireland,Munster,87.0,,Breast,IV,2013-11-12,2014-04-02,2015-03-26,Immunotherapy,Private,Alive,41.0,BRCA1,Yes,Never,None,,Medium,Urban,,10.0,Yes,No,Hypertension,1.0
PT08574,Germany,Berlin,40.0,Female,Colorectal,I,2017-05-30,2017-10-24,2018-05-20,Surgery,Public,Alive,61.0,None,Yes,Never,Moderate,24.7,Low,Urban,Private Insurance,1.0,No,No,None,7.0
,Sweden,Skåne,82.0,,Prostate,III,2014-12-21,2015-02-10,2015-07-16,Radiation,Public,Alive,76.0,EGFR,Yes,Former,None,20.7,Low,Urban,NHS,9.0,No,No,Hypertension,2.0
PT08576,Poland,Silesian,25.0,Female,Lung,II,2021-05-13,2021-09-16,2022-06-07,Chemotherapy,Public,Alive,88.0,BRCA1,No,Current,,22.3,High,Urban,NHS,16.0,No,No,Cardiovascular Disease,6.0
PT08577,France,Île-de-France,43.0,Male,,II,2017-03-16,2017-03-18,,Chemotherapy,Public,Alive,118.0,BRCA1,No,Never,Moderate,31.1,Low,Urban,Private Insurance,8.0,No,Yes,Hypertension,
PT08578,Norway,Oslo,72.0,Male,Lung,II,2015-12-15,2015-12-25,2016-09-03,Radiation,Public,Alive,83.0,BRCA1,No,Never,None,35.1,Medium,Urban,Private Insurance,12.0,No,No,Obesity,6.0
PT08579,Finland,Pirkanmaa,69.0,Female,Ovarian,II,,2021-06-01,2022-05-27,Radiation,Public,Deceased,118.0,EGFR,No,Current,Moderate,21.4,Medium,Urban,NHS,4.0,No,No,,8.0
PT08580,Norway,Vestland,31.0,Male,Colorectal,III,2019-04-16,2019-05-16,2019-07-13,Radiation,,Alive,31.0,KRAS,Yes,Former,Moderate,33.0,High,Rural,Statutory Health Insurance,6.0,No,No,Obesity,6.0
PT08581,Denmark,Zealand,75.0,Female,Prostate,IV,2019-06-30,2019-09-03,2020-04-06,Radiation,Research Institute,Deceased,89.0,KRAS,No,Current,None,21.3,Low,Urban,Statutory Health Insurance,17.0,No,Yes,None,
PT08582,Spain,Andalusia,34.0,Male,Breast,II,2021-08-19,2021-12-06,2022-09-25,Targeted Therapy,Public,Deceased,19.0,KRAS,Yes,Never,Heavy,33.8,Medium,Urban,Statutory Health Insurance,9.0,No,No,Diabetes,7.0
PT08583,Belgium,Brussels,59.0,Male,Pancreatic,III,2013-03-18,2013-05-01,2014-03-07,Immunotherapy,Private,Alive,44.0,BRCA1,No,Never,Moderate,33.2,Low,Urban,NHS,11.0,No,No,None,1.0
PT08584,Germany,Berlin,60.0,Female,Leukemia,III,2010-08-14,2010-09-25,2011-05-24,Radiation,Public,Alive,101.0,KRAS,No,Never,Moderate,36.9,High,Urban,Private Insurance,19.0,No,Yes,Cardiovascular Disease,3.0
PT08585,Italy,Sicily,88.0,,Breast,II,2023-07-05,2023-07-08,2024-01-02,Targeted Therapy,Private,Deceased,116.0,KRAS,Yes,Former,Moderate,32.7,Medium,Urban,NHS,14.0,No,No,Obesity,10.0
PT08586,Belgium,Flanders,88.0,Female,Ovarian,II,2017-07-02,2017-10-21,2017-11-23,Surgery,Research Institute,Alive,65.0,EGFR,No,Never,Moderate,19.5,,Urban,,18.0,No,No,Hypertension,7.0
PT08587,Spain,Andalusia,25.0,Male,Pancreatic,III,2013-08-26,2014-01-31,2014-12-18,Chemotherapy,Public,Alive,99.0,BRCA1,Yes,Never,None,36.6,,Urban,Private Insurance,1.0,No,No,Obesity,1.0
PT08588,Finland,Uusimaa,86.0,Male,Lung,I,2011-02-23,2011-08-07,2012-02-23,Surgery,Private,Alive,33.0,,Yes,Never,None,32.4,Low,Urban,NHS,2.0,No,Yes,,7.0
PT08589,Netherlands,Utrecht,52.0,Male,Colorectal,II,2022-08-16,2022-09-13,2023-05-21,Surgery,Private,Deceased,49.0,BRCA1,,Former,None,22.6,High,Urban,NHS,11.0,No,No,None,3.0
PT08590,Poland,Lesser Poland,,Male,Prostate,,2022-01-02,2022-02-22,2022-06-14,Targeted Therapy,Research Institute,Alive,50.0,EGFR,No,Never,Heavy,38.7,Medium,Urban,Statutory Health Insurance,13.0,No,No,Hypertension,5.0
PT08591,Spain,Catalonia,40.0,,Ovarian,III,2016-02-27,2016-06-21,2016-12-21,Targeted Therapy,Public,Alive,23.0,KRAS,Yes,Current,None,37.3,Medium,Urban,NHS,8.0,No,No,None,9.0
PT08592,Switzerland,Geneva,84.0,Female,Ovarian,II,2023-08-09,2023-12-12,2024-10-28,Radiation,Public,Alive,35.0,EGFR,Yes,Never,Moderate,27.3,Medium,Urban,Statutory Health Insurance,16.0,No,No,Hypertension,2.0
PT08593,Italy,Veneto,36.0,Male,Colorectal,I,2017-06-07,2017-06-20,2018-01-04,Radiation,Research Institute,Deceased,107.0,EGFR,No,Current,Moderate,31.0,Medium,Rural,Private Insurance,19.0,No,No,None,5.0
PT08594,Switzerland,Geneva,27.0,Female,Colorectal,I,,,2018-10-22,,Public,Alive,75.0,None,No,Never,Moderate,32.7,Low,Urban,NHS,2.0,No,No,Obesity,2.0
PT08595,Spain,Andalusia,83.0,Male,Lung,II,2010-06-17,2010-11-18,2011-10-19,Immunotherapy,Research Institute,Deceased,75.0,BRCA1,Yes,Former,None,36.6,High,Urban,Statutory Health Insurance,8.0,No,No,None,2.0
PT08596,Ireland,Munster,47.0,Male,Colorectal,I,2023-09-19,2024-01-01,2024-10-21,Radiation,Private,Alive,8.0,None,Yes,Current,None,25.8,Low,Urban,NHS,11.0,No,No,None,5.0
PT08597,Spain,Madrid,32.0,Male,Prostate,I,2014-08-26,2015-01-31,2015-10-03,Surgery,Public,Alive,12.0,BRCA1,Yes,Former,Moderate,32.9,High,Urban,NHS,11.0,No,No,Obesity,4.0
PT08598,Germany,North Rhine-Westphalia,32.0,Non-binary,Ovarian,II,2013-08-11,2014-01-10,,Radiation,Public,Alive,113.0,None,No,Never,Heavy,,Low,Urban,Private Insurance,9.0,No,No,Cardiovascular Disease,10.0
PT08599,Finland,Southwest Finland,57.0,Female,Breast,III,2018-06-10,,2018-12-07,Radiation,Public,Alive,,KRAS,No,Former,Heavy,26.1,Low,,Private Insurance,17.0,No,No,Diabetes,8.0
PT08600,Poland,Lesser Poland,44.0,,Colorectal,I,2016-08-01,2016-11-14,2017-05-31,Immunotherapy,Public,Alive,87.0,None,No,Never,None,27.3,Medium,Urban,Private Insurance,4.0,No,No,Obesity,5.0
PT08601,Belgium,Brussels,81.0,Female,,I,2015-06-18,2015-10-06,2016-07-30,Targeted Therapy,Public,Lost to Follow-up,,None,No,Former,None,27.3,Low,Urban,NHS,7.0,No,No,Obesity,4.0
PT08602,Spain,Andalusia,42.0,Female,Prostate,,2015-12-19,2016-01-04,2016-08-06,Immunotherapy,,Alive,70.0,None,Yes,Never,Moderate,26.9,Medium,Urban,Statutory Health Insurance,18.0,No,No,Obesity,3.0
PT08603,Finland,Southwest Finland,40.0,Female,Lung,I,2022-11-13,2023-03-03,2023-11-29,Radiation,Public,Alive,32.0,EGFR,Yes,Former,None,29.9,Medium,Urban,Statutory Health Insurance,12.0,Yes,No,Obesity,5.0
PT08604,Denmark,Capital Region,73.0,Female,Colorectal,I,2019-04-09,2019-06-03,,Immunotherapy,Public,Lost to Follow-up,,KRAS,No,,Moderate,19.0,High,Rural,Statutory Health Insurance,18.0,Yes,No,Obesity,10.0
PT08605,Sweden,Västra Götaland,82.0,Male,,II,2010-04-21,2010-10-15,2011-06-20,Radiation,Public,Alive,59.0,KRAS,,Never,,39.9,Medium,Rural,Private Insurance,7.0,Yes,Yes,Diabetes,9.0
PT08606,Spain,Catalonia,49.0,Female,,II,2010-09-04,2011-01-09,2011-12-26,Immunotherapy,Private,Alive,84.0,EGFR,No,Never,Moderate,24.7,Low,Urban,Private Insurance,6.0,Yes,No,Diabetes,1.0
PT08607,Ireland,Dublin,87.0,Female,Breast,II,2022-05-05,2022-07-24,2023-05-03,Chemotherapy,Public,Deceased,48.0,EGFR,No,Never,None,,High,Urban,Private Insurance,8.0,No,Yes,None,4.0
PT08608,Poland,Silesian,51.0,Female,Breast,III,2017-03-05,2017-04-26,2017-11-02,Chemotherapy,Private,Deceased,29.0,EGFR,No,Current,None,24.3,Medium,Urban,Private Insurance,16.0,No,No,Obesity,5.0
PT08609,Sweden,Stockholm,43.0,Female,Pancreatic,II,2022-06-12,2022-07-31,2023-07-29,Radiation,Public,Alive,96.0,EGFR,No,Never,Moderate,38.6,Medium,Urban,NHS,9.0,No,No,Obesity,7.0
PT08610,,Oslo,,Male,,I,2015-06-09,2015-07-27,2015-09-21,Immunotherapy,Private,Alive,,EGFR,No,Former,None,39.4,Low,Rural,Private Insurance,13.0,No,No,Obesity,2.0
PT08611,Sweden,Västra Götaland,20.0,Male,Colorectal,I,2013-12-15,2014-02-27,2015-01-28,Radiation,Private,Lost to Follow-up,,KRAS,Yes,Never,None,39.6,Low,Urban,NHS,7.0,No,No,Diabetes,2.0
PT08612,Ireland,Munster,22.0,Female,Pancreatic,IV,2014-01-19,2014-04-11,2014-07-08,,Public,Alive,98.0,None,No,Never,,27.6,Medium,Urban,Private Insurance,11.0,Yes,No,Diabetes,9.0
PT08613,Austria,,47.0,Female,Ovarian,IV,2017-08-23,2017-09-30,2018-01-15,Targeted Therapy,Public,Alive,89.0,None,No,Never,None,31.3,Low,Urban,NHS,1.0,No,No,Obesity,1.0
PT08614,Norway,Vestland,62.0,Male,Prostate,I,2021-07-22,2021-08-08,2022-02-08,Immunotherapy,Public,Alive,45.0,None,Yes,Never,None,36.1,,Urban,Statutory Health Insurance,8.0,Yes,,None,4.0
PT08615,Poland,Masovian,65.0,Male,Ovarian,I,2018-03-08,2018-04-18,2018-11-20,Immunotherapy,Public,Alive,35.0,BRCA1,No,Never,None,21.3,Low,Urban,Private Insurance,5.0,No,No,Hypertension,
PT08616,France,Provence-Alpes-Côte d'Azur,20.0,,Colorectal,II,2016-04-26,2016-06-19,2017-01-18,Radiation,Public,Alive,49.0,None,No,Never,Heavy,26.4,High,Urban,Private Insurance,16.0,No,Yes,Cardiovascular Disease,4.0
PT08617,France,Île-de-France,57.0,,Lung,II,2011-06-19,2011-07-29,2012-07-20,Immunotherapy,Public,Alive,87.0,KRAS,Yes,Never,Moderate,24.7,Medium,Urban,Statutory Health Insurance,5.0,No,No,Diabetes,5.0
PT08618,Belgium,Brussels,54.0,Male,Breast,II,2010-03-21,,2010-10-29,,Public,Lost to Follow-up,,EGFR,No,Never,None,28.7,Medium,Urban,Statutory Health Insurance,3.0,Yes,No,None,5.0
PT08619,Poland,Lesser Poland,73.0,Male,Pancreatic,II,2021-12-16,2022-03-16,2023-02-13,Radiation,Public,Alive,106.0,BRCA1,Yes,Former,Moderate,35.5,Low,Urban,NHS,6.0,No,No,None,
PT08620,Italy,Sicily,43.0,Female,Ovarian,I,2019-12-16,2020-05-18,2021-01-22,Surgery,Public,Deceased,88.0,BRCA1,No,Former,Moderate,31.8,Medium,Urban,NHS,11.0,No,No,Cardiovascular Disease,2.0
PT08621,Italy,Veneto,47.0,Female,Pancreatic,I,2011-02-06,2011-04-23,2011-12-24,Radiation,Public,Deceased,20.0,BRCA1,Yes,Never,None,20.6,Medium,Rural,NHS,9.0,Yes,No,,
PT08622,Switzerland,Geneva,41.0,,Breast,II,2018-07-22,2018-12-15,2019-06-07,Immunotherapy,Research Institute,Deceased,54.0,KRAS,No,Never,None,22.5,Low,Rural,Private Insurance,12.0,No,Yes,Hypertension,2.0
PT08623,Finland,Uusimaa,35.0,Female,Lung,IV,2021-12-16,2022-01-20,2022-10-25,Chemotherapy,Private,Alive,92.0,BRCA1,No,Never,Moderate,20.9,Medium,Urban,NHS,5.0,No,No,Cardiovascular Disease,2.0
PT08624,Sweden,Västra Götaland,32.0,Male,Leukemia,I,2012-06-14,2012-10-15,2013-07-27,Targeted Therapy,Public,Alive,48.0,BRCA1,Yes,Former,Moderate,22.8,Medium,Urban,Private Insurance,7.0,No,No,Diabetes,9.0
PT08625,Netherlands,Utrecht,81.0,Male,Leukemia,III,2020-04-21,2020-08-19,2021-08-09,Immunotherapy,Private,Alive,11.0,EGFR,No,Never,Moderate,18.7,High,Urban,Statutory Health Insurance,13.0,No,Yes,Diabetes,9.0
PT08626,Austria,Styria,62.0,Female,Ovarian,II,2022-03-25,2022-05-20,2022-06-19,Immunotherapy,Public,Alive,55.0,KRAS,Yes,Never,Moderate,37.4,Low,Urban,Private Insurance,14.0,No,No,None,1.0
PT08627,Italy,Sicily,51.0,Male,Leukemia,,2020-09-01,2020-12-27,2021-07-10,Immunotherapy,Public,Deceased,51.0,KRAS,No,Never,None,36.6,Medium,Urban,Statutory Health Insurance,14.0,,No,Diabetes,3.0
PT08628,Netherlands,South Holland,86.0,Female,Colorectal,IV,2017-07-22,2017-08-21,,Surgery,Research Institute,Deceased,107.0,BRCA1,No,Current,Heavy,30.2,Low,Urban,Statutory Health Insurance,1.0,No,No,Hypertension,1.0
PT08629,Ireland,Dublin,76.0,Female,Pancreatic,II,2016-02-18,2016-08-09,2017-03-23,Chemotherapy,Private,Deceased,45.0,BRCA1,No,Never,Moderate,34.9,Low,Urban,Statutory Health Insurance,15.0,No,No,Diabetes,5.0
PT08630,Austria,Vienna,84.0,Male,Lung,II,2012-09-06,2012-11-20,2013-07-03,Immunotherapy,Public,Alive,113.0,None,No,Never,Moderate,40.0,High,Rural,NHS,3.0,No,No,Cardiovascular Disease,9.0
PT08631,Switzerland,Zurich,88.0,Female,Colorectal,,2018-06-22,2018-08-13,2019-06-19,Radiation,Public,Alive,35.0,,Yes,Never,Moderate,30.8,High,Rural,NHS,11.0,No,No,None,7.0
PT08632,France,Auvergne-Rhône-Alpes,68.0,Female,,I,2014-04-25,2014-06-19,2014-11-11,Chemotherapy,Public,Alive,118.0,KRAS,No,Current,None,31.5,Medium,Rural,NHS,11.0,No,Yes,Diabetes,6.0
PT08633,Norway,Oslo,52.0,Female,,II,2020-11-25,2021-04-12,,Chemotherapy,Research Institute,Alive,79.0,BRCA1,No,Current,,37.0,Low,Urban,Private Insurance,5.0,No,,Obesity,9.0
PT08634,Poland,Lesser Poland,38.0,Male,Lung,II,2013-09-21,2013-10-25,2013-12-15,Immunotherapy,Public,Alive,35.0,KRAS,No,Never,Moderate,29.7,Low,Urban,NHS,17.0,Yes,No,Cardiovascular Disease,9.0
PT08635,Germany,North Rhine-Westphalia,55.0,Male,Colorectal,I,2014-04-03,2014-09-09,2015-07-04,Radiation,,Deceased,6.0,KRAS,Yes,Never,None,19.1,High,Rural,Private Insurance,16.0,No,,Obesity,9.0
PT08636,,Madrid,89.0,Female,Ovarian,II,2016-12-10,2017-06-06,2017-10-10,Chemotherapy,Public,Alive,34.0,BRCA1,No,Former,Heavy,25.6,Medium,Urban,Statutory Health Insurance,19.0,No,No,Obesity,10.0
PT08637,Switzerland,Bern,34.0,Non-binary,Pancreatic,I,2013-04-02,2013-09-05,2013-10-14,Targeted Therapy,Public,Deceased,,EGFR,Yes,Never,None,33.8,Medium,Urban,NHS,10.0,Yes,Yes,Obesity,1.0
PT08638,Spain,Madrid,43.0,Male,Lung,,2021-02-19,2021-06-06,2022-04-05,Radiation,Public,Alive,100.0,EGFR,Yes,Never,None,33.5,Medium,Urban,NHS,19.0,No,No,Diabetes,6.0
PT08639,Ireland,Connacht,46.0,Non-binary,Leukemia,III,2013-10-15,2013-11-21,,Chemotherapy,Public,Alive,20.0,EGFR,No,Current,Moderate,39.9,Low,Urban,NHS,,No,No,None,8.0
PT08640,Germany,Berlin,68.0,Female,Leukemia,I,2018-11-15,2019-04-24,2020-03-30,Chemotherapy,Public,Alive,22.0,EGFR,No,Former,None,34.3,Medium,Rural,Statutory Health Insurance,17.0,No,No,Cardiovascular Disease,6.0
PT08641,Germany,Berlin,42.0,Female,,,2016-07-23,2016-08-27,2016-11-20,Radiation,Private,Deceased,13.0,KRAS,,Never,Moderate,,,Urban,Statutory Health Insurance,,No,No,Hypertension,10.0
PT08642,Poland,Silesian,52.0,Male,Breast,IV,2023-04-24,2023-07-18,2023-10-04,Surgery,Private,Deceased,109.0,EGFR,Yes,Former,None,39.0,Low,Urban,NHS,11.0,Yes,No,None,4.0
PT08643,Norway,Vestland,60.0,Male,Lung,I,2018-12-28,2019-01-29,2019-06-23,Radiation,Private,Alive,,EGFR,No,Never,None,18.7,Medium,,NHS,2.0,No,No,,2.0
PT08644,Belgium,Flanders,75.0,Male,Prostate,II,2015-03-24,2015-04-01,2016-01-13,Targeted Therapy,Private,Alive,51.0,KRAS,No,,Moderate,32.2,Low,Urban,NHS,7.0,No,No,Obesity,5.0
PT08645,Netherlands,South Holland,48.0,Male,Ovarian,II,2017-03-09,2017-08-19,2018-08-13,Surgery,Private,Alive,,EGFR,Yes,Never,None,23.6,High,Rural,Statutory Health Insurance,2.0,No,No,Diabetes,9.0
PT08646,Austria,Tyrol,50.0,Non-binary,Prostate,II,2017-01-21,2017-02-13,2017-06-06,Immunotherapy,Public,Alive,,BRCA1,Yes,Former,,23.4,Medium,Urban,Private Insurance,8.0,No,No,Diabetes,6.0
PT08647,Italy,Lombardy,84.0,Male,Colorectal,III,2018-08-28,2018-11-29,2019-10-18,Surgery,Public,Alive,111.0,EGFR,Yes,Current,Moderate,30.5,Medium,Urban,NHS,,Yes,No,Hypertension,1.0
PT08648,Belgium,Wallonia,37.0,Female,Breast,II,2012-11-03,2013-04-18,2013-09-25,Targeted Therapy,Public,Alive,33.0,EGFR,No,Former,Heavy,,Low,Urban,NHS,,No,,Cardiovascular Disease,8.0
PT08649,Belgium,Brussels,25.0,Male,Lung,I,2010-01-19,2010-02-07,2010-06-24,Targeted Therapy,Public,Deceased,95.0,EGFR,No,Never,None,24.2,,Rural,Statutory Health Insurance,8.0,No,No,Diabetes,9.0
PT08650,Poland,Lesser Poland,,Female,Leukemia,I,2011-09-13,2011-10-28,2012-01-18,Targeted Therapy,Public,Deceased,89.0,BRCA1,Yes,Former,None,23.1,Medium,Urban,Private Insurance,3.0,No,No,Diabetes,5.0
PT08651,Ireland,Munster,59.0,Male,Colorectal,III,2019-11-21,2019-12-27,2020-10-30,Chemotherapy,Research Institute,Deceased,82.0,BRCA1,No,Never,None,26.9,Low,Urban,NHS,16.0,No,No,None,6.0
PT08652,Belgium,Wallonia,84.0,Male,Lung,I,2020-10-06,2021-04-01,2021-05-28,Surgery,Public,Alive,36.0,BRCA1,Yes,Never,None,19.0,Medium,Urban,Private Insurance,4.0,No,No,Hypertension,4.0
PT08653,Netherlands,South Holland,61.0,Male,Lung,III,2014-02-22,2014-04-19,2014-10-25,Targeted Therapy,Public,Alive,56.0,BRCA1,Yes,Never,Moderate,25.1,High,Urban,NHS,7.0,No,No,Cardiovascular Disease,2.0
PT08654,Austria,Tyrol,87.0,Female,Lung,III,2016-07-12,2016-09-14,2017-05-31,Surgery,Public,Alive,,KRAS,Yes,Never,Moderate,21.9,Low,Rural,Private Insurance,12.0,Yes,No,Diabetes,2.0
PT08655,France,Auvergne-Rhône-Alpes,51.0,Male,Breast,I,2016-05-22,2016-07-23,2017-03-13,Surgery,Public,Alive,34.0,EGFR,Yes,Current,Moderate,,Medium,Urban,Statutory Health Insurance,9.0,No,,Hypertension,2.0
PT08656,Norway,Trøndelag,29.0,Male,Lung,I,2021-11-28,2022-01-26,,Immunotherapy,Public,Deceased,,EGFR,Yes,Never,Moderate,36.3,Medium,Urban,,17.0,No,No,Cardiovascular Disease,7.0
,France,Auvergne-Rhône-Alpes,88.0,Male,Breast,I,2017-03-29,2017-03-30,2018-01-12,Immunotherapy,Public,Alive,109.0,None,No,Former,Moderate,39.9,Medium,Urban,NHS,7.0,,Yes,Cardiovascular Disease,10.0
PT08658,Denmark,Central Denmark,28.0,Non-binary,Breast,II,2019-09-27,2020-01-02,2020-02-03,Immunotherapy,Research Institute,Alive,19.0,BRCA1,Yes,Former,Moderate,27.7,Medium,,NHS,,Yes,No,Diabetes,3.0
PT08659,Netherlands,Utrecht,88.0,Female,Pancreatic,III,2013-07-25,2013-10-10,2014-08-14,Chemotherapy,Public,Deceased,89.0,BRCA1,No,Never,None,20.1,Medium,Urban,Private Insurance,9.0,No,Yes,Obesity,10.0
PT08660,Norway,Trøndelag,80.0,Female,Lung,I,2019-04-30,2019-05-05,2020-04-27,Chemotherapy,Public,Deceased,46.0,EGFR,No,Former,Moderate,35.1,Low,,NHS,11.0,No,No,Hypertension,1.0
PT08661,Finland,Uusimaa,30.0,Female,Pancreatic,,2018-12-26,2019-05-22,2019-07-23,Immunotherapy,Private,Deceased,40.0,EGFR,No,Never,Moderate,36.4,Low,Urban,NHS,7.0,No,Yes,Diabetes,4.0
PT08662,Norway,Trøndelag,87.0,Male,Leukemia,II,,2011-11-27,2012-11-10,Targeted Therapy,Public,Alive,10.0,EGFR,Yes,Former,Moderate,24.5,Medium,Urban,NHS,19.0,No,Yes,Cardiovascular Disease,10.0
PT08663,Finland,Pirkanmaa,27.0,Female,Pancreatic,I,2013-06-17,2013-08-13,2014-03-20,Radiation,,Alive,69.0,BRCA1,No,,Moderate,27.9,Low,Urban,NHS,16.0,Yes,No,Obesity,7.0
PT08664,Switzerland,Zurich,68.0,Male,Pancreatic,II,2012-07-07,2012-12-24,2013-10-31,Chemotherapy,Public,Alive,84.0,BRCA1,No,Never,None,25.8,Medium,Rural,NHS,2.0,No,No,Obesity,8.0
PT08665,Portugal,Lisbon,43.0,Male,Ovarian,II,2023-06-17,2023-08-29,2024-07-16,Radiation,Private,Alive,61.0,KRAS,,Never,Moderate,39.4,Medium,Urban,Statutory Health Insurance,7.0,No,No,Diabetes,
PT08666,Poland,Silesian,52.0,Female,Ovarian,II,2011-11-12,,2012-10-16,Chemotherapy,Private,Alive,82.0,None,No,Never,Moderate,36.6,Medium,Rural,Private Insurance,3.0,No,No,Obesity,6.0
PT08667,,Andalusia,38.0,Female,Ovarian,II,2017-11-03,2018-01-27,2018-05-10,Surgery,Public,Alive,6.0,KRAS,Yes,Former,None,24.0,Medium,Urban,Private Insurance,11.0,Yes,No,Cardiovascular Disease,1.0
PT08668,Norway,Oslo,21.0,Male,Lung,II,,2023-07-26,2023-10-07,Targeted Therapy,Research Institute,Alive,,KRAS,No,Former,Moderate,32.7,Medium,Urban,,9.0,No,No,Obesity,10.0
PT08669,Norway,Trøndelag,74.0,Male,Leukemia,II,2023-10-22,2023-12-14,2024-05-30,Chemotherapy,Public,Alive,17.0,KRAS,No,Current,Heavy,31.7,High,Urban,NHS,5.0,Yes,No,Diabetes,6.0
,Germany,Bavaria,30.0,Female,Colorectal,I,2011-04-18,,2012-04-18,Surgery,Private,Alive,101.0,EGFR,Yes,Never,None,28.6,Medium,Urban,Statutory Health Insurance,14.0,No,No,None,9.0
PT08671,Netherlands,Utrecht,36.0,Female,Prostate,II,2014-11-28,2015-04-03,2015-12-15,Targeted Therapy,Private,Alive,26.0,KRAS,Yes,Current,None,33.7,Medium,Rural,Private Insurance,8.0,No,No,Hypertension,4.0
PT08672,Ireland,Munster,61.0,Male,Colorectal,II,2017-07-06,2017-10-17,,Chemotherapy,Public,Alive,81.0,KRAS,No,Never,None,36.2,High,Urban,Private Insurance,6.0,No,No,Hypertension,7.0
PT08673,Spain,Madrid,80.0,Male,Breast,I,,2022-02-23,2022-04-12,Targeted Therapy,Private,Alive,,None,Yes,Never,Moderate,38.8,High,Rural,NHS,13.0,,No,Cardiovascular Disease,10.0
PT08674,Ireland,Dublin,22.0,Female,Colorectal,I,2019-07-12,2019-09-01,2020-04-15,Chemotherapy,Public,Alive,38.0,KRAS,No,Former,Moderate,28.3,Low,Rural,NHS,,No,Yes,Obesity,
PT08675,Belgium,Brussels,54.0,Female,Prostate,I,2019-07-03,2019-07-08,2020-06-13,Immunotherapy,Public,Alive,9.0,KRAS,No,Former,None,32.3,Medium,Urban,NHS,9.0,No,No,Hypertension,3.0
PT08676,Portugal,Lisbon,85.0,Non-binary,Prostate,I,2014-09-04,2015-02-01,2016-01-01,Chemotherapy,Public,Lost to Follow-up,,BRCA1,,Never,Moderate,,Low,,Private Insurance,18.0,No,No,Cardiovascular Disease,2.0
PT08677,Italy,Lombardy,20.0,Male,Leukemia,II,2020-01-13,,,Chemotherapy,Public,Alive,56.0,BRCA1,Yes,,None,29.2,Medium,Rural,Statutory Health Insurance,2.0,Yes,No,Hypertension,4.0
PT08678,Norway,Vestland,26.0,Female,Ovarian,I,2021-05-07,2021-09-19,2022-02-04,Surgery,Research Institute,Alive,54.0,None,No,Never,None,36.2,Medium,Urban,Private Insurance,17.0,No,No,Diabetes,10.0
PT08679,Sweden,Västra Götaland,39.0,Male,Colorectal,II,2023-03-16,2023-05-19,2024-01-14,Immunotherapy,Research Institute,Alive,78.0,EGFR,Yes,Never,Moderate,18.4,High,Urban,Private Insurance,13.0,No,No,Diabetes,1.0
PT08680,Switzerland,Zurich,62.0,Female,Breast,II,2018-03-31,2018-04-26,2018-07-21,Radiation,Public,Alive,44.0,None,No,Never,None,33.3,Low,,NHS,2.0,No,No,Hypertension,4.0
PT08681,Spain,Andalusia,25.0,Male,Pancreatic,II,2018-09-02,2018-09-27,2019-01-29,Targeted Therapy,Public,Deceased,76.0,BRCA1,No,Never,,21.9,Low,Rural,Statutory Health Insurance,8.0,Yes,No,,9.0
PT08682,,Oslo,74.0,Male,Pancreatic,III,2015-12-06,2016-02-13,2016-07-13,Radiation,Public,Deceased,23.0,EGFR,No,Never,Moderate,26.8,Medium,Urban,NHS,16.0,Yes,No,Diabetes,5.0
PT08683,Portugal,Algarve,40.0,Male,Breast,,2022-11-19,2023-04-28,2024-02-18,Radiation,Public,Deceased,64.0,KRAS,No,Never,Moderate,36.1,Low,Urban,Statutory Health Insurance,11.0,No,No,Hypertension,6.0
PT08684,Switzerland,Geneva,70.0,Female,Leukemia,I,2013-01-02,2013-01-10,2013-10-20,Immunotherapy,Private,Alive,28.0,KRAS,No,Former,Heavy,35.7,Low,Urban,Private Insurance,5.0,No,No,None,7.0
PT08685,Belgium,Flanders,,Female,Pancreatic,I,2021-04-25,2021-05-04,2021-10-25,Immunotherapy,Public,Deceased,,KRAS,Yes,Never,Heavy,28.0,Medium,Urban,Private Insurance,,No,No,None,6.0
PT08686,Portugal,Algarve,54.0,Female,Leukemia,I,2019-04-25,2019-06-18,2020-04-13,Immunotherapy,Public,Alive,25.0,None,Yes,Never,Moderate,18.7,Medium,Rural,Statutory Health Insurance,1.0,No,No,Cardiovascular Disease,3.0
PT08687,Belgium,Brussels,27.0,Female,Pancreatic,II,,2014-01-09,2014-07-17,Surgery,Private,Alive,36.0,KRAS,Yes,,Moderate,,Medium,Rural,NHS,15.0,No,Yes,None,3.0
PT08688,Netherlands,Utrecht,87.0,,Pancreatic,I,2021-09-22,2022-03-13,,Surgery,Public,Alive,94.0,BRCA1,Yes,Current,Moderate,25.5,Low,Rural,NHS,6.0,No,No,Obesity,6.0
PT08689,Poland,Lesser Poland,35.0,Male,Colorectal,II,2016-11-11,2017-04-29,2017-10-14,Targeted Therapy,Public,Alive,105.0,BRCA1,No,Never,Heavy,22.4,Medium,Rural,Statutory Health Insurance,14.0,No,No,None,5.0
PT08690,Netherlands,Utrecht,86.0,Non-binary,Leukemia,IV,2018-04-27,2018-10-14,2019-08-08,Immunotherapy,Public,Deceased,72.0,BRCA1,No,Former,None,20.9,Low,Urban,Statutory Health Insurance,8.0,No,No,Obesity,7.0
PT08691,Belgium,Brussels,83.0,Male,Prostate,I,2012-02-17,,2012-08-31,Radiation,Private,Alive,58.0,EGFR,Yes,Current,None,25.0,Medium,Urban,Statutory Health Insurance,12.0,Yes,No,Diabetes,8.0
PT08692,Norway,Trøndelag,21.0,Male,,IV,,2013-12-15,2014-09-11,Targeted Therapy,Public,Alive,59.0,EGFR,No,Never,Moderate,27.0,Medium,Urban,NHS,11.0,No,No,None,8.0
PT08693,Italy,Sicily,20.0,Non-binary,Pancreatic,IV,2013-12-20,2014-04-26,2014-10-28,Surgery,Research Institute,Alive,67.0,,No,Current,None,34.0,Low,Rural,NHS,8.0,No,No,Hypertension,2.0
PT08694,Portugal,Algarve,77.0,,Ovarian,III,2019-06-26,2019-12-14,2020-01-28,Chemotherapy,Public,Lost to Follow-up,,None,Yes,Never,Moderate,30.5,Medium,Urban,Private Insurance,8.0,No,,Hypertension,5.0
PT08695,Ireland,Connacht,20.0,Female,Prostate,IV,2017-12-09,2018-04-24,2019-03-11,Chemotherapy,Public,Deceased,25.0,None,No,,Moderate,30.4,Medium,Urban,Statutory Health Insurance,8.0,No,No,Hypertension,4.0
PT08696,Italy,Sicily,26.0,Male,Lung,I,2022-05-01,2022-10-22,2023-07-19,,Public,Lost to Follow-up,,EGFR,Yes,Former,Moderate,36.6,Medium,Urban,Statutory Health Insurance,2.0,No,No,Hypertension,10.0
PT08697,France,Île-de-France,88.0,Female,Prostate,I,2021-05-29,2021-07-02,2022-01-15,Surgery,Research Institute,Lost to Follow-up,,EGFR,Yes,Never,Moderate,37.8,Medium,Urban,Statutory Health Insurance,1.0,Yes,No,Diabetes,2.0
PT08698,Denmark,Central Denmark,37.0,Female,Ovarian,I,2016-01-06,2016-03-14,2016-11-29,,Public,Deceased,30.0,KRAS,Yes,Current,Heavy,26.8,High,Urban,Private Insurance,16.0,No,No,Cardiovascular Disease,10.0
,Switzerland,Bern,51.0,,Breast,I,2013-12-31,2014-05-23,2014-09-20,Surgery,Public,Alive,99.0,KRAS,No,Never,Moderate,36.6,Medium,Urban,Private Insurance,4.0,Yes,No,,10.0
,France,Provence-Alpes-Côte d'Azur,64.0,Female,Lung,II,2020-08-06,2020-12-30,2021-09-17,Immunotherapy,Research Institute,Alive,56.0,BRCA1,No,Current,None,36.0,Low,Urban,,5.0,No,No,Cardiovascular Disease,3.0
PT08701,Austria,Styria,52.0,Female,Colorectal,III,2013-10-12,2014-02-28,2014-03-31,,Public,Alive,26.0,None,No,Current,None,23.0,Medium,Rural,NHS,3.0,Yes,No,Obesity,3.0
PT08702,Switzerland,Zurich,68.0,Male,Ovarian,I,2018-02-04,2018-07-01,2019-02-20,Radiation,Public,Deceased,53.0,KRAS,Yes,Never,None,19.1,Low,Urban,NHS,9.0,No,No,Obesity,1.0
PT08703,Belgium,Wallonia,52.0,Male,Lung,I,2013-08-21,2013-11-02,2014-08-16,Immunotherapy,Public,Deceased,104.0,None,Yes,Never,None,38.3,Medium,Rural,Private Insurance,14.0,No,No,Diabetes,
PT08704,Italy,Sicily,87.0,Male,Leukemia,III,2013-02-13,2013-03-10,2013-12-15,Radiation,Public,Alive,59.0,,Yes,Never,Moderate,39.7,Low,Urban,NHS,3.0,No,No,None,4.0
PT08705,Finland,Southwest Finland,47.0,Female,Breast,I,2023-03-10,2023-08-07,2024-07-26,Targeted Therapy,Private,Alive,104.0,EGFR,No,Current,,31.1,Low,Urban,Private Insurance,15.0,No,No,None,7.0
PT08706,,Zealand,72.0,Female,Leukemia,II,2018-07-20,2019-01-01,2019-04-10,,Public,Alive,,KRAS,,Never,None,25.5,High,Urban,Statutory Health Insurance,9.0,Yes,No,Hypertension,3.0
PT08707,Finland,Uusimaa,63.0,Female,Prostate,I,2012-12-31,2013-05-18,2013-08-05,Radiation,Public,,21.0,KRAS,No,Never,Moderate,32.5,Medium,Rural,Private Insurance,17.0,No,No,Obesity,4.0
PT08708,Switzerland,Zurich,74.0,Male,,III,,2021-02-27,2021-09-20,Targeted Therapy,Private,Alive,92.0,KRAS,Yes,Former,Moderate,19.1,Medium,Urban,Private Insurance,10.0,No,No,Cardiovascular Disease,
PT08709,,Lombardy,29.0,Male,Breast,II,2014-07-22,2014-09-12,2015-03-12,Surgery,Public,Alive,65.0,,No,Never,Moderate,34.5,Medium,Rural,Statutory Health Insurance,3.0,No,No,Hypertension,7.0
PT08710,Portugal,Lisbon,33.0,Male,Colorectal,III,2023-10-11,2023-12-27,2024-08-21,Immunotherapy,Public,Alive,80.0,KRAS,No,Never,Moderate,22.6,High,Urban,Statutory Health Insurance,8.0,No,No,Diabetes,1.0
PT08711,Belgium,Brussels,55.0,Male,Pancreatic,I,2017-09-09,2017-11-16,2018-08-17,Surgery,Research Institute,Deceased,17.0,BRCA1,No,Never,,20.1,High,Urban,Private Insurance,3.0,No,No,None,5.0
PT08712,Finland,Southwest Finland,53.0,Female,Breast,IV,2017-11-13,2017-12-11,2018-05-11,Immunotherapy,Public,Alive,104.0,EGFR,Yes,Never,Moderate,37.8,High,Urban,Statutory Health Insurance,14.0,No,No,Diabetes,6.0
PT08713,Finland,Southwest Finland,37.0,Non-binary,Ovarian,II,2021-08-09,2022-01-14,2022-07-30,Chemotherapy,,Alive,74.0,EGFR,Yes,Never,Moderate,30.3,Medium,Urban,Private Insurance,5.0,Yes,No,Cardiovascular Disease,6.0
PT08714,Belgium,Brussels,35.0,Male,Leukemia,III,2013-04-05,2013-09-26,2014-03-04,Radiation,Private,Alive,108.0,BRCA1,Yes,Never,Moderate,28.8,Medium,Urban,Statutory Health Insurance,16.0,No,No,,2.0
PT08715,Poland,Lesser Poland,56.0,Female,Prostate,IV,2018-08-08,2019-01-23,2019-05-05,Surgery,Public,Deceased,61.0,BRCA1,No,Former,None,31.6,Medium,Urban,Private Insurance,4.0,No,No,Obesity,10.0
PT08716,Finland,Pirkanmaa,60.0,Male,Lung,II,2023-12-06,2024-05-03,2024-10-26,Surgery,Private,Alive,110.0,KRAS,Yes,Never,Moderate,,Medium,Urban,NHS,6.0,No,No,,6.0
,France,Île-de-France,44.0,Female,Colorectal,,2019-11-01,2020-03-23,2020-07-27,Radiation,Public,Alive,49.0,EGFR,Yes,Current,None,22.2,Low,Urban,NHS,,Yes,No,Diabetes,5.0
PT08718,Portugal,Algarve,27.0,Male,Breast,I,2013-04-01,2013-08-10,2013-09-27,Radiation,Public,Alive,43.0,KRAS,No,Former,Moderate,22.6,Medium,Urban,NHS,18.0,No,Yes,Diabetes,9.0
PT08719,Netherlands,Utrecht,37.0,Female,Breast,II,,2014-08-07,2015-02-13,Targeted Therapy,,Alive,27.0,None,,Never,None,33.5,Medium,Urban,Private Insurance,,No,No,Obesity,10.0
PT08720,Ireland,Munster,87.0,Male,Pancreatic,IV,2019-03-13,,2020-03-10,,,Alive,,KRAS,No,Never,Moderate,36.2,Low,Rural,Statutory Health Insurance,18.0,No,No,Hypertension,6.0
PT08721,Denmark,Capital Region,67.0,Female,Colorectal,,2019-02-07,2019-02-15,2020-01-27,Targeted Therapy,Public,,26.0,KRAS,,Never,Heavy,38.6,Medium,Urban,Statutory Health Insurance,11.0,No,No,Diabetes,2.0
PT08722,Italy,Lombardy,89.0,Male,Lung,IV,2011-12-07,2012-04-22,2012-06-20,Surgery,Private,Deceased,96.0,None,Yes,Never,,35.6,Medium,Urban,NHS,8.0,No,Yes,Diabetes,6.0
PT08723,Finland,Pirkanmaa,86.0,Male,Prostate,III,2020-08-16,,2021-05-11,,Public,Alive,114.0,EGFR,No,Never,,29.5,High,Urban,Statutory Health Insurance,15.0,No,Yes,,5.0
PT08724,Belgium,Brussels,37.0,Female,Breast,II,2021-12-01,2022-03-01,2022-10-06,Chemotherapy,Public,,18.0,None,Yes,Former,None,33.7,High,Urban,Private Insurance,16.0,Yes,No,None,4.0
PT08725,,Provence-Alpes-Côte d'Azur,37.0,Male,Breast,II,2017-11-29,2018-04-08,2018-09-25,Surgery,,Alive,99.0,KRAS,No,Never,Moderate,29.7,High,Urban,,9.0,No,No,Diabetes,6.0
PT08726,Germany,North Rhine-Westphalia,75.0,Female,Colorectal,I,2014-03-10,2014-08-22,2014-09-23,Surgery,Public,,,KRAS,No,Never,None,32.4,Medium,Urban,NHS,16.0,No,No,Diabetes,9.0
PT08727,Ireland,Munster,42.0,Non-binary,Colorectal,I,2022-11-29,2023-04-18,2024-04-14,Immunotherapy,Public,Deceased,51.0,KRAS,No,Never,Moderate,19.7,Medium,Rural,Private Insurance,,No,Yes,None,4.0
PT08728,Austria,Vienna,54.0,,Breast,I,2020-11-07,2020-11-26,2021-06-03,Targeted Therapy,Public,Deceased,64.0,,,Current,Heavy,32.2,Low,Rural,Statutory Health Insurance,10.0,No,Yes,Hypertension,
PT08729,Portugal,Algarve,25.0,Female,Breast,II,2015-01-23,2015-02-19,2016-01-30,Immunotherapy,Research Institute,Lost to Follow-up,,BRCA1,No,Current,None,25.0,Low,Urban,Statutory Health Insurance,16.0,No,No,Diabetes,8.0
PT08730,Sweden,Skåne,45.0,Male,Pancreatic,IV,2019-10-17,2020-03-17,2020-06-15,Surgery,Public,Alive,84.0,BRCA1,No,Never,,29.8,Medium,Urban,NHS,15.0,Yes,No,None,1.0
PT08731,Sweden,Stockholm,80.0,Female,Breast,II,2014-03-27,2014-04-12,2015-01-31,Radiation,,Alive,23.0,KRAS,Yes,Never,Moderate,21.0,Medium,Urban,Statutory Health Insurance,12.0,Yes,Yes,Obesity,3.0
PT08732,Spain,Andalusia,34.0,Male,Leukemia,II,2020-05-29,2020-05-31,2020-09-04,Chemotherapy,,Deceased,48.0,KRAS,No,Never,None,30.1,Medium,Urban,Private Insurance,4.0,No,No,Hypertension,3.0
PT08733,Portugal,Lisbon,51.0,Female,Breast,I,2017-02-19,2017-07-18,2017-11-19,Immunotherapy,Public,Alive,60.0,KRAS,Yes,Never,None,32.6,Medium,Urban,Private Insurance,,No,No,Hypertension,7.0
PT08734,Germany,North Rhine-Westphalia,31.0,Male,Prostate,III,2021-01-16,2021-01-26,2021-09-19,Surgery,Public,,80.0,KRAS,Yes,Never,None,22.4,Medium,Rural,NHS,3.0,No,No,None,7.0
PT08735,Norway,Vestland,24.0,Female,Prostate,II,2010-12-11,2011-03-27,2011-07-02,Targeted Therapy,Private,,107.0,KRAS,,Former,None,20.2,Medium,Urban,NHS,14.0,Yes,No,None,7.0
PT08736,Italy,Lombardy,83.0,Male,Ovarian,II,2016-08-23,2016-09-09,2017-06-06,Immunotherapy,Research Institute,Deceased,76.0,KRAS,No,Never,Moderate,26.3,Low,Rural,Statutory Health Insurance,14.0,No,No,Obesity,7.0
PT08737,Norway,Vestland,46.0,Male,Pancreatic,IV,2021-07-29,2021-08-05,2021-09-20,Surgery,Private,Deceased,110.0,KRAS,No,Never,Moderate,28.0,Medium,Urban,Statutory Health Insurance,9.0,No,No,Cardiovascular Disease,4.0
PT08738,Italy,Lombardy,64.0,Male,Lung,IV,,2013-07-04,,Targeted Therapy,Private,Deceased,103.0,EGFR,Yes,Never,Moderate,32.1,Low,Urban,Statutory Health Insurance,2.0,No,,None,4.0
PT08739,Switzerland,Zurich,54.0,,Colorectal,III,2023-03-06,2023-08-31,2024-08-09,Targeted Therapy,Private,Alive,37.0,EGFR,No,Former,None,,Low,Urban,Statutory Health Insurance,8.0,No,No,Diabetes,8.0
PT08740,Portugal,,45.0,Male,Lung,IV,2014-06-07,2014-06-17,2015-02-22,Chemotherapy,Public,Deceased,82.0,BRCA1,Yes,Former,,28.3,Medium,Urban,NHS,3.0,No,No,Cardiovascular Disease,3.0
PT08741,Sweden,Stockholm,42.0,Male,Breast,II,2021-06-04,2021-06-20,2022-02-07,Radiation,Public,Alive,21.0,BRCA1,No,Former,None,38.2,,Urban,Statutory Health Insurance,5.0,No,No,,6.0
PT08742,Italy,Veneto,32.0,Female,Colorectal,III,2013-03-09,,2013-10-14,Chemotherapy,Private,Deceased,95.0,,No,Never,Moderate,27.1,Low,Urban,Private Insurance,15.0,No,,Cardiovascular Disease,4.0
PT08743,,,22.0,Male,,II,2018-10-05,2019-02-19,2019-04-29,Targeted Therapy,Public,Deceased,45.0,EGFR,No,Never,Moderate,21.8,High,Urban,NHS,3.0,No,,Cardiovascular Disease,6.0
PT08744,,Porto,48.0,Female,Colorectal,I,2023-10-08,2023-10-21,2024-03-29,Immunotherapy,Public,Lost to Follow-up,,None,Yes,Current,Heavy,36.5,Medium,Urban,Statutory Health Insurance,18.0,No,No,Cardiovascular Disease,4.0
PT08745,Ireland,Connacht,85.0,Male,Pancreatic,IV,2012-01-24,2012-07-18,2013-02-10,Radiation,Research Institute,Alive,46.0,KRAS,No,Current,,27.3,Medium,Urban,Private Insurance,14.0,No,No,None,9.0
PT08746,Portugal,Algarve,83.0,Male,Ovarian,I,,2014-10-01,2015-03-08,Targeted Therapy,Public,Alive,59.0,EGFR,Yes,Current,Moderate,31.9,High,Urban,NHS,15.0,No,No,Hypertension,10.0
PT08747,Denmark,Capital Region,47.0,Female,Leukemia,I,,2021-11-10,2021-12-17,Radiation,Public,Alive,39.0,None,No,Former,Heavy,,High,Urban,Private Insurance,,No,No,Obesity,5.0
PT08748,Poland,Lesser Poland,55.0,Female,Ovarian,I,2022-07-04,2022-08-03,2023-07-16,Immunotherapy,Private,Alive,90.0,None,Yes,Never,None,31.7,Medium,Urban,Statutory Health Insurance,9.0,,,,10.0
PT08749,Ireland,Munster,25.0,Female,Leukemia,II,2021-08-17,2021-10-28,2022-06-06,Surgery,Private,Alive,23.0,EGFR,Yes,Current,Moderate,36.6,Medium,Rural,,16.0,No,No,Hypertension,8.0
PT08750,Denmark,Capital Region,30.0,Female,Leukemia,I,2021-03-23,2021-04-03,2022-01-30,,Public,Lost to Follow-up,,KRAS,No,Never,None,32.3,Low,Urban,Statutory Health Insurance,6.0,No,No,Diabetes,2.0
PT08751,Sweden,Stockholm,57.0,Male,Ovarian,,2018-06-17,2018-10-08,2019-09-01,Targeted Therapy,Private,Deceased,25.0,EGFR,No,Never,Moderate,35.9,Medium,Urban,NHS,11.0,No,No,Obesity,4.0
PT08752,Finland,Southwest Finland,53.0,Female,Pancreatic,IV,2017-01-15,2017-03-31,2017-12-10,Targeted Therapy,Public,Alive,81.0,None,No,Former,None,28.0,Medium,Urban,Statutory Health Insurance,13.0,No,No,Hypertension,10.0
PT08753,Poland,Silesian,86.0,,Ovarian,I,2021-11-30,2022-01-17,2022-09-21,Chemotherapy,Public,Alive,90.0,None,No,Former,Moderate,39.6,,Rural,Private Insurance,5.0,No,No,None,3.0
PT08754,Netherlands,North Holland,65.0,Male,Lung,III,2018-07-04,2018-07-11,2018-08-11,Targeted Therapy,Research Institute,Deceased,109.0,BRCA1,Yes,,None,29.9,Medium,,Private Insurance,9.0,No,No,Diabetes,7.0
PT08755,Denmark,Central Denmark,48.0,Female,Colorectal,I,2022-10-30,2022-10-31,2023-05-23,Surgery,Private,Alive,101.0,KRAS,Yes,Former,None,33.0,Medium,Urban,,1.0,No,No,Cardiovascular Disease,8.0
PT08756,Portugal,Lisbon,79.0,Female,Lung,I,2015-03-02,2015-05-28,,Surgery,Research Institute,Deceased,111.0,None,No,Never,Moderate,22.2,Medium,Urban,,14.0,No,No,Diabetes,9.0
PT08757,Spain,Catalonia,73.0,Male,Colorectal,III,2022-02-05,2022-03-09,2022-10-01,Chemotherapy,Private,Deceased,14.0,,No,Former,None,27.1,High,Rural,Statutory Health Insurance,13.0,No,No,None,5.0
PT08758,France,Île-de-France,88.0,Female,Breast,IV,2022-06-15,2022-08-16,2022-12-16,,Public,Lost to Follow-up,,KRAS,Yes,Never,Moderate,28.3,Low,Urban,NHS,13.0,No,No,Diabetes,3.0
PT08759,Sweden,Stockholm,28.0,Female,Leukemia,I,2020-09-08,2021-01-29,2021-11-25,Radiation,Private,Deceased,52.0,EGFR,No,Former,Moderate,36.2,Low,Urban,NHS,1.0,Yes,No,None,5.0
PT08760,Belgium,Brussels,,Female,Leukemia,II,2017-12-18,2018-03-20,2018-07-21,Surgery,Private,Alive,66.0,None,No,Never,Moderate,35.0,High,Rural,NHS,7.0,No,No,Obesity,2.0
PT08761,,Västra Götaland,87.0,Male,Colorectal,,2022-03-13,2022-05-30,2023-02-19,Radiation,Public,Alive,16.0,KRAS,Yes,Never,Moderate,29.9,High,Urban,NHS,15.0,Yes,Yes,Obesity,4.0
PT08762,Poland,Lesser Poland,77.0,Female,Lung,IV,2021-04-21,,2021-08-07,Targeted Therapy,Private,Alive,16.0,BRCA1,No,Former,Heavy,35.7,High,Urban,NHS,1.0,No,No,Obesity,8.0
PT08763,Austria,Styria,71.0,Male,Lung,I,2013-09-13,2013-10-17,2014-03-19,Targeted Therapy,Public,Alive,107.0,None,No,Former,None,35.8,High,Rural,Private Insurance,17.0,No,No,None,4.0
PT08764,Spain,Catalonia,53.0,Male,,II,2011-03-12,2011-08-07,2012-04-05,Immunotherapy,Public,Alive,33.0,EGFR,Yes,Current,Moderate,32.5,Medium,Urban,NHS,17.0,No,No,Obesity,8.0
PT08765,Sweden,Stockholm,54.0,Male,Leukemia,IV,2019-07-23,2019-11-18,2020-05-22,Radiation,,Deceased,86.0,BRCA1,No,Current,Moderate,38.7,High,Rural,NHS,14.0,No,No,Cardiovascular Disease,2.0
PT08766,Belgium,Wallonia,52.0,Female,Leukemia,II,2020-12-01,,2021-04-13,Surgery,Public,Alive,102.0,EGFR,Yes,Never,Moderate,,Medium,,Private Insurance,18.0,Yes,No,None,
PT08767,Norway,Oslo,51.0,Female,Lung,IV,2023-07-16,2023-08-13,2023-12-15,Chemotherapy,Public,Alive,118.0,KRAS,No,Former,None,22.8,Medium,Urban,Statutory Health Insurance,9.0,No,No,Hypertension,7.0
PT08768,Germany,North Rhine-Westphalia,74.0,Female,Leukemia,IV,2017-10-31,2017-11-11,2018-06-17,Surgery,Public,Deceased,103.0,,No,Former,Moderate,25.6,Low,Rural,Private Insurance,17.0,No,No,None,8.0
PT08769,Finland,Uusimaa,27.0,Female,Lung,II,2021-06-04,2021-11-09,2022-04-09,Radiation,Private,Alive,29.0,EGFR,No,Current,Moderate,,Medium,Urban,Statutory Health Insurance,10.0,No,No,Obesity,4.0
PT08770,Portugal,Porto,65.0,Male,Prostate,II,2012-12-09,2013-01-16,2014-01-02,Radiation,Private,Deceased,26.0,EGFR,Yes,Current,Moderate,27.3,Medium,Rural,NHS,6.0,No,No,Diabetes,9.0
PT08771,Netherlands,,33.0,Male,Colorectal,I,2016-10-25,2017-03-03,2017-05-15,Surgery,,Alive,112.0,KRAS,Yes,Never,Moderate,25.5,,Urban,Private Insurance,2.0,No,No,Hypertension,
,Spain,Andalusia,27.0,Female,Colorectal,IV,2011-11-01,2012-03-01,2012-12-15,Surgery,Research Institute,Alive,,EGFR,Yes,Former,Moderate,35.3,Low,Urban,Statutory Health Insurance,19.0,No,No,Diabetes,2.0
PT08773,Germany,Berlin,73.0,Non-binary,Prostate,I,2011-04-08,2011-09-16,2012-08-05,Immunotherapy,Private,Alive,40.0,BRCA1,No,Current,None,35.7,Medium,Urban,Private Insurance,11.0,No,No,None,9.0
PT08774,Spain,Madrid,40.0,Female,,III,2011-01-12,2011-05-01,2011-12-04,Targeted Therapy,Private,Alive,42.0,None,No,Current,Moderate,,Medium,Rural,Private Insurance,13.0,No,No,Obesity,10.0
PT08775,France,Auvergne-Rhône-Alpes,33.0,Male,Ovarian,II,2017-02-06,2017-04-12,2018-03-12,Immunotherapy,,Lost to Follow-up,,BRCA1,No,Former,Moderate,29.2,Low,Urban,NHS,10.0,No,No,Cardiovascular Disease,2.0
PT08776,Ireland,Dublin,21.0,Male,Breast,II,2011-03-12,2011-08-31,2012-06-16,Surgery,Research Institute,Alive,16.0,EGFR,Yes,Never,Moderate,37.3,Medium,Urban,Private Insurance,10.0,No,Yes,Hypertension,6.0
PT08777,Portugal,Lisbon,80.0,Male,Leukemia,I,2012-10-17,2012-12-20,2013-03-04,Surgery,Research Institute,Deceased,37.0,KRAS,No,Current,Moderate,29.7,Medium,Urban,Private Insurance,7.0,No,No,Diabetes,8.0
PT08778,Ireland,Munster,36.0,Male,Lung,II,2011-12-25,2012-01-03,,Chemotherapy,Public,Deceased,108.0,None,Yes,Never,Moderate,38.5,Medium,Urban,NHS,3.0,No,No,Cardiovascular Disease,8.0
PT08779,Belgium,Flanders,67.0,Male,Pancreatic,I,2018-01-18,2018-02-19,2018-12-09,Targeted Therapy,Research Institute,Alive,31.0,None,No,Never,Moderate,36.4,Medium,Urban,Private Insurance,4.0,No,No,Diabetes,10.0
PT08780,Belgium,Wallonia,27.0,Female,Breast,I,2016-01-12,2016-03-06,2017-02-04,Chemotherapy,Private,Lost to Follow-up,,,No,Never,None,28.0,Medium,,Private Insurance,1.0,No,No,Cardiovascular Disease,8.0
PT08781,Germany,Berlin,75.0,Female,Prostate,I,2021-12-13,2022-04-17,2022-06-21,Targeted Therapy,Public,Alive,,KRAS,No,Current,None,38.6,Low,Urban,Private Insurance,13.0,No,Yes,Hypertension,7.0
PT08782,Italy,Veneto,36.0,Female,Colorectal,I,2019-12-03,2019-12-29,2020-12-18,Targeted Therapy,Private,Deceased,110.0,BRCA1,No,Current,Heavy,35.3,Low,Urban,Statutory Health Insurance,9.0,Yes,No,Cardiovascular Disease,2.0
PT08783,Germany,,,Male,Colorectal,II,2016-01-17,2016-03-19,,Radiation,Public,Alive,81.0,EGFR,No,Former,Heavy,39.1,Medium,Urban,NHS,7.0,No,No,Cardiovascular Disease,5.0
PT08784,Belgium,Flanders,31.0,Male,Ovarian,II,2021-07-17,2021-11-03,2022-09-20,Targeted Therapy,Public,Alive,,EGFR,No,Never,None,22.6,High,Urban,NHS,,No,No,Hypertension,7.0
PT08785,Austria,Styria,57.0,Female,,I,2019-04-09,2019-09-26,2020-09-13,Surgery,Public,,25.0,EGFR,No,Current,Heavy,33.2,Medium,Urban,Statutory Health Insurance,10.0,No,Yes,None,9.0
PT08786,Spain,Catalonia,37.0,Female,Colorectal,II,2015-09-25,2016-03-19,2016-07-29,Targeted Therapy,Public,Alive,107.0,BRCA1,Yes,Former,Moderate,38.3,Medium,Urban,Statutory Health Insurance,17.0,No,Yes,Hypertension,4.0
PT08787,Switzerland,Zurich,45.0,Female,Leukemia,III,2016-11-21,2017-04-04,2018-03-31,Immunotherapy,Private,Alive,39.0,None,No,Current,None,18.0,Medium,Urban,Statutory Health Insurance,19.0,No,No,Diabetes,4.0
PT08788,Ireland,Munster,56.0,Female,Ovarian,II,2019-06-16,2019-10-12,2020-02-29,Radiation,Private,,96.0,BRCA1,Yes,Former,None,20.1,Medium,Urban,NHS,11.0,No,Yes,Hypertension,4.0
PT08789,Italy,Sicily,89.0,Female,Ovarian,IV,,2017-05-23,2018-03-21,Chemotherapy,Public,Alive,59.0,BRCA1,Yes,Never,None,20.7,Medium,Urban,NHS,18.0,Yes,No,Obesity,5.0
PT08790,Finland,Uusimaa,60.0,Male,Lung,I,2023-12-18,2024-05-17,2024-07-06,Targeted Therapy,Public,Alive,103.0,KRAS,Yes,Current,Moderate,26.9,Low,Urban,,6.0,No,No,Obesity,6.0
PT08791,Austria,Styria,61.0,Male,,III,2021-01-09,2021-04-22,2021-12-12,Chemotherapy,Private,Alive,70.0,None,No,Never,Moderate,37.3,Low,Rural,Statutory Health Insurance,12.0,Yes,No,Diabetes,4.0
PT08792,France,Auvergne-Rhône-Alpes,60.0,Female,Prostate,II,2013-02-18,2013-03-15,2013-07-19,Surgery,Public,Alive,84.0,EGFR,No,Current,Moderate,28.5,Low,Urban,Private Insurance,11.0,No,Yes,Diabetes,8.0
PT08793,Ireland,Munster,66.0,Male,Pancreatic,II,2018-03-28,2018-08-16,2019-07-21,Chemotherapy,Private,,19.0,KRAS,Yes,,,19.8,Low,Urban,NHS,7.0,No,No,None,5.0
PT08794,Portugal,Lisbon,33.0,Male,Lung,II,2013-08-05,2014-01-05,2014-12-01,Targeted Therapy,Private,Alive,48.0,EGFR,No,Never,Moderate,22.8,Medium,Urban,Statutory Health Insurance,14.0,No,,Obesity,3.0
PT08795,Ireland,Connacht,20.0,Male,Leukemia,II,2017-01-03,2017-01-20,2017-07-05,,Research Institute,Deceased,32.0,KRAS,Yes,Never,,25.7,Low,Rural,Private Insurance,4.0,No,No,Diabetes,10.0
PT08796,Sweden,Stockholm,36.0,Male,Colorectal,II,2019-12-09,2020-03-26,2020-06-18,Surgery,Private,Deceased,72.0,KRAS,Yes,Never,None,37.4,High,Rural,,19.0,Yes,No,Hypertension,
PT08797,Austria,Tyrol,74.0,Female,,III,2022-10-06,2022-11-02,2023-01-20,Targeted Therapy,Private,Alive,7.0,BRCA1,No,,Moderate,22.4,High,Urban,Private Insurance,14.0,No,No,Hypertension,8.0
PT08798,Denmark,Central Denmark,72.0,Male,Lung,I,2012-10-24,2013-03-12,2013-04-30,Chemotherapy,Private,Alive,81.0,KRAS,Yes,Former,Moderate,33.5,High,Urban,Statutory Health Insurance,7.0,No,No,Cardiovascular Disease,7.0
PT08799,Germany,,50.0,Male,Leukemia,II,2021-03-10,2021-07-22,2022-05-04,Chemotherapy,Research Institute,Alive,68.0,KRAS,No,Never,Moderate,36.7,Low,Urban,Statutory Health Insurance,5.0,No,No,Obesity,1.0
PT08800,Ireland,Dublin,81.0,Female,Ovarian,III,2015-04-21,2015-07-09,2016-02-28,Surgery,Public,Alive,56.0,None,No,Current,Moderate,,Medium,Urban,Private Insurance,12.0,No,No,Cardiovascular Disease,8.0
PT08801,Austria,Styria,27.0,Female,Lung,II,2023-04-10,2023-05-17,2023-12-24,Immunotherapy,Public,Alive,103.0,None,Yes,Never,Moderate,31.5,High,Urban,Statutory Health Insurance,3.0,,No,Diabetes,8.0
PT08802,Portugal,Lisbon,49.0,Female,Colorectal,I,2014-06-04,2014-09-24,2015-08-10,Immunotherapy,Research Institute,Alive,98.0,KRAS,No,Former,,29.9,Low,Urban,NHS,16.0,No,No,Cardiovascular Disease,6.0
PT08803,Austria,Tyrol,85.0,Female,Pancreatic,I,2021-10-06,2022-01-20,2022-06-22,Radiation,Research Institute,Deceased,115.0,None,No,Former,None,34.8,High,Rural,,6.0,No,Yes,None,2.0
PT08804,France,Provence-Alpes-Côte d'Azur,64.0,Female,,I,2021-11-30,2022-03-30,2022-09-01,Surgery,Public,Alive,92.0,KRAS,Yes,Never,Moderate,29.5,Medium,Rural,Private Insurance,5.0,No,No,Diabetes,1.0
PT08805,Netherlands,South Holland,37.0,Female,Ovarian,I,2010-07-18,2010-12-30,2011-08-09,Immunotherapy,Public,Deceased,54.0,None,No,Former,,38.7,Medium,Urban,NHS,17.0,,No,Obesity,10.0
PT08806,Italy,Sicily,64.0,Male,Pancreatic,I,2015-10-22,2015-12-20,2016-09-12,Chemotherapy,Public,Alive,78.0,None,No,Never,Moderate,37.0,Medium,Rural,Statutory Health Insurance,15.0,No,No,Cardiovascular Disease,10.0
PT08807,Portugal,Algarve,38.0,Male,Colorectal,I,2012-08-08,2012-08-18,2013-05-22,,Private,Deceased,20.0,KRAS,No,Former,Moderate,34.5,Medium,Urban,NHS,13.0,No,No,Hypertension,6.0
PT08808,Switzerland,Zurich,,Female,Ovarian,I,2017-06-28,2017-06-29,2018-06-02,Chemotherapy,,Deceased,6.0,EGFR,No,Never,Moderate,25.3,Medium,Urban,NHS,5.0,No,No,Cardiovascular Disease,8.0
PT08809,Italy,Veneto,69.0,Female,Colorectal,II,2016-03-16,2016-05-07,2017-01-16,Chemotherapy,Public,Alive,42.0,KRAS,Yes,Never,Heavy,31.3,Low,Urban,Private Insurance,6.0,Yes,No,Hypertension,4.0
PT08810,Norway,Vestland,44.0,Female,Breast,IV,2014-10-26,2015-03-21,2015-10-25,Radiation,Private,Deceased,108.0,KRAS,No,Never,None,20.8,Low,Urban,Statutory Health Insurance,11.0,No,,None,5.0
PT08811,Switzerland,Geneva,57.0,Female,Ovarian,IV,2013-12-27,2014-03-24,2015-01-08,Radiation,Private,Deceased,15.0,EGFR,No,Former,Moderate,26.7,Low,Urban,Statutory Health Insurance,10.0,No,Yes,Cardiovascular Disease,10.0
PT08812,Italy,Lombardy,55.0,Female,Colorectal,I,2011-02-11,2011-02-16,2011-10-25,Targeted Therapy,Private,Alive,26.0,None,Yes,Never,Heavy,29.9,Medium,Urban,NHS,9.0,,No,Diabetes,9.0
PT08813,Poland,Silesian,87.0,Male,Ovarian,I,2012-03-05,2012-07-11,2012-11-24,Surgery,Public,Alive,40.0,BRCA1,No,Never,Moderate,25.6,Medium,Rural,Private Insurance,,No,Yes,Obesity,3.0
PT08814,Sweden,Skåne,75.0,,Ovarian,II,2017-10-11,2018-01-21,2018-05-19,Immunotherapy,Private,,55.0,BRCA1,No,Never,None,20.0,Medium,Urban,Statutory Health Insurance,2.0,No,No,Diabetes,9.0
PT08815,Denmark,Capital Region,58.0,Male,Breast,I,2013-01-21,2013-05-19,2013-09-15,Radiation,Public,Alive,39.0,BRCA1,Yes,Current,Moderate,24.9,Medium,Urban,NHS,17.0,No,No,Diabetes,
PT08816,Germany,North Rhine-Westphalia,82.0,Male,Colorectal,II,2013-01-08,2013-05-05,2013-07-30,Surgery,Private,Alive,110.0,EGFR,No,Never,Heavy,38.3,Medium,Rural,Private Insurance,4.0,No,Yes,Obesity,9.0
PT08817,Norway,Trøndelag,26.0,Male,Ovarian,II,2021-06-19,2021-09-30,2021-11-06,Radiation,Public,,80.0,KRAS,No,Never,Moderate,,Medium,Urban,Statutory Health Insurance,12.0,No,No,Diabetes,3.0
PT08818,Switzerland,Zurich,77.0,Male,Ovarian,II,2017-01-23,2017-04-26,2017-10-30,Immunotherapy,Public,Alive,53.0,KRAS,Yes,Current,Moderate,22.3,High,Rural,NHS,,Yes,,Diabetes,8.0
PT08819,Norway,Oslo,78.0,Female,,III,2015-11-01,2015-12-19,2016-05-23,,Public,Alive,59.0,EGFR,Yes,Former,Heavy,35.5,High,Urban,Statutory Health Insurance,1.0,No,No,Diabetes,3.0
PT08820,Spain,Andalusia,67.0,Female,Leukemia,III,2022-05-03,2022-06-05,2022-07-09,Targeted Therapy,Public,Alive,115.0,EGFR,Yes,Former,Moderate,37.9,High,Urban,Statutory Health Insurance,6.0,No,No,None,10.0
PT08821,Italy,Sicily,24.0,Female,Pancreatic,IV,2016-10-27,2017-02-07,2017-10-31,Surgery,,Alive,73.0,EGFR,No,Current,None,30.3,Low,,NHS,12.0,No,No,Obesity,5.0
PT08822,Finland,Southwest Finland,55.0,Male,Colorectal,I,2015-12-18,2016-01-12,2017-01-08,Surgery,Public,Alive,79.0,None,No,Former,None,27.5,High,Rural,Statutory Health Insurance,12.0,,No,Obesity,5.0
PT08823,,Dublin,44.0,Male,Lung,IV,2023-04-29,2023-06-12,2024-05-18,Chemotherapy,Research Institute,Alive,117.0,BRCA1,No,Former,Moderate,25.9,Low,Rural,Private Insurance,10.0,Yes,No,Hypertension,3.0
PT08824,Switzerland,Geneva,64.0,Female,Colorectal,II,2020-10-17,2021-01-16,2021-03-22,,Public,Alive,15.0,,No,Current,,21.6,High,Rural,Statutory Health Insurance,3.0,No,No,Hypertension,10.0
PT08825,Finland,Pirkanmaa,,Male,Prostate,II,2021-09-19,2022-01-18,2022-06-09,Radiation,Research Institute,Deceased,108.0,None,No,Former,Moderate,19.2,Medium,Urban,Private Insurance,13.0,No,No,None,7.0
PT08826,Italy,Sicily,26.0,Female,Leukemia,IV,2017-06-05,,2018-03-27,Chemotherapy,Research Institute,Alive,36.0,BRCA1,No,Former,Moderate,22.8,High,Urban,Private Insurance,13.0,No,No,Cardiovascular Disease,1.0
PT08827,Finland,Uusimaa,77.0,Male,Leukemia,IV,2010-12-31,2011-03-07,2011-05-07,Radiation,Public,Deceased,,BRCA1,No,Never,None,28.6,,Urban,Statutory Health Insurance,2.0,Yes,No,Cardiovascular Disease,7.0
PT08828,Denmark,Central Denmark,85.0,Female,Colorectal,,2010-07-15,2010-11-20,2011-04-16,Targeted Therapy,Private,Deceased,118.0,EGFR,No,Never,Moderate,19.1,Medium,,Private Insurance,,No,No,Cardiovascular Disease,1.0
PT08829,Belgium,Brussels,58.0,Male,Prostate,II,2021-10-15,2022-03-17,2023-03-03,Chemotherapy,Public,Deceased,16.0,BRCA1,Yes,,None,39.5,High,Urban,NHS,2.0,No,No,Hypertension,6.0
PT08830,Portugal,Lisbon,37.0,,Ovarian,II,2021-08-01,2022-01-21,2022-02-23,Immunotherapy,Private,Lost to Follow-up,,EGFR,No,Former,None,33.3,High,Urban,Private Insurance,3.0,No,No,Diabetes,10.0
PT08831,Switzerland,Zurich,20.0,Male,Pancreatic,III,2022-11-03,2022-11-26,2023-09-18,Surgery,Private,Alive,9.0,BRCA1,Yes,Former,None,25.6,Low,Rural,,17.0,Yes,No,None,5.0
PT08832,Austria,Tyrol,82.0,Female,,III,2020-01-03,2020-04-12,2021-03-11,Targeted Therapy,Public,Alive,92.0,KRAS,No,Former,None,27.4,High,Urban,Private Insurance,13.0,No,No,None,9.0
,Poland,Silesian,22.0,Male,Lung,III,2022-08-05,2023-01-21,2023-10-07,Targeted Therapy,Private,Alive,111.0,None,Yes,Former,None,39.8,Medium,Rural,Statutory Health Insurance,2.0,No,No,Obesity,10.0
PT08834,Ireland,Munster,40.0,Female,Ovarian,II,2022-07-09,2022-10-04,2023-05-22,Radiation,Public,Alive,110.0,,Yes,Never,Heavy,25.8,High,Urban,Private Insurance,7.0,No,No,Obesity,5.0
PT08835,Netherlands,South Holland,49.0,Male,Leukemia,II,2022-06-06,,2023-08-27,Immunotherapy,Private,Alive,,KRAS,No,Current,Heavy,21.4,Medium,Urban,Statutory Health Insurance,17.0,,No,None,10.0
PT08836,Austria,Styria,30.0,Male,Ovarian,I,2017-06-24,2017-12-02,2018-11-18,Immunotherapy,Public,Alive,10.0,EGFR,Yes,Former,None,27.6,Medium,Urban,Private Insurance,5.0,No,No,Cardiovascular Disease,10.0
PT08837,Netherlands,North Holland,41.0,Female,Leukemia,IV,2015-12-11,2016-04-10,2017-03-08,Targeted Therapy,Private,Alive,27.0,BRCA1,No,Never,None,22.4,,Rural,Private Insurance,6.0,No,No,None,4.0
PT08838,Belgium,Flanders,76.0,Female,Pancreatic,I,2015-06-09,2015-07-07,2016-07-02,Targeted Therapy,Private,Deceased,44.0,,No,Never,Moderate,30.9,High,Urban,NHS,2.0,No,Yes,Diabetes,7.0
PT08839,Italy,Veneto,22.0,Female,Prostate,II,2016-12-16,2016-12-24,2017-02-03,Surgery,Private,Alive,46.0,BRCA1,Yes,Former,Heavy,26.4,Medium,Urban,NHS,11.0,No,No,Diabetes,9.0
PT08840,Austria,Styria,49.0,Male,Breast,,2020-12-04,,2021-07-04,Immunotherapy,Private,,16.0,None,No,Current,Moderate,23.8,,,Private Insurance,16.0,No,No,Cardiovascular Disease,9.0
PT08841,Belgium,,64.0,Male,Pancreatic,II,2022-04-13,2022-08-03,2023-03-27,Targeted Therapy,Public,Alive,63.0,None,Yes,Former,Moderate,24.4,,Urban,Statutory Health Insurance,3.0,Yes,No,None,6.0
PT08842,Poland,Masovian,55.0,Female,Prostate,III,2015-10-12,2016-03-03,2016-07-19,Surgery,Public,Alive,16.0,EGFR,Yes,Current,,39.2,Low,Urban,NHS,13.0,No,No,Diabetes,4.0
PT08843,Sweden,Västra Götaland,83.0,Male,Ovarian,III,2020-11-09,,2021-06-04,Radiation,Public,Lost to Follow-up,,KRAS,Yes,Never,Moderate,26.3,Medium,Urban,NHS,12.0,No,No,Cardiovascular Disease,2.0
PT08844,Sweden,Västra Götaland,73.0,Female,Lung,I,2019-07-13,2019-08-19,2019-09-30,Immunotherapy,Private,Alive,53.0,EGFR,Yes,Former,Moderate,38.6,High,Urban,Private Insurance,9.0,No,No,,2.0
PT08845,France,Provence-Alpes-Côte d'Azur,87.0,Male,Prostate,II,2017-01-11,2017-06-07,2017-11-10,Chemotherapy,Research Institute,Deceased,77.0,None,No,Former,Moderate,30.1,Medium,Urban,Statutory Health Insurance,2.0,No,No,None,5.0
PT08846,Spain,Catalonia,69.0,Non-binary,Pancreatic,III,2021-11-19,2022-03-06,2022-12-06,,Public,Alive,58.0,None,Yes,Never,Heavy,30.4,Low,Rural,NHS,,Yes,No,None,4.0
PT08847,France,,50.0,Male,Breast,II,2023-10-30,2024-04-26,2025-04-02,Targeted Therapy,Public,,62.0,BRCA1,,Never,Moderate,19.9,Medium,Rural,Private Insurance,7.0,No,Yes,Cardiovascular Disease,8.0
PT08848,Poland,Masovian,48.0,Male,Ovarian,II,2021-12-28,2022-04-27,2023-02-06,Targeted Therapy,Private,Alive,45.0,,No,Never,None,39.5,Medium,Rural,Statutory Health Insurance,13.0,Yes,,Obesity,7.0
PT08849,Germany,,78.0,Female,Lung,II,2020-08-28,2020-11-21,2021-06-09,Surgery,Private,Alive,103.0,None,Yes,Current,Moderate,29.5,Medium,Urban,Statutory Health Insurance,13.0,No,No,None,9.0
PT08850,Sweden,Skåne,55.0,Non-binary,Lung,I,2015-03-27,,2016-05-01,Targeted Therapy,Private,Deceased,54.0,EGFR,No,Former,Moderate,36.7,Medium,Urban,Statutory Health Insurance,15.0,Yes,No,Cardiovascular Disease,4.0
PT08851,Italy,Sicily,86.0,Non-binary,Breast,II,2011-12-12,2012-04-08,2013-01-12,Targeted Therapy,Public,Deceased,67.0,BRCA1,No,Never,Moderate,33.1,Medium,Rural,NHS,15.0,Yes,No,Diabetes,4.0
PT08852,Spain,Catalonia,30.0,,Colorectal,I,2021-03-14,2021-06-14,2021-09-10,Surgery,Research Institute,Alive,66.0,EGFR,Yes,Former,None,28.7,High,Urban,,12.0,No,Yes,Hypertension,1.0
PT08853,Italy,Veneto,30.0,Female,Prostate,I,2014-05-10,2014-06-15,2015-04-08,Chemotherapy,Public,Alive,57.0,None,,Former,Moderate,33.2,Medium,Urban,NHS,11.0,No,No,Obesity,4.0
PT08854,Portugal,Porto,,Female,Pancreatic,II,2023-10-07,2023-12-26,2024-06-29,Surgery,Public,Alive,33.0,EGFR,No,Current,Heavy,20.4,Medium,Urban,Statutory Health Insurance,1.0,,No,None,1.0
PT08855,Germany,North Rhine-Westphalia,72.0,Female,Lung,II,2023-01-03,2023-01-15,2023-02-18,Immunotherapy,Public,Deceased,71.0,EGFR,No,Never,Moderate,19.3,Medium,Rural,NHS,17.0,No,No,Diabetes,5.0
PT08856,Spain,Andalusia,33.0,Female,,I,2013-09-02,2013-09-30,2013-12-11,Immunotherapy,Research Institute,Deceased,82.0,BRCA1,No,Never,Moderate,25.8,Low,Urban,Statutory Health Insurance,,No,No,Hypertension,7.0
PT08857,Spain,Madrid,83.0,Female,Prostate,III,2012-04-01,2012-05-04,2012-08-07,Targeted Therapy,Public,Deceased,47.0,None,No,Never,Moderate,22.2,Low,Urban,NHS,4.0,Yes,Yes,Diabetes,6.0
PT08858,Spain,Catalonia,29.0,Female,Ovarian,II,2016-02-23,2016-05-08,2016-10-18,Targeted Therapy,Public,Alive,83.0,EGFR,No,Never,Moderate,37.5,High,Urban,Private Insurance,12.0,No,No,Diabetes,3.0
PT08859,Denmark,Capital Region,50.0,Female,Breast,IV,2021-12-29,2022-03-18,2022-11-15,Chemotherapy,Private,Alive,74.0,EGFR,No,Never,None,24.6,High,Urban,Private Insurance,17.0,No,No,Cardiovascular Disease,1.0
PT08860,Denmark,Capital Region,55.0,Female,Leukemia,II,2014-06-05,,2014-12-29,Chemotherapy,Public,Alive,40.0,,Yes,Current,Moderate,32.6,,Urban,Statutory Health Insurance,19.0,No,,Obesity,1.0
PT08861,Spain,Andalusia,29.0,Female,Breast,I,2018-09-16,2018-11-05,2019-09-01,Radiation,Private,Lost to Follow-up,,EGFR,No,Current,Moderate,,High,Rural,NHS,19.0,,No,Cardiovascular Disease,8.0
PT08862,Switzerland,Bern,45.0,Male,Prostate,III,2020-08-02,2020-08-31,2021-02-22,Immunotherapy,Private,Deceased,103.0,KRAS,No,Never,Moderate,19.4,Low,Urban,Private Insurance,7.0,No,No,Diabetes,4.0
PT08863,Finland,Southwest Finland,39.0,Male,Lung,II,2021-07-12,2021-09-08,2021-11-25,Immunotherapy,Public,Lost to Follow-up,,None,Yes,Never,Moderate,33.6,Low,Urban,Statutory Health Insurance,15.0,No,No,None,9.0
PT08864,Denmark,Zealand,63.0,Male,Ovarian,II,2023-11-08,2023-12-04,2024-06-25,Radiation,Public,Alive,14.0,EGFR,Yes,Never,None,18.2,Medium,Urban,NHS,9.0,No,No,Cardiovascular Disease,8.0
PT08865,Poland,Lesser Poland,81.0,Male,Prostate,II,,2012-02-15,2012-03-17,Radiation,Public,Alive,12.0,KRAS,No,Never,None,,High,Rural,Statutory Health Insurance,12.0,No,No,Diabetes,7.0
PT08866,Finland,Southwest Finland,28.0,Female,,I,2015-04-16,2015-05-03,2016-03-20,Immunotherapy,Public,Alive,62.0,EGFR,No,Never,None,39.7,Low,Rural,Private Insurance,18.0,Yes,No,None,9.0
PT08867,Portugal,Lisbon,43.0,Female,Leukemia,II,2016-12-28,2017-05-10,2017-06-14,Targeted Therapy,Public,Alive,41.0,BRCA1,Yes,Current,Heavy,23.1,Low,Urban,NHS,17.0,No,No,Diabetes,4.0
PT08868,Germany,,31.0,Female,Lung,I,2010-11-27,2011-01-25,2011-10-24,Immunotherapy,Research Institute,Deceased,40.0,None,No,Current,Heavy,21.5,Medium,Urban,Private Insurance,19.0,,No,Hypertension,
PT08869,France,Île-de-France,79.0,Female,Ovarian,II,2018-05-02,2018-09-23,2018-12-03,Radiation,Public,Deceased,19.0,EGFR,Yes,Current,Moderate,29.0,Medium,Urban,Private Insurance,18.0,,No,Obesity,5.0
PT08870,Belgium,Wallonia,35.0,Male,Leukemia,IV,2021-02-01,,,Chemotherapy,,Deceased,79.0,None,No,Former,None,38.9,Medium,Urban,NHS,1.0,No,No,,7.0
PT08871,Spain,Madrid,,Female,Ovarian,III,2011-10-29,2012-01-31,2012-03-16,Surgery,Research Institute,Alive,86.0,BRCA1,Yes,Current,Moderate,24.6,Medium,Urban,Statutory Health Insurance,14.0,No,No,Hypertension,10.0
PT08872,Switzerland,Geneva,51.0,Female,Colorectal,I,2019-04-10,2019-09-06,2020-04-26,Chemotherapy,Public,Lost to Follow-up,,None,No,Former,Moderate,25.0,Low,Rural,Private Insurance,1.0,No,No,Cardiovascular Disease,3.0
PT08873,Poland,Masovian,54.0,Male,Pancreatic,IV,2022-10-22,2022-10-27,2023-06-29,Chemotherapy,Public,Deceased,79.0,None,No,Never,Heavy,31.6,Medium,Rural,NHS,7.0,No,No,Diabetes,
PT08874,Austria,Vienna,62.0,Female,Breast,II,2011-11-22,2011-12-18,2012-03-29,Radiation,Research Institute,,,None,No,Never,None,33.7,Low,Urban,Statutory Health Insurance,17.0,No,No,Hypertension,8.0
PT08875,,Pirkanmaa,72.0,Female,Colorectal,I,2014-08-31,2015-02-18,2015-05-25,Immunotherapy,Private,Alive,37.0,None,No,Current,Moderate,29.9,Medium,Rural,Statutory Health Insurance,10.0,Yes,No,Obesity,5.0
PT08876,Ireland,Dublin,39.0,Male,Prostate,III,2018-06-05,2018-09-25,2019-01-13,Radiation,Private,Alive,29.0,None,No,Current,Heavy,22.9,High,Rural,Private Insurance,16.0,No,No,Hypertension,10.0
PT08877,Norway,Vestland,27.0,Female,Colorectal,II,2023-04-29,2023-09-02,2023-10-31,Radiation,Private,Deceased,44.0,KRAS,Yes,Current,Heavy,37.9,High,Urban,NHS,15.0,Yes,No,Hypertension,2.0
PT08878,,Île-de-France,,Female,,I,2021-12-26,2022-03-22,2022-05-17,Targeted Therapy,Private,Alive,89.0,KRAS,No,Current,None,29.5,Medium,Urban,NHS,13.0,No,Yes,None,1.0
PT08879,Netherlands,North Holland,89.0,Male,Lung,I,2016-05-26,2016-09-12,2017-01-07,Targeted Therapy,Private,Alive,39.0,None,Yes,Current,,38.8,,Urban,NHS,18.0,Yes,No,Hypertension,9.0
PT08880,Italy,Lombardy,35.0,Female,Pancreatic,II,2016-03-02,2016-03-04,2016-06-05,Surgery,Public,Deceased,44.0,EGFR,No,Never,None,28.5,Medium,Urban,Private Insurance,4.0,No,No,Hypertension,3.0
PT08881,Norway,,88.0,Male,Leukemia,I,2018-01-30,2018-03-15,2019-02-02,Targeted Therapy,Public,Deceased,45.0,KRAS,No,Former,None,21.0,Low,Urban,Statutory Health Insurance,18.0,Yes,No,None,1.0
PT08882,Belgium,Flanders,72.0,Male,Ovarian,III,2016-07-07,2016-10-21,2017-10-14,Surgery,Public,Deceased,20.0,None,No,Never,None,26.1,Medium,Urban,Private Insurance,16.0,No,No,Diabetes,8.0
PT08883,Spain,Andalusia,,Female,Lung,II,2013-06-10,2013-11-11,2014-05-03,Chemotherapy,Public,Deceased,54.0,None,No,Current,Heavy,30.0,High,Urban,NHS,17.0,No,No,Hypertension,5.0
PT08884,Austria,Styria,70.0,Male,Pancreatic,II,2010-02-01,2010-05-21,2010-08-14,Chemotherapy,Public,Alive,65.0,EGFR,Yes,Former,Heavy,22.3,Medium,Urban,Private Insurance,6.0,No,No,Hypertension,3.0
PT08885,Belgium,Flanders,25.0,Female,Colorectal,I,2010-07-11,2010-08-24,2011-06-16,Radiation,Public,Lost to Follow-up,,KRAS,No,Current,None,26.9,High,Urban,Statutory Health Insurance,,No,No,None,9.0
PT08886,,Southwest Finland,52.0,,Prostate,III,2022-04-30,,2023-07-07,Chemotherapy,Public,Alive,19.0,KRAS,Yes,Never,None,20.3,Medium,Urban,Private Insurance,13.0,No,No,Obesity,5.0
,Spain,Madrid,34.0,Male,Colorectal,II,2017-04-04,2017-05-23,2018-04-17,Targeted Therapy,Private,Deceased,109.0,BRCA1,No,Never,Moderate,37.6,Medium,Urban,Statutory Health Insurance,10.0,No,No,Obesity,2.0
PT08888,Italy,Lombardy,33.0,Female,Breast,II,2015-09-14,2015-12-14,2016-02-16,Targeted Therapy,Private,Alive,20.0,EGFR,Yes,Never,Moderate,39.1,Low,Urban,Private Insurance,12.0,No,Yes,Cardiovascular Disease,7.0
PT08889,Finland,Southwest Finland,58.0,Male,Breast,III,2020-11-13,2021-02-02,2021-05-26,Targeted Therapy,Private,,17.0,,No,Never,Moderate,28.0,High,,Private Insurance,3.0,Yes,Yes,Cardiovascular Disease,1.0
PT08890,Portugal,Algarve,82.0,Male,Prostate,I,2016-07-07,2016-11-18,2017-06-14,Immunotherapy,,Deceased,23.0,EGFR,No,Former,None,37.7,Low,Urban,Statutory Health Insurance,3.0,No,No,,4.0
PT08891,Denmark,Zealand,24.0,Female,Pancreatic,,2021-04-05,2021-09-03,2022-06-23,Targeted Therapy,Public,Alive,20.0,EGFR,No,Never,,21.9,Medium,Urban,Statutory Health Insurance,18.0,,No,Cardiovascular Disease,2.0
PT08892,Portugal,Lisbon,71.0,Female,Lung,II,2012-05-03,2012-07-24,2012-11-01,Radiation,Public,Alive,11.0,EGFR,Yes,Never,Moderate,19.5,,Urban,Statutory Health Insurance,3.0,Yes,No,,
PT08893,Italy,Veneto,35.0,Female,Ovarian,II,2015-08-19,2015-10-01,2015-12-06,Radiation,,Alive,66.0,EGFR,No,Current,Moderate,25.2,Medium,Urban,Private Insurance,1.0,No,No,Diabetes,5.0
PT08894,Portugal,Porto,57.0,,,I,2013-07-25,2013-09-07,2014-01-15,Chemotherapy,Public,Deceased,13.0,EGFR,No,Current,Moderate,23.3,Medium,Urban,NHS,17.0,No,No,Cardiovascular Disease,4.0
PT08895,Switzerland,Zurich,72.0,Female,Breast,I,2015-01-02,2015-03-09,2015-08-18,Surgery,Private,Alive,115.0,None,No,Former,None,23.2,Medium,Urban,NHS,19.0,No,Yes,None,6.0
PT08896,,Connacht,72.0,Female,Breast,II,2021-09-02,2021-10-17,,Immunotherapy,Public,Alive,55.0,BRCA1,Yes,Never,None,35.1,Low,Rural,NHS,17.0,No,No,Cardiovascular Disease,8.0
PT08897,Poland,Masovian,65.0,Male,Prostate,IV,2014-06-05,2014-06-24,2015-04-26,Surgery,Private,Alive,23.0,BRCA1,No,Former,Moderate,,Low,Urban,NHS,10.0,No,No,Diabetes,4.0
PT08898,Switzerland,Bern,34.0,Male,Lung,,2021-04-15,2021-04-19,2021-05-23,Immunotherapy,Private,Alive,111.0,KRAS,No,Never,Moderate,30.4,High,,Private Insurance,15.0,No,No,Obesity,3.0
PT08899,Denmark,Capital Region,78.0,Male,Colorectal,I,2010-04-28,2010-08-03,2010-09-24,Radiation,Private,Alive,100.0,None,Yes,Never,None,33.9,Medium,Rural,Statutory Health Insurance,13.0,No,No,Hypertension,10.0
PT08900,Norway,Trøndelag,69.0,Male,Leukemia,III,,2017-11-24,2018-06-26,Radiation,Public,,106.0,EGFR,No,Current,Moderate,24.2,,Urban,Private Insurance,6.0,No,No,Cardiovascular Disease,4.0
PT08901,Ireland,Munster,28.0,Female,Prostate,II,2016-07-27,2016-10-31,2017-10-22,Immunotherapy,Private,Alive,72.0,None,No,Never,Moderate,33.4,Medium,Rural,Private Insurance,8.0,No,No,Obesity,5.0
PT08902,Netherlands,South Holland,45.0,Female,Lung,II,2013-07-20,2013-12-04,2014-03-08,Chemotherapy,Research Institute,Deceased,29.0,BRCA1,Yes,Former,Moderate,34.6,Low,,Private Insurance,12.0,No,No,None,2.0
PT08903,Germany,Berlin,22.0,Female,Leukemia,II,2010-11-13,2011-02-22,2011-08-17,Targeted Therapy,Research Institute,Alive,100.0,,Yes,Former,Moderate,38.8,Low,Urban,Private Insurance,10.0,No,No,Obesity,4.0
PT08904,Poland,Masovian,66.0,Male,Ovarian,II,2019-11-10,2019-12-28,2020-10-10,Targeted Therapy,Public,,96.0,None,No,Never,None,19.9,,Urban,Statutory Health Insurance,10.0,No,No,Diabetes,1.0
PT08905,Austria,Vienna,24.0,,Prostate,II,2014-09-16,2015-02-27,,Surgery,Private,Alive,93.0,KRAS,Yes,Never,Heavy,36.6,Low,Urban,NHS,4.0,No,No,Diabetes,5.0
PT08906,Belgium,Flanders,81.0,Male,Colorectal,I,2012-12-07,2012-12-25,2013-05-29,Radiation,Public,Deceased,45.0,None,No,Never,Heavy,21.6,Medium,Urban,Private Insurance,,No,No,Diabetes,6.0
PT08907,Belgium,Brussels,24.0,Female,Colorectal,III,2012-11-05,2012-12-15,2013-06-21,Targeted Therapy,Research Institute,Alive,29.0,EGFR,No,Current,None,27.4,Medium,Rural,Statutory Health Insurance,15.0,No,No,Diabetes,10.0
PT08908,Denmark,Central Denmark,29.0,Male,Lung,I,2014-02-02,2014-04-08,2015-03-20,Radiation,Research Institute,Deceased,61.0,EGFR,Yes,Never,Moderate,18.1,Low,Urban,Statutory Health Insurance,10.0,No,No,Cardiovascular Disease,3.0
PT08909,Poland,Silesian,82.0,Female,Lung,I,2020-05-04,2020-10-03,2020-12-15,Radiation,Public,Alive,50.0,EGFR,No,Current,Moderate,39.0,Medium,Urban,Statutory Health Insurance,7.0,No,No,Obesity,8.0
PT08910,Austria,Vienna,44.0,Male,Colorectal,I,2013-07-30,,2014-09-11,Radiation,Research Institute,Alive,17.0,None,No,Never,Moderate,39.2,High,Urban,NHS,,Yes,No,None,4.0
PT08911,Portugal,Lisbon,63.0,Female,,III,2015-08-24,2016-02-10,2016-08-06,Targeted Therapy,Private,Alive,44.0,None,Yes,Former,None,39.1,High,Rural,Private Insurance,18.0,No,No,Obesity,3.0
PT08912,Poland,Silesian,,Female,Prostate,II,2013-10-03,2013-11-25,2014-06-24,Targeted Therapy,Private,Deceased,96.0,None,Yes,Former,Heavy,,Medium,Urban,Private Insurance,16.0,No,No,Obesity,3.0
PT08913,Austria,Styria,49.0,Female,Pancreatic,III,2011-01-02,2011-03-05,2011-10-19,Targeted Therapy,Public,Deceased,34.0,EGFR,No,Never,Moderate,24.8,Low,Urban,NHS,11.0,No,Yes,Cardiovascular Disease,5.0
PT08914,Sweden,Skåne,33.0,Male,Ovarian,III,2021-11-02,2022-03-08,2022-08-25,Immunotherapy,Public,Alive,6.0,BRCA1,Yes,Current,Moderate,26.8,High,Rural,Statutory Health Insurance,2.0,No,No,Cardiovascular Disease,
PT08915,Portugal,Algarve,62.0,,Pancreatic,I,2014-07-10,2014-11-01,2015-06-30,Targeted Therapy,Research Institute,Deceased,6.0,None,Yes,Never,Moderate,39.5,High,Rural,Statutory Health Insurance,7.0,No,No,None,9.0
PT08916,Spain,Madrid,47.0,Male,Lung,II,2019-06-07,2019-11-17,2020-05-05,Radiation,Public,Alive,42.0,BRCA1,No,Former,Moderate,,High,Rural,NHS,11.0,No,No,None,7.0
PT08917,Finland,Uusimaa,38.0,Female,Leukemia,II,,2024-02-16,2025-01-18,,Private,Alive,17.0,EGFR,No,Former,None,32.2,High,Urban,NHS,19.0,No,No,Hypertension,8.0
PT08918,Italy,Veneto,61.0,Male,Colorectal,,2020-08-25,2021-01-12,2021-11-21,Surgery,Public,,73.0,EGFR,No,Current,None,26.5,Low,,NHS,12.0,No,Yes,Obesity,1.0
PT08919,Norway,Vestland,39.0,Male,Leukemia,I,2012-01-06,,2012-06-21,,Private,Deceased,76.0,EGFR,No,Current,Heavy,39.4,Low,Rural,Statutory Health Insurance,18.0,No,No,,3.0
PT08920,Italy,Sicily,30.0,,,IV,2019-11-22,2020-04-20,2020-11-09,Immunotherapy,Public,,114.0,EGFR,No,Never,None,33.7,Medium,Urban,Private Insurance,16.0,Yes,No,Diabetes,7.0
PT08921,Austria,Tyrol,73.0,Female,Ovarian,III,,2021-05-01,2021-11-22,Surgery,Public,,53.0,KRAS,No,Former,Moderate,29.4,Low,Urban,Statutory Health Insurance,13.0,No,No,Obesity,10.0
PT08922,Poland,Lesser Poland,43.0,Female,Lung,II,2019-07-09,2019-09-15,2020-06-06,Immunotherapy,Research Institute,Alive,45.0,,No,Former,Moderate,,High,Urban,Private Insurance,5.0,,No,Obesity,10.0
PT08923,Denmark,Central Denmark,89.0,Female,Breast,III,2018-07-29,2018-10-08,2019-06-19,Immunotherapy,Public,Deceased,20.0,None,No,Former,None,19.7,Medium,Rural,NHS,9.0,Yes,No,Cardiovascular Disease,2.0
PT08924,Denmark,Capital Region,36.0,Female,Colorectal,III,2012-05-16,2012-10-14,2013-01-05,Radiation,Public,Alive,31.0,BRCA1,No,Never,Moderate,26.3,Low,Rural,NHS,11.0,No,Yes,Hypertension,2.0
PT08925,Poland,Masovian,47.0,Female,Ovarian,I,2011-10-22,2012-01-25,2012-07-27,Radiation,Private,Deceased,60.0,EGFR,Yes,Current,Moderate,21.0,Medium,Urban,NHS,16.0,Yes,No,Hypertension,8.0
PT08926,Sweden,Västra Götaland,,Female,Pancreatic,II,2018-07-21,2018-12-03,,Radiation,Public,Alive,30.0,EGFR,No,Never,None,34.2,Low,Rural,Statutory Health Insurance,7.0,No,No,,4.0
PT08927,Ireland,Connacht,74.0,Male,Pancreatic,I,2015-02-03,2015-06-09,2015-10-09,Radiation,Public,Alive,100.0,KRAS,No,,Heavy,37.3,Medium,Urban,Statutory Health Insurance,6.0,Yes,No,Cardiovascular Disease,5.0
PT08928,Austria,Vienna,29.0,Female,,I,2016-06-23,2016-07-15,2016-11-16,Surgery,Public,Alive,47.0,EGFR,No,Former,Heavy,38.5,Medium,Rural,NHS,18.0,No,No,None,2.0
PT08929,Finland,Uusimaa,,Female,Lung,I,2020-03-21,2020-07-02,2021-06-11,Chemotherapy,Research Institute,Alive,30.0,None,Yes,Never,Moderate,,Medium,Urban,Statutory Health Insurance,2.0,Yes,No,,2.0
PT08930,Ireland,Dublin,77.0,Male,Colorectal,IV,2022-11-25,2023-01-04,2023-02-20,Chemotherapy,Private,Alive,30.0,None,No,Never,Moderate,22.7,Medium,Urban,Private Insurance,7.0,No,No,None,9.0
PT08931,France,Provence-Alpes-Côte d'Azur,53.0,Female,Breast,II,2011-05-04,2011-09-28,2012-03-27,Surgery,Public,Alive,30.0,KRAS,Yes,Current,None,29.3,Medium,Urban,NHS,14.0,,No,Hypertension,6.0
PT08932,Poland,,62.0,Male,Breast,III,2022-12-30,2023-02-21,2024-02-02,Chemotherapy,Private,Deceased,22.0,EGFR,No,Former,,34.2,Low,Rural,Private Insurance,14.0,No,No,Diabetes,10.0
PT08933,Belgium,Brussels,30.0,Male,Breast,I,2015-06-03,2015-07-03,2015-12-04,Targeted Therapy,Public,Alive,80.0,None,Yes,Never,None,32.2,Low,Rural,NHS,16.0,No,Yes,,9.0
,Ireland,Dublin,,Female,Breast,I,2017-06-24,2017-11-25,2018-10-20,Targeted Therapy,Public,Alive,26.0,BRCA1,Yes,Current,Moderate,40.0,High,Rural,NHS,10.0,Yes,No,None,10.0
PT08935,Denmark,,77.0,Female,Ovarian,IV,2015-12-12,2016-04-13,2016-11-03,Targeted Therapy,Private,Lost to Follow-up,,None,Yes,Never,Moderate,23.6,Low,Urban,Statutory Health Insurance,5.0,No,No,None,4.0
PT08936,Switzerland,Geneva,65.0,Female,Prostate,II,,2012-05-24,,Radiation,Public,Alive,63.0,KRAS,No,Former,None,30.9,Medium,Urban,,5.0,,No,None,3.0
,Finland,Southwest Finland,80.0,Male,Colorectal,,,2022-10-19,2022-12-24,Targeted Therapy,Public,Alive,21.0,,Yes,Current,None,24.0,Medium,Urban,Statutory Health Insurance,8.0,No,No,Cardiovascular Disease,1.0
PT08938,Italy,Lombardy,81.0,Female,Colorectal,I,2023-01-25,2023-06-24,2024-06-16,Immunotherapy,Public,Alive,116.0,None,No,Former,Moderate,,Medium,Urban,NHS,3.0,No,No,Diabetes,7.0
PT08939,Finland,Pirkanmaa,20.0,Male,Colorectal,IV,2020-12-12,2021-02-11,2021-08-17,Immunotherapy,Research Institute,Deceased,102.0,EGFR,No,,Moderate,24.4,,Urban,Statutory Health Insurance,,No,No,Cardiovascular Disease,1.0
PT08940,Austria,Tyrol,40.0,Male,Ovarian,II,2013-11-12,2014-01-24,2014-07-15,Surgery,Private,Lost to Follow-up,,EGFR,Yes,Former,Moderate,33.9,Low,Urban,NHS,6.0,No,Yes,Obesity,8.0
,Germany,North Rhine-Westphalia,81.0,Male,Pancreatic,I,2017-05-17,2017-07-02,2018-03-20,Immunotherapy,Public,Deceased,107.0,None,No,Former,None,32.0,Low,Urban,NHS,19.0,No,No,Hypertension,
PT08942,Ireland,Connacht,83.0,Male,Ovarian,III,2010-06-27,2010-08-24,2011-07-22,Surgery,Public,Alive,12.0,BRCA1,Yes,Former,None,21.8,Low,Urban,Statutory Health Insurance,8.0,No,No,Cardiovascular Disease,8.0
PT08943,Finland,Southwest Finland,75.0,Male,Breast,III,2013-09-20,2013-10-19,2014-01-03,Chemotherapy,Public,Alive,80.0,BRCA1,Yes,Never,,22.9,Medium,Urban,Private Insurance,16.0,No,No,Diabetes,8.0
PT08944,Finland,Uusimaa,20.0,Female,Breast,I,2022-09-06,2022-10-29,2023-06-20,Immunotherapy,Public,Deceased,10.0,BRCA1,Yes,Former,None,28.6,High,Rural,Private Insurance,14.0,No,No,Hypertension,6.0
PT08945,Norway,Oslo,40.0,Female,Pancreatic,IV,2019-11-11,2020-04-05,2021-01-30,Immunotherapy,Research Institute,Deceased,,EGFR,No,Never,Moderate,,Low,Rural,NHS,10.0,No,No,Obesity,2.0
,Italy,Sicily,41.0,Non-binary,Ovarian,III,2020-10-07,2021-03-15,2021-10-12,Surgery,Private,Alive,84.0,None,Yes,Former,Moderate,21.5,Low,Urban,Private Insurance,3.0,No,No,Hypertension,1.0
PT08947,Netherlands,South Holland,73.0,Female,Pancreatic,II,2014-08-23,2014-09-24,2015-05-08,Immunotherapy,Research Institute,Alive,30.0,None,No,Never,None,24.3,Medium,Rural,Statutory Health Insurance,14.0,No,No,None,1.0
PT08948,Denmark,Central Denmark,23.0,Male,Lung,I,2019-01-07,2019-01-16,2019-12-09,Surgery,Public,Alive,13.0,None,Yes,Never,Moderate,20.7,Medium,Urban,Private Insurance,5.0,No,No,None,8.0
PT08949,Austria,Styria,84.0,Female,Prostate,II,2014-06-26,2014-08-02,2014-12-28,Immunotherapy,Private,Alive,6.0,BRCA1,No,Never,Moderate,20.0,Medium,Urban,NHS,1.0,No,No,Obesity,2.0
PT08950,Netherlands,South Holland,70.0,Female,Pancreatic,I,2017-12-15,2017-12-23,2018-03-24,Radiation,Public,Alive,67.0,BRCA1,No,Current,None,27.5,Low,Urban,NHS,13.0,No,No,None,10.0
PT08951,,,82.0,Male,Colorectal,II,2016-07-03,2016-12-02,2017-10-08,Chemotherapy,Public,Alive,,KRAS,No,Never,None,22.9,High,Rural,Statutory Health Insurance,16.0,,No,Cardiovascular Disease,4.0
PT08952,Spain,Madrid,34.0,Female,Prostate,III,2022-11-10,2023-01-17,2023-02-27,Immunotherapy,Private,Alive,83.0,KRAS,,Never,None,24.4,Low,Urban,NHS,3.0,No,No,None,3.0
PT08953,Denmark,Central Denmark,55.0,Female,Ovarian,III,2023-01-18,,2023-12-30,Chemotherapy,Public,Deceased,52.0,EGFR,Yes,Former,Moderate,31.8,Medium,Urban,Private Insurance,11.0,No,No,Hypertension,7.0
PT08954,Italy,Sicily,48.0,Male,Pancreatic,II,2019-07-18,2019-09-02,2020-02-03,Immunotherapy,Public,Alive,65.0,BRCA1,Yes,Never,None,32.9,Medium,Urban,NHS,8.0,No,No,None,10.0
PT08955,Norway,Vestland,71.0,Female,Colorectal,I,2017-09-20,2017-10-07,2018-08-25,Immunotherapy,Public,Alive,48.0,None,No,Former,Moderate,18.7,Low,Urban,Private Insurance,8.0,No,No,Cardiovascular Disease,3.0
PT08956,Portugal,Algarve,65.0,Female,Breast,IV,2023-06-20,2023-07-11,2023-12-24,Radiation,Private,Alive,10.0,BRCA1,Yes,Current,None,25.5,Low,Urban,Private Insurance,8.0,No,No,Obesity,10.0
PT08957,Belgium,Flanders,,Female,,I,2016-05-25,2016-07-12,2017-02-23,Targeted Therapy,Public,Deceased,95.0,EGFR,Yes,Never,None,,Low,Urban,Private Insurance,2.0,No,No,Diabetes,2.0
PT08958,Sweden,Skåne,48.0,Male,Breast,I,2019-05-14,2019-05-23,2019-12-21,Targeted Therapy,Public,Deceased,108.0,BRCA1,Yes,Current,None,37.3,,Urban,Private Insurance,7.0,No,No,Diabetes,4.0
PT08959,Netherlands,North Holland,66.0,Female,Colorectal,III,2012-12-25,2012-12-30,2013-11-26,Chemotherapy,Private,Alive,27.0,BRCA1,,Former,Moderate,27.9,Low,Urban,Private Insurance,4.0,No,,Cardiovascular Disease,4.0
PT08960,Netherlands,South Holland,44.0,Female,Leukemia,III,2015-12-02,2015-12-08,2016-04-10,Chemotherapy,Private,,68.0,KRAS,Yes,Former,Moderate,25.5,Low,Rural,Statutory Health Insurance,10.0,No,No,Diabetes,5.0
PT08961,Netherlands,North Holland,35.0,,Ovarian,,2020-09-29,2021-03-24,2021-12-14,Radiation,Private,Deceased,7.0,None,No,Former,None,21.9,High,Rural,Private Insurance,6.0,Yes,No,None,2.0
PT08962,Sweden,Stockholm,60.0,Male,Breast,IV,2015-01-02,2015-02-17,2015-06-27,Surgery,Public,Alive,104.0,BRCA1,No,Never,Moderate,36.5,Medium,Urban,Private Insurance,1.0,No,No,None,5.0
PT08963,Italy,Sicily,84.0,Male,Lung,IV,2014-06-08,2014-09-13,2014-10-19,Chemotherapy,Public,Alive,107.0,BRCA1,No,Former,Moderate,37.3,Low,Rural,Statutory Health Insurance,7.0,No,No,Cardiovascular Disease,
PT08964,Finland,Pirkanmaa,88.0,,Pancreatic,II,2016-05-12,,2017-02-02,Targeted Therapy,Private,Alive,8.0,EGFR,Yes,Never,None,39.4,Low,Urban,NHS,18.0,No,No,None,9.0
PT08965,Finland,Pirkanmaa,39.0,Male,Breast,,2023-10-16,2024-01-25,2024-09-19,Radiation,Public,Alive,6.0,BRCA1,Yes,Former,Moderate,37.5,High,Rural,Statutory Health Insurance,4.0,,No,Diabetes,9.0
PT08966,Belgium,Flanders,88.0,Male,Lung,II,2018-01-11,2018-05-22,2019-01-09,Surgery,Public,Alive,103.0,EGFR,No,Former,Moderate,34.9,High,Urban,,15.0,No,No,Obesity,7.0
PT08967,Portugal,Porto,55.0,Male,Prostate,I,2012-02-25,2012-08-02,2013-02-12,Radiation,Public,Alive,110.0,EGFR,No,Former,Moderate,28.9,Low,Urban,Statutory Health Insurance,9.0,No,No,Diabetes,1.0
PT08968,Switzerland,Bern,77.0,Female,Ovarian,I,2020-10-11,,2022-01-22,Targeted Therapy,Public,Alive,16.0,EGFR,Yes,Former,Moderate,33.9,Medium,Urban,Statutory Health Insurance,9.0,No,,Obesity,5.0
PT08969,Denmark,Zealand,67.0,Female,,I,2018-02-09,2018-05-23,2019-04-09,Radiation,Public,Alive,104.0,None,Yes,Former,None,31.2,Medium,Urban,NHS,5.0,No,No,Cardiovascular Disease,
PT08970,Austria,Vienna,21.0,Female,Pancreatic,I,2018-05-17,2018-09-29,2018-10-29,Immunotherapy,Research Institute,Alive,74.0,BRCA1,No,Current,None,34.5,Medium,Urban,NHS,10.0,No,No,None,10.0
PT08971,Ireland,Munster,48.0,Male,Breast,II,,2020-01-27,2020-07-03,Targeted Therapy,Public,Alive,98.0,BRCA1,No,Former,None,33.5,Low,Urban,Statutory Health Insurance,18.0,No,Yes,Diabetes,6.0
PT08972,Spain,Madrid,35.0,Female,Pancreatic,II,2020-03-03,2020-06-03,2021-01-24,Surgery,Public,Deceased,,EGFR,Yes,Never,Moderate,28.0,Low,Rural,NHS,18.0,No,No,Cardiovascular Disease,1.0
PT08973,Netherlands,South Holland,,Male,Prostate,II,2023-04-13,2023-08-13,2024-07-04,Radiation,,Alive,112.0,KRAS,Yes,Current,Moderate,,High,Rural,Private Insurance,8.0,No,No,Obesity,1.0
PT08974,Poland,Silesian,81.0,Female,Pancreatic,,2022-07-12,2022-12-02,2023-02-10,Targeted Therapy,Research Institute,Alive,6.0,BRCA1,Yes,Never,Moderate,32.4,Medium,Urban,Private Insurance,6.0,No,No,Obesity,7.0
PT08975,Italy,Veneto,23.0,Male,Lung,III,2019-07-30,2019-08-06,2019-12-06,Targeted Therapy,Public,Deceased,38.0,,No,Former,None,37.0,Medium,Urban,NHS,3.0,No,No,Diabetes,6.0
PT08976,Finland,Southwest Finland,87.0,Male,Leukemia,IV,2010-01-17,2010-04-26,2010-09-06,Surgery,Public,Alive,51.0,EGFR,Yes,Former,Moderate,28.0,High,Urban,NHS,19.0,No,No,Obesity,4.0
PT08977,Portugal,Algarve,70.0,Male,Ovarian,II,,2021-08-25,2022-05-22,Targeted Therapy,Public,Alive,35.0,KRAS,Yes,Never,None,26.3,Medium,Urban,Statutory Health Insurance,19.0,No,Yes,Hypertension,3.0
PT08978,Spain,Madrid,52.0,Female,Pancreatic,I,2022-04-15,2022-09-28,2023-07-14,Surgery,Public,Alive,82.0,EGFR,No,Never,Heavy,36.8,Low,Urban,Private Insurance,3.0,Yes,No,Cardiovascular Disease,2.0
PT08979,Austria,Tyrol,43.0,Female,Ovarian,I,2012-11-29,2013-04-14,2013-10-30,Targeted Therapy,Public,Alive,57.0,None,Yes,Former,Moderate,24.4,Medium,Urban,Private Insurance,6.0,No,Yes,None,6.0
PT08980,Denmark,Capital Region,44.0,Male,Pancreatic,III,2012-07-04,2012-10-10,2013-07-24,Radiation,Private,Alive,114.0,None,Yes,Former,Moderate,38.1,High,Urban,Statutory Health Insurance,12.0,No,No,Hypertension,9.0
PT08981,Finland,Southwest Finland,47.0,Male,Ovarian,III,2020-09-20,2021-01-27,2021-11-02,Surgery,Public,Alive,14.0,BRCA1,No,Never,Moderate,29.9,Low,Urban,Statutory Health Insurance,,,No,None,9.0
PT08982,Netherlands,Utrecht,26.0,Male,Lung,I,2014-08-19,2015-01-13,2015-12-11,Surgery,Research Institute,Lost to Follow-up,,EGFR,No,Never,None,26.0,Low,Urban,Private Insurance,3.0,,No,Diabetes,3.0
PT08983,Poland,Silesian,55.0,Female,,IV,2010-10-11,,2010-12-28,Targeted Therapy,Public,Alive,77.0,KRAS,No,Never,None,26.8,Low,Urban,Statutory Health Insurance,13.0,No,No,Hypertension,1.0
PT08984,Austria,Tyrol,29.0,Male,Colorectal,II,2018-03-25,2018-06-20,2018-10-09,Immunotherapy,Private,Alive,80.0,None,No,Former,Moderate,30.0,Low,Urban,NHS,17.0,No,No,None,1.0
PT08985,France,Auvergne-Rhône-Alpes,55.0,Male,Colorectal,I,2023-12-22,2023-12-26,2024-11-05,Surgery,Public,Alive,8.0,KRAS,No,Former,None,25.1,Medium,Rural,NHS,10.0,No,No,Cardiovascular Disease,9.0
PT08986,Ireland,Munster,37.0,Female,Colorectal,III,2019-04-25,2019-09-02,2020-06-14,Immunotherapy,Private,Deceased,53.0,None,Yes,Never,Moderate,35.1,Low,Urban,Private Insurance,13.0,No,No,Hypertension,4.0
PT08987,Ireland,Dublin,25.0,Female,Pancreatic,II,2014-10-16,2014-11-08,2015-10-17,Chemotherapy,Research Institute,Deceased,31.0,BRCA1,Yes,Current,Moderate,39.6,Low,Rural,Private Insurance,17.0,Yes,No,Cardiovascular Disease,3.0
PT08988,Switzerland,Geneva,26.0,Male,Prostate,I,2013-10-09,2014-01-24,2015-01-11,Radiation,Research Institute,Alive,89.0,EGFR,Yes,Former,Moderate,36.1,,Urban,Statutory Health Insurance,14.0,No,No,None,3.0
PT08989,Switzerland,Zurich,31.0,,Lung,II,,2015-03-30,2015-05-21,Immunotherapy,Private,Deceased,58.0,None,Yes,Former,None,20.7,Medium,Urban,Private Insurance,9.0,No,No,Hypertension,2.0
PT08990,Finland,,60.0,Female,Pancreatic,III,2023-04-09,2023-10-05,2024-06-22,Radiation,Research Institute,Alive,17.0,,,Former,Heavy,25.2,Medium,Rural,Statutory Health Insurance,17.0,No,No,Hypertension,3.0
,France,Provence-Alpes-Côte d'Azur,82.0,Female,Ovarian,II,2018-07-23,2018-10-12,2019-09-11,Surgery,Private,Alive,71.0,EGFR,Yes,Former,,29.3,Medium,Urban,Statutory Health Insurance,16.0,No,No,Hypertension,7.0
PT08992,Netherlands,Utrecht,44.0,Male,Breast,I,2020-07-20,2020-12-26,2021-10-04,Radiation,Research Institute,Alive,88.0,BRCA1,No,,Moderate,37.4,Medium,Urban,Private Insurance,,No,Yes,Cardiovascular Disease,4.0
PT08993,Netherlands,North Holland,72.0,Female,Pancreatic,IV,2019-03-31,2019-05-28,2019-08-28,Immunotherapy,Private,Alive,70.0,EGFR,No,Current,None,28.2,Low,Urban,NHS,9.0,No,Yes,None,1.0
PT08994,Italy,Sicily,,Female,Colorectal,I,2016-06-24,2016-12-05,2017-11-03,Surgery,Public,Alive,98.0,EGFR,Yes,Never,None,25.1,High,Rural,Private Insurance,10.0,No,Yes,None,4.0
PT08995,Denmark,Capital Region,25.0,Non-binary,Lung,I,,2023-03-22,2023-06-03,Immunotherapy,Public,Deceased,28.0,BRCA1,No,Never,Moderate,35.1,,Rural,Private Insurance,2.0,No,No,Diabetes,3.0
PT08996,Austria,Tyrol,81.0,Male,Breast,II,2012-12-04,2013-04-04,2013-06-23,Surgery,Public,Alive,117.0,None,No,Former,None,34.3,High,Urban,Statutory Health Insurance,4.0,No,No,None,4.0
PT08997,Denmark,Zealand,85.0,Female,Lung,IV,2016-08-06,,2017-08-23,Immunotherapy,Public,Deceased,,None,Yes,,Heavy,21.1,High,,Statutory Health Insurance,14.0,Yes,No,Obesity,9.0
PT08998,Norway,Oslo,28.0,Female,,II,2021-03-26,2021-03-30,2021-12-24,Surgery,Public,Alive,48.0,None,No,Former,Heavy,21.6,High,Rural,NHS,15.0,No,No,None,6.0
PT08999,,,86.0,Female,Colorectal,III,2023-10-18,2023-11-15,2024-07-08,Immunotherapy,Public,Alive,103.0,None,No,Current,None,29.2,Medium,Urban,NHS,10.0,No,Yes,Cardiovascular Disease,10.0
PT09000,Ireland,Dublin,35.0,Female,Leukemia,IV,2021-02-07,2021-03-12,2021-05-21,Chemotherapy,Public,Alive,110.0,KRAS,No,Former,Moderate,36.9,Low,Urban,Private Insurance,4.0,No,No,Diabetes,9.0
PT09001,Spain,Catalonia,,Male,Pancreatic,III,2018-12-05,2019-02-17,2019-08-20,Immunotherapy,Public,Alive,88.0,EGFR,Yes,Never,None,24.1,Medium,Rural,Private Insurance,6.0,No,No,Diabetes,
PT09002,Spain,Madrid,59.0,Male,Ovarian,I,2016-11-07,2017-04-15,2017-08-20,Immunotherapy,Public,Alive,101.0,None,Yes,Never,Moderate,31.9,Medium,Urban,NHS,10.0,No,No,Hypertension,8.0
PT09003,Belgium,Brussels,,Male,Colorectal,III,2022-09-12,2022-09-17,2022-12-12,,Research Institute,Deceased,88.0,EGFR,No,Never,Moderate,27.4,Low,Rural,NHS,8.0,Yes,,Hypertension,5.0
PT09004,France,Auvergne-Rhône-Alpes,57.0,Female,Colorectal,III,2023-11-25,,2024-06-21,Radiation,Private,Alive,64.0,None,No,Never,Moderate,18.5,Low,Urban,Statutory Health Insurance,14.0,No,No,Cardiovascular Disease,10.0
PT09005,Sweden,Skåne,54.0,Female,Prostate,I,2011-01-04,2011-06-06,2012-03-29,,Research Institute,Alive,114.0,,Yes,Former,Moderate,28.3,Medium,Rural,Statutory Health Insurance,,No,No,None,2.0
PT09006,France,Provence-Alpes-Côte d'Azur,87.0,Female,Breast,II,2023-01-27,2023-07-15,2023-10-12,Immunotherapy,Private,Lost to Follow-up,,None,No,Current,Moderate,32.0,Medium,Urban,Private Insurance,13.0,No,No,Obesity,2.0
PT09007,Norway,Vestland,78.0,Female,Colorectal,III,2016-08-30,2016-09-16,2016-12-18,Radiation,Private,Alive,99.0,EGFR,,Never,Heavy,37.1,Medium,Urban,Private Insurance,18.0,No,No,Obesity,6.0
PT09008,Italy,Veneto,33.0,Male,Breast,I,2023-01-31,2023-04-01,2024-01-15,Targeted Therapy,Public,Alive,102.0,None,Yes,Former,Moderate,24.3,Medium,Urban,NHS,8.0,No,Yes,Diabetes,10.0
PT09009,Belgium,Flanders,66.0,Male,Breast,I,2011-01-31,2011-03-05,2011-10-10,Radiation,Public,Alive,66.0,KRAS,No,Never,Moderate,31.0,Low,Rural,Statutory Health Insurance,19.0,No,,None,4.0
PT09010,,North Holland,61.0,Female,Prostate,,2011-06-24,,2012-02-06,Targeted Therapy,Public,Lost to Follow-up,,KRAS,No,Never,Moderate,38.4,Medium,Rural,Statutory Health Insurance,17.0,No,No,Cardiovascular Disease,2.0
,Norway,Oslo,70.0,Non-binary,Colorectal,IV,2017-04-21,2017-10-16,2018-07-16,Surgery,Private,Deceased,47.0,None,Yes,Former,None,31.2,High,Rural,Private Insurance,10.0,No,No,Cardiovascular Disease,2.0
PT09012,,Sicily,38.0,Male,Pancreatic,I,2013-03-16,2013-08-22,2014-03-16,Targeted Therapy,Public,Alive,116.0,None,No,Never,None,38.0,Medium,Rural,,3.0,Yes,No,None,9.0
PT09013,Sweden,,85.0,Male,Prostate,II,,2013-12-11,2014-06-17,Chemotherapy,Public,Alive,108.0,BRCA1,,Never,None,,Low,Urban,Statutory Health Insurance,8.0,No,No,Cardiovascular Disease,6.0
PT09014,Poland,Lesser Poland,66.0,Male,Prostate,III,2020-01-24,2020-07-16,2020-09-25,Chemotherapy,Public,Alive,70.0,BRCA1,No,Current,Moderate,31.4,Low,Urban,Statutory Health Insurance,7.0,No,No,Cardiovascular Disease,9.0
PT09015,Finland,Southwest Finland,84.0,Male,Leukemia,III,2014-03-11,2014-06-30,2014-08-18,Radiation,Public,Alive,29.0,EGFR,Yes,Never,Moderate,33.8,Low,,NHS,5.0,No,No,Hypertension,7.0
PT09016,Finland,Uusimaa,61.0,Male,Pancreatic,IV,2014-02-06,2014-06-18,2014-11-06,Chemotherapy,Public,Alive,119.0,EGFR,No,Current,None,,Medium,Rural,Statutory Health Insurance,7.0,,,Obesity,10.0
,Switzerland,Zurich,57.0,Female,Prostate,III,2020-06-10,2020-07-11,2021-03-09,,Private,Alive,40.0,BRCA1,No,Never,Moderate,29.2,High,Rural,NHS,17.0,No,No,Cardiovascular Disease,5.0
PT09018,Spain,Andalusia,32.0,Male,Leukemia,III,2017-07-20,2017-07-24,2017-11-26,Radiation,Private,Alive,30.0,None,Yes,Never,Heavy,32.3,Low,Urban,,11.0,Yes,,Diabetes,10.0
PT09019,Portugal,Lisbon,63.0,Male,Breast,IV,2022-10-16,2023-02-16,2023-04-06,Immunotherapy,Public,Lost to Follow-up,,None,No,Current,Moderate,33.3,High,Urban,NHS,5.0,,No,Obesity,7.0
PT09020,Austria,Styria,43.0,Female,Pancreatic,I,2017-12-16,2018-01-03,2018-02-17,Surgery,Public,Deceased,20.0,EGFR,Yes,Never,None,21.5,Medium,,Private Insurance,2.0,No,No,Hypertension,5.0
PT09021,Austria,Vienna,49.0,Non-binary,,I,2012-06-03,2012-08-24,2012-11-18,Targeted Therapy,Public,Alive,32.0,BRCA1,Yes,Former,,24.7,Medium,Rural,,16.0,,No,None,
PT09022,Ireland,Munster,89.0,Male,Breast,II,2023-09-10,2023-10-14,2024-08-13,Radiation,Public,Deceased,20.0,None,Yes,Never,,37.7,,Rural,NHS,12.0,Yes,No,Hypertension,6.0
PT09023,Switzerland,,57.0,Female,Lung,II,2011-05-18,2011-07-05,2012-03-13,Chemotherapy,Public,Lost to Follow-up,,KRAS,No,Former,Moderate,23.3,Medium,Rural,Statutory Health Insurance,18.0,No,No,Cardiovascular Disease,5.0
,,,42.0,Male,,I,2018-03-04,2018-05-06,2018-06-17,Targeted Therapy,Private,Deceased,21.0,None,Yes,Former,Moderate,32.0,Medium,Urban,Statutory Health Insurance,3.0,No,No,None,2.0
PT09025,Norway,Vestland,76.0,Female,Ovarian,II,2021-05-08,2021-05-22,2022-02-22,Immunotherapy,Private,Alive,111.0,KRAS,Yes,Current,Moderate,19.2,Medium,Urban,Private Insurance,1.0,No,Yes,None,4.0
PT09026,Italy,Lombardy,,Female,Lung,III,2019-11-03,2020-02-01,2020-03-21,Surgery,Public,Alive,67.0,KRAS,No,Former,Moderate,36.1,Low,Urban,Private Insurance,3.0,No,No,Hypertension,5.0
PT09027,Denmark,Capital Region,55.0,Female,Breast,IV,,,2016-09-07,Surgery,Private,Deceased,61.0,EGFR,Yes,Never,Moderate,31.0,Medium,Rural,Private Insurance,19.0,Yes,No,Hypertension,8.0
PT09028,Germany,North Rhine-Westphalia,76.0,Male,Colorectal,I,2010-08-13,2010-09-15,2011-06-10,Chemotherapy,Public,Deceased,27.0,,Yes,Never,None,29.1,Medium,Urban,Statutory Health Insurance,6.0,No,No,Diabetes,
PT09029,Finland,Pirkanmaa,20.0,,,II,2015-10-31,2016-01-20,,Immunotherapy,Research Institute,Alive,92.0,BRCA1,No,Never,Moderate,34.3,,Urban,NHS,18.0,Yes,No,Diabetes,
PT09030,Sweden,Skåne,22.0,Female,Prostate,I,2016-02-08,2016-07-27,2017-02-10,Surgery,Private,Alive,70.0,None,,Former,Heavy,34.8,High,Urban,Statutory Health Insurance,5.0,No,Yes,Cardiovascular Disease,4.0
PT09031,Switzerland,Zurich,33.0,Male,Pancreatic,III,2011-06-06,2011-10-12,2012-10-07,Targeted Therapy,Public,Alive,22.0,KRAS,Yes,Current,Moderate,23.4,Medium,Rural,NHS,4.0,No,No,Diabetes,3.0
PT09032,Ireland,Munster,53.0,Male,Ovarian,II,2023-09-08,2024-02-15,2024-12-20,Targeted Therapy,Private,Deceased,,None,No,Never,None,39.5,High,Urban,,4.0,No,No,Diabetes,6.0
PT09033,Ireland,Munster,89.0,Female,Lung,IV,2019-05-25,2019-09-14,2020-05-01,Chemotherapy,,Alive,16.0,EGFR,No,Never,None,38.1,Low,Urban,Statutory Health Insurance,5.0,Yes,No,Diabetes,9.0
PT09034,Belgium,Wallonia,88.0,Female,Pancreatic,I,2018-02-23,2018-06-02,2019-05-22,Immunotherapy,Private,Lost to Follow-up,,BRCA1,Yes,Never,Moderate,22.7,Medium,,NHS,2.0,No,Yes,Hypertension,7.0
PT09035,,South Holland,70.0,Male,Breast,II,2021-11-09,2022-03-04,2022-09-08,Targeted Therapy,Public,Alive,7.0,EGFR,No,Former,None,25.2,High,Urban,NHS,16.0,No,No,None,3.0
PT09036,Spain,Catalonia,48.0,Female,Colorectal,I,2014-01-30,2014-07-20,2015-06-28,Surgery,Public,Alive,98.0,None,Yes,Never,Moderate,26.3,Low,Urban,Statutory Health Insurance,8.0,No,No,Diabetes,6.0
PT09037,Switzerland,Geneva,67.0,Male,Breast,II,2023-04-05,2023-08-26,2023-12-31,Targeted Therapy,Public,Alive,63.0,KRAS,No,Former,None,35.2,Medium,Urban,Private Insurance,14.0,,No,None,2.0
PT09038,Sweden,Skåne,35.0,Male,Colorectal,IV,2017-02-06,2017-03-28,2018-03-08,Surgery,Public,Alive,75.0,BRCA1,Yes,Never,Moderate,25.3,High,Urban,NHS,19.0,No,No,None,4.0
PT09039,Netherlands,Utrecht,76.0,Female,Pancreatic,IV,2021-05-01,2021-08-25,2021-10-04,Immunotherapy,Private,Alive,17.0,,Yes,Current,None,32.7,Medium,Urban,NHS,19.0,No,Yes,Diabetes,1.0
PT09040,Ireland,Connacht,29.0,,Lung,II,2022-04-05,2022-06-15,2022-09-25,Chemotherapy,Private,Alive,60.0,EGFR,Yes,Former,Heavy,32.5,Medium,Urban,Statutory Health Insurance,7.0,No,No,Hypertension,4.0
PT09041,Ireland,Munster,38.0,Male,Prostate,III,2013-03-02,2013-05-04,2014-01-02,Chemotherapy,Public,Deceased,119.0,None,Yes,Never,None,30.4,Low,Urban,NHS,10.0,No,No,None,6.0
PT09042,Denmark,Central Denmark,86.0,Male,Prostate,I,2022-04-26,2022-07-05,2022-09-12,Chemotherapy,Public,Alive,,BRCA1,Yes,Never,Moderate,31.7,High,Urban,Statutory Health Insurance,,No,No,Obesity,3.0
PT09043,Switzerland,Bern,55.0,Female,Breast,I,2019-06-04,2019-10-19,2020-06-12,Radiation,Public,Alive,114.0,BRCA1,No,Current,Moderate,23.0,Low,Urban,Statutory Health Insurance,3.0,Yes,No,None,7.0
PT09044,Norway,,23.0,Male,Pancreatic,IV,2021-05-12,2021-09-30,2022-01-11,Chemotherapy,Public,Alive,82.0,None,Yes,Current,Moderate,21.4,Medium,Urban,,7.0,,Yes,Cardiovascular Disease,
PT09045,Austria,Tyrol,52.0,Non-binary,,,2011-10-16,2012-01-28,2012-03-31,Chemotherapy,Public,Lost to Follow-up,,None,No,Former,None,25.4,Medium,Urban,NHS,19.0,No,Yes,Hypertension,5.0
PT09046,Spain,Catalonia,47.0,Male,Lung,I,2017-02-21,2017-07-17,2017-10-16,,Research Institute,Alive,71.0,EGFR,,Never,Moderate,28.7,Low,Rural,Private Insurance,3.0,,No,Hypertension,6.0
,Spain,Andalusia,28.0,Female,Ovarian,,2023-05-07,2023-10-17,2024-02-02,Immunotherapy,Private,Alive,97.0,BRCA1,Yes,Former,None,29.7,Low,Rural,Private Insurance,11.0,No,No,Hypertension,2.0
PT09048,Finland,Pirkanmaa,25.0,Male,Colorectal,II,,2010-06-09,2010-12-28,Immunotherapy,Public,Alive,71.0,None,No,Former,,21.8,Medium,Rural,Private Insurance,1.0,No,Yes,Hypertension,5.0
PT09049,France,Auvergne-Rhône-Alpes,68.0,,Colorectal,I,2010-05-18,2010-09-20,2011-01-22,Targeted Therapy,Research Institute,Deceased,6.0,KRAS,No,Never,None,33.4,High,Rural,Statutory Health Insurance,18.0,No,No,Hypertension,
PT09050,Portugal,Porto,41.0,Female,Colorectal,III,2011-06-17,2011-10-09,2011-11-12,Chemotherapy,Private,Alive,114.0,None,No,Never,Heavy,20.1,Low,Rural,NHS,8.0,No,No,None,
PT09051,Switzerland,Zurich,67.0,Male,Pancreatic,II,2023-09-02,2023-10-08,2024-09-08,Immunotherapy,Public,Alive,85.0,None,Yes,Never,Moderate,39.7,High,Urban,Statutory Health Insurance,2.0,No,No,Obesity,
PT09052,Switzerland,Bern,40.0,Male,Lung,II,2019-03-28,2019-05-13,2019-08-08,Immunotherapy,Public,,70.0,KRAS,Yes,Current,Moderate,35.4,Low,Urban,NHS,8.0,Yes,No,Hypertension,4.0
PT09053,Finland,,52.0,Male,Pancreatic,I,2011-12-16,2012-05-29,2012-10-28,Immunotherapy,Public,Alive,36.0,EGFR,No,Never,,37.8,Medium,,Private Insurance,17.0,No,Yes,,3.0
PT09054,Netherlands,South Holland,75.0,Male,Ovarian,II,2020-02-08,2020-06-09,,Immunotherapy,Public,Deceased,113.0,KRAS,No,Former,Moderate,28.2,Medium,Urban,Statutory Health Insurance,6.0,No,No,Cardiovascular Disease,4.0
PT09055,Portugal,Lisbon,48.0,Male,Colorectal,III,2018-08-12,2018-11-02,2018-12-04,,Private,Alive,101.0,None,Yes,Never,None,,,Urban,Statutory Health Insurance,6.0,No,Yes,Hypertension,4.0
PT09056,Portugal,Lisbon,72.0,Female,Ovarian,IV,2016-05-13,,2016-12-08,Chemotherapy,Private,Alive,23.0,None,Yes,Former,None,39.7,Medium,Urban,Statutory Health Insurance,16.0,No,No,,4.0
PT09057,Spain,Madrid,,Female,Ovarian,IV,2011-02-25,,,Immunotherapy,Public,Alive,51.0,KRAS,No,,Moderate,28.4,Medium,Urban,Statutory Health Insurance,,No,Yes,Obesity,6.0
PT09058,Sweden,Västra Götaland,,Male,Pancreatic,II,2018-05-03,2018-08-04,2019-07-02,Surgery,Public,Lost to Follow-up,,KRAS,Yes,Former,Moderate,36.4,Low,Urban,Statutory Health Insurance,6.0,No,No,None,6.0
PT09059,Portugal,Lisbon,66.0,Male,Prostate,IV,2015-10-06,2015-12-13,2016-10-25,Radiation,Public,Alive,31.0,BRCA1,Yes,Former,None,32.8,,Urban,Statutory Health Insurance,5.0,No,No,None,9.0
PT09060,Sweden,Stockholm,32.0,Male,Breast,I,2022-10-09,2022-12-24,2023-03-11,,Public,Lost to Follow-up,,KRAS,No,Never,None,22.5,High,Urban,Statutory Health Insurance,6.0,No,No,Diabetes,1.0
PT09061,Germany,North Rhine-Westphalia,46.0,Male,Leukemia,I,2021-05-27,2021-08-12,2022-05-21,Surgery,Public,,29.0,KRAS,Yes,Never,None,26.9,Medium,Urban,Private Insurance,18.0,Yes,No,,8.0
PT09062,Netherlands,,81.0,Female,Colorectal,III,2018-12-14,2019-05-05,2019-07-09,Targeted Therapy,Research Institute,Alive,46.0,None,Yes,Former,Moderate,33.8,Low,Urban,Private Insurance,,No,,Diabetes,8.0
PT09063,Sweden,Stockholm,64.0,,Ovarian,I,2013-03-21,2013-06-07,2013-10-02,,Public,Deceased,117.0,BRCA1,No,Never,Heavy,21.4,Low,,Statutory Health Insurance,16.0,,Yes,None,3.0
PT09064,France,Auvergne-Rhône-Alpes,22.0,Male,Prostate,I,2011-12-21,2012-06-17,,Radiation,Research Institute,Deceased,35.0,KRAS,No,Current,None,25.1,Medium,Urban,Private Insurance,11.0,No,No,Cardiovascular Disease,10.0
PT09065,Netherlands,North Holland,41.0,Male,Pancreatic,IV,2021-09-23,2021-12-18,2022-02-05,Radiation,Private,Alive,13.0,,Yes,Current,Moderate,25.2,Low,Rural,NHS,14.0,,No,Hypertension,
PT09066,Italy,Sicily,46.0,Female,Ovarian,III,2014-08-14,2014-08-23,2015-01-30,Radiation,Private,Deceased,73.0,BRCA1,No,Never,None,27.2,Low,Rural,Statutory Health Insurance,18.0,,No,Cardiovascular Disease,9.0
PT09067,Netherlands,Utrecht,74.0,Male,Prostate,I,,2018-11-07,2019-06-21,Surgery,Private,Alive,51.0,KRAS,Yes,Never,Moderate,18.0,Medium,Rural,Statutory Health Insurance,18.0,No,Yes,Diabetes,3.0
PT09068,Ireland,Dublin,86.0,Male,,III,2019-10-12,2020-01-01,2020-10-07,Radiation,Public,Deceased,65.0,KRAS,No,Former,Moderate,24.6,High,Urban,NHS,3.0,No,No,Hypertension,2.0
PT09069,Finland,Southwest Finland,52.0,Female,Breast,III,2010-06-29,2010-09-25,2011-09-05,Immunotherapy,Private,Alive,51.0,None,No,Never,Moderate,22.6,Low,Urban,Statutory Health Insurance,4.0,Yes,No,Diabetes,7.0
PT09070,Spain,Madrid,21.0,Female,Leukemia,IV,2014-11-08,2015-01-16,2015-08-31,Surgery,,Alive,94.0,BRCA1,Yes,Former,Moderate,38.7,Medium,Rural,Statutory Health Insurance,,No,No,Diabetes,8.0
PT09071,Ireland,Connacht,65.0,,Leukemia,II,2010-01-08,2010-06-19,,Chemotherapy,Research Institute,Alive,95.0,None,Yes,Never,Moderate,36.4,Medium,Urban,NHS,1.0,Yes,,Obesity,5.0
PT09072,Spain,Catalonia,52.0,Female,Ovarian,III,2021-08-26,2021-12-10,2022-07-15,Radiation,Private,Alive,79.0,KRAS,No,Never,Moderate,29.6,Medium,Urban,NHS,8.0,Yes,No,Cardiovascular Disease,1.0
PT09073,Italy,Lombardy,77.0,Male,Leukemia,III,2016-11-22,2017-01-26,2017-12-07,Surgery,Research Institute,,6.0,BRCA1,No,Former,Moderate,20.0,Medium,Urban,Private Insurance,13.0,No,No,None,9.0
PT09074,Germany,Bavaria,26.0,Female,Lung,III,2021-03-24,2021-04-20,2021-11-02,Radiation,Research Institute,Alive,100.0,BRCA1,Yes,Never,Moderate,,Medium,Rural,Private Insurance,3.0,No,No,Cardiovascular Disease,10.0
PT09075,Switzerland,Bern,34.0,Male,Lung,III,,2018-05-14,2018-11-27,Targeted Therapy,Public,Alive,67.0,,No,Current,None,26.6,Medium,Urban,Private Insurance,9.0,No,No,Cardiovascular Disease,4.0
,Sweden,Västra Götaland,45.0,Female,Prostate,II,2022-04-04,,2022-11-03,Immunotherapy,Research Institute,Alive,51.0,KRAS,Yes,Never,Moderate,34.9,High,Urban,NHS,13.0,No,No,Obesity,9.0
PT09077,Finland,Uusimaa,30.0,Female,Pancreatic,II,2023-10-21,,2024-06-25,,,Deceased,24.0,EGFR,No,Current,Moderate,23.0,Low,Urban,Private Insurance,3.0,No,No,None,5.0
PT09078,Norway,Trøndelag,57.0,Male,Breast,IV,2015-06-26,2015-08-18,2016-07-13,Radiation,Private,Alive,,EGFR,No,Never,None,31.9,High,Urban,Statutory Health Insurance,2.0,No,No,Obesity,6.0
PT09079,Denmark,Capital Region,46.0,Female,Colorectal,II,2023-09-13,2024-01-24,2024-03-30,Surgery,Private,Deceased,,BRCA1,No,Former,Heavy,27.7,Low,Urban,Private Insurance,10.0,Yes,No,None,
PT09080,Italy,Lombardy,26.0,Female,Breast,I,2020-04-13,2020-08-08,2020-10-28,Immunotherapy,Public,Alive,107.0,None,No,Current,None,29.2,Medium,Urban,Private Insurance,11.0,No,No,Cardiovascular Disease,6.0
PT09081,Portugal,Algarve,20.0,Male,Lung,III,2012-08-30,2013-01-23,2013-11-06,Targeted Therapy,Public,Alive,,BRCA1,No,Never,Moderate,22.4,Medium,Urban,Private Insurance,6.0,No,No,Hypertension,1.0
PT09082,Netherlands,South Holland,40.0,Female,Prostate,,2022-01-17,2022-06-30,2022-08-12,Immunotherapy,Private,Alive,63.0,EGFR,No,Never,,37.2,Medium,Urban,Private Insurance,11.0,No,No,Diabetes,7.0
PT09083,,Flanders,49.0,Female,Colorectal,II,2017-09-21,2017-12-27,2018-02-12,Immunotherapy,Public,Deceased,95.0,KRAS,Yes,Never,None,33.1,Medium,,Statutory Health Insurance,8.0,No,No,,4.0
PT09084,Belgium,Wallonia,27.0,Female,Leukemia,I,2018-04-24,2018-08-30,2019-01-20,Radiation,Public,Alive,84.0,None,No,Never,Moderate,27.0,Low,Urban,NHS,1.0,No,No,Cardiovascular Disease,
PT09085,Italy,Lombardy,22.0,Male,Leukemia,III,2020-03-31,2020-05-24,2020-12-17,Immunotherapy,Public,Deceased,68.0,EGFR,Yes,Never,Moderate,26.1,Medium,Urban,Statutory Health Insurance,18.0,No,No,Hypertension,3.0
PT09086,Austria,Styria,74.0,Male,Lung,IV,2021-12-16,2022-05-27,2023-03-23,Chemotherapy,Private,Deceased,82.0,EGFR,Yes,Former,None,19.3,Low,Rural,Statutory Health Insurance,4.0,Yes,No,Obesity,1.0
PT09087,Italy,Lombardy,34.0,Male,Prostate,III,2021-07-20,2021-08-21,,Chemotherapy,Private,Alive,15.0,KRAS,Yes,Former,Moderate,26.7,High,Urban,Statutory Health Insurance,8.0,No,No,None,4.0
PT09088,Norway,Trøndelag,55.0,Male,Ovarian,I,2022-08-12,2022-10-02,2023-02-27,Targeted Therapy,Public,Alive,59.0,BRCA1,No,Never,None,23.0,Low,Urban,NHS,10.0,,No,Obesity,7.0
PT09089,Spain,Andalusia,25.0,Female,Pancreatic,IV,2016-05-15,2016-09-23,2017-09-17,Targeted Therapy,Public,Deceased,23.0,EGFR,No,Never,None,36.5,High,Urban,NHS,7.0,No,No,Diabetes,9.0
PT09090,Italy,Veneto,61.0,Male,Breast,II,2019-06-01,2019-08-05,2019-11-11,,Private,Deceased,74.0,KRAS,No,Never,None,24.5,Medium,Urban,Statutory Health Insurance,6.0,No,No,Cardiovascular Disease,10.0
PT09091,,Madrid,69.0,Male,Lung,II,2017-10-09,,2018-03-04,Radiation,Public,Deceased,64.0,KRAS,Yes,Former,Heavy,30.8,Medium,Urban,Statutory Health Insurance,10.0,No,No,Cardiovascular Disease,4.0
PT09092,Switzerland,Geneva,37.0,Male,Pancreatic,II,2023-03-09,2023-03-22,2023-12-12,Targeted Therapy,Public,Deceased,49.0,KRAS,No,Never,None,32.3,Medium,Urban,Statutory Health Insurance,7.0,No,No,Diabetes,2.0
PT09093,France,Île-de-France,69.0,Male,,IV,2023-09-12,2023-09-20,2024-06-16,Surgery,Public,Alive,114.0,BRCA1,Yes,Former,Moderate,31.5,High,Urban,Private Insurance,8.0,,No,Obesity,2.0
PT09094,Switzerland,Bern,49.0,Female,Breast,I,2015-02-17,,2016-07-15,Targeted Therapy,Research Institute,Alive,101.0,KRAS,,Never,Moderate,31.7,Low,Urban,Private Insurance,17.0,No,,Diabetes,8.0
PT09095,Belgium,Brussels,58.0,Female,Colorectal,III,2011-02-01,2011-07-09,2012-04-09,Surgery,Public,Alive,54.0,EGFR,Yes,Former,None,35.3,Medium,Urban,Private Insurance,11.0,No,No,Cardiovascular Disease,6.0
PT09096,Poland,Masovian,31.0,Male,Breast,II,2016-06-06,2016-06-14,,Radiation,Private,Alive,105.0,KRAS,No,Former,Heavy,,High,Urban,NHS,17.0,No,No,Hypertension,9.0
PT09097,Norway,Vestland,78.0,Male,Colorectal,I,2019-06-28,2019-08-25,2020-06-10,Radiation,Public,Deceased,116.0,KRAS,No,Current,Moderate,21.4,Low,Urban,NHS,,Yes,No,Diabetes,3.0
PT09098,Sweden,Stockholm,63.0,Male,Pancreatic,IV,2022-11-12,2023-03-16,2023-09-07,Targeted Therapy,Private,Alive,61.0,EGFR,Yes,Never,Moderate,28.9,Medium,Urban,Statutory Health Insurance,5.0,No,No,Obesity,1.0
PT09099,Portugal,Algarve,23.0,Male,Prostate,II,,2022-01-20,2022-12-19,Chemotherapy,Public,Alive,25.0,KRAS,No,Former,Moderate,18.3,,Urban,NHS,12.0,Yes,No,Diabetes,10.0
PT09100,Finland,Uusimaa,55.0,Male,Lung,,2010-01-01,2010-04-14,2011-03-05,Immunotherapy,Public,Alive,29.0,EGFR,Yes,Former,Heavy,34.0,High,Rural,Statutory Health Insurance,9.0,No,No,Hypertension,8.0
PT09101,Finland,Southwest Finland,67.0,Female,Breast,I,2013-04-09,2013-07-05,2013-10-10,Targeted Therapy,Private,Lost to Follow-up,,BRCA1,Yes,Former,,20.1,Low,Rural,NHS,7.0,No,No,Diabetes,6.0
PT09102,Norway,Trøndelag,33.0,Male,Prostate,III,2018-04-29,2018-09-12,2018-12-06,Surgery,Private,Alive,84.0,BRCA1,Yes,Never,None,24.2,Medium,Urban,NHS,16.0,No,No,Obesity,2.0
PT09103,Netherlands,North Holland,68.0,Female,Prostate,III,2013-01-04,2013-03-06,2013-08-27,Radiation,Public,Alive,45.0,KRAS,No,Former,None,25.8,Medium,,NHS,15.0,No,Yes,Hypertension,9.0
PT09104,Austria,Styria,86.0,Female,Breast,II,2019-09-22,2019-12-07,2020-02-26,Targeted Therapy,Public,Alive,63.0,BRCA1,Yes,Never,None,36.8,Low,Rural,Private Insurance,14.0,Yes,No,None,7.0
PT09105,Spain,Madrid,28.0,Male,Leukemia,II,2017-04-25,2017-08-17,2018-01-18,Radiation,Public,Alive,28.0,,Yes,Former,Moderate,34.9,Medium,Rural,NHS,8.0,Yes,Yes,Hypertension,2.0
PT09106,Switzerland,Zurich,40.0,Female,Pancreatic,,2012-02-01,2012-07-14,,Targeted Therapy,Public,Lost to Follow-up,,None,No,Never,None,37.0,Medium,Urban,Private Insurance,14.0,Yes,,None,3.0
PT09107,,Lombardy,35.0,Female,Leukemia,III,2021-12-11,2022-03-23,2022-08-27,Radiation,Public,Alive,46.0,KRAS,Yes,Never,Moderate,39.9,Low,Urban,Statutory Health Insurance,2.0,No,No,None,4.0
PT09108,Spain,Andalusia,35.0,Female,Colorectal,II,2010-04-06,2010-07-22,2010-09-14,Chemotherapy,Private,Alive,64.0,EGFR,No,Never,Moderate,30.5,High,Urban,NHS,16.0,No,No,Cardiovascular Disease,9.0
PT09109,Austria,Vienna,47.0,Female,Prostate,III,2020-12-30,2021-04-03,2021-07-02,Surgery,Public,Alive,19.0,EGFR,Yes,Never,Moderate,21.2,Medium,Urban,Private Insurance,13.0,,No,Hypertension,6.0
PT09110,Belgium,Flanders,70.0,Male,Lung,III,2017-09-01,2017-11-14,2018-04-20,,Public,Alive,110.0,EGFR,No,Never,Heavy,28.9,Medium,Urban,NHS,3.0,No,No,Diabetes,4.0
PT09111,Poland,Masovian,75.0,Female,Lung,I,2014-04-23,2014-09-17,2015-03-24,Radiation,Private,Alive,,,Yes,Former,None,36.7,Medium,Urban,NHS,2.0,Yes,No,None,1.0
PT09112,Austria,,76.0,Male,Prostate,,2022-01-25,2022-02-12,2022-11-19,Targeted Therapy,Research Institute,Alive,108.0,None,Yes,Former,Moderate,24.5,Low,Rural,,7.0,No,No,Diabetes,3.0
PT09113,Germany,Berlin,71.0,Female,Leukemia,,2010-09-24,,2012-01-26,Surgery,Research Institute,Alive,16.0,EGFR,No,Former,None,30.7,Low,Rural,NHS,7.0,No,,None,7.0
PT09114,Finland,Southwest Finland,65.0,Male,Pancreatic,IV,2020-01-13,2020-05-05,2020-11-02,Targeted Therapy,Private,Alive,91.0,None,No,Never,Heavy,21.4,High,Urban,NHS,,Yes,No,Cardiovascular Disease,7.0
PT09115,Poland,Silesian,57.0,Male,Prostate,III,2013-01-26,2013-06-23,2014-06-02,Immunotherapy,Public,Alive,104.0,KRAS,No,,None,21.4,High,Urban,NHS,2.0,Yes,Yes,Diabetes,1.0
PT09116,Spain,Andalusia,67.0,Female,Ovarian,I,2017-02-17,2017-02-19,2017-06-20,Radiation,Public,Alive,36.0,BRCA1,No,Never,Heavy,31.3,Medium,Urban,Statutory Health Insurance,10.0,No,No,Hypertension,1.0
PT09117,Switzerland,Zurich,60.0,Male,Colorectal,IV,2018-10-11,2018-11-10,2019-06-30,Surgery,Private,Alive,22.0,None,No,Former,Moderate,38.8,High,Urban,Statutory Health Insurance,3.0,No,No,Diabetes,5.0
PT09118,Finland,Southwest Finland,78.0,Male,Prostate,III,2022-09-25,2023-03-23,,Chemotherapy,Public,Alive,,None,Yes,Never,Moderate,23.7,Low,Rural,Statutory Health Insurance,13.0,No,Yes,Diabetes,4.0
PT09119,France,Île-de-France,86.0,,Breast,I,2013-01-22,2013-07-13,,Immunotherapy,,Deceased,112.0,EGFR,Yes,Former,None,33.0,High,Urban,,7.0,No,No,Hypertension,9.0
PT09120,,Andalusia,85.0,Female,Leukemia,III,2018-11-26,2019-01-12,2019-06-14,Targeted Therapy,Research Institute,Alive,58.0,BRCA1,Yes,Never,None,35.2,Low,Urban,Statutory Health Insurance,6.0,No,No,None,7.0
PT09121,Belgium,Flanders,46.0,,,IV,2015-03-10,2015-04-22,2015-09-14,Targeted Therapy,Public,Alive,51.0,EGFR,Yes,Current,Moderate,23.7,Medium,Urban,,2.0,No,No,Diabetes,10.0
PT09122,,Berlin,51.0,Female,Breast,I,2016-04-22,2016-05-03,2016-11-18,Immunotherapy,Private,Alive,114.0,KRAS,No,Current,Moderate,23.3,Medium,Urban,Private Insurance,15.0,Yes,No,Cardiovascular Disease,3.0
PT09123,Netherlands,North Holland,75.0,Female,Prostate,IV,2018-03-25,2018-09-11,2019-02-14,Chemotherapy,Public,Deceased,83.0,KRAS,Yes,Never,Heavy,35.7,,Rural,Statutory Health Insurance,4.0,No,No,Obesity,1.0
PT09124,Finland,Southwest Finland,29.0,Female,Pancreatic,IV,2017-09-02,2017-09-21,2017-12-12,Chemotherapy,Public,Alive,30.0,BRCA1,No,Current,Moderate,19.6,Medium,Rural,Statutory Health Insurance,15.0,No,No,Diabetes,6.0
PT09125,Poland,Masovian,59.0,Male,Prostate,I,2020-09-21,2021-01-30,2021-08-17,Targeted Therapy,Public,,30.0,None,No,Never,Moderate,25.2,Medium,Rural,NHS,3.0,Yes,No,None,6.0
PT09126,Finland,Uusimaa,36.0,Male,Pancreatic,IV,2014-07-11,2014-07-15,2015-04-14,Targeted Therapy,Public,Alive,60.0,BRCA1,Yes,Never,Moderate,29.5,Medium,Urban,Statutory Health Insurance,7.0,No,No,Hypertension,5.0
PT09127,Netherlands,South Holland,77.0,Female,Lung,IV,2022-09-28,2023-01-17,2023-11-26,Chemotherapy,Research Institute,Alive,27.0,BRCA1,No,Never,Moderate,23.9,Low,Urban,Statutory Health Insurance,13.0,No,No,Cardiovascular Disease,3.0
PT09128,Sweden,Västra Götaland,25.0,Male,Pancreatic,I,2023-01-29,2023-07-14,2023-10-12,Chemotherapy,Public,Alive,95.0,None,No,Current,Moderate,20.2,High,Rural,Statutory Health Insurance,3.0,Yes,No,Obesity,8.0
PT09129,Ireland,Munster,58.0,Male,Breast,I,2016-09-03,2017-02-12,2017-05-11,Chemotherapy,Private,Alive,47.0,BRCA1,Yes,Current,Moderate,37.7,Medium,,Private Insurance,,No,Yes,None,8.0
PT09130,Sweden,Stockholm,37.0,Male,Prostate,II,2017-08-05,2017-09-25,2018-01-07,Targeted Therapy,Private,Alive,17.0,KRAS,No,Current,Moderate,27.9,Medium,Rural,NHS,19.0,No,No,Hypertension,3.0
PT09131,Italy,Lombardy,61.0,Female,Lung,II,2023-03-26,2023-09-01,2024-04-30,Radiation,Private,Alive,60.0,BRCA1,Yes,Former,,21.6,Low,Urban,Private Insurance,18.0,No,No,None,1.0
PT09132,Finland,Pirkanmaa,23.0,Male,Ovarian,III,2021-01-28,2021-05-12,2021-10-14,Immunotherapy,Private,,48.0,EGFR,Yes,,Moderate,39.4,Low,Urban,Private Insurance,8.0,No,No,None,5.0
PT09133,Italy,Sicily,39.0,Female,Breast,II,2015-09-27,2015-12-19,2016-06-17,,Public,Alive,101.0,KRAS,No,Never,Moderate,37.9,Medium,Rural,Statutory Health Insurance,15.0,No,No,Obesity,2.0
PT09134,Poland,Masovian,47.0,Female,Lung,IV,2017-04-12,2017-05-19,2017-08-21,Targeted Therapy,Private,Alive,43.0,None,Yes,Current,Moderate,24.0,Medium,Urban,Statutory Health Insurance,3.0,No,No,Hypertension,2.0
PT09135,Finland,Uusimaa,59.0,Female,Leukemia,IV,2017-10-13,2018-04-03,2018-11-26,Surgery,Private,Deceased,10.0,None,Yes,Former,None,18.8,,Rural,NHS,,No,No,Hypertension,6.0
PT09136,Germany,Berlin,84.0,Non-binary,Colorectal,II,,2019-04-16,2019-09-08,Targeted Therapy,Private,Alive,59.0,EGFR,No,Never,,25.1,High,Urban,Statutory Health Insurance,10.0,No,No,Obesity,3.0
PT09137,Portugal,Porto,63.0,Male,Breast,II,2016-04-19,2016-08-05,2016-11-30,Radiation,Public,Alive,22.0,None,Yes,Never,Moderate,20.3,Low,Urban,Statutory Health Insurance,10.0,No,No,Hypertension,7.0
PT09138,Spain,Andalusia,42.0,Female,Prostate,II,2014-09-23,2015-01-06,2015-02-14,Radiation,Public,Deceased,90.0,None,No,Never,None,27.6,High,Urban,NHS,15.0,No,No,Obesity,4.0
PT09139,Norway,Trøndelag,76.0,Female,Pancreatic,II,2011-05-28,2011-06-15,2011-09-02,Chemotherapy,Private,,114.0,,No,Never,Heavy,30.4,Medium,Rural,Private Insurance,2.0,No,No,None,1.0
,France,Auvergne-Rhône-Alpes,66.0,Female,Leukemia,II,2012-03-06,2012-03-31,2012-08-04,Immunotherapy,Public,Alive,22.0,KRAS,No,Former,None,19.3,Low,Urban,,4.0,No,No,,8.0
PT09141,Denmark,Zealand,32.0,Female,Ovarian,I,,2023-12-16,2024-09-22,,Public,Lost to Follow-up,,EGFR,Yes,Never,,39.5,,Urban,NHS,10.0,No,Yes,Hypertension,7.0
PT09142,Italy,Lombardy,35.0,Male,Lung,I,2021-08-22,2021-09-16,2021-12-17,Immunotherapy,Public,Alive,37.0,,No,Never,Moderate,28.9,High,Rural,Private Insurance,11.0,No,No,Cardiovascular Disease,2.0
PT09143,,Southwest Finland,74.0,Female,Colorectal,I,2014-06-15,2014-09-07,2014-12-31,Surgery,Public,Lost to Follow-up,,BRCA1,Yes,Former,Moderate,32.4,Low,Urban,NHS,11.0,Yes,No,Obesity,10.0
PT09144,Sweden,Stockholm,84.0,Male,Pancreatic,IV,2018-12-26,2019-02-15,2019-09-25,Immunotherapy,Public,Alive,67.0,EGFR,Yes,Former,Moderate,23.8,Low,Urban,Private Insurance,1.0,No,No,Hypertension,8.0
PT09145,France,Auvergne-Rhône-Alpes,35.0,Non-binary,Breast,I,2022-02-06,2022-02-16,2022-05-14,Immunotherapy,Public,Lost to Follow-up,,KRAS,Yes,Never,Moderate,31.2,Medium,Rural,Statutory Health Insurance,12.0,No,No,Obesity,5.0
PT09146,Ireland,Dublin,56.0,Female,Colorectal,I,2012-11-30,2013-05-26,,Chemotherapy,Public,,39.0,None,No,Never,Moderate,28.5,Medium,Urban,NHS,10.0,No,No,Obesity,3.0
PT09147,Belgium,Flanders,71.0,Female,Leukemia,,,2011-05-02,2012-03-28,Surgery,Public,Alive,64.0,None,Yes,Former,None,36.8,Low,Urban,Private Insurance,9.0,No,No,Obesity,
PT09148,Ireland,Dublin,29.0,Female,Colorectal,,2016-08-16,2017-01-29,2017-12-08,Radiation,,Deceased,111.0,None,No,Former,None,22.8,Low,Urban,Statutory Health Insurance,5.0,Yes,No,Cardiovascular Disease,2.0
PT09149,Finland,Southwest Finland,57.0,Male,Breast,I,2018-03-18,2018-06-18,2018-11-14,Immunotherapy,Public,Alive,74.0,,Yes,Never,None,18.1,Medium,Rural,NHS,17.0,No,No,Obesity,2.0
PT09150,Germany,Berlin,63.0,Male,Leukemia,III,2017-05-06,2017-09-09,2018-05-04,Surgery,Private,Alive,95.0,KRAS,No,Never,None,22.0,Medium,Urban,,12.0,No,No,None,1.0
PT09151,Sweden,Stockholm,73.0,Female,Lung,II,2020-03-22,2020-07-13,2021-03-23,Surgery,,Alive,9.0,EGFR,Yes,Former,None,23.0,Medium,Urban,Private Insurance,19.0,No,No,Hypertension,7.0
PT09152,France,Île-de-France,70.0,Male,Breast,I,2012-01-22,2012-05-15,2013-04-24,Radiation,Public,Lost to Follow-up,,EGFR,No,Former,Moderate,27.7,Medium,Rural,Private Insurance,16.0,No,No,None,10.0
PT09153,France,Auvergne-Rhône-Alpes,71.0,Male,Colorectal,II,2013-08-29,2013-10-14,2014-07-30,Chemotherapy,Public,Alive,114.0,BRCA1,No,Never,Moderate,,Medium,Rural,Private Insurance,18.0,Yes,No,Diabetes,5.0
PT09154,Finland,,89.0,Female,Breast,II,2013-07-25,2013-10-03,2014-02-20,Surgery,Private,Alive,89.0,BRCA1,No,Former,Moderate,24.0,Medium,Urban,Statutory Health Insurance,4.0,No,No,Diabetes,6.0
PT09155,Belgium,Brussels,78.0,Male,Leukemia,II,2022-02-04,2022-02-15,2022-07-18,Radiation,Public,Deceased,100.0,None,Yes,Former,None,24.4,Medium,Urban,NHS,7.0,No,No,Hypertension,3.0
PT09156,Belgium,Wallonia,32.0,Female,Colorectal,III,2015-05-15,2015-08-06,2016-02-20,Targeted Therapy,Public,Alive,,BRCA1,No,Former,None,22.5,Medium,Rural,Private Insurance,1.0,No,No,None,5.0
PT09157,Italy,Lombardy,60.0,,,I,2022-09-25,2023-02-16,,Surgery,Public,Alive,75.0,BRCA1,No,Former,Moderate,19.7,Low,Urban,Private Insurance,,No,No,None,10.0
PT09158,Italy,Veneto,,Female,Ovarian,II,2018-07-03,2018-12-10,,Targeted Therapy,Public,Alive,86.0,BRCA1,No,Never,Moderate,35.1,Medium,Urban,Private Insurance,12.0,No,Yes,Cardiovascular Disease,
PT09159,Denmark,Capital Region,69.0,Female,Ovarian,III,2021-07-11,2021-11-18,2022-10-31,Targeted Therapy,Research Institute,Alive,112.0,EGFR,No,Current,Moderate,18.8,Low,Urban,Statutory Health Insurance,6.0,No,Yes,Cardiovascular Disease,9.0
,Austria,Styria,76.0,Male,Pancreatic,IV,2010-01-02,2010-03-01,2010-04-10,,Private,Alive,94.0,EGFR,No,,Moderate,31.8,Medium,Urban,NHS,11.0,No,No,Cardiovascular Disease,10.0
PT09161,Germany,Bavaria,69.0,Male,Prostate,IV,2012-01-20,2012-04-14,2012-06-02,Radiation,Private,Lost to Follow-up,,EGFR,No,Never,,37.0,Medium,Rural,Private Insurance,3.0,Yes,No,Cardiovascular Disease,6.0
PT09162,France,Auvergne-Rhône-Alpes,76.0,Male,Lung,II,2018-06-07,2018-11-20,2019-07-25,Targeted Therapy,Public,Alive,9.0,EGFR,No,Former,Moderate,26.3,Low,Urban,Statutory Health Insurance,1.0,No,Yes,Obesity,
PT09163,,Utrecht,73.0,Non-binary,Breast,II,2017-10-19,2018-01-06,,,Public,Lost to Follow-up,,None,Yes,Never,None,31.3,High,Rural,Private Insurance,19.0,No,No,Hypertension,4.0
PT09164,Spain,Catalonia,85.0,Male,Prostate,II,,2020-01-27,2020-04-27,Immunotherapy,Private,Alive,19.0,None,No,Current,None,31.8,Medium,Urban,,1.0,No,No,Hypertension,7.0
PT09165,Belgium,Brussels,27.0,Male,Pancreatic,IV,2022-10-13,2022-12-23,2023-05-20,Targeted Therapy,Public,Alive,108.0,BRCA1,Yes,Never,None,20.7,High,Urban,Statutory Health Insurance,6.0,No,No,,9.0
PT09166,Spain,Andalusia,,Female,Pancreatic,III,2021-06-10,2021-10-04,2022-09-18,Targeted Therapy,Public,Alive,86.0,,No,Former,Moderate,22.9,Medium,Urban,Private Insurance,16.0,Yes,No,None,3.0
PT09167,Austria,Styria,28.0,Male,Leukemia,II,2012-10-30,2013-01-05,2013-08-08,Immunotherapy,Public,Deceased,65.0,BRCA1,No,Never,Heavy,22.6,High,Rural,Private Insurance,4.0,No,No,None,3.0
PT09168,Germany,Bavaria,79.0,Female,Pancreatic,,2011-03-10,2011-03-25,2011-09-02,Radiation,Public,Alive,84.0,EGFR,No,Never,None,20.5,High,Urban,NHS,1.0,Yes,No,Cardiovascular Disease,2.0
,Poland,Masovian,82.0,Female,Ovarian,II,2011-09-10,2011-12-03,2012-07-19,Chemotherapy,Public,Alive,94.0,EGFR,Yes,Former,None,32.6,Low,Urban,Statutory Health Insurance,9.0,No,No,None,7.0
PT09170,Finland,Uusimaa,22.0,Female,Colorectal,I,2012-02-29,,2012-11-30,Chemotherapy,Private,Alive,56.0,BRCA1,Yes,Never,None,28.1,Medium,Rural,Private Insurance,14.0,Yes,No,Cardiovascular Disease,3.0
PT09171,Sweden,Skåne,32.0,Female,Colorectal,IV,2019-12-02,2020-01-29,2020-07-18,Targeted Therapy,Public,Lost to Follow-up,,None,No,Never,Moderate,26.2,Low,Urban,NHS,17.0,No,No,Obesity,7.0
PT09172,Germany,Bavaria,,Male,Leukemia,I,2017-12-27,2018-01-23,2018-10-28,Surgery,,Alive,18.0,KRAS,No,Current,None,37.0,Medium,Rural,NHS,2.0,No,No,Obesity,1.0
PT09173,Germany,North Rhine-Westphalia,71.0,Female,Pancreatic,I,2022-02-03,2022-06-26,,Surgery,Public,Alive,104.0,KRAS,No,Former,None,38.9,Low,Urban,Statutory Health Insurance,1.0,,No,Obesity,5.0
PT09174,Netherlands,Utrecht,81.0,Female,Breast,IV,2012-03-08,2012-03-11,2013-01-26,Targeted Therapy,,Alive,79.0,None,No,Never,None,28.8,Low,Rural,Private Insurance,5.0,No,No,Obesity,9.0
PT09175,Portugal,Porto,27.0,Male,Lung,I,2014-11-14,2015-04-19,2015-08-16,Surgery,Private,Alive,109.0,BRCA1,No,Former,None,36.6,Medium,Urban,Statutory Health Insurance,1.0,No,Yes,Hypertension,7.0
PT09176,Poland,Lesser Poland,64.0,Male,Ovarian,I,,2018-06-29,2019-05-04,Chemotherapy,Public,Alive,35.0,EGFR,No,Current,Moderate,38.1,Medium,Urban,Private Insurance,19.0,No,No,None,10.0
PT09177,Austria,Vienna,72.0,Female,Prostate,II,2020-04-15,2020-06-19,2020-10-08,Chemotherapy,Public,Deceased,87.0,None,Yes,Never,Moderate,24.8,High,Urban,NHS,12.0,,No,Diabetes,2.0
PT09178,,Central Denmark,,Male,Leukemia,II,2018-11-15,,2019-06-01,Immunotherapy,Public,Alive,72.0,KRAS,Yes,Current,Heavy,18.5,Medium,Rural,Private Insurance,6.0,Yes,No,Hypertension,10.0
PT09179,Netherlands,South Holland,76.0,Female,Pancreatic,II,2011-10-14,2011-10-25,2012-01-25,Chemotherapy,Public,Alive,23.0,None,,Current,Moderate,34.0,Low,Urban,Private Insurance,6.0,No,Yes,Hypertension,10.0
PT09180,Belgium,Flanders,73.0,Male,Breast,II,2013-07-20,2013-08-14,2014-07-12,Radiation,Private,Deceased,26.0,KRAS,No,Never,Moderate,24.6,Medium,Urban,NHS,3.0,No,No,Cardiovascular Disease,6.0
PT09181,Switzerland,Bern,38.0,Male,Breast,,2017-07-16,2017-07-20,2018-07-09,Chemotherapy,Public,Alive,94.0,EGFR,No,Current,Moderate,18.5,Medium,Urban,Statutory Health Insurance,8.0,,No,Obesity,7.0
PT09182,Finland,Uusimaa,86.0,Female,Prostate,,2022-03-23,2022-06-14,2023-04-10,Targeted Therapy,,,49.0,BRCA1,No,Never,Moderate,,Medium,Urban,NHS,15.0,,No,Obesity,10.0
PT09183,Denmark,Zealand,65.0,Male,Leukemia,II,2011-04-17,2011-06-10,2012-02-12,Surgery,Public,Alive,62.0,BRCA1,No,Current,Moderate,,,Urban,Statutory Health Insurance,18.0,No,No,Obesity,1.0
PT09184,Netherlands,South Holland,29.0,Female,Lung,III,2023-04-14,2023-06-13,,Surgery,Public,Lost to Follow-up,,None,No,Current,None,26.7,Medium,Urban,Statutory Health Insurance,11.0,No,Yes,,9.0
PT09185,Norway,Oslo,37.0,Male,Ovarian,II,2013-08-11,2014-01-14,2014-06-24,Chemotherapy,Private,Deceased,61.0,BRCA1,No,Former,Heavy,24.1,Medium,Urban,Statutory Health Insurance,4.0,No,Yes,None,5.0
PT09186,Denmark,Capital Region,31.0,Male,Lung,II,2023-08-15,2023-12-31,2024-07-19,Chemotherapy,Research Institute,Alive,109.0,None,No,Never,None,36.9,Medium,Rural,Statutory Health Insurance,4.0,No,No,Cardiovascular Disease,4.0
PT09187,Germany,Berlin,68.0,Female,Leukemia,II,2023-10-04,2024-03-16,,Surgery,Private,Alive,52.0,EGFR,No,Former,Moderate,29.2,Medium,Rural,Private Insurance,18.0,No,No,Hypertension,5.0
PT09188,Norway,Oslo,42.0,Female,Colorectal,,,2012-11-29,2013-07-07,Surgery,Public,Alive,12.0,KRAS,Yes,Never,None,35.4,Medium,Rural,NHS,5.0,No,No,None,4.0
PT09189,France,Provence-Alpes-Côte d'Azur,81.0,Female,Ovarian,I,2022-12-27,2023-06-06,2023-09-26,Chemotherapy,Research Institute,Alive,100.0,None,No,Never,None,25.4,Medium,Rural,Statutory Health Insurance,7.0,No,No,None,3.0
PT09190,France,,30.0,Female,Pancreatic,III,2017-04-04,2017-06-02,2017-12-02,Radiation,Private,Alive,104.0,EGFR,Yes,Never,Moderate,24.7,High,Rural,Statutory Health Insurance,5.0,No,Yes,,9.0
PT09191,Switzerland,Bern,75.0,Female,Lung,I,2019-11-19,2020-05-10,2020-12-10,Radiation,Private,Alive,74.0,KRAS,No,Former,None,35.6,Low,Rural,Statutory Health Insurance,6.0,No,No,Diabetes,4.0
PT09192,France,Auvergne-Rhône-Alpes,74.0,,Colorectal,III,2014-05-31,2014-11-26,2015-08-21,Surgery,Private,Deceased,78.0,None,Yes,Never,,,Medium,Rural,Statutory Health Insurance,7.0,No,No,Diabetes,3.0
PT09193,Sweden,Västra Götaland,44.0,Male,Leukemia,I,2017-02-07,2017-03-25,2018-03-07,Immunotherapy,Private,Alive,70.0,KRAS,No,Never,None,34.0,Medium,Urban,Statutory Health Insurance,11.0,No,No,None,10.0
PT09194,Poland,,28.0,Female,Pancreatic,III,2010-07-26,,2011-04-24,Radiation,Private,Alive,24.0,BRCA1,Yes,Former,None,25.5,Low,Rural,Statutory Health Insurance,10.0,No,No,Obesity,
PT09195,Finland,Uusimaa,31.0,Male,Breast,IV,2023-05-17,2023-08-18,2024-02-25,Targeted Therapy,Public,Alive,46.0,EGFR,Yes,Never,None,,High,Urban,Private Insurance,10.0,No,No,Obesity,6.0
PT09196,,Capital Region,30.0,Male,,II,2018-11-11,2019-03-23,2019-08-25,Surgery,Public,Alive,101.0,BRCA1,Yes,Never,None,34.4,Medium,Urban,Private Insurance,11.0,No,,Cardiovascular Disease,8.0
PT09197,Denmark,Zealand,57.0,,Breast,II,2010-05-04,2010-10-21,2011-09-05,Radiation,Private,Alive,71.0,KRAS,No,Never,Heavy,31.5,Low,Urban,Private Insurance,9.0,Yes,No,Cardiovascular Disease,1.0
PT09198,Finland,Southwest Finland,47.0,Male,Leukemia,II,2021-12-17,2022-05-21,2022-10-27,Chemotherapy,Public,Alive,87.0,KRAS,No,Never,None,29.4,Medium,Urban,Statutory Health Insurance,2.0,No,No,Obesity,4.0
PT09199,Sweden,Skåne,27.0,Female,Ovarian,IV,2011-04-19,2011-09-02,2012-07-26,Immunotherapy,Public,Deceased,22.0,BRCA1,,Former,Moderate,32.0,Low,Urban,Statutory Health Insurance,10.0,No,No,None,9.0
PT09200,Austria,Styria,66.0,Male,Colorectal,I,2010-12-20,2011-04-04,2012-03-26,Chemotherapy,Public,Alive,63.0,EGFR,Yes,Former,None,18.9,Low,Urban,Statutory Health Insurance,9.0,No,No,Cardiovascular Disease,6.0
PT09201,Poland,Lesser Poland,55.0,Male,Pancreatic,III,2015-11-15,2015-12-31,2016-02-19,Chemotherapy,,,104.0,EGFR,Yes,Current,None,32.3,High,Rural,NHS,19.0,Yes,,Cardiovascular Disease,2.0
PT09202,Switzerland,Bern,69.0,Male,Colorectal,III,2011-06-21,2011-11-04,2012-04-21,Immunotherapy,Public,Alive,73.0,EGFR,No,,Moderate,24.3,High,Urban,Statutory Health Insurance,12.0,No,No,Cardiovascular Disease,5.0
,Netherlands,South Holland,28.0,Male,Pancreatic,II,2012-12-20,2013-01-15,2013-03-21,,Private,Alive,52.0,BRCA1,No,,None,27.0,High,Rural,Statutory Health Insurance,2.0,,No,None,4.0
PT09204,Sweden,Västra Götaland,79.0,Female,Ovarian,I,2013-01-22,2013-01-23,2013-11-05,Chemotherapy,Private,Alive,70.0,BRCA1,No,Former,None,30.7,High,Urban,Statutory Health Insurance,4.0,No,No,Obesity,4.0
PT09205,Netherlands,North Holland,,Male,Leukemia,I,2018-04-16,2018-08-06,2019-01-26,Surgery,Public,Deceased,19.0,KRAS,Yes,Never,None,24.6,Low,Urban,Statutory Health Insurance,19.0,Yes,No,Obesity,6.0
PT09206,Netherlands,North Holland,72.0,Male,,III,2012-08-19,2012-11-17,2013-02-03,Surgery,Public,Deceased,82.0,None,No,Never,Moderate,,Medium,Urban,Statutory Health Insurance,15.0,,No,Hypertension,7.0
PT09207,Sweden,Skåne,36.0,Male,Leukemia,I,2012-01-28,2012-03-07,2012-04-11,Surgery,Public,Alive,117.0,,No,Never,Moderate,22.6,Medium,Urban,Private Insurance,8.0,No,Yes,Cardiovascular Disease,2.0
PT09208,Belgium,Flanders,72.0,Male,Breast,II,2018-01-15,2018-06-01,2018-11-01,Chemotherapy,Public,Deceased,21.0,BRCA1,No,Former,Moderate,39.4,Medium,Urban,Private Insurance,6.0,No,No,None,4.0
PT09209,Belgium,Brussels,47.0,Female,Colorectal,II,2014-11-24,2014-12-21,2015-09-01,Surgery,Private,Alive,38.0,KRAS,No,Never,None,21.4,Medium,Rural,Private Insurance,10.0,No,No,Diabetes,8.0
PT09210,Italy,Sicily,82.0,Male,Prostate,I,2013-08-12,2014-01-07,2014-11-01,Chemotherapy,Private,Deceased,104.0,BRCA1,Yes,,Moderate,34.4,Medium,Rural,Private Insurance,7.0,No,No,Hypertension,1.0
PT09211,Norway,Trøndelag,34.0,Male,Lung,II,2011-11-13,2011-11-29,2012-06-18,Surgery,Public,Alive,10.0,KRAS,No,Former,None,38.6,Medium,Urban,Statutory Health Insurance,16.0,,No,Obesity,8.0
PT09212,Germany,North Rhine-Westphalia,38.0,,Colorectal,IV,2012-05-01,2012-07-07,2012-08-14,Targeted Therapy,Public,Alive,61.0,EGFR,No,Former,None,37.7,Low,Urban,NHS,4.0,No,No,Obesity,1.0
,Denmark,Capital Region,89.0,Male,Leukemia,III,2020-09-14,2020-10-06,2021-06-19,Chemotherapy,Private,Deceased,42.0,KRAS,,Never,Moderate,29.9,Medium,Rural,Statutory Health Insurance,12.0,,No,Diabetes,9.0
PT09214,Sweden,Stockholm,,Non-binary,Leukemia,III,2012-01-20,2012-04-02,2012-10-04,Targeted Therapy,Public,Alive,17.0,None,No,Never,Moderate,26.2,Medium,Urban,Statutory Health Insurance,16.0,Yes,No,Cardiovascular Disease,2.0
,Austria,Styria,67.0,Male,Breast,III,2021-09-05,2022-01-03,2022-08-12,Surgery,Public,Deceased,116.0,BRCA1,No,Never,,28.5,Medium,Urban,Private Insurance,18.0,No,No,Hypertension,6.0
PT09216,Germany,Berlin,,,Lung,III,2012-05-12,2012-09-25,2013-04-02,Chemotherapy,Private,Alive,108.0,BRCA1,No,Former,Moderate,18.5,Medium,Rural,NHS,18.0,No,No,None,4.0
PT09217,,Silesian,56.0,Female,Pancreatic,II,2016-06-04,2016-10-17,2017-03-14,Immunotherapy,Research Institute,Lost to Follow-up,,EGFR,No,Never,Moderate,32.8,High,Rural,Statutory Health Insurance,9.0,No,No,None,9.0
PT09218,Norway,Oslo,21.0,Male,Colorectal,IV,2011-12-09,2012-02-23,2012-06-20,Targeted Therapy,Public,Lost to Follow-up,,None,Yes,Former,Moderate,31.4,Medium,Rural,Private Insurance,3.0,No,No,Cardiovascular Disease,7.0
PT09219,Spain,,83.0,Non-binary,Ovarian,II,2020-11-11,2020-11-12,2021-06-09,Radiation,Public,Alive,78.0,EGFR,No,Never,Moderate,27.4,High,Urban,Statutory Health Insurance,14.0,No,No,Diabetes,4.0
PT09220,Netherlands,Utrecht,55.0,Female,Lung,II,2023-07-24,2023-12-11,2024-12-04,Radiation,Public,Alive,70.0,None,No,Never,Moderate,39.5,Medium,Urban,Private Insurance,8.0,No,No,None,6.0
PT09221,Norway,Oslo,24.0,Female,Lung,II,2017-06-08,2017-06-22,2017-11-30,Immunotherapy,Private,Alive,42.0,BRCA1,Yes,Former,Heavy,21.8,Medium,Urban,NHS,15.0,No,No,Obesity,3.0
PT09222,Denmark,Central Denmark,83.0,Male,Colorectal,II,2012-07-08,,2013-01-25,Immunotherapy,Public,Alive,87.0,BRCA1,No,Former,Moderate,30.8,Low,Rural,NHS,18.0,No,No,None,8.0
PT09223,Poland,Masovian,26.0,Female,Breast,I,,2017-11-15,2018-03-04,Radiation,Public,,70.0,EGFR,No,Never,None,30.3,Medium,Rural,NHS,12.0,No,No,None,7.0
PT09224,Austria,Styria,89.0,Male,Pancreatic,I,2013-09-02,2013-11-18,2014-02-18,Chemotherapy,Private,Alive,52.0,None,Yes,Current,Moderate,20.4,Low,Urban,NHS,18.0,No,No,None,9.0
PT09225,France,Provence-Alpes-Côte d'Azur,,Male,Breast,,2014-08-02,2014-11-18,2015-10-09,Surgery,Private,Alive,,BRCA1,Yes,Former,Moderate,28.4,Medium,Rural,Statutory Health Insurance,16.0,Yes,No,Cardiovascular Disease,6.0
PT09226,Denmark,Zealand,65.0,Female,,I,2010-09-21,2010-12-04,2011-04-20,Chemotherapy,Public,Alive,28.0,EGFR,Yes,Never,,19.1,Medium,Urban,Statutory Health Insurance,4.0,No,No,Cardiovascular Disease,7.0
PT09227,Poland,Masovian,59.0,Female,Breast,II,2020-03-21,2020-07-10,2021-06-29,Radiation,,Alive,22.0,,Yes,Current,None,27.3,Low,Urban,Private Insurance,,No,No,Cardiovascular Disease,10.0
PT09228,Denmark,Central Denmark,80.0,Male,Prostate,IV,2011-04-25,2011-08-28,2012-03-28,,Research Institute,Deceased,47.0,None,No,Current,Moderate,18.4,High,Urban,NHS,17.0,No,No,Obesity,10.0
PT09229,Poland,Lesser Poland,65.0,,Lung,II,2023-11-04,,2024-08-03,Targeted Therapy,Public,Alive,67.0,BRCA1,Yes,Never,Moderate,21.3,Low,Urban,Statutory Health Insurance,12.0,Yes,No,,1.0
PT09230,Norway,Trøndelag,47.0,,Prostate,I,2017-10-24,2018-03-29,2018-07-20,,Private,Deceased,108.0,EGFR,No,Current,Heavy,,Medium,Urban,NHS,5.0,Yes,Yes,Hypertension,1.0
PT09231,Germany,North Rhine-Westphalia,54.0,Male,Breast,III,2013-01-24,,2014-06-01,Surgery,Public,Alive,117.0,BRCA1,No,Never,None,34.4,Low,Rural,Statutory Health Insurance,14.0,No,No,Obesity,8.0
PT09232,Belgium,Wallonia,20.0,Male,Pancreatic,I,2013-11-18,2014-01-20,2014-12-22,Radiation,Public,Alive,107.0,BRCA1,No,Former,None,29.1,Low,Rural,NHS,10.0,No,No,None,6.0
PT09233,Switzerland,Geneva,48.0,Male,,II,2022-08-25,2022-09-17,2023-06-21,Radiation,Public,Alive,59.0,KRAS,No,Former,Heavy,29.7,Medium,,Statutory Health Insurance,19.0,No,,Cardiovascular Disease,10.0
PT09234,Poland,Lesser Poland,28.0,,Lung,,2019-05-20,2019-11-07,2020-09-12,Surgery,Private,Deceased,49.0,,No,Former,None,26.4,Medium,Urban,Private Insurance,8.0,No,No,Diabetes,6.0
PT09235,Spain,Madrid,28.0,Female,Colorectal,I,2023-12-13,2023-12-23,2024-08-16,Targeted Therapy,Public,Deceased,,KRAS,Yes,Never,None,31.3,Low,Urban,Private Insurance,18.0,No,No,Diabetes,7.0
PT09236,Belgium,Brussels,41.0,Male,Leukemia,I,2011-02-06,2011-07-20,2012-06-10,Immunotherapy,Public,Alive,36.0,KRAS,Yes,Current,Moderate,36.1,Low,Urban,,12.0,Yes,No,None,3.0
PT09237,Ireland,Munster,82.0,Female,Lung,I,2014-02-03,2014-07-30,2014-09-02,Immunotherapy,Research Institute,Alive,48.0,None,Yes,Never,None,38.0,Medium,Urban,Private Insurance,15.0,No,Yes,Hypertension,1.0
PT09238,Belgium,Flanders,85.0,Female,Colorectal,I,2017-05-23,2017-10-12,2018-06-26,Immunotherapy,Private,Deceased,15.0,None,No,Never,Heavy,39.9,Low,Rural,NHS,12.0,No,Yes,Diabetes,7.0
PT09239,Ireland,Dublin,77.0,Female,Breast,I,2020-07-17,2020-10-21,2021-05-30,Targeted Therapy,Public,Alive,108.0,KRAS,No,Former,Moderate,,Medium,Urban,Statutory Health Insurance,13.0,No,No,Diabetes,1.0
PT09240,Netherlands,South Holland,89.0,Male,Prostate,IV,2020-10-12,2020-11-15,2021-04-27,Chemotherapy,Private,Alive,54.0,None,Yes,Current,None,20.5,High,Urban,Private Insurance,7.0,No,No,None,8.0
PT09241,Portugal,Lisbon,74.0,Female,Colorectal,II,2022-09-03,2022-12-07,2023-03-22,Chemotherapy,Public,Alive,17.0,None,Yes,Current,None,21.2,Medium,Urban,NHS,17.0,No,No,Cardiovascular Disease,5.0
PT09242,,Västra Götaland,,Female,Ovarian,IV,2020-04-16,2020-05-25,2021-04-21,Targeted Therapy,Public,Alive,42.0,KRAS,Yes,Never,None,29.0,Medium,Urban,Private Insurance,10.0,No,Yes,Cardiovascular Disease,
PT09243,Norway,Vestland,38.0,Male,Pancreatic,II,2018-08-15,2019-01-22,2019-06-10,,Public,Alive,38.0,BRCA1,No,Never,Moderate,32.9,High,Urban,,17.0,,No,Diabetes,9.0
PT09244,Sweden,Skåne,52.0,Male,Leukemia,III,2011-12-11,2012-02-29,2012-09-11,Immunotherapy,Public,Deceased,49.0,EGFR,Yes,Never,Moderate,20.8,Medium,Urban,NHS,14.0,No,Yes,,2.0
PT09245,Spain,Andalusia,84.0,Female,Breast,I,2019-05-20,2019-10-17,2020-01-15,Targeted Therapy,,,38.0,None,No,Current,None,26.8,Low,Urban,Private Insurance,5.0,No,No,Diabetes,9.0
PT09246,Switzerland,Zurich,,Male,Ovarian,I,2015-04-24,2015-08-02,2016-01-08,Surgery,Public,Alive,50.0,KRAS,No,Current,Moderate,30.8,Low,Urban,Statutory Health Insurance,7.0,No,No,Obesity,4.0
PT09247,Spain,Catalonia,31.0,Female,Leukemia,II,2012-09-06,2013-02-16,2013-03-20,Targeted Therapy,Public,Alive,113.0,BRCA1,No,Never,Heavy,22.4,High,Urban,NHS,19.0,Yes,No,Diabetes,4.0
PT09248,Spain,,62.0,Male,Pancreatic,IV,2011-03-01,2011-03-24,2011-09-04,Radiation,,,52.0,EGFR,Yes,Never,Moderate,33.4,,Rural,Statutory Health Insurance,18.0,Yes,,None,7.0
PT09249,Ireland,,36.0,Male,Pancreatic,I,2021-06-11,2021-07-06,2022-02-13,Immunotherapy,Private,Deceased,77.0,EGFR,No,Former,Heavy,25.5,Low,Urban,Statutory Health Insurance,2.0,No,No,Diabetes,10.0
PT09250,France,,87.0,Male,Prostate,II,2012-03-02,2012-07-14,2012-10-13,Immunotherapy,Public,Alive,81.0,BRCA1,No,Former,Moderate,24.0,High,Rural,Statutory Health Insurance,4.0,No,No,Hypertension,8.0
PT09251,Switzerland,Bern,48.0,Male,Leukemia,I,,2023-04-05,2024-03-09,Radiation,Private,Alive,58.0,KRAS,No,Former,None,19.6,Low,Rural,Private Insurance,16.0,No,Yes,Hypertension,3.0
,Norway,Trøndelag,74.0,Male,Pancreatic,II,2018-01-27,2018-02-02,2018-11-03,Immunotherapy,Public,Deceased,32.0,BRCA1,No,Never,Heavy,33.0,Medium,Urban,NHS,15.0,No,Yes,Obesity,4.0
PT09253,Spain,Madrid,26.0,Female,Colorectal,III,2021-05-15,2021-06-03,2021-08-24,Radiation,Public,Deceased,112.0,EGFR,Yes,Current,None,,Medium,Urban,Private Insurance,2.0,No,Yes,Hypertension,7.0
PT09254,Ireland,Dublin,63.0,Male,,III,2014-06-24,2014-07-13,2014-08-20,Radiation,Public,Deceased,106.0,None,No,Never,Moderate,20.6,Medium,Urban,NHS,1.0,No,No,Hypertension,8.0
PT09255,,Vestland,,Female,Pancreatic,I,2020-05-11,2020-08-29,2021-02-03,Immunotherapy,,Lost to Follow-up,,None,No,Current,Moderate,24.7,Medium,Urban,Private Insurance,6.0,No,,Obesity,3.0
,Denmark,Central Denmark,79.0,Female,Colorectal,I,2012-08-26,2012-12-15,2013-05-01,Targeted Therapy,Private,Alive,64.0,KRAS,No,Current,None,34.0,Medium,Urban,NHS,12.0,No,No,Cardiovascular Disease,
PT09257,Ireland,Connacht,25.0,Male,Breast,,2022-04-24,2022-07-28,2023-06-14,Radiation,Private,Alive,104.0,EGFR,Yes,Current,None,24.2,High,,Statutory Health Insurance,9.0,,No,Cardiovascular Disease,5.0
PT09258,Finland,Uusimaa,26.0,Male,Prostate,IV,2012-08-09,2012-11-04,2013-01-22,Surgery,Private,Alive,96.0,None,Yes,Former,Moderate,18.7,Medium,Urban,NHS,10.0,No,No,Hypertension,10.0
PT09259,France,Auvergne-Rhône-Alpes,65.0,Female,Prostate,II,2011-06-06,,2012-06-21,Radiation,Public,Deceased,80.0,KRAS,,Former,Moderate,31.4,Medium,Urban,,1.0,No,No,Cardiovascular Disease,1.0
,Germany,Bavaria,76.0,Male,Lung,II,2015-05-29,2015-06-11,2015-09-17,Surgery,Public,Alive,55.0,KRAS,No,Never,None,30.8,Medium,Rural,Statutory Health Insurance,13.0,No,,Diabetes,5.0
PT09261,France,Auvergne-Rhône-Alpes,73.0,Male,Ovarian,II,2015-02-26,2015-05-23,2015-09-27,Targeted Therapy,Private,Deceased,79.0,BRCA1,No,,Heavy,37.1,High,Urban,Statutory Health Insurance,6.0,No,No,Diabetes,1.0
PT09262,Norway,Oslo,65.0,Female,Lung,I,2022-08-18,2023-02-12,2023-06-24,Radiation,Public,Alive,25.0,KRAS,No,Former,Moderate,21.6,Medium,Urban,Private Insurance,10.0,Yes,No,Cardiovascular Disease,5.0
PT09263,Portugal,Porto,29.0,Male,Colorectal,III,2023-12-16,2024-03-01,2024-04-15,Radiation,Public,Deceased,102.0,KRAS,Yes,Never,Moderate,38.9,,Urban,Statutory Health Insurance,12.0,No,No,None,3.0
PT09264,Norway,Trøndelag,23.0,Male,Pancreatic,I,2022-06-11,2022-11-17,2023-03-05,Radiation,Public,Alive,61.0,,Yes,Never,Moderate,19.1,Medium,Urban,,6.0,No,No,Cardiovascular Disease,9.0
PT09265,Denmark,Capital Region,86.0,Female,Leukemia,III,2018-07-29,2018-10-14,2019-07-03,Surgery,Public,Deceased,23.0,KRAS,No,Current,Moderate,30.5,High,Rural,Statutory Health Insurance,4.0,Yes,No,None,8.0
PT09266,Poland,Silesian,44.0,Female,Pancreatic,II,2018-08-18,2018-09-10,2019-05-28,Targeted Therapy,Public,,85.0,BRCA1,No,Never,Heavy,35.2,Low,Urban,Statutory Health Insurance,17.0,No,,Cardiovascular Disease,8.0
PT09267,Denmark,Zealand,80.0,Male,Pancreatic,III,2021-03-19,2021-05-28,2022-04-20,Immunotherapy,Public,Lost to Follow-up,,EGFR,No,,Heavy,34.8,Medium,Urban,NHS,16.0,No,Yes,Cardiovascular Disease,10.0
PT09268,Italy,Sicily,57.0,Female,Leukemia,I,2017-04-07,,,Chemotherapy,Public,Alive,70.0,None,Yes,Former,Moderate,32.5,Medium,Urban,NHS,7.0,No,No,Diabetes,9.0
PT09269,Norway,Trøndelag,51.0,Female,,IV,2016-10-10,2016-12-07,2017-09-20,Radiation,Public,Deceased,108.0,EGFR,No,Never,None,39.2,Medium,Urban,Private Insurance,18.0,No,,Hypertension,6.0
PT09270,Finland,Pirkanmaa,,Female,Prostate,I,2019-12-04,2020-04-20,2020-12-16,Radiation,Public,Alive,84.0,None,Yes,Former,Heavy,27.4,Low,Urban,NHS,10.0,Yes,No,Hypertension,2.0
PT09271,France,Auvergne-Rhône-Alpes,56.0,Male,Colorectal,III,2011-06-06,2011-08-13,2012-03-13,Radiation,Public,,59.0,None,No,Never,Moderate,32.5,Low,Urban,Private Insurance,5.0,No,No,,9.0
PT09272,Switzerland,Geneva,22.0,Non-binary,Leukemia,III,2021-10-31,2022-04-21,2022-12-01,Immunotherapy,Public,Alive,10.0,None,No,Current,Moderate,20.7,,Rural,Private Insurance,9.0,Yes,No,Hypertension,5.0
PT09273,Portugal,Algarve,32.0,Male,Lung,II,2023-11-15,2024-01-24,2024-04-02,Targeted Therapy,Public,Alive,20.0,BRCA1,Yes,Former,None,25.8,Medium,Urban,NHS,19.0,No,No,Cardiovascular Disease,8.0
PT09274,Germany,Bavaria,53.0,Female,Colorectal,II,2021-06-28,2021-09-18,2022-04-26,Surgery,Private,Deceased,67.0,None,No,Never,None,20.6,Low,Urban,Statutory Health Insurance,9.0,No,No,Cardiovascular Disease,4.0
PT09275,Switzerland,Bern,84.0,Male,Breast,IV,2022-09-26,,2023-09-13,Immunotherapy,Public,Alive,91.0,KRAS,,Former,Moderate,30.5,High,Urban,Statutory Health Insurance,,Yes,No,Obesity,3.0
PT09276,Spain,Madrid,27.0,Female,Colorectal,I,2010-08-11,2010-12-03,2011-03-03,Targeted Therapy,Private,Alive,114.0,EGFR,No,Former,Moderate,37.4,High,Urban,NHS,6.0,No,No,Obesity,2.0
PT09277,Finland,Pirkanmaa,28.0,Male,,IV,2014-10-16,,2015-06-10,Chemotherapy,Private,Alive,43.0,EGFR,No,Never,Moderate,25.9,Medium,Urban,Private Insurance,10.0,No,Yes,Obesity,10.0
PT09278,Spain,Andalusia,47.0,Male,Ovarian,I,2017-08-30,,2018-11-01,Targeted Therapy,Private,Alive,50.0,KRAS,Yes,,Moderate,33.3,High,Rural,Private Insurance,17.0,No,Yes,Obesity,9.0
PT09279,,Madrid,37.0,Female,Breast,II,2016-10-11,2017-03-27,2017-12-16,Targeted Therapy,Private,Alive,94.0,KRAS,No,Never,Moderate,23.5,Low,Urban,NHS,5.0,No,No,Cardiovascular Disease,7.0
PT09280,Portugal,Algarve,61.0,Male,Pancreatic,I,2018-08-03,2019-01-11,2019-03-17,Surgery,Private,Alive,66.0,,Yes,Former,Moderate,30.2,Low,Rural,NHS,8.0,Yes,No,Diabetes,1.0
PT09281,Finland,Southwest Finland,,Male,Lung,I,2019-02-08,,,Targeted Therapy,Private,Alive,57.0,BRCA1,Yes,Current,,21.2,Low,Urban,Statutory Health Insurance,2.0,No,No,Hypertension,10.0
PT09282,Italy,Lombardy,89.0,Female,Lung,I,2012-05-31,2012-08-19,2012-10-18,Targeted Therapy,Private,,102.0,EGFR,No,Never,None,18.2,Medium,Urban,NHS,5.0,No,No,Diabetes,8.0
PT09283,Spain,,52.0,Female,Leukemia,I,2016-05-30,2016-11-03,2017-07-15,Radiation,Public,Alive,65.0,KRAS,No,Never,None,39.8,Medium,Urban,Statutory Health Insurance,13.0,No,Yes,Obesity,7.0
PT09284,,Bern,73.0,Male,Breast,IV,2010-08-09,2011-01-01,2011-06-02,Surgery,Private,Alive,105.0,KRAS,No,Current,Moderate,36.5,Medium,Urban,Private Insurance,2.0,No,Yes,,7.0
PT09285,Austria,Vienna,55.0,Male,Lung,III,2016-06-18,2016-11-30,2017-09-18,Targeted Therapy,Private,Alive,29.0,KRAS,Yes,Never,None,31.9,High,Rural,NHS,1.0,No,No,Obesity,6.0
PT09286,Austria,Styria,75.0,Female,Breast,I,2022-10-22,2023-03-05,2023-08-04,Targeted Therapy,Public,Alive,68.0,BRCA1,No,Never,Moderate,23.9,Medium,,Statutory Health Insurance,2.0,No,No,Obesity,5.0
PT09287,Poland,Masovian,36.0,Female,Colorectal,,2019-12-28,2020-06-19,2021-02-21,,Private,Alive,65.0,BRCA1,Yes,Current,None,34.4,Medium,Urban,Statutory Health Insurance,18.0,No,No,Cardiovascular Disease,7.0
PT09288,Netherlands,Utrecht,29.0,Male,Ovarian,III,2010-09-09,2010-09-23,2011-07-25,Surgery,Private,Alive,15.0,,No,Former,Moderate,20.2,Medium,Urban,Statutory Health Insurance,1.0,Yes,No,Cardiovascular Disease,8.0
PT09289,Portugal,Porto,63.0,Female,Prostate,II,2014-11-23,2015-05-07,2015-09-11,Chemotherapy,Public,Alive,51.0,,No,Former,None,31.9,Low,Urban,NHS,5.0,Yes,Yes,Obesity,5.0
PT09290,Norway,Trøndelag,21.0,Female,,III,2010-10-07,2011-01-29,2011-03-05,,Public,Lost to Follow-up,,None,No,Former,None,35.7,Low,Rural,Private Insurance,4.0,No,No,None,3.0
PT09291,Italy,Veneto,33.0,Male,Prostate,II,2022-01-07,2022-04-24,2022-09-23,Immunotherapy,,Alive,73.0,KRAS,Yes,Former,None,32.8,High,Urban,Private Insurance,11.0,Yes,Yes,None,2.0
PT09292,Austria,Vienna,,Male,Lung,III,2021-09-14,2021-11-29,2022-03-24,Targeted Therapy,Private,Alive,11.0,None,No,Never,Moderate,34.7,Low,Urban,Private Insurance,19.0,No,Yes,Obesity,3.0
PT09293,Portugal,Porto,21.0,Male,Leukemia,II,2016-02-15,2016-05-08,2017-01-22,Immunotherapy,Public,Alive,78.0,None,Yes,Never,Moderate,19.6,Low,Urban,NHS,7.0,Yes,No,Cardiovascular Disease,6.0
PT09294,,,38.0,Female,Prostate,III,2015-10-03,2015-12-27,2016-04-15,Immunotherapy,Private,Alive,49.0,BRCA1,No,Never,Moderate,18.9,High,Urban,Statutory Health Insurance,4.0,Yes,No,Cardiovascular Disease,5.0
PT09295,Germany,Berlin,20.0,Male,Pancreatic,I,2019-12-29,2020-01-27,2020-09-03,Chemotherapy,Public,Alive,83.0,KRAS,No,Never,Moderate,27.5,High,Rural,Private Insurance,1.0,No,No,Obesity,3.0
PT09296,Finland,Pirkanmaa,21.0,Male,Ovarian,II,2014-07-09,2014-08-27,2015-06-07,Targeted Therapy,Public,Deceased,97.0,BRCA1,No,Former,None,35.4,Medium,Urban,Statutory Health Insurance,8.0,No,No,Cardiovascular Disease,3.0
,Poland,Silesian,46.0,Female,Leukemia,I,2016-06-21,2016-06-23,2016-09-01,Surgery,Private,Alive,87.0,None,No,Never,None,24.6,High,Urban,Private Insurance,13.0,No,Yes,None,9.0
PT09298,Germany,North Rhine-Westphalia,21.0,Male,Ovarian,II,2016-02-09,2016-05-08,2017-01-10,Radiation,Public,Alive,36.0,KRAS,No,Former,Heavy,34.3,Low,Urban,Statutory Health Insurance,16.0,No,No,None,
PT09299,Ireland,Dublin,70.0,Female,Prostate,II,2019-02-14,2019-04-25,2019-09-15,Targeted Therapy,Private,Deceased,40.0,EGFR,,Never,None,,Medium,Rural,NHS,19.0,No,No,Obesity,6.0
PT09300,Austria,Vienna,29.0,Male,Colorectal,III,2010-01-24,2010-03-11,2010-10-26,Immunotherapy,Research Institute,Deceased,40.0,EGFR,,,None,32.4,Low,Urban,Statutory Health Insurance,5.0,No,No,Diabetes,7.0
PT09301,France,Auvergne-Rhône-Alpes,38.0,Female,Ovarian,I,2023-07-18,2023-09-19,2024-03-01,Immunotherapy,Public,Alive,105.0,None,Yes,Never,Heavy,38.3,Medium,Urban,Statutory Health Insurance,1.0,No,No,None,4.0
PT09302,Germany,North Rhine-Westphalia,32.0,Male,Prostate,II,2010-09-13,2011-01-10,2011-08-26,Targeted Therapy,Research Institute,Alive,24.0,None,No,Former,Moderate,28.1,High,Urban,Statutory Health Insurance,17.0,No,No,Diabetes,5.0
PT09303,Spain,Andalusia,67.0,Male,Leukemia,I,2013-05-22,2013-08-15,,Chemotherapy,,Deceased,38.0,EGFR,No,Former,Heavy,19.3,Medium,Urban,Statutory Health Insurance,10.0,Yes,No,Cardiovascular Disease,2.0
PT09304,Poland,,75.0,Female,Lung,III,2020-10-17,2021-03-15,2022-03-02,Surgery,Public,Deceased,100.0,BRCA1,Yes,,Moderate,33.9,Medium,Rural,NHS,17.0,No,No,Obesity,2.0
PT09305,Ireland,Connacht,75.0,Female,Ovarian,III,2019-10-08,2019-11-04,2020-10-31,Radiation,Public,Alive,94.0,KRAS,Yes,Never,Heavy,37.4,High,Urban,Private Insurance,8.0,No,No,None,6.0
PT09306,Belgium,Brussels,69.0,Female,Pancreatic,III,,2012-12-22,2013-11-22,Chemotherapy,Private,Alive,116.0,KRAS,Yes,Never,Moderate,26.0,Low,Rural,Private Insurance,14.0,Yes,No,Diabetes,9.0
PT09307,Spain,Catalonia,64.0,Female,Colorectal,IV,2012-03-05,2012-06-13,2012-08-25,Surgery,Private,Deceased,64.0,None,No,Never,None,26.2,Medium,Urban,Statutory Health Insurance,15.0,Yes,,,10.0
PT09308,Finland,Pirkanmaa,78.0,Female,Leukemia,IV,2014-01-26,2014-03-06,2014-10-26,Targeted Therapy,Public,Alive,52.0,BRCA1,Yes,Former,Moderate,25.3,Medium,Urban,Statutory Health Insurance,16.0,No,Yes,Cardiovascular Disease,4.0
PT09309,Italy,Lombardy,58.0,Female,Breast,III,2016-10-19,2016-12-16,2017-10-28,,Public,Alive,115.0,KRAS,Yes,Never,None,20.3,High,Urban,NHS,4.0,Yes,,Diabetes,5.0
PT09310,Poland,Silesian,40.0,Female,Prostate,I,2023-12-28,2024-02-11,2025-01-28,Radiation,Private,,76.0,BRCA1,No,Current,None,24.7,Medium,Urban,NHS,5.0,Yes,No,None,6.0
PT09311,Netherlands,Utrecht,74.0,Female,Colorectal,I,2023-09-10,2024-01-30,2024-10-07,Surgery,Public,Alive,73.0,KRAS,No,Never,None,27.3,Medium,Rural,Statutory Health Insurance,18.0,No,No,None,5.0
PT09312,Netherlands,Utrecht,76.0,Female,Lung,II,2013-05-19,2013-10-16,2014-07-31,,Public,Alive,,EGFR,Yes,Former,None,27.2,Medium,Urban,Private Insurance,17.0,No,Yes,Obesity,4.0
PT09313,Portugal,Porto,,Female,Ovarian,IV,2020-11-29,2020-12-16,2021-04-14,Surgery,,Alive,7.0,None,No,Never,None,22.5,Medium,Urban,NHS,15.0,No,Yes,Hypertension,
PT09314,Norway,Trøndelag,89.0,Male,Breast,II,2017-10-25,2018-03-31,2018-08-10,Radiation,Public,Deceased,94.0,None,No,Never,Moderate,30.2,Medium,,NHS,11.0,No,Yes,Cardiovascular Disease,4.0
PT09315,Germany,Berlin,68.0,Male,Ovarian,I,2015-06-18,2015-07-26,2016-03-16,Targeted Therapy,Public,Alive,,KRAS,Yes,Never,Heavy,29.9,,Urban,NHS,15.0,No,No,None,2.0
PT09316,Portugal,Lisbon,63.0,Male,Prostate,IV,2016-05-22,,2017-08-15,Immunotherapy,Private,Deceased,39.0,,No,Current,None,26.4,Medium,Rural,NHS,2.0,No,No,Hypertension,4.0
PT09317,Sweden,Skåne,54.0,Female,,II,2016-04-10,2016-05-11,2017-02-27,Immunotherapy,Public,,108.0,KRAS,Yes,Never,Heavy,38.6,Low,Urban,Private Insurance,12.0,No,No,None,3.0
PT09318,Switzerland,Zurich,24.0,Female,Pancreatic,III,2012-02-01,2012-05-09,2012-07-04,Chemotherapy,Private,Alive,116.0,BRCA1,Yes,Never,Moderate,39.2,Medium,Urban,NHS,8.0,No,Yes,Cardiovascular Disease,8.0
PT09319,Ireland,Dublin,70.0,Female,Leukemia,III,2021-08-09,2021-10-06,2021-11-11,Targeted Therapy,,Alive,106.0,KRAS,Yes,Never,Moderate,33.0,High,Urban,NHS,13.0,No,No,Hypertension,10.0
PT09320,Denmark,Zealand,76.0,Male,Ovarian,III,2014-11-20,2015-02-19,2015-12-09,Targeted Therapy,Public,,58.0,BRCA1,No,Never,None,24.3,Medium,Urban,NHS,12.0,Yes,Yes,Cardiovascular Disease,1.0
PT09321,Italy,,77.0,Male,Prostate,III,2010-11-16,2010-12-03,2011-02-12,Chemotherapy,Private,Alive,30.0,KRAS,Yes,Former,Moderate,38.6,High,Urban,Statutory Health Insurance,14.0,Yes,No,Diabetes,3.0
PT09322,Finland,Pirkanmaa,55.0,Female,Colorectal,III,2020-12-06,2021-04-05,,Surgery,Public,Alive,27.0,KRAS,No,Current,Moderate,33.9,Medium,Urban,Statutory Health Insurance,1.0,No,No,Cardiovascular Disease,2.0
PT09323,Belgium,Wallonia,29.0,Female,Prostate,III,2022-05-26,2022-06-18,2022-12-18,Chemotherapy,Private,Alive,118.0,None,No,Never,None,27.7,High,Urban,Statutory Health Insurance,14.0,No,No,None,6.0
PT09324,Portugal,Algarve,69.0,Male,Pancreatic,II,2019-12-30,2020-05-26,2020-08-24,Targeted Therapy,Private,Alive,42.0,BRCA1,No,Never,Moderate,37.3,Medium,Urban,Private Insurance,14.0,No,No,Hypertension,5.0
PT09325,France,Provence-Alpes-Côte d'Azur,56.0,Female,Colorectal,III,2021-07-19,2021-10-23,2022-08-24,Immunotherapy,Private,Alive,6.0,EGFR,Yes,Current,Moderate,21.4,Low,Rural,Statutory Health Insurance,17.0,,No,Cardiovascular Disease,4.0
PT09326,Spain,Andalusia,39.0,Male,,III,2023-05-22,2023-05-26,2024-01-31,Surgery,Private,Alive,,EGFR,No,Former,Moderate,32.6,Medium,Rural,Statutory Health Insurance,6.0,No,Yes,Obesity,10.0
PT09327,Germany,Bavaria,32.0,Male,,II,2017-08-11,2017-10-23,2018-02-08,Targeted Therapy,Research Institute,Alive,117.0,EGFR,No,Current,None,24.1,High,Urban,NHS,17.0,No,Yes,Hypertension,2.0
PT09328,Switzerland,Zurich,38.0,Female,Ovarian,I,2023-04-08,,2023-10-16,Radiation,Public,Deceased,84.0,None,Yes,Current,None,30.1,Low,,Private Insurance,12.0,No,No,None,8.0
PT09329,Germany,Bavaria,,Female,Colorectal,II,2019-11-25,2020-01-13,2020-04-30,Immunotherapy,Public,Alive,,BRCA1,Yes,Current,Moderate,24.4,High,Rural,,7.0,Yes,Yes,None,
PT09330,Sweden,Stockholm,64.0,Female,Ovarian,,2015-06-20,2015-10-07,2015-12-26,Immunotherapy,Private,Alive,83.0,EGFR,No,Never,Moderate,30.8,Medium,Urban,Statutory Health Insurance,12.0,No,No,Diabetes,3.0
PT09331,Germany,Berlin,79.0,Male,Breast,I,2013-07-20,2013-08-15,2014-08-09,Chemotherapy,Research Institute,Deceased,12.0,BRCA1,No,Former,Moderate,,Low,Urban,Private Insurance,13.0,No,No,Hypertension,9.0
PT09332,Sweden,Västra Götaland,87.0,Male,Lung,III,2018-11-20,2018-12-22,2019-09-17,Targeted Therapy,Public,Alive,72.0,BRCA1,No,Current,Heavy,30.8,Medium,Urban,NHS,6.0,No,No,Diabetes,2.0
PT09333,Sweden,Skåne,76.0,Male,Pancreatic,I,,2016-05-02,2016-10-06,Targeted Therapy,Public,Alive,71.0,KRAS,No,Former,None,19.7,High,Rural,Private Insurance,9.0,No,No,None,9.0
PT09334,Norway,Vestland,73.0,Male,Colorectal,I,2010-04-20,,2011-04-21,Chemotherapy,Research Institute,Alive,62.0,None,Yes,Former,Moderate,18.1,Medium,Urban,Statutory Health Insurance,14.0,No,No,Cardiovascular Disease,8.0
PT09335,Sweden,Västra Götaland,56.0,Female,Ovarian,I,2011-02-16,2011-08-03,2012-04-17,Targeted Therapy,Private,Alive,41.0,EGFR,No,Current,Moderate,35.2,Medium,Rural,NHS,,No,No,Diabetes,5.0
PT09336,Norway,Trøndelag,56.0,Male,Colorectal,II,2010-03-12,2010-04-18,2010-11-28,Targeted Therapy,Public,Alive,98.0,EGFR,Yes,Current,Moderate,24.1,Low,,NHS,15.0,No,No,Cardiovascular Disease,10.0
PT09337,France,Île-de-France,33.0,Male,Colorectal,I,2020-03-16,2020-09-11,2021-01-19,Immunotherapy,Public,Alive,79.0,None,No,Never,Moderate,33.3,High,Urban,Private Insurance,13.0,No,No,Cardiovascular Disease,1.0
PT09338,Spain,Madrid,,Male,Prostate,II,2011-12-19,2012-02-14,2013-01-13,Surgery,Public,Alive,18.0,None,No,Never,Moderate,18.9,Low,Urban,Private Insurance,16.0,No,No,None,7.0
PT09339,Norway,Oslo,61.0,Female,Pancreatic,IV,2016-10-06,2016-12-25,2017-01-27,Radiation,Public,Alive,108.0,KRAS,No,Never,,32.6,High,Urban,Statutory Health Insurance,5.0,No,Yes,None,1.0
PT09340,Sweden,Skåne,20.0,Female,Lung,III,2016-04-07,2016-06-18,2017-04-28,Radiation,Public,Alive,107.0,BRCA1,Yes,Never,Moderate,33.7,Low,Urban,Private Insurance,,No,Yes,None,8.0
PT09341,Netherlands,Utrecht,42.0,Female,Pancreatic,IV,2020-01-23,2020-01-26,2020-09-11,Surgery,Public,Deceased,88.0,KRAS,No,Former,Moderate,33.6,Medium,Rural,NHS,14.0,No,No,Hypertension,7.0
PT09342,Germany,Bavaria,83.0,Male,Prostate,II,2011-12-20,2012-05-08,2012-11-15,Radiation,,,49.0,KRAS,Yes,Former,Heavy,36.7,,Urban,NHS,8.0,No,Yes,Cardiovascular Disease,10.0
PT09343,Belgium,Wallonia,47.0,Male,Ovarian,IV,2010-05-07,2010-08-26,2011-05-22,Surgery,,Deceased,87.0,EGFR,No,Never,None,37.0,Medium,Urban,Private Insurance,3.0,No,No,None,6.0
PT09344,Austria,Styria,23.0,Male,Colorectal,III,2011-03-02,2011-06-01,2012-01-02,Targeted Therapy,,Deceased,67.0,EGFR,No,Never,Moderate,22.4,Low,Rural,,2.0,No,No,Obesity,5.0
PT09345,Norway,Trøndelag,60.0,Male,Pancreatic,IV,2016-05-14,2016-07-04,2016-10-22,Chemotherapy,Private,Alive,73.0,BRCA1,No,Current,None,30.7,Medium,,Statutory Health Insurance,16.0,,No,Hypertension,3.0
PT09346,Poland,Lesser Poland,79.0,Male,Colorectal,I,2016-12-16,2017-05-04,2017-08-15,Targeted Therapy,Public,Alive,52.0,BRCA1,Yes,Former,None,18.5,Medium,Urban,NHS,8.0,Yes,No,Cardiovascular Disease,9.0
PT09347,Switzerland,Bern,37.0,Male,Lung,I,2016-09-01,2017-01-13,,Chemotherapy,Public,Deceased,35.0,KRAS,No,Former,Moderate,19.9,Low,Urban,Private Insurance,2.0,No,No,Obesity,10.0
PT09348,France,Provence-Alpes-Côte d'Azur,82.0,Female,Breast,I,2017-09-19,2018-02-06,2018-10-30,Surgery,Research Institute,Lost to Follow-up,,None,Yes,Never,None,,Medium,Urban,Statutory Health Insurance,1.0,No,No,None,3.0
,Spain,Andalusia,80.0,Non-binary,Prostate,IV,2011-06-20,2011-07-15,2012-03-14,Targeted Therapy,Public,Alive,78.0,KRAS,Yes,,None,18.8,Medium,,NHS,12.0,No,No,Cardiovascular Disease,4.0
PT09350,Norway,Trøndelag,68.0,Male,Breast,III,,2019-09-30,2020-01-18,Surgery,Public,Deceased,119.0,None,Yes,Current,Moderate,25.6,Medium,Rural,Private Insurance,10.0,No,No,Obesity,6.0
PT09351,Austria,Vienna,66.0,Female,Pancreatic,II,2016-05-23,2016-08-11,2017-04-20,Immunotherapy,Public,,40.0,BRCA1,Yes,Former,Moderate,32.1,Low,Rural,NHS,7.0,No,Yes,Hypertension,8.0
PT09352,Poland,Masovian,58.0,Male,Colorectal,II,2016-10-28,2016-12-03,2017-07-09,,Public,Alive,56.0,,Yes,Former,Heavy,35.9,High,Urban,Statutory Health Insurance,5.0,Yes,No,Hypertension,9.0
PT09353,Netherlands,North Holland,25.0,Female,Ovarian,III,2013-02-18,2013-08-01,2014-03-19,Targeted Therapy,Private,Alive,58.0,EGFR,No,Current,None,27.6,Low,Rural,Private Insurance,8.0,No,No,Cardiovascular Disease,
PT09354,Norway,Trøndelag,72.0,Female,,IV,2014-09-18,2014-10-09,2015-05-17,Chemotherapy,Public,Alive,106.0,EGFR,No,Never,None,28.7,,Urban,Statutory Health Insurance,11.0,No,No,Obesity,4.0
PT09355,Poland,Masovian,44.0,Female,Colorectal,III,2019-07-23,2019-09-10,2020-03-27,Immunotherapy,Research Institute,Deceased,15.0,KRAS,No,Current,None,18.1,Medium,Urban,,9.0,Yes,No,Diabetes,1.0
PT09356,Norway,Trøndelag,,Male,Leukemia,III,2020-08-06,2020-10-29,2021-07-07,Targeted Therapy,Research Institute,Alive,48.0,BRCA1,No,Never,Moderate,37.1,Medium,Rural,Statutory Health Insurance,6.0,Yes,No,Cardiovascular Disease,1.0
PT09357,Denmark,Zealand,24.0,Male,Leukemia,II,2014-11-15,2015-03-13,2015-04-28,Targeted Therapy,Public,Deceased,108.0,EGFR,Yes,,Moderate,39.7,,Rural,NHS,1.0,Yes,No,Diabetes,5.0
PT09358,Germany,Berlin,84.0,Male,Breast,II,2018-08-14,2018-10-13,2019-05-29,Targeted Therapy,Research Institute,Alive,6.0,None,Yes,Never,Moderate,27.9,Medium,,Statutory Health Insurance,5.0,No,Yes,Diabetes,1.0
PT09359,Netherlands,North Holland,27.0,Male,Leukemia,IV,2012-06-24,2012-10-08,2013-07-02,Immunotherapy,Research Institute,Deceased,7.0,BRCA1,Yes,Former,Moderate,24.7,High,Rural,Private Insurance,19.0,No,,Hypertension,5.0
PT09360,Finland,Pirkanmaa,58.0,Female,Ovarian,III,2015-11-02,2016-03-04,2016-11-25,Targeted Therapy,Private,Alive,106.0,None,No,Never,Moderate,21.9,Low,Rural,Statutory Health Insurance,1.0,Yes,No,,1.0
PT09361,Germany,Bavaria,62.0,Female,Pancreatic,III,2023-09-19,2023-10-08,2024-07-08,Chemotherapy,Public,Alive,10.0,KRAS,No,Current,None,33.9,Medium,Rural,Private Insurance,4.0,No,Yes,Obesity,10.0
PT09362,Spain,Andalusia,24.0,Female,Lung,I,2018-01-02,2018-05-21,2019-04-19,,,Alive,,KRAS,,Never,Moderate,27.0,High,Urban,Statutory Health Insurance,18.0,No,No,Diabetes,9.0
PT09363,Switzerland,Geneva,23.0,Female,Pancreatic,I,2015-01-22,2015-04-10,2015-12-16,Radiation,Public,Alive,114.0,,No,Former,None,25.4,Medium,Rural,NHS,16.0,Yes,No,Obesity,9.0
PT09364,Ireland,Dublin,20.0,Female,Breast,I,2010-11-03,2011-02-11,2011-07-03,Surgery,Public,Lost to Follow-up,,BRCA1,No,Never,Moderate,31.0,Low,Urban,Statutory Health Insurance,3.0,No,No,Cardiovascular Disease,3.0
PT09365,Belgium,Flanders,75.0,Male,Pancreatic,II,2019-08-18,2019-12-27,2020-11-14,Radiation,,Alive,100.0,None,,Former,None,35.8,Medium,Urban,NHS,2.0,No,,Obesity,10.0
PT09366,Finland,Uusimaa,64.0,Male,Leukemia,II,2020-03-19,2020-07-25,2021-05-07,Chemotherapy,Research Institute,Deceased,44.0,BRCA1,No,Never,None,33.6,High,Urban,Private Insurance,17.0,Yes,Yes,Hypertension,3.0
PT09367,Netherlands,South Holland,84.0,Female,,IV,2022-02-19,2022-06-06,2022-08-29,,Private,Alive,33.0,EGFR,Yes,Never,Moderate,35.8,Medium,Urban,NHS,16.0,No,Yes,Cardiovascular Disease,8.0
PT09368,Finland,,22.0,Male,,III,2011-06-01,2011-10-19,2012-04-03,Surgery,,Alive,76.0,None,No,Former,Heavy,29.7,High,Rural,Statutory Health Insurance,19.0,Yes,No,Diabetes,2.0
PT09369,Portugal,Algarve,41.0,Male,Pancreatic,I,2010-04-11,2010-06-12,2011-05-18,Chemotherapy,Public,Deceased,56.0,EGFR,No,Never,Moderate,30.7,Medium,Urban,Private Insurance,10.0,No,No,Cardiovascular Disease,2.0
PT09370,Belgium,Brussels,75.0,Male,Lung,I,2015-11-18,2016-01-02,,,Private,Alive,7.0,None,,Never,Moderate,18.3,Low,Urban,Private Insurance,13.0,No,Yes,Hypertension,4.0
PT09371,Belgium,Flanders,37.0,Female,Ovarian,III,2016-01-30,2016-03-27,2016-08-28,Targeted Therapy,Private,Alive,113.0,None,Yes,Never,Moderate,27.5,Low,Urban,Private Insurance,1.0,No,No,None,1.0
PT09372,Ireland,Dublin,44.0,Female,Breast,II,2017-09-30,2018-02-07,2018-04-01,Surgery,Public,Alive,80.0,KRAS,No,Never,Moderate,35.7,Medium,Urban,Private Insurance,17.0,No,No,Obesity,7.0
PT09373,Germany,North Rhine-Westphalia,67.0,Male,,III,2015-03-24,,2016-05-11,Radiation,Private,Alive,53.0,KRAS,No,Never,None,31.7,Low,,Private Insurance,19.0,No,No,Hypertension,5.0
PT09374,Spain,Catalonia,50.0,Female,Pancreatic,II,2010-01-28,2010-02-16,2010-06-17,Targeted Therapy,Public,Alive,119.0,BRCA1,Yes,Never,None,33.2,Medium,Urban,NHS,5.0,No,No,Obesity,3.0
PT09375,Portugal,Algarve,49.0,Female,Ovarian,I,2023-04-15,2023-06-15,2023-09-03,Targeted Therapy,Public,Alive,88.0,BRCA1,Yes,Current,None,21.3,Low,Urban,Statutory Health Insurance,5.0,No,No,Diabetes,3.0
PT09376,Poland,Lesser Poland,85.0,Female,Ovarian,I,2019-02-19,2019-07-21,2020-03-06,,,Alive,32.0,EGFR,No,Never,Moderate,38.1,Low,Urban,NHS,16.0,No,No,Diabetes,
PT09377,Spain,Madrid,29.0,Female,Pancreatic,II,2016-06-20,2016-06-25,2016-12-28,Chemotherapy,,Deceased,53.0,KRAS,Yes,Never,Moderate,34.5,Medium,Rural,Private Insurance,13.0,No,,None,
PT09378,Portugal,Algarve,78.0,Female,Lung,II,2021-04-26,2021-09-27,2022-03-22,Immunotherapy,Private,Lost to Follow-up,,KRAS,Yes,Former,Moderate,37.7,High,Rural,Private Insurance,7.0,No,No,Cardiovascular Disease,5.0
PT09379,Belgium,Wallonia,70.0,Female,Leukemia,III,2020-01-25,2020-07-06,2020-11-05,Immunotherapy,Public,Deceased,69.0,EGFR,No,Never,None,24.3,High,,NHS,13.0,No,,,9.0
PT09380,Austria,Tyrol,28.0,Male,Breast,III,2018-10-30,2018-11-18,2019-07-12,Chemotherapy,Public,Alive,92.0,None,Yes,Never,None,30.9,,Rural,Private Insurance,9.0,No,Yes,None,6.0
PT09381,Austria,Tyrol,73.0,,Prostate,IV,2016-07-03,,2016-09-06,,Research Institute,Alive,100.0,None,Yes,Never,Moderate,35.7,Low,Rural,Statutory Health Insurance,8.0,No,No,Diabetes,4.0
PT09382,Portugal,Algarve,81.0,Male,Pancreatic,IV,2010-02-17,2010-08-08,2010-12-07,Radiation,Private,Alive,75.0,,No,,,27.1,High,Urban,Statutory Health Insurance,6.0,No,No,Cardiovascular Disease,3.0
PT09383,Austria,Tyrol,28.0,Male,Breast,II,2020-03-02,2020-07-27,2021-07-02,Immunotherapy,Private,Deceased,54.0,BRCA1,No,Former,Moderate,25.5,Medium,Rural,NHS,10.0,,No,,7.0
PT09384,Denmark,Zealand,28.0,Male,Leukemia,II,2010-01-06,2010-04-22,2010-07-06,Targeted Therapy,Private,Alive,14.0,KRAS,No,Former,Moderate,26.9,Medium,Rural,Statutory Health Insurance,5.0,No,No,Diabetes,6.0
PT09385,Germany,Bavaria,43.0,Male,Prostate,III,2012-02-09,2012-04-30,2012-10-19,Immunotherapy,Public,,38.0,BRCA1,No,Current,None,32.0,Medium,Urban,Statutory Health Insurance,,Yes,,Diabetes,1.0
PT09386,Portugal,Algarve,58.0,Male,Prostate,I,2013-09-24,2014-02-11,2014-11-17,Radiation,Research Institute,Alive,28.0,BRCA1,Yes,,Heavy,26.1,Medium,Urban,Statutory Health Insurance,,No,No,Diabetes,6.0
PT09387,Germany,Berlin,27.0,Male,Ovarian,IV,2019-02-23,2019-08-05,2020-04-14,Targeted Therapy,Research Institute,Alive,98.0,KRAS,Yes,Former,None,22.8,Medium,Urban,Private Insurance,1.0,No,No,Cardiovascular Disease,6.0
PT09388,Netherlands,South Holland,44.0,Male,Lung,II,2012-03-27,2012-06-25,2013-01-07,Surgery,Public,Alive,109.0,EGFR,No,Former,Moderate,29.2,Medium,Urban,,12.0,Yes,No,,1.0
PT09389,Belgium,Wallonia,85.0,Female,Colorectal,IV,2020-06-25,2020-10-20,2021-10-02,Targeted Therapy,Public,Alive,99.0,,No,Former,Moderate,19.5,Medium,Urban,Statutory Health Insurance,6.0,No,No,Diabetes,3.0
PT09390,Finland,Southwest Finland,29.0,Female,Leukemia,IV,2010-01-08,2010-05-13,2010-12-25,Surgery,Research Institute,Deceased,75.0,BRCA1,No,Current,None,37.9,High,Urban,Statutory Health Insurance,16.0,No,No,Cardiovascular Disease,6.0
PT09391,Italy,Lombardy,43.0,Female,Colorectal,II,2023-05-05,2023-07-16,2024-07-09,Chemotherapy,Public,Deceased,65.0,BRCA1,No,Former,Moderate,38.5,Low,Urban,Private Insurance,8.0,,No,Diabetes,5.0
PT09392,Denmark,Central Denmark,78.0,,Leukemia,I,2023-01-11,2023-04-25,2023-10-30,Radiation,Private,Deceased,22.0,BRCA1,Yes,Current,Moderate,39.7,High,,NHS,12.0,No,Yes,Obesity,9.0
PT09393,Italy,Veneto,50.0,Male,Breast,II,2016-12-07,2017-01-01,,Immunotherapy,Public,Deceased,7.0,None,No,Never,Heavy,34.7,Medium,Urban,Statutory Health Insurance,6.0,No,No,Diabetes,1.0
,Norway,Oslo,30.0,Male,Colorectal,II,2017-07-22,2017-12-22,2018-09-01,Chemotherapy,Private,Alive,44.0,EGFR,Yes,Former,Moderate,35.7,,Rural,,14.0,,No,Cardiovascular Disease,5.0
PT09395,Switzerland,Zurich,25.0,Male,Ovarian,III,2010-11-25,2011-04-15,2011-12-16,Chemotherapy,Private,Alive,19.0,EGFR,No,Current,Heavy,36.5,High,Urban,Statutory Health Insurance,1.0,Yes,No,Cardiovascular Disease,3.0
PT09396,Germany,Bavaria,89.0,Female,Pancreatic,I,2022-04-23,2022-06-04,2023-04-28,Targeted Therapy,Research Institute,Alive,85.0,KRAS,Yes,Never,,21.8,Medium,Urban,Private Insurance,19.0,,No,Diabetes,9.0
PT09397,Italy,Veneto,51.0,,,II,2023-05-08,2023-09-28,2023-12-04,Targeted Therapy,Private,Alive,42.0,None,No,Never,None,22.5,Low,Rural,Private Insurance,7.0,No,No,Diabetes,5.0
PT09398,Sweden,Skåne,58.0,Female,Ovarian,IV,2015-03-28,2015-04-20,2015-10-09,Surgery,Public,Deceased,110.0,BRCA1,Yes,Never,None,36.0,High,Urban,Statutory Health Insurance,10.0,No,No,Hypertension,7.0
PT09399,Sweden,Stockholm,67.0,Female,Pancreatic,IV,2016-07-13,2016-08-10,2016-09-19,Surgery,Public,Alive,93.0,BRCA1,No,Current,Moderate,27.2,High,Urban,NHS,4.0,Yes,Yes,Obesity,9.0
PT09400,Switzerland,Bern,32.0,Male,Pancreatic,I,2020-11-24,2021-03-16,2022-01-20,Chemotherapy,Public,Alive,73.0,BRCA1,Yes,Never,Moderate,35.4,,Urban,Private Insurance,11.0,No,No,None,2.0
PT09401,Portugal,,78.0,Female,Prostate,IV,2016-10-02,2016-10-15,2016-12-22,Chemotherapy,Public,Alive,34.0,BRCA1,No,Former,,21.2,Low,Urban,NHS,15.0,Yes,No,Diabetes,10.0
PT09402,Ireland,Connacht,86.0,Male,Lung,I,2018-04-26,2018-07-31,2018-10-24,Targeted Therapy,Public,Alive,115.0,None,,Current,Moderate,19.1,Medium,Urban,NHS,12.0,No,No,Cardiovascular Disease,4.0
PT09403,France,Île-de-France,75.0,Male,Ovarian,III,2013-04-09,2013-06-23,,Targeted Therapy,Public,Alive,95.0,EGFR,No,Former,Moderate,26.7,High,Urban,NHS,11.0,No,No,Diabetes,1.0
PT09404,Italy,Veneto,60.0,Female,Leukemia,I,2010-04-11,2010-09-30,2011-03-26,Immunotherapy,Private,Alive,24.0,,Yes,Former,Heavy,24.0,Low,Urban,Private Insurance,8.0,Yes,No,Obesity,4.0
PT09405,Portugal,Porto,75.0,Non-binary,Lung,IV,2016-09-27,2016-11-01,2017-10-04,Radiation,Public,Deceased,23.0,BRCA1,No,Former,None,35.9,Medium,Urban,,14.0,No,No,None,9.0
PT09406,Norway,Oslo,54.0,,Leukemia,III,2010-11-19,2011-01-05,2011-03-09,Immunotherapy,Private,Deceased,97.0,KRAS,Yes,Never,None,38.2,Low,Urban,NHS,12.0,Yes,No,Diabetes,7.0
PT09407,Netherlands,Utrecht,,Female,Pancreatic,II,2021-04-17,2021-09-27,2022-08-23,Radiation,Public,Alive,97.0,,Yes,Current,Moderate,32.4,Medium,Urban,NHS,17.0,No,No,Hypertension,8.0
PT09408,Spain,Madrid,86.0,Male,Prostate,I,2019-12-29,2020-02-17,2021-02-12,Chemotherapy,Public,Deceased,,EGFR,Yes,Never,None,20.3,High,Urban,NHS,18.0,,No,Cardiovascular Disease,1.0
PT09409,Portugal,Algarve,53.0,,,I,2023-04-09,2023-07-05,2023-11-11,Targeted Therapy,Private,Alive,17.0,KRAS,Yes,Never,None,18.3,Low,Urban,,4.0,No,No,None,3.0
PT09410,Ireland,,89.0,Male,Prostate,III,2018-06-04,2018-07-14,2019-04-29,Immunotherapy,Private,Deceased,90.0,EGFR,Yes,Never,None,35.1,High,Rural,NHS,5.0,No,No,Obesity,4.0
PT09411,Finland,,30.0,Male,Prostate,IV,2011-08-30,2011-11-15,2012-09-08,Radiation,Public,Alive,37.0,KRAS,No,Former,None,37.2,Medium,Urban,Private Insurance,12.0,Yes,No,,2.0
PT09412,,Veneto,46.0,Male,Ovarian,III,2011-06-01,2011-07-13,2011-10-09,Surgery,Public,Alive,73.0,BRCA1,Yes,Never,Moderate,38.9,Low,Urban,NHS,10.0,No,No,Obesity,6.0
PT09413,France,Auvergne-Rhône-Alpes,67.0,Female,Prostate,,2013-01-13,2013-06-05,2014-05-23,Radiation,Public,Deceased,28.0,EGFR,No,Current,Moderate,,Medium,Rural,Private Insurance,16.0,No,No,Hypertension,8.0
PT09414,Sweden,Stockholm,43.0,,,III,2021-11-14,2022-01-13,2022-03-28,Radiation,Private,Deceased,63.0,,Yes,Never,None,18.7,Medium,Rural,NHS,10.0,No,No,Hypertension,2.0
PT09415,Italy,Lombardy,37.0,Female,Lung,IV,2012-04-18,2012-06-15,2013-05-13,Targeted Therapy,Public,Alive,18.0,EGFR,No,Never,Moderate,28.5,Medium,Urban,Private Insurance,19.0,No,No,None,7.0
PT09416,Netherlands,North Holland,46.0,Female,Breast,III,2013-01-26,2013-02-28,2013-10-21,Immunotherapy,Public,Alive,22.0,None,No,Never,Moderate,28.8,Medium,Urban,Private Insurance,15.0,No,,None,5.0
PT09417,France,Provence-Alpes-Côte d'Azur,73.0,Male,Colorectal,I,2020-11-09,2021-04-26,2021-09-14,,Public,Alive,100.0,EGFR,Yes,Never,Heavy,18.9,Medium,Rural,Statutory Health Insurance,6.0,No,No,Hypertension,9.0
PT09418,Netherlands,North Holland,74.0,Female,,III,2019-02-24,,2019-11-23,Immunotherapy,Public,Alive,27.0,BRCA1,No,Never,None,,Medium,Urban,Private Insurance,15.0,No,No,Hypertension,1.0
PT09419,Germany,Bavaria,40.0,Female,Pancreatic,II,2013-08-29,2014-02-06,2014-07-09,Chemotherapy,Public,Deceased,78.0,BRCA1,Yes,Never,None,34.8,Medium,Urban,NHS,19.0,,No,,3.0
PT09420,,Uusimaa,78.0,Male,Colorectal,IV,2013-06-13,2013-11-13,2014-05-20,Surgery,Public,Alive,11.0,BRCA1,Yes,Former,Heavy,22.5,High,Urban,,14.0,No,Yes,Hypertension,8.0
PT09421,Finland,Southwest Finland,53.0,Female,Breast,II,2018-12-25,2019-02-22,2020-02-02,Targeted Therapy,Public,Alive,78.0,KRAS,No,Never,Moderate,32.3,Medium,Urban,NHS,10.0,No,No,Obesity,6.0
PT09422,Sweden,,77.0,Male,Leukemia,I,2015-02-05,2015-07-10,2015-08-09,Radiation,Public,,71.0,BRCA1,No,Former,Moderate,35.9,Low,Urban,NHS,13.0,,Yes,Diabetes,1.0
PT09423,Finland,Uusimaa,67.0,Female,Ovarian,I,2011-10-07,,2012-08-17,Immunotherapy,Private,Deceased,64.0,EGFR,Yes,Never,None,36.8,High,Urban,NHS,,No,No,Cardiovascular Disease,2.0
PT09424,Netherlands,,73.0,Female,Breast,III,2016-02-07,2016-03-03,2017-01-16,,Public,Alive,67.0,BRCA1,No,Never,None,37.1,Low,Urban,Private Insurance,7.0,No,No,Cardiovascular Disease,2.0
PT09425,Denmark,Zealand,37.0,Female,,I,2011-08-20,2011-12-31,2012-09-03,Chemotherapy,Public,Alive,13.0,BRCA1,No,Never,Moderate,35.3,Medium,Urban,NHS,3.0,No,Yes,Hypertension,7.0
PT09426,Norway,Oslo,22.0,Non-binary,Pancreatic,IV,2017-09-11,2017-11-12,,Immunotherapy,Research Institute,Alive,53.0,KRAS,No,Former,Moderate,31.6,Medium,Urban,Statutory Health Insurance,11.0,No,No,Cardiovascular Disease,4.0
PT09427,Italy,Sicily,43.0,Female,,I,2022-06-03,2022-11-21,2023-06-25,Radiation,Public,Alive,111.0,EGFR,No,Never,Moderate,19.9,Medium,Urban,,18.0,Yes,No,Diabetes,7.0
PT09428,Austria,,20.0,Male,Leukemia,I,2011-04-13,2011-07-26,2011-11-26,Chemotherapy,Public,Alive,14.0,KRAS,No,Current,None,23.7,Medium,Urban,Private Insurance,3.0,No,No,Hypertension,4.0
PT09429,Germany,Berlin,25.0,Male,Colorectal,I,2012-08-22,,2013-01-17,Radiation,Research Institute,Alive,104.0,BRCA1,,Current,None,29.7,High,Rural,NHS,12.0,No,No,Cardiovascular Disease,5.0
PT09430,Belgium,Wallonia,38.0,Male,Ovarian,I,2014-06-26,2014-10-09,2014-12-28,Chemotherapy,Public,Alive,107.0,KRAS,No,,None,26.1,Medium,Urban,Private Insurance,1.0,No,No,Diabetes,9.0
PT09431,Sweden,Skåne,62.0,Male,Prostate,,2017-08-18,2017-11-17,2017-12-21,Radiation,Research Institute,Alive,26.0,None,No,Never,Moderate,33.6,Low,Rural,Statutory Health Insurance,4.0,Yes,No,Hypertension,6.0
PT09432,Netherlands,Utrecht,27.0,Female,Leukemia,II,2017-09-14,2018-02-25,2018-09-08,,Private,Deceased,43.0,None,Yes,Never,None,20.6,Low,Urban,Statutory Health Insurance,3.0,No,No,None,8.0
PT09433,Ireland,Dublin,88.0,Male,Leukemia,I,2010-08-15,2010-12-17,2011-07-28,Targeted Therapy,Public,Alive,81.0,KRAS,Yes,Never,Moderate,38.8,Medium,Rural,NHS,12.0,Yes,No,None,2.0
PT09434,Spain,Catalonia,71.0,Non-binary,Breast,I,2017-09-09,2017-12-16,2018-06-10,Immunotherapy,Public,Alive,112.0,EGFR,No,Former,None,25.5,Medium,Rural,Statutory Health Insurance,17.0,No,No,Diabetes,2.0
PT09435,Norway,Trøndelag,66.0,Female,,II,2013-07-28,2013-12-13,2014-06-26,Radiation,Public,Alive,115.0,EGFR,No,Former,Moderate,29.4,Low,Urban,NHS,15.0,No,No,Obesity,5.0
PT09436,France,Île-de-France,47.0,Male,Ovarian,III,2011-05-29,2011-09-21,2012-06-10,Surgery,Private,Deceased,46.0,EGFR,,,,25.4,High,Urban,Private Insurance,18.0,No,No,None,9.0
PT09437,Finland,Uusimaa,65.0,Male,Lung,,2010-07-31,2010-12-28,2011-03-17,Targeted Therapy,Public,Alive,115.0,EGFR,Yes,Former,None,35.6,Low,Urban,Private Insurance,16.0,No,,Hypertension,10.0
PT09438,France,,23.0,Male,Ovarian,I,2012-02-09,2012-05-05,2013-05-03,Targeted Therapy,Private,Alive,8.0,KRAS,No,Never,Moderate,21.4,Low,Rural,Private Insurance,13.0,No,Yes,Hypertension,7.0
PT09439,Poland,Masovian,27.0,Female,Prostate,II,2019-01-25,2019-02-22,2019-09-01,Radiation,Research Institute,Alive,29.0,BRCA1,No,Former,Moderate,25.8,High,Urban,NHS,5.0,No,No,Cardiovascular Disease,10.0
PT09440,Denmark,Capital Region,80.0,Female,Ovarian,II,,2011-04-24,2011-07-23,Radiation,Public,Deceased,117.0,KRAS,No,Former,Moderate,,Low,Rural,NHS,,No,,Diabetes,2.0
PT09441,Poland,Masovian,36.0,Male,Breast,II,2018-12-03,2019-02-25,2019-11-28,Surgery,Public,Alive,33.0,EGFR,Yes,Former,Moderate,19.0,,Urban,Statutory Health Insurance,1.0,No,No,Hypertension,8.0
PT09442,Netherlands,Utrecht,53.0,Female,Colorectal,III,2010-09-17,2010-11-19,2011-08-22,Radiation,Public,Alive,66.0,EGFR,No,Never,None,31.4,Low,Urban,Statutory Health Insurance,10.0,No,No,,10.0
PT09443,Norway,Trøndelag,39.0,Female,Colorectal,IV,2014-10-21,,2015-06-29,Surgery,Public,Alive,60.0,EGFR,Yes,Former,None,33.3,Medium,Rural,NHS,18.0,Yes,No,Obesity,6.0
PT09444,Germany,Berlin,53.0,Female,Colorectal,I,2016-07-25,2016-08-17,2017-03-14,Radiation,Public,Alive,47.0,None,,Never,Moderate,38.9,Low,Urban,Private Insurance,19.0,Yes,No,Cardiovascular Disease,5.0
PT09445,Austria,Styria,62.0,Female,Colorectal,I,2023-02-24,2023-04-16,2023-07-22,Surgery,Public,Deceased,112.0,EGFR,No,Never,Moderate,39.5,Low,Rural,Private Insurance,6.0,No,No,Diabetes,7.0
PT09446,Sweden,Stockholm,29.0,Male,Colorectal,I,2010-02-15,2010-06-07,2010-12-14,Chemotherapy,Private,Alive,78.0,KRAS,Yes,Former,Heavy,23.7,Low,Urban,Private Insurance,2.0,No,No,Obesity,10.0
,Italy,Veneto,49.0,Male,Breast,II,2012-05-26,2012-08-14,2012-12-21,Immunotherapy,Public,Alive,9.0,KRAS,No,Never,None,32.7,High,Urban,Statutory Health Insurance,10.0,,Yes,Cardiovascular Disease,2.0
PT09448,Belgium,Brussels,44.0,Female,Lung,I,2017-12-27,2018-06-01,,Immunotherapy,Research Institute,Alive,96.0,BRCA1,No,Never,Moderate,19.8,High,Urban,Private Insurance,4.0,No,No,None,2.0
,Switzerland,Geneva,76.0,Non-binary,Lung,II,2015-05-10,2015-09-03,2016-06-27,Radiation,Public,Lost to Follow-up,,None,No,Former,None,33.9,High,Urban,Private Insurance,1.0,No,No,Diabetes,2.0
PT09450,Finland,,82.0,Male,Colorectal,IV,2014-05-20,2014-05-21,2014-09-06,Radiation,Public,Deceased,8.0,EGFR,No,Never,None,25.3,Low,Urban,NHS,13.0,No,No,Cardiovascular Disease,5.0
PT09451,Spain,Catalonia,66.0,Male,Lung,I,2016-03-24,2016-08-14,2017-03-20,Immunotherapy,Public,Alive,80.0,KRAS,No,Never,Moderate,22.7,Low,Urban,NHS,2.0,No,No,Cardiovascular Disease,9.0
PT09452,Germany,Bavaria,22.0,Male,Prostate,II,2014-10-06,2014-10-21,2015-02-24,Immunotherapy,Private,Alive,78.0,BRCA1,No,Former,Moderate,18.4,Low,Urban,NHS,6.0,No,No,,8.0
PT09453,Portugal,Algarve,65.0,Male,Lung,III,2018-09-26,2018-11-08,2019-10-07,Surgery,Private,Alive,67.0,BRCA1,No,Current,None,29.6,Medium,Urban,Private Insurance,2.0,No,No,Hypertension,4.0
PT09454,Sweden,Västra Götaland,55.0,Male,Ovarian,I,,2011-04-12,2011-10-24,Surgery,Private,Alive,52.0,None,Yes,Never,None,21.9,Medium,Urban,NHS,3.0,No,No,Hypertension,1.0
PT09455,Italy,Veneto,45.0,Male,Leukemia,I,2014-03-11,2014-06-22,2014-09-13,,Public,Alive,99.0,BRCA1,Yes,Never,None,30.8,Low,Urban,NHS,12.0,No,No,Cardiovascular Disease,5.0
PT09456,Poland,Silesian,29.0,Female,Colorectal,III,2011-07-10,2011-11-12,2012-05-18,Chemotherapy,Research Institute,Alive,40.0,BRCA1,Yes,Current,None,29.2,,Rural,Statutory Health Insurance,,No,No,Cardiovascular Disease,5.0
PT09457,Switzerland,Geneva,53.0,Male,Ovarian,I,2015-08-11,2015-09-18,,Surgery,Public,Alive,67.0,EGFR,No,Never,None,31.6,High,Rural,Statutory Health Insurance,13.0,No,No,Hypertension,10.0
PT09458,France,Provence-Alpes-Côte d'Azur,,Male,Leukemia,III,2012-01-01,2012-03-04,2012-08-30,Chemotherapy,Public,Alive,66.0,None,No,Never,Moderate,23.4,Medium,Urban,Private Insurance,11.0,Yes,No,Cardiovascular Disease,6.0
PT09459,Portugal,Porto,74.0,Male,Leukemia,I,2023-03-17,,2024-05-14,Targeted Therapy,Private,,,BRCA1,Yes,Never,Moderate,20.6,Low,Urban,Statutory Health Insurance,10.0,No,No,Diabetes,10.0
PT09460,Norway,Oslo,29.0,Female,Colorectal,II,2021-01-16,2021-03-08,2021-10-16,Surgery,Private,Alive,20.0,None,Yes,Current,Moderate,35.2,Medium,Urban,NHS,11.0,Yes,No,Diabetes,2.0
PT09461,Portugal,Porto,76.0,Female,Pancreatic,III,2013-03-09,2013-05-26,2013-08-11,Chemotherapy,Public,Alive,99.0,EGFR,Yes,Never,Moderate,,Medium,Urban,Statutory Health Insurance,8.0,No,No,Cardiovascular Disease,2.0
PT09462,Norway,Vestland,64.0,Non-binary,Breast,I,2023-09-28,2023-12-20,2024-04-19,Chemotherapy,Public,Alive,,BRCA1,No,Current,None,26.4,Medium,Rural,NHS,14.0,No,Yes,None,3.0
PT09463,Italy,Lombardy,69.0,Female,Pancreatic,I,2013-07-23,2013-12-24,2014-05-07,Radiation,Public,Alive,57.0,BRCA1,No,Never,None,26.5,Medium,Rural,Statutory Health Insurance,17.0,No,Yes,Diabetes,6.0
PT09464,Norway,Vestland,83.0,Male,Lung,I,2022-03-21,2022-06-26,2023-05-02,Radiation,Public,Alive,69.0,KRAS,No,Never,None,37.0,Low,Urban,Private Insurance,10.0,Yes,No,,10.0
PT09465,Ireland,Munster,21.0,,Pancreatic,IV,2022-12-03,2023-05-26,2023-07-15,Radiation,Private,Alive,108.0,,Yes,Never,Moderate,21.8,Medium,Urban,NHS,8.0,No,No,Hypertension,3.0
PT09466,Denmark,Capital Region,64.0,Female,Prostate,III,2015-07-14,2015-12-01,2016-10-07,Immunotherapy,Private,Alive,61.0,EGFR,No,Never,Moderate,25.6,Low,Rural,Statutory Health Insurance,12.0,No,No,Hypertension,4.0
PT09467,Denmark,Central Denmark,81.0,Female,Pancreatic,I,2020-02-04,2020-05-07,2020-10-12,Immunotherapy,Private,,,BRCA1,No,Current,None,24.1,Medium,Urban,NHS,14.0,No,No,Cardiovascular Disease,9.0
PT09468,Portugal,Porto,33.0,Female,Pancreatic,III,2015-04-25,2015-09-12,,Immunotherapy,Private,Alive,7.0,EGFR,Yes,Never,None,20.8,Medium,Rural,,12.0,No,Yes,Obesity,8.0
PT09469,France,Auvergne-Rhône-Alpes,34.0,Female,Breast,III,2022-01-14,2022-02-12,2022-09-03,Surgery,Public,Alive,76.0,KRAS,Yes,Current,Moderate,30.0,Low,Urban,Private Insurance,15.0,No,No,,9.0
PT09470,Switzerland,Zurich,33.0,Female,Prostate,IV,2018-05-30,2018-09-12,2019-06-09,,Private,Alive,66.0,BRCA1,Yes,Current,Moderate,31.8,Medium,Urban,Statutory Health Insurance,4.0,No,No,None,8.0
PT09471,Italy,Veneto,50.0,,Pancreatic,II,2019-08-01,2019-10-01,2020-07-17,,Public,Alive,62.0,KRAS,Yes,Former,Moderate,37.3,Medium,Rural,Statutory Health Insurance,15.0,Yes,No,Hypertension,1.0
PT09472,Austria,Styria,48.0,Female,Colorectal,IV,2013-04-25,2013-06-05,2013-12-19,Surgery,Public,Deceased,105.0,None,No,Never,None,32.3,Low,Urban,Statutory Health Insurance,12.0,No,Yes,Hypertension,10.0
PT09473,France,Auvergne-Rhône-Alpes,46.0,Female,Lung,II,2021-08-24,,2022-07-12,Immunotherapy,Private,Alive,14.0,BRCA1,Yes,Never,Heavy,19.1,,Urban,NHS,18.0,No,No,None,10.0
PT09474,Finland,,28.0,Male,Pancreatic,IV,2013-09-16,2013-11-01,2014-01-22,Chemotherapy,Private,Alive,95.0,None,No,Former,Moderate,19.1,Medium,Urban,,12.0,No,Yes,None,8.0
PT09475,Austria,Vienna,39.0,Female,Breast,I,2019-02-11,2019-07-19,,,Public,Deceased,57.0,EGFR,No,Never,Moderate,19.3,Low,Urban,NHS,9.0,No,No,Diabetes,6.0
PT09476,Switzerland,Zurich,77.0,Female,Colorectal,I,2015-11-01,2015-12-10,,Radiation,Public,Deceased,15.0,BRCA1,No,Never,,23.6,Low,Urban,,4.0,No,No,None,7.0
PT09477,Portugal,,68.0,Male,Breast,III,2021-04-02,2021-05-12,2022-03-22,Immunotherapy,Research Institute,Alive,36.0,None,Yes,Never,Moderate,23.5,Medium,Urban,NHS,5.0,No,No,None,7.0
PT09478,Belgium,Flanders,76.0,Male,Leukemia,III,2018-12-12,2019-06-09,2019-09-22,Chemotherapy,Private,Alive,111.0,BRCA1,Yes,Never,Moderate,35.1,High,,Private Insurance,9.0,Yes,No,Cardiovascular Disease,9.0
PT09479,Poland,Lesser Poland,35.0,Male,Pancreatic,II,2013-05-20,2013-05-22,2013-11-03,Radiation,Public,Alive,20.0,None,Yes,Current,,19.1,High,Urban,,12.0,Yes,No,Cardiovascular Disease,2.0
PT09480,Switzerland,Bern,27.0,Male,Lung,II,2021-07-05,2021-12-08,2022-04-23,Radiation,Public,Alive,22.0,EGFR,Yes,Never,Heavy,31.4,Low,Rural,NHS,18.0,No,No,Diabetes,8.0
PT09481,Switzerland,Bern,86.0,Male,Lung,II,2022-12-10,2023-01-30,2023-04-12,Targeted Therapy,Public,Deceased,32.0,None,,Never,Moderate,31.1,Low,Rural,NHS,18.0,Yes,No,Obesity,10.0
PT09482,Poland,Silesian,38.0,Male,Colorectal,I,2017-08-10,2017-12-08,2018-08-17,Immunotherapy,Private,Alive,,KRAS,Yes,Current,Moderate,,Medium,Urban,Statutory Health Insurance,,No,No,Diabetes,9.0
PT09483,Italy,Sicily,86.0,Male,Colorectal,I,2021-08-31,2021-09-08,,Surgery,,Deceased,,EGFR,No,,Moderate,18.5,Medium,Urban,Statutory Health Insurance,4.0,No,No,Diabetes,
PT09484,Denmark,Zealand,55.0,Male,Colorectal,I,2017-12-18,2018-01-18,2018-07-28,Chemotherapy,Public,Alive,105.0,BRCA1,Yes,Never,Moderate,36.2,Medium,Urban,Statutory Health Insurance,13.0,No,No,Cardiovascular Disease,8.0
PT09485,Switzerland,Bern,79.0,,Lung,II,2022-03-01,2022-04-09,2022-08-06,Chemotherapy,Public,,,BRCA1,Yes,Never,None,26.3,High,Rural,Statutory Health Insurance,17.0,No,No,Cardiovascular Disease,2.0
PT09486,Sweden,Västra Götaland,55.0,Male,Pancreatic,I,2012-11-14,2013-02-05,2013-10-20,Immunotherapy,Private,Alive,97.0,BRCA1,No,Former,Moderate,27.9,High,,NHS,14.0,No,No,Hypertension,6.0
,Belgium,Brussels,30.0,Male,,I,2015-05-14,2015-10-05,2016-08-06,Chemotherapy,Public,Deceased,77.0,KRAS,No,Former,None,32.7,Medium,Urban,Statutory Health Insurance,2.0,Yes,No,Cardiovascular Disease,6.0
PT09488,France,Île-de-France,70.0,,Lung,IV,2014-04-28,2014-05-21,2014-11-13,Surgery,Private,Alive,55.0,None,Yes,Former,Moderate,32.6,Low,Urban,NHS,19.0,No,Yes,None,4.0
PT09489,Netherlands,North Holland,74.0,Female,Colorectal,I,2020-02-16,2020-07-04,2020-11-06,Chemotherapy,Public,Alive,97.0,None,No,Never,None,24.1,Medium,Urban,Private Insurance,18.0,No,No,Cardiovascular Disease,4.0
,Norway,Oslo,73.0,Male,Prostate,,2010-12-16,2011-04-16,2011-05-16,Immunotherapy,Private,Deceased,113.0,EGFR,Yes,Never,None,18.3,Medium,Urban,Private Insurance,19.0,No,No,None,8.0
PT09491,Spain,Madrid,36.0,,Pancreatic,IV,2014-01-18,2014-03-28,2014-10-22,,,Deceased,35.0,EGFR,No,Former,None,35.7,Low,Urban,Statutory Health Insurance,13.0,No,No,Hypertension,5.0
PT09492,Netherlands,North Holland,,Male,Leukemia,I,2014-12-26,2015-01-07,2015-07-16,Targeted Therapy,Public,Deceased,46.0,EGFR,No,Never,Moderate,34.6,Medium,Rural,NHS,17.0,No,No,Diabetes,1.0
PT09493,Portugal,Lisbon,61.0,Non-binary,Lung,I,2013-05-26,2013-07-01,2013-08-25,Immunotherapy,Public,,98.0,EGFR,Yes,Former,Moderate,32.1,Medium,Rural,Private Insurance,15.0,No,No,None,1.0
PT09494,,Pirkanmaa,43.0,Female,Prostate,II,2020-10-05,2020-12-01,2021-11-05,Targeted Therapy,Private,Alive,17.0,EGFR,No,Never,Moderate,38.6,Low,,Private Insurance,12.0,No,Yes,Obesity,9.0
PT09495,Portugal,Algarve,36.0,Male,Pancreatic,II,,2012-10-26,2013-01-08,Chemotherapy,Public,Alive,104.0,,No,Former,Moderate,22.5,Low,Urban,Private Insurance,3.0,No,,Cardiovascular Disease,9.0
PT09496,Finland,Uusimaa,67.0,Male,Ovarian,II,2020-03-09,2020-06-09,2020-12-10,Surgery,Public,Deceased,88.0,EGFR,No,Never,Moderate,20.3,Low,,Private Insurance,4.0,No,,Diabetes,4.0
PT09497,Belgium,Flanders,89.0,Male,Ovarian,,2014-03-22,2014-06-20,2015-05-22,Chemotherapy,Public,Alive,59.0,EGFR,Yes,Former,None,40.0,Medium,Rural,Private Insurance,12.0,No,No,Obesity,4.0
PT09498,Netherlands,Utrecht,26.0,Male,Leukemia,IV,2020-02-23,2020-02-27,2020-04-24,Immunotherapy,Public,Alive,51.0,None,,Former,None,37.1,Medium,Urban,NHS,16.0,No,No,None,8.0
PT09499,Spain,Catalonia,33.0,Female,Ovarian,I,2020-02-19,2020-07-12,2021-03-10,Targeted Therapy,Public,Alive,74.0,None,No,Never,None,18.9,High,Urban,Private Insurance,5.0,No,Yes,Diabetes,3.0
PT09500,Portugal,Algarve,30.0,Female,Lung,III,2019-09-09,2019-10-01,2019-11-07,Targeted Therapy,Public,,81.0,EGFR,Yes,Never,None,25.3,Medium,Urban,Statutory Health Insurance,14.0,Yes,No,Hypertension,6.0
PT09501,Finland,Southwest Finland,31.0,Female,Ovarian,I,2012-03-30,2012-07-15,,Chemotherapy,Research Institute,Deceased,75.0,EGFR,No,Former,None,29.4,High,Urban,Private Insurance,3.0,Yes,No,None,8.0
PT09502,Netherlands,Utrecht,24.0,Male,Pancreatic,II,2020-09-14,2020-11-23,2021-01-02,Immunotherapy,Public,Alive,10.0,BRCA1,No,Never,Moderate,31.8,Low,Rural,Private Insurance,3.0,No,No,Hypertension,5.0
PT09503,Germany,Bavaria,24.0,Female,Pancreatic,I,2020-12-30,2021-05-18,2022-01-02,Chemotherapy,Public,Alive,93.0,EGFR,No,Never,Moderate,27.2,Medium,Urban,Statutory Health Insurance,9.0,No,Yes,Diabetes,5.0
PT09504,Finland,Southwest Finland,39.0,Male,Colorectal,II,2010-07-28,2011-01-14,2011-07-16,Radiation,Public,Alive,110.0,BRCA1,Yes,Never,Moderate,19.9,Low,Rural,NHS,16.0,No,No,Diabetes,10.0
PT09505,Sweden,Västra Götaland,73.0,Male,Lung,III,2015-02-28,2015-05-24,2015-10-22,Immunotherapy,Public,Alive,23.0,None,No,Never,Moderate,28.4,High,Rural,,2.0,Yes,No,,3.0
PT09506,Germany,Bavaria,74.0,Female,Pancreatic,I,,2022-06-08,2023-01-11,Immunotherapy,,Alive,30.0,EGFR,No,Former,None,30.0,Medium,Urban,NHS,19.0,No,No,Hypertension,10.0
PT09507,Poland,Silesian,77.0,Male,Leukemia,,2015-10-30,2016-04-22,2017-03-19,Surgery,Public,Alive,63.0,EGFR,No,Never,Moderate,24.9,Medium,Urban,Statutory Health Insurance,15.0,No,No,None,9.0
PT09508,France,Île-de-France,,Female,Colorectal,II,2020-12-02,2021-05-01,2021-10-17,Radiation,Public,Alive,61.0,BRCA1,No,Never,Moderate,21.5,High,Rural,Statutory Health Insurance,13.0,No,No,None,3.0
PT09509,Sweden,Skåne,43.0,Female,Pancreatic,,2010-04-17,2010-05-17,2011-02-05,Targeted Therapy,Private,Alive,33.0,EGFR,No,Never,Moderate,29.4,High,Urban,Statutory Health Insurance,12.0,No,No,None,
PT09510,Spain,Catalonia,,Male,Breast,III,2017-05-19,2017-10-24,2017-12-05,Chemotherapy,Public,Alive,54.0,KRAS,No,,None,24.1,Low,Urban,Statutory Health Insurance,17.0,No,No,Obesity,3.0
PT09511,Norway,Vestland,67.0,Female,Prostate,III,2016-10-21,2017-03-31,2017-11-17,Targeted Therapy,Private,Alive,93.0,EGFR,Yes,Former,Moderate,23.3,Medium,Urban,Statutory Health Insurance,5.0,No,No,Hypertension,4.0
PT09512,Portugal,Porto,41.0,Male,Pancreatic,III,2018-06-13,2018-09-25,2019-07-15,Immunotherapy,Public,Deceased,92.0,BRCA1,Yes,Never,None,33.9,Medium,Urban,Private Insurance,7.0,No,,None,4.0
,Switzerland,Zurich,,Male,Ovarian,II,2023-02-08,2023-07-16,2023-11-24,Chemotherapy,Research Institute,Alive,70.0,BRCA1,No,Never,None,30.3,Medium,Urban,Statutory Health Insurance,1.0,No,No,None,4.0
PT09514,Austria,Styria,67.0,Female,Colorectal,II,2021-01-12,2021-06-26,2022-02-03,Targeted Therapy,Private,Alive,83.0,BRCA1,No,Never,None,34.3,Low,Urban,,,No,No,Hypertension,2.0
PT09515,Switzerland,Zurich,48.0,Female,Colorectal,I,2013-11-26,2014-01-18,2014-06-28,,Public,Deceased,88.0,None,Yes,Current,Moderate,27.9,Low,Urban,Statutory Health Insurance,,No,No,None,4.0
,Finland,Southwest Finland,69.0,,Leukemia,III,,2023-01-16,2023-12-22,Targeted Therapy,Research Institute,Deceased,43.0,EGFR,No,Current,Moderate,,High,Urban,Statutory Health Insurance,6.0,No,No,,2.0
PT09517,Spain,Catalonia,29.0,,Pancreatic,II,2013-01-22,2013-06-25,2014-02-22,Chemotherapy,Public,Deceased,102.0,KRAS,Yes,Former,Moderate,28.8,High,Urban,Private Insurance,12.0,No,No,None,4.0
PT09518,Sweden,Skåne,46.0,Non-binary,Pancreatic,IV,2015-10-31,2016-03-13,2017-03-04,Targeted Therapy,Public,Alive,106.0,KRAS,Yes,Never,Heavy,31.1,Low,Urban,NHS,17.0,No,No,Diabetes,5.0
PT09519,Germany,Bavaria,47.0,Male,Leukemia,IV,2021-02-08,2021-04-03,2021-06-26,Targeted Therapy,Research Institute,Deceased,75.0,None,No,Never,Heavy,35.1,High,Rural,Private Insurance,8.0,No,No,Obesity,4.0
PT09520,Poland,Masovian,28.0,Female,Prostate,IV,2010-08-29,2011-01-08,2011-05-13,Chemotherapy,Public,Alive,39.0,EGFR,Yes,Never,Moderate,30.8,Medium,Urban,Private Insurance,15.0,No,No,Diabetes,3.0
PT09521,Germany,Bavaria,45.0,Female,Leukemia,,2010-06-14,2010-09-01,2011-08-09,Surgery,Private,Alive,28.0,BRCA1,No,Never,None,35.5,Medium,Urban,Private Insurance,7.0,No,No,Hypertension,6.0
PT09522,,Provence-Alpes-Côte d'Azur,27.0,Female,Colorectal,II,2014-02-05,2014-03-13,2014-10-13,Chemotherapy,Research Institute,,96.0,None,No,Never,None,29.3,,Rural,NHS,15.0,No,No,Cardiovascular Disease,10.0
PT09523,Netherlands,North Holland,21.0,Male,Prostate,IV,2018-06-29,2018-08-31,,Targeted Therapy,Private,Alive,19.0,BRCA1,No,Never,Moderate,31.5,Medium,Rural,Private Insurance,5.0,,No,Hypertension,4.0
PT09524,Poland,Silesian,76.0,Female,Ovarian,III,2016-11-11,,2017-09-21,Radiation,Private,Alive,91.0,KRAS,Yes,Never,,18.5,Low,Urban,Statutory Health Insurance,15.0,,No,Obesity,
PT09525,Belgium,Brussels,71.0,Male,Prostate,III,2010-10-31,2010-12-27,2011-05-06,Immunotherapy,,Alive,43.0,EGFR,Yes,Never,None,37.0,,Urban,NHS,11.0,Yes,No,Diabetes,8.0
PT09526,Austria,Vienna,77.0,Female,Lung,I,2023-01-27,2023-04-17,2023-07-28,Surgery,Public,Alive,83.0,,,Current,Heavy,,High,Rural,Statutory Health Insurance,15.0,No,No,Hypertension,8.0
PT09527,Norway,Vestland,22.0,Female,Colorectal,III,,2023-06-08,2024-05-28,Chemotherapy,Research Institute,Alive,91.0,None,No,Former,None,34.3,Low,Urban,Private Insurance,19.0,No,No,Hypertension,10.0
PT09528,Ireland,Connacht,27.0,Male,Colorectal,II,2012-06-30,2012-12-15,2013-02-04,Immunotherapy,,Alive,50.0,EGFR,Yes,Current,Moderate,27.8,Medium,Rural,Statutory Health Insurance,19.0,No,,Diabetes,
PT09529,Ireland,Dublin,78.0,Male,Leukemia,II,2023-12-12,2024-04-10,2024-11-26,Surgery,Private,Alive,66.0,KRAS,No,Former,Moderate,37.6,Medium,Urban,Private Insurance,13.0,Yes,No,Diabetes,5.0
PT09530,Netherlands,South Holland,21.0,Female,Colorectal,IV,2018-02-20,2018-07-04,2019-01-22,Radiation,Private,Alive,14.0,BRCA1,No,Never,Moderate,24.7,Medium,Urban,NHS,13.0,Yes,No,None,6.0
PT09531,Switzerland,Zurich,81.0,Female,Pancreatic,,2021-01-02,2021-05-31,2021-11-19,Immunotherapy,,Alive,80.0,KRAS,Yes,Current,Moderate,39.4,Medium,Urban,Statutory Health Insurance,8.0,No,No,None,4.0
PT09532,Poland,Masovian,68.0,Male,Leukemia,III,2017-07-24,2017-08-02,2018-01-24,Chemotherapy,Private,Alive,113.0,EGFR,Yes,Current,Moderate,34.2,Low,Urban,Private Insurance,4.0,No,No,Cardiovascular Disease,
PT09533,Poland,,,Male,Ovarian,II,2011-08-29,2012-02-16,2012-12-08,Radiation,Public,Alive,81.0,None,,Former,Moderate,31.5,High,Rural,NHS,19.0,No,No,Obesity,3.0
PT09534,Spain,Andalusia,48.0,Female,Colorectal,II,2012-11-04,2012-12-02,2013-02-03,Chemotherapy,Public,Alive,94.0,BRCA1,No,,Moderate,38.7,High,Rural,Statutory Health Insurance,7.0,No,No,Hypertension,2.0
PT09535,Belgium,Brussels,36.0,Male,Pancreatic,I,2011-02-11,2011-03-28,2012-02-24,Immunotherapy,Private,Deceased,7.0,KRAS,Yes,Never,Moderate,29.9,Low,Urban,Private Insurance,18.0,Yes,,Obesity,10.0
PT09536,Portugal,Algarve,41.0,Male,Lung,II,2012-12-07,2013-02-03,2013-05-26,Chemotherapy,Public,Alive,14.0,None,Yes,Former,Heavy,26.0,High,Rural,Private Insurance,3.0,No,No,Obesity,9.0
PT09537,Austria,Tyrol,25.0,Female,Colorectal,II,2021-07-11,2021-08-09,2021-10-25,Radiation,Research Institute,Alive,55.0,,Yes,Former,None,33.3,Medium,Urban,NHS,17.0,No,,Obesity,6.0
PT09538,,Geneva,81.0,Male,Lung,II,2022-08-27,2022-11-30,2023-11-26,Radiation,Private,Alive,50.0,KRAS,Yes,Former,None,23.4,High,Rural,,1.0,No,Yes,Hypertension,7.0
PT09539,Austria,Vienna,50.0,Male,Ovarian,III,2023-06-19,,2024-09-07,Immunotherapy,Public,Alive,40.0,EGFR,No,Current,None,29.5,High,Rural,Private Insurance,1.0,No,No,None,1.0
PT09540,Netherlands,South Holland,81.0,Male,Colorectal,II,2022-03-02,2022-04-28,2022-11-30,Immunotherapy,Public,Alive,101.0,None,No,Former,Heavy,37.7,High,Urban,Statutory Health Insurance,6.0,No,No,Obesity,4.0
PT09541,Italy,Veneto,31.0,,Colorectal,IV,,2023-12-13,2024-11-03,Targeted Therapy,Private,Lost to Follow-up,,EGFR,Yes,,Moderate,27.7,Low,Urban,NHS,16.0,No,No,Diabetes,1.0
PT09542,Spain,Catalonia,31.0,Male,Breast,II,2013-12-23,2014-04-10,2015-03-25,Radiation,,,67.0,KRAS,No,Current,Heavy,27.3,Low,Urban,Statutory Health Insurance,2.0,No,No,None,5.0
PT09543,Italy,Sicily,82.0,Female,Ovarian,III,2016-09-19,2017-01-29,2017-09-19,Targeted Therapy,Private,Deceased,83.0,,No,Former,,25.4,High,Rural,NHS,6.0,No,No,None,9.0
PT09544,Sweden,Västra Götaland,,Female,Pancreatic,I,2018-03-07,2018-03-23,2018-06-09,Chemotherapy,Public,Alive,98.0,KRAS,No,Former,None,32.4,Medium,Urban,Private Insurance,16.0,No,No,None,5.0
,Poland,Masovian,44.0,Male,Colorectal,I,2017-08-21,2017-12-30,2018-05-26,Immunotherapy,Private,Alive,62.0,BRCA1,No,Never,Moderate,23.9,High,Urban,NHS,8.0,No,No,Obesity,10.0
PT09546,France,Provence-Alpes-Côte d'Azur,41.0,Female,Lung,III,2020-01-18,2020-04-16,2020-11-14,Surgery,Public,Alive,88.0,None,Yes,Former,None,35.8,Medium,Urban,,9.0,No,No,Cardiovascular Disease,
PT09547,France,Auvergne-Rhône-Alpes,37.0,Male,Prostate,I,2010-07-20,2010-10-09,2011-02-07,Chemotherapy,Public,Deceased,105.0,None,No,Former,Moderate,31.9,Medium,Rural,NHS,,No,No,Diabetes,4.0
PT09548,Belgium,Wallonia,64.0,Female,Lung,IV,2012-02-22,2012-07-21,2013-05-17,Targeted Therapy,Public,Alive,51.0,None,Yes,Never,None,,Low,Rural,Statutory Health Insurance,10.0,No,No,,9.0
PT09549,Austria,,87.0,Male,Pancreatic,I,2017-07-23,2017-10-13,2018-03-23,Radiation,Research Institute,Alive,74.0,BRCA1,No,Former,Moderate,38.3,High,Urban,NHS,4.0,No,No,None,4.0
PT09550,Netherlands,,31.0,Female,Colorectal,IV,2023-06-23,2023-09-27,2024-03-10,Immunotherapy,Public,Alive,86.0,KRAS,,Current,Moderate,25.0,Low,Rural,Statutory Health Insurance,2.0,No,No,None,6.0
PT09551,Spain,Andalusia,,Male,Leukemia,II,,2020-07-26,2021-07-06,Immunotherapy,Public,Alive,103.0,None,,Never,None,36.1,Medium,Rural,Private Insurance,9.0,Yes,Yes,Cardiovascular Disease,9.0
PT09552,Sweden,Skåne,52.0,Male,Breast,II,2012-07-27,2012-09-22,2013-02-25,Chemotherapy,Public,Alive,112.0,BRCA1,Yes,Never,Moderate,19.2,Medium,Urban,Private Insurance,6.0,Yes,,Hypertension,4.0
PT09553,Italy,Veneto,82.0,Female,Leukemia,I,2018-07-14,2018-12-14,2019-08-31,Chemotherapy,,Alive,91.0,BRCA1,Yes,Never,Moderate,25.2,High,Rural,Private Insurance,16.0,No,No,Cardiovascular Disease,9.0
PT09554,Germany,Berlin,37.0,Male,Breast,II,2019-11-27,2019-12-25,2020-12-23,Immunotherapy,Public,Alive,119.0,EGFR,Yes,Never,Moderate,35.0,,Rural,NHS,9.0,No,No,Obesity,3.0
,Finland,Uusimaa,73.0,Female,Breast,I,2016-08-17,2017-02-01,2017-09-30,Targeted Therapy,,Alive,80.0,,No,Never,None,19.6,Medium,Rural,Private Insurance,12.0,Yes,No,Hypertension,8.0
PT09556,Germany,Bavaria,46.0,Male,Leukemia,II,2012-02-03,2012-07-03,2013-03-13,Radiation,Research Institute,Deceased,35.0,KRAS,,,Moderate,31.1,Low,Urban,Private Insurance,2.0,No,No,Cardiovascular Disease,2.0
PT09557,France,Île-de-France,44.0,Male,Pancreatic,II,2017-12-04,2018-04-19,2018-05-28,Immunotherapy,Public,Alive,55.0,BRCA1,No,Never,None,34.7,High,Rural,Statutory Health Insurance,5.0,No,No,Cardiovascular Disease,
PT09558,Switzerland,Bern,53.0,Female,Colorectal,III,2013-06-08,2013-10-27,2014-02-13,Immunotherapy,Public,,98.0,BRCA1,No,Former,Moderate,33.6,Medium,Rural,Private Insurance,2.0,No,No,None,5.0
PT09559,Denmark,Capital Region,79.0,Male,Lung,IV,2022-08-25,2023-02-13,2023-07-04,Chemotherapy,Public,,20.0,EGFR,No,Never,Moderate,35.1,Medium,Rural,Statutory Health Insurance,14.0,Yes,No,None,10.0
PT09560,Germany,North Rhine-Westphalia,73.0,Female,Leukemia,II,,2015-04-04,2016-02-09,Radiation,Public,Alive,41.0,BRCA1,No,Former,Moderate,21.6,Medium,Rural,Private Insurance,1.0,No,No,Cardiovascular Disease,10.0
PT09561,Italy,Veneto,24.0,Female,Prostate,I,2023-08-07,2023-09-23,2024-07-26,Immunotherapy,Private,Alive,44.0,BRCA1,,Former,Moderate,25.0,Medium,Urban,Statutory Health Insurance,14.0,No,No,Obesity,5.0
PT09562,Norway,Oslo,55.0,Male,Breast,II,2013-06-23,2013-07-03,2013-09-28,Chemotherapy,Public,Alive,86.0,KRAS,No,Former,Moderate,34.7,Low,Urban,NHS,4.0,No,No,Cardiovascular Disease,3.0
PT09563,Norway,Vestland,73.0,Female,Lung,III,2021-06-25,2021-08-05,2022-05-13,Surgery,Public,Alive,65.0,None,Yes,,Moderate,30.9,High,Urban,Private Insurance,13.0,No,Yes,Diabetes,5.0
PT09564,Spain,Madrid,55.0,Male,Ovarian,I,2017-10-11,,2018-12-04,Immunotherapy,Research Institute,Alive,32.0,BRCA1,Yes,Never,Moderate,19.9,Low,Rural,Statutory Health Insurance,3.0,No,Yes,Diabetes,4.0
PT09565,Spain,Catalonia,88.0,Male,Ovarian,III,2011-12-14,2012-06-08,2013-06-04,Surgery,Public,Alive,59.0,None,Yes,,Moderate,38.3,Medium,Urban,Private Insurance,3.0,No,No,Cardiovascular Disease,1.0
PT09566,Switzerland,Zurich,58.0,Female,Prostate,I,2011-11-05,2011-11-20,2012-06-03,Radiation,Public,Alive,7.0,EGFR,No,Never,Moderate,21.7,Low,Urban,NHS,6.0,No,No,Hypertension,6.0
,Ireland,Dublin,89.0,Male,Lung,I,2022-08-10,2022-10-23,2023-05-21,Radiation,Research Institute,Deceased,75.0,EGFR,Yes,Former,None,31.0,Low,Urban,NHS,18.0,No,No,Diabetes,2.0
,Spain,Catalonia,23.0,,Colorectal,II,2012-07-30,,2012-10-21,Immunotherapy,Public,Lost to Follow-up,,EGFR,No,Never,Moderate,22.6,Medium,Rural,NHS,17.0,No,No,Hypertension,1.0
PT09569,Belgium,Wallonia,84.0,Female,Prostate,II,2012-07-31,2013-01-21,2013-09-03,Targeted Therapy,Public,Deceased,9.0,None,No,Former,None,36.0,Low,Urban,NHS,13.0,No,Yes,Hypertension,3.0
PT09570,Norway,Oslo,59.0,Female,Pancreatic,II,2022-03-30,2022-05-28,2022-08-24,Chemotherapy,Private,Deceased,92.0,,Yes,Former,Moderate,30.8,Medium,Urban,NHS,19.0,No,No,Obesity,10.0
PT09571,France,Auvergne-Rhône-Alpes,56.0,Female,Pancreatic,III,2020-04-01,2020-09-24,2020-12-19,Chemotherapy,Public,Deceased,52.0,KRAS,Yes,Never,None,27.0,Low,Urban,Private Insurance,11.0,No,No,Cardiovascular Disease,1.0
PT09572,Germany,Berlin,86.0,Female,Leukemia,I,2015-04-01,2015-07-28,2016-03-13,Targeted Therapy,Public,,100.0,None,Yes,Never,None,34.2,Medium,Urban,Private Insurance,16.0,No,No,Obesity,
PT09573,Belgium,,50.0,Female,Lung,I,,2020-08-11,2020-12-26,Surgery,Private,Deceased,53.0,BRCA1,Yes,Former,None,25.7,High,Urban,NHS,14.0,No,No,Obesity,9.0
PT09574,Germany,Berlin,66.0,Female,Ovarian,III,2016-08-25,2016-12-29,2017-06-16,Radiation,Research Institute,Alive,62.0,BRCA1,Yes,Former,None,18.0,Low,Rural,Statutory Health Insurance,2.0,No,No,Obesity,8.0
PT09575,Austria,Tyrol,46.0,Male,Pancreatic,II,2019-03-29,2019-05-10,2019-12-26,Immunotherapy,Private,Deceased,70.0,None,No,Never,Moderate,20.0,Low,Urban,Statutory Health Insurance,5.0,No,No,Cardiovascular Disease,5.0
PT09576,Portugal,Algarve,70.0,Non-binary,Pancreatic,I,2013-04-04,2013-05-25,,Chemotherapy,Public,Alive,113.0,BRCA1,No,Never,Moderate,19.3,Medium,Urban,Private Insurance,2.0,No,No,,6.0
PT09577,Netherlands,North Holland,39.0,Male,Leukemia,,2023-04-19,2023-06-08,2024-02-29,Chemotherapy,Public,Deceased,63.0,EGFR,No,Never,Moderate,22.8,Low,Urban,NHS,18.0,Yes,,Hypertension,1.0
PT09578,Spain,Madrid,32.0,Female,Leukemia,III,2018-02-01,2018-05-04,2018-06-03,Immunotherapy,Private,Lost to Follow-up,,EGFR,Yes,Never,Moderate,38.0,High,Urban,Statutory Health Insurance,10.0,Yes,No,,2.0
PT09579,Germany,Bavaria,82.0,Female,Pancreatic,I,2016-05-02,2016-08-15,2016-11-06,Immunotherapy,Public,Deceased,56.0,EGFR,Yes,Never,None,22.1,Medium,Urban,Statutory Health Insurance,6.0,Yes,No,None,7.0
PT09580,Italy,Sicily,63.0,Female,Lung,III,,2020-02-08,2020-11-11,Chemotherapy,Public,Deceased,52.0,KRAS,,Never,Moderate,30.9,Medium,Urban,Private Insurance,3.0,No,No,Diabetes,6.0
PT09581,Poland,Masovian,43.0,Female,Lung,II,2013-06-06,2013-11-22,2014-10-16,Chemotherapy,Private,Alive,82.0,None,No,Never,Moderate,35.3,High,Urban,Statutory Health Insurance,2.0,No,No,Obesity,5.0
PT09582,Poland,Silesian,22.0,Male,Breast,I,2015-03-25,2015-05-22,2015-06-27,Chemotherapy,Private,Deceased,75.0,None,Yes,Former,Heavy,34.3,Low,Rural,,9.0,No,No,Hypertension,6.0
PT09583,Ireland,Munster,29.0,Male,,II,2016-02-25,2016-07-01,2017-03-27,Immunotherapy,Public,Alive,39.0,EGFR,Yes,Current,,25.2,High,Urban,Statutory Health Insurance,7.0,No,No,Cardiovascular Disease,10.0
PT09584,Italy,Sicily,84.0,Female,Prostate,II,2017-04-28,2017-05-02,2018-02-17,Surgery,Public,Alive,42.0,,Yes,Former,None,28.5,High,Urban,NHS,11.0,Yes,No,Obesity,10.0
PT09585,Spain,Catalonia,68.0,,Ovarian,IV,2019-02-07,2019-08-03,2020-06-03,Chemotherapy,,Alive,85.0,KRAS,,Former,Moderate,19.7,Low,Urban,Statutory Health Insurance,9.0,Yes,No,Diabetes,10.0
PT09586,France,Provence-Alpes-Côte d'Azur,77.0,Female,Prostate,III,2017-02-15,2017-06-26,2017-09-01,Surgery,Public,Alive,60.0,KRAS,,Former,Moderate,20.2,Low,Urban,Private Insurance,,No,No,Obesity,6.0
PT09587,Sweden,Stockholm,,Male,Prostate,II,2010-06-04,2010-07-06,2011-02-10,Chemotherapy,Public,,101.0,None,Yes,Current,Moderate,23.4,Low,Urban,Statutory Health Insurance,2.0,No,Yes,Cardiovascular Disease,3.0
PT09588,Finland,Pirkanmaa,85.0,Female,Breast,I,2017-10-18,2018-04-11,2019-04-07,Immunotherapy,Research Institute,Alive,49.0,None,No,Never,Moderate,21.3,High,,Statutory Health Insurance,6.0,No,No,None,3.0
PT09589,Spain,Andalusia,50.0,Female,Leukemia,IV,2017-04-28,2017-06-29,,Targeted Therapy,Private,Alive,84.0,None,No,Former,Moderate,19.5,Medium,Urban,Private Insurance,11.0,Yes,No,None,8.0
PT09590,Ireland,Dublin,87.0,Male,Pancreatic,III,2020-08-01,2020-12-23,2021-06-26,Surgery,Research Institute,Alive,73.0,None,Yes,Never,None,23.7,Medium,Rural,Statutory Health Insurance,9.0,No,Yes,Hypertension,
PT09591,Sweden,Skåne,56.0,Female,Colorectal,I,2021-02-05,2021-02-23,2021-04-05,Targeted Therapy,Public,Alive,48.0,KRAS,No,Current,,29.8,High,Urban,Statutory Health Insurance,11.0,,Yes,None,5.0
PT09592,Sweden,Skåne,43.0,Female,Colorectal,I,2019-12-21,2020-05-03,2021-02-03,Chemotherapy,Public,Alive,81.0,BRCA1,No,Current,Moderate,22.6,Medium,,Statutory Health Insurance,18.0,Yes,No,None,6.0
PT09593,Sweden,Västra Götaland,63.0,Male,Ovarian,III,2016-07-07,2016-10-21,2017-05-10,Chemotherapy,Public,Alive,15.0,EGFR,No,Never,None,24.2,Low,Rural,Private Insurance,2.0,No,No,Hypertension,10.0
PT09594,Netherlands,Utrecht,60.0,Female,Pancreatic,III,2022-05-01,2022-07-05,2022-08-18,Immunotherapy,Public,Alive,71.0,BRCA1,Yes,Former,Moderate,36.1,High,Urban,Statutory Health Insurance,9.0,No,No,None,5.0
PT09595,Spain,Catalonia,70.0,Female,Lung,I,2014-03-08,2014-05-27,,Targeted Therapy,Private,Deceased,93.0,EGFR,No,Former,None,34.5,High,Rural,NHS,7.0,No,No,Diabetes,9.0
PT09596,Switzerland,Zurich,61.0,Male,Breast,III,2011-09-18,2011-10-25,2012-02-26,Targeted Therapy,Public,,21.0,KRAS,No,,Moderate,18.7,Medium,Urban,Private Insurance,16.0,No,No,None,8.0
PT09597,Denmark,Zealand,,Female,Lung,,2011-11-17,2012-01-29,2012-10-29,Chemotherapy,Public,Alive,40.0,BRCA1,Yes,Never,Moderate,19.8,Low,Urban,NHS,7.0,No,No,None,3.0
PT09598,Belgium,Wallonia,67.0,Male,Colorectal,I,2014-01-05,2014-03-27,2015-01-12,Radiation,Private,Alive,45.0,EGFR,Yes,Never,Moderate,38.4,Medium,Urban,,7.0,Yes,No,None,2.0
PT09599,Italy,Veneto,23.0,,Lung,II,2016-09-29,2017-01-07,2017-04-10,,Public,Alive,86.0,None,,Never,None,26.0,Low,Urban,Private Insurance,11.0,Yes,No,,9.0
PT09600,Austria,Vienna,79.0,Male,Breast,II,2019-07-04,2019-09-01,2020-04-26,Targeted Therapy,Public,Deceased,116.0,KRAS,No,Never,None,18.5,Medium,Urban,NHS,5.0,No,No,Hypertension,7.0
PT09601,Portugal,Algarve,58.0,Female,Breast,III,2023-11-05,2024-02-08,2024-10-09,Targeted Therapy,Public,Deceased,,None,No,Current,None,26.6,Low,Rural,NHS,16.0,No,No,None,1.0
PT09602,France,Île-de-France,24.0,Female,Breast,II,2021-08-07,2022-01-16,2022-03-21,Surgery,Private,Alive,98.0,EGFR,,Never,None,,Medium,Rural,NHS,15.0,Yes,,Cardiovascular Disease,7.0
PT09603,France,Auvergne-Rhône-Alpes,25.0,Male,Colorectal,I,2012-05-19,2012-06-25,2012-08-04,Chemotherapy,Private,Alive,67.0,KRAS,No,Never,None,37.9,Medium,Urban,Private Insurance,2.0,No,No,None,7.0
PT09604,Poland,,33.0,Male,Breast,IV,2018-06-05,2018-11-14,2019-09-18,Radiation,Public,Deceased,39.0,KRAS,No,Never,Moderate,33.4,High,Urban,Statutory Health Insurance,,No,No,None,4.0
PT09605,France,Île-de-France,89.0,Male,Prostate,I,2020-06-10,2020-11-30,2021-11-07,Immunotherapy,Private,Alive,47.0,,No,Never,Moderate,,Medium,Urban,NHS,4.0,No,No,Obesity,2.0
PT09606,Denmark,Zealand,31.0,Female,Prostate,III,2015-04-16,2015-07-26,2015-11-13,Surgery,Private,Alive,100.0,BRCA1,No,Current,None,39.7,Medium,Urban,Private Insurance,12.0,No,Yes,Obesity,4.0
,Finland,Southwest Finland,81.0,Male,Ovarian,,2012-06-23,2012-10-30,,Radiation,Private,Deceased,86.0,KRAS,Yes,Current,None,21.3,Low,Urban,NHS,11.0,No,No,Cardiovascular Disease,3.0
PT09608,Netherlands,South Holland,,Female,Pancreatic,I,2015-01-25,2015-03-19,2015-09-29,,Research Institute,Deceased,9.0,EGFR,No,Former,Heavy,26.1,High,Urban,NHS,19.0,No,No,Cardiovascular Disease,
PT09609,Sweden,Stockholm,73.0,Male,Ovarian,I,2015-07-16,,2015-12-17,Chemotherapy,Public,Alive,68.0,KRAS,No,Former,None,25.8,High,Rural,NHS,18.0,Yes,No,Hypertension,10.0
PT09610,,Auvergne-Rhône-Alpes,31.0,Female,Breast,IV,2013-05-27,2013-10-17,2014-02-03,Chemotherapy,Public,Lost to Follow-up,,KRAS,Yes,Never,None,28.8,Medium,Rural,NHS,14.0,Yes,No,Hypertension,4.0
PT09611,Belgium,Flanders,27.0,Female,Prostate,II,2017-03-11,,2017-06-28,Radiation,Public,Alive,28.0,BRCA1,No,Never,Moderate,20.5,Low,Urban,,6.0,No,No,None,2.0
PT09612,Spain,Andalusia,35.0,Female,Breast,I,2017-06-04,2017-06-18,2018-01-03,Chemotherapy,Public,Alive,16.0,BRCA1,No,Never,None,,High,,Private Insurance,11.0,Yes,No,None,6.0
PT09613,Netherlands,North Holland,71.0,Male,Colorectal,IV,2013-07-18,2013-11-03,2014-05-07,Immunotherapy,,Alive,,KRAS,No,Never,Moderate,32.0,Medium,Urban,Private Insurance,2.0,No,No,Obesity,4.0
PT09614,Belgium,Wallonia,45.0,Female,Prostate,II,2017-08-17,2017-11-23,2018-04-07,Chemotherapy,Public,Alive,66.0,EGFR,Yes,Never,Moderate,28.0,Low,Rural,Statutory Health Insurance,10.0,No,No,Diabetes,2.0
PT09615,Denmark,Capital Region,27.0,,Colorectal,II,,2021-07-19,,Surgery,Public,Deceased,74.0,EGFR,Yes,Never,Moderate,20.2,Low,Urban,Private Insurance,12.0,Yes,No,Obesity,6.0
,Portugal,Lisbon,64.0,,Prostate,III,2012-05-13,2012-05-14,2013-02-08,Immunotherapy,,Alive,57.0,BRCA1,No,Never,None,34.7,High,Rural,Private Insurance,4.0,No,,None,8.0
PT09617,Spain,Andalusia,38.0,Male,,III,2014-04-06,2014-08-29,2015-08-23,Surgery,Public,Deceased,108.0,None,Yes,Current,None,38.4,Low,Rural,Private Insurance,18.0,No,No,Cardiovascular Disease,2.0
PT09618,,Lombardy,36.0,Non-binary,Leukemia,II,2017-01-04,2017-03-01,2017-11-14,Surgery,,Deceased,66.0,KRAS,No,Never,Moderate,,Low,Urban,NHS,11.0,Yes,No,Hypertension,6.0
PT09619,Denmark,Zealand,84.0,Male,Pancreatic,I,2016-04-21,2016-09-01,2017-03-02,Targeted Therapy,Public,Alive,101.0,EGFR,Yes,Never,None,23.2,,Urban,Private Insurance,2.0,No,No,Diabetes,5.0
PT09620,Norway,Oslo,48.0,Male,Pancreatic,II,2012-01-07,2012-05-31,2013-04-29,Targeted Therapy,Public,Alive,10.0,EGFR,Yes,Former,None,39.0,Medium,Rural,Private Insurance,,No,No,None,3.0
PT09621,Denmark,Capital Region,33.0,Female,Pancreatic,III,2012-02-18,2012-03-07,2012-09-30,Chemotherapy,Public,Deceased,108.0,None,,Never,Moderate,21.1,Medium,Urban,,3.0,Yes,No,None,7.0
PT09622,Sweden,Stockholm,,Female,Ovarian,IV,2019-08-24,2019-11-21,2020-01-08,Immunotherapy,Public,Alive,22.0,EGFR,No,Never,Heavy,28.5,Medium,Rural,Private Insurance,15.0,No,No,Cardiovascular Disease,3.0
PT09623,Austria,Vienna,32.0,Female,,II,2022-11-29,2023-01-23,2024-01-18,Radiation,Public,Alive,92.0,None,No,Former,Heavy,,High,Rural,Statutory Health Insurance,16.0,No,Yes,Hypertension,9.0
PT09624,Denmark,Zealand,82.0,Male,Prostate,III,2021-06-15,,,Targeted Therapy,Private,Alive,39.0,EGFR,Yes,Never,Moderate,19.0,High,Urban,Statutory Health Insurance,10.0,Yes,No,,8.0
PT09625,Portugal,Algarve,52.0,Male,Leukemia,I,2013-11-15,2014-05-11,2015-02-25,Immunotherapy,Private,Alive,99.0,,,Never,None,35.8,High,Urban,Statutory Health Insurance,12.0,No,Yes,Diabetes,9.0
PT09626,Portugal,Porto,48.0,Female,Breast,IV,2023-02-06,2023-07-07,2024-04-23,Targeted Therapy,Public,Alive,96.0,EGFR,No,Never,Moderate,32.7,Low,Urban,Statutory Health Insurance,10.0,No,No,Diabetes,2.0
,Switzerland,Bern,56.0,Male,Lung,II,2022-12-20,2023-04-03,2024-02-27,Immunotherapy,Private,Deceased,102.0,,No,Former,Heavy,34.4,Low,Urban,NHS,12.0,No,Yes,Hypertension,2.0
PT09628,,Vestland,65.0,Female,Leukemia,III,2023-09-27,2023-10-18,2024-07-03,Chemotherapy,,Alive,21.0,KRAS,No,Never,Moderate,22.6,Medium,Rural,NHS,19.0,No,No,Hypertension,5.0
PT09629,,Masovian,43.0,Female,Ovarian,IV,2021-12-17,2022-05-23,2022-09-04,Surgery,Private,Alive,113.0,KRAS,Yes,Former,Moderate,,Low,,Private Insurance,2.0,No,No,None,6.0
PT09630,Denmark,Capital Region,33.0,Male,Leukemia,III,2022-12-16,2023-06-08,2024-01-12,Targeted Therapy,,Deceased,100.0,EGFR,Yes,Never,None,39.9,High,Urban,NHS,16.0,Yes,No,None,10.0
,Germany,Berlin,24.0,Male,Breast,III,2011-06-06,2011-09-14,2012-02-02,Surgery,Public,Lost to Follow-up,,None,No,Former,Moderate,25.9,High,Urban,Statutory Health Insurance,18.0,No,No,None,8.0
PT09632,Germany,Berlin,72.0,Female,Leukemia,III,2017-10-18,2017-10-28,2018-07-18,Surgery,Private,Alive,9.0,KRAS,No,Current,Moderate,18.5,Medium,Urban,NHS,11.0,No,No,Obesity,4.0
PT09633,Netherlands,North Holland,49.0,Male,Leukemia,IV,2021-04-04,2021-06-27,2022-01-18,Radiation,Public,Alive,57.0,BRCA1,No,Never,None,25.8,Medium,,Private Insurance,4.0,Yes,,Obesity,2.0
PT09634,Italy,Veneto,79.0,Male,Leukemia,III,2016-08-12,2016-10-04,2016-12-20,Radiation,Research Institute,Alive,25.0,KRAS,Yes,Former,None,26.4,Low,Urban,Private Insurance,10.0,No,No,None,5.0
PT09635,Belgium,Brussels,47.0,Male,Pancreatic,III,2023-05-22,2023-09-26,2024-04-19,Chemotherapy,Public,Alive,53.0,EGFR,No,Current,Moderate,37.5,Medium,Rural,NHS,3.0,No,No,Cardiovascular Disease,
PT09636,Poland,Masovian,45.0,Male,Pancreatic,III,2022-03-14,2022-07-27,2023-03-29,Immunotherapy,Public,Alive,101.0,KRAS,No,Never,None,24.1,Medium,Rural,NHS,18.0,No,No,Diabetes,1.0
PT09637,Switzerland,Geneva,37.0,Female,Prostate,I,2010-08-19,2010-09-18,2011-06-06,Chemotherapy,Private,Alive,103.0,None,,Never,Heavy,35.5,Medium,Rural,,10.0,Yes,No,Diabetes,2.0
PT09638,Portugal,,55.0,Female,Pancreatic,II,2022-11-21,2023-02-22,2023-05-11,Immunotherapy,,Alive,56.0,None,Yes,Never,None,20.4,Medium,Urban,NHS,9.0,,No,Obesity,9.0
PT09639,Poland,Masovian,27.0,Female,Leukemia,II,2019-06-27,2019-08-21,2019-12-26,Radiation,Public,Alive,50.0,None,Yes,Current,Heavy,29.2,Low,Urban,Private Insurance,9.0,No,No,None,8.0
PT09640,Austria,Vienna,37.0,Male,Lung,II,2017-01-08,2017-03-14,,Chemotherapy,Public,Deceased,85.0,BRCA1,No,Former,,27.0,Medium,Urban,Statutory Health Insurance,18.0,No,Yes,None,
PT09641,Sweden,Västra Götaland,77.0,Female,Ovarian,III,2011-06-03,2011-06-24,2012-05-03,Immunotherapy,Private,Alive,116.0,BRCA1,No,Current,Moderate,25.2,Medium,Urban,,5.0,No,No,Hypertension,6.0
PT09642,Austria,Tyrol,51.0,Non-binary,Pancreatic,I,2011-04-29,2011-05-06,2012-03-12,Radiation,Private,Alive,98.0,EGFR,No,Never,Heavy,35.1,Low,Rural,Private Insurance,16.0,No,No,Cardiovascular Disease,7.0
PT09643,Switzerland,Zurich,68.0,Female,Prostate,I,2015-10-14,2015-11-27,2016-07-24,Immunotherapy,Private,Alive,54.0,KRAS,No,Former,None,31.2,Medium,Urban,Statutory Health Insurance,16.0,No,Yes,Cardiovascular Disease,1.0
PT09644,Italy,Sicily,67.0,Female,Ovarian,II,2016-03-16,2016-05-23,2016-10-26,Chemotherapy,Public,Alive,109.0,None,No,Never,Moderate,38.9,,Rural,Private Insurance,2.0,No,No,,
PT09645,Portugal,Porto,84.0,Male,Prostate,II,2020-07-18,2020-10-29,2021-10-10,Targeted Therapy,Private,Alive,98.0,BRCA1,Yes,Former,Moderate,25.9,Low,Urban,NHS,19.0,Yes,No,Cardiovascular Disease,10.0
PT09646,Germany,Berlin,52.0,Female,Colorectal,II,2021-09-11,2022-02-01,2022-12-23,Targeted Therapy,Public,Deceased,61.0,EGFR,Yes,Current,Moderate,20.7,High,Urban,NHS,9.0,Yes,No,Obesity,1.0
PT09647,Finland,Pirkanmaa,69.0,Male,Leukemia,IV,2020-07-31,2020-11-06,2021-03-17,Chemotherapy,Private,Deceased,8.0,BRCA1,No,Never,Moderate,,Medium,Rural,Private Insurance,19.0,No,No,Cardiovascular Disease,8.0
PT09648,,Tyrol,23.0,Female,Ovarian,III,2023-09-14,,,Surgery,Public,Alive,47.0,None,No,Never,Moderate,33.0,Low,Urban,NHS,2.0,No,No,Hypertension,1.0
PT09649,,Lisbon,55.0,Female,Lung,II,2012-10-30,2013-02-08,2013-10-05,Targeted Therapy,Public,Alive,76.0,None,No,Never,Moderate,32.4,Medium,Urban,NHS,2.0,No,No,None,5.0
PT09650,Belgium,Brussels,47.0,Female,Lung,I,2012-02-05,2012-06-15,2012-12-03,Targeted Therapy,Private,,47.0,None,Yes,Never,None,31.9,Medium,Urban,Statutory Health Insurance,3.0,No,Yes,Diabetes,3.0
PT09651,Finland,Uusimaa,22.0,Female,Colorectal,III,2019-03-15,2019-09-07,2020-07-23,Targeted Therapy,Public,Deceased,109.0,EGFR,Yes,Never,Heavy,33.8,Low,Rural,Private Insurance,15.0,No,No,Obesity,2.0
PT09652,Portugal,Porto,25.0,Female,Lung,III,2023-10-06,2023-11-22,2024-05-16,Surgery,Public,Alive,90.0,None,Yes,Never,Heavy,20.3,Medium,Urban,NHS,11.0,Yes,No,Cardiovascular Disease,2.0
PT09653,Germany,Bavaria,64.0,Male,Ovarian,II,2012-09-14,2013-03-04,,Radiation,Private,Deceased,104.0,BRCA1,Yes,Never,Moderate,24.3,Low,Rural,NHS,1.0,No,No,Cardiovascular Disease,2.0
PT09654,Portugal,Porto,42.0,Male,Prostate,I,2010-01-16,2010-04-26,2011-04-25,Radiation,Public,Alive,106.0,None,No,Never,Moderate,30.6,Medium,Urban,NHS,3.0,Yes,No,Hypertension,2.0
PT09655,Spain,Catalonia,26.0,Female,Breast,I,2014-04-20,,2015-02-10,,Public,Alive,34.0,EGFR,,Never,Moderate,27.6,Medium,Urban,NHS,4.0,,No,Diabetes,9.0
PT09656,France,Île-de-France,,,Prostate,I,,2022-06-26,2023-03-19,Surgery,Public,Alive,100.0,None,Yes,Never,None,29.2,High,Urban,Private Insurance,3.0,Yes,No,Diabetes,
PT09657,Switzerland,Geneva,84.0,Male,,II,2010-03-20,2010-04-25,2010-10-11,Chemotherapy,Private,Deceased,22.0,KRAS,Yes,Never,Moderate,22.7,Medium,Urban,Statutory Health Insurance,4.0,No,No,Diabetes,4.0
PT09658,Spain,Catalonia,25.0,Male,Breast,III,2018-06-16,2018-09-07,2019-01-10,Chemotherapy,Public,Deceased,112.0,KRAS,Yes,Never,None,31.4,Medium,Urban,Private Insurance,12.0,No,No,Hypertension,6.0
PT09659,Spain,Andalusia,43.0,Male,Lung,IV,2014-12-24,2015-04-01,2015-10-29,Chemotherapy,Private,Lost to Follow-up,,EGFR,,Never,Moderate,25.4,Medium,Urban,Private Insurance,7.0,No,No,Diabetes,2.0
PT09660,Poland,,56.0,Non-binary,Leukemia,II,2012-11-10,2013-01-29,2013-10-11,Radiation,Public,Alive,90.0,BRCA1,No,Former,Moderate,35.6,High,Urban,NHS,8.0,No,No,Diabetes,9.0
PT09661,Finland,Pirkanmaa,64.0,Male,Ovarian,III,2014-05-31,2014-11-20,2015-06-30,Immunotherapy,Public,Deceased,33.0,BRCA1,No,Current,Moderate,30.9,Low,Urban,Private Insurance,11.0,No,No,Obesity,3.0
PT09662,Spain,Madrid,70.0,Female,Breast,IV,2011-03-08,2011-04-28,,Targeted Therapy,Public,Alive,65.0,KRAS,Yes,Never,Moderate,39.9,Medium,Urban,NHS,4.0,No,No,Cardiovascular Disease,9.0
PT09663,Ireland,Connacht,64.0,Female,Prostate,III,2017-02-16,2017-05-13,2018-03-21,Chemotherapy,Public,Alive,92.0,KRAS,Yes,Never,None,31.0,Medium,Urban,Private Insurance,19.0,No,Yes,Hypertension,1.0
PT09664,Netherlands,South Holland,82.0,Male,Prostate,III,2015-09-07,2016-02-14,2016-05-29,Targeted Therapy,Public,Alive,100.0,EGFR,Yes,Former,Moderate,19.2,Medium,Rural,NHS,2.0,No,No,Hypertension,1.0
PT09665,,North Holland,48.0,Female,Pancreatic,IV,2011-09-05,2011-09-07,2012-06-07,Surgery,Public,Lost to Follow-up,,None,No,Current,Moderate,22.8,High,Urban,Statutory Health Insurance,,No,No,None,
PT09666,Switzerland,Geneva,,,Prostate,II,2021-11-29,2021-12-16,2022-12-04,Radiation,Public,Alive,97.0,BRCA1,Yes,Never,None,23.5,Medium,Rural,NHS,17.0,No,No,Diabetes,7.0
PT09667,Germany,,29.0,Female,Ovarian,I,2010-09-29,2010-10-22,2011-04-17,Chemotherapy,Public,Deceased,52.0,EGFR,Yes,Never,Moderate,18.6,Medium,Urban,Statutory Health Insurance,19.0,No,No,Cardiovascular Disease,1.0
PT09668,Spain,Andalusia,54.0,Male,Ovarian,IV,2020-02-25,2020-08-15,2021-02-05,Immunotherapy,Research Institute,Alive,16.0,KRAS,Yes,Never,Heavy,38.2,Medium,Urban,Private Insurance,11.0,No,No,Diabetes,1.0
PT09669,Portugal,Porto,74.0,Male,Pancreatic,II,2022-10-02,2022-11-17,2023-04-11,Radiation,Public,Alive,70.0,EGFR,No,Never,Heavy,31.8,Low,Rural,Private Insurance,13.0,,No,None,
PT09670,Germany,North Rhine-Westphalia,44.0,Male,Prostate,III,2022-02-18,2022-07-08,2023-06-04,Surgery,Public,,65.0,EGFR,No,Current,Moderate,35.9,High,Urban,NHS,3.0,Yes,No,,1.0
PT09671,Belgium,Flanders,64.0,Male,Colorectal,III,2012-01-28,2012-03-22,2013-03-20,Targeted Therapy,Public,Deceased,93.0,EGFR,No,Never,Moderate,30.9,Low,Urban,NHS,11.0,No,No,Diabetes,4.0
PT09672,Netherlands,Utrecht,31.0,Female,Lung,II,2021-10-13,2021-10-26,2021-12-04,Radiation,Public,Alive,66.0,BRCA1,Yes,Former,,36.9,High,Urban,NHS,2.0,Yes,Yes,Hypertension,1.0
PT09673,Sweden,Skåne,23.0,,Leukemia,,2021-04-23,2021-07-03,2021-11-30,Targeted Therapy,Public,Deceased,,EGFR,No,Former,Heavy,31.8,Medium,Urban,Statutory Health Insurance,15.0,Yes,No,Hypertension,4.0
PT09674,Poland,Lesser Poland,86.0,Female,Pancreatic,II,2010-04-24,2010-05-09,2010-11-02,Chemotherapy,Private,Alive,48.0,EGFR,No,Never,None,19.8,Low,Urban,Statutory Health Insurance,,Yes,No,None,10.0
PT09675,Switzerland,Zurich,36.0,Male,Colorectal,I,2023-09-26,2023-11-27,2024-08-09,Surgery,Private,Deceased,44.0,None,No,Former,Moderate,18.6,Medium,Urban,Statutory Health Insurance,17.0,No,No,Hypertension,2.0
PT09676,Austria,Vienna,84.0,Female,Lung,,2015-05-17,2015-10-16,,Immunotherapy,Public,Alive,96.0,KRAS,No,,None,27.8,Medium,Rural,NHS,2.0,No,No,Diabetes,5.0
PT09677,Portugal,Lisbon,72.0,Female,Ovarian,II,2018-05-24,2018-08-02,2019-07-15,Radiation,Research Institute,Alive,6.0,,No,Never,Heavy,32.1,Low,Urban,NHS,15.0,No,No,None,1.0
PT09678,Portugal,Algarve,76.0,Female,Pancreatic,I,2020-10-23,2021-01-02,2021-04-20,Targeted Therapy,Public,Alive,14.0,None,Yes,Never,Moderate,36.6,Low,Urban,Private Insurance,14.0,No,Yes,Diabetes,9.0
PT09679,Netherlands,Utrecht,47.0,Male,Breast,II,2012-04-13,2012-08-22,2013-02-07,Surgery,Private,Alive,109.0,None,No,Current,Moderate,37.7,Low,Rural,Statutory Health Insurance,18.0,No,No,,6.0
PT09680,Belgium,Wallonia,35.0,Female,Colorectal,I,2012-07-17,2012-12-21,2013-02-12,Surgery,Public,Alive,90.0,KRAS,No,Current,Moderate,36.1,Medium,Urban,NHS,14.0,,No,Hypertension,3.0
PT09681,Denmark,Capital Region,40.0,Male,Pancreatic,III,2015-09-14,2015-10-05,2016-09-07,Chemotherapy,Public,Deceased,79.0,None,Yes,Former,Moderate,20.3,Medium,Urban,Private Insurance,3.0,No,No,Diabetes,2.0
PT09682,Sweden,Stockholm,61.0,Male,Ovarian,IV,2017-12-25,2018-02-17,2018-11-01,Radiation,Private,Deceased,14.0,KRAS,No,Never,Moderate,34.6,Low,Urban,NHS,4.0,,No,Diabetes,9.0
PT09683,Italy,Sicily,73.0,Female,Colorectal,II,2013-09-05,2014-01-17,2014-12-01,Chemotherapy,Public,Alive,8.0,None,No,Never,Moderate,25.7,,Rural,Statutory Health Insurance,1.0,No,No,Cardiovascular Disease,
PT09684,Belgium,Brussels,51.0,Non-binary,Colorectal,II,2021-10-23,2022-02-21,2023-02-10,Chemotherapy,Public,Lost to Follow-up,,BRCA1,Yes,Former,None,36.9,Medium,Urban,Statutory Health Insurance,14.0,No,No,Hypertension,2.0
PT09685,Italy,Sicily,57.0,Female,Colorectal,IV,2015-09-23,2015-10-04,2016-09-26,Chemotherapy,Private,,34.0,KRAS,No,Current,Moderate,36.2,Medium,Urban,NHS,14.0,Yes,No,Hypertension,
PT09686,Austria,Vienna,89.0,Female,Breast,I,2013-04-12,2013-09-14,2014-01-21,Surgery,Private,Alive,91.0,KRAS,No,Never,Moderate,32.3,,Urban,Statutory Health Insurance,5.0,No,No,Diabetes,6.0
PT09687,Germany,North Rhine-Westphalia,57.0,Female,Prostate,II,2020-07-17,2020-11-19,2021-03-17,Targeted Therapy,Research Institute,Deceased,107.0,KRAS,No,Never,Heavy,38.1,Low,Urban,NHS,14.0,Yes,No,Cardiovascular Disease,3.0
PT09688,Germany,North Rhine-Westphalia,73.0,Non-binary,Ovarian,I,2010-07-17,2010-09-27,2010-11-02,Targeted Therapy,Public,Alive,47.0,None,No,Former,Moderate,29.9,Low,Rural,Statutory Health Insurance,14.0,No,No,Hypertension,4.0
PT09689,Ireland,Munster,79.0,Female,Colorectal,II,2012-05-06,2012-08-23,2013-03-11,Immunotherapy,Public,Alive,110.0,None,,Former,,23.3,Medium,Rural,Private Insurance,17.0,,No,Diabetes,1.0
PT09690,Norway,,66.0,Male,Lung,I,2022-01-15,2022-02-11,2022-11-30,Immunotherapy,Research Institute,Alive,48.0,KRAS,No,Current,Moderate,32.4,Low,Rural,Private Insurance,6.0,No,No,None,5.0
PT09691,Netherlands,South Holland,31.0,Female,Prostate,I,2015-06-02,2015-11-09,2016-10-20,,Public,Lost to Follow-up,,BRCA1,Yes,Never,None,22.2,Medium,Urban,NHS,1.0,No,No,Cardiovascular Disease,5.0
PT09692,Switzerland,Bern,72.0,Male,Breast,I,2018-09-06,2018-12-08,2019-02-07,Chemotherapy,Public,Alive,99.0,BRCA1,No,Never,None,34.8,High,,NHS,14.0,No,Yes,,4.0
PT09693,Netherlands,South Holland,52.0,Male,Leukemia,II,2022-04-28,2022-05-31,2023-01-28,Surgery,Public,Alive,29.0,EGFR,No,Never,Heavy,37.3,Low,Urban,Private Insurance,5.0,No,No,Diabetes,6.0
,Poland,,47.0,Female,Breast,II,2012-09-20,2012-09-25,2012-12-22,Chemotherapy,Private,Alive,8.0,KRAS,No,Former,None,32.6,Medium,Urban,Private Insurance,2.0,No,No,Diabetes,
PT09695,Italy,Veneto,22.0,Male,Leukemia,III,2012-04-25,2012-05-04,2013-05-03,Chemotherapy,,Alive,13.0,EGFR,Yes,Never,Moderate,28.8,Low,Urban,Statutory Health Insurance,16.0,No,No,Diabetes,7.0
PT09696,Belgium,Wallonia,45.0,Male,Lung,,2014-10-14,2015-03-04,2015-05-02,Chemotherapy,Public,Alive,50.0,None,No,Never,Moderate,38.9,Medium,Urban,Private Insurance,6.0,No,No,None,8.0
PT09697,Sweden,Västra Götaland,73.0,Male,,I,2023-08-06,2023-11-08,2024-08-23,Radiation,Public,Deceased,31.0,EGFR,No,Never,Moderate,35.4,Medium,Urban,Private Insurance,15.0,No,No,Hypertension,1.0
PT09698,Spain,Madrid,59.0,Female,Pancreatic,III,2014-04-17,2014-08-13,2014-10-15,,Public,Alive,116.0,KRAS,No,Never,None,28.1,Low,Urban,Private Insurance,11.0,No,No,Obesity,8.0
PT09699,Finland,Uusimaa,85.0,Non-binary,Colorectal,II,2010-12-12,2011-03-11,2011-08-24,Chemotherapy,Public,Alive,104.0,BRCA1,Yes,Former,Moderate,30.1,High,Urban,NHS,10.0,Yes,No,Diabetes,9.0
PT09700,,Tyrol,87.0,Male,Prostate,I,2010-06-05,2010-10-17,2011-09-27,Immunotherapy,Public,Alive,108.0,EGFR,Yes,Never,Moderate,33.8,Medium,Urban,Statutory Health Insurance,17.0,No,No,Diabetes,8.0
PT09701,Spain,Andalusia,66.0,Male,Ovarian,I,2023-10-12,2024-01-23,2024-09-30,Immunotherapy,Private,Alive,56.0,None,No,Never,None,27.7,Medium,Urban,Private Insurance,7.0,No,No,Diabetes,8.0
PT09702,Sweden,Skåne,,Male,Pancreatic,III,2020-06-07,2020-08-20,2021-01-11,Targeted Therapy,Public,Alive,100.0,KRAS,No,Former,None,26.9,Low,Rural,Statutory Health Insurance,12.0,Yes,No,Diabetes,10.0
PT09703,Switzerland,Geneva,61.0,Female,Prostate,III,2010-05-22,2010-11-02,2011-06-02,Surgery,Public,Alive,60.0,EGFR,No,Former,None,37.1,Low,Urban,Statutory Health Insurance,10.0,No,No,Cardiovascular Disease,1.0
PT09704,Spain,,53.0,Female,Colorectal,II,2010-04-14,2010-08-17,,Radiation,Public,Alive,38.0,None,No,Former,Moderate,25.9,Medium,Urban,,12.0,No,No,Hypertension,10.0
PT09705,Italy,Sicily,40.0,Female,Prostate,II,2013-05-23,2013-11-17,2014-01-14,Chemotherapy,Research Institute,Alive,110.0,EGFR,No,Never,Moderate,39.8,Medium,Rural,Statutory Health Insurance,12.0,No,No,Hypertension,7.0
PT09706,France,Île-de-France,63.0,Male,Breast,II,2021-02-01,2021-03-21,2022-02-23,Radiation,Public,Alive,40.0,EGFR,Yes,Former,Moderate,25.5,Medium,Urban,NHS,8.0,No,No,Obesity,9.0
PT09707,Denmark,Central Denmark,21.0,Female,Colorectal,III,2021-07-05,2021-09-26,2022-04-22,Targeted Therapy,Public,Alive,85.0,BRCA1,Yes,Never,None,,Medium,Urban,NHS,6.0,No,No,Diabetes,10.0
PT09708,Ireland,Munster,78.0,Female,Colorectal,IV,2019-09-02,2019-09-13,2020-07-16,Immunotherapy,Public,Deceased,16.0,EGFR,No,Never,Heavy,29.2,High,Urban,Statutory Health Insurance,11.0,No,No,,3.0
PT09709,Portugal,Lisbon,35.0,,Prostate,II,2020-08-11,,2021-11-04,Immunotherapy,Public,Alive,54.0,KRAS,No,Never,Moderate,19.3,Medium,Urban,NHS,4.0,No,Yes,,4.0
PT09710,Finland,Pirkanmaa,39.0,Male,Ovarian,I,2013-06-06,2013-10-14,2014-09-01,Surgery,Private,Alive,84.0,BRCA1,Yes,Never,None,35.6,Medium,Urban,NHS,19.0,Yes,No,Diabetes,8.0
PT09711,Belgium,Wallonia,45.0,Male,Pancreatic,I,2022-12-06,2022-12-13,2023-05-19,Surgery,Private,Alive,30.0,KRAS,No,Current,None,36.3,Medium,Urban,NHS,11.0,,Yes,Diabetes,8.0
PT09712,Ireland,Munster,35.0,Non-binary,Leukemia,I,2010-07-27,2010-11-09,2011-07-29,Targeted Therapy,Public,Deceased,,KRAS,No,Never,Moderate,34.4,Low,Rural,NHS,15.0,No,Yes,Obesity,7.0
PT09713,Denmark,Central Denmark,89.0,Female,Ovarian,III,,2023-05-12,2024-04-12,Surgery,Private,Deceased,78.0,KRAS,Yes,,Moderate,38.3,,,Private Insurance,3.0,Yes,Yes,Obesity,8.0
PT09714,Sweden,Västra Götaland,42.0,Female,,I,2020-02-08,2020-03-10,2020-06-20,Targeted Therapy,Private,Deceased,15.0,,Yes,Former,Moderate,19.4,Medium,Rural,NHS,2.0,No,Yes,Diabetes,3.0
PT09715,Sweden,Skåne,61.0,Female,Lung,II,2014-10-29,2015-02-27,2015-10-28,,Research Institute,Deceased,92.0,,Yes,Former,None,24.8,High,Rural,NHS,2.0,No,No,Cardiovascular Disease,2.0
PT09716,France,Île-de-France,56.0,Female,Ovarian,III,2011-12-19,2012-06-10,2013-02-02,Chemotherapy,Public,Alive,50.0,None,Yes,Former,None,39.7,Low,Rural,Private Insurance,5.0,Yes,No,Cardiovascular Disease,3.0
PT09717,Spain,Andalusia,25.0,Female,Leukemia,,2020-09-13,2020-12-03,2021-11-19,Immunotherapy,Public,Deceased,11.0,EGFR,Yes,Never,None,29.1,Medium,Urban,Statutory Health Insurance,17.0,No,Yes,None,6.0
PT09718,Poland,Masovian,56.0,Male,Breast,III,2013-11-29,2014-02-16,2014-05-18,Chemotherapy,Private,Alive,33.0,KRAS,No,Never,Heavy,23.9,Low,Urban,Statutory Health Insurance,13.0,Yes,Yes,Hypertension,9.0
PT09719,Italy,Veneto,41.0,Male,Colorectal,II,2021-09-16,2022-01-29,2022-11-06,Radiation,Private,Alive,18.0,EGFR,Yes,Current,Moderate,26.0,Medium,Rural,Private Insurance,10.0,No,No,Obesity,2.0
PT09720,France,Île-de-France,25.0,Female,Colorectal,II,2011-10-03,2012-01-05,2012-03-18,Surgery,Private,Deceased,114.0,None,Yes,Former,,38.7,High,Rural,Private Insurance,7.0,No,Yes,None,5.0
PT09721,Spain,Madrid,51.0,Female,Breast,,2014-12-28,2015-05-19,2016-03-22,Immunotherapy,Research Institute,Alive,82.0,EGFR,Yes,Never,None,33.9,Medium,Urban,NHS,16.0,No,No,Hypertension,10.0
PT09722,Italy,Veneto,36.0,,Lung,III,2018-05-07,2018-08-10,2018-09-19,Surgery,Private,Deceased,69.0,None,No,Former,Heavy,20.7,Medium,Urban,Private Insurance,9.0,No,No,Diabetes,9.0
PT09723,Poland,Masovian,57.0,Male,Colorectal,II,2018-11-02,2018-11-11,2019-06-10,Chemotherapy,Public,Deceased,115.0,BRCA1,No,Never,None,23.6,High,Urban,Statutory Health Insurance,1.0,Yes,No,Obesity,1.0
PT09724,,Zealand,36.0,Male,Leukemia,III,2015-04-04,2015-04-13,2015-11-11,Surgery,Public,Deceased,119.0,KRAS,No,Former,None,20.4,Medium,Rural,Private Insurance,5.0,No,No,None,8.0
PT09725,Finland,Pirkanmaa,56.0,Male,Breast,III,2013-11-11,2014-03-04,2014-06-02,,Public,Alive,35.0,None,Yes,Never,Heavy,37.0,Low,Urban,Private Insurance,13.0,No,No,None,6.0
PT09726,,Algarve,42.0,Male,Colorectal,III,2011-04-16,2011-08-16,2012-03-12,Chemotherapy,Public,Alive,10.0,KRAS,Yes,Never,None,26.0,Low,Rural,Statutory Health Insurance,7.0,No,Yes,Diabetes,2.0
PT09727,Poland,Masovian,68.0,Female,Leukemia,III,2021-03-23,2021-07-31,2021-12-30,Surgery,Private,Deceased,76.0,KRAS,Yes,Former,Moderate,39.5,Low,Urban,NHS,17.0,No,No,Obesity,4.0
PT09728,Finland,Southwest Finland,80.0,Female,Breast,II,2016-03-01,2016-06-17,2016-08-07,Chemotherapy,Public,Deceased,60.0,EGFR,No,Former,Moderate,39.6,Medium,Urban,Private Insurance,11.0,No,No,Hypertension,9.0
PT09729,Belgium,Brussels,68.0,Female,Breast,II,2013-11-02,2014-01-27,2014-02-28,Surgery,Public,Alive,95.0,None,No,Never,None,32.5,Low,Rural,NHS,16.0,No,,None,7.0
PT09730,Sweden,,80.0,Female,Breast,III,2022-10-23,2022-11-08,2023-08-03,Surgery,,Alive,92.0,,Yes,Never,Heavy,,Medium,Rural,,,No,No,None,3.0
PT09731,Norway,Trøndelag,51.0,,Lung,I,2022-11-13,2022-11-15,2023-07-06,Chemotherapy,,Alive,57.0,BRCA1,Yes,Never,Heavy,28.9,Medium,Rural,Statutory Health Insurance,6.0,No,Yes,None,6.0
PT09732,Sweden,Stockholm,82.0,Male,Breast,III,2014-02-06,2014-07-07,2015-06-22,Radiation,Public,Alive,33.0,BRCA1,No,Former,None,27.2,Medium,Rural,Private Insurance,5.0,No,No,None,8.0
PT09733,Poland,Masovian,26.0,Male,Ovarian,II,2019-06-25,2019-10-29,2020-07-30,Chemotherapy,Public,Lost to Follow-up,,,Yes,Never,None,26.4,Medium,Urban,NHS,5.0,Yes,No,None,1.0
PT09734,Poland,Masovian,41.0,Male,Pancreatic,,2014-09-17,2015-01-13,2015-08-16,,Private,Alive,,KRAS,No,Never,None,38.4,Medium,Rural,,11.0,No,Yes,Obesity,4.0
PT09735,Belgium,Brussels,25.0,Female,Prostate,II,2011-08-02,2012-01-05,2012-07-23,Immunotherapy,Public,,102.0,EGFR,Yes,Former,Heavy,26.8,Medium,Rural,NHS,9.0,Yes,No,Obesity,1.0
PT09736,Germany,,80.0,Male,Prostate,,2023-09-14,,2024-04-19,,,Alive,82.0,None,No,Former,Moderate,39.2,Medium,Urban,Statutory Health Insurance,1.0,No,No,Obesity,2.0
PT09737,Spain,Catalonia,33.0,Female,Breast,III,2016-10-19,2016-12-01,,Surgery,,,54.0,None,No,Current,Moderate,35.2,Low,Urban,Statutory Health Insurance,17.0,No,No,Hypertension,7.0
PT09738,Norway,Oslo,35.0,Male,Colorectal,III,2015-10-12,2015-12-14,2016-06-21,Chemotherapy,Public,Alive,103.0,EGFR,Yes,,Heavy,23.1,Low,Rural,Statutory Health Insurance,8.0,No,No,Obesity,3.0
PT09739,Poland,Masovian,22.0,Female,Ovarian,I,,2017-06-18,2018-02-26,Surgery,Private,Deceased,82.0,KRAS,Yes,Current,None,25.5,Medium,Urban,Private Insurance,4.0,No,No,None,
PT09740,Italy,Veneto,28.0,,Ovarian,I,2012-01-13,2012-06-06,2012-07-30,Surgery,Public,Deceased,100.0,BRCA1,,,None,21.3,High,Urban,,9.0,No,No,None,4.0
PT09741,Austria,Styria,66.0,Female,Prostate,III,2021-09-10,2022-02-21,2023-01-22,Immunotherapy,Public,Alive,98.0,None,No,Never,Moderate,21.4,Low,Rural,Statutory Health Insurance,,Yes,No,None,10.0
PT09742,Poland,Lesser Poland,61.0,Male,Leukemia,IV,2020-09-09,2020-09-28,,Chemotherapy,Public,Alive,100.0,None,No,Never,Heavy,30.2,Medium,Rural,NHS,17.0,Yes,No,,8.0
PT09743,Sweden,Skåne,61.0,Male,Leukemia,I,2023-10-02,2024-02-12,2024-07-12,Targeted Therapy,Public,Deceased,53.0,BRCA1,No,Never,None,24.1,Low,Urban,NHS,3.0,No,No,None,1.0
PT09744,,Silesian,42.0,Female,Colorectal,II,2015-07-24,2015-08-16,2016-03-18,Immunotherapy,Private,Alive,36.0,,No,Never,None,38.8,Medium,Urban,Private Insurance,6.0,No,Yes,Hypertension,3.0
PT09745,Austria,Tyrol,22.0,Non-binary,Leukemia,I,2018-07-05,2018-10-21,2019-01-24,Surgery,Private,Deceased,29.0,EGFR,Yes,Never,Heavy,26.0,Low,Rural,NHS,5.0,Yes,No,Diabetes,3.0
PT09746,Austria,Styria,20.0,Female,Pancreatic,IV,2021-08-31,2021-09-19,,Surgery,Research Institute,Alive,115.0,,Yes,Current,Moderate,19.0,,Urban,Private Insurance,17.0,No,No,Obesity,
,,South Holland,86.0,Female,Colorectal,I,2023-10-03,2024-02-08,2024-12-02,Targeted Therapy,Private,Alive,99.0,KRAS,Yes,Never,None,20.6,Low,Urban,,12.0,No,No,Diabetes,1.0
PT09748,Norway,,22.0,Female,Leukemia,I,,2016-06-15,2016-07-29,Surgery,,Deceased,76.0,BRCA1,No,Current,Moderate,26.1,Low,Urban,Statutory Health Insurance,17.0,No,No,Diabetes,10.0
PT09749,Belgium,Wallonia,68.0,Female,Breast,I,2018-12-09,2019-05-13,2019-06-17,Radiation,Private,Alive,25.0,BRCA1,No,Never,Moderate,29.6,Low,,NHS,10.0,Yes,No,Hypertension,10.0
PT09750,Poland,Masovian,86.0,Male,Ovarian,,2022-01-16,,,Targeted Therapy,Public,Alive,7.0,BRCA1,No,Never,Moderate,18.6,Medium,Urban,NHS,9.0,No,No,Cardiovascular Disease,7.0
PT09751,Netherlands,North Holland,,Male,Leukemia,IV,2014-10-01,2014-10-26,2015-02-17,Surgery,Research Institute,Alive,87.0,BRCA1,,Current,Moderate,25.6,Medium,Rural,Private Insurance,11.0,No,No,Diabetes,6.0
PT09752,Germany,Berlin,23.0,Male,,II,2023-07-15,2023-07-21,2023-09-30,,Private,Alive,81.0,KRAS,No,Never,Moderate,34.3,Low,Urban,NHS,15.0,No,No,Hypertension,2.0
PT09753,Netherlands,,50.0,Non-binary,Breast,I,2023-10-03,2023-12-23,2024-08-26,Immunotherapy,Public,Deceased,63.0,KRAS,No,Never,Moderate,20.2,High,Urban,Statutory Health Insurance,5.0,No,No,None,5.0
PT09754,,Tyrol,85.0,Female,Leukemia,II,2016-09-21,2016-12-06,2017-06-16,Radiation,Public,Deceased,59.0,KRAS,No,Never,Moderate,20.5,Medium,Urban,NHS,4.0,No,No,Diabetes,4.0
PT09755,Ireland,Dublin,83.0,Female,Leukemia,I,2021-04-02,2021-04-27,2022-01-18,Targeted Therapy,Public,Deceased,90.0,EGFR,Yes,Current,Moderate,24.9,Medium,Rural,Private Insurance,8.0,No,No,Diabetes,4.0
PT09756,Italy,Sicily,50.0,Male,Leukemia,I,2013-12-25,2014-04-23,2014-08-12,Targeted Therapy,Public,Lost to Follow-up,,None,No,Never,,20.2,Medium,,Statutory Health Insurance,14.0,No,No,Hypertension,8.0
PT09757,Germany,North Rhine-Westphalia,82.0,Male,Breast,IV,2015-10-28,2016-02-27,2016-12-14,Surgery,Public,Lost to Follow-up,,BRCA1,No,Former,Moderate,26.4,Medium,Urban,Statutory Health Insurance,2.0,No,No,None,5.0
PT09758,Spain,Madrid,85.0,Non-binary,Leukemia,IV,2020-10-30,2021-04-22,2021-08-07,Surgery,Private,Deceased,44.0,EGFR,No,Former,Moderate,33.8,Low,Rural,Statutory Health Insurance,5.0,No,No,Cardiovascular Disease,9.0
PT09759,Sweden,Skåne,50.0,Male,Leukemia,IV,2010-01-01,2010-04-14,2011-03-08,Chemotherapy,Public,Alive,24.0,KRAS,No,Never,None,39.6,,Rural,NHS,5.0,No,No,Cardiovascular Disease,3.0
PT09760,Netherlands,North Holland,66.0,Female,Ovarian,II,2023-12-02,2024-01-30,2024-07-25,Radiation,Public,Alive,75.0,KRAS,Yes,Never,,19.0,Medium,Rural,Private Insurance,11.0,No,No,Obesity,4.0
PT09761,Poland,Lesser Poland,41.0,Male,Pancreatic,I,2011-10-09,2012-02-05,2012-06-22,Targeted Therapy,Public,Deceased,78.0,EGFR,No,Never,Moderate,30.7,Medium,Urban,NHS,3.0,No,No,None,7.0
PT09762,Netherlands,North Holland,65.0,Male,Lung,III,,2017-02-10,2017-04-28,Surgery,Private,Deceased,9.0,EGFR,No,Never,None,23.0,Medium,Urban,NHS,3.0,No,No,Hypertension,8.0
PT09763,Ireland,Dublin,77.0,Female,,I,2015-02-12,2015-07-14,2016-01-14,Targeted Therapy,Private,Lost to Follow-up,,EGFR,No,Former,Moderate,27.7,Medium,Urban,NHS,19.0,No,No,Cardiovascular Disease,6.0
PT09764,Austria,Styria,80.0,Male,Pancreatic,I,2018-09-22,2018-12-06,2019-03-21,Radiation,Public,Alive,25.0,EGFR,No,Former,None,39.9,Medium,Urban,NHS,11.0,No,No,Cardiovascular Disease,3.0
PT09765,Belgium,Wallonia,65.0,Male,Prostate,I,2017-03-08,,2018-01-12,Immunotherapy,Public,Deceased,8.0,None,Yes,Never,Moderate,39.9,High,Rural,Private Insurance,3.0,No,No,None,9.0
PT09766,Spain,Madrid,20.0,Female,Ovarian,IV,2019-02-28,2019-07-09,2019-12-04,Radiation,Public,Alive,78.0,KRAS,No,Former,Heavy,31.4,Medium,Rural,NHS,,Yes,No,Cardiovascular Disease,
PT09767,Poland,Silesian,44.0,Female,Colorectal,III,2011-12-09,2012-05-25,2013-03-20,Targeted Therapy,Research Institute,Alive,96.0,None,No,Never,Moderate,21.7,Low,Urban,NHS,19.0,No,No,Diabetes,1.0
PT09768,Netherlands,Utrecht,80.0,Female,Ovarian,I,2019-04-19,,2020-08-31,Surgery,Public,Alive,67.0,EGFR,Yes,Current,Moderate,29.0,Medium,Rural,Private Insurance,6.0,No,No,Hypertension,10.0
PT09769,Belgium,Brussels,33.0,Female,Lung,I,2011-08-26,2011-11-21,2011-12-30,Targeted Therapy,Research Institute,Alive,74.0,EGFR,No,Never,None,36.4,Medium,Urban,Statutory Health Insurance,8.0,,No,Obesity,2.0
PT09770,Norway,Vestland,64.0,Male,Pancreatic,III,2017-10-02,2018-02-03,2018-10-13,Chemotherapy,Private,Alive,73.0,EGFR,No,Current,Moderate,30.6,High,Urban,NHS,,Yes,Yes,Hypertension,3.0
PT09771,Poland,Lesser Poland,58.0,Male,Pancreatic,III,2022-04-21,2022-07-07,2023-07-01,Radiation,Public,Alive,24.0,EGFR,No,Never,Moderate,33.8,,Urban,Statutory Health Insurance,15.0,No,No,None,3.0
PT09772,Belgium,Wallonia,85.0,Female,Leukemia,III,2020-01-10,2020-04-12,2020-07-15,Chemotherapy,Private,Deceased,106.0,None,No,Current,Moderate,35.0,Medium,Urban,Statutory Health Insurance,13.0,No,No,,4.0
PT09773,Austria,Styria,51.0,Male,Prostate,,2023-04-07,2023-06-25,2024-01-18,Targeted Therapy,Public,Lost to Follow-up,,EGFR,Yes,Never,Moderate,28.0,Low,Rural,Private Insurance,10.0,No,No,Hypertension,6.0
PT09774,Ireland,Connacht,77.0,Male,,,2019-04-07,2019-04-15,2019-11-07,Targeted Therapy,Research Institute,Alive,21.0,KRAS,No,Former,Moderate,32.7,Medium,Urban,NHS,2.0,No,No,Diabetes,7.0
PT09775,Poland,Silesian,75.0,Female,Leukemia,III,2021-04-02,2021-07-09,2021-09-08,Chemotherapy,Private,Alive,27.0,EGFR,No,Former,Moderate,20.7,Medium,Urban,Private Insurance,7.0,No,No,Obesity,2.0
PT09776,Italy,Lombardy,25.0,Male,Pancreatic,IV,2015-11-27,2016-03-23,2016-06-25,Surgery,Public,Alive,85.0,KRAS,No,Never,None,26.4,Medium,Urban,Statutory Health Insurance,12.0,No,Yes,None,3.0
PT09777,Poland,Silesian,86.0,Female,Ovarian,I,2020-09-14,2020-11-08,2021-01-02,Surgery,,Alive,26.0,,No,Never,None,29.2,Medium,Urban,Private Insurance,19.0,Yes,No,Diabetes,3.0
PT09778,Portugal,Algarve,69.0,Male,Pancreatic,II,2015-09-22,2015-10-29,2016-06-11,Radiation,Public,Deceased,61.0,BRCA1,Yes,Current,Heavy,34.0,Medium,Rural,Statutory Health Insurance,16.0,No,No,Diabetes,6.0
PT09779,Finland,Pirkanmaa,57.0,Male,Leukemia,I,2017-11-12,2018-02-10,2018-10-27,Chemotherapy,Public,Alive,65.0,BRCA1,No,Never,None,28.2,,,,5.0,No,No,None,
PT09780,Ireland,Munster,22.0,Male,Lung,II,2016-08-02,2016-08-16,2016-11-18,Radiation,Private,Deceased,39.0,KRAS,No,Never,Moderate,39.1,Medium,Urban,Private Insurance,10.0,No,No,Diabetes,6.0
PT09781,Spain,Andalusia,24.0,Female,Breast,I,2022-07-07,2022-12-30,2023-09-26,Radiation,Public,,74.0,KRAS,Yes,Never,,24.3,Low,Urban,Statutory Health Insurance,18.0,No,Yes,Obesity,
PT09782,Belgium,Flanders,43.0,Male,Lung,III,2013-01-03,2013-04-02,2014-02-17,Immunotherapy,Public,Alive,85.0,KRAS,Yes,,Moderate,21.9,Medium,Urban,Private Insurance,7.0,No,No,Hypertension,8.0
PT09783,Austria,Vienna,73.0,Female,Breast,I,2015-05-05,2015-07-11,2016-01-08,Radiation,Private,Deceased,71.0,EGFR,No,Never,None,22.4,Low,Rural,Private Insurance,10.0,No,No,Diabetes,1.0
PT09784,Denmark,Capital Region,53.0,Female,Prostate,II,2019-04-02,2019-09-09,2020-08-14,Radiation,Research Institute,Lost to Follow-up,,None,Yes,Current,Moderate,,High,Rural,Statutory Health Insurance,13.0,No,No,,6.0
PT09785,Norway,Trøndelag,58.0,Male,Colorectal,II,2020-06-21,2020-12-02,2021-07-02,Immunotherapy,Research Institute,Alive,18.0,KRAS,No,Former,None,29.7,Medium,Urban,NHS,,No,Yes,Diabetes,5.0
PT09786,Sweden,Stockholm,67.0,Female,Leukemia,IV,2016-12-27,2017-05-09,2017-09-04,Radiation,Private,Alive,101.0,None,Yes,Never,,24.9,Medium,Urban,NHS,4.0,No,No,Diabetes,4.0
PT09787,Germany,Berlin,68.0,Female,Lung,III,2017-11-22,2018-02-09,2018-11-29,Radiation,Public,Alive,83.0,None,Yes,Never,None,37.1,High,Urban,Private Insurance,6.0,Yes,No,Cardiovascular Disease,10.0
PT09788,Norway,Oslo,53.0,Female,,I,2023-09-02,,2024-08-07,Radiation,Private,Alive,26.0,None,No,Never,Moderate,33.4,Medium,Urban,Statutory Health Insurance,18.0,No,No,Cardiovascular Disease,10.0
,Sweden,Skåne,26.0,Male,Lung,I,2015-07-04,2015-07-22,2015-09-16,Chemotherapy,Public,Alive,65.0,BRCA1,Yes,Never,None,23.8,High,,Private Insurance,9.0,Yes,,None,5.0
PT09790,Austria,Styria,37.0,Female,Pancreatic,II,2011-05-09,2011-05-20,2012-02-24,Immunotherapy,Public,Alive,73.0,None,,Never,None,34.8,Medium,Urban,Statutory Health Insurance,12.0,No,No,,7.0
PT09791,Italy,Sicily,89.0,Female,Breast,II,2015-01-26,2015-04-10,2015-11-16,Surgery,Public,Deceased,111.0,KRAS,No,Former,,30.7,,Urban,Statutory Health Insurance,5.0,No,No,Obesity,2.0
PT09792,,Capital Region,53.0,Male,Leukemia,,2023-07-15,2023-11-24,2024-04-29,Radiation,Research Institute,Alive,79.0,KRAS,No,Never,Moderate,,High,Urban,NHS,9.0,No,Yes,Obesity,1.0
PT09793,Italy,Veneto,70.0,Male,Pancreatic,III,2015-11-29,2016-04-03,2017-03-14,Chemotherapy,Public,Deceased,51.0,BRCA1,No,Never,Moderate,38.7,Low,Urban,NHS,6.0,No,Yes,Hypertension,9.0
PT09794,Switzerland,Zurich,87.0,Male,Breast,I,2022-09-11,2023-02-06,2023-07-29,Chemotherapy,Private,Deceased,21.0,EGFR,No,,Heavy,23.4,High,Urban,Private Insurance,14.0,No,No,Diabetes,4.0
PT09795,Norway,Vestland,33.0,Male,Pancreatic,IV,2016-04-13,2016-08-24,2017-07-31,Chemotherapy,Public,Deceased,60.0,KRAS,Yes,Never,Moderate,38.2,High,Urban,Private Insurance,18.0,No,No,None,1.0
PT09796,France,Provence-Alpes-Côte d'Azur,88.0,Male,,I,2023-04-04,,2024-01-26,Immunotherapy,Public,Alive,16.0,BRCA1,Yes,Never,None,33.5,High,Rural,Statutory Health Insurance,2.0,Yes,Yes,Cardiovascular Disease,5.0
PT09797,Denmark,Capital Region,27.0,Male,Breast,I,2019-04-10,2019-08-29,2020-05-13,Immunotherapy,Research Institute,Alive,38.0,EGFR,No,Never,Moderate,22.6,Medium,Urban,NHS,18.0,Yes,No,Diabetes,1.0
PT09798,Italy,Sicily,34.0,Male,Pancreatic,II,2013-11-19,2014-01-31,2014-04-02,Targeted Therapy,Private,Alive,,None,No,Current,None,38.0,High,Urban,Statutory Health Insurance,15.0,Yes,No,None,2.0
PT09799,Netherlands,North Holland,78.0,Female,Prostate,II,2020-06-23,2020-06-26,2020-10-12,Radiation,Private,Deceased,55.0,,No,Never,Moderate,27.7,High,Urban,Private Insurance,15.0,No,,Obesity,8.0
PT09800,Ireland,Connacht,30.0,Female,Leukemia,I,2020-09-27,2020-09-29,2021-08-01,Surgery,,Alive,57.0,None,Yes,Former,Moderate,,Medium,Rural,Private Insurance,10.0,,No,Diabetes,2.0
PT09801,Poland,Silesian,39.0,Female,Colorectal,III,2017-11-29,2018-04-18,2018-07-12,Surgery,Public,Alive,80.0,BRCA1,No,Former,Moderate,23.9,Medium,Urban,Private Insurance,5.0,No,Yes,Diabetes,9.0
PT09802,Germany,Bavaria,,,Lung,II,,2023-05-10,2023-08-01,Targeted Therapy,Public,Alive,97.0,BRCA1,No,Never,Heavy,34.0,Medium,Rural,Statutory Health Insurance,13.0,No,No,Diabetes,9.0
PT09803,Norway,Oslo,55.0,Male,Ovarian,I,2010-08-29,2010-10-24,2010-12-12,Surgery,Public,Alive,67.0,KRAS,No,Current,None,38.7,Low,Urban,Statutory Health Insurance,3.0,Yes,No,Obesity,8.0
PT09804,Germany,North Rhine-Westphalia,33.0,Male,Breast,IV,2023-02-13,2023-04-12,2023-11-29,,Public,Alive,103.0,BRCA1,No,Never,Moderate,23.2,Medium,Rural,Statutory Health Insurance,12.0,No,,None,9.0
PT09805,Finland,Pirkanmaa,77.0,Female,Leukemia,IV,2017-12-12,2018-05-04,2019-01-11,Surgery,Public,Deceased,46.0,None,No,Never,Moderate,38.2,Medium,Urban,Private Insurance,17.0,Yes,No,Obesity,3.0
PT09806,Poland,Lesser Poland,57.0,Male,,III,2016-07-28,2016-07-29,2017-01-03,Radiation,Public,Deceased,16.0,BRCA1,Yes,Former,Moderate,19.4,Low,Urban,NHS,5.0,No,No,Obesity,2.0
PT09807,Switzerland,Bern,20.0,,Leukemia,III,2010-04-04,2010-07-26,2011-07-20,Immunotherapy,Research Institute,Deceased,12.0,None,No,Former,Moderate,20.7,Medium,Urban,Private Insurance,12.0,No,No,Obesity,9.0
PT09808,Netherlands,Utrecht,84.0,Male,Pancreatic,I,2019-04-22,2019-07-02,,Immunotherapy,Research Institute,Alive,84.0,None,No,Never,Moderate,26.0,Medium,Urban,Private Insurance,3.0,No,No,Diabetes,9.0
PT09809,Portugal,Porto,20.0,Male,Lung,I,2014-10-10,,2015-10-04,Radiation,Public,Deceased,89.0,None,Yes,Never,Heavy,,Medium,Urban,Private Insurance,6.0,Yes,No,Cardiovascular Disease,5.0
PT09810,Netherlands,Utrecht,79.0,Male,Leukemia,II,2020-12-24,2021-02-07,2022-01-17,Radiation,Private,Alive,21.0,None,,Former,Heavy,30.6,Low,Rural,Statutory Health Insurance,4.0,No,Yes,Hypertension,6.0
PT09811,Germany,North Rhine-Westphalia,44.0,Male,Colorectal,,2021-05-11,2021-10-02,2022-03-08,Immunotherapy,Public,Alive,34.0,EGFR,No,Never,None,19.0,Low,Urban,Statutory Health Insurance,17.0,No,No,Diabetes,10.0
PT09812,Spain,Catalonia,29.0,Male,Ovarian,II,2022-03-24,2022-07-25,2023-01-11,Radiation,Public,Alive,10.0,None,No,Former,Heavy,18.8,Medium,Urban,Private Insurance,9.0,No,No,Hypertension,1.0
PT09813,Finland,,69.0,,Leukemia,I,2020-11-12,2020-11-29,2021-10-12,Targeted Therapy,Private,Alive,90.0,,No,Never,Moderate,32.5,Low,,Private Insurance,13.0,No,No,Hypertension,9.0
PT09814,Germany,Bavaria,31.0,Male,Ovarian,II,2017-04-11,2017-05-11,2017-08-18,Immunotherapy,Public,Alive,69.0,None,Yes,Never,Moderate,27.8,Medium,Urban,Private Insurance,1.0,No,Yes,None,4.0
PT09815,Denmark,Central Denmark,51.0,Female,Leukemia,I,2014-01-08,2014-02-14,2014-08-23,,Private,Deceased,20.0,EGFR,Yes,Never,Heavy,,High,Urban,Private Insurance,6.0,No,No,Diabetes,1.0
PT09816,Denmark,Central Denmark,52.0,Female,Ovarian,I,2017-05-01,2017-05-19,,Immunotherapy,Public,Alive,11.0,None,No,Never,Moderate,18.7,High,Rural,Private Insurance,9.0,Yes,No,Hypertension,10.0
PT09817,Spain,Andalusia,45.0,Female,Breast,II,2019-03-16,2019-03-27,2019-05-07,Surgery,Private,Alive,54.0,KRAS,Yes,,Moderate,40.0,,Urban,Statutory Health Insurance,13.0,Yes,No,None,6.0
PT09818,France,Provence-Alpes-Côte d'Azur,61.0,Male,,II,2016-08-02,2016-10-01,2017-08-15,Surgery,Private,Alive,92.0,,Yes,Former,Moderate,31.0,Medium,Urban,Private Insurance,6.0,No,No,Hypertension,7.0
PT09819,Italy,Lombardy,69.0,Female,Ovarian,I,2015-10-10,2016-03-12,2016-05-07,Targeted Therapy,Private,Deceased,113.0,None,No,Never,Moderate,38.1,Medium,Urban,NHS,9.0,No,No,Diabetes,3.0
PT09820,Sweden,Stockholm,80.0,Male,Breast,I,2013-06-29,2013-09-17,2013-10-29,Immunotherapy,Public,Alive,56.0,None,Yes,,None,26.0,Low,Urban,NHS,5.0,No,No,Hypertension,
PT09821,Belgium,Flanders,60.0,Male,Breast,II,2023-04-18,2023-05-26,2023-10-25,Immunotherapy,Public,Alive,47.0,BRCA1,Yes,Current,Moderate,30.3,,Rural,NHS,15.0,Yes,Yes,Diabetes,4.0
PT09822,Poland,Silesian,76.0,Female,Pancreatic,III,2023-05-04,2023-09-18,2024-05-07,Targeted Therapy,Public,Alive,114.0,KRAS,No,Never,Heavy,27.4,Medium,Urban,NHS,15.0,,No,Cardiovascular Disease,9.0
PT09823,Switzerland,Geneva,21.0,Male,Ovarian,II,2022-10-06,2022-11-21,2023-08-31,Immunotherapy,Private,Alive,98.0,BRCA1,No,Former,Moderate,20.6,High,Urban,Statutory Health Insurance,,No,Yes,Cardiovascular Disease,2.0
PT09824,,Uusimaa,89.0,Male,Leukemia,III,2012-12-05,2013-05-26,2014-01-13,Surgery,Public,Alive,70.0,BRCA1,No,Former,Moderate,27.6,Medium,Rural,NHS,13.0,Yes,No,Diabetes,10.0
PT09825,Spain,Madrid,50.0,Male,Colorectal,I,2013-02-15,,2013-10-08,Radiation,Public,Alive,10.0,BRCA1,No,Never,None,23.2,Medium,Urban,Statutory Health Insurance,2.0,Yes,No,None,9.0
PT09826,Belgium,Wallonia,42.0,Male,Lung,I,2014-04-16,2014-05-09,2014-12-10,Targeted Therapy,Public,Alive,78.0,BRCA1,Yes,Never,Moderate,23.8,Medium,Urban,Statutory Health Insurance,11.0,Yes,Yes,None,3.0
PT09827,Sweden,Skåne,73.0,,Breast,III,2016-12-01,2017-03-17,2018-03-01,Targeted Therapy,Public,Deceased,84.0,BRCA1,Yes,Never,Heavy,34.6,Low,Urban,NHS,19.0,No,Yes,Hypertension,9.0
,Finland,Uusimaa,,Non-binary,Prostate,II,2012-07-04,2012-08-07,,Radiation,Private,Deceased,118.0,BRCA1,No,Current,None,25.5,Low,Urban,Private Insurance,5.0,No,No,Cardiovascular Disease,3.0
PT09829,Germany,North Rhine-Westphalia,38.0,Male,Leukemia,II,2021-12-22,2022-05-21,2022-12-15,Surgery,Public,Alive,102.0,EGFR,No,Never,Heavy,34.3,High,Rural,Private Insurance,1.0,No,No,Hypertension,5.0
PT09830,Italy,Veneto,67.0,Male,Colorectal,IV,2022-06-03,2022-11-04,2023-04-14,Radiation,Private,Deceased,29.0,,No,Never,Moderate,39.6,High,Urban,Statutory Health Insurance,13.0,Yes,No,Diabetes,2.0
,Portugal,Porto,21.0,Female,Colorectal,II,2020-07-23,2020-09-16,2021-08-11,Immunotherapy,Public,Deceased,42.0,BRCA1,Yes,Former,None,25.2,Medium,Urban,Statutory Health Insurance,11.0,No,No,Hypertension,6.0
PT09832,Finland,Southwest Finland,30.0,Female,Breast,I,2017-12-14,2017-12-29,2018-02-14,Radiation,Public,Alive,58.0,KRAS,No,Current,Moderate,23.2,Medium,Rural,Statutory Health Insurance,1.0,No,,Obesity,6.0
PT09833,Denmark,Zealand,63.0,Female,Pancreatic,IV,2014-12-21,2015-03-10,2015-04-26,Targeted Therapy,Public,Alive,11.0,BRCA1,No,Current,Moderate,34.6,Medium,Rural,NHS,2.0,No,Yes,Hypertension,8.0
,Germany,Berlin,78.0,Female,Breast,I,2018-01-08,2018-01-19,2018-02-23,Chemotherapy,Public,Alive,44.0,None,No,Former,Moderate,30.6,Medium,Urban,Statutory Health Insurance,5.0,No,No,Obesity,1.0
PT09835,Norway,Vestland,78.0,Female,Pancreatic,III,2014-12-07,2015-02-03,2015-09-07,Immunotherapy,Public,Deceased,80.0,None,Yes,Former,Moderate,35.5,High,Urban,NHS,4.0,No,No,None,1.0
PT09836,Norway,Vestland,57.0,Female,Prostate,II,2017-10-22,,2018-07-11,Radiation,Public,Deceased,94.0,KRAS,No,Never,None,21.5,Low,Urban,Private Insurance,19.0,Yes,No,Hypertension,2.0
PT09837,Sweden,Västra Götaland,44.0,Male,Prostate,II,2020-06-14,2020-09-03,2020-11-14,Radiation,Public,Alive,67.0,KRAS,,Never,,32.4,Medium,,Private Insurance,8.0,No,No,Diabetes,2.0
PT09838,Netherlands,North Holland,40.0,Female,Breast,II,2020-05-21,2020-10-29,2021-08-04,Surgery,Private,Deceased,87.0,KRAS,Yes,Never,Moderate,33.9,High,Urban,NHS,15.0,No,No,Cardiovascular Disease,8.0
PT09839,Italy,Veneto,61.0,,Lung,II,2014-07-19,2015-01-07,2015-08-21,Immunotherapy,Public,Alive,91.0,KRAS,No,Never,Moderate,20.9,Medium,Urban,,9.0,,No,Cardiovascular Disease,9.0
PT09840,Poland,Masovian,55.0,Female,Ovarian,III,2014-06-07,2014-09-04,2015-04-24,Surgery,Private,Deceased,65.0,EGFR,No,Former,None,21.4,Medium,Urban,Private Insurance,17.0,Yes,No,None,2.0
PT09841,,Brussels,28.0,Non-binary,Breast,IV,2011-08-17,2011-12-30,2012-10-19,Targeted Therapy,Public,Alive,46.0,None,No,Former,None,38.7,Medium,Rural,,15.0,No,No,Diabetes,7.0
PT09842,Denmark,Central Denmark,31.0,Male,Breast,I,2015-09-02,2015-12-28,2016-10-19,Targeted Therapy,Private,Alive,83.0,EGFR,No,Never,Moderate,22.2,High,Urban,Statutory Health Insurance,12.0,No,No,Obesity,1.0
PT09843,Netherlands,South Holland,29.0,Male,Colorectal,III,2011-10-10,2011-12-01,2012-07-06,Surgery,Private,Deceased,15.0,BRCA1,Yes,Former,Moderate,33.1,High,Urban,Private Insurance,9.0,No,No,,
PT09844,Finland,Pirkanmaa,78.0,Non-binary,Breast,I,2013-08-22,2013-09-04,2014-09-03,Immunotherapy,Public,Lost to Follow-up,,KRAS,Yes,Never,None,30.0,Medium,Urban,Private Insurance,16.0,,Yes,Hypertension,7.0
PT09845,Switzerland,Bern,24.0,Male,Breast,,2013-11-24,2013-12-26,2014-10-24,Surgery,Public,Alive,86.0,EGFR,,Never,Moderate,36.2,Medium,,NHS,11.0,No,No,Cardiovascular Disease,7.0
PT09846,Germany,Bavaria,52.0,Female,Breast,IV,2012-05-30,2012-07-08,2013-01-31,Surgery,Public,Alive,98.0,EGFR,No,Current,Moderate,19.1,High,Urban,Statutory Health Insurance,15.0,No,Yes,Obesity,4.0
PT09847,Netherlands,Utrecht,88.0,Male,Lung,II,2013-05-19,2013-08-05,,Immunotherapy,Private,Alive,75.0,None,No,Never,None,18.3,Medium,Rural,NHS,8.0,No,No,Diabetes,
PT09848,Italy,Veneto,82.0,Female,,I,2014-06-06,2014-08-08,2015-06-03,,Public,Alive,12.0,EGFR,Yes,Current,Moderate,34.5,Medium,Urban,NHS,,No,No,Obesity,
PT09849,Poland,Masovian,48.0,Female,Leukemia,II,2015-11-14,2015-12-04,2016-02-10,Chemotherapy,Public,,10.0,BRCA1,No,Never,Moderate,,Low,Rural,NHS,7.0,,Yes,Hypertension,2.0
PT09850,Portugal,,37.0,Male,Leukemia,I,2013-12-27,,2014-06-10,Surgery,Public,Alive,32.0,BRCA1,No,Former,None,31.9,Medium,Rural,Statutory Health Insurance,4.0,No,No,None,2.0
PT09851,Ireland,Connacht,25.0,Male,Leukemia,,2017-10-01,2018-03-08,2018-05-31,Surgery,Public,Alive,40.0,None,No,Never,Moderate,26.4,Low,Urban,Private Insurance,10.0,,No,Obesity,2.0
PT09852,Poland,Silesian,72.0,,Leukemia,III,2012-12-08,2013-03-23,2013-12-17,Radiation,Public,Alive,60.0,None,Yes,Former,None,27.7,Medium,Rural,Private Insurance,12.0,No,No,Cardiovascular Disease,4.0
PT09853,Ireland,Dublin,51.0,Female,Colorectal,IV,2020-03-21,2020-08-15,2021-06-05,Immunotherapy,Public,Alive,22.0,None,No,Current,Moderate,35.1,Low,Urban,Statutory Health Insurance,2.0,No,No,None,3.0
PT09854,Ireland,Munster,61.0,Female,Breast,I,2012-12-14,2013-03-25,2013-10-31,Radiation,Research Institute,Deceased,12.0,None,No,Never,None,29.3,,Urban,Private Insurance,6.0,No,No,Hypertension,2.0
PT09855,France,Île-de-France,66.0,Male,Leukemia,I,,2023-09-30,2024-08-07,Targeted Therapy,Private,Alive,66.0,EGFR,No,Current,None,33.1,Medium,Urban,Statutory Health Insurance,19.0,No,No,Cardiovascular Disease,6.0
PT09856,Austria,Styria,50.0,Male,Breast,I,2022-08-24,2022-11-04,2023-05-15,Radiation,Public,Alive,70.0,BRCA1,No,Current,Moderate,38.9,Low,Rural,Statutory Health Insurance,8.0,No,No,Diabetes,5.0
PT09857,Norway,,81.0,Female,Ovarian,I,2023-06-16,2023-09-02,2024-06-02,Immunotherapy,Public,Alive,20.0,KRAS,No,Never,Moderate,24.0,Medium,Urban,Private Insurance,6.0,Yes,Yes,Diabetes,9.0
PT09858,Switzerland,Bern,75.0,Female,Ovarian,IV,2015-05-23,2015-10-28,2016-10-07,Surgery,,Alive,107.0,BRCA1,No,Never,Moderate,21.4,Medium,Urban,Statutory Health Insurance,5.0,No,,Diabetes,6.0
PT09859,Portugal,Porto,,Male,Leukemia,IV,2010-03-29,2010-07-13,2011-03-13,Surgery,Public,Alive,63.0,KRAS,No,Former,Moderate,36.7,Medium,Rural,Statutory Health Insurance,5.0,No,,Obesity,4.0
PT09860,Spain,Catalonia,45.0,Male,Lung,III,2022-03-10,2022-08-19,2023-06-30,Chemotherapy,Public,Deceased,54.0,BRCA1,No,,Moderate,33.3,High,Urban,Statutory Health Insurance,8.0,No,No,Hypertension,9.0
PT09861,Switzerland,Bern,46.0,Female,Breast,,2012-12-24,2013-06-09,2013-10-06,Targeted Therapy,Public,Deceased,80.0,None,Yes,Never,None,28.6,Medium,Rural,Private Insurance,14.0,No,No,Diabetes,4.0
PT09862,Sweden,Skåne,76.0,,Colorectal,III,2016-02-17,2016-04-06,2016-10-19,Surgery,Public,Deceased,57.0,KRAS,Yes,Current,Moderate,30.5,Low,Urban,NHS,6.0,No,No,,8.0
,Portugal,Porto,46.0,Female,Pancreatic,I,2011-10-16,2012-01-25,2012-08-21,Radiation,Research Institute,,31.0,BRCA1,Yes,Never,Moderate,38.0,Low,Urban,Private Insurance,15.0,Yes,Yes,,1.0
PT09864,Ireland,Connacht,78.0,Female,Lung,I,2018-07-07,2018-11-04,2019-03-17,Chemotherapy,,Alive,48.0,None,No,Former,None,39.1,Low,Urban,Private Insurance,3.0,No,,Obesity,3.0
PT09865,Ireland,Munster,81.0,Female,Pancreatic,II,2013-10-29,2014-03-11,2014-06-06,Chemotherapy,Public,Alive,58.0,BRCA1,No,Former,None,,Medium,Urban,Private Insurance,10.0,No,No,Cardiovascular Disease,9.0
PT09866,Spain,Andalusia,39.0,Female,Lung,,2023-01-13,2023-04-28,2024-04-12,Targeted Therapy,Private,Alive,118.0,KRAS,No,Former,None,33.9,Medium,Urban,Statutory Health Insurance,17.0,No,,Diabetes,1.0
PT09867,Spain,Madrid,,Female,Colorectal,II,2016-08-24,2016-10-06,,Chemotherapy,Research Institute,Deceased,112.0,,No,Never,Moderate,39.4,Low,Rural,Statutory Health Insurance,11.0,No,No,Cardiovascular Disease,9.0
PT09868,Netherlands,Utrecht,35.0,Male,Lung,II,2015-09-16,2015-11-02,2016-04-05,,Public,Alive,61.0,None,Yes,Never,Moderate,22.1,Medium,Urban,Statutory Health Insurance,4.0,No,No,Hypertension,4.0
PT09869,Belgium,Wallonia,63.0,Male,Ovarian,I,2012-01-09,2012-06-02,2012-12-05,Radiation,Private,Alive,83.0,KRAS,No,Former,Heavy,21.9,Medium,Urban,Statutory Health Insurance,3.0,Yes,No,Obesity,9.0
PT09870,Ireland,Munster,49.0,Male,Breast,III,2018-03-19,2018-04-07,2019-01-16,,,,82.0,None,No,Former,Moderate,20.8,Medium,Urban,NHS,12.0,No,No,Cardiovascular Disease,6.0
PT09871,Finland,Uusimaa,59.0,Female,Prostate,IV,2020-10-25,2021-04-17,2021-06-13,Surgery,Private,Alive,73.0,EGFR,No,Current,None,27.3,High,Rural,Statutory Health Insurance,14.0,No,No,Diabetes,3.0
,Sweden,,84.0,Female,Prostate,II,2018-10-12,2019-02-06,2019-10-04,Radiation,Private,Alive,117.0,BRCA1,Yes,Current,Heavy,35.2,High,Urban,Statutory Health Insurance,15.0,No,No,Diabetes,8.0
PT09873,Denmark,Capital Region,48.0,Male,Leukemia,III,2021-03-30,2021-05-25,2022-03-16,Targeted Therapy,Research Institute,Deceased,106.0,BRCA1,No,Never,Moderate,29.9,Medium,Urban,Statutory Health Insurance,11.0,No,Yes,None,6.0
PT09874,Spain,Madrid,49.0,Female,Ovarian,II,2022-02-16,2022-07-20,2023-05-12,Chemotherapy,Public,Alive,,None,No,,Moderate,26.5,Low,Rural,Private Insurance,8.0,No,No,Obesity,8.0
PT09875,Sweden,Västra Götaland,51.0,Male,Leukemia,,2016-10-02,2017-02-21,2017-12-01,,Public,Deceased,19.0,EGFR,Yes,Current,Moderate,30.6,High,Rural,Statutory Health Insurance,12.0,No,No,Obesity,4.0
PT09876,Denmark,Capital Region,29.0,Male,Breast,II,2012-05-30,2012-08-30,2013-04-04,Surgery,Public,,82.0,BRCA1,No,Never,Heavy,25.7,Medium,Urban,Private Insurance,9.0,No,No,Hypertension,7.0
PT09877,Spain,Andalusia,70.0,Male,Colorectal,II,2016-06-13,2016-10-23,2016-12-21,Chemotherapy,,Alive,22.0,KRAS,No,Former,Moderate,29.2,Medium,,,2.0,Yes,No,None,
PT09878,,Veneto,27.0,Female,Breast,II,2022-10-21,2023-03-01,2024-01-29,Targeted Therapy,Public,Alive,116.0,None,No,Never,Moderate,,Low,Urban,,8.0,No,No,Cardiovascular Disease,5.0
PT09879,Denmark,Capital Region,70.0,Female,Leukemia,I,2021-09-05,2021-11-23,,Targeted Therapy,Private,Alive,44.0,KRAS,Yes,Former,Moderate,38.2,,Urban,NHS,17.0,No,No,Hypertension,3.0
PT09880,Switzerland,Geneva,55.0,Female,,IV,2018-10-26,2019-03-25,2020-02-01,Targeted Therapy,Private,Alive,53.0,EGFR,No,Former,None,29.7,High,Urban,Statutory Health Insurance,4.0,Yes,No,None,1.0
PT09881,Austria,Tyrol,74.0,Female,Pancreatic,IV,2014-03-17,2014-07-07,2015-05-08,Chemotherapy,Public,Alive,11.0,None,Yes,Never,Moderate,32.5,Low,Urban,Private Insurance,18.0,Yes,No,Cardiovascular Disease,2.0
PT09882,Poland,Lesser Poland,54.0,Male,Ovarian,II,2020-11-22,2021-01-11,2021-08-15,Chemotherapy,Research Institute,Alive,27.0,BRCA1,No,Never,None,24.5,Low,Urban,Statutory Health Insurance,19.0,No,No,None,4.0
PT09883,,Bavaria,55.0,Female,Breast,,2022-08-23,,2023-02-11,Chemotherapy,Public,Deceased,92.0,None,Yes,Current,Moderate,26.0,Low,Urban,Private Insurance,17.0,No,No,Cardiovascular Disease,8.0
PT09884,Netherlands,South Holland,75.0,Male,Breast,III,2023-10-16,2024-01-22,2024-03-21,Surgery,Public,Alive,42.0,BRCA1,Yes,Former,Heavy,39.5,Medium,Rural,NHS,13.0,No,No,Diabetes,4.0
PT09885,Denmark,Capital Region,55.0,Male,Colorectal,,2011-03-16,2011-04-01,2011-10-08,Targeted Therapy,Private,Deceased,105.0,EGFR,No,Current,None,31.4,Medium,Urban,Statutory Health Insurance,10.0,No,No,Obesity,9.0
PT09886,Italy,Sicily,80.0,Male,Leukemia,I,2015-08-09,2015-09-15,2016-02-29,,Public,Alive,110.0,KRAS,No,Current,None,24.6,High,Urban,Private Insurance,12.0,No,Yes,Hypertension,3.0
PT09887,France,Provence-Alpes-Côte d'Azur,81.0,Male,,I,2016-01-04,2016-04-13,2017-04-09,Radiation,Public,Deceased,48.0,,No,Never,Moderate,19.6,Medium,Urban,NHS,11.0,No,No,Obesity,3.0
PT09888,France,Provence-Alpes-Côte d'Azur,44.0,,Lung,IV,2012-06-04,2012-06-26,2012-09-29,Chemotherapy,Research Institute,Alive,50.0,KRAS,Yes,,Moderate,31.4,Medium,Urban,Statutory Health Insurance,5.0,No,No,Obesity,3.0
PT09889,Portugal,Porto,83.0,Male,,III,2010-10-25,2011-02-24,2011-11-02,Targeted Therapy,Public,Alive,104.0,BRCA1,,,Moderate,19.8,Medium,Rural,Private Insurance,15.0,Yes,No,Cardiovascular Disease,4.0
PT09890,,Geneva,79.0,Female,Lung,III,2017-10-27,2017-11-28,2018-07-03,Targeted Therapy,,Deceased,101.0,None,No,Never,None,21.6,Medium,Rural,NHS,4.0,No,Yes,Cardiovascular Disease,6.0
PT09891,Sweden,Stockholm,76.0,Male,Prostate,II,2012-06-12,2012-12-01,2013-02-05,Chemotherapy,Research Institute,Deceased,70.0,KRAS,No,,Moderate,22.8,Medium,Urban,Private Insurance,11.0,No,No,Cardiovascular Disease,5.0
PT09892,,Vestland,89.0,Female,Leukemia,III,2011-10-22,,2012-09-02,Surgery,Private,Deceased,9.0,None,Yes,Never,Heavy,32.1,Medium,Rural,NHS,16.0,No,No,Cardiovascular Disease,7.0
PT09893,Italy,Veneto,71.0,Male,Lung,II,2010-05-04,2010-07-16,2010-10-10,Radiation,Public,Deceased,116.0,BRCA1,No,Never,Moderate,26.9,Medium,Rural,NHS,4.0,Yes,No,,10.0
PT09894,Belgium,Wallonia,75.0,,Colorectal,II,2019-07-15,2019-08-17,2019-11-21,Radiation,Public,Alive,,KRAS,Yes,Former,Moderate,34.1,Low,Urban,Statutory Health Insurance,15.0,Yes,No,Hypertension,7.0
PT09895,Netherlands,North Holland,82.0,Male,Pancreatic,III,2020-07-18,2020-11-15,2021-01-11,Immunotherapy,Public,Deceased,102.0,KRAS,Yes,Never,Moderate,22.9,High,Urban,NHS,5.0,No,No,Hypertension,5.0
PT09896,Austria,Styria,87.0,Male,Leukemia,IV,2010-09-05,2010-12-11,2011-05-31,Chemotherapy,Public,Alive,112.0,BRCA1,Yes,Current,Moderate,37.5,Medium,Urban,NHS,7.0,No,No,None,8.0
PT09897,Germany,Berlin,39.0,Male,Lung,IV,2014-01-25,2014-06-04,2014-11-19,Radiation,Research Institute,Alive,62.0,BRCA1,Yes,Never,Moderate,22.7,,Urban,Statutory Health Insurance,9.0,No,No,Hypertension,5.0
PT09898,Poland,Lesser Poland,73.0,Female,Breast,III,2013-11-06,2013-11-20,2014-08-08,,Private,Alive,39.0,None,No,Current,Heavy,18.7,Medium,Urban,,5.0,No,No,Obesity,10.0
PT09899,Germany,Bavaria,20.0,Female,Leukemia,III,2013-02-03,2013-05-15,2013-09-28,Surgery,,Alive,35.0,KRAS,No,Former,Moderate,27.9,Medium,Urban,NHS,9.0,No,Yes,Obesity,8.0
PT09900,Denmark,Zealand,29.0,Male,Lung,III,2018-01-08,2018-03-10,2018-08-23,Chemotherapy,Research Institute,Alive,44.0,,Yes,,None,20.7,Medium,Urban,Statutory Health Insurance,6.0,No,No,Diabetes,2.0
PT09901,Denmark,Capital Region,42.0,Male,Ovarian,IV,2023-01-26,2023-04-01,2023-10-11,Chemotherapy,,Deceased,84.0,KRAS,No,Never,Moderate,27.4,High,Urban,Statutory Health Insurance,19.0,No,No,Hypertension,1.0
PT09902,Netherlands,North Holland,70.0,Female,Breast,II,2014-01-13,2014-04-09,2014-10-02,Radiation,Private,Alive,101.0,BRCA1,Yes,Former,Moderate,39.3,Medium,Rural,Private Insurance,,No,Yes,Obesity,3.0
PT09903,Poland,Silesian,43.0,Male,Prostate,I,2016-12-02,2017-01-01,2017-10-30,Radiation,Public,Alive,95.0,None,,Never,Heavy,35.6,Low,Rural,Private Insurance,8.0,,No,Hypertension,10.0
PT09904,Denmark,,32.0,Male,,III,2011-04-14,2011-05-11,2012-04-08,Targeted Therapy,Public,Deceased,44.0,EGFR,No,Former,None,28.1,Medium,Rural,NHS,4.0,No,No,None,9.0
PT09905,Ireland,Munster,48.0,Female,Leukemia,IV,2017-09-27,2017-11-30,2018-06-26,Immunotherapy,Public,Alive,77.0,BRCA1,No,Current,Moderate,34.0,Medium,Urban,Statutory Health Insurance,11.0,Yes,Yes,Hypertension,5.0
PT09906,Netherlands,North Holland,77.0,Female,Leukemia,II,,2023-11-03,2024-02-27,Radiation,Private,Deceased,95.0,KRAS,Yes,Never,None,27.4,High,Urban,NHS,15.0,No,No,Diabetes,9.0
PT09907,Poland,Lesser Poland,62.0,Female,Lung,III,2015-04-03,2015-05-26,2015-09-08,Chemotherapy,,Alive,22.0,None,Yes,Never,None,18.0,Low,Rural,NHS,8.0,No,No,Obesity,5.0
PT09908,Belgium,Flanders,29.0,Female,Prostate,I,2010-12-05,,2011-06-10,Targeted Therapy,Private,Alive,,KRAS,Yes,Never,None,35.6,Low,Urban,Statutory Health Insurance,18.0,No,No,None,8.0
,Norway,Trøndelag,50.0,Male,Colorectal,IV,2020-02-15,2020-07-02,2020-09-27,,Research Institute,Deceased,104.0,KRAS,No,Current,Moderate,34.8,Low,Urban,Statutory Health Insurance,19.0,No,,None,7.0
PT09910,Poland,Silesian,33.0,Male,Lung,III,2020-06-30,2020-12-02,2021-08-11,Chemotherapy,,Alive,17.0,EGFR,No,,Moderate,38.2,Low,Urban,Private Insurance,18.0,No,No,Cardiovascular Disease,
PT09911,Sweden,Stockholm,53.0,Male,Lung,II,2022-03-09,2022-08-21,,Targeted Therapy,Private,Alive,11.0,KRAS,No,Former,Moderate,20.5,,Urban,NHS,8.0,No,No,Diabetes,2.0
,Italy,Sicily,36.0,Female,Colorectal,III,2015-08-15,2015-12-23,2016-03-23,Chemotherapy,Public,Alive,34.0,BRCA1,Yes,Never,,35.9,Low,Urban,NHS,3.0,No,Yes,Diabetes,3.0
PT09913,Switzerland,Zurich,40.0,Female,Colorectal,III,2010-09-03,2010-12-06,2011-05-27,Chemotherapy,Public,,19.0,BRCA1,No,Former,Moderate,35.8,Low,Urban,Statutory Health Insurance,18.0,No,No,,
PT09914,Germany,Berlin,86.0,Male,Colorectal,IV,,2013-01-01,2013-04-07,Chemotherapy,Private,Alive,6.0,KRAS,No,Former,Heavy,26.0,Low,Urban,Private Insurance,5.0,No,,Obesity,2.0
PT09915,Denmark,Central Denmark,77.0,Male,Pancreatic,IV,2011-10-09,2011-11-21,2012-04-24,,Public,Alive,96.0,BRCA1,Yes,Current,Heavy,26.9,Medium,Rural,Private Insurance,12.0,No,No,None,4.0
PT09916,Spain,Catalonia,27.0,Male,Colorectal,,2011-03-20,2011-08-14,2012-07-17,Radiation,Research Institute,Alive,44.0,KRAS,No,Never,Moderate,27.2,Low,Rural,Statutory Health Insurance,5.0,No,No,Obesity,8.0
PT09917,Switzerland,Geneva,57.0,Male,Ovarian,I,2010-10-14,2011-02-06,,Immunotherapy,Public,Deceased,11.0,EGFR,Yes,Never,None,25.8,High,Urban,Private Insurance,14.0,,No,Hypertension,9.0
PT09918,,Vestland,45.0,Male,Colorectal,III,2021-10-17,2022-01-24,2022-09-13,Surgery,Public,Alive,102.0,KRAS,Yes,Never,None,30.8,Low,Rural,Statutory Health Insurance,1.0,No,,Obesity,1.0
PT09919,Italy,Sicily,83.0,Female,,IV,2019-11-18,,,Surgery,Research Institute,,116.0,None,Yes,Former,Moderate,29.3,Medium,Urban,Statutory Health Insurance,3.0,No,No,None,
PT09920,Belgium,Brussels,49.0,Non-binary,Breast,,2012-04-28,2012-06-19,2012-11-05,Radiation,Public,Alive,117.0,,Yes,,Moderate,30.7,Low,,Statutory Health Insurance,12.0,No,Yes,Hypertension,10.0
PT09921,Norway,Vestland,28.0,Male,Colorectal,I,2014-02-17,2014-06-23,2014-12-17,Chemotherapy,Private,Alive,49.0,None,No,Never,None,31.2,Low,Urban,Statutory Health Insurance,4.0,No,Yes,Diabetes,5.0
PT09922,France,Île-de-France,51.0,Male,Pancreatic,II,2010-12-01,2011-04-02,2011-09-05,Chemotherapy,Public,Deceased,,KRAS,No,Never,Moderate,33.3,Medium,Urban,Statutory Health Insurance,6.0,,No,Cardiovascular Disease,4.0
PT09923,Poland,Lesser Poland,30.0,Male,Pancreatic,II,2012-06-05,2012-07-07,2012-12-04,Targeted Therapy,Public,,,None,No,Never,Moderate,,Medium,Urban,NHS,15.0,No,,Hypertension,
PT09924,Portugal,Algarve,53.0,Male,Prostate,III,2021-01-24,2021-04-14,2021-06-13,,Public,,100.0,EGFR,No,Never,Moderate,22.2,High,Urban,NHS,17.0,No,No,None,2.0
PT09925,Belgium,Flanders,37.0,Male,Pancreatic,I,2021-09-07,,2022-08-04,,Public,Alive,118.0,None,Yes,Never,Moderate,29.6,Low,Rural,NHS,6.0,No,No,Obesity,4.0
PT09926,Germany,Bavaria,38.0,Female,Ovarian,I,2012-05-24,2012-06-29,2012-09-07,Surgery,Private,Alive,106.0,EGFR,Yes,Never,Moderate,27.5,,Rural,Statutory Health Insurance,19.0,No,No,Cardiovascular Disease,1.0
PT09927,France,Île-de-France,73.0,Male,Ovarian,IV,2017-01-10,2017-07-04,2018-02-22,Surgery,Public,Lost to Follow-up,,None,Yes,Never,Moderate,33.7,Low,,Statutory Health Insurance,2.0,No,No,Obesity,9.0
PT09928,Austria,Tyrol,,Non-binary,Prostate,I,2020-02-04,2020-05-02,2020-07-19,Targeted Therapy,,Lost to Follow-up,,,Yes,Never,None,30.5,Medium,,NHS,,No,No,None,3.0
PT09929,Austria,Styria,31.0,,Colorectal,III,2013-08-23,,2014-06-09,Targeted Therapy,Private,Alive,37.0,None,Yes,Never,None,33.2,Medium,Urban,Statutory Health Insurance,9.0,No,No,Diabetes,4.0
PT09930,Denmark,Zealand,23.0,Female,Pancreatic,II,2016-01-10,2016-05-01,2017-01-13,Targeted Therapy,Private,Alive,102.0,,No,Never,Moderate,,Low,Rural,Private Insurance,13.0,No,No,Hypertension,7.0
PT09931,Netherlands,,62.0,Male,Breast,,2022-07-19,2022-09-09,2023-08-15,Surgery,Private,Alive,89.0,EGFR,Yes,Former,None,39.8,,Urban,NHS,12.0,No,Yes,Cardiovascular Disease,2.0
PT09932,Finland,Southwest Finland,46.0,Female,Prostate,I,2014-11-09,2015-01-01,2015-03-03,Radiation,Public,Alive,10.0,None,No,Former,Heavy,,Medium,Urban,Statutory Health Insurance,19.0,Yes,No,None,1.0
PT09933,Norway,,70.0,Male,Breast,I,2015-07-21,2015-09-27,2016-04-22,Chemotherapy,Private,Deceased,52.0,BRCA1,No,Current,Moderate,26.7,Medium,Urban,Statutory Health Insurance,14.0,Yes,No,None,
PT09934,Austria,Tyrol,24.0,Male,Ovarian,II,2020-04-11,2020-08-22,2021-04-05,Radiation,Public,Alive,22.0,BRCA1,Yes,Never,None,33.8,Low,Rural,NHS,15.0,Yes,No,Diabetes,5.0
PT09935,Poland,Silesian,25.0,Male,Lung,IV,2022-05-04,2022-07-26,2023-04-16,Surgery,Public,Alive,38.0,BRCA1,Yes,,Heavy,18.6,Medium,Urban,Statutory Health Insurance,14.0,No,No,Diabetes,1.0
PT09936,Poland,,75.0,Female,Ovarian,II,2013-12-15,2014-06-09,2015-04-28,Surgery,Private,Alive,47.0,None,No,,Moderate,36.2,Low,Urban,NHS,,No,No,Hypertension,2.0
PT09937,Germany,Berlin,,Male,Ovarian,I,2022-08-01,2022-11-24,2023-03-10,,Private,Deceased,28.0,EGFR,,Former,None,30.7,Medium,Urban,NHS,7.0,No,No,Diabetes,7.0
PT09938,Sweden,Stockholm,63.0,Male,Breast,III,2011-07-22,2011-12-21,2012-10-20,Radiation,Private,Alive,,BRCA1,No,Current,None,37.4,Medium,Rural,Private Insurance,12.0,No,No,Obesity,7.0
PT09939,Norway,Trøndelag,34.0,Male,Colorectal,I,2014-08-25,2014-12-27,2015-10-14,Surgery,Research Institute,Alive,55.0,BRCA1,No,Former,Moderate,29.9,Medium,Urban,Private Insurance,2.0,No,Yes,Diabetes,6.0
PT09940,Ireland,Connacht,61.0,Male,Pancreatic,,2023-01-17,2023-05-23,2023-10-21,Immunotherapy,Private,Alive,34.0,,Yes,Former,Moderate,18.6,Medium,Urban,NHS,10.0,,No,Diabetes,2.0
PT09941,Norway,Trøndelag,30.0,Male,Ovarian,I,2018-08-10,2018-11-30,2019-05-02,Radiation,Public,Alive,69.0,BRCA1,Yes,Never,None,28.9,Medium,Urban,Statutory Health Insurance,7.0,Yes,No,Hypertension,2.0
,,Andalusia,30.0,Male,Pancreatic,,2013-01-05,2013-01-06,2013-03-21,Radiation,Public,Alive,107.0,None,Yes,Never,Moderate,37.7,Low,,Statutory Health Insurance,8.0,No,,None,9.0
PT09943,Norway,Oslo,85.0,,Leukemia,I,2010-02-15,2010-05-25,2010-07-09,Surgery,Public,Deceased,9.0,BRCA1,Yes,Never,Moderate,23.7,Low,Rural,NHS,18.0,No,No,Obesity,9.0
PT09944,Poland,Silesian,,Male,Colorectal,II,2017-10-23,2017-10-25,,Chemotherapy,Public,Alive,107.0,KRAS,Yes,Current,None,25.0,Low,Urban,,,No,No,Hypertension,1.0
PT09945,Spain,Catalonia,77.0,Female,Lung,II,2017-09-07,2018-01-23,2018-07-31,Surgery,Public,,12.0,,No,Former,None,18.7,Low,Rural,Statutory Health Insurance,6.0,No,No,Diabetes,8.0
PT09946,Portugal,Porto,40.0,Female,,II,2014-03-19,2014-05-17,2015-03-27,Radiation,Research Institute,Deceased,84.0,None,No,Never,None,36.7,Low,Rural,NHS,16.0,No,Yes,None,2.0
PT09947,Denmark,Central Denmark,40.0,Male,Breast,I,2017-08-15,2017-08-21,2017-11-10,Immunotherapy,Private,Alive,67.0,None,No,Former,Moderate,37.1,High,Urban,Private Insurance,5.0,Yes,No,Diabetes,7.0
PT09948,Italy,Veneto,20.0,Female,Prostate,IV,2012-01-31,2012-05-14,2012-09-01,Radiation,Public,Alive,64.0,KRAS,Yes,Never,Moderate,21.6,Low,Urban,NHS,6.0,No,Yes,Diabetes,
PT09949,Belgium,Brussels,77.0,Female,Ovarian,III,2014-02-21,2014-05-15,2015-05-04,Surgery,Public,Alive,26.0,EGFR,No,Former,None,22.7,Low,Rural,Private Insurance,7.0,No,No,None,3.0
PT09950,Germany,Bavaria,32.0,Female,Colorectal,III,2011-10-23,,2013-02-24,Targeted Therapy,Public,Alive,21.0,None,Yes,Never,Moderate,,Medium,Urban,Private Insurance,11.0,No,No,Diabetes,4.0
PT09951,Netherlands,South Holland,25.0,Female,Pancreatic,II,2011-11-29,2012-05-11,2012-08-16,Chemotherapy,Public,Deceased,75.0,None,No,Never,Moderate,22.7,High,Urban,Private Insurance,1.0,No,No,Obesity,5.0
PT09952,Austria,Vienna,77.0,Female,Prostate,III,2012-10-27,2012-12-14,2013-02-25,Radiation,Private,Alive,18.0,KRAS,No,Never,Moderate,22.7,High,Rural,Private Insurance,3.0,No,No,Cardiovascular Disease,1.0
PT09953,Ireland,Munster,36.0,Male,Breast,I,2012-04-04,2012-09-08,2013-07-15,Immunotherapy,Public,Alive,13.0,BRCA1,Yes,Never,Moderate,26.8,Medium,Urban,Statutory Health Insurance,1.0,No,Yes,None,7.0
PT09954,Spain,Catalonia,31.0,Female,Pancreatic,IV,2016-05-28,2016-09-25,,Immunotherapy,Private,Alive,102.0,BRCA1,No,Former,None,30.4,Medium,Rural,Statutory Health Insurance,15.0,No,Yes,Cardiovascular Disease,2.0
PT09955,,Uusimaa,71.0,Male,Lung,I,2012-09-05,2013-02-21,2013-09-08,Immunotherapy,Public,Alive,66.0,None,Yes,Former,Moderate,18.6,Medium,Rural,Statutory Health Insurance,6.0,No,Yes,,2.0
PT09956,Belgium,Flanders,89.0,Female,Ovarian,III,2013-07-27,2013-10-23,2014-02-04,Chemotherapy,Public,Alive,8.0,KRAS,Yes,,Moderate,37.3,High,Urban,Statutory Health Insurance,19.0,No,No,Obesity,9.0
PT09957,Netherlands,Utrecht,71.0,Male,Ovarian,III,2017-01-27,2017-06-04,2017-07-11,Radiation,Public,Deceased,116.0,KRAS,No,,None,33.9,Low,Rural,Statutory Health Insurance,2.0,No,No,Cardiovascular Disease,7.0
PT09958,Finland,Pirkanmaa,56.0,Female,Colorectal,III,2022-01-25,2022-04-08,2022-10-26,Targeted Therapy,Research Institute,Alive,51.0,None,No,Former,None,19.9,Low,Urban,Private Insurance,4.0,No,No,Cardiovascular Disease,
PT09959,Finland,Southwest Finland,22.0,,Prostate,IV,2020-05-24,2020-06-25,2020-11-26,Surgery,Public,Alive,67.0,BRCA1,Yes,Current,Heavy,30.7,Low,Rural,Private Insurance,16.0,No,No,Cardiovascular Disease,9.0
PT09960,France,Auvergne-Rhône-Alpes,27.0,Female,,I,2014-09-21,2015-01-03,2015-09-03,Radiation,Public,Alive,28.0,None,No,Former,Moderate,20.9,Low,Rural,Private Insurance,19.0,No,No,Obesity,
PT09961,Portugal,Lisbon,29.0,Female,Ovarian,III,2016-12-13,,2017-10-26,Radiation,Public,Alive,13.0,BRCA1,Yes,Former,None,33.1,Low,Urban,NHS,11.0,No,No,None,10.0
PT09962,,Madrid,66.0,,Colorectal,II,2023-11-10,2024-02-03,2024-07-20,Targeted Therapy,Public,Alive,25.0,KRAS,Yes,Never,Moderate,22.3,Low,Urban,Statutory Health Insurance,2.0,No,No,None,2.0
PT09963,Poland,Lesser Poland,,Female,Pancreatic,I,2016-05-20,2016-06-06,2016-12-07,Chemotherapy,Research Institute,Alive,35.0,EGFR,No,Never,None,23.2,,,Statutory Health Insurance,18.0,,No,None,6.0
,Ireland,Munster,83.0,Male,Colorectal,II,2020-06-26,2020-07-20,2020-12-31,Surgery,,Deceased,115.0,KRAS,No,Never,None,36.6,Low,Urban,Statutory Health Insurance,1.0,No,No,Obesity,10.0
PT09965,Spain,Catalonia,61.0,Female,Prostate,III,2011-07-11,2011-11-16,2012-06-17,Surgery,Public,,80.0,KRAS,Yes,Never,None,24.8,Low,Urban,Private Insurance,3.0,Yes,,Cardiovascular Disease,10.0
PT09966,Sweden,Skåne,62.0,Female,Lung,II,2013-01-27,2013-04-28,,Surgery,Private,Alive,59.0,None,No,Never,,36.4,Low,Urban,NHS,16.0,No,No,Diabetes,6.0
PT09967,Poland,Silesian,28.0,Female,Colorectal,II,2015-10-17,2016-02-06,2016-08-20,Radiation,Public,Alive,25.0,KRAS,No,Current,Heavy,34.7,High,Rural,Statutory Health Insurance,10.0,No,No,Obesity,6.0
PT09968,Austria,Vienna,33.0,Female,Lung,II,2015-10-27,2016-01-17,,Targeted Therapy,Public,Alive,7.0,KRAS,Yes,Former,None,25.0,Medium,Urban,Statutory Health Insurance,19.0,No,Yes,Obesity,5.0
PT09969,Italy,Lombardy,23.0,Male,Lung,III,2018-10-23,2019-01-17,2019-11-19,Targeted Therapy,Public,Alive,103.0,None,No,Never,,33.2,Medium,Urban,Private Insurance,8.0,No,No,None,1.0
PT09970,Portugal,Porto,21.0,Male,Ovarian,IV,,2010-03-22,,Chemotherapy,Private,Alive,22.0,KRAS,Yes,Former,Moderate,18.2,Low,Rural,,16.0,Yes,No,Hypertension,6.0
PT09971,Spain,Catalonia,20.0,Female,Ovarian,I,2011-05-29,2011-06-26,,Targeted Therapy,Research Institute,Alive,20.0,None,No,Never,Moderate,30.6,Medium,Rural,NHS,13.0,No,,Diabetes,3.0
PT09972,Spain,Catalonia,84.0,Female,Breast,II,2023-12-08,2024-03-23,2024-10-17,Targeted Therapy,Private,Alive,70.0,BRCA1,No,Current,None,36.2,Medium,Urban,Private Insurance,2.0,No,No,Diabetes,4.0
PT09973,Finland,Southwest Finland,65.0,Male,Pancreatic,II,,2023-09-19,2024-02-04,Surgery,Public,Deceased,116.0,KRAS,No,Never,None,36.6,Low,,Statutory Health Insurance,5.0,No,No,Obesity,6.0
PT09974,Belgium,Brussels,78.0,Female,Prostate,I,2021-07-31,2021-11-29,2022-04-24,Chemotherapy,Private,Alive,74.0,BRCA1,No,Former,None,31.6,Medium,Urban,NHS,7.0,No,,Diabetes,3.0
PT09975,,Wallonia,26.0,Male,Breast,IV,2018-06-18,2018-11-12,2019-09-10,Targeted Therapy,Public,Lost to Follow-up,,BRCA1,No,Never,Moderate,25.8,Medium,Urban,Statutory Health Insurance,18.0,No,,None,10.0
,Finland,Uusimaa,85.0,Female,Leukemia,I,2017-07-02,2017-07-10,2017-11-22,Targeted Therapy,Research Institute,Deceased,103.0,KRAS,,Never,Moderate,39.4,Low,Rural,Statutory Health Insurance,2.0,No,Yes,Obesity,4.0
PT09977,Germany,North Rhine-Westphalia,34.0,Female,Ovarian,I,2017-11-16,2017-12-04,2018-10-13,Targeted Therapy,Public,Alive,74.0,KRAS,No,Current,None,39.8,Medium,Urban,Statutory Health Insurance,3.0,No,No,Hypertension,10.0
PT09978,Ireland,Dublin,66.0,Male,Pancreatic,III,2015-07-25,2015-08-31,2016-05-17,,Public,Alive,109.0,KRAS,No,Former,None,18.5,Medium,Rural,NHS,6.0,Yes,Yes,Diabetes,9.0
PT09979,Poland,Silesian,59.0,Female,Breast,I,2018-09-27,2019-03-19,2019-09-11,Surgery,Private,Alive,114.0,EGFR,No,Former,None,21.5,Medium,Rural,NHS,19.0,,No,Cardiovascular Disease,6.0
PT09980,Sweden,Västra Götaland,61.0,Female,Colorectal,III,2019-04-30,2019-06-07,2020-05-13,Radiation,Public,Alive,77.0,EGFR,Yes,Never,,39.5,Medium,Rural,NHS,11.0,No,Yes,Diabetes,9.0
PT09981,Finland,Uusimaa,70.0,Male,Colorectal,III,2020-12-04,2020-12-06,2021-01-25,Chemotherapy,Public,Alive,73.0,None,No,Former,None,39.9,Medium,Urban,Private Insurance,3.0,No,Yes,Diabetes,1.0
PT09982,Spain,Madrid,54.0,Male,Colorectal,I,2011-06-15,2011-11-05,2012-09-05,Radiation,Public,Alive,48.0,BRCA1,No,Never,Moderate,38.8,Medium,Urban,Statutory Health Insurance,17.0,No,No,Diabetes,3.0
,France,Île-de-France,,Male,Leukemia,I,2021-05-28,2021-07-26,2022-02-12,Surgery,Private,Alive,17.0,KRAS,Yes,Never,Moderate,19.7,Medium,Urban,Private Insurance,10.0,Yes,No,Diabetes,2.0
PT09984,Italy,Veneto,76.0,Female,Lung,I,,2011-05-24,2011-07-23,Radiation,Private,Alive,105.0,BRCA1,No,Former,None,32.4,Medium,Rural,Private Insurance,6.0,Yes,No,None,2.0
PT09985,Finland,Southwest Finland,57.0,Male,Ovarian,I,2014-06-18,2014-10-29,2014-12-06,Targeted Therapy,Private,Deceased,113.0,KRAS,,Never,None,19.4,Low,Urban,Statutory Health Insurance,5.0,Yes,No,None,10.0
PT09986,Portugal,Algarve,27.0,Male,Colorectal,I,2020-03-22,2020-07-06,2021-06-06,Chemotherapy,Public,Alive,99.0,KRAS,Yes,,Heavy,28.4,Medium,Urban,Private Insurance,12.0,No,No,Obesity,6.0
PT09987,Belgium,Brussels,82.0,Male,Pancreatic,IV,2020-02-25,2020-07-22,2020-09-21,Targeted Therapy,Private,Deceased,88.0,None,No,Former,None,39.5,Low,Rural,NHS,2.0,,Yes,None,9.0
PT09988,Norway,Vestland,23.0,Female,Pancreatic,III,2019-01-07,2019-03-30,2019-11-16,Chemotherapy,Public,Alive,27.0,KRAS,No,Never,Moderate,37.1,Low,Rural,Statutory Health Insurance,15.0,No,No,None,2.0
PT09989,Ireland,,,Female,Ovarian,I,2010-03-08,,2011-02-20,Radiation,Public,Deceased,97.0,BRCA1,No,Never,None,20.8,Medium,Urban,Statutory Health Insurance,7.0,No,No,Hypertension,1.0
PT09990,Portugal,Lisbon,71.0,Female,Breast,IV,2017-10-25,2018-02-15,2018-09-29,Targeted Therapy,Public,Alive,99.0,EGFR,No,Former,None,29.9,Medium,Urban,Statutory Health Insurance,18.0,No,No,None,8.0
PT09991,Ireland,Munster,57.0,Male,Lung,I,2016-03-28,2016-06-17,2017-02-06,Surgery,Research Institute,Deceased,,BRCA1,Yes,Former,None,21.1,Medium,Urban,Private Insurance,17.0,Yes,Yes,,7.0
PT09992,,Oslo,24.0,Female,Breast,III,2011-10-30,,,Targeted Therapy,Public,Alive,110.0,BRCA1,Yes,Never,None,21.3,,Rural,Private Insurance,16.0,No,No,Cardiovascular Disease,7.0
PT09993,Norway,Trøndelag,89.0,Female,Breast,I,2020-11-12,2020-12-01,2021-01-01,Immunotherapy,Private,,25.0,EGFR,Yes,Never,None,20.8,Low,Rural,NHS,16.0,Yes,No,None,1.0
PT09994,Denmark,Zealand,43.0,Male,Colorectal,I,2010-05-30,2010-08-25,2011-06-07,Surgery,Research Institute,Alive,119.0,None,No,Former,Moderate,20.1,High,Rural,NHS,12.0,No,No,Obesity,1.0
PT09995,Belgium,Wallonia,36.0,Male,Breast,III,2013-02-06,2013-03-05,2013-12-23,Chemotherapy,Public,Alive,20.0,KRAS,Yes,Current,Moderate,22.5,Medium,Urban,Private Insurance,10.0,No,No,Hypertension,1.0
PT09996,Austria,Styria,45.0,,Ovarian,II,2023-06-16,2023-10-10,2024-01-16,Immunotherapy,Private,Alive,13.0,BRCA1,Yes,Former,Moderate,38.2,Medium,Urban,NHS,11.0,No,No,None,3.0
PT09997,Netherlands,North Holland,22.0,,Leukemia,II,2022-11-24,2023-05-13,2023-12-22,Targeted Therapy,Public,Alive,42.0,None,No,Current,None,25.9,High,Rural,NHS,,No,No,Cardiovascular Disease,3.0
PT09998,Norway,Oslo,21.0,,Pancreatic,II,2011-06-24,2011-10-18,2012-07-19,Targeted Therapy,Public,Deceased,33.0,KRAS,No,Never,Moderate,36.8,High,Urban,NHS,17.0,Yes,Yes,Diabetes,10.0
PT09999,Ireland,Dublin,21.0,Male,Pancreatic,I,2014-12-27,2015-02-10,2016-01-09,Targeted Therapy,Private,Alive,16.0,KRAS,No,Never,Moderate,18.8,Low,Rural,Private Insurance,3.0,Yes,No,Obesity,7.0
PT10000,Netherlands,Utrecht,41.0,Female,Pancreatic,,2011-04-20,2011-07-07,2011-11-29,Targeted Therapy,Private,Alive,75.0,None,No,Never,None,30.9,Medium,Rural,Private Insurance,,Yes,Yes,,9.0
